data_2ipa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ipa _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 tpp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.25 171.33 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.31 1.444 . . . . 0.0 107.401 167.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.04 96.7 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.94 165.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -126.21 144.03 50.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.51 175.1 6.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.731 1.212 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -158.52 -169.09 2.62 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.696 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -43.81 -36.1 2.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.739 2.816 . . . . 0.0 115.533 -163.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.25 -25.01 2.51 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.551 1.141 . . . . 0.0 111.5 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 m -64.95 -17.57 64.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.528 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -49.46 -58.02 5.94 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.1 0.864 . . . . 0.0 109.27 166.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -43.21 99.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.782 0.833 . . . . 0.0 110.621 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -23.04 62.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -99.44 -17.01 18.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.228 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -110.29 -12.43 14.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.182 1.355 . . . . 0.0 113.621 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m -63.9 -11.17 25.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -139.91 156.59 46.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.063 1.301 . . . . 0.0 109.055 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.57 53.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.37 133.2 68.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.1 t -143.93 135.31 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -161.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.6 tp -111.31 99.5 8.29 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.37 138.07 33.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.58 153.56 50.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 109.218 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -133.89 120.08 19.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.543 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -143.16 154.31 43.76 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.231 1.412 . . . . 0.0 108.501 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.8 165.16 8.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.799 0.84 . . . . 0.0 109.025 170.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.37 -19.09 6.21 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.72 2.947 . . . . 0.0 116.483 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -55.09 -25.73 33.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.194 1.398 . . . . 0.0 114.493 -173.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -138.63 159.37 42.27 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.481 1.037 . . . . 0.0 111.441 -166.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.82 -48.87 31.88 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.554 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -47.92 -29.33 11.57 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.005 3.136 . . . . 0.0 115.352 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 m -53.41 -26.93 21.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.58 1.082 . . . . 0.0 113.26 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -108.46 10.89 27.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.827 1.251 . . . . 0.0 111.322 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -118.73 -42.55 2.73 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.481 1.113 . . . . 0.0 109.438 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.82 -34.73 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.854 -0.529 . . . . 0.0 109.584 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.42 -57.98 22.93 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.617 -1.182 . . . . 0.0 112.68 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.55 -33.97 54.33 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.604 1.609 . . . . 0.0 111.5 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.04 -40.03 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.525 1.057 . . . . 0.0 110.965 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 mt -70.82 -37.59 73.23 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.254 0.934 . . . . 0.0 110.725 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.16 -36.36 81.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.117 0.871 . . . . 0.0 110.475 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.62 -25.28 64.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.454 1.102 . . . . 0.0 111.059 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.31 -46.42 23.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.136 0.975 . . . . 0.0 109.862 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.61 -43.19 99.31 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 122.796 0.438 . . . . 0.0 111.444 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.13 -9.32 58.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -97.33 -48.81 5.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.274 0.943 . . . . 0.0 110.875 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.6 ptm -137.7 13.89 2.94 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -15.04 33.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.019 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.03 -25.45 58.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.758 1.279 . . . . 0.0 112.508 168.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 -10.47 10.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.653 0.781 . . . . 0.0 112.432 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -132.19 135.66 46.5 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.223 0.92 . . . . 0.0 109.612 -162.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -95.68 144.54 26.01 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 164.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.95 142.49 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.58 147.36 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 40.5 mtpt -127.18 148.24 50.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.514 0.597 . . . . 0.0 110.742 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 121.2 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 167.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.56 110.94 9.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 164.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.283 27.6 m -87.34 48.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 122.263 1.03 . . . . 0.0 112.357 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -141.06 -40.67 0.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.454 1.102 . . . . 0.0 109.228 154.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -76.06 -40.61 52.84 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.913 0.885 . . . . 0.0 111.461 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.94 24.59 4.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.807 1.243 . . . . 0.0 110.621 -167.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.4 -5.15 6.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.45 -44.33 84.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.262 0.937 . . . . 0.0 110.796 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -60.61 -41.04 94.01 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.698 0.681 . . . . 0.0 110.488 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -53.66 42.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.181 0.592 . . . . 0.0 109.493 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.69 95.33 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.19 -47.97 83.34 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.155 0.982 . . . . 0.0 110.893 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.93 -22.48 60.72 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.192 0.451 . . . . 0.0 111.424 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.4 19.09 31.1 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.221 0.915 . . . . 0.0 112.025 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -76.02 142.14 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 163.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.9 ptm -151.47 22.17 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.886 0.474 . . . . 0.0 111.914 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.69 156.18 40.8 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.445 -0.784 . . . . 0.0 110.893 -153.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.1 mm -130.41 138.74 33.72 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.377 -168.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.8 162.58 83.93 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 N-CA-C 108.299 -1.462 . . . . 0.0 108.299 -22.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.6 m -132.94 150.12 52.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 169.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.2 mt -143.16 127.75 18.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -170.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -124.1 115.29 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.62 126.2 45.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -123.81 155.11 38.58 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.595 0.758 . . . . 0.0 109.553 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -144.29 144.49 31.51 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 161.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.5 t70 43.81 35.9 1.19 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.833 1.653 . . . . 0.0 113.687 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.56 15.61 59.8 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.938 -1.479 . . . . 0.0 115.776 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.68 149.77 45.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.49 2.145 . . . . 0.0 110.784 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.81 143.25 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 m -132.31 -18.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.485 1.114 . . . . 0.0 112.162 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.02 156.79 43.31 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.78 32.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -173.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.3 m -150.31 139.84 21.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.71 45.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.68 156.04 23.23 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.665 1.126 . . . . 0.0 110.374 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.09 147.79 46.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.303 1.441 . . . . 0.0 111.378 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.3 141.88 33.23 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.612 1.565 . . . . 0.0 107.683 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.21 167.06 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.501 2.134 . . . . 0.0 110.63 167.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -50.34 -51.33 46.54 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.915 1.286 . . . . 0.0 112.726 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.12 -39.83 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 110.368 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.91 -38.29 76.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.789 -0.569 . . . . 0.0 110.856 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.78 -39.8 80.01 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.462 0.574 . . . . 0.0 110.77 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.15 -39.86 94.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.44 0.563 . . . . 0.0 109.686 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.72 -44.62 96.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.972 0.509 . . . . 0.0 110.626 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.24 -43.47 70.9 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.217 1.007 . . . . 0.0 111.383 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.4 p -84.04 -35.24 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.975 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -58.11 -27.58 63.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.416 1.007 . . . . 0.0 112.632 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -54.72 -27.54 41.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.166 0.986 . . . . 0.0 113.568 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -128.79 -21.28 3.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.341 0.973 . . . . 0.0 112.581 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.424 1.49 . . . . 0.0 109.771 167.426 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -73.42 92.56 1.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 m120 113.14 127.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 130.916 3.686 . . . . 0.0 107.575 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -143.47 111.84 6.32 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.97 133.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 146.97 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.863 1.665 . . . . 0.0 107.287 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -127.54 143.53 51.17 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.905 0.882 . . . . 0.0 110.137 -165.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -106.33 140.89 38.54 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.2 114.38 15.0 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.37 140.23 15.1 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.475 0.484 . . . . 0.0 111.389 -166.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -50.6 121.97 6.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.997 1.319 . . . . 0.0 110.628 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.13 -14.94 1.47 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.598 1.571 . . . . 0.0 114.601 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 45.18 24.31 0.13 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.505 1.922 . . . . 0.0 113.117 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -73.98 -34.74 64.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.413 -0.805 . . . . 0.0 110.877 -166.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.53 -69.71 0.47 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -161.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 mtm105 -58.67 -44.97 90.36 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.683 -171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.32 -37.91 84.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.064 0.847 . . . . 0.0 110.516 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -61.41 -43.37 98.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.135 0.574 . . . . 0.0 109.812 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.16 -48.16 79.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.957 1.303 . . . . 0.0 109.732 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.54 77.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.389 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.2 -28.29 64.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.806 1.184 . . . . 0.0 110.911 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.39 -50.04 57.79 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -59.77 -43.45 94.33 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.373 0.587 . . . . 0.0 111.649 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.6 -55.65 29.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 109.419 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -69.62 -10.97 60.36 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -80.1 -9.26 59.69 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.575 1.534 . . . . 0.0 112.897 171.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -129.97 -24.62 2.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.531 1.132 . . . . 0.0 112.794 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.3 mt -105.81 94.27 5.09 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.64 -165.04 5.59 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.814 0.721 . . . . 0.0 112.425 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.84 -17.36 15.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.306 1.442 . . . . 0.0 113.37 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.489 1.515 . . . . 0.0 112.363 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -127.28 161.25 29.04 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.086 1.754 . . . . 0.0 109.617 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -134.08 133.63 41.35 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.0 t -129.86 126.57 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -164.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.84 162.51 33.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.815 1.246 . . . . 0.0 109.065 -173.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 7.1 m -150.91 135.83 17.42 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.76 177.65 10.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.94 0.791 . . . . 0.0 112.134 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.26 176.51 46.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.892 1.234 . . . . 0.0 111.216 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 tt -36.77 -55.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.896 2.078 . . . . 0.0 114.876 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -134.29 31.38 3.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.153 1.381 . . . . 0.0 108.671 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.52 145.35 44.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.999 1.32 . . . . 0.0 112.604 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t60 148.33 84.66 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 130.534 3.533 . . . . 0.0 105.544 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.85 157.61 16.73 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.403 1.001 . . . . 0.0 111.197 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -139.65 93.7 2.69 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -66.31 127.58 93.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.55 -20.88 59.48 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.363 2.042 . . . . 0.0 113.015 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.71 80.32 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.455 1.025 . . . . 0.0 111.689 174.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.68 66.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.58 0.627 . . . . 0.0 109.875 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.2 -51.99 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.11 -45.6 79.43 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.809 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.32 75.76 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.696 0.68 . . . . 0.0 111.513 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.2 mmm -76.42 -32.64 58.6 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.4 -0.812 . . . . 0.0 111.709 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -62.92 -28.22 69.91 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.084 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.19 -25.07 58.4 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.77 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.4 m -121.83 16.32 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.846 1.259 . . . . 0.0 111.186 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.23 34.9 81.73 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.312 -0.716 . . . . 0.0 113.147 171.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -117.1 135.97 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -98.69 135.13 40.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 pt -134.44 10.56 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.581 0.752 . . . . 0.0 111.77 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.7 m -60.01 -23.7 63.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.306 1.042 . . . . 0.0 112.695 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -77.36 -18.01 57.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.013 1.325 . . . . 0.0 113.339 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.54 166.72 14.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.198 0.999 . . . . 0.0 112.8 -167.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.6 p -139.43 -177.68 5.04 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.003 2.121 . . . . 0.0 108.22 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.6 p -159.42 171.06 20.44 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -149.77 164.82 34.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 pt -61.95 164.04 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.189 0.518 . . . . 0.0 110.4 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.9 pt -48.63 128.96 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 109.306 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -137.71 98.55 3.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.798 1.285 . . . . 0.0 109.98 -172.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.71 -28.8 36.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.216 2.606 . . . . 0.0 112.638 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.58 -24.26 67.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.948 0.795 . . . . 0.0 111.628 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.62 -40.85 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.962 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.8 tt -62.45 -48.46 79.54 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.266 1.394 . . . . 0.0 110.536 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -18.65 65.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.467 1.03 . . . . 0.0 111.874 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.62 -13.29 52.05 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.211 1.004 . . . . 0.0 112.032 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 166.08 15.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.034 0.833 . . . . 0.0 110.773 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.72 -27.62 16.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 111.155 168.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.59 128.13 15.07 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.826 1.25 . . . . 0.0 107.776 -161.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.03 118.26 56.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -83.86 110.71 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 165.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -67.94 123.98 22.11 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 156.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.1 tp -118.57 31.43 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.521 0.728 . . . . 0.0 109.974 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.534 0.329 0 C-N-CA 125.072 1.349 . . . . 0.0 108.162 172.749 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 119.465 -0.303 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.48 19.58 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.679 1.592 . . . . 0.0 114.833 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm 67.83 25.42 7.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.198 1.399 . . . . 0.0 112.459 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 30.4 m 36.85 53.59 2.65 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 0.0 114.497 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.71 150.27 54.32 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.439 2.093 . . . . 0.0 112.123 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.63 3.09 15.5 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -170.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p 40.81 89.55 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.435 2.294 . . . . 0.0 114.123 166.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.69 151.98 59.52 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.62 1.01 4.72 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.064 3.176 . . . . 0.0 114.242 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 42.8 m170 -61.69 -16.25 47.31 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.6 143.64 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.179 0.992 . . . . 0.0 109.362 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -79.25 151.99 30.84 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -136.32 147.23 47.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -152.07 158.9 43.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 161.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -97.5 131.17 44.37 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -123.1 -29.36 3.9 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.553 1.141 . . . . 0.0 110.175 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -79.57 161.45 46.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 168.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.54 -4.47 0.33 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.709 0.803 . . . . 0.0 112.305 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -158.1 170.89 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.698 1.999 . . . . 0.0 107.259 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -136.17 113.64 10.54 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 123.833 0.853 . . . . 0.0 110.992 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.47 -19.85 54.69 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.166 2.577 . . . . 0.0 112.893 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.95 -7.92 32.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.157 0.89 . . . . 0.0 112.092 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -115.51 19.33 15.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.202 1.401 . . . . 0.0 110.604 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.76 155.24 2.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.858 0.863 . . . . 0.0 111.043 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -57.66 -29.37 64.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.116 0.966 . . . . 0.0 112.42 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.46 -8.66 30.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.661 -1.077 . . . . 0.0 113.89 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 76.6 p -67.43 156.64 36.08 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.169 1.484 . . . . 0.0 107.825 166.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.64 -39.38 84.17 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.705 -0.622 . . . . 0.0 110.145 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.2 -44.56 68.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.326 0.65 . . . . 0.0 111.203 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -70.56 -35.7 73.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.383 0.992 . . . . 0.0 110.043 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -56.86 -58.34 8.54 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.137 0.881 . . . . 0.0 109.641 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -60.27 -42.02 94.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.992 0.814 . . . . 0.0 110.342 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.44 92.15 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.495 1.043 . . . . 0.0 111.885 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -62.97 -46.96 85.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.117 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -58.08 -50.75 72.37 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -64.48 -43.27 94.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.821 1.248 . . . . 0.0 111.312 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -63.91 -47.95 78.53 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.595 0.634 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.65 -35.97 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -62.21 -45.44 93.37 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.665 1.186 . . . . 0.0 110.45 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.1 -42.43 96.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.046 0.384 . . . . 0.0 110.683 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.58 -54.35 37.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.063 0.545 . . . . 0.0 110.304 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.56 -43.55 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.401 1.081 . . . . 0.0 109.322 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.38 75.51 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 118.652 0.66 . . . . 0.0 111.794 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -59.77 -44.03 94.07 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.098 0.449 . . . . 0.0 110.906 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -63.26 -45.69 90.34 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.769 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.32 -36.41 81.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.504 1.047 . . . . 0.0 110.461 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -61.33 -45.76 93.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.316 0.507 . . . . 0.0 110.028 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.08 -44.21 94.93 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.535 0.607 . . . . 0.0 110.586 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.22 -38.51 80.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.882 0.765 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.16 72.22 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.734 0.697 . . . . 0.0 112.163 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.49 -41.92 23.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.31 0.644 . . . . 0.0 110.529 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 76.6 p -85.19 -34.53 22.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.478 0.581 . . . . 0.0 111.578 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.7 64.15 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 118.365 -1.241 . . . . 0.0 112.701 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.172 2.189 . . . . 0.0 111.591 -163.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.03 157.03 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.78 2.432 . . . . 0.0 112.756 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.61 112.94 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.82 168.66 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.86 1.664 . . . . 0.0 108.274 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -124.31 117.67 25.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.665 1.586 . . . . 0.0 108.477 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.9 171.41 12.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.6 1.16 . . . . 0.0 110.595 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -155.85 -178.19 7.11 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.085 1.754 . . . . 0.0 107.313 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -37.0 -33.94 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 130.932 3.693 . . . . 0.0 117.004 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.06 -31.76 0.9 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.822 1.249 . . . . 0.0 110.926 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -60.76 -19.23 58.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.692 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -47.19 -50.02 21.61 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 120.028 1.286 . . . . 0.0 109.874 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -66.09 -43.83 86.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.078 0.399 . . . . 0.0 110.211 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.96 85.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.545 0.212 . . . . 0.0 110.56 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -74.12 -13.76 60.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.745 1.218 . . . . 0.0 112.593 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -121.76 0.58 9.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.785 1.175 . . . . 0.0 113.134 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.9 m -74.87 -2.85 28.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.541 0.737 . . . . 0.0 112.949 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.66 156.47 45.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.128 0.971 . . . . 0.0 110.485 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.19 -161.56 37.5 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.377 1.465 . . . . 0.0 112.063 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.23 129.62 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.66 155.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.629 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 tp -128.83 91.5 3.23 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.767 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.5 148.58 33.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -141.65 148.43 39.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.819 1.248 . . . . 0.0 109.238 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -130.15 109.62 10.96 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.675 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.7 p-90 -130.93 149.88 52.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.834 1.653 . . . . 0.0 108.155 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -172.98 164.05 3.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 109.42 169.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.53 -16.02 9.93 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.82 3.014 . . . . 0.0 116.691 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -50.46 -28.78 8.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.735 1.614 . . . . 0.0 113.74 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.88 146.36 51.6 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 119.14 0.882 . . . . 0.0 111.811 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.14 -50.26 61.42 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.596 -1.113 . . . . 0.0 110.706 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -46.58 -26.65 4.49 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.222 3.281 . . . . 0.0 116.867 170.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 m -57.77 -29.58 64.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 121.4 1.909 . . . . 0.0 112.286 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -97.65 9.35 42.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.283 1.033 . . . . 0.0 111.813 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -119.61 -43.1 2.6 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.062 0.945 . . . . 0.0 109.602 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.15 -34.76 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.607 0.763 . . . . 0.0 109.066 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.18 -61.25 6.26 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.9 -41.19 64.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.958 1.772 . . . . 0.0 111.659 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.24 -40.57 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.06 0.544 . . . . 0.0 110.819 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 mt -73.08 -38.49 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.4 0.546 . . . . 0.0 110.292 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.92 -34.14 77.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.284 0.947 . . . . 0.0 109.833 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.91 -27.47 64.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.96 1.304 . . . . 0.0 111.603 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.81 -43.59 45.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.48 1.112 . . . . 0.0 110.195 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.61 -35.98 62.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.22 -13.21 62.07 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.378 -0.826 . . . . 0.0 112.019 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -49.7 5.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.743 1.617 . . . . 0.0 110.504 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.5 16.68 2.74 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.805 0.842 . . . . 0.0 111.741 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.06 -3.22 22.19 Favored Glycine 0 CA--C 1.521 0.446 0 O-C-N 121.23 -0.919 . . . . 0.0 113.974 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.34 -24.15 65.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.333 1.053 . . . . 0.0 111.104 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.44 -20.95 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.523 1.129 . . . . 0.0 112.226 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.64 149.66 46.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 110.874 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.36 150.48 40.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.529 1.532 . . . . 0.0 108.335 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mt -130.39 140.89 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 t -136.78 108.92 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.675 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 21.6 mtpp -84.68 151.14 24.65 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.367 -0.833 . . . . 0.0 109.757 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -113.59 128.03 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.26 103.78 11.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.88 48.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.075 1.35 . . . . 0.0 112.092 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -156.11 -43.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.833 1.253 . . . . 0.0 109.578 168.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.27 -36.5 29.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 109.868 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -133.24 27.11 4.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 111.925 -168.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -69.76 -5.31 24.43 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -50.0 -49.69 49.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.582 1.953 . . . . 0.0 110.647 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.6 m -58.26 -35.95 72.53 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 123.122 0.569 . . . . 0.0 111.466 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.54 0.84 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.15 -45.31 15.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.204 0.907 . . . . 0.0 113.625 170.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.097 0.948 . . . . 0.0 111.033 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.99 -30.48 67.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.177 0.444 . . . . 0.0 110.36 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.27 67.65 0.81 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.6 t -139.17 127.67 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.315 0.1 OUTLIER -137.3 17.11 2.96 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.883 0.311 . . . . 0.0 111.22 174.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 p -137.48 159.89 40.67 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.884 2.474 . . . . 0.0 110.722 -170.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.14 149.02 56.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.03 148.09 87.43 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 109.701 -0.923 . . . . 0.0 109.701 -10.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -122.76 145.16 48.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.21 136.55 54.78 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.976 1.71 . . . . 0.0 106.518 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.4 mt -121.44 102.7 8.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.69 122.53 38.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.88 153.19 44.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.521 1.128 . . . . 0.0 108.12 -171.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -140.23 138.65 35.23 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.88 27.29 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.541 1.937 . . . . 0.0 114.412 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 15.97 43.1 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.083 1.325 . . . . 0.0 115.945 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -130.85 142.8 50.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.038 1.419 . . . . 0.0 110.524 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.28 140.71 19.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.35 -21.59 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.185 0.994 . . . . 0.0 109.985 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.64 161.6 41.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.174 1.389 . . . . 0.0 109.087 169.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.23 148.3 31.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -149.99 145.99 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.82 67.74 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.41 157.86 10.18 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.16 1.838 . . . . 0.0 109.02 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -74.33 157.8 35.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.933 0.493 . . . . 0.0 111.107 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.43 145.33 25.83 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.64 165.88 30.54 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.528 2.152 . . . . 0.0 110.704 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -45.95 -47.88 16.45 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.373 1.869 . . . . 0.0 112.416 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.17 -43.34 74.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.477 0.581 . . . . 0.0 111.23 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.3 -32.79 74.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.745 -0.597 . . . . 0.0 110.72 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -52.18 64.35 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.937 0.895 . . . . 0.0 109.903 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.96 -38.84 92.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.1 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.69 -46.29 90.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.704 0.684 . . . . 0.0 111.437 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.52 -40.78 79.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.755 1.222 . . . . 0.0 111.198 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -88.05 -39.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.885 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -56.37 -34.88 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.517 1.053 . . . . 0.0 111.801 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.08 -6.96 25.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.56 -27.11 3.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.668 1.187 . . . . 0.0 112.666 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 tp . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.988 2.115 . . . . 0.0 109.388 171.633 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.78 143.38 44.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.1 m120 63.77 119.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.184 0 C-N-CA 128.71 2.804 . . . . 0.0 110.639 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -164.26 134.3 4.05 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mt -106.65 143.25 17.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.41 143.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.45 144.39 51.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.489 0.715 . . . . 0.0 111.553 -168.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -103.58 144.04 31.96 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.8 tp -128.97 114.47 16.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 75.4 m -142.77 135.41 27.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.871 0.868 . . . . 0.0 111.139 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -48.75 113.7 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.737 1.215 . . . . 0.0 110.976 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.53 8.41 51.52 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.941 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 7.02 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 130.738 3.615 . . . . 0.0 115.536 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -142.28 5.96 1.69 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.01 -70.24 0.26 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.794 1.179 . . . . 0.0 112.385 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -47.2 -52.98 14.31 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.09 0.859 . . . . 0.0 110.495 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -55.63 -52.44 63.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.067 1.747 . . . . 0.0 111.801 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -53.85 -50.07 67.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.094 0.958 . . . . 0.0 110.606 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.0 ttm -62.59 -42.24 99.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.269 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.86 82.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.619 -1.181 . . . . 0.0 112.019 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.59 -45.65 89.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.732 1.605 . . . . 0.0 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.89 -43.63 57.85 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -58.07 -39.45 78.52 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.993 0.896 . . . . 0.0 111.495 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.23 62.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -65.26 -24.22 67.26 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.779 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.19 -14.98 63.28 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -126.46 -12.01 6.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.934 1.293 . . . . 0.0 113.131 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.11 85.6 2.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.89 -165.92 0.89 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.073 1.321 . . . . 0.0 113.173 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.79 -17.82 18.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.653 1.181 . . . . 0.0 113.214 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.57 -21.31 25.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.884 1.673 . . . . 0.0 112.411 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -127.83 161.62 28.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.391 1.476 . . . . 0.0 109.158 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -132.79 135.53 45.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -125.34 132.17 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -169.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -143.08 171.23 14.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.773 1.629 . . . . 0.0 108.035 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 81.7 p -158.92 154.07 25.34 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.519 -0.738 . . . . 0.0 110.788 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.06 169.97 23.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.904 0.881 . . . . 0.0 111.807 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.43 -176.22 39.18 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.592 0.615 . . . . 0.0 112.578 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 tt -50.73 -57.44 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.007 1.723 . . . . 0.0 114.043 -172.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -133.1 29.68 4.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.75 1.62 . . . . 0.0 108.816 -169.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 159.19 34.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.956 2.102 . . . . 0.0 113.06 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 136.24 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 130.723 3.609 . . . . 0.0 104.782 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.93 29.55 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -172.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.56 82.62 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -62.76 128.88 92.49 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -58.6 -23.34 64.77 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.093 1.862 . . . . 0.0 112.953 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.413 HD22 ' HG2' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -62.8 -36.06 81.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.821 1.191 . . . . 0.0 111.305 172.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.43 64.9 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.749 0.704 . . . . 0.0 110.073 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.56 -51.26 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -59.56 -43.95 93.42 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 123.2 0.6 . . . . 0.0 110.593 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.28 -31.38 63.57 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 112.523 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -37.05 24.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.254 -0.904 . . . . 0.0 110.493 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.44 -24.67 67.93 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.288 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.79 -32.84 60.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.948 1.249 . . . . 0.0 111.633 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 m -114.56 15.89 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.285 1.434 . . . . 0.0 110.997 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.17 34.98 91.37 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.283 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -106.01 132.65 52.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.64 135.89 33.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.548 ' C ' ' H ' ' B' ' 61' ' ' ASN . 13.6 pt -132.31 20.9 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.482 0.713 . . . . 0.0 110.829 169.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -70.96 24.42 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.793 0.837 . . . . 0.0 112.067 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.548 ' H ' ' C ' ' B' ' 59' ' ' ILE . 12.1 p30 -143.86 -4.47 0.84 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.841 3.657 . . . . 0.0 110.755 -169.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.33 153.55 20.36 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.307 0.958 . . . . 0.0 110.341 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 55.1 p -134.28 -175.71 3.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.549 1.94 . . . . 0.0 108.863 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 23.5 p -155.87 -177.18 6.38 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -163.56 165.22 23.78 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.232 1.813 . . . . 0.0 107.79 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.84 167.18 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.551 0.741 . . . . 0.0 111.728 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -48.33 131.08 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.225 1.01 . . . . 0.0 108.671 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -146.01 97.12 2.91 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.279 1.037 . . . . 0.0 109.409 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 17.5 m -47.87 -26.62 1.75 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.02 1.728 . . . . 0.0 114.603 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.27 -18.04 60.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.153 1.342 . . . . 0.0 112.647 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.24 -33.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 109.184 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -61.63 -60.14 4.13 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.036 0.834 . . . . 0.0 109.17 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -24.42 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.748 0.704 . . . . 0.0 110.836 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -75.59 -23.37 56.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.777 . . . . 0.0 112.588 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 173.29 1.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.687 1.195 . . . . 0.0 112.155 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.15 -33.91 12.46 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.869 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -139.41 139.35 37.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.331 1.452 . . . . 0.0 109.395 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.8 t -117.01 96.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -80.16 115.11 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 47.9 m -71.75 131.43 43.09 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 tp -135.08 6.09 3.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -167.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-N 120.219 1.372 . . . . 0.0 114.271 -169.324 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.239 0 CA-C-O 119.372 -0.347 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.51 11.99 2.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.56 0.744 . . . . 0.0 112.726 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm 90.17 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.306 2.642 . . . . 0.0 111.127 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m 31.38 54.85 0.85 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 126.987 2.115 . . . . 0.0 113.151 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.46 135.31 47.24 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 CA-C-N 120.602 1.251 . . . . 0.0 112.173 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.59 6.05 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -171.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p 38.36 93.9 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 127.838 2.455 . . . . 0.0 114.379 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -56.15 141.39 87.69 Favored 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 122.485 2.123 . . . . 0.0 108.26 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -61.78 -1.3 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.323 3.349 . . . . 0.0 116.95 -168.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -69.15 -9.38 52.52 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.164 0.893 . . . . 0.0 112.829 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 144.93 36.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.906 1.282 . . . . 0.0 111.192 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -73.84 153.18 40.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -146.83 143.78 28.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.779 0.718 . . . . 0.0 109.498 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -150.15 144.21 25.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.52 127.7 33.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -111.85 -12.31 13.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.185 0.994 . . . . 0.0 110.591 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.58 161.42 31.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -158.24 26.81 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.788 1.235 . . . . 0.0 110.541 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -149.47 161.54 41.91 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.871 2.469 . . . . 0.0 106.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -147.54 139.55 14.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.228 0.922 . . . . 0.0 109.291 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.413 ' HG2' HD22 ' B' ' 47' ' ' ASN . 91.3 Cg_endo -78.0 -19.16 12.51 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.437 2.092 . . . . 0.0 113.336 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.82 -4.06 11.44 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.837 1.199 . . . . 0.0 111.03 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -98.41 6.22 47.44 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.427 1.091 . . . . 0.0 111.05 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.02 153.38 1.38 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.114 0.566 . . . . 0.0 110.065 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -54.42 -43.81 71.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.8 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.34 -19.59 2.64 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.6 p -69.53 165.92 20.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.38 -42.16 99.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.527 0.68 . . . . 0.0 110.289 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.61 -42.82 77.57 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 116.929 -1.51 . . . . 0.0 109.326 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.28 -35.26 61.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 121.184 1.811 . . . . 0.0 109.693 -173.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -55.3 -56.6 18.13 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 118.501 0.591 . . . . 0.0 110.693 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -64.35 -40.45 95.89 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.886 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.77 91.62 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.804 0.842 . . . . 0.0 111.765 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.55 -49.88 69.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.284 2.6 p90 -71.1 -27.06 63.32 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.793 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -64.53 -51.35 63.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.558 1.072 . . . . 0.0 109.668 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -59.83 -51.33 70.19 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.38 -43.76 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.575 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.53 -46.51 80.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.876 1.216 . . . . 0.0 111.533 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.01 -44.47 96.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 123.217 0.323 . . . . 0.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -51.66 59.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.369 0.668 . . . . 0.0 110.467 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.77 -45.49 91.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.536 1.134 . . . . 0.0 110.176 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.38 -44.01 91.41 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -60.26 -49.08 79.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.458 1.129 . . . . 0.0 111.306 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -59.01 -44.03 91.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.837 0.455 . . . . 0.0 110.803 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.72 -36.41 67.78 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.757 0.708 . . . . 0.0 111.696 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -66.95 -49.74 64.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.845 -0.534 . . . . 0.0 110.426 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -61.5 -38.26 86.7 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.742 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -56.15 -38.81 71.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.95 1.25 . . . . 0.0 111.077 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.37 -31.53 71.43 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -87.88 -47.85 8.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.839 1.656 . . . . 0.0 111.629 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.0 p -83.63 -28.18 28.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.672 2.389 . . . . 0.0 110.983 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.25 17.18 55.61 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.613 -1.104 . . . . 0.0 111.473 -168.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.249 1.06 0 C-N-CA 127.93 2.492 . . . . 0.0 112.003 -169.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.59 172.55 18.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.03 1.732 . . . . 0.0 107.067 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.88 96.2 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 102.845 -3.021 . . . . 0.0 102.845 168.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.28 168.69 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.831 1.652 . . . . 0.0 108.115 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.25 111.77 16.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.14 1.376 . . . . 0.0 108.358 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.9 172.8 13.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.574 1.15 . . . . 0.0 110.527 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -155.34 -174.87 5.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.933 2.093 . . . . 0.0 105.898 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -41.19 -36.81 0.8 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.019 2.527 . . . . 0.0 115.572 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -129.85 -30.19 2.05 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.559 1.144 . . . . 0.0 111.522 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 m -61.57 -22.74 65.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.059 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.65 -55.62 18.31 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.384 0.993 . . . . 0.0 108.773 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -62.11 -43.79 98.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.139 -0.35 . . . . 0.0 110.183 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.78 82.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.386 0.136 . . . . 0.0 111.295 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -79.84 -13.79 59.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.412 1.085 . . . . 0.0 113.143 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.5 p -118.33 -3.94 10.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.604 1.093 . . . . 0.0 113.535 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -73.75 -5.02 38.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.24 155.7 45.98 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.461 1.104 . . . . 0.0 109.825 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.64 -163.04 44.12 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.843 1.211 . . . . 0.0 112.163 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.43 132.14 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.37 149.82 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 113.45 -1.705 . . . . 0.0 107.797 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tt -124.98 100.83 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.931 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.17 148.72 26.61 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -142.41 149.7 39.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -130.06 115.54 17.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -169.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.614 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.5 p-90 -137.58 154.35 49.8 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.901 1.68 . . . . 0.0 108.007 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -174.48 162.15 2.69 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.068 0.947 . . . . 0.0 108.95 169.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.97 -19.04 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.635 2.89 . . . . 0.0 116.895 -174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -52.62 -33.88 48.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.837 1.198 . . . . 0.0 114.078 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.15 163.23 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.972 0.805 . . . . 0.0 112.76 -169.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.12 -48.78 57.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.923 -1.487 . . . . 0.0 113.197 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.78 -27.59 20.63 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.571 2.847 . . . . 0.0 115.397 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 m -57.17 -23.77 49.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.695 1.134 . . . . 0.0 113.25 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -108.87 12.71 25.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.111 0.964 . . . . 0.0 111.575 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -122.71 -44.11 2.23 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.292 1.037 . . . . 0.0 109.67 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -64.38 -34.22 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 121.685 -0.634 . . . . 0.0 109.451 169.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.47 11.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.911 -1.042 . . . . 0.0 112.39 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -59.05 -41.03 65.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.967 1.778 . . . . 0.0 111.631 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.46 -40.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.115 0.566 . . . . 0.0 110.877 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.8 mt -73.59 -40.92 63.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.691 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.87 -34.51 78.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.013 0.824 . . . . 0.0 109.737 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -70.35 -21.39 62.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.077 1.351 . . . . 0.0 112.184 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.89 -42.09 18.14 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 119.161 0.892 . . . . 0.0 110.125 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.39 -37.61 85.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.944 -0.472 . . . . 0.0 110.831 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -72.21 -4.86 31.87 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -107.71 -43.17 4.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.674 1.589 . . . . 0.0 111.032 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.63 15.57 2.34 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.363 0.665 . . . . 0.0 112.535 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.79 -2.18 11.24 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.392 -0.817 . . . . 0.0 113.867 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.86 -24.0 65.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.328 1.051 . . . . 0.0 111.147 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -11.7 8.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.74 0.816 . . . . 0.0 112.682 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -139.4 149.54 44.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.32 1.048 . . . . 0.0 111.622 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.99 147.67 38.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.068 1.747 . . . . 0.0 108.327 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mt -119.41 143.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.44 109.32 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.614 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.6 mtpp -84.03 151.78 24.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.341 -0.85 . . . . 0.0 109.3 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mm -118.99 120.86 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 170.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.59 105.94 7.95 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 33.9 m -78.43 49.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -156.01 -41.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.801 1.241 . . . . 0.0 108.977 167.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.73 -33.98 21.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.063 0.945 . . . . 0.0 111.079 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -134.05 27.99 3.84 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.518 1.527 . . . . 0.0 110.796 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -72.09 -5.74 37.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.825 0.85 . . . . 0.0 112.898 -170.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -53.27 -48.17 68.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.3 1.84 . . . . 0.0 110.769 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 m -56.29 -41.57 76.1 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.091 0.556 . . . . 0.0 110.837 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.96 -64.57 0.83 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.67 -43.82 11.74 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.985 0.802 . . . . 0.0 113.454 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.02 -44.63 95.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.24 1.02 . . . . 0.0 111.663 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -73.64 -21.35 60.32 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.477 0.58 . . . . 0.0 111.731 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.03 64.72 0.99 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.05 129.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.5 ptm -150.64 23.11 0.79 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.74 161.44 35.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.101 1.76 . . . . 0.0 112.027 -168.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.1 136.98 29.67 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.53 146.51 47.78 Favored 'Cis proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.067 -1.551 . . . . 0.0 108.067 -10.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -116.58 151.72 35.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 169.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tt -148.82 123.7 9.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -170.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.5 mt -122.24 106.09 10.81 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.54 131.96 33.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.88 158.33 39.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.815 0.846 . . . . 0.0 109.382 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -144.27 139.64 28.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 44.95 28.35 0.36 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.605 1.962 . . . . 0.0 113.761 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.56 10.32 47.67 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 116.103 1.201 . . . . 0.0 116.103 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -133.72 145.17 49.62 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.909 1.354 . . . . 0.0 111.528 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.25 137.37 24.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.96 -19.41 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.51 1.124 . . . . 0.0 111.635 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.8 159.18 43.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.001 0.819 . . . . 0.0 110.185 169.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.62 147.94 28.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -171.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.2 m -152.58 147.55 26.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.8 t -133.63 64.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.56 159.57 10.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.236 1.874 . . . . 0.0 109.535 -169.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.53 167.86 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.578 0.751 . . . . 0.0 112.032 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -150.31 141.58 14.91 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.422 1.489 . . . . 0.0 107.459 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.88 165.95 29.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.118 . . . . 0.0 110.388 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.98 -48.71 21.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.74 1.616 . . . . 0.0 112.39 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.1 -42.79 79.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.161 0.437 . . . . 0.0 110.897 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.39 -29.95 68.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.035 -0.416 . . . . 0.0 111.011 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -52.3 61.09 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.934 0.894 . . . . 0.0 109.207 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -63.6 -36.28 83.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.799 -0.62 . . . . 0.0 109.654 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.15 -46.46 88.87 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.678 0.672 . . . . 0.0 111.224 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.9 tp -54.64 -40.39 68.93 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.073 0.949 . . . . 0.0 110.96 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.27 -41.14 13.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 118.819 -0.61 . . . . 0.0 112.071 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -56.7 -33.55 66.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.581 1.082 . . . . 0.0 111.45 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -70.07 -6.47 34.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -127.66 -21.98 3.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.168 1.387 . . . . 0.0 112.659 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--O 1.249 1.072 0 C-N-CA 127.286 2.234 . . . . 0.0 109.05 171.319 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -139.36 41.45 2.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.314 1.045 . . . . 0.0 109.36 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m120 130.58 132.77 0.0 OUTLIER 'General case' 0 C--N 1.341 0.198 1 C-N-CA 132.385 4.274 . . . . 0.0 107.513 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -157.08 145.85 19.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 130.175 3.39 . . . . 0.0 102.499 168.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.49 139.44 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 118.755 0.707 . . . . 0.0 109.431 -168.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.68 140.0 46.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -132.04 149.01 52.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.4 155.48 31.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.392 0.542 . . . . 0.0 110.11 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -133.2 132.4 41.49 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.028 1.331 . . . . 0.0 107.925 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -162.26 157.24 22.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.3 m -47.8 107.88 0.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.996 1.318 . . . . 0.0 111.435 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.75 59.4 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.685 -1.064 . . . . 0.0 113.443 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.324 0.3 OUTLIER 39.01 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.537 2.735 . . . . 0.0 116.044 -173.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -64.85 169.05 5.51 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.284 1.04 . . . . 0.0 108.543 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 46.37 -94.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.425 2.29 . . . . 0.0 113.717 169.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.67 -50.06 64.0 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.774 1.63 . . . . 0.0 111.219 -169.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.2 m -66.97 -41.7 86.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.237 0.926 . . . . 0.0 112.17 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -59.41 -49.3 78.32 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.402 1.096 . . . . 0.0 109.823 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 18.9 ttm -65.31 -40.57 93.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.429 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.69 -36.86 73.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.068 0.947 . . . . 0.0 110.297 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.94 60.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 109.911 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.7 -46.23 62.26 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -55.37 -44.19 75.82 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.611 0.764 . . . . 0.0 111.483 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.77 61.91 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.121 0.568 . . . . 0.0 110.108 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.426 ' HE3' ' HB ' ' B' ' 34' ' ' VAL . 65.2 mttt -65.64 -20.57 66.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.509 -168.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.87 -14.74 62.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.384 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -40.21 2.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.791 1.178 . . . . 0.0 112.382 174.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.76 75.68 6.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.41 -163.6 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.575 2.036 . . . . 0.0 112.564 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.49 -13.86 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.752 1.221 . . . . 0.0 113.21 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -57.69 -23.79 53.45 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.928 168.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -127.63 171.36 11.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.391 2.276 . . . . 0.0 110.424 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -139.74 129.32 24.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 168.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.426 ' HB ' ' HE3' ' B' ' 25' ' ' LYS . 13.9 t -123.18 129.02 75.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -171.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -143.09 169.33 17.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.396 1.478 . . . . 0.0 108.536 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 74.6 p -154.97 162.83 40.97 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.415 -0.803 . . . . 0.0 110.867 172.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 178.77 9.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.344 1.458 . . . . 0.0 108.859 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.27 -176.62 44.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 tt -48.8 -52.96 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.089 1.756 . . . . 0.0 113.991 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -130.36 26.27 5.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.909 2.084 . . . . 0.0 107.992 -169.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.9 46.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.705 1.602 . . . . 0.0 112.965 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 78.4 t60 133.85 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 131.244 3.817 . . . . 0.0 104.458 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.13 175.5 46.58 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -153.21 102.78 2.65 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 171.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -73.56 126.09 90.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.44 -22.18 70.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.861 1.707 . . . . 0.0 112.514 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -37.5 78.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.252 0.933 . . . . 0.0 110.796 170.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.32 -38.58 65.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.32 -55.88 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.6 -45.9 77.37 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.274 0.63 . . . . 0.0 111.06 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.12 -33.51 65.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.448 1.099 . . . . 0.0 112.512 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 1.1 mmt -82.54 -38.87 23.13 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.934 0.893 . . . . 0.0 110.453 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -60.83 -29.7 69.65 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.896 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.98 -31.46 60.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.471 1.032 . . . . 0.0 111.814 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.95 15.1 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.146 1.379 . . . . 0.0 110.821 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.78 34.03 81.82 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.163 -1.354 . . . . 0.0 113.034 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -107.43 149.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.07 135.12 54.8 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' B' ' 61' ' ' ASN . 21.9 pt -137.84 22.68 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.94 1.296 . . . . 0.0 110.448 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -67.59 14.73 0.05 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' B' ' 59' ' ' ILE . 0.1 OUTLIER -141.4 13.69 2.17 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.047 2.139 . . . . 0.0 111.641 -174.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -53.3 162.38 0.75 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.309 -1.494 . . . . 0.0 113.559 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -149.63 161.16 42.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.22 2.208 . . . . 0.0 105.619 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 67.1 m -157.89 -172.87 4.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.89 1.276 . . . . 0.0 109.021 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.55 163.67 24.51 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.149 1.379 . . . . 0.0 109.389 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.0 165.75 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.227 1.011 . . . . 0.0 111.411 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 pt -50.29 128.59 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.199 0.6 . . . . 0.0 110.452 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -143.14 104.5 4.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.261 1.029 . . . . 0.0 109.575 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -53.55 -25.65 17.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.682 1.593 . . . . 0.0 113.282 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -17.64 62.91 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.591 1.087 . . . . 0.0 112.498 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -129.78 -37.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.146 0.978 . . . . 0.0 108.903 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.29 -50.19 28.95 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.1 0.863 . . . . 0.0 110.254 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -24.41 67.54 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.928 0.786 . . . . 0.0 110.7 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -73.75 -23.05 59.69 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.119 1.368 . . . . 0.0 112.337 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.0 166.56 3.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.939 1.295 . . . . 0.0 112.268 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.75 -34.15 17.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.709 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 18.6 tp -146.93 139.87 25.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 0.0 110.594 -170.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.81 110.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 125.976 1.711 . . . . 0.0 107.786 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.78 102.3 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 75.4 m -71.37 128.75 36.9 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 68.5 mt -136.14 64.19 1.57 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.298 1.039 . . . . 0.0 109.178 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.234 0.261 0 O-C-N 121.554 -0.716 . . . . 0.0 110.457 171.07 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -66.47 20.04 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -170.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm 71.67 21.03 4.48 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.071 -1.643 . . . . 0.0 111.948 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.0 m 29.24 56.97 0.68 Allowed Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 128.369 2.668 . . . . 0.0 113.162 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.55 132.29 48.13 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.609 2.206 . . . . 0.0 112.856 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 4.06 33.78 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.5 p 41.64 94.1 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.222 2.209 . . . . 0.0 113.494 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -60.0 143.87 99.53 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.203 1.935 . . . . 0.0 110.488 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.21 -2.83 5.27 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.509 3.473 . . . . 0.0 115.028 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -63.92 -11.62 29.79 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.829 0.852 . . . . 0.0 111.678 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.41 143.94 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 109.605 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -73.18 159.02 34.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -145.6 146.95 31.56 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.49 -1.381 . . . . 0.0 109.35 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -146.86 156.51 43.16 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -114.98 133.29 56.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.337 1.455 . . . . 0.0 108.1 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.11 1.29 1.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.04 -62.27 2.5 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 39.9 p90 47.49 14.72 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.23 2.612 . . . . 0.0 115.328 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -161.24 161.9 30.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.174 2.19 . . . . 0.0 106.473 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -141.94 105.91 5.76 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.175 0.99 . . . . 0.0 110.427 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.76 -10.92 18.45 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.636 3.558 . . . . 0.0 112.981 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.58 0.28 5.62 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.737 1.153 . . . . 0.0 111.517 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -121.22 -60.77 1.61 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . 0.406 ' HA ' ' CD2' ' B' ' 119' ' ' PHE . . . 43.39 -170.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 113.59 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -90.81 138.72 31.37 Favored 'General case' 0 C--O 1.236 0.388 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -83.0 56.82 5.08 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.641 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 p -121.65 164.16 17.79 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 169.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.18 -39.05 89.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.479 0.657 . . . . 0.0 110.61 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.04 -42.89 59.6 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.768 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -76.2 -29.93 57.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.941 1.246 . . . . 0.0 109.891 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.8 -59.6 4.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.792 0.724 . . . . 0.0 109.436 169.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -57.84 -41.97 83.45 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.97 90.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.869 0.868 . . . . 0.0 112.006 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 6.3 m-85 -65.81 -43.85 87.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.158 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -58.7 -47.57 84.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.219 0.918 . . . . 0.0 108.958 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -65.53 -43.71 89.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 111.111 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -60.67 -53.67 54.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.34 -41.4 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.414 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -36.87 85.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 120.299 1.409 . . . . 0.0 112.011 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.04 -41.49 90.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.996 0.362 . . . . 0.0 111.043 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.21 -49.09 68.47 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.996 0.519 . . . . 0.0 110.192 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -56.57 -47.66 81.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 124.216 1.006 . . . . 0.0 109.234 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.63 95.93 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 119.677 1.126 . . . . 0.0 111.737 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -65.12 -43.3 92.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.322 0.561 . . . . 0.0 111.584 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -48.13 81.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.012 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.26 -32.68 74.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.556 1.071 . . . . 0.0 111.208 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.06 -38.17 82.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.446 0.566 . . . . 0.0 110.677 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -62.13 -34.72 76.91 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.779 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . 0.429 ' CE2' ' HE3' ' B' ' 139' ' ' LYS . 20.9 m-85 -63.6 -35.79 81.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 122.325 2.329 . . . . 0.0 109.458 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.54 83.53 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.138 0.575 . . . . 0.0 110.837 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -84.22 -43.76 14.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.194 1.398 . . . . 0.0 112.0 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -93.04 -21.41 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.442 1.897 . . . . 0.0 111.544 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.17 20.12 60.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.708 0.671 . . . . 0.0 111.463 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . 0.429 ' HE3' ' CE2' ' B' ' 134' ' ' PHE . 10.3 tppt? . . . . . 0 C--O 1.251 1.178 0 C-N-CA 128.698 2.799 . . . . 0.0 112.692 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.84 171.25 20.75 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.871 1.668 . . . . 0.0 106.915 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.47 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -79.88 170.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.829 1.651 . . . . 0.0 107.42 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -124.75 129.81 51.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.906 1.282 . . . . 0.0 108.287 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.23 177.1 5.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.042 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 t -159.62 -173.56 4.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.399 1.88 . . . . 0.0 106.247 168.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -36.89 -36.58 0.12 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 129.599 3.159 . . . . 0.0 116.447 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -133.41 -29.87 1.35 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 111.438 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 m -60.46 -22.26 63.28 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.353 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -51.26 -54.02 29.95 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.18 0.9 . . . . 0.0 109.407 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -61.45 -44.08 97.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.045 -0.409 . . . . 0.0 110.033 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -36.46 81.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.999 -0.091 . . . . 0.0 111.204 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -80.13 -14.31 58.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.335 1.054 . . . . 0.0 113.252 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.2 p -117.79 -4.0 11.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.651 1.114 . . . . 0.0 112.907 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -72.85 -8.84 57.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.07 153.99 44.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.338 1.055 . . . . 0.0 109.246 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.67 -160.55 49.7 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.404 1.002 . . . . 0.0 111.532 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 t -113.96 129.15 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.19 122.2 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.151 -168.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -92.39 100.84 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 108.185 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.33 149.73 25.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.09 150.8 44.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.411 1.485 . . . . 0.0 109.284 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -132.84 113.04 12.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.583 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.4 p-90 -132.79 153.28 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.126 1.771 . . . . 0.0 107.416 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.81 165.04 7.27 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 119.146 0.885 . . . . 0.0 111.122 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.66 -18.08 8.09 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.147 3.231 . . . . 0.0 116.285 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -58.22 -19.65 35.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.798 1.181 . . . . 0.0 114.088 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.0 161.57 39.07 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.76 1.163 . . . . 0.0 113.814 -169.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.06 21.91 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.794 -1.559 . . . . 0.0 112.777 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.56 -27.33 18.89 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.326 2.684 . . . . 0.0 114.94 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -58.51 -18.36 28.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 113.839 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -113.48 11.57 18.44 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.524 1.13 . . . . 0.0 111.697 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mtm -121.35 -43.67 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.099 0.96 . . . . 0.0 109.467 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.1 -36.03 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.445 0.698 . . . . 0.0 109.272 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.37 -57.91 21.74 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.979 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -60.27 -39.56 66.78 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.962 1.775 . . . . 0.0 111.676 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.45 -36.78 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.27 1.028 . . . . 0.0 111.178 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.1 mt -72.36 -41.58 66.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.699 0.681 . . . . 0.0 110.687 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.84 -35.01 79.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.999 0.818 . . . . 0.0 109.848 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.16 -28.7 68.34 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.773 1.229 . . . . 0.0 112.06 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.9 tp -76.41 -46.27 27.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.193 0.597 . . . . 0.0 110.282 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.38 -36.25 71.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.123 0.419 . . . . 0.0 110.759 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -68.42 -9.2 46.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.133 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.08 -51.96 3.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.168 0.987 . . . . 0.0 110.742 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -127.56 14.7 7.07 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.835 0.854 . . . . 0.0 112.238 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.87 -6.44 12.22 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.082 -1.011 . . . . 0.0 114.209 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.37 -23.22 67.22 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.829 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.06 -15.08 8.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.688 1.195 . . . . 0.0 112.515 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 tp -127.95 149.8 50.17 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.749 1.22 . . . . 0.0 112.139 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -114.34 147.53 38.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.85 141.82 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 t -139.21 113.1 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.583 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpt -87.48 155.0 20.2 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.284 -0.885 . . . . 0.0 110.184 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -124.52 127.27 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 171.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -83.05 104.99 13.67 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.334 27.5 m -77.98 48.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -153.54 -42.71 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.481 1.513 . . . . 0.0 108.677 167.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.78 -42.62 19.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.688 0.676 . . . . 0.0 110.767 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -134.59 38.08 3.08 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.42 1.088 . . . . 0.0 111.053 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -69.25 -4.93 19.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.887 1.275 . . . . 0.0 113.147 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.74 -47.16 70.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.982 1.713 . . . . 0.0 111.049 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.3 m -58.81 -40.97 85.71 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.618 0.645 . . . . 0.0 111.061 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.87 -55.28 13.49 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.7 -45.26 39.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.934 0.778 . . . . 0.0 113.213 169.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.73 -41.39 95.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.226 1.013 . . . . 0.0 111.036 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -80.62 -5.45 56.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.151 0.981 . . . . 0.0 112.707 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.34 60.38 5.55 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.44 -64.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 10.5 mtm 58.89 5.14 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.389 2.676 . . . . 0.0 115.242 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.4 p -143.38 159.55 42.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.811 1.187 . . . . 0.0 112.921 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 141.54 41.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.79 151.33 71.78 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 N-CA-C 106.942 -1.984 . . . . 0.0 106.942 -11.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.7 m -123.99 147.01 48.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -122.99 138.17 54.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.188 1.795 . . . . 0.0 106.64 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.34 107.81 12.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.61 128.46 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.58 151.24 43.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.58 0.752 . . . . 0.0 109.496 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -137.73 135.92 36.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.0 t70 43.8 29.98 0.34 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.705 2.002 . . . . 0.0 114.432 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.59 15.74 42.24 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.548 1.071 . . . . 0.0 115.758 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -130.45 144.67 51.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.521 1.16 . . . . 0.0 110.115 172.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.11 134.45 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.94 -22.99 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.699 1.199 . . . . 0.0 110.091 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.17 165.69 28.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.967 0.907 . . . . 0.0 110.329 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 149.33 29.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.8 m -153.51 139.39 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 169.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.04 67.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -171.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.37 156.56 9.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.873 1.702 . . . . 0.0 109.596 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.9 148.22 51.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.157 0.583 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.66 142.11 27.47 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -70.07 166.34 28.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.355 2.036 . . . . 0.0 110.703 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -46.58 -47.05 19.88 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.494 1.918 . . . . 0.0 112.495 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.5 -43.29 77.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.931 0.787 . . . . 0.0 111.055 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.89 76.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.779 -0.575 . . . . 0.0 110.4 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -53.32 59.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.264 1.026 . . . . 0.0 109.707 173.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.05 -38.18 85.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.572 -174.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.03 -46.66 88.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.981 0.81 . . . . 0.0 111.146 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -58.09 -38.68 76.87 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.887 1.275 . . . . 0.0 111.682 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 p -88.74 -40.54 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.509 -0.281 . . . . 0.0 111.079 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -57.72 -32.83 67.8 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.406 1.082 . . . . 0.0 111.854 -176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -69.46 -5.96 27.28 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -126.63 -27.39 3.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.015 1.326 . . . . 0.0 112.581 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.247 0.952 0 C-N-CA 126.155 1.782 . . . . 0.0 107.539 169.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.63 19.43 2.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.162 0.985 . . . . 0.0 112.575 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -157.46 129.68 7.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -153.48 148.86 27.11 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 129.041 2.936 . . . . 0.0 104.649 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.35 146.38 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.28 144.29 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.59 141.38 49.66 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -116.47 145.46 43.28 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 mt -121.05 114.29 21.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 m -136.87 136.37 38.65 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.6 m -52.36 119.48 4.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.711 0.804 . . . . 0.0 109.344 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.25 0.29 5.67 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.724 1.631 . . . . 0.0 115.091 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.2 t30 44.1 26.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.919 2.088 . . . . 0.0 113.328 -169.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.8 m -68.43 -42.93 78.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.67 -61.85 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -54.97 -46.35 75.05 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 120.718 1.599 . . . . 0.0 111.48 -174.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.4 p -51.58 -49.55 61.88 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.9 1.68 . . . . 0.0 112.115 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.28 -46.78 85.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.099 0.96 . . . . 0.0 110.532 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 30.5 ttm -63.02 -45.22 93.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.41 90.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.085 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -27.52 58.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.424 1.465 . . . . 0.0 110.441 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.98 -50.99 42.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.01 -39.63 72.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.638 0.775 . . . . 0.0 111.41 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.37 -52.98 62.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -64.77 -23.19 67.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.8 -14.18 61.46 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -126.7 -16.67 5.19 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.609 1.163 . . . . 0.0 113.31 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -121.84 77.68 1.39 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.34 -161.3 1.01 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.685 1.612 . . . . 0.0 113.09 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.81 -20.83 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.438 -1.036 . . . . 0.0 113.18 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -58.73 -16.3 15.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.506 1.922 . . . . 0.0 112.889 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -128.29 156.95 42.21 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.406 1.882 . . . . 0.0 109.045 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -125.54 143.09 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.34 137.19 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.61 158.12 44.23 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.132 1.373 . . . . 0.0 108.222 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 77.3 p -147.18 150.2 34.45 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.75 172.84 17.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.067 0.947 . . . . 0.0 111.768 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.79 -172.27 35.43 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.266 0.936 . . . . 0.0 111.818 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 tt -53.88 -57.6 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 113.62 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.02 28.41 4.16 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.205 1.802 . . . . 0.0 108.002 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.83 148.18 40.22 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.896 2.078 . . . . 0.0 112.066 -170.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 145.16 66.22 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 131.568 3.947 . . . . 0.0 104.371 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.12 152.09 23.26 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -139.81 100.7 4.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -71.52 128.44 89.91 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -59.73 -21.86 65.11 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.028 1.819 . . . . 0.0 112.813 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -36.01 80.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.701 1.137 . . . . 0.0 111.293 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.56 -38.55 67.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.83 -51.62 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -59.05 -42.65 90.79 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.353 0.661 . . . . 0.0 110.727 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.51 -32.06 57.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.127 0.971 . . . . 0.0 112.18 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 65.2 mmm -84.77 -34.67 22.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.176 0.898 . . . . 0.0 111.276 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -62.53 -24.05 67.3 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.163 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.0 -31.67 63.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.858 1.208 . . . . 0.0 111.673 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.66 15.11 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.196 1.398 . . . . 0.0 111.2 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.74 41.42 98.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.598 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.09 146.4 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -119.26 135.13 54.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.089 0.556 . . . . 0.0 109.967 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.62 25.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 126.969 2.108 . . . . 0.0 109.713 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.8 m -68.09 14.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.518 -1.364 . . . . 0.0 113.403 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.2 23.96 0.93 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.321 1.848 . . . . 0.0 112.251 -169.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -47.46 150.17 0.99 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.82 1.645 . . . . 0.0 114.013 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -128.32 41.17 3.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.851 2.06 . . . . 0.0 110.437 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 12.7 m -59.83 172.33 0.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.04 1.336 . . . . 0.0 113.375 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -166.22 168.2 15.45 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.392 1.477 . . . . 0.0 109.78 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.2 pt -65.37 170.69 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.032 1.333 . . . . 0.0 112.348 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -48.95 132.21 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.329 0.652 . . . . 0.0 109.241 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -138.26 95.96 3.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.915 1.34 . . . . 0.0 108.263 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -44.69 -31.18 1.09 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.741 2.017 . . . . 0.0 114.673 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.64 -22.77 62.47 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-N 119.298 0.954 . . . . 0.0 110.636 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -39.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.457 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.89 -50.92 71.48 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.616 1.098 . . . . 0.0 110.145 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -29.17 69.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.546 0.612 . . . . 0.0 111.353 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -85.31 -11.35 54.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.192 1.397 . . . . 0.0 112.743 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 171.12 5.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.742 0.782 . . . . 0.0 110.683 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -105.28 -12.62 15.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.171 0.989 . . . . 0.0 111.58 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.17 145.59 24.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.398 1.079 . . . . 0.0 109.252 173.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.64 99.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.4 102.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -65.39 119.56 11.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tp -135.31 53.29 1.98 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.627 0.771 . . . . 0.0 111.592 -167.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.631 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.43 20.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.328 2.651 . . . . 0.0 116.117 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 68.64 27.85 5.88 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.3 1.84 . . . . 0.0 112.859 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 33.96 48.32 0.56 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.085 2.154 . . . . 0.0 112.789 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.87 136.05 70.54 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.872 2.381 . . . . 0.0 112.451 -168.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -1.37 50.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 116.71 -1.614 . . . . 0.0 114.852 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p 46.07 86.63 0.13 Allowed Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.374 1.47 . . . . 0.0 112.879 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -58.36 143.94 96.89 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.461 2.107 . . . . 0.0 110.112 -169.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.9 5.53 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 125.072 3.848 . . . . 0.0 116.212 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -63.95 -12.18 35.14 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 112.29 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.63 154.25 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 0.988 . . . . 0.0 111.375 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -74.33 156.25 37.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.488 1.915 . . . . 0.0 109.834 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.74 144.56 30.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.719 -1.238 . . . . 0.0 108.09 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.44 147.3 27.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -87.26 133.68 33.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.576 1.15 . . . . 0.0 109.658 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -140.32 25.01 2.27 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.704 1.601 . . . . 0.0 110.327 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.68 155.62 26.48 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -157.36 19.91 0.29 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.532 1.933 . . . . 0.0 109.05 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -170.24 175.55 4.87 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 129.257 3.023 . . . . 0.0 105.719 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -161.32 138.39 6.54 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 168.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' B' ' 108' ' ' ARG . 95.6 Cg_endo -74.44 -17.43 21.09 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.743 . . . . 0.0 112.306 -170.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.93 6.62 1.15 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.681 1.128 . . . . 0.0 110.769 168.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' B' ' 106' ' ' PRO . 5.6 mmm180 -122.0 12.73 10.46 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 110.501 177.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.44 158.18 0.44 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -34.65 72.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.828 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.07 -15.1 6.53 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 115.759 1.064 . . . . 0.0 115.759 168.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.5 p -70.33 162.7 28.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.51 -40.11 95.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.515 0.674 . . . . 0.0 110.558 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.84 -42.79 85.18 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.09 -1.433 . . . . 0.0 109.087 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -73.99 -33.16 63.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.928 1.694 . . . . 0.0 109.73 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -56.54 -56.77 17.08 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 119.119 0.872 . . . . 0.0 110.721 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -64.27 -39.78 94.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.758 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.59 98.07 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.29 -0.881 . . . . 0.0 111.996 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.84 -51.54 61.52 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.285 1.3 p90 -70.12 -30.91 68.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 117.546 -1.216 . . . . 0.0 112.542 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -72.58 -41.65 65.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 120.268 1.395 . . . . 0.0 111.004 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -59.52 -54.1 50.48 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.108 0.963 . . . . 0.0 109.302 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.33 -39.42 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.449 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.43 ' HA ' ' SD ' ' B' ' 19' ' ' MET . 5.4 tmm_? -56.92 -45.36 82.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.339 1.427 . . . . 0.0 112.08 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.09 -45.48 94.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.076 0.398 . . . . 0.0 110.65 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.2 -41.58 73.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.713 0.233 . . . . 0.0 111.281 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -60.22 -47.84 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.337 -0.852 . . . . 0.0 109.275 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.76 97.04 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.934 0.788 . . . . 0.0 111.239 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -59.52 -50.83 72.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.379 1.089 . . . . 0.0 111.98 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -69.76 -33.14 72.01 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.506 -0.746 . . . . 0.0 111.448 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.1 -36.48 77.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.249 0.931 . . . . 0.0 111.023 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -57.05 -41.15 78.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.168 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.46 -36.41 75.91 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 116.487 -1.72 . . . . 0.0 112.375 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -64.97 -37.32 87.26 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 122.437 2.381 . . . . 0.0 111.111 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.74 70.8 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -91.85 -38.86 12.07 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 112.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 63.5 p -101.62 -19.27 15.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.335 1.854 . . . . 0.0 110.979 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.42 32.44 64.3 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.835 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 124.083 0.953 . . . . 0.0 111.499 -174.377 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.42 152.9 4.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.637 1.175 . . . . 0.0 109.924 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.23 95.46 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 168.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.06 167.16 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.338 1.455 . . . . 0.0 107.336 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -126.96 117.84 23.32 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.02 176.76 9.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.112 1.365 . . . . 0.0 110.264 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -154.77 -173.2 4.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.884 2.074 . . . . 0.0 106.048 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -39.55 -33.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.872 3.269 . . . . 0.0 116.511 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -133.52 -21.88 1.97 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.951 1.3 . . . . 0.0 112.234 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -38.39 75.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.136 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -71.03 123.88 23.09 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.7 m 116.83 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 1 C-N-CA 131.772 4.029 . . . . 0.0 105.471 -169.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.07 99.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.0 110.578 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -79.65 -8.77 59.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.473 1.509 . . . . 0.0 112.163 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 p -124.25 -2.09 8.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.44 1.018 . . . . 0.0 113.429 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.6 m -72.19 -10.61 60.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.81 155.75 45.57 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.792 0.724 . . . . 0.0 110.432 -172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.86 -158.2 51.77 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 124.223 0.916 . . . . 0.0 110.999 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.66 124.22 71.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.05 115.7 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.156 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.7 tp -87.69 92.89 9.27 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 148.04 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -142.75 149.99 39.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -132.29 110.83 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.583 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.0 p-90 -131.08 152.73 50.07 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.806 1.643 . . . . 0.0 107.477 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.69 162.4 8.32 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 118.882 0.765 . . . . 0.0 110.297 169.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.88 -14.88 6.27 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.916 3.078 . . . . 0.0 115.993 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -61.49 -27.48 68.62 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.83 1.195 . . . . 0.0 113.663 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.66 154.95 47.64 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.448 1.022 . . . . 0.0 112.162 -169.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.93 -49.07 79.25 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 117.955 -1.469 . . . . 0.0 113.729 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.99 -24.71 25.65 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.035 2.49 . . . . 0.0 115.323 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 m -59.15 -21.25 59.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 120.249 1.386 . . . . 0.0 113.502 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.07 7.96 34.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.952 0.901 . . . . 0.0 111.89 174.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.1 mtm -118.59 -44.9 2.63 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.273 0.942 . . . . 0.0 109.562 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.11 -34.59 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.587 0.755 . . . . 0.0 109.301 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.84 -61.54 5.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.15 0.98 . . . . 0.0 112.243 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -60.06 -39.91 65.81 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.077 1.852 . . . . 0.0 111.84 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.26 -44.81 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.677 0.791 . . . . 0.0 110.429 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.39 -44.75 90.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.207 0.458 . . . . 0.0 110.094 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.17 -36.56 82.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.066 0.394 . . . . 0.0 110.441 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.19 -32.68 73.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.643 1.177 . . . . 0.0 111.908 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.78 -45.71 57.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.218 1.407 . . . . 0.0 109.889 175.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.82 -36.33 72.88 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.389 -0.82 . . . . 0.0 111.312 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.99 -6.65 29.09 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.129 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -104.86 -47.09 4.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.974 1.31 . . . . 0.0 111.585 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.4 ptm -134.58 18.19 3.6 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.402 0.681 . . . . 0.0 112.09 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 -6.77 24.02 Favored Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.871 -1.143 . . . . 0.0 113.82 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.74 -23.88 67.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.44 0.62 . . . . 0.0 110.807 169.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 -24.61 7.88 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.937 1.295 . . . . 0.0 111.59 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 tp -110.28 152.14 26.52 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 111.838 -169.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.73 148.48 49.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.94 144.05 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 t -138.25 111.19 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.583 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 33.1 mtpt -84.53 159.39 20.71 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.543 -0.723 . . . . 0.0 109.239 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.22 122.69 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 170.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.89 107.35 10.36 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 32.7 m -79.14 48.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.88 -45.52 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.461 1.505 . . . . 0.0 108.456 167.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.27 -36.39 34.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.984 0.914 . . . . 0.0 110.934 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -133.19 29.24 4.04 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 0.0 110.604 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -72.43 -5.99 40.48 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -54.15 -47.62 71.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.638 1.575 . . . . 0.0 110.902 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.2 m -56.11 -40.89 74.41 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.598 0.759 . . . . 0.0 111.367 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.76 -57.23 4.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.22 -42.46 41.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.836 0.732 . . . . 0.0 113.561 169.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -62.81 -43.39 98.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.364 1.082 . . . . 0.0 110.834 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -71.46 -31.61 67.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.077 0.399 . . . . 0.0 110.325 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.12 68.7 1.18 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 -170.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.68 -66.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.8 mtm 58.45 7.16 0.66 Allowed 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 127.472 2.309 . . . . 0.0 114.801 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -143.99 160.98 39.9 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.273 1.397 . . . . 0.0 112.991 -169.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 138.56 32.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 109.649 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.17 138.44 33.68 Favored 'Cis proline' 0 N--CA 1.449 -1.104 0 N-CA-C 105.866 -2.398 . . . . 0.0 105.866 -11.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -107.81 150.44 27.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 tp -141.36 123.23 15.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -170.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.0 mt -121.21 105.35 10.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.31 108.59 15.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.33 149.52 23.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -146.57 130.43 17.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.98 30.76 0.44 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.489 1.916 . . . . 0.0 113.329 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.06 8.66 55.13 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 171.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -133.31 151.61 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.765 1.226 . . . . 0.0 110.521 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -70.97 132.72 32.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.44 -23.01 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.981 1.313 . . . . 0.0 110.729 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -146.58 160.57 41.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.523 1.129 . . . . 0.0 109.769 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 148.53 30.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -152.08 149.52 28.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.36 -0.837 . . . . 0.0 108.905 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.75 62.76 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.03 154.12 9.43 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.973 1.273 . . . . 0.0 110.714 -170.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.31 162.9 9.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.426 1.491 . . . . 0.0 112.087 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.33 139.26 10.75 Favored Pre-proline 0 N--CA 1.469 0.486 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -69.43 171.35 14.26 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 111.012 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -38.69 -55.69 1.43 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.469 2.307 . . . . 0.0 111.924 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.88 -42.41 63.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.496 -173.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.68 78.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.849 -0.532 . . . . 0.0 110.992 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.86 -47.51 58.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.507 0.323 . . . . 0.0 110.283 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -63.26 -35.72 81.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.38 -47.53 78.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.173 0.442 . . . . 0.0 110.713 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.72 -38.17 71.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.573 0.749 . . . . 0.0 111.587 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.33 -38.66 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.404 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.22 -25.75 64.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.363 0.983 . . . . 0.0 112.56 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -55.09 -26.08 35.65 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.675 0.79 . . . . 0.0 112.614 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.25 -28.42 3.69 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.438 1.095 . . . . 0.0 111.973 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.328 1.851 . . . . 0.0 108.19 174.453 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.43 22.12 1.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.899 0.88 . . . . 0.0 112.399 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.2 127.74 6.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -146.42 142.28 28.0 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 129.523 3.129 . . . . 0.0 105.273 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -125.4 142.6 41.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 109.0 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.1 151.05 31.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.836 1.254 . . . . 0.0 107.682 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -132.87 151.65 51.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.979 1.311 . . . . 0.0 108.26 -169.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -126.84 147.44 50.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.926 0.89 . . . . 0.0 109.212 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.57 130.41 38.37 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.774 0.83 . . . . 0.0 109.428 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -145.44 149.69 35.16 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.434 1.494 . . . . 0.0 110.351 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -59.63 130.17 45.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.79 37.18 8.96 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.025 1.774 . . . . 0.0 112.85 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -39.87 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.235 1.814 . . . . 0.0 114.961 -168.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.1 m -139.24 4.19 2.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.403 1.081 . . . . 0.0 111.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.88 -49.18 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -59.26 -57.22 13.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.831 1.651 . . . . 0.0 112.047 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -75.42 -26.15 58.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.287 0.949 . . . . 0.0 110.965 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -51.29 -49.66 60.82 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.805 1.642 . . . . 0.0 109.676 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' MET . . . . . 0.418 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 24.2 ttm -69.12 -45.2 70.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.659 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.38 90.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.879 0.871 . . . . 0.0 111.946 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -73.94 -33.27 63.86 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.175 0.898 . . . . 0.0 110.798 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.31 70.75 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -59.38 -40.89 87.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.715 0.806 . . . . 0.0 111.601 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.88 71.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -64.26 -24.81 67.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.07 -13.08 62.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -126.82 -8.47 6.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.82 1.248 . . . . 0.0 112.906 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -133.33 81.84 1.95 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -171.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 -161.88 2.14 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.442 1.496 . . . . 0.0 113.07 -171.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.23 -21.14 31.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.729 1.211 . . . . 0.0 113.373 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.14 -14.2 6.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.604 1.962 . . . . 0.0 113.008 169.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -136.48 158.17 45.06 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.094 1.758 . . . . 0.0 109.081 -174.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -132.68 151.38 51.98 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.5 t -135.41 142.9 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -145.32 161.6 39.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.332 0.653 . . . . 0.0 109.911 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.3 m -137.63 145.47 42.76 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.342 1.457 . . . . 0.0 109.165 -169.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.85 164.32 38.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.684 0.754 . . . . 0.0 112.179 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.43 -177.23 46.14 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.333 1.921 . . . . 0.0 108.875 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -57.19 -56.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.577 1.151 . . . . 0.0 112.813 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -132.17 23.76 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.76 2.024 . . . . 0.0 108.005 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.82 118.61 6.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.229 2.212 . . . . 0.0 111.01 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -161.7 -0.17 0.05 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.04 0.536 . . . . 0.0 111.626 169.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.86 168.63 51.25 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -144.71 77.12 1.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.51 131.5 90.67 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -172.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.63 -21.68 48.23 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.968 1.779 . . . . 0.0 112.755 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -37.38 83.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.863 1.211 . . . . 0.0 111.817 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.63 -38.09 65.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 119.099 0.863 . . . . 0.0 109.927 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.56 -51.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.12 -42.55 90.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.989 0.916 . . . . 0.0 110.679 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.78 -30.71 61.74 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.754 0.822 . . . . 0.0 112.304 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.1 mmm -86.41 -33.74 20.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.003 0.819 . . . . 0.0 111.134 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -62.19 -25.59 67.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.187 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -56.51 -30.16 62.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.918 1.236 . . . . 0.0 111.516 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 m -117.27 15.11 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.242 1.417 . . . . 0.0 111.195 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.6 39.95 97.18 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.946 -0.919 . . . . 0.0 112.879 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -115.38 126.99 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -87.15 134.56 33.51 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.917 -0.489 . . . . 0.0 109.752 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -131.51 14.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.288 0.635 . . . . 0.0 111.246 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -59.45 -20.14 52.93 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.171 0.896 . . . . 0.0 110.949 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -76.27 -11.28 59.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.4 2.28 . . . . 0.0 114.116 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -63.83 165.07 9.1 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.368 1.44 . . . . 0.0 113.164 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.2 p -128.44 -37.15 1.83 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.765 1.626 . . . . 0.0 112.08 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.2 m 64.51 162.03 0.12 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.759 2.023 . . . . 0.0 112.803 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -165.52 160.5 17.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.611 1.164 . . . . 0.0 110.212 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -78.14 178.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.731 2.012 . . . . 0.0 111.27 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.12 134.88 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -145.23 103.39 3.84 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.778 1.231 . . . . 0.0 108.283 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -48.26 -30.33 4.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.341 1.856 . . . . 0.0 113.748 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.61 -21.78 66.54 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.068 0.849 . . . . 0.0 111.716 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -118.7 -36.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 117.792 -1.099 . . . . 0.0 108.931 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.01 -51.38 69.89 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.876 1.217 . . . . 0.0 109.059 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.63 -27.59 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.07 0.85 . . . . 0.0 111.622 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -85.72 -18.48 32.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.519 1.128 . . . . 0.0 112.444 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.12 160.22 6.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.233 1.016 . . . . 0.0 111.235 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.9 -33.49 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.638 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.4 tp -146.69 139.3 25.1 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.225 1.41 . . . . 0.0 109.399 -171.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.77 107.58 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.875 1.67 . . . . 0.0 106.734 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.69 100.78 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -75.6 102.41 5.29 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 101.209 -3.626 . . . . 0.0 101.209 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -116.64 11.19 14.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -166.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.52 -0.196 0 CA-C-N 119.355 0.979 . . . . 0.0 112.217 -169.574 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.62 9.72 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -172.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.3 0.3 OUTLIER 50.78 31.0 5.49 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.85 2.06 . . . . 0.0 114.641 -169.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.5 m 38.69 52.8 3.77 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 128.057 2.543 . . . . 0.0 113.926 170.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.21 131.11 41.52 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.029 2.486 . . . . 0.0 111.576 -169.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.5 2.12 34.42 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -174.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p 45.72 88.3 0.1 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.622 1.569 . . . . 0.0 113.244 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -56.02 141.18 86.94 Favored 'Trans proline' 0 CA--C 1.55 1.323 0 C-N-CA 122.549 2.166 . . . . 0.0 110.263 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.23 -2.51 3.17 Favored 'Trans proline' 0 C--N 1.351 0.663 1 C-N-CA 125.38 4.053 . . . . 0.0 116.961 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -65.7 -9.81 31.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.175 0.898 . . . . 0.0 111.506 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.81 144.39 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.828 1.251 . . . . 0.0 109.844 -169.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.6 156.61 32.6 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.742 0.817 . . . . 0.0 108.94 171.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -145.08 143.62 30.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -137.21 139.83 41.31 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -89.93 135.13 33.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.673 1.189 . . . . 0.0 108.787 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -140.08 14.47 2.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.95 1.7 . . . . 0.0 110.323 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.34 167.1 54.43 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 123.941 0.781 . . . . 0.0 113.328 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -164.04 -43.11 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.137 1.775 . . . . 0.0 109.469 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -165.21 175.31 9.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.688 1.995 . . . . 0.0 109.798 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -139.26 137.87 19.83 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.26 -18.02 16.43 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.266 1.977 . . . . 0.0 113.078 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.96 6.98 1.78 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.002 1.273 . . . . 0.0 110.226 168.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -118.7 10.68 12.52 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.339 1.455 . . . . 0.0 110.901 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.84 156.76 0.91 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.314 0.646 . . . . 0.0 110.119 171.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -35.8 73.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.512 -172.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.1 -21.32 3.92 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -69.76 166.75 18.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.13 -42.47 99.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.441 0.639 . . . . 0.0 110.292 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.83 -43.03 76.38 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 117.072 -1.442 . . . . 0.0 109.32 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.2 -34.91 61.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 121.034 1.743 . . . . 0.0 109.827 -173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -55.84 -56.62 18.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.631 0.651 . . . . 0.0 110.763 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -64.56 -39.78 94.38 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.853 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.95 92.46 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.896 0.878 . . . . 0.0 111.665 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -63.31 -51.74 64.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.288 2.2 p90 -70.77 -25.81 63.06 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.0 -172.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -65.61 -51.53 58.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.706 1.139 . . . . 0.0 109.746 172.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -57.27 -51.34 69.76 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.32 -49.02 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 118.333 -0.842 . . . . 0.0 109.485 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.418 ' HA ' ' SD ' ' B' ' 19' ' ' MET . 7.6 tmm_? -56.52 -48.29 77.53 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 111.85 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.78 -43.44 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.326 0.391 . . . . 0.0 110.965 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -66.41 -49.96 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -48.5 79.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.806 1.243 . . . . 0.0 109.991 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.72 -42.45 95.27 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -61.37 -44.51 97.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.799 0.8 . . . . 0.0 112.025 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -69.97 -36.85 75.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.084 0.856 . . . . 0.0 111.759 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.56 -33.54 62.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.553 1.07 . . . . 0.0 111.38 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.28 -43.96 96.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.784 0.72 . . . . 0.0 109.201 170.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.33 -39.05 81.92 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.595 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.66 -42.61 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 122.476 2.398 . . . . 0.0 110.222 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.38 72.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.07 -37.83 18.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.825 1.25 . . . . 0.0 112.959 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.2 p -101.14 -20.09 15.47 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.801 1.64 . . . . 0.0 111.613 -169.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.37 50.01 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.75 0.691 . . . . 0.0 111.51 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . 0.478 ' HA ' ' HE3' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 C-N-CA 128.229 2.612 . . . . 0.0 112.681 -169.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.25 160.93 0.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.645 2.378 . . . . 0.0 112.882 -169.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.52 102.84 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -73.09 166.73 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.772 1.629 . . . . 0.0 108.258 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.81 133.9 46.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.23 176.04 5.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.859 1.264 . . . . 0.0 110.189 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.0 p -137.98 -170.73 2.85 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.101 1.761 . . . . 0.0 109.232 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -44.46 -30.37 0.85 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.88 2.472 . . . . 0.0 113.9 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -138.45 -22.82 1.0 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.481 1.112 . . . . 0.0 112.959 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 m -59.03 -36.06 74.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -71.75 122.72 21.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m 117.71 -60.93 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.707 1 C-N-CA 131.977 4.111 . . . . 0.0 106.065 -169.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.2 95.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.424 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -81.68 -9.24 59.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.612 1.565 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.1 p -122.77 -6.59 8.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -168.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -79.98 -1.48 39.8 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -140.39 147.61 40.01 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.238 0.926 . . . . 0.0 109.787 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.56 -174.63 31.37 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.332 0.968 . . . . 0.0 111.659 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.31 129.97 45.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.06 119.51 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.123 0.969 . . . . 0.0 109.009 -168.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.8 107.53 18.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.73 27.82 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.477 1.035 . . . . 0.0 108.282 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -135.7 152.45 51.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.866 1.667 . . . . 0.0 108.84 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -132.22 114.2 14.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.595 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.3 p-90 -135.58 153.07 51.8 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.034 1.733 . . . . 0.0 108.191 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.51 163.33 7.06 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 119.262 0.937 . . . . 0.0 109.183 169.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.86 -16.86 9.41 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.486 2.791 . . . . 0.0 116.384 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -57.67 -27.43 62.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.79 159.49 41.7 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.633 1.106 . . . . 0.0 112.494 -169.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.73 -48.65 75.1 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.039 -1.423 . . . . 0.0 112.677 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.68 -30.69 17.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.657 2.904 . . . . 0.0 115.461 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.71 -25.47 62.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 120.247 1.385 . . . . 0.0 112.924 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -103.89 10.06 36.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.27 1.028 . . . . 0.0 111.708 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.4 mtm -120.78 -44.36 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.192 0.997 . . . . 0.0 109.481 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.44 -34.94 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 0.0 109.254 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.16 6.98 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.183 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.82 -40.16 74.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.009 1.806 . . . . 0.0 111.671 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.97 -42.01 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.007 0.523 . . . . 0.0 110.548 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.26 -40.12 71.17 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.499 0.59 . . . . 0.0 110.812 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.32 -35.32 80.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.275 0.943 . . . . 0.0 109.723 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.8 -25.32 63.72 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.405 1.482 . . . . 0.0 112.363 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.417 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 48.3 tp -79.42 -44.48 21.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 109.637 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.5 -37.48 74.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.723 0.297 . . . . 0.0 110.793 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -68.64 -10.04 53.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.275 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -101.89 -48.18 4.35 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.148 0.979 . . . . 0.0 111.149 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -134.14 15.41 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.419 0.688 . . . . 0.0 112.331 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.95 -2.88 26.3 Favored Glycine 0 CA--C 1.52 0.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.912 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.5 -24.8 64.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.202 1.001 . . . . 0.0 110.808 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -23.01 9.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.164 0.986 . . . . 0.0 112.061 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.57 147.54 46.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.593 1.157 . . . . 0.0 111.57 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -107.42 143.88 35.12 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.7 mt -128.14 139.23 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.84 141.86 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 125.722 1.609 . . . . 0.0 106.672 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.2 mtpp -113.41 159.52 19.37 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.262 0.625 . . . . 0.0 109.576 173.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.56 121.16 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 170.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.2 106.2 6.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 33.0 m -78.66 50.19 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -155.7 -45.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.491 1.516 . . . . 0.0 108.291 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.04 -36.71 35.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 110.869 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -134.08 28.67 3.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 111.019 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -71.77 -6.27 40.18 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.653 0.781 . . . . 0.0 112.735 -171.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -53.74 -49.3 68.46 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.009 1.724 . . . . 0.0 110.708 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -60.04 -34.67 73.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.387 0.675 . . . . 0.0 111.677 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.06 -64.01 0.94 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.82 -45.84 7.45 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.802 0.715 . . . . 0.0 113.298 169.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.29 -43.15 96.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.124 0.962 . . . . 0.0 111.506 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -84.56 -4.98 59.26 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.639 0.776 . . . . 0.0 112.659 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.45 66.32 1.61 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.1 t -144.1 131.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.6 ptm -149.97 24.71 0.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -140.48 161.31 38.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.622 1.569 . . . . 0.0 112.727 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 136.17 28.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.572 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.11 145.42 41.32 Favored 'Cis proline' 0 N--CA 1.45 -1.052 0 N-CA-C 107.43 -1.796 . . . . 0.0 107.43 -11.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.2 m -113.81 145.23 41.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.1 133.06 54.77 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.2 mt -122.11 110.1 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -101.82 122.23 53.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.34 1.456 . . . . 0.0 108.547 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.51 130.31 20.38 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 43.13 31.1 0.33 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.609 2.364 . . . . 0.0 114.804 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.16 -19.15 5.77 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.988 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -136.43 149.49 48.28 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.24 1.52 . . . . 0.0 113.24 -168.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.58 138.83 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.81 -26.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.855 1.662 . . . . 0.0 109.418 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -144.07 157.51 44.28 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -154.6 133.45 12.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.98 -2.229 . . . . 0.0 104.98 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.3 t -155.17 148.79 25.3 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.5 t -138.75 82.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.24 160.01 10.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.435 1.017 . . . . 0.0 110.883 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -66.67 145.58 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.118 0.959 . . . . 0.0 111.118 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -135.91 138.92 29.01 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 124.724 1.21 . . . . 0.0 108.167 170.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.25 169.74 17.57 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.195 1.93 . . . . 0.0 109.946 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 18.1 tptm -46.03 -48.58 16.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.072 1.749 . . . . 0.0 112.41 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.68 -42.37 74.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 118.005 0.366 . . . . 0.0 111.132 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.67 85.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.134 0.425 . . . . 0.0 110.662 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.45 45.8 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.509 0.724 . . . . 0.0 109.305 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -65.32 -37.47 87.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.56 -47.27 86.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.63 0.65 . . . . 0.0 110.957 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.48 -40.07 77.77 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.417 0.687 . . . . 0.0 111.292 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -85.72 -41.61 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 123.064 0.228 . . . . 0.0 110.627 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -56.69 -27.35 58.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.751 1.221 . . . . 0.0 112.302 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -50.08 -32.68 16.28 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.974 1.31 . . . . 0.0 112.294 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -135.81 -8.48 2.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.249 1.041 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.164 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 52.3 48.31 22.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.894 1.677 . . . . 0.0 113.113 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 135.73 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.171 3.788 . . . . 0.0 109.151 169.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -150.66 158.48 44.2 Favored 'General case' 0 C--N 1.325 -0.491 1 C-N-CA 133.896 4.878 . . . . 0.0 103.905 169.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mt -122.61 142.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.657 1.117 . . . . 0.0 109.215 -169.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -143.44 146.94 20.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.33 1.452 . . . . 0.0 107.125 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.59 134.55 37.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.049 0.539 . . . . 0.0 109.835 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.58 143.09 26.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -132.51 111.11 10.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -140.05 143.18 36.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.174 0.99 . . . . 0.0 108.665 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -42.81 96.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.806 2.442 . . . . 0.0 112.681 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.39 36.64 89.91 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.637 -1.091 . . . . 0.0 111.185 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -2.34 103.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 129.764 3.226 . . . . 0.0 113.696 -169.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -122.51 -145.58 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.067 -2.333 . . . . 0.0 104.787 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.4 -50.7 1.53 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -168.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.461 ' HE ' ' HG ' ' B' ' 81' ' ' LEU . 27.5 mtp85 -53.68 -51.15 64.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.784 1.175 . . . . 0.0 111.003 -172.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -43.31 73.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.144 -171.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -54.92 -49.66 70.74 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.098 0.959 . . . . 0.0 110.241 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' MET . . . . . 0.439 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 26.2 ttm -63.01 -44.26 96.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.484 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 117.765 -1.112 . . . . 0.0 112.491 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -64.92 -47.3 78.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.649 1.568 . . . . 0.0 109.636 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.75 -47.75 89.66 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.497 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -61.92 -42.62 99.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 117.375 0.587 . . . . 0.0 112.283 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.1 83.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -65.64 -26.96 68.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.206 -170.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -18.22 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.313 0.961 . . . . 0.0 113.285 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.432 ' CE2' ' HE3' ' B' ' 132' ' ' LYS . 1.9 m-85 -119.05 -11.5 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 113.078 -175.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 39.0 mt -103.05 -125.46 0.2 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.78 -168.71 40.84 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.64 -16.1 60.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.556 1.143 . . . . 0.0 111.805 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -53.84 -25.55 20.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 111.268 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -130.3 158.65 39.2 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.713 1.205 . . . . 0.0 110.825 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -128.14 125.71 39.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 67.0 t -115.36 134.42 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 -169.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.1 168.94 18.64 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.463 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -146.6 150.73 36.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.943 0.897 . . . . 0.0 110.353 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.39 166.4 31.15 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.126 1.37 . . . . 0.0 110.375 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.29 -178.44 47.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.175 1.369 . . . . 0.0 110.333 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -52.76 -54.03 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.619 1.168 . . . . 0.0 113.739 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.01 27.88 4.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.581 1.953 . . . . 0.0 108.269 -169.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.74 140.65 49.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.195 1.798 . . . . 0.0 111.942 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 p80 158.43 56.99 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.334 3.054 . . . . 0.0 107.719 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.9 93.97 0.15 Allowed Glycine 0 C--N 1.336 0.574 0 O-C-N 121.219 -0.926 . . . . 0.0 111.404 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.0 tp -72.65 91.02 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -66.21 126.59 92.26 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.896 0.878 . . . . 0.0 109.774 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.75 -26.58 68.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.186 1.924 . . . . 0.0 113.266 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -20.04 65.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.151 1.341 . . . . 0.0 112.204 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.39 -38.2 24.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 110.147 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.51 -51.22 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.33 -38.49 83.93 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.808 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.67 65.19 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.722 0.692 . . . . 0.0 111.842 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' MET . . . . . 0.423 ' HE3' ' CD1' ' B' ' 23' ' ' TRP . 52.8 mmm -76.66 -35.38 58.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.22 0.918 . . . . 0.0 111.163 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -62.33 -24.53 67.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.389 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.47 -26.93 65.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.76 1.164 . . . . 0.0 111.721 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.5 m -120.28 15.01 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.196 1.398 . . . . 0.0 111.151 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.1 42.41 99.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.94 0.781 . . . . 0.0 112.598 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -115.11 155.67 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 172.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -124.14 140.93 52.49 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.789 0.836 . . . . 0.0 109.473 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 37.5 pt -138.23 22.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.671 1.588 . . . . 0.0 109.794 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -60.71 -15.53 30.04 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 120.641 -1.287 . . . . 0.0 111.881 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -63.15 -31.45 72.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.687 2.395 . . . . 0.0 114.172 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -62.45 158.14 18.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.587 1.155 . . . . 0.0 111.16 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.6 t -149.89 -30.65 0.22 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.628 0.771 . . . . 0.0 112.426 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p 56.52 173.74 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.847 2.059 . . . . 0.0 115.272 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -166.47 166.01 16.63 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.281 2.232 . . . . 0.0 107.997 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 31.2 pt -68.55 174.73 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.332 1.053 . . . . 0.0 111.366 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -48.64 131.95 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -147.3 97.51 2.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.192 0.996 . . . . 0.0 108.886 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 9.7 m -50.73 -25.41 4.31 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.926 1.291 . . . . 0.0 114.021 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.71 -21.26 65.64 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.647 1.567 . . . . 0.0 112.098 -175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.55 -37.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tt -68.12 -41.84 81.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.821 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.37 66.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.678 1.126 . . . . 0.0 111.379 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -82.77 -13.52 56.12 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.145 0.978 . . . . 0.0 112.383 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.8 162.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.44 1.018 . . . . 0.0 111.449 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.68 -34.57 16.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.627 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 23.2 tp -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.091 1.356 . . . . 0.0 109.221 -171.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.49 104.1 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.19 99.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -65.43 121.55 15.13 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 169.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.461 ' HG ' ' HE ' ' B' ' 16' ' ' ARG . 4.4 tp -135.58 54.26 1.93 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.832 0.853 . . . . 0.0 111.14 -167.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 126.846 2.059 . . . . 0.0 105.827 171.856 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.21 16.07 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm 74.89 22.3 1.9 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.238 1.815 . . . . 0.0 112.194 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 29.03 57.17 0.66 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 128.149 2.58 . . . . 0.0 112.859 -173.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.04 133.4 51.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.617 2.211 . . . . 0.0 111.914 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.06 -4.65 57.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p 44.28 103.13 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 127.89 2.476 . . . . 0.0 113.858 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -63.56 145.02 91.43 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.461 1.441 . . . . 0.0 109.645 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.59 -4.54 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.119 3.213 . . . . 0.0 114.513 -170.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -61.3 -12.71 14.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.44 147.33 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.218 1.007 . . . . 0.0 110.524 -170.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -77.25 157.96 30.52 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -145.03 145.91 31.68 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.751 -1.218 . . . . 0.0 109.104 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.55 151.32 34.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -108.56 140.48 41.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.895 1.278 . . . . 0.0 110.64 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -144.24 22.61 1.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.724 1.21 . . . . 0.0 111.034 -170.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.94 25.45 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.161 0.886 . . . . 0.0 110.949 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -154.57 -30.4 0.11 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.95 1.7 . . . . 0.0 110.564 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.13 165.0 37.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.92 2.488 . . . . 0.0 107.364 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.12 139.29 20.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.301 1.441 . . . . 0.0 108.328 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.66 -17.86 9.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.355 2.036 . . . . 0.0 113.769 -169.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.01 -0.25 5.43 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.39 0.996 . . . . 0.0 110.666 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 11.17 15.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.894 1.277 . . . . 0.0 110.989 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.52 159.84 0.31 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.059 0.944 . . . . 0.0 110.729 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.51 -36.09 68.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.654 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.96 5.32 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 115.73 1.052 . . . . 0.0 115.73 168.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 65.6 p -69.98 165.08 22.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.8 -42.73 99.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.44 0.638 . . . . 0.0 110.208 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.1 -43.29 82.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.857 -1.545 . . . . 0.0 109.395 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.95 -35.73 62.12 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 121.232 1.833 . . . . 0.0 109.428 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -57.08 -53.94 52.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.679 0.672 . . . . 0.0 110.656 171.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . 0.439 ' HA ' ' CD2' ' B' ' 120' ' ' PHE . 7.6 t90 -62.93 -45.19 93.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.694 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.97 99.51 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.943 0.897 . . . . 0.0 111.857 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.12 -48.78 72.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' B' ' 117' ' ' TRP 0.253 0.3 OUTLIER -65.92 -38.91 89.91 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.366 -174.685 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.02 -48.5 80.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.374 0.988 . . . . 0.0 110.672 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -63.13 -52.15 63.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.91 -35.45 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.222 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.497 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.1 tmm_? -61.84 -43.99 97.74 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.781 1.173 . . . . 0.0 112.373 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.46 -46.19 80.48 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.17 0.441 . . . . 0.0 110.725 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.66 -41.35 68.86 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 122.32 -0.238 . . . . 0.0 111.57 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.3 -46.25 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.105 0.962 . . . . 0.0 109.642 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.19 98.39 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.07 -44.54 94.68 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.262 1.031 . . . . 0.0 112.325 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -72.42 -34.93 68.19 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.044 -1.035 . . . . 0.0 111.489 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -36.08 68.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.682 1.128 . . . . 0.0 111.415 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.432 ' HE3' ' CE2' ' B' ' 27' ' ' TYR . 9.4 ptmt -67.18 -37.39 83.62 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.165 0.893 . . . . 0.0 109.576 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.76 -43.19 98.33 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 117.302 -1.332 . . . . 0.0 110.855 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -57.44 -41.25 80.09 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 121.579 1.99 . . . . 0.0 110.552 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.09 73.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.824 0.85 . . . . 0.0 112.617 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.33 -41.73 14.29 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.459 1.503 . . . . 0.0 111.158 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.6 p -90.06 -23.62 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.129 1.372 . . . . 0.0 110.452 -169.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 51.3 54.33 24.14 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.602 1.561 . . . . 0.0 114.533 -169.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.9 168.06 23.61 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.431 2.292 . . . . 0.0 106.293 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.05 99.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 169.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.41 165.33 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.943 1.297 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 118.25 28.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 107.909 172.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.15 172.86 12.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.982 0.913 . . . . 0.0 108.616 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t -155.34 -177.7 6.73 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 169.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -36.92 -36.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 129.529 3.132 . . . . 0.0 116.275 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.7 -30.95 1.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.518 1.127 . . . . 0.0 111.421 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 m -61.74 -19.39 62.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.732 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -50.61 -50.52 53.94 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.346 0.975 . . . . 0.0 109.535 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -62.62 -44.77 95.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.087 -0.383 . . . . 0.0 110.064 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.15 92.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.417 -0.177 . . . . 0.0 111.017 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -72.09 -21.0 61.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.061 0.944 . . . . 0.0 112.81 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.5 p -110.41 -4.03 15.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.174 0.99 . . . . 0.0 112.117 -169.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -70.78 -11.77 61.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.112 0.965 . . . . 0.0 113.304 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.24 146.53 35.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.867 0.758 . . . . 0.0 109.918 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.8 -171.43 26.46 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.761 1.172 . . . . 0.0 111.949 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.85 133.45 34.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -142.01 116.05 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -81.73 134.2 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.27 139.69 53.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 169.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -132.24 148.65 52.46 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.734 1.614 . . . . 0.0 108.757 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.49 110.83 12.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -169.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.57 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.9 p-90 -129.28 152.55 48.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.562 1.945 . . . . 0.0 107.634 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -171.83 164.05 4.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.783 1.174 . . . . 0.0 111.761 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -56.99 -9.38 4.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.461 3.441 . . . . 0.0 117.476 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -48.47 -46.91 38.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.256 1.389 . . . . 0.0 111.889 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.7 m -152.61 165.42 35.28 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.19 -46.3 27.53 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.161 2.315 . . . . 0.0 115.861 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -51.6 -32.37 44.08 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.818 2.809 . . . . 0.0 114.611 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -58.58 -30.18 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 120.266 1.393 . . . . 0.0 112.743 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.91 7.92 45.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.594 1.157 . . . . 0.0 111.838 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.1 mtm -117.67 -44.02 2.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.034 0.934 . . . . 0.0 109.339 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.14 -33.25 55.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.344 1.058 . . . . 0.0 109.4 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.53 -60.46 10.26 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.294 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.25 -39.86 81.0 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.03 1.82 . . . . 0.0 111.47 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.67 -41.42 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.029 0.531 . . . . 0.0 110.586 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 mp -71.15 -38.45 72.23 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 118.907 0.776 . . . . 0.0 110.897 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.28 -34.95 79.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.033 . . . . 0.0 109.9 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -69.86 -30.56 68.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.564 1.146 . . . . 0.0 111.288 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.84 -43.77 64.99 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.582 1.153 . . . . 0.0 110.112 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.59 -37.3 65.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.523 -0.735 . . . . 0.0 110.962 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.86 -14.31 62.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.844 -0.535 . . . . 0.0 111.735 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.12 -49.25 6.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.943 1.297 . . . . 0.0 110.554 -176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.29 16.34 2.78 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.802 0.841 . . . . 0.0 112.115 -169.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.63 2.87 10.07 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.408 -0.808 . . . . 0.0 113.769 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.39 -24.62 61.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.785 1.234 . . . . 0.0 110.593 169.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -19.1 11.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.004 0.921 . . . . 0.0 112.57 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.28 144.91 51.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.687 1.195 . . . . 0.0 110.733 -168.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.45 144.34 30.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -127.19 135.91 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.15 143.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 22.7 mtpp -117.77 156.35 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.441 0.564 . . . . 0.0 110.49 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -126.26 125.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.26 107.7 12.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 169.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.289 33.7 m -82.85 50.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.42 -35.13 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.446 -0.783 . . . . 0.0 111.329 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -103.95 -27.26 12.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.583 1.153 . . . . 0.0 109.777 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.12 25.1 5.24 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.602 1.161 . . . . 0.0 111.634 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.8 -1.79 23.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.687 1.195 . . . . 0.0 112.982 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.55 -46.44 83.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.014 1.326 . . . . 0.0 110.84 -173.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.32 -39.91 70.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.099 0.863 . . . . 0.0 111.422 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.34 -64.29 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -171.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.61 -41.33 9.42 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.166 0.889 . . . . 0.0 114.103 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -62.85 -46.92 85.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.892 1.346 . . . . 0.0 110.534 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -69.79 -33.78 72.84 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.231 0.469 . . . . 0.0 110.457 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.55 68.02 0.81 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -137.28 132.69 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 100.488 -3.893 . . . . 0.0 100.488 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.7 mtm -147.83 17.04 1.12 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.079 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.8 p -133.92 162.04 33.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 112.339 -168.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.66 139.33 35.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.253 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.91 135.57 16.88 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 N-CA-C 106.26 -2.246 . . . . 0.0 106.26 -11.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.6 m -103.77 140.41 37.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -117.15 135.48 53.73 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 107.659 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.5 mt -121.15 113.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 169.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.09 124.67 43.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -122.69 155.04 37.23 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.909 0.884 . . . . 0.0 109.546 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.36 141.69 24.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 45.47 30.76 0.78 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.353 1.861 . . . . 0.0 113.56 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.72 9.8 51.65 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 116.428 1.331 . . . . 0.0 116.428 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.79 149.56 47.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.718 1.259 . . . . 0.0 111.502 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.71 138.28 21.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.75 -20.75 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.599 1.16 . . . . 0.0 110.966 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -144.51 153.86 42.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.134 0.879 . . . . 0.0 108.914 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -139.83 137.29 34.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.3 t -151.16 148.84 28.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.0 t -138.82 112.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.32 155.84 6.62 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.93 142.68 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.635 0.718 . . . . 0.0 110.537 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -136.01 140.81 34.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -68.64 167.91 21.46 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.343 2.029 . . . . 0.0 110.357 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -44.24 -49.58 9.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.616 1.966 . . . . 0.0 112.281 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -43.6 70.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.28 0.491 . . . . 0.0 111.445 -174.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.59 87.92 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.958 -0.464 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -54.4 45.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.5 0.72 . . . . 0.0 109.612 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.07 -38.87 92.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.546 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.99 -44.04 97.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.759 0.424 . . . . 0.0 111.506 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.09 -44.3 91.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.147 0.979 . . . . 0.0 110.703 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.71 -36.71 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.1 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.24 -30.72 62.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 112.131 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -56.56 -26.58 55.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 112.954 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -125.82 -16.75 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.122 0.969 . . . . 0.0 112.265 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 126.619 1.968 . . . . 0.0 108.701 169.827 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -58.83 131.59 51.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.776 1.231 . . . . 0.0 111.074 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 m120 71.01 124.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.191 2.996 . . . . 0.0 112.378 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -146.73 143.71 28.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 130.809 3.644 . . . . 0.0 103.604 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mt -123.12 142.38 39.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 120.571 1.532 . . . . 0.0 108.344 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.22 142.27 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -128.88 138.3 51.95 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -110.83 148.59 32.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -142.08 112.17 6.93 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 42.4 p -158.51 149.26 20.34 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.741 0.416 . . . . 0.0 111.187 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -47.8 120.59 3.49 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.347 1.459 . . . . 0.0 111.866 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.19 13.69 58.21 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.477 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -7.02 85.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 129.486 3.114 . . . . 0.0 114.926 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -152.53 6.77 0.42 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.368 0.667 . . . . 0.0 111.951 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.44 -93.03 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.869 1.213 . . . . 0.0 111.47 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -24.97 67.61 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.425 -0.797 . . . . 0.0 112.221 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.8 p -61.05 -47.7 85.17 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.519 2.328 . . . . 0.0 112.464 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -64.12 -44.98 90.57 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.796 1.284 . . . . 0.0 108.525 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ttm -59.74 -50.83 72.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.84 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.14 79.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.46 -0.775 . . . . 0.0 111.907 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.64 -26.68 45.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.818 1.19 . . . . 0.0 110.547 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.56 -47.35 69.77 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.462 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 19.4 m95 -54.73 -42.6 71.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 111.319 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.74 72.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -173.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -65.42 -22.26 66.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -69.02 -15.27 63.43 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.312 0.96 . . . . 0.0 113.472 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -130.95 -44.01 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.529 1.059 . . . . 0.0 112.44 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -79.47 73.2 6.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.091 1.756 . . . . 0.0 106.351 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.11 -151.17 0.18 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 127.277 2.37 . . . . 0.0 113.748 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.15 -19.53 63.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.824 1.25 . . . . 0.0 113.399 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.92 -19.49 64.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.2 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -122.39 160.23 25.88 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.378 0.99 . . . . 0.0 111.558 -169.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -133.64 142.18 47.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.852 2.061 . . . . 0.0 105.925 170.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.05 135.01 59.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -142.11 164.51 29.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -146.01 136.37 23.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -169.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 166.75 29.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.481 0.713 . . . . 0.0 111.103 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.06 -172.54 38.73 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 118.018 0.372 . . . . 0.0 113.453 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.421 HG13 ' HE3' ' B' ' 88' ' ' LYS . 2.4 tt -49.04 -57.58 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.634 1.974 . . . . 0.0 113.417 -172.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -135.31 28.89 3.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.147 1.779 . . . . 0.0 108.746 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.01 151.76 47.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 79.6 t60 143.34 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 130.444 3.498 . . . . 0.0 105.049 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.19 177.54 48.43 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.823 -0.548 . . . . 0.0 111.779 -172.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -153.05 92.64 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -65.3 127.36 92.83 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.87 -21.55 71.01 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -36.49 81.14 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 120.171 1.35 . . . . 0.0 110.71 172.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.1 -39.17 63.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -57.8 -53.59 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -60.56 -40.96 93.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.899 0.88 . . . . 0.0 110.883 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.19 -37.0 61.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.55 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 68.5 mmm -82.15 -34.38 29.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.225 0.92 . . . . 0.0 111.496 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.96 -23.41 67.4 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.016 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.87 -31.65 66.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.047 1.294 . . . . 0.0 111.624 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.36 14.34 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.045 1.338 . . . . 0.0 111.268 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.23 41.96 98.09 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.938 -0.923 . . . . 0.0 112.556 175.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.81 147.4 20.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -118.6 135.45 54.43 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 pt -137.02 16.3 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.619 1.568 . . . . 0.0 110.611 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -60.47 -10.04 4.45 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -99.0 -14.15 19.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.048 1.739 . . . . 0.0 113.387 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -58.69 161.3 4.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 t -161.77 -175.78 4.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.802 2.041 . . . . 0.0 107.393 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.6 m -145.47 -162.27 1.47 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.599 1.56 . . . . 0.0 109.803 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -160.35 167.72 26.81 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.74 2.416 . . . . 0.0 106.918 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.6 pt -64.95 168.14 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.47 0.708 . . . . 0.0 111.623 173.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -47.06 129.2 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 108.816 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -137.55 98.55 3.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.897 1.332 . . . . 0.0 109.388 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.0 m -43.87 -32.37 1.07 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.364 2.266 . . . . 0.0 114.045 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.92 -16.57 59.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.164 0.893 . . . . 0.0 112.252 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.04 -37.65 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 117.846 -1.073 . . . . 0.0 109.339 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.09 -55.41 29.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.616 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -23.21 66.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.835 0.289 . . . . 0.0 110.929 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.49 -22.89 28.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.9 2.08 . . . . 0.0 112.814 -175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.05 173.51 1.39 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.985 1.314 . . . . 0.0 111.8 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.17 -24.81 15.55 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.958 0.903 . . . . 0.0 111.614 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 18.5 tp -151.25 143.03 23.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.977 1.311 . . . . 0.0 109.548 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.59 106.37 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 127.165 2.186 . . . . 0.0 106.66 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.22 99.79 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -66.88 128.83 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 tp -125.51 48.85 1.99 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.916 0.887 . . . . 0.0 111.498 -167.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 107.877 175.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -64.83 18.91 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.699 2.4 . . . . 0.0 116.62 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . 0.421 ' HE3' HG13 ' B' ' 39' ' ' ILE . 60.7 mttt 83.15 18.86 0.24 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 128.744 2.818 . . . . 0.0 112.216 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.2 m 32.9 52.82 0.93 Allowed Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 126.502 1.921 . . . . 0.0 111.67 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.87 132.59 22.05 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.056 2.504 . . . . 0.0 114.409 -168.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.85 -1.16 56.13 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 116.774 -1.584 . . . . 0.0 114.459 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p 43.49 89.54 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.476 1.51 . . . . 0.0 113.62 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -57.27 137.57 82.26 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.03 2.487 . . . . 0.0 109.714 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.18 10.97 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.892 3.728 . . . . 0.0 116.015 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -67.65 -9.48 43.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.299 1.04 . . . . 0.0 111.844 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.55 153.14 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.71 1.204 . . . . 0.0 110.115 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -72.82 153.7 40.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.35 1.06 . . . . 0.0 109.254 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -143.06 144.75 32.39 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.9 150.67 27.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -92.75 137.38 32.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -139.61 39.47 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.389 1.476 . . . . 0.0 108.525 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.29 167.79 29.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -157.77 -15.93 0.08 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.728 1.211 . . . . 0.0 111.575 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.54 168.22 25.61 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.232 2.213 . . . . 0.0 106.448 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -142.72 117.38 6.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.139 0.976 . . . . 0.0 109.075 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' B' ' 108' ' ' ARG . 98.0 Cg_endo -72.71 -17.91 25.62 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.682 2.921 . . . . 0.0 112.752 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.5 -0.56 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.516 1.053 . . . . 0.0 112.067 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' B' ' 106' ' ' PRO . 5.4 mmm-85 -123.43 11.23 9.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.59 1.556 . . . . 0.0 111.379 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.95 152.91 0.71 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.133 0.973 . . . . 0.0 111.563 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -35.39 73.77 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.837 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.36 9.13 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -72.92 149.81 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -47.82 -41.6 24.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.583 1.553 . . . . 0.0 111.507 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.61 -40.45 69.79 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.425 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -78.0 -31.55 50.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.907 1.23 . . . . 0.0 109.651 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -63.15 -48.48 78.29 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 119.147 0.885 . . . . 0.0 110.029 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . 0.407 ' CD1' ' CZ ' ' B' ' 120' ' ' PHE . 6.1 t90 -64.92 -46.63 80.85 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.751 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.63 95.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.544 0.738 . . . . 0.0 112.125 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.86 -50.22 71.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' B' ' 117' ' ' TRP 0.251 0.5 OUTLIER -66.51 -40.27 89.1 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.482 -174.66 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -62.2 -49.04 77.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.375 0.989 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -64.96 -48.87 72.49 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.9 -35.12 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.547 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.462 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 6.8 tmm_? -60.11 -44.73 94.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.102 1.319 . . . . 0.0 111.732 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.58 -45.81 84.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.678 0.391 . . . . 0.0 110.923 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.82 -47.58 74.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.776 0.262 . . . . 0.0 110.908 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.8 mt -54.25 -49.89 59.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.415 1.486 . . . . 0.0 109.579 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.21 -42.82 97.76 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.203 -0.776 . . . . 0.0 111.249 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -61.28 -46.19 91.39 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.229 1.015 . . . . 0.0 111.61 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.7 -37.67 85.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.88 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.798 0.726 . . . . 0.0 110.86 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.89 -37.12 83.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.851 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.34 -36.85 78.95 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.581 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -62.11 -41.34 98.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 122.863 2.574 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.27 67.63 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 124.169 0.918 . . . . 0.0 112.356 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.01 -43.92 11.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 111.839 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.8 p -88.49 -17.78 29.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.868 2.067 . . . . 0.0 110.994 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.32 49.82 73.5 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.537 -174.685 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 mtt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.2 149.84 7.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.046 1.338 . . . . 0.0 109.434 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.66 98.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 102.558 -3.127 . . . . 0.0 102.558 168.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.54 165.38 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.924 1.289 . . . . 0.0 107.787 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 122.17 41.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.56 172.47 11.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -161.17 -176.32 5.37 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -36.94 -42.01 0.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.875 2.47 . . . . 0.0 115.487 -169.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.33 -29.83 3.21 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.29 1.036 . . . . 0.0 111.533 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m -62.24 -23.28 66.58 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.336 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.15 -54.26 38.36 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.51 1.05 . . . . 0.0 109.051 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -61.46 -45.09 95.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.078 -0.389 . . . . 0.0 109.988 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.73 89.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.309 0.1 . . . . 0.0 111.214 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -74.75 -22.95 58.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.146 0.978 . . . . 0.0 112.557 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 p -106.79 -6.57 17.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.305 0.957 . . . . 0.0 112.691 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -71.65 -10.26 59.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.12 147.36 34.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.087 0.955 . . . . 0.0 109.434 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.81 -175.13 27.6 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.631 1.11 . . . . 0.0 111.959 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -93.22 132.79 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 169.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.5 t -141.22 116.71 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -169.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -82.23 127.33 33.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.4 138.73 51.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.963 0.801 . . . . 0.0 108.988 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.26 146.89 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.09 1.356 . . . . 0.0 108.902 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.23 114.29 16.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -169.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.54 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.7 p-90 -132.96 156.14 47.83 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.762 1.625 . . . . 0.0 107.153 -170.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -176.37 167.28 1.51 Allowed Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.471 1.108 . . . . 0.0 110.749 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.51 -13.59 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.348 3.366 . . . . 0.0 116.601 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -60.13 -20.57 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.292 1.405 . . . . 0.0 113.648 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.13 152.14 38.8 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.86 1.209 . . . . 0.0 113.235 -171.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.41 -49.24 71.69 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.131 -1.371 . . . . 0.0 112.304 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -50.64 -27.27 19.1 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 115.815 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -58.71 -20.85 52.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 120.48 1.491 . . . . 0.0 113.209 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.62 12.15 27.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.906 1.282 . . . . 0.0 111.42 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -122.15 -43.61 2.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.33 1.052 . . . . 0.0 109.427 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.81 -33.59 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.846 0.858 . . . . 0.0 109.242 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.64 25.14 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 117.942 -1.027 . . . . 0.0 112.471 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.53 -39.41 75.58 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.159 1.906 . . . . 0.0 111.576 174.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 t -55.45 -41.2 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.18 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.7 -43.53 84.09 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.106 0.866 . . . . 0.0 111.151 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.96 -35.41 79.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.795 0.725 . . . . 0.0 109.97 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -68.5 -40.12 81.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.58 1.152 . . . . 0.0 110.692 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.6 -46.05 84.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.734 1.213 . . . . 0.0 110.014 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.0 -40.85 71.61 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.184 -0.323 . . . . 0.0 110.822 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -70.37 -6.9 38.71 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.957 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -102.08 -47.31 4.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.627 1.171 . . . . 0.0 111.092 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.2 ptm -134.76 13.6 3.68 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 112.414 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.67 10.97 4.7 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.204 -0.935 . . . . 0.0 113.638 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.85 -26.17 37.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.497 1.519 . . . . 0.0 109.485 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.67 -24.42 11.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.107 0.963 . . . . 0.0 112.124 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 tp -125.3 148.57 48.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.676 1.59 . . . . 0.0 110.728 -168.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -104.55 144.4 31.74 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mt -127.2 137.68 57.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 t -139.01 145.11 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.54 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 23.6 mtpt -122.12 157.15 32.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.324 0.511 . . . . 0.0 110.767 175.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mm -125.37 127.35 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -87.97 107.46 18.73 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -76.29 39.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -146.19 -38.34 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.468 1.107 . . . . 0.0 109.168 168.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.88 -42.19 19.91 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.5 0.72 . . . . 0.0 111.179 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -138.96 36.61 2.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.238 1.018 . . . . 0.0 111.792 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -70.2 -6.49 34.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 113.429 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -50.81 -45.01 59.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.281 1.832 . . . . 0.0 110.796 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.6 m -54.5 -44.74 72.97 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.828 0.851 . . . . 0.0 111.199 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.21 -57.13 4.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.329 1.052 . . . . 0.0 108.996 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.61 -45.86 47.14 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.058 0.837 . . . . 0.0 113.557 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.0 -43.24 99.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.02 0.91 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.72 -33.35 73.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.293 0.497 . . . . 0.0 109.883 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.48 64.99 0.97 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.24 -61.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.252 7.0 ptm 49.44 7.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.815 3.246 . . . . 0.0 115.406 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.4 p -140.68 163.96 31.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 111.987 -172.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -142.66 149.64 51.09 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.096 0.959 . . . . 0.0 108.925 -174.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.42 134.47 31.84 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 106.962 -1.976 . . . . 0.0 106.962 -11.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.7 m -112.27 146.74 37.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -131.79 121.47 24.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.4 mt -115.02 112.17 22.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.19 127.21 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -126.33 156.73 39.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.941 0.896 . . . . 0.0 109.587 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -146.66 140.08 25.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.8 t70 44.86 30.41 0.55 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.265 1.826 . . . . 0.0 114.125 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.64 14.69 49.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.835 1.207 . . . . 0.0 115.899 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.51 148.31 52.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.745 1.218 . . . . 0.0 110.803 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.81 134.87 29.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -122.79 -22.41 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.796 1.238 . . . . 0.0 109.799 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -146.68 156.15 42.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.548 1.139 . . . . 0.0 109.477 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 133.59 16.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.2 p -154.12 163.28 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.471 0.653 . . . . 0.0 110.246 172.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.9 113.74 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.54 153.95 6.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.22 142.18 58.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.914 0.486 . . . . 0.0 110.612 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -134.32 140.69 36.63 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -66.84 169.51 14.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.201 1.934 . . . . 0.0 110.109 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -50.03 31.9 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.595 1.158 . . . . 0.0 111.082 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.81 -43.22 72.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.924 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.19 87.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.061 0.392 . . . . 0.0 110.33 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.8 tp -68.46 -46.99 68.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.928 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.63 -36.24 83.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.69 -47.03 82.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.306 0.503 . . . . 0.0 110.713 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.2 -39.13 78.16 Favored 'General case' 0 N--CA 1.459 -0.015 0 C-N-CA 123.659 0.783 . . . . 0.0 111.512 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -81.61 -41.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.795 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -54.39 -31.87 55.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.594 1.158 . . . . 0.0 112.177 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -56.23 -24.73 44.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.478 1.111 . . . . 0.0 113.218 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -128.83 -16.55 4.15 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.078 0.951 . . . . 0.0 112.518 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--O 1.248 1.025 0 C-N-CA 127.176 2.19 . . . . 0.0 108.812 169.905 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.6 86.92 2.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 m120 74.72 130.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.016 2.926 . . . . 0.0 112.103 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.452 ' HE3' ' CZ3' ' B' ' 32' ' ' TRP . 37.2 mtmt -127.69 122.98 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 128.846 2.858 . . . . 0.0 103.363 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mt -90.54 142.97 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 110.353 -167.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.43 150.23 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.703 1.601 . . . . 0.0 107.225 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.56 157.37 45.92 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.16 0.584 . . . . 0.0 111.831 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -116.63 142.79 46.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.946 1.299 . . . . 0.0 107.593 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 23.7 mt -126.21 125.7 42.85 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 71.8 m -155.17 135.05 12.84 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.321 1.848 . . . . 0.0 109.133 -169.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.2 m -51.33 118.58 3.37 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.802 1.241 . . . . 0.0 110.927 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.97 4.68 11.78 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.701 -1.055 . . . . 0.0 113.737 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 3.1 t30 33.26 40.05 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.246 2.619 . . . . 0.0 113.74 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -81.75 -40.63 22.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.711 0.804 . . . . 0.0 111.126 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.38 -55.69 0.9 Allowed 'General case' 0 CA--C 1.526 0.058 0 C-N-CA 123.471 0.709 . . . . 0.0 112.707 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -49.89 -60.47 2.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.306 1.042 . . . . 0.0 110.184 -169.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -73.18 -28.43 62.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.602 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -54.86 -46.97 74.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -43.93 67.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.103 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.92 89.12 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 118.82 0.737 . . . . 0.0 112.374 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.65 -32.03 69.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.896 0.771 . . . . 0.0 110.582 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.67 -51.2 53.94 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -56.72 -32.91 65.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.88 1.272 . . . . 0.0 112.278 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.2 -53.82 7.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 111.079 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.54 -26.73 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -62.62 -17.57 60.55 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 173.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.4 -10.15 5.17 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.78 1.232 . . . . 0.0 113.011 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -124.69 81.54 1.96 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -163.23 3.01 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.063 1.792 . . . . 0.0 112.585 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.99 -9.91 18.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.915 1.286 . . . . 0.0 113.641 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -61.17 -22.53 64.82 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.903 -1.123 . . . . 0.0 109.745 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . 0.452 ' CZ3' ' HE3' ' B' ' 4' ' ' LYS . 30.9 m95 -126.7 177.37 6.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.363 2.265 . . . . 0.0 108.46 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -157.26 130.55 7.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.73 142.42 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.58 169.76 16.99 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.048 1.739 . . . . 0.0 108.21 -174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 98.5 p -150.13 149.79 30.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.74 174.09 15.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.459 0.704 . . . . 0.0 111.313 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.98 -177.66 41.01 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.535 -0.302 . . . . 0.0 113.119 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.462 HG13 ' HE3' ' B' ' 88' ' ' LYS . 3.0 tt -43.97 -58.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.315 2.246 . . . . 0.0 114.228 -173.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -134.37 30.09 3.57 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.308 1.843 . . . . 0.0 108.191 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.37 137.01 55.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.355 1.862 . . . . 0.0 114.571 -169.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 172.14 114.4 0.01 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 130.377 3.471 . . . . 0.0 102.412 169.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.18 -179.72 43.61 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 118.875 0.761 . . . . 0.0 112.214 -174.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.5 tp -164.07 93.07 0.69 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 169.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -64.61 125.9 89.66 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.08 -21.14 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.036 1.824 . . . . 0.0 112.715 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -37.41 83.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.273 0.942 . . . . 0.0 111.143 171.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.16 61.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t -57.22 -50.93 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.55 -44.77 85.45 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.561 0.619 . . . . 0.0 110.496 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.36 -22.81 45.07 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.96 0.904 . . . . 0.0 112.694 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 77.8 mmm -102.65 -34.13 9.18 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.365 0.984 . . . . 0.0 112.301 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -60.22 -27.9 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.172 0.896 . . . . 0.0 110.092 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.73 -33.04 32.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.755 1.622 . . . . 0.0 112.383 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.89 17.39 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.299 1.44 . . . . 0.0 110.796 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.27 37.95 93.33 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.935 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 47.4 mt -115.94 107.32 22.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 172.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -73.22 132.65 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 30.8 pt -135.81 19.05 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.991 1.316 . . . . 0.0 110.823 173.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -59.76 -15.64 21.74 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.837 0.744 . . . . 0.0 111.963 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -83.97 -15.29 48.35 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.7 2.4 . . . . 0.0 114.345 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -69.9 159.55 33.47 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.742 1.156 . . . . 0.0 112.762 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 66.8 p -139.64 -169.78 2.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.125 2.57 . . . . 0.0 108.806 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 p -157.86 -173.43 4.36 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.101 0.961 . . . . 0.0 108.708 169.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -166.44 159.25 14.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 127.491 2.316 . . . . 0.0 108.017 -170.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.64 166.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.05 0.94 . . . . 0.0 111.888 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -50.07 133.28 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -142.85 98.79 3.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.237 1.017 . . . . 0.0 109.161 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.6 m -44.49 -32.43 1.4 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.827 2.051 . . . . 0.0 113.773 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.92 -17.65 63.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.383 0.992 . . . . 0.0 112.648 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -126.93 -34.01 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.811 0.844 . . . . 0.0 108.852 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.25 -54.18 23.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.603 1.092 . . . . 0.0 110.172 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -23.93 67.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.986 0.812 . . . . 0.0 110.416 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.91 -23.02 55.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.806 1.642 . . . . 0.0 112.138 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.94 165.69 3.11 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.763 1.225 . . . . 0.0 111.8 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.15 -29.32 15.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.036 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -145.26 133.91 22.16 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.156 0.982 . . . . 0.0 110.996 -173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.55 116.33 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.074 1.75 . . . . 0.0 108.227 170.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.38 109.33 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -76.17 123.32 25.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 167.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 tp -116.32 39.09 3.2 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.732 -0.605 . . . . 0.0 109.489 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.448 -0.574 0 C-N-CA 123.369 0.668 . . . . 0.0 111.644 -168.797 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.15 38.17 0.05 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.67 1.988 . . . . 0.0 115.055 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . 0.462 ' HE3' HG13 ' B' ' 39' ' ' ILE . 14.1 mttt 64.37 21.94 12.62 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.642 -1.911 . . . . 0.0 111.742 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p 30.41 62.38 0.96 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 127.504 2.322 . . . . 0.0 112.049 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.36 132.18 49.29 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.791 2.327 . . . . 0.0 111.066 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.6 3.18 55.64 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p 43.2 92.22 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.009 2.524 . . . . 0.0 113.698 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -61.71 147.51 95.16 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.013 1.809 . . . . 0.0 109.942 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.4 -2.52 6.16 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.915 3.743 . . . . 0.0 115.348 -169.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -62.58 -10.03 10.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.6 1.16 . . . . 0.0 112.154 170.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.1 t -137.52 143.95 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.842 1.257 . . . . 0.0 109.525 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -76.04 155.46 34.86 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -139.98 142.61 36.31 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.833 -1.167 . . . . 0.0 108.993 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -145.45 159.28 43.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 169.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -106.74 128.72 54.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -119.16 8.73 11.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.583 1.153 . . . . 0.0 110.501 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.58 162.38 24.62 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -157.81 24.63 0.27 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.776 1.23 . . . . 0.0 109.422 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.35 172.62 18.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.407 1.883 . . . . 0.0 106.642 -171.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -148.25 116.14 4.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.57 1.148 . . . . 0.0 108.737 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.24 -28.51 22.86 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.13 2.553 . . . . 0.0 111.917 -171.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.79 -3.28 3.16 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.448 1.099 . . . . 0.0 112.755 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -97.05 5.74 49.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.249 1.02 . . . . 0.0 111.673 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.75 142.9 3.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.778 0.831 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -55.24 -45.95 76.04 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.474 0.71 . . . . 0.0 109.914 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.32 -15.11 4.22 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.8 p -69.22 162.37 27.27 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.74 -39.08 90.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.473 0.654 . . . . 0.0 110.534 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.04 -41.43 82.1 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 116.983 -1.484 . . . . 0.0 109.05 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.85 -31.46 59.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 120.851 1.66 . . . . 0.0 109.607 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -57.12 -62.91 1.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -59.44 -39.99 85.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.03 95.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.608 0.763 . . . . 0.0 112.305 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -63.17 -48.27 79.1 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 118.583 0.628 . . . . 0.0 109.474 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -65.89 -40.46 91.59 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -65.85 -46.69 77.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.265 1.026 . . . . 0.0 110.297 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -60.23 -49.52 77.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.21 -46.76 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.018 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -62.59 -39.62 94.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.154 1.343 . . . . 0.0 111.347 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.26 -43.87 96.74 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.212 0.32 . . . . 0.0 110.615 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.66 -55.36 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.128 0.571 . . . . 0.0 109.641 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.1 mt -54.86 -52.45 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.309 1.044 . . . . 0.0 109.416 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.98 97.84 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.817 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -61.38 -47.15 87.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.42 1.11 . . . . 0.0 111.409 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -65.81 -41.11 92.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.466 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.46 -37.86 83.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.771 0.714 . . . . 0.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -62.92 -47.13 84.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.588 0.631 . . . . 0.0 109.731 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.05 -36.11 82.49 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.253 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.62 -40.94 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 121.543 1.974 . . . . 0.0 110.735 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.64 71.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.27 0.628 . . . . 0.0 112.629 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.99 -37.05 13.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 111.636 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 51.4 p -100.3 -14.13 18.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.72 1.608 . . . . 0.0 111.546 -169.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.98 48.37 86.62 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.108 0.563 . . . . 0.0 111.876 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.08 169.66 21.99 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.334 1.453 . . . . 0.0 107.778 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.29 93.65 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 169.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.01 170.71 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.473 1.909 . . . . 0.0 107.804 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -129.24 130.84 46.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.846 0.858 . . . . 0.0 108.757 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.55 176.94 6.37 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.411 1.884 . . . . 0.0 110.375 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -152.03 -176.73 5.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.043 1.737 . . . . 0.0 106.692 169.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -38.67 -37.6 0.34 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.774 2.83 . . . . 0.0 116.067 -169.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -128.81 -30.6 2.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.301 1.04 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.8 m -61.49 -20.89 63.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.422 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -49.47 -53.33 23.69 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -64.2 -45.04 90.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.09 77.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.397 -0.189 . . . . 0.0 111.369 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.37 -14.03 59.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.723 1.209 . . . . 0.0 112.494 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 p -120.79 -6.38 9.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.66 1.118 . . . . 0.0 113.474 -169.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.1 m -78.11 -0.77 29.43 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.382 -0.824 . . . . 0.0 113.11 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.86 145.51 36.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.16 0.984 . . . . 0.0 108.935 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.99 -170.86 54.68 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.893 0.759 . . . . 0.0 111.752 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.99 116.47 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.1 t -133.18 118.98 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.09 137.61 32.2 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.9 144.8 47.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -139.3 144.48 38.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 108.275 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.48 111.52 15.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.431 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.3 p-90 -131.52 154.16 49.06 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.926 1.69 . . . . 0.0 108.153 -169.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.89 163.14 7.88 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.896 0.771 . . . . 0.0 110.07 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -54.02 -14.02 5.45 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.981 3.121 . . . . 0.0 116.272 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -60.8 -24.32 65.74 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.836 1.198 . . . . 0.0 113.84 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.22 155.8 47.53 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.523 1.056 . . . . 0.0 112.335 -169.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.65 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.166 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.26 -27.41 23.05 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.347 2.698 . . . . 0.0 115.139 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m -57.83 -20.47 36.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 120.108 1.322 . . . . 0.0 113.324 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 11.33 22.71 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.404 1.082 . . . . 0.0 111.352 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.9 mtm -122.34 -43.65 2.29 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.09 -37.92 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.11 -58.55 14.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.203 -0.904 . . . . 0.0 112.332 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.75 -39.22 75.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.111 1.874 . . . . 0.0 111.919 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.01 -39.98 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.781 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.97 -42.82 80.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.989 0.813 . . . . 0.0 110.491 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.9 -36.88 85.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.558 0.617 . . . . 0.0 110.009 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.66 -36.91 81.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.301 -0.874 . . . . 0.0 110.642 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.93 -44.61 92.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.426 1.09 . . . . 0.0 110.231 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.66 -34.74 72.35 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.565 -0.71 . . . . 0.0 111.425 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.14 -27.02 68.64 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.451 -0.78 . . . . 0.0 111.657 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -90.29 -42.99 10.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.641 1.176 . . . . 0.0 111.291 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.1 ptm -144.2 18.98 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.704 0.802 . . . . 0.0 112.126 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.15 -7.0 15.27 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.311 -0.868 . . . . 0.0 114.309 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.35 -22.78 67.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.711 0.804 . . . . 0.0 111.054 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 -10.66 7.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.852 1.261 . . . . 0.0 112.779 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.9 tp -127.48 150.53 49.62 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.497 1.119 . . . . 0.0 112.092 -168.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -124.27 150.03 45.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.38 143.0 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.1 121.43 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.79 0.723 . . . . 0.0 109.215 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.431 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.9 mmmm -85.91 155.54 20.88 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mm -128.22 116.13 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 101.759 -3.422 . . . . 0.0 101.759 168.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.29 107.7 9.88 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.315 33.2 m -79.6 48.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -154.87 -45.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.34 1.456 . . . . 0.0 108.527 167.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.3 -35.84 30.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.175 0.99 . . . . 0.0 110.91 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -133.89 30.27 3.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.625 1.57 . . . . 0.0 110.514 -169.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -73.73 -5.84 43.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -56.05 -45.78 79.14 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.3 1.44 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.9 m -54.85 -42.62 72.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.335 0.654 . . . . 0.0 110.755 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.21 0.73 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.13 -44.2 14.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.103 0.858 . . . . 0.0 113.411 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.93 -44.99 87.67 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.265 1.033 . . . . 0.0 111.442 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -69.53 -26.71 64.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.743 0.701 . . . . 0.0 110.369 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.81 65.98 0.83 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.86 130.59 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 101.189 -3.634 . . . . 0.0 101.189 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 29.8 mtm -148.78 21.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -138.96 163.08 33.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.814 1.245 . . . . 0.0 113.603 -167.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.17 135.57 27.4 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.266 -0.874 . . . . 0.0 109.497 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -85.98 125.05 8.53 Favored 'Cis proline' 0 N--CA 1.45 -1.042 0 N-CA-C 106.001 -2.346 . . . . 0.0 106.001 -11.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.0 m -88.9 148.14 23.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.26 119.69 10.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.9 mt -118.2 109.63 16.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.86 138.42 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.24 157.09 41.84 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.419 1.088 . . . . 0.0 111.251 -172.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -138.11 127.75 25.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.71 1.204 . . . . 0.0 107.79 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 36.48 37.99 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.252 2.621 . . . . 0.0 115.507 168.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.94 -30.67 2.35 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.44 158.9 44.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -165.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.43 134.88 28.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.393 1.077 . . . . 0.0 108.721 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -122.42 -24.88 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.837 1.655 . . . . 0.0 111.321 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -144.78 153.35 41.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.95 146.96 33.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.6 m -155.1 153.82 31.45 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.519 1.128 . . . . 0.0 108.631 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.68 69.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.01 159.46 15.93 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 121.717 -0.614 . . . . 0.0 111.779 -173.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.48 145.5 56.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.275 0.63 . . . . 0.0 110.906 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.51 141.31 35.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.031 1.332 . . . . 0.0 107.744 170.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.31 169.46 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.589 2.193 . . . . 0.0 110.558 169.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 -45.01 70.27 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.416 1.086 . . . . 0.0 111.971 -173.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.27 -41.97 84.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.201 0.201 . . . . 0.0 110.693 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.73 76.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.093 -0.38 . . . . 0.0 110.843 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -52.89 57.47 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.454 0.645 . . . . 0.0 109.895 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -62.83 -36.99 85.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.82 -46.7 88.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.729 0.695 . . . . 0.0 111.428 173.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.85 -28.82 62.21 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.829 1.252 . . . . 0.0 111.912 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.2 -42.13 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -57.34 -27.96 62.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.047 -1.033 . . . . 0.0 112.103 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -59.57 -22.54 61.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.57 -16.37 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 169.212 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.98 21.34 0.43 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -169.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.15 128.78 8.54 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 103.857 -2.645 . . . . 0.0 103.857 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -148.39 144.43 27.48 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 130.254 3.421 . . . . 0.0 104.605 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 mt -122.27 142.02 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -141.19 140.95 31.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -121.93 139.91 53.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -169.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -121.96 132.9 54.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -138.9 116.84 11.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.661 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.32 150.26 43.77 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.106 0.963 . . . . 0.0 111.005 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 83.9 m -45.05 106.28 0.07 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.843 1.657 . . . . 0.0 111.352 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.33 39.33 58.87 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.106 1.336 . . . . 0.0 111.188 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -39.09 125.41 1.56 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 38.9 p -141.64 -3.53 1.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.175 168.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.01 -80.42 0.38 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.29 1.036 . . . . 0.0 113.06 -169.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -52.43 -42.74 64.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.565 1.53 . . . . 0.0 113.062 -169.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -76.05 -25.14 55.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.665 1.121 . . . . 0.0 111.948 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.421 HE22 ' C ' ' B' ' 63' ' ' THR . 52.5 mm-40 -62.0 -47.66 83.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.708 1.14 . . . . 0.0 109.588 169.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.1 mtp -66.91 -43.99 81.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.97 93.71 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.705 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.0 -33.68 75.08 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.756 1.162 . . . . 0.0 110.96 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.61 -49.08 58.24 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.44 -41.04 75.77 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.182 0.993 . . . . 0.0 111.233 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.94 87.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -66.19 -19.85 65.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.461 -169.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -78.09 -16.26 58.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.608 1.094 . . . . 0.0 113.505 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.23 -16.42 3.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.86 -116.52 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.73 -167.93 38.07 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 119.161 0.892 . . . . 0.0 110.928 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.54 -20.71 63.55 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.219 1.008 . . . . 0.0 111.348 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -54.28 -24.3 18.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.133 2.173 . . . . 0.0 112.546 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -123.72 156.85 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.355 1.062 . . . . 0.0 110.708 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -125.84 139.56 53.39 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.98 140.25 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.58 157.53 46.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.531 0.732 . . . . 0.0 109.901 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 10.0 p -135.24 131.78 37.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.185 1.394 . . . . 0.0 109.194 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.31 173.75 14.12 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.43 -175.85 46.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.006 1.765 . . . . 0.0 110.405 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 tt -52.43 -53.64 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.83 25.9 4.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.564 1.546 . . . . 0.0 109.078 -174.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.63 147.37 49.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.396 1.879 . . . . 0.0 112.245 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 29.7 p80 174.02 -17.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.579 2.352 . . . . 0.0 110.885 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.26 53.65 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-O 121.871 0.706 . . . . 0.0 113.018 -169.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.78 86.64 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 170.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -59.21 132.97 87.77 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.22 -22.52 57.43 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.757 1.638 . . . . 0.0 112.428 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -56.07 -56.08 25.2 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.4 75.06 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.288 0.949 . . . . 0.0 110.423 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.89 -55.56 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -56.64 -45.93 81.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 110.852 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.85 66.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.97 2.108 . . . . 0.0 111.331 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.3 mmm -89.03 -31.95 17.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.284 0.634 . . . . 0.0 110.27 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -61.63 -25.86 67.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.926 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.68 -27.99 66.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.171 1.351 . . . . 0.0 111.409 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.66 15.61 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.014 1.326 . . . . 0.0 110.971 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.39 93.38 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.693 -1.059 . . . . 0.0 112.964 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 82.1 mt -113.9 109.18 27.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.99 138.44 52.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 pt -134.82 16.07 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.856 0.862 . . . . 0.0 111.309 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 m -60.91 -13.79 18.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.246 0.93 . . . . 0.0 113.187 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -94.08 -13.98 26.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.9 1.68 . . . . 0.0 113.097 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.09 166.49 11.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.549 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.421 ' C ' HE22 ' B' ' 18' ' ' GLN . 13.9 t -156.25 -179.17 7.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.5 1.92 . . . . 0.0 107.458 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 64.0 m -143.41 -174.41 4.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.74 1.616 . . . . 0.0 107.675 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -150.98 171.47 17.23 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.022 1.329 . . . . 0.0 107.596 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.9 pt -62.66 170.71 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.071 0.851 . . . . 0.0 110.821 170.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.81 132.16 6.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -141.95 98.01 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.241 1.019 . . . . 0.0 108.419 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.8 m -47.15 -28.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.544 1.938 . . . . 0.0 114.451 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.08 -22.02 61.42 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 119.496 1.044 . . . . 0.0 110.515 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -40.57 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.693 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.57 -54.48 42.45 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.741 1.155 . . . . 0.0 109.47 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -22.89 67.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.025 0.829 . . . . 0.0 111.69 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.4 -12.58 54.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.738 1.215 . . . . 0.0 113.132 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.85 167.01 12.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.278 0.945 . . . . 0.0 110.544 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.38 -35.35 16.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.733 169.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 23.5 tp -146.38 136.05 23.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.113 1.365 . . . . 0.0 109.814 -172.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 16.0 t -105.06 105.22 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.5 109.4 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -68.49 132.12 46.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 39.1 mt -118.94 151.03 38.9 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.319 -0.723 0 C-N-CA 128.837 2.855 . . . . 0.0 111.623 174.466 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -85.13 18.72 2.45 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.872 -1.143 . . . . 0.0 113.795 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.305 0.2 OUTLIER 53.32 35.21 19.65 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.102 1.761 . . . . 0.0 113.49 -169.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 37.36 52.6 2.66 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.642 2.377 . . . . 0.0 114.212 172.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.49 130.69 37.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.211 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.87 0.48 50.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 116.636 -1.649 . . . . 0.0 115.14 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.9 p 46.43 89.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.948 1.299 . . . . 0.0 113.436 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.98 143.48 92.33 Favored 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 123.132 2.554 . . . . 0.0 110.424 -169.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.19 4.23 0.79 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.092 3.861 . . . . 0.0 116.21 -169.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -67.8 -7.41 27.49 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.397 -0.814 . . . . 0.0 111.941 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -135.84 150.12 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.085 0.954 . . . . 0.0 111.055 -168.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -75.58 158.07 32.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -143.63 147.06 33.78 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.74 -1.225 . . . . 0.0 109.17 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.39 151.4 30.77 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -100.45 131.86 46.14 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.207 1.003 . . . . 0.0 109.627 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -115.88 10.75 15.34 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.04 0.936 . . . . 0.0 111.372 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.57 162.42 35.93 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 121.299 -0.876 . . . . 0.0 111.784 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -144.45 34.76 1.18 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.51 2.324 . . . . 0.0 107.985 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.15 139.27 20.14 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.035 2.134 . . . . 0.0 105.76 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -136.68 125.3 15.15 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 120.072 1.305 . . . . 0.0 111.216 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -82.9 -22.63 4.18 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.566 2.844 . . . . 0.0 113.684 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.77 63.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 118.44 0.564 . . . . 0.0 109.826 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -92.62 -64.61 1.08 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . 0.476 ' HA ' ' CD2' ' B' ' 119' ' ' PHE . . . 46.6 -176.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.147 1.779 . . . . 0.0 114.451 -170.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -40.04 77.08 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.09 -20.41 5.05 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.2 p -70.65 166.7 20.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.632 0.716 . . . . 0.0 109.396 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -41.63 90.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.266 0.555 . . . . 0.0 110.937 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.12 -41.18 62.01 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.668 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.27 -31.85 58.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.569 1.531 . . . . 0.0 109.895 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -58.08 -58.4 8.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -58.98 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.276 0.489 . . . . 0.0 110.605 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.19 97.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.237 -0.914 . . . . 0.0 111.632 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 6.9 m-85 -66.57 -41.0 89.24 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.446 -0.787 . . . . 0.0 109.905 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -54.99 -52.91 61.65 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.289 0.95 . . . . 0.0 109.138 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -67.32 -45.82 75.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.74 0.816 . . . . 0.0 111.004 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttp-105 -62.07 -45.64 92.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.64 -43.19 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.741 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -64.45 -35.43 80.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.32 1.418 . . . . 0.0 111.009 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.46 -45.04 92.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.963 0.347 . . . . 0.0 111.424 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.45 -50.7 72.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.643 0.777 . . . . 0.0 110.195 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.7 -52.66 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.782 1.233 . . . . 0.0 109.342 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.05 -41.84 98.38 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 118.971 -0.905 . . . . 0.0 111.721 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -59.3 -46.53 88.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.297 1.049 . . . . 0.0 110.865 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -66.48 -37.87 86.06 Favored 'General case' 0 C--N 1.335 -0.049 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.499 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.67 -42.44 95.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.892 1.224 . . . . 0.0 110.912 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.53 -43.78 88.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.335 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.27 -40.06 89.04 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 117.361 -1.304 . . . . 0.0 110.654 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.35 -39.43 87.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 121.893 2.133 . . . . 0.0 111.29 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.73 70.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.153 0.581 . . . . 0.0 112.248 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.03 -44.73 9.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.581 1.552 . . . . 0.0 111.319 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.3 p -88.39 -24.39 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.291 1.836 . . . . 0.0 110.632 -169.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 49.11 51.14 26.27 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -169.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 125.246 1.418 . . . . 0.0 112.379 -172.65 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.37 161.14 0.08 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.496 2.318 . . . . 0.0 112.842 -170.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.5 109.6 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.4 t -80.86 167.15 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.827 1.651 . . . . 0.0 107.71 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -125.7 118.18 25.07 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.143 0.977 . . . . 0.0 108.411 170.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.98 174.0 10.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.299 1.439 . . . . 0.0 110.015 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -156.3 -175.87 5.66 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.306 1.442 . . . . 0.0 107.51 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -31.45 -40.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 130.794 3.638 . . . . 0.0 117.101 -169.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.23 -29.58 2.02 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.841 1.256 . . . . 0.0 111.033 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -59.23 -22.56 61.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.731 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -48.58 -51.77 26.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.164 1.347 . . . . 0.0 110.521 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 m -64.89 -45.01 87.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.23 0.468 . . . . 0.0 109.83 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.44 -36.73 83.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.34 -0.225 . . . . 0.0 110.884 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -76.77 -13.83 59.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.722 1.209 . . . . 0.0 112.471 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.5 p -119.8 -2.81 10.31 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.66 1.118 . . . . 0.0 112.504 -170.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.3 m -71.73 -10.89 60.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.18 147.66 38.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.562 0.745 . . . . 0.0 109.809 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.93 -167.56 45.59 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.49 1.043 . . . . 0.0 111.611 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 t -102.58 122.25 54.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.03 115.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -81.07 140.5 35.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.0 44.18 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -141.6 148.2 38.86 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 109.001 -171.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -130.64 115.23 16.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.551 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.5 p-90 -133.7 156.15 48.46 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.603 1.561 . . . . 0.0 107.455 -171.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -176.2 167.88 1.5 Allowed Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.118 0.967 . . . . 0.0 110.905 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.05 -18.0 2.82 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.205 3.27 . . . . 0.0 116.407 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -57.77 -21.89 44.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.333 1.424 . . . . 0.0 114.174 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.73 158.08 44.25 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.672 1.124 . . . . 0.0 112.602 -171.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.6 -49.78 28.79 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.212 -1.327 . . . . 0.0 111.896 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -49.2 -27.29 12.47 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.819 3.013 . . . . 0.0 115.762 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.55 -23.23 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.45 1.477 . . . . 0.0 113.409 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -105.71 9.88 32.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.097 0.959 . . . . 0.0 112.035 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.6 mtm -120.46 -42.35 2.55 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.09 0.956 . . . . 0.0 109.586 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.98 -38.01 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.75 -58.65 13.37 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.187 -0.911 . . . . 0.0 112.259 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.01 -39.72 68.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 111.856 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.32 -41.9 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.231 0.469 . . . . 0.0 110.578 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.09 -42.52 80.24 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.554 0.615 . . . . 0.0 110.573 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.95 -39.81 94.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.733 0.697 . . . . 0.0 109.669 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -68.52 -24.21 64.63 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.102 -0.999 . . . . 0.0 112.11 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 42.0 tp -77.79 -45.61 23.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.648 1.179 . . . . 0.0 109.837 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.77 -34.83 74.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.293 0.497 . . . . 0.0 110.964 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -59.36 -26.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 172.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -96.61 -46.33 6.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.173 0.589 . . . . 0.0 111.433 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.6 ptm -134.49 15.44 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 112.228 -169.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.04 16.9 Favored Glycine 0 CA--C 1.52 0.382 0 O-C-N 121.19 -0.944 . . . . 0.0 114.212 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.83 -24.08 64.33 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.836 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -25.92 7.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.59 1.156 . . . . 0.0 111.494 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.0 tp -112.62 151.67 29.83 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.324 1.45 . . . . 0.0 110.584 -169.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.77 148.53 46.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.1 mt -131.66 137.09 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.3 t -137.17 113.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.4 mtpt -88.36 162.43 16.56 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.126 -0.984 . . . . 0.0 110.182 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -131.12 124.5 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -84.32 109.43 17.81 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.5 m -79.7 39.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -145.46 -37.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 168.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -74.89 -52.02 12.37 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.919 1.288 . . . . 0.0 109.842 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.14 46.68 1.93 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.364 1.066 . . . . 0.0 111.235 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.12 -3.05 20.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.899 1.28 . . . . 0.0 113.138 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -56.38 -42.76 78.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.026 1.33 . . . . 0.0 110.894 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -54.53 -43.22 71.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.021 0.828 . . . . 0.0 111.371 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.96 -57.77 4.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.92 -43.0 39.4 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.908 0.766 . . . . 0.0 113.593 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -64.56 -42.11 95.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.506 1.153 . . . . 0.0 111.115 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -70.17 -30.69 67.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.371 0.532 . . . . 0.0 110.146 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.34 67.5 1.2 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -171.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.28 -62.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.265 6.7 ptm 49.28 10.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.135 2.974 . . . . 0.0 115.183 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.8 p -140.89 162.98 34.17 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.565 1.546 . . . . 0.0 112.598 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.6 mm -142.7 148.3 45.8 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.162 0.985 . . . . 0.0 108.682 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -78.17 137.91 48.6 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 N-CA-C 106.477 -2.163 . . . . 0.0 106.477 -11.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -115.16 147.17 40.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -130.38 124.21 31.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.7 mt -121.56 112.48 18.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.2 t -104.75 128.49 58.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.31 156.9 41.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.239 1.016 . . . . 0.0 110.367 -169.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -146.02 139.25 25.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.73 29.57 0.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.318 1.847 . . . . 0.0 113.509 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.84 54.84 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.665 1.233 . . . . 0.0 111.21 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.76 138.14 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.95 -18.54 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.304 1.441 . . . . 0.0 111.241 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -141.05 157.36 45.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.227 0.922 . . . . 0.0 110.25 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.37 142.22 22.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 m -155.09 151.69 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.95 88.37 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 169.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.48 158.79 11.43 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -67.5 149.88 49.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.99 0.516 . . . . 0.0 110.501 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.88 135.8 14.76 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.69 169.19 16.51 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.315 2.01 . . . . 0.0 110.412 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -45.72 -48.22 15.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.894 1.678 . . . . 0.0 112.348 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.93 -43.66 71.21 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.259 0.481 . . . . 0.0 111.275 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.54 97.15 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.124 -0.36 . . . . 0.0 110.332 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -52.15 66.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.258 0.623 . . . . 0.0 109.711 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.53 -39.83 94.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.631 -0.699 . . . . 0.0 109.413 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.65 -45.77 92.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.807 0.73 . . . . 0.0 110.964 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.8 -37.55 76.6 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 125.277 1.431 . . . . 0.0 111.233 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.34 -37.09 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.824 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -57.98 -33.73 69.22 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.641 1.11 . . . . 0.0 111.374 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.41 -7.44 37.66 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -125.62 -23.55 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.867 1.267 . . . . 0.0 112.481 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.5 tp . . . . . 0 C--O 1.248 1.014 0 C-N-CA 127.168 2.187 . . . . 0.0 108.847 170.646 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -141.43 161.07 38.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.874 0.87 . . . . 0.0 109.658 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.27 28.5 m120 65.32 117.73 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 129.906 3.283 . . . . 0.0 113.567 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -153.94 137.22 15.72 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.99 3.316 . . . . 0.0 103.402 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -114.19 141.48 30.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -169.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.49 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.9 152.8 49.83 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.881 0.872 . . . . 0.0 110.429 -169.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -119.75 135.17 54.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.7 tp -128.99 119.01 23.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -144.35 163.26 34.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 0.0 111.186 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.7 m -61.33 134.3 56.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.93 5.19 0.37 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.357 2.408 . . . . 0.0 118.587 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.319 1.9 t-20 12.98 71.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.424 2.69 . . . . 0.0 112.57 -169.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.5 p -135.33 -27.07 1.23 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.094 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.37 -68.0 0.78 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.332 0.969 . . . . 0.0 112.225 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.34 -55.86 6.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.478 0.581 . . . . 0.0 112.176 -169.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -37.42 81.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.891 -171.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -53.88 -43.88 69.97 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.075 1.35 . . . . 0.0 109.837 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 10.5 mtp -70.04 -49.21 53.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 -40.51 96.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.888 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.87 -33.94 72.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.529 1.059 . . . . 0.0 110.775 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.01 71.5 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -55.85 -39.7 71.82 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.046 0.938 . . . . 0.0 111.394 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.62 75.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -23.99 67.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.402 -169.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.52 -18.16 60.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.02 -23.12 4.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.884 0.766 . . . . 0.0 112.697 -174.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.6 mt -83.19 -113.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.69 -170.33 36.59 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.93 -17.69 57.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.837 0.855 . . . . 0.0 111.615 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -56.17 -23.55 35.73 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.42 1.888 . . . . 0.0 111.843 169.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -120.92 161.75 21.04 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.283 1.433 . . . . 0.0 109.674 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -124.21 135.74 53.67 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 t -127.81 134.16 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -139.71 166.19 25.27 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.691 1.196 . . . . 0.0 108.786 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 68.6 m -143.35 150.73 39.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.588 0.755 . . . . 0.0 110.261 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.99 158.86 44.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.784 1.234 . . . . 0.0 110.366 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 -176.39 38.53 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.116 0.865 . . . . 0.0 110.941 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.444 HG13 ' HE3' ' B' ' 88' ' ' LYS . 1.3 tt -53.69 -63.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 113.482 -169.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.406 ' H ' HG21 ' B' ' 39' ' ' ILE . 77.7 mm-40 -141.28 33.49 1.7 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.766 2.426 . . . . 0.0 105.76 -172.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.13 146.73 52.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.636 2.774 . . . . 0.0 114.26 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -177.24 17.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.899 1.68 . . . . 0.0 111.967 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.86 172.41 40.39 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 120.892 -1.13 . . . . 0.0 112.04 -169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.8 tp -148.68 75.5 1.31 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.89 131.29 79.26 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 125.023 1.329 . . . . 0.0 108.945 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.0 -22.28 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.966 1.777 . . . . 0.0 112.62 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.23 -54.67 44.17 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 119.616 1.098 . . . . 0.0 108.118 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.84 77.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.689 1.131 . . . . 0.0 110.538 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.77 -54.65 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -56.31 -46.08 79.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.006 0.922 . . . . 0.0 110.899 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -34.08 63.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.734 2.014 . . . . 0.0 111.673 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.0 mmm -92.11 -31.21 15.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.114 0.566 . . . . 0.0 110.481 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -61.65 -26.14 67.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.795 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.67 -31.57 64.56 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.961 1.255 . . . . 0.0 111.248 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.47 15.92 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.185 1.394 . . . . 0.0 110.852 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.51 37.55 93.83 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.908 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 81.8 mt -114.13 107.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.9 138.51 54.71 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 pt -133.42 13.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.624 0.77 . . . . 0.0 111.558 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -60.88 -14.34 21.49 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.925 0.784 . . . . 0.0 112.375 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -85.85 -16.05 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.809 1.644 . . . . 0.0 113.659 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.35 153.4 3.97 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.6 p -116.16 159.86 21.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.921 2.088 . . . . 0.0 108.953 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -148.34 153.71 38.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.803 1.241 . . . . 0.0 108.184 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -164.52 161.83 21.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.963 0.801 . . . . 0.0 111.462 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.4 pt -70.43 174.83 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.655 1.182 . . . . 0.0 111.466 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.07 134.0 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.632 0.773 . . . . 0.0 108.918 169.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.93 95.37 2.76 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.477 1.132 . . . . 0.0 109.237 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.44 -34.29 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.878 2.071 . . . . 0.0 113.744 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.81 -20.82 66.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.072 0.851 . . . . 0.0 112.185 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -122.57 -35.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.7 tt -66.21 -46.69 76.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.654 0.661 . . . . 0.0 110.633 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -30.42 71.58 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.847 0.749 . . . . 0.0 110.42 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -78.42 -18.24 55.24 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.662 1.185 . . . . 0.0 112.88 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 167.34 1.75 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.171 0.986 . . . . 0.0 111.961 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -90.19 -25.32 20.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.565 1.146 . . . . 0.0 111.286 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.34 128.68 11.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.994 0.918 . . . . 0.0 109.467 -173.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.09 100.6 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.872 1.669 . . . . 0.0 107.391 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.67 109.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -75.49 101.48 4.87 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 tp -80.98 -43.63 19.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.762 -0.586 . . . . 0.0 111.703 -168.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 123.269 0.627 . . . . 0.0 110.463 175.152 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.209 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -101.05 -1.23 34.73 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . 0.444 ' HE3' HG13 ' B' ' 39' ' ' ILE . 3.4 tttt 73.09 19.04 3.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.852 2.061 . . . . 0.0 113.335 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 30.63 55.68 0.79 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.304 2.242 . . . . 0.0 112.521 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.31 139.69 91.09 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.169 1.913 . . . . 0.0 109.795 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.62 4.1 52.14 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.1 p 40.1 98.54 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 128.919 2.888 . . . . 0.0 114.947 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -61.48 138.42 75.92 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.077 1.851 . . . . 0.0 108.856 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.81 3.18 1.62 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.788 3.659 . . . . 0.0 116.398 -168.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -63.33 -13.9 44.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.041 0.837 . . . . 0.0 112.017 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.47 151.32 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.201 0.91 . . . . 0.0 111.483 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 154.73 40.53 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.04 1.736 . . . . 0.0 108.865 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -139.93 145.5 38.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -151.47 141.85 22.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.5 139.72 33.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.75 0.704 . . . . 0.0 111.088 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -123.57 -63.95 1.19 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.009 0.524 . . . . 0.0 112.126 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.83 -44.01 39.81 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 55.86 27.55 11.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.27 1.828 . . . . 0.0 112.997 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -156.18 172.28 18.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.881 1.272 . . . . 0.0 109.032 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -135.12 113.34 11.41 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.166 1.387 . . . . 0.0 108.417 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.92 -21.01 21.55 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.866 3.044 . . . . 0.0 112.513 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.15 8.36 0.78 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.243 1.017 . . . . 0.0 112.385 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -117.79 13.93 14.22 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.254 1.421 . . . . 0.0 111.288 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.0 151.73 0.6 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.1 0.96 . . . . 0.0 110.984 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.24 -46.16 76.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 -172.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.86 -17.13 3.93 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.2 p -69.63 162.88 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.44 -41.06 88.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.397 0.617 . . . . 0.0 110.791 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -72.16 -43.9 63.91 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 117.079 -1.438 . . . . 0.0 109.851 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.19 -31.05 60.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 121.19 1.813 . . . . 0.0 110.024 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -59.37 -60.4 3.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.54 -39.13 86.77 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.04 97.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.36 -0.838 . . . . 0.0 112.317 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.64 -46.12 83.89 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -58.09 -50.15 74.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.19 -49.01 68.81 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.006 0.922 . . . . 0.0 110.69 -174.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -64.43 -44.09 92.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.894 0.77 . . . . 0.0 110.284 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.82 -42.09 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.985 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -34.82 78.91 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.435 1.47 . . . . 0.0 110.868 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.32 -44.57 83.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.87 0.468 . . . . 0.0 111.484 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.28 -48.31 78.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 17.1 mt -51.44 -53.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.944 1.297 . . . . 0.0 109.066 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.84 -41.71 99.66 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.252 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -63.4 -41.13 98.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.386 1.093 . . . . 0.0 111.765 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -71.72 -31.83 67.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.07 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.21 -48.08 79.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.354 0.979 . . . . 0.0 111.021 171.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -68.94 -37.64 78.98 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.989 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.62 -45.77 88.49 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.788 169.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -59.61 -38.41 81.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.423 1.919 . . . . 0.0 111.128 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.59 76.66 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.17 -44.75 12.66 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.594 1.557 . . . . 0.0 112.162 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.3 p -91.94 -23.0 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.687 1.995 . . . . 0.0 111.198 -169.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.03 54.15 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.306 0.955 . . . . 0.0 112.241 -169.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 127.761 2.425 . . . . 0.0 112.794 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.23 165.41 0.09 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.061 2.145 . . . . 0.0 113.32 -171.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.19 105.34 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.88 169.68 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.54 1.936 . . . . 0.0 108.614 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -123.14 114.81 20.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.073 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.95 170.94 15.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.996 0.918 . . . . 0.0 109.861 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -156.41 174.5 15.32 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.37 1.868 . . . . 0.0 106.148 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -32.71 -40.65 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 129.277 3.031 . . . . 0.0 116.425 -169.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.06 -31.08 3.14 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.26 1.024 . . . . 0.0 111.651 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -62.42 -21.45 65.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.558 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -50.85 -51.4 51.64 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.796 1.18 . . . . 0.0 109.178 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -62.64 -44.58 95.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.068 -0.395 . . . . 0.0 110.012 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.74 87.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.429 -0.169 . . . . 0.0 110.906 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.75 -12.85 60.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.723 1.209 . . . . 0.0 112.89 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.8 p -118.46 -5.87 10.76 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.626 1.103 . . . . 0.0 112.591 -170.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.3 m -75.81 -7.38 54.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.972 . . . . 0.0 113.454 -175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.05 155.35 45.39 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.366 1.066 . . . . 0.0 109.057 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.15 -155.6 48.86 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.27 0.938 . . . . 0.0 111.052 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.05 131.4 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 t -138.89 122.02 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.15 -168.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -94.35 94.74 8.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 107.891 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.41 148.61 28.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -141.37 146.68 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.665 1.586 . . . . 0.0 109.15 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -129.44 114.25 15.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.423 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.1 p-90 -124.63 161.75 25.59 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.148 1.379 . . . . 0.0 107.358 -174.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.34 159.34 23.82 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.5 -26.37 44.83 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.421 2.08 . . . . 0.0 114.281 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -51.29 -33.43 28.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -171.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -154.85 166.96 31.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.425 1.466 . . . . 0.0 114.075 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.61 -45.63 95.32 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.385 -1.786 . . . . 0.0 114.431 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.78 -29.65 43.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.383 2.592 . . . . 0.0 114.472 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -59.29 -18.74 40.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.139 1.336 . . . . 0.0 114.089 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -114.23 12.32 17.68 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.644 1.177 . . . . 0.0 111.162 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.1 mtm -121.52 -43.79 2.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.589 1.156 . . . . 0.0 109.238 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.68 -37.99 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.964 0.906 . . . . 0.0 109.226 169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.13 -57.88 19.78 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.045 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.7 -39.74 60.92 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.125 1.883 . . . . 0.0 112.064 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.17 -40.49 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.138 0.975 . . . . 0.0 110.85 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.47 -44.37 74.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.947 0.794 . . . . 0.0 110.524 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.8 -37.82 88.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.489 0.586 . . . . 0.0 109.909 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -72.34 -19.97 61.56 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.148 -0.97 . . . . 0.0 111.831 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 tp -80.89 -44.67 17.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.64 1.176 . . . . 0.0 108.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.7 -34.12 73.47 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.764 -0.585 . . . . 0.0 111.063 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.79 -24.81 66.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.779 -0.576 . . . . 0.0 112.176 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -97.13 -44.3 7.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.796 0.838 . . . . 0.0 111.302 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.3 ptm -139.49 14.33 2.56 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.857 0.863 . . . . 0.0 112.108 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.7 -5.11 22.49 Favored Glycine 0 C--O 1.227 -0.341 0 O-C-N 121.088 -1.007 . . . . 0.0 114.07 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.65 -24.25 66.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 110.788 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 -27.07 8.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.391 1.076 . . . . 0.0 111.875 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -116.01 151.01 36.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.466 1.506 . . . . 0.0 112.059 -168.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -116.97 148.56 41.32 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.81 143.55 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.6 t -140.54 120.18 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.6 mmmm -87.31 154.13 20.93 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.651 0.66 . . . . 0.0 110.963 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -127.98 115.18 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 102.933 -2.988 . . . . 0.0 102.933 168.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -88.26 87.87 7.45 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 m -42.61 -44.48 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.871 1.669 . . . . 0.0 113.669 -172.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.7 -23.9 65.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.489 1.495 . . . . 0.0 112.443 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -108.53 -30.24 8.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.588 1.555 . . . . 0.0 111.873 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -135.59 25.06 3.43 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -168.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.68 -5.79 13.13 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.585 -0.697 . . . . 0.0 112.645 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.84 -28.35 49.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 111.162 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -74.83 -46.92 33.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 0.0 109.847 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.45 -71.07 0.2 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.357 1.463 . . . . 0.0 111.989 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.37 -41.08 11.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.622 1.105 . . . . 0.0 113.292 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.8 -44.58 89.47 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 118.457 -0.783 . . . . 0.0 111.571 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -65.08 -40.73 95.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.21 67.98 0.41 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.93 127.47 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.3 ptm -147.19 19.38 1.23 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.118 -0.468 . . . . 0.0 109.991 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' B' ' 90' ' ' PRO . 3.3 m -141.86 169.86 16.8 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.587 1.155 . . . . 0.0 110.573 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.6 mm -137.92 145.16 46.99 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 107.563 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.15 134.59 30.76 Favored 'Cis proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 -10.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.0 m -102.16 146.68 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.98 137.47 54.6 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.964 1.706 . . . . 0.0 106.639 170.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -124.95 112.45 16.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.68 119.61 49.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.49 152.07 37.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.061 0.944 . . . . 0.0 109.421 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.7 136.13 38.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.2 t70 43.14 28.09 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.886 2.074 . . . . 0.0 114.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.68 48.34 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.579 1.085 . . . . 0.0 115.317 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -129.98 143.96 51.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.891 1.276 . . . . 0.0 110.058 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.0 139.4 19.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.95 -22.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.961 1.304 . . . . 0.0 111.187 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.64 161.01 39.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.723 0.773 . . . . 0.0 109.877 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -155.76 147.08 22.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.8 m -153.4 149.93 28.31 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.089 -1.007 . . . . 0.0 108.432 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.86 68.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.99 156.18 10.83 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.028 1.775 . . . . 0.0 109.521 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -73.22 163.99 27.32 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.886 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -149.89 135.95 10.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.638 1.575 . . . . 0.0 107.26 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -68.58 167.74 21.84 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.0 109.903 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -169.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.96 -43.94 70.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.271 0.487 . . . . 0.0 110.853 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.46 78.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.326 0.512 . . . . 0.0 110.403 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.9 tp -70.7 -48.48 54.42 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.439 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -61.13 -37.68 83.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.2 -48.43 81.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.766 1.166 . . . . 0.0 110.827 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.46 -42.22 70.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.715 1.206 . . . . 0.0 111.291 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -90.52 -37.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.195 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -21.94 64.06 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.345 1.429 . . . . 0.0 112.594 -176.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -78.98 -5.92 55.04 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.128 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -126.4 -30.21 2.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.85 1.26 . . . . 0.0 111.993 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 C--O 1.249 1.065 0 C-N-CA 125.978 1.711 . . . . 0.0 108.408 169.771 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.08 136.4 53.71 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 109.448 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m120 69.85 127.36 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.967 2.507 . . . . 0.0 110.712 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -137.76 119.06 14.63 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 128.822 2.849 . . . . 0.0 103.98 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.61 139.6 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -169.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.08 149.28 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.906 1.282 . . . . 0.0 107.567 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -133.72 146.6 50.93 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.439 -168.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.2 140.53 48.48 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 31.8 tp -136.71 110.97 8.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.5 p -146.22 156.21 43.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -57.78 129.82 43.63 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.863 1.665 . . . . 0.0 111.477 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.41 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 46.9 39.25 11.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.335 23.1 t-20 -37.07 99.85 0.02 OUTLIER 'General case' 0 C--N 1.345 0.39 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -166.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -144.47 -2.18 0.88 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.834 1.253 . . . . 0.0 111.626 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.93 -60.71 0.73 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -171.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -51.9 60.83 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.781 -1.2 . . . . 0.0 111.862 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 14.9 m -64.34 -34.27 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.142 0.177 . . . . 0.0 110.811 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -60.57 -50.73 72.37 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.141 1.776 . . . . 0.0 109.636 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 6.0 ptp -67.56 -40.09 84.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.72 94.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.838 0.855 . . . . 0.0 111.683 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.07 -30.27 64.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.332 0.969 . . . . 0.0 111.251 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.37 -50.59 54.99 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.417 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -55.93 -37.26 68.71 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.117 0.967 . . . . 0.0 111.585 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.67 56.02 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 122.599 0.36 . . . . 0.0 110.414 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -65.16 -24.36 67.37 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.85 -12.52 61.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.414 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 10.9 m-85 -130.39 -14.33 3.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.433 1.093 . . . . 0.0 113.876 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 25.4 mt -120.19 88.49 2.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.22 -166.86 0.57 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.78 1.657 . . . . 0.0 113.586 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.71 -17.0 12.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.623 1.169 . . . . 0.0 112.718 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.29 -24.38 7.34 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.702 1.601 . . . . 0.0 110.946 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -127.46 153.4 46.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.048 1.739 . . . . 0.0 110.061 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 135.21 47.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.04 152.98 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -169.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -145.99 164.06 33.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.438 1.095 . . . . 0.0 109.236 177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.5 m -142.22 126.08 17.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 108.958 -169.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.16 -177.85 6.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.499 0.591 . . . . 0.0 111.266 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.69 -167.75 40.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.41 HG22 ' H ' ' B' ' 12' ' ' GLY . 16.0 tt -70.11 154.65 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 31.8 58.13 0.33 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 130.016 3.326 . . . . 0.0 110.041 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.29 137.53 53.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.459 1.103 . . . . 0.0 111.896 -168.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 28.0 p80 174.99 -2.36 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.84 2.056 . . . . 0.0 111.568 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.09 174.97 54.3 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.923 0.783 . . . . 0.0 111.828 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 tp -139.33 83.83 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -55.39 128.93 68.44 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.58 1.152 . . . . 0.0 108.03 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.73 -21.67 57.42 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.735 1.623 . . . . 0.0 112.326 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -57.44 -54.21 49.37 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 168.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.93 80.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.089 1.313 . . . . 0.0 110.893 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.22 -54.11 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.35 -43.42 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.393 0.677 . . . . 0.0 110.757 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -35.54 62.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.712 2.005 . . . . 0.0 110.339 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 75.1 mmm -93.75 -33.0 13.78 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.988 0.915 . . . . 0.0 111.831 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -59.84 -29.41 68.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.034 0.834 . . . . 0.0 110.901 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -60.32 -33.03 71.81 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.388 0.994 . . . . 0.0 111.63 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.87 13.95 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.609 1.164 . . . . 0.0 111.363 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.2 38.62 92.09 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.648 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.75 107.54 22.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.54 137.82 52.75 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.62 13.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 123.751 0.821 . . . . 0.0 111.773 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -60.4 -15.83 29.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.125 0.875 . . . . 0.0 112.543 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -81.6 -17.07 49.55 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.557 1.543 . . . . 0.0 113.556 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -54.52 154.04 5.14 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -125.51 158.42 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.184 2.194 . . . . 0.0 108.86 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 6.4 m -150.12 157.3 42.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.784 1.234 . . . . 0.0 108.354 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -162.39 168.84 21.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.581 1.152 . . . . 0.0 109.621 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 10.7 pt -69.21 172.23 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.296 1.038 . . . . 0.0 112.124 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -44.24 131.31 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 125.517 1.527 . . . . 0.0 108.413 175.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -142.69 94.25 2.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.863 0.84 . . . . 0.0 108.926 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -50.63 -24.01 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.259 1.423 . . . . 0.0 114.791 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 -29.43 66.35 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 120.661 1.573 . . . . 0.0 109.917 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.37 -42.08 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.172 171.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -63.12 -49.59 73.82 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.652 1.114 . . . . 0.0 110.578 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -29.49 70.74 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.884 1.22 . . . . 0.0 110.138 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -77.12 -14.67 59.76 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.553 1.141 . . . . 0.0 112.867 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.17 163.64 19.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.176 0.988 . . . . 0.0 110.167 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.81 -36.94 16.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.828 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -145.33 139.89 27.35 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.415 0.686 . . . . 0.0 111.357 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.4 t -118.54 109.64 27.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 126.252 1.821 . . . . 0.0 107.538 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.7 97.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -66.2 125.86 26.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 167.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -129.96 61.67 1.57 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.958 0.903 . . . . 0.0 111.437 -167.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 51.4 m . . . . . 0 CA--C 1.536 0.409 0 C-N-CA 124.796 1.239 . . . . 0.0 108.299 169.736 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -73.55 43.53 0.14 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.65 1.58 . . . . 0.0 113.882 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 52.54 -155.71 0.18 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.808 1.643 . . . . 0.0 110.706 -169.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.68 63.54 59.53 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.57 2.348 . . . . 0.0 105.421 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 37.4 Cg_exo -57.14 128.3 29.18 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.932 1.755 . . . . 0.0 110.572 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 3.11 48.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.149 -0.929 . . . . 0.0 113.036 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p 37.05 91.93 0.06 OUTLIER Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 128.283 2.633 . . . . 0.0 113.695 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -55.2 130.09 38.8 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.399 2.733 . . . . 0.0 107.939 -174.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.83 2.66 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 126.129 4.553 . . . . 0.0 118.351 -168.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.9 -24.82 68.02 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 119.446 1.021 . . . . 0.0 109.87 169.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.03 153.53 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.39 1.076 . . . . 0.0 112.393 175.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -93.38 154.72 17.8 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 167.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -152.94 146.08 24.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.532 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -156.11 154.78 31.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 168.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -104.77 140.22 38.41 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.885 1.274 . . . . 0.0 109.284 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -142.81 -1.17 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.12 -58.65 3.34 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.387 0.994 . . . . 0.0 110.939 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 55.78 14.83 1.42 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.264 1.825 . . . . 0.0 113.656 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -163.2 171.06 16.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 0.0 107.822 -169.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -150.51 104.92 3.09 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.311 1.045 . . . . 0.0 108.984 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.45 -29.6 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.931 2.42 . . . . 0.0 114.301 -169.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.28 64.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.526 0.731 . . . . 0.0 111.026 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -83.67 -56.7 3.57 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . 0.416 ' HA ' ' CD2' ' B' ' 119' ' ' PHE . . . 44.29 -176.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.097 2.159 . . . . 0.0 115.233 -169.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.54 -40.46 73.4 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.1 -20.9 4.69 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 49.1 p -70.93 166.4 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.689 0.745 . . . . 0.0 109.385 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.95 -39.66 86.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.119 0.485 . . . . 0.0 111.042 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -75.65 -42.69 50.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 117.504 -1.236 . . . . 0.0 109.593 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.39 -30.14 60.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.513 1.506 . . . . 0.0 110.231 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -57.21 -59.25 5.39 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 169.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -61.47 -38.8 88.57 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.794 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.56 94.05 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.216 -0.928 . . . . 0.0 111.865 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 4.0 m-85 -64.63 -46.49 82.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.216 -0.421 . . . . 0.0 109.965 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -56.3 -49.62 73.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -62.54 -48.54 79.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.853 1.661 . . . . 0.0 110.128 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -60.22 -51.9 67.59 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.86 -41.67 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.61 -0.709 . . . . 0.0 109.427 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.417 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 3.7 tmm_? -59.62 -43.01 93.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.511 1.051 . . . . 0.0 111.777 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.8 -46.23 88.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.263 0.483 . . . . 0.0 110.928 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.73 -38.89 73.59 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.23 -0.294 . . . . 0.0 110.99 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.25 -45.74 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.36 1.064 . . . . 0.0 108.875 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.81 -42.7 86.03 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-O 119.165 -0.797 . . . . 0.0 111.682 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -56.97 -45.66 82.73 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.346 1.073 . . . . 0.0 110.988 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -61.34 -39.64 91.33 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.612 0.765 . . . . 0.0 110.44 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.01 -34.15 57.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 119.094 0.861 . . . . 0.0 112.589 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.414 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.9 ttmt -66.83 -39.17 87.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.751 0.705 . . . . 0.0 109.413 172.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -61.31 -35.22 76.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 117.296 -1.335 . . . . 0.0 110.077 169.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.4 -41.07 88.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 120.881 1.673 . . . . 0.0 109.814 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.64 70.47 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.81 0.844 . . . . 0.0 112.591 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -92.27 -36.55 13.16 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.378 1.471 . . . . 0.0 112.721 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 70.6 p -109.1 -11.81 14.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.962 1.705 . . . . 0.0 111.905 -169.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.75 23.63 67.41 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.034 1.302 . . . . 0.0 113.515 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.034 1.734 . . . . 0.0 106.848 -169.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 tpp . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.31 171.15 19.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.639 1.576 . . . . 0.0 107.571 170.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.2 93.82 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.73 171.29 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.148 1.779 . . . . 0.0 107.842 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.82 144.92 49.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.279 1.032 . . . . 0.0 109.174 172.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.25 169.94 8.91 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.257 1.823 . . . . 0.0 108.594 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -156.54 -173.79 4.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -38.67 -39.48 0.5 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.932 2.493 . . . . 0.0 115.811 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -129.01 -30.2 2.24 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.337 1.055 . . . . 0.0 111.505 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -60.77 -25.25 66.38 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.657 -0.687 . . . . 0.0 111.815 172.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -52.15 -56.55 13.8 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.064 0.847 . . . . 0.0 109.226 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -61.02 -44.16 97.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.89 -34.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.352 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.41 -12.91 57.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.573 1.149 . . . . 0.0 113.333 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.4 p -120.83 -7.92 9.48 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.096 1.316 . . . . 0.0 114.398 -168.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -78.71 -2.32 38.74 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -140.43 153.0 46.14 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.28 1.032 . . . . 0.0 109.237 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.14 -157.23 49.38 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.71 128.92 72.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.36 115.16 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.9 tt -78.93 139.06 38.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.62 141.56 51.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.54 142.09 48.03 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.372 1.469 . . . . 0.0 108.563 -173.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.5 116.42 21.07 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -135.02 154.23 51.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.95 1.3 . . . . 0.0 108.711 -170.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.1 161.49 18.46 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.51 0.724 . . . . 0.0 109.651 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.87 -14.83 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.498 2.799 . . . . 0.0 116.514 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -55.15 -24.21 25.34 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.4 p -155.94 169.6 24.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.771 1.168 . . . . 0.0 113.481 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.57 89.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.39 -1.783 . . . . 0.0 114.28 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.31 -28.46 43.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.381 2.591 . . . . 0.0 114.311 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -59.2 -16.83 22.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.898 1.226 . . . . 0.0 113.828 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -116.59 13.0 15.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.737 1.215 . . . . 0.0 111.525 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.0 mtm -122.91 -43.62 2.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.301 1.04 . . . . 0.0 109.415 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.09 -38.06 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -56.49 32.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.716 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.57 -38.68 80.88 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.87 1.713 . . . . 0.0 111.54 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.49 -38.11 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.9 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.52 -48.03 79.22 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 119.559 1.072 . . . . 0.0 109.979 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -66.57 -35.7 80.84 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.905 -0.497 . . . . 0.0 109.848 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.62 -15.33 61.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.74 1.616 . . . . 0.0 112.833 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.25 -44.6 10.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 108.56 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.7 -37.98 76.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.298 -0.251 . . . . 0.0 111.082 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -68.4 -9.85 51.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.948 -0.548 . . . . 0.0 112.15 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.0 -48.32 3.77 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.112 0.965 . . . . 0.0 110.967 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -132.35 16.11 4.52 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.822 0.849 . . . . 0.0 112.45 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.54 19.23 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 121.175 -0.953 . . . . 0.0 114.134 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.28 -23.83 65.71 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 169.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.3 -18.81 9.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.191 0.996 . . . . 0.0 112.439 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.9 tp -128.47 148.08 50.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.364 1.066 . . . . 0.0 111.413 -168.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -110.54 146.98 35.09 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.92 142.23 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.43 140.27 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -106.77 145.34 32.2 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 123.868 0.867 . . . . 0.0 110.281 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.02 122.78 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -85.47 111.21 19.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.261 33.8 m -82.48 41.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -148.49 -38.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.932 0.893 . . . . 0.0 109.415 168.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.86 -51.4 12.6 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.88 1.272 . . . . 0.0 109.862 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.47 47.77 2.17 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.68 1.192 . . . . 0.0 110.088 -172.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -73.55 -1.75 19.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.861 1.265 . . . . 0.0 112.758 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -55.28 -44.47 75.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.243 1.417 . . . . 0.0 110.86 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -57.92 -41.72 83.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.685 0.675 . . . . 0.0 111.152 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.24 -61.81 1.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.455 1.102 . . . . 0.0 108.719 -171.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.86 -41.74 28.53 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.753 -1.026 . . . . 0.0 113.851 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -62.75 -44.35 96.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.432 1.616 . . . . 0.0 110.961 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -71.78 -11.78 60.98 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.196 0.453 . . . . 0.0 111.276 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.66 56.13 6.9 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 m -103.71 -46.41 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.976 0.888 . . . . 0.0 108.942 -169.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.3 mtm 52.73 15.23 0.5 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 127.574 2.35 . . . . 0.0 113.397 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 m -138.08 159.77 41.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.589 1.155 . . . . 0.0 110.945 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.46 143.77 42.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.07 129.91 20.09 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 N-CA-C 107.71 -1.689 . . . . 0.0 107.71 -10.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -98.04 145.36 26.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tp -137.01 126.57 25.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -124.82 110.45 14.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.99 120.22 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 171.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp -112.47 150.79 30.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.697 1.199 . . . . 0.0 109.298 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -150.77 124.75 9.26 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.09 27.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.5 2.72 . . . . 0.0 114.93 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.32 -24.01 3.26 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.606 -1.108 . . . . 0.0 115.378 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.48 159.04 43.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.032 1.416 . . . . 0.0 113.156 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.15 133.62 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.59 -20.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.888 1.275 . . . . 0.0 111.04 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.76 157.7 44.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.235 1.014 . . . . 0.0 109.524 169.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.94 148.28 29.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -171.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -152.71 149.54 28.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.06 57.68 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.09 20.4 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.921 1.724 . . . . 0.0 110.622 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -66.63 157.2 33.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.995 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -148.13 135.33 10.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -68.43 169.66 16.6 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.484 2.123 . . . . 0.0 110.412 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -46.8 65.43 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 112.034 -171.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.77 -42.13 77.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.849 0.093 . . . . 0.0 110.958 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.28 81.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.866 -0.521 . . . . 0.0 110.423 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.83 -47.67 71.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.19 -37.15 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.723 -0.655 . . . . 0.0 109.54 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.11 -46.63 86.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.675 0.67 . . . . 0.0 110.93 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -56.02 -41.64 75.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.439 0.696 . . . . 0.0 111.093 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -83.15 -42.0 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.506 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.4 -35.53 67.88 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.523 1.129 . . . . 0.0 111.801 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -69.18 -7.67 38.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.36 -25.7 4.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.472 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.606 1.962 . . . . 0.0 109.275 173.947 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.14 27.49 4.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.842 1.257 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -157.39 129.73 7.31 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.87 114.3 22.39 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 129.333 3.053 . . . . 0.0 103.677 174.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -90.12 141.16 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.22 141.49 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -131.53 138.86 49.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -115.76 152.66 32.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.75 0.705 . . . . 0.0 109.305 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 mt -132.11 118.35 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.6 p -150.22 157.49 43.14 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.804 1.242 . . . . 0.0 109.402 169.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 31.3 m -53.6 123.97 13.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.313 1.045 . . . . 0.0 110.361 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.95 18.49 11.79 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.657 0.646 . . . . 0.0 113.312 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t30 43.05 47.68 5.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.189 1.796 . . . . 0.0 112.691 -169.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -74.77 -157.35 0.06 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.82 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -33.92 -63.3 0.27 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.55 2.74 . . . . 0.0 116.82 -168.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -57.99 -47.23 83.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 0.896 . . . . 0.0 111.611 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -60.51 -49.4 77.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.718 0.69 . . . . 0.0 111.681 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -57.14 -48.8 77.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.317 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.4 ttm -66.81 -42.93 85.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.551 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.93 84.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.923 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.16 -28.93 57.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.615 1.098 . . . . 0.0 111.179 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 -43.86 48.44 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -56.1 -41.72 75.65 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.18 0.99 . . . . 0.0 111.117 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.45 -50.58 70.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -63.39 -21.76 66.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 118.079 -0.962 . . . . 0.0 113.277 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.37 -16.45 63.93 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.612 1.096 . . . . 0.0 113.824 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.6 -39.79 0.57 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.896 1.226 . . . . 0.0 113.107 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.417 ' HG ' ' CG ' ' B' ' 32' ' ' TRP . 4.3 tp -77.45 75.6 4.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.534 2.734 . . . . 0.0 105.081 169.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.64 -166.9 1.86 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.85 2.167 . . . . 0.0 114.767 -169.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -56.93 -20.61 24.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.23 1.412 . . . . 0.0 112.968 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -55.65 -20.54 14.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 112.482 169.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . 0.417 ' CG ' ' HG ' ' B' ' 28' ' ' LEU . 63.9 m95 -118.22 174.17 6.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.383 1.873 . . . . 0.0 109.789 -176.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 114.61 5.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.78 149.2 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -150.8 167.36 27.7 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 168.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -152.17 147.54 26.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 110.391 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.06 178.16 9.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.855 1.262 . . . . 0.0 111.216 -169.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.14 -175.63 42.75 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -47.75 -58.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.492 . . . . 0.0 114.541 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.07 31.56 4.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.573 1.549 . . . . 0.0 108.425 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.45 151.32 47.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.68 1.992 . . . . 0.0 115.17 -169.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 p80 162.8 47.2 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 130.906 3.683 . . . . 0.0 107.567 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.8 177.28 27.86 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.894 0.759 . . . . 0.0 112.017 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 36.3 tp -161.28 83.67 0.64 Allowed 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.44 126.47 90.66 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.476 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.41 -24.98 75.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.214 1.943 . . . . 0.0 112.722 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.3 -51.17 70.9 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.76 74.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.849 1.204 . . . . 0.0 111.214 -175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.04 -53.76 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.58 -48.09 80.33 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 110.567 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.984 1.714 . . . . 0.0 111.855 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.72 -43.49 14.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.861 0.864 . . . . 0.0 110.051 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.24 -30.71 69.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.623 0.647 . . . . 0.0 110.832 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -27.59 62.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.874 1.27 . . . . 0.0 112.292 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.37 15.48 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.147 1.379 . . . . 0.0 111.158 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.66 72.66 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.179 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 63.0 mt -110.19 149.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -117.93 135.45 54.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.589 0.756 . . . . 0.0 108.993 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.409 ' C ' ' H ' ' B' ' 61' ' ' ASN . 19.4 pt -136.56 17.4 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.4 1.08 . . . . 0.0 111.048 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -67.23 13.46 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -169.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' B' ' 59' ' ' ILE . 28.3 t30 -137.75 -4.56 1.78 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.235 2.614 . . . . 0.0 111.539 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -57.92 147.73 27.94 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.532 1.06 . . . . 0.0 111.324 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -126.89 168.95 13.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.61 1.964 . . . . 0.0 109.184 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 7.0 p -155.03 -174.45 4.99 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.172 0.989 . . . . 0.0 108.442 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -159.23 168.51 26.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.559 1.543 . . . . 0.0 107.933 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.7 pt -60.26 164.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.464 0.705 . . . . 0.0 111.304 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -48.22 127.04 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -135.83 99.17 4.1 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.67 1.224 . . . . 0.0 109.194 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -42.68 -31.68 0.49 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.731 2.413 . . . . 0.0 114.559 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.07 -17.67 63.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.243 0.928 . . . . 0.0 112.212 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.33 -38.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.345 1.058 . . . . 0.0 109.04 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.77 -56.56 18.22 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.02 1.282 . . . . 0.0 109.332 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.0 66.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.566 0.621 . . . . 0.0 111.279 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.41 -24.76 36.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.025 1.73 . . . . 0.0 112.525 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.55 172.03 2.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.481 1.513 . . . . 0.0 112.149 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.92 -36.93 13.85 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.67 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 tp -143.64 133.26 23.64 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 109.634 -171.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.38 115.15 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.16 107.82 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.1 m -75.53 88.06 2.67 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 167.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 48.01 1.16 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.949 1.7 . . . . 0.0 107.114 -169.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.443 -0.785 0 C-N-CA 124.725 1.21 . . . . 0.0 109.937 -169.732 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.64 50.15 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.327 1.451 . . . . 0.0 113.527 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 52.78 -147.53 0.47 Allowed 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.999 -1.063 . . . . 0.0 108.627 -169.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.48 55.53 1.98 Allowed Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 126.683 1.993 . . . . 0.0 106.1 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.7 135.03 50.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.181 1.254 . . . . 0.0 112.003 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . 0.255 0.0 OUTLIER -83.69 4.93 26.51 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p 39.91 84.88 0.17 Allowed Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 125.245 1.418 . . . . 0.0 113.063 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -53.57 138.97 67.03 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.201 2.601 . . . . 0.0 110.614 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.95 8.6 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 125.669 4.246 . . . . 0.0 117.225 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.04 -5.13 20.0 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.218 -0.926 . . . . 0.0 111.608 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.9 149.88 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.655 1.182 . . . . 0.0 110.473 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.85 155.75 35.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -142.2 146.99 35.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 120.713 -1.242 . . . . 0.0 108.507 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -139.4 151.46 46.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -133.9 115.93 15.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -152.64 1.73 0.31 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.17 -53.33 45.6 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.756 1.162 . . . . 0.0 111.123 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.8 t80 58.18 -12.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.405 2.682 . . . . 0.0 117.03 169.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -152.28 82.0 1.25 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.252 1.421 . . . . 0.0 108.497 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.05 129.6 77.94 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.646 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.08 -26.64 9.06 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.661 2.907 . . . . 0.0 112.909 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.73 11.85 0.45 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.601 1.092 . . . . 0.0 112.035 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -123.61 16.18 9.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.234 2.214 . . . . 0.0 111.14 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.06 153.12 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -67.63 140.81 56.87 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.51 58.28 4.99 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.268 -168.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -127.17 149.87 49.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.19 -40.32 46.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.698 1.599 . . . . 0.0 111.507 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.83 -41.06 60.6 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.916 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.15 -31.49 49.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.948 0.795 . . . . 0.0 109.8 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -57.64 -59.85 4.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -62.75 -39.83 95.36 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.665 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.6 84.2 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.684 0.794 . . . . 0.0 112.313 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -63.95 -47.74 79.29 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.46 -40.51 96.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.387 0.54 . . . . 0.0 110.399 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -64.34 -51.69 62.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.691 1.196 . . . . 0.0 109.627 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.2 ttp-105 -59.1 -46.12 89.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.75 -43.86 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.377 -1.297 . . . . 0.0 111.19 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.69 81.99 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.554 1.979 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.42 -45.7 89.75 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.58 -53.79 46.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.665 0.786 . . . . 0.0 110.354 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.69 -47.38 85.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.938 0.895 . . . . 0.0 109.765 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.96 -44.11 98.56 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -62.05 -43.66 98.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.049 0.925 . . . . 0.0 111.801 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -65.3 -45.93 82.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.421 0.555 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.67 -31.87 70.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.057 0.844 . . . . 0.0 111.198 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.87 -39.84 91.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.103 171.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -59.7 -38.37 81.39 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.075 -1.44 . . . . 0.0 111.155 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -60.26 -37.23 79.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.69 2.041 . . . . 0.0 109.928 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.36 79.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.374 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -81.75 -47.92 12.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.411 1.085 . . . . 0.0 111.672 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.1 p -82.0 -24.19 35.56 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.835 2.054 . . . . 0.0 112.526 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.94 24.17 62.4 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 C-N-CA 128.381 2.672 . . . . 0.0 112.226 -169.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.54 169.74 23.96 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.556 1.542 . . . . 0.0 107.581 171.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.76 96.53 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.36 166.27 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.148 1.379 . . . . 0.0 108.065 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -126.03 116.14 20.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.151 1.38 . . . . 0.0 108.088 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.14 173.95 10.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.861 1.264 . . . . 0.0 111.157 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -155.36 179.07 9.52 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.986 2.514 . . . . 0.0 105.544 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -48.33 -29.88 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.543 1.937 . . . . 0.0 115.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.79 -27.29 3.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.85 0.86 . . . . 0.0 112.394 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.3 m -59.86 -40.35 88.28 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.83 122.28 18.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 167.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m 118.9 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.693 1 C-N-CA 132.034 4.133 . . . . 0.0 106.126 -169.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.32 93.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 110.361 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -80.03 -13.15 59.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.42 1.488 . . . . 0.0 112.225 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.0 p -120.24 -9.96 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -168.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -80.81 0.28 35.56 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.165 0.893 . . . . 0.0 113.299 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.1 150.87 47.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.997 0.817 . . . . 0.0 110.159 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.83 -152.55 51.74 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.22 131.66 69.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.73 114.37 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -169.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.48 97.36 7.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 107.474 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.43 26.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -138.84 147.54 42.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.439 1.496 . . . . 0.0 109.299 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -128.49 110.96 12.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -171.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.537 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.0 p-90 -123.35 150.01 44.19 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -173.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.3 154.94 22.69 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.351 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.67 -20.76 22.65 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.981 2.454 . . . . 0.0 115.426 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -49.65 -28.81 6.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.761 2.024 . . . . 0.0 115.755 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -156.55 169.66 24.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.72 1.6 . . . . 0.0 113.463 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.6 -45.3 96.6 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.364 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -52.21 -29.63 38.45 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.533 2.666 . . . . 0.0 114.96 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -58.82 -20.99 55.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 120.32 1.418 . . . . 0.0 113.783 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -109.5 11.61 24.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.389 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -121.6 -43.85 2.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.385 1.074 . . . . 0.0 109.426 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.61 -35.62 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.003 0.921 . . . . 0.0 109.577 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.23 14.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.827 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.01 -38.59 77.15 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.018 1.812 . . . . 0.0 111.784 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.04 -41.57 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.169 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mp -66.37 -41.08 89.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.226 0.921 . . . . 0.0 110.987 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.98 -35.51 80.77 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.085 0.857 . . . . 0.0 110.063 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -71.2 -24.12 62.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.802 1.241 . . . . 0.0 112.152 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.442 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 3.4 tm? -81.55 -44.97 16.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.132 1.373 . . . . 0.0 108.735 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.11 -38.47 88.3 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.922 -0.486 . . . . 0.0 111.058 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.95 -5.02 31.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.479 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -105.31 -49.14 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.517 1.127 . . . . 0.0 111.038 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.4 ptm -130.38 15.12 5.55 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.235 0.614 . . . . 0.0 112.152 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -5.85 23.39 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 121.223 -0.923 . . . . 0.0 113.453 170.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.51 -25.23 67.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.009 1.324 . . . . 0.0 110.668 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -25.36 6.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.284 1.034 . . . . 0.0 112.126 -175.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.1 tp -118.84 153.35 34.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.678 1.191 . . . . 0.0 112.428 -167.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -116.1 147.92 40.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.95 144.8 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.63 143.12 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 22.4 mtpt -117.3 152.26 35.24 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.831 0.741 . . . . 0.0 110.417 175.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mm -115.5 115.17 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -80.0 76.93 6.72 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 108.508 169.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -31.83 -59.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 129.081 2.952 . . . . 0.0 114.264 -174.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.71 -23.42 64.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 121.528 1.967 . . . . 0.0 112.788 -170.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.93 -32.12 10.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.412 1.485 . . . . 0.0 112.066 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -136.51 25.15 3.17 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -70.08 -0.08 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.584 1.154 . . . . 0.0 112.851 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -50.61 -46.51 58.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.549 1.14 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -56.57 -43.71 80.26 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.676 0.79 . . . . 0.0 111.634 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.93 2.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.728 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.57 -43.57 28.53 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.911 1.243 . . . . 0.0 113.423 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -64.08 -41.59 97.27 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.442 1.121 . . . . 0.0 111.216 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -70.34 -35.92 73.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.61 0.641 . . . . 0.0 110.101 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.35 69.06 1.0 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.428 -2.269 . . . . 0.0 107.428 -169.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.87 -60.76 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.3 ptm 50.64 7.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.166 2.987 . . . . 0.0 115.158 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 p -142.97 165.22 27.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.667 1.587 . . . . 0.0 112.146 -171.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.0 mm -142.76 145.54 34.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.209 1.403 . . . . 0.0 107.336 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.16 133.98 26.92 Favored 'Cis proline' 0 N--CA 1.452 -0.914 0 N-CA-C 106.603 -2.114 . . . . 0.0 106.603 -11.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.2 m -114.19 142.28 46.45 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.79 137.48 53.36 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -124.37 105.37 9.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 169.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.82 112.85 24.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.78 151.87 21.17 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.719 0.808 . . . . 0.0 109.116 174.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -149.39 126.5 11.32 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 44.7 22.36 0.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.176 2.59 . . . . 0.0 115.097 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.32 -22.57 3.21 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.229 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.13 159.33 42.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.921 1.36 . . . . 0.0 112.679 -168.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.69 134.04 30.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.27 -18.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.092 1.357 . . . . 0.0 110.917 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -144.7 154.8 43.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.41 133.69 15.3 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 p -150.55 158.36 44.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.474 0.579 . . . . 0.0 109.926 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.22 71.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 122.387 1.089 . . . . 0.0 108.708 -169.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 157.22 12.15 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 121.287 -0.883 . . . . 0.0 111.422 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.85 148.78 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.995 0.518 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -142.56 131.03 11.63 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.36 167.94 17.4 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.809 1.673 . . . . 0.0 109.723 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -46.24 -46.07 17.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.717 1.607 . . . . 0.0 112.468 -176.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.86 -42.98 69.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.229 0.468 . . . . 0.0 111.461 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.93 79.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.722 -0.612 . . . . 0.0 110.631 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -54.5 42.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.56 0.744 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.34 -38.75 92.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.626 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.49 -47.62 84.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.993 0.815 . . . . 0.0 110.884 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.61 -43.86 80.57 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.766 0.827 . . . . 0.0 110.693 -174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.72 -33.03 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.747 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -61.89 -26.92 68.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.653 1.115 . . . . 0.0 111.552 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -22.91 35.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.13 0.972 . . . . 0.0 112.629 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -129.74 -22.02 3.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.736 0.814 . . . . 0.0 112.393 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.99 2.116 . . . . 0.0 108.543 172.365 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.76 136.69 45.53 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.251 6.5 m120 67.35 120.78 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 128.542 2.737 . . . . 0.0 111.417 -170.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -148.89 137.38 21.12 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 129.178 2.991 . . . . 0.0 104.145 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.67 139.93 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 109.159 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tt -137.61 143.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.418 ' CD1' HD23 ' B' ' 72' ' ' LEU . 24.1 t80 -138.08 142.95 40.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -169.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -115.8 144.36 44.11 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 mt -133.19 122.28 23.77 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.4 p -165.82 156.89 13.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.349 1.06 . . . . 0.0 109.673 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 56.0 m -52.24 118.61 3.64 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.33 1.052 . . . . 0.0 112.129 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.58 3.26 2.1 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 124.892 1.37 . . . . 0.0 113.979 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 39.51 24.18 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.438 2.695 . . . . 0.0 114.54 -169.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 -40.08 77.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.36 -73.28 0.51 Allowed 'General case' 0 C--O 1.227 -0.08 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -168.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -32.83 68.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.641 -0.662 . . . . 0.0 112.377 -169.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -43.77 76.75 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.366 1.066 . . . . 0.0 110.379 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -55.75 -45.26 78.06 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 110.388 174.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 16.3 ttm -67.99 -46.42 71.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.829 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.23 87.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.31 0.644 . . . . 0.0 111.218 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.96 -28.65 57.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.268 0.94 . . . . 0.0 110.644 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.93 -44.53 46.18 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.406 ' HE1' ' HB2' ' B' ' 124' ' ' ARG . 23.1 m95 -54.49 -41.97 70.18 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.158 0.979 . . . . 0.0 110.887 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.33 -50.68 71.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -66.45 -21.5 66.2 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.387 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -66.31 -16.67 64.23 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.467 1.03 . . . . 0.0 113.025 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.67 -4.49 4.14 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.587 1.155 . . . . 0.0 113.007 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.01 89.75 3.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.51 -171.6 1.38 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.815 0.722 . . . . 0.0 111.962 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.46 -18.15 16.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.436 1.094 . . . . 0.0 112.893 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -54.07 -18.86 4.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.518 1.927 . . . . 0.0 112.655 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.26 158.22 44.72 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.817 1.247 . . . . 0.0 109.62 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -130.35 133.36 46.36 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.014 0.926 . . . . 0.0 108.572 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.72 142.96 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.669 1.587 . . . . 0.0 107.367 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.97 159.47 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 m -139.82 142.37 36.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.07 178.22 10.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.104 0.962 . . . . 0.0 109.839 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.11 -177.71 47.67 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -44.21 -57.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.676 1.99 . . . . 0.0 114.154 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.98 29.59 4.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.335 1.454 . . . . 0.0 108.446 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.3 42.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.46 1.904 . . . . 0.0 113.964 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 75.7 t60 141.17 104.43 0.0 OUTLIER 'General case' 0 C--O 1.235 0.34 0 C-N-CA 130.656 3.582 . . . . 0.0 104.361 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.94 48.19 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -171.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -163.19 94.68 0.83 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.29 1.836 . . . . 0.0 106.67 169.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -68.99 126.55 92.88 Favored Pre-proline 0 C--O 1.239 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.64 -20.87 60.11 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.99 1.794 . . . . 0.0 112.846 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -37.23 84.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.508 1.049 . . . . 0.0 111.199 171.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.98 -34.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.33 -52.18 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -56.21 -46.58 79.4 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.88 0.764 . . . . 0.0 110.553 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.37 -32.46 64.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.007 0.923 . . . . 0.0 111.842 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.7 -38.56 25.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.695 0.798 . . . . 0.0 110.76 177.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -27.21 69.15 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.983 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.474 ' CD ' ' HE ' ' B' ' 124' ' ' ARG . 35.3 mt-10 -55.05 -32.67 62.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.478 1.035 . . . . 0.0 111.817 172.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.12 14.56 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.042 1.337 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.77 35.42 91.99 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.38 -1.233 . . . . 0.0 113.152 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.2 mt -104.95 145.16 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 170.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.66 136.0 53.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 29.0 pt -138.15 17.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 110.655 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -60.39 -13.91 15.9 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -91.72 -14.28 30.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.751 1.62 . . . . 0.0 113.237 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.21 151.31 23.28 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.539 1.161 . . . . 0.0 112.417 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.5 t -152.87 171.79 17.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.588 1.955 . . . . 0.0 107.105 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.0 m -153.69 -167.8 2.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.845 0.858 . . . . 0.0 111.028 -169.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -159.53 168.54 25.92 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.809 1.644 . . . . 0.0 109.562 -171.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.52 172.5 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.111 1.364 . . . . 0.0 112.134 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.31 132.86 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -143.98 100.17 3.52 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.309 1.052 . . . . 0.0 109.457 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.0 m -44.77 -32.32 1.5 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.108 2.163 . . . . 0.0 113.974 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.8 -17.3 64.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.128 0.876 . . . . 0.0 112.351 -174.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.16 -35.62 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.111 0.965 . . . . 0.0 108.842 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.418 HD23 ' CD1' ' B' ' 7' ' ' TYR . 2.2 tm? -63.01 -57.3 11.17 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.584 1.084 . . . . 0.0 109.98 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -22.36 66.93 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.44 0.564 . . . . 0.0 110.05 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.84 -24.38 44.44 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.064 2.146 . . . . 0.0 112.696 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.2 167.71 2.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.854 1.262 . . . . 0.0 111.347 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.9 -30.77 14.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.33 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -149.19 135.5 19.24 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 110.505 -172.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.7 t -107.02 108.02 24.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 127.494 2.318 . . . . 0.0 107.983 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.09 106.32 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -72.97 122.3 21.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 167.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.2 132.92 42.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 127.415 2.286 . . . . 0.0 113.293 176.26 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.67 42.67 0.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.421 1.489 . . . . 0.0 112.075 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm 61.27 -149.79 0.4 Allowed 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.306 -1.496 . . . . 0.0 107.064 -168.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -139.74 71.21 36.85 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.83 129.27 29.89 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.93 1.754 . . . . 0.0 109.019 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.24 5.83 45.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p 39.08 88.65 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 127.942 2.497 . . . . 0.0 113.03 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -58.47 139.0 88.91 Favored 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 122.382 2.055 . . . . 0.0 108.663 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.65 -0.24 1.85 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.957 3.771 . . . . 0.0 115.455 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -61.75 -12.64 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.451 1.101 . . . . 0.0 111.26 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.42 149.03 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.487 1.515 . . . . 0.0 109.237 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -82.97 155.56 23.93 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 ttm-85 -139.7 144.67 37.66 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.126 -0.984 . . . . 0.0 108.479 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -150.85 147.7 27.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.6 130.9 35.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -116.75 18.42 14.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.48 162.35 35.33 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -137.53 18.93 2.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.517 1.127 . . . . 0.0 110.15 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.12 158.38 44.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.178 1.791 . . . . 0.0 107.535 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -134.14 119.64 14.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.873 1.269 . . . . 0.0 107.663 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 -27.2 40.76 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.343 2.695 . . . . 0.0 112.56 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.1 -5.22 6.07 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.633 1.106 . . . . 0.0 112.709 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -100.99 8.25 43.12 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.61 1.164 . . . . 0.0 111.356 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.63 144.05 2.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.17 -45.78 75.75 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 123.845 0.716 . . . . 0.0 109.98 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.74 -16.04 4.04 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.8 p -68.76 162.23 26.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.67 -38.78 92.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 110.776 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.69 -42.57 77.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 117.109 -1.424 . . . . 0.0 109.206 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.58 -31.56 62.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 120.925 1.693 . . . . 0.0 109.555 -175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -56.64 -63.58 1.15 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -58.24 -39.63 79.63 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.04 94.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.812 0.845 . . . . 0.0 112.231 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.71 -45.61 85.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.825 0.739 . . . . 0.0 109.564 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -64.84 -43.36 93.29 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -67.35 -41.99 84.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.611 0.764 . . . . 0.0 111.097 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -59.43 -52.23 66.51 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.32 -42.04 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.396 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.474 ' HE ' ' CD ' ' B' ' 54' ' ' GLU . 41.1 ptt85 -62.24 -37.4 85.25 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.094 1.316 . . . . 0.0 111.471 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.84 -44.01 94.45 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.228 0.33 . . . . 0.0 110.299 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.08 -57.69 9.77 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.738 0.415 . . . . 0.0 110.22 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 12.4 mt -57.53 -47.9 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.345 1.058 . . . . 0.0 109.727 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.35 97.74 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.984 -0.898 . . . . 0.0 111.31 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -44.6 88.25 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.651 1.225 . . . . 0.0 110.762 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.58 92.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.1 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.24 -38.45 78.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.691 1.132 . . . . 0.0 111.328 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.89 -41.18 99.32 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -60.84 -39.95 91.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 116.988 -1.482 . . . . 0.0 110.993 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -58.9 -37.54 76.85 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.856 2.116 . . . . 0.0 111.26 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -31.28 71.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.132 0.573 . . . . 0.0 112.496 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.66 -43.54 10.67 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.537 . . . . 0.0 111.17 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.5 p -89.78 -24.29 21.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.21 1.804 . . . . 0.0 110.729 -169.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 55.29 31.62 56.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 111.608 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt . . . . . 0 C--O 1.245 0.826 0 C-N-CA 123.97 0.908 . . . . 0.0 111.477 -172.438 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.72 165.32 36.35 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.765 1.226 . . . . 0.0 108.176 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.08 101.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 t -80.48 169.47 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.882 1.673 . . . . 0.0 107.54 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.89 53.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.709 0.804 . . . . 0.0 109.188 169.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.23 171.51 8.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.998 1.719 . . . . 0.0 109.713 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -134.94 -170.25 2.53 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.472 1.509 . . . . 0.0 108.821 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -45.09 -29.27 0.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.374 2.27 . . . . 0.0 113.488 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -135.88 -31.18 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.976 1.311 . . . . 0.0 112.097 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -63.53 -21.36 66.29 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.69 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -52.18 -58.04 7.8 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.185 0.902 . . . . 0.0 109.417 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -60.71 -43.85 97.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.956 0.344 . . . . 0.0 110.185 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.15 77.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.367 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -84.23 -15.81 45.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.393 1.077 . . . . 0.0 113.109 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.2 p -114.95 -7.15 12.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.755 1.161 . . . . 0.0 113.805 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -74.7 -5.62 44.21 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.1 153.49 45.45 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.558 1.143 . . . . 0.0 109.053 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.98 -161.02 49.99 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.058 0.837 . . . . 0.0 111.148 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.56 129.53 70.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.15 119.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.157 -168.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.7 98.45 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.84 150.89 27.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -140.46 150.73 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.573 1.549 . . . . 0.0 109.319 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -132.66 115.74 15.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.587 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -136.62 152.9 50.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.919 1.688 . . . . 0.0 107.988 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.9 163.27 6.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.036 0.835 . . . . 0.0 110.41 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.63 -11.98 3.9 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.364 3.376 . . . . 0.0 116.719 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -59.98 -17.44 38.32 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.865 1.211 . . . . 0.0 113.811 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.95 155.68 41.83 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.945 1.248 . . . . 0.0 114.07 -170.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.88 -46.68 80.68 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.725 -1.597 . . . . 0.0 112.81 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -49.0 -31.05 19.43 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.4 2.734 . . . . 0.0 114.785 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -60.52 -15.18 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 120.06 1.3 . . . . 0.0 114.028 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 9.45 13.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.286 1.435 . . . . 0.0 111.339 176.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.6 mtm -120.1 -44.61 2.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.311 1.044 . . . . 0.0 109.486 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.97 -36.42 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.16 18.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.768 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.11 -39.86 55.9 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.879 1.719 . . . . 0.0 111.728 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.16 -33.73 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.328 1.051 . . . . 0.0 111.468 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.81 -41.63 59.6 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.888 0.767 . . . . 0.0 110.687 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.74 -33.09 75.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.203 0.911 . . . . 0.0 109.709 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.04 -25.76 63.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.018 1.327 . . . . 0.0 111.672 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.2 tp -77.1 -44.72 29.5 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 119.063 0.847 . . . . 0.0 109.96 173.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.49 -34.79 70.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.671 -0.643 . . . . 0.0 111.112 -172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.67 -10.69 59.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.511 -0.743 . . . . 0.0 112.251 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -99.79 -42.77 6.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.279 1.432 . . . . 0.0 110.931 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.1 ptm -143.08 18.38 1.94 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.37 0.668 . . . . 0.0 112.399 -172.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.43 -4.6 13.33 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 121.243 -0.911 . . . . 0.0 114.299 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.69 -23.63 66.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.026 0.93 . . . . 0.0 110.919 169.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.24 -11.76 8.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.527 1.131 . . . . 0.0 112.48 -174.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -128.29 148.62 50.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.982 1.313 . . . . 0.0 111.454 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -114.42 147.56 39.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mt -125.22 141.07 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 t -138.95 113.02 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.8 mtpt -86.54 155.08 20.63 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.243 -0.91 . . . . 0.0 110.337 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.75 122.52 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.58 108.74 12.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.306 33.6 m -79.2 47.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -153.01 -41.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.791 1.237 . . . . 0.0 108.984 167.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -83.64 -34.6 25.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.065 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -134.62 27.78 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.958 1.303 . . . . 0.0 110.807 -170.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -71.55 -7.54 48.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.021 0.928 . . . . 0.0 112.851 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -49.05 -51.96 28.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.768 2.027 . . . . 0.0 110.322 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.2 m -61.34 -32.6 72.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.636 0.775 . . . . 0.0 111.829 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.74 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.77 -46.58 7.51 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.676 0.655 . . . . 0.0 113.325 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -60.35 -40.68 91.59 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.097 0.959 . . . . 0.0 111.631 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -89.98 -0.0 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.811 0.845 . . . . 0.0 112.497 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.05 68.81 1.44 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t -146.45 129.99 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 100.951 -3.722 . . . . 0.0 100.951 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -144.44 16.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.306 0.242 . . . . 0.0 110.847 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -130.77 170.11 14.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.121 2.568 . . . . 0.0 112.64 -168.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.88 143.52 46.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.695 0.798 . . . . 0.0 108.902 172.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.26 154.26 65.73 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 -11.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -127.48 147.45 50.31 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -124.3 137.69 54.47 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 106.655 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.7 mt -124.27 107.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -82.41 110.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.3 mp -106.61 148.71 27.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -147.68 125.44 11.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 41.17 30.44 0.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.27 2.628 . . . . 0.0 114.413 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.66 -23.38 4.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.827 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.27 156.88 46.3 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.244 1.522 . . . . 0.0 113.263 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.07 135.76 27.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.14 -22.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.182 1.393 . . . . 0.0 110.554 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -147.4 163.83 35.23 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.287 1.035 . . . . 0.0 110.418 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.34 149.19 30.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -153.46 142.44 21.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.6 72.71 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.35 156.73 8.43 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.441 1.496 . . . . 0.0 110.05 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.3 148.39 51.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.371 0.668 . . . . 0.0 110.456 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.7 141.79 26.2 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.2 167.61 25.69 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.463 2.109 . . . . 0.0 110.834 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.32 -47.72 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 112.799 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.07 -42.51 76.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 110.799 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -32.44 73.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.111 -0.368 . . . . 0.0 110.436 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -54.56 45.51 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.563 1.145 . . . . 0.0 109.681 172.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.87 -39.24 90.51 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.6 -46.29 90.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.314 0.506 . . . . 0.0 111.325 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.86 -41.0 81.5 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.198 0.999 . . . . 0.0 111.105 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.9 -37.32 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.252 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -57.79 -25.88 61.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.632 1.105 . . . . 0.0 112.553 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -53.08 -26.75 17.23 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.005 0.922 . . . . 0.0 112.645 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -128.88 -23.96 3.01 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 112.674 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 170.224 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.96 35.0 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.032 -1.043 . . . . 0.0 110.696 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -152.39 131.69 12.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -137.94 118.62 14.03 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 129.315 3.046 . . . . 0.0 106.431 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mm -90.56 131.78 36.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tt -133.62 135.0 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -169.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -117.15 144.14 45.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -131.75 128.37 38.72 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.232 1.013 . . . . 0.0 108.622 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 66.7 m -148.38 144.27 27.38 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 124.577 1.151 . . . . 0.0 109.096 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 26.2 m -53.69 121.21 7.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.915 0.886 . . . . 0.0 110.185 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.516 ' H ' ' CG2' ' B' ' 39' ' ' ILE . . . 50.01 35.01 24.72 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.948 1.261 . . . . 0.0 111.792 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -31.58 101.85 0.02 OUTLIER 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -135.8 -0.98 2.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.997 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.81 -79.33 0.37 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.194 1.361 . . . . 0.0 113.264 -169.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -46.12 75.67 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.714 0.806 . . . . 0.0 113.074 -169.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.8 m -69.47 -28.56 66.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.111 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -68.26 -47.04 68.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.689 1.131 . . . . 0.0 110.073 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.14 -42.27 76.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.258 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.35 96.85 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.584 -0.697 . . . . 0.0 111.367 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.17 -30.96 65.5 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.1 0.863 . . . . 0.0 110.898 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.58 -50.31 62.87 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -57.22 -33.36 67.45 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.347 1.059 . . . . 0.0 112.225 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.01 -53.41 7.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.571 0.748 . . . . 0.0 111.234 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -68.46 -17.98 64.31 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -168.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.1 -17.75 54.27 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.418 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 33.1 m-85 -126.46 -37.6 2.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.373 0.988 . . . . 0.0 111.996 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.24 71.79 4.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.757 1.623 . . . . 0.0 106.62 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.05 -147.14 0.09 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.562 2.03 . . . . 0.0 114.671 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.19 -23.82 62.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.461 1.104 . . . . 0.0 113.021 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -65.37 -13.27 58.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.247 1.019 . . . . 0.0 113.244 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -123.53 151.93 42.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.431 1.014 . . . . 0.0 111.712 -169.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -132.12 82.74 2.04 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.633 1.973 . . . . 0.0 105.854 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.71 139.68 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.31 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -144.8 166.87 24.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 p -143.28 145.91 33.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.771 -0.581 . . . . 0.0 111.615 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.75 177.79 10.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.296 0.638 . . . . 0.0 112.38 -173.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.35 -178.75 48.53 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.643 0.64 . . . . 0.0 112.289 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.516 ' CG2' ' H ' ' B' ' 12' ' ' GLY . 2.9 tt -46.64 -56.35 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 127.632 2.373 . . . . 0.0 113.272 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -133.87 30.49 3.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.569 1.548 . . . . 0.0 108.779 -172.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 154.79 40.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.843 2.057 . . . . 0.0 112.075 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 137.45 82.88 0.0 OUTLIER 'General case' 0 C--O 1.236 0.37 0 C-N-CA 130.891 3.676 . . . . 0.0 105.274 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.21 175.3 46.64 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -172.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.3 88.92 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -60.48 124.4 78.32 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 125.544 1.538 . . . . 0.0 108.056 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.76 -18.41 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.799 1.666 . . . . 0.0 112.401 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -59.12 -56.81 17.43 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.86 1.209 . . . . 0.0 108.429 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.37 76.05 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.894 1.225 . . . . 0.0 109.719 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.86 -55.81 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.44 -45.51 80.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.917 0.887 . . . . 0.0 110.486 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.89 56.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.378 1.871 . . . . 0.0 111.17 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 73.9 mmm -92.68 -32.16 14.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.632 0.773 . . . . 0.0 111.765 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.06 -26.67 67.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.846 171.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -58.54 -28.73 65.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.412 1.006 . . . . 0.0 112.019 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.46 16.34 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.873 1.269 . . . . 0.0 110.578 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.09 95.21 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.643 -1.087 . . . . 0.0 112.608 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.5 mt -114.32 109.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.51 132.66 43.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' B' ' 61' ' ' ASN . 13.8 pt -134.9 18.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.566 1.146 . . . . 0.0 111.019 173.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.4 m -65.31 14.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -169.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' B' ' 59' ' ' ILE . 30.0 t30 -140.8 -2.7 1.32 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.95 2.5 . . . . 0.0 112.173 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -47.34 -59.52 3.14 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p 53.06 -171.72 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.74 1.616 . . . . 0.0 112.293 -171.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -163.08 -169.53 2.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.459 1.104 . . . . 0.0 109.029 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.2 168.76 23.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.193 2.597 . . . . 0.0 106.555 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.85 175.4 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 120.212 1.369 . . . . 0.0 112.295 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -54.42 36.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 C-N-CA 129.195 2.998 . . . . 0.0 118.11 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -52.32 106.4 0.15 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.93 2.092 . . . . 0.0 113.532 -173.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.1 m -51.51 -26.35 8.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.113 1.765 . . . . 0.0 114.378 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.69 -23.94 66.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.57 1.077 . . . . 0.0 111.845 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.31 -40.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -58.8 -51.61 69.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.355 0.525 . . . . 0.0 110.779 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -26.01 64.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.488 0.586 . . . . 0.0 110.941 -177.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -79.53 -19.14 50.28 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.435 1.094 . . . . 0.0 112.229 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.08 159.19 7.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 111.222 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.3 -22.77 35.51 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.867 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.81 153.22 32.69 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.106 0.962 . . . . 0.0 111.132 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.52 99.32 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 127.22 2.208 . . . . 0.0 105.657 169.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.39 100.46 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.7 m -70.57 125.98 28.32 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.28 136.08 33.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 CA--C 1.538 0.517 0 C-N-CA 128.488 2.715 . . . . 0.0 113.509 175.131 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -72.01 35.45 0.06 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.97 1.308 . . . . 0.0 113.751 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 64.46 35.23 9.64 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.113 1.765 . . . . 0.0 112.853 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.8 p 33.07 50.54 0.68 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.552 1.941 . . . . 0.0 113.151 174.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.28 133.99 61.45 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.452 2.101 . . . . 0.0 114.0 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -23.77 53.18 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.313 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p 51.86 117.83 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.712 2.405 . . . . 0.0 113.367 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.38 150.26 64.16 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.931 1.754 . . . . 0.0 109.285 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.86 -5.45 10.63 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.634 2.89 . . . . 0.0 114.125 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -62.11 -17.31 57.31 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.197 0.999 . . . . 0.0 112.086 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.95 149.99 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.217 0.917 . . . . 0.0 111.031 -173.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -75.66 151.91 37.66 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.482 1.113 . . . . 0.0 108.954 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 ttp-105 -139.07 137.95 36.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -147.69 149.43 32.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -91.78 133.8 35.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . 0.431 ' CZ2' ' HE3' ' B' ' 139' ' ' LYS . 88.6 m95 -125.51 9.36 7.78 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.0 159.93 27.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.5 9.19 4.67 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.705 0.802 . . . . 0.0 111.289 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -150.19 163.72 37.51 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.097 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.34 121.47 15.39 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 125.097 1.359 . . . . 0.0 108.608 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.97 -29.63 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.859 2.373 . . . . 0.0 112.166 -173.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.26 -7.62 6.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.256 0.934 . . . . 0.0 112.994 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt-85 -83.74 -1.65 54.61 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.085 -0.959 . . . . 0.0 112.095 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -34.64 127.4 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.73 1.612 . . . . 0.0 112.507 -175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -69.3 136.76 52.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.98 29.88 2.39 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -167.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 26.3 p -89.57 159.32 17.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.565 1.683 . . . . 0.0 107.262 169.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.95 -37.2 83.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.31 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -77.31 -43.09 34.32 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 117.489 -1.244 . . . . 0.0 109.409 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.1 -27.33 54.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 120.563 1.529 . . . . 0.0 110.269 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -59.83 -57.42 12.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -60.2 -40.91 91.74 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.08 91.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.069 0.948 . . . . 0.0 111.932 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.73 -45.46 92.61 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.617 0.644 . . . . 0.0 109.786 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.66 -49.89 74.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -62.2 -47.0 86.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.778 1.231 . . . . 0.0 110.11 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -56.87 -55.39 35.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 49.8 t -75.13 -39.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.119 -171.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -64.05 -39.48 94.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.751 1.614 . . . . 0.0 111.281 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.95 -41.89 95.1 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.216 0.462 . . . . 0.0 111.105 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -67.36 -46.92 71.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.819 0.448 . . . . 0.0 110.07 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.0 mt -53.09 -49.39 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.042 1.337 . . . . 0.0 108.607 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.99 -50.19 70.5 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 118.387 0.539 . . . . 0.0 112.538 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -64.03 -41.67 97.35 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.632 0.216 . . . . 0.0 110.724 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -66.62 -43.54 84.47 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.615 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.05 -34.32 78.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.759 1.163 . . . . 0.0 111.376 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.418 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 39.3 ttmt -60.94 -32.07 71.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.194 0.906 . . . . 0.0 111.16 174.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.05 -30.19 71.4 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-O 116.902 -1.523 . . . . 0.0 112.06 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -63.1 -37.37 86.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 122.454 2.388 . . . . 0.0 109.785 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.89 73.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.611 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -81.92 -43.3 18.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.366 1.066 . . . . 0.0 112.049 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 82.1 p -88.34 -18.38 28.58 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.65 1.98 . . . . 0.0 111.074 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.51 15.16 75.17 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.158 0.885 . . . . 0.0 112.107 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . 0.431 ' HE3' ' CZ2' ' B' ' 101' ' ' TRP . 5.0 ttpm? . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.116 1.367 . . . . 0.0 109.434 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.76 155.64 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.786 2.434 . . . . 0.0 111.839 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.5 107.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.2 t -79.48 167.14 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.904 1.682 . . . . 0.0 107.988 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -122.99 119.25 29.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.123 1.369 . . . . 0.0 107.924 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.67 168.92 19.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.914 0.886 . . . . 0.0 108.783 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 p -135.26 -167.23 1.97 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.781 1.232 . . . . 0.0 109.354 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -51.88 -20.33 2.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.143 1.777 . . . . 0.0 113.751 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -140.78 -31.72 0.6 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.667 1.187 . . . . 0.0 112.811 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.4 m -63.26 -19.57 64.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.165 0.893 . . . . 0.0 112.202 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -50.6 -55.18 17.44 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 109.76 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -62.29 -44.23 96.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.104 -0.372 . . . . 0.0 110.036 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.06 83.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.946 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -79.87 -19.6 47.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.991 0.917 . . . . 0.0 113.047 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 p -108.96 -7.51 15.39 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.661 1.119 . . . . 0.0 112.943 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -72.22 -7.2 47.96 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -141.8 154.11 44.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 109.615 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.82 -157.15 51.13 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 124.951 1.262 . . . . 0.0 111.996 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 t -113.43 131.41 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 t -140.13 116.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 122.257 1.027 . . . . 0.0 108.493 -169.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.69 121.59 25.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.3 36.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -141.57 149.86 41.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 109.538 -170.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -132.2 113.25 13.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -169.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.641 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.1 p-90 -132.76 149.3 52.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.845 1.658 . . . . 0.0 107.876 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.88 165.12 6.07 Favored Pre-proline 0 C--O 1.235 0.331 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.34 -17.44 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.882 3.055 . . . . 0.0 116.02 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -52.48 -26.8 13.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.854 1.662 . . . . 0.0 114.318 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.55 150.92 48.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.721 1.146 . . . . 0.0 111.509 -172.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.25 -50.9 57.16 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.496 -1.169 . . . . 0.0 111.459 172.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -46.54 -26.15 4.03 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.423 3.415 . . . . 0.0 117.076 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -56.51 -35.46 68.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 121.538 1.972 . . . . 0.0 111.726 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -90.18 7.92 35.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.963 0.905 . . . . 0.0 111.883 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -118.56 -42.82 2.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.023 0.929 . . . . 0.0 109.606 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.63 -33.99 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.793 0.837 . . . . 0.0 109.269 169.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.8 -60.95 7.87 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.08 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.14 -40.19 72.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.07 1.847 . . . . 0.0 111.614 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.18 -40.02 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.473 0.579 . . . . 0.0 110.525 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.72 -39.32 64.38 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.767 0.712 . . . . 0.0 111.574 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.37 -34.92 79.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.43 1.014 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.54 -17.85 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.198 1.399 . . . . 0.0 112.643 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.0 tp -86.94 -43.63 12.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.235 1.014 . . . . 0.0 108.794 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.78 -37.46 70.46 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.146 -0.346 . . . . 0.0 110.945 -175.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.8 -11.86 59.38 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.561 . . . . 0.0 111.942 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -100.02 -47.85 4.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -135.81 15.01 3.36 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.504 0.722 . . . . 0.0 112.392 -170.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.83 -2.09 21.43 Favored Glycine 0 CA--C 1.52 0.383 0 O-C-N 121.093 -1.004 . . . . 0.0 113.951 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.21 -25.27 65.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.696 0.798 . . . . 0.0 110.624 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 -26.84 9.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 -177.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.0 tp -119.76 146.53 45.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.036 1.335 . . . . 0.0 111.886 -168.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -103.31 143.54 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 168.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.1 mt -124.74 136.48 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.39 124.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.641 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpp -99.85 156.28 17.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.036 0.834 . . . . 0.0 109.716 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mm -116.61 127.95 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.01 104.99 10.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 169.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.01 41.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.437 1.113 . . . . 0.0 111.844 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.1 -44.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.594 1.158 . . . . 0.0 110.479 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 110.262 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.75 30.22 3.76 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.59 1.156 . . . . 0.0 110.74 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -3.56 32.56 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.434 1.094 . . . . 0.0 112.586 -169.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -52.14 -45.16 64.9 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.584 1.554 . . . . 0.0 111.233 -169.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -65.71 -26.27 67.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.48 -64.33 0.89 Allowed 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.072 -1.018 . . . . 0.0 108.801 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.22 -38.48 19.03 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.937 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -60.82 -48.58 81.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.37 1.585 . . . . 0.0 110.117 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.54 -13.2 60.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.569 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.95 55.93 14.69 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.67 -43.82 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.6 ptm 45.29 19.77 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 129.415 3.086 . . . . 0.0 113.567 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -133.72 155.66 49.35 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.039 1.736 . . . . 0.0 109.516 -174.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.9 mt -142.45 143.64 27.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 119.034 0.834 . . . . 0.0 109.091 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -67.52 144.83 72.62 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.303 0.787 . . . . 0.0 110.317 -10.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.5 m -114.4 142.03 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.89 136.08 54.12 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.8 mt -125.93 109.15 12.14 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 103.784 -2.673 . . . . 0.0 103.784 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.8 t -83.53 118.51 31.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.11 151.58 36.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.19 0.996 . . . . 0.0 108.498 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -147.87 144.04 27.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 43.69 28.4 0.22 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.952 2.101 . . . . 0.0 113.67 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.16 8.09 55.53 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.928 1.251 . . . . 0.0 116.164 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -134.99 147.87 49.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.926 1.363 . . . . 0.0 111.886 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.0 140.7 17.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.98 0.912 . . . . 0.0 109.186 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.42 -20.79 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.982 1.313 . . . . 0.0 111.122 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.74 161.67 40.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.173 0.989 . . . . 0.0 109.713 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 m -154.19 148.74 26.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.1 m -151.58 150.2 30.04 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.383 1.073 . . . . 0.0 108.531 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -133.18 63.0 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.591 1.556 . . . . 0.0 107.135 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.53 168.13 37.36 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.647 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.06 152.21 45.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.183 0.993 . . . . 0.0 111.034 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 141.2 17.51 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 169.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.81 168.38 23.09 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.447 2.098 . . . . 0.0 110.388 173.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -44.69 65.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 112.524 -170.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.83 -43.84 74.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 117.472 0.124 . . . . 0.0 110.867 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.25 75.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.973 -0.454 . . . . 0.0 110.346 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -53.74 53.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.805 . . . . 0.0 109.844 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.61 -38.25 90.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -61.78 -48.25 81.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.508 0.595 . . . . 0.0 110.75 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -55.86 -44.27 77.9 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 124.457 1.103 . . . . 0.0 110.898 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.03 -37.04 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.508 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -58.94 -26.36 64.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.172 0.989 . . . . 0.0 112.208 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -22.67 39.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.644 0.778 . . . . 0.0 112.459 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -131.12 -19.67 2.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.133 0.973 . . . . 0.0 112.969 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--O 1.248 1.017 0 C-N-CA 127.521 2.329 . . . . 0.0 107.87 170.393 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.84 128.62 36.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.22 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.325 2.65 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -137.83 128.74 27.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -92.88 144.65 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.623 0.577 . . . . 0.0 110.377 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.7 147.98 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.642 1.577 . . . . 0.0 106.746 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.45 142.64 37.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -169.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -97.84 143.27 28.62 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -145.27 131.42 19.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -169.79 172.01 6.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.32 1.848 . . . . 0.0 108.96 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -48.61 125.01 9.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.495 1.518 . . . . 0.0 109.832 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.49 4.9 0.27 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.209 1.861 . . . . 0.0 117.699 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 t30 47.4 18.32 0.1 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.63 1.715 . . . . 0.0 113.315 -169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 9.9 p -84.43 57.42 4.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.341 2.257 . . . . 0.0 114.787 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 136.94 -58.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.446 3.098 . . . . 0.0 113.433 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -53.95 -53.97 45.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.807 0.843 . . . . 0.0 110.948 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.39 -33.16 72.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.88 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -58.7 -48.33 81.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.681 0.673 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 8.1 ptp -69.83 -41.51 74.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.09 99.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.507 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.08 -31.11 68.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.755 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.57 60.88 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.466 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 25.5 m95 -56.56 -36.47 69.35 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.619 1.168 . . . . 0.0 111.688 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.41 -55.12 8.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 122.577 0.351 . . . . 0.0 110.477 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.35 -24.44 67.25 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.88 -16.17 63.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.29 0.95 . . . . 0.0 113.364 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.461 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 7.5 m-85 -124.7 -12.46 7.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 112.858 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -114.69 83.45 1.9 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.126 -2.175 . . . . 0.0 105.126 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.49 -168.73 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.421 1.01 . . . . 0.0 112.075 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.51 -5.03 4.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.177 0.991 . . . . 0.0 113.07 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.35 -24.81 67.55 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.623 -1.298 . . . . 0.0 109.564 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -123.11 179.31 4.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.474 1.91 . . . . 0.0 108.93 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -155.48 127.6 7.64 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.3 p -123.32 143.42 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.909 0.484 . . . . 0.0 110.094 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.49 171.23 14.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.151 1.78 . . . . 0.0 108.76 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -147.07 145.35 29.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.289 1.035 . . . . 0.0 109.126 -172.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.94 170.58 21.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.166 0.987 . . . . 0.0 111.775 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.76 178.61 46.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.202 1.382 . . . . 0.0 110.554 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 tt -48.67 -54.54 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.541 1.936 . . . . 0.0 113.775 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -135.1 31.42 3.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.097 1.759 . . . . 0.0 108.035 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.12 128.15 34.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.599 1.959 . . . . 0.0 115.957 -168.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -166.41 1.38 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.641 2.376 . . . . 0.0 110.62 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.9 109.49 3.44 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 120.725 -1.234 . . . . 0.0 114.864 -168.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.6 tp -82.52 83.13 7.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -62.12 123.68 79.04 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.633 -0.698 . . . . 0.0 109.782 -176.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.73 -23.42 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.224 1.95 . . . . 0.0 113.201 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -33.73 76.16 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.762 1.165 . . . . 0.0 110.856 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -34.46 50.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.187 0.449 . . . . 0.0 109.947 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.67 -51.38 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -56.49 -46.12 80.65 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.287 0.635 . . . . 0.0 110.709 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.49 -32.56 58.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.26 1.024 . . . . 0.0 112.323 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mmm -90.54 -30.06 17.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.241 -0.912 . . . . 0.0 111.323 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.87 -24.73 67.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.437 169.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' B' ' 124' ' ' ARG . 42.8 mt-10 -55.52 -36.37 66.65 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.829 1.195 . . . . 0.0 111.201 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.28 15.92 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.19 1.396 . . . . 0.0 111.296 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.56 41.58 99.12 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.036 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 39.1 mt -114.64 116.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 171.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.79 132.12 43.17 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -131.78 13.08 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.28 169.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 75.3 p -59.76 -17.59 36.46 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.667 1.121 . . . . 0.0 111.495 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -80.37 -12.5 59.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.503 2.321 . . . . 0.0 114.282 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -69.96 157.0 38.29 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.374 1.443 . . . . 0.0 112.335 -171.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -129.65 168.81 15.9 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.542 2.337 . . . . 0.0 108.809 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.3 m -156.21 168.62 26.71 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.948 -1.095 . . . . 0.0 110.714 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -162.79 162.67 26.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.68 1.992 . . . . 0.0 108.763 -169.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.24 172.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 0.0 112.424 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.39 133.31 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -145.5 99.96 3.37 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.167 0.984 . . . . 0.0 108.8 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -49.55 -28.0 5.09 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.673 1.989 . . . . 0.0 113.699 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.65 -18.37 63.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.247 0.93 . . . . 0.0 112.387 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.68 -34.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.089 0.956 . . . . 0.0 108.745 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.03 -54.9 14.97 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.594 1.088 . . . . 0.0 110.173 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -26.31 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.906 0.776 . . . . 0.0 110.159 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -72.83 -24.04 60.85 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 112.357 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.35 164.74 4.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.851 1.261 . . . . 0.0 112.194 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.15 -31.0 15.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.134 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -145.16 135.93 24.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.283 1.033 . . . . 0.0 110.661 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 t -113.56 115.02 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.28 108.81 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.7 m -73.92 145.61 44.62 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.36 31.29 4.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.929 0.892 . . . . 0.0 111.635 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.258 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 111.19 0.07 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.88 -8.79 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.36 2.264 . . . . 0.0 115.776 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm 92.51 15.89 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 128.492 2.717 . . . . 0.0 111.366 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 6.9 m 37.66 49.11 1.5 Allowed Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.673 1.589 . . . . 0.0 111.716 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.72 131.43 46.01 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.574 -1.356 . . . . 0.0 108.574 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.58 8.14 32.78 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -168.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 14.3 p 40.95 81.57 0.24 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.953 1.701 . . . . 0.0 112.705 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -57.38 141.73 94.89 Favored 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 122.649 2.233 . . . . 0.0 111.304 -169.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -49.95 -12.53 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 127.014 5.143 . . . . 0.0 118.672 -170.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -60.27 -16.35 33.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.328 0.967 . . . . 0.0 111.785 171.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.2 137.7 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 109.124 -172.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -75.82 156.4 34.48 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -142.42 147.95 37.01 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.217 -0.927 . . . . 0.0 110.538 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -150.0 161.28 42.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.623 1.569 . . . . 0.0 107.5 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -99.22 123.63 43.66 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 168.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -109.6 2.98 20.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.409 0.684 . . . . 0.0 110.108 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.6 149.23 21.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 105.779 -2.928 . . . . 0.0 105.779 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -146.82 10.0 1.03 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.974 1.71 . . . . 0.0 110.633 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -153.28 168.59 25.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.742 2.417 . . . . 0.0 105.984 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -133.33 115.82 13.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.63 0.772 . . . . 0.0 109.412 -171.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.17 -25.24 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.004 2.469 . . . . 0.0 113.584 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -8.38 21.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.179 0.9 . . . . 0.0 111.819 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -93.88 10.99 30.98 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 111.835 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.47 148.49 0.67 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.832 1.253 . . . . 0.0 112.767 -173.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -55.45 -47.4 76.09 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.119 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.93 -17.38 4.14 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 115.552 0.981 . . . . 0.0 115.552 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.43 158.88 34.29 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.54 -37.77 79.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.354 0.597 . . . . 0.0 111.157 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -73.36 -43.75 60.04 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.119 -1.42 . . . . 0.0 109.814 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.3 -28.24 59.63 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 121.208 1.822 . . . . 0.0 110.259 -172.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -60.41 -59.14 5.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 118.73 0.695 . . . . 0.0 109.765 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -60.64 -39.62 88.99 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.553 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.4 95.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.276 0.631 . . . . 0.0 112.24 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.21 -47.3 83.11 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -61.09 -51.42 69.2 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -62.47 -43.72 98.14 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.03 0.932 . . . . 0.0 111.518 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -60.94 -52.75 63.72 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 35.5 t -69.81 -36.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.466 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.3 tmm_? -60.23 -43.34 96.14 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.572 1.078 . . . . 0.0 111.774 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.85 -44.78 96.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.31 0.505 . . . . 0.0 110.822 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -63.13 -51.7 65.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.43 0.692 . . . . 0.0 110.117 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -54.19 -49.59 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.624 1.57 . . . . 0.0 109.054 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.23 -43.1 81.37 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 118.936 -0.925 . . . . 0.0 112.316 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -44.38 94.98 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.806 1.303 . . . . 0.0 110.428 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -34.72 78.6 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.577 178.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.73 1.15 . . . . 0.0 111.492 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.461 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -62.75 -41.24 99.11 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -62.4 -40.54 96.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 117.395 -1.288 . . . . 0.0 111.301 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -60.56 -36.24 78.0 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 121.665 2.029 . . . . 0.0 111.295 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.61 -28.58 69.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.029 0.531 . . . . 0.0 112.431 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.69 -46.6 7.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.609 1.564 . . . . 0.0 111.141 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 62.9 p -89.14 -27.21 20.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.278 1.831 . . . . 0.0 110.784 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.13 25.94 54.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.9 -169.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.748 1.619 . . . . 0.0 111.82 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.32 172.3 18.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.839 1.656 . . . . 0.0 107.493 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.74 97.09 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 168.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.02 167.98 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.509 1.523 . . . . 0.0 108.009 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -128.07 112.76 14.95 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.799 0.84 . . . . 0.0 108.983 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.04 10.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.579 1.552 . . . . 0.0 110.095 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -159.71 -173.39 4.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.966 2.107 . . . . 0.0 105.617 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.62 -36.62 0.42 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.37 2.668 . . . . 0.0 115.934 -169.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -130.57 -29.96 1.92 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.586 1.154 . . . . 0.0 111.543 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -23.06 65.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.149 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -51.55 -56.48 13.2 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.356 0.98 . . . . 0.0 109.244 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -62.36 -44.25 96.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -36.65 81.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -174.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -80.15 -16.95 53.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.072 0.949 . . . . 0.0 113.056 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.8 p -114.06 -7.18 13.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.651 1.114 . . . . 0.0 113.113 -169.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -77.48 -3.95 43.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.41 148.38 37.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.226 1.011 . . . . 0.0 109.092 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.08 -170.84 40.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.19 0.9 . . . . 0.0 111.62 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.43 125.81 54.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 t -140.03 117.96 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.6 135.89 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.7 46.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.41 151.25 49.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.279 1.432 . . . . 0.0 108.626 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.7 111.34 13.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.557 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.3 p-90 -131.68 155.11 48.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.716 1.606 . . . . 0.0 107.789 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.11 162.67 9.13 Favored Pre-proline 0 C--O 1.233 0.188 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.8 -19.0 10.03 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.613 2.875 . . . . 0.0 116.167 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -57.69 -26.4 61.65 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.6 161.66 34.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.457 1.026 . . . . 0.0 112.997 -169.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.72 -48.76 53.93 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.168 -1.351 . . . . 0.0 112.658 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -51.38 -27.07 22.83 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.099 2.532 . . . . 0.0 115.11 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -60.51 -13.89 16.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 119.624 1.102 . . . . 0.0 113.798 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -118.1 12.28 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.664 1.186 . . . . 0.0 111.449 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.0 mtm -123.67 -45.69 2.04 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.358 1.063 . . . . 0.0 109.642 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.78 -34.72 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -58.26 17.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.14 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.05 -39.16 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.762 1.641 . . . . 0.0 111.639 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.89 -34.56 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.957 0.903 . . . . 0.0 111.3 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.1 mt -71.37 -44.13 65.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.993 0.815 . . . . 0.0 110.534 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.92 -36.55 83.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.65 0.659 . . . . 0.0 109.469 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.35 -18.68 62.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 112.314 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.3 tp -79.55 -45.76 18.63 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.617 1.099 . . . . 0.0 108.879 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.06 -35.58 76.72 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.881 -0.512 . . . . 0.0 111.496 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -64.95 -19.65 66.07 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.502 -0.749 . . . . 0.0 112.21 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -95.84 -42.91 8.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.679 1.192 . . . . 0.0 111.225 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ptm -144.27 17.95 1.72 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.343 0.657 . . . . 0.0 112.283 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -5.76 14.12 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.35 -0.844 . . . . 0.0 114.312 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.72 -23.41 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.671 0.788 . . . . 0.0 111.033 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -15.51 8.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.446 -175.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.0 149.84 50.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.608 1.163 . . . . 0.0 112.267 -168.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -112.95 144.55 42.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.28 146.4 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.69 146.85 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.1 mtpt -121.82 147.57 45.79 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 121.83 -0.544 . . . . 0.0 110.377 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.82 128.74 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.94 103.5 14.72 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 170.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.305 32.6 m -77.6 50.51 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 122.616 1.198 . . . . 0.0 114.179 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.29 -44.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.594 1.557 . . . . 0.0 108.519 168.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -75.24 -50.58 15.7 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.019 1.327 . . . . 0.0 110.065 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -132.11 37.74 3.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.908 1.283 . . . . 0.0 110.873 -170.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -67.04 -4.2 9.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.601 1.161 . . . . 0.0 112.872 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -53.26 -47.88 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.114 1.766 . . . . 0.0 110.851 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.0 m -55.29 -41.51 72.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.848 0.749 . . . . 0.0 111.154 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 -65.43 0.72 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -170.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.86 -42.88 15.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.128 0.87 . . . . 0.0 113.361 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -63.45 -44.55 94.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.428 1.114 . . . . 0.0 111.377 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -68.04 -34.8 77.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.603 0.638 . . . . 0.0 109.796 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.07 66.24 0.71 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 -169.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.35 132.7 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.2 mtm -149.02 18.99 0.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.29 160.37 38.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -167.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.21 134.39 26.09 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.214 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.67 132.7 15.98 Favored 'Cis proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.443 -1.791 . . . . 0.0 107.443 -11.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.5 m -98.77 150.35 21.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 169.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.81 117.47 8.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.75 111.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -93.49 134.7 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.17 158.06 39.11 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.643 1.177 . . . . 0.0 110.286 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -147.95 137.42 22.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.99 29.01 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.042 2.537 . . . . 0.0 114.902 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.43 -28.3 2.79 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 116.595 1.398 . . . . 0.0 116.595 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.68 158.72 43.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.418 1.609 . . . . 0.0 114.839 -167.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.39 136.54 26.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.288 1.035 . . . . 0.0 108.28 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.01 -21.07 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.784 1.633 . . . . 0.0 111.428 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -144.72 157.87 44.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.961 0.8 . . . . 0.0 108.922 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.1 148.42 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -169.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.9 m -153.62 148.59 26.66 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.777 1.231 . . . . 0.0 108.011 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.26 66.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.65 156.94 8.98 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -73.46 156.71 37.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.676 0.39 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -153.37 150.63 24.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.203 1.001 . . . . 0.0 108.652 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.84 172.81 12.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.847 2.365 . . . . 0.0 111.536 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -45.9 71.14 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.237 1.015 . . . . 0.0 111.966 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.26 -39.95 93.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.863 0.301 . . . . 0.0 110.429 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.893 0.477 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.97 -54.82 36.35 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.322 1.049 . . . . 0.0 109.645 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.81 -36.6 84.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.34 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.41 -47.09 87.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.887 0.767 . . . . 0.0 110.933 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -55.67 -42.14 74.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.213 0.605 . . . . 0.0 110.545 -174.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.1 -40.49 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 123.667 0.604 . . . . 0.0 111.245 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -57.46 -25.65 60.01 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.906 -1.121 . . . . 0.0 112.417 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -50.49 -31.17 14.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.691 1.196 . . . . 0.0 112.4 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -137.87 -7.14 1.64 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.786 2.034 . . . . 0.0 105.985 169.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.79 145.36 42.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 65.12 122.65 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 128.112 2.565 . . . . 0.0 111.298 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -147.69 145.21 28.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 129.122 2.969 . . . . 0.0 104.224 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 6.4 mt -123.45 145.95 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 119.59 1.087 . . . . 0.0 108.584 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.0 148.3 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.904 1.282 . . . . 0.0 107.836 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.66 149.34 52.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 109.988 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.06 145.74 41.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.45 127.49 44.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 8.5 m -151.26 170.31 19.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.508 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -67.16 89.51 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.393 1.077 . . . . 0.0 110.924 172.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.31 20.53 58.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 117.073 -1.96 . . . . 0.0 114.835 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 26.01 84.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 124.769 2.224 . . . . 0.0 112.932 -177.034 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -152.41 167.71 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.529 3.132 . . . . 0.0 104.94 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 42.03 -103.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.227 1.811 . . . . 0.0 112.956 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -40.73 27.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.037 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -53.35 33.5 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.146 1.339 . . . . 0.0 109.769 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -49.91 -48.31 51.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.353 2.261 . . . . 0.0 109.64 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.3 ttm -67.79 -45.16 75.62 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.903 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.31 83.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.562 1.145 . . . . 0.0 110.728 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.61 -32.06 63.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 111.853 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.98 -49.65 57.18 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -58.77 -37.94 77.37 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.258 1.023 . . . . 0.0 111.769 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.47 -49.38 77.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -65.0 -22.65 67.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.31 -20.14 66.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.156 0.889 . . . . 0.0 112.951 175.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.499 ' CD1' ' HE2' ' B' ' 132' ' ' LYS . 0.1 OUTLIER -132.35 -0.54 3.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.379 0.991 . . . . 0.0 113.428 -175.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mt -126.42 85.83 2.44 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.4 -165.95 1.05 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.562 2.029 . . . . 0.0 114.204 -169.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.13 -20.05 23.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.673 1.189 . . . . 0.0 112.894 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.87 -23.99 34.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.156 1.782 . . . . 0.0 112.225 169.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -123.88 155.6 37.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.732 1.613 . . . . 0.0 110.6 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -131.22 144.91 51.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.132 1.773 . . . . 0.0 106.674 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.71 148.27 31.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 108.511 -171.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -147.88 162.42 39.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 52.4 m -134.12 140.42 46.57 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.036 1.335 . . . . 0.0 108.263 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.97 174.37 13.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 111.295 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.5 -174.93 44.31 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -51.23 -55.65 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.332 1.853 . . . . 0.0 114.157 -173.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -138.18 29.57 2.49 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.957 1.703 . . . . 0.0 108.655 -171.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.6 157.39 37.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.69 1.996 . . . . 0.0 114.193 -169.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 146.98 104.97 0.0 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 131.072 3.749 . . . . 0.0 104.414 172.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.6 174.38 46.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 14.5 tp -154.84 65.36 0.66 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.518 1.127 . . . . 0.0 108.064 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -49.87 121.73 13.04 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.315 1.446 . . . . 0.0 110.494 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -64.8 -24.44 61.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.202 1.935 . . . . 0.0 113.399 -175.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -18.37 64.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.703 1.592 . . . . 0.0 112.15 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.84 -40.58 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -60.2 -50.74 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.74 -42.68 84.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.95 0.9 . . . . 0.0 110.687 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.45 -30.55 60.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.565 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mmm -84.49 -40.64 17.42 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.519 1.054 . . . . 0.0 110.907 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.91 -29.15 68.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.541 0.61 . . . . 0.0 110.824 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.79 -28.28 67.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.498 0.719 . . . . 0.0 112.088 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.67 16.0 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.954 1.302 . . . . 0.0 110.765 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.08 38.87 92.74 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.497 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.76 150.46 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -124.3 139.63 53.73 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.998 0.919 . . . . 0.0 109.104 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.448 ' HB ' HE21 ' B' ' 62' ' ' GLN . 30.7 pt -140.67 17.56 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.102 1.361 . . . . 0.0 110.745 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -67.48 15.82 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' B' ' 59' ' ' ILE . 29.9 t30 -143.26 -5.11 0.87 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.161 2.585 . . . . 0.0 112.019 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.448 HE21 ' HB ' ' B' ' 59' ' ' ILE . 2.8 pt20 -56.67 144.71 31.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.684 1.129 . . . . 0.0 112.1 -169.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -69.04 155.77 39.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.981 1.312 . . . . 0.0 110.38 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 9.0 m -167.29 145.99 4.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 107.306 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -171.18 167.7 6.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.844 1.258 . . . . 0.0 109.837 -170.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.83 168.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.045 0.839 . . . . 0.0 111.41 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -48.99 135.55 6.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -144.32 103.84 4.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.307 1.051 . . . . 0.0 109.143 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.9 m -49.15 -27.27 3.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.626 1.57 . . . . 0.0 113.864 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.08 -22.76 64.92 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.725 1.148 . . . . 0.0 111.652 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.0 -42.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 117.75 -1.119 . . . . 0.0 108.622 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 tt -61.06 -51.35 69.54 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.91 1.232 . . . . 0.0 109.451 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -25.17 68.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.218 0.917 . . . . 0.0 111.412 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.96 -18.65 33.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.597 1.159 . . . . 0.0 112.894 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.89 163.46 4.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.216 1.007 . . . . 0.0 111.29 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.55 -32.71 15.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.839 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 tp -143.91 144.43 31.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.027 1.331 . . . . 0.0 109.725 -172.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.6 108.67 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 169.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 74.8 t -82.34 105.99 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -65.5 129.27 39.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 168.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 tp -139.94 66.39 1.4 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.715 0.406 . . . . 0.0 111.699 -168.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.332 -0.171 0 O-C-N 122.03 -0.419 . . . . 0.0 110.312 169.628 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.86 -6.68 2.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm 96.58 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.317 3.047 . . . . 0.0 110.979 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.8 m 38.37 45.77 0.82 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.044 2.137 . . . . 0.0 113.179 -169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.09 132.78 39.52 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.395 2.063 . . . . 0.0 112.031 -169.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.59 1.75 36.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 116.74 -1.6 . . . . 0.0 114.594 -175.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.8 p 45.08 89.76 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.538 1.535 . . . . 0.0 113.294 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -54.95 138.11 77.33 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.775 2.317 . . . . 0.0 109.485 -169.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.76 3.07 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.666 1 C-N-CA 125.318 4.012 . . . . 0.0 117.124 -168.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -67.55 -5.81 17.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.158 0.983 . . . . 0.0 112.332 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 148.33 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 110.147 -169.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -78.63 158.92 28.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.963 0.905 . . . . 0.0 108.839 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -151.73 145.37 24.97 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.757 -1.214 . . . . 0.0 109.488 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -155.73 148.43 24.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.82 137.79 32.08 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -139.57 -21.59 0.91 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.16 149.61 19.47 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 119.583 1.083 . . . . 0.0 110.648 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -160.75 169.3 23.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.38 1.872 . . . . 0.0 107.387 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.91 46.75 26.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.243 1.417 . . . . 0.0 112.399 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -43.61 116.62 2.3 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.766 2.026 . . . . 0.0 113.592 -171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' B' ' 108' ' ' ARG . 61.2 Cg_endo -72.23 -16.62 28.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.97 3.113 . . . . 0.0 113.318 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.87 -2.52 1.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.314 1.416 . . . . 0.0 111.824 169.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' B' ' 106' ' ' PRO . 5.1 mmm-85 -125.88 13.01 7.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.154 1.782 . . . . 0.0 110.934 -171.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.29 154.21 0.42 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.729 0.811 . . . . 0.0 109.884 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -53.3 -44.08 68.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.867 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.4 2.74 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 115.001 0.76 . . . . 0.0 115.001 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.4 p -68.94 166.02 18.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.0 -42.18 98.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.401 0.62 . . . . 0.0 110.311 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -69.23 -42.19 75.99 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.918 -1.515 . . . . 0.0 109.403 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.78 -35.66 60.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.149 1.795 . . . . 0.0 109.713 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -56.38 -52.53 64.27 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 121.719 -0.613 . . . . 0.0 110.728 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -63.95 -44.72 91.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.773 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.84 86.92 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.441 1.096 . . . . 0.0 111.667 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.89 -49.67 69.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.44 69.01 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.951 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -65.27 -50.51 65.47 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.39 1.076 . . . . 0.0 109.457 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -59.85 -48.34 82.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.87 -37.92 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 117.535 -1.221 . . . . 0.0 110.862 -176.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.29 -38.92 92.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.453 1.933 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.86 -44.89 93.89 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.483 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.05 -56.49 14.64 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.308 0.643 . . . . 0.0 110.148 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.8 mt -56.91 -47.7 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.837 1.255 . . . . 0.0 110.255 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.17 96.62 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.93 -42.89 99.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.79 0.795 . . . . 0.0 111.891 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.6 -0.688 . . . . 0.0 111.908 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.5 -33.6 69.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.572 1.078 . . . . 0.0 110.709 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' B' ' 27' ' ' TYR . 22.6 ttmt -61.03 -43.97 98.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.888 170.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.46 -41.04 96.61 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.36 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.94 -40.74 85.58 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.77 2.077 . . . . 0.0 110.496 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.62 74.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.32 -39.82 17.24 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.267 1.427 . . . . 0.0 111.623 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.7 p -97.38 -16.0 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.005 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 65.44 25.34 71.32 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.887 1.232 . . . . 0.0 112.332 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.749 1.219 . . . . 0.0 108.466 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.64 165.07 37.66 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.157 1.383 . . . . 0.0 107.529 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.66 101.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 168.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.13 166.83 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -121.92 107.33 12.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.85 175.46 4.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.422 1.089 . . . . 0.0 109.679 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -159.41 -172.71 3.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.92 1.688 . . . . 0.0 107.054 169.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -38.18 -41.8 0.63 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.092 2.957 . . . . 0.0 115.941 -169.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -128.41 -27.86 2.61 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.224 1.41 . . . . 0.0 111.064 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -61.74 -23.55 66.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.753 -1.118 . . . . 0.0 111.87 172.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -54.69 -54.45 41.63 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.617 1.553 . . . . 0.0 107.952 169.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -57.96 -47.84 81.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.367 0.531 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.12 96.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.556 0.217 . . . . 0.0 111.305 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -80.07 -15.71 56.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.772 1.229 . . . . 0.0 112.169 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.1 p -107.11 -9.28 16.21 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.122 0.969 . . . . 0.0 112.613 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 m -71.3 -3.13 18.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.83 0.741 . . . . 0.0 112.991 -175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -144.12 155.97 44.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.314 1.446 . . . . 0.0 108.119 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -167.4 54.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 123.878 0.751 . . . . 0.0 112.407 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.97 121.27 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 172.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.83 124.49 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 122.739 1.257 . . . . 0.0 108.207 -170.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.9 tp -83.43 100.23 10.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.53 141.16 36.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.22 145.25 45.47 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.392 1.077 . . . . 0.0 109.328 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.79 109.13 10.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -170.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.532 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.6 p-90 -121.79 160.03 25.46 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.71 159.29 17.33 Favored Pre-proline 0 C--O 1.233 0.2 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.23 -27.16 46.08 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.234 1.956 . . . . 0.0 113.062 168.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -58.61 -24.65 61.45 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 151.58 50.96 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.928 1.24 . . . . 0.0 111.875 -169.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.34 -48.73 71.15 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.201 -1.333 . . . . 0.0 112.512 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.79 -27.35 20.01 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.435 2.757 . . . . 0.0 115.464 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -58.59 -18.56 31.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 120.172 1.351 . . . . 0.0 113.644 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.95 12.11 20.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.315 1.046 . . . . 0.0 111.522 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.9 mtm -122.88 -43.93 2.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.6 1.16 . . . . 0.0 109.546 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.53 -35.88 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.405 0.682 . . . . 0.0 109.337 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.54 23.53 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.243 -0.884 . . . . 0.0 112.01 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.17 -40.51 59.43 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.664 1.576 . . . . 0.0 111.493 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.65 -38.27 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.892 0.769 . . . . 0.0 111.197 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.4 mt -66.59 -48.69 68.78 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-N 118.568 0.622 . . . . 0.0 110.095 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.62 -36.43 82.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.776 0.322 . . . . 0.0 110.42 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.31 -24.53 66.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.259 1.424 . . . . 0.0 111.723 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.8 tp -84.55 -40.02 18.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.69 0.677 . . . . 0.0 110.976 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.18 -33.14 72.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.982 -0.449 . . . . 0.0 110.473 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -70.53 -3.81 19.88 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -113.64 -42.43 3.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.624 1.569 . . . . 0.0 111.609 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.6 ptm -136.04 16.79 3.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.825 0.85 . . . . 0.0 112.336 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.84 -5.42 18.72 Favored Glycine 0 C--O 1.227 -0.286 0 O-C-N 120.771 -1.205 . . . . 0.0 114.23 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.94 -23.8 67.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.425 0.612 . . . . 0.0 111.342 169.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -32.87 4.87 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 110.983 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 151.6 19.82 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.978 1.311 . . . . 0.0 111.816 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -128.23 154.18 46.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.4 143.53 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.84 109.61 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 47.5 mtpt -82.91 157.09 23.19 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 120.56 -1.338 . . . . 0.0 109.75 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mm -130.08 124.02 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -85.75 109.8 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.0 m -73.15 9.96 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -171.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.85 -34.58 4.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.315 0.962 . . . . 0.0 110.644 169.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.69 -43.13 12.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.869 0.759 . . . . 0.0 111.447 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -141.79 42.94 1.71 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.643 1.211 . . . . 0.0 110.819 -170.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -4.25 45.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.717 1.207 . . . . 0.0 113.833 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -52.4 -43.87 65.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.257 1.023 . . . . 0.0 110.342 -169.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.8 m -58.08 -38.84 77.14 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.38 1.072 . . . . 0.0 112.379 174.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.42 -64.29 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.323 1.049 . . . . 0.0 109.115 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.41 -41.43 17.12 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.645 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -62.2 -43.12 99.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.296 1.548 . . . . 0.0 111.131 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -76.58 -9.32 58.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.193 0.597 . . . . 0.0 112.422 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.79 60.26 6.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 -173.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.17 -64.07 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 -173.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 mtm 58.0 5.13 0.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.23 2.612 . . . . 0.0 114.719 172.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -141.02 157.38 45.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.346 0.975 . . . . 0.0 111.638 -169.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.2 mm -138.96 139.51 23.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.37 138.77 49.14 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 -10.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.5 m -112.97 143.56 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.8 mt -120.84 127.54 52.0 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.95 1.7 . . . . 0.0 107.465 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -116.25 114.39 24.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.47 122.13 46.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.92 153.08 38.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 110.167 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -137.12 130.79 31.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.001 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.7 t70 42.15 35.23 0.56 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.791 2.036 . . . . 0.0 114.21 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.9 -8.51 23.5 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 116.628 1.411 . . . . 0.0 116.628 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.73 152.39 47.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.444 1.622 . . . . 0.0 112.942 -169.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.86 141.93 16.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.78 1.232 . . . . 0.0 108.663 175.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.74 -22.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 124.166 0.986 . . . . 0.0 109.537 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -153.76 166.44 32.85 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 122.587 1.184 . . . . 0.0 107.805 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -158.13 132.5 8.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.939 1.696 . . . . 0.0 106.703 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m -147.62 148.63 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.064 0.945 . . . . 0.0 109.053 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.21 124.22 41.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.18 156.17 9.28 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 124.618 1.104 . . . . 0.0 110.675 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.2 148.99 46.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.314 0.557 . . . . 0.0 111.211 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.03 148.04 18.93 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.5 177.68 6.49 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.33 2.687 . . . . 0.0 112.443 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -33.25 69.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.345 1.458 . . . . 0.0 112.334 -169.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -81.85 -40.72 22.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.081 0.552 . . . . 0.0 110.199 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.21 92.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.051 0.54 . . . . 0.0 110.65 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.84 -52.58 64.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.823 0.849 . . . . 0.0 109.72 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.1 -36.39 77.51 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.478 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.06 -46.64 88.86 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.551 1.068 . . . . 0.0 110.599 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.5 tp -58.23 -40.28 81.29 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 124.809 1.244 . . . . 0.0 111.673 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -87.97 -40.57 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.164 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -57.77 -34.29 69.41 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.977 1.311 . . . . 0.0 112.131 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -65.61 -8.73 21.71 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -123.77 -33.54 3.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.501 1.12 . . . . 0.0 112.197 174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.247 0.925 0 C-N-CA 126.752 2.021 . . . . 0.0 109.717 178.688 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -79.16 80.2 5.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.987 0.915 . . . . 0.0 108.756 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m120 78.98 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.654 2.781 . . . . 0.0 111.753 175.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -125.34 123.76 40.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 129.598 3.159 . . . . 0.0 103.725 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -92.78 141.46 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.76 -168.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.3 tt -133.65 140.44 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -131.24 136.16 47.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -110.44 141.86 42.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.85 123.03 36.36 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 78.7 p -156.1 147.67 22.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -46.47 111.74 0.41 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.425 1.49 . . . . 0.0 111.848 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.22 11.01 50.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.711 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 38.18 35.51 0.09 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.916 2.486 . . . . 0.0 113.793 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -69.64 -46.74 65.47 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.65 -65.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -168.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -33.89 68.45 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.833 0.742 . . . . 0.0 111.736 -174.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.3 p -56.24 -55.65 30.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.31 1.444 . . . . 0.0 111.398 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -52.1 -49.76 62.95 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.346 1.858 . . . . 0.0 109.657 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 9.2 ttm -67.83 -46.02 73.0 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.599 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.819 0.848 . . . . 0.0 110.77 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.0 -27.72 61.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.111 0.869 . . . . 0.0 110.149 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.05 -45.94 24.21 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -55.27 -33.67 63.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.414 1.086 . . . . 0.0 111.34 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.64 11.87 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.888 0.875 . . . . 0.0 110.604 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -64.96 -22.84 67.07 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.403 1.002 . . . . 0.0 113.665 -168.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.14 -16.35 52.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 170.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 11.9 m-85 -130.01 -40.85 1.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.395 1.078 . . . . 0.0 112.789 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.22 75.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.624 1.97 . . . . 0.0 106.234 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -164.04 1.2 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.977 1.751 . . . . 0.0 112.255 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.49 -7.9 8.03 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.543 -0.974 . . . . 0.0 113.137 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.16 -19.29 62.92 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.909 -1.119 . . . . 0.0 109.573 168.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -130.87 175.7 8.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 127.776 2.431 . . . . 0.0 110.121 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -153.04 129.9 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.35 144.31 14.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.871 0.868 . . . . 0.0 109.273 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.46 156.8 46.72 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 107.308 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.2 m -145.5 137.69 25.61 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.52 173.39 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.617 0.767 . . . . 0.0 111.339 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.08 40.64 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 122.247 -0.283 . . . . 0.0 112.978 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -53.19 -57.19 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 113.679 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -132.11 30.7 4.22 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.079 1.752 . . . . 0.0 108.039 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.8 149.93 49.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.563 1.945 . . . . 0.0 112.82 -169.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 146.45 100.4 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 130.995 3.718 . . . . 0.0 104.071 177.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.23 -179.29 48.7 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -171.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 23.0 tp -161.45 100.86 1.19 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -60.88 122.62 70.28 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.352 -0.832 . . . . 0.0 108.782 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.62 -26.56 80.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 121.734 1.622 . . . . 0.0 112.097 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.573 ' ND2' ' CE1' ' B' ' 120' ' ' PHE . 1.2 t30 -68.25 -27.92 66.76 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.979 -1.076 . . . . 0.0 112.086 171.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.127 1.785 . . . . 0.0 109.746 171.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.87 -51.66 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -52.57 -47.97 66.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.852 0.751 . . . . 0.0 109.977 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.89 57.24 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.655 1.182 . . . . 0.0 111.508 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.86 -38.79 20.71 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -61.75 -28.74 69.65 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.553 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.44 -27.95 64.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.931 0.787 . . . . 0.0 111.908 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.09 14.15 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 110.97 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.7 36.38 82.59 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.466 -1.186 . . . . 0.0 113.222 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.97 149.07 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -116.8 137.1 52.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.793 0.837 . . . . 0.0 108.92 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.2 pt -139.31 16.95 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 124.861 1.264 . . . . 0.0 110.836 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -58.91 -15.21 11.68 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -91.44 -15.8 28.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.308 1.443 . . . . 0.0 113.498 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -56.65 151.45 13.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.6 p -133.47 174.14 10.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.663 2.385 . . . . 0.0 109.359 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 15.7 m -153.01 -173.77 4.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.143 0.977 . . . . 0.0 109.517 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -161.66 167.93 24.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.274 1.829 . . . . 0.0 108.044 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.0 pt -63.37 169.1 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -48.62 135.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -142.0 98.84 3.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.544 1.164 . . . . 0.0 108.211 -171.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -51.38 -28.07 11.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.48 1.912 . . . . 0.0 113.989 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.81 -23.34 61.54 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 119.608 1.094 . . . . 0.0 110.494 -172.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -33.64 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 118.285 -0.865 . . . . 0.0 109.788 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.61 -52.93 61.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.639 1.109 . . . . 0.0 109.522 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -29.07 66.36 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.24 0.473 . . . . 0.0 110.964 -176.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -87.12 -12.45 47.06 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.673 1.589 . . . . 0.0 112.663 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.96 162.35 22.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.967 0.889 . . . . 0.0 110.434 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.89 -34.15 15.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.052 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.43 142.97 33.66 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.744 1.217 . . . . 0.0 110.202 -172.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -114.56 103.76 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 169.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.8 98.12 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -66.77 122.88 18.64 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 tp -124.66 52.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 110.083 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 124.18 0.992 . . . . 0.0 108.761 171.468 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -71.24 28.08 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -169.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt 80.84 17.45 0.55 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.709 2.004 . . . . 0.0 112.432 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 m 34.63 52.09 1.26 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.353 1.861 . . . . 0.0 112.732 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.5 131.03 40.27 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.812 1.675 . . . . 0.0 110.785 -169.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -1.24 57.49 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 116.785 -1.579 . . . . 0.0 113.706 -175.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.9 p 48.0 95.47 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 126.12 1.768 . . . . 0.0 114.177 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.49 132.79 52.72 Favored 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 122.17 1.913 . . . . 0.0 109.51 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.4 -5.28 11.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.819 3.679 . . . . 0.0 117.817 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -74.4 15.35 0.35 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.093 1.315 . . . . 0.0 112.237 170.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 t -135.29 142.92 38.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.364 1.866 . . . . 0.0 106.736 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -69.99 153.69 42.9 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -141.39 141.12 33.79 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -145.97 157.97 43.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.56 137.06 47.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -142.02 -2.12 1.18 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.615 0.766 . . . . 0.0 112.668 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.68 -54.06 4.39 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 59.11 -2.68 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.534 2.334 . . . . 0.0 115.076 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -160.92 170.13 21.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.331 2.653 . . . . 0.0 105.771 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -137.97 106.62 8.12 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 118.877 0.762 . . . . 0.0 109.36 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' B' ' 108' ' ' ARG . 95.4 Cg_endo -66.82 -36.0 25.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 124.033 3.155 . . . . 0.0 112.175 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.88 -13.63 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 129.598 3.159 . . . . 0.0 113.918 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' B' ' 106' ' ' PRO . 8.6 mmm-85 -103.45 -54.42 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.394 1.478 . . . . 0.0 107.488 -172.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . 39.25 -164.11 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.468 1.907 . . . . 0.0 113.34 -170.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -70.11 -48.03 59.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.37 -22.12 2.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 62.6 p -71.02 168.54 16.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.3 -41.96 98.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.379 0.609 . . . . 0.0 110.516 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.55 -41.13 69.49 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 117.395 -1.288 . . . . 0.0 109.066 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -76.59 -33.44 58.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.544 1.52 . . . . 0.0 110.036 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -56.07 -56.51 19.94 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.009 0.822 . . . . 0.0 109.154 169.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -59.38 -41.87 90.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.45 93.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.59 1.156 . . . . 0.0 112.006 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -64.53 -46.98 80.55 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.573 ' CE1' ' ND2' ' B' ' 47' ' ' ASN . 14.5 m-85 -64.82 -36.07 83.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.425 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -61.27 -49.23 77.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.132 0.878 . . . . 0.0 110.046 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.9 ttp-105 -62.84 -52.53 62.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.27 -35.71 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.26 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 30.7 ptt85 -61.68 -41.05 97.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.212 1.824 . . . . 0.0 111.132 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.97 -43.7 94.91 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.459 0.475 . . . . 0.0 110.377 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -68.63 -50.56 50.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 0.0 110.887 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 mt -56.05 -48.67 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.405 1.082 . . . . 0.0 109.114 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.32 -46.96 92.26 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.45 -47.07 85.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.801 0.8 . . . . 0.0 111.737 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -62.95 -47.54 82.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.068 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.81 -37.04 86.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.374 0.534 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 41.3 ttmt -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.97 0.805 . . . . 0.0 109.739 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.2 -37.34 79.95 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-O 116.74 -1.6 . . . . 0.0 111.16 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -59.38 -40.09 85.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 122.008 2.185 . . . . 0.0 110.039 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.05 75.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.202 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.45 -47.68 11.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.393 1.077 . . . . 0.0 111.796 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.2 p -82.7 -22.73 34.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.969 2.108 . . . . 0.0 112.103 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.7 11.24 62.35 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -168.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . 0.418 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.685 2.394 . . . . 0.0 113.772 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.32 167.36 28.91 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.318 1.447 . . . . 0.0 107.84 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.1 98.51 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 169.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.14 168.6 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.714 1.606 . . . . 0.0 108.307 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -125.11 122.1 36.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.811 1.245 . . . . 0.0 109.09 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.33 171.7 13.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.858 1.663 . . . . 0.0 109.859 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -136.09 -167.83 2.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.082 1.753 . . . . 0.0 108.614 169.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -47.12 -27.78 1.53 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.387 2.275 . . . . 0.0 113.627 170.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.49 -30.8 0.82 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.662 1.185 . . . . 0.0 112.06 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m -62.57 -20.02 64.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.895 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -48.32 -55.7 9.98 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.608 1.094 . . . . 0.0 110.427 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -64.18 -44.55 91.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.949 0.34 . . . . 0.0 110.168 -176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.23 81.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.924 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -82.2 -13.3 57.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.401 1.081 . . . . 0.0 112.541 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 66.6 p -115.89 -5.82 12.04 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 0.0 112.914 -170.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -74.75 -6.05 46.74 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.86 147.13 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.245 1.018 . . . . 0.0 109.346 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.13 -175.8 34.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.309 0.957 . . . . 0.0 111.689 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.59 125.75 48.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -136.03 117.95 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.111 0.964 . . . . 0.0 108.727 -169.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -89.66 116.06 27.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.87 135.81 39.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.883 0.765 . . . . 0.0 109.027 173.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.91 138.7 53.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.068 1.347 . . . . 0.0 108.984 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -119.88 105.07 10.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.425 ' CD1' ' CE ' ' A' ' 54' ' ' LYS . 4.8 p-90 -123.77 147.78 47.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.896 1.278 . . . . 0.0 108.202 -173.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -166.36 160.62 12.29 Favored Pre-proline 0 CA--C 1.534 0.344 0 O-C-N 121.545 -0.722 . . . . 0.0 111.56 171.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.73 -7.58 2.36 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.453 3.435 . . . . 0.0 116.504 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -54.73 -29.28 53.07 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.718 1.207 . . . . 0.0 113.104 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -163.58 162.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.13 -47.55 10.25 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.46 2.457 . . . . 0.0 115.596 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.57 -30.78 56.36 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.582 2.691 . . . . 0.0 114.041 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 m -62.48 -18.11 61.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.658 1.572 . . . . 0.0 113.909 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.79 22.03 13.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 0.0 111.211 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.2 mtm -131.24 -38.79 1.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.704 1.202 . . . . 0.0 110.27 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.82 -37.02 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.196 -0.94 . . . . 0.0 108.607 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.23 -54.31 57.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.874 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -58.96 -39.71 78.29 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.285 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.17 -38.96 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.055 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.01 -44.51 76.4 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.69 1.132 . . . . 0.0 110.589 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.53 -34.45 77.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.856 0.753 . . . . 0.0 109.813 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -71.2 -19.8 62.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.749 1.62 . . . . 0.0 112.54 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -84.24 -44.63 13.7 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 108.596 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.89 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.385 -0.197 . . . . 0.0 111.127 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.71 -10.09 56.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.236 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.46 -47.08 4.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.24 1.016 . . . . 0.0 111.064 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.7 ptm -135.46 15.96 3.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.528 0.731 . . . . 0.0 112.215 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.6 -3.47 20.68 Favored Glycine 0 CA--C 1.519 0.343 0 O-C-N 121.102 -0.999 . . . . 0.0 114.192 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.67 -24.43 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.83 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 -25.49 8.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.509 1.124 . . . . 0.0 111.83 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.1 tp -118.46 146.56 44.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 111.483 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.79 147.78 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.82 145.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.67 148.33 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' CE ' ' CD1' ' A' ' 25' ' ' TRP . 15.0 mtpt -122.09 146.56 47.08 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 118.862 0.755 . . . . 0.0 111.187 175.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -107.78 132.97 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.29 88.98 6.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -70.41 50.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 127.416 2.286 . . . . 0.0 114.761 -168.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -159.48 -33.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.067 2.147 . . . . 0.0 109.234 169.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -89.53 -42.34 11.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.688 0.795 . . . . 0.0 109.522 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -133.19 33.85 3.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.329 1.052 . . . . 0.0 111.648 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.58 -7.07 9.01 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.907 1.283 . . . . 0.0 113.375 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -47.39 -50.06 23.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 110.552 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.0 m -59.66 -36.11 75.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.234 0.614 . . . . 0.0 111.938 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.77 -57.31 6.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.45 -43.16 51.98 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.985 0.802 . . . . 0.0 113.434 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.94 -38.29 90.43 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.604 1.162 . . . . 0.0 110.97 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -76.89 -32.12 57.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.584 0.629 . . . . 0.0 110.077 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 77.59 1.38 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -170.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.86 -64.81 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.413 3.1 ppp? 45.47 24.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.428 2.691 . . . . 0.0 114.96 172.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.1 p -149.32 163.97 36.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.187 2.195 . . . . 0.0 110.96 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.3 mm -140.54 146.48 45.12 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -175.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.78 143.52 67.67 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 -10.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.4 m -119.37 150.16 40.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.267 0.556 . . . . 0.0 110.517 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.28 124.6 32.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -116.27 113.87 23.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.5 127.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.17 157.25 35.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.533 1.133 . . . . 0.0 110.169 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.82 130.86 20.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.43 32.29 0.5 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.447 2.299 . . . . 0.0 114.572 170.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.31 -19.2 6.03 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 116.489 1.356 . . . . 0.0 116.489 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -135.29 151.82 50.92 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 119.425 1.612 . . . . 0.0 112.878 -168.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -69.05 137.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.74 -25.21 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.997 1.719 . . . . 0.0 109.553 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -143.89 152.76 41.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.06 137.07 27.34 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.5 t -151.27 146.28 25.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.7 t -140.6 76.57 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.97 163.64 18.6 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.409 1.004 . . . . 0.0 110.878 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.37 147.38 51.13 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.807 0.803 . . . . 0.0 110.644 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -139.32 144.44 40.22 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.633 1.173 . . . . 0.0 108.482 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.55 170.94 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.521 2.147 . . . . 0.0 110.052 169.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -45.31 69.98 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.998 0.919 . . . . 0.0 112.359 -173.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.7 -43.12 76.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.541 0.155 . . . . 0.0 110.782 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.1 84.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.0 -0.438 . . . . 0.0 110.61 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 tp -67.68 -47.64 68.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.427 0.103 . . . . 0.0 110.979 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.94 -37.85 88.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.15 -46.21 88.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.819 0.447 . . . . 0.0 110.8 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.2 tp -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 110.825 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.47 -41.16 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.588 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -55.33 -29.06 57.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 112.412 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -49.11 -33.87 12.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.219 1.408 . . . . 0.0 112.306 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -135.72 -6.56 2.18 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.659 1.984 . . . . 0.0 108.576 170.166 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.02 125.39 26.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.253 31.5 m120 61.53 119.94 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 C-N-CA 129.317 3.047 . . . . 0.0 113.939 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -148.46 141.12 24.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.562 3.145 . . . . 0.0 103.731 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mt -117.95 144.5 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.845 1.202 . . . . 0.0 107.777 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.76 146.57 19.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -130.33 128.32 41.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.6 133.95 49.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -132.99 117.43 17.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -168.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 58.0 m -139.9 163.99 31.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 124.118 0.886 . . . . 0.0 111.875 -168.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.6 m -68.54 114.06 6.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.73 41.39 35.02 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.338 1.447 . . . . 0.0 112.801 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -36.53 104.31 0.03 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 18.0 m -135.21 0.97 2.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.77 169.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.11 -55.11 0.09 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.142 0.977 . . . . 0.0 112.902 -169.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -57.84 -54.67 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.176 0.444 . . . . 0.0 110.599 -171.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.7 m -76.73 -26.74 54.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.702 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -54.85 -51.1 66.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.822 1.192 . . . . 0.0 110.488 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 13.9 ttm -67.73 -44.19 78.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.529 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.75 99.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.368 0.667 . . . . 0.0 111.568 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.83 -31.76 61.76 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.418 1.008 . . . . 0.0 110.683 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -42.62 74.46 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -56.73 -40.0 74.94 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 117.931 0.865 . . . . 0.0 111.21 170.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.24 -54.23 43.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -69.84 -17.83 63.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.836 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.03 -14.93 63.36 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.874 1.216 . . . . 0.0 112.579 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.49 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 2.5 m-85 -126.32 -20.86 4.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.265 1.026 . . . . 0.0 113.732 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.26 -107.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 -172.28 40.78 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 119.126 0.875 . . . . 0.0 111.426 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.68 -20.22 65.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.35 1.46 . . . . 0.0 111.962 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.45 -40.18 74.41 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.97 0.908 . . . . 0.0 111.471 174.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.54 153.09 18.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.864 0.84 . . . . 0.0 112.587 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -124.61 107.33 10.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.48 103.28 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -92.51 160.98 14.8 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.806 0.842 . . . . 0.0 108.781 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -151.01 134.9 16.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.498 0.719 . . . . 0.0 109.576 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.67 176.92 11.98 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.343 0.592 . . . . 0.0 112.353 -174.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.22 -177.84 47.22 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.924 1.249 . . . . 0.0 111.141 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.5 tt -52.55 -53.33 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.116 1.366 . . . . 0.0 113.255 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -133.31 29.05 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.147 1.779 . . . . 0.0 108.611 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.86 146.8 54.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.168 2.187 . . . . 0.0 111.766 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 144.91 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 129.987 3.315 . . . . 0.0 105.287 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.89 162.67 33.45 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 62.3 tp -140.61 76.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.36 128.85 90.37 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.25 -20.05 45.35 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.936 1.757 . . . . 0.0 112.63 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -38.64 90.34 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 120.077 1.308 . . . . 0.0 111.777 171.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.31 60.26 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.824 0.738 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -60.41 -52.76 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 171.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -58.44 -44.27 89.11 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.695 0.798 . . . . 0.0 110.824 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.12 68.02 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.914 0.885 . . . . 0.0 111.791 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -39.58 53.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -63.03 -26.29 68.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.49 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.03 -29.52 60.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.035 1.288 . . . . 0.0 111.643 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 m -116.85 16.86 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.244 1.418 . . . . 0.0 111.242 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.73 33.97 88.67 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.444 -1.198 . . . . 0.0 113.423 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.71 150.89 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 169.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -118.34 137.84 52.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.806 0.843 . . . . 0.0 108.97 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' B' ' 61' ' ' ASN . 21.5 pt -137.81 18.14 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 124.571 1.149 . . . . 0.0 110.988 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -67.03 15.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' B' ' 59' ' ' ILE . 30.1 t30 -137.26 -6.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.24 2.616 . . . . 0.0 111.822 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.9 157.06 22.53 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.128 -0.983 . . . . 0.0 110.942 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.9 p -123.44 176.62 6.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.39 1.876 . . . . 0.0 109.707 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -157.99 170.26 22.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -165.43 163.28 19.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.527 1.931 . . . . 0.0 108.15 -176.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.4 pt -64.97 167.37 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.787 0.835 . . . . 0.0 111.801 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -49.43 138.72 4.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.489 0.715 . . . . 0.0 109.58 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.45 103.79 3.85 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.469 1.128 . . . . 0.0 108.954 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -48.84 -32.53 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.944 1.698 . . . . 0.0 113.924 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.0 -22.91 63.08 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.419 0.554 . . . . 0.0 111.194 -169.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.87 -39.42 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.147 -0.93 . . . . 0.0 109.344 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.05 -49.43 77.67 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.573 1.079 . . . . 0.0 110.449 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -25.21 67.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.918 0.781 . . . . 0.0 111.416 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -87.62 -11.41 48.59 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.996 1.318 . . . . 0.0 113.018 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.64 169.74 5.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.025 0.916 . . . . 0.0 111.281 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -85.29 -34.98 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 169.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 tp -151.41 144.13 24.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.974 1.309 . . . . 0.0 109.933 -173.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.82 101.91 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 126.269 1.827 . . . . 0.0 107.074 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 88.6 t -80.49 100.82 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 82.9 m -78.85 131.39 36.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -150.66 64.78 0.93 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.915 0.864 . . . . 0.0 111.65 -174.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 124.438 1.095 . . . . 0.0 109.736 169.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.44 14.74 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.611 1.965 . . . . 0.0 113.978 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm 77.3 31.02 0.5 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.114 2.566 . . . . 0.0 111.799 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 p 29.78 56.45 0.73 Allowed Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.596 1.958 . . . . 0.0 112.694 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.77 131.98 46.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.191 2.594 . . . . 0.0 110.162 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.99 0.4 55.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.979 -173.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.6 p 46.28 90.39 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.986 2.114 . . . . 0.0 113.147 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -64.54 147.21 90.24 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.026 2.484 . . . . 0.0 108.842 -169.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.21 -0.06 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.112 3.208 . . . . 0.0 115.359 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -64.08 -16.95 62.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.752 0.821 . . . . 0.0 111.754 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 152.39 37.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.416 1.007 . . . . 0.0 112.796 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -80.08 154.72 27.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 168.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -139.79 146.22 39.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -144.81 149.31 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 133.48 50.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.291 1.036 . . . . 0.0 108.423 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -131.39 -5.7 3.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.386 1.074 . . . . 0.0 111.626 -171.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.62 147.18 16.26 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -144.09 24.41 1.63 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.699 1.599 . . . . 0.0 110.884 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -152.45 163.41 39.59 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.085 2.154 . . . . 0.0 106.499 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -147.31 121.9 5.13 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.288 1.404 . . . . 0.0 108.349 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.03 -21.59 15.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.548 2.165 . . . . 0.0 112.876 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.25 -6.14 12.81 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.551 1.069 . . . . 0.0 112.16 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -103.54 12.13 35.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.822 1.249 . . . . 0.0 111.544 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.68 148.9 0.66 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.001 1.321 . . . . 0.0 112.55 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -38.56 85.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.942 -171.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.47 -20.49 4.93 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 169.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.6 p -69.93 163.59 25.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.66 -39.57 84.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.265 0.555 . . . . 0.0 110.919 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.89 -44.64 61.05 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.349 -1.31 . . . . 0.0 109.87 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -73.82 -29.12 61.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 120.922 1.692 . . . . 0.0 110.5 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -58.17 -62.34 1.9 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.526 0.603 . . . . 0.0 109.516 170.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -60.44 -40.14 90.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.13 99.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.057 -177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.89 -46.0 83.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.798 0.726 . . . . 0.0 109.648 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -63.34 -44.15 95.71 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.956 0.902 . . . . 0.0 111.41 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 -59.13 -49.47 77.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.02 -38.79 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.587 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -55.65 -46.3 77.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.948 1.703 . . . . 0.0 111.495 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.09 -44.62 95.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.204 0.315 . . . . 0.0 110.762 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -61.44 2.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 110.133 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -39.96 60.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.614 1.565 . . . . 0.0 110.956 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.96 76.65 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 118.531 -1.15 . . . . 0.0 110.861 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -58.93 -46.66 87.42 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.373 1.587 . . . . 0.0 111.209 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.05 -50.33 73.08 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -37.27 75.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.485 0.584 . . . . 0.0 112.319 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.49 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -60.69 -42.34 96.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.97 -41.3 95.56 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.864 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.8 -37.64 74.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.802 2.547 . . . . 0.0 111.372 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.49 -29.94 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.5 -46.89 8.36 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.163 1.785 . . . . 0.0 110.983 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.6 p -79.17 -28.48 42.71 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.661 1.984 . . . . 0.0 109.087 -172.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 47.44 44.11 21.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm . . . . . 0 C--O 1.247 0.957 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.232 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 tpp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 118.906 -0.568 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.53 169.22 24.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.175 1.39 . . . . 0.0 108.268 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.54 100.48 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.25 167.3 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.858 1.663 . . . . 0.0 108.72 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -121.14 112.4 18.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.628 1.571 . . . . 0.0 108.017 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.05 172.49 13.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.325 1.05 . . . . 0.0 110.156 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -156.69 -177.77 6.86 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.633 1.973 . . . . 0.0 106.447 169.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -38.45 -38.83 0.4 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.673 2.789 . . . . 0.0 116.005 -169.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.18 -31.3 2.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.125 0.97 . . . . 0.0 111.154 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -61.68 -21.76 64.73 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 117.816 -1.088 . . . . 0.0 112.293 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -48.66 -51.32 28.97 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.323 1.42 . . . . 0.0 110.166 169.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -64.85 -45.29 86.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.03 87.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.532 0.206 . . . . 0.0 110.87 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -74.34 -16.1 60.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.546 1.138 . . . . 0.0 112.434 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.9 p -115.64 -2.83 12.39 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 112.122 -171.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.8 m -72.61 -10.83 60.26 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.73 144.47 34.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.135 0.879 . . . . 0.0 110.111 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.62 -174.92 31.09 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.59 1.091 . . . . 0.0 111.808 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -89.99 129.84 40.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.2 116.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -169.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.6 tp -79.23 138.25 37.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.12 115.08 15.93 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.367 0.985 . . . . 0.0 109.24 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -111.97 147.67 35.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.01 1.324 . . . . 0.0 110.203 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -128.52 109.05 11.03 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.601 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -129.7 153.14 48.45 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.066 1.746 . . . . 0.0 107.711 -170.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -171.24 162.24 5.24 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 119.426 1.012 . . . . 0.0 109.836 169.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.63 -19.79 14.96 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.917 3.078 . . . . 0.0 116.626 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -53.72 -30.46 44.01 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.999 1.32 . . . . 0.0 114.293 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 161.27 34.27 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.31 0.959 . . . . 0.0 113.214 -169.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.79 -48.92 52.59 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.08 -1.4 . . . . 0.0 112.669 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.4 -28.0 19.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.363 2.709 . . . . 0.0 115.075 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.85 -20.31 49.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 119.742 1.156 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.63 13.8 21.23 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.126 0.97 . . . . 0.0 111.442 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.1 mtm -123.73 -46.05 2.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.249 1.02 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.0 -34.75 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.15 10.94 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.691 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -59.66 -39.84 70.38 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.02 1.813 . . . . 0.0 111.634 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.35 -39.07 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 118.65 0.659 . . . . 0.0 110.451 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 mp -72.53 -39.76 67.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.991 0.814 . . . . 0.0 111.466 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.42 -33.48 75.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.723 1.147 . . . . 0.0 110.049 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.06 -21.56 59.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.0 1.32 . . . . 0.0 111.597 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.9 -44.71 16.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 108.932 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.46 -32.42 69.96 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.436 -1.415 . . . . 0.0 111.211 -172.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -67.14 -6.88 19.54 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.537 -0.727 . . . . 0.0 112.755 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.8 -46.61 3.33 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.733 2.013 . . . . 0.0 109.615 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . 0.289 59.7 mmm -104.08 -12.42 16.77 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 125.486 1.515 . . . . 0.0 113.121 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.99 -7.8 9.33 Favored Glycine 0 C--N 1.318 -0.457 0 N-CA-C 113.962 0.345 . . . . 0.0 113.962 -171.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.03 -25.54 65.43 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.16 2.184 . . . . 0.0 112.489 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.7 -20.37 3.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.169 1.388 . . . . 0.0 112.074 -171.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 51' ' ' LYS . 1.6 tm? -129.43 156.41 44.14 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.21 1.404 . . . . 0.0 112.32 -166.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.41 ' H ' HD23 ' A' ' 50' ' ' LEU . 87.7 tttt -122.61 148.06 45.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.589 1.556 . . . . 0.0 108.28 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.7 mt -128.15 144.13 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.23 146.49 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.601 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 24.7 mtpt -121.32 153.02 38.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.181 0.446 . . . . 0.0 110.883 173.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -121.29 127.33 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.29 106.74 15.31 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.299 33.4 m -79.76 49.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -177.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -154.52 -42.18 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.538 1.135 . . . . 0.0 109.453 168.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -84.36 -40.97 17.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.053 1.341 . . . . 0.0 109.831 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -127.73 28.78 5.57 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.283 1.833 . . . . 0.0 111.3 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.98 -3.44 26.04 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.477 0.711 . . . . 0.0 112.696 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.75 -46.76 74.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.815 1.646 . . . . 0.0 111.127 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.15 -46.12 75.69 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.34 -63.93 0.97 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.723 0.809 . . . . 0.0 108.989 -169.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.21 -46.3 15.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.051 0.834 . . . . 0.0 113.096 174.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.02 -42.95 99.91 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.238 1.019 . . . . 0.0 111.724 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -69.17 -18.93 63.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.549 . . . . 0.0 110.712 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.22 66.48 1.52 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.12 129.9 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.6 mtm -147.64 20.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -134.32 160.69 37.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.608 1.163 . . . . 0.0 113.98 -167.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 136.45 29.14 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.042 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.43 128.48 11.64 Favored 'Cis proline' 0 N--CA 1.453 -0.869 0 N-CA-C 106.367 -2.205 . . . . 0.0 106.367 -11.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.6 m -92.91 140.49 29.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -136.45 92.79 2.81 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -80.5 132.36 35.68 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.67 120.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -127.96 157.95 39.2 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.057 0.943 . . . . 0.0 109.502 -170.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.06 144.08 25.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 169.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.8 30.29 0.83 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.178 1.791 . . . . 0.0 113.538 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.0 11.99 58.19 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.828 1.204 . . . . 0.0 115.939 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.31 149.26 50.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.647 1.224 . . . . 0.0 111.297 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.38 141.83 15.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 m -128.8 -20.62 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.504 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 153.0 40.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.241 1.016 . . . . 0.0 109.123 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.56 116.61 7.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -177.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -135.67 147.27 48.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.58 95.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.46 155.9 7.62 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -64.78 143.0 58.24 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.673 0.737 . . . . 0.0 110.526 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 139.75 32.05 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 169.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.24 167.24 22.62 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.463 2.109 . . . . 0.0 110.333 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -46.92 -46.71 21.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.702 1.601 . . . . 0.0 112.386 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.2 -44.34 72.3 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.562 0.619 . . . . 0.0 111.118 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.32 83.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.122 -0.361 . . . . 0.0 110.415 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -52.08 63.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.131 0.572 . . . . 0.0 109.998 176.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -64.24 -36.26 83.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.983 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.96 -49.37 77.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.167 0.439 . . . . 0.0 110.981 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.49 -40.03 85.71 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 123.683 0.793 . . . . 0.0 111.557 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.04 -40.73 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.228 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -55.0 -30.65 59.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.365 1.066 . . . . 0.0 112.276 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -59.62 -18.12 38.92 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.146 0.978 . . . . 0.0 113.298 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -131.88 -22.81 2.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.337 0.971 . . . . 0.0 112.774 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.2 tp . . . . . 0 C--O 1.248 0.984 0 C-N-CA 126.484 1.913 . . . . 0.0 107.528 169.866 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.67 24.22 2.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.839 0.855 . . . . 0.0 112.605 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.98 133.85 11.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 169.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -142.65 118.29 10.42 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 129.302 3.041 . . . . 0.0 104.23 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.72 130.66 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -134.34 139.67 47.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -127.13 142.27 51.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.201 1.0 . . . . 0.0 108.511 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -126.41 107.38 10.23 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.146 0.978 . . . . 0.0 108.558 -172.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.97 127.31 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 91.9 p -152.17 162.51 41.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.077 0.399 . . . . 0.0 111.407 169.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 76.5 m -50.05 115.54 1.46 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.623 1.169 . . . . 0.0 110.145 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.46 19.46 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.685 2.088 . . . . 0.0 115.541 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 42.08 31.9 0.27 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.195 1.398 . . . . 0.0 111.493 -168.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -85.95 17.8 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.364 -1.46 . . . . 0.0 113.166 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.67 -67.66 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.662 1.185 . . . . 0.0 111.887 169.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.54 -56.62 15.48 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -168.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m -70.51 -32.99 70.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.891 -169.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.66 -50.15 55.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.305 1.05 . . . . 0.0 111.394 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' MET . . . . . 0.409 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 31.4 ttm -67.76 -47.12 70.1 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.76 -175.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.99 97.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.001 0.92 . . . . 0.0 111.114 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.57 -31.18 69.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.569 1.077 . . . . 0.0 111.069 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.75 -49.7 53.32 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -56.34 -39.79 73.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.81 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.7 -51.52 64.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -63.37 -22.55 66.95 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -69.87 -11.19 60.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.483 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 14.4 m-85 -130.17 -44.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.735 1.214 . . . . 0.0 111.657 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.44 75.37 8.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.329 2.252 . . . . 0.0 105.521 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.52 -159.07 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.821 2.153 . . . . 0.0 113.306 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.19 -21.21 21.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.439 1.096 . . . . 0.0 113.245 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.13 -19.85 15.09 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.35 1.86 . . . . 0.0 113.071 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -128.66 161.22 30.16 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.818 1.247 . . . . 0.0 111.005 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.5 136.95 49.48 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.66 136.1 60.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -140.36 157.15 45.98 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.178 0.991 . . . . 0.0 109.217 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -138.43 140.66 39.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.734 1.213 . . . . 0.0 108.56 -172.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.36 173.84 16.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.913 0.485 . . . . 0.0 110.953 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.87 -171.4 42.05 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.304 0.954 . . . . 0.0 111.193 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.73 -56.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.008 1.723 . . . . 0.0 113.999 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.38 31.0 2.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.711 2.004 . . . . 0.0 107.581 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.02 131.09 47.46 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.519 1.928 . . . . 0.0 113.821 -169.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -171.21 8.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.175 1.79 . . . . 0.0 111.31 169.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.73 107.56 3.13 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 119.175 0.898 . . . . 0.0 111.696 -169.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -78.39 86.7 4.44 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -62.04 125.43 85.23 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.534 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.3 -20.08 53.73 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.243 1.962 . . . . 0.0 113.013 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.413 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -60.52 -39.63 88.52 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.696 1.135 . . . . 0.0 111.027 171.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.25 59.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.76 -50.81 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -56.93 -47.01 81.61 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 123.375 0.67 . . . . 0.0 110.28 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.55 -33.26 59.81 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.208 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 82.6 mmm -91.67 -30.64 16.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.997 0.817 . . . . 0.0 111.219 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.47 -24.39 67.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.845 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.67 -31.39 68.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.929 1.24 . . . . 0.0 111.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 m -113.73 15.36 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.085 1.354 . . . . 0.0 110.808 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.67 39.97 98.59 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.634 -1.092 . . . . 0.0 112.824 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.56 107.88 24.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.33 132.7 48.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 pt -127.99 11.42 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.881 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -19.81 46.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.06 0.845 . . . . 0.0 111.163 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -76.97 -13.83 59.92 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.493 2.317 . . . . 0.0 114.073 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -62.9 161.62 12.53 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.217 1.371 . . . . 0.0 113.586 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 63.8 p -126.44 171.23 11.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.883 2.473 . . . . 0.0 108.528 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -157.89 163.62 37.74 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.819 -1.176 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -167.78 164.94 14.28 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 -175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.5 pt -69.29 175.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 111.274 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.53 133.62 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -143.17 104.8 4.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.869 0.842 . . . . 0.0 108.988 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -46.92 -28.63 1.67 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.766 2.026 . . . . 0.0 114.022 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.85 -15.77 62.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.125 0.875 . . . . 0.0 112.049 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.48 -38.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.38 1.072 . . . . 0.0 109.259 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 tt -65.31 -58.54 5.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 120.206 1.366 . . . . 0.0 109.399 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -24.08 66.57 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.362 0.528 . . . . 0.0 110.757 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -78.63 -26.13 45.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 113.092 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 169.33 2.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.467 1.507 . . . . 0.0 111.959 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -91.31 -30.34 16.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.413 ' HG ' ' HE2' ' B' ' 97' ' ' LYS . 0.8 OUTLIER -148.07 138.63 22.97 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.189 0.996 . . . . 0.0 110.556 -170.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 t -113.57 106.14 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.64 114.35 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 30.4 m -77.21 129.23 35.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 168.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.6 tp -131.43 56.12 1.82 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.998 0.919 . . . . 0.0 111.304 -168.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 CA--C 1.534 0.334 0 O-C-N 120.883 -1.135 . . . . 0.0 109.339 170.571 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.5 -0.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.116 2.166 . . . . 0.0 116.685 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 85.89 7.39 0.36 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.472 2.309 . . . . 0.0 111.528 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.6 m 32.79 49.63 0.55 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 127.821 2.448 . . . . 0.0 113.5 -170.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.48 134.15 38.69 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.731 2.287 . . . . 0.0 111.685 -169.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 0.23 49.87 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 116.987 -1.482 . . . . 0.0 114.882 -172.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p 48.31 88.45 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.202 1.401 . . . . 0.0 112.879 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.6 146.61 74.98 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 122.802 2.335 . . . . 0.0 110.112 -169.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.76 2.96 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 125.551 4.167 . . . . 0.0 116.617 -168.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -68.39 -6.16 23.03 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.951 0.796 . . . . 0.0 111.945 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.95 147.31 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.533 1.133 . . . . 0.0 110.26 -169.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.413 ' HE2' ' HG ' ' B' ' 77' ' ' LEU . 2.6 tmmm? -72.73 156.53 38.84 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -151.43 139.11 19.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.627 -1.296 . . . . 0.0 108.472 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -149.11 144.86 26.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.31 136.73 34.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -133.76 -10.64 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.958 0.903 . . . . 0.0 111.655 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.44 168.08 49.6 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.11 -7.28 0.18 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.432 0.693 . . . . 0.0 112.836 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -161.98 179.41 8.03 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.262 1.425 . . . . 0.0 107.928 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -135.76 114.91 11.21 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.26 1.424 . . . . 0.0 108.389 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.05 -18.58 21.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.474 2.783 . . . . 0.0 112.855 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.88 -7.19 7.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.786 1.176 . . . . 0.0 112.461 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -101.66 11.3 39.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.359 1.464 . . . . 0.0 111.347 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.64 147.05 0.65 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.481 1.112 . . . . 0.0 111.595 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -53.37 -45.99 69.43 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 124.078 0.861 . . . . 0.0 109.889 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.98 -20.48 2.86 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 53.2 p -68.7 165.38 19.59 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.37 -41.72 97.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.48 0.657 . . . . 0.0 110.308 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.98 -43.73 67.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 117.007 -1.473 . . . . 0.0 109.718 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.36 -32.43 62.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.18 1.809 . . . . 0.0 109.582 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -56.2 -62.28 1.82 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.153 0.581 . . . . 0.0 109.658 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.89 -39.78 86.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.989 0.916 . . . . 0.0 112.25 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -64.33 -44.92 90.02 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.9 m-30 -60.88 -51.53 68.9 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -64.08 -46.8 82.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 111.299 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -65.51 -48.61 71.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.084 0.402 . . . . 0.0 110.016 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.07 -40.23 88.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.151 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.409 ' HA ' ' SD ' ' B' ' 19' ' ' MET . 13.6 ttp180 -58.17 -46.73 85.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.543 1.065 . . . . 0.0 111.84 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.23 -44.09 83.47 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.183 0.447 . . . . 0.0 110.524 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -74.37 -39.52 62.7 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.66 -49.17 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 108.913 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.55 -41.44 96.17 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.409 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -56.78 -51.34 69.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 118.13 0.965 . . . . 0.0 111.228 174.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -63.7 -42.31 98.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.638 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.5 -40.88 96.49 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.152 0.887 . . . . 0.0 112.202 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.483 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 41.5 ttmt -60.13 -38.0 81.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.461 0.573 . . . . 0.0 110.416 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.64 77.9 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 116.672 -1.633 . . . . 0.0 112.611 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -59.16 -34.46 72.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 122.539 2.427 . . . . 0.0 110.957 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.69 -32.53 73.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.086 0.554 . . . . 0.0 111.036 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -88.63 -44.57 10.52 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.293 1.437 . . . . 0.0 111.239 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 68.0 p -87.04 -17.44 32.94 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.899 2.08 . . . . 0.0 111.017 -170.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.32 39.57 92.83 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.225 0.917 . . . . 0.0 110.932 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.743 0.817 . . . . 0.0 112.293 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.67 157.86 0.08 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.916 2.486 . . . . 0.0 113.074 -171.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.83 100.92 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 t -74.87 165.98 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.243 1.417 . . . . 0.0 108.057 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -125.79 117.46 23.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.319 1.048 . . . . 0.0 108.625 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.79 171.82 14.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.667 1.587 . . . . 0.0 110.12 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -156.02 -176.07 5.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.642 1.577 . . . . 0.0 107.053 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -36.67 -36.97 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 130.202 3.401 . . . . 0.0 116.743 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.97 -30.24 1.23 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.999 1.32 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -60.84 -22.18 63.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.335 -0.84 . . . . 0.0 112.319 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -50.79 -52.44 40.96 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.613 1.097 . . . . 0.0 109.292 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.45 -44.57 96.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.02 80.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.444 -0.16 . . . . 0.0 111.13 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.38 -11.95 59.98 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.855 1.262 . . . . 0.0 112.843 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -123.29 -3.09 8.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.942 1.246 . . . . 0.0 113.27 -169.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -71.33 -10.74 60.25 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.65 156.87 45.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.11 0.964 . . . . 0.0 109.574 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.98 -150.92 48.34 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.359 0.98 . . . . 0.0 110.988 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.42 132.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.0 t -143.13 116.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.94 123.33 27.16 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.47 140.15 46.31 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -134.09 151.32 51.33 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.876 1.671 . . . . 0.0 108.786 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -131.66 117.35 18.54 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -169.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.572 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.9 p-90 -139.58 153.89 47.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.344 1.458 . . . . 0.0 108.849 -169.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.48 158.33 9.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.262 1.025 . . . . 0.0 108.489 168.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.37 -15.18 5.4 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.764 2.976 . . . . 0.0 116.846 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -59.86 -24.75 64.48 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.12 160.26 36.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.456 1.026 . . . . 0.0 112.588 -169.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.24 -49.62 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.253 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.1 -28.09 24.03 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.225 2.617 . . . . 0.0 115.093 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 m -59.38 -16.42 22.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.585 1.084 . . . . 0.0 113.692 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -116.92 14.98 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.788 1.235 . . . . 0.0 111.681 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.0 mtm -123.47 -45.2 2.08 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.182 0.993 . . . . 0.0 109.416 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tp -62.77 -34.9 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.798 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.84 24.02 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.985 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.04 -40.1 73.96 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.955 1.77 . . . . 0.0 111.476 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.44 -37.93 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.467 0.576 . . . . 0.0 110.701 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mp -71.58 -41.22 69.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.952 0.796 . . . . 0.0 111.363 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.06 -35.13 80.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.673 1.124 . . . . 0.0 109.727 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.3 -16.41 61.9 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.619 1.567 . . . . 0.0 112.608 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -86.98 -43.45 12.35 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 124.657 1.183 . . . . 0.0 108.382 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.2 -36.59 69.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.79 -0.569 . . . . 0.0 111.118 -174.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.78 -12.55 61.61 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.614 -0.679 . . . . 0.0 112.193 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -99.92 -42.57 6.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.366 1.467 . . . . 0.0 110.797 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -145.03 17.89 1.59 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.665 0.786 . . . . 0.0 112.284 -172.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.91 -1.99 21.36 Favored Glycine 0 CA--C 1.523 0.574 0 O-C-N 121.343 -0.848 . . . . 0.0 113.984 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.37 -24.88 63.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.599 1.16 . . . . 0.0 110.97 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.12 -18.3 11.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.911 0.884 . . . . 0.0 112.576 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -130.63 147.32 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 111.101 -168.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -107.11 146.01 31.77 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 168.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.71 137.44 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 t -136.58 141.56 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.572 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 26.3 mtpt -116.41 152.79 33.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -117.72 120.75 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -79.03 109.37 13.27 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.48 33.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -141.8 -42.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.057 -1.027 . . . . 0.0 109.819 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -79.82 -36.12 37.37 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.94 0.896 . . . . 0.0 110.67 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -134.2 32.37 3.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.439 1.495 . . . . 0.0 109.94 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -15.26 62.9 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.21 -169.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -50.54 -44.57 56.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.971 1.309 . . . . 0.0 111.783 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -60.38 -38.61 84.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.895 0.77 . . . . 0.0 111.872 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -66.91 0.5 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.83 1.252 . . . . 0.0 108.883 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.23 -44.84 5.04 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.641 1.115 . . . . 0.0 113.609 170.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -64.44 -45.2 88.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.574 1.187 . . . . 0.0 111.535 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -70.02 -31.57 69.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.49 0.586 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 68.05 0.74 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.8 t -142.39 132.49 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 100.744 -3.799 . . . . 0.0 100.744 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 10.3 ptm -150.59 17.66 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.767 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -138.3 163.56 31.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.222 2.209 . . . . 0.0 111.155 -169.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 143.89 49.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.944 0.898 . . . . 0.0 108.781 176.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.91 149.6 38.77 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 N-CA-C 107.345 -1.829 . . . . 0.0 107.345 -11.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.7 m -118.45 147.52 43.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 172.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.6 mt -125.71 141.71 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -129.0 106.86 9.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.04 118.63 31.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -110.31 149.05 30.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.518 0.727 . . . . 0.0 109.405 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -148.75 132.95 17.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.6 t70 43.23 30.84 0.32 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.678 1.991 . . . . 0.0 113.499 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.64 9.99 57.09 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.43 152.59 51.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.693 1.197 . . . . 0.0 110.757 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.07 133.06 32.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -120.24 -22.45 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.223 1.409 . . . . 0.0 110.704 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.36 163.73 34.64 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.215 1.006 . . . . 0.0 110.063 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.74 150.39 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -169.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -154.79 151.25 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.52 67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.76 154.92 8.94 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -170.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -71.86 158.88 35.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.946 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.59 143.63 20.46 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.18 168.15 22.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.352 2.035 . . . . 0.0 110.425 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -44.99 70.94 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.085 0.954 . . . . 0.0 112.071 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.86 -43.17 84.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.563 0.165 . . . . 0.0 110.891 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.0 78.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.04 -0.412 . . . . 0.0 110.666 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -53.21 59.65 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 109.477 175.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -64.44 -37.81 88.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.72 -46.61 88.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.425 0.557 . . . . 0.0 111.264 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -58.08 -40.12 80.29 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 123.868 0.867 . . . . 0.0 111.151 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.95 -39.87 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.267 -0.397 . . . . 0.0 110.687 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -56.36 -28.24 58.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.583 1.153 . . . . 0.0 112.414 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -56.35 -22.39 30.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.149 0.98 . . . . 0.0 112.959 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -127.97 -26.17 2.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.052 0.941 . . . . 0.0 112.338 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.704 1.602 . . . . 0.0 108.033 171.211 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.69 142.5 40.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.289 0.636 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m120 70.63 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 128.608 2.763 . . . . 0.0 110.566 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 127.23 27.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.57 136.16 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -137.91 140.46 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.38 139.89 49.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.898 0.479 . . . . 0.0 110.775 -169.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -100.94 141.18 34.19 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.62 120.07 10.99 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -172.23 155.92 3.75 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -39.53 102.19 0.02 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.18 1.792 . . . . 0.0 112.707 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.27 22.35 50.16 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.652 -1.638 . . . . 0.0 113.784 171.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 33.5 2.67 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 1 C-N-CA 132.715 4.406 . . . . 0.0 121.046 173.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -70.84 -5.95 34.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.914 -1.741 . . . . 0.0 115.312 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.31 -95.65 0.48 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 120.496 1.498 . . . . 0.0 111.102 -177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -37.5 62.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.611 0.765 . . . . 0.0 112.536 -171.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -44.42 97.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.62 0.646 . . . . 0.0 110.089 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -56.7 -48.62 77.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.051 0.94 . . . . 0.0 110.188 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -43.3 91.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 124.068 0.855 . . . . 0.0 108.906 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.75 71.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.942 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -48.29 80.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.903 1.229 . . . . 0.0 109.883 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 -47.17 92.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -58.36 -42.34 86.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 112.055 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.27 -54.25 36.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.46 -23.66 65.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.703 -1.142 . . . . 0.0 112.025 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -68.22 -21.19 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.883 1.219 . . . . 0.0 113.558 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.402 ' CE2' ' HE3' ' B' ' 132' ' ' LYS . 2.3 m-85 -115.69 -16.31 11.27 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.971 0.908 . . . . 0.0 112.715 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.53 -128.23 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.13 -174.4 40.23 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 127.3 2.381 . . . . 0.0 107.361 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.61 -14.24 40.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.376 1.088 . . . . 0.0 112.026 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -52.79 -28.0 20.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.309 1.444 . . . . 0.0 110.429 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -122.46 168.65 11.86 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.24 2.216 . . . . 0.0 107.228 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -139.04 106.21 5.48 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 120.974 -1.079 . . . . 0.0 108.982 -173.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 82.3 t -99.31 132.22 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.67 166.73 23.82 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.517 1.527 . . . . 0.0 108.775 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 37.3 m -147.15 150.55 35.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.484 1.114 . . . . 0.0 109.213 176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.56 177.35 11.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.975 0.91 . . . . 0.0 110.03 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.24 -175.78 47.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.401 1.477 . . . . 0.0 110.035 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -53.07 -55.45 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.346 1.458 . . . . 0.0 113.114 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.12 29.82 5.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.343 1.457 . . . . 0.0 108.297 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 121.47 14.77 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.092 2.157 . . . . 0.0 111.72 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -174.85 -19.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.46 1.504 . . . . 0.0 111.194 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.76 179.31 53.6 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 124.333 0.968 . . . . 0.0 113.981 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -147.26 92.31 2.09 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.416 1.486 . . . . 0.0 107.041 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.57 129.06 94.07 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.622 1.169 . . . . 0.0 108.16 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -59.53 -19.66 53.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.875 1.717 . . . . 0.0 112.809 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -38.72 88.8 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.104 1.32 . . . . 0.0 111.239 171.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.72 65.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.91 -52.7 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.675 0.79 . . . . 0.0 110.264 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -36.94 58.45 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.996 0.918 . . . . 0.0 111.206 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.7 mmm -82.3 -30.54 30.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.141 0.882 . . . . 0.0 111.568 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -61.62 -25.47 67.38 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.47 1.032 . . . . 0.0 110.992 171.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.15 -22.46 66.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.768 1.167 . . . . 0.0 112.246 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 p -116.67 9.7 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.978 1.711 . . . . 0.0 109.526 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.0 38.79 96.54 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 120.964 -1.085 . . . . 0.0 111.928 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.9 mt -114.48 140.35 35.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.25 136.8 44.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 pt -135.78 15.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.437 1.095 . . . . 0.0 110.855 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 17.1 p -59.48 -13.12 7.65 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.657 1.117 . . . . 0.0 113.63 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -91.29 -14.81 30.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.862 1.665 . . . . 0.0 113.492 176.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.69 142.0 53.95 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.746 1.157 . . . . 0.0 112.611 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -129.36 173.6 10.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.893 2.477 . . . . 0.0 108.486 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.3 m -155.36 -175.38 5.41 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.966 -1.083 . . . . 0.0 110.924 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -155.93 158.87 38.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.94 1.696 . . . . 0.0 109.031 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.5 pt -71.61 170.31 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.583 1.153 . . . . 0.0 112.215 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.7 127.45 5.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -146.01 97.18 2.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.351 1.072 . . . . 0.0 108.75 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -46.42 -27.37 1.06 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.348 1.859 . . . . 0.0 114.429 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.78 -17.9 61.84 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.94 1.245 . . . . 0.0 112.604 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.19 -34.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.917 0.887 . . . . 0.0 108.933 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.66 -54.77 19.67 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.365 0.984 . . . . 0.0 110.209 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -22.41 67.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.561 0.619 . . . . 0.0 110.48 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.1 -20.79 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.809 1.644 . . . . 0.0 112.418 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.56 167.34 2.68 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.759 1.224 . . . . 0.0 111.947 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.29 -28.58 16.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.74 169.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.53 132.45 19.13 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 110.73 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.19 99.98 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -81.09 102.69 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 57.5 m -67.04 136.09 54.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 tp -125.13 43.54 3.02 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 CA--C 1.54 0.59 0 C-N-CA 124.64 1.176 . . . . 0.0 112.724 174.763 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 17.73 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 130.96 3.704 . . . . 0.0 110.643 -168.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -157.12 32.89 0.29 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 128.996 2.918 . . . . 0.0 107.663 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 m 32.38 52.8 0.84 Allowed Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.421 1.888 . . . . 0.0 112.478 -168.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -45.43 131.76 12.22 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.486 2.79 . . . . 0.0 114.8 -169.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.42 -1.3 56.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.2 p 44.36 93.05 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.888 2.075 . . . . 0.0 113.831 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -55.89 134.97 67.27 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.776 2.317 . . . . 0.0 109.089 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.16 8.47 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.765 3.643 . . . . 0.0 116.095 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -67.8 -6.08 19.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.087 0.955 . . . . 0.0 111.904 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.37 146.79 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 109.391 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -69.67 156.14 39.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -144.36 142.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.404 0 O-C-N 121.029 -1.044 . . . . 0.0 108.208 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.85 154.07 32.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 169.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -95.95 127.31 41.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -110.02 -3.62 16.37 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.706 0.802 . . . . 0.0 110.499 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 162.38 13.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -145.82 -9.39 0.54 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.398 1.079 . . . . 0.0 111.738 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -156.87 168.58 27.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.353 2.261 . . . . 0.0 106.02 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -125.33 112.15 26.04 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.035 0.934 . . . . 0.0 108.636 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.0 -22.91 34.86 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.404 3.403 . . . . 0.0 113.189 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.87 -10.69 9.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.976 0.807 . . . . 0.0 112.637 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -97.82 7.95 45.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 111.858 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.61 143.29 2.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.027 0.931 . . . . 0.0 112.362 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -57.04 -47.7 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.968 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.15 -17.25 4.1 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 44.0 p -70.16 159.87 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.61 -38.81 82.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.352 0.596 . . . . 0.0 111.068 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -72.71 -43.43 63.02 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.764 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.49 -30.82 59.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.103 1.774 . . . . 0.0 110.077 -172.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -59.89 -57.11 14.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.76 -0.638 . . . . 0.0 109.837 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -61.5 -41.68 97.66 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.146 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.32 87.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.144 0.884 . . . . 0.0 112.372 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -62.92 -47.63 82.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -64.13 -43.38 95.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -59.43 -53.84 53.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.018 1.727 . . . . 0.0 109.693 -173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.08 -49.36 70.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.1 -41.19 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.216 -0.897 . . . . 0.0 109.736 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp-105 -58.39 -47.17 84.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.974 1.261 . . . . 0.0 111.21 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.31 -43.49 88.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.242 0.474 . . . . 0.0 110.92 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -64.72 -48.87 73.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.05 0.54 . . . . 0.0 110.06 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.88 -50.66 59.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 125.206 1.402 . . . . 0.0 110.042 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.21 -40.84 95.0 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -61.58 -42.99 99.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.17 0.985 . . . . 0.0 111.689 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -69.74 -34.16 73.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.956 0.798 . . . . 0.0 111.345 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.19 -37.8 66.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.698 1.135 . . . . 0.0 111.756 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.402 ' HE3' ' CE2' ' B' ' 27' ' ' TYR . 7.9 ptmt -67.75 -37.34 82.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.945 0.793 . . . . 0.0 109.836 175.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -59.24 -40.75 86.92 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.218 -1.372 . . . . 0.0 109.904 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -60.4 -38.15 83.06 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 122.163 2.256 . . . . 0.0 111.181 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.99 70.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.037 0.535 . . . . 0.0 112.221 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.22 -47.57 8.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.474 1.51 . . . . 0.0 111.499 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.1 p -84.19 -23.28 30.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 110.78 -169.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 50.58 41.28 41.73 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.273 1.429 . . . . 0.0 113.613 -169.049 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.51 170.04 21.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.27 1.428 . . . . 0.0 107.882 169.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 96.81 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 169.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.06 167.63 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.594 1.557 . . . . 0.0 108.132 178.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -123.6 120.28 32.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.257 1.423 . . . . 0.0 107.771 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.52 169.25 15.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.314 1.046 . . . . 0.0 109.214 176.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -133.59 -167.25 1.9 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.557 1.543 . . . . 0.0 108.245 169.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.26 -27.09 2.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.955 2.102 . . . . 0.0 113.409 169.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -136.53 -31.25 0.88 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 111.947 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.0 m -63.81 -20.51 65.84 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.807 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -52.24 -58.38 6.81 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.247 0.931 . . . . 0.0 109.272 169.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -62.58 -43.18 99.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.908 -0.495 . . . . 0.0 110.316 -176.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.79 83.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.193 -174.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -81.34 -16.13 53.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.207 1.003 . . . . 0.0 112.927 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -114.2 -4.19 13.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.446 1.021 . . . . 0.0 113.578 -169.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 m -73.4 -4.57 34.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.66 156.98 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.806 1.242 . . . . 0.0 109.554 -177.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.09 -163.36 45.24 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 124.754 1.169 . . . . 0.0 112.058 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.46 134.97 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.82 149.13 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 113.679 -1.6 . . . . 0.0 108.674 -168.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.4 tp -119.0 100.89 7.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.982 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.84 144.77 25.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -139.49 148.85 43.25 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.417 1.487 . . . . 0.0 108.724 -173.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.34 105.5 7.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -169.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.57 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.1 p-90 -123.7 151.58 42.99 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.237 1.815 . . . . 0.0 107.62 -169.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -166.75 163.09 11.08 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.689 0.677 . . . . 0.0 111.316 173.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.32 -10.42 8.51 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.179 3.253 . . . . 0.0 116.534 -177.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -50.12 -49.33 52.21 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.472 -1.251 . . . . 0.0 112.482 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -152.67 168.57 25.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -173.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.24 -54.07 3.91 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 127.865 2.65 . . . . 0.0 115.821 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -53.33 -29.73 49.09 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.597 2.699 . . . . 0.0 114.816 -173.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -61.02 -14.89 26.33 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.779 1.172 . . . . 0.0 114.047 174.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 8.78 19.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.6 1.56 . . . . 0.0 111.167 177.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.8 mtp -125.16 -44.91 1.87 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.477 1.111 . . . . 0.0 108.441 -175.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.91 -35.95 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 -59.28 10.49 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.275 1.03 . . . . 0.0 112.356 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.71 -40.75 61.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.188 1.925 . . . . 0.0 111.607 174.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -40.15 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.238 0.615 . . . . 0.0 110.865 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.82 -43.72 74.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.935 0.789 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.49 -35.16 80.07 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.99 0.814 . . . . 0.0 109.93 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.53 -17.55 62.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.507 1.523 . . . . 0.0 112.536 174.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -87.63 -44.42 11.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.48 1.112 . . . . 0.0 108.674 176.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -70.23 -36.41 74.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.137 -0.352 . . . . 0.0 110.934 -175.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -69.1 -8.52 46.09 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.919 -0.563 . . . . 0.0 112.32 175.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.91 -46.49 4.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.496 1.118 . . . . 0.0 111.23 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.6 ptm -135.63 15.98 3.37 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.063 0.945 . . . . 0.0 112.304 -171.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.89 -4.82 11.79 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 120.978 -1.077 . . . . 0.0 114.228 170.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.06 -23.33 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.752 0.821 . . . . 0.0 111.054 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -14.38 8.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.259 1.024 . . . . 0.0 112.262 -174.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -129.06 142.01 51.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.515 1.126 . . . . 0.0 111.854 -168.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.52 146.86 27.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 168.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.6 mt -123.49 144.59 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.03 143.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.57 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 29.2 mtpt -118.56 150.48 39.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.65 0.659 . . . . 0.0 110.197 174.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -118.91 127.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 169.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.49 105.12 12.4 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.297 34.6 m -79.64 46.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -152.2 -38.77 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.549 1.14 . . . . 0.0 109.435 168.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -78.79 -52.34 8.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.948 1.299 . . . . 0.0 110.101 177.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.04 46.0 2.47 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.884 1.274 . . . . 0.0 110.052 -172.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.62 2.83 5.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.75 1.62 . . . . 0.0 113.032 -176.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.7 -45.46 89.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.104 1.361 . . . . 0.0 111.102 -169.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -59.64 -36.16 75.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.386 0.994 . . . . 0.0 111.469 173.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.58 -58.41 3.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.67 -39.2 45.8 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.075 0.845 . . . . 0.0 113.807 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.11 -43.45 98.41 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.008 1.404 . . . . 0.0 110.821 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -74.92 -11.46 60.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.356 0.662 . . . . 0.0 111.745 173.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.85 55.56 13.73 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.065 1.317 . . . . 0.0 109.85 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.64 -46.89 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 117.911 0.855 . . . . 0.0 109.495 -169.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mtm 53.87 14.6 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 127.936 2.494 . . . . 0.0 113.583 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.6 m -135.59 163.6 29.75 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.835 1.198 . . . . 0.0 112.993 -168.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mm -135.09 137.61 27.34 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.975 0.91 . . . . 0.0 110.176 -177.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.74 125.85 10.38 Favored 'Cis proline' 0 N--CA 1.454 -0.846 0 N-CA-C 105.496 -2.54 . . . . 0.0 105.496 -11.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.8 m -85.4 146.36 27.02 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tp -137.21 125.49 23.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.05 108.3 13.21 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 177.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.8 129.79 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.4 156.31 42.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -142.2 138.7 31.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 44.17 28.45 0.27 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.867 2.067 . . . . 0.0 114.258 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.06 41.62 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 124.725 1.155 . . . . 0.0 115.748 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -130.95 143.62 50.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.735 1.268 . . . . 0.0 110.414 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 134.03 30.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -125.73 -22.74 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.356 1.063 . . . . 0.0 109.925 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.81 161.98 40.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.601 1.161 . . . . 0.0 109.534 169.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 148.64 29.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -154.16 155.89 36.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.56 72.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.29 154.83 9.05 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.954 -171.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -65.25 149.21 50.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.212 0.605 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.59 140.29 20.08 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.72 169.19 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 175.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -45.91 67.22 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.038 0.935 . . . . 0.0 112.078 -171.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.12 -43.82 77.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.45 0.114 . . . . 0.0 110.864 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.44 83.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.12 -0.362 . . . . 0.0 110.171 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 tp -68.17 -46.59 70.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.515 0.326 . . . . 0.0 110.781 178.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -62.65 -38.74 91.48 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.71 -45.64 91.82 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.579 0.627 . . . . 0.0 110.906 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.8 tp -58.65 -36.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.988 1.315 . . . . 0.0 111.644 -175.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.08 -40.78 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.469 174.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -56.99 -34.32 67.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.989 0.916 . . . . 0.0 111.555 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.52 -6.82 33.2 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.09 -22.9 4.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.904 1.282 . . . . 0.0 112.736 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.254 2.222 . . . . 0.0 109.063 170.378 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mpp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.91 139.29 58.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.524 0.73 . . . . 0.0 110.177 -178.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.453 0.1 OUTLIER 31.15 103.21 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.441 3.096 . . . . 0.0 119.129 -179.067 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.84 120.36 23.35 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.35 140.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -169.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.16 145.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -131.41 150.51 52.12 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.704 0.802 . . . . 0.0 110.548 -168.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -113.61 143.37 44.69 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.911 1.284 . . . . 0.0 107.582 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.8 tp -145.52 109.21 4.73 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -169.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -166.81 153.66 8.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.173 0.989 . . . . 0.0 109.974 -178.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 94.8 m -38.43 116.52 0.55 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.22 2.208 . . . . 0.0 113.607 -169.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.31 8.45 31.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.01 0.814 . . . . 0.0 113.763 172.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . 0.559 HD21 ' NE2' ' B' ' 18' ' ' GLN . 7.4 t30 52.53 20.63 1.53 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.919 1.288 . . . . 0.0 112.384 -169.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 10.5 m -67.27 133.8 50.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.427 -0.795 . . . . 0.0 109.933 -174.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 56.53 -85.65 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 169.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -40.74 67.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.998 0.817 . . . . 0.0 111.829 -169.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -33.76 76.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.03 0.932 . . . . 0.0 111.403 -177.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.559 ' NE2' HD21 ' B' ' 13' ' ' ASN . 41.2 mm-40 -68.95 -52.28 30.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.63 1.572 . . . . 0.0 108.949 175.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 11.3 ptp -65.83 -37.55 86.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.712 -174.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.41 80.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.979 -0.534 . . . . 0.0 110.495 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.73 -28.29 66.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.976 176.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.02 -46.37 10.52 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 119.217 0.917 . . . . 0.0 111.215 173.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -53.59 -44.06 69.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 124.712 1.205 . . . . 0.0 111.223 173.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -49.73 72.21 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.97 -28.47 70.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.665 -171.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.69 -15.81 62.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.425 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 1.1 m-85 -127.29 -17.37 4.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.4 -124.53 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.24 -168.6 38.03 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.55 -18.68 31.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.262 1.425 . . . . 0.0 112.361 172.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -55.83 -20.57 15.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.468 1.507 . . . . 0.0 111.192 169.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -134.16 168.2 19.27 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.334 1.453 . . . . 0.0 111.516 -177.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -137.42 126.13 23.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 169.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.23 124.37 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -169.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -135.13 169.49 17.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.034 0.934 . . . . 0.0 109.068 177.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -146.92 140.35 25.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.96 177.36 9.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.888 . . . . 0.0 112.227 -177.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 -175.2 44.8 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.453 1.025 . . . . 0.0 112.349 176.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.437 HG13 ' HE3' ' B' ' 88' ' ' LYS . 2.4 tt -41.06 -64.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.062 . . . . 0.0 114.607 -170.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.15 31.93 4.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.394 2.278 . . . . 0.0 107.014 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.55 138.58 40.45 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -168.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -177.86 21.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 129.054 2.942 . . . . 0.0 108.414 169.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.42 58.09 4.42 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 117.111 1.605 . . . . 0.0 117.111 -168.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.7 tp -67.85 115.22 7.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.174 1.987 . . . . 0.0 106.897 168.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -110.13 130.27 23.03 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -174.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -21.18 51.75 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.274 1.982 . . . . 0.0 112.887 177.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.56 -35.55 79.83 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.764 1.166 . . . . 0.0 111.654 172.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.64 -33.19 53.61 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.871 0.76 . . . . 0.0 109.621 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.09 -49.9 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -59.39 -45.77 90.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.377 -0.827 . . . . 0.0 110.807 176.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.63 69.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.353 1.061 . . . . 0.0 111.526 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -77.11 -40.86 44.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.818 0.847 . . . . 0.0 110.001 176.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.26 -27.67 69.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.502 178.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.8 -30.27 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.84 1.2 . . . . 0.0 111.85 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.08 16.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.221 1.408 . . . . 0.0 110.81 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.07 28.44 72.92 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.162 -1.354 . . . . 0.0 113.491 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.41 152.05 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 169.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -124.18 140.17 53.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.3 pt -135.94 17.77 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.979 1.312 . . . . 0.0 110.868 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -59.44 -17.07 27.91 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.421 -0.799 . . . . 0.0 111.978 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -77.9 -18.03 56.61 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.282 1.833 . . . . 0.0 113.907 174.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -65.59 167.14 9.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.697 1.237 . . . . 0.0 112.761 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -153.21 174.98 13.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.653 1.981 . . . . 0.0 106.681 170.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -149.89 174.46 12.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.623 0.769 . . . . 0.0 110.318 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -161.55 164.35 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.876 1.67 . . . . 0.0 109.217 -169.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 pt -63.02 165.57 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.702 1.201 . . . . 0.0 112.716 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.58 128.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -134.75 100.14 4.53 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.698 1.237 . . . . 0.0 108.34 -176.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.3 m -46.28 -29.82 1.79 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.132 2.173 . . . . 0.0 113.674 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.87 -25.22 68.18 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.392 0.996 . . . . 0.0 111.446 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.92 -42.14 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.35 -49.44 76.96 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.608 1.094 . . . . 0.0 110.199 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -27.76 69.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 110.95 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -84.9 -20.18 31.14 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.817 1.247 . . . . 0.0 112.413 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.19 157.16 10.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.295 1.045 . . . . 0.0 110.649 175.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.7 -33.29 20.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.776 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -146.28 135.0 22.29 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.954 -169.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.0 t -111.29 116.08 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 126.222 1.809 . . . . 0.0 107.559 172.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 46.3 t -88.81 105.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -70.99 134.51 47.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 167.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.4 tp -132.54 38.89 3.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 C--N 1.329 -0.294 0 O-C-N 121.299 -0.875 . . . . 0.0 109.35 169.861 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -73.74 3.13 6.89 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -169.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 88' ' ' LYS . . . . . 0.437 ' HE3' HG13 ' B' ' 39' ' ' ILE . 61.4 mttt 88.15 5.0 0.25 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.441 2.696 . . . . 0.0 110.018 -169.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 21.0 m 33.57 54.68 1.38 Allowed Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 127.052 2.141 . . . . 0.0 111.063 -169.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.51 140.89 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.917 3.078 . . . . 0.0 114.255 -168.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.21 4.43 52.28 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -172.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.1 p 44.24 86.22 0.14 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.453 1.501 . . . . 0.0 113.259 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -55.09 143.1 75.56 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 122.505 2.137 . . . . 0.0 109.534 -172.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.44 4.47 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.605 1 C-N-CA 126.041 4.494 . . . . 0.0 117.572 -168.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.04 -5.42 21.8 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.452 -0.78 . . . . 0.0 111.995 169.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.6 148.56 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.678 1.191 . . . . 0.0 110.492 -168.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -84.63 157.23 21.23 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -144.09 148.53 35.25 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.561 -1.337 . . . . 0.0 109.701 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -152.32 151.52 30.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.99 126.34 42.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -118.44 -3.09 10.96 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.506 1.122 . . . . 0.0 111.329 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.65 142.07 13.44 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 175.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.84 12.32 1.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.006 2.123 . . . . 0.0 109.922 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -154.32 164.01 39.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.069 2.547 . . . . 0.0 105.973 -173.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -147.41 109.79 3.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 118.9 0.773 . . . . 0.0 110.072 -171.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' B' ' 108' ' ' ARG . 72.9 Cg_endo -72.35 -21.61 22.81 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.237 3.291 . . . . 0.0 112.678 -172.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.35 2.72 0.55 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.681 1.193 . . . . 0.0 112.518 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' B' ' 106' ' ' PRO . 7.6 mmm180 -123.71 13.85 9.34 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.438 1.495 . . . . 0.0 111.309 -177.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.79 148.08 1.13 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.225 1.01 . . . . 0.0 111.38 177.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -56.2 -46.94 79.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.091 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.05 -16.31 4.71 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 169.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.25 158.47 34.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -37.53 78.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.422 0.629 . . . . 0.0 111.262 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.58 -43.26 60.2 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.926 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.97 -28.82 60.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 121.126 1.785 . . . . 0.0 110.078 -172.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -60.43 -59.39 5.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.739 0.7 . . . . 0.0 109.722 171.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.84 -39.66 89.9 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.17 97.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.572 -0.705 . . . . 0.0 112.133 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.54 -46.44 85.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -62.8 -46.16 89.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -64.18 -46.38 84.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.358 1.063 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 41.1 ttp-105 -58.69 -49.67 76.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.66 -42.65 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.234 -175.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -65.75 -37.06 85.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.611 1.55 . . . . 0.0 111.993 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.89 -46.36 90.95 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.293 0.37 . . . . 0.0 110.495 175.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.91 -50.9 62.8 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.152 0.581 . . . . 0.0 110.687 -179.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.69 -49.84 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.242 1.017 . . . . 0.0 109.483 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.26 96.15 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 119.017 -0.88 . . . . 0.0 111.828 -174.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -61.04 -45.89 92.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.704 1.252 . . . . 0.0 110.642 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.42 -39.85 92.64 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.696 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.37 -33.69 71.73 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 119.137 0.88 . . . . 0.0 111.715 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.425 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 39.8 ttmt -65.73 -42.78 90.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.22 174.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.8 -38.72 86.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.144 -1.407 . . . . 0.0 111.106 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.77 -38.26 78.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 121.691 2.041 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.2 -34.53 72.25 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.67 -46.79 11.13 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.297 1.039 . . . . 0.0 111.591 -177.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 61.1 p -84.05 -27.64 28.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.238 1.815 . . . . 0.0 111.396 -169.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.72 25.65 51.97 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -168.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.103 0 C-N-CA 126.745 2.018 . . . . 0.0 112.467 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 tpp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.25 171.33 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.31 1.444 . . . . 0.0 107.401 167.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.04 96.7 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.94 165.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -126.21 144.03 50.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.51 175.1 6.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.731 1.212 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -158.52 -169.09 2.62 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.696 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -43.81 -36.1 2.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.739 2.816 . . . . 0.0 115.533 -163.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.25 -25.01 2.51 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.551 1.141 . . . . 0.0 111.5 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 m -64.95 -17.57 64.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.528 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -49.46 -58.02 5.94 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.1 0.864 . . . . 0.0 109.27 166.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -43.21 99.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.782 0.833 . . . . 0.0 110.621 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -23.04 62.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -99.44 -17.01 18.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.228 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -110.29 -12.43 14.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.182 1.355 . . . . 0.0 113.621 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m -63.9 -11.17 25.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -139.91 156.59 46.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.063 1.301 . . . . 0.0 109.055 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.57 53.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.37 133.2 68.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.1 t -143.93 135.31 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -161.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.6 tp -111.31 99.5 8.29 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.37 138.07 33.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.58 153.56 50.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 109.218 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -133.89 120.08 19.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.543 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -143.16 154.31 43.76 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.231 1.412 . . . . 0.0 108.501 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.8 165.16 8.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.799 0.84 . . . . 0.0 109.025 170.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.37 -19.09 6.21 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.72 2.947 . . . . 0.0 116.483 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -55.09 -25.73 33.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.194 1.398 . . . . 0.0 114.493 -173.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -138.63 159.37 42.27 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.481 1.037 . . . . 0.0 111.441 -166.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.82 -48.87 31.88 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.554 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -47.92 -29.33 11.57 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.005 3.136 . . . . 0.0 115.352 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 m -53.41 -26.93 21.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.58 1.082 . . . . 0.0 113.26 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -108.46 10.89 27.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.827 1.251 . . . . 0.0 111.322 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -118.73 -42.55 2.73 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.481 1.113 . . . . 0.0 109.438 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.82 -34.73 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.854 -0.529 . . . . 0.0 109.584 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.42 -57.98 22.93 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.617 -1.182 . . . . 0.0 112.68 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.55 -33.97 54.33 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.604 1.609 . . . . 0.0 111.5 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.04 -40.03 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.525 1.057 . . . . 0.0 110.965 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 mt -70.82 -37.59 73.23 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.254 0.934 . . . . 0.0 110.725 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.16 -36.36 81.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.117 0.871 . . . . 0.0 110.475 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.62 -25.28 64.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.454 1.102 . . . . 0.0 111.059 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.31 -46.42 23.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.136 0.975 . . . . 0.0 109.862 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.61 -43.19 99.31 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 122.796 0.438 . . . . 0.0 111.444 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.13 -9.32 58.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -97.33 -48.81 5.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.274 0.943 . . . . 0.0 110.875 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.6 ptm -137.7 13.89 2.94 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -15.04 33.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.019 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.03 -25.45 58.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.758 1.279 . . . . 0.0 112.508 168.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 -10.47 10.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.653 0.781 . . . . 0.0 112.432 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -132.19 135.66 46.5 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.223 0.92 . . . . 0.0 109.612 -162.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -95.68 144.54 26.01 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 164.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.95 142.49 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.58 147.36 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 40.5 mtpt -127.18 148.24 50.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.514 0.597 . . . . 0.0 110.742 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 121.2 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 167.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.56 110.94 9.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 164.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.283 27.6 m -87.34 48.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 122.263 1.03 . . . . 0.0 112.357 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -141.06 -40.67 0.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.454 1.102 . . . . 0.0 109.228 154.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -76.06 -40.61 52.84 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.913 0.885 . . . . 0.0 111.461 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.94 24.59 4.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.807 1.243 . . . . 0.0 110.621 -167.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.4 -5.15 6.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.45 -44.33 84.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.262 0.937 . . . . 0.0 110.796 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -60.61 -41.04 94.01 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.698 0.681 . . . . 0.0 110.488 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -53.66 42.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.181 0.592 . . . . 0.0 109.493 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.69 95.33 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.19 -47.97 83.34 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.155 0.982 . . . . 0.0 110.893 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.93 -22.48 60.72 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.192 0.451 . . . . 0.0 111.424 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.4 19.09 31.1 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.221 0.915 . . . . 0.0 112.025 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -76.02 142.14 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 163.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.9 ptm -151.47 22.17 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.886 0.474 . . . . 0.0 111.914 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.69 156.18 40.8 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.445 -0.784 . . . . 0.0 110.893 -153.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.1 mm -130.41 138.74 33.72 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.377 -168.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.8 162.58 83.93 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 N-CA-C 108.299 -1.462 . . . . 0.0 108.299 -22.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.6 m -132.94 150.12 52.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 169.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.2 mt -143.16 127.75 18.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -170.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -124.1 115.29 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.62 126.2 45.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -123.81 155.11 38.58 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.595 0.758 . . . . 0.0 109.553 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -144.29 144.49 31.51 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 161.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.5 t70 43.81 35.9 1.19 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.833 1.653 . . . . 0.0 113.687 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.56 15.61 59.8 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.938 -1.479 . . . . 0.0 115.776 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.68 149.77 45.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.49 2.145 . . . . 0.0 110.784 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.81 143.25 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 m -132.31 -18.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.485 1.114 . . . . 0.0 112.162 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.02 156.79 43.31 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.78 32.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -173.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.3 m -150.31 139.84 21.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.71 45.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.68 156.04 23.23 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.665 1.126 . . . . 0.0 110.374 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.09 147.79 46.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.303 1.441 . . . . 0.0 111.378 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.3 141.88 33.23 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.612 1.565 . . . . 0.0 107.683 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.21 167.06 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.501 2.134 . . . . 0.0 110.63 167.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -50.34 -51.33 46.54 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.915 1.286 . . . . 0.0 112.726 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.12 -39.83 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 110.368 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.91 -38.29 76.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.789 -0.569 . . . . 0.0 110.856 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.78 -39.8 80.01 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.462 0.574 . . . . 0.0 110.77 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.15 -39.86 94.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.44 0.563 . . . . 0.0 109.686 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.72 -44.62 96.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.972 0.509 . . . . 0.0 110.626 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.24 -43.47 70.9 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.217 1.007 . . . . 0.0 111.383 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.4 p -84.04 -35.24 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.975 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -58.11 -27.58 63.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.416 1.007 . . . . 0.0 112.632 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -54.72 -27.54 41.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.166 0.986 . . . . 0.0 113.568 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -128.79 -21.28 3.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.341 0.973 . . . . 0.0 112.581 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.424 1.49 . . . . 0.0 109.771 167.426 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -73.42 92.56 1.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 m120 113.14 127.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 130.916 3.686 . . . . 0.0 107.575 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -143.47 111.84 6.32 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.97 133.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 146.97 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.863 1.665 . . . . 0.0 107.287 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -127.54 143.53 51.17 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.905 0.882 . . . . 0.0 110.137 -165.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -106.33 140.89 38.54 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.2 114.38 15.0 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.37 140.23 15.1 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.475 0.484 . . . . 0.0 111.389 -166.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -50.6 121.97 6.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.997 1.319 . . . . 0.0 110.628 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.13 -14.94 1.47 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.598 1.571 . . . . 0.0 114.601 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 45.18 24.31 0.13 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.505 1.922 . . . . 0.0 113.117 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -73.98 -34.74 64.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.413 -0.805 . . . . 0.0 110.877 -166.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.53 -69.71 0.47 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -161.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 mtm105 -58.67 -44.97 90.36 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.683 -171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.32 -37.91 84.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.064 0.847 . . . . 0.0 110.516 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -61.41 -43.37 98.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.135 0.574 . . . . 0.0 109.812 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.16 -48.16 79.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.957 1.303 . . . . 0.0 109.732 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.54 77.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.389 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.2 -28.29 64.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.806 1.184 . . . . 0.0 110.911 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.39 -50.04 57.79 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -59.77 -43.45 94.33 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.373 0.587 . . . . 0.0 111.649 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.6 -55.65 29.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 109.419 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -69.62 -10.97 60.36 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -80.1 -9.26 59.69 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.575 1.534 . . . . 0.0 112.897 171.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -129.97 -24.62 2.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.531 1.132 . . . . 0.0 112.794 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.3 mt -105.81 94.27 5.09 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.64 -165.04 5.59 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.814 0.721 . . . . 0.0 112.425 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.84 -17.36 15.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.306 1.442 . . . . 0.0 113.37 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.489 1.515 . . . . 0.0 112.363 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -127.28 161.25 29.04 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.086 1.754 . . . . 0.0 109.617 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -134.08 133.63 41.35 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.0 t -129.86 126.57 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -164.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.84 162.51 33.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.815 1.246 . . . . 0.0 109.065 -173.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 7.1 m -150.91 135.83 17.42 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.76 177.65 10.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.94 0.791 . . . . 0.0 112.134 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.26 176.51 46.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.892 1.234 . . . . 0.0 111.216 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 tt -36.77 -55.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.896 2.078 . . . . 0.0 114.876 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -134.29 31.38 3.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.153 1.381 . . . . 0.0 108.671 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.52 145.35 44.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.999 1.32 . . . . 0.0 112.604 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t60 148.33 84.66 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 130.534 3.533 . . . . 0.0 105.544 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.85 157.61 16.73 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.403 1.001 . . . . 0.0 111.197 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -139.65 93.7 2.69 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -66.31 127.58 93.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.55 -20.88 59.48 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.363 2.042 . . . . 0.0 113.015 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.71 80.32 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.455 1.025 . . . . 0.0 111.689 174.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.68 66.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.58 0.627 . . . . 0.0 109.875 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.2 -51.99 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.11 -45.6 79.43 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.809 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.32 75.76 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.696 0.68 . . . . 0.0 111.513 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.2 mmm -76.42 -32.64 58.6 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.4 -0.812 . . . . 0.0 111.709 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -62.92 -28.22 69.91 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.084 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.19 -25.07 58.4 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.77 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.4 m -121.83 16.32 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.846 1.259 . . . . 0.0 111.186 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.23 34.9 81.73 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.312 -0.716 . . . . 0.0 113.147 171.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -117.1 135.97 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -98.69 135.13 40.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 pt -134.44 10.56 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.581 0.752 . . . . 0.0 111.77 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.7 m -60.01 -23.7 63.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.306 1.042 . . . . 0.0 112.695 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -77.36 -18.01 57.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.013 1.325 . . . . 0.0 113.339 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.54 166.72 14.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.198 0.999 . . . . 0.0 112.8 -167.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.6 p -139.43 -177.68 5.04 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.003 2.121 . . . . 0.0 108.22 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.6 p -159.42 171.06 20.44 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -149.77 164.82 34.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 pt -61.95 164.04 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.189 0.518 . . . . 0.0 110.4 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.9 pt -48.63 128.96 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 109.306 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -137.71 98.55 3.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.798 1.285 . . . . 0.0 109.98 -172.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.71 -28.8 36.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.216 2.606 . . . . 0.0 112.638 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.58 -24.26 67.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.948 0.795 . . . . 0.0 111.628 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.62 -40.85 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.962 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.8 tt -62.45 -48.46 79.54 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.266 1.394 . . . . 0.0 110.536 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -18.65 65.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.467 1.03 . . . . 0.0 111.874 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.62 -13.29 52.05 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.211 1.004 . . . . 0.0 112.032 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 166.08 15.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.034 0.833 . . . . 0.0 110.773 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.72 -27.62 16.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 111.155 168.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.59 128.13 15.07 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.826 1.25 . . . . 0.0 107.776 -161.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.03 118.26 56.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -83.86 110.71 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 165.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -67.94 123.98 22.11 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 156.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.1 tp -118.57 31.43 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.521 0.728 . . . . 0.0 109.974 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -140.78 166.81 23.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.072 1.349 . . . . 0.0 108.162 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.27 53.1 0.67 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 162.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -144.56 159.26 43.07 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.998 1.719 . . . . 0.0 109.39 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.34 -4.58 10.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.809 1.243 . . . . 0.0 113.132 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.06 -10.06 57.44 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.589 1.086 . . . . 0.0 111.536 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.48 19.58 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.679 1.592 . . . . 0.0 114.833 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm 67.83 25.42 7.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.198 1.399 . . . . 0.0 112.459 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 30.4 m 36.85 53.59 2.65 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 0.0 114.497 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.71 150.27 54.32 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.439 2.093 . . . . 0.0 112.123 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.63 3.09 15.5 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -170.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p 40.81 89.55 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.435 2.294 . . . . 0.0 114.123 166.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.69 151.98 59.52 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.62 1.01 4.72 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.064 3.176 . . . . 0.0 114.242 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 42.8 m170 -61.69 -16.25 47.31 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.6 143.64 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.179 0.992 . . . . 0.0 109.362 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -79.25 151.99 30.84 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -136.32 147.23 47.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -152.07 158.9 43.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 161.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -97.5 131.17 44.37 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -123.1 -29.36 3.9 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.553 1.141 . . . . 0.0 110.175 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -79.57 161.45 46.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 168.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.54 -4.47 0.33 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.709 0.803 . . . . 0.0 112.305 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -158.1 170.89 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.698 1.999 . . . . 0.0 107.259 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -136.17 113.64 10.54 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 123.833 0.853 . . . . 0.0 110.992 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.47 -19.85 54.69 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.166 2.577 . . . . 0.0 112.893 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.95 -7.92 32.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.157 0.89 . . . . 0.0 112.092 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -115.51 19.33 15.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.202 1.401 . . . . 0.0 110.604 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.76 155.24 2.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.858 0.863 . . . . 0.0 111.043 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -57.66 -29.37 64.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.116 0.966 . . . . 0.0 112.42 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.46 -8.66 30.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.661 -1.077 . . . . 0.0 113.89 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 76.6 p -67.43 156.64 36.08 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.169 1.484 . . . . 0.0 107.825 166.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.64 -39.38 84.17 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.705 -0.622 . . . . 0.0 110.145 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.2 -44.56 68.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.326 0.65 . . . . 0.0 111.203 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -70.56 -35.7 73.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.383 0.992 . . . . 0.0 110.043 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -56.86 -58.34 8.54 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.137 0.881 . . . . 0.0 109.641 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -60.27 -42.02 94.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.992 0.814 . . . . 0.0 110.342 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.44 92.15 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.495 1.043 . . . . 0.0 111.885 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -62.97 -46.96 85.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.117 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -58.08 -50.75 72.37 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -64.48 -43.27 94.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.821 1.248 . . . . 0.0 111.312 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -63.91 -47.95 78.53 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.595 0.634 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.65 -35.97 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -62.21 -45.44 93.37 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.665 1.186 . . . . 0.0 110.45 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.1 -42.43 96.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.046 0.384 . . . . 0.0 110.683 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.58 -54.35 37.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.063 0.545 . . . . 0.0 110.304 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.56 -43.55 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.401 1.081 . . . . 0.0 109.322 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.38 75.51 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 118.652 0.66 . . . . 0.0 111.794 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -59.77 -44.03 94.07 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.098 0.449 . . . . 0.0 110.906 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -63.26 -45.69 90.34 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.769 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.32 -36.41 81.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.504 1.047 . . . . 0.0 110.461 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -61.33 -45.76 93.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.316 0.507 . . . . 0.0 110.028 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.08 -44.21 94.93 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.535 0.607 . . . . 0.0 110.586 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.22 -38.51 80.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.882 0.765 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.16 72.22 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.734 0.697 . . . . 0.0 112.163 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.49 -41.92 23.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.31 0.644 . . . . 0.0 110.529 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 76.6 p -85.19 -34.53 22.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.478 0.581 . . . . 0.0 111.578 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.7 64.15 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 118.365 -1.241 . . . . 0.0 112.701 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.172 2.189 . . . . 0.0 111.591 -163.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.03 157.03 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.78 2.432 . . . . 0.0 112.756 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.61 112.94 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.82 168.66 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.86 1.664 . . . . 0.0 108.274 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -124.31 117.67 25.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.665 1.586 . . . . 0.0 108.477 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.9 171.41 12.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.6 1.16 . . . . 0.0 110.595 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -155.85 -178.19 7.11 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.085 1.754 . . . . 0.0 107.313 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -37.0 -33.94 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 130.932 3.693 . . . . 0.0 117.004 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.06 -31.76 0.9 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.822 1.249 . . . . 0.0 110.926 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -60.76 -19.23 58.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.692 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -47.19 -50.02 21.61 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 120.028 1.286 . . . . 0.0 109.874 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -66.09 -43.83 86.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.078 0.399 . . . . 0.0 110.211 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.96 85.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.545 0.212 . . . . 0.0 110.56 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -74.12 -13.76 60.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.745 1.218 . . . . 0.0 112.593 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -121.76 0.58 9.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.785 1.175 . . . . 0.0 113.134 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.9 m -74.87 -2.85 28.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.541 0.737 . . . . 0.0 112.949 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.66 156.47 45.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.128 0.971 . . . . 0.0 110.485 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.19 -161.56 37.5 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.377 1.465 . . . . 0.0 112.063 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.23 129.62 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.66 155.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.629 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 tp -128.83 91.5 3.23 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.767 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.5 148.58 33.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -141.65 148.43 39.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.819 1.248 . . . . 0.0 109.238 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -130.15 109.62 10.96 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.675 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.7 p-90 -130.93 149.88 52.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.834 1.653 . . . . 0.0 108.155 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -172.98 164.05 3.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 109.42 169.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.53 -16.02 9.93 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.82 3.014 . . . . 0.0 116.691 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -50.46 -28.78 8.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.735 1.614 . . . . 0.0 113.74 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.88 146.36 51.6 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 119.14 0.882 . . . . 0.0 111.811 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.14 -50.26 61.42 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.596 -1.113 . . . . 0.0 110.706 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -46.58 -26.65 4.49 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.222 3.281 . . . . 0.0 116.867 170.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 m -57.77 -29.58 64.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 121.4 1.909 . . . . 0.0 112.286 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -97.65 9.35 42.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.283 1.033 . . . . 0.0 111.813 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -119.61 -43.1 2.6 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.062 0.945 . . . . 0.0 109.602 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.15 -34.76 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.607 0.763 . . . . 0.0 109.066 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.18 -61.25 6.26 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.9 -41.19 64.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.958 1.772 . . . . 0.0 111.659 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.24 -40.57 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.06 0.544 . . . . 0.0 110.819 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 mt -73.08 -38.49 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.4 0.546 . . . . 0.0 110.292 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.92 -34.14 77.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.284 0.947 . . . . 0.0 109.833 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.91 -27.47 64.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.96 1.304 . . . . 0.0 111.603 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.81 -43.59 45.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.48 1.112 . . . . 0.0 110.195 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.61 -35.98 62.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.22 -13.21 62.07 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.378 -0.826 . . . . 0.0 112.019 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -49.7 5.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.743 1.617 . . . . 0.0 110.504 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.5 16.68 2.74 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.805 0.842 . . . . 0.0 111.741 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.06 -3.22 22.19 Favored Glycine 0 CA--C 1.521 0.446 0 O-C-N 121.23 -0.919 . . . . 0.0 113.974 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.34 -24.15 65.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.333 1.053 . . . . 0.0 111.104 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.44 -20.95 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.523 1.129 . . . . 0.0 112.226 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.64 149.66 46.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 110.874 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.36 150.48 40.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.529 1.532 . . . . 0.0 108.335 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mt -130.39 140.89 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 t -136.78 108.92 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.675 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 21.6 mtpp -84.68 151.14 24.65 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.367 -0.833 . . . . 0.0 109.757 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -113.59 128.03 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.26 103.78 11.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.88 48.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.075 1.35 . . . . 0.0 112.092 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -156.11 -43.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.833 1.253 . . . . 0.0 109.578 168.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.27 -36.5 29.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 109.868 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -133.24 27.11 4.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 111.925 -168.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -69.76 -5.31 24.43 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -50.0 -49.69 49.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.582 1.953 . . . . 0.0 110.647 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.6 m -58.26 -35.95 72.53 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 123.122 0.569 . . . . 0.0 111.466 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.54 0.84 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.15 -45.31 15.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.204 0.907 . . . . 0.0 113.625 170.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.097 0.948 . . . . 0.0 111.033 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.99 -30.48 67.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.177 0.444 . . . . 0.0 110.36 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.27 67.65 0.81 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.6 t -139.17 127.67 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.315 0.1 OUTLIER -137.3 17.11 2.96 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.883 0.311 . . . . 0.0 111.22 174.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 p -137.48 159.89 40.67 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.884 2.474 . . . . 0.0 110.722 -170.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.14 149.02 56.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.03 148.09 87.43 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 109.701 -0.923 . . . . 0.0 109.701 -10.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -122.76 145.16 48.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.21 136.55 54.78 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.976 1.71 . . . . 0.0 106.518 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.4 mt -121.44 102.7 8.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.69 122.53 38.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.88 153.19 44.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.521 1.128 . . . . 0.0 108.12 -171.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -140.23 138.65 35.23 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.88 27.29 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.541 1.937 . . . . 0.0 114.412 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 15.97 43.1 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.083 1.325 . . . . 0.0 115.945 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -130.85 142.8 50.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.038 1.419 . . . . 0.0 110.524 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.28 140.71 19.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.35 -21.59 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.185 0.994 . . . . 0.0 109.985 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.64 161.6 41.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.174 1.389 . . . . 0.0 109.087 169.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.23 148.3 31.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -149.99 145.99 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.82 67.74 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.41 157.86 10.18 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.16 1.838 . . . . 0.0 109.02 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -74.33 157.8 35.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.933 0.493 . . . . 0.0 111.107 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.43 145.33 25.83 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.64 165.88 30.54 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.528 2.152 . . . . 0.0 110.704 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -45.95 -47.88 16.45 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.373 1.869 . . . . 0.0 112.416 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.17 -43.34 74.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.477 0.581 . . . . 0.0 111.23 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.3 -32.79 74.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.745 -0.597 . . . . 0.0 110.72 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -52.18 64.35 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.937 0.895 . . . . 0.0 109.903 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.96 -38.84 92.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.1 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.69 -46.29 90.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.704 0.684 . . . . 0.0 111.437 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.52 -40.78 79.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.755 1.222 . . . . 0.0 111.198 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -88.05 -39.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.885 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -56.37 -34.88 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.517 1.053 . . . . 0.0 111.801 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.08 -6.96 25.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.56 -27.11 3.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.668 1.187 . . . . 0.0 112.666 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 tp . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.988 2.115 . . . . 0.0 109.388 171.633 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.78 143.38 44.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.1 m120 63.77 119.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.184 0 C-N-CA 128.71 2.804 . . . . 0.0 110.639 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -164.26 134.3 4.05 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mt -106.65 143.25 17.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.41 143.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.45 144.39 51.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.489 0.715 . . . . 0.0 111.553 -168.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -103.58 144.04 31.96 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.8 tp -128.97 114.47 16.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 75.4 m -142.77 135.41 27.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.871 0.868 . . . . 0.0 111.139 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -48.75 113.7 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.737 1.215 . . . . 0.0 110.976 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.53 8.41 51.52 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.941 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 7.02 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 130.738 3.615 . . . . 0.0 115.536 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -142.28 5.96 1.69 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.01 -70.24 0.26 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.794 1.179 . . . . 0.0 112.385 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -47.2 -52.98 14.31 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.09 0.859 . . . . 0.0 110.495 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -55.63 -52.44 63.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.067 1.747 . . . . 0.0 111.801 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -53.85 -50.07 67.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.094 0.958 . . . . 0.0 110.606 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.0 ttm -62.59 -42.24 99.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.269 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.86 82.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.619 -1.181 . . . . 0.0 112.019 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.59 -45.65 89.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.732 1.605 . . . . 0.0 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.89 -43.63 57.85 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -58.07 -39.45 78.52 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.993 0.896 . . . . 0.0 111.495 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.23 62.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -65.26 -24.22 67.26 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.779 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.19 -14.98 63.28 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -126.46 -12.01 6.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.934 1.293 . . . . 0.0 113.131 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.11 85.6 2.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.89 -165.92 0.89 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.073 1.321 . . . . 0.0 113.173 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.79 -17.82 18.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.653 1.181 . . . . 0.0 113.214 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.57 -21.31 25.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.884 1.673 . . . . 0.0 112.411 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -127.83 161.62 28.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.391 1.476 . . . . 0.0 109.158 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -132.79 135.53 45.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -125.34 132.17 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -169.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -143.08 171.23 14.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.773 1.629 . . . . 0.0 108.035 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 81.7 p -158.92 154.07 25.34 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.519 -0.738 . . . . 0.0 110.788 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.06 169.97 23.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.904 0.881 . . . . 0.0 111.807 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.43 -176.22 39.18 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.592 0.615 . . . . 0.0 112.578 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 tt -50.73 -57.44 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.007 1.723 . . . . 0.0 114.043 -172.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -133.1 29.68 4.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.75 1.62 . . . . 0.0 108.816 -169.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 159.19 34.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.956 2.102 . . . . 0.0 113.06 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 136.24 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 130.723 3.609 . . . . 0.0 104.782 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.93 29.55 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -172.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.56 82.62 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -62.76 128.88 92.49 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -58.6 -23.34 64.77 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.093 1.862 . . . . 0.0 112.953 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.413 HD22 ' HG2' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -62.8 -36.06 81.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.821 1.191 . . . . 0.0 111.305 172.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.43 64.9 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.749 0.704 . . . . 0.0 110.073 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.56 -51.26 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -59.56 -43.95 93.42 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 123.2 0.6 . . . . 0.0 110.593 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.28 -31.38 63.57 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 112.523 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -37.05 24.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.254 -0.904 . . . . 0.0 110.493 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.44 -24.67 67.93 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.288 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.79 -32.84 60.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.948 1.249 . . . . 0.0 111.633 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 m -114.56 15.89 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.285 1.434 . . . . 0.0 110.997 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.17 34.98 91.37 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.283 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -106.01 132.65 52.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.64 135.89 33.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.548 ' C ' ' H ' ' B' ' 61' ' ' ASN . 13.6 pt -132.31 20.9 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.482 0.713 . . . . 0.0 110.829 169.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -70.96 24.42 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.793 0.837 . . . . 0.0 112.067 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.548 ' H ' ' C ' ' B' ' 59' ' ' ILE . 12.1 p30 -143.86 -4.47 0.84 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.841 3.657 . . . . 0.0 110.755 -169.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.33 153.55 20.36 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.307 0.958 . . . . 0.0 110.341 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 55.1 p -134.28 -175.71 3.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.549 1.94 . . . . 0.0 108.863 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 23.5 p -155.87 -177.18 6.38 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -163.56 165.22 23.78 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.232 1.813 . . . . 0.0 107.79 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.84 167.18 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.551 0.741 . . . . 0.0 111.728 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -48.33 131.08 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.225 1.01 . . . . 0.0 108.671 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -146.01 97.12 2.91 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.279 1.037 . . . . 0.0 109.409 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 17.5 m -47.87 -26.62 1.75 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.02 1.728 . . . . 0.0 114.603 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.27 -18.04 60.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.153 1.342 . . . . 0.0 112.647 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.24 -33.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 109.184 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -61.63 -60.14 4.13 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.036 0.834 . . . . 0.0 109.17 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -24.42 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.748 0.704 . . . . 0.0 110.836 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -75.59 -23.37 56.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.777 . . . . 0.0 112.588 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 173.29 1.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.687 1.195 . . . . 0.0 112.155 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.15 -33.91 12.46 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.869 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -139.41 139.35 37.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.331 1.452 . . . . 0.0 109.395 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.8 t -117.01 96.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -80.16 115.11 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 47.9 m -71.75 131.43 43.09 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 tp -135.08 6.09 3.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -167.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m -157.34 -22.57 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.219 1.372 . . . . 0.0 114.271 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 160.1 178.35 34.02 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -145.42 -48.67 0.23 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.64 0.72 . . . . 0.0 111.086 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.55 -56.36 20.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.446 0.566 . . . . 0.0 110.974 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.42 67.79 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 119.372 -0.347 . . . . 0.0 111.347 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.51 11.99 2.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.56 0.744 . . . . 0.0 112.726 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm 90.17 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.306 2.642 . . . . 0.0 111.127 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m 31.38 54.85 0.85 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 126.987 2.115 . . . . 0.0 113.151 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.46 135.31 47.24 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 CA-C-N 120.602 1.251 . . . . 0.0 112.173 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.59 6.05 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -171.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p 38.36 93.9 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 127.838 2.455 . . . . 0.0 114.379 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -56.15 141.39 87.69 Favored 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 122.485 2.123 . . . . 0.0 108.26 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -61.78 -1.3 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.323 3.349 . . . . 0.0 116.95 -168.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -69.15 -9.38 52.52 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.164 0.893 . . . . 0.0 112.829 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 144.93 36.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.906 1.282 . . . . 0.0 111.192 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -73.84 153.18 40.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -146.83 143.78 28.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.779 0.718 . . . . 0.0 109.498 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -150.15 144.21 25.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.52 127.7 33.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -111.85 -12.31 13.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.185 0.994 . . . . 0.0 110.591 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.58 161.42 31.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -158.24 26.81 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.788 1.235 . . . . 0.0 110.541 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -149.47 161.54 41.91 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.871 2.469 . . . . 0.0 106.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -147.54 139.55 14.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.228 0.922 . . . . 0.0 109.291 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.413 ' HG2' HD22 ' B' ' 47' ' ' ASN . 91.3 Cg_endo -78.0 -19.16 12.51 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.437 2.092 . . . . 0.0 113.336 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.82 -4.06 11.44 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.837 1.199 . . . . 0.0 111.03 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -98.41 6.22 47.44 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.427 1.091 . . . . 0.0 111.05 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.02 153.38 1.38 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.114 0.566 . . . . 0.0 110.065 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -54.42 -43.81 71.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.8 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.34 -19.59 2.64 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.6 p -69.53 165.92 20.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.38 -42.16 99.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.527 0.68 . . . . 0.0 110.289 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.61 -42.82 77.57 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 116.929 -1.51 . . . . 0.0 109.326 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.28 -35.26 61.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 121.184 1.811 . . . . 0.0 109.693 -173.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -55.3 -56.6 18.13 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 118.501 0.591 . . . . 0.0 110.693 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -64.35 -40.45 95.89 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.886 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.77 91.62 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.804 0.842 . . . . 0.0 111.765 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.55 -49.88 69.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.284 2.6 p90 -71.1 -27.06 63.32 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.793 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -64.53 -51.35 63.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.558 1.072 . . . . 0.0 109.668 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -59.83 -51.33 70.19 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.38 -43.76 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.575 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.53 -46.51 80.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.876 1.216 . . . . 0.0 111.533 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.01 -44.47 96.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 123.217 0.323 . . . . 0.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -51.66 59.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.369 0.668 . . . . 0.0 110.467 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.77 -45.49 91.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.536 1.134 . . . . 0.0 110.176 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.38 -44.01 91.41 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -60.26 -49.08 79.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.458 1.129 . . . . 0.0 111.306 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -59.01 -44.03 91.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.837 0.455 . . . . 0.0 110.803 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.72 -36.41 67.78 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.757 0.708 . . . . 0.0 111.696 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -66.95 -49.74 64.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.845 -0.534 . . . . 0.0 110.426 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -61.5 -38.26 86.7 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.742 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -56.15 -38.81 71.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.95 1.25 . . . . 0.0 111.077 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.37 -31.53 71.43 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -87.88 -47.85 8.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.839 1.656 . . . . 0.0 111.629 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.0 p -83.63 -28.18 28.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.672 2.389 . . . . 0.0 110.983 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.25 17.18 55.61 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.613 -1.104 . . . . 0.0 111.473 -168.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.249 1.06 0 C-N-CA 127.93 2.492 . . . . 0.0 112.003 -169.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.59 172.55 18.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.03 1.732 . . . . 0.0 107.067 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.88 96.2 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 102.845 -3.021 . . . . 0.0 102.845 168.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.28 168.69 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.831 1.652 . . . . 0.0 108.115 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.25 111.77 16.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.14 1.376 . . . . 0.0 108.358 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.9 172.8 13.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.574 1.15 . . . . 0.0 110.527 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -155.34 -174.87 5.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.933 2.093 . . . . 0.0 105.898 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -41.19 -36.81 0.8 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.019 2.527 . . . . 0.0 115.572 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -129.85 -30.19 2.05 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.559 1.144 . . . . 0.0 111.522 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 m -61.57 -22.74 65.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.059 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.65 -55.62 18.31 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.384 0.993 . . . . 0.0 108.773 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -62.11 -43.79 98.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.139 -0.35 . . . . 0.0 110.183 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.78 82.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.386 0.136 . . . . 0.0 111.295 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -79.84 -13.79 59.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.412 1.085 . . . . 0.0 113.143 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.5 p -118.33 -3.94 10.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.604 1.093 . . . . 0.0 113.535 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -73.75 -5.02 38.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.24 155.7 45.98 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.461 1.104 . . . . 0.0 109.825 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.64 -163.04 44.12 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.843 1.211 . . . . 0.0 112.163 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.43 132.14 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.37 149.82 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 113.45 -1.705 . . . . 0.0 107.797 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tt -124.98 100.83 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.931 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.17 148.72 26.61 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -142.41 149.7 39.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -130.06 115.54 17.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -169.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.614 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.5 p-90 -137.58 154.35 49.8 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.901 1.68 . . . . 0.0 108.007 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -174.48 162.15 2.69 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.068 0.947 . . . . 0.0 108.95 169.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.97 -19.04 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.635 2.89 . . . . 0.0 116.895 -174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -52.62 -33.88 48.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.837 1.198 . . . . 0.0 114.078 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.15 163.23 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.972 0.805 . . . . 0.0 112.76 -169.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.12 -48.78 57.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.923 -1.487 . . . . 0.0 113.197 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.78 -27.59 20.63 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.571 2.847 . . . . 0.0 115.397 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 m -57.17 -23.77 49.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.695 1.134 . . . . 0.0 113.25 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -108.87 12.71 25.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.111 0.964 . . . . 0.0 111.575 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -122.71 -44.11 2.23 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.292 1.037 . . . . 0.0 109.67 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -64.38 -34.22 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 121.685 -0.634 . . . . 0.0 109.451 169.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.47 11.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.911 -1.042 . . . . 0.0 112.39 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -59.05 -41.03 65.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.967 1.778 . . . . 0.0 111.631 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.46 -40.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.115 0.566 . . . . 0.0 110.877 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.8 mt -73.59 -40.92 63.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.691 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.87 -34.51 78.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.013 0.824 . . . . 0.0 109.737 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -70.35 -21.39 62.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.077 1.351 . . . . 0.0 112.184 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.89 -42.09 18.14 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 119.161 0.892 . . . . 0.0 110.125 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.39 -37.61 85.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.944 -0.472 . . . . 0.0 110.831 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -72.21 -4.86 31.87 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -107.71 -43.17 4.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.674 1.589 . . . . 0.0 111.032 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.63 15.57 2.34 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.363 0.665 . . . . 0.0 112.535 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.79 -2.18 11.24 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.392 -0.817 . . . . 0.0 113.867 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.86 -24.0 65.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.328 1.051 . . . . 0.0 111.147 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -11.7 8.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.74 0.816 . . . . 0.0 112.682 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -139.4 149.54 44.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.32 1.048 . . . . 0.0 111.622 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.99 147.67 38.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.068 1.747 . . . . 0.0 108.327 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mt -119.41 143.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.44 109.32 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.614 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.6 mtpp -84.03 151.78 24.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.341 -0.85 . . . . 0.0 109.3 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mm -118.99 120.86 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 170.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.59 105.94 7.95 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 33.9 m -78.43 49.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -156.01 -41.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.801 1.241 . . . . 0.0 108.977 167.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.73 -33.98 21.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.063 0.945 . . . . 0.0 111.079 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -134.05 27.99 3.84 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.518 1.527 . . . . 0.0 110.796 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -72.09 -5.74 37.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.825 0.85 . . . . 0.0 112.898 -170.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -53.27 -48.17 68.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.3 1.84 . . . . 0.0 110.769 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 m -56.29 -41.57 76.1 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.091 0.556 . . . . 0.0 110.837 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.96 -64.57 0.83 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.67 -43.82 11.74 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.985 0.802 . . . . 0.0 113.454 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.02 -44.63 95.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.24 1.02 . . . . 0.0 111.663 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -73.64 -21.35 60.32 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.477 0.58 . . . . 0.0 111.731 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.03 64.72 0.99 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.05 129.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.5 ptm -150.64 23.11 0.79 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.74 161.44 35.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.101 1.76 . . . . 0.0 112.027 -168.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.1 136.98 29.67 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.53 146.51 47.78 Favored 'Cis proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.067 -1.551 . . . . 0.0 108.067 -10.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -116.58 151.72 35.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 169.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tt -148.82 123.7 9.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -170.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.5 mt -122.24 106.09 10.81 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.54 131.96 33.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.88 158.33 39.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.815 0.846 . . . . 0.0 109.382 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -144.27 139.64 28.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 44.95 28.35 0.36 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.605 1.962 . . . . 0.0 113.761 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.56 10.32 47.67 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 116.103 1.201 . . . . 0.0 116.103 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -133.72 145.17 49.62 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.909 1.354 . . . . 0.0 111.528 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.25 137.37 24.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.96 -19.41 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.51 1.124 . . . . 0.0 111.635 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.8 159.18 43.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.001 0.819 . . . . 0.0 110.185 169.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.62 147.94 28.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -171.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.2 m -152.58 147.55 26.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.8 t -133.63 64.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.56 159.57 10.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.236 1.874 . . . . 0.0 109.535 -169.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.53 167.86 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.578 0.751 . . . . 0.0 112.032 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -150.31 141.58 14.91 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.422 1.489 . . . . 0.0 107.459 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.88 165.95 29.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.118 . . . . 0.0 110.388 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.98 -48.71 21.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.74 1.616 . . . . 0.0 112.39 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.1 -42.79 79.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.161 0.437 . . . . 0.0 110.897 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.39 -29.95 68.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.035 -0.416 . . . . 0.0 111.011 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -52.3 61.09 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.934 0.894 . . . . 0.0 109.207 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -63.6 -36.28 83.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.799 -0.62 . . . . 0.0 109.654 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.15 -46.46 88.87 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.678 0.672 . . . . 0.0 111.224 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.9 tp -54.64 -40.39 68.93 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.073 0.949 . . . . 0.0 110.96 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.27 -41.14 13.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 118.819 -0.61 . . . . 0.0 112.071 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -56.7 -33.55 66.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.581 1.082 . . . . 0.0 111.45 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -70.07 -6.47 34.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -127.66 -21.98 3.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.168 1.387 . . . . 0.0 112.659 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--O 1.249 1.072 0 C-N-CA 127.286 2.234 . . . . 0.0 109.05 171.319 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -139.36 41.45 2.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.314 1.045 . . . . 0.0 109.36 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m120 130.58 132.77 0.0 OUTLIER 'General case' 0 C--N 1.341 0.198 1 C-N-CA 132.385 4.274 . . . . 0.0 107.513 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -157.08 145.85 19.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 130.175 3.39 . . . . 0.0 102.499 168.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.49 139.44 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 118.755 0.707 . . . . 0.0 109.431 -168.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.68 140.0 46.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -132.04 149.01 52.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.4 155.48 31.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.392 0.542 . . . . 0.0 110.11 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -133.2 132.4 41.49 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.028 1.331 . . . . 0.0 107.925 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -162.26 157.24 22.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.3 m -47.8 107.88 0.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.996 1.318 . . . . 0.0 111.435 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.75 59.4 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.685 -1.064 . . . . 0.0 113.443 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.324 0.3 OUTLIER 39.01 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.537 2.735 . . . . 0.0 116.044 -173.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -64.85 169.05 5.51 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.284 1.04 . . . . 0.0 108.543 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 46.37 -94.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.425 2.29 . . . . 0.0 113.717 169.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.67 -50.06 64.0 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.774 1.63 . . . . 0.0 111.219 -169.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.2 m -66.97 -41.7 86.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.237 0.926 . . . . 0.0 112.17 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -59.41 -49.3 78.32 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.402 1.096 . . . . 0.0 109.823 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 18.9 ttm -65.31 -40.57 93.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.429 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.69 -36.86 73.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.068 0.947 . . . . 0.0 110.297 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.94 60.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 109.911 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.7 -46.23 62.26 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -55.37 -44.19 75.82 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.611 0.764 . . . . 0.0 111.483 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.77 61.91 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.121 0.568 . . . . 0.0 110.108 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.426 ' HE3' ' HB ' ' B' ' 34' ' ' VAL . 65.2 mttt -65.64 -20.57 66.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.509 -168.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.87 -14.74 62.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.384 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -40.21 2.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.791 1.178 . . . . 0.0 112.382 174.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.76 75.68 6.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.41 -163.6 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.575 2.036 . . . . 0.0 112.564 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.49 -13.86 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.752 1.221 . . . . 0.0 113.21 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -57.69 -23.79 53.45 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.928 168.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -127.63 171.36 11.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.391 2.276 . . . . 0.0 110.424 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -139.74 129.32 24.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 168.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.426 ' HB ' ' HE3' ' B' ' 25' ' ' LYS . 13.9 t -123.18 129.02 75.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -171.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -143.09 169.33 17.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.396 1.478 . . . . 0.0 108.536 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 74.6 p -154.97 162.83 40.97 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.415 -0.803 . . . . 0.0 110.867 172.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 178.77 9.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.344 1.458 . . . . 0.0 108.859 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.27 -176.62 44.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 tt -48.8 -52.96 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.089 1.756 . . . . 0.0 113.991 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -130.36 26.27 5.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.909 2.084 . . . . 0.0 107.992 -169.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.9 46.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.705 1.602 . . . . 0.0 112.965 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 78.4 t60 133.85 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 131.244 3.817 . . . . 0.0 104.458 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.13 175.5 46.58 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -153.21 102.78 2.65 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 171.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -73.56 126.09 90.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.44 -22.18 70.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.861 1.707 . . . . 0.0 112.514 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -37.5 78.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.252 0.933 . . . . 0.0 110.796 170.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.32 -38.58 65.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.32 -55.88 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.6 -45.9 77.37 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.274 0.63 . . . . 0.0 111.06 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.12 -33.51 65.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.448 1.099 . . . . 0.0 112.512 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 1.1 mmt -82.54 -38.87 23.13 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.934 0.893 . . . . 0.0 110.453 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -60.83 -29.7 69.65 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.896 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.98 -31.46 60.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.471 1.032 . . . . 0.0 111.814 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.95 15.1 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.146 1.379 . . . . 0.0 110.821 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.78 34.03 81.82 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.163 -1.354 . . . . 0.0 113.034 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -107.43 149.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.07 135.12 54.8 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' B' ' 61' ' ' ASN . 21.9 pt -137.84 22.68 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.94 1.296 . . . . 0.0 110.448 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -67.59 14.73 0.05 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' B' ' 59' ' ' ILE . 0.1 OUTLIER -141.4 13.69 2.17 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.047 2.139 . . . . 0.0 111.641 -174.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -53.3 162.38 0.75 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.309 -1.494 . . . . 0.0 113.559 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -149.63 161.16 42.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.22 2.208 . . . . 0.0 105.619 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 67.1 m -157.89 -172.87 4.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.89 1.276 . . . . 0.0 109.021 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.55 163.67 24.51 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.149 1.379 . . . . 0.0 109.389 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.0 165.75 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.227 1.011 . . . . 0.0 111.411 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 pt -50.29 128.59 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.199 0.6 . . . . 0.0 110.452 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -143.14 104.5 4.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.261 1.029 . . . . 0.0 109.575 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -53.55 -25.65 17.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.682 1.593 . . . . 0.0 113.282 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -17.64 62.91 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.591 1.087 . . . . 0.0 112.498 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -129.78 -37.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.146 0.978 . . . . 0.0 108.903 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.29 -50.19 28.95 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.1 0.863 . . . . 0.0 110.254 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -24.41 67.54 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.928 0.786 . . . . 0.0 110.7 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -73.75 -23.05 59.69 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.119 1.368 . . . . 0.0 112.337 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.0 166.56 3.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.939 1.295 . . . . 0.0 112.268 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.75 -34.15 17.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.709 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 18.6 tp -146.93 139.87 25.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 0.0 110.594 -170.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.81 110.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 125.976 1.711 . . . . 0.0 107.786 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.78 102.3 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 75.4 m -71.37 128.75 36.9 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 68.5 mt -136.14 64.19 1.57 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.298 1.039 . . . . 0.0 109.178 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -153.96 -178.65 7.22 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.554 -0.716 . . . . 0.0 110.457 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -134.88 35.94 2.13 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 127.285 2.374 . . . . 0.0 108.297 171.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -145.07 156.55 43.98 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.66 2.384 . . . . 0.0 107.16 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -127.44 11.33 6.84 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.064 0.946 . . . . 0.0 113.106 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.84 -8.83 47.33 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.487 1.04 . . . . 0.0 112.243 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -66.47 20.04 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -170.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm 71.67 21.03 4.48 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.071 -1.643 . . . . 0.0 111.948 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.0 m 29.24 56.97 0.68 Allowed Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 128.369 2.668 . . . . 0.0 113.162 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.55 132.29 48.13 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.609 2.206 . . . . 0.0 112.856 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 4.06 33.78 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.5 p 41.64 94.1 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.222 2.209 . . . . 0.0 113.494 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -60.0 143.87 99.53 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.203 1.935 . . . . 0.0 110.488 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.21 -2.83 5.27 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.509 3.473 . . . . 0.0 115.028 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -63.92 -11.62 29.79 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.829 0.852 . . . . 0.0 111.678 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.41 143.94 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 109.605 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -73.18 159.02 34.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -145.6 146.95 31.56 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.49 -1.381 . . . . 0.0 109.35 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -146.86 156.51 43.16 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -114.98 133.29 56.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.337 1.455 . . . . 0.0 108.1 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.11 1.29 1.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.04 -62.27 2.5 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 39.9 p90 47.49 14.72 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.23 2.612 . . . . 0.0 115.328 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -161.24 161.9 30.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.174 2.19 . . . . 0.0 106.473 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -141.94 105.91 5.76 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.175 0.99 . . . . 0.0 110.427 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.76 -10.92 18.45 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.636 3.558 . . . . 0.0 112.981 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.58 0.28 5.62 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.737 1.153 . . . . 0.0 111.517 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -121.22 -60.77 1.61 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . 0.406 ' HA ' ' CD2' ' B' ' 119' ' ' PHE . . . 43.39 -170.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 113.59 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -90.81 138.72 31.37 Favored 'General case' 0 C--O 1.236 0.388 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -83.0 56.82 5.08 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.641 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 p -121.65 164.16 17.79 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 169.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.18 -39.05 89.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.479 0.657 . . . . 0.0 110.61 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.04 -42.89 59.6 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.768 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -76.2 -29.93 57.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.941 1.246 . . . . 0.0 109.891 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.8 -59.6 4.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.792 0.724 . . . . 0.0 109.436 169.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -57.84 -41.97 83.45 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.97 90.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.869 0.868 . . . . 0.0 112.006 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 6.3 m-85 -65.81 -43.85 87.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.158 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -58.7 -47.57 84.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.219 0.918 . . . . 0.0 108.958 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -65.53 -43.71 89.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 111.111 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -60.67 -53.67 54.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.34 -41.4 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.414 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -36.87 85.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 120.299 1.409 . . . . 0.0 112.011 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.04 -41.49 90.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.996 0.362 . . . . 0.0 111.043 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.21 -49.09 68.47 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.996 0.519 . . . . 0.0 110.192 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -56.57 -47.66 81.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 124.216 1.006 . . . . 0.0 109.234 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.63 95.93 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 119.677 1.126 . . . . 0.0 111.737 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -65.12 -43.3 92.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.322 0.561 . . . . 0.0 111.584 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -48.13 81.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.012 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.26 -32.68 74.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.556 1.071 . . . . 0.0 111.208 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.06 -38.17 82.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.446 0.566 . . . . 0.0 110.677 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -62.13 -34.72 76.91 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.779 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . 0.429 ' CE2' ' HE3' ' B' ' 139' ' ' LYS . 20.9 m-85 -63.6 -35.79 81.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 122.325 2.329 . . . . 0.0 109.458 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.54 83.53 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.138 0.575 . . . . 0.0 110.837 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -84.22 -43.76 14.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.194 1.398 . . . . 0.0 112.0 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -93.04 -21.41 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.442 1.897 . . . . 0.0 111.544 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.17 20.12 60.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.708 0.671 . . . . 0.0 111.463 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.429 ' HE3' ' CE2' ' B' ' 134' ' ' PHE . 10.3 tppt? . . . . . 0 C--O 1.251 1.178 0 C-N-CA 128.698 2.799 . . . . 0.0 112.692 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.84 171.25 20.75 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.871 1.668 . . . . 0.0 106.915 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.47 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -79.88 170.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.829 1.651 . . . . 0.0 107.42 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -124.75 129.81 51.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.906 1.282 . . . . 0.0 108.287 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.23 177.1 5.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.042 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 t -159.62 -173.56 4.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.399 1.88 . . . . 0.0 106.247 168.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -36.89 -36.58 0.12 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 129.599 3.159 . . . . 0.0 116.447 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -133.41 -29.87 1.35 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 111.438 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 m -60.46 -22.26 63.28 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.353 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -51.26 -54.02 29.95 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.18 0.9 . . . . 0.0 109.407 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -61.45 -44.08 97.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.045 -0.409 . . . . 0.0 110.033 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -36.46 81.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.999 -0.091 . . . . 0.0 111.204 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -80.13 -14.31 58.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.335 1.054 . . . . 0.0 113.252 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.2 p -117.79 -4.0 11.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.651 1.114 . . . . 0.0 112.907 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -72.85 -8.84 57.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.07 153.99 44.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.338 1.055 . . . . 0.0 109.246 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.67 -160.55 49.7 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.404 1.002 . . . . 0.0 111.532 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 t -113.96 129.15 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.19 122.2 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.151 -168.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -92.39 100.84 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 108.185 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.33 149.73 25.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.09 150.8 44.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.411 1.485 . . . . 0.0 109.284 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -132.84 113.04 12.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.583 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.4 p-90 -132.79 153.28 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.126 1.771 . . . . 0.0 107.416 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.81 165.04 7.27 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 119.146 0.885 . . . . 0.0 111.122 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.66 -18.08 8.09 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.147 3.231 . . . . 0.0 116.285 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -58.22 -19.65 35.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.798 1.181 . . . . 0.0 114.088 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.0 161.57 39.07 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.76 1.163 . . . . 0.0 113.814 -169.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.06 21.91 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.794 -1.559 . . . . 0.0 112.777 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.56 -27.33 18.89 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.326 2.684 . . . . 0.0 114.94 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -58.51 -18.36 28.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 113.839 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -113.48 11.57 18.44 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.524 1.13 . . . . 0.0 111.697 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mtm -121.35 -43.67 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.099 0.96 . . . . 0.0 109.467 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.1 -36.03 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.445 0.698 . . . . 0.0 109.272 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.37 -57.91 21.74 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.979 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -60.27 -39.56 66.78 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.962 1.775 . . . . 0.0 111.676 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.45 -36.78 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.27 1.028 . . . . 0.0 111.178 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.1 mt -72.36 -41.58 66.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.699 0.681 . . . . 0.0 110.687 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.84 -35.01 79.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.999 0.818 . . . . 0.0 109.848 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.16 -28.7 68.34 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.773 1.229 . . . . 0.0 112.06 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.9 tp -76.41 -46.27 27.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.193 0.597 . . . . 0.0 110.282 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.38 -36.25 71.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.123 0.419 . . . . 0.0 110.759 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -68.42 -9.2 46.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.133 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.08 -51.96 3.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.168 0.987 . . . . 0.0 110.742 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -127.56 14.7 7.07 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.835 0.854 . . . . 0.0 112.238 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.87 -6.44 12.22 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.082 -1.011 . . . . 0.0 114.209 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.37 -23.22 67.22 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.829 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.06 -15.08 8.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.688 1.195 . . . . 0.0 112.515 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 tp -127.95 149.8 50.17 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.749 1.22 . . . . 0.0 112.139 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -114.34 147.53 38.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.85 141.82 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 t -139.21 113.1 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.583 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpt -87.48 155.0 20.2 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.284 -0.885 . . . . 0.0 110.184 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -124.52 127.27 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 171.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -83.05 104.99 13.67 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.334 27.5 m -77.98 48.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -153.54 -42.71 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.481 1.513 . . . . 0.0 108.677 167.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.78 -42.62 19.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.688 0.676 . . . . 0.0 110.767 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -134.59 38.08 3.08 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.42 1.088 . . . . 0.0 111.053 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -69.25 -4.93 19.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.887 1.275 . . . . 0.0 113.147 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.74 -47.16 70.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.982 1.713 . . . . 0.0 111.049 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.3 m -58.81 -40.97 85.71 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.618 0.645 . . . . 0.0 111.061 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.87 -55.28 13.49 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.7 -45.26 39.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.934 0.778 . . . . 0.0 113.213 169.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.73 -41.39 95.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.226 1.013 . . . . 0.0 111.036 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -80.62 -5.45 56.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.151 0.981 . . . . 0.0 112.707 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.34 60.38 5.55 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.44 -64.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 10.5 mtm 58.89 5.14 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.389 2.676 . . . . 0.0 115.242 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.4 p -143.38 159.55 42.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.811 1.187 . . . . 0.0 112.921 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 141.54 41.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.79 151.33 71.78 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 N-CA-C 106.942 -1.984 . . . . 0.0 106.942 -11.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.7 m -123.99 147.01 48.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -122.99 138.17 54.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.188 1.795 . . . . 0.0 106.64 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.34 107.81 12.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.61 128.46 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.58 151.24 43.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.58 0.752 . . . . 0.0 109.496 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -137.73 135.92 36.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.0 t70 43.8 29.98 0.34 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.705 2.002 . . . . 0.0 114.432 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.59 15.74 42.24 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.548 1.071 . . . . 0.0 115.758 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -130.45 144.67 51.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.521 1.16 . . . . 0.0 110.115 172.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.11 134.45 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.94 -22.99 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.699 1.199 . . . . 0.0 110.091 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.17 165.69 28.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.967 0.907 . . . . 0.0 110.329 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 149.33 29.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.8 m -153.51 139.39 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 169.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.04 67.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -171.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.37 156.56 9.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.873 1.702 . . . . 0.0 109.596 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.9 148.22 51.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.157 0.583 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.66 142.11 27.47 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -70.07 166.34 28.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.355 2.036 . . . . 0.0 110.703 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -46.58 -47.05 19.88 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.494 1.918 . . . . 0.0 112.495 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.5 -43.29 77.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.931 0.787 . . . . 0.0 111.055 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.89 76.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.779 -0.575 . . . . 0.0 110.4 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.04 -53.32 59.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.264 1.026 . . . . 0.0 109.707 173.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.05 -38.18 85.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.572 -174.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.03 -46.66 88.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.981 0.81 . . . . 0.0 111.146 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -58.09 -38.68 76.87 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.887 1.275 . . . . 0.0 111.682 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 p -88.74 -40.54 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.509 -0.281 . . . . 0.0 111.079 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -57.72 -32.83 67.8 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.406 1.082 . . . . 0.0 111.854 -176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -69.46 -5.96 27.28 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -126.63 -27.39 3.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.015 1.326 . . . . 0.0 112.581 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.247 0.952 0 C-N-CA 126.155 1.782 . . . . 0.0 107.539 169.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.63 19.43 2.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.162 0.985 . . . . 0.0 112.575 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -157.46 129.68 7.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -153.48 148.86 27.11 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 129.041 2.936 . . . . 0.0 104.649 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.35 146.38 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.28 144.29 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.59 141.38 49.66 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -116.47 145.46 43.28 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 mt -121.05 114.29 21.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 m -136.87 136.37 38.65 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.6 m -52.36 119.48 4.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.711 0.804 . . . . 0.0 109.344 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.25 0.29 5.67 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.724 1.631 . . . . 0.0 115.091 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.2 t30 44.1 26.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.919 2.088 . . . . 0.0 113.328 -169.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.8 m -68.43 -42.93 78.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.67 -61.85 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -54.97 -46.35 75.05 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 120.718 1.599 . . . . 0.0 111.48 -174.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.4 p -51.58 -49.55 61.88 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.9 1.68 . . . . 0.0 112.115 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.28 -46.78 85.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.099 0.96 . . . . 0.0 110.532 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 30.5 ttm -63.02 -45.22 93.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.41 90.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.085 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -27.52 58.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.424 1.465 . . . . 0.0 110.441 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.98 -50.99 42.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.01 -39.63 72.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.638 0.775 . . . . 0.0 111.41 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.37 -52.98 62.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -64.77 -23.19 67.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.8 -14.18 61.46 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -126.7 -16.67 5.19 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.609 1.163 . . . . 0.0 113.31 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -121.84 77.68 1.39 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.34 -161.3 1.01 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.685 1.612 . . . . 0.0 113.09 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.81 -20.83 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.438 -1.036 . . . . 0.0 113.18 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -58.73 -16.3 15.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.506 1.922 . . . . 0.0 112.889 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -128.29 156.95 42.21 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.406 1.882 . . . . 0.0 109.045 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -125.54 143.09 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.34 137.19 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.61 158.12 44.23 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.132 1.373 . . . . 0.0 108.222 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 77.3 p -147.18 150.2 34.45 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.75 172.84 17.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.067 0.947 . . . . 0.0 111.768 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.79 -172.27 35.43 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.266 0.936 . . . . 0.0 111.818 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 tt -53.88 -57.6 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 113.62 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.02 28.41 4.16 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.205 1.802 . . . . 0.0 108.002 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.83 148.18 40.22 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.896 2.078 . . . . 0.0 112.066 -170.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 145.16 66.22 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 131.568 3.947 . . . . 0.0 104.371 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.12 152.09 23.26 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -139.81 100.7 4.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -71.52 128.44 89.91 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -59.73 -21.86 65.11 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.028 1.819 . . . . 0.0 112.813 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -36.01 80.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.701 1.137 . . . . 0.0 111.293 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.56 -38.55 67.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.83 -51.62 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -59.05 -42.65 90.79 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.353 0.661 . . . . 0.0 110.727 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.51 -32.06 57.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.127 0.971 . . . . 0.0 112.18 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 65.2 mmm -84.77 -34.67 22.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.176 0.898 . . . . 0.0 111.276 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -62.53 -24.05 67.3 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.163 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.0 -31.67 63.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.858 1.208 . . . . 0.0 111.673 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.66 15.11 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.196 1.398 . . . . 0.0 111.2 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.74 41.42 98.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.598 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.09 146.4 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -119.26 135.13 54.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.089 0.556 . . . . 0.0 109.967 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.62 25.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 126.969 2.108 . . . . 0.0 109.713 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.8 m -68.09 14.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.518 -1.364 . . . . 0.0 113.403 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.2 23.96 0.93 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.321 1.848 . . . . 0.0 112.251 -169.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -47.46 150.17 0.99 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.82 1.645 . . . . 0.0 114.013 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -128.32 41.17 3.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.851 2.06 . . . . 0.0 110.437 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 12.7 m -59.83 172.33 0.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.04 1.336 . . . . 0.0 113.375 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -166.22 168.2 15.45 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.392 1.477 . . . . 0.0 109.78 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.2 pt -65.37 170.69 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.032 1.333 . . . . 0.0 112.348 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -48.95 132.21 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.329 0.652 . . . . 0.0 109.241 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -138.26 95.96 3.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.915 1.34 . . . . 0.0 108.263 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -44.69 -31.18 1.09 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.741 2.017 . . . . 0.0 114.673 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.64 -22.77 62.47 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-N 119.298 0.954 . . . . 0.0 110.636 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -39.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.457 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.89 -50.92 71.48 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.616 1.098 . . . . 0.0 110.145 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -29.17 69.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.546 0.612 . . . . 0.0 111.353 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -85.31 -11.35 54.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.192 1.397 . . . . 0.0 112.743 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 171.12 5.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.742 0.782 . . . . 0.0 110.683 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -105.28 -12.62 15.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.171 0.989 . . . . 0.0 111.58 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.17 145.59 24.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.398 1.079 . . . . 0.0 109.252 173.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.64 99.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.4 102.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -65.39 119.56 11.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tp -135.31 53.29 1.98 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.627 0.771 . . . . 0.0 111.592 -167.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 92.0 p -166.25 175.74 8.08 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.18 7.93 2.38 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.505 174.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.61 -19.85 63.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.93 1.365 . . . . 0.0 110.663 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . 53.92 43.64 30.57 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.746 2.018 . . . . 0.0 112.825 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -116.96 11.08 14.23 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.725 0.81 . . . . 0.0 110.43 170.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.43 20.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.328 2.651 . . . . 0.0 116.117 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 68.64 27.85 5.88 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.3 1.84 . . . . 0.0 112.859 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 33.96 48.32 0.56 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.085 2.154 . . . . 0.0 112.789 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.87 136.05 70.54 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.872 2.381 . . . . 0.0 112.451 -168.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -1.37 50.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 116.71 -1.614 . . . . 0.0 114.852 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p 46.07 86.63 0.13 Allowed Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.374 1.47 . . . . 0.0 112.879 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -58.36 143.94 96.89 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.461 2.107 . . . . 0.0 110.112 -169.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.9 5.53 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 125.072 3.848 . . . . 0.0 116.212 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -63.95 -12.18 35.14 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 112.29 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.63 154.25 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 0.988 . . . . 0.0 111.375 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -74.33 156.25 37.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.488 1.915 . . . . 0.0 109.834 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.74 144.56 30.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.719 -1.238 . . . . 0.0 108.09 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.44 147.3 27.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -87.26 133.68 33.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.576 1.15 . . . . 0.0 109.658 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -140.32 25.01 2.27 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.704 1.601 . . . . 0.0 110.327 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.68 155.62 26.48 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -157.36 19.91 0.29 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.532 1.933 . . . . 0.0 109.05 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -170.24 175.55 4.87 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 129.257 3.023 . . . . 0.0 105.719 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -161.32 138.39 6.54 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 168.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' B' ' 108' ' ' ARG . 95.6 Cg_endo -74.44 -17.43 21.09 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.743 . . . . 0.0 112.306 -170.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.93 6.62 1.15 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.681 1.128 . . . . 0.0 110.769 168.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' B' ' 106' ' ' PRO . 5.6 mmm180 -122.0 12.73 10.46 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 110.501 177.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.44 158.18 0.44 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -34.65 72.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.828 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.07 -15.1 6.53 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 115.759 1.064 . . . . 0.0 115.759 168.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.5 p -70.33 162.7 28.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.51 -40.11 95.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.515 0.674 . . . . 0.0 110.558 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.84 -42.79 85.18 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.09 -1.433 . . . . 0.0 109.087 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -73.99 -33.16 63.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.928 1.694 . . . . 0.0 109.73 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -56.54 -56.77 17.08 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 119.119 0.872 . . . . 0.0 110.721 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -64.27 -39.78 94.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.758 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.59 98.07 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.29 -0.881 . . . . 0.0 111.996 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.84 -51.54 61.52 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.285 1.3 p90 -70.12 -30.91 68.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 117.546 -1.216 . . . . 0.0 112.542 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -72.58 -41.65 65.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 120.268 1.395 . . . . 0.0 111.004 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -59.52 -54.1 50.48 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.108 0.963 . . . . 0.0 109.302 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.33 -39.42 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.449 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.43 ' HA ' ' SD ' ' B' ' 19' ' ' MET . 5.4 tmm_? -56.92 -45.36 82.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.339 1.427 . . . . 0.0 112.08 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.09 -45.48 94.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.076 0.398 . . . . 0.0 110.65 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.2 -41.58 73.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.713 0.233 . . . . 0.0 111.281 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -60.22 -47.84 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.337 -0.852 . . . . 0.0 109.275 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.76 97.04 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.934 0.788 . . . . 0.0 111.239 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -59.52 -50.83 72.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.379 1.089 . . . . 0.0 111.98 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -69.76 -33.14 72.01 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.506 -0.746 . . . . 0.0 111.448 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.1 -36.48 77.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.249 0.931 . . . . 0.0 111.023 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -57.05 -41.15 78.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.168 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.46 -36.41 75.91 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 116.487 -1.72 . . . . 0.0 112.375 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -64.97 -37.32 87.26 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 122.437 2.381 . . . . 0.0 111.111 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.74 70.8 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -91.85 -38.86 12.07 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 112.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 63.5 p -101.62 -19.27 15.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.335 1.854 . . . . 0.0 110.979 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.42 32.44 64.3 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.835 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 124.083 0.953 . . . . 0.0 111.499 -174.377 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.42 152.9 4.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.637 1.175 . . . . 0.0 109.924 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.23 95.46 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 168.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.06 167.16 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.338 1.455 . . . . 0.0 107.336 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -126.96 117.84 23.32 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.02 176.76 9.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.112 1.365 . . . . 0.0 110.264 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -154.77 -173.2 4.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.884 2.074 . . . . 0.0 106.048 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -39.55 -33.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.872 3.269 . . . . 0.0 116.511 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -133.52 -21.88 1.97 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.951 1.3 . . . . 0.0 112.234 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -38.39 75.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.136 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -71.03 123.88 23.09 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.7 m 116.83 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 1 C-N-CA 131.772 4.029 . . . . 0.0 105.471 -169.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.07 99.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.0 110.578 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -79.65 -8.77 59.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.473 1.509 . . . . 0.0 112.163 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 p -124.25 -2.09 8.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.44 1.018 . . . . 0.0 113.429 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.6 m -72.19 -10.61 60.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.81 155.75 45.57 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.792 0.724 . . . . 0.0 110.432 -172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.86 -158.2 51.77 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 124.223 0.916 . . . . 0.0 110.999 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.66 124.22 71.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.05 115.7 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.156 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.7 tp -87.69 92.89 9.27 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 148.04 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -142.75 149.99 39.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -132.29 110.83 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.583 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.0 p-90 -131.08 152.73 50.07 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.806 1.643 . . . . 0.0 107.477 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.69 162.4 8.32 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 118.882 0.765 . . . . 0.0 110.297 169.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.88 -14.88 6.27 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.916 3.078 . . . . 0.0 115.993 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -61.49 -27.48 68.62 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.83 1.195 . . . . 0.0 113.663 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.66 154.95 47.64 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.448 1.022 . . . . 0.0 112.162 -169.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.93 -49.07 79.25 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 117.955 -1.469 . . . . 0.0 113.729 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.99 -24.71 25.65 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.035 2.49 . . . . 0.0 115.323 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 m -59.15 -21.25 59.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 120.249 1.386 . . . . 0.0 113.502 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.07 7.96 34.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.952 0.901 . . . . 0.0 111.89 174.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.1 mtm -118.59 -44.9 2.63 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.273 0.942 . . . . 0.0 109.562 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.11 -34.59 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.587 0.755 . . . . 0.0 109.301 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.84 -61.54 5.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.15 0.98 . . . . 0.0 112.243 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -60.06 -39.91 65.81 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.077 1.852 . . . . 0.0 111.84 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.26 -44.81 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.677 0.791 . . . . 0.0 110.429 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.39 -44.75 90.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.207 0.458 . . . . 0.0 110.094 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.17 -36.56 82.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.066 0.394 . . . . 0.0 110.441 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.19 -32.68 73.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.643 1.177 . . . . 0.0 111.908 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.78 -45.71 57.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.218 1.407 . . . . 0.0 109.889 175.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.82 -36.33 72.88 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.389 -0.82 . . . . 0.0 111.312 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.99 -6.65 29.09 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.129 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -104.86 -47.09 4.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.974 1.31 . . . . 0.0 111.585 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.4 ptm -134.58 18.19 3.6 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.402 0.681 . . . . 0.0 112.09 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 -6.77 24.02 Favored Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.871 -1.143 . . . . 0.0 113.82 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.74 -23.88 67.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.44 0.62 . . . . 0.0 110.807 169.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 -24.61 7.88 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.937 1.295 . . . . 0.0 111.59 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 tp -110.28 152.14 26.52 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 111.838 -169.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.73 148.48 49.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.94 144.05 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 t -138.25 111.19 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.583 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 33.1 mtpt -84.53 159.39 20.71 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.543 -0.723 . . . . 0.0 109.239 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.22 122.69 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 170.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.89 107.35 10.36 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 32.7 m -79.14 48.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.88 -45.52 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.461 1.505 . . . . 0.0 108.456 167.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.27 -36.39 34.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.984 0.914 . . . . 0.0 110.934 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -133.19 29.24 4.04 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 0.0 110.604 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -72.43 -5.99 40.48 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -54.15 -47.62 71.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.638 1.575 . . . . 0.0 110.902 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.2 m -56.11 -40.89 74.41 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.598 0.759 . . . . 0.0 111.367 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.76 -57.23 4.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.22 -42.46 41.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.836 0.732 . . . . 0.0 113.561 169.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -62.81 -43.39 98.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.364 1.082 . . . . 0.0 110.834 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -71.46 -31.61 67.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.077 0.399 . . . . 0.0 110.325 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.12 68.7 1.18 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 -170.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.68 -66.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.8 mtm 58.45 7.16 0.66 Allowed 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 127.472 2.309 . . . . 0.0 114.801 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -143.99 160.98 39.9 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.273 1.397 . . . . 0.0 112.991 -169.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 138.56 32.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 109.649 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.17 138.44 33.68 Favored 'Cis proline' 0 N--CA 1.449 -1.104 0 N-CA-C 105.866 -2.398 . . . . 0.0 105.866 -11.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -107.81 150.44 27.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 tp -141.36 123.23 15.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -170.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.0 mt -121.21 105.35 10.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.31 108.59 15.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.33 149.52 23.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -146.57 130.43 17.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.98 30.76 0.44 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.489 1.916 . . . . 0.0 113.329 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.06 8.66 55.13 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 171.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -133.31 151.61 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.765 1.226 . . . . 0.0 110.521 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -70.97 132.72 32.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.44 -23.01 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.981 1.313 . . . . 0.0 110.729 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -146.58 160.57 41.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.523 1.129 . . . . 0.0 109.769 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 148.53 30.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -152.08 149.52 28.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.36 -0.837 . . . . 0.0 108.905 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.75 62.76 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.03 154.12 9.43 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.973 1.273 . . . . 0.0 110.714 -170.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.31 162.9 9.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.426 1.491 . . . . 0.0 112.087 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.33 139.26 10.75 Favored Pre-proline 0 N--CA 1.469 0.486 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -69.43 171.35 14.26 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 111.012 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -38.69 -55.69 1.43 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.469 2.307 . . . . 0.0 111.924 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.88 -42.41 63.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.496 -173.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.68 78.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.849 -0.532 . . . . 0.0 110.992 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.86 -47.51 58.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.507 0.323 . . . . 0.0 110.283 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -63.26 -35.72 81.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.38 -47.53 78.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.173 0.442 . . . . 0.0 110.713 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.72 -38.17 71.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.573 0.749 . . . . 0.0 111.587 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.33 -38.66 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.404 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.22 -25.75 64.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.363 0.983 . . . . 0.0 112.56 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -55.09 -26.08 35.65 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.675 0.79 . . . . 0.0 112.614 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.25 -28.42 3.69 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.438 1.095 . . . . 0.0 111.973 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.328 1.851 . . . . 0.0 108.19 174.453 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.43 22.12 1.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.899 0.88 . . . . 0.0 112.399 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.2 127.74 6.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -146.42 142.28 28.0 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 129.523 3.129 . . . . 0.0 105.273 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -125.4 142.6 41.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 109.0 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.1 151.05 31.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.836 1.254 . . . . 0.0 107.682 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -132.87 151.65 51.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.979 1.311 . . . . 0.0 108.26 -169.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -126.84 147.44 50.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.926 0.89 . . . . 0.0 109.212 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.57 130.41 38.37 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.774 0.83 . . . . 0.0 109.428 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -145.44 149.69 35.16 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.434 1.494 . . . . 0.0 110.351 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -59.63 130.17 45.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.79 37.18 8.96 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.025 1.774 . . . . 0.0 112.85 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -39.87 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.235 1.814 . . . . 0.0 114.961 -168.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.1 m -139.24 4.19 2.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.403 1.081 . . . . 0.0 111.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.88 -49.18 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -59.26 -57.22 13.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.831 1.651 . . . . 0.0 112.047 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -75.42 -26.15 58.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.287 0.949 . . . . 0.0 110.965 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -51.29 -49.66 60.82 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.805 1.642 . . . . 0.0 109.676 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' MET . . . . . 0.418 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 24.2 ttm -69.12 -45.2 70.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.659 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.38 90.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.879 0.871 . . . . 0.0 111.946 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -73.94 -33.27 63.86 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.175 0.898 . . . . 0.0 110.798 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.31 70.75 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -59.38 -40.89 87.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.715 0.806 . . . . 0.0 111.601 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.88 71.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -64.26 -24.81 67.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.07 -13.08 62.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -126.82 -8.47 6.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.82 1.248 . . . . 0.0 112.906 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -133.33 81.84 1.95 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -171.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 -161.88 2.14 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.442 1.496 . . . . 0.0 113.07 -171.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.23 -21.14 31.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.729 1.211 . . . . 0.0 113.373 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.14 -14.2 6.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.604 1.962 . . . . 0.0 113.008 169.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -136.48 158.17 45.06 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.094 1.758 . . . . 0.0 109.081 -174.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -132.68 151.38 51.98 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.5 t -135.41 142.9 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -145.32 161.6 39.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.332 0.653 . . . . 0.0 109.911 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.3 m -137.63 145.47 42.76 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.342 1.457 . . . . 0.0 109.165 -169.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.85 164.32 38.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.684 0.754 . . . . 0.0 112.179 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.43 -177.23 46.14 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.333 1.921 . . . . 0.0 108.875 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -57.19 -56.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.577 1.151 . . . . 0.0 112.813 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -132.17 23.76 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.76 2.024 . . . . 0.0 108.005 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.82 118.61 6.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.229 2.212 . . . . 0.0 111.01 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -161.7 -0.17 0.05 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.04 0.536 . . . . 0.0 111.626 169.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.86 168.63 51.25 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -144.71 77.12 1.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.51 131.5 90.67 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -172.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.63 -21.68 48.23 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.968 1.779 . . . . 0.0 112.755 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -37.38 83.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.863 1.211 . . . . 0.0 111.817 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.63 -38.09 65.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 119.099 0.863 . . . . 0.0 109.927 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.56 -51.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.12 -42.55 90.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.989 0.916 . . . . 0.0 110.679 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.78 -30.71 61.74 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.754 0.822 . . . . 0.0 112.304 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.1 mmm -86.41 -33.74 20.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.003 0.819 . . . . 0.0 111.134 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -62.19 -25.59 67.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.187 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -56.51 -30.16 62.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.918 1.236 . . . . 0.0 111.516 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 m -117.27 15.11 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.242 1.417 . . . . 0.0 111.195 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.6 39.95 97.18 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.946 -0.919 . . . . 0.0 112.879 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -115.38 126.99 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -87.15 134.56 33.51 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.917 -0.489 . . . . 0.0 109.752 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -131.51 14.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.288 0.635 . . . . 0.0 111.246 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -59.45 -20.14 52.93 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.171 0.896 . . . . 0.0 110.949 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -76.27 -11.28 59.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.4 2.28 . . . . 0.0 114.116 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -63.83 165.07 9.1 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.368 1.44 . . . . 0.0 113.164 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.2 p -128.44 -37.15 1.83 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.765 1.626 . . . . 0.0 112.08 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.2 m 64.51 162.03 0.12 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.759 2.023 . . . . 0.0 112.803 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -165.52 160.5 17.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.611 1.164 . . . . 0.0 110.212 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -78.14 178.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.731 2.012 . . . . 0.0 111.27 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.12 134.88 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -145.23 103.39 3.84 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.778 1.231 . . . . 0.0 108.283 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -48.26 -30.33 4.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.341 1.856 . . . . 0.0 113.748 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.61 -21.78 66.54 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.068 0.849 . . . . 0.0 111.716 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -118.7 -36.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 117.792 -1.099 . . . . 0.0 108.931 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.01 -51.38 69.89 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.876 1.217 . . . . 0.0 109.059 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.63 -27.59 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.07 0.85 . . . . 0.0 111.622 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -85.72 -18.48 32.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.519 1.128 . . . . 0.0 112.444 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.12 160.22 6.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.233 1.016 . . . . 0.0 111.235 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.9 -33.49 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.638 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.4 tp -146.69 139.3 25.1 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.225 1.41 . . . . 0.0 109.399 -171.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.77 107.58 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.875 1.67 . . . . 0.0 106.734 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.69 100.78 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -75.6 102.41 5.29 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 101.209 -3.626 . . . . 0.0 101.209 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -116.64 11.19 14.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -166.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m -136.41 -75.38 0.43 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.355 0.979 . . . . 0.0 112.217 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 173.78 164.6 29.18 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -119.4 23.51 11.2 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.815 1.646 . . . . 0.0 111.278 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.26 68.68 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.152 0.981 . . . . 0.0 112.6 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.55 4.09 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 176.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.62 9.72 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -172.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.3 0.3 OUTLIER 50.78 31.0 5.49 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.85 2.06 . . . . 0.0 114.641 -169.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.5 m 38.69 52.8 3.77 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 128.057 2.543 . . . . 0.0 113.926 170.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.21 131.11 41.52 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.029 2.486 . . . . 0.0 111.576 -169.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.5 2.12 34.42 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -174.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p 45.72 88.3 0.1 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.622 1.569 . . . . 0.0 113.244 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -56.02 141.18 86.94 Favored 'Trans proline' 0 CA--C 1.55 1.323 0 C-N-CA 122.549 2.166 . . . . 0.0 110.263 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.23 -2.51 3.17 Favored 'Trans proline' 0 C--N 1.351 0.663 1 C-N-CA 125.38 4.053 . . . . 0.0 116.961 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -65.7 -9.81 31.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.175 0.898 . . . . 0.0 111.506 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.81 144.39 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.828 1.251 . . . . 0.0 109.844 -169.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.6 156.61 32.6 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.742 0.817 . . . . 0.0 108.94 171.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -145.08 143.62 30.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -137.21 139.83 41.31 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -89.93 135.13 33.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.673 1.189 . . . . 0.0 108.787 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -140.08 14.47 2.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.95 1.7 . . . . 0.0 110.323 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.34 167.1 54.43 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 123.941 0.781 . . . . 0.0 113.328 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -164.04 -43.11 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.137 1.775 . . . . 0.0 109.469 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -165.21 175.31 9.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.688 1.995 . . . . 0.0 109.798 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -139.26 137.87 19.83 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.26 -18.02 16.43 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.266 1.977 . . . . 0.0 113.078 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.96 6.98 1.78 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.002 1.273 . . . . 0.0 110.226 168.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -118.7 10.68 12.52 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.339 1.455 . . . . 0.0 110.901 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.84 156.76 0.91 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.314 0.646 . . . . 0.0 110.119 171.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -35.8 73.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.512 -172.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.1 -21.32 3.92 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -69.76 166.75 18.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.13 -42.47 99.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.441 0.639 . . . . 0.0 110.292 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.83 -43.03 76.38 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 117.072 -1.442 . . . . 0.0 109.32 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.2 -34.91 61.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 121.034 1.743 . . . . 0.0 109.827 -173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -55.84 -56.62 18.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.631 0.651 . . . . 0.0 110.763 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -64.56 -39.78 94.38 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.853 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.95 92.46 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.896 0.878 . . . . 0.0 111.665 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -63.31 -51.74 64.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.288 2.2 p90 -70.77 -25.81 63.06 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.0 -172.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -65.61 -51.53 58.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.706 1.139 . . . . 0.0 109.746 172.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -57.27 -51.34 69.76 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.32 -49.02 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 118.333 -0.842 . . . . 0.0 109.485 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.418 ' HA ' ' SD ' ' B' ' 19' ' ' MET . 7.6 tmm_? -56.52 -48.29 77.53 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 111.85 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.78 -43.44 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.326 0.391 . . . . 0.0 110.965 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -66.41 -49.96 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -48.5 79.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.806 1.243 . . . . 0.0 109.991 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.72 -42.45 95.27 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -61.37 -44.51 97.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.799 0.8 . . . . 0.0 112.025 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -69.97 -36.85 75.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.084 0.856 . . . . 0.0 111.759 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.56 -33.54 62.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.553 1.07 . . . . 0.0 111.38 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.28 -43.96 96.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.784 0.72 . . . . 0.0 109.201 170.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.33 -39.05 81.92 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.595 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.66 -42.61 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 122.476 2.398 . . . . 0.0 110.222 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.38 72.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.07 -37.83 18.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.825 1.25 . . . . 0.0 112.959 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.2 p -101.14 -20.09 15.47 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.801 1.64 . . . . 0.0 111.613 -169.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.37 50.01 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.75 0.691 . . . . 0.0 111.51 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.478 ' HA ' ' HE3' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 C-N-CA 128.229 2.612 . . . . 0.0 112.681 -169.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.25 160.93 0.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.645 2.378 . . . . 0.0 112.882 -169.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.52 102.84 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -73.09 166.73 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.772 1.629 . . . . 0.0 108.258 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.81 133.9 46.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.23 176.04 5.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.859 1.264 . . . . 0.0 110.189 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.0 p -137.98 -170.73 2.85 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.101 1.761 . . . . 0.0 109.232 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -44.46 -30.37 0.85 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.88 2.472 . . . . 0.0 113.9 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -138.45 -22.82 1.0 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.481 1.112 . . . . 0.0 112.959 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 m -59.03 -36.06 74.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -71.75 122.72 21.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m 117.71 -60.93 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.707 1 C-N-CA 131.977 4.111 . . . . 0.0 106.065 -169.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.2 95.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.424 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -81.68 -9.24 59.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.612 1.565 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.1 p -122.77 -6.59 8.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -168.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -79.98 -1.48 39.8 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -140.39 147.61 40.01 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.238 0.926 . . . . 0.0 109.787 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.56 -174.63 31.37 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.332 0.968 . . . . 0.0 111.659 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.31 129.97 45.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.06 119.51 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.123 0.969 . . . . 0.0 109.009 -168.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.8 107.53 18.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.73 27.82 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.477 1.035 . . . . 0.0 108.282 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -135.7 152.45 51.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.866 1.667 . . . . 0.0 108.84 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -132.22 114.2 14.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.595 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.3 p-90 -135.58 153.07 51.8 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.034 1.733 . . . . 0.0 108.191 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.51 163.33 7.06 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 119.262 0.937 . . . . 0.0 109.183 169.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.86 -16.86 9.41 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.486 2.791 . . . . 0.0 116.384 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -57.67 -27.43 62.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.79 159.49 41.7 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.633 1.106 . . . . 0.0 112.494 -169.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.73 -48.65 75.1 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.039 -1.423 . . . . 0.0 112.677 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.68 -30.69 17.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.657 2.904 . . . . 0.0 115.461 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.71 -25.47 62.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 120.247 1.385 . . . . 0.0 112.924 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -103.89 10.06 36.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.27 1.028 . . . . 0.0 111.708 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.4 mtm -120.78 -44.36 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.192 0.997 . . . . 0.0 109.481 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.44 -34.94 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 0.0 109.254 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.16 6.98 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.183 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.82 -40.16 74.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.009 1.806 . . . . 0.0 111.671 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.97 -42.01 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.007 0.523 . . . . 0.0 110.548 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.26 -40.12 71.17 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.499 0.59 . . . . 0.0 110.812 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.32 -35.32 80.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.275 0.943 . . . . 0.0 109.723 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.8 -25.32 63.72 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.405 1.482 . . . . 0.0 112.363 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.417 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 48.3 tp -79.42 -44.48 21.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 109.637 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.5 -37.48 74.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.723 0.297 . . . . 0.0 110.793 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -68.64 -10.04 53.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.275 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -101.89 -48.18 4.35 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.148 0.979 . . . . 0.0 111.149 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -134.14 15.41 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.419 0.688 . . . . 0.0 112.331 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.95 -2.88 26.3 Favored Glycine 0 CA--C 1.52 0.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.912 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.5 -24.8 64.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.202 1.001 . . . . 0.0 110.808 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -23.01 9.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.164 0.986 . . . . 0.0 112.061 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.57 147.54 46.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.593 1.157 . . . . 0.0 111.57 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -107.42 143.88 35.12 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.7 mt -128.14 139.23 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.84 141.86 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 125.722 1.609 . . . . 0.0 106.672 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.2 mtpp -113.41 159.52 19.37 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.262 0.625 . . . . 0.0 109.576 173.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.56 121.16 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 170.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.2 106.2 6.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 33.0 m -78.66 50.19 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -155.7 -45.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.491 1.516 . . . . 0.0 108.291 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.04 -36.71 35.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 110.869 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -134.08 28.67 3.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 111.019 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -71.77 -6.27 40.18 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.653 0.781 . . . . 0.0 112.735 -171.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -53.74 -49.3 68.46 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.009 1.724 . . . . 0.0 110.708 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -60.04 -34.67 73.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.387 0.675 . . . . 0.0 111.677 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.06 -64.01 0.94 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.82 -45.84 7.45 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.802 0.715 . . . . 0.0 113.298 169.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.29 -43.15 96.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.124 0.962 . . . . 0.0 111.506 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -84.56 -4.98 59.26 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.639 0.776 . . . . 0.0 112.659 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.45 66.32 1.61 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.1 t -144.1 131.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.6 ptm -149.97 24.71 0.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -140.48 161.31 38.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.622 1.569 . . . . 0.0 112.727 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 136.17 28.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.572 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.11 145.42 41.32 Favored 'Cis proline' 0 N--CA 1.45 -1.052 0 N-CA-C 107.43 -1.796 . . . . 0.0 107.43 -11.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.2 m -113.81 145.23 41.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.1 133.06 54.77 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.2 mt -122.11 110.1 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -101.82 122.23 53.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.34 1.456 . . . . 0.0 108.547 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.51 130.31 20.38 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 43.13 31.1 0.33 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.609 2.364 . . . . 0.0 114.804 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.16 -19.15 5.77 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.988 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -136.43 149.49 48.28 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.24 1.52 . . . . 0.0 113.24 -168.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.58 138.83 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.81 -26.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.855 1.662 . . . . 0.0 109.418 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -144.07 157.51 44.28 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -154.6 133.45 12.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.98 -2.229 . . . . 0.0 104.98 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.3 t -155.17 148.79 25.3 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.5 t -138.75 82.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.24 160.01 10.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.435 1.017 . . . . 0.0 110.883 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -66.67 145.58 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.118 0.959 . . . . 0.0 111.118 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -135.91 138.92 29.01 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 124.724 1.21 . . . . 0.0 108.167 170.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.25 169.74 17.57 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.195 1.93 . . . . 0.0 109.946 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 18.1 tptm -46.03 -48.58 16.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.072 1.749 . . . . 0.0 112.41 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.68 -42.37 74.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 118.005 0.366 . . . . 0.0 111.132 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.67 85.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.134 0.425 . . . . 0.0 110.662 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.45 45.8 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.509 0.724 . . . . 0.0 109.305 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -65.32 -37.47 87.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.56 -47.27 86.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.63 0.65 . . . . 0.0 110.957 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.48 -40.07 77.77 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.417 0.687 . . . . 0.0 111.292 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -85.72 -41.61 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 123.064 0.228 . . . . 0.0 110.627 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -56.69 -27.35 58.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.751 1.221 . . . . 0.0 112.302 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -50.08 -32.68 16.28 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.974 1.31 . . . . 0.0 112.294 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -135.81 -8.48 2.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.249 1.041 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.164 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 52.3 48.31 22.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.894 1.677 . . . . 0.0 113.113 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 135.73 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.171 3.788 . . . . 0.0 109.151 169.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -150.66 158.48 44.2 Favored 'General case' 0 C--N 1.325 -0.491 1 C-N-CA 133.896 4.878 . . . . 0.0 103.905 169.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mt -122.61 142.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.657 1.117 . . . . 0.0 109.215 -169.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -143.44 146.94 20.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.33 1.452 . . . . 0.0 107.125 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.59 134.55 37.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.049 0.539 . . . . 0.0 109.835 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.58 143.09 26.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -132.51 111.11 10.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -140.05 143.18 36.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.174 0.99 . . . . 0.0 108.665 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -42.81 96.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.806 2.442 . . . . 0.0 112.681 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.39 36.64 89.91 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.637 -1.091 . . . . 0.0 111.185 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -2.34 103.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 129.764 3.226 . . . . 0.0 113.696 -169.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -122.51 -145.58 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.067 -2.333 . . . . 0.0 104.787 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -38.4 -50.7 1.53 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -168.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.461 ' HE ' ' HG ' ' B' ' 81' ' ' LEU . 27.5 mtp85 -53.68 -51.15 64.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.784 1.175 . . . . 0.0 111.003 -172.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -43.31 73.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.144 -171.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -54.92 -49.66 70.74 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.098 0.959 . . . . 0.0 110.241 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' MET . . . . . 0.439 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 26.2 ttm -63.01 -44.26 96.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.484 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 117.765 -1.112 . . . . 0.0 112.491 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -64.92 -47.3 78.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.649 1.568 . . . . 0.0 109.636 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.75 -47.75 89.66 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.497 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -61.92 -42.62 99.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 117.375 0.587 . . . . 0.0 112.283 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.1 83.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -65.64 -26.96 68.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.206 -170.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -18.22 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.313 0.961 . . . . 0.0 113.285 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.432 ' CE2' ' HE3' ' B' ' 132' ' ' LYS . 1.9 m-85 -119.05 -11.5 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 113.078 -175.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 39.0 mt -103.05 -125.46 0.2 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.78 -168.71 40.84 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.64 -16.1 60.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.556 1.143 . . . . 0.0 111.805 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -53.84 -25.55 20.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 111.268 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -130.3 158.65 39.2 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.713 1.205 . . . . 0.0 110.825 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -128.14 125.71 39.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 67.0 t -115.36 134.42 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 -169.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.1 168.94 18.64 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.463 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -146.6 150.73 36.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.943 0.897 . . . . 0.0 110.353 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.39 166.4 31.15 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.126 1.37 . . . . 0.0 110.375 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.29 -178.44 47.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.175 1.369 . . . . 0.0 110.333 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -52.76 -54.03 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.619 1.168 . . . . 0.0 113.739 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.01 27.88 4.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.581 1.953 . . . . 0.0 108.269 -169.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.74 140.65 49.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.195 1.798 . . . . 0.0 111.942 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 p80 158.43 56.99 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.334 3.054 . . . . 0.0 107.719 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.9 93.97 0.15 Allowed Glycine 0 C--N 1.336 0.574 0 O-C-N 121.219 -0.926 . . . . 0.0 111.404 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.0 tp -72.65 91.02 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -66.21 126.59 92.26 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.896 0.878 . . . . 0.0 109.774 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.75 -26.58 68.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.186 1.924 . . . . 0.0 113.266 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -20.04 65.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.151 1.341 . . . . 0.0 112.204 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.39 -38.2 24.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 110.147 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.51 -51.22 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.33 -38.49 83.93 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.808 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.67 65.19 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.722 0.692 . . . . 0.0 111.842 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' MET . . . . . 0.423 ' HE3' ' CD1' ' B' ' 23' ' ' TRP . 52.8 mmm -76.66 -35.38 58.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.22 0.918 . . . . 0.0 111.163 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -62.33 -24.53 67.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.389 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.47 -26.93 65.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.76 1.164 . . . . 0.0 111.721 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.5 m -120.28 15.01 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.196 1.398 . . . . 0.0 111.151 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.1 42.41 99.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.94 0.781 . . . . 0.0 112.598 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -115.11 155.67 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 172.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -124.14 140.93 52.49 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.789 0.836 . . . . 0.0 109.473 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 37.5 pt -138.23 22.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.671 1.588 . . . . 0.0 109.794 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -60.71 -15.53 30.04 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 120.641 -1.287 . . . . 0.0 111.881 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -63.15 -31.45 72.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.687 2.395 . . . . 0.0 114.172 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -62.45 158.14 18.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.587 1.155 . . . . 0.0 111.16 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.6 t -149.89 -30.65 0.22 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.628 0.771 . . . . 0.0 112.426 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p 56.52 173.74 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.847 2.059 . . . . 0.0 115.272 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -166.47 166.01 16.63 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.281 2.232 . . . . 0.0 107.997 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 31.2 pt -68.55 174.73 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.332 1.053 . . . . 0.0 111.366 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -48.64 131.95 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -147.3 97.51 2.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.192 0.996 . . . . 0.0 108.886 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 9.7 m -50.73 -25.41 4.31 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.926 1.291 . . . . 0.0 114.021 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.71 -21.26 65.64 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.647 1.567 . . . . 0.0 112.098 -175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.55 -37.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tt -68.12 -41.84 81.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.821 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.37 66.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.678 1.126 . . . . 0.0 111.379 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -82.77 -13.52 56.12 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.145 0.978 . . . . 0.0 112.383 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.8 162.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.44 1.018 . . . . 0.0 111.449 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.68 -34.57 16.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.627 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 23.2 tp -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.091 1.356 . . . . 0.0 109.221 -171.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.49 104.1 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.19 99.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -65.43 121.55 15.13 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 169.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.461 ' HG ' ' HE ' ' B' ' 16' ' ' ARG . 4.4 tp -135.58 54.26 1.93 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.832 0.853 . . . . 0.0 111.14 -167.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -165.85 -168.64 1.33 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.846 2.059 . . . . 0.0 105.827 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.5 40.1 0.54 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 123.883 0.754 . . . . 0.0 111.379 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -133.7 127.97 34.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.915 0.857 . . . . 0.0 108.888 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.86 -5.42 25.68 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -169.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.15 -12.3 18.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.433 1.47 . . . . 0.0 112.731 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.21 16.07 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm 74.89 22.3 1.9 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.238 1.815 . . . . 0.0 112.194 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 29.03 57.17 0.66 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 128.149 2.58 . . . . 0.0 112.859 -173.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.04 133.4 51.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.617 2.211 . . . . 0.0 111.914 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.06 -4.65 57.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p 44.28 103.13 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 127.89 2.476 . . . . 0.0 113.858 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -63.56 145.02 91.43 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.461 1.441 . . . . 0.0 109.645 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.59 -4.54 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.119 3.213 . . . . 0.0 114.513 -170.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -61.3 -12.71 14.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.44 147.33 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.218 1.007 . . . . 0.0 110.524 -170.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -77.25 157.96 30.52 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -145.03 145.91 31.68 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.751 -1.218 . . . . 0.0 109.104 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.55 151.32 34.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -108.56 140.48 41.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.895 1.278 . . . . 0.0 110.64 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -144.24 22.61 1.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.724 1.21 . . . . 0.0 111.034 -170.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.94 25.45 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.161 0.886 . . . . 0.0 110.949 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -154.57 -30.4 0.11 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.95 1.7 . . . . 0.0 110.564 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.13 165.0 37.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.92 2.488 . . . . 0.0 107.364 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.12 139.29 20.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.301 1.441 . . . . 0.0 108.328 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.66 -17.86 9.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.355 2.036 . . . . 0.0 113.769 -169.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.01 -0.25 5.43 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.39 0.996 . . . . 0.0 110.666 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 11.17 15.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.894 1.277 . . . . 0.0 110.989 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.52 159.84 0.31 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.059 0.944 . . . . 0.0 110.729 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.51 -36.09 68.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.654 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.96 5.32 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 115.73 1.052 . . . . 0.0 115.73 168.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 65.6 p -69.98 165.08 22.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.8 -42.73 99.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.44 0.638 . . . . 0.0 110.208 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.1 -43.29 82.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.857 -1.545 . . . . 0.0 109.395 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.95 -35.73 62.12 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 121.232 1.833 . . . . 0.0 109.428 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -57.08 -53.94 52.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.679 0.672 . . . . 0.0 110.656 171.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . 0.439 ' HA ' ' CD2' ' B' ' 120' ' ' PHE . 7.6 t90 -62.93 -45.19 93.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.694 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.97 99.51 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.943 0.897 . . . . 0.0 111.857 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.12 -48.78 72.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' B' ' 117' ' ' TRP 0.253 0.3 OUTLIER -65.92 -38.91 89.91 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.366 -174.685 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.02 -48.5 80.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.374 0.988 . . . . 0.0 110.672 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -63.13 -52.15 63.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.91 -35.45 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.222 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.497 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.1 tmm_? -61.84 -43.99 97.74 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.781 1.173 . . . . 0.0 112.373 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.46 -46.19 80.48 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.17 0.441 . . . . 0.0 110.725 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.66 -41.35 68.86 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 122.32 -0.238 . . . . 0.0 111.57 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.3 -46.25 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.105 0.962 . . . . 0.0 109.642 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.19 98.39 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.07 -44.54 94.68 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.262 1.031 . . . . 0.0 112.325 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -72.42 -34.93 68.19 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.044 -1.035 . . . . 0.0 111.489 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -36.08 68.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.682 1.128 . . . . 0.0 111.415 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.432 ' HE3' ' CE2' ' B' ' 27' ' ' TYR . 9.4 ptmt -67.18 -37.39 83.62 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.165 0.893 . . . . 0.0 109.576 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.76 -43.19 98.33 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 117.302 -1.332 . . . . 0.0 110.855 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -57.44 -41.25 80.09 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 121.579 1.99 . . . . 0.0 110.552 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.09 73.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.824 0.85 . . . . 0.0 112.617 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.33 -41.73 14.29 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.459 1.503 . . . . 0.0 111.158 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.6 p -90.06 -23.62 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.129 1.372 . . . . 0.0 110.452 -169.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 51.3 54.33 24.14 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.602 1.561 . . . . 0.0 114.533 -169.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.9 168.06 23.61 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.431 2.292 . . . . 0.0 106.293 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.05 99.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 169.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.41 165.33 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.943 1.297 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 118.25 28.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 107.909 172.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.15 172.86 12.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.982 0.913 . . . . 0.0 108.616 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t -155.34 -177.7 6.73 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 169.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -36.92 -36.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 129.529 3.132 . . . . 0.0 116.275 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.7 -30.95 1.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.518 1.127 . . . . 0.0 111.421 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 m -61.74 -19.39 62.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.732 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -50.61 -50.52 53.94 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.346 0.975 . . . . 0.0 109.535 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -62.62 -44.77 95.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.087 -0.383 . . . . 0.0 110.064 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.15 92.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.417 -0.177 . . . . 0.0 111.017 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -72.09 -21.0 61.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.061 0.944 . . . . 0.0 112.81 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.5 p -110.41 -4.03 15.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.174 0.99 . . . . 0.0 112.117 -169.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -70.78 -11.77 61.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.112 0.965 . . . . 0.0 113.304 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.24 146.53 35.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.867 0.758 . . . . 0.0 109.918 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.8 -171.43 26.46 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.761 1.172 . . . . 0.0 111.949 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.85 133.45 34.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -142.01 116.05 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -81.73 134.2 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.27 139.69 53.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 169.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -132.24 148.65 52.46 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.734 1.614 . . . . 0.0 108.757 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.49 110.83 12.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -169.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.57 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.9 p-90 -129.28 152.55 48.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.562 1.945 . . . . 0.0 107.634 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -171.83 164.05 4.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.783 1.174 . . . . 0.0 111.761 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -56.99 -9.38 4.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.461 3.441 . . . . 0.0 117.476 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -48.47 -46.91 38.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.256 1.389 . . . . 0.0 111.889 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.7 m -152.61 165.42 35.28 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.19 -46.3 27.53 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.161 2.315 . . . . 0.0 115.861 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -51.6 -32.37 44.08 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.818 2.809 . . . . 0.0 114.611 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -58.58 -30.18 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 120.266 1.393 . . . . 0.0 112.743 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.91 7.92 45.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.594 1.157 . . . . 0.0 111.838 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.1 mtm -117.67 -44.02 2.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.034 0.934 . . . . 0.0 109.339 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.14 -33.25 55.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.344 1.058 . . . . 0.0 109.4 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.53 -60.46 10.26 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.294 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.25 -39.86 81.0 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.03 1.82 . . . . 0.0 111.47 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.67 -41.42 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.029 0.531 . . . . 0.0 110.586 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 mp -71.15 -38.45 72.23 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 118.907 0.776 . . . . 0.0 110.897 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.28 -34.95 79.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.033 . . . . 0.0 109.9 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -69.86 -30.56 68.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.564 1.146 . . . . 0.0 111.288 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.84 -43.77 64.99 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.582 1.153 . . . . 0.0 110.112 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.59 -37.3 65.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.523 -0.735 . . . . 0.0 110.962 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.86 -14.31 62.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.844 -0.535 . . . . 0.0 111.735 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.12 -49.25 6.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.943 1.297 . . . . 0.0 110.554 -176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.29 16.34 2.78 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.802 0.841 . . . . 0.0 112.115 -169.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.63 2.87 10.07 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.408 -0.808 . . . . 0.0 113.769 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.39 -24.62 61.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.785 1.234 . . . . 0.0 110.593 169.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -19.1 11.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.004 0.921 . . . . 0.0 112.57 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.28 144.91 51.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.687 1.195 . . . . 0.0 110.733 -168.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.45 144.34 30.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -127.19 135.91 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.15 143.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 22.7 mtpp -117.77 156.35 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.441 0.564 . . . . 0.0 110.49 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -126.26 125.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.26 107.7 12.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 169.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.289 33.7 m -82.85 50.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.42 -35.13 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.446 -0.783 . . . . 0.0 111.329 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -103.95 -27.26 12.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.583 1.153 . . . . 0.0 109.777 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.12 25.1 5.24 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.602 1.161 . . . . 0.0 111.634 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.8 -1.79 23.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.687 1.195 . . . . 0.0 112.982 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.55 -46.44 83.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.014 1.326 . . . . 0.0 110.84 -173.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.32 -39.91 70.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.099 0.863 . . . . 0.0 111.422 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.34 -64.29 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -171.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.61 -41.33 9.42 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.166 0.889 . . . . 0.0 114.103 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -62.85 -46.92 85.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.892 1.346 . . . . 0.0 110.534 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -69.79 -33.78 72.84 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.231 0.469 . . . . 0.0 110.457 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.55 68.02 0.81 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -137.28 132.69 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 100.488 -3.893 . . . . 0.0 100.488 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.7 mtm -147.83 17.04 1.12 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.079 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.8 p -133.92 162.04 33.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 112.339 -168.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.66 139.33 35.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.253 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.91 135.57 16.88 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 N-CA-C 106.26 -2.246 . . . . 0.0 106.26 -11.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.6 m -103.77 140.41 37.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -117.15 135.48 53.73 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 107.659 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.5 mt -121.15 113.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 169.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.09 124.67 43.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -122.69 155.04 37.23 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.909 0.884 . . . . 0.0 109.546 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.36 141.69 24.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 45.47 30.76 0.78 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.353 1.861 . . . . 0.0 113.56 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.72 9.8 51.65 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 116.428 1.331 . . . . 0.0 116.428 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.79 149.56 47.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.718 1.259 . . . . 0.0 111.502 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.71 138.28 21.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.75 -20.75 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.599 1.16 . . . . 0.0 110.966 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -144.51 153.86 42.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.134 0.879 . . . . 0.0 108.914 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -139.83 137.29 34.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.3 t -151.16 148.84 28.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.0 t -138.82 112.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.32 155.84 6.62 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.93 142.68 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.635 0.718 . . . . 0.0 110.537 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -136.01 140.81 34.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -68.64 167.91 21.46 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.343 2.029 . . . . 0.0 110.357 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -44.24 -49.58 9.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.616 1.966 . . . . 0.0 112.281 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -43.6 70.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.28 0.491 . . . . 0.0 111.445 -174.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.59 87.92 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.958 -0.464 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -54.4 45.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.5 0.72 . . . . 0.0 109.612 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.07 -38.87 92.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.546 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.99 -44.04 97.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.759 0.424 . . . . 0.0 111.506 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.09 -44.3 91.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.147 0.979 . . . . 0.0 110.703 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.71 -36.71 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.1 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.24 -30.72 62.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 112.131 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -56.56 -26.58 55.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 112.954 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -125.82 -16.75 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.122 0.969 . . . . 0.0 112.265 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 126.619 1.968 . . . . 0.0 108.701 169.827 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -58.83 131.59 51.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.776 1.231 . . . . 0.0 111.074 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 m120 71.01 124.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.191 2.996 . . . . 0.0 112.378 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -146.73 143.71 28.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 130.809 3.644 . . . . 0.0 103.604 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mt -123.12 142.38 39.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 120.571 1.532 . . . . 0.0 108.344 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.22 142.27 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -128.88 138.3 51.95 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -110.83 148.59 32.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -142.08 112.17 6.93 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 42.4 p -158.51 149.26 20.34 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.741 0.416 . . . . 0.0 111.187 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -47.8 120.59 3.49 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.347 1.459 . . . . 0.0 111.866 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.19 13.69 58.21 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.477 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -7.02 85.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 129.486 3.114 . . . . 0.0 114.926 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -152.53 6.77 0.42 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.368 0.667 . . . . 0.0 111.951 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.44 -93.03 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.869 1.213 . . . . 0.0 111.47 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -24.97 67.61 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.425 -0.797 . . . . 0.0 112.221 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.8 p -61.05 -47.7 85.17 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.519 2.328 . . . . 0.0 112.464 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -64.12 -44.98 90.57 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.796 1.284 . . . . 0.0 108.525 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ttm -59.74 -50.83 72.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.84 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.14 79.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.46 -0.775 . . . . 0.0 111.907 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.64 -26.68 45.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.818 1.19 . . . . 0.0 110.547 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.56 -47.35 69.77 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.462 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 19.4 m95 -54.73 -42.6 71.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 111.319 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.74 72.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -173.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -65.42 -22.26 66.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -69.02 -15.27 63.43 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.312 0.96 . . . . 0.0 113.472 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -130.95 -44.01 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.529 1.059 . . . . 0.0 112.44 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -79.47 73.2 6.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.091 1.756 . . . . 0.0 106.351 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.11 -151.17 0.18 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 127.277 2.37 . . . . 0.0 113.748 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.15 -19.53 63.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.824 1.25 . . . . 0.0 113.399 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.92 -19.49 64.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.2 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -122.39 160.23 25.88 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.378 0.99 . . . . 0.0 111.558 -169.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -133.64 142.18 47.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.852 2.061 . . . . 0.0 105.925 170.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.05 135.01 59.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -142.11 164.51 29.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -146.01 136.37 23.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -169.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 166.75 29.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.481 0.713 . . . . 0.0 111.103 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.06 -172.54 38.73 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 118.018 0.372 . . . . 0.0 113.453 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.421 HG13 ' HE3' ' B' ' 88' ' ' LYS . 2.4 tt -49.04 -57.58 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.634 1.974 . . . . 0.0 113.417 -172.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -135.31 28.89 3.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.147 1.779 . . . . 0.0 108.746 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.01 151.76 47.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 79.6 t60 143.34 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 130.444 3.498 . . . . 0.0 105.049 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.19 177.54 48.43 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.823 -0.548 . . . . 0.0 111.779 -172.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -153.05 92.64 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -65.3 127.36 92.83 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.87 -21.55 71.01 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -36.49 81.14 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 120.171 1.35 . . . . 0.0 110.71 172.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.1 -39.17 63.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -57.8 -53.59 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -60.56 -40.96 93.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.899 0.88 . . . . 0.0 110.883 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.19 -37.0 61.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.55 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 68.5 mmm -82.15 -34.38 29.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.225 0.92 . . . . 0.0 111.496 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.96 -23.41 67.4 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.016 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.87 -31.65 66.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.047 1.294 . . . . 0.0 111.624 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.36 14.34 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.045 1.338 . . . . 0.0 111.268 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.23 41.96 98.09 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.938 -0.923 . . . . 0.0 112.556 175.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.81 147.4 20.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -118.6 135.45 54.43 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 pt -137.02 16.3 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.619 1.568 . . . . 0.0 110.611 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -60.47 -10.04 4.45 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -99.0 -14.15 19.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.048 1.739 . . . . 0.0 113.387 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -58.69 161.3 4.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 t -161.77 -175.78 4.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.802 2.041 . . . . 0.0 107.393 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.6 m -145.47 -162.27 1.47 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.599 1.56 . . . . 0.0 109.803 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -160.35 167.72 26.81 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.74 2.416 . . . . 0.0 106.918 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.6 pt -64.95 168.14 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.47 0.708 . . . . 0.0 111.623 173.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -47.06 129.2 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 108.816 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -137.55 98.55 3.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.897 1.332 . . . . 0.0 109.388 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.0 m -43.87 -32.37 1.07 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.364 2.266 . . . . 0.0 114.045 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.92 -16.57 59.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.164 0.893 . . . . 0.0 112.252 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.04 -37.65 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 117.846 -1.073 . . . . 0.0 109.339 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.09 -55.41 29.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.616 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -23.21 66.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.835 0.289 . . . . 0.0 110.929 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.49 -22.89 28.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.9 2.08 . . . . 0.0 112.814 -175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.05 173.51 1.39 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.985 1.314 . . . . 0.0 111.8 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.17 -24.81 15.55 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.958 0.903 . . . . 0.0 111.614 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 18.5 tp -151.25 143.03 23.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.977 1.311 . . . . 0.0 109.548 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.59 106.37 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 127.165 2.186 . . . . 0.0 106.66 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.22 99.79 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -66.88 128.83 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 tp -125.51 48.85 1.99 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.916 0.887 . . . . 0.0 111.498 -167.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 47.5 m -162.05 176.79 10.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 107.877 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.16 46.9 1.07 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -147.82 161.7 40.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.574 1.95 . . . . 0.0 108.042 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -131.81 1.71 4.0 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.261 1.424 . . . . 0.0 112.576 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.03 -19.03 4.16 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.31 0.959 . . . . 0.0 112.827 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -64.83 18.91 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.699 2.4 . . . . 0.0 116.62 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . 0.421 ' HE3' HG13 ' B' ' 39' ' ' ILE . 60.7 mttt 83.15 18.86 0.24 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 128.744 2.818 . . . . 0.0 112.216 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.2 m 32.9 52.82 0.93 Allowed Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 126.502 1.921 . . . . 0.0 111.67 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.87 132.59 22.05 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.056 2.504 . . . . 0.0 114.409 -168.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.85 -1.16 56.13 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 116.774 -1.584 . . . . 0.0 114.459 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p 43.49 89.54 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.476 1.51 . . . . 0.0 113.62 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -57.27 137.57 82.26 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.03 2.487 . . . . 0.0 109.714 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.18 10.97 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.892 3.728 . . . . 0.0 116.015 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -67.65 -9.48 43.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.299 1.04 . . . . 0.0 111.844 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.55 153.14 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.71 1.204 . . . . 0.0 110.115 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -72.82 153.7 40.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.35 1.06 . . . . 0.0 109.254 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -143.06 144.75 32.39 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.9 150.67 27.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -92.75 137.38 32.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -139.61 39.47 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.389 1.476 . . . . 0.0 108.525 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.29 167.79 29.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -157.77 -15.93 0.08 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.728 1.211 . . . . 0.0 111.575 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.54 168.22 25.61 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.232 2.213 . . . . 0.0 106.448 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -142.72 117.38 6.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.139 0.976 . . . . 0.0 109.075 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' B' ' 108' ' ' ARG . 98.0 Cg_endo -72.71 -17.91 25.62 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.682 2.921 . . . . 0.0 112.752 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.5 -0.56 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.516 1.053 . . . . 0.0 112.067 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' B' ' 106' ' ' PRO . 5.4 mmm-85 -123.43 11.23 9.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.59 1.556 . . . . 0.0 111.379 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.95 152.91 0.71 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.133 0.973 . . . . 0.0 111.563 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -35.39 73.77 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.837 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.36 9.13 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -72.92 149.81 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -47.82 -41.6 24.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.583 1.553 . . . . 0.0 111.507 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.61 -40.45 69.79 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.425 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -78.0 -31.55 50.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.907 1.23 . . . . 0.0 109.651 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -63.15 -48.48 78.29 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 119.147 0.885 . . . . 0.0 110.029 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . 0.407 ' CD1' ' CZ ' ' B' ' 120' ' ' PHE . 6.1 t90 -64.92 -46.63 80.85 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.751 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.63 95.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.544 0.738 . . . . 0.0 112.125 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.86 -50.22 71.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' B' ' 117' ' ' TRP 0.251 0.5 OUTLIER -66.51 -40.27 89.1 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.482 -174.66 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -62.2 -49.04 77.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.375 0.989 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -64.96 -48.87 72.49 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.9 -35.12 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.547 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.462 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 6.8 tmm_? -60.11 -44.73 94.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.102 1.319 . . . . 0.0 111.732 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.58 -45.81 84.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.678 0.391 . . . . 0.0 110.923 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.82 -47.58 74.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.776 0.262 . . . . 0.0 110.908 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.8 mt -54.25 -49.89 59.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.415 1.486 . . . . 0.0 109.579 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.21 -42.82 97.76 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.203 -0.776 . . . . 0.0 111.249 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -61.28 -46.19 91.39 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.229 1.015 . . . . 0.0 111.61 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.7 -37.67 85.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.88 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.798 0.726 . . . . 0.0 110.86 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.89 -37.12 83.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.851 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.34 -36.85 78.95 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.581 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -62.11 -41.34 98.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 122.863 2.574 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.27 67.63 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 124.169 0.918 . . . . 0.0 112.356 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.01 -43.92 11.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 111.839 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.8 p -88.49 -17.78 29.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.868 2.067 . . . . 0.0 110.994 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.32 49.82 73.5 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.537 -174.685 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 mtt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.2 149.84 7.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.046 1.338 . . . . 0.0 109.434 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.66 98.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 102.558 -3.127 . . . . 0.0 102.558 168.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.54 165.38 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.924 1.289 . . . . 0.0 107.787 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 122.17 41.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.56 172.47 11.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -161.17 -176.32 5.37 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -36.94 -42.01 0.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.875 2.47 . . . . 0.0 115.487 -169.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.33 -29.83 3.21 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.29 1.036 . . . . 0.0 111.533 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m -62.24 -23.28 66.58 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.336 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.15 -54.26 38.36 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.51 1.05 . . . . 0.0 109.051 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -61.46 -45.09 95.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.078 -0.389 . . . . 0.0 109.988 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.73 89.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.309 0.1 . . . . 0.0 111.214 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -74.75 -22.95 58.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.146 0.978 . . . . 0.0 112.557 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 p -106.79 -6.57 17.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.305 0.957 . . . . 0.0 112.691 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -71.65 -10.26 59.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.12 147.36 34.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.087 0.955 . . . . 0.0 109.434 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.81 -175.13 27.6 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.631 1.11 . . . . 0.0 111.959 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -93.22 132.79 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 169.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.5 t -141.22 116.71 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -169.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -82.23 127.33 33.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.4 138.73 51.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.963 0.801 . . . . 0.0 108.988 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.26 146.89 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.09 1.356 . . . . 0.0 108.902 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.23 114.29 16.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -169.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.54 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.7 p-90 -132.96 156.14 47.83 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.762 1.625 . . . . 0.0 107.153 -170.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -176.37 167.28 1.51 Allowed Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.471 1.108 . . . . 0.0 110.749 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.51 -13.59 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.348 3.366 . . . . 0.0 116.601 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -60.13 -20.57 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.292 1.405 . . . . 0.0 113.648 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.13 152.14 38.8 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.86 1.209 . . . . 0.0 113.235 -171.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.41 -49.24 71.69 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.131 -1.371 . . . . 0.0 112.304 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -50.64 -27.27 19.1 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 115.815 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -58.71 -20.85 52.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 120.48 1.491 . . . . 0.0 113.209 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.62 12.15 27.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.906 1.282 . . . . 0.0 111.42 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -122.15 -43.61 2.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.33 1.052 . . . . 0.0 109.427 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.81 -33.59 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.846 0.858 . . . . 0.0 109.242 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.64 25.14 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 117.942 -1.027 . . . . 0.0 112.471 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.53 -39.41 75.58 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.159 1.906 . . . . 0.0 111.576 174.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 t -55.45 -41.2 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.18 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.7 -43.53 84.09 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.106 0.866 . . . . 0.0 111.151 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.96 -35.41 79.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.795 0.725 . . . . 0.0 109.97 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -68.5 -40.12 81.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.58 1.152 . . . . 0.0 110.692 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.6 -46.05 84.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.734 1.213 . . . . 0.0 110.014 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.0 -40.85 71.61 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.184 -0.323 . . . . 0.0 110.822 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -70.37 -6.9 38.71 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.957 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -102.08 -47.31 4.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.627 1.171 . . . . 0.0 111.092 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.2 ptm -134.76 13.6 3.68 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 112.414 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.67 10.97 4.7 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.204 -0.935 . . . . 0.0 113.638 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.85 -26.17 37.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.497 1.519 . . . . 0.0 109.485 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.67 -24.42 11.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.107 0.963 . . . . 0.0 112.124 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 tp -125.3 148.57 48.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.676 1.59 . . . . 0.0 110.728 -168.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -104.55 144.4 31.74 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mt -127.2 137.68 57.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 t -139.01 145.11 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.54 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 23.6 mtpt -122.12 157.15 32.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.324 0.511 . . . . 0.0 110.767 175.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mm -125.37 127.35 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -87.97 107.46 18.73 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -76.29 39.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -146.19 -38.34 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.468 1.107 . . . . 0.0 109.168 168.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.88 -42.19 19.91 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.5 0.72 . . . . 0.0 111.179 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -138.96 36.61 2.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.238 1.018 . . . . 0.0 111.792 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -70.2 -6.49 34.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 113.429 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -50.81 -45.01 59.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.281 1.832 . . . . 0.0 110.796 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.6 m -54.5 -44.74 72.97 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.828 0.851 . . . . 0.0 111.199 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.21 -57.13 4.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.329 1.052 . . . . 0.0 108.996 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.61 -45.86 47.14 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.058 0.837 . . . . 0.0 113.557 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.0 -43.24 99.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.02 0.91 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.72 -33.35 73.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.293 0.497 . . . . 0.0 109.883 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.48 64.99 0.97 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.24 -61.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.252 7.0 ptm 49.44 7.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.815 3.246 . . . . 0.0 115.406 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.4 p -140.68 163.96 31.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 111.987 -172.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -142.66 149.64 51.09 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.096 0.959 . . . . 0.0 108.925 -174.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.42 134.47 31.84 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 106.962 -1.976 . . . . 0.0 106.962 -11.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.7 m -112.27 146.74 37.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -131.79 121.47 24.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.4 mt -115.02 112.17 22.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.19 127.21 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -126.33 156.73 39.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.941 0.896 . . . . 0.0 109.587 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -146.66 140.08 25.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.8 t70 44.86 30.41 0.55 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.265 1.826 . . . . 0.0 114.125 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.64 14.69 49.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.835 1.207 . . . . 0.0 115.899 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.51 148.31 52.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.745 1.218 . . . . 0.0 110.803 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.81 134.87 29.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -122.79 -22.41 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.796 1.238 . . . . 0.0 109.799 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -146.68 156.15 42.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.548 1.139 . . . . 0.0 109.477 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 133.59 16.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.2 p -154.12 163.28 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.471 0.653 . . . . 0.0 110.246 172.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.9 113.74 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.54 153.95 6.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.22 142.18 58.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.914 0.486 . . . . 0.0 110.612 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -134.32 140.69 36.63 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -66.84 169.51 14.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.201 1.934 . . . . 0.0 110.109 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -50.03 31.9 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.595 1.158 . . . . 0.0 111.082 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.81 -43.22 72.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.924 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.19 87.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.061 0.392 . . . . 0.0 110.33 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.8 tp -68.46 -46.99 68.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.928 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.63 -36.24 83.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.69 -47.03 82.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.306 0.503 . . . . 0.0 110.713 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.2 -39.13 78.16 Favored 'General case' 0 N--CA 1.459 -0.015 0 C-N-CA 123.659 0.783 . . . . 0.0 111.512 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -81.61 -41.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.795 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -54.39 -31.87 55.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.594 1.158 . . . . 0.0 112.177 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -56.23 -24.73 44.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.478 1.111 . . . . 0.0 113.218 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -128.83 -16.55 4.15 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.078 0.951 . . . . 0.0 112.518 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--O 1.248 1.025 0 C-N-CA 127.176 2.19 . . . . 0.0 108.812 169.905 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.6 86.92 2.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 m120 74.72 130.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.016 2.926 . . . . 0.0 112.103 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.452 ' HE3' ' CZ3' ' B' ' 32' ' ' TRP . 37.2 mtmt -127.69 122.98 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 128.846 2.858 . . . . 0.0 103.363 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mt -90.54 142.97 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 110.353 -167.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.43 150.23 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.703 1.601 . . . . 0.0 107.225 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.56 157.37 45.92 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.16 0.584 . . . . 0.0 111.831 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -116.63 142.79 46.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.946 1.299 . . . . 0.0 107.593 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 23.7 mt -126.21 125.7 42.85 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 71.8 m -155.17 135.05 12.84 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.321 1.848 . . . . 0.0 109.133 -169.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.2 m -51.33 118.58 3.37 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.802 1.241 . . . . 0.0 110.927 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.97 4.68 11.78 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.701 -1.055 . . . . 0.0 113.737 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 3.1 t30 33.26 40.05 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.246 2.619 . . . . 0.0 113.74 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -81.75 -40.63 22.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.711 0.804 . . . . 0.0 111.126 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.38 -55.69 0.9 Allowed 'General case' 0 CA--C 1.526 0.058 0 C-N-CA 123.471 0.709 . . . . 0.0 112.707 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -49.89 -60.47 2.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.306 1.042 . . . . 0.0 110.184 -169.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -73.18 -28.43 62.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.602 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -54.86 -46.97 74.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -43.93 67.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.103 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.92 89.12 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 118.82 0.737 . . . . 0.0 112.374 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.65 -32.03 69.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.896 0.771 . . . . 0.0 110.582 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.67 -51.2 53.94 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -56.72 -32.91 65.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.88 1.272 . . . . 0.0 112.278 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.2 -53.82 7.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 111.079 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.54 -26.73 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -62.62 -17.57 60.55 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 173.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.4 -10.15 5.17 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.78 1.232 . . . . 0.0 113.011 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -124.69 81.54 1.96 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -163.23 3.01 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.063 1.792 . . . . 0.0 112.585 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.99 -9.91 18.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.915 1.286 . . . . 0.0 113.641 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -61.17 -22.53 64.82 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.903 -1.123 . . . . 0.0 109.745 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . 0.452 ' CZ3' ' HE3' ' B' ' 4' ' ' LYS . 30.9 m95 -126.7 177.37 6.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.363 2.265 . . . . 0.0 108.46 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -157.26 130.55 7.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.73 142.42 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.58 169.76 16.99 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.048 1.739 . . . . 0.0 108.21 -174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 98.5 p -150.13 149.79 30.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.74 174.09 15.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.459 0.704 . . . . 0.0 111.313 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.98 -177.66 41.01 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.535 -0.302 . . . . 0.0 113.119 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.462 HG13 ' HE3' ' B' ' 88' ' ' LYS . 3.0 tt -43.97 -58.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.315 2.246 . . . . 0.0 114.228 -173.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -134.37 30.09 3.57 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.308 1.843 . . . . 0.0 108.191 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.37 137.01 55.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.355 1.862 . . . . 0.0 114.571 -169.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 172.14 114.4 0.01 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 130.377 3.471 . . . . 0.0 102.412 169.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.18 -179.72 43.61 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 118.875 0.761 . . . . 0.0 112.214 -174.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.5 tp -164.07 93.07 0.69 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 169.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -64.61 125.9 89.66 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.08 -21.14 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.036 1.824 . . . . 0.0 112.715 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -37.41 83.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.273 0.942 . . . . 0.0 111.143 171.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.16 61.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t -57.22 -50.93 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.55 -44.77 85.45 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.561 0.619 . . . . 0.0 110.496 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.36 -22.81 45.07 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.96 0.904 . . . . 0.0 112.694 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 77.8 mmm -102.65 -34.13 9.18 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.365 0.984 . . . . 0.0 112.301 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -60.22 -27.9 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.172 0.896 . . . . 0.0 110.092 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.73 -33.04 32.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.755 1.622 . . . . 0.0 112.383 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.89 17.39 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.299 1.44 . . . . 0.0 110.796 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.27 37.95 93.33 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.935 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 47.4 mt -115.94 107.32 22.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 172.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -73.22 132.65 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 30.8 pt -135.81 19.05 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.991 1.316 . . . . 0.0 110.823 173.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -59.76 -15.64 21.74 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.837 0.744 . . . . 0.0 111.963 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -83.97 -15.29 48.35 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.7 2.4 . . . . 0.0 114.345 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -69.9 159.55 33.47 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.742 1.156 . . . . 0.0 112.762 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 66.8 p -139.64 -169.78 2.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.125 2.57 . . . . 0.0 108.806 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 p -157.86 -173.43 4.36 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.101 0.961 . . . . 0.0 108.708 169.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -166.44 159.25 14.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 127.491 2.316 . . . . 0.0 108.017 -170.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.64 166.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.05 0.94 . . . . 0.0 111.888 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -50.07 133.28 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -142.85 98.79 3.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.237 1.017 . . . . 0.0 109.161 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.6 m -44.49 -32.43 1.4 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.827 2.051 . . . . 0.0 113.773 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.92 -17.65 63.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.383 0.992 . . . . 0.0 112.648 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -126.93 -34.01 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.811 0.844 . . . . 0.0 108.852 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.25 -54.18 23.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.603 1.092 . . . . 0.0 110.172 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -23.93 67.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.986 0.812 . . . . 0.0 110.416 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.91 -23.02 55.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.806 1.642 . . . . 0.0 112.138 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.94 165.69 3.11 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.763 1.225 . . . . 0.0 111.8 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.15 -29.32 15.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.036 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -145.26 133.91 22.16 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.156 0.982 . . . . 0.0 110.996 -173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.55 116.33 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.074 1.75 . . . . 0.0 108.227 170.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.38 109.33 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -76.17 123.32 25.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 167.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 tp -116.32 39.09 3.2 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.732 -0.605 . . . . 0.0 109.489 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 5.4 m -153.93 165.18 36.91 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.369 0.668 . . . . 0.0 111.644 -168.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.91 48.1 0.97 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 105.858 -2.897 . . . . 0.0 105.858 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -149.64 159.77 44.06 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.148 2.179 . . . . 0.0 107.58 -169.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -132.64 2.67 3.78 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.704 1.602 . . . . 0.0 112.192 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.26 -17.58 20.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.938 0.895 . . . . 0.0 112.601 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.15 38.17 0.05 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.67 1.988 . . . . 0.0 115.055 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . 0.462 ' HE3' HG13 ' B' ' 39' ' ' ILE . 14.1 mttt 64.37 21.94 12.62 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.642 -1.911 . . . . 0.0 111.742 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p 30.41 62.38 0.96 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 127.504 2.322 . . . . 0.0 112.049 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.36 132.18 49.29 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.791 2.327 . . . . 0.0 111.066 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.6 3.18 55.64 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p 43.2 92.22 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.009 2.524 . . . . 0.0 113.698 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -61.71 147.51 95.16 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.013 1.809 . . . . 0.0 109.942 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.4 -2.52 6.16 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.915 3.743 . . . . 0.0 115.348 -169.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -62.58 -10.03 10.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.6 1.16 . . . . 0.0 112.154 170.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.1 t -137.52 143.95 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.842 1.257 . . . . 0.0 109.525 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -76.04 155.46 34.86 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -139.98 142.61 36.31 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.833 -1.167 . . . . 0.0 108.993 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -145.45 159.28 43.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 169.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -106.74 128.72 54.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -119.16 8.73 11.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.583 1.153 . . . . 0.0 110.501 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.58 162.38 24.62 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -157.81 24.63 0.27 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.776 1.23 . . . . 0.0 109.422 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.35 172.62 18.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.407 1.883 . . . . 0.0 106.642 -171.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -148.25 116.14 4.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.57 1.148 . . . . 0.0 108.737 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.24 -28.51 22.86 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.13 2.553 . . . . 0.0 111.917 -171.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.79 -3.28 3.16 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.448 1.099 . . . . 0.0 112.755 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -97.05 5.74 49.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.249 1.02 . . . . 0.0 111.673 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.75 142.9 3.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.778 0.831 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -55.24 -45.95 76.04 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.474 0.71 . . . . 0.0 109.914 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.32 -15.11 4.22 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.8 p -69.22 162.37 27.27 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.74 -39.08 90.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.473 0.654 . . . . 0.0 110.534 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.04 -41.43 82.1 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 116.983 -1.484 . . . . 0.0 109.05 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.85 -31.46 59.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 120.851 1.66 . . . . 0.0 109.607 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -57.12 -62.91 1.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -59.44 -39.99 85.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.03 95.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.608 0.763 . . . . 0.0 112.305 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -63.17 -48.27 79.1 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 118.583 0.628 . . . . 0.0 109.474 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -65.89 -40.46 91.59 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -65.85 -46.69 77.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.265 1.026 . . . . 0.0 110.297 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -60.23 -49.52 77.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.21 -46.76 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.018 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -62.59 -39.62 94.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.154 1.343 . . . . 0.0 111.347 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.26 -43.87 96.74 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.212 0.32 . . . . 0.0 110.615 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.66 -55.36 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.128 0.571 . . . . 0.0 109.641 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.1 mt -54.86 -52.45 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.309 1.044 . . . . 0.0 109.416 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.98 97.84 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.817 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -61.38 -47.15 87.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.42 1.11 . . . . 0.0 111.409 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -65.81 -41.11 92.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.466 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.46 -37.86 83.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.771 0.714 . . . . 0.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -62.92 -47.13 84.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.588 0.631 . . . . 0.0 109.731 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.05 -36.11 82.49 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.253 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.62 -40.94 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 121.543 1.974 . . . . 0.0 110.735 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.64 71.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.27 0.628 . . . . 0.0 112.629 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.99 -37.05 13.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 111.636 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 51.4 p -100.3 -14.13 18.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.72 1.608 . . . . 0.0 111.546 -169.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.98 48.37 86.62 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.108 0.563 . . . . 0.0 111.876 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.08 169.66 21.99 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.334 1.453 . . . . 0.0 107.778 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.29 93.65 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 169.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.01 170.71 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.473 1.909 . . . . 0.0 107.804 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -129.24 130.84 46.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.846 0.858 . . . . 0.0 108.757 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.55 176.94 6.37 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.411 1.884 . . . . 0.0 110.375 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -152.03 -176.73 5.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.043 1.737 . . . . 0.0 106.692 169.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -38.67 -37.6 0.34 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.774 2.83 . . . . 0.0 116.067 -169.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -128.81 -30.6 2.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.301 1.04 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.8 m -61.49 -20.89 63.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.422 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -49.47 -53.33 23.69 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -64.2 -45.04 90.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.09 77.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.397 -0.189 . . . . 0.0 111.369 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.37 -14.03 59.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.723 1.209 . . . . 0.0 112.494 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 p -120.79 -6.38 9.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.66 1.118 . . . . 0.0 113.474 -169.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.1 m -78.11 -0.77 29.43 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.382 -0.824 . . . . 0.0 113.11 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.86 145.51 36.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.16 0.984 . . . . 0.0 108.935 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.99 -170.86 54.68 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.893 0.759 . . . . 0.0 111.752 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.99 116.47 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.1 t -133.18 118.98 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.09 137.61 32.2 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.9 144.8 47.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -139.3 144.48 38.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 108.275 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.48 111.52 15.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.431 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.3 p-90 -131.52 154.16 49.06 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.926 1.69 . . . . 0.0 108.153 -169.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.89 163.14 7.88 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.896 0.771 . . . . 0.0 110.07 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -54.02 -14.02 5.45 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.981 3.121 . . . . 0.0 116.272 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -60.8 -24.32 65.74 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.836 1.198 . . . . 0.0 113.84 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.22 155.8 47.53 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.523 1.056 . . . . 0.0 112.335 -169.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.65 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.166 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.26 -27.41 23.05 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.347 2.698 . . . . 0.0 115.139 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m -57.83 -20.47 36.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 120.108 1.322 . . . . 0.0 113.324 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 11.33 22.71 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.404 1.082 . . . . 0.0 111.352 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.9 mtm -122.34 -43.65 2.29 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.09 -37.92 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.11 -58.55 14.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.203 -0.904 . . . . 0.0 112.332 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.75 -39.22 75.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.111 1.874 . . . . 0.0 111.919 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.01 -39.98 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.781 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.97 -42.82 80.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.989 0.813 . . . . 0.0 110.491 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.9 -36.88 85.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.558 0.617 . . . . 0.0 110.009 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.66 -36.91 81.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.301 -0.874 . . . . 0.0 110.642 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.93 -44.61 92.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.426 1.09 . . . . 0.0 110.231 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.66 -34.74 72.35 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.565 -0.71 . . . . 0.0 111.425 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.14 -27.02 68.64 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.451 -0.78 . . . . 0.0 111.657 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -90.29 -42.99 10.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.641 1.176 . . . . 0.0 111.291 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.1 ptm -144.2 18.98 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.704 0.802 . . . . 0.0 112.126 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.15 -7.0 15.27 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.311 -0.868 . . . . 0.0 114.309 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.35 -22.78 67.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.711 0.804 . . . . 0.0 111.054 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 -10.66 7.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.852 1.261 . . . . 0.0 112.779 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.9 tp -127.48 150.53 49.62 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.497 1.119 . . . . 0.0 112.092 -168.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -124.27 150.03 45.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.38 143.0 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.1 121.43 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.79 0.723 . . . . 0.0 109.215 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.431 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.9 mmmm -85.91 155.54 20.88 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mm -128.22 116.13 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 101.759 -3.422 . . . . 0.0 101.759 168.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.29 107.7 9.88 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.315 33.2 m -79.6 48.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -154.87 -45.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.34 1.456 . . . . 0.0 108.527 167.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.3 -35.84 30.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.175 0.99 . . . . 0.0 110.91 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -133.89 30.27 3.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.625 1.57 . . . . 0.0 110.514 -169.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -73.73 -5.84 43.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -56.05 -45.78 79.14 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.3 1.44 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.9 m -54.85 -42.62 72.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.335 0.654 . . . . 0.0 110.755 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.21 0.73 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.13 -44.2 14.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.103 0.858 . . . . 0.0 113.411 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.93 -44.99 87.67 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.265 1.033 . . . . 0.0 111.442 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -69.53 -26.71 64.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.743 0.701 . . . . 0.0 110.369 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.81 65.98 0.83 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.86 130.59 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 101.189 -3.634 . . . . 0.0 101.189 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 29.8 mtm -148.78 21.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -138.96 163.08 33.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.814 1.245 . . . . 0.0 113.603 -167.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.17 135.57 27.4 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.266 -0.874 . . . . 0.0 109.497 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -85.98 125.05 8.53 Favored 'Cis proline' 0 N--CA 1.45 -1.042 0 N-CA-C 106.001 -2.346 . . . . 0.0 106.001 -11.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.0 m -88.9 148.14 23.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.26 119.69 10.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.9 mt -118.2 109.63 16.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.86 138.42 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.24 157.09 41.84 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.419 1.088 . . . . 0.0 111.251 -172.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -138.11 127.75 25.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.71 1.204 . . . . 0.0 107.79 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 36.48 37.99 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.252 2.621 . . . . 0.0 115.507 168.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.94 -30.67 2.35 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.44 158.9 44.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -165.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.43 134.88 28.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.393 1.077 . . . . 0.0 108.721 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -122.42 -24.88 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.837 1.655 . . . . 0.0 111.321 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -144.78 153.35 41.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.95 146.96 33.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.6 m -155.1 153.82 31.45 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.519 1.128 . . . . 0.0 108.631 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.68 69.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.01 159.46 15.93 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 121.717 -0.614 . . . . 0.0 111.779 -173.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.48 145.5 56.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.275 0.63 . . . . 0.0 110.906 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.51 141.31 35.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.031 1.332 . . . . 0.0 107.744 170.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.31 169.46 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.589 2.193 . . . . 0.0 110.558 169.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 -45.01 70.27 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.416 1.086 . . . . 0.0 111.971 -173.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.27 -41.97 84.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.201 0.201 . . . . 0.0 110.693 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.73 76.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.093 -0.38 . . . . 0.0 110.843 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -52.89 57.47 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.454 0.645 . . . . 0.0 109.895 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -62.83 -36.99 85.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.82 -46.7 88.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.729 0.695 . . . . 0.0 111.428 173.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.85 -28.82 62.21 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.829 1.252 . . . . 0.0 111.912 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.2 -42.13 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -57.34 -27.96 62.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.047 -1.033 . . . . 0.0 112.103 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -59.57 -22.54 61.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.57 -16.37 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 169.212 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.98 21.34 0.43 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -169.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.15 128.78 8.54 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 103.857 -2.645 . . . . 0.0 103.857 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -148.39 144.43 27.48 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 130.254 3.421 . . . . 0.0 104.605 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 mt -122.27 142.02 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -141.19 140.95 31.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -121.93 139.91 53.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -169.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -121.96 132.9 54.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -138.9 116.84 11.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.661 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.32 150.26 43.77 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.106 0.963 . . . . 0.0 111.005 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 83.9 m -45.05 106.28 0.07 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.843 1.657 . . . . 0.0 111.352 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.33 39.33 58.87 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.106 1.336 . . . . 0.0 111.188 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -39.09 125.41 1.56 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 38.9 p -141.64 -3.53 1.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.175 168.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.01 -80.42 0.38 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.29 1.036 . . . . 0.0 113.06 -169.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -52.43 -42.74 64.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.565 1.53 . . . . 0.0 113.062 -169.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -76.05 -25.14 55.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.665 1.121 . . . . 0.0 111.948 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.421 HE22 ' C ' ' B' ' 63' ' ' THR . 52.5 mm-40 -62.0 -47.66 83.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.708 1.14 . . . . 0.0 109.588 169.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.1 mtp -66.91 -43.99 81.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.97 93.71 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.705 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.0 -33.68 75.08 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.756 1.162 . . . . 0.0 110.96 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.61 -49.08 58.24 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.44 -41.04 75.77 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.182 0.993 . . . . 0.0 111.233 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.94 87.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -66.19 -19.85 65.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.461 -169.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -78.09 -16.26 58.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.608 1.094 . . . . 0.0 113.505 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.23 -16.42 3.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.86 -116.52 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.73 -167.93 38.07 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 119.161 0.892 . . . . 0.0 110.928 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.54 -20.71 63.55 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.219 1.008 . . . . 0.0 111.348 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -54.28 -24.3 18.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.133 2.173 . . . . 0.0 112.546 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -123.72 156.85 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.355 1.062 . . . . 0.0 110.708 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -125.84 139.56 53.39 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.98 140.25 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.58 157.53 46.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.531 0.732 . . . . 0.0 109.901 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 10.0 p -135.24 131.78 37.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.185 1.394 . . . . 0.0 109.194 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.31 173.75 14.12 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.43 -175.85 46.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.006 1.765 . . . . 0.0 110.405 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 tt -52.43 -53.64 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.83 25.9 4.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.564 1.546 . . . . 0.0 109.078 -174.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.63 147.37 49.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.396 1.879 . . . . 0.0 112.245 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 29.7 p80 174.02 -17.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.579 2.352 . . . . 0.0 110.885 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.26 53.65 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-O 121.871 0.706 . . . . 0.0 113.018 -169.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.78 86.64 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 170.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -59.21 132.97 87.77 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.22 -22.52 57.43 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.757 1.638 . . . . 0.0 112.428 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -56.07 -56.08 25.2 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.4 75.06 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.288 0.949 . . . . 0.0 110.423 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.89 -55.56 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -56.64 -45.93 81.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 110.852 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.85 66.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.97 2.108 . . . . 0.0 111.331 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.3 mmm -89.03 -31.95 17.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.284 0.634 . . . . 0.0 110.27 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -61.63 -25.86 67.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.926 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.68 -27.99 66.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.171 1.351 . . . . 0.0 111.409 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.66 15.61 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.014 1.326 . . . . 0.0 110.971 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.39 93.38 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.693 -1.059 . . . . 0.0 112.964 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 82.1 mt -113.9 109.18 27.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.99 138.44 52.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 pt -134.82 16.07 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.856 0.862 . . . . 0.0 111.309 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 m -60.91 -13.79 18.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.246 0.93 . . . . 0.0 113.187 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -94.08 -13.98 26.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.9 1.68 . . . . 0.0 113.097 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.09 166.49 11.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.549 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.421 ' C ' HE22 ' B' ' 18' ' ' GLN . 13.9 t -156.25 -179.17 7.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.5 1.92 . . . . 0.0 107.458 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 64.0 m -143.41 -174.41 4.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.74 1.616 . . . . 0.0 107.675 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -150.98 171.47 17.23 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.022 1.329 . . . . 0.0 107.596 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.9 pt -62.66 170.71 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.071 0.851 . . . . 0.0 110.821 170.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.81 132.16 6.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -141.95 98.01 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.241 1.019 . . . . 0.0 108.419 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.8 m -47.15 -28.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.544 1.938 . . . . 0.0 114.451 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.08 -22.02 61.42 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 119.496 1.044 . . . . 0.0 110.515 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -40.57 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.693 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.57 -54.48 42.45 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.741 1.155 . . . . 0.0 109.47 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -22.89 67.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.025 0.829 . . . . 0.0 111.69 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.4 -12.58 54.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.738 1.215 . . . . 0.0 113.132 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.85 167.01 12.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.278 0.945 . . . . 0.0 110.544 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.38 -35.35 16.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.733 169.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 23.5 tp -146.38 136.05 23.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.113 1.365 . . . . 0.0 109.814 -172.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 16.0 t -105.06 105.22 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.5 109.4 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -68.49 132.12 46.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 39.1 mt -118.94 151.03 38.9 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m 78.34 -33.11 0.16 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 128.837 2.855 . . . . 0.0 111.623 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.83 145.86 18.67 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 105.198 -3.161 . . . . 0.0 105.198 -169.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -67.4 126.29 28.82 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -128.24 -29.14 2.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.259 1.024 . . . . 0.0 110.565 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.61 21.88 0.28 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.916 1.286 . . . . 0.0 110.031 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -85.13 18.72 2.45 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.872 -1.143 . . . . 0.0 113.795 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.305 0.2 OUTLIER 53.32 35.21 19.65 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.102 1.761 . . . . 0.0 113.49 -169.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 37.36 52.6 2.66 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.642 2.377 . . . . 0.0 114.212 172.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.49 130.69 37.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.211 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.87 0.48 50.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 116.636 -1.649 . . . . 0.0 115.14 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.9 p 46.43 89.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.948 1.299 . . . . 0.0 113.436 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.98 143.48 92.33 Favored 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 123.132 2.554 . . . . 0.0 110.424 -169.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.19 4.23 0.79 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.092 3.861 . . . . 0.0 116.21 -169.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -67.8 -7.41 27.49 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.397 -0.814 . . . . 0.0 111.941 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -135.84 150.12 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.085 0.954 . . . . 0.0 111.055 -168.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -75.58 158.07 32.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -143.63 147.06 33.78 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.74 -1.225 . . . . 0.0 109.17 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.39 151.4 30.77 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -100.45 131.86 46.14 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.207 1.003 . . . . 0.0 109.627 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -115.88 10.75 15.34 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.04 0.936 . . . . 0.0 111.372 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.57 162.42 35.93 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 121.299 -0.876 . . . . 0.0 111.784 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -144.45 34.76 1.18 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.51 2.324 . . . . 0.0 107.985 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.15 139.27 20.14 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.035 2.134 . . . . 0.0 105.76 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -136.68 125.3 15.15 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 120.072 1.305 . . . . 0.0 111.216 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -82.9 -22.63 4.18 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.566 2.844 . . . . 0.0 113.684 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.77 63.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 118.44 0.564 . . . . 0.0 109.826 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -92.62 -64.61 1.08 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . 0.476 ' HA ' ' CD2' ' B' ' 119' ' ' PHE . . . 46.6 -176.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.147 1.779 . . . . 0.0 114.451 -170.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -40.04 77.08 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.09 -20.41 5.05 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.2 p -70.65 166.7 20.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.632 0.716 . . . . 0.0 109.396 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -41.63 90.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.266 0.555 . . . . 0.0 110.937 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.12 -41.18 62.01 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.668 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.27 -31.85 58.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.569 1.531 . . . . 0.0 109.895 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -58.08 -58.4 8.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -58.98 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.276 0.489 . . . . 0.0 110.605 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.19 97.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.237 -0.914 . . . . 0.0 111.632 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 6.9 m-85 -66.57 -41.0 89.24 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.446 -0.787 . . . . 0.0 109.905 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -54.99 -52.91 61.65 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.289 0.95 . . . . 0.0 109.138 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -67.32 -45.82 75.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.74 0.816 . . . . 0.0 111.004 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttp-105 -62.07 -45.64 92.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.64 -43.19 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.741 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -64.45 -35.43 80.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.32 1.418 . . . . 0.0 111.009 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.46 -45.04 92.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.963 0.347 . . . . 0.0 111.424 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.45 -50.7 72.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.643 0.777 . . . . 0.0 110.195 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.7 -52.66 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.782 1.233 . . . . 0.0 109.342 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.05 -41.84 98.38 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 118.971 -0.905 . . . . 0.0 111.721 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -59.3 -46.53 88.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.297 1.049 . . . . 0.0 110.865 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -66.48 -37.87 86.06 Favored 'General case' 0 C--N 1.335 -0.049 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.499 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.67 -42.44 95.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.892 1.224 . . . . 0.0 110.912 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.53 -43.78 88.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.335 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.27 -40.06 89.04 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 117.361 -1.304 . . . . 0.0 110.654 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.35 -39.43 87.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 121.893 2.133 . . . . 0.0 111.29 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.73 70.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.153 0.581 . . . . 0.0 112.248 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.03 -44.73 9.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.581 1.552 . . . . 0.0 111.319 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.3 p -88.39 -24.39 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.291 1.836 . . . . 0.0 110.632 -169.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 49.11 51.14 26.27 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -169.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 125.246 1.418 . . . . 0.0 112.379 -172.65 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.37 161.14 0.08 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.496 2.318 . . . . 0.0 112.842 -170.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.5 109.6 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.4 t -80.86 167.15 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.827 1.651 . . . . 0.0 107.71 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -125.7 118.18 25.07 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.143 0.977 . . . . 0.0 108.411 170.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.98 174.0 10.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.299 1.439 . . . . 0.0 110.015 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -156.3 -175.87 5.66 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.306 1.442 . . . . 0.0 107.51 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -31.45 -40.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 130.794 3.638 . . . . 0.0 117.101 -169.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.23 -29.58 2.02 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.841 1.256 . . . . 0.0 111.033 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -59.23 -22.56 61.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.731 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -48.58 -51.77 26.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.164 1.347 . . . . 0.0 110.521 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 m -64.89 -45.01 87.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.23 0.468 . . . . 0.0 109.83 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.44 -36.73 83.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.34 -0.225 . . . . 0.0 110.884 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -76.77 -13.83 59.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.722 1.209 . . . . 0.0 112.471 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.5 p -119.8 -2.81 10.31 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.66 1.118 . . . . 0.0 112.504 -170.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.3 m -71.73 -10.89 60.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.18 147.66 38.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.562 0.745 . . . . 0.0 109.809 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.93 -167.56 45.59 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.49 1.043 . . . . 0.0 111.611 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 t -102.58 122.25 54.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.03 115.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -81.07 140.5 35.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.0 44.18 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -141.6 148.2 38.86 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 109.001 -171.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -130.64 115.23 16.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.551 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.5 p-90 -133.7 156.15 48.46 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.603 1.561 . . . . 0.0 107.455 -171.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -176.2 167.88 1.5 Allowed Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.118 0.967 . . . . 0.0 110.905 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.05 -18.0 2.82 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.205 3.27 . . . . 0.0 116.407 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -57.77 -21.89 44.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.333 1.424 . . . . 0.0 114.174 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.73 158.08 44.25 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.672 1.124 . . . . 0.0 112.602 -171.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.6 -49.78 28.79 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.212 -1.327 . . . . 0.0 111.896 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -49.2 -27.29 12.47 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.819 3.013 . . . . 0.0 115.762 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.55 -23.23 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.45 1.477 . . . . 0.0 113.409 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -105.71 9.88 32.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.097 0.959 . . . . 0.0 112.035 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.6 mtm -120.46 -42.35 2.55 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.09 0.956 . . . . 0.0 109.586 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.98 -38.01 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.75 -58.65 13.37 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.187 -0.911 . . . . 0.0 112.259 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.01 -39.72 68.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 111.856 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.32 -41.9 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.231 0.469 . . . . 0.0 110.578 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.09 -42.52 80.24 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.554 0.615 . . . . 0.0 110.573 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.95 -39.81 94.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.733 0.697 . . . . 0.0 109.669 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -68.52 -24.21 64.63 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.102 -0.999 . . . . 0.0 112.11 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 42.0 tp -77.79 -45.61 23.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.648 1.179 . . . . 0.0 109.837 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.77 -34.83 74.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.293 0.497 . . . . 0.0 110.964 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -59.36 -26.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 172.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -96.61 -46.33 6.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.173 0.589 . . . . 0.0 111.433 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.6 ptm -134.49 15.44 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 112.228 -169.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.04 16.9 Favored Glycine 0 CA--C 1.52 0.382 0 O-C-N 121.19 -0.944 . . . . 0.0 114.212 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.83 -24.08 64.33 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.836 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -25.92 7.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.59 1.156 . . . . 0.0 111.494 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.0 tp -112.62 151.67 29.83 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.324 1.45 . . . . 0.0 110.584 -169.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.77 148.53 46.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.1 mt -131.66 137.09 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.3 t -137.17 113.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.4 mtpt -88.36 162.43 16.56 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.126 -0.984 . . . . 0.0 110.182 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -131.12 124.5 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -84.32 109.43 17.81 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.5 m -79.7 39.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -145.46 -37.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 168.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -74.89 -52.02 12.37 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.919 1.288 . . . . 0.0 109.842 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.14 46.68 1.93 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.364 1.066 . . . . 0.0 111.235 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -72.12 -3.05 20.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.899 1.28 . . . . 0.0 113.138 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -56.38 -42.76 78.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.026 1.33 . . . . 0.0 110.894 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -54.53 -43.22 71.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.021 0.828 . . . . 0.0 111.371 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.96 -57.77 4.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.92 -43.0 39.4 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.908 0.766 . . . . 0.0 113.593 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -64.56 -42.11 95.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.506 1.153 . . . . 0.0 111.115 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -70.17 -30.69 67.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.371 0.532 . . . . 0.0 110.146 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.34 67.5 1.2 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -171.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.28 -62.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.265 6.7 ptm 49.28 10.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.135 2.974 . . . . 0.0 115.183 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.8 p -140.89 162.98 34.17 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.565 1.546 . . . . 0.0 112.598 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.6 mm -142.7 148.3 45.8 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.162 0.985 . . . . 0.0 108.682 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -78.17 137.91 48.6 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 N-CA-C 106.477 -2.163 . . . . 0.0 106.477 -11.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -115.16 147.17 40.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -130.38 124.21 31.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.7 mt -121.56 112.48 18.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.2 t -104.75 128.49 58.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.31 156.9 41.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.239 1.016 . . . . 0.0 110.367 -169.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -146.02 139.25 25.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.73 29.57 0.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.318 1.847 . . . . 0.0 113.509 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.84 54.84 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.665 1.233 . . . . 0.0 111.21 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.76 138.14 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.95 -18.54 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.304 1.441 . . . . 0.0 111.241 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -141.05 157.36 45.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.227 0.922 . . . . 0.0 110.25 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.37 142.22 22.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 m -155.09 151.69 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.95 88.37 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 169.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.48 158.79 11.43 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -67.5 149.88 49.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.99 0.516 . . . . 0.0 110.501 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.88 135.8 14.76 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.69 169.19 16.51 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.315 2.01 . . . . 0.0 110.412 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -45.72 -48.22 15.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.894 1.678 . . . . 0.0 112.348 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.93 -43.66 71.21 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.259 0.481 . . . . 0.0 111.275 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.54 97.15 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.124 -0.36 . . . . 0.0 110.332 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -52.15 66.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.258 0.623 . . . . 0.0 109.711 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.53 -39.83 94.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.631 -0.699 . . . . 0.0 109.413 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.65 -45.77 92.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.807 0.73 . . . . 0.0 110.964 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.8 -37.55 76.6 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 125.277 1.431 . . . . 0.0 111.233 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.34 -37.09 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.824 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -57.98 -33.73 69.22 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.641 1.11 . . . . 0.0 111.374 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.41 -7.44 37.66 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -125.62 -23.55 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.867 1.267 . . . . 0.0 112.481 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.5 tp . . . . . 0 C--O 1.248 1.014 0 C-N-CA 127.168 2.187 . . . . 0.0 108.847 170.646 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -141.43 161.07 38.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.874 0.87 . . . . 0.0 109.658 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.27 28.5 m120 65.32 117.73 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 129.906 3.283 . . . . 0.0 113.567 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -153.94 137.22 15.72 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.99 3.316 . . . . 0.0 103.402 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -114.19 141.48 30.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -169.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.49 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.9 152.8 49.83 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.881 0.872 . . . . 0.0 110.429 -169.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -119.75 135.17 54.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.7 tp -128.99 119.01 23.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -144.35 163.26 34.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 0.0 111.186 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.7 m -61.33 134.3 56.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.93 5.19 0.37 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.357 2.408 . . . . 0.0 118.587 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.319 1.9 t-20 12.98 71.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.424 2.69 . . . . 0.0 112.57 -169.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.5 p -135.33 -27.07 1.23 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.094 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.37 -68.0 0.78 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.332 0.969 . . . . 0.0 112.225 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.34 -55.86 6.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.478 0.581 . . . . 0.0 112.176 -169.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -37.42 81.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.891 -171.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -53.88 -43.88 69.97 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.075 1.35 . . . . 0.0 109.837 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 10.5 mtp -70.04 -49.21 53.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 -40.51 96.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.888 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.87 -33.94 72.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.529 1.059 . . . . 0.0 110.775 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.01 71.5 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -55.85 -39.7 71.82 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.046 0.938 . . . . 0.0 111.394 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.62 75.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -23.99 67.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.402 -169.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.52 -18.16 60.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.02 -23.12 4.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.884 0.766 . . . . 0.0 112.697 -174.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.6 mt -83.19 -113.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.69 -170.33 36.59 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.93 -17.69 57.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.837 0.855 . . . . 0.0 111.615 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -56.17 -23.55 35.73 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.42 1.888 . . . . 0.0 111.843 169.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -120.92 161.75 21.04 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.283 1.433 . . . . 0.0 109.674 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -124.21 135.74 53.67 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 t -127.81 134.16 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -139.71 166.19 25.27 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.691 1.196 . . . . 0.0 108.786 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 68.6 m -143.35 150.73 39.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.588 0.755 . . . . 0.0 110.261 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.99 158.86 44.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.784 1.234 . . . . 0.0 110.366 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 -176.39 38.53 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.116 0.865 . . . . 0.0 110.941 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.444 HG13 ' HE3' ' B' ' 88' ' ' LYS . 1.3 tt -53.69 -63.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 113.482 -169.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.406 ' H ' HG21 ' B' ' 39' ' ' ILE . 77.7 mm-40 -141.28 33.49 1.7 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.766 2.426 . . . . 0.0 105.76 -172.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.13 146.73 52.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.636 2.774 . . . . 0.0 114.26 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -177.24 17.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.899 1.68 . . . . 0.0 111.967 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.86 172.41 40.39 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 120.892 -1.13 . . . . 0.0 112.04 -169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.8 tp -148.68 75.5 1.31 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.89 131.29 79.26 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 125.023 1.329 . . . . 0.0 108.945 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.0 -22.28 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.966 1.777 . . . . 0.0 112.62 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.23 -54.67 44.17 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 119.616 1.098 . . . . 0.0 108.118 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.84 77.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.689 1.131 . . . . 0.0 110.538 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.77 -54.65 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -56.31 -46.08 79.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.006 0.922 . . . . 0.0 110.899 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -34.08 63.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.734 2.014 . . . . 0.0 111.673 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.0 mmm -92.11 -31.21 15.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.114 0.566 . . . . 0.0 110.481 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -61.65 -26.14 67.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.795 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.67 -31.57 64.56 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.961 1.255 . . . . 0.0 111.248 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.47 15.92 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.185 1.394 . . . . 0.0 110.852 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.51 37.55 93.83 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.908 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 81.8 mt -114.13 107.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.9 138.51 54.71 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 pt -133.42 13.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.624 0.77 . . . . 0.0 111.558 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -60.88 -14.34 21.49 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.925 0.784 . . . . 0.0 112.375 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -85.85 -16.05 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.809 1.644 . . . . 0.0 113.659 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.35 153.4 3.97 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.6 p -116.16 159.86 21.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.921 2.088 . . . . 0.0 108.953 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -148.34 153.71 38.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.803 1.241 . . . . 0.0 108.184 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -164.52 161.83 21.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.963 0.801 . . . . 0.0 111.462 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.4 pt -70.43 174.83 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.655 1.182 . . . . 0.0 111.466 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.07 134.0 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.632 0.773 . . . . 0.0 108.918 169.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.93 95.37 2.76 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.477 1.132 . . . . 0.0 109.237 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.44 -34.29 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.878 2.071 . . . . 0.0 113.744 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.81 -20.82 66.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.072 0.851 . . . . 0.0 112.185 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -122.57 -35.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.7 tt -66.21 -46.69 76.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.654 0.661 . . . . 0.0 110.633 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -30.42 71.58 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.847 0.749 . . . . 0.0 110.42 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -78.42 -18.24 55.24 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.662 1.185 . . . . 0.0 112.88 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 167.34 1.75 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.171 0.986 . . . . 0.0 111.961 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -90.19 -25.32 20.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.565 1.146 . . . . 0.0 111.286 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.34 128.68 11.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.994 0.918 . . . . 0.0 109.467 -173.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.09 100.6 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.872 1.669 . . . . 0.0 107.391 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.67 109.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -75.49 101.48 4.87 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 tp -80.98 -43.63 19.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.762 -0.586 . . . . 0.0 111.703 -168.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 16.5 m -73.36 174.11 8.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.269 0.627 . . . . 0.0 110.463 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.45 -82.04 1.21 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 106.996 -2.442 . . . . 0.0 106.996 169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -164.86 132.63 3.19 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.496 1.518 . . . . 0.0 107.177 170.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.31 -51.58 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.99 0.916 . . . . 0.0 109.681 170.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.22 63.29 0.45 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -101.05 -1.23 34.73 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . 0.444 ' HE3' HG13 ' B' ' 39' ' ' ILE . 3.4 tttt 73.09 19.04 3.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.852 2.061 . . . . 0.0 113.335 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 30.63 55.68 0.79 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.304 2.242 . . . . 0.0 112.521 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.31 139.69 91.09 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.169 1.913 . . . . 0.0 109.795 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.62 4.1 52.14 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.1 p 40.1 98.54 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 128.919 2.888 . . . . 0.0 114.947 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -61.48 138.42 75.92 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.077 1.851 . . . . 0.0 108.856 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.81 3.18 1.62 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.788 3.659 . . . . 0.0 116.398 -168.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -63.33 -13.9 44.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.041 0.837 . . . . 0.0 112.017 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.47 151.32 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.201 0.91 . . . . 0.0 111.483 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 154.73 40.53 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.04 1.736 . . . . 0.0 108.865 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -139.93 145.5 38.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -151.47 141.85 22.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.5 139.72 33.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.75 0.704 . . . . 0.0 111.088 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -123.57 -63.95 1.19 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.009 0.524 . . . . 0.0 112.126 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.83 -44.01 39.81 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 55.86 27.55 11.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.27 1.828 . . . . 0.0 112.997 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -156.18 172.28 18.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.881 1.272 . . . . 0.0 109.032 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -135.12 113.34 11.41 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.166 1.387 . . . . 0.0 108.417 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.92 -21.01 21.55 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.866 3.044 . . . . 0.0 112.513 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.15 8.36 0.78 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.243 1.017 . . . . 0.0 112.385 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -117.79 13.93 14.22 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.254 1.421 . . . . 0.0 111.288 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.0 151.73 0.6 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.1 0.96 . . . . 0.0 110.984 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.24 -46.16 76.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 -172.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.86 -17.13 3.93 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.2 p -69.63 162.88 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.44 -41.06 88.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.397 0.617 . . . . 0.0 110.791 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -72.16 -43.9 63.91 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 117.079 -1.438 . . . . 0.0 109.851 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.19 -31.05 60.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 121.19 1.813 . . . . 0.0 110.024 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -59.37 -60.4 3.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.54 -39.13 86.77 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.04 97.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.36 -0.838 . . . . 0.0 112.317 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.64 -46.12 83.89 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -58.09 -50.15 74.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.19 -49.01 68.81 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.006 0.922 . . . . 0.0 110.69 -174.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -64.43 -44.09 92.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.894 0.77 . . . . 0.0 110.284 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.82 -42.09 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.985 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -34.82 78.91 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.435 1.47 . . . . 0.0 110.868 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.32 -44.57 83.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.87 0.468 . . . . 0.0 111.484 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.28 -48.31 78.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 17.1 mt -51.44 -53.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.944 1.297 . . . . 0.0 109.066 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.84 -41.71 99.66 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.252 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -63.4 -41.13 98.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.386 1.093 . . . . 0.0 111.765 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -71.72 -31.83 67.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.07 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.21 -48.08 79.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.354 0.979 . . . . 0.0 111.021 171.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -68.94 -37.64 78.98 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.989 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.62 -45.77 88.49 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.788 169.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -59.61 -38.41 81.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.423 1.919 . . . . 0.0 111.128 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.59 76.66 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.17 -44.75 12.66 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.594 1.557 . . . . 0.0 112.162 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.3 p -91.94 -23.0 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.687 1.995 . . . . 0.0 111.198 -169.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.03 54.15 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.306 0.955 . . . . 0.0 112.241 -169.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 127.761 2.425 . . . . 0.0 112.794 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.23 165.41 0.09 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.061 2.145 . . . . 0.0 113.32 -171.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.19 105.34 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.88 169.68 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.54 1.936 . . . . 0.0 108.614 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -123.14 114.81 20.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.073 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.95 170.94 15.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.996 0.918 . . . . 0.0 109.861 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -156.41 174.5 15.32 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.37 1.868 . . . . 0.0 106.148 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -32.71 -40.65 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 129.277 3.031 . . . . 0.0 116.425 -169.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.06 -31.08 3.14 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.26 1.024 . . . . 0.0 111.651 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -62.42 -21.45 65.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.558 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -50.85 -51.4 51.64 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.796 1.18 . . . . 0.0 109.178 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -62.64 -44.58 95.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.068 -0.395 . . . . 0.0 110.012 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.74 87.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.429 -0.169 . . . . 0.0 110.906 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.75 -12.85 60.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.723 1.209 . . . . 0.0 112.89 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.8 p -118.46 -5.87 10.76 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.626 1.103 . . . . 0.0 112.591 -170.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.3 m -75.81 -7.38 54.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.972 . . . . 0.0 113.454 -175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.05 155.35 45.39 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.366 1.066 . . . . 0.0 109.057 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.15 -155.6 48.86 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.27 0.938 . . . . 0.0 111.052 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.05 131.4 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 t -138.89 122.02 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.15 -168.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -94.35 94.74 8.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 107.891 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.41 148.61 28.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -141.37 146.68 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.665 1.586 . . . . 0.0 109.15 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -129.44 114.25 15.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.423 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.1 p-90 -124.63 161.75 25.59 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.148 1.379 . . . . 0.0 107.358 -174.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.34 159.34 23.82 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.5 -26.37 44.83 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.421 2.08 . . . . 0.0 114.281 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -51.29 -33.43 28.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -171.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -154.85 166.96 31.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.425 1.466 . . . . 0.0 114.075 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.61 -45.63 95.32 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.385 -1.786 . . . . 0.0 114.431 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.78 -29.65 43.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.383 2.592 . . . . 0.0 114.472 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -59.29 -18.74 40.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.139 1.336 . . . . 0.0 114.089 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -114.23 12.32 17.68 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.644 1.177 . . . . 0.0 111.162 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.1 mtm -121.52 -43.79 2.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.589 1.156 . . . . 0.0 109.238 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.68 -37.99 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.964 0.906 . . . . 0.0 109.226 169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.13 -57.88 19.78 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.045 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.7 -39.74 60.92 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.125 1.883 . . . . 0.0 112.064 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.17 -40.49 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.138 0.975 . . . . 0.0 110.85 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.47 -44.37 74.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.947 0.794 . . . . 0.0 110.524 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.8 -37.82 88.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.489 0.586 . . . . 0.0 109.909 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -72.34 -19.97 61.56 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.148 -0.97 . . . . 0.0 111.831 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 tp -80.89 -44.67 17.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.64 1.176 . . . . 0.0 108.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.7 -34.12 73.47 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.764 -0.585 . . . . 0.0 111.063 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.79 -24.81 66.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.779 -0.576 . . . . 0.0 112.176 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -97.13 -44.3 7.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.796 0.838 . . . . 0.0 111.302 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.3 ptm -139.49 14.33 2.56 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.857 0.863 . . . . 0.0 112.108 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.7 -5.11 22.49 Favored Glycine 0 C--O 1.227 -0.341 0 O-C-N 121.088 -1.007 . . . . 0.0 114.07 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.65 -24.25 66.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 110.788 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 -27.07 8.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.391 1.076 . . . . 0.0 111.875 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -116.01 151.01 36.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.466 1.506 . . . . 0.0 112.059 -168.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -116.97 148.56 41.32 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.81 143.55 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.6 t -140.54 120.18 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.6 mmmm -87.31 154.13 20.93 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.651 0.66 . . . . 0.0 110.963 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -127.98 115.18 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 102.933 -2.988 . . . . 0.0 102.933 168.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -88.26 87.87 7.45 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 m -42.61 -44.48 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.871 1.669 . . . . 0.0 113.669 -172.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.7 -23.9 65.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.489 1.495 . . . . 0.0 112.443 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -108.53 -30.24 8.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.588 1.555 . . . . 0.0 111.873 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -135.59 25.06 3.43 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -168.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.68 -5.79 13.13 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.585 -0.697 . . . . 0.0 112.645 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.84 -28.35 49.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 111.162 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -74.83 -46.92 33.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 0.0 109.847 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.45 -71.07 0.2 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.357 1.463 . . . . 0.0 111.989 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.37 -41.08 11.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.622 1.105 . . . . 0.0 113.292 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.8 -44.58 89.47 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 118.457 -0.783 . . . . 0.0 111.571 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -65.08 -40.73 95.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.21 67.98 0.41 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.93 127.47 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.3 ptm -147.19 19.38 1.23 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.118 -0.468 . . . . 0.0 109.991 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' B' ' 90' ' ' PRO . 3.3 m -141.86 169.86 16.8 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.587 1.155 . . . . 0.0 110.573 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.6 mm -137.92 145.16 46.99 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 107.563 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.15 134.59 30.76 Favored 'Cis proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 -10.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.0 m -102.16 146.68 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.98 137.47 54.6 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.964 1.706 . . . . 0.0 106.639 170.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -124.95 112.45 16.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.68 119.61 49.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.49 152.07 37.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.061 0.944 . . . . 0.0 109.421 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.7 136.13 38.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.2 t70 43.14 28.09 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.886 2.074 . . . . 0.0 114.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.68 48.34 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.579 1.085 . . . . 0.0 115.317 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -129.98 143.96 51.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.891 1.276 . . . . 0.0 110.058 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.0 139.4 19.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.95 -22.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.961 1.304 . . . . 0.0 111.187 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.64 161.01 39.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.723 0.773 . . . . 0.0 109.877 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -155.76 147.08 22.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.8 m -153.4 149.93 28.31 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.089 -1.007 . . . . 0.0 108.432 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.86 68.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.99 156.18 10.83 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.028 1.775 . . . . 0.0 109.521 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -73.22 163.99 27.32 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.886 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -149.89 135.95 10.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.638 1.575 . . . . 0.0 107.26 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -68.58 167.74 21.84 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.0 109.903 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -169.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.96 -43.94 70.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.271 0.487 . . . . 0.0 110.853 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.46 78.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.326 0.512 . . . . 0.0 110.403 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.9 tp -70.7 -48.48 54.42 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.439 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -61.13 -37.68 83.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.2 -48.43 81.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.766 1.166 . . . . 0.0 110.827 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.46 -42.22 70.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.715 1.206 . . . . 0.0 111.291 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -90.52 -37.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.195 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -21.94 64.06 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.345 1.429 . . . . 0.0 112.594 -176.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -78.98 -5.92 55.04 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.128 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -126.4 -30.21 2.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.85 1.26 . . . . 0.0 111.993 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 C--O 1.249 1.065 0 C-N-CA 125.978 1.711 . . . . 0.0 108.408 169.771 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.08 136.4 53.71 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 109.448 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m120 69.85 127.36 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.967 2.507 . . . . 0.0 110.712 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -137.76 119.06 14.63 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 128.822 2.849 . . . . 0.0 103.98 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.61 139.6 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -169.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.08 149.28 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.906 1.282 . . . . 0.0 107.567 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -133.72 146.6 50.93 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.439 -168.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.2 140.53 48.48 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 31.8 tp -136.71 110.97 8.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.5 p -146.22 156.21 43.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -57.78 129.82 43.63 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.863 1.665 . . . . 0.0 111.477 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.41 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 46.9 39.25 11.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.335 23.1 t-20 -37.07 99.85 0.02 OUTLIER 'General case' 0 C--N 1.345 0.39 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -166.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -144.47 -2.18 0.88 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.834 1.253 . . . . 0.0 111.626 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.93 -60.71 0.73 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -171.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -51.9 60.83 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.781 -1.2 . . . . 0.0 111.862 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 14.9 m -64.34 -34.27 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.142 0.177 . . . . 0.0 110.811 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -60.57 -50.73 72.37 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.141 1.776 . . . . 0.0 109.636 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 6.0 ptp -67.56 -40.09 84.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.72 94.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.838 0.855 . . . . 0.0 111.683 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.07 -30.27 64.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.332 0.969 . . . . 0.0 111.251 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.37 -50.59 54.99 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.417 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -55.93 -37.26 68.71 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.117 0.967 . . . . 0.0 111.585 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.67 56.02 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 122.599 0.36 . . . . 0.0 110.414 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -65.16 -24.36 67.37 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.85 -12.52 61.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.414 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 10.9 m-85 -130.39 -14.33 3.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.433 1.093 . . . . 0.0 113.876 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 25.4 mt -120.19 88.49 2.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.22 -166.86 0.57 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.78 1.657 . . . . 0.0 113.586 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.71 -17.0 12.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.623 1.169 . . . . 0.0 112.718 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.29 -24.38 7.34 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.702 1.601 . . . . 0.0 110.946 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -127.46 153.4 46.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.048 1.739 . . . . 0.0 110.061 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 135.21 47.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.04 152.98 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -169.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -145.99 164.06 33.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.438 1.095 . . . . 0.0 109.236 177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.5 m -142.22 126.08 17.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 108.958 -169.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.16 -177.85 6.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.499 0.591 . . . . 0.0 111.266 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.69 -167.75 40.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.41 HG22 ' H ' ' B' ' 12' ' ' GLY . 16.0 tt -70.11 154.65 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 31.8 58.13 0.33 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 130.016 3.326 . . . . 0.0 110.041 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.29 137.53 53.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.459 1.103 . . . . 0.0 111.896 -168.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 28.0 p80 174.99 -2.36 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.84 2.056 . . . . 0.0 111.568 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.09 174.97 54.3 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.923 0.783 . . . . 0.0 111.828 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 tp -139.33 83.83 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -55.39 128.93 68.44 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.58 1.152 . . . . 0.0 108.03 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.73 -21.67 57.42 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.735 1.623 . . . . 0.0 112.326 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -57.44 -54.21 49.37 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 168.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.93 80.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.089 1.313 . . . . 0.0 110.893 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.22 -54.11 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.35 -43.42 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.393 0.677 . . . . 0.0 110.757 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -35.54 62.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.712 2.005 . . . . 0.0 110.339 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 75.1 mmm -93.75 -33.0 13.78 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.988 0.915 . . . . 0.0 111.831 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -59.84 -29.41 68.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.034 0.834 . . . . 0.0 110.901 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -60.32 -33.03 71.81 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.388 0.994 . . . . 0.0 111.63 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.87 13.95 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.609 1.164 . . . . 0.0 111.363 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.2 38.62 92.09 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.648 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.75 107.54 22.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.54 137.82 52.75 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.62 13.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 123.751 0.821 . . . . 0.0 111.773 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -60.4 -15.83 29.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.125 0.875 . . . . 0.0 112.543 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -81.6 -17.07 49.55 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.557 1.543 . . . . 0.0 113.556 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -54.52 154.04 5.14 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -125.51 158.42 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.184 2.194 . . . . 0.0 108.86 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 6.4 m -150.12 157.3 42.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.784 1.234 . . . . 0.0 108.354 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -162.39 168.84 21.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.581 1.152 . . . . 0.0 109.621 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 10.7 pt -69.21 172.23 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.296 1.038 . . . . 0.0 112.124 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -44.24 131.31 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 125.517 1.527 . . . . 0.0 108.413 175.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -142.69 94.25 2.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.863 0.84 . . . . 0.0 108.926 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -50.63 -24.01 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.259 1.423 . . . . 0.0 114.791 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 -29.43 66.35 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 120.661 1.573 . . . . 0.0 109.917 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.37 -42.08 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.172 171.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -63.12 -49.59 73.82 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.652 1.114 . . . . 0.0 110.578 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -29.49 70.74 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.884 1.22 . . . . 0.0 110.138 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -77.12 -14.67 59.76 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.553 1.141 . . . . 0.0 112.867 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.17 163.64 19.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.176 0.988 . . . . 0.0 110.167 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.81 -36.94 16.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.828 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -145.33 139.89 27.35 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.415 0.686 . . . . 0.0 111.357 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.4 t -118.54 109.64 27.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 126.252 1.821 . . . . 0.0 107.538 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.7 97.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -66.2 125.86 26.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 167.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -129.96 61.67 1.57 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.958 0.903 . . . . 0.0 111.437 -167.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 51.4 m -155.42 -172.68 4.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.796 1.239 . . . . 0.0 108.299 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -147.66 42.09 0.9 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -141.31 153.43 45.16 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.842 1.257 . . . . 0.0 109.374 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.48 -11.34 54.48 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.58 -18.68 64.38 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.464 1.029 . . . . 0.0 112.986 -173.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -73.55 43.53 0.14 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.65 1.58 . . . . 0.0 113.882 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 52.54 -155.71 0.18 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.808 1.643 . . . . 0.0 110.706 -169.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.68 63.54 59.53 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.57 2.348 . . . . 0.0 105.421 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 37.4 Cg_exo -57.14 128.3 29.18 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.932 1.755 . . . . 0.0 110.572 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 3.11 48.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.149 -0.929 . . . . 0.0 113.036 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p 37.05 91.93 0.06 OUTLIER Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 128.283 2.633 . . . . 0.0 113.695 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -55.2 130.09 38.8 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.399 2.733 . . . . 0.0 107.939 -174.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.83 2.66 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 126.129 4.553 . . . . 0.0 118.351 -168.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.9 -24.82 68.02 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 119.446 1.021 . . . . 0.0 109.87 169.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.03 153.53 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.39 1.076 . . . . 0.0 112.393 175.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -93.38 154.72 17.8 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 167.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -152.94 146.08 24.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.532 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -156.11 154.78 31.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 168.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -104.77 140.22 38.41 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.885 1.274 . . . . 0.0 109.284 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -142.81 -1.17 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.12 -58.65 3.34 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.387 0.994 . . . . 0.0 110.939 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 55.78 14.83 1.42 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.264 1.825 . . . . 0.0 113.656 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -163.2 171.06 16.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 0.0 107.822 -169.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -150.51 104.92 3.09 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.311 1.045 . . . . 0.0 108.984 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.45 -29.6 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.931 2.42 . . . . 0.0 114.301 -169.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.28 64.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.526 0.731 . . . . 0.0 111.026 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -83.67 -56.7 3.57 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . 0.416 ' HA ' ' CD2' ' B' ' 119' ' ' PHE . . . 44.29 -176.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.097 2.159 . . . . 0.0 115.233 -169.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.54 -40.46 73.4 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.1 -20.9 4.69 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 49.1 p -70.93 166.4 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.689 0.745 . . . . 0.0 109.385 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.95 -39.66 86.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.119 0.485 . . . . 0.0 111.042 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -75.65 -42.69 50.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 117.504 -1.236 . . . . 0.0 109.593 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.39 -30.14 60.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.513 1.506 . . . . 0.0 110.231 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -57.21 -59.25 5.39 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 169.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -61.47 -38.8 88.57 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.794 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.56 94.05 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.216 -0.928 . . . . 0.0 111.865 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 4.0 m-85 -64.63 -46.49 82.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.216 -0.421 . . . . 0.0 109.965 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -56.3 -49.62 73.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -62.54 -48.54 79.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.853 1.661 . . . . 0.0 110.128 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -60.22 -51.9 67.59 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.86 -41.67 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.61 -0.709 . . . . 0.0 109.427 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.417 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 3.7 tmm_? -59.62 -43.01 93.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.511 1.051 . . . . 0.0 111.777 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.8 -46.23 88.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.263 0.483 . . . . 0.0 110.928 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.73 -38.89 73.59 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.23 -0.294 . . . . 0.0 110.99 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.25 -45.74 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.36 1.064 . . . . 0.0 108.875 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.81 -42.7 86.03 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-O 119.165 -0.797 . . . . 0.0 111.682 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -56.97 -45.66 82.73 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.346 1.073 . . . . 0.0 110.988 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -61.34 -39.64 91.33 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.612 0.765 . . . . 0.0 110.44 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.01 -34.15 57.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 119.094 0.861 . . . . 0.0 112.589 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.414 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.9 ttmt -66.83 -39.17 87.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.751 0.705 . . . . 0.0 109.413 172.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -61.31 -35.22 76.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 117.296 -1.335 . . . . 0.0 110.077 169.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.4 -41.07 88.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 120.881 1.673 . . . . 0.0 109.814 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.64 70.47 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.81 0.844 . . . . 0.0 112.591 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -92.27 -36.55 13.16 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.378 1.471 . . . . 0.0 112.721 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 70.6 p -109.1 -11.81 14.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.962 1.705 . . . . 0.0 111.905 -169.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.75 23.63 67.41 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.034 1.302 . . . . 0.0 113.515 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.034 1.734 . . . . 0.0 106.848 -169.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 tpp . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.31 171.15 19.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.639 1.576 . . . . 0.0 107.571 170.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.2 93.82 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.73 171.29 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.148 1.779 . . . . 0.0 107.842 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.82 144.92 49.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.279 1.032 . . . . 0.0 109.174 172.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.25 169.94 8.91 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.257 1.823 . . . . 0.0 108.594 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -156.54 -173.79 4.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -38.67 -39.48 0.5 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.932 2.493 . . . . 0.0 115.811 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -129.01 -30.2 2.24 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.337 1.055 . . . . 0.0 111.505 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -60.77 -25.25 66.38 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.657 -0.687 . . . . 0.0 111.815 172.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -52.15 -56.55 13.8 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.064 0.847 . . . . 0.0 109.226 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -61.02 -44.16 97.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.89 -34.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.352 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.41 -12.91 57.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.573 1.149 . . . . 0.0 113.333 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.4 p -120.83 -7.92 9.48 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.096 1.316 . . . . 0.0 114.398 -168.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -78.71 -2.32 38.74 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -140.43 153.0 46.14 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.28 1.032 . . . . 0.0 109.237 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.14 -157.23 49.38 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.71 128.92 72.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.36 115.16 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.9 tt -78.93 139.06 38.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.62 141.56 51.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.54 142.09 48.03 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.372 1.469 . . . . 0.0 108.563 -173.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.5 116.42 21.07 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -135.02 154.23 51.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.95 1.3 . . . . 0.0 108.711 -170.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.1 161.49 18.46 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.51 0.724 . . . . 0.0 109.651 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.87 -14.83 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.498 2.799 . . . . 0.0 116.514 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -55.15 -24.21 25.34 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.4 p -155.94 169.6 24.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.771 1.168 . . . . 0.0 113.481 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.57 89.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.39 -1.783 . . . . 0.0 114.28 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.31 -28.46 43.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.381 2.591 . . . . 0.0 114.311 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -59.2 -16.83 22.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.898 1.226 . . . . 0.0 113.828 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -116.59 13.0 15.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.737 1.215 . . . . 0.0 111.525 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.0 mtm -122.91 -43.62 2.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.301 1.04 . . . . 0.0 109.415 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.09 -38.06 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -56.49 32.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.716 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.57 -38.68 80.88 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.87 1.713 . . . . 0.0 111.54 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.49 -38.11 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.9 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.52 -48.03 79.22 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 119.559 1.072 . . . . 0.0 109.979 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -66.57 -35.7 80.84 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.905 -0.497 . . . . 0.0 109.848 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.62 -15.33 61.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.74 1.616 . . . . 0.0 112.833 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.25 -44.6 10.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 108.56 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.7 -37.98 76.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.298 -0.251 . . . . 0.0 111.082 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -68.4 -9.85 51.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.948 -0.548 . . . . 0.0 112.15 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.0 -48.32 3.77 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.112 0.965 . . . . 0.0 110.967 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -132.35 16.11 4.52 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.822 0.849 . . . . 0.0 112.45 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.54 19.23 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 121.175 -0.953 . . . . 0.0 114.134 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.28 -23.83 65.71 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 169.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.3 -18.81 9.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.191 0.996 . . . . 0.0 112.439 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.9 tp -128.47 148.08 50.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.364 1.066 . . . . 0.0 111.413 -168.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -110.54 146.98 35.09 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.92 142.23 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.43 140.27 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -106.77 145.34 32.2 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 123.868 0.867 . . . . 0.0 110.281 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.02 122.78 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -85.47 111.21 19.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.261 33.8 m -82.48 41.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -148.49 -38.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.932 0.893 . . . . 0.0 109.415 168.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.86 -51.4 12.6 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.88 1.272 . . . . 0.0 109.862 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.47 47.77 2.17 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.68 1.192 . . . . 0.0 110.088 -172.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -73.55 -1.75 19.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.861 1.265 . . . . 0.0 112.758 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -55.28 -44.47 75.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.243 1.417 . . . . 0.0 110.86 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -57.92 -41.72 83.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.685 0.675 . . . . 0.0 111.152 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.24 -61.81 1.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.455 1.102 . . . . 0.0 108.719 -171.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.86 -41.74 28.53 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.753 -1.026 . . . . 0.0 113.851 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -62.75 -44.35 96.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.432 1.616 . . . . 0.0 110.961 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -71.78 -11.78 60.98 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.196 0.453 . . . . 0.0 111.276 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.66 56.13 6.9 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 m -103.71 -46.41 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.976 0.888 . . . . 0.0 108.942 -169.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.3 mtm 52.73 15.23 0.5 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 127.574 2.35 . . . . 0.0 113.397 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 m -138.08 159.77 41.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.589 1.155 . . . . 0.0 110.945 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.46 143.77 42.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.07 129.91 20.09 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 N-CA-C 107.71 -1.689 . . . . 0.0 107.71 -10.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -98.04 145.36 26.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tp -137.01 126.57 25.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -124.82 110.45 14.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.99 120.22 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 171.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp -112.47 150.79 30.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.697 1.199 . . . . 0.0 109.298 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -150.77 124.75 9.26 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.09 27.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.5 2.72 . . . . 0.0 114.93 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.32 -24.01 3.26 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.606 -1.108 . . . . 0.0 115.378 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.48 159.04 43.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.032 1.416 . . . . 0.0 113.156 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.15 133.62 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.59 -20.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.888 1.275 . . . . 0.0 111.04 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.76 157.7 44.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.235 1.014 . . . . 0.0 109.524 169.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.94 148.28 29.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -171.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -152.71 149.54 28.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.06 57.68 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.09 20.4 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.921 1.724 . . . . 0.0 110.622 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -66.63 157.2 33.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.995 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -148.13 135.33 10.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -68.43 169.66 16.6 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.484 2.123 . . . . 0.0 110.412 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -46.8 65.43 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 112.034 -171.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.77 -42.13 77.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.849 0.093 . . . . 0.0 110.958 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.28 81.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.866 -0.521 . . . . 0.0 110.423 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.83 -47.67 71.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.19 -37.15 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.723 -0.655 . . . . 0.0 109.54 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.11 -46.63 86.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.675 0.67 . . . . 0.0 110.93 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -56.02 -41.64 75.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.439 0.696 . . . . 0.0 111.093 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -83.15 -42.0 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.506 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.4 -35.53 67.88 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.523 1.129 . . . . 0.0 111.801 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -69.18 -7.67 38.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.36 -25.7 4.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.472 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.606 1.962 . . . . 0.0 109.275 173.947 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.14 27.49 4.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.842 1.257 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -157.39 129.73 7.31 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.87 114.3 22.39 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 129.333 3.053 . . . . 0.0 103.677 174.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -90.12 141.16 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.22 141.49 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -131.53 138.86 49.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -115.76 152.66 32.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.75 0.705 . . . . 0.0 109.305 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 mt -132.11 118.35 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.6 p -150.22 157.49 43.14 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.804 1.242 . . . . 0.0 109.402 169.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 31.3 m -53.6 123.97 13.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.313 1.045 . . . . 0.0 110.361 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.95 18.49 11.79 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.657 0.646 . . . . 0.0 113.312 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t30 43.05 47.68 5.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.189 1.796 . . . . 0.0 112.691 -169.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -74.77 -157.35 0.06 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.82 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -33.92 -63.3 0.27 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.55 2.74 . . . . 0.0 116.82 -168.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -57.99 -47.23 83.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 0.896 . . . . 0.0 111.611 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -60.51 -49.4 77.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.718 0.69 . . . . 0.0 111.681 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -57.14 -48.8 77.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.317 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.4 ttm -66.81 -42.93 85.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.551 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.93 84.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.923 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.16 -28.93 57.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.615 1.098 . . . . 0.0 111.179 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 -43.86 48.44 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -56.1 -41.72 75.65 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.18 0.99 . . . . 0.0 111.117 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.45 -50.58 70.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -63.39 -21.76 66.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 118.079 -0.962 . . . . 0.0 113.277 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.37 -16.45 63.93 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.612 1.096 . . . . 0.0 113.824 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.6 -39.79 0.57 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.896 1.226 . . . . 0.0 113.107 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.417 ' HG ' ' CG ' ' B' ' 32' ' ' TRP . 4.3 tp -77.45 75.6 4.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.534 2.734 . . . . 0.0 105.081 169.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.64 -166.9 1.86 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.85 2.167 . . . . 0.0 114.767 -169.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -56.93 -20.61 24.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.23 1.412 . . . . 0.0 112.968 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -55.65 -20.54 14.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 112.482 169.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . 0.417 ' CG ' ' HG ' ' B' ' 28' ' ' LEU . 63.9 m95 -118.22 174.17 6.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.383 1.873 . . . . 0.0 109.789 -176.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 114.61 5.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.78 149.2 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -150.8 167.36 27.7 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 168.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -152.17 147.54 26.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 110.391 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.06 178.16 9.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.855 1.262 . . . . 0.0 111.216 -169.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.14 -175.63 42.75 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -47.75 -58.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.492 . . . . 0.0 114.541 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.07 31.56 4.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.573 1.549 . . . . 0.0 108.425 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.45 151.32 47.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.68 1.992 . . . . 0.0 115.17 -169.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 p80 162.8 47.2 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 130.906 3.683 . . . . 0.0 107.567 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.8 177.28 27.86 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.894 0.759 . . . . 0.0 112.017 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 36.3 tp -161.28 83.67 0.64 Allowed 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.44 126.47 90.66 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.476 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.41 -24.98 75.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.214 1.943 . . . . 0.0 112.722 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.3 -51.17 70.9 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.76 74.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.849 1.204 . . . . 0.0 111.214 -175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.04 -53.76 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.58 -48.09 80.33 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 110.567 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.984 1.714 . . . . 0.0 111.855 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.72 -43.49 14.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.861 0.864 . . . . 0.0 110.051 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.24 -30.71 69.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.623 0.647 . . . . 0.0 110.832 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -27.59 62.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.874 1.27 . . . . 0.0 112.292 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.37 15.48 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.147 1.379 . . . . 0.0 111.158 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.66 72.66 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.179 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 63.0 mt -110.19 149.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -117.93 135.45 54.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.589 0.756 . . . . 0.0 108.993 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.409 ' C ' ' H ' ' B' ' 61' ' ' ASN . 19.4 pt -136.56 17.4 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.4 1.08 . . . . 0.0 111.048 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -67.23 13.46 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -169.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' B' ' 59' ' ' ILE . 28.3 t30 -137.75 -4.56 1.78 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.235 2.614 . . . . 0.0 111.539 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -57.92 147.73 27.94 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.532 1.06 . . . . 0.0 111.324 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -126.89 168.95 13.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.61 1.964 . . . . 0.0 109.184 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 7.0 p -155.03 -174.45 4.99 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.172 0.989 . . . . 0.0 108.442 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -159.23 168.51 26.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.559 1.543 . . . . 0.0 107.933 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.7 pt -60.26 164.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.464 0.705 . . . . 0.0 111.304 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -48.22 127.04 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -135.83 99.17 4.1 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.67 1.224 . . . . 0.0 109.194 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -42.68 -31.68 0.49 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.731 2.413 . . . . 0.0 114.559 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.07 -17.67 63.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.243 0.928 . . . . 0.0 112.212 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.33 -38.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.345 1.058 . . . . 0.0 109.04 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.77 -56.56 18.22 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.02 1.282 . . . . 0.0 109.332 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.0 66.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.566 0.621 . . . . 0.0 111.279 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.41 -24.76 36.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.025 1.73 . . . . 0.0 112.525 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.55 172.03 2.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.481 1.513 . . . . 0.0 112.149 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.92 -36.93 13.85 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.67 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 14.4 tp -143.64 133.26 23.64 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 109.634 -171.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.38 115.15 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.16 107.82 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.1 m -75.53 88.06 2.67 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 167.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 48.01 1.16 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.949 1.7 . . . . 0.0 107.114 -169.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 2.8 p -148.1 170.13 18.46 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.725 1.21 . . . . 0.0 109.937 -169.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.78 43.81 0.74 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -145.92 118.31 8.46 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.68 -7.36 50.05 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -169.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.59 -13.44 61.01 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.64 50.15 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.327 1.451 . . . . 0.0 113.527 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 52.78 -147.53 0.47 Allowed 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.999 -1.063 . . . . 0.0 108.627 -169.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.48 55.53 1.98 Allowed Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 126.683 1.993 . . . . 0.0 106.1 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.7 135.03 50.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.181 1.254 . . . . 0.0 112.003 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . 0.255 0.0 OUTLIER -83.69 4.93 26.51 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p 39.91 84.88 0.17 Allowed Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 125.245 1.418 . . . . 0.0 113.063 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -53.57 138.97 67.03 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.201 2.601 . . . . 0.0 110.614 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.95 8.6 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 125.669 4.246 . . . . 0.0 117.225 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.04 -5.13 20.0 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.218 -0.926 . . . . 0.0 111.608 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.9 149.88 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.655 1.182 . . . . 0.0 110.473 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.85 155.75 35.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -142.2 146.99 35.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 120.713 -1.242 . . . . 0.0 108.507 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -139.4 151.46 46.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -133.9 115.93 15.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -152.64 1.73 0.31 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.17 -53.33 45.6 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.756 1.162 . . . . 0.0 111.123 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.8 t80 58.18 -12.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.405 2.682 . . . . 0.0 117.03 169.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -152.28 82.0 1.25 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.252 1.421 . . . . 0.0 108.497 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.05 129.6 77.94 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.646 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.08 -26.64 9.06 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.661 2.907 . . . . 0.0 112.909 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.73 11.85 0.45 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.601 1.092 . . . . 0.0 112.035 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -123.61 16.18 9.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.234 2.214 . . . . 0.0 111.14 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.06 153.12 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -67.63 140.81 56.87 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.51 58.28 4.99 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.268 -168.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -127.17 149.87 49.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.19 -40.32 46.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.698 1.599 . . . . 0.0 111.507 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.83 -41.06 60.6 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.916 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.15 -31.49 49.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.948 0.795 . . . . 0.0 109.8 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -57.64 -59.85 4.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -62.75 -39.83 95.36 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.665 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.6 84.2 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.684 0.794 . . . . 0.0 112.313 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -63.95 -47.74 79.29 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.46 -40.51 96.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.387 0.54 . . . . 0.0 110.399 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -64.34 -51.69 62.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.691 1.196 . . . . 0.0 109.627 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.2 ttp-105 -59.1 -46.12 89.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.75 -43.86 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.377 -1.297 . . . . 0.0 111.19 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.69 81.99 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.554 1.979 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.42 -45.7 89.75 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.58 -53.79 46.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.665 0.786 . . . . 0.0 110.354 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.69 -47.38 85.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.938 0.895 . . . . 0.0 109.765 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.96 -44.11 98.56 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -62.05 -43.66 98.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.049 0.925 . . . . 0.0 111.801 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -65.3 -45.93 82.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.421 0.555 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.67 -31.87 70.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.057 0.844 . . . . 0.0 111.198 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.87 -39.84 91.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.103 171.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -59.7 -38.37 81.39 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.075 -1.44 . . . . 0.0 111.155 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -60.26 -37.23 79.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.69 2.041 . . . . 0.0 109.928 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.36 79.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.374 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -81.75 -47.92 12.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.411 1.085 . . . . 0.0 111.672 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.1 p -82.0 -24.19 35.56 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.835 2.054 . . . . 0.0 112.526 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.94 24.17 62.4 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 C-N-CA 128.381 2.672 . . . . 0.0 112.226 -169.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.54 169.74 23.96 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.556 1.542 . . . . 0.0 107.581 171.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.76 96.53 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.36 166.27 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.148 1.379 . . . . 0.0 108.065 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -126.03 116.14 20.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.151 1.38 . . . . 0.0 108.088 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.14 173.95 10.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.861 1.264 . . . . 0.0 111.157 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -155.36 179.07 9.52 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.986 2.514 . . . . 0.0 105.544 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -48.33 -29.88 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.543 1.937 . . . . 0.0 115.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.79 -27.29 3.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.85 0.86 . . . . 0.0 112.394 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.3 m -59.86 -40.35 88.28 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.83 122.28 18.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 167.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m 118.9 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.693 1 C-N-CA 132.034 4.133 . . . . 0.0 106.126 -169.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.32 93.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 110.361 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -80.03 -13.15 59.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.42 1.488 . . . . 0.0 112.225 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.0 p -120.24 -9.96 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -168.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -80.81 0.28 35.56 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.165 0.893 . . . . 0.0 113.299 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.1 150.87 47.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.997 0.817 . . . . 0.0 110.159 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.83 -152.55 51.74 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.22 131.66 69.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.73 114.37 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -169.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.48 97.36 7.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 107.474 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.43 26.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -138.84 147.54 42.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.439 1.496 . . . . 0.0 109.299 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -128.49 110.96 12.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -171.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.537 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.0 p-90 -123.35 150.01 44.19 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -173.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.3 154.94 22.69 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.351 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.67 -20.76 22.65 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.981 2.454 . . . . 0.0 115.426 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -49.65 -28.81 6.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.761 2.024 . . . . 0.0 115.755 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -156.55 169.66 24.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.72 1.6 . . . . 0.0 113.463 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.6 -45.3 96.6 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.364 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -52.21 -29.63 38.45 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.533 2.666 . . . . 0.0 114.96 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -58.82 -20.99 55.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 120.32 1.418 . . . . 0.0 113.783 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -109.5 11.61 24.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.389 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -121.6 -43.85 2.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.385 1.074 . . . . 0.0 109.426 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.61 -35.62 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.003 0.921 . . . . 0.0 109.577 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.23 14.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.827 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.01 -38.59 77.15 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.018 1.812 . . . . 0.0 111.784 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.04 -41.57 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.169 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mp -66.37 -41.08 89.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.226 0.921 . . . . 0.0 110.987 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.98 -35.51 80.77 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.085 0.857 . . . . 0.0 110.063 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -71.2 -24.12 62.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.802 1.241 . . . . 0.0 112.152 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.442 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 3.4 tm? -81.55 -44.97 16.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.132 1.373 . . . . 0.0 108.735 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.11 -38.47 88.3 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.922 -0.486 . . . . 0.0 111.058 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.95 -5.02 31.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.479 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -105.31 -49.14 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.517 1.127 . . . . 0.0 111.038 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.4 ptm -130.38 15.12 5.55 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.235 0.614 . . . . 0.0 112.152 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -5.85 23.39 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 121.223 -0.923 . . . . 0.0 113.453 170.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.51 -25.23 67.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.009 1.324 . . . . 0.0 110.668 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -25.36 6.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.284 1.034 . . . . 0.0 112.126 -175.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.1 tp -118.84 153.35 34.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.678 1.191 . . . . 0.0 112.428 -167.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -116.1 147.92 40.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.95 144.8 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.63 143.12 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 22.4 mtpt -117.3 152.26 35.24 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.831 0.741 . . . . 0.0 110.417 175.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mm -115.5 115.17 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -80.0 76.93 6.72 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 108.508 169.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -31.83 -59.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 129.081 2.952 . . . . 0.0 114.264 -174.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.71 -23.42 64.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 121.528 1.967 . . . . 0.0 112.788 -170.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.93 -32.12 10.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.412 1.485 . . . . 0.0 112.066 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -136.51 25.15 3.17 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -70.08 -0.08 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.584 1.154 . . . . 0.0 112.851 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -50.61 -46.51 58.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.549 1.14 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -56.57 -43.71 80.26 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.676 0.79 . . . . 0.0 111.634 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.93 2.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.728 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.57 -43.57 28.53 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.911 1.243 . . . . 0.0 113.423 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -64.08 -41.59 97.27 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.442 1.121 . . . . 0.0 111.216 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -70.34 -35.92 73.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.61 0.641 . . . . 0.0 110.101 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.35 69.06 1.0 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.428 -2.269 . . . . 0.0 107.428 -169.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.87 -60.76 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.3 ptm 50.64 7.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.166 2.987 . . . . 0.0 115.158 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 p -142.97 165.22 27.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.667 1.587 . . . . 0.0 112.146 -171.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.0 mm -142.76 145.54 34.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.209 1.403 . . . . 0.0 107.336 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.16 133.98 26.92 Favored 'Cis proline' 0 N--CA 1.452 -0.914 0 N-CA-C 106.603 -2.114 . . . . 0.0 106.603 -11.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.2 m -114.19 142.28 46.45 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.79 137.48 53.36 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -124.37 105.37 9.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 169.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.82 112.85 24.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.78 151.87 21.17 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.719 0.808 . . . . 0.0 109.116 174.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -149.39 126.5 11.32 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 44.7 22.36 0.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.176 2.59 . . . . 0.0 115.097 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.32 -22.57 3.21 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.229 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.13 159.33 42.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.921 1.36 . . . . 0.0 112.679 -168.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.69 134.04 30.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.27 -18.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.092 1.357 . . . . 0.0 110.917 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -144.7 154.8 43.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.41 133.69 15.3 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 p -150.55 158.36 44.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.474 0.579 . . . . 0.0 109.926 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.22 71.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 122.387 1.089 . . . . 0.0 108.708 -169.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 157.22 12.15 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 121.287 -0.883 . . . . 0.0 111.422 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.85 148.78 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.995 0.518 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -142.56 131.03 11.63 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.36 167.94 17.4 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.809 1.673 . . . . 0.0 109.723 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -46.24 -46.07 17.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.717 1.607 . . . . 0.0 112.468 -176.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.86 -42.98 69.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.229 0.468 . . . . 0.0 111.461 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.93 79.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.722 -0.612 . . . . 0.0 110.631 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -54.5 42.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.56 0.744 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.34 -38.75 92.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.626 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.49 -47.62 84.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.993 0.815 . . . . 0.0 110.884 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.61 -43.86 80.57 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.766 0.827 . . . . 0.0 110.693 -174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.72 -33.03 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.747 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -61.89 -26.92 68.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.653 1.115 . . . . 0.0 111.552 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -22.91 35.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.13 0.972 . . . . 0.0 112.629 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -129.74 -22.02 3.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.736 0.814 . . . . 0.0 112.393 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.99 2.116 . . . . 0.0 108.543 172.365 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.76 136.69 45.53 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.251 6.5 m120 67.35 120.78 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 128.542 2.737 . . . . 0.0 111.417 -170.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -148.89 137.38 21.12 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 129.178 2.991 . . . . 0.0 104.145 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.67 139.93 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 109.159 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tt -137.61 143.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.418 ' CD1' HD23 ' B' ' 72' ' ' LEU . 24.1 t80 -138.08 142.95 40.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -169.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -115.8 144.36 44.11 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 mt -133.19 122.28 23.77 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.4 p -165.82 156.89 13.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.349 1.06 . . . . 0.0 109.673 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.449 ' HG1' ' CG ' ' B' ' 84' ' ' ASP . 56.0 m -52.24 118.61 3.64 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.33 1.052 . . . . 0.0 112.129 -169.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.58 3.26 2.1 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 124.892 1.37 . . . . 0.0 113.979 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 39.51 24.18 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.438 2.695 . . . . 0.0 114.54 -169.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 -40.08 77.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.36 -73.28 0.51 Allowed 'General case' 0 C--O 1.227 -0.08 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -168.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -32.83 68.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.641 -0.662 . . . . 0.0 112.377 -169.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -43.77 76.75 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.366 1.066 . . . . 0.0 110.379 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -55.75 -45.26 78.06 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 110.388 174.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 16.3 ttm -67.99 -46.42 71.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.829 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.23 87.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.31 0.644 . . . . 0.0 111.218 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.96 -28.65 57.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.268 0.94 . . . . 0.0 110.644 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.93 -44.53 46.18 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.406 ' HE1' ' HB2' ' B' ' 124' ' ' ARG . 23.1 m95 -54.49 -41.97 70.18 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.158 0.979 . . . . 0.0 110.887 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.33 -50.68 71.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -66.45 -21.5 66.2 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.387 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -66.31 -16.67 64.23 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.467 1.03 . . . . 0.0 113.025 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.67 -4.49 4.14 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.587 1.155 . . . . 0.0 113.007 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.01 89.75 3.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.51 -171.6 1.38 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.815 0.722 . . . . 0.0 111.962 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.46 -18.15 16.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.436 1.094 . . . . 0.0 112.893 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -54.07 -18.86 4.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.518 1.927 . . . . 0.0 112.655 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.26 158.22 44.72 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.817 1.247 . . . . 0.0 109.62 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -130.35 133.36 46.36 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.014 0.926 . . . . 0.0 108.572 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.72 142.96 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.669 1.587 . . . . 0.0 107.367 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.97 159.47 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 m -139.82 142.37 36.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.07 178.22 10.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.104 0.962 . . . . 0.0 109.839 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.11 -177.71 47.67 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -44.21 -57.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.676 1.99 . . . . 0.0 114.154 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.98 29.59 4.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.335 1.454 . . . . 0.0 108.446 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.3 42.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.46 1.904 . . . . 0.0 113.964 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 75.7 t60 141.17 104.43 0.0 OUTLIER 'General case' 0 C--O 1.235 0.34 0 C-N-CA 130.656 3.582 . . . . 0.0 104.361 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.94 48.19 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -171.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -163.19 94.68 0.83 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.29 1.836 . . . . 0.0 106.67 169.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -68.99 126.55 92.88 Favored Pre-proline 0 C--O 1.239 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.64 -20.87 60.11 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.99 1.794 . . . . 0.0 112.846 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -37.23 84.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.508 1.049 . . . . 0.0 111.199 171.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.98 -34.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.33 -52.18 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -56.21 -46.58 79.4 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.88 0.764 . . . . 0.0 110.553 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.37 -32.46 64.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.007 0.923 . . . . 0.0 111.842 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.7 -38.56 25.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.695 0.798 . . . . 0.0 110.76 177.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -27.21 69.15 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.983 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.474 ' CD ' ' HE ' ' B' ' 124' ' ' ARG . 35.3 mt-10 -55.05 -32.67 62.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.478 1.035 . . . . 0.0 111.817 172.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.12 14.56 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.042 1.337 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.77 35.42 91.99 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.38 -1.233 . . . . 0.0 113.152 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.2 mt -104.95 145.16 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 170.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.66 136.0 53.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 29.0 pt -138.15 17.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 110.655 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -60.39 -13.91 15.9 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -91.72 -14.28 30.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.751 1.62 . . . . 0.0 113.237 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.21 151.31 23.28 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.539 1.161 . . . . 0.0 112.417 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.5 t -152.87 171.79 17.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.588 1.955 . . . . 0.0 107.105 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.0 m -153.69 -167.8 2.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.845 0.858 . . . . 0.0 111.028 -169.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -159.53 168.54 25.92 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.809 1.644 . . . . 0.0 109.562 -171.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.52 172.5 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.111 1.364 . . . . 0.0 112.134 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.31 132.86 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -143.98 100.17 3.52 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.309 1.052 . . . . 0.0 109.457 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.0 m -44.77 -32.32 1.5 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.108 2.163 . . . . 0.0 113.974 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.8 -17.3 64.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.128 0.876 . . . . 0.0 112.351 -174.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.16 -35.62 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.111 0.965 . . . . 0.0 108.842 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.418 HD23 ' CD1' ' B' ' 7' ' ' TYR . 2.2 tm? -63.01 -57.3 11.17 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.584 1.084 . . . . 0.0 109.98 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -22.36 66.93 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.44 0.564 . . . . 0.0 110.05 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.84 -24.38 44.44 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.064 2.146 . . . . 0.0 112.696 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.2 167.71 2.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.854 1.262 . . . . 0.0 111.347 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.9 -30.77 14.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.33 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -149.19 135.5 19.24 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 110.505 -172.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.7 t -107.02 108.02 24.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 127.494 2.318 . . . . 0.0 107.983 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.09 106.32 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -72.97 122.3 21.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 167.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.2 132.92 42.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 13.4 m 72.59 -15.72 0.48 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.415 2.286 . . . . 0.0 113.293 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.61 34.95 91.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 107.834 -2.106 . . . . 0.0 107.834 -169.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.449 ' CG ' ' HG1' ' B' ' 11' ' ' THR . 8.0 t0 -64.2 118.07 8.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.551 0.74 . . . . 0.0 111.645 -168.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.42 -20.48 63.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.383 0.673 . . . . 0.0 112.81 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.03 -8.53 59.11 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.821 0.737 . . . . 0.0 112.346 -175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.67 42.67 0.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.421 1.489 . . . . 0.0 112.075 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm 61.27 -149.79 0.4 Allowed 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.306 -1.496 . . . . 0.0 107.064 -168.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -139.74 71.21 36.85 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.83 129.27 29.89 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.93 1.754 . . . . 0.0 109.019 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.24 5.83 45.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p 39.08 88.65 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 127.942 2.497 . . . . 0.0 113.03 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -58.47 139.0 88.91 Favored 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 122.382 2.055 . . . . 0.0 108.663 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.65 -0.24 1.85 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.957 3.771 . . . . 0.0 115.455 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -61.75 -12.64 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.451 1.101 . . . . 0.0 111.26 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.42 149.03 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.487 1.515 . . . . 0.0 109.237 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -82.97 155.56 23.93 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 ttm-85 -139.7 144.67 37.66 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.126 -0.984 . . . . 0.0 108.479 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -150.85 147.7 27.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.6 130.9 35.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -116.75 18.42 14.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.48 162.35 35.33 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -137.53 18.93 2.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.517 1.127 . . . . 0.0 110.15 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.12 158.38 44.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.178 1.791 . . . . 0.0 107.535 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -134.14 119.64 14.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.873 1.269 . . . . 0.0 107.663 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 -27.2 40.76 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.343 2.695 . . . . 0.0 112.56 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.1 -5.22 6.07 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.633 1.106 . . . . 0.0 112.709 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -100.99 8.25 43.12 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.61 1.164 . . . . 0.0 111.356 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.63 144.05 2.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.17 -45.78 75.75 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 123.845 0.716 . . . . 0.0 109.98 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.74 -16.04 4.04 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.8 p -68.76 162.23 26.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.67 -38.78 92.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 110.776 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.69 -42.57 77.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 117.109 -1.424 . . . . 0.0 109.206 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.58 -31.56 62.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 120.925 1.693 . . . . 0.0 109.555 -175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -56.64 -63.58 1.15 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -58.24 -39.63 79.63 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.04 94.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.812 0.845 . . . . 0.0 112.231 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.71 -45.61 85.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.825 0.739 . . . . 0.0 109.564 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -64.84 -43.36 93.29 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -67.35 -41.99 84.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.611 0.764 . . . . 0.0 111.097 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -59.43 -52.23 66.51 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.32 -42.04 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.396 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.474 ' HE ' ' CD ' ' B' ' 54' ' ' GLU . 41.1 ptt85 -62.24 -37.4 85.25 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.094 1.316 . . . . 0.0 111.471 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.84 -44.01 94.45 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.228 0.33 . . . . 0.0 110.299 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.08 -57.69 9.77 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.738 0.415 . . . . 0.0 110.22 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 12.4 mt -57.53 -47.9 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.345 1.058 . . . . 0.0 109.727 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.35 97.74 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.984 -0.898 . . . . 0.0 111.31 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -44.6 88.25 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.651 1.225 . . . . 0.0 110.762 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.58 92.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.1 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.24 -38.45 78.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.691 1.132 . . . . 0.0 111.328 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.89 -41.18 99.32 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -60.84 -39.95 91.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 116.988 -1.482 . . . . 0.0 110.993 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -58.9 -37.54 76.85 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.856 2.116 . . . . 0.0 111.26 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -31.28 71.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.132 0.573 . . . . 0.0 112.496 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.66 -43.54 10.67 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.537 . . . . 0.0 111.17 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.5 p -89.78 -24.29 21.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.21 1.804 . . . . 0.0 110.729 -169.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 55.29 31.62 56.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 111.608 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt . . . . . 0 C--O 1.245 0.826 0 C-N-CA 123.97 0.908 . . . . 0.0 111.477 -172.438 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.72 165.32 36.35 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.765 1.226 . . . . 0.0 108.176 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.08 101.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 t -80.48 169.47 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.882 1.673 . . . . 0.0 107.54 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.89 53.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.709 0.804 . . . . 0.0 109.188 169.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.23 171.51 8.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.998 1.719 . . . . 0.0 109.713 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -134.94 -170.25 2.53 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.472 1.509 . . . . 0.0 108.821 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -45.09 -29.27 0.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.374 2.27 . . . . 0.0 113.488 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -135.88 -31.18 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.976 1.311 . . . . 0.0 112.097 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -63.53 -21.36 66.29 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.69 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -52.18 -58.04 7.8 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.185 0.902 . . . . 0.0 109.417 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -60.71 -43.85 97.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.956 0.344 . . . . 0.0 110.185 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.15 77.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.367 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -84.23 -15.81 45.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.393 1.077 . . . . 0.0 113.109 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.2 p -114.95 -7.15 12.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.755 1.161 . . . . 0.0 113.805 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -74.7 -5.62 44.21 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.1 153.49 45.45 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.558 1.143 . . . . 0.0 109.053 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.98 -161.02 49.99 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.058 0.837 . . . . 0.0 111.148 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.56 129.53 70.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.15 119.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.157 -168.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.7 98.45 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.84 150.89 27.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -140.46 150.73 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.573 1.549 . . . . 0.0 109.319 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -132.66 115.74 15.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.587 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -136.62 152.9 50.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.919 1.688 . . . . 0.0 107.988 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.9 163.27 6.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.036 0.835 . . . . 0.0 110.41 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.63 -11.98 3.9 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.364 3.376 . . . . 0.0 116.719 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -59.98 -17.44 38.32 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.865 1.211 . . . . 0.0 113.811 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.95 155.68 41.83 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.945 1.248 . . . . 0.0 114.07 -170.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.88 -46.68 80.68 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.725 -1.597 . . . . 0.0 112.81 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -49.0 -31.05 19.43 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.4 2.734 . . . . 0.0 114.785 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -60.52 -15.18 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 120.06 1.3 . . . . 0.0 114.028 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 9.45 13.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.286 1.435 . . . . 0.0 111.339 176.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.6 mtm -120.1 -44.61 2.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.311 1.044 . . . . 0.0 109.486 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.97 -36.42 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.16 18.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.768 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.11 -39.86 55.9 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.879 1.719 . . . . 0.0 111.728 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.16 -33.73 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.328 1.051 . . . . 0.0 111.468 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.81 -41.63 59.6 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.888 0.767 . . . . 0.0 110.687 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.74 -33.09 75.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.203 0.911 . . . . 0.0 109.709 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.04 -25.76 63.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.018 1.327 . . . . 0.0 111.672 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.2 tp -77.1 -44.72 29.5 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 119.063 0.847 . . . . 0.0 109.96 173.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.49 -34.79 70.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.671 -0.643 . . . . 0.0 111.112 -172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.67 -10.69 59.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.511 -0.743 . . . . 0.0 112.251 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -99.79 -42.77 6.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.279 1.432 . . . . 0.0 110.931 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.1 ptm -143.08 18.38 1.94 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.37 0.668 . . . . 0.0 112.399 -172.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.43 -4.6 13.33 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 121.243 -0.911 . . . . 0.0 114.299 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.69 -23.63 66.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.026 0.93 . . . . 0.0 110.919 169.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.24 -11.76 8.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.527 1.131 . . . . 0.0 112.48 -174.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -128.29 148.62 50.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.982 1.313 . . . . 0.0 111.454 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -114.42 147.56 39.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mt -125.22 141.07 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 t -138.95 113.02 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.8 mtpt -86.54 155.08 20.63 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.243 -0.91 . . . . 0.0 110.337 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.75 122.52 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.58 108.74 12.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.306 33.6 m -79.2 47.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -153.01 -41.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.791 1.237 . . . . 0.0 108.984 167.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -83.64 -34.6 25.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.065 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -134.62 27.78 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.958 1.303 . . . . 0.0 110.807 -170.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -71.55 -7.54 48.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.021 0.928 . . . . 0.0 112.851 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -49.05 -51.96 28.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.768 2.027 . . . . 0.0 110.322 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.2 m -61.34 -32.6 72.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.636 0.775 . . . . 0.0 111.829 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.74 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.77 -46.58 7.51 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.676 0.655 . . . . 0.0 113.325 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -60.35 -40.68 91.59 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.097 0.959 . . . . 0.0 111.631 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -89.98 -0.0 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.811 0.845 . . . . 0.0 112.497 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.05 68.81 1.44 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t -146.45 129.99 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 100.951 -3.722 . . . . 0.0 100.951 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -144.44 16.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.306 0.242 . . . . 0.0 110.847 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -130.77 170.11 14.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.121 2.568 . . . . 0.0 112.64 -168.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.88 143.52 46.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.695 0.798 . . . . 0.0 108.902 172.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.26 154.26 65.73 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 -11.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -127.48 147.45 50.31 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -124.3 137.69 54.47 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 106.655 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.7 mt -124.27 107.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -82.41 110.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.3 mp -106.61 148.71 27.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -147.68 125.44 11.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 41.17 30.44 0.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.27 2.628 . . . . 0.0 114.413 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.66 -23.38 4.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.827 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.27 156.88 46.3 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.244 1.522 . . . . 0.0 113.263 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.07 135.76 27.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.14 -22.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.182 1.393 . . . . 0.0 110.554 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -147.4 163.83 35.23 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.287 1.035 . . . . 0.0 110.418 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.34 149.19 30.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -153.46 142.44 21.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.6 72.71 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.35 156.73 8.43 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.441 1.496 . . . . 0.0 110.05 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.3 148.39 51.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.371 0.668 . . . . 0.0 110.456 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.7 141.79 26.2 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.2 167.61 25.69 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.463 2.109 . . . . 0.0 110.834 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.32 -47.72 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 112.799 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.07 -42.51 76.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 110.799 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -32.44 73.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.111 -0.368 . . . . 0.0 110.436 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -54.56 45.51 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.563 1.145 . . . . 0.0 109.681 172.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.87 -39.24 90.51 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.6 -46.29 90.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.314 0.506 . . . . 0.0 111.325 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.86 -41.0 81.5 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.198 0.999 . . . . 0.0 111.105 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.9 -37.32 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.252 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -57.79 -25.88 61.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.632 1.105 . . . . 0.0 112.553 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -53.08 -26.75 17.23 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.005 0.922 . . . . 0.0 112.645 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -128.88 -23.96 3.01 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 112.674 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 170.224 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.96 35.0 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.032 -1.043 . . . . 0.0 110.696 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -152.39 131.69 12.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -137.94 118.62 14.03 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 129.315 3.046 . . . . 0.0 106.431 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mm -90.56 131.78 36.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tt -133.62 135.0 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -169.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -117.15 144.14 45.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -131.75 128.37 38.72 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.232 1.013 . . . . 0.0 108.622 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 66.7 m -148.38 144.27 27.38 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 124.577 1.151 . . . . 0.0 109.096 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 26.2 m -53.69 121.21 7.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.915 0.886 . . . . 0.0 110.185 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.516 ' H ' ' CG2' ' B' ' 39' ' ' ILE . . . 50.01 35.01 24.72 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.948 1.261 . . . . 0.0 111.792 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -31.58 101.85 0.02 OUTLIER 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -135.8 -0.98 2.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.997 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.81 -79.33 0.37 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.194 1.361 . . . . 0.0 113.264 -169.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -46.12 75.67 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.714 0.806 . . . . 0.0 113.074 -169.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.8 m -69.47 -28.56 66.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.111 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -68.26 -47.04 68.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.689 1.131 . . . . 0.0 110.073 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.14 -42.27 76.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.258 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.35 96.85 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.584 -0.697 . . . . 0.0 111.367 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.17 -30.96 65.5 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.1 0.863 . . . . 0.0 110.898 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.58 -50.31 62.87 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -57.22 -33.36 67.45 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.347 1.059 . . . . 0.0 112.225 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.01 -53.41 7.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.571 0.748 . . . . 0.0 111.234 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -68.46 -17.98 64.31 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -168.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.1 -17.75 54.27 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.418 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 33.1 m-85 -126.46 -37.6 2.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.373 0.988 . . . . 0.0 111.996 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.24 71.79 4.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.757 1.623 . . . . 0.0 106.62 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.05 -147.14 0.09 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.562 2.03 . . . . 0.0 114.671 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.19 -23.82 62.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.461 1.104 . . . . 0.0 113.021 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -65.37 -13.27 58.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.247 1.019 . . . . 0.0 113.244 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -123.53 151.93 42.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.431 1.014 . . . . 0.0 111.712 -169.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -132.12 82.74 2.04 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.633 1.973 . . . . 0.0 105.854 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.71 139.68 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.31 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -144.8 166.87 24.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 p -143.28 145.91 33.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.771 -0.581 . . . . 0.0 111.615 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.75 177.79 10.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.296 0.638 . . . . 0.0 112.38 -173.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.35 -178.75 48.53 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.643 0.64 . . . . 0.0 112.289 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.516 ' CG2' ' H ' ' B' ' 12' ' ' GLY . 2.9 tt -46.64 -56.35 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 127.632 2.373 . . . . 0.0 113.272 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -133.87 30.49 3.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.569 1.548 . . . . 0.0 108.779 -172.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 154.79 40.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.843 2.057 . . . . 0.0 112.075 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 137.45 82.88 0.0 OUTLIER 'General case' 0 C--O 1.236 0.37 0 C-N-CA 130.891 3.676 . . . . 0.0 105.274 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.21 175.3 46.64 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -172.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.3 88.92 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -60.48 124.4 78.32 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 125.544 1.538 . . . . 0.0 108.056 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.76 -18.41 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.799 1.666 . . . . 0.0 112.401 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -59.12 -56.81 17.43 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.86 1.209 . . . . 0.0 108.429 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.37 76.05 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.894 1.225 . . . . 0.0 109.719 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.86 -55.81 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.44 -45.51 80.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.917 0.887 . . . . 0.0 110.486 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.89 56.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.378 1.871 . . . . 0.0 111.17 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 73.9 mmm -92.68 -32.16 14.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.632 0.773 . . . . 0.0 111.765 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.06 -26.67 67.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.846 171.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -58.54 -28.73 65.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.412 1.006 . . . . 0.0 112.019 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.46 16.34 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.873 1.269 . . . . 0.0 110.578 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.09 95.21 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.643 -1.087 . . . . 0.0 112.608 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.5 mt -114.32 109.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.51 132.66 43.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' B' ' 61' ' ' ASN . 13.8 pt -134.9 18.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.566 1.146 . . . . 0.0 111.019 173.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.4 m -65.31 14.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -169.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' B' ' 59' ' ' ILE . 30.0 t30 -140.8 -2.7 1.32 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.95 2.5 . . . . 0.0 112.173 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -47.34 -59.52 3.14 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p 53.06 -171.72 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.74 1.616 . . . . 0.0 112.293 -171.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -163.08 -169.53 2.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.459 1.104 . . . . 0.0 109.029 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.2 168.76 23.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.193 2.597 . . . . 0.0 106.555 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.85 175.4 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 120.212 1.369 . . . . 0.0 112.295 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -54.42 36.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 C-N-CA 129.195 2.998 . . . . 0.0 118.11 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -52.32 106.4 0.15 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.93 2.092 . . . . 0.0 113.532 -173.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.1 m -51.51 -26.35 8.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.113 1.765 . . . . 0.0 114.378 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.69 -23.94 66.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.57 1.077 . . . . 0.0 111.845 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.31 -40.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -58.8 -51.61 69.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.355 0.525 . . . . 0.0 110.779 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -26.01 64.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.488 0.586 . . . . 0.0 110.941 -177.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -79.53 -19.14 50.28 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.435 1.094 . . . . 0.0 112.229 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.08 159.19 7.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 111.222 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.3 -22.77 35.51 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.867 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.81 153.22 32.69 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.106 0.962 . . . . 0.0 111.132 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.52 99.32 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 127.22 2.208 . . . . 0.0 105.657 169.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.39 100.46 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.7 m -70.57 125.98 28.32 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.28 136.08 33.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.4 m 76.42 -26.49 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.488 2.715 . . . . 0.0 113.509 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.22 32.94 65.07 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -90.32 115.02 27.2 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.652 0.781 . . . . 0.0 110.88 -169.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.82 -20.76 65.37 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.1 -19.27 30.93 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.548 0.739 . . . . 0.0 112.488 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -72.01 35.45 0.06 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.97 1.308 . . . . 0.0 113.751 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 64.46 35.23 9.64 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.113 1.765 . . . . 0.0 112.853 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.8 p 33.07 50.54 0.68 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.552 1.941 . . . . 0.0 113.151 174.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.28 133.99 61.45 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.452 2.101 . . . . 0.0 114.0 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -23.77 53.18 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.313 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p 51.86 117.83 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.712 2.405 . . . . 0.0 113.367 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.38 150.26 64.16 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.931 1.754 . . . . 0.0 109.285 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.86 -5.45 10.63 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.634 2.89 . . . . 0.0 114.125 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -62.11 -17.31 57.31 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.197 0.999 . . . . 0.0 112.086 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.95 149.99 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.217 0.917 . . . . 0.0 111.031 -173.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -75.66 151.91 37.66 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.482 1.113 . . . . 0.0 108.954 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 ttp-105 -139.07 137.95 36.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -147.69 149.43 32.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -91.78 133.8 35.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . 0.431 ' CZ2' ' HE3' ' B' ' 139' ' ' LYS . 88.6 m95 -125.51 9.36 7.78 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.0 159.93 27.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.5 9.19 4.67 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.705 0.802 . . . . 0.0 111.289 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -150.19 163.72 37.51 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.097 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.34 121.47 15.39 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 125.097 1.359 . . . . 0.0 108.608 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.97 -29.63 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.859 2.373 . . . . 0.0 112.166 -173.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.26 -7.62 6.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.256 0.934 . . . . 0.0 112.994 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt-85 -83.74 -1.65 54.61 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.085 -0.959 . . . . 0.0 112.095 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -34.64 127.4 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.73 1.612 . . . . 0.0 112.507 -175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -69.3 136.76 52.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.98 29.88 2.39 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -167.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 26.3 p -89.57 159.32 17.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.565 1.683 . . . . 0.0 107.262 169.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.95 -37.2 83.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.31 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -77.31 -43.09 34.32 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 117.489 -1.244 . . . . 0.0 109.409 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.1 -27.33 54.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 120.563 1.529 . . . . 0.0 110.269 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -59.83 -57.42 12.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -60.2 -40.91 91.74 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.08 91.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.069 0.948 . . . . 0.0 111.932 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.73 -45.46 92.61 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.617 0.644 . . . . 0.0 109.786 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.66 -49.89 74.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -62.2 -47.0 86.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.778 1.231 . . . . 0.0 110.11 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -56.87 -55.39 35.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 49.8 t -75.13 -39.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.119 -171.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -64.05 -39.48 94.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.751 1.614 . . . . 0.0 111.281 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.95 -41.89 95.1 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.216 0.462 . . . . 0.0 111.105 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -67.36 -46.92 71.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.819 0.448 . . . . 0.0 110.07 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.0 mt -53.09 -49.39 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.042 1.337 . . . . 0.0 108.607 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.99 -50.19 70.5 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 118.387 0.539 . . . . 0.0 112.538 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -64.03 -41.67 97.35 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.632 0.216 . . . . 0.0 110.724 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -66.62 -43.54 84.47 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.615 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.05 -34.32 78.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.759 1.163 . . . . 0.0 111.376 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.418 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 39.3 ttmt -60.94 -32.07 71.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.194 0.906 . . . . 0.0 111.16 174.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.05 -30.19 71.4 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-O 116.902 -1.523 . . . . 0.0 112.06 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -63.1 -37.37 86.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 122.454 2.388 . . . . 0.0 109.785 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.89 73.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.611 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -81.92 -43.3 18.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.366 1.066 . . . . 0.0 112.049 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 82.1 p -88.34 -18.38 28.58 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.65 1.98 . . . . 0.0 111.074 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.51 15.16 75.17 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.158 0.885 . . . . 0.0 112.107 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.431 ' HE3' ' CZ2' ' B' ' 101' ' ' TRP . 5.0 ttpm? . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.116 1.367 . . . . 0.0 109.434 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.76 155.64 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.786 2.434 . . . . 0.0 111.839 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.5 107.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.2 t -79.48 167.14 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.904 1.682 . . . . 0.0 107.988 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -122.99 119.25 29.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.123 1.369 . . . . 0.0 107.924 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.67 168.92 19.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.914 0.886 . . . . 0.0 108.783 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 p -135.26 -167.23 1.97 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.781 1.232 . . . . 0.0 109.354 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -51.88 -20.33 2.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.143 1.777 . . . . 0.0 113.751 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -140.78 -31.72 0.6 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.667 1.187 . . . . 0.0 112.811 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.4 m -63.26 -19.57 64.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.165 0.893 . . . . 0.0 112.202 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -50.6 -55.18 17.44 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 109.76 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -62.29 -44.23 96.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.104 -0.372 . . . . 0.0 110.036 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.06 83.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.946 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -79.87 -19.6 47.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.991 0.917 . . . . 0.0 113.047 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 p -108.96 -7.51 15.39 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.661 1.119 . . . . 0.0 112.943 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -72.22 -7.2 47.96 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -141.8 154.11 44.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 109.615 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.82 -157.15 51.13 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 124.951 1.262 . . . . 0.0 111.996 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 t -113.43 131.41 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 t -140.13 116.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 122.257 1.027 . . . . 0.0 108.493 -169.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.69 121.59 25.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.3 36.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -141.57 149.86 41.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 109.538 -170.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -132.2 113.25 13.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -169.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.641 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.1 p-90 -132.76 149.3 52.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.845 1.658 . . . . 0.0 107.876 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.88 165.12 6.07 Favored Pre-proline 0 C--O 1.235 0.331 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.34 -17.44 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.882 3.055 . . . . 0.0 116.02 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -52.48 -26.8 13.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.854 1.662 . . . . 0.0 114.318 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.55 150.92 48.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.721 1.146 . . . . 0.0 111.509 -172.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.25 -50.9 57.16 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.496 -1.169 . . . . 0.0 111.459 172.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -46.54 -26.15 4.03 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.423 3.415 . . . . 0.0 117.076 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -56.51 -35.46 68.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 121.538 1.972 . . . . 0.0 111.726 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -90.18 7.92 35.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.963 0.905 . . . . 0.0 111.883 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -118.56 -42.82 2.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.023 0.929 . . . . 0.0 109.606 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.63 -33.99 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.793 0.837 . . . . 0.0 109.269 169.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.8 -60.95 7.87 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.08 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.14 -40.19 72.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.07 1.847 . . . . 0.0 111.614 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.18 -40.02 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.473 0.579 . . . . 0.0 110.525 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.72 -39.32 64.38 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.767 0.712 . . . . 0.0 111.574 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.37 -34.92 79.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.43 1.014 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.54 -17.85 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.198 1.399 . . . . 0.0 112.643 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.0 tp -86.94 -43.63 12.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.235 1.014 . . . . 0.0 108.794 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.78 -37.46 70.46 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.146 -0.346 . . . . 0.0 110.945 -175.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.8 -11.86 59.38 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.561 . . . . 0.0 111.942 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -100.02 -47.85 4.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -135.81 15.01 3.36 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.504 0.722 . . . . 0.0 112.392 -170.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.83 -2.09 21.43 Favored Glycine 0 CA--C 1.52 0.383 0 O-C-N 121.093 -1.004 . . . . 0.0 113.951 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.21 -25.27 65.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.696 0.798 . . . . 0.0 110.624 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 -26.84 9.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 -177.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.0 tp -119.76 146.53 45.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.036 1.335 . . . . 0.0 111.886 -168.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -103.31 143.54 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 168.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.1 mt -124.74 136.48 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.39 124.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.641 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpp -99.85 156.28 17.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.036 0.834 . . . . 0.0 109.716 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mm -116.61 127.95 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.01 104.99 10.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 169.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.01 41.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.437 1.113 . . . . 0.0 111.844 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.1 -44.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.594 1.158 . . . . 0.0 110.479 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 110.262 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.75 30.22 3.76 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.59 1.156 . . . . 0.0 110.74 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -3.56 32.56 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.434 1.094 . . . . 0.0 112.586 -169.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -52.14 -45.16 64.9 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.584 1.554 . . . . 0.0 111.233 -169.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -65.71 -26.27 67.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.48 -64.33 0.89 Allowed 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.072 -1.018 . . . . 0.0 108.801 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.22 -38.48 19.03 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.937 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -60.82 -48.58 81.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.37 1.585 . . . . 0.0 110.117 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.54 -13.2 60.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.569 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.95 55.93 14.69 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.67 -43.82 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.6 ptm 45.29 19.77 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 129.415 3.086 . . . . 0.0 113.567 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -133.72 155.66 49.35 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.039 1.736 . . . . 0.0 109.516 -174.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.9 mt -142.45 143.64 27.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 119.034 0.834 . . . . 0.0 109.091 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -67.52 144.83 72.62 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.303 0.787 . . . . 0.0 110.317 -10.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.5 m -114.4 142.03 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.89 136.08 54.12 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.8 mt -125.93 109.15 12.14 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 103.784 -2.673 . . . . 0.0 103.784 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.8 t -83.53 118.51 31.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.11 151.58 36.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.19 0.996 . . . . 0.0 108.498 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -147.87 144.04 27.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 43.69 28.4 0.22 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.952 2.101 . . . . 0.0 113.67 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.16 8.09 55.53 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.928 1.251 . . . . 0.0 116.164 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -134.99 147.87 49.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.926 1.363 . . . . 0.0 111.886 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.0 140.7 17.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.98 0.912 . . . . 0.0 109.186 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.42 -20.79 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.982 1.313 . . . . 0.0 111.122 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.74 161.67 40.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.173 0.989 . . . . 0.0 109.713 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 m -154.19 148.74 26.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.1 m -151.58 150.2 30.04 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.383 1.073 . . . . 0.0 108.531 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -133.18 63.0 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.591 1.556 . . . . 0.0 107.135 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.53 168.13 37.36 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.647 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.06 152.21 45.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.183 0.993 . . . . 0.0 111.034 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 141.2 17.51 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 169.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.81 168.38 23.09 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.447 2.098 . . . . 0.0 110.388 173.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -44.69 65.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 112.524 -170.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.83 -43.84 74.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 117.472 0.124 . . . . 0.0 110.867 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.25 75.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.973 -0.454 . . . . 0.0 110.346 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -53.74 53.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.805 . . . . 0.0 109.844 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.61 -38.25 90.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -61.78 -48.25 81.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.508 0.595 . . . . 0.0 110.75 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -55.86 -44.27 77.9 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 124.457 1.103 . . . . 0.0 110.898 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.03 -37.04 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.508 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -58.94 -26.36 64.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.172 0.989 . . . . 0.0 112.208 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -22.67 39.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.644 0.778 . . . . 0.0 112.459 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -131.12 -19.67 2.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.133 0.973 . . . . 0.0 112.969 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--O 1.248 1.017 0 C-N-CA 127.521 2.329 . . . . 0.0 107.87 170.393 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.84 128.62 36.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.22 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.325 2.65 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -137.83 128.74 27.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -92.88 144.65 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.623 0.577 . . . . 0.0 110.377 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.7 147.98 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.642 1.577 . . . . 0.0 106.746 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.45 142.64 37.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -169.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -97.84 143.27 28.62 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -145.27 131.42 19.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -169.79 172.01 6.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.32 1.848 . . . . 0.0 108.96 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -48.61 125.01 9.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.495 1.518 . . . . 0.0 109.832 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.49 4.9 0.27 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.209 1.861 . . . . 0.0 117.699 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 t30 47.4 18.32 0.1 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.63 1.715 . . . . 0.0 113.315 -169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 9.9 p -84.43 57.42 4.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.341 2.257 . . . . 0.0 114.787 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 136.94 -58.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.446 3.098 . . . . 0.0 113.433 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -53.95 -53.97 45.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.807 0.843 . . . . 0.0 110.948 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.39 -33.16 72.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.88 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -58.7 -48.33 81.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.681 0.673 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 8.1 ptp -69.83 -41.51 74.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.09 99.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.507 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.08 -31.11 68.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.755 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.57 60.88 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.466 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 25.5 m95 -56.56 -36.47 69.35 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.619 1.168 . . . . 0.0 111.688 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.41 -55.12 8.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 122.577 0.351 . . . . 0.0 110.477 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.35 -24.44 67.25 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.88 -16.17 63.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.29 0.95 . . . . 0.0 113.364 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.461 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 7.5 m-85 -124.7 -12.46 7.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 112.858 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -114.69 83.45 1.9 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.126 -2.175 . . . . 0.0 105.126 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.49 -168.73 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.421 1.01 . . . . 0.0 112.075 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.51 -5.03 4.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.177 0.991 . . . . 0.0 113.07 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.35 -24.81 67.55 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.623 -1.298 . . . . 0.0 109.564 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -123.11 179.31 4.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.474 1.91 . . . . 0.0 108.93 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -155.48 127.6 7.64 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.3 p -123.32 143.42 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.909 0.484 . . . . 0.0 110.094 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.49 171.23 14.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.151 1.78 . . . . 0.0 108.76 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -147.07 145.35 29.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.289 1.035 . . . . 0.0 109.126 -172.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.94 170.58 21.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.166 0.987 . . . . 0.0 111.775 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.76 178.61 46.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.202 1.382 . . . . 0.0 110.554 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 tt -48.67 -54.54 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.541 1.936 . . . . 0.0 113.775 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -135.1 31.42 3.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.097 1.759 . . . . 0.0 108.035 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.12 128.15 34.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.599 1.959 . . . . 0.0 115.957 -168.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -166.41 1.38 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.641 2.376 . . . . 0.0 110.62 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.9 109.49 3.44 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 120.725 -1.234 . . . . 0.0 114.864 -168.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.6 tp -82.52 83.13 7.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -62.12 123.68 79.04 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.633 -0.698 . . . . 0.0 109.782 -176.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.73 -23.42 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.224 1.95 . . . . 0.0 113.201 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -33.73 76.16 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.762 1.165 . . . . 0.0 110.856 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -34.46 50.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.187 0.449 . . . . 0.0 109.947 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.67 -51.38 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -56.49 -46.12 80.65 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.287 0.635 . . . . 0.0 110.709 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.49 -32.56 58.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.26 1.024 . . . . 0.0 112.323 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mmm -90.54 -30.06 17.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.241 -0.912 . . . . 0.0 111.323 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.87 -24.73 67.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.437 169.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' B' ' 124' ' ' ARG . 42.8 mt-10 -55.52 -36.37 66.65 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.829 1.195 . . . . 0.0 111.201 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.28 15.92 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.19 1.396 . . . . 0.0 111.296 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.56 41.58 99.12 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.036 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 39.1 mt -114.64 116.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 171.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.79 132.12 43.17 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -131.78 13.08 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.28 169.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 75.3 p -59.76 -17.59 36.46 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.667 1.121 . . . . 0.0 111.495 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -80.37 -12.5 59.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.503 2.321 . . . . 0.0 114.282 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -69.96 157.0 38.29 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.374 1.443 . . . . 0.0 112.335 -171.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -129.65 168.81 15.9 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.542 2.337 . . . . 0.0 108.809 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.3 m -156.21 168.62 26.71 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.948 -1.095 . . . . 0.0 110.714 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -162.79 162.67 26.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.68 1.992 . . . . 0.0 108.763 -169.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.24 172.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 0.0 112.424 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.39 133.31 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -145.5 99.96 3.37 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.167 0.984 . . . . 0.0 108.8 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -49.55 -28.0 5.09 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.673 1.989 . . . . 0.0 113.699 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.65 -18.37 63.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.247 0.93 . . . . 0.0 112.387 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.68 -34.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.089 0.956 . . . . 0.0 108.745 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.03 -54.9 14.97 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.594 1.088 . . . . 0.0 110.173 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -26.31 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.906 0.776 . . . . 0.0 110.159 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -72.83 -24.04 60.85 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 112.357 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.35 164.74 4.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.851 1.261 . . . . 0.0 112.194 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.15 -31.0 15.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.134 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -145.16 135.93 24.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.283 1.033 . . . . 0.0 110.661 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 t -113.56 115.02 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.28 108.81 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.7 m -73.92 145.61 44.62 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.36 31.29 4.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.929 0.892 . . . . 0.0 111.635 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -157.49 174.59 15.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.62 57.88 0.71 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -137.67 179.56 6.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.262 1.425 . . . . 0.0 109.737 -169.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -132.31 -8.15 3.35 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.377 1.871 . . . . 0.0 112.118 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.75 -22.21 57.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.55 0.74 . . . . 0.0 111.19 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.88 -8.79 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.36 2.264 . . . . 0.0 115.776 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm 92.51 15.89 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 128.492 2.717 . . . . 0.0 111.366 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 6.9 m 37.66 49.11 1.5 Allowed Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.673 1.589 . . . . 0.0 111.716 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.72 131.43 46.01 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.574 -1.356 . . . . 0.0 108.574 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.58 8.14 32.78 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -168.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 14.3 p 40.95 81.57 0.24 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.953 1.701 . . . . 0.0 112.705 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -57.38 141.73 94.89 Favored 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 122.649 2.233 . . . . 0.0 111.304 -169.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -49.95 -12.53 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 127.014 5.143 . . . . 0.0 118.672 -170.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -60.27 -16.35 33.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.328 0.967 . . . . 0.0 111.785 171.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.2 137.7 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 109.124 -172.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -75.82 156.4 34.48 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -142.42 147.95 37.01 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.217 -0.927 . . . . 0.0 110.538 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -150.0 161.28 42.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.623 1.569 . . . . 0.0 107.5 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -99.22 123.63 43.66 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 168.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -109.6 2.98 20.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.409 0.684 . . . . 0.0 110.108 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.6 149.23 21.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 105.779 -2.928 . . . . 0.0 105.779 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -146.82 10.0 1.03 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.974 1.71 . . . . 0.0 110.633 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -153.28 168.59 25.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.742 2.417 . . . . 0.0 105.984 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -133.33 115.82 13.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.63 0.772 . . . . 0.0 109.412 -171.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.17 -25.24 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.004 2.469 . . . . 0.0 113.584 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -8.38 21.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.179 0.9 . . . . 0.0 111.819 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -93.88 10.99 30.98 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 111.835 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.47 148.49 0.67 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.832 1.253 . . . . 0.0 112.767 -173.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -55.45 -47.4 76.09 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.119 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.93 -17.38 4.14 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 115.552 0.981 . . . . 0.0 115.552 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.43 158.88 34.29 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.54 -37.77 79.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.354 0.597 . . . . 0.0 111.157 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -73.36 -43.75 60.04 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.119 -1.42 . . . . 0.0 109.814 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.3 -28.24 59.63 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 121.208 1.822 . . . . 0.0 110.259 -172.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -60.41 -59.14 5.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 118.73 0.695 . . . . 0.0 109.765 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -60.64 -39.62 88.99 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.553 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.4 95.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.276 0.631 . . . . 0.0 112.24 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.21 -47.3 83.11 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -61.09 -51.42 69.2 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -62.47 -43.72 98.14 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.03 0.932 . . . . 0.0 111.518 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -60.94 -52.75 63.72 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 35.5 t -69.81 -36.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.466 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.3 tmm_? -60.23 -43.34 96.14 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.572 1.078 . . . . 0.0 111.774 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.85 -44.78 96.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.31 0.505 . . . . 0.0 110.822 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -63.13 -51.7 65.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.43 0.692 . . . . 0.0 110.117 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -54.19 -49.59 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.624 1.57 . . . . 0.0 109.054 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.23 -43.1 81.37 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 118.936 -0.925 . . . . 0.0 112.316 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -44.38 94.98 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.806 1.303 . . . . 0.0 110.428 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -34.72 78.6 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.577 178.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.73 1.15 . . . . 0.0 111.492 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.461 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -62.75 -41.24 99.11 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -62.4 -40.54 96.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 117.395 -1.288 . . . . 0.0 111.301 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -60.56 -36.24 78.0 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 121.665 2.029 . . . . 0.0 111.295 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.61 -28.58 69.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.029 0.531 . . . . 0.0 112.431 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.69 -46.6 7.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.609 1.564 . . . . 0.0 111.141 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 62.9 p -89.14 -27.21 20.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.278 1.831 . . . . 0.0 110.784 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.13 25.94 54.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.9 -169.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.748 1.619 . . . . 0.0 111.82 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.32 172.3 18.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.839 1.656 . . . . 0.0 107.493 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.74 97.09 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 168.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.02 167.98 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.509 1.523 . . . . 0.0 108.009 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -128.07 112.76 14.95 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.799 0.84 . . . . 0.0 108.983 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.04 10.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.579 1.552 . . . . 0.0 110.095 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -159.71 -173.39 4.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.966 2.107 . . . . 0.0 105.617 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.62 -36.62 0.42 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.37 2.668 . . . . 0.0 115.934 -169.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -130.57 -29.96 1.92 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.586 1.154 . . . . 0.0 111.543 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -23.06 65.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.149 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -51.55 -56.48 13.2 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.356 0.98 . . . . 0.0 109.244 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -62.36 -44.25 96.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -36.65 81.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -174.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -80.15 -16.95 53.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.072 0.949 . . . . 0.0 113.056 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.8 p -114.06 -7.18 13.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.651 1.114 . . . . 0.0 113.113 -169.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -77.48 -3.95 43.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.41 148.38 37.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.226 1.011 . . . . 0.0 109.092 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.08 -170.84 40.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.19 0.9 . . . . 0.0 111.62 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.43 125.81 54.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 t -140.03 117.96 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.6 135.89 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.7 46.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.41 151.25 49.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.279 1.432 . . . . 0.0 108.626 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.7 111.34 13.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.557 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.3 p-90 -131.68 155.11 48.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.716 1.606 . . . . 0.0 107.789 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.11 162.67 9.13 Favored Pre-proline 0 C--O 1.233 0.188 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.8 -19.0 10.03 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.613 2.875 . . . . 0.0 116.167 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -57.69 -26.4 61.65 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.6 161.66 34.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.457 1.026 . . . . 0.0 112.997 -169.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.72 -48.76 53.93 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.168 -1.351 . . . . 0.0 112.658 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -51.38 -27.07 22.83 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.099 2.532 . . . . 0.0 115.11 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -60.51 -13.89 16.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 119.624 1.102 . . . . 0.0 113.798 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -118.1 12.28 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.664 1.186 . . . . 0.0 111.449 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.0 mtm -123.67 -45.69 2.04 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.358 1.063 . . . . 0.0 109.642 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.78 -34.72 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -58.26 17.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.14 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.05 -39.16 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.762 1.641 . . . . 0.0 111.639 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.89 -34.56 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.957 0.903 . . . . 0.0 111.3 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.1 mt -71.37 -44.13 65.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.993 0.815 . . . . 0.0 110.534 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.92 -36.55 83.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.65 0.659 . . . . 0.0 109.469 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.35 -18.68 62.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 112.314 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.3 tp -79.55 -45.76 18.63 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.617 1.099 . . . . 0.0 108.879 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.06 -35.58 76.72 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.881 -0.512 . . . . 0.0 111.496 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -64.95 -19.65 66.07 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.502 -0.749 . . . . 0.0 112.21 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -95.84 -42.91 8.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.679 1.192 . . . . 0.0 111.225 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ptm -144.27 17.95 1.72 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.343 0.657 . . . . 0.0 112.283 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -5.76 14.12 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.35 -0.844 . . . . 0.0 114.312 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.72 -23.41 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.671 0.788 . . . . 0.0 111.033 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -15.51 8.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.446 -175.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.0 149.84 50.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.608 1.163 . . . . 0.0 112.267 -168.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -112.95 144.55 42.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.28 146.4 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.69 146.85 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.1 mtpt -121.82 147.57 45.79 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 121.83 -0.544 . . . . 0.0 110.377 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.82 128.74 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.94 103.5 14.72 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 170.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.305 32.6 m -77.6 50.51 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 122.616 1.198 . . . . 0.0 114.179 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.29 -44.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.594 1.557 . . . . 0.0 108.519 168.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -75.24 -50.58 15.7 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.019 1.327 . . . . 0.0 110.065 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -132.11 37.74 3.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.908 1.283 . . . . 0.0 110.873 -170.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -67.04 -4.2 9.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.601 1.161 . . . . 0.0 112.872 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -53.26 -47.88 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.114 1.766 . . . . 0.0 110.851 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.0 m -55.29 -41.51 72.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.848 0.749 . . . . 0.0 111.154 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 -65.43 0.72 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -170.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.86 -42.88 15.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.128 0.87 . . . . 0.0 113.361 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -63.45 -44.55 94.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.428 1.114 . . . . 0.0 111.377 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -68.04 -34.8 77.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.603 0.638 . . . . 0.0 109.796 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.07 66.24 0.71 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 -169.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.35 132.7 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.2 mtm -149.02 18.99 0.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.29 160.37 38.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -167.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.21 134.39 26.09 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.214 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.67 132.7 15.98 Favored 'Cis proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.443 -1.791 . . . . 0.0 107.443 -11.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.5 m -98.77 150.35 21.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 169.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.81 117.47 8.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.75 111.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -93.49 134.7 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.17 158.06 39.11 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.643 1.177 . . . . 0.0 110.286 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -147.95 137.42 22.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.99 29.01 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.042 2.537 . . . . 0.0 114.902 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.43 -28.3 2.79 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 116.595 1.398 . . . . 0.0 116.595 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.68 158.72 43.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.418 1.609 . . . . 0.0 114.839 -167.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.39 136.54 26.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.288 1.035 . . . . 0.0 108.28 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.01 -21.07 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.784 1.633 . . . . 0.0 111.428 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -144.72 157.87 44.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.961 0.8 . . . . 0.0 108.922 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.1 148.42 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -169.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.9 m -153.62 148.59 26.66 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.777 1.231 . . . . 0.0 108.011 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.26 66.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.65 156.94 8.98 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -73.46 156.71 37.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.676 0.39 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -153.37 150.63 24.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.203 1.001 . . . . 0.0 108.652 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.84 172.81 12.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.847 2.365 . . . . 0.0 111.536 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -45.9 71.14 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.237 1.015 . . . . 0.0 111.966 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.26 -39.95 93.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.863 0.301 . . . . 0.0 110.429 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.893 0.477 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.97 -54.82 36.35 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.322 1.049 . . . . 0.0 109.645 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.81 -36.6 84.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.34 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.41 -47.09 87.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.887 0.767 . . . . 0.0 110.933 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -55.67 -42.14 74.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.213 0.605 . . . . 0.0 110.545 -174.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.1 -40.49 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 123.667 0.604 . . . . 0.0 111.245 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -57.46 -25.65 60.01 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.906 -1.121 . . . . 0.0 112.417 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -50.49 -31.17 14.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.691 1.196 . . . . 0.0 112.4 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -137.87 -7.14 1.64 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.786 2.034 . . . . 0.0 105.985 169.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.79 145.36 42.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 65.12 122.65 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 128.112 2.565 . . . . 0.0 111.298 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -147.69 145.21 28.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 129.122 2.969 . . . . 0.0 104.224 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 6.4 mt -123.45 145.95 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 119.59 1.087 . . . . 0.0 108.584 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.0 148.3 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.904 1.282 . . . . 0.0 107.836 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.66 149.34 52.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 109.988 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.06 145.74 41.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.45 127.49 44.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 8.5 m -151.26 170.31 19.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.508 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -67.16 89.51 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.393 1.077 . . . . 0.0 110.924 172.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.31 20.53 58.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 117.073 -1.96 . . . . 0.0 114.835 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 26.01 84.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 124.769 2.224 . . . . 0.0 112.932 -177.034 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -152.41 167.71 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.529 3.132 . . . . 0.0 104.94 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 42.03 -103.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.227 1.811 . . . . 0.0 112.956 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -40.73 27.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.037 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -53.35 33.5 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.146 1.339 . . . . 0.0 109.769 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -49.91 -48.31 51.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.353 2.261 . . . . 0.0 109.64 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.3 ttm -67.79 -45.16 75.62 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.903 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.31 83.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.562 1.145 . . . . 0.0 110.728 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.61 -32.06 63.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 111.853 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.98 -49.65 57.18 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -58.77 -37.94 77.37 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.258 1.023 . . . . 0.0 111.769 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.47 -49.38 77.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -65.0 -22.65 67.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.31 -20.14 66.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.156 0.889 . . . . 0.0 112.951 175.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.499 ' CD1' ' HE2' ' B' ' 132' ' ' LYS . 0.1 OUTLIER -132.35 -0.54 3.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.379 0.991 . . . . 0.0 113.428 -175.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mt -126.42 85.83 2.44 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.4 -165.95 1.05 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.562 2.029 . . . . 0.0 114.204 -169.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.13 -20.05 23.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.673 1.189 . . . . 0.0 112.894 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.87 -23.99 34.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.156 1.782 . . . . 0.0 112.225 169.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -123.88 155.6 37.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.732 1.613 . . . . 0.0 110.6 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -131.22 144.91 51.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.132 1.773 . . . . 0.0 106.674 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.71 148.27 31.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 108.511 -171.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -147.88 162.42 39.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 52.4 m -134.12 140.42 46.57 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.036 1.335 . . . . 0.0 108.263 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.97 174.37 13.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 111.295 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.5 -174.93 44.31 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -51.23 -55.65 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.332 1.853 . . . . 0.0 114.157 -173.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -138.18 29.57 2.49 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.957 1.703 . . . . 0.0 108.655 -171.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.6 157.39 37.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.69 1.996 . . . . 0.0 114.193 -169.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 146.98 104.97 0.0 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 131.072 3.749 . . . . 0.0 104.414 172.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.6 174.38 46.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 14.5 tp -154.84 65.36 0.66 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.518 1.127 . . . . 0.0 108.064 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -49.87 121.73 13.04 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.315 1.446 . . . . 0.0 110.494 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -64.8 -24.44 61.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.202 1.935 . . . . 0.0 113.399 -175.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -18.37 64.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.703 1.592 . . . . 0.0 112.15 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.84 -40.58 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -60.2 -50.74 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.74 -42.68 84.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.95 0.9 . . . . 0.0 110.687 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.45 -30.55 60.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.565 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mmm -84.49 -40.64 17.42 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.519 1.054 . . . . 0.0 110.907 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.91 -29.15 68.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.541 0.61 . . . . 0.0 110.824 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.79 -28.28 67.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.498 0.719 . . . . 0.0 112.088 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.67 16.0 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.954 1.302 . . . . 0.0 110.765 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.08 38.87 92.74 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.497 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.76 150.46 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -124.3 139.63 53.73 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.998 0.919 . . . . 0.0 109.104 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.448 ' HB ' HE21 ' B' ' 62' ' ' GLN . 30.7 pt -140.67 17.56 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.102 1.361 . . . . 0.0 110.745 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -67.48 15.82 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' B' ' 59' ' ' ILE . 29.9 t30 -143.26 -5.11 0.87 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.161 2.585 . . . . 0.0 112.019 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.448 HE21 ' HB ' ' B' ' 59' ' ' ILE . 2.8 pt20 -56.67 144.71 31.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.684 1.129 . . . . 0.0 112.1 -169.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -69.04 155.77 39.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.981 1.312 . . . . 0.0 110.38 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 9.0 m -167.29 145.99 4.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 107.306 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -171.18 167.7 6.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.844 1.258 . . . . 0.0 109.837 -170.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.83 168.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.045 0.839 . . . . 0.0 111.41 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -48.99 135.55 6.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -144.32 103.84 4.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.307 1.051 . . . . 0.0 109.143 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.9 m -49.15 -27.27 3.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.626 1.57 . . . . 0.0 113.864 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.08 -22.76 64.92 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.725 1.148 . . . . 0.0 111.652 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.0 -42.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 117.75 -1.119 . . . . 0.0 108.622 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 tt -61.06 -51.35 69.54 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.91 1.232 . . . . 0.0 109.451 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -25.17 68.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.218 0.917 . . . . 0.0 111.412 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.96 -18.65 33.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.597 1.159 . . . . 0.0 112.894 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.89 163.46 4.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.216 1.007 . . . . 0.0 111.29 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.55 -32.71 15.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.839 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 tp -143.91 144.43 31.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.027 1.331 . . . . 0.0 109.725 -172.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.6 108.67 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 169.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 74.8 t -82.34 105.99 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -65.5 129.27 39.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 168.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 tp -139.94 66.39 1.4 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.715 0.406 . . . . 0.0 111.699 -168.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 54.4 p -164.29 -45.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 O-C-N 122.03 -0.419 . . . . 0.0 110.312 169.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.81 28.2 43.3 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -141.29 120.89 13.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.584 0.754 . . . . 0.0 111.197 -169.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.34 -17.6 59.27 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.715 1.606 . . . . 0.0 113.865 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.91 -13.49 16.15 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.197 0.908 . . . . 0.0 111.743 174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.86 -6.68 2.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm 96.58 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.317 3.047 . . . . 0.0 110.979 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.8 m 38.37 45.77 0.82 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.044 2.137 . . . . 0.0 113.179 -169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.09 132.78 39.52 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.395 2.063 . . . . 0.0 112.031 -169.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.59 1.75 36.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 116.74 -1.6 . . . . 0.0 114.594 -175.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.8 p 45.08 89.76 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.538 1.535 . . . . 0.0 113.294 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -54.95 138.11 77.33 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.775 2.317 . . . . 0.0 109.485 -169.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.76 3.07 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.666 1 C-N-CA 125.318 4.012 . . . . 0.0 117.124 -168.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -67.55 -5.81 17.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.158 0.983 . . . . 0.0 112.332 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 148.33 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 110.147 -169.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -78.63 158.92 28.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.963 0.905 . . . . 0.0 108.839 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -151.73 145.37 24.97 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.757 -1.214 . . . . 0.0 109.488 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -155.73 148.43 24.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.82 137.79 32.08 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -139.57 -21.59 0.91 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.16 149.61 19.47 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 119.583 1.083 . . . . 0.0 110.648 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -160.75 169.3 23.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.38 1.872 . . . . 0.0 107.387 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.91 46.75 26.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.243 1.417 . . . . 0.0 112.399 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -43.61 116.62 2.3 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.766 2.026 . . . . 0.0 113.592 -171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' B' ' 108' ' ' ARG . 61.2 Cg_endo -72.23 -16.62 28.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.97 3.113 . . . . 0.0 113.318 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.87 -2.52 1.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.314 1.416 . . . . 0.0 111.824 169.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' B' ' 106' ' ' PRO . 5.1 mmm-85 -125.88 13.01 7.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.154 1.782 . . . . 0.0 110.934 -171.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.29 154.21 0.42 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.729 0.811 . . . . 0.0 109.884 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -53.3 -44.08 68.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.867 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.4 2.74 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 115.001 0.76 . . . . 0.0 115.001 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.4 p -68.94 166.02 18.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.0 -42.18 98.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.401 0.62 . . . . 0.0 110.311 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -69.23 -42.19 75.99 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.918 -1.515 . . . . 0.0 109.403 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.78 -35.66 60.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.149 1.795 . . . . 0.0 109.713 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -56.38 -52.53 64.27 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 121.719 -0.613 . . . . 0.0 110.728 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -63.95 -44.72 91.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.773 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.84 86.92 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.441 1.096 . . . . 0.0 111.667 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.89 -49.67 69.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.44 69.01 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.951 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -65.27 -50.51 65.47 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.39 1.076 . . . . 0.0 109.457 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -59.85 -48.34 82.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.87 -37.92 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 117.535 -1.221 . . . . 0.0 110.862 -176.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.29 -38.92 92.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.453 1.933 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.86 -44.89 93.89 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.483 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.05 -56.49 14.64 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.308 0.643 . . . . 0.0 110.148 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.8 mt -56.91 -47.7 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.837 1.255 . . . . 0.0 110.255 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.17 96.62 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.93 -42.89 99.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.79 0.795 . . . . 0.0 111.891 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.6 -0.688 . . . . 0.0 111.908 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.5 -33.6 69.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.572 1.078 . . . . 0.0 110.709 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' B' ' 27' ' ' TYR . 22.6 ttmt -61.03 -43.97 98.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.888 170.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.46 -41.04 96.61 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.36 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.94 -40.74 85.58 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.77 2.077 . . . . 0.0 110.496 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.62 74.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.32 -39.82 17.24 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.267 1.427 . . . . 0.0 111.623 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.7 p -97.38 -16.0 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.005 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 65.44 25.34 71.32 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.887 1.232 . . . . 0.0 112.332 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.749 1.219 . . . . 0.0 108.466 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.64 165.07 37.66 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.157 1.383 . . . . 0.0 107.529 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.66 101.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 168.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.13 166.83 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -121.92 107.33 12.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.85 175.46 4.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.422 1.089 . . . . 0.0 109.679 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -159.41 -172.71 3.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.92 1.688 . . . . 0.0 107.054 169.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -38.18 -41.8 0.63 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.092 2.957 . . . . 0.0 115.941 -169.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -128.41 -27.86 2.61 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.224 1.41 . . . . 0.0 111.064 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -61.74 -23.55 66.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.753 -1.118 . . . . 0.0 111.87 172.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -54.69 -54.45 41.63 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.617 1.553 . . . . 0.0 107.952 169.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -57.96 -47.84 81.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.367 0.531 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.12 96.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.556 0.217 . . . . 0.0 111.305 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -80.07 -15.71 56.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.772 1.229 . . . . 0.0 112.169 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.1 p -107.11 -9.28 16.21 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.122 0.969 . . . . 0.0 112.613 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 m -71.3 -3.13 18.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.83 0.741 . . . . 0.0 112.991 -175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -144.12 155.97 44.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.314 1.446 . . . . 0.0 108.119 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -167.4 54.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 123.878 0.751 . . . . 0.0 112.407 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.97 121.27 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 172.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.83 124.49 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 122.739 1.257 . . . . 0.0 108.207 -170.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.9 tp -83.43 100.23 10.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.53 141.16 36.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.22 145.25 45.47 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.392 1.077 . . . . 0.0 109.328 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.79 109.13 10.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -170.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.532 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.6 p-90 -121.79 160.03 25.46 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.71 159.29 17.33 Favored Pre-proline 0 C--O 1.233 0.2 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.23 -27.16 46.08 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.234 1.956 . . . . 0.0 113.062 168.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -58.61 -24.65 61.45 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 151.58 50.96 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.928 1.24 . . . . 0.0 111.875 -169.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.34 -48.73 71.15 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.201 -1.333 . . . . 0.0 112.512 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.79 -27.35 20.01 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.435 2.757 . . . . 0.0 115.464 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -58.59 -18.56 31.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 120.172 1.351 . . . . 0.0 113.644 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.95 12.11 20.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.315 1.046 . . . . 0.0 111.522 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.9 mtm -122.88 -43.93 2.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.6 1.16 . . . . 0.0 109.546 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.53 -35.88 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.405 0.682 . . . . 0.0 109.337 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.54 23.53 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.243 -0.884 . . . . 0.0 112.01 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.17 -40.51 59.43 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.664 1.576 . . . . 0.0 111.493 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.65 -38.27 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.892 0.769 . . . . 0.0 111.197 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.4 mt -66.59 -48.69 68.78 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-N 118.568 0.622 . . . . 0.0 110.095 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.62 -36.43 82.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.776 0.322 . . . . 0.0 110.42 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.31 -24.53 66.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.259 1.424 . . . . 0.0 111.723 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.8 tp -84.55 -40.02 18.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.69 0.677 . . . . 0.0 110.976 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.18 -33.14 72.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.982 -0.449 . . . . 0.0 110.473 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -70.53 -3.81 19.88 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -113.64 -42.43 3.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.624 1.569 . . . . 0.0 111.609 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.6 ptm -136.04 16.79 3.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.825 0.85 . . . . 0.0 112.336 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.84 -5.42 18.72 Favored Glycine 0 C--O 1.227 -0.286 0 O-C-N 120.771 -1.205 . . . . 0.0 114.23 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.94 -23.8 67.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.425 0.612 . . . . 0.0 111.342 169.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -32.87 4.87 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 110.983 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 151.6 19.82 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.978 1.311 . . . . 0.0 111.816 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -128.23 154.18 46.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.4 143.53 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.84 109.61 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 47.5 mtpt -82.91 157.09 23.19 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 120.56 -1.338 . . . . 0.0 109.75 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mm -130.08 124.02 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -85.75 109.8 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.0 m -73.15 9.96 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -171.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.85 -34.58 4.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.315 0.962 . . . . 0.0 110.644 169.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.69 -43.13 12.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.869 0.759 . . . . 0.0 111.447 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -141.79 42.94 1.71 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.643 1.211 . . . . 0.0 110.819 -170.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -4.25 45.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.717 1.207 . . . . 0.0 113.833 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -52.4 -43.87 65.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.257 1.023 . . . . 0.0 110.342 -169.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.8 m -58.08 -38.84 77.14 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.38 1.072 . . . . 0.0 112.379 174.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.42 -64.29 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.323 1.049 . . . . 0.0 109.115 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.41 -41.43 17.12 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.645 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -62.2 -43.12 99.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.296 1.548 . . . . 0.0 111.131 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -76.58 -9.32 58.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.193 0.597 . . . . 0.0 112.422 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.79 60.26 6.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 -173.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.17 -64.07 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 -173.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 mtm 58.0 5.13 0.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.23 2.612 . . . . 0.0 114.719 172.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -141.02 157.38 45.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.346 0.975 . . . . 0.0 111.638 -169.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.2 mm -138.96 139.51 23.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.37 138.77 49.14 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 -10.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.5 m -112.97 143.56 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.8 mt -120.84 127.54 52.0 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.95 1.7 . . . . 0.0 107.465 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -116.25 114.39 24.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.47 122.13 46.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.92 153.08 38.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 110.167 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -137.12 130.79 31.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.001 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.7 t70 42.15 35.23 0.56 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.791 2.036 . . . . 0.0 114.21 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.9 -8.51 23.5 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 116.628 1.411 . . . . 0.0 116.628 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.73 152.39 47.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.444 1.622 . . . . 0.0 112.942 -169.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.86 141.93 16.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.78 1.232 . . . . 0.0 108.663 175.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.74 -22.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 124.166 0.986 . . . . 0.0 109.537 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -153.76 166.44 32.85 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 122.587 1.184 . . . . 0.0 107.805 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -158.13 132.5 8.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.939 1.696 . . . . 0.0 106.703 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m -147.62 148.63 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.064 0.945 . . . . 0.0 109.053 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.21 124.22 41.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.18 156.17 9.28 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 124.618 1.104 . . . . 0.0 110.675 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.2 148.99 46.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.314 0.557 . . . . 0.0 111.211 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.03 148.04 18.93 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.5 177.68 6.49 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.33 2.687 . . . . 0.0 112.443 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -33.25 69.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.345 1.458 . . . . 0.0 112.334 -169.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -81.85 -40.72 22.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.081 0.552 . . . . 0.0 110.199 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.21 92.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.051 0.54 . . . . 0.0 110.65 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.84 -52.58 64.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.823 0.849 . . . . 0.0 109.72 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.1 -36.39 77.51 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.478 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.06 -46.64 88.86 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.551 1.068 . . . . 0.0 110.599 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.5 tp -58.23 -40.28 81.29 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 124.809 1.244 . . . . 0.0 111.673 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -87.97 -40.57 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.164 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -57.77 -34.29 69.41 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.977 1.311 . . . . 0.0 112.131 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -65.61 -8.73 21.71 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -123.77 -33.54 3.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.501 1.12 . . . . 0.0 112.197 174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.247 0.925 0 C-N-CA 126.752 2.021 . . . . 0.0 109.717 178.688 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -79.16 80.2 5.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.987 0.915 . . . . 0.0 108.756 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m120 78.98 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.654 2.781 . . . . 0.0 111.753 175.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -125.34 123.76 40.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 129.598 3.159 . . . . 0.0 103.725 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -92.78 141.46 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.76 -168.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.3 tt -133.65 140.44 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -131.24 136.16 47.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -110.44 141.86 42.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.85 123.03 36.36 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 78.7 p -156.1 147.67 22.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -46.47 111.74 0.41 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.425 1.49 . . . . 0.0 111.848 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.22 11.01 50.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.711 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 38.18 35.51 0.09 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.916 2.486 . . . . 0.0 113.793 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -69.64 -46.74 65.47 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.65 -65.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -168.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -33.89 68.45 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.833 0.742 . . . . 0.0 111.736 -174.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.3 p -56.24 -55.65 30.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.31 1.444 . . . . 0.0 111.398 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -52.1 -49.76 62.95 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.346 1.858 . . . . 0.0 109.657 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 9.2 ttm -67.83 -46.02 73.0 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.599 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.819 0.848 . . . . 0.0 110.77 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.0 -27.72 61.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.111 0.869 . . . . 0.0 110.149 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.05 -45.94 24.21 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -55.27 -33.67 63.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.414 1.086 . . . . 0.0 111.34 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.64 11.87 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.888 0.875 . . . . 0.0 110.604 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -64.96 -22.84 67.07 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.403 1.002 . . . . 0.0 113.665 -168.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.14 -16.35 52.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 170.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 11.9 m-85 -130.01 -40.85 1.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.395 1.078 . . . . 0.0 112.789 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.22 75.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.624 1.97 . . . . 0.0 106.234 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -164.04 1.2 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.977 1.751 . . . . 0.0 112.255 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.49 -7.9 8.03 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.543 -0.974 . . . . 0.0 113.137 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.16 -19.29 62.92 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.909 -1.119 . . . . 0.0 109.573 168.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -130.87 175.7 8.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 127.776 2.431 . . . . 0.0 110.121 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -153.04 129.9 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.35 144.31 14.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.871 0.868 . . . . 0.0 109.273 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.46 156.8 46.72 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 107.308 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.2 m -145.5 137.69 25.61 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.52 173.39 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.617 0.767 . . . . 0.0 111.339 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.08 40.64 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 122.247 -0.283 . . . . 0.0 112.978 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -53.19 -57.19 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 113.679 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -132.11 30.7 4.22 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.079 1.752 . . . . 0.0 108.039 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.8 149.93 49.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.563 1.945 . . . . 0.0 112.82 -169.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 146.45 100.4 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 130.995 3.718 . . . . 0.0 104.071 177.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.23 -179.29 48.7 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -171.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 23.0 tp -161.45 100.86 1.19 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -60.88 122.62 70.28 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.352 -0.832 . . . . 0.0 108.782 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.62 -26.56 80.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 121.734 1.622 . . . . 0.0 112.097 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.573 ' ND2' ' CE1' ' B' ' 120' ' ' PHE . 1.2 t30 -68.25 -27.92 66.76 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.979 -1.076 . . . . 0.0 112.086 171.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.127 1.785 . . . . 0.0 109.746 171.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.87 -51.66 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -52.57 -47.97 66.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.852 0.751 . . . . 0.0 109.977 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.89 57.24 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.655 1.182 . . . . 0.0 111.508 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.86 -38.79 20.71 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -61.75 -28.74 69.65 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.553 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.44 -27.95 64.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.931 0.787 . . . . 0.0 111.908 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.09 14.15 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 110.97 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.7 36.38 82.59 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.466 -1.186 . . . . 0.0 113.222 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.97 149.07 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -116.8 137.1 52.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.793 0.837 . . . . 0.0 108.92 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.2 pt -139.31 16.95 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 124.861 1.264 . . . . 0.0 110.836 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -58.91 -15.21 11.68 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -91.44 -15.8 28.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.308 1.443 . . . . 0.0 113.498 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -56.65 151.45 13.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.6 p -133.47 174.14 10.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.663 2.385 . . . . 0.0 109.359 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 15.7 m -153.01 -173.77 4.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.143 0.977 . . . . 0.0 109.517 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -161.66 167.93 24.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.274 1.829 . . . . 0.0 108.044 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.0 pt -63.37 169.1 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -48.62 135.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -142.0 98.84 3.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.544 1.164 . . . . 0.0 108.211 -171.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -51.38 -28.07 11.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.48 1.912 . . . . 0.0 113.989 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.81 -23.34 61.54 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 119.608 1.094 . . . . 0.0 110.494 -172.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -33.64 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 118.285 -0.865 . . . . 0.0 109.788 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.61 -52.93 61.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.639 1.109 . . . . 0.0 109.522 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -29.07 66.36 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.24 0.473 . . . . 0.0 110.964 -176.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -87.12 -12.45 47.06 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.673 1.589 . . . . 0.0 112.663 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.96 162.35 22.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.967 0.889 . . . . 0.0 110.434 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.89 -34.15 15.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.052 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.43 142.97 33.66 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.744 1.217 . . . . 0.0 110.202 -172.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -114.56 103.76 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 169.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.8 98.12 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -66.77 122.88 18.64 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 tp -124.66 52.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 110.083 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -153.02 -174.82 5.07 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.18 0.992 . . . . 0.0 108.761 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.1 44.56 1.2 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 106.789 -2.525 . . . . 0.0 106.789 169.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -150.97 164.59 36.02 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.215 2.206 . . . . 0.0 108.244 -169.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -131.38 7.45 4.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.229 1.412 . . . . 0.0 112.701 -172.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.21 -15.9 49.71 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.889 0.768 . . . . 0.0 112.709 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -71.24 28.08 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -169.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt 80.84 17.45 0.55 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.709 2.004 . . . . 0.0 112.432 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 m 34.63 52.09 1.26 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.353 1.861 . . . . 0.0 112.732 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.5 131.03 40.27 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.812 1.675 . . . . 0.0 110.785 -169.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -1.24 57.49 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 116.785 -1.579 . . . . 0.0 113.706 -175.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.9 p 48.0 95.47 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 126.12 1.768 . . . . 0.0 114.177 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.49 132.79 52.72 Favored 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 122.17 1.913 . . . . 0.0 109.51 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.4 -5.28 11.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.819 3.679 . . . . 0.0 117.817 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -74.4 15.35 0.35 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.093 1.315 . . . . 0.0 112.237 170.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 t -135.29 142.92 38.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.364 1.866 . . . . 0.0 106.736 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -69.99 153.69 42.9 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -141.39 141.12 33.79 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -145.97 157.97 43.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.56 137.06 47.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -142.02 -2.12 1.18 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.615 0.766 . . . . 0.0 112.668 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.68 -54.06 4.39 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 59.11 -2.68 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.534 2.334 . . . . 0.0 115.076 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -160.92 170.13 21.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.331 2.653 . . . . 0.0 105.771 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -137.97 106.62 8.12 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 118.877 0.762 . . . . 0.0 109.36 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' B' ' 108' ' ' ARG . 95.4 Cg_endo -66.82 -36.0 25.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 124.033 3.155 . . . . 0.0 112.175 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.88 -13.63 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 129.598 3.159 . . . . 0.0 113.918 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' B' ' 106' ' ' PRO . 8.6 mmm-85 -103.45 -54.42 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.394 1.478 . . . . 0.0 107.488 -172.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . 39.25 -164.11 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.468 1.907 . . . . 0.0 113.34 -170.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -70.11 -48.03 59.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.37 -22.12 2.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 62.6 p -71.02 168.54 16.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.3 -41.96 98.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.379 0.609 . . . . 0.0 110.516 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.55 -41.13 69.49 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 117.395 -1.288 . . . . 0.0 109.066 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -76.59 -33.44 58.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.544 1.52 . . . . 0.0 110.036 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -56.07 -56.51 19.94 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.009 0.822 . . . . 0.0 109.154 169.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -59.38 -41.87 90.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.45 93.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.59 1.156 . . . . 0.0 112.006 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -64.53 -46.98 80.55 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.573 ' CE1' ' ND2' ' B' ' 47' ' ' ASN . 14.5 m-85 -64.82 -36.07 83.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.425 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -61.27 -49.23 77.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.132 0.878 . . . . 0.0 110.046 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.9 ttp-105 -62.84 -52.53 62.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.27 -35.71 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.26 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 30.7 ptt85 -61.68 -41.05 97.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.212 1.824 . . . . 0.0 111.132 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.97 -43.7 94.91 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.459 0.475 . . . . 0.0 110.377 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -68.63 -50.56 50.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 0.0 110.887 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 mt -56.05 -48.67 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.405 1.082 . . . . 0.0 109.114 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.32 -46.96 92.26 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.45 -47.07 85.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.801 0.8 . . . . 0.0 111.737 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -62.95 -47.54 82.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.068 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.81 -37.04 86.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.374 0.534 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 41.3 ttmt -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.97 0.805 . . . . 0.0 109.739 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.2 -37.34 79.95 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-O 116.74 -1.6 . . . . 0.0 111.16 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -59.38 -40.09 85.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 122.008 2.185 . . . . 0.0 110.039 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.05 75.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.202 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.45 -47.68 11.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.393 1.077 . . . . 0.0 111.796 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.2 p -82.7 -22.73 34.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.969 2.108 . . . . 0.0 112.103 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.7 11.24 62.35 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -168.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.418 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.685 2.394 . . . . 0.0 113.772 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.32 167.36 28.91 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.318 1.447 . . . . 0.0 107.84 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.1 98.51 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 169.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.14 168.6 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.714 1.606 . . . . 0.0 108.307 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -125.11 122.1 36.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.811 1.245 . . . . 0.0 109.09 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.33 171.7 13.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.858 1.663 . . . . 0.0 109.859 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -136.09 -167.83 2.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.082 1.753 . . . . 0.0 108.614 169.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -47.12 -27.78 1.53 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.387 2.275 . . . . 0.0 113.627 170.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.49 -30.8 0.82 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.662 1.185 . . . . 0.0 112.06 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m -62.57 -20.02 64.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.895 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -48.32 -55.7 9.98 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.608 1.094 . . . . 0.0 110.427 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -64.18 -44.55 91.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.949 0.34 . . . . 0.0 110.168 -176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.23 81.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.924 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -82.2 -13.3 57.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.401 1.081 . . . . 0.0 112.541 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 66.6 p -115.89 -5.82 12.04 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 0.0 112.914 -170.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -74.75 -6.05 46.74 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.86 147.13 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.245 1.018 . . . . 0.0 109.346 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.13 -175.8 34.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.309 0.957 . . . . 0.0 111.689 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.59 125.75 48.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -136.03 117.95 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.111 0.964 . . . . 0.0 108.727 -169.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -89.66 116.06 27.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.87 135.81 39.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.883 0.765 . . . . 0.0 109.027 173.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.91 138.7 53.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.068 1.347 . . . . 0.0 108.984 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -119.88 105.07 10.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.425 ' CD1' ' CE ' ' A' ' 54' ' ' LYS . 4.8 p-90 -123.77 147.78 47.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.896 1.278 . . . . 0.0 108.202 -173.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -166.36 160.62 12.29 Favored Pre-proline 0 CA--C 1.534 0.344 0 O-C-N 121.545 -0.722 . . . . 0.0 111.56 171.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.73 -7.58 2.36 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.453 3.435 . . . . 0.0 116.504 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -54.73 -29.28 53.07 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.718 1.207 . . . . 0.0 113.104 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -163.58 162.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.13 -47.55 10.25 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.46 2.457 . . . . 0.0 115.596 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.57 -30.78 56.36 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.582 2.691 . . . . 0.0 114.041 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 m -62.48 -18.11 61.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.658 1.572 . . . . 0.0 113.909 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.79 22.03 13.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 0.0 111.211 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.2 mtm -131.24 -38.79 1.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.704 1.202 . . . . 0.0 110.27 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.82 -37.02 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.196 -0.94 . . . . 0.0 108.607 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.23 -54.31 57.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.874 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -58.96 -39.71 78.29 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.285 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.17 -38.96 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.055 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.01 -44.51 76.4 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.69 1.132 . . . . 0.0 110.589 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.53 -34.45 77.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.856 0.753 . . . . 0.0 109.813 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -71.2 -19.8 62.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.749 1.62 . . . . 0.0 112.54 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -84.24 -44.63 13.7 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 108.596 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.89 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.385 -0.197 . . . . 0.0 111.127 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.71 -10.09 56.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.236 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.46 -47.08 4.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.24 1.016 . . . . 0.0 111.064 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.7 ptm -135.46 15.96 3.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.528 0.731 . . . . 0.0 112.215 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.6 -3.47 20.68 Favored Glycine 0 CA--C 1.519 0.343 0 O-C-N 121.102 -0.999 . . . . 0.0 114.192 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.67 -24.43 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.83 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 -25.49 8.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.509 1.124 . . . . 0.0 111.83 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.1 tp -118.46 146.56 44.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 111.483 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.79 147.78 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.82 145.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.67 148.33 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' CE ' ' CD1' ' A' ' 25' ' ' TRP . 15.0 mtpt -122.09 146.56 47.08 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 118.862 0.755 . . . . 0.0 111.187 175.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -107.78 132.97 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.29 88.98 6.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -70.41 50.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 127.416 2.286 . . . . 0.0 114.761 -168.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -159.48 -33.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.067 2.147 . . . . 0.0 109.234 169.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -89.53 -42.34 11.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.688 0.795 . . . . 0.0 109.522 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -133.19 33.85 3.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.329 1.052 . . . . 0.0 111.648 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.58 -7.07 9.01 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.907 1.283 . . . . 0.0 113.375 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -47.39 -50.06 23.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 110.552 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.0 m -59.66 -36.11 75.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.234 0.614 . . . . 0.0 111.938 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.77 -57.31 6.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.45 -43.16 51.98 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.985 0.802 . . . . 0.0 113.434 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.94 -38.29 90.43 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.604 1.162 . . . . 0.0 110.97 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -76.89 -32.12 57.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.584 0.629 . . . . 0.0 110.077 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 77.59 1.38 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -170.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.86 -64.81 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.413 3.1 ppp? 45.47 24.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.428 2.691 . . . . 0.0 114.96 172.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.1 p -149.32 163.97 36.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.187 2.195 . . . . 0.0 110.96 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.3 mm -140.54 146.48 45.12 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -175.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.78 143.52 67.67 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 -10.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.4 m -119.37 150.16 40.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.267 0.556 . . . . 0.0 110.517 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.28 124.6 32.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -116.27 113.87 23.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.5 127.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.17 157.25 35.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.533 1.133 . . . . 0.0 110.169 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.82 130.86 20.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.43 32.29 0.5 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.447 2.299 . . . . 0.0 114.572 170.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.31 -19.2 6.03 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 116.489 1.356 . . . . 0.0 116.489 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -135.29 151.82 50.92 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 119.425 1.612 . . . . 0.0 112.878 -168.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -69.05 137.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.74 -25.21 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.997 1.719 . . . . 0.0 109.553 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -143.89 152.76 41.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.06 137.07 27.34 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.5 t -151.27 146.28 25.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.7 t -140.6 76.57 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.97 163.64 18.6 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.409 1.004 . . . . 0.0 110.878 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.37 147.38 51.13 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.807 0.803 . . . . 0.0 110.644 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -139.32 144.44 40.22 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.633 1.173 . . . . 0.0 108.482 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.55 170.94 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.521 2.147 . . . . 0.0 110.052 169.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -45.31 69.98 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.998 0.919 . . . . 0.0 112.359 -173.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.7 -43.12 76.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.541 0.155 . . . . 0.0 110.782 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.1 84.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.0 -0.438 . . . . 0.0 110.61 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 tp -67.68 -47.64 68.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.427 0.103 . . . . 0.0 110.979 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.94 -37.85 88.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.15 -46.21 88.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.819 0.447 . . . . 0.0 110.8 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.2 tp -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 110.825 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.47 -41.16 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.588 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -55.33 -29.06 57.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 112.412 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -49.11 -33.87 12.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.219 1.408 . . . . 0.0 112.306 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -135.72 -6.56 2.18 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.659 1.984 . . . . 0.0 108.576 170.166 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.02 125.39 26.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.253 31.5 m120 61.53 119.94 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 C-N-CA 129.317 3.047 . . . . 0.0 113.939 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -148.46 141.12 24.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.562 3.145 . . . . 0.0 103.731 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mt -117.95 144.5 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.845 1.202 . . . . 0.0 107.777 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.76 146.57 19.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -130.33 128.32 41.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.6 133.95 49.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -132.99 117.43 17.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -168.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 58.0 m -139.9 163.99 31.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 124.118 0.886 . . . . 0.0 111.875 -168.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.6 m -68.54 114.06 6.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.73 41.39 35.02 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.338 1.447 . . . . 0.0 112.801 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -36.53 104.31 0.03 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 18.0 m -135.21 0.97 2.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.77 169.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.11 -55.11 0.09 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.142 0.977 . . . . 0.0 112.902 -169.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -57.84 -54.67 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.176 0.444 . . . . 0.0 110.599 -171.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.7 m -76.73 -26.74 54.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.702 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -54.85 -51.1 66.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.822 1.192 . . . . 0.0 110.488 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 13.9 ttm -67.73 -44.19 78.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.529 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.75 99.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.368 0.667 . . . . 0.0 111.568 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.83 -31.76 61.76 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.418 1.008 . . . . 0.0 110.683 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -42.62 74.46 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -56.73 -40.0 74.94 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 117.931 0.865 . . . . 0.0 111.21 170.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.24 -54.23 43.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -69.84 -17.83 63.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.836 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.03 -14.93 63.36 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.874 1.216 . . . . 0.0 112.579 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.49 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 2.5 m-85 -126.32 -20.86 4.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.265 1.026 . . . . 0.0 113.732 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.26 -107.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 -172.28 40.78 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 119.126 0.875 . . . . 0.0 111.426 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.68 -20.22 65.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.35 1.46 . . . . 0.0 111.962 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.45 -40.18 74.41 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.97 0.908 . . . . 0.0 111.471 174.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.54 153.09 18.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.864 0.84 . . . . 0.0 112.587 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -124.61 107.33 10.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.48 103.28 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -92.51 160.98 14.8 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.806 0.842 . . . . 0.0 108.781 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -151.01 134.9 16.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.498 0.719 . . . . 0.0 109.576 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.67 176.92 11.98 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.343 0.592 . . . . 0.0 112.353 -174.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.22 -177.84 47.22 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.924 1.249 . . . . 0.0 111.141 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.5 tt -52.55 -53.33 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.116 1.366 . . . . 0.0 113.255 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -133.31 29.05 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.147 1.779 . . . . 0.0 108.611 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.86 146.8 54.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.168 2.187 . . . . 0.0 111.766 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 144.91 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 129.987 3.315 . . . . 0.0 105.287 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.89 162.67 33.45 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 62.3 tp -140.61 76.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.36 128.85 90.37 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.25 -20.05 45.35 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.936 1.757 . . . . 0.0 112.63 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -38.64 90.34 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 120.077 1.308 . . . . 0.0 111.777 171.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.31 60.26 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.824 0.738 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -60.41 -52.76 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 171.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -58.44 -44.27 89.11 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.695 0.798 . . . . 0.0 110.824 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.12 68.02 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.914 0.885 . . . . 0.0 111.791 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -39.58 53.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -63.03 -26.29 68.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.49 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.03 -29.52 60.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.035 1.288 . . . . 0.0 111.643 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 m -116.85 16.86 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.244 1.418 . . . . 0.0 111.242 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.73 33.97 88.67 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.444 -1.198 . . . . 0.0 113.423 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.71 150.89 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 169.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -118.34 137.84 52.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.806 0.843 . . . . 0.0 108.97 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' B' ' 61' ' ' ASN . 21.5 pt -137.81 18.14 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 124.571 1.149 . . . . 0.0 110.988 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -67.03 15.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' B' ' 59' ' ' ILE . 30.1 t30 -137.26 -6.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.24 2.616 . . . . 0.0 111.822 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.9 157.06 22.53 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.128 -0.983 . . . . 0.0 110.942 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.9 p -123.44 176.62 6.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.39 1.876 . . . . 0.0 109.707 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -157.99 170.26 22.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -165.43 163.28 19.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.527 1.931 . . . . 0.0 108.15 -176.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.4 pt -64.97 167.37 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.787 0.835 . . . . 0.0 111.801 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -49.43 138.72 4.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.489 0.715 . . . . 0.0 109.58 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.45 103.79 3.85 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.469 1.128 . . . . 0.0 108.954 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -48.84 -32.53 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.944 1.698 . . . . 0.0 113.924 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.0 -22.91 63.08 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.419 0.554 . . . . 0.0 111.194 -169.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.87 -39.42 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.147 -0.93 . . . . 0.0 109.344 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.05 -49.43 77.67 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.573 1.079 . . . . 0.0 110.449 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -25.21 67.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.918 0.781 . . . . 0.0 111.416 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -87.62 -11.41 48.59 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.996 1.318 . . . . 0.0 113.018 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.64 169.74 5.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.025 0.916 . . . . 0.0 111.281 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -85.29 -34.98 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 169.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 tp -151.41 144.13 24.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.974 1.309 . . . . 0.0 109.933 -173.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.82 101.91 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 126.269 1.827 . . . . 0.0 107.074 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 88.6 t -80.49 100.82 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 82.9 m -78.85 131.39 36.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -150.66 64.78 0.93 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.915 0.864 . . . . 0.0 111.65 -174.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 58.7 m -166.87 -38.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.438 1.095 . . . . 0.0 109.736 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 156.48 -171.84 34.17 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.518 2.485 . . . . 0.0 106.914 -169.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -143.3 64.19 1.35 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.191 0.995 . . . . 0.0 108.408 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -157.63 -77.79 0.08 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.162 1.385 . . . . 0.0 109.313 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.7 -28.1 69.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.92 0.488 . . . . 0.0 111.55 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.44 14.74 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.611 1.965 . . . . 0.0 113.978 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm 77.3 31.02 0.5 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.114 2.566 . . . . 0.0 111.799 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 p 29.78 56.45 0.73 Allowed Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.596 1.958 . . . . 0.0 112.694 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.77 131.98 46.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.191 2.594 . . . . 0.0 110.162 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.99 0.4 55.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.979 -173.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.6 p 46.28 90.39 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.986 2.114 . . . . 0.0 113.147 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -64.54 147.21 90.24 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.026 2.484 . . . . 0.0 108.842 -169.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.21 -0.06 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.112 3.208 . . . . 0.0 115.359 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -64.08 -16.95 62.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.752 0.821 . . . . 0.0 111.754 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 152.39 37.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.416 1.007 . . . . 0.0 112.796 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -80.08 154.72 27.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 168.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -139.79 146.22 39.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -144.81 149.31 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 133.48 50.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.291 1.036 . . . . 0.0 108.423 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -131.39 -5.7 3.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.386 1.074 . . . . 0.0 111.626 -171.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.62 147.18 16.26 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -144.09 24.41 1.63 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.699 1.599 . . . . 0.0 110.884 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -152.45 163.41 39.59 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.085 2.154 . . . . 0.0 106.499 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -147.31 121.9 5.13 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.288 1.404 . . . . 0.0 108.349 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.03 -21.59 15.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.548 2.165 . . . . 0.0 112.876 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.25 -6.14 12.81 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.551 1.069 . . . . 0.0 112.16 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -103.54 12.13 35.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.822 1.249 . . . . 0.0 111.544 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.68 148.9 0.66 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.001 1.321 . . . . 0.0 112.55 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -38.56 85.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.942 -171.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.47 -20.49 4.93 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 169.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.6 p -69.93 163.59 25.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.66 -39.57 84.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.265 0.555 . . . . 0.0 110.919 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.89 -44.64 61.05 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.349 -1.31 . . . . 0.0 109.87 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -73.82 -29.12 61.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 120.922 1.692 . . . . 0.0 110.5 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -58.17 -62.34 1.9 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.526 0.603 . . . . 0.0 109.516 170.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -60.44 -40.14 90.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.13 99.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.057 -177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.89 -46.0 83.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.798 0.726 . . . . 0.0 109.648 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -63.34 -44.15 95.71 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.956 0.902 . . . . 0.0 111.41 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 -59.13 -49.47 77.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.02 -38.79 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.587 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -55.65 -46.3 77.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.948 1.703 . . . . 0.0 111.495 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.09 -44.62 95.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.204 0.315 . . . . 0.0 110.762 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -61.44 2.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 110.133 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -39.96 60.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.614 1.565 . . . . 0.0 110.956 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.96 76.65 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 118.531 -1.15 . . . . 0.0 110.861 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -58.93 -46.66 87.42 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.373 1.587 . . . . 0.0 111.209 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.05 -50.33 73.08 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -37.27 75.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.485 0.584 . . . . 0.0 112.319 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.49 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -60.69 -42.34 96.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.97 -41.3 95.56 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.864 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.8 -37.64 74.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.802 2.547 . . . . 0.0 111.372 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.49 -29.94 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.5 -46.89 8.36 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.163 1.785 . . . . 0.0 110.983 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.6 p -79.17 -28.48 42.71 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.661 1.984 . . . . 0.0 109.087 -172.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 47.44 44.11 21.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm . . . . . 0 C--O 1.247 0.957 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.232 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 tpp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 118.906 -0.568 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.53 169.22 24.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.175 1.39 . . . . 0.0 108.268 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.54 100.48 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.25 167.3 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.858 1.663 . . . . 0.0 108.72 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -121.14 112.4 18.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.628 1.571 . . . . 0.0 108.017 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.05 172.49 13.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.325 1.05 . . . . 0.0 110.156 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -156.69 -177.77 6.86 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.633 1.973 . . . . 0.0 106.447 169.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -38.45 -38.83 0.4 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.673 2.789 . . . . 0.0 116.005 -169.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.18 -31.3 2.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.125 0.97 . . . . 0.0 111.154 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -61.68 -21.76 64.73 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 117.816 -1.088 . . . . 0.0 112.293 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -48.66 -51.32 28.97 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.323 1.42 . . . . 0.0 110.166 169.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -64.85 -45.29 86.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.03 87.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.532 0.206 . . . . 0.0 110.87 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -74.34 -16.1 60.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.546 1.138 . . . . 0.0 112.434 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.9 p -115.64 -2.83 12.39 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 112.122 -171.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.8 m -72.61 -10.83 60.26 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.73 144.47 34.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.135 0.879 . . . . 0.0 110.111 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.62 -174.92 31.09 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.59 1.091 . . . . 0.0 111.808 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -89.99 129.84 40.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.2 116.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -169.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.6 tp -79.23 138.25 37.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.12 115.08 15.93 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.367 0.985 . . . . 0.0 109.24 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -111.97 147.67 35.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.01 1.324 . . . . 0.0 110.203 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -128.52 109.05 11.03 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.601 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -129.7 153.14 48.45 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.066 1.746 . . . . 0.0 107.711 -170.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -171.24 162.24 5.24 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 119.426 1.012 . . . . 0.0 109.836 169.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.63 -19.79 14.96 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.917 3.078 . . . . 0.0 116.626 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -53.72 -30.46 44.01 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.999 1.32 . . . . 0.0 114.293 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 161.27 34.27 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.31 0.959 . . . . 0.0 113.214 -169.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.79 -48.92 52.59 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.08 -1.4 . . . . 0.0 112.669 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.4 -28.0 19.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.363 2.709 . . . . 0.0 115.075 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.85 -20.31 49.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 119.742 1.156 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.63 13.8 21.23 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.126 0.97 . . . . 0.0 111.442 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.1 mtm -123.73 -46.05 2.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.249 1.02 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.0 -34.75 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.15 10.94 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.691 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -59.66 -39.84 70.38 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.02 1.813 . . . . 0.0 111.634 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.35 -39.07 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 118.65 0.659 . . . . 0.0 110.451 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 mp -72.53 -39.76 67.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.991 0.814 . . . . 0.0 111.466 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.42 -33.48 75.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.723 1.147 . . . . 0.0 110.049 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.06 -21.56 59.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.0 1.32 . . . . 0.0 111.597 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.9 -44.71 16.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 108.932 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.46 -32.42 69.96 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.436 -1.415 . . . . 0.0 111.211 -172.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -67.14 -6.88 19.54 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.537 -0.727 . . . . 0.0 112.755 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.8 -46.61 3.33 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.733 2.013 . . . . 0.0 109.615 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . 0.289 59.7 mmm -104.08 -12.42 16.77 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 125.486 1.515 . . . . 0.0 113.121 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.99 -7.8 9.33 Favored Glycine 0 C--N 1.318 -0.457 0 N-CA-C 113.962 0.345 . . . . 0.0 113.962 -171.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.03 -25.54 65.43 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.16 2.184 . . . . 0.0 112.489 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.7 -20.37 3.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.169 1.388 . . . . 0.0 112.074 -171.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 51' ' ' LYS . 1.6 tm? -129.43 156.41 44.14 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.21 1.404 . . . . 0.0 112.32 -166.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.41 ' H ' HD23 ' A' ' 50' ' ' LEU . 87.7 tttt -122.61 148.06 45.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.589 1.556 . . . . 0.0 108.28 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.7 mt -128.15 144.13 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.23 146.49 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.601 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 24.7 mtpt -121.32 153.02 38.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.181 0.446 . . . . 0.0 110.883 173.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -121.29 127.33 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.29 106.74 15.31 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.299 33.4 m -79.76 49.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -177.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -154.52 -42.18 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.538 1.135 . . . . 0.0 109.453 168.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -84.36 -40.97 17.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.053 1.341 . . . . 0.0 109.831 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -127.73 28.78 5.57 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.283 1.833 . . . . 0.0 111.3 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.98 -3.44 26.04 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.477 0.711 . . . . 0.0 112.696 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.75 -46.76 74.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.815 1.646 . . . . 0.0 111.127 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.15 -46.12 75.69 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.34 -63.93 0.97 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.723 0.809 . . . . 0.0 108.989 -169.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.21 -46.3 15.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.051 0.834 . . . . 0.0 113.096 174.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.02 -42.95 99.91 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.238 1.019 . . . . 0.0 111.724 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -69.17 -18.93 63.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.549 . . . . 0.0 110.712 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.22 66.48 1.52 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.12 129.9 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.6 mtm -147.64 20.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -134.32 160.69 37.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.608 1.163 . . . . 0.0 113.98 -167.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 136.45 29.14 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.042 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.43 128.48 11.64 Favored 'Cis proline' 0 N--CA 1.453 -0.869 0 N-CA-C 106.367 -2.205 . . . . 0.0 106.367 -11.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.6 m -92.91 140.49 29.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -136.45 92.79 2.81 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -80.5 132.36 35.68 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.67 120.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -127.96 157.95 39.2 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.057 0.943 . . . . 0.0 109.502 -170.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.06 144.08 25.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 169.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.8 30.29 0.83 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.178 1.791 . . . . 0.0 113.538 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.0 11.99 58.19 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.828 1.204 . . . . 0.0 115.939 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.31 149.26 50.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.647 1.224 . . . . 0.0 111.297 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.38 141.83 15.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 m -128.8 -20.62 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.504 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 153.0 40.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.241 1.016 . . . . 0.0 109.123 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.56 116.61 7.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -177.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -135.67 147.27 48.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.58 95.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.46 155.9 7.62 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -64.78 143.0 58.24 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.673 0.737 . . . . 0.0 110.526 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 139.75 32.05 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 169.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.24 167.24 22.62 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.463 2.109 . . . . 0.0 110.333 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -46.92 -46.71 21.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.702 1.601 . . . . 0.0 112.386 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.2 -44.34 72.3 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.562 0.619 . . . . 0.0 111.118 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.32 83.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.122 -0.361 . . . . 0.0 110.415 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -52.08 63.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.131 0.572 . . . . 0.0 109.998 176.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -64.24 -36.26 83.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.983 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.96 -49.37 77.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.167 0.439 . . . . 0.0 110.981 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.49 -40.03 85.71 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 123.683 0.793 . . . . 0.0 111.557 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.04 -40.73 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.228 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -55.0 -30.65 59.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.365 1.066 . . . . 0.0 112.276 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -59.62 -18.12 38.92 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.146 0.978 . . . . 0.0 113.298 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -131.88 -22.81 2.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.337 0.971 . . . . 0.0 112.774 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.2 tp . . . . . 0 C--O 1.248 0.984 0 C-N-CA 126.484 1.913 . . . . 0.0 107.528 169.866 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.67 24.22 2.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.839 0.855 . . . . 0.0 112.605 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.98 133.85 11.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 169.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -142.65 118.29 10.42 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 129.302 3.041 . . . . 0.0 104.23 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.72 130.66 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -134.34 139.67 47.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -127.13 142.27 51.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.201 1.0 . . . . 0.0 108.511 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -126.41 107.38 10.23 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.146 0.978 . . . . 0.0 108.558 -172.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.97 127.31 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 91.9 p -152.17 162.51 41.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.077 0.399 . . . . 0.0 111.407 169.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 76.5 m -50.05 115.54 1.46 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.623 1.169 . . . . 0.0 110.145 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.46 19.46 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.685 2.088 . . . . 0.0 115.541 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 42.08 31.9 0.27 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.195 1.398 . . . . 0.0 111.493 -168.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -85.95 17.8 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.364 -1.46 . . . . 0.0 113.166 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.67 -67.66 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.662 1.185 . . . . 0.0 111.887 169.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.54 -56.62 15.48 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -168.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m -70.51 -32.99 70.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.891 -169.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.66 -50.15 55.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.305 1.05 . . . . 0.0 111.394 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' MET . . . . . 0.409 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 31.4 ttm -67.76 -47.12 70.1 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.76 -175.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.99 97.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.001 0.92 . . . . 0.0 111.114 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.57 -31.18 69.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.569 1.077 . . . . 0.0 111.069 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.75 -49.7 53.32 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -56.34 -39.79 73.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.81 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.7 -51.52 64.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -63.37 -22.55 66.95 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -69.87 -11.19 60.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.483 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 14.4 m-85 -130.17 -44.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.735 1.214 . . . . 0.0 111.657 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.44 75.37 8.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.329 2.252 . . . . 0.0 105.521 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.52 -159.07 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.821 2.153 . . . . 0.0 113.306 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.19 -21.21 21.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.439 1.096 . . . . 0.0 113.245 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.13 -19.85 15.09 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.35 1.86 . . . . 0.0 113.071 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -128.66 161.22 30.16 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.818 1.247 . . . . 0.0 111.005 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.5 136.95 49.48 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.66 136.1 60.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -140.36 157.15 45.98 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.178 0.991 . . . . 0.0 109.217 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -138.43 140.66 39.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.734 1.213 . . . . 0.0 108.56 -172.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.36 173.84 16.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.913 0.485 . . . . 0.0 110.953 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.87 -171.4 42.05 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.304 0.954 . . . . 0.0 111.193 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.73 -56.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.008 1.723 . . . . 0.0 113.999 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.38 31.0 2.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.711 2.004 . . . . 0.0 107.581 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.02 131.09 47.46 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.519 1.928 . . . . 0.0 113.821 -169.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -171.21 8.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.175 1.79 . . . . 0.0 111.31 169.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.73 107.56 3.13 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 119.175 0.898 . . . . 0.0 111.696 -169.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -78.39 86.7 4.44 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -62.04 125.43 85.23 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.534 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.3 -20.08 53.73 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.243 1.962 . . . . 0.0 113.013 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.413 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -60.52 -39.63 88.52 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.696 1.135 . . . . 0.0 111.027 171.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.25 59.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.76 -50.81 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -56.93 -47.01 81.61 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 123.375 0.67 . . . . 0.0 110.28 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.55 -33.26 59.81 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.208 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 82.6 mmm -91.67 -30.64 16.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.997 0.817 . . . . 0.0 111.219 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.47 -24.39 67.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.845 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.67 -31.39 68.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.929 1.24 . . . . 0.0 111.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 m -113.73 15.36 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.085 1.354 . . . . 0.0 110.808 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.67 39.97 98.59 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.634 -1.092 . . . . 0.0 112.824 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.56 107.88 24.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.33 132.7 48.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 pt -127.99 11.42 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.881 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -19.81 46.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.06 0.845 . . . . 0.0 111.163 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -76.97 -13.83 59.92 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.493 2.317 . . . . 0.0 114.073 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -62.9 161.62 12.53 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.217 1.371 . . . . 0.0 113.586 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 63.8 p -126.44 171.23 11.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.883 2.473 . . . . 0.0 108.528 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -157.89 163.62 37.74 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.819 -1.176 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -167.78 164.94 14.28 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 -175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.5 pt -69.29 175.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 111.274 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.53 133.62 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -143.17 104.8 4.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.869 0.842 . . . . 0.0 108.988 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -46.92 -28.63 1.67 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.766 2.026 . . . . 0.0 114.022 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.85 -15.77 62.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.125 0.875 . . . . 0.0 112.049 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.48 -38.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.38 1.072 . . . . 0.0 109.259 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 tt -65.31 -58.54 5.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 120.206 1.366 . . . . 0.0 109.399 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -24.08 66.57 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.362 0.528 . . . . 0.0 110.757 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -78.63 -26.13 45.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 113.092 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 169.33 2.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.467 1.507 . . . . 0.0 111.959 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -91.31 -30.34 16.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.413 ' HG ' ' HE2' ' B' ' 97' ' ' LYS . 0.8 OUTLIER -148.07 138.63 22.97 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.189 0.996 . . . . 0.0 110.556 -170.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 t -113.57 106.14 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.64 114.35 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 30.4 m -77.21 129.23 35.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 168.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.6 tp -131.43 56.12 1.82 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.998 0.919 . . . . 0.0 111.304 -168.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 69.7 m -153.86 172.72 16.93 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.883 -1.135 . . . . 0.0 109.339 170.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -127.24 45.42 1.15 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -152.84 162.32 41.44 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.471 2.308 . . . . 0.0 107.829 -169.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -125.58 2.71 7.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.391 1.077 . . . . 0.0 112.774 -170.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.01 -16.15 63.65 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.62 -0.675 . . . . 0.0 111.714 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.5 -0.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.116 2.166 . . . . 0.0 116.685 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 85.89 7.39 0.36 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.472 2.309 . . . . 0.0 111.528 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.6 m 32.79 49.63 0.55 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 127.821 2.448 . . . . 0.0 113.5 -170.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.48 134.15 38.69 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.731 2.287 . . . . 0.0 111.685 -169.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 0.23 49.87 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 116.987 -1.482 . . . . 0.0 114.882 -172.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p 48.31 88.45 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.202 1.401 . . . . 0.0 112.879 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.6 146.61 74.98 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 122.802 2.335 . . . . 0.0 110.112 -169.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.76 2.96 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 125.551 4.167 . . . . 0.0 116.617 -168.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -68.39 -6.16 23.03 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.951 0.796 . . . . 0.0 111.945 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.95 147.31 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.533 1.133 . . . . 0.0 110.26 -169.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.413 ' HE2' ' HG ' ' B' ' 77' ' ' LEU . 2.6 tmmm? -72.73 156.53 38.84 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -151.43 139.11 19.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.627 -1.296 . . . . 0.0 108.472 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -149.11 144.86 26.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.31 136.73 34.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -133.76 -10.64 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.958 0.903 . . . . 0.0 111.655 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.44 168.08 49.6 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.11 -7.28 0.18 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.432 0.693 . . . . 0.0 112.836 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -161.98 179.41 8.03 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.262 1.425 . . . . 0.0 107.928 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -135.76 114.91 11.21 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.26 1.424 . . . . 0.0 108.389 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.05 -18.58 21.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.474 2.783 . . . . 0.0 112.855 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.88 -7.19 7.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.786 1.176 . . . . 0.0 112.461 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -101.66 11.3 39.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.359 1.464 . . . . 0.0 111.347 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.64 147.05 0.65 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.481 1.112 . . . . 0.0 111.595 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -53.37 -45.99 69.43 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 124.078 0.861 . . . . 0.0 109.889 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.98 -20.48 2.86 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 53.2 p -68.7 165.38 19.59 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.37 -41.72 97.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.48 0.657 . . . . 0.0 110.308 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.98 -43.73 67.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 117.007 -1.473 . . . . 0.0 109.718 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.36 -32.43 62.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.18 1.809 . . . . 0.0 109.582 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -56.2 -62.28 1.82 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.153 0.581 . . . . 0.0 109.658 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.89 -39.78 86.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.989 0.916 . . . . 0.0 112.25 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -64.33 -44.92 90.02 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.9 m-30 -60.88 -51.53 68.9 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -64.08 -46.8 82.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 111.299 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -65.51 -48.61 71.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.084 0.402 . . . . 0.0 110.016 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.07 -40.23 88.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.151 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.409 ' HA ' ' SD ' ' B' ' 19' ' ' MET . 13.6 ttp180 -58.17 -46.73 85.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.543 1.065 . . . . 0.0 111.84 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.23 -44.09 83.47 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.183 0.447 . . . . 0.0 110.524 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -74.37 -39.52 62.7 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.66 -49.17 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 108.913 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.55 -41.44 96.17 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.409 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -56.78 -51.34 69.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 118.13 0.965 . . . . 0.0 111.228 174.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -63.7 -42.31 98.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.638 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.5 -40.88 96.49 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.152 0.887 . . . . 0.0 112.202 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.483 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 41.5 ttmt -60.13 -38.0 81.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.461 0.573 . . . . 0.0 110.416 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.64 77.9 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 116.672 -1.633 . . . . 0.0 112.611 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -59.16 -34.46 72.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 122.539 2.427 . . . . 0.0 110.957 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.69 -32.53 73.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.086 0.554 . . . . 0.0 111.036 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -88.63 -44.57 10.52 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.293 1.437 . . . . 0.0 111.239 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 68.0 p -87.04 -17.44 32.94 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.899 2.08 . . . . 0.0 111.017 -170.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.32 39.57 92.83 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.225 0.917 . . . . 0.0 110.932 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.743 0.817 . . . . 0.0 112.293 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.67 157.86 0.08 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.916 2.486 . . . . 0.0 113.074 -171.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.83 100.92 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 t -74.87 165.98 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.243 1.417 . . . . 0.0 108.057 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -125.79 117.46 23.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.319 1.048 . . . . 0.0 108.625 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.79 171.82 14.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.667 1.587 . . . . 0.0 110.12 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -156.02 -176.07 5.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.642 1.577 . . . . 0.0 107.053 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -36.67 -36.97 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 130.202 3.401 . . . . 0.0 116.743 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.97 -30.24 1.23 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.999 1.32 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -60.84 -22.18 63.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.335 -0.84 . . . . 0.0 112.319 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -50.79 -52.44 40.96 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.613 1.097 . . . . 0.0 109.292 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.45 -44.57 96.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.02 80.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.444 -0.16 . . . . 0.0 111.13 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.38 -11.95 59.98 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.855 1.262 . . . . 0.0 112.843 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -123.29 -3.09 8.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.942 1.246 . . . . 0.0 113.27 -169.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -71.33 -10.74 60.25 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.65 156.87 45.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.11 0.964 . . . . 0.0 109.574 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.98 -150.92 48.34 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.359 0.98 . . . . 0.0 110.988 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.42 132.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.0 t -143.13 116.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.94 123.33 27.16 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.47 140.15 46.31 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -134.09 151.32 51.33 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.876 1.671 . . . . 0.0 108.786 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -131.66 117.35 18.54 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -169.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.572 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.9 p-90 -139.58 153.89 47.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.344 1.458 . . . . 0.0 108.849 -169.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.48 158.33 9.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.262 1.025 . . . . 0.0 108.489 168.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.37 -15.18 5.4 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.764 2.976 . . . . 0.0 116.846 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -59.86 -24.75 64.48 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.12 160.26 36.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.456 1.026 . . . . 0.0 112.588 -169.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.24 -49.62 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.253 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.1 -28.09 24.03 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.225 2.617 . . . . 0.0 115.093 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 m -59.38 -16.42 22.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.585 1.084 . . . . 0.0 113.692 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -116.92 14.98 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.788 1.235 . . . . 0.0 111.681 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.0 mtm -123.47 -45.2 2.08 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.182 0.993 . . . . 0.0 109.416 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tp -62.77 -34.9 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.798 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.84 24.02 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.985 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.04 -40.1 73.96 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.955 1.77 . . . . 0.0 111.476 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.44 -37.93 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.467 0.576 . . . . 0.0 110.701 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mp -71.58 -41.22 69.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.952 0.796 . . . . 0.0 111.363 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.06 -35.13 80.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.673 1.124 . . . . 0.0 109.727 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.3 -16.41 61.9 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.619 1.567 . . . . 0.0 112.608 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -86.98 -43.45 12.35 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 124.657 1.183 . . . . 0.0 108.382 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.2 -36.59 69.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.79 -0.569 . . . . 0.0 111.118 -174.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.78 -12.55 61.61 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.614 -0.679 . . . . 0.0 112.193 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -99.92 -42.57 6.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.366 1.467 . . . . 0.0 110.797 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -145.03 17.89 1.59 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.665 0.786 . . . . 0.0 112.284 -172.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.91 -1.99 21.36 Favored Glycine 0 CA--C 1.523 0.574 0 O-C-N 121.343 -0.848 . . . . 0.0 113.984 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.37 -24.88 63.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.599 1.16 . . . . 0.0 110.97 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.12 -18.3 11.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.911 0.884 . . . . 0.0 112.576 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -130.63 147.32 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 111.101 -168.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -107.11 146.01 31.77 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 168.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.71 137.44 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 t -136.58 141.56 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.572 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 26.3 mtpt -116.41 152.79 33.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -117.72 120.75 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -79.03 109.37 13.27 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.48 33.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -141.8 -42.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.057 -1.027 . . . . 0.0 109.819 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -79.82 -36.12 37.37 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.94 0.896 . . . . 0.0 110.67 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -134.2 32.37 3.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.439 1.495 . . . . 0.0 109.94 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -15.26 62.9 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.21 -169.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -50.54 -44.57 56.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.971 1.309 . . . . 0.0 111.783 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -60.38 -38.61 84.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.895 0.77 . . . . 0.0 111.872 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -66.91 0.5 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.83 1.252 . . . . 0.0 108.883 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.23 -44.84 5.04 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.641 1.115 . . . . 0.0 113.609 170.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -64.44 -45.2 88.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.574 1.187 . . . . 0.0 111.535 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -70.02 -31.57 69.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.49 0.586 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 68.05 0.74 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.8 t -142.39 132.49 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 100.744 -3.799 . . . . 0.0 100.744 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 10.3 ptm -150.59 17.66 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.767 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -138.3 163.56 31.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.222 2.209 . . . . 0.0 111.155 -169.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 143.89 49.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.944 0.898 . . . . 0.0 108.781 176.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.91 149.6 38.77 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 N-CA-C 107.345 -1.829 . . . . 0.0 107.345 -11.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.7 m -118.45 147.52 43.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 172.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.6 mt -125.71 141.71 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -129.0 106.86 9.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.04 118.63 31.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -110.31 149.05 30.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.518 0.727 . . . . 0.0 109.405 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -148.75 132.95 17.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.6 t70 43.23 30.84 0.32 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.678 1.991 . . . . 0.0 113.499 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.64 9.99 57.09 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.43 152.59 51.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.693 1.197 . . . . 0.0 110.757 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.07 133.06 32.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -120.24 -22.45 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.223 1.409 . . . . 0.0 110.704 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.36 163.73 34.64 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.215 1.006 . . . . 0.0 110.063 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.74 150.39 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -169.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -154.79 151.25 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.52 67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.76 154.92 8.94 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -170.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -71.86 158.88 35.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.946 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.59 143.63 20.46 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.18 168.15 22.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.352 2.035 . . . . 0.0 110.425 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -44.99 70.94 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.085 0.954 . . . . 0.0 112.071 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.86 -43.17 84.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.563 0.165 . . . . 0.0 110.891 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.0 78.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.04 -0.412 . . . . 0.0 110.666 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -53.21 59.65 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 109.477 175.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -64.44 -37.81 88.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.72 -46.61 88.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.425 0.557 . . . . 0.0 111.264 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -58.08 -40.12 80.29 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 123.868 0.867 . . . . 0.0 111.151 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.95 -39.87 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.267 -0.397 . . . . 0.0 110.687 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -56.36 -28.24 58.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.583 1.153 . . . . 0.0 112.414 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -56.35 -22.39 30.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.149 0.98 . . . . 0.0 112.959 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -127.97 -26.17 2.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.052 0.941 . . . . 0.0 112.338 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.704 1.602 . . . . 0.0 108.033 171.211 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.69 142.5 40.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.289 0.636 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m120 70.63 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 128.608 2.763 . . . . 0.0 110.566 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 127.23 27.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.57 136.16 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -137.91 140.46 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.38 139.89 49.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.898 0.479 . . . . 0.0 110.775 -169.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -100.94 141.18 34.19 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.62 120.07 10.99 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -172.23 155.92 3.75 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -39.53 102.19 0.02 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.18 1.792 . . . . 0.0 112.707 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.27 22.35 50.16 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.652 -1.638 . . . . 0.0 113.784 171.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 33.5 2.67 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 1 C-N-CA 132.715 4.406 . . . . 0.0 121.046 173.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -70.84 -5.95 34.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.914 -1.741 . . . . 0.0 115.312 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.31 -95.65 0.48 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 120.496 1.498 . . . . 0.0 111.102 -177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -37.5 62.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.611 0.765 . . . . 0.0 112.536 -171.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -44.42 97.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.62 0.646 . . . . 0.0 110.089 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -56.7 -48.62 77.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.051 0.94 . . . . 0.0 110.188 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -43.3 91.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 124.068 0.855 . . . . 0.0 108.906 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.75 71.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.942 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -48.29 80.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.903 1.229 . . . . 0.0 109.883 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 -47.17 92.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -58.36 -42.34 86.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 112.055 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.27 -54.25 36.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.46 -23.66 65.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.703 -1.142 . . . . 0.0 112.025 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -68.22 -21.19 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.883 1.219 . . . . 0.0 113.558 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.402 ' CE2' ' HE3' ' B' ' 132' ' ' LYS . 2.3 m-85 -115.69 -16.31 11.27 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.971 0.908 . . . . 0.0 112.715 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.53 -128.23 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.13 -174.4 40.23 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 127.3 2.381 . . . . 0.0 107.361 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.61 -14.24 40.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.376 1.088 . . . . 0.0 112.026 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -52.79 -28.0 20.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.309 1.444 . . . . 0.0 110.429 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -122.46 168.65 11.86 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.24 2.216 . . . . 0.0 107.228 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -139.04 106.21 5.48 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 120.974 -1.079 . . . . 0.0 108.982 -173.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 82.3 t -99.31 132.22 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.67 166.73 23.82 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.517 1.527 . . . . 0.0 108.775 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 37.3 m -147.15 150.55 35.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.484 1.114 . . . . 0.0 109.213 176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.56 177.35 11.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.975 0.91 . . . . 0.0 110.03 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.24 -175.78 47.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.401 1.477 . . . . 0.0 110.035 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -53.07 -55.45 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.346 1.458 . . . . 0.0 113.114 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.12 29.82 5.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.343 1.457 . . . . 0.0 108.297 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 121.47 14.77 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.092 2.157 . . . . 0.0 111.72 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -174.85 -19.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.46 1.504 . . . . 0.0 111.194 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.76 179.31 53.6 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 124.333 0.968 . . . . 0.0 113.981 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -147.26 92.31 2.09 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.416 1.486 . . . . 0.0 107.041 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.57 129.06 94.07 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.622 1.169 . . . . 0.0 108.16 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -59.53 -19.66 53.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.875 1.717 . . . . 0.0 112.809 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -38.72 88.8 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.104 1.32 . . . . 0.0 111.239 171.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.72 65.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.91 -52.7 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.675 0.79 . . . . 0.0 110.264 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -36.94 58.45 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.996 0.918 . . . . 0.0 111.206 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.7 mmm -82.3 -30.54 30.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.141 0.882 . . . . 0.0 111.568 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -61.62 -25.47 67.38 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.47 1.032 . . . . 0.0 110.992 171.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.15 -22.46 66.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.768 1.167 . . . . 0.0 112.246 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 p -116.67 9.7 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.978 1.711 . . . . 0.0 109.526 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.0 38.79 96.54 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 120.964 -1.085 . . . . 0.0 111.928 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.9 mt -114.48 140.35 35.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.25 136.8 44.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 pt -135.78 15.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.437 1.095 . . . . 0.0 110.855 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 17.1 p -59.48 -13.12 7.65 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.657 1.117 . . . . 0.0 113.63 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -91.29 -14.81 30.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.862 1.665 . . . . 0.0 113.492 176.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.69 142.0 53.95 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.746 1.157 . . . . 0.0 112.611 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -129.36 173.6 10.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.893 2.477 . . . . 0.0 108.486 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.3 m -155.36 -175.38 5.41 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.966 -1.083 . . . . 0.0 110.924 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -155.93 158.87 38.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.94 1.696 . . . . 0.0 109.031 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.5 pt -71.61 170.31 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.583 1.153 . . . . 0.0 112.215 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.7 127.45 5.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -146.01 97.18 2.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.351 1.072 . . . . 0.0 108.75 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -46.42 -27.37 1.06 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.348 1.859 . . . . 0.0 114.429 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.78 -17.9 61.84 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.94 1.245 . . . . 0.0 112.604 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.19 -34.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.917 0.887 . . . . 0.0 108.933 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.66 -54.77 19.67 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.365 0.984 . . . . 0.0 110.209 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -22.41 67.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.561 0.619 . . . . 0.0 110.48 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.1 -20.79 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.809 1.644 . . . . 0.0 112.418 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.56 167.34 2.68 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.759 1.224 . . . . 0.0 111.947 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.29 -28.58 16.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.74 169.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.53 132.45 19.13 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 110.73 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.19 99.98 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -81.09 102.69 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 57.5 m -67.04 136.09 54.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 tp -125.13 43.54 3.02 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 66.2 m -158.34 -16.83 0.07 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.64 1.176 . . . . 0.0 112.724 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.5 -42.7 2.9 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -148.27 144.74 27.84 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.119 2.168 . . . . 0.0 105.617 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.42 149.46 31.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.793 0.837 . . . . 0.0 109.505 -171.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.74 -54.85 18.59 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 17.73 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 130.96 3.704 . . . . 0.0 110.643 -168.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -157.12 32.89 0.29 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 128.996 2.918 . . . . 0.0 107.663 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 m 32.38 52.8 0.84 Allowed Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.421 1.888 . . . . 0.0 112.478 -168.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -45.43 131.76 12.22 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.486 2.79 . . . . 0.0 114.8 -169.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.42 -1.3 56.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.2 p 44.36 93.05 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.888 2.075 . . . . 0.0 113.831 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -55.89 134.97 67.27 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.776 2.317 . . . . 0.0 109.089 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.16 8.47 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.765 3.643 . . . . 0.0 116.095 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -67.8 -6.08 19.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.087 0.955 . . . . 0.0 111.904 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.37 146.79 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 109.391 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -69.67 156.14 39.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -144.36 142.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.404 0 O-C-N 121.029 -1.044 . . . . 0.0 108.208 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.85 154.07 32.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 169.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -95.95 127.31 41.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -110.02 -3.62 16.37 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.706 0.802 . . . . 0.0 110.499 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 162.38 13.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -145.82 -9.39 0.54 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.398 1.079 . . . . 0.0 111.738 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -156.87 168.58 27.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.353 2.261 . . . . 0.0 106.02 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -125.33 112.15 26.04 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.035 0.934 . . . . 0.0 108.636 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.0 -22.91 34.86 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.404 3.403 . . . . 0.0 113.189 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.87 -10.69 9.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.976 0.807 . . . . 0.0 112.637 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -97.82 7.95 45.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 111.858 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.61 143.29 2.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.027 0.931 . . . . 0.0 112.362 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -57.04 -47.7 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.968 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.15 -17.25 4.1 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 44.0 p -70.16 159.87 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.61 -38.81 82.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.352 0.596 . . . . 0.0 111.068 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -72.71 -43.43 63.02 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.764 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.49 -30.82 59.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.103 1.774 . . . . 0.0 110.077 -172.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -59.89 -57.11 14.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.76 -0.638 . . . . 0.0 109.837 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -61.5 -41.68 97.66 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.146 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.32 87.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.144 0.884 . . . . 0.0 112.372 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -62.92 -47.63 82.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -64.13 -43.38 95.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -59.43 -53.84 53.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.018 1.727 . . . . 0.0 109.693 -173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.08 -49.36 70.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.1 -41.19 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.216 -0.897 . . . . 0.0 109.736 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp-105 -58.39 -47.17 84.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.974 1.261 . . . . 0.0 111.21 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.31 -43.49 88.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.242 0.474 . . . . 0.0 110.92 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -64.72 -48.87 73.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.05 0.54 . . . . 0.0 110.06 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.88 -50.66 59.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 125.206 1.402 . . . . 0.0 110.042 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.21 -40.84 95.0 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -61.58 -42.99 99.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.17 0.985 . . . . 0.0 111.689 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -69.74 -34.16 73.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.956 0.798 . . . . 0.0 111.345 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.19 -37.8 66.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.698 1.135 . . . . 0.0 111.756 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.402 ' HE3' ' CE2' ' B' ' 27' ' ' TYR . 7.9 ptmt -67.75 -37.34 82.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.945 0.793 . . . . 0.0 109.836 175.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -59.24 -40.75 86.92 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.218 -1.372 . . . . 0.0 109.904 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -60.4 -38.15 83.06 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 122.163 2.256 . . . . 0.0 111.181 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.99 70.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.037 0.535 . . . . 0.0 112.221 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.22 -47.57 8.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.474 1.51 . . . . 0.0 111.499 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.1 p -84.19 -23.28 30.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 110.78 -169.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 50.58 41.28 41.73 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.273 1.429 . . . . 0.0 113.613 -169.049 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.51 170.04 21.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.27 1.428 . . . . 0.0 107.882 169.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 96.81 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 169.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.06 167.63 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.594 1.557 . . . . 0.0 108.132 178.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -123.6 120.28 32.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.257 1.423 . . . . 0.0 107.771 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.52 169.25 15.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.314 1.046 . . . . 0.0 109.214 176.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -133.59 -167.25 1.9 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.557 1.543 . . . . 0.0 108.245 169.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.26 -27.09 2.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.955 2.102 . . . . 0.0 113.409 169.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -136.53 -31.25 0.88 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 111.947 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.0 m -63.81 -20.51 65.84 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.807 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -52.24 -58.38 6.81 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.247 0.931 . . . . 0.0 109.272 169.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -62.58 -43.18 99.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.908 -0.495 . . . . 0.0 110.316 -176.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.79 83.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.193 -174.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -81.34 -16.13 53.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.207 1.003 . . . . 0.0 112.927 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -114.2 -4.19 13.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.446 1.021 . . . . 0.0 113.578 -169.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 m -73.4 -4.57 34.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.66 156.98 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.806 1.242 . . . . 0.0 109.554 -177.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.09 -163.36 45.24 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 124.754 1.169 . . . . 0.0 112.058 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.46 134.97 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.82 149.13 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 113.679 -1.6 . . . . 0.0 108.674 -168.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.4 tp -119.0 100.89 7.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.982 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.84 144.77 25.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -139.49 148.85 43.25 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.417 1.487 . . . . 0.0 108.724 -173.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.34 105.5 7.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -169.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.57 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.1 p-90 -123.7 151.58 42.99 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.237 1.815 . . . . 0.0 107.62 -169.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -166.75 163.09 11.08 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.689 0.677 . . . . 0.0 111.316 173.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.32 -10.42 8.51 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.179 3.253 . . . . 0.0 116.534 -177.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -50.12 -49.33 52.21 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.472 -1.251 . . . . 0.0 112.482 -177.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -152.67 168.57 25.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -173.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.24 -54.07 3.91 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 127.865 2.65 . . . . 0.0 115.821 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -53.33 -29.73 49.09 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.597 2.699 . . . . 0.0 114.816 -173.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -61.02 -14.89 26.33 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.779 1.172 . . . . 0.0 114.047 174.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 8.78 19.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.6 1.56 . . . . 0.0 111.167 177.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.8 mtp -125.16 -44.91 1.87 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.477 1.111 . . . . 0.0 108.441 -175.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.91 -35.95 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 -59.28 10.49 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.275 1.03 . . . . 0.0 112.356 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.71 -40.75 61.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.188 1.925 . . . . 0.0 111.607 174.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -40.15 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.238 0.615 . . . . 0.0 110.865 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.82 -43.72 74.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.935 0.789 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.49 -35.16 80.07 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.99 0.814 . . . . 0.0 109.93 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.53 -17.55 62.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.507 1.523 . . . . 0.0 112.536 174.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -87.63 -44.42 11.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.48 1.112 . . . . 0.0 108.674 176.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -70.23 -36.41 74.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.137 -0.352 . . . . 0.0 110.934 -175.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -69.1 -8.52 46.09 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.919 -0.563 . . . . 0.0 112.32 175.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.91 -46.49 4.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.496 1.118 . . . . 0.0 111.23 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.6 ptm -135.63 15.98 3.37 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.063 0.945 . . . . 0.0 112.304 -171.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.89 -4.82 11.79 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 120.978 -1.077 . . . . 0.0 114.228 170.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.06 -23.33 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.752 0.821 . . . . 0.0 111.054 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -14.38 8.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.259 1.024 . . . . 0.0 112.262 -174.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -129.06 142.01 51.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.515 1.126 . . . . 0.0 111.854 -168.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.52 146.86 27.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 168.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.6 mt -123.49 144.59 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.03 143.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.57 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 29.2 mtpt -118.56 150.48 39.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.65 0.659 . . . . 0.0 110.197 174.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -118.91 127.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 169.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.49 105.12 12.4 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.297 34.6 m -79.64 46.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -152.2 -38.77 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.549 1.14 . . . . 0.0 109.435 168.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -78.79 -52.34 8.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.948 1.299 . . . . 0.0 110.101 177.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.04 46.0 2.47 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.884 1.274 . . . . 0.0 110.052 -172.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.62 2.83 5.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.75 1.62 . . . . 0.0 113.032 -176.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.7 -45.46 89.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.104 1.361 . . . . 0.0 111.102 -169.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -59.64 -36.16 75.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.386 0.994 . . . . 0.0 111.469 173.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.58 -58.41 3.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.67 -39.2 45.8 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.075 0.845 . . . . 0.0 113.807 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.11 -43.45 98.41 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.008 1.404 . . . . 0.0 110.821 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -74.92 -11.46 60.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.356 0.662 . . . . 0.0 111.745 173.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.85 55.56 13.73 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.065 1.317 . . . . 0.0 109.85 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.64 -46.89 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 117.911 0.855 . . . . 0.0 109.495 -169.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mtm 53.87 14.6 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 127.936 2.494 . . . . 0.0 113.583 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.6 m -135.59 163.6 29.75 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.835 1.198 . . . . 0.0 112.993 -168.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mm -135.09 137.61 27.34 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.975 0.91 . . . . 0.0 110.176 -177.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.74 125.85 10.38 Favored 'Cis proline' 0 N--CA 1.454 -0.846 0 N-CA-C 105.496 -2.54 . . . . 0.0 105.496 -11.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.8 m -85.4 146.36 27.02 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tp -137.21 125.49 23.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.05 108.3 13.21 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 177.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.8 129.79 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.4 156.31 42.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -142.2 138.7 31.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 44.17 28.45 0.27 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.867 2.067 . . . . 0.0 114.258 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.06 41.62 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 124.725 1.155 . . . . 0.0 115.748 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -130.95 143.62 50.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.735 1.268 . . . . 0.0 110.414 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 134.03 30.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -125.73 -22.74 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.356 1.063 . . . . 0.0 109.925 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.81 161.98 40.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.601 1.161 . . . . 0.0 109.534 169.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 148.64 29.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.006 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -154.16 155.89 36.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.56 72.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.29 154.83 9.05 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.954 -171.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -65.25 149.21 50.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.212 0.605 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.59 140.29 20.08 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.72 169.19 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 175.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -45.91 67.22 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.038 0.935 . . . . 0.0 112.078 -171.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.12 -43.82 77.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.45 0.114 . . . . 0.0 110.864 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.44 83.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.12 -0.362 . . . . 0.0 110.171 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 tp -68.17 -46.59 70.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.515 0.326 . . . . 0.0 110.781 178.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -62.65 -38.74 91.48 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.71 -45.64 91.82 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.579 0.627 . . . . 0.0 110.906 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.8 tp -58.65 -36.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.988 1.315 . . . . 0.0 111.644 -175.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.08 -40.78 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.469 174.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -56.99 -34.32 67.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.989 0.916 . . . . 0.0 111.555 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.52 -6.82 33.2 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.09 -22.9 4.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.904 1.282 . . . . 0.0 112.736 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.254 2.222 . . . . 0.0 109.063 170.378 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mpp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.91 139.29 58.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.524 0.73 . . . . 0.0 110.177 -178.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.453 0.1 OUTLIER 31.15 103.21 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.441 3.096 . . . . 0.0 119.129 -179.067 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.84 120.36 23.35 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.35 140.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -169.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.16 145.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -131.41 150.51 52.12 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.704 0.802 . . . . 0.0 110.548 -168.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -113.61 143.37 44.69 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.911 1.284 . . . . 0.0 107.582 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.8 tp -145.52 109.21 4.73 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -169.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -166.81 153.66 8.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.173 0.989 . . . . 0.0 109.974 -178.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 94.8 m -38.43 116.52 0.55 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.22 2.208 . . . . 0.0 113.607 -169.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.31 8.45 31.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.01 0.814 . . . . 0.0 113.763 172.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . 0.559 HD21 ' NE2' ' B' ' 18' ' ' GLN . 7.4 t30 52.53 20.63 1.53 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.919 1.288 . . . . 0.0 112.384 -169.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 10.5 m -67.27 133.8 50.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.427 -0.795 . . . . 0.0 109.933 -174.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 56.53 -85.65 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 169.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -40.74 67.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.998 0.817 . . . . 0.0 111.829 -169.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -33.76 76.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.03 0.932 . . . . 0.0 111.403 -177.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.559 ' NE2' HD21 ' B' ' 13' ' ' ASN . 41.2 mm-40 -68.95 -52.28 30.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.63 1.572 . . . . 0.0 108.949 175.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 11.3 ptp -65.83 -37.55 86.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.712 -174.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.41 80.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.979 -0.534 . . . . 0.0 110.495 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.73 -28.29 66.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.976 176.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.02 -46.37 10.52 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 119.217 0.917 . . . . 0.0 111.215 173.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -53.59 -44.06 69.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 124.712 1.205 . . . . 0.0 111.223 173.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -49.73 72.21 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.97 -28.47 70.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.665 -171.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.69 -15.81 62.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.425 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 1.1 m-85 -127.29 -17.37 4.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.4 -124.53 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.24 -168.6 38.03 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.55 -18.68 31.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.262 1.425 . . . . 0.0 112.361 172.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -55.83 -20.57 15.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.468 1.507 . . . . 0.0 111.192 169.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -134.16 168.2 19.27 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.334 1.453 . . . . 0.0 111.516 -177.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -137.42 126.13 23.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 169.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.23 124.37 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -169.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -135.13 169.49 17.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.034 0.934 . . . . 0.0 109.068 177.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -146.92 140.35 25.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.96 177.36 9.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.888 . . . . 0.0 112.227 -177.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 -175.2 44.8 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.453 1.025 . . . . 0.0 112.349 176.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.437 HG13 ' HE3' ' B' ' 88' ' ' LYS . 2.4 tt -41.06 -64.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.062 . . . . 0.0 114.607 -170.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.15 31.93 4.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.394 2.278 . . . . 0.0 107.014 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.55 138.58 40.45 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -168.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -177.86 21.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 129.054 2.942 . . . . 0.0 108.414 169.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.42 58.09 4.42 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 117.111 1.605 . . . . 0.0 117.111 -168.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.7 tp -67.85 115.22 7.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.174 1.987 . . . . 0.0 106.897 168.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -110.13 130.27 23.03 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -174.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -21.18 51.75 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.274 1.982 . . . . 0.0 112.887 177.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.56 -35.55 79.83 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.764 1.166 . . . . 0.0 111.654 172.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.64 -33.19 53.61 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.871 0.76 . . . . 0.0 109.621 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.09 -49.9 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -59.39 -45.77 90.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.377 -0.827 . . . . 0.0 110.807 176.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.63 69.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.353 1.061 . . . . 0.0 111.526 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -77.11 -40.86 44.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.818 0.847 . . . . 0.0 110.001 176.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.26 -27.67 69.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.502 178.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.8 -30.27 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.84 1.2 . . . . 0.0 111.85 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.08 16.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.221 1.408 . . . . 0.0 110.81 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.07 28.44 72.92 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.162 -1.354 . . . . 0.0 113.491 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.41 152.05 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 169.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -124.18 140.17 53.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.3 pt -135.94 17.77 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.979 1.312 . . . . 0.0 110.868 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -59.44 -17.07 27.91 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.421 -0.799 . . . . 0.0 111.978 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -77.9 -18.03 56.61 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.282 1.833 . . . . 0.0 113.907 174.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -65.59 167.14 9.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.697 1.237 . . . . 0.0 112.761 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -153.21 174.98 13.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.653 1.981 . . . . 0.0 106.681 170.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -149.89 174.46 12.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.623 0.769 . . . . 0.0 110.318 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -161.55 164.35 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.876 1.67 . . . . 0.0 109.217 -169.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 pt -63.02 165.57 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.702 1.201 . . . . 0.0 112.716 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.58 128.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -134.75 100.14 4.53 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.698 1.237 . . . . 0.0 108.34 -176.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.3 m -46.28 -29.82 1.79 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.132 2.173 . . . . 0.0 113.674 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.87 -25.22 68.18 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.392 0.996 . . . . 0.0 111.446 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.92 -42.14 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.35 -49.44 76.96 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.608 1.094 . . . . 0.0 110.199 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -27.76 69.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 110.95 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -84.9 -20.18 31.14 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.817 1.247 . . . . 0.0 112.413 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.19 157.16 10.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.295 1.045 . . . . 0.0 110.649 175.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.7 -33.29 20.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.776 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -146.28 135.0 22.29 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.954 -169.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.0 t -111.29 116.08 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 126.222 1.809 . . . . 0.0 107.559 172.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 46.3 t -88.81 105.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -70.99 134.51 47.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 167.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.4 tp -132.54 38.89 3.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 62.3 p -169.04 -40.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.299 -0.875 . . . . 0.0 109.35 169.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.28 10.46 84.67 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -172.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.81 137.33 39.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.798 0.799 . . . . 0.0 110.634 -169.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.74 -17.03 61.16 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -170.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.39 -12.3 60.03 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.589 1.086 . . . . 0.0 112.453 -173.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -73.74 3.13 6.89 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -169.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 88' ' ' LYS . . . . . 0.437 ' HE3' HG13 ' B' ' 39' ' ' ILE . 61.4 mttt 88.15 5.0 0.25 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.441 2.696 . . . . 0.0 110.018 -169.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 21.0 m 33.57 54.68 1.38 Allowed Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 127.052 2.141 . . . . 0.0 111.063 -169.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.51 140.89 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.917 3.078 . . . . 0.0 114.255 -168.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.21 4.43 52.28 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -172.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.1 p 44.24 86.22 0.14 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.453 1.501 . . . . 0.0 113.259 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -55.09 143.1 75.56 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 122.505 2.137 . . . . 0.0 109.534 -172.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.44 4.47 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.605 1 C-N-CA 126.041 4.494 . . . . 0.0 117.572 -168.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.04 -5.42 21.8 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.452 -0.78 . . . . 0.0 111.995 169.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.6 148.56 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.678 1.191 . . . . 0.0 110.492 -168.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -84.63 157.23 21.23 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -144.09 148.53 35.25 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.561 -1.337 . . . . 0.0 109.701 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -152.32 151.52 30.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.99 126.34 42.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -118.44 -3.09 10.96 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.506 1.122 . . . . 0.0 111.329 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.65 142.07 13.44 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 175.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.84 12.32 1.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.006 2.123 . . . . 0.0 109.922 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -154.32 164.01 39.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.069 2.547 . . . . 0.0 105.973 -173.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -147.41 109.79 3.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 118.9 0.773 . . . . 0.0 110.072 -171.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' B' ' 108' ' ' ARG . 72.9 Cg_endo -72.35 -21.61 22.81 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.237 3.291 . . . . 0.0 112.678 -172.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.35 2.72 0.55 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.681 1.193 . . . . 0.0 112.518 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' B' ' 106' ' ' PRO . 7.6 mmm180 -123.71 13.85 9.34 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.438 1.495 . . . . 0.0 111.309 -177.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.79 148.08 1.13 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.225 1.01 . . . . 0.0 111.38 177.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -56.2 -46.94 79.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.091 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.05 -16.31 4.71 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 169.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.25 158.47 34.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -37.53 78.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.422 0.629 . . . . 0.0 111.262 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.58 -43.26 60.2 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.926 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.97 -28.82 60.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 121.126 1.785 . . . . 0.0 110.078 -172.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -60.43 -59.39 5.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.739 0.7 . . . . 0.0 109.722 171.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.84 -39.66 89.9 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.17 97.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.572 -0.705 . . . . 0.0 112.133 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.54 -46.44 85.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -62.8 -46.16 89.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -64.18 -46.38 84.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.358 1.063 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 41.1 ttp-105 -58.69 -49.67 76.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.66 -42.65 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.234 -175.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -65.75 -37.06 85.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.611 1.55 . . . . 0.0 111.993 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.89 -46.36 90.95 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.293 0.37 . . . . 0.0 110.495 175.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.91 -50.9 62.8 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.152 0.581 . . . . 0.0 110.687 -179.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.69 -49.84 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.242 1.017 . . . . 0.0 109.483 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.26 96.15 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 119.017 -0.88 . . . . 0.0 111.828 -174.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -61.04 -45.89 92.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.704 1.252 . . . . 0.0 110.642 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.42 -39.85 92.64 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.696 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.37 -33.69 71.73 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 119.137 0.88 . . . . 0.0 111.715 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.425 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 39.8 ttmt -65.73 -42.78 90.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.22 174.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.8 -38.72 86.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.144 -1.407 . . . . 0.0 111.106 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.77 -38.26 78.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 121.691 2.041 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.2 -34.53 72.25 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.67 -46.79 11.13 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.297 1.039 . . . . 0.0 111.591 -177.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 61.1 p -84.05 -27.64 28.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.238 1.815 . . . . 0.0 111.396 -169.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.72 25.65 51.97 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -168.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.103 0 C-N-CA 126.745 2.018 . . . . 0.0 112.467 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 tpp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.25 171.33 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.31 1.444 . . . . 0.0 107.401 167.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.04 96.7 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.94 165.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -126.21 144.03 50.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.51 175.1 6.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.731 1.212 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -158.52 -169.09 2.62 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.696 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -43.81 -36.1 2.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.739 2.816 . . . . 0.0 115.533 -163.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.25 -25.01 2.51 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.551 1.141 . . . . 0.0 111.5 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 m -64.95 -17.57 64.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.528 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -49.46 -58.02 5.94 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.1 0.864 . . . . 0.0 109.27 166.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -43.21 99.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.782 0.833 . . . . 0.0 110.621 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -23.04 62.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -99.44 -17.01 18.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.228 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -110.29 -12.43 14.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.182 1.355 . . . . 0.0 113.621 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m -63.9 -11.17 25.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -139.91 156.59 46.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.063 1.301 . . . . 0.0 109.055 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.57 53.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.37 133.2 68.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.1 t -143.93 135.31 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -161.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.6 tp -111.31 99.5 8.29 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.37 138.07 33.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.58 153.56 50.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 109.218 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -133.89 120.08 19.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -170.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.548 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -143.16 154.31 43.76 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.231 1.412 . . . . 0.0 108.501 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.8 165.16 8.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.799 0.84 . . . . 0.0 109.025 170.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.37 -19.09 6.21 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.72 2.947 . . . . 0.0 116.483 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -55.09 -25.73 33.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.194 1.398 . . . . 0.0 114.493 -173.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -138.63 159.37 42.27 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.481 1.037 . . . . 0.0 111.441 -166.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.82 -48.87 31.88 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.554 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -47.92 -29.33 11.57 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.005 3.136 . . . . 0.0 115.352 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 m -53.41 -26.93 21.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.58 1.082 . . . . 0.0 113.26 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -108.46 10.89 27.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.827 1.251 . . . . 0.0 111.322 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -118.73 -42.55 2.73 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.481 1.113 . . . . 0.0 109.438 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.82 -34.73 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.854 -0.529 . . . . 0.0 109.584 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.42 -57.98 22.93 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.617 -1.182 . . . . 0.0 112.68 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.55 -33.97 54.33 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.604 1.609 . . . . 0.0 111.5 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.04 -40.03 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.525 1.057 . . . . 0.0 110.965 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 mt -70.82 -37.59 73.23 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.254 0.934 . . . . 0.0 110.725 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.16 -36.36 81.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.117 0.871 . . . . 0.0 110.475 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.62 -25.28 64.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.454 1.102 . . . . 0.0 111.059 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.31 -46.42 23.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.136 0.975 . . . . 0.0 109.862 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.61 -43.19 99.31 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 122.796 0.438 . . . . 0.0 111.444 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.13 -9.32 58.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -97.33 -48.81 5.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.274 0.943 . . . . 0.0 110.875 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.6 ptm -137.7 13.89 2.94 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -15.04 33.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.019 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.03 -25.45 58.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.758 1.279 . . . . 0.0 112.508 168.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 -10.47 10.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.653 0.781 . . . . 0.0 112.432 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -132.19 135.66 46.5 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.223 0.92 . . . . 0.0 109.612 -162.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -95.68 144.54 26.01 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 164.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.95 142.49 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.58 147.36 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.548 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 40.5 mtpt -127.18 148.24 50.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.514 0.597 . . . . 0.0 110.742 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 121.2 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 167.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.56 110.94 9.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 164.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.283 27.6 m -87.34 48.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 122.263 1.03 . . . . 0.0 112.357 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -141.06 -40.67 0.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.454 1.102 . . . . 0.0 109.228 154.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -76.06 -40.61 52.84 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.913 0.885 . . . . 0.0 111.461 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.94 24.59 4.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.807 1.243 . . . . 0.0 110.621 -167.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.4 -5.15 6.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.45 -44.33 84.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.262 0.937 . . . . 0.0 110.796 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -60.61 -41.04 94.01 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.698 0.681 . . . . 0.0 110.488 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -53.66 42.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.181 0.592 . . . . 0.0 109.493 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.69 95.33 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.19 -47.97 83.34 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.155 0.982 . . . . 0.0 110.893 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.93 -22.48 60.72 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.192 0.451 . . . . 0.0 111.424 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.4 19.09 31.1 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.221 0.915 . . . . 0.0 112.025 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -76.02 142.14 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 163.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.422 ' CE ' HD13 ' B' ' 72' ' ' LEU . 1.9 ptm -151.47 22.17 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.886 0.474 . . . . 0.0 111.914 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.69 156.18 40.8 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.445 -0.784 . . . . 0.0 110.893 -153.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.1 mm -130.41 138.74 33.72 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.377 -168.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.8 162.58 83.93 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 N-CA-C 108.299 -1.462 . . . . 0.0 108.299 -22.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.6 m -132.94 150.12 52.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 169.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.2 mt -143.16 127.75 18.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -170.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -124.1 115.29 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.62 126.2 45.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -123.81 155.11 38.58 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.595 0.758 . . . . 0.0 109.553 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -144.29 144.49 31.51 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 161.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.5 t70 43.81 35.9 1.19 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.833 1.653 . . . . 0.0 113.687 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.56 15.61 59.8 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.938 -1.479 . . . . 0.0 115.776 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.68 149.77 45.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.49 2.145 . . . . 0.0 110.784 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.81 143.25 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 m -132.31 -18.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.485 1.114 . . . . 0.0 112.162 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.02 156.79 43.31 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.78 32.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -173.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.3 m -150.31 139.84 21.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.408 HG12 ' HD3' ' B' ' 88' ' ' LYS . 62.1 t -136.71 45.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -171.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.68 156.04 23.23 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.665 1.126 . . . . 0.0 110.374 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.09 147.79 46.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.303 1.441 . . . . 0.0 111.378 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.3 141.88 33.23 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.612 1.565 . . . . 0.0 107.683 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.21 167.06 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.501 2.134 . . . . 0.0 110.63 167.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -50.34 -51.33 46.54 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.915 1.286 . . . . 0.0 112.726 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.12 -39.83 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 110.368 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.91 -38.29 76.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.789 -0.569 . . . . 0.0 110.856 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.78 -39.8 80.01 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.462 0.574 . . . . 0.0 110.77 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.15 -39.86 94.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.44 0.563 . . . . 0.0 109.686 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.72 -44.62 96.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.972 0.509 . . . . 0.0 110.626 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.24 -43.47 70.9 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.217 1.007 . . . . 0.0 111.383 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.4 p -84.04 -35.24 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.975 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -58.11 -27.58 63.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.416 1.007 . . . . 0.0 112.632 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -54.72 -27.54 41.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.166 0.986 . . . . 0.0 113.568 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -128.79 -21.28 3.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.341 0.973 . . . . 0.0 112.581 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.424 1.49 . . . . 0.0 109.771 167.426 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -73.42 92.56 1.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 m120 113.14 127.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 130.916 3.686 . . . . 0.0 107.575 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -143.47 111.84 6.32 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.97 133.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 146.97 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.863 1.665 . . . . 0.0 107.287 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.42 ' CD2' HD12 ' B' ' 72' ' ' LEU . 0.8 OUTLIER -127.54 143.53 51.17 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.905 0.882 . . . . 0.0 110.137 -165.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -106.33 140.89 38.54 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.2 114.38 15.0 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.37 140.23 15.1 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.475 0.484 . . . . 0.0 111.389 -166.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -50.6 121.97 6.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.997 1.319 . . . . 0.0 110.628 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.13 -14.94 1.47 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.598 1.571 . . . . 0.0 114.601 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 45.18 24.31 0.13 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.505 1.922 . . . . 0.0 113.117 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -73.98 -34.74 64.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.413 -0.805 . . . . 0.0 110.877 -166.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.53 -69.71 0.47 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -161.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' B' ' 105' ' ' ASP . 11.6 mtm105 -58.67 -44.97 90.36 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.683 -171.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.32 -37.91 84.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.064 0.847 . . . . 0.0 110.516 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -61.41 -43.37 98.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.135 0.574 . . . . 0.0 109.812 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.16 -48.16 79.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.957 1.303 . . . . 0.0 109.732 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.54 77.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.389 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.2 -28.29 64.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.806 1.184 . . . . 0.0 110.911 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.39 -50.04 57.79 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.416 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 42.1 m95 -59.77 -43.45 94.33 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.373 0.587 . . . . 0.0 111.649 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.6 -55.65 29.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 109.419 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -69.62 -10.97 60.36 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -80.1 -9.26 59.69 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.575 1.534 . . . . 0.0 112.897 171.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -129.97 -24.62 2.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.531 1.132 . . . . 0.0 112.794 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.3 mt -105.81 94.27 5.09 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.64 -165.04 5.59 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.814 0.721 . . . . 0.0 112.425 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.84 -17.36 15.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.306 1.442 . . . . 0.0 113.37 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.489 1.515 . . . . 0.0 112.363 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -127.28 161.25 29.04 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.086 1.754 . . . . 0.0 109.617 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -134.08 133.63 41.35 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.0 t -129.86 126.57 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -164.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.84 162.51 33.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.815 1.246 . . . . 0.0 109.065 -173.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 7.1 m -150.91 135.83 17.42 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.76 177.65 10.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.94 0.791 . . . . 0.0 112.134 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.26 176.51 46.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.892 1.234 . . . . 0.0 111.216 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 tt -36.77 -55.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.896 2.078 . . . . 0.0 114.876 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -134.29 31.38 3.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.153 1.381 . . . . 0.0 108.671 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.52 145.35 44.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.999 1.32 . . . . 0.0 112.604 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t60 148.33 84.66 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 130.534 3.533 . . . . 0.0 105.544 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.85 157.61 16.73 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.403 1.001 . . . . 0.0 111.197 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -139.65 93.7 2.69 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -66.31 127.58 93.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.55 -20.88 59.48 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.363 2.042 . . . . 0.0 113.015 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.71 80.32 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.455 1.025 . . . . 0.0 111.689 174.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.68 66.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.58 0.627 . . . . 0.0 109.875 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.2 -51.99 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.11 -45.6 79.43 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.809 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.32 75.76 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.696 0.68 . . . . 0.0 111.513 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.2 mmm -76.42 -32.64 58.6 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.4 -0.812 . . . . 0.0 111.709 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -62.92 -28.22 69.91 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.084 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.19 -25.07 58.4 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.77 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.4 m -121.83 16.32 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.846 1.259 . . . . 0.0 111.186 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.23 34.9 81.73 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.312 -0.716 . . . . 0.0 113.147 171.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -117.1 135.97 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -98.69 135.13 40.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 pt -134.44 10.56 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.581 0.752 . . . . 0.0 111.77 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.7 m -60.01 -23.7 63.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.306 1.042 . . . . 0.0 112.695 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -77.36 -18.01 57.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.013 1.325 . . . . 0.0 113.339 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.54 166.72 14.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.198 0.999 . . . . 0.0 112.8 -167.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.6 p -139.43 -177.68 5.04 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.003 2.121 . . . . 0.0 108.22 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.6 p -159.42 171.06 20.44 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -149.77 164.82 34.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 pt -61.95 164.04 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.189 0.518 . . . . 0.0 110.4 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.415 HG23 ' H ' ' B' ' 67' ' ' ILE . 4.9 pt -48.63 128.96 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 109.306 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -137.71 98.55 3.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.798 1.285 . . . . 0.0 109.98 -172.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.71 -28.8 36.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.216 2.606 . . . . 0.0 112.638 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.58 -24.26 67.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.948 0.795 . . . . 0.0 111.628 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.62 -40.85 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.962 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.422 HD13 ' CE ' ' A' ' 70' ' ' MET . 9.8 tt -62.45 -48.46 79.54 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.266 1.394 . . . . 0.0 110.536 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -18.65 65.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.467 1.03 . . . . 0.0 111.874 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.62 -13.29 52.05 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.211 1.004 . . . . 0.0 112.032 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 166.08 15.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.034 0.833 . . . . 0.0 110.773 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.72 -27.62 16.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 111.155 168.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.59 128.13 15.07 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.826 1.25 . . . . 0.0 107.776 -161.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.03 118.26 56.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -83.86 110.71 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 165.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -67.94 123.98 22.11 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 156.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.1 tp -118.57 31.43 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.521 0.728 . . . . 0.0 109.974 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.534 0.329 0 C-N-CA 125.072 1.349 . . . . 0.0 108.162 172.749 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 119.465 -0.303 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.48 19.58 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.679 1.592 . . . . 0.0 114.833 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LYS . . . . . 0.408 ' HD3' HG12 ' A' ' 88' ' ' VAL . 13.9 ttmm 67.83 25.42 7.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.198 1.399 . . . . 0.0 112.459 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 30.4 m 36.85 53.59 2.65 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 0.0 114.497 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.71 150.27 54.32 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.439 2.093 . . . . 0.0 112.123 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.63 3.09 15.5 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -170.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p 40.81 89.55 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.435 2.294 . . . . 0.0 114.123 166.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.69 151.98 59.52 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.62 1.01 4.72 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.064 3.176 . . . . 0.0 114.242 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 42.8 m170 -61.69 -16.25 47.31 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.6 143.64 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.179 0.992 . . . . 0.0 109.362 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -79.25 151.99 30.84 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -136.32 147.23 47.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -152.07 158.9 43.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 161.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -97.5 131.17 44.37 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -123.1 -29.36 3.9 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.553 1.141 . . . . 0.0 110.175 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -79.57 161.45 46.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 168.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.54 -4.47 0.33 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.709 0.803 . . . . 0.0 112.305 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -158.1 170.89 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.698 1.999 . . . . 0.0 107.259 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' B' ' 16' ' ' ARG . 56.4 t0 -136.17 113.64 10.54 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 123.833 0.853 . . . . 0.0 110.992 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.47 -19.85 54.69 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.166 2.577 . . . . 0.0 112.893 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.95 -7.92 32.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.157 0.89 . . . . 0.0 112.092 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -115.51 19.33 15.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.202 1.401 . . . . 0.0 110.604 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.76 155.24 2.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.858 0.863 . . . . 0.0 111.043 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -57.66 -29.37 64.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.116 0.966 . . . . 0.0 112.42 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.46 -8.66 30.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.661 -1.077 . . . . 0.0 113.89 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 76.6 p -67.43 156.64 36.08 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.169 1.484 . . . . 0.0 107.825 166.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.64 -39.38 84.17 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.705 -0.622 . . . . 0.0 110.145 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.2 -44.56 68.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.326 0.65 . . . . 0.0 111.203 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -70.56 -35.7 73.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.383 0.992 . . . . 0.0 110.043 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -56.86 -58.34 8.54 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.137 0.881 . . . . 0.0 109.641 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -60.27 -42.02 94.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.992 0.814 . . . . 0.0 110.342 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.44 92.15 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.495 1.043 . . . . 0.0 111.885 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -62.97 -46.96 85.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.117 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -58.08 -50.75 72.37 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -64.48 -43.27 94.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.821 1.248 . . . . 0.0 111.312 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -63.91 -47.95 78.53 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.595 0.634 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.65 -35.97 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.416 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.9 tmm_? -62.21 -45.44 93.37 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.665 1.186 . . . . 0.0 110.45 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.1 -42.43 96.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.046 0.384 . . . . 0.0 110.683 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.58 -54.35 37.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.063 0.545 . . . . 0.0 110.304 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.56 -43.55 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.401 1.081 . . . . 0.0 109.322 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.38 75.51 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 118.652 0.66 . . . . 0.0 111.794 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -59.77 -44.03 94.07 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.098 0.449 . . . . 0.0 110.906 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -63.26 -45.69 90.34 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.769 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.9 mm? -67.32 -36.41 81.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.504 1.047 . . . . 0.0 110.461 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -61.33 -45.76 93.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.316 0.507 . . . . 0.0 110.028 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.08 -44.21 94.93 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.535 0.607 . . . . 0.0 110.586 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.22 -38.51 80.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.882 0.765 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.16 72.22 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.734 0.697 . . . . 0.0 112.163 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.49 -41.92 23.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.31 0.644 . . . . 0.0 110.529 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 76.6 p -85.19 -34.53 22.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.478 0.581 . . . . 0.0 111.578 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.7 64.15 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 118.365 -1.241 . . . . 0.0 112.701 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.172 2.189 . . . . 0.0 111.591 -163.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.03 157.03 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.78 2.432 . . . . 0.0 112.756 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.61 112.94 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.82 168.66 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.86 1.664 . . . . 0.0 108.274 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -124.31 117.67 25.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.665 1.586 . . . . 0.0 108.477 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -84.9 171.41 12.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.6 1.16 . . . . 0.0 110.595 174.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -155.85 -178.19 7.11 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.085 1.754 . . . . 0.0 107.313 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -37.0 -33.94 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 130.932 3.693 . . . . 0.0 117.004 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.06 -31.76 0.9 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.822 1.249 . . . . 0.0 110.926 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -60.76 -19.23 58.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.692 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -47.19 -50.02 21.61 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 120.028 1.286 . . . . 0.0 109.874 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -66.09 -43.83 86.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.078 0.399 . . . . 0.0 110.211 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.96 85.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.545 0.212 . . . . 0.0 110.56 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -74.12 -13.76 60.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.745 1.218 . . . . 0.0 112.593 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -121.76 0.58 9.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.785 1.175 . . . . 0.0 113.134 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.9 m -74.87 -2.85 28.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.541 0.737 . . . . 0.0 112.949 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.66 156.47 45.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.128 0.971 . . . . 0.0 110.485 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.19 -161.56 37.5 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.377 1.465 . . . . 0.0 112.063 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.23 129.62 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.66 155.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.629 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 tp -128.83 91.5 3.23 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.767 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.5 148.58 33.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -141.65 148.43 39.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.819 1.248 . . . . 0.0 109.238 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -130.15 109.62 10.96 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.693 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.7 p-90 -130.93 149.88 52.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.834 1.653 . . . . 0.0 108.155 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -172.98 164.05 3.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 109.42 169.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.53 -16.02 9.93 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.82 3.014 . . . . 0.0 116.691 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.457 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 24.6 m95 -50.46 -28.78 8.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.735 1.614 . . . . 0.0 113.74 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.88 146.36 51.6 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 119.14 0.882 . . . . 0.0 111.811 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.14 -50.26 61.42 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.596 -1.113 . . . . 0.0 110.706 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -46.58 -26.65 4.49 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.222 3.281 . . . . 0.0 116.867 170.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 m -57.77 -29.58 64.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 121.4 1.909 . . . . 0.0 112.286 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -97.65 9.35 42.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.283 1.033 . . . . 0.0 111.813 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -119.61 -43.1 2.6 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.062 0.945 . . . . 0.0 109.602 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.15 -34.76 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.607 0.763 . . . . 0.0 109.066 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.18 -61.25 6.26 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.9 -41.19 64.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.958 1.772 . . . . 0.0 111.659 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.24 -40.57 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.06 0.544 . . . . 0.0 110.819 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 mt -73.08 -38.49 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.4 0.546 . . . . 0.0 110.292 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.92 -34.14 77.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.284 0.947 . . . . 0.0 109.833 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.91 -27.47 64.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.96 1.304 . . . . 0.0 111.603 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.81 -43.59 45.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.48 1.112 . . . . 0.0 110.195 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.61 -35.98 62.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.22 -13.21 62.07 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.378 -0.826 . . . . 0.0 112.019 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -49.7 5.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.743 1.617 . . . . 0.0 110.504 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.5 16.68 2.74 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.805 0.842 . . . . 0.0 111.741 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.06 -3.22 22.19 Favored Glycine 0 CA--C 1.521 0.446 0 O-C-N 121.23 -0.919 . . . . 0.0 113.974 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.34 -24.15 65.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.333 1.053 . . . . 0.0 111.104 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.44 -20.95 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.523 1.129 . . . . 0.0 112.226 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.64 149.66 46.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 110.874 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.36 150.48 40.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.529 1.532 . . . . 0.0 108.335 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mt -130.39 140.89 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 6' ' ' ALA . 12.6 t -136.78 108.92 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.693 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 21.6 mtpp -84.68 151.14 24.65 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.367 -0.833 . . . . 0.0 109.757 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -113.59 128.03 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.26 103.78 11.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.88 48.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.075 1.35 . . . . 0.0 112.092 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -156.11 -43.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.833 1.253 . . . . 0.0 109.578 168.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.27 -36.5 29.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 109.868 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -133.24 27.11 4.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 111.925 -168.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -69.76 -5.31 24.43 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -50.0 -49.69 49.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.582 1.953 . . . . 0.0 110.647 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.6 m -58.26 -35.95 72.53 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 123.122 0.569 . . . . 0.0 111.466 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.54 0.84 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.15 -45.31 15.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.204 0.907 . . . . 0.0 113.625 170.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.097 0.948 . . . . 0.0 111.033 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.99 -30.48 67.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.177 0.444 . . . . 0.0 110.36 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.27 67.65 0.81 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.6 t -139.17 127.67 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.422 ' SD ' HD12 ' B' ' 67' ' ' ILE 0.315 0.1 OUTLIER -137.3 17.11 2.96 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.883 0.311 . . . . 0.0 111.22 174.61 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 p -137.48 159.89 40.67 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.884 2.474 . . . . 0.0 110.722 -170.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.14 149.02 56.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.03 148.09 87.43 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 109.701 -0.923 . . . . 0.0 109.701 -10.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -122.76 145.16 48.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.21 136.55 54.78 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.976 1.71 . . . . 0.0 106.518 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.4 mt -121.44 102.7 8.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.69 122.53 38.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.88 153.19 44.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.521 1.128 . . . . 0.0 108.12 -171.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -140.23 138.65 35.23 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.88 27.29 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.541 1.937 . . . . 0.0 114.412 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 15.97 43.1 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.083 1.325 . . . . 0.0 115.945 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -130.85 142.8 50.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.038 1.419 . . . . 0.0 110.524 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.28 140.71 19.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.35 -21.59 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.185 0.994 . . . . 0.0 109.985 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.64 161.6 41.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.174 1.389 . . . . 0.0 109.087 169.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.23 148.3 31.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -149.99 145.99 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.721 HG12 ' HD3' ' B' ' 88' ' ' LYS . 11.1 t -137.82 67.74 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.41 157.86 10.18 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.16 1.838 . . . . 0.0 109.02 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -74.33 157.8 35.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.933 0.493 . . . . 0.0 111.107 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.43 145.33 25.83 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.64 165.88 30.54 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.528 2.152 . . . . 0.0 110.704 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -45.95 -47.88 16.45 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.373 1.869 . . . . 0.0 112.416 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.17 -43.34 74.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.477 0.581 . . . . 0.0 111.23 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.3 -32.79 74.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.745 -0.597 . . . . 0.0 110.72 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -52.18 64.35 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.937 0.895 . . . . 0.0 109.903 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.96 -38.84 92.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.1 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.69 -46.29 90.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.704 0.684 . . . . 0.0 111.437 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.52 -40.78 79.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.755 1.222 . . . . 0.0 111.198 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -88.05 -39.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.885 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 12.3 t30 -56.37 -34.88 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.517 1.053 . . . . 0.0 111.801 -176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.08 -6.96 25.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.56 -27.11 3.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.668 1.187 . . . . 0.0 112.666 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 19.5 tp . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.988 2.115 . . . . 0.0 109.388 171.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.78 143.38 44.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.1 m120 63.77 119.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.184 0 C-N-CA 128.71 2.804 . . . . 0.0 110.639 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -164.26 134.3 4.05 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mt -106.65 143.25 17.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.41 143.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.45 144.39 51.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.489 0.715 . . . . 0.0 111.553 -168.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -103.58 144.04 31.96 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.8 tp -128.97 114.47 16.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 75.4 m -142.77 135.41 27.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.871 0.868 . . . . 0.0 111.139 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -48.75 113.7 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.737 1.215 . . . . 0.0 110.976 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.53 8.41 51.52 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.941 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 7.02 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 130.738 3.615 . . . . 0.0 115.536 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -142.28 5.96 1.69 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.01 -70.24 0.26 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.794 1.179 . . . . 0.0 112.385 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -47.2 -52.98 14.31 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.09 0.859 . . . . 0.0 110.495 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -55.63 -52.44 63.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.067 1.747 . . . . 0.0 111.801 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -53.85 -50.07 67.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.094 0.958 . . . . 0.0 110.606 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.0 ttm -62.59 -42.24 99.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.269 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.86 82.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.619 -1.181 . . . . 0.0 112.019 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.59 -45.65 89.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.732 1.605 . . . . 0.0 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.89 -43.63 57.85 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -58.07 -39.45 78.52 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.993 0.896 . . . . 0.0 111.495 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.23 62.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -65.26 -24.22 67.26 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.779 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.19 -14.98 63.28 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -126.46 -12.01 6.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.934 1.293 . . . . 0.0 113.131 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.11 85.6 2.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.89 -165.92 0.89 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.073 1.321 . . . . 0.0 113.173 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.79 -17.82 18.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.653 1.181 . . . . 0.0 113.214 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.57 -21.31 25.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.884 1.673 . . . . 0.0 112.411 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -127.83 161.62 28.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.391 1.476 . . . . 0.0 109.158 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -132.79 135.53 45.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -125.34 132.17 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -169.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -143.08 171.23 14.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.773 1.629 . . . . 0.0 108.035 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 81.7 p -158.92 154.07 25.34 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.519 -0.738 . . . . 0.0 110.788 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.06 169.97 23.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.904 0.881 . . . . 0.0 111.807 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.43 -176.22 39.18 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.592 0.615 . . . . 0.0 112.578 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 tt -50.73 -57.44 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.007 1.723 . . . . 0.0 114.043 -172.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -133.1 29.68 4.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.75 1.62 . . . . 0.0 108.816 -169.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 159.19 34.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.956 2.102 . . . . 0.0 113.06 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 136.24 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 130.723 3.609 . . . . 0.0 104.782 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.93 29.55 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -172.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.56 82.62 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -62.76 128.88 92.49 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -58.6 -23.34 64.77 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.093 1.862 . . . . 0.0 112.953 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.444 HD21 ' HG2' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -62.8 -36.06 81.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.821 1.191 . . . . 0.0 111.305 172.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.43 64.9 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.749 0.704 . . . . 0.0 110.073 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.56 -51.26 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -59.56 -43.95 93.42 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 123.2 0.6 . . . . 0.0 110.593 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.28 -31.38 63.57 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 112.523 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -37.05 24.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.254 -0.904 . . . . 0.0 110.493 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.44 -24.67 67.93 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.288 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.79 -32.84 60.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.948 1.249 . . . . 0.0 111.633 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 m -114.56 15.89 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.285 1.434 . . . . 0.0 110.997 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.17 34.98 91.37 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.283 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -106.01 132.65 52.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.64 135.89 33.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.5 ' C ' ' H ' ' B' ' 61' ' ' ASN . 13.6 pt -132.31 20.9 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.482 0.713 . . . . 0.0 110.829 169.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -70.96 24.42 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.793 0.837 . . . . 0.0 112.067 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.5 ' H ' ' C ' ' B' ' 59' ' ' ILE . 12.1 p30 -143.86 -4.47 0.84 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.841 3.657 . . . . 0.0 110.755 -169.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.33 153.55 20.36 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.307 0.958 . . . . 0.0 110.341 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 55.1 p -134.28 -175.71 3.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.549 1.94 . . . . 0.0 108.863 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 23.5 p -155.87 -177.18 6.38 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -163.56 165.22 23.78 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.232 1.813 . . . . 0.0 107.79 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.84 167.18 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.551 0.741 . . . . 0.0 111.728 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.422 HD12 ' SD ' ' A' ' 70' ' ' MET . 0.2 OUTLIER -48.33 131.08 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.225 1.01 . . . . 0.0 108.671 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -146.01 97.12 2.91 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.279 1.037 . . . . 0.0 109.409 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 17.5 m -47.87 -26.62 1.75 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.02 1.728 . . . . 0.0 114.603 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.27 -18.04 60.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.153 1.342 . . . . 0.0 112.647 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.24 -33.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 109.184 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -61.63 -60.14 4.13 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.036 0.834 . . . . 0.0 109.17 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -24.42 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.748 0.704 . . . . 0.0 110.836 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -75.59 -23.37 56.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.777 . . . . 0.0 112.588 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 173.29 1.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.687 1.195 . . . . 0.0 112.155 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.15 -33.91 12.46 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.869 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -139.41 139.35 37.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.331 1.452 . . . . 0.0 109.395 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.8 t -117.01 96.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -80.16 115.11 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 47.9 m -71.75 131.43 43.09 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 tp -135.08 6.09 3.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -167.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-N 120.219 1.372 . . . . 0.0 114.271 -169.324 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.239 0 CA-C-O 119.372 -0.347 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.51 11.99 2.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.56 0.744 . . . . 0.0 112.726 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LYS . . . . . 0.721 ' HD3' HG12 ' A' ' 88' ' ' VAL . 14.2 ttmm 90.17 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.306 2.642 . . . . 0.0 111.127 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m 31.38 54.85 0.85 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 126.987 2.115 . . . . 0.0 113.151 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.46 135.31 47.24 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 CA-C-N 120.602 1.251 . . . . 0.0 112.173 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.59 6.05 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -171.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p 38.36 93.9 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 127.838 2.455 . . . . 0.0 114.379 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -56.15 141.39 87.69 Favored 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 122.485 2.123 . . . . 0.0 108.26 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -61.78 -1.3 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.323 3.349 . . . . 0.0 116.95 -168.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -69.15 -9.38 52.52 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.164 0.893 . . . . 0.0 112.829 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 144.93 36.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.906 1.282 . . . . 0.0 111.192 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -73.84 153.18 40.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -146.83 143.78 28.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.779 0.718 . . . . 0.0 109.498 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -150.15 144.21 25.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.52 127.7 33.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -111.85 -12.31 13.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.185 0.994 . . . . 0.0 110.591 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.58 161.42 31.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -158.24 26.81 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.788 1.235 . . . . 0.0 110.541 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -149.47 161.54 41.91 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.871 2.469 . . . . 0.0 106.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -147.54 139.55 14.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.228 0.922 . . . . 0.0 109.291 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.444 ' HG2' HD21 ' B' ' 47' ' ' ASN . 91.3 Cg_endo -78.0 -19.16 12.51 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.437 2.092 . . . . 0.0 113.336 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.82 -4.06 11.44 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.837 1.199 . . . . 0.0 111.03 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -98.41 6.22 47.44 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.427 1.091 . . . . 0.0 111.05 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.02 153.38 1.38 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.114 0.566 . . . . 0.0 110.065 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -54.42 -43.81 71.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.8 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.34 -19.59 2.64 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.6 p -69.53 165.92 20.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.38 -42.16 99.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.527 0.68 . . . . 0.0 110.289 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.61 -42.82 77.57 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 116.929 -1.51 . . . . 0.0 109.326 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.28 -35.26 61.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 121.184 1.811 . . . . 0.0 109.693 -173.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -55.3 -56.6 18.13 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 118.501 0.591 . . . . 0.0 110.693 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -64.35 -40.45 95.89 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.886 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.77 91.62 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.804 0.842 . . . . 0.0 111.765 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.55 -49.88 69.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.284 2.6 p90 -71.1 -27.06 63.32 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.793 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -64.53 -51.35 63.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.558 1.072 . . . . 0.0 109.668 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -59.83 -51.33 70.19 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.38 -43.76 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.575 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.53 -46.51 80.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.876 1.216 . . . . 0.0 111.533 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.01 -44.47 96.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 123.217 0.323 . . . . 0.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -51.66 59.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.369 0.668 . . . . 0.0 110.467 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.77 -45.49 91.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.536 1.134 . . . . 0.0 110.176 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.38 -44.01 91.41 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -60.26 -49.08 79.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.458 1.129 . . . . 0.0 111.306 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -59.01 -44.03 91.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.837 0.455 . . . . 0.0 110.803 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.72 -36.41 67.78 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.757 0.708 . . . . 0.0 111.696 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -66.95 -49.74 64.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.845 -0.534 . . . . 0.0 110.426 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -61.5 -38.26 86.7 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.742 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -56.15 -38.81 71.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.95 1.25 . . . . 0.0 111.077 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.37 -31.53 71.43 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -87.88 -47.85 8.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.839 1.656 . . . . 0.0 111.629 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.0 p -83.63 -28.18 28.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.672 2.389 . . . . 0.0 110.983 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.25 17.18 55.61 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.613 -1.104 . . . . 0.0 111.473 -168.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.249 1.06 0 C-N-CA 127.93 2.492 . . . . 0.0 112.003 -169.941 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.59 172.55 18.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.03 1.732 . . . . 0.0 107.067 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.88 96.2 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 102.845 -3.021 . . . . 0.0 102.845 168.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.28 168.69 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.831 1.652 . . . . 0.0 108.115 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.25 111.77 16.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.14 1.376 . . . . 0.0 108.358 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -80.9 172.8 13.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.574 1.15 . . . . 0.0 110.527 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -155.34 -174.87 5.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.933 2.093 . . . . 0.0 105.898 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -41.19 -36.81 0.8 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.019 2.527 . . . . 0.0 115.572 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -129.85 -30.19 2.05 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.559 1.144 . . . . 0.0 111.522 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 m -61.57 -22.74 65.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.059 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.65 -55.62 18.31 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.384 0.993 . . . . 0.0 108.773 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -62.11 -43.79 98.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.139 -0.35 . . . . 0.0 110.183 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.78 82.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.386 0.136 . . . . 0.0 111.295 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -79.84 -13.79 59.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.412 1.085 . . . . 0.0 113.143 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.5 p -118.33 -3.94 10.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.604 1.093 . . . . 0.0 113.535 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -73.75 -5.02 38.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.24 155.7 45.98 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.461 1.104 . . . . 0.0 109.825 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.64 -163.04 44.12 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.843 1.211 . . . . 0.0 112.163 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.43 132.14 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.37 149.82 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 113.45 -1.705 . . . . 0.0 107.797 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tt -124.98 100.83 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.931 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.17 148.72 26.61 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -142.41 149.7 39.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -130.06 115.54 17.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -169.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.62 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.5 p-90 -137.58 154.35 49.8 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.901 1.68 . . . . 0.0 108.007 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -174.48 162.15 2.69 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.068 0.947 . . . . 0.0 108.95 169.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.97 -19.04 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.635 2.89 . . . . 0.0 116.895 -174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.44 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 10.3 m95 -52.62 -33.88 48.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.837 1.198 . . . . 0.0 114.078 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.15 163.23 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.972 0.805 . . . . 0.0 112.76 -169.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.12 -48.78 57.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.923 -1.487 . . . . 0.0 113.197 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.78 -27.59 20.63 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.571 2.847 . . . . 0.0 115.397 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 m -57.17 -23.77 49.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.695 1.134 . . . . 0.0 113.25 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -108.87 12.71 25.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.111 0.964 . . . . 0.0 111.575 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -122.71 -44.11 2.23 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.292 1.037 . . . . 0.0 109.67 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -64.38 -34.22 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 121.685 -0.634 . . . . 0.0 109.451 169.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.47 11.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.911 -1.042 . . . . 0.0 112.39 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -59.05 -41.03 65.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.967 1.778 . . . . 0.0 111.631 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.46 -40.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.115 0.566 . . . . 0.0 110.877 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.8 mt -73.59 -40.92 63.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.691 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.87 -34.51 78.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.013 0.824 . . . . 0.0 109.737 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -70.35 -21.39 62.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.077 1.351 . . . . 0.0 112.184 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.89 -42.09 18.14 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 119.161 0.892 . . . . 0.0 110.125 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.39 -37.61 85.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.944 -0.472 . . . . 0.0 110.831 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -72.21 -4.86 31.87 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -107.71 -43.17 4.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.674 1.589 . . . . 0.0 111.032 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.63 15.57 2.34 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.363 0.665 . . . . 0.0 112.535 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.79 -2.18 11.24 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.392 -0.817 . . . . 0.0 113.867 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.86 -24.0 65.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.328 1.051 . . . . 0.0 111.147 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -11.7 8.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.74 0.816 . . . . 0.0 112.682 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -139.4 149.54 44.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.32 1.048 . . . . 0.0 111.622 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.99 147.67 38.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.068 1.747 . . . . 0.0 108.327 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mt -119.41 143.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 6' ' ' ALA . 5.0 t -137.44 109.32 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.6 mtpp -84.03 151.78 24.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.341 -0.85 . . . . 0.0 109.3 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mm -118.99 120.86 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 170.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.59 105.94 7.95 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 33.9 m -78.43 49.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -156.01 -41.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.801 1.241 . . . . 0.0 108.977 167.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.73 -33.98 21.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.063 0.945 . . . . 0.0 111.079 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -134.05 27.99 3.84 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.518 1.527 . . . . 0.0 110.796 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -72.09 -5.74 37.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.825 0.85 . . . . 0.0 112.898 -170.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -53.27 -48.17 68.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.3 1.84 . . . . 0.0 110.769 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 m -56.29 -41.57 76.1 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.091 0.556 . . . . 0.0 110.837 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.96 -64.57 0.83 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.67 -43.82 11.74 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.985 0.802 . . . . 0.0 113.454 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.02 -44.63 95.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.24 1.02 . . . . 0.0 111.663 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -73.64 -21.35 60.32 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.477 0.58 . . . . 0.0 111.731 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.03 64.72 0.99 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.05 129.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.5 ptm -150.64 23.11 0.79 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.74 161.44 35.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.101 1.76 . . . . 0.0 112.027 -168.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.1 136.98 29.67 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.53 146.51 47.78 Favored 'Cis proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.067 -1.551 . . . . 0.0 108.067 -10.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -116.58 151.72 35.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 169.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tt -148.82 123.7 9.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -170.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.5 mt -122.24 106.09 10.81 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.54 131.96 33.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.88 158.33 39.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.815 0.846 . . . . 0.0 109.382 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -144.27 139.64 28.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 44.95 28.35 0.36 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.605 1.962 . . . . 0.0 113.761 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.56 10.32 47.67 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 116.103 1.201 . . . . 0.0 116.103 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -133.72 145.17 49.62 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.909 1.354 . . . . 0.0 111.528 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.25 137.37 24.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.96 -19.41 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.51 1.124 . . . . 0.0 111.635 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.8 159.18 43.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.001 0.819 . . . . 0.0 110.185 169.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.62 147.94 28.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -171.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.2 m -152.58 147.55 26.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.8 t -133.63 64.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.56 159.57 10.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.236 1.874 . . . . 0.0 109.535 -169.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.53 167.86 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.578 0.751 . . . . 0.0 112.032 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -150.31 141.58 14.91 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.422 1.489 . . . . 0.0 107.459 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.88 165.95 29.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.118 . . . . 0.0 110.388 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.98 -48.71 21.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.74 1.616 . . . . 0.0 112.39 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.1 -42.79 79.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.161 0.437 . . . . 0.0 110.897 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.39 -29.95 68.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.035 -0.416 . . . . 0.0 111.011 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -52.3 61.09 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.934 0.894 . . . . 0.0 109.207 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -63.6 -36.28 83.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.799 -0.62 . . . . 0.0 109.654 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.15 -46.46 88.87 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.678 0.672 . . . . 0.0 111.224 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.9 tp -54.64 -40.39 68.93 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.073 0.949 . . . . 0.0 110.96 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.27 -41.14 13.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 118.819 -0.61 . . . . 0.0 112.071 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -56.7 -33.55 66.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.581 1.082 . . . . 0.0 111.45 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -70.07 -6.47 34.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -127.66 -21.98 3.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.168 1.387 . . . . 0.0 112.659 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--O 1.249 1.072 0 C-N-CA 127.286 2.234 . . . . 0.0 109.05 171.319 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -139.36 41.45 2.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.314 1.045 . . . . 0.0 109.36 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m120 130.58 132.77 0.0 OUTLIER 'General case' 0 C--N 1.341 0.198 1 C-N-CA 132.385 4.274 . . . . 0.0 107.513 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.402 ' HE3' ' CE3' ' B' ' 32' ' ' TRP . 53.1 pttt -157.08 145.85 19.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 130.175 3.39 . . . . 0.0 102.499 168.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.49 139.44 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 118.755 0.707 . . . . 0.0 109.431 -168.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.68 140.0 46.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -132.04 149.01 52.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.4 155.48 31.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.392 0.542 . . . . 0.0 110.11 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -133.2 132.4 41.49 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.028 1.331 . . . . 0.0 107.925 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -162.26 157.24 22.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.3 m -47.8 107.88 0.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.996 1.318 . . . . 0.0 111.435 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.75 59.4 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.685 -1.064 . . . . 0.0 113.443 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.324 0.3 OUTLIER 39.01 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.537 2.735 . . . . 0.0 116.044 -173.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -64.85 169.05 5.51 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.284 1.04 . . . . 0.0 108.543 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 46.37 -94.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.425 2.29 . . . . 0.0 113.717 169.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.67 -50.06 64.0 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.774 1.63 . . . . 0.0 111.219 -169.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.2 m -66.97 -41.7 86.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.237 0.926 . . . . 0.0 112.17 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -59.41 -49.3 78.32 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.402 1.096 . . . . 0.0 109.823 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 18.9 ttm -65.31 -40.57 93.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.429 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.69 -36.86 73.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.068 0.947 . . . . 0.0 110.297 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.94 60.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 109.911 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.7 -46.23 62.26 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -55.37 -44.19 75.82 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.611 0.764 . . . . 0.0 111.483 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.77 61.91 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.121 0.568 . . . . 0.0 110.108 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.458 ' HE3' ' HB ' ' B' ' 34' ' ' VAL . 65.2 mttt -65.64 -20.57 66.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.509 -168.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.87 -14.74 62.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.384 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -40.21 2.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.791 1.178 . . . . 0.0 112.382 174.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' B' ' 135' ' ' ALA . 10.0 mp -79.76 75.68 6.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.41 -163.6 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.575 2.036 . . . . 0.0 112.564 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.49 -13.86 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.752 1.221 . . . . 0.0 113.21 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -57.69 -23.79 53.45 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.928 168.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' TRP . . . . . 0.402 ' CE3' ' HE3' ' B' ' 4' ' ' LYS . 41.7 m95 -127.63 171.36 11.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.391 2.276 . . . . 0.0 110.424 -177.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -139.74 129.32 24.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 168.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.458 ' HB ' ' HE3' ' B' ' 25' ' ' LYS . 13.9 t -123.18 129.02 75.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -171.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -143.09 169.33 17.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.396 1.478 . . . . 0.0 108.536 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 74.6 p -154.97 162.83 40.97 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.415 -0.803 . . . . 0.0 110.867 172.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 178.77 9.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.344 1.458 . . . . 0.0 108.859 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.27 -176.62 44.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 tt -48.8 -52.96 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.089 1.756 . . . . 0.0 113.991 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -130.36 26.27 5.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.909 2.084 . . . . 0.0 107.992 -169.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.9 46.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.705 1.602 . . . . 0.0 112.965 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 78.4 t60 133.85 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 131.244 3.817 . . . . 0.0 104.458 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.13 175.5 46.58 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -153.21 102.78 2.65 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 171.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -73.56 126.09 90.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.44 -22.18 70.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.861 1.707 . . . . 0.0 112.514 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.406 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -59.54 -37.5 78.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.252 0.933 . . . . 0.0 110.796 170.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -73.32 -38.58 65.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.32 -55.88 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.6 -45.9 77.37 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.274 0.63 . . . . 0.0 111.06 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.12 -33.51 65.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.448 1.099 . . . . 0.0 112.512 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 1.1 mmt -82.54 -38.87 23.13 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.934 0.893 . . . . 0.0 110.453 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -60.83 -29.7 69.65 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.896 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.98 -31.46 60.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.471 1.032 . . . . 0.0 111.814 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.95 15.1 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.146 1.379 . . . . 0.0 110.821 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.78 34.03 81.82 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.163 -1.354 . . . . 0.0 113.034 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -107.43 149.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.07 135.12 54.8 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.84 22.68 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.94 1.296 . . . . 0.0 110.448 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -67.59 14.73 0.05 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.4 13.69 2.17 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.047 2.139 . . . . 0.0 111.641 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -53.3 162.38 0.75 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.309 -1.494 . . . . 0.0 113.559 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -149.63 161.16 42.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.22 2.208 . . . . 0.0 105.619 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 67.1 m -157.89 -172.87 4.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.89 1.276 . . . . 0.0 109.021 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.55 163.67 24.51 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.149 1.379 . . . . 0.0 109.389 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.0 165.75 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.227 1.011 . . . . 0.0 111.411 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 pt -50.29 128.59 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.199 0.6 . . . . 0.0 110.452 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -143.14 104.5 4.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.261 1.029 . . . . 0.0 109.575 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -53.55 -25.65 17.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.682 1.593 . . . . 0.0 113.282 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -17.64 62.91 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.591 1.087 . . . . 0.0 112.498 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -129.78 -37.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.146 0.978 . . . . 0.0 108.903 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.29 -50.19 28.95 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.1 0.863 . . . . 0.0 110.254 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -24.41 67.54 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.928 0.786 . . . . 0.0 110.7 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -73.75 -23.05 59.69 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.119 1.368 . . . . 0.0 112.337 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.0 166.56 3.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.939 1.295 . . . . 0.0 112.268 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.75 -34.15 17.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.709 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.639 HD13 ' HD2' ' B' ' 97' ' ' LYS . 18.6 tp -146.93 139.87 25.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 0.0 110.594 -170.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.81 110.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 125.976 1.711 . . . . 0.0 107.786 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.78 102.3 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 75.4 m -71.37 128.75 36.9 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 68.5 mt -136.14 64.19 1.57 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.298 1.039 . . . . 0.0 109.178 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.234 0.261 0 O-C-N 121.554 -0.716 . . . . 0.0 110.457 171.07 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -66.47 20.04 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -170.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm 71.67 21.03 4.48 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.071 -1.643 . . . . 0.0 111.948 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.0 m 29.24 56.97 0.68 Allowed Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 128.369 2.668 . . . . 0.0 113.162 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.55 132.29 48.13 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.609 2.206 . . . . 0.0 112.856 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.453 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.55 4.06 33.78 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -175.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.5 p 41.64 94.1 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.222 2.209 . . . . 0.0 113.494 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -60.0 143.87 99.53 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.203 1.935 . . . . 0.0 110.488 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.21 -2.83 5.27 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.509 3.473 . . . . 0.0 115.028 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -63.92 -11.62 29.79 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.829 0.852 . . . . 0.0 111.678 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.41 143.94 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 109.605 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.639 ' HD2' HD13 ' B' ' 77' ' ' LEU . 3.3 tmmm? -73.18 159.02 34.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -145.6 146.95 31.56 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.49 -1.381 . . . . 0.0 109.35 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -146.86 156.51 43.16 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -114.98 133.29 56.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.337 1.455 . . . . 0.0 108.1 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.11 1.29 1.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.04 -62.27 2.5 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 39.9 p90 47.49 14.72 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.23 2.612 . . . . 0.0 115.328 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -161.24 161.9 30.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.174 2.19 . . . . 0.0 106.473 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -141.94 105.91 5.76 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.175 0.99 . . . . 0.0 110.427 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.76 -10.92 18.45 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.636 3.558 . . . . 0.0 112.981 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.58 0.28 5.62 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.737 1.153 . . . . 0.0 111.517 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -121.22 -60.77 1.61 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . 43.39 -170.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 113.59 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -90.81 138.72 31.37 Favored 'General case' 0 C--O 1.236 0.388 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -83.0 56.82 5.08 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.641 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 p -121.65 164.16 17.79 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 169.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.18 -39.05 89.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.479 0.657 . . . . 0.0 110.61 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.04 -42.89 59.6 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.768 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -76.2 -29.93 57.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.941 1.246 . . . . 0.0 109.891 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.8 -59.6 4.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.792 0.724 . . . . 0.0 109.436 169.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -57.84 -41.97 83.45 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.97 90.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.869 0.868 . . . . 0.0 112.006 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -65.81 -43.85 87.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.158 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.3 m-30 -58.7 -47.57 84.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.219 0.918 . . . . 0.0 108.958 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -65.53 -43.71 89.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 111.111 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -60.67 -53.67 54.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.34 -41.4 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.414 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -36.87 85.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 120.299 1.409 . . . . 0.0 112.011 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.04 -41.49 90.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.996 0.362 . . . . 0.0 111.043 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.21 -49.09 68.47 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.996 0.519 . . . . 0.0 110.192 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -56.57 -47.66 81.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 124.216 1.006 . . . . 0.0 109.234 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.63 95.93 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 119.677 1.126 . . . . 0.0 111.737 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -65.12 -43.3 92.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.322 0.561 . . . . 0.0 111.584 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -48.13 81.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.012 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.7 mm? -65.26 -32.68 74.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.556 1.071 . . . . 0.0 111.208 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.06 -38.17 82.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.446 0.566 . . . . 0.0 110.677 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -62.13 -34.72 76.91 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.779 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' PHE . . . . . 0.43 ' CE2' ' HE3' ' B' ' 139' ' ' LYS . 20.9 m-85 -63.6 -35.79 81.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 122.325 2.329 . . . . 0.0 109.458 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' B' ' 28' ' ' LEU . . . -62.82 -36.54 83.53 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.138 0.575 . . . . 0.0 110.837 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -84.22 -43.76 14.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.194 1.398 . . . . 0.0 112.0 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -93.04 -21.41 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.442 1.897 . . . . 0.0 111.544 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.17 20.12 60.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.708 0.671 . . . . 0.0 111.463 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.43 ' HE3' ' CE2' ' B' ' 134' ' ' PHE . 10.3 tppt? . . . . . 0 C--O 1.251 1.178 0 C-N-CA 128.698 2.799 . . . . 0.0 112.692 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.84 171.25 20.75 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.871 1.668 . . . . 0.0 106.915 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.47 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -79.88 170.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.829 1.651 . . . . 0.0 107.42 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -124.75 129.81 51.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.906 1.282 . . . . 0.0 108.287 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.455 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -95.23 177.1 5.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.042 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 t -159.62 -173.56 4.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.399 1.88 . . . . 0.0 106.247 168.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -36.89 -36.58 0.12 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 129.599 3.159 . . . . 0.0 116.447 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -133.41 -29.87 1.35 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 111.438 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 m -60.46 -22.26 63.28 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.353 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -51.26 -54.02 29.95 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.18 0.9 . . . . 0.0 109.407 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -61.45 -44.08 97.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.045 -0.409 . . . . 0.0 110.033 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -36.46 81.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.999 -0.091 . . . . 0.0 111.204 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -80.13 -14.31 58.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.335 1.054 . . . . 0.0 113.252 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.2 p -117.79 -4.0 11.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.651 1.114 . . . . 0.0 112.907 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -72.85 -8.84 57.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.07 153.99 44.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.338 1.055 . . . . 0.0 109.246 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.67 -160.55 49.7 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.404 1.002 . . . . 0.0 111.532 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 t -113.96 129.15 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.19 122.2 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.151 -168.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -92.39 100.84 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 108.185 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.33 149.73 25.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.09 150.8 44.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.411 1.485 . . . . 0.0 109.284 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -132.84 113.04 12.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.4 p-90 -132.79 153.28 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.126 1.771 . . . . 0.0 107.416 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.81 165.04 7.27 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 119.146 0.885 . . . . 0.0 111.122 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.66 -18.08 8.09 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.147 3.231 . . . . 0.0 116.285 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -58.22 -19.65 35.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.798 1.181 . . . . 0.0 114.088 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.0 161.57 39.07 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.76 1.163 . . . . 0.0 113.814 -169.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.06 21.91 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.794 -1.559 . . . . 0.0 112.777 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.56 -27.33 18.89 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.326 2.684 . . . . 0.0 114.94 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -58.51 -18.36 28.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 113.839 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -113.48 11.57 18.44 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.524 1.13 . . . . 0.0 111.697 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mtm -121.35 -43.67 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.099 0.96 . . . . 0.0 109.467 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.1 -36.03 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.445 0.698 . . . . 0.0 109.272 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.37 -57.91 21.74 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.979 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -60.27 -39.56 66.78 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.962 1.775 . . . . 0.0 111.676 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG12 HD22 ' A' ' 96' ' ' LEU . 2.2 t -56.45 -36.78 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.27 1.028 . . . . 0.0 111.178 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.1 mt -72.36 -41.58 66.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.699 0.681 . . . . 0.0 110.687 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.84 -35.01 79.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.999 0.818 . . . . 0.0 109.848 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.16 -28.7 68.34 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.773 1.229 . . . . 0.0 112.06 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD11 ' SD ' ' A' ' 46' ' ' MET . 47.9 tp -76.41 -46.27 27.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.193 0.597 . . . . 0.0 110.282 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.38 -36.25 71.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.123 0.419 . . . . 0.0 110.759 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -68.42 -9.2 46.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.133 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.08 -51.96 3.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.168 0.987 . . . . 0.0 110.742 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.407 ' SD ' HD11 ' A' ' 42' ' ' LEU . 19.7 ptm -127.56 14.7 7.07 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.835 0.854 . . . . 0.0 112.238 -170.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.87 -6.44 12.22 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.082 -1.011 . . . . 0.0 114.209 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.37 -23.22 67.22 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.829 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.06 -15.08 8.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.688 1.195 . . . . 0.0 112.515 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 tp -127.95 149.8 50.17 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.749 1.22 . . . . 0.0 112.139 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -114.34 147.53 38.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.85 141.82 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 10.0 t -139.21 113.1 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpt -87.48 155.0 20.2 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.284 -0.885 . . . . 0.0 110.184 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -124.52 127.27 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 171.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -83.05 104.99 13.67 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.334 27.5 m -77.98 48.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -153.54 -42.71 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.481 1.513 . . . . 0.0 108.677 167.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.78 -42.62 19.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.688 0.676 . . . . 0.0 110.767 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -134.59 38.08 3.08 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.42 1.088 . . . . 0.0 111.053 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -69.25 -4.93 19.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.887 1.275 . . . . 0.0 113.147 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.74 -47.16 70.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.982 1.713 . . . . 0.0 111.049 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.3 m -58.81 -40.97 85.71 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.618 0.645 . . . . 0.0 111.061 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.87 -55.28 13.49 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.7 -45.26 39.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.934 0.778 . . . . 0.0 113.213 169.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.73 -41.39 95.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.226 1.013 . . . . 0.0 111.036 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -80.62 -5.45 56.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.151 0.981 . . . . 0.0 112.707 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.34 60.38 5.55 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.44 -64.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.46 ' CE ' HD13 ' B' ' 72' ' ' LEU . 10.5 mtm 58.89 5.14 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.389 2.676 . . . . 0.0 115.242 173.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.4 p -143.38 159.55 42.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.811 1.187 . . . . 0.0 112.921 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 141.54 41.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.79 151.33 71.78 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 N-CA-C 106.942 -1.984 . . . . 0.0 106.942 -11.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.7 m -123.99 147.01 48.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -122.99 138.17 54.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.188 1.795 . . . . 0.0 106.64 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.34 107.81 12.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.61 128.46 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.58 151.24 43.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.58 0.752 . . . . 0.0 109.496 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -137.73 135.92 36.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.0 t70 43.8 29.98 0.34 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.705 2.002 . . . . 0.0 114.432 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.59 15.74 42.24 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.548 1.071 . . . . 0.0 115.758 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -130.45 144.67 51.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.521 1.16 . . . . 0.0 110.115 172.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.11 134.45 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.94 -22.99 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.699 1.199 . . . . 0.0 110.091 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.17 165.69 28.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.967 0.907 . . . . 0.0 110.329 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 149.33 29.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.8 m -153.51 139.39 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 169.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.04 67.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -171.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.37 156.56 9.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.873 1.702 . . . . 0.0 109.596 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.9 148.22 51.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.157 0.583 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.66 142.11 27.47 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -70.07 166.34 28.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.355 2.036 . . . . 0.0 110.703 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -46.58 -47.05 19.88 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.494 1.918 . . . . 0.0 112.495 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.5 -43.29 77.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.931 0.787 . . . . 0.0 111.055 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.89 76.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.779 -0.575 . . . . 0.0 110.4 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.614 HD22 HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -58.04 -53.32 59.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.264 1.026 . . . . 0.0 109.707 173.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.05 -38.18 85.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.572 -174.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.03 -46.66 88.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.981 0.81 . . . . 0.0 111.146 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -58.09 -38.68 76.87 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.887 1.275 . . . . 0.0 111.682 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 p -88.74 -40.54 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.509 -0.281 . . . . 0.0 111.079 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -57.72 -32.83 67.8 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.406 1.082 . . . . 0.0 111.854 -176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -69.46 -5.96 27.28 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -126.63 -27.39 3.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.015 1.326 . . . . 0.0 112.581 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.247 0.952 0 C-N-CA 126.155 1.782 . . . . 0.0 107.539 169.92 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.63 19.43 2.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.162 0.985 . . . . 0.0 112.575 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -157.46 129.68 7.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -153.48 148.86 27.11 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 129.041 2.936 . . . . 0.0 104.649 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.35 146.38 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.28 144.29 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.59 141.38 49.66 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -116.47 145.46 43.28 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 mt -121.05 114.29 21.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 m -136.87 136.37 38.65 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.6 m -52.36 119.48 4.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.711 0.804 . . . . 0.0 109.344 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.25 0.29 5.67 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.724 1.631 . . . . 0.0 115.091 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.2 t30 44.1 26.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.919 2.088 . . . . 0.0 113.328 -169.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.8 m -68.43 -42.93 78.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.67 -61.85 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -54.97 -46.35 75.05 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 120.718 1.599 . . . . 0.0 111.48 -174.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.4 p -51.58 -49.55 61.88 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.9 1.68 . . . . 0.0 112.115 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.28 -46.78 85.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.099 0.96 . . . . 0.0 110.532 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 30.5 ttm -63.02 -45.22 93.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.41 90.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.085 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -27.52 58.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.424 1.465 . . . . 0.0 110.441 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.98 -50.99 42.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.01 -39.63 72.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.638 0.775 . . . . 0.0 111.41 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.37 -52.98 62.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -64.77 -23.19 67.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.8 -14.18 61.46 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -126.7 -16.67 5.19 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.609 1.163 . . . . 0.0 113.31 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -121.84 77.68 1.39 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.34 -161.3 1.01 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.685 1.612 . . . . 0.0 113.09 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.81 -20.83 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.438 -1.036 . . . . 0.0 113.18 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -58.73 -16.3 15.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.506 1.922 . . . . 0.0 112.889 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -128.29 156.95 42.21 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.406 1.882 . . . . 0.0 109.045 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -125.54 143.09 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.34 137.19 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.61 158.12 44.23 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.132 1.373 . . . . 0.0 108.222 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 77.3 p -147.18 150.2 34.45 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.75 172.84 17.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.067 0.947 . . . . 0.0 111.768 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.79 -172.27 35.43 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.266 0.936 . . . . 0.0 111.818 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 tt -53.88 -57.6 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 113.62 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.02 28.41 4.16 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.205 1.802 . . . . 0.0 108.002 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.83 148.18 40.22 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.896 2.078 . . . . 0.0 112.066 -170.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 145.16 66.22 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 131.568 3.947 . . . . 0.0 104.371 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.12 152.09 23.26 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -139.81 100.7 4.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -71.52 128.44 89.91 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -59.73 -21.86 65.11 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.028 1.819 . . . . 0.0 112.813 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -36.01 80.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.701 1.137 . . . . 0.0 111.293 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.56 -38.55 67.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.83 -51.62 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -59.05 -42.65 90.79 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.353 0.661 . . . . 0.0 110.727 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.51 -32.06 57.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.127 0.971 . . . . 0.0 112.18 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 65.2 mmm -84.77 -34.67 22.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.176 0.898 . . . . 0.0 111.276 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -62.53 -24.05 67.3 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.163 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.0 -31.67 63.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.858 1.208 . . . . 0.0 111.673 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.66 15.11 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.196 1.398 . . . . 0.0 111.2 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.74 41.42 98.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.598 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.09 146.4 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -119.26 135.13 54.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.089 0.556 . . . . 0.0 109.967 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.62 25.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 126.969 2.108 . . . . 0.0 109.713 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.8 m -68.09 14.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.518 -1.364 . . . . 0.0 113.403 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.2 23.96 0.93 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.321 1.848 . . . . 0.0 112.251 -169.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -47.46 150.17 0.99 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.82 1.645 . . . . 0.0 114.013 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -128.32 41.17 3.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.851 2.06 . . . . 0.0 110.437 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 12.7 m -59.83 172.33 0.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.04 1.336 . . . . 0.0 113.375 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -166.22 168.2 15.45 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.392 1.477 . . . . 0.0 109.78 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.2 pt -65.37 170.69 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.032 1.333 . . . . 0.0 112.348 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -48.95 132.21 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.329 0.652 . . . . 0.0 109.241 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -138.26 95.96 3.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.915 1.34 . . . . 0.0 108.263 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -44.69 -31.18 1.09 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.741 2.017 . . . . 0.0 114.673 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.64 -22.77 62.47 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-N 119.298 0.954 . . . . 0.0 110.636 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -39.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.457 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.46 HD13 ' CE ' ' A' ' 70' ' ' MET . 7.5 tt -60.89 -50.92 71.48 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.616 1.098 . . . . 0.0 110.145 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -29.17 69.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.546 0.612 . . . . 0.0 111.353 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -85.31 -11.35 54.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.192 1.397 . . . . 0.0 112.743 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 171.12 5.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.742 0.782 . . . . 0.0 110.683 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -105.28 -12.62 15.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.171 0.989 . . . . 0.0 111.58 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.17 145.59 24.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.398 1.079 . . . . 0.0 109.252 173.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.64 99.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.4 102.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -65.39 119.56 11.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tp -135.31 53.29 1.98 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.627 0.771 . . . . 0.0 111.592 -167.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.631 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.43 20.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.328 2.651 . . . . 0.0 116.117 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 68.64 27.85 5.88 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.3 1.84 . . . . 0.0 112.859 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 33.96 48.32 0.56 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.085 2.154 . . . . 0.0 112.789 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.87 136.05 70.54 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.872 2.381 . . . . 0.0 112.451 -168.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.439 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.62 -1.37 50.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 116.71 -1.614 . . . . 0.0 114.852 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p 46.07 86.63 0.13 Allowed Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.374 1.47 . . . . 0.0 112.879 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -58.36 143.94 96.89 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.461 2.107 . . . . 0.0 110.112 -169.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.9 5.53 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 125.072 3.848 . . . . 0.0 116.212 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -63.95 -12.18 35.14 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 112.29 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.63 154.25 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 0.988 . . . . 0.0 111.375 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -74.33 156.25 37.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.488 1.915 . . . . 0.0 109.834 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.74 144.56 30.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.719 -1.238 . . . . 0.0 108.09 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.44 147.3 27.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -87.26 133.68 33.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.576 1.15 . . . . 0.0 109.658 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -140.32 25.01 2.27 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.704 1.601 . . . . 0.0 110.327 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.68 155.62 26.48 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -157.36 19.91 0.29 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.532 1.933 . . . . 0.0 109.05 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -170.24 175.55 4.87 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 129.257 3.023 . . . . 0.0 105.719 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -161.32 138.39 6.54 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 168.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.44 -17.43 21.09 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.743 . . . . 0.0 112.306 -170.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.93 6.62 1.15 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.681 1.128 . . . . 0.0 110.769 168.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -122.0 12.73 10.46 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 110.501 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.44 158.18 0.44 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -34.65 72.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.828 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.07 -15.1 6.53 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 115.759 1.064 . . . . 0.0 115.759 168.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.5 p -70.33 162.7 28.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.51 -40.11 95.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.515 0.674 . . . . 0.0 110.558 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.84 -42.79 85.18 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.09 -1.433 . . . . 0.0 109.087 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -73.99 -33.16 63.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.928 1.694 . . . . 0.0 109.73 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -56.54 -56.77 17.08 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 119.119 0.872 . . . . 0.0 110.721 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -64.27 -39.78 94.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.758 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.59 98.07 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.29 -0.881 . . . . 0.0 111.996 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.84 -51.54 61.52 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.285 1.3 p90 -70.12 -30.91 68.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 117.546 -1.216 . . . . 0.0 112.542 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -72.58 -41.65 65.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 120.268 1.395 . . . . 0.0 111.004 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -59.52 -54.1 50.48 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.108 0.963 . . . . 0.0 109.302 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.33 -39.42 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.449 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.413 ' HA ' ' SD ' ' B' ' 19' ' ' MET . 5.4 tmm_? -56.92 -45.36 82.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.339 1.427 . . . . 0.0 112.08 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.09 -45.48 94.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.076 0.398 . . . . 0.0 110.65 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.2 -41.58 73.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.713 0.233 . . . . 0.0 111.281 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -60.22 -47.84 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.337 -0.852 . . . . 0.0 109.275 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.76 97.04 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.934 0.788 . . . . 0.0 111.239 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -59.52 -50.83 72.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.379 1.089 . . . . 0.0 111.98 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -69.76 -33.14 72.01 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.506 -0.746 . . . . 0.0 111.448 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.1 mm? -69.1 -36.48 77.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.249 0.931 . . . . 0.0 111.023 175.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -57.05 -41.15 78.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.168 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.46 -36.41 75.91 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 116.487 -1.72 . . . . 0.0 112.375 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -64.97 -37.32 87.26 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 122.437 2.381 . . . . 0.0 111.111 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.74 70.8 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -91.85 -38.86 12.07 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 112.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 63.5 p -101.62 -19.27 15.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.335 1.854 . . . . 0.0 110.979 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.42 32.44 64.3 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.835 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 124.083 0.953 . . . . 0.0 111.499 -174.377 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.42 152.9 4.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.637 1.175 . . . . 0.0 109.924 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.23 95.46 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 168.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.06 167.16 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.338 1.455 . . . . 0.0 107.336 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -126.96 117.84 23.32 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -79.02 176.76 9.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.112 1.365 . . . . 0.0 110.264 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -154.77 -173.2 4.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.884 2.074 . . . . 0.0 106.048 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -39.55 -33.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.872 3.269 . . . . 0.0 116.511 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -133.52 -21.88 1.97 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.951 1.3 . . . . 0.0 112.234 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -38.39 75.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.136 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -71.03 123.88 23.09 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.7 m 116.83 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 1 C-N-CA 131.772 4.029 . . . . 0.0 105.471 -169.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.07 99.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.0 110.578 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -79.65 -8.77 59.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.473 1.509 . . . . 0.0 112.163 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 p -124.25 -2.09 8.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.44 1.018 . . . . 0.0 113.429 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.6 m -72.19 -10.61 60.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.81 155.75 45.57 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.792 0.724 . . . . 0.0 110.432 -172.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.86 -158.2 51.77 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 124.223 0.916 . . . . 0.0 110.999 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.66 124.22 71.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.05 115.7 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.156 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.7 tp -87.69 92.89 9.27 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 148.04 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -142.75 149.99 39.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -132.29 110.83 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.582 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.0 p-90 -131.08 152.73 50.07 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.806 1.643 . . . . 0.0 107.477 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.69 162.4 8.32 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 118.882 0.765 . . . . 0.0 110.297 169.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.88 -14.88 6.27 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.916 3.078 . . . . 0.0 115.993 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -61.49 -27.48 68.62 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.83 1.195 . . . . 0.0 113.663 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.66 154.95 47.64 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.448 1.022 . . . . 0.0 112.162 -169.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.93 -49.07 79.25 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 117.955 -1.469 . . . . 0.0 113.729 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.99 -24.71 25.65 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.035 2.49 . . . . 0.0 115.323 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 m -59.15 -21.25 59.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 120.249 1.386 . . . . 0.0 113.502 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.07 7.96 34.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.952 0.901 . . . . 0.0 111.89 174.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.1 mtm -118.59 -44.9 2.63 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.273 0.942 . . . . 0.0 109.562 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.11 -34.59 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.587 0.755 . . . . 0.0 109.301 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.4 ' HB3' ' CD ' ' A' ' 37' ' ' PRO . . . -54.84 -61.54 5.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.15 0.98 . . . . 0.0 112.243 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 36' ' ' ALA . 6.8 Cg_endo -60.06 -39.91 65.81 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.077 1.852 . . . . 0.0 111.84 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.26 -44.81 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.677 0.791 . . . . 0.0 110.429 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.39 -44.75 90.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.207 0.458 . . . . 0.0 110.094 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.17 -36.56 82.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.066 0.394 . . . . 0.0 110.441 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.19 -32.68 73.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.643 1.177 . . . . 0.0 111.908 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -72.78 -45.71 57.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.218 1.407 . . . . 0.0 109.889 175.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.82 -36.33 72.88 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.389 -0.82 . . . . 0.0 111.312 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.99 -6.65 29.09 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.129 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -104.86 -47.09 4.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.974 1.31 . . . . 0.0 111.585 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.4 ptm -134.58 18.19 3.6 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.402 0.681 . . . . 0.0 112.09 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 -6.77 24.02 Favored Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.871 -1.143 . . . . 0.0 113.82 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.74 -23.88 67.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.44 0.62 . . . . 0.0 110.807 169.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 -24.61 7.88 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.937 1.295 . . . . 0.0 111.59 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 tp -110.28 152.14 26.52 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 111.838 -169.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.73 148.48 49.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.94 144.05 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 11.0 t -138.25 111.19 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.582 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 33.1 mtpt -84.53 159.39 20.71 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.543 -0.723 . . . . 0.0 109.239 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.22 122.69 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 170.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.89 107.35 10.36 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 32.7 m -79.14 48.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.88 -45.52 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.461 1.505 . . . . 0.0 108.456 167.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.27 -36.39 34.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.984 0.914 . . . . 0.0 110.934 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -133.19 29.24 4.04 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 0.0 110.604 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -72.43 -5.99 40.48 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -54.15 -47.62 71.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.638 1.575 . . . . 0.0 110.902 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.2 m -56.11 -40.89 74.41 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.598 0.759 . . . . 0.0 111.367 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.76 -57.23 4.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.22 -42.46 41.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.836 0.732 . . . . 0.0 113.561 169.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -62.81 -43.39 98.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.364 1.082 . . . . 0.0 110.834 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -71.46 -31.61 67.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.077 0.399 . . . . 0.0 110.325 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.12 68.7 1.18 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 -170.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.68 -66.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.423 ' CE ' HD13 ' B' ' 72' ' ' LEU . 7.8 mtm 58.45 7.16 0.66 Allowed 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 127.472 2.309 . . . . 0.0 114.801 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -143.99 160.98 39.9 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.273 1.397 . . . . 0.0 112.991 -169.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 138.56 32.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 109.649 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.17 138.44 33.68 Favored 'Cis proline' 0 N--CA 1.449 -1.104 0 N-CA-C 105.866 -2.398 . . . . 0.0 105.866 -11.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -107.81 150.44 27.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 tp -141.36 123.23 15.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -170.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.0 mt -121.21 105.35 10.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.31 108.59 15.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.33 149.52 23.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -146.57 130.43 17.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.98 30.76 0.44 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.489 1.916 . . . . 0.0 113.329 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.06 8.66 55.13 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 171.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -133.31 151.61 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.765 1.226 . . . . 0.0 110.521 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -70.97 132.72 32.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.44 -23.01 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.981 1.313 . . . . 0.0 110.729 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -146.58 160.57 41.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.523 1.129 . . . . 0.0 109.769 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 148.53 30.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -152.08 149.52 28.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.36 -0.837 . . . . 0.0 108.905 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.75 62.76 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.03 154.12 9.43 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.973 1.273 . . . . 0.0 110.714 -170.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.31 162.9 9.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.426 1.491 . . . . 0.0 112.087 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.33 139.26 10.75 Favored Pre-proline 0 N--CA 1.469 0.486 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -69.43 171.35 14.26 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 111.012 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -38.69 -55.69 1.43 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.469 2.307 . . . . 0.0 111.924 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.88 -42.41 63.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.496 -173.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.68 78.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.849 -0.532 . . . . 0.0 110.992 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.86 -47.51 58.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.507 0.323 . . . . 0.0 110.283 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB2' HD13 ' A' ' 42' ' ' LEU . 7.9 pt20 -63.26 -35.72 81.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.38 -47.53 78.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.173 0.442 . . . . 0.0 110.713 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.72 -38.17 71.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.573 0.749 . . . . 0.0 111.587 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.33 -38.66 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.404 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.22 -25.75 64.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.363 0.983 . . . . 0.0 112.56 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -55.09 -26.08 35.65 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.675 0.79 . . . . 0.0 112.614 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.25 -28.42 3.69 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.438 1.095 . . . . 0.0 111.973 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.328 1.851 . . . . 0.0 108.19 174.453 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.43 22.12 1.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.899 0.88 . . . . 0.0 112.399 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.2 127.74 6.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -146.42 142.28 28.0 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 129.523 3.129 . . . . 0.0 105.273 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -125.4 142.6 41.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 109.0 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.1 151.05 31.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.836 1.254 . . . . 0.0 107.682 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -132.87 151.65 51.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.979 1.311 . . . . 0.0 108.26 -169.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -126.84 147.44 50.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.926 0.89 . . . . 0.0 109.212 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.57 130.41 38.37 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.774 0.83 . . . . 0.0 109.428 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -145.44 149.69 35.16 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.434 1.494 . . . . 0.0 110.351 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -59.63 130.17 45.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.79 37.18 8.96 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.025 1.774 . . . . 0.0 112.85 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -39.87 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.235 1.814 . . . . 0.0 114.961 -168.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.1 m -139.24 4.19 2.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.403 1.081 . . . . 0.0 111.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.88 -49.18 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -59.26 -57.22 13.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.831 1.651 . . . . 0.0 112.047 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -75.42 -26.15 58.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.287 0.949 . . . . 0.0 110.965 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -51.29 -49.66 60.82 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.805 1.642 . . . . 0.0 109.676 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.2 ttm -69.12 -45.2 70.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.659 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.38 90.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.879 0.871 . . . . 0.0 111.946 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -73.94 -33.27 63.86 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.175 0.898 . . . . 0.0 110.798 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.31 70.75 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -59.38 -40.89 87.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.715 0.806 . . . . 0.0 111.601 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.88 71.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -64.26 -24.81 67.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.07 -13.08 62.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -126.82 -8.47 6.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.82 1.248 . . . . 0.0 112.906 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -133.33 81.84 1.95 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -171.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 -161.88 2.14 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.442 1.496 . . . . 0.0 113.07 -171.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.23 -21.14 31.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.729 1.211 . . . . 0.0 113.373 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.14 -14.2 6.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.604 1.962 . . . . 0.0 113.008 169.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -136.48 158.17 45.06 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.094 1.758 . . . . 0.0 109.081 -174.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -132.68 151.38 51.98 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.5 t -135.41 142.9 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -145.32 161.6 39.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.332 0.653 . . . . 0.0 109.911 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.3 m -137.63 145.47 42.76 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.342 1.457 . . . . 0.0 109.165 -169.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.85 164.32 38.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.684 0.754 . . . . 0.0 112.179 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.43 -177.23 46.14 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.333 1.921 . . . . 0.0 108.875 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -57.19 -56.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.577 1.151 . . . . 0.0 112.813 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -132.17 23.76 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.76 2.024 . . . . 0.0 108.005 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.82 118.61 6.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.229 2.212 . . . . 0.0 111.01 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -161.7 -0.17 0.05 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.04 0.536 . . . . 0.0 111.626 169.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.86 168.63 51.25 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -144.71 77.12 1.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.51 131.5 90.67 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -172.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.63 -21.68 48.23 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.968 1.779 . . . . 0.0 112.755 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -37.38 83.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.863 1.211 . . . . 0.0 111.817 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.63 -38.09 65.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 119.099 0.863 . . . . 0.0 109.927 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.56 -51.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.12 -42.55 90.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.989 0.916 . . . . 0.0 110.679 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.78 -30.71 61.74 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.754 0.822 . . . . 0.0 112.304 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.1 mmm -86.41 -33.74 20.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.003 0.819 . . . . 0.0 111.134 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -62.19 -25.59 67.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.187 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -56.51 -30.16 62.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.918 1.236 . . . . 0.0 111.516 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 m -117.27 15.11 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.242 1.417 . . . . 0.0 111.195 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.6 39.95 97.18 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.946 -0.919 . . . . 0.0 112.879 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -115.38 126.99 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -87.15 134.56 33.51 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.917 -0.489 . . . . 0.0 109.752 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -131.51 14.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.288 0.635 . . . . 0.0 111.246 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -59.45 -20.14 52.93 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.171 0.896 . . . . 0.0 110.949 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -76.27 -11.28 59.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.4 2.28 . . . . 0.0 114.116 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -63.83 165.07 9.1 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.368 1.44 . . . . 0.0 113.164 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.2 p -128.44 -37.15 1.83 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.765 1.626 . . . . 0.0 112.08 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.2 m 64.51 162.03 0.12 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.759 2.023 . . . . 0.0 112.803 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -165.52 160.5 17.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.611 1.164 . . . . 0.0 110.212 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -78.14 178.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.731 2.012 . . . . 0.0 111.27 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.12 134.88 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -145.23 103.39 3.84 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.778 1.231 . . . . 0.0 108.283 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -48.26 -30.33 4.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.341 1.856 . . . . 0.0 113.748 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.61 -21.78 66.54 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.068 0.849 . . . . 0.0 111.716 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -118.7 -36.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 117.792 -1.099 . . . . 0.0 108.931 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.423 HD13 ' CE ' ' A' ' 70' ' ' MET . 6.3 tt -60.01 -51.38 69.89 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.876 1.217 . . . . 0.0 109.059 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.63 -27.59 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.07 0.85 . . . . 0.0 111.622 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -85.72 -18.48 32.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.519 1.128 . . . . 0.0 112.444 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.12 160.22 6.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.233 1.016 . . . . 0.0 111.235 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.9 -33.49 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.638 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.595 HD13 ' HD2' ' B' ' 97' ' ' LYS . 13.4 tp -146.69 139.3 25.1 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.225 1.41 . . . . 0.0 109.399 -171.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.77 107.58 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.875 1.67 . . . . 0.0 106.734 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.69 100.78 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -75.6 102.41 5.29 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 101.209 -3.626 . . . . 0.0 101.209 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -116.64 11.19 14.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -166.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.52 -0.196 0 CA-C-N 119.355 0.979 . . . . 0.0 112.217 -169.574 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.62 9.72 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -172.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.3 0.3 OUTLIER 50.78 31.0 5.49 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.85 2.06 . . . . 0.0 114.641 -169.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.5 m 38.69 52.8 3.77 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 128.057 2.543 . . . . 0.0 113.926 170.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.21 131.11 41.52 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.029 2.486 . . . . 0.0 111.576 -169.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.411 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.5 2.12 34.42 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -174.444 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p 45.72 88.3 0.1 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.622 1.569 . . . . 0.0 113.244 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -56.02 141.18 86.94 Favored 'Trans proline' 0 CA--C 1.55 1.323 0 C-N-CA 122.549 2.166 . . . . 0.0 110.263 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.23 -2.51 3.17 Favored 'Trans proline' 0 C--N 1.351 0.663 1 C-N-CA 125.38 4.053 . . . . 0.0 116.961 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -65.7 -9.81 31.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.175 0.898 . . . . 0.0 111.506 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.81 144.39 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.828 1.251 . . . . 0.0 109.844 -169.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.595 ' HD2' HD13 ' B' ' 77' ' ' LEU . 0.7 OUTLIER -76.6 156.61 32.6 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.742 0.817 . . . . 0.0 108.94 171.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -145.08 143.62 30.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -137.21 139.83 41.31 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -89.93 135.13 33.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.673 1.189 . . . . 0.0 108.787 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -140.08 14.47 2.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.95 1.7 . . . . 0.0 110.323 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.34 167.1 54.43 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 123.941 0.781 . . . . 0.0 113.328 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -164.04 -43.11 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.137 1.775 . . . . 0.0 109.469 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -165.21 175.31 9.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.688 1.995 . . . . 0.0 109.798 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -139.26 137.87 19.83 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.26 -18.02 16.43 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.266 1.977 . . . . 0.0 113.078 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.96 6.98 1.78 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.002 1.273 . . . . 0.0 110.226 168.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -118.7 10.68 12.52 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.339 1.455 . . . . 0.0 110.901 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.84 156.76 0.91 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.314 0.646 . . . . 0.0 110.119 171.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -35.8 73.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.512 -172.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.1 -21.32 3.92 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -69.76 166.75 18.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.13 -42.47 99.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.441 0.639 . . . . 0.0 110.292 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.7 pt-20 -68.83 -43.03 76.38 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 117.072 -1.442 . . . . 0.0 109.32 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.2 -34.91 61.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 121.034 1.743 . . . . 0.0 109.827 -173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -55.84 -56.62 18.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.631 0.651 . . . . 0.0 110.763 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -64.56 -39.78 94.38 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.853 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.95 92.46 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.896 0.878 . . . . 0.0 111.665 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -63.31 -51.74 64.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.288 2.2 p90 -70.77 -25.81 63.06 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.0 -172.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -65.61 -51.53 58.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.706 1.139 . . . . 0.0 109.746 172.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -57.27 -51.34 69.76 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.32 -49.02 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 118.333 -0.842 . . . . 0.0 109.485 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -56.52 -48.29 77.53 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 111.85 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.78 -43.44 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.326 0.391 . . . . 0.0 110.965 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -66.41 -49.96 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -48.5 79.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.806 1.243 . . . . 0.0 109.991 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.72 -42.45 95.27 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -61.37 -44.51 97.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.799 0.8 . . . . 0.0 112.025 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -69.97 -36.85 75.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.084 0.856 . . . . 0.0 111.759 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.1 mm? -74.56 -33.54 62.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.553 1.07 . . . . 0.0 111.38 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.28 -43.96 96.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.784 0.72 . . . . 0.0 109.201 170.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.33 -39.05 81.92 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.595 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.66 -42.61 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 122.476 2.398 . . . . 0.0 110.222 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.38 72.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.07 -37.83 18.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.825 1.25 . . . . 0.0 112.959 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.2 p -101.14 -20.09 15.47 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.801 1.64 . . . . 0.0 111.613 -169.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.37 50.01 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.75 0.691 . . . . 0.0 111.51 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 C-N-CA 128.229 2.612 . . . . 0.0 112.681 -169.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.25 160.93 0.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.645 2.378 . . . . 0.0 112.882 -169.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.52 102.84 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -73.09 166.73 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.772 1.629 . . . . 0.0 108.258 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.81 133.9 46.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.23 176.04 5.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.859 1.264 . . . . 0.0 110.189 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.0 p -137.98 -170.73 2.85 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.101 1.761 . . . . 0.0 109.232 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -44.46 -30.37 0.85 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.88 2.472 . . . . 0.0 113.9 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -138.45 -22.82 1.0 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.481 1.112 . . . . 0.0 112.959 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 m -59.03 -36.06 74.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -71.75 122.72 21.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m 117.71 -60.93 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.707 1 C-N-CA 131.977 4.111 . . . . 0.0 106.065 -169.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.2 95.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.424 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -81.68 -9.24 59.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.612 1.565 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.1 p -122.77 -6.59 8.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -168.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -79.98 -1.48 39.8 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -140.39 147.61 40.01 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.238 0.926 . . . . 0.0 109.787 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.56 -174.63 31.37 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.332 0.968 . . . . 0.0 111.659 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.31 129.97 45.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.06 119.51 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.123 0.969 . . . . 0.0 109.009 -168.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.8 107.53 18.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.73 27.82 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.477 1.035 . . . . 0.0 108.282 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -135.7 152.45 51.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.866 1.667 . . . . 0.0 108.84 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -132.22 114.2 14.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.597 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.3 p-90 -135.58 153.07 51.8 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.034 1.733 . . . . 0.0 108.191 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.51 163.33 7.06 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 119.262 0.937 . . . . 0.0 109.183 169.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.86 -16.86 9.41 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.486 2.791 . . . . 0.0 116.384 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -57.67 -27.43 62.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.79 159.49 41.7 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.633 1.106 . . . . 0.0 112.494 -169.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.73 -48.65 75.1 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.039 -1.423 . . . . 0.0 112.677 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.68 -30.69 17.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.657 2.904 . . . . 0.0 115.461 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.71 -25.47 62.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 120.247 1.385 . . . . 0.0 112.924 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -103.89 10.06 36.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.27 1.028 . . . . 0.0 111.708 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.4 mtm -120.78 -44.36 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.192 0.997 . . . . 0.0 109.481 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.44 -34.94 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 0.0 109.254 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.16 6.98 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.183 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.82 -40.16 74.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.009 1.806 . . . . 0.0 111.671 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.97 -42.01 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.007 0.523 . . . . 0.0 110.548 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.26 -40.12 71.17 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.499 0.59 . . . . 0.0 110.812 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.32 -35.32 80.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.275 0.943 . . . . 0.0 109.723 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.8 -25.32 63.72 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.405 1.482 . . . . 0.0 112.363 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.427 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 48.3 tp -79.42 -44.48 21.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 109.637 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.5 -37.48 74.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.723 0.297 . . . . 0.0 110.793 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -68.64 -10.04 53.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.275 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -101.89 -48.18 4.35 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.148 0.979 . . . . 0.0 111.149 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -134.14 15.41 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.419 0.688 . . . . 0.0 112.331 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.95 -2.88 26.3 Favored Glycine 0 CA--C 1.52 0.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.912 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.5 -24.8 64.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.202 1.001 . . . . 0.0 110.808 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -23.01 9.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.164 0.986 . . . . 0.0 112.061 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.57 147.54 46.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.593 1.157 . . . . 0.0 111.57 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -107.42 143.88 35.12 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.7 mt -128.14 139.23 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.84 141.86 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 125.722 1.609 . . . . 0.0 106.672 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.597 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.2 mtpp -113.41 159.52 19.37 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.262 0.625 . . . . 0.0 109.576 173.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.56 121.16 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 170.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.2 106.2 6.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 33.0 m -78.66 50.19 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -155.7 -45.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.491 1.516 . . . . 0.0 108.291 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.04 -36.71 35.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 110.869 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -134.08 28.67 3.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 111.019 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -71.77 -6.27 40.18 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.653 0.781 . . . . 0.0 112.735 -171.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -53.74 -49.3 68.46 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.009 1.724 . . . . 0.0 110.708 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -60.04 -34.67 73.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.387 0.675 . . . . 0.0 111.677 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.06 -64.01 0.94 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.82 -45.84 7.45 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.802 0.715 . . . . 0.0 113.298 169.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.29 -43.15 96.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.124 0.962 . . . . 0.0 111.506 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -84.56 -4.98 59.26 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.639 0.776 . . . . 0.0 112.659 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.45 66.32 1.61 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.1 t -144.1 131.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.814 ' HG3' HD12 ' B' ' 67' ' ' ILE . 25.6 ptm -149.97 24.71 0.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -140.48 161.31 38.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.622 1.569 . . . . 0.0 112.727 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 136.17 28.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.572 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.11 145.42 41.32 Favored 'Cis proline' 0 N--CA 1.45 -1.052 0 N-CA-C 107.43 -1.796 . . . . 0.0 107.43 -11.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.2 m -113.81 145.23 41.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.1 133.06 54.77 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.2 mt -122.11 110.1 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -101.82 122.23 53.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.34 1.456 . . . . 0.0 108.547 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.51 130.31 20.38 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 43.13 31.1 0.33 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.609 2.364 . . . . 0.0 114.804 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.16 -19.15 5.77 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.988 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -136.43 149.49 48.28 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.24 1.52 . . . . 0.0 113.24 -168.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.58 138.83 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.81 -26.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.855 1.662 . . . . 0.0 109.418 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -144.07 157.51 44.28 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -154.6 133.45 12.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.98 -2.229 . . . . 0.0 104.98 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.3 t -155.17 148.79 25.3 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.5 t -138.75 82.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.24 160.01 10.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.435 1.017 . . . . 0.0 110.883 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -66.67 145.58 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.118 0.959 . . . . 0.0 111.118 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -135.91 138.92 29.01 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 124.724 1.21 . . . . 0.0 108.167 170.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.25 169.74 17.57 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.195 1.93 . . . . 0.0 109.946 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 18.1 tptm -46.03 -48.58 16.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.072 1.749 . . . . 0.0 112.41 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.68 -42.37 74.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 118.005 0.366 . . . . 0.0 111.132 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.67 85.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.134 0.425 . . . . 0.0 110.662 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.45 45.8 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.509 0.724 . . . . 0.0 109.305 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -65.32 -37.47 87.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.56 -47.27 86.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.63 0.65 . . . . 0.0 110.957 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.48 -40.07 77.77 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.417 0.687 . . . . 0.0 111.292 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -85.72 -41.61 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 123.064 0.228 . . . . 0.0 110.627 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -56.69 -27.35 58.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.751 1.221 . . . . 0.0 112.302 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -50.08 -32.68 16.28 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.974 1.31 . . . . 0.0 112.294 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -135.81 -8.48 2.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.249 1.041 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.164 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 52.3 48.31 22.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.894 1.677 . . . . 0.0 113.113 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 135.73 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.171 3.788 . . . . 0.0 109.151 169.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -150.66 158.48 44.2 Favored 'General case' 0 C--N 1.325 -0.491 1 C-N-CA 133.896 4.878 . . . . 0.0 103.905 169.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mt -122.61 142.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.657 1.117 . . . . 0.0 109.215 -169.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -143.44 146.94 20.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.33 1.452 . . . . 0.0 107.125 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.59 134.55 37.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.049 0.539 . . . . 0.0 109.835 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.58 143.09 26.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -132.51 111.11 10.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -140.05 143.18 36.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.174 0.99 . . . . 0.0 108.665 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -42.81 96.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.806 2.442 . . . . 0.0 112.681 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.39 36.64 89.91 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.637 -1.091 . . . . 0.0 111.185 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -2.34 103.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 129.764 3.226 . . . . 0.0 113.696 -169.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -122.51 -145.58 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.067 -2.333 . . . . 0.0 104.787 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . -38.4 -50.7 1.53 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -168.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.489 ' HE ' ' HG ' ' B' ' 81' ' ' LEU . 27.5 mtp85 -53.68 -51.15 64.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.784 1.175 . . . . 0.0 111.003 -172.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -43.31 73.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.144 -171.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -54.92 -49.66 70.74 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.098 0.959 . . . . 0.0 110.241 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 26.2 ttm -63.01 -44.26 96.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.484 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 117.765 -1.112 . . . . 0.0 112.491 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -64.92 -47.3 78.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.649 1.568 . . . . 0.0 109.636 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.75 -47.75 89.66 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.527 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -61.92 -42.62 99.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 117.375 0.587 . . . . 0.0 112.283 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.1 83.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -65.64 -26.96 68.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.206 -170.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -18.22 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.313 0.961 . . . . 0.0 113.285 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.443 ' CZ ' ' HE3' ' B' ' 132' ' ' LYS . 1.9 m-85 -119.05 -11.5 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 113.078 -175.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 39.0 mt -103.05 -125.46 0.2 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.78 -168.71 40.84 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.64 -16.1 60.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.556 1.143 . . . . 0.0 111.805 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -53.84 -25.55 20.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 111.268 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -130.3 158.65 39.2 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.713 1.205 . . . . 0.0 110.825 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -128.14 125.71 39.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 67.0 t -115.36 134.42 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 -169.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.1 168.94 18.64 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.463 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -146.6 150.73 36.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.943 0.897 . . . . 0.0 110.353 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 67' ' ' ILE . . . -151.39 166.4 31.15 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.126 1.37 . . . . 0.0 110.375 -177.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.29 -178.44 47.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.175 1.369 . . . . 0.0 110.333 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -52.76 -54.03 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.619 1.168 . . . . 0.0 113.739 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.01 27.88 4.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.581 1.953 . . . . 0.0 108.269 -169.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.74 140.65 49.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.195 1.798 . . . . 0.0 111.942 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 p80 158.43 56.99 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.334 3.054 . . . . 0.0 107.719 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.9 93.97 0.15 Allowed Glycine 0 C--N 1.336 0.574 0 O-C-N 121.219 -0.926 . . . . 0.0 111.404 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.0 tp -72.65 91.02 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -66.21 126.59 92.26 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.896 0.878 . . . . 0.0 109.774 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.75 -26.58 68.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.186 1.924 . . . . 0.0 113.266 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -20.04 65.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.151 1.341 . . . . 0.0 112.204 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -82.39 -38.2 24.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 110.147 174.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.51 -51.22 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.33 -38.49 83.93 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.808 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.67 65.19 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.722 0.692 . . . . 0.0 111.842 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 52.8 mmm -76.66 -35.38 58.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.22 0.918 . . . . 0.0 111.163 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -62.33 -24.53 67.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.389 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.47 -26.93 65.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.76 1.164 . . . . 0.0 111.721 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.5 m -120.28 15.01 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.196 1.398 . . . . 0.0 111.151 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.1 42.41 99.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.94 0.781 . . . . 0.0 112.598 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -115.11 155.67 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 172.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -124.14 140.93 52.49 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.789 0.836 . . . . 0.0 109.473 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 37.5 pt -138.23 22.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.671 1.588 . . . . 0.0 109.794 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -60.71 -15.53 30.04 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 120.641 -1.287 . . . . 0.0 111.881 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -63.15 -31.45 72.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.687 2.395 . . . . 0.0 114.172 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -62.45 158.14 18.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.587 1.155 . . . . 0.0 111.16 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.6 t -149.89 -30.65 0.22 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.628 0.771 . . . . 0.0 112.426 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p 56.52 173.74 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.847 2.059 . . . . 0.0 115.272 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -166.47 166.01 16.63 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.281 2.232 . . . . 0.0 107.997 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 31.2 pt -68.55 174.73 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.332 1.053 . . . . 0.0 111.366 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.814 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.2 OUTLIER -48.64 131.95 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.186 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -147.3 97.51 2.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.192 0.996 . . . . 0.0 108.886 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 9.7 m -50.73 -25.41 4.31 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.926 1.291 . . . . 0.0 114.021 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.71 -21.26 65.64 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.647 1.567 . . . . 0.0 112.098 -175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.55 -37.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tt -68.12 -41.84 81.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.821 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.37 66.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.678 1.126 . . . . 0.0 111.379 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -82.77 -13.52 56.12 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.145 0.978 . . . . 0.0 112.383 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.8 162.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.44 1.018 . . . . 0.0 111.449 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.68 -34.57 16.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.627 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' B' ' 97' ' ' LYS . 23.2 tp -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.091 1.356 . . . . 0.0 109.221 -171.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.49 104.1 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.19 99.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -65.43 121.55 15.13 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 169.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.489 ' HG ' ' HE ' ' B' ' 16' ' ' ARG . 4.4 tp -135.58 54.26 1.93 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.832 0.853 . . . . 0.0 111.14 -167.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 126.846 2.059 . . . . 0.0 105.827 171.856 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.21 16.07 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm 74.89 22.3 1.9 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.238 1.815 . . . . 0.0 112.194 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 29.03 57.17 0.66 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 128.149 2.58 . . . . 0.0 112.859 -173.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.04 133.4 51.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.617 2.211 . . . . 0.0 111.914 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.435 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.06 -4.65 57.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -174.645 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p 44.28 103.13 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 127.89 2.476 . . . . 0.0 113.858 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -63.56 145.02 91.43 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.461 1.441 . . . . 0.0 109.645 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.59 -4.54 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.119 3.213 . . . . 0.0 114.513 -170.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -61.3 -12.71 14.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.44 147.33 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.218 1.007 . . . . 0.0 110.524 -170.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.4 tmmm? -77.25 157.96 30.52 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 169.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -145.03 145.91 31.68 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.751 -1.218 . . . . 0.0 109.104 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.55 151.32 34.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -108.56 140.48 41.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.895 1.278 . . . . 0.0 110.64 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -144.24 22.61 1.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.724 1.21 . . . . 0.0 111.034 -170.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.94 25.45 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.161 0.886 . . . . 0.0 110.949 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -154.57 -30.4 0.11 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.95 1.7 . . . . 0.0 110.564 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.13 165.0 37.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.92 2.488 . . . . 0.0 107.364 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.12 139.29 20.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.301 1.441 . . . . 0.0 108.328 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.66 -17.86 9.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.355 2.036 . . . . 0.0 113.769 -169.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.01 -0.25 5.43 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.39 0.996 . . . . 0.0 110.666 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 11.17 15.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.894 1.277 . . . . 0.0 110.989 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.52 159.84 0.31 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.059 0.944 . . . . 0.0 110.729 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.51 -36.09 68.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.654 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.96 5.32 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 115.73 1.052 . . . . 0.0 115.73 168.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 65.6 p -69.98 165.08 22.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.8 -42.73 99.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.44 0.638 . . . . 0.0 110.208 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.1 -43.29 82.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.857 -1.545 . . . . 0.0 109.395 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.95 -35.73 62.12 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 121.232 1.833 . . . . 0.0 109.428 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -57.08 -53.94 52.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.679 0.672 . . . . 0.0 110.656 171.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' TRP . . . . . 0.434 ' HA ' ' CD2' ' B' ' 120' ' ' PHE . 7.6 t90 -62.93 -45.19 93.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.694 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.97 99.51 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.943 0.897 . . . . 0.0 111.857 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.12 -48.78 72.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.434 ' CD2' ' HA ' ' B' ' 117' ' ' TRP 0.253 0.3 OUTLIER -65.92 -38.91 89.91 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.366 -174.685 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.02 -48.5 80.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.374 0.988 . . . . 0.0 110.672 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -63.13 -52.15 63.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.91 -35.45 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.222 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.527 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.1 tmm_? -61.84 -43.99 97.74 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.781 1.173 . . . . 0.0 112.373 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.46 -46.19 80.48 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.17 0.441 . . . . 0.0 110.725 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.66 -41.35 68.86 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 122.32 -0.238 . . . . 0.0 111.57 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.3 -46.25 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.105 0.962 . . . . 0.0 109.642 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.19 98.39 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.07 -44.54 94.68 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.262 1.031 . . . . 0.0 112.325 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -72.42 -34.93 68.19 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.044 -1.035 . . . . 0.0 111.489 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -36.08 68.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.682 1.128 . . . . 0.0 111.415 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.443 ' HE3' ' CZ ' ' B' ' 27' ' ' TYR . 9.4 ptmt -67.18 -37.39 83.62 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.165 0.893 . . . . 0.0 109.576 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.76 -43.19 98.33 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 117.302 -1.332 . . . . 0.0 110.855 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -57.44 -41.25 80.09 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 121.579 1.99 . . . . 0.0 110.552 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.09 73.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.824 0.85 . . . . 0.0 112.617 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.33 -41.73 14.29 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.459 1.503 . . . . 0.0 111.158 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.6 p -90.06 -23.62 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.129 1.372 . . . . 0.0 110.452 -169.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 51.3 54.33 24.14 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.602 1.561 . . . . 0.0 114.533 -169.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.9 168.06 23.61 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.431 2.292 . . . . 0.0 106.293 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.05 99.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 169.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.41 165.33 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.943 1.297 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 118.25 28.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 107.909 172.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.15 172.86 12.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.982 0.913 . . . . 0.0 108.616 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t -155.34 -177.7 6.73 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 169.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -36.92 -36.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 129.529 3.132 . . . . 0.0 116.275 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.7 -30.95 1.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.518 1.127 . . . . 0.0 111.421 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 m -61.74 -19.39 62.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.732 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -50.61 -50.52 53.94 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.346 0.975 . . . . 0.0 109.535 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -62.62 -44.77 95.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.087 -0.383 . . . . 0.0 110.064 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.15 92.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.417 -0.177 . . . . 0.0 111.017 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -72.09 -21.0 61.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.061 0.944 . . . . 0.0 112.81 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.5 p -110.41 -4.03 15.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.174 0.99 . . . . 0.0 112.117 -169.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -70.78 -11.77 61.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.112 0.965 . . . . 0.0 113.304 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.24 146.53 35.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.867 0.758 . . . . 0.0 109.918 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.8 -171.43 26.46 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.761 1.172 . . . . 0.0 111.949 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.85 133.45 34.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -142.01 116.05 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -81.73 134.2 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.27 139.69 53.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 169.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -132.24 148.65 52.46 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.734 1.614 . . . . 0.0 108.757 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.49 110.83 12.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -169.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.573 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.9 p-90 -129.28 152.55 48.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.562 1.945 . . . . 0.0 107.634 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -171.83 164.05 4.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.783 1.174 . . . . 0.0 111.761 170.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -56.99 -9.38 4.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.461 3.441 . . . . 0.0 117.476 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.525 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 71.3 m95 -48.47 -46.91 38.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.256 1.389 . . . . 0.0 111.889 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.7 m -152.61 165.42 35.28 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.19 -46.3 27.53 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.161 2.315 . . . . 0.0 115.861 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -51.6 -32.37 44.08 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.818 2.809 . . . . 0.0 114.611 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -58.58 -30.18 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 120.266 1.393 . . . . 0.0 112.743 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.91 7.92 45.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.594 1.157 . . . . 0.0 111.838 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.1 mtm -117.67 -44.02 2.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.034 0.934 . . . . 0.0 109.339 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.14 -33.25 55.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.344 1.058 . . . . 0.0 109.4 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.53 -60.46 10.26 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.294 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.25 -39.86 81.0 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.03 1.82 . . . . 0.0 111.47 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.67 -41.42 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.029 0.531 . . . . 0.0 110.586 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 mp -71.15 -38.45 72.23 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 118.907 0.776 . . . . 0.0 110.897 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.28 -34.95 79.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.033 . . . . 0.0 109.9 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -69.86 -30.56 68.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.564 1.146 . . . . 0.0 111.288 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.84 -43.77 64.99 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.582 1.153 . . . . 0.0 110.112 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.59 -37.3 65.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.523 -0.735 . . . . 0.0 110.962 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.86 -14.31 62.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.844 -0.535 . . . . 0.0 111.735 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.12 -49.25 6.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.943 1.297 . . . . 0.0 110.554 -176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.29 16.34 2.78 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.802 0.841 . . . . 0.0 112.115 -169.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.63 2.87 10.07 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.408 -0.808 . . . . 0.0 113.769 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.39 -24.62 61.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.785 1.234 . . . . 0.0 110.593 169.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -19.1 11.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.004 0.921 . . . . 0.0 112.57 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.28 144.91 51.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.687 1.195 . . . . 0.0 110.733 -168.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.45 144.34 30.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -127.19 135.91 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.15 143.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 22.7 mtpp -117.77 156.35 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.441 0.564 . . . . 0.0 110.49 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -126.26 125.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.26 107.7 12.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 169.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.289 33.7 m -82.85 50.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.42 -35.13 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.446 -0.783 . . . . 0.0 111.329 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -103.95 -27.26 12.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.583 1.153 . . . . 0.0 109.777 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.12 25.1 5.24 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.602 1.161 . . . . 0.0 111.634 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.8 -1.79 23.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.687 1.195 . . . . 0.0 112.982 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.55 -46.44 83.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.014 1.326 . . . . 0.0 110.84 -173.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.32 -39.91 70.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.099 0.863 . . . . 0.0 111.422 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.34 -64.29 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -171.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.61 -41.33 9.42 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.166 0.889 . . . . 0.0 114.103 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -62.85 -46.92 85.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.892 1.346 . . . . 0.0 110.534 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -69.79 -33.78 72.84 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.231 0.469 . . . . 0.0 110.457 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.55 68.02 0.81 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -137.28 132.69 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 100.488 -3.893 . . . . 0.0 100.488 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.408 ' HB2' HD12 ' B' ' 67' ' ' ILE . 28.7 mtm -147.83 17.04 1.12 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.079 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.8 p -133.92 162.04 33.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 112.339 -168.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.66 139.33 35.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.253 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.91 135.57 16.88 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 N-CA-C 106.26 -2.246 . . . . 0.0 106.26 -11.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.6 m -103.77 140.41 37.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -117.15 135.48 53.73 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 107.659 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.5 mt -121.15 113.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 169.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.09 124.67 43.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -122.69 155.04 37.23 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.909 0.884 . . . . 0.0 109.546 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.36 141.69 24.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 45.47 30.76 0.78 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.353 1.861 . . . . 0.0 113.56 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.72 9.8 51.65 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 116.428 1.331 . . . . 0.0 116.428 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.79 149.56 47.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.718 1.259 . . . . 0.0 111.502 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.71 138.28 21.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.75 -20.75 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.599 1.16 . . . . 0.0 110.966 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -144.51 153.86 42.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.134 0.879 . . . . 0.0 108.914 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -139.83 137.29 34.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.3 t -151.16 148.84 28.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.0 t -138.82 112.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.32 155.84 6.62 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.93 142.68 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.635 0.718 . . . . 0.0 110.537 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -136.01 140.81 34.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -68.64 167.91 21.46 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.343 2.029 . . . . 0.0 110.357 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -44.24 -49.58 9.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.616 1.966 . . . . 0.0 112.281 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -43.6 70.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.28 0.491 . . . . 0.0 111.445 -174.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.59 87.92 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.958 -0.464 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -54.4 45.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.5 0.72 . . . . 0.0 109.612 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.07 -38.87 92.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.546 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' A' ' 102' ' ' LYS . 35.8 tt0 -61.99 -44.04 97.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.759 0.424 . . . . 0.0 111.506 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.09 -44.3 91.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.147 0.979 . . . . 0.0 110.703 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.71 -36.71 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.1 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.24 -30.72 62.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 112.131 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.411 ' HE2' ' HG2' ' A' ' 98' ' ' GLU . 41.4 mttm -56.56 -26.58 55.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 112.954 175.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -125.82 -16.75 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.122 0.969 . . . . 0.0 112.265 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 126.619 1.968 . . . . 0.0 108.701 169.827 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -58.83 131.59 51.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.776 1.231 . . . . 0.0 111.074 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 m120 71.01 124.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.191 2.996 . . . . 0.0 112.378 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -146.73 143.71 28.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 130.809 3.644 . . . . 0.0 103.604 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mt -123.12 142.38 39.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 120.571 1.532 . . . . 0.0 108.344 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.22 142.27 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -128.88 138.3 51.95 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -110.83 148.59 32.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -142.08 112.17 6.93 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 42.4 p -158.51 149.26 20.34 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.741 0.416 . . . . 0.0 111.187 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -47.8 120.59 3.49 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.347 1.459 . . . . 0.0 111.866 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.425 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 65.19 13.69 58.21 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.477 174.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -7.02 85.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 129.486 3.114 . . . . 0.0 114.926 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -152.53 6.77 0.42 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.368 0.667 . . . . 0.0 111.951 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.44 -93.03 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.869 1.213 . . . . 0.0 111.47 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -24.97 67.61 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.425 -0.797 . . . . 0.0 112.221 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.8 p -61.05 -47.7 85.17 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.519 2.328 . . . . 0.0 112.464 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -64.12 -44.98 90.57 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.796 1.284 . . . . 0.0 108.525 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ttm -59.74 -50.83 72.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.84 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.14 79.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.46 -0.775 . . . . 0.0 111.907 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.64 -26.68 45.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.818 1.19 . . . . 0.0 110.547 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.56 -47.35 69.77 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.494 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 19.4 m95 -54.73 -42.6 71.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 111.319 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.74 72.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -173.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -65.42 -22.26 66.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -69.02 -15.27 63.43 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.312 0.96 . . . . 0.0 113.472 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -130.95 -44.01 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.529 1.059 . . . . 0.0 112.44 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -79.47 73.2 6.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.091 1.756 . . . . 0.0 106.351 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.11 -151.17 0.18 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 127.277 2.37 . . . . 0.0 113.748 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.15 -19.53 63.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.824 1.25 . . . . 0.0 113.399 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.92 -19.49 64.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.2 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -122.39 160.23 25.88 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.378 0.99 . . . . 0.0 111.558 -169.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -133.64 142.18 47.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.852 2.061 . . . . 0.0 105.925 170.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.05 135.01 59.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -142.11 164.51 29.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -146.01 136.37 23.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -169.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 166.75 29.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.481 0.713 . . . . 0.0 111.103 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.06 -172.54 38.73 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 118.018 0.372 . . . . 0.0 113.453 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.425 HG22 ' H ' ' B' ' 12' ' ' GLY . 2.4 tt -49.04 -57.58 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.634 1.974 . . . . 0.0 113.417 -172.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -135.31 28.89 3.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.147 1.779 . . . . 0.0 108.746 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.01 151.76 47.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 79.6 t60 143.34 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 130.444 3.498 . . . . 0.0 105.049 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.19 177.54 48.43 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.823 -0.548 . . . . 0.0 111.779 -172.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -153.05 92.64 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -65.3 127.36 92.83 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.87 -21.55 71.01 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -36.49 81.14 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 120.171 1.35 . . . . 0.0 110.71 172.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.1 -39.17 63.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -57.8 -53.59 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -60.56 -40.96 93.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.899 0.88 . . . . 0.0 110.883 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.19 -37.0 61.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.55 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 68.5 mmm -82.15 -34.38 29.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.225 0.92 . . . . 0.0 111.496 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.96 -23.41 67.4 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.016 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.87 -31.65 66.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.047 1.294 . . . . 0.0 111.624 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.36 14.34 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.045 1.338 . . . . 0.0 111.268 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.23 41.96 98.09 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.938 -0.923 . . . . 0.0 112.556 175.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.81 147.4 20.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -118.6 135.45 54.43 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 pt -137.02 16.3 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.619 1.568 . . . . 0.0 110.611 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -60.47 -10.04 4.45 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -99.0 -14.15 19.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.048 1.739 . . . . 0.0 113.387 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -58.69 161.3 4.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 t -161.77 -175.78 4.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.802 2.041 . . . . 0.0 107.393 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.6 m -145.47 -162.27 1.47 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.599 1.56 . . . . 0.0 109.803 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -160.35 167.72 26.81 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.74 2.416 . . . . 0.0 106.918 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.6 pt -64.95 168.14 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.47 0.708 . . . . 0.0 111.623 173.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 70' ' ' MET . 1.4 pt -47.06 129.2 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 108.816 176.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -137.55 98.55 3.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.897 1.332 . . . . 0.0 109.388 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.0 m -43.87 -32.37 1.07 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.364 2.266 . . . . 0.0 114.045 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.92 -16.57 59.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.164 0.893 . . . . 0.0 112.252 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.04 -37.65 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 117.846 -1.073 . . . . 0.0 109.339 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.09 -55.41 29.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.616 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -23.21 66.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.835 0.289 . . . . 0.0 110.929 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.49 -22.89 28.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.9 2.08 . . . . 0.0 112.814 -175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.05 173.51 1.39 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.985 1.314 . . . . 0.0 111.8 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.17 -24.81 15.55 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.958 0.903 . . . . 0.0 111.614 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' B' ' 97' ' ' LYS . 18.5 tp -151.25 143.03 23.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.977 1.311 . . . . 0.0 109.548 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.59 106.37 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 127.165 2.186 . . . . 0.0 106.66 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.22 99.79 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -66.88 128.83 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 tp -125.51 48.85 1.99 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.916 0.887 . . . . 0.0 111.498 -167.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 107.877 175.848 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -64.83 18.91 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.699 2.4 . . . . 0.0 116.62 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LYS . . . . . 0.415 ' HE3' HG13 ' B' ' 39' ' ' ILE . 60.7 mttt 83.15 18.86 0.24 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 128.744 2.818 . . . . 0.0 112.216 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.2 m 32.9 52.82 0.93 Allowed Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 126.502 1.921 . . . . 0.0 111.67 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.87 132.59 22.05 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.056 2.504 . . . . 0.0 114.409 -168.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.418 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.85 -1.16 56.13 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 116.774 -1.584 . . . . 0.0 114.459 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p 43.49 89.54 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.476 1.51 . . . . 0.0 113.62 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -57.27 137.57 82.26 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.03 2.487 . . . . 0.0 109.714 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.18 10.97 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.892 3.728 . . . . 0.0 116.015 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -67.65 -9.48 43.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.299 1.04 . . . . 0.0 111.844 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.55 153.14 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.71 1.204 . . . . 0.0 110.115 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.482 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.5 tmmm? -72.82 153.7 40.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.35 1.06 . . . . 0.0 109.254 174.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -143.06 144.75 32.39 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.9 150.67 27.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -92.75 137.38 32.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -139.61 39.47 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.389 1.476 . . . . 0.0 108.525 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.29 167.79 29.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -157.77 -15.93 0.08 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.728 1.211 . . . . 0.0 111.575 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.54 168.22 25.61 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.232 2.213 . . . . 0.0 106.448 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -142.72 117.38 6.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.139 0.976 . . . . 0.0 109.075 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.71 -17.91 25.62 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.682 2.921 . . . . 0.0 112.752 -175.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.5 -0.56 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.516 1.053 . . . . 0.0 112.067 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 -123.43 11.23 9.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.59 1.556 . . . . 0.0 111.379 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.95 152.91 0.71 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.133 0.973 . . . . 0.0 111.563 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -35.39 73.77 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.837 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.36 9.13 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -72.92 149.81 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -47.82 -41.6 24.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.583 1.553 . . . . 0.0 111.507 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.61 -40.45 69.79 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.425 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -78.0 -31.55 50.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.907 1.23 . . . . 0.0 109.651 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -63.15 -48.48 78.29 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 119.147 0.885 . . . . 0.0 110.029 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' TRP . . . . . 0.407 ' CD1' ' CZ ' ' B' ' 120' ' ' PHE . 6.1 t90 -64.92 -46.63 80.85 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.751 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.63 95.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.544 0.738 . . . . 0.0 112.125 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.86 -50.22 71.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' B' ' 117' ' ' TRP 0.251 0.5 OUTLIER -66.51 -40.27 89.1 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.482 -174.66 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -62.2 -49.04 77.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.375 0.989 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -64.96 -48.87 72.49 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.9 -35.12 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.547 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.494 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 6.8 tmm_? -60.11 -44.73 94.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.102 1.319 . . . . 0.0 111.732 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.58 -45.81 84.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.678 0.391 . . . . 0.0 110.923 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.82 -47.58 74.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.776 0.262 . . . . 0.0 110.908 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.8 mt -54.25 -49.89 59.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.415 1.486 . . . . 0.0 109.579 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.21 -42.82 97.76 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.203 -0.776 . . . . 0.0 111.249 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -61.28 -46.19 91.39 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.229 1.015 . . . . 0.0 111.61 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.7 -37.67 85.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.88 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.798 0.726 . . . . 0.0 110.86 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.89 -37.12 83.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.851 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.34 -36.85 78.95 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.581 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -62.11 -41.34 98.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 122.863 2.574 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.27 67.63 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 124.169 0.918 . . . . 0.0 112.356 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.01 -43.92 11.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 111.839 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.8 p -88.49 -17.78 29.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.868 2.067 . . . . 0.0 110.994 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.32 49.82 73.5 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.537 -174.685 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 mtt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.2 149.84 7.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.046 1.338 . . . . 0.0 109.434 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.66 98.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 102.558 -3.127 . . . . 0.0 102.558 168.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.54 165.38 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.924 1.289 . . . . 0.0 107.787 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 122.17 41.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -84.56 172.47 11.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -161.17 -176.32 5.37 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -36.94 -42.01 0.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.875 2.47 . . . . 0.0 115.487 -169.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.33 -29.83 3.21 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.29 1.036 . . . . 0.0 111.533 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m -62.24 -23.28 66.58 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.336 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.15 -54.26 38.36 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.51 1.05 . . . . 0.0 109.051 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -61.46 -45.09 95.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.078 -0.389 . . . . 0.0 109.988 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.73 89.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.309 0.1 . . . . 0.0 111.214 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -74.75 -22.95 58.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.146 0.978 . . . . 0.0 112.557 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 p -106.79 -6.57 17.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.305 0.957 . . . . 0.0 112.691 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -71.65 -10.26 59.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.12 147.36 34.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.087 0.955 . . . . 0.0 109.434 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.81 -175.13 27.6 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.631 1.11 . . . . 0.0 111.959 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 104' ' ' LEU . 22.1 t -93.22 132.79 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 169.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.5 t -141.22 116.71 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -169.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -82.23 127.33 33.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.4 138.73 51.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.963 0.801 . . . . 0.0 108.988 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.26 146.89 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.09 1.356 . . . . 0.0 108.902 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.23 114.29 16.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -169.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.538 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.7 p-90 -132.96 156.14 47.83 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.762 1.625 . . . . 0.0 107.153 -170.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -176.37 167.28 1.51 Allowed Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.471 1.108 . . . . 0.0 110.749 169.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.51 -13.59 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.348 3.366 . . . . 0.0 116.601 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -60.13 -20.57 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.292 1.405 . . . . 0.0 113.648 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.13 152.14 38.8 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.86 1.209 . . . . 0.0 113.235 -171.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.41 -49.24 71.69 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.131 -1.371 . . . . 0.0 112.304 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -50.64 -27.27 19.1 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 115.815 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -58.71 -20.85 52.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 120.48 1.491 . . . . 0.0 113.209 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.62 12.15 27.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.906 1.282 . . . . 0.0 111.42 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -122.15 -43.61 2.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.33 1.052 . . . . 0.0 109.427 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.81 -33.59 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.846 0.858 . . . . 0.0 109.242 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.64 25.14 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 117.942 -1.027 . . . . 0.0 112.471 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.53 -39.41 75.58 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.159 1.906 . . . . 0.0 111.576 174.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 93' ' ' LYS . 3.0 t -55.45 -41.2 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.18 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.7 -43.53 84.09 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.106 0.866 . . . . 0.0 111.151 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.96 -35.41 79.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.795 0.725 . . . . 0.0 109.97 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -68.5 -40.12 81.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.58 1.152 . . . . 0.0 110.692 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.6 -46.05 84.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.734 1.213 . . . . 0.0 110.014 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.0 -40.85 71.61 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.184 -0.323 . . . . 0.0 110.822 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -70.37 -6.9 38.71 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.957 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -102.08 -47.31 4.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.627 1.171 . . . . 0.0 111.092 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.2 ptm -134.76 13.6 3.68 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 112.414 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.67 10.97 4.7 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.204 -0.935 . . . . 0.0 113.638 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.85 -26.17 37.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.497 1.519 . . . . 0.0 109.485 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.67 -24.42 11.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.107 0.963 . . . . 0.0 112.124 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 tp -125.3 148.57 48.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.676 1.59 . . . . 0.0 110.728 -168.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -104.55 144.4 31.74 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mt -127.2 137.68 57.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 4.9 t -139.01 145.11 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -173.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 23.6 mtpt -122.12 157.15 32.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.324 0.511 . . . . 0.0 110.767 175.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mm -125.37 127.35 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -87.97 107.46 18.73 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.835 HG21 HD11 ' A' ' 72' ' ' ILE . 33.2 m -76.29 39.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -146.19 -38.34 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.468 1.107 . . . . 0.0 109.168 168.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.88 -42.19 19.91 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.5 0.72 . . . . 0.0 111.179 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -138.96 36.61 2.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.238 1.018 . . . . 0.0 111.792 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -70.2 -6.49 34.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 113.429 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -50.81 -45.01 59.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.281 1.832 . . . . 0.0 110.796 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.6 m -54.5 -44.74 72.97 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.828 0.851 . . . . 0.0 111.199 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.21 -57.13 4.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.329 1.052 . . . . 0.0 108.996 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.61 -45.86 47.14 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.058 0.837 . . . . 0.0 113.557 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.0 -43.24 99.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.02 0.91 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.72 -33.35 73.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.293 0.497 . . . . 0.0 109.883 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.48 64.99 0.97 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.24 -61.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.252 7.0 ptm 49.44 7.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.815 3.246 . . . . 0.0 115.406 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.4 p -140.68 163.96 31.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 111.987 -172.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.835 HD11 HG21 ' A' ' 57' ' ' VAL . 26.0 mm -142.66 149.64 51.09 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.096 0.959 . . . . 0.0 108.925 -174.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.42 134.47 31.84 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 106.962 -1.976 . . . . 0.0 106.962 -11.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.7 m -112.27 146.74 37.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -131.79 121.47 24.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.4 mt -115.02 112.17 22.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.19 127.21 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -126.33 156.73 39.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.941 0.896 . . . . 0.0 109.587 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -146.66 140.08 25.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.8 t70 44.86 30.41 0.55 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.265 1.826 . . . . 0.0 114.125 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.64 14.69 49.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.835 1.207 . . . . 0.0 115.899 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.51 148.31 52.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.745 1.218 . . . . 0.0 110.803 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.81 134.87 29.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -122.79 -22.41 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.796 1.238 . . . . 0.0 109.799 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -146.68 156.15 42.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.548 1.139 . . . . 0.0 109.477 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 133.59 16.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.2 p -154.12 163.28 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.471 0.653 . . . . 0.0 110.246 172.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.9 113.74 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.54 153.95 6.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.22 142.18 58.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.914 0.486 . . . . 0.0 110.612 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -134.32 140.69 36.63 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -66.84 169.51 14.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.201 1.934 . . . . 0.0 110.109 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HA ' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -48.33 -50.03 31.9 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.595 1.158 . . . . 0.0 111.082 -175.283 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.81 -43.22 72.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.924 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.19 87.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.061 0.392 . . . . 0.0 110.33 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.8 tp -68.46 -46.99 68.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.928 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.63 -36.24 83.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.69 -47.03 82.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.306 0.503 . . . . 0.0 110.713 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.2 -39.13 78.16 Favored 'General case' 0 N--CA 1.459 -0.015 0 C-N-CA 123.659 0.783 . . . . 0.0 111.512 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -81.61 -41.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.795 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -54.39 -31.87 55.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.594 1.158 . . . . 0.0 112.177 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -56.23 -24.73 44.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.478 1.111 . . . . 0.0 113.218 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -128.83 -16.55 4.15 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.078 0.951 . . . . 0.0 112.518 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HA ' HG21 ' A' ' 19' ' ' VAL . 16.7 tp . . . . . 0 C--O 1.248 1.025 0 C-N-CA 127.176 2.19 . . . . 0.0 108.812 169.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.6 86.92 2.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 m120 74.72 130.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.016 2.926 . . . . 0.0 112.103 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.454 ' HE3' ' CZ3' ' B' ' 32' ' ' TRP . 37.2 mtmt -127.69 122.98 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 128.846 2.858 . . . . 0.0 103.363 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mt -90.54 142.97 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 110.353 -167.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.43 150.23 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.703 1.601 . . . . 0.0 107.225 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.56 157.37 45.92 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.16 0.584 . . . . 0.0 111.831 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -116.63 142.79 46.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.946 1.299 . . . . 0.0 107.593 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 23.7 mt -126.21 125.7 42.85 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 71.8 m -155.17 135.05 12.84 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.321 1.848 . . . . 0.0 109.133 -169.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.2 m -51.33 118.58 3.37 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.802 1.241 . . . . 0.0 110.927 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.97 4.68 11.78 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.701 -1.055 . . . . 0.0 113.737 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 3.1 t30 33.26 40.05 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.246 2.619 . . . . 0.0 113.74 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -81.75 -40.63 22.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.711 0.804 . . . . 0.0 111.126 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.38 -55.69 0.9 Allowed 'General case' 0 CA--C 1.526 0.058 0 C-N-CA 123.471 0.709 . . . . 0.0 112.707 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -49.89 -60.47 2.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.306 1.042 . . . . 0.0 110.184 -169.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -73.18 -28.43 62.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.602 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -54.86 -46.97 74.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -43.93 67.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.103 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.92 89.12 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 118.82 0.737 . . . . 0.0 112.374 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.65 -32.03 69.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.896 0.771 . . . . 0.0 110.582 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.67 -51.2 53.94 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -56.72 -32.91 65.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.88 1.272 . . . . 0.0 112.278 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.2 -53.82 7.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 111.079 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.54 -26.73 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -62.62 -17.57 60.55 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 173.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.4 -10.15 5.17 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.78 1.232 . . . . 0.0 113.011 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -124.69 81.54 1.96 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -163.23 3.01 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.063 1.792 . . . . 0.0 112.585 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.99 -9.91 18.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.915 1.286 . . . . 0.0 113.641 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -61.17 -22.53 64.82 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.903 -1.123 . . . . 0.0 109.745 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' TRP . . . . . 0.454 ' CZ3' ' HE3' ' B' ' 4' ' ' LYS . 30.9 m95 -126.7 177.37 6.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.363 2.265 . . . . 0.0 108.46 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -157.26 130.55 7.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.73 142.42 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.58 169.76 16.99 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.048 1.739 . . . . 0.0 108.21 -174.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 98.5 p -150.13 149.79 30.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.74 174.09 15.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.459 0.704 . . . . 0.0 111.313 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.98 -177.66 41.01 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.535 -0.302 . . . . 0.0 113.119 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.445 HG13 ' HE3' ' B' ' 88' ' ' LYS . 3.0 tt -43.97 -58.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.315 2.246 . . . . 0.0 114.228 -173.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -134.37 30.09 3.57 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.308 1.843 . . . . 0.0 108.191 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.37 137.01 55.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.355 1.862 . . . . 0.0 114.571 -169.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 172.14 114.4 0.01 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 130.377 3.471 . . . . 0.0 102.412 169.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.18 -179.72 43.61 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 118.875 0.761 . . . . 0.0 112.214 -174.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.5 tp -164.07 93.07 0.69 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 169.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -64.61 125.9 89.66 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.08 -21.14 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.036 1.824 . . . . 0.0 112.715 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.41 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -61.51 -37.41 83.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.273 0.942 . . . . 0.0 111.143 171.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.16 61.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t -57.22 -50.93 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.55 -44.77 85.45 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.561 0.619 . . . . 0.0 110.496 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.36 -22.81 45.07 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.96 0.904 . . . . 0.0 112.694 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 77.8 mmm -102.65 -34.13 9.18 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.365 0.984 . . . . 0.0 112.301 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -60.22 -27.9 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.172 0.896 . . . . 0.0 110.092 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.73 -33.04 32.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.755 1.622 . . . . 0.0 112.383 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.89 17.39 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.299 1.44 . . . . 0.0 110.796 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.27 37.95 93.33 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.935 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 47.4 mt -115.94 107.32 22.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 172.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -73.22 132.65 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 30.8 pt -135.81 19.05 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.991 1.316 . . . . 0.0 110.823 173.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -59.76 -15.64 21.74 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.837 0.744 . . . . 0.0 111.963 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -83.97 -15.29 48.35 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.7 2.4 . . . . 0.0 114.345 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -69.9 159.55 33.47 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.742 1.156 . . . . 0.0 112.762 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 66.8 p -139.64 -169.78 2.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.125 2.57 . . . . 0.0 108.806 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 p -157.86 -173.43 4.36 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.101 0.961 . . . . 0.0 108.708 169.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -166.44 159.25 14.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 127.491 2.316 . . . . 0.0 108.017 -170.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.64 166.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.05 0.94 . . . . 0.0 111.888 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -50.07 133.28 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -142.85 98.79 3.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.237 1.017 . . . . 0.0 109.161 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.6 m -44.49 -32.43 1.4 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.827 2.051 . . . . 0.0 113.773 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.92 -17.65 63.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.383 0.992 . . . . 0.0 112.648 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -126.93 -34.01 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.811 0.844 . . . . 0.0 108.852 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.25 -54.18 23.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.603 1.092 . . . . 0.0 110.172 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -23.93 67.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.986 0.812 . . . . 0.0 110.416 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.91 -23.02 55.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.806 1.642 . . . . 0.0 112.138 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.94 165.69 3.11 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.763 1.225 . . . . 0.0 111.8 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.15 -29.32 15.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.036 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -145.26 133.91 22.16 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.156 0.982 . . . . 0.0 110.996 -173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.438 HG23 HG11 ' B' ' 96' ' ' VAL . 20.6 t -107.55 116.33 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.074 1.75 . . . . 0.0 108.227 170.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.38 109.33 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -76.17 123.32 25.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 167.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 tp -116.32 39.09 3.2 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.732 -0.605 . . . . 0.0 109.489 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.448 -0.574 0 C-N-CA 123.369 0.668 . . . . 0.0 111.644 -168.797 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.15 38.17 0.05 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.67 1.988 . . . . 0.0 115.055 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LYS . . . . . 0.445 ' HE3' HG13 ' B' ' 39' ' ' ILE . 14.1 mttt 64.37 21.94 12.62 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.642 -1.911 . . . . 0.0 111.742 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p 30.41 62.38 0.96 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 127.504 2.322 . . . . 0.0 112.049 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.36 132.18 49.29 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.791 2.327 . . . . 0.0 111.066 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.6 3.18 55.64 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p 43.2 92.22 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.009 2.524 . . . . 0.0 113.698 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -61.71 147.51 95.16 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.013 1.809 . . . . 0.0 109.942 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.4 -2.52 6.16 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.915 3.743 . . . . 0.0 115.348 -169.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -62.58 -10.03 10.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.6 1.16 . . . . 0.0 112.154 170.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.438 HG11 HG23 ' B' ' 78' ' ' VAL . 2.1 t -137.52 143.95 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.842 1.257 . . . . 0.0 109.525 -169.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -76.04 155.46 34.86 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -139.98 142.61 36.31 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.833 -1.167 . . . . 0.0 108.993 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -145.45 159.28 43.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 169.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -106.74 128.72 54.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -119.16 8.73 11.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.583 1.153 . . . . 0.0 110.501 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.58 162.38 24.62 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -157.81 24.63 0.27 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.776 1.23 . . . . 0.0 109.422 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.35 172.62 18.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.407 1.883 . . . . 0.0 106.642 -171.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -148.25 116.14 4.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.57 1.148 . . . . 0.0 108.737 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.24 -28.51 22.86 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.13 2.553 . . . . 0.0 111.917 -171.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.79 -3.28 3.16 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.448 1.099 . . . . 0.0 112.755 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -97.05 5.74 49.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.249 1.02 . . . . 0.0 111.673 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.75 142.9 3.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.778 0.831 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -55.24 -45.95 76.04 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.474 0.71 . . . . 0.0 109.914 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.32 -15.11 4.22 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.8 p -69.22 162.37 27.27 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.74 -39.08 90.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.473 0.654 . . . . 0.0 110.534 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.04 -41.43 82.1 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 116.983 -1.484 . . . . 0.0 109.05 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.85 -31.46 59.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 120.851 1.66 . . . . 0.0 109.607 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -57.12 -62.91 1.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -59.44 -39.99 85.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.03 95.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.608 0.763 . . . . 0.0 112.305 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -63.17 -48.27 79.1 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 118.583 0.628 . . . . 0.0 109.474 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.5 m-30 -65.89 -40.46 91.59 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -65.85 -46.69 77.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.265 1.026 . . . . 0.0 110.297 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -60.23 -49.52 77.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.21 -46.76 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.018 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -62.59 -39.62 94.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.154 1.343 . . . . 0.0 111.347 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.26 -43.87 96.74 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.212 0.32 . . . . 0.0 110.615 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.66 -55.36 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.128 0.571 . . . . 0.0 109.641 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.1 mt -54.86 -52.45 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.309 1.044 . . . . 0.0 109.416 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.98 97.84 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.817 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -61.38 -47.15 87.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.42 1.11 . . . . 0.0 111.409 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -65.81 -41.11 92.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.466 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.46 -37.86 83.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.771 0.714 . . . . 0.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -62.92 -47.13 84.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.588 0.631 . . . . 0.0 109.731 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.05 -36.11 82.49 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.253 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.62 -40.94 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 121.543 1.974 . . . . 0.0 110.735 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.64 71.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.27 0.628 . . . . 0.0 112.629 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.99 -37.05 13.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 111.636 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 51.4 p -100.3 -14.13 18.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.72 1.608 . . . . 0.0 111.546 -169.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.98 48.37 86.62 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.108 0.563 . . . . 0.0 111.876 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.08 169.66 21.99 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.334 1.453 . . . . 0.0 107.778 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.29 93.65 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 169.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.01 170.71 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.473 1.909 . . . . 0.0 107.804 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -129.24 130.84 46.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.846 0.858 . . . . 0.0 108.757 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.55 176.94 6.37 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.411 1.884 . . . . 0.0 110.375 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -152.03 -176.73 5.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.043 1.737 . . . . 0.0 106.692 169.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -38.67 -37.6 0.34 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.774 2.83 . . . . 0.0 116.067 -169.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -128.81 -30.6 2.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.301 1.04 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.8 m -61.49 -20.89 63.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.422 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -49.47 -53.33 23.69 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -64.2 -45.04 90.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.09 77.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.397 -0.189 . . . . 0.0 111.369 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.37 -14.03 59.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.723 1.209 . . . . 0.0 112.494 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 p -120.79 -6.38 9.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.66 1.118 . . . . 0.0 113.474 -169.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.1 m -78.11 -0.77 29.43 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.382 -0.824 . . . . 0.0 113.11 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.86 145.51 36.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.16 0.984 . . . . 0.0 108.935 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.99 -170.86 54.68 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.893 0.759 . . . . 0.0 111.752 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.99 116.47 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.1 t -133.18 118.98 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.09 137.61 32.2 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.9 144.8 47.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -139.3 144.48 38.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 108.275 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.48 111.52 15.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.441 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.3 p-90 -131.52 154.16 49.06 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.926 1.69 . . . . 0.0 108.153 -169.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.89 163.14 7.88 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.896 0.771 . . . . 0.0 110.07 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -54.02 -14.02 5.45 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.981 3.121 . . . . 0.0 116.272 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -60.8 -24.32 65.74 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.836 1.198 . . . . 0.0 113.84 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.22 155.8 47.53 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.523 1.056 . . . . 0.0 112.335 -169.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.65 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.166 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.26 -27.41 23.05 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.347 2.698 . . . . 0.0 115.139 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m -57.83 -20.47 36.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 120.108 1.322 . . . . 0.0 113.324 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 11.33 22.71 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.404 1.082 . . . . 0.0 111.352 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.9 mtm -122.34 -43.65 2.29 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.09 -37.92 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.11 -58.55 14.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.203 -0.904 . . . . 0.0 112.332 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.75 -39.22 75.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.111 1.874 . . . . 0.0 111.919 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' A' ' 93' ' ' LYS . 2.2 t -57.01 -39.98 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.781 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.97 -42.82 80.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.989 0.813 . . . . 0.0 110.491 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.9 -36.88 85.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.558 0.617 . . . . 0.0 110.009 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.66 -36.91 81.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.301 -0.874 . . . . 0.0 110.642 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.93 -44.61 92.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.426 1.09 . . . . 0.0 110.231 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.66 -34.74 72.35 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.565 -0.71 . . . . 0.0 111.425 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.14 -27.02 68.64 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.451 -0.78 . . . . 0.0 111.657 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -90.29 -42.99 10.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.641 1.176 . . . . 0.0 111.291 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.1 ptm -144.2 18.98 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.704 0.802 . . . . 0.0 112.126 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.15 -7.0 15.27 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.311 -0.868 . . . . 0.0 114.309 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.35 -22.78 67.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.711 0.804 . . . . 0.0 111.054 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 -10.66 7.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.852 1.261 . . . . 0.0 112.779 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.9 tp -127.48 150.53 49.62 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.497 1.119 . . . . 0.0 112.092 -168.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -124.27 150.03 45.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.38 143.0 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.1 121.43 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.79 0.723 . . . . 0.0 109.215 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.9 mmmm -85.91 155.54 20.88 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mm -128.22 116.13 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 101.759 -3.422 . . . . 0.0 101.759 168.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.29 107.7 9.88 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.315 33.2 m -79.6 48.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -154.87 -45.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.34 1.456 . . . . 0.0 108.527 167.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.3 -35.84 30.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.175 0.99 . . . . 0.0 110.91 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -133.89 30.27 3.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.625 1.57 . . . . 0.0 110.514 -169.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -73.73 -5.84 43.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -56.05 -45.78 79.14 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.3 1.44 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.9 m -54.85 -42.62 72.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.335 0.654 . . . . 0.0 110.755 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.21 0.73 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.13 -44.2 14.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.103 0.858 . . . . 0.0 113.411 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.93 -44.99 87.67 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.265 1.033 . . . . 0.0 111.442 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -69.53 -26.71 64.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.743 0.701 . . . . 0.0 110.369 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.81 65.98 0.83 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.86 130.59 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 101.189 -3.634 . . . . 0.0 101.189 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.475 ' CE ' HD13 ' B' ' 72' ' ' LEU . 29.8 mtm -148.78 21.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -138.96 163.08 33.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.814 1.245 . . . . 0.0 113.603 -167.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.17 135.57 27.4 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.266 -0.874 . . . . 0.0 109.497 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -85.98 125.05 8.53 Favored 'Cis proline' 0 N--CA 1.45 -1.042 0 N-CA-C 106.001 -2.346 . . . . 0.0 106.001 -11.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.0 m -88.9 148.14 23.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.26 119.69 10.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.9 mt -118.2 109.63 16.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.86 138.42 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.24 157.09 41.84 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.419 1.088 . . . . 0.0 111.251 -172.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -138.11 127.75 25.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.71 1.204 . . . . 0.0 107.79 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 36.48 37.99 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.252 2.621 . . . . 0.0 115.507 168.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.94 -30.67 2.35 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.44 158.9 44.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -165.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.43 134.88 28.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.393 1.077 . . . . 0.0 108.721 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -122.42 -24.88 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.837 1.655 . . . . 0.0 111.321 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -144.78 153.35 41.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.95 146.96 33.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.6 m -155.1 153.82 31.45 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.519 1.128 . . . . 0.0 108.631 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.68 69.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.01 159.46 15.93 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 121.717 -0.614 . . . . 0.0 111.779 -173.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.48 145.5 56.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.275 0.63 . . . . 0.0 110.906 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.51 141.31 35.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.031 1.332 . . . . 0.0 107.744 170.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.31 169.46 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.589 2.193 . . . . 0.0 110.558 169.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HA ' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -53.7 -45.01 70.27 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.416 1.086 . . . . 0.0 111.971 -173.384 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.27 -41.97 84.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.201 0.201 . . . . 0.0 110.693 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.73 76.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.093 -0.38 . . . . 0.0 110.843 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -52.89 57.47 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.454 0.645 . . . . 0.0 109.895 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -62.83 -36.99 85.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.82 -46.7 88.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.729 0.695 . . . . 0.0 111.428 173.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.85 -28.82 62.21 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.829 1.252 . . . . 0.0 111.912 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.2 -42.13 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -57.34 -27.96 62.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.047 -1.033 . . . . 0.0 112.103 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -59.57 -22.54 61.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.57 -16.37 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 169.212 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.98 21.34 0.43 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -169.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.15 128.78 8.54 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 103.857 -2.645 . . . . 0.0 103.857 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -148.39 144.43 27.48 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 130.254 3.421 . . . . 0.0 104.605 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 mt -122.27 142.02 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -141.19 140.95 31.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -121.93 139.91 53.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -169.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -121.96 132.9 54.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -138.9 116.84 11.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.661 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.32 150.26 43.77 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.106 0.963 . . . . 0.0 111.005 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 83.9 m -45.05 106.28 0.07 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.843 1.657 . . . . 0.0 111.352 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.442 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 53.33 39.33 58.87 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.106 1.336 . . . . 0.0 111.188 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -39.09 125.41 1.56 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 38.9 p -141.64 -3.53 1.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.175 168.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.01 -80.42 0.38 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.29 1.036 . . . . 0.0 113.06 -169.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -52.43 -42.74 64.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.565 1.53 . . . . 0.0 113.062 -169.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -76.05 -25.14 55.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.665 1.121 . . . . 0.0 111.948 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.423 HE22 ' C ' ' B' ' 63' ' ' THR . 52.5 mm-40 -62.0 -47.66 83.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.708 1.14 . . . . 0.0 109.588 169.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.1 mtp -66.91 -43.99 81.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.97 93.71 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.705 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.0 -33.68 75.08 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.756 1.162 . . . . 0.0 110.96 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.61 -49.08 58.24 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.44 -41.04 75.77 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.182 0.993 . . . . 0.0 111.233 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.94 87.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -66.19 -19.85 65.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.461 -169.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -78.09 -16.26 58.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.608 1.094 . . . . 0.0 113.505 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.23 -16.42 3.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.86 -116.52 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.73 -167.93 38.07 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 119.161 0.892 . . . . 0.0 110.928 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.54 -20.71 63.55 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.219 1.008 . . . . 0.0 111.348 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -54.28 -24.3 18.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.133 2.173 . . . . 0.0 112.546 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -123.72 156.85 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.355 1.062 . . . . 0.0 110.708 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -125.84 139.56 53.39 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.98 140.25 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.58 157.53 46.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.531 0.732 . . . . 0.0 109.901 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 10.0 p -135.24 131.78 37.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.185 1.394 . . . . 0.0 109.194 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.31 173.75 14.12 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.43 -175.85 46.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.006 1.765 . . . . 0.0 110.405 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.442 HG22 ' H ' ' B' ' 12' ' ' GLY . 3.0 tt -52.43 -53.64 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.83 25.9 4.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.564 1.546 . . . . 0.0 109.078 -174.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.63 147.37 49.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.396 1.879 . . . . 0.0 112.245 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 29.7 p80 174.02 -17.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.579 2.352 . . . . 0.0 110.885 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.26 53.65 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-O 121.871 0.706 . . . . 0.0 113.018 -169.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.78 86.64 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 170.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -59.21 132.97 87.77 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.22 -22.52 57.43 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.757 1.638 . . . . 0.0 112.428 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -56.07 -56.08 25.2 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.4 75.06 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.288 0.949 . . . . 0.0 110.423 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.89 -55.56 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -56.64 -45.93 81.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 110.852 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.85 66.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.97 2.108 . . . . 0.0 111.331 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.3 mmm -89.03 -31.95 17.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.284 0.634 . . . . 0.0 110.27 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -61.63 -25.86 67.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.926 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.68 -27.99 66.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.171 1.351 . . . . 0.0 111.409 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.66 15.61 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.014 1.326 . . . . 0.0 110.971 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.39 93.38 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.693 -1.059 . . . . 0.0 112.964 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 82.1 mt -113.9 109.18 27.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.99 138.44 52.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 pt -134.82 16.07 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.856 0.862 . . . . 0.0 111.309 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 m -60.91 -13.79 18.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.246 0.93 . . . . 0.0 113.187 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -94.08 -13.98 26.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.9 1.68 . . . . 0.0 113.097 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.09 166.49 11.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.549 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.423 ' C ' HE22 ' B' ' 18' ' ' GLN . 13.9 t -156.25 -179.17 7.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.5 1.92 . . . . 0.0 107.458 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 64.0 m -143.41 -174.41 4.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.74 1.616 . . . . 0.0 107.675 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -150.98 171.47 17.23 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.022 1.329 . . . . 0.0 107.596 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.9 pt -62.66 170.71 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.071 0.851 . . . . 0.0 110.821 170.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.81 132.16 6.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -141.95 98.01 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.241 1.019 . . . . 0.0 108.419 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.8 m -47.15 -28.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.544 1.938 . . . . 0.0 114.451 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.08 -22.02 61.42 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 119.496 1.044 . . . . 0.0 110.515 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -40.57 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.693 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.475 HD13 ' CE ' ' A' ' 70' ' ' MET . 7.1 tt -61.57 -54.48 42.45 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.741 1.155 . . . . 0.0 109.47 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -22.89 67.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.025 0.829 . . . . 0.0 111.69 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.4 -12.58 54.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.738 1.215 . . . . 0.0 113.132 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.85 167.01 12.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.278 0.945 . . . . 0.0 110.544 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.38 -35.35 16.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.733 169.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.538 HD13 ' HD2' ' B' ' 97' ' ' LYS . 23.5 tp -146.38 136.05 23.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.113 1.365 . . . . 0.0 109.814 -172.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.454 HG21 HD21 ' B' ' 72' ' ' LEU . 16.0 t -105.06 105.22 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.5 109.4 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -68.49 132.12 46.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 39.1 mt -118.94 151.03 38.9 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.319 -0.723 0 C-N-CA 128.837 2.855 . . . . 0.0 111.623 174.466 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -85.13 18.72 2.45 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.872 -1.143 . . . . 0.0 113.795 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.305 0.2 OUTLIER 53.32 35.21 19.65 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.102 1.761 . . . . 0.0 113.49 -169.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 37.36 52.6 2.66 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.642 2.377 . . . . 0.0 114.212 172.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.49 130.69 37.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.211 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.41 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.87 0.48 50.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 116.636 -1.649 . . . . 0.0 115.14 -175.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.9 p 46.43 89.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.948 1.299 . . . . 0.0 113.436 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.98 143.48 92.33 Favored 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 123.132 2.554 . . . . 0.0 110.424 -169.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.19 4.23 0.79 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.092 3.861 . . . . 0.0 116.21 -169.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -67.8 -7.41 27.49 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.397 -0.814 . . . . 0.0 111.941 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -135.84 150.12 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.085 0.954 . . . . 0.0 111.055 -168.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.538 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.0 tmmm? -75.58 158.07 32.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -143.63 147.06 33.78 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.74 -1.225 . . . . 0.0 109.17 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.39 151.4 30.77 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -100.45 131.86 46.14 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.207 1.003 . . . . 0.0 109.627 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -115.88 10.75 15.34 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.04 0.936 . . . . 0.0 111.372 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.57 162.42 35.93 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 121.299 -0.876 . . . . 0.0 111.784 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -144.45 34.76 1.18 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.51 2.324 . . . . 0.0 107.985 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.15 139.27 20.14 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.035 2.134 . . . . 0.0 105.76 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -136.68 125.3 15.15 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 120.072 1.305 . . . . 0.0 111.216 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -82.9 -22.63 4.18 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.566 2.844 . . . . 0.0 113.684 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.77 63.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 118.44 0.564 . . . . 0.0 109.826 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -92.62 -64.61 1.08 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' B' ' 119' ' ' PHE . . . 46.6 -176.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.147 1.779 . . . . 0.0 114.451 -170.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -40.04 77.08 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.09 -20.41 5.05 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.2 p -70.65 166.7 20.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.632 0.716 . . . . 0.0 109.396 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -41.63 90.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.266 0.555 . . . . 0.0 110.937 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.12 -41.18 62.01 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.668 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.27 -31.85 58.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.569 1.531 . . . . 0.0 109.895 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -58.08 -58.4 8.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -58.98 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.276 0.489 . . . . 0.0 110.605 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.19 97.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.237 -0.914 . . . . 0.0 111.632 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 6.9 m-85 -66.57 -41.0 89.24 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.446 -0.787 . . . . 0.0 109.905 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -54.99 -52.91 61.65 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.289 0.95 . . . . 0.0 109.138 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -67.32 -45.82 75.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.74 0.816 . . . . 0.0 111.004 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttp-105 -62.07 -45.64 92.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.64 -43.19 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.741 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -64.45 -35.43 80.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.32 1.418 . . . . 0.0 111.009 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.46 -45.04 92.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.963 0.347 . . . . 0.0 111.424 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.45 -50.7 72.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.643 0.777 . . . . 0.0 110.195 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.7 -52.66 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.782 1.233 . . . . 0.0 109.342 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.05 -41.84 98.38 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 118.971 -0.905 . . . . 0.0 111.721 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -59.3 -46.53 88.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.297 1.049 . . . . 0.0 110.865 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -66.48 -37.87 86.06 Favored 'General case' 0 C--N 1.335 -0.049 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.499 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' B' ' 131' ' ' LEU . 2.4 mm? -64.67 -42.44 95.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.892 1.224 . . . . 0.0 110.912 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.53 -43.78 88.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.335 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.27 -40.06 89.04 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 117.361 -1.304 . . . . 0.0 110.654 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.35 -39.43 87.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 121.893 2.133 . . . . 0.0 111.29 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.73 70.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.153 0.581 . . . . 0.0 112.248 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.03 -44.73 9.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.581 1.552 . . . . 0.0 111.319 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.3 p -88.39 -24.39 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.291 1.836 . . . . 0.0 110.632 -169.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 49.11 51.14 26.27 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -169.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 125.246 1.418 . . . . 0.0 112.379 -172.65 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.37 161.14 0.08 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.496 2.318 . . . . 0.0 112.842 -170.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.5 109.6 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.4 t -80.86 167.15 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.827 1.651 . . . . 0.0 107.71 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -125.7 118.18 25.07 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.143 0.977 . . . . 0.0 108.411 170.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.461 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -75.98 174.0 10.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.299 1.439 . . . . 0.0 110.015 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -156.3 -175.87 5.66 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.306 1.442 . . . . 0.0 107.51 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -31.45 -40.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 130.794 3.638 . . . . 0.0 117.101 -169.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.23 -29.58 2.02 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.841 1.256 . . . . 0.0 111.033 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -59.23 -22.56 61.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.731 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -48.58 -51.77 26.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.164 1.347 . . . . 0.0 110.521 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 m -64.89 -45.01 87.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.23 0.468 . . . . 0.0 109.83 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.44 -36.73 83.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.34 -0.225 . . . . 0.0 110.884 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -76.77 -13.83 59.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.722 1.209 . . . . 0.0 112.471 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.5 p -119.8 -2.81 10.31 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.66 1.118 . . . . 0.0 112.504 -170.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.3 m -71.73 -10.89 60.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.18 147.66 38.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.562 0.745 . . . . 0.0 109.809 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.93 -167.56 45.59 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.49 1.043 . . . . 0.0 111.611 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 104' ' ' LEU . 28.5 t -102.58 122.25 54.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.03 115.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -81.07 140.5 35.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.0 44.18 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -141.6 148.2 38.86 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 109.001 -171.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -130.64 115.23 16.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.55 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.5 p-90 -133.7 156.15 48.46 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.603 1.561 . . . . 0.0 107.455 -171.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -176.2 167.88 1.5 Allowed Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.118 0.967 . . . . 0.0 110.905 169.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.05 -18.0 2.82 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.205 3.27 . . . . 0.0 116.407 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -57.77 -21.89 44.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.333 1.424 . . . . 0.0 114.174 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.73 158.08 44.25 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.672 1.124 . . . . 0.0 112.602 -171.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.6 -49.78 28.79 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.212 -1.327 . . . . 0.0 111.896 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -49.2 -27.29 12.47 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.819 3.013 . . . . 0.0 115.762 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.55 -23.23 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.45 1.477 . . . . 0.0 113.409 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -105.71 9.88 32.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.097 0.959 . . . . 0.0 112.035 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.6 mtm -120.46 -42.35 2.55 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.09 0.956 . . . . 0.0 109.586 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.98 -38.01 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.75 -58.65 13.37 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.187 -0.911 . . . . 0.0 112.259 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.01 -39.72 68.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 111.856 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.32 -41.9 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.231 0.469 . . . . 0.0 110.578 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.09 -42.52 80.24 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.554 0.615 . . . . 0.0 110.573 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.95 -39.81 94.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.733 0.697 . . . . 0.0 109.669 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -68.52 -24.21 64.63 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.102 -0.999 . . . . 0.0 112.11 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.444 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 42.0 tp -77.79 -45.61 23.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.648 1.179 . . . . 0.0 109.837 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HB2' HD12 ' A' ' 52' ' ' ILE . 25.3 t70 -69.77 -34.83 74.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.293 0.497 . . . . 0.0 110.964 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -59.36 -26.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 172.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -96.61 -46.33 6.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.173 0.589 . . . . 0.0 111.433 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.6 ptm -134.49 15.44 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 112.228 -169.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.04 16.9 Favored Glycine 0 CA--C 1.52 0.382 0 O-C-N 121.19 -0.944 . . . . 0.0 114.212 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.83 -24.08 64.33 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.836 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -25.92 7.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.59 1.156 . . . . 0.0 111.494 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.0 tp -112.62 151.67 29.83 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.324 1.45 . . . . 0.0 110.584 -169.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.77 148.53 46.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 43' ' ' ASP . 75.1 mt -131.66 137.09 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 14.3 t -137.17 113.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.4 mtpt -88.36 162.43 16.56 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.126 -0.984 . . . . 0.0 110.182 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -131.12 124.5 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -84.32 109.43 17.81 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.848 HG21 HD11 ' A' ' 72' ' ' ILE . 32.5 m -79.7 39.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -145.46 -37.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 168.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -74.89 -52.02 12.37 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.919 1.288 . . . . 0.0 109.842 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.14 46.68 1.93 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.364 1.066 . . . . 0.0 111.235 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.4 ' CD ' ' HD3' ' B' ' 94' ' ' PRO . 10.7 pt20 -72.12 -3.05 20.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.899 1.28 . . . . 0.0 113.138 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -56.38 -42.76 78.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.026 1.33 . . . . 0.0 110.894 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -54.53 -43.22 71.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.021 0.828 . . . . 0.0 111.371 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.96 -57.77 4.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.92 -43.0 39.4 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.908 0.766 . . . . 0.0 113.593 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -64.56 -42.11 95.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.506 1.153 . . . . 0.0 111.115 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -70.17 -30.69 67.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.371 0.532 . . . . 0.0 110.146 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.34 67.5 1.2 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -171.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.28 -62.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.496 ' HG3' HD12 ' B' ' 67' ' ' ILE 0.265 6.7 ptm 49.28 10.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.135 2.974 . . . . 0.0 115.183 178.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.8 p -140.89 162.98 34.17 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.565 1.546 . . . . 0.0 112.598 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.848 HD11 HG21 ' A' ' 57' ' ' VAL . 28.6 mm -142.7 148.3 45.8 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.162 0.985 . . . . 0.0 108.682 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -78.17 137.91 48.6 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 N-CA-C 106.477 -2.163 . . . . 0.0 106.477 -11.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -115.16 147.17 40.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -130.38 124.21 31.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.7 mt -121.56 112.48 18.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.2 t -104.75 128.49 58.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.31 156.9 41.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.239 1.016 . . . . 0.0 110.367 -169.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -146.02 139.25 25.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.73 29.57 0.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.318 1.847 . . . . 0.0 113.509 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.84 54.84 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.665 1.233 . . . . 0.0 111.21 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.76 138.14 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.95 -18.54 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.304 1.441 . . . . 0.0 111.241 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -141.05 157.36 45.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.227 0.922 . . . . 0.0 110.25 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.37 142.22 22.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 m -155.09 151.69 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.95 88.37 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 169.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.48 158.79 11.43 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -67.5 149.88 49.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.99 0.516 . . . . 0.0 110.501 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.88 135.8 14.76 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.69 169.19 16.51 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.315 2.01 . . . . 0.0 110.412 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -45.72 -48.22 15.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.894 1.678 . . . . 0.0 112.348 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.93 -43.66 71.21 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.259 0.481 . . . . 0.0 111.275 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.54 97.15 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.124 -0.36 . . . . 0.0 110.332 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -52.15 66.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.258 0.623 . . . . 0.0 109.711 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.53 -39.83 94.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.631 -0.699 . . . . 0.0 109.413 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.65 -45.77 92.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.807 0.73 . . . . 0.0 110.964 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.8 -37.55 76.6 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 125.277 1.431 . . . . 0.0 111.233 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.34 -37.09 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.824 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -57.98 -33.73 69.22 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.641 1.11 . . . . 0.0 111.374 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.41 -7.44 37.66 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -125.62 -23.55 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.867 1.267 . . . . 0.0 112.481 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.435 ' HA ' HG21 ' A' ' 19' ' ' VAL . 18.5 tp . . . . . 0 C--O 1.248 1.014 0 C-N-CA 127.168 2.187 . . . . 0.0 108.847 170.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -141.43 161.07 38.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.874 0.87 . . . . 0.0 109.658 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.27 28.5 m120 65.32 117.73 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 129.906 3.283 . . . . 0.0 113.567 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -153.94 137.22 15.72 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.99 3.316 . . . . 0.0 103.402 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -114.19 141.48 30.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -169.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.49 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.9 152.8 49.83 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.881 0.872 . . . . 0.0 110.429 -169.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -119.75 135.17 54.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.7 tp -128.99 119.01 23.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -144.35 163.26 34.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 0.0 111.186 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.456 ' HG1' ' N ' ' B' ' 86' ' ' ALA . 14.7 m -61.33 134.3 56.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.469 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 53.93 5.19 0.37 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.357 2.408 . . . . 0.0 118.587 169.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ASN . . . . . 0.47 ' ND2' ' H ' ' B' ' 65' ' ' ASP 0.319 1.8 t30 12.98 71.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.424 2.69 . . . . 0.0 112.57 -169.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.5 p -135.33 -27.07 1.23 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.094 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.37 -68.0 0.78 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.332 0.969 . . . . 0.0 112.225 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.47 HH21 ' HB3' ' B' ' 107' ' ' ALA . 0.0 OUTLIER -46.34 -55.86 6.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.478 0.581 . . . . 0.0 112.176 -169.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -37.42 81.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.891 -171.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -53.88 -43.88 69.97 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.075 1.35 . . . . 0.0 109.837 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 10.5 mtp -70.04 -49.21 53.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 -40.51 96.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.888 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.87 -33.94 72.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.529 1.059 . . . . 0.0 110.775 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.01 71.5 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -55.85 -39.7 71.82 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.046 0.938 . . . . 0.0 111.394 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.62 75.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -174.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -23.99 67.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.402 -169.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.52 -18.16 60.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.02 -23.12 4.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.884 0.766 . . . . 0.0 112.697 -174.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.6 mt -83.19 -113.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.69 -170.33 36.59 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.93 -17.69 57.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.837 0.855 . . . . 0.0 111.615 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -56.17 -23.55 35.73 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.42 1.888 . . . . 0.0 111.843 169.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -120.92 161.75 21.04 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.283 1.433 . . . . 0.0 109.674 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -124.21 135.74 53.67 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 t -127.81 134.16 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -139.71 166.19 25.27 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.691 1.196 . . . . 0.0 108.786 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 68.6 m -143.35 150.73 39.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.588 0.755 . . . . 0.0 110.261 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' B' ' 67' ' ' ILE . . . -148.99 158.86 44.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.784 1.234 . . . . 0.0 110.366 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 -176.39 38.53 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.116 0.865 . . . . 0.0 110.941 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.469 HG22 ' H ' ' B' ' 12' ' ' GLY . 1.3 tt -53.69 -63.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 113.482 -169.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -141.28 33.49 1.7 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.766 2.426 . . . . 0.0 105.76 -172.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.13 146.73 52.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.636 2.774 . . . . 0.0 114.26 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -177.24 17.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.899 1.68 . . . . 0.0 111.967 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.86 172.41 40.39 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 120.892 -1.13 . . . . 0.0 112.04 -169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.8 tp -148.68 75.5 1.31 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.89 131.29 79.26 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 125.023 1.329 . . . . 0.0 108.945 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.0 -22.28 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.966 1.777 . . . . 0.0 112.62 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.23 -54.67 44.17 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 119.616 1.098 . . . . 0.0 108.118 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.84 77.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.689 1.131 . . . . 0.0 110.538 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.77 -54.65 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -56.31 -46.08 79.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.006 0.922 . . . . 0.0 110.899 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -34.08 63.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.734 2.014 . . . . 0.0 111.673 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.0 mmm -92.11 -31.21 15.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.114 0.566 . . . . 0.0 110.481 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -61.65 -26.14 67.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.795 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.67 -31.57 64.56 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.961 1.255 . . . . 0.0 111.248 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.47 15.92 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.185 1.394 . . . . 0.0 110.852 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.51 37.55 93.83 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.908 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 81.8 mt -114.13 107.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.9 138.51 54.71 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 pt -133.42 13.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.624 0.77 . . . . 0.0 111.558 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -60.88 -14.34 21.49 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.925 0.784 . . . . 0.0 112.375 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -85.85 -16.05 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.809 1.644 . . . . 0.0 113.659 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.35 153.4 3.97 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.6 p -116.16 159.86 21.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.921 2.088 . . . . 0.0 108.953 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -148.34 153.71 38.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.803 1.241 . . . . 0.0 108.184 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.47 ' H ' ' ND2' ' B' ' 13' ' ' ASN . 39.2 t0 -164.52 161.83 21.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.963 0.801 . . . . 0.0 111.462 -169.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.4 pt -70.43 174.83 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.655 1.182 . . . . 0.0 111.466 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.575 ' HA ' ' HB1' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -52.07 134.0 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.632 0.773 . . . . 0.0 108.918 169.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.93 95.37 2.76 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.477 1.132 . . . . 0.0 109.237 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.44 -34.29 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.878 2.071 . . . . 0.0 113.744 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.81 -20.82 66.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.072 0.851 . . . . 0.0 112.185 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -122.57 -35.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.7 tt -66.21 -46.69 76.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.654 0.661 . . . . 0.0 110.633 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -30.42 71.58 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.847 0.749 . . . . 0.0 110.42 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -78.42 -18.24 55.24 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.662 1.185 . . . . 0.0 112.88 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 167.34 1.75 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.171 0.986 . . . . 0.0 111.961 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -90.19 -25.32 20.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.565 1.146 . . . . 0.0 111.286 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.34 128.68 11.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.994 0.918 . . . . 0.0 109.467 -173.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.09 100.6 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.872 1.669 . . . . 0.0 107.391 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.67 109.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -75.49 101.48 4.87 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.456 HD11 HG12 ' B' ' 127' ' ' ILE . 15.6 tp -80.98 -43.63 19.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.762 -0.586 . . . . 0.0 111.703 -168.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 123.269 0.627 . . . . 0.0 110.463 175.152 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.456 ' N ' ' HG1' ' B' ' 11' ' ' THR . . . . . . . . 0 C--O 1.225 -0.209 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -101.05 -1.23 34.73 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LYS . . . . . 0.419 ' HE3' HG13 ' B' ' 39' ' ' ILE . 3.4 tttt 73.09 19.04 3.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.852 2.061 . . . . 0.0 113.335 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 30.63 55.68 0.79 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.304 2.242 . . . . 0.0 112.521 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.31 139.69 91.09 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.169 1.913 . . . . 0.0 109.795 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.62 4.1 52.14 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.1 p 40.1 98.54 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 128.919 2.888 . . . . 0.0 114.947 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -61.48 138.42 75.92 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.077 1.851 . . . . 0.0 108.856 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.4 ' HD3' ' CD ' ' A' ' 61' ' ' GLN . 57.6 Cg_endo -66.81 3.18 1.62 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.788 3.659 . . . . 0.0 116.398 -168.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -63.33 -13.9 44.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.041 0.837 . . . . 0.0 112.017 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.47 151.32 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.201 0.91 . . . . 0.0 111.483 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 154.73 40.53 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.04 1.736 . . . . 0.0 108.865 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -139.93 145.5 38.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -151.47 141.85 22.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.5 139.72 33.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.75 0.704 . . . . 0.0 111.088 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -123.57 -63.95 1.19 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.009 0.524 . . . . 0.0 112.126 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.83 -44.01 39.81 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 55.86 27.55 11.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.27 1.828 . . . . 0.0 112.997 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -156.18 172.28 18.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.881 1.272 . . . . 0.0 109.032 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -135.12 113.34 11.41 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.166 1.387 . . . . 0.0 108.417 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.92 -21.01 21.55 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.866 3.044 . . . . 0.0 112.513 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.47 ' HB3' HH21 ' B' ' 16' ' ' ARG . . . -70.15 8.36 0.78 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.243 1.017 . . . . 0.0 112.385 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -117.79 13.93 14.22 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.254 1.421 . . . . 0.0 111.288 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.0 151.73 0.6 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.1 0.96 . . . . 0.0 110.984 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.24 -46.16 76.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 -172.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.86 -17.13 3.93 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.2 p -69.63 162.88 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.44 -41.06 88.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.397 0.617 . . . . 0.0 110.791 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -72.16 -43.9 63.91 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 117.079 -1.438 . . . . 0.0 109.851 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.19 -31.05 60.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 121.19 1.813 . . . . 0.0 110.024 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -59.37 -60.4 3.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.54 -39.13 86.77 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.04 97.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.36 -0.838 . . . . 0.0 112.317 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.64 -46.12 83.89 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -58.09 -50.15 74.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.19 -49.01 68.81 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.006 0.922 . . . . 0.0 110.69 -174.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -64.43 -44.09 92.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.894 0.77 . . . . 0.0 110.284 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.82 -42.09 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.985 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -34.82 78.91 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.435 1.47 . . . . 0.0 110.868 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.32 -44.57 83.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.87 0.468 . . . . 0.0 111.484 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.28 -48.31 78.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.456 HG12 HD11 ' B' ' 81' ' ' LEU . 17.1 mt -51.44 -53.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.944 1.297 . . . . 0.0 109.066 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.84 -41.71 99.66 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.252 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -63.4 -41.13 98.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.386 1.093 . . . . 0.0 111.765 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -71.72 -31.83 67.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.07 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' B' ' 131' ' ' LEU . 1.7 mm? -63.21 -48.08 79.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.354 0.979 . . . . 0.0 111.021 171.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -68.94 -37.64 78.98 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.989 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.62 -45.77 88.49 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.788 169.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -59.61 -38.41 81.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.423 1.919 . . . . 0.0 111.128 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.59 76.66 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.17 -44.75 12.66 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.594 1.557 . . . . 0.0 112.162 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.3 p -91.94 -23.0 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.687 1.995 . . . . 0.0 111.198 -169.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.03 54.15 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.306 0.955 . . . . 0.0 112.241 -169.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 127.761 2.425 . . . . 0.0 112.794 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.23 165.41 0.09 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.061 2.145 . . . . 0.0 113.32 -171.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.19 105.34 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.88 169.68 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.54 1.936 . . . . 0.0 108.614 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -123.14 114.81 20.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.073 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -80.95 170.94 15.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.996 0.918 . . . . 0.0 109.861 174.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -156.41 174.5 15.32 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.37 1.868 . . . . 0.0 106.148 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -32.71 -40.65 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 129.277 3.031 . . . . 0.0 116.425 -169.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.06 -31.08 3.14 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.26 1.024 . . . . 0.0 111.651 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -62.42 -21.45 65.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.558 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -50.85 -51.4 51.64 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.796 1.18 . . . . 0.0 109.178 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -62.64 -44.58 95.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.068 -0.395 . . . . 0.0 110.012 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.74 87.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.429 -0.169 . . . . 0.0 110.906 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.75 -12.85 60.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.723 1.209 . . . . 0.0 112.89 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.8 p -118.46 -5.87 10.76 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.626 1.103 . . . . 0.0 112.591 -170.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.3 m -75.81 -7.38 54.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.972 . . . . 0.0 113.454 -175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.05 155.35 45.39 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.366 1.066 . . . . 0.0 109.057 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.15 -155.6 48.86 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.27 0.938 . . . . 0.0 111.052 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.05 131.4 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 t -138.89 122.02 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.15 -168.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -94.35 94.74 8.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 107.891 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.41 148.61 28.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -141.37 146.68 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.665 1.586 . . . . 0.0 109.15 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -129.44 114.25 15.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.433 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.1 p-90 -124.63 161.75 25.59 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.148 1.379 . . . . 0.0 107.358 -174.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.34 159.34 23.82 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.5 -26.37 44.83 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.421 2.08 . . . . 0.0 114.281 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -51.29 -33.43 28.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -171.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -154.85 166.96 31.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.425 1.466 . . . . 0.0 114.075 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.61 -45.63 95.32 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.385 -1.786 . . . . 0.0 114.431 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.78 -29.65 43.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.383 2.592 . . . . 0.0 114.472 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -59.29 -18.74 40.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.139 1.336 . . . . 0.0 114.089 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -114.23 12.32 17.68 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.644 1.177 . . . . 0.0 111.162 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.1 mtm -121.52 -43.79 2.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.589 1.156 . . . . 0.0 109.238 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.68 -37.99 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.964 0.906 . . . . 0.0 109.226 169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.13 -57.88 19.78 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.045 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.7 -39.74 60.92 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.125 1.883 . . . . 0.0 112.064 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.17 -40.49 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.138 0.975 . . . . 0.0 110.85 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.47 -44.37 74.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.947 0.794 . . . . 0.0 110.524 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.8 -37.82 88.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.489 0.586 . . . . 0.0 109.909 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -72.34 -19.97 61.56 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.148 -0.97 . . . . 0.0 111.831 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 tp -80.89 -44.67 17.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.64 1.176 . . . . 0.0 108.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.7 -34.12 73.47 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.764 -0.585 . . . . 0.0 111.063 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.79 -24.81 66.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.779 -0.576 . . . . 0.0 112.176 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -97.13 -44.3 7.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.796 0.838 . . . . 0.0 111.302 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.3 ptm -139.49 14.33 2.56 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.857 0.863 . . . . 0.0 112.108 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.7 -5.11 22.49 Favored Glycine 0 C--O 1.227 -0.341 0 O-C-N 121.088 -1.007 . . . . 0.0 114.07 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.65 -24.25 66.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 110.788 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 -27.07 8.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.391 1.076 . . . . 0.0 111.875 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -116.01 151.01 36.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.466 1.506 . . . . 0.0 112.059 -168.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -116.97 148.56 41.32 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.81 143.55 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 5.6 t -140.54 120.18 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.6 mmmm -87.31 154.13 20.93 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.651 0.66 . . . . 0.0 110.963 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -127.98 115.18 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 102.933 -2.988 . . . . 0.0 102.933 168.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -88.26 87.87 7.45 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 m -42.61 -44.48 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.871 1.669 . . . . 0.0 113.669 -172.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.7 -23.9 65.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.489 1.495 . . . . 0.0 112.443 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -108.53 -30.24 8.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.588 1.555 . . . . 0.0 111.873 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -135.59 25.06 3.43 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -168.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.68 -5.79 13.13 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.585 -0.697 . . . . 0.0 112.645 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.84 -28.35 49.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 111.162 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -74.83 -46.92 33.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 0.0 109.847 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.45 -71.07 0.2 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.357 1.463 . . . . 0.0 111.989 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.37 -41.08 11.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.622 1.105 . . . . 0.0 113.292 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.8 -44.58 89.47 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 118.457 -0.783 . . . . 0.0 111.571 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -65.08 -40.73 95.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.21 67.98 0.41 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.93 127.47 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.838 ' HG3' HD12 ' B' ' 67' ' ' ILE . 15.3 ptm -147.19 19.38 1.23 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.118 -0.468 . . . . 0.0 109.991 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' B' ' 90' ' ' PRO . 3.3 m -141.86 169.86 16.8 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.587 1.155 . . . . 0.0 110.573 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.6 mm -137.92 145.16 46.99 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 107.563 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.15 134.59 30.76 Favored 'Cis proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 -10.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.0 m -102.16 146.68 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.98 137.47 54.6 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.964 1.706 . . . . 0.0 106.639 170.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -124.95 112.45 16.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.68 119.61 49.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.49 152.07 37.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.061 0.944 . . . . 0.0 109.421 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.7 136.13 38.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.2 t70 43.14 28.09 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.886 2.074 . . . . 0.0 114.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.68 48.34 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.579 1.085 . . . . 0.0 115.317 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -129.98 143.96 51.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.891 1.276 . . . . 0.0 110.058 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.0 139.4 19.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.95 -22.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.961 1.304 . . . . 0.0 111.187 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.64 161.01 39.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.723 0.773 . . . . 0.0 109.877 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -155.76 147.08 22.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.8 m -153.4 149.93 28.31 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.089 -1.007 . . . . 0.0 108.432 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.86 68.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.99 156.18 10.83 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.028 1.775 . . . . 0.0 109.521 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -73.22 163.99 27.32 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.886 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.519 ' HE3' HD22 ' A' ' 99' ' ' LEU . 5.8 mtmm -149.89 135.95 10.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.638 1.575 . . . . 0.0 107.26 174.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -68.58 167.74 21.84 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.0 109.903 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -169.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.96 -43.94 70.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.271 0.487 . . . . 0.0 110.853 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.46 78.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.326 0.512 . . . . 0.0 110.403 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 96' ' ' LEU . 17.9 tp -70.7 -48.48 54.42 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.439 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -61.13 -37.68 83.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.2 -48.43 81.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.766 1.166 . . . . 0.0 110.827 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.519 HD22 ' HE3' ' A' ' 91' ' ' LYS . 11.6 tp -54.46 -42.22 70.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.715 1.206 . . . . 0.0 111.291 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -90.52 -37.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.195 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -61.01 -21.94 64.06 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.345 1.429 . . . . 0.0 112.594 -176.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -78.98 -5.92 55.04 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.128 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -126.4 -30.21 2.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.85 1.26 . . . . 0.0 111.993 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 2.4 tm? . . . . . 0 C--O 1.249 1.065 0 C-N-CA 125.978 1.711 . . . . 0.0 108.408 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.08 136.4 53.71 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 109.448 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m120 69.85 127.36 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.967 2.507 . . . . 0.0 110.712 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -137.76 119.06 14.63 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 128.822 2.849 . . . . 0.0 103.98 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.61 139.6 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -169.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.08 149.28 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.906 1.282 . . . . 0.0 107.567 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.514 ' CD1' HD12 ' B' ' 72' ' ' LEU . 2.6 t80 -133.72 146.6 50.93 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.439 -168.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.2 140.53 48.48 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 31.8 tp -136.71 110.97 8.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.5 p -146.22 156.21 43.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -57.78 129.82 43.63 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.863 1.665 . . . . 0.0 111.477 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.422 ' H ' ' CG2' ' B' ' 39' ' ' ILE . . . 46.9 39.25 11.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.335 23.1 t-20 -37.07 99.85 0.02 OUTLIER 'General case' 0 C--N 1.345 0.39 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -166.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -144.47 -2.18 0.88 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.834 1.253 . . . . 0.0 111.626 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.93 -60.71 0.73 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -171.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -51.9 60.83 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.781 -1.2 . . . . 0.0 111.862 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 14.9 m -64.34 -34.27 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.142 0.177 . . . . 0.0 110.811 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -60.57 -50.73 72.37 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.141 1.776 . . . . 0.0 109.636 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 6.0 ptp -67.56 -40.09 84.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.72 94.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.838 0.855 . . . . 0.0 111.683 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.07 -30.27 64.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.332 0.969 . . . . 0.0 111.251 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.37 -50.59 54.99 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.443 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -55.93 -37.26 68.71 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.117 0.967 . . . . 0.0 111.585 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.67 56.02 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 122.599 0.36 . . . . 0.0 110.414 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -65.16 -24.36 67.37 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.85 -12.52 61.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.417 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 10.9 m-85 -130.39 -14.33 3.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.433 1.093 . . . . 0.0 113.876 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 25.4 mt -120.19 88.49 2.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.22 -166.86 0.57 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.78 1.657 . . . . 0.0 113.586 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.71 -17.0 12.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.623 1.169 . . . . 0.0 112.718 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.29 -24.38 7.34 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.702 1.601 . . . . 0.0 110.946 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -127.46 153.4 46.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.048 1.739 . . . . 0.0 110.061 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 135.21 47.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.04 152.98 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -169.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -145.99 164.06 33.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.438 1.095 . . . . 0.0 109.236 177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.5 m -142.22 126.08 17.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 108.958 -169.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.16 -177.85 6.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.499 0.591 . . . . 0.0 111.266 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.69 -167.75 40.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.422 ' CG2' ' H ' ' B' ' 12' ' ' GLY . 16.0 tt -70.11 154.65 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 31.8 58.13 0.33 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 130.016 3.326 . . . . 0.0 110.041 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.29 137.53 53.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.459 1.103 . . . . 0.0 111.896 -168.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 28.0 p80 174.99 -2.36 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.84 2.056 . . . . 0.0 111.568 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.09 174.97 54.3 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.923 0.783 . . . . 0.0 111.828 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 tp -139.33 83.83 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -55.39 128.93 68.44 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.58 1.152 . . . . 0.0 108.03 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.73 -21.67 57.42 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.735 1.623 . . . . 0.0 112.326 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -57.44 -54.21 49.37 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 168.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.93 80.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.089 1.313 . . . . 0.0 110.893 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.22 -54.11 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.35 -43.42 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.393 0.677 . . . . 0.0 110.757 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -35.54 62.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.712 2.005 . . . . 0.0 110.339 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 75.1 mmm -93.75 -33.0 13.78 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.988 0.915 . . . . 0.0 111.831 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -59.84 -29.41 68.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.034 0.834 . . . . 0.0 110.901 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -60.32 -33.03 71.81 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.388 0.994 . . . . 0.0 111.63 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.87 13.95 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.609 1.164 . . . . 0.0 111.363 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.2 38.62 92.09 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.648 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.75 107.54 22.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.54 137.82 52.75 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.62 13.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 123.751 0.821 . . . . 0.0 111.773 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -60.4 -15.83 29.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.125 0.875 . . . . 0.0 112.543 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -81.6 -17.07 49.55 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.557 1.543 . . . . 0.0 113.556 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -54.52 154.04 5.14 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -125.51 158.42 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.184 2.194 . . . . 0.0 108.86 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 6.4 m -150.12 157.3 42.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.784 1.234 . . . . 0.0 108.354 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -162.39 168.84 21.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.581 1.152 . . . . 0.0 109.621 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 10.7 pt -69.21 172.23 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.296 1.038 . . . . 0.0 112.124 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.838 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.6 OUTLIER -44.24 131.31 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 125.517 1.527 . . . . 0.0 108.413 175.401 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -142.69 94.25 2.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.863 0.84 . . . . 0.0 108.926 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -50.63 -24.01 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.259 1.423 . . . . 0.0 114.791 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 -29.43 66.35 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 120.661 1.573 . . . . 0.0 109.917 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.37 -42.08 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.172 171.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.521 HD13 ' CE ' ' A' ' 70' ' ' MET . 4.5 tt -63.12 -49.59 73.82 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.652 1.114 . . . . 0.0 110.578 -174.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -29.49 70.74 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.884 1.22 . . . . 0.0 110.138 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -77.12 -14.67 59.76 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.553 1.141 . . . . 0.0 112.867 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.17 163.64 19.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.176 0.988 . . . . 0.0 110.167 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.81 -36.94 16.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.828 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.425 HD23 ' CE ' ' B' ' 97' ' ' LYS . 2.8 tm? -145.33 139.89 27.35 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.415 0.686 . . . . 0.0 111.357 -168.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.4 t -118.54 109.64 27.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 126.252 1.821 . . . . 0.0 107.538 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.7 97.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -66.2 125.86 26.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 167.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -129.96 61.67 1.57 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.958 0.903 . . . . 0.0 111.437 -167.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 51.4 m . . . . . 0 CA--C 1.536 0.409 0 C-N-CA 124.796 1.239 . . . . 0.0 108.299 169.736 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -73.55 43.53 0.14 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.65 1.58 . . . . 0.0 113.882 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 52.54 -155.71 0.18 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.808 1.643 . . . . 0.0 110.706 -169.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.68 63.54 59.53 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.57 2.348 . . . . 0.0 105.421 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 37.4 Cg_exo -57.14 128.3 29.18 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.932 1.755 . . . . 0.0 110.572 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 3.11 48.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.149 -0.929 . . . . 0.0 113.036 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p 37.05 91.93 0.06 OUTLIER Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 128.283 2.633 . . . . 0.0 113.695 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -55.2 130.09 38.8 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.399 2.733 . . . . 0.0 107.939 -174.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.83 2.66 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 126.129 4.553 . . . . 0.0 118.351 -168.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.9 -24.82 68.02 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 119.446 1.021 . . . . 0.0 109.87 169.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.03 153.53 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.39 1.076 . . . . 0.0 112.393 175.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.425 ' CE ' HD23 ' B' ' 77' ' ' LEU . 4.6 tmmm? -93.38 154.72 17.8 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 167.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -152.94 146.08 24.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.532 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -156.11 154.78 31.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 168.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -104.77 140.22 38.41 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.885 1.274 . . . . 0.0 109.284 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -142.81 -1.17 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.12 -58.65 3.34 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.387 0.994 . . . . 0.0 110.939 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 55.78 14.83 1.42 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.264 1.825 . . . . 0.0 113.656 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -163.2 171.06 16.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 0.0 107.822 -169.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -150.51 104.92 3.09 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.311 1.045 . . . . 0.0 108.984 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.45 -29.6 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.931 2.42 . . . . 0.0 114.301 -169.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.28 64.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.526 0.731 . . . . 0.0 111.026 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -83.67 -56.7 3.57 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' ALA . . . . . 0.437 ' HB3' ' HE3' ' B' ' 116' ' ' LYS . . . 44.29 -176.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.097 2.159 . . . . 0.0 115.233 -169.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.54 -40.46 73.4 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.1 -20.9 4.69 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 49.1 p -70.93 166.4 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.689 0.745 . . . . 0.0 109.385 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.95 -39.66 86.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.119 0.485 . . . . 0.0 111.042 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.4 pt-20 -75.65 -42.69 50.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 117.504 -1.236 . . . . 0.0 109.593 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.39 -30.14 60.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.513 1.506 . . . . 0.0 110.231 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' B' ' 109' ' ' ALA . 2.9 mmpt? -57.21 -59.25 5.39 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 169.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -61.47 -38.8 88.57 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.794 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.56 94.05 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.216 -0.928 . . . . 0.0 111.865 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 4.0 m-85 -64.63 -46.49 82.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.216 -0.421 . . . . 0.0 109.965 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -56.3 -49.62 73.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -62.54 -48.54 79.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.853 1.661 . . . . 0.0 110.128 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -60.22 -51.9 67.59 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.86 -41.67 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.61 -0.709 . . . . 0.0 109.427 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.443 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 3.7 tmm_? -59.62 -43.01 93.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.511 1.051 . . . . 0.0 111.777 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.8 -46.23 88.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.263 0.483 . . . . 0.0 110.928 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.73 -38.89 73.59 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.23 -0.294 . . . . 0.0 110.99 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.25 -45.74 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.36 1.064 . . . . 0.0 108.875 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.81 -42.7 86.03 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-O 119.165 -0.797 . . . . 0.0 111.682 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -56.97 -45.66 82.73 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.346 1.073 . . . . 0.0 110.988 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -61.34 -39.64 91.33 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.612 0.765 . . . . 0.0 110.44 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.4 mm? -77.01 -34.15 57.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 119.094 0.861 . . . . 0.0 112.589 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.9 ttmt -66.83 -39.17 87.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.751 0.705 . . . . 0.0 109.413 172.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -61.31 -35.22 76.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 117.296 -1.335 . . . . 0.0 110.077 169.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.4 -41.07 88.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 120.881 1.673 . . . . 0.0 109.814 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.64 70.47 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.81 0.844 . . . . 0.0 112.591 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -92.27 -36.55 13.16 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.378 1.471 . . . . 0.0 112.721 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 70.6 p -109.1 -11.81 14.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.962 1.705 . . . . 0.0 111.905 -169.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.75 23.63 67.41 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.034 1.302 . . . . 0.0 113.515 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.034 1.734 . . . . 0.0 106.848 -169.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 tpp . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.31 171.15 19.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.639 1.576 . . . . 0.0 107.571 170.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.2 93.82 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.73 171.29 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.148 1.779 . . . . 0.0 107.842 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.82 144.92 49.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.279 1.032 . . . . 0.0 109.174 172.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.439 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -116.25 169.94 8.91 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.257 1.823 . . . . 0.0 108.594 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -156.54 -173.79 4.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -38.67 -39.48 0.5 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.932 2.493 . . . . 0.0 115.811 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -129.01 -30.2 2.24 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.337 1.055 . . . . 0.0 111.505 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -60.77 -25.25 66.38 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.657 -0.687 . . . . 0.0 111.815 172.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -52.15 -56.55 13.8 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.064 0.847 . . . . 0.0 109.226 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -61.02 -44.16 97.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.89 -34.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.352 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.41 -12.91 57.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.573 1.149 . . . . 0.0 113.333 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.4 p -120.83 -7.92 9.48 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.096 1.316 . . . . 0.0 114.398 -168.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -78.71 -2.32 38.74 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -140.43 153.0 46.14 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.28 1.032 . . . . 0.0 109.237 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.14 -157.23 49.38 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.71 128.92 72.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.36 115.16 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.9 tt -78.93 139.06 38.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.62 141.56 51.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.54 142.09 48.03 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.372 1.469 . . . . 0.0 108.563 -173.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.5 116.42 21.07 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -135.02 154.23 51.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.95 1.3 . . . . 0.0 108.711 -170.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.1 161.49 18.46 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.51 0.724 . . . . 0.0 109.651 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.87 -14.83 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.498 2.799 . . . . 0.0 116.514 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -55.15 -24.21 25.34 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.4 p -155.94 169.6 24.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.771 1.168 . . . . 0.0 113.481 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.57 89.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.39 -1.783 . . . . 0.0 114.28 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.31 -28.46 43.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.381 2.591 . . . . 0.0 114.311 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -59.2 -16.83 22.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.898 1.226 . . . . 0.0 113.828 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -116.59 13.0 15.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.737 1.215 . . . . 0.0 111.525 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.0 mtm -122.91 -43.62 2.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.301 1.04 . . . . 0.0 109.415 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.09 -38.06 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -56.49 32.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.716 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.57 -38.68 80.88 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.87 1.713 . . . . 0.0 111.54 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.49 -38.11 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.9 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.52 -48.03 79.22 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 119.559 1.072 . . . . 0.0 109.979 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -66.57 -35.7 80.84 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.905 -0.497 . . . . 0.0 109.848 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.62 -15.33 61.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.74 1.616 . . . . 0.0 112.833 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.25 -44.6 10.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 108.56 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.7 -37.98 76.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.298 -0.251 . . . . 0.0 111.082 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -68.4 -9.85 51.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.948 -0.548 . . . . 0.0 112.15 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.0 -48.32 3.77 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.112 0.965 . . . . 0.0 110.967 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -132.35 16.11 4.52 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.822 0.849 . . . . 0.0 112.45 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.54 19.23 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 121.175 -0.953 . . . . 0.0 114.134 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.28 -23.83 65.71 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 169.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.3 -18.81 9.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.191 0.996 . . . . 0.0 112.439 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.9 tp -128.47 148.08 50.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.364 1.066 . . . . 0.0 111.413 -168.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -110.54 146.98 35.09 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.92 142.23 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 3.5 t -136.43 140.27 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -106.77 145.34 32.2 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 123.868 0.867 . . . . 0.0 110.281 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.02 122.78 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -85.47 111.21 19.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.261 33.8 m -82.48 41.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -148.49 -38.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.932 0.893 . . . . 0.0 109.415 168.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.86 -51.4 12.6 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.88 1.272 . . . . 0.0 109.862 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.47 47.77 2.17 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.68 1.192 . . . . 0.0 110.088 -172.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -73.55 -1.75 19.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.861 1.265 . . . . 0.0 112.758 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -55.28 -44.47 75.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.243 1.417 . . . . 0.0 110.86 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -57.92 -41.72 83.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.685 0.675 . . . . 0.0 111.152 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB1' ' CE ' ' B' ' 91' ' ' MET . . . -69.24 -61.81 1.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.455 1.102 . . . . 0.0 108.719 -171.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.86 -41.74 28.53 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.753 -1.026 . . . . 0.0 113.851 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -62.75 -44.35 96.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.432 1.616 . . . . 0.0 110.961 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -71.78 -11.78 60.98 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.196 0.453 . . . . 0.0 111.276 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.66 56.13 6.9 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 m -103.71 -46.41 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.976 0.888 . . . . 0.0 108.942 -169.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.3 mtm 52.73 15.23 0.5 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 127.574 2.35 . . . . 0.0 113.397 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 m -138.08 159.77 41.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.589 1.155 . . . . 0.0 110.945 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.46 143.77 42.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.07 129.91 20.09 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 N-CA-C 107.71 -1.689 . . . . 0.0 107.71 -10.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -98.04 145.36 26.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tp -137.01 126.57 25.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -124.82 110.45 14.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.99 120.22 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 171.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp -112.47 150.79 30.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.697 1.199 . . . . 0.0 109.298 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -150.77 124.75 9.26 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.09 27.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.5 2.72 . . . . 0.0 114.93 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.32 -24.01 3.26 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.606 -1.108 . . . . 0.0 115.378 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.48 159.04 43.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.032 1.416 . . . . 0.0 113.156 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.15 133.62 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.59 -20.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.888 1.275 . . . . 0.0 111.04 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.76 157.7 44.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.235 1.014 . . . . 0.0 109.524 169.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.94 148.28 29.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -171.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -152.71 149.54 28.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.06 57.68 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.09 20.4 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.921 1.724 . . . . 0.0 110.622 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -66.63 157.2 33.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.995 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -148.13 135.33 10.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -68.43 169.66 16.6 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.484 2.123 . . . . 0.0 110.412 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -46.8 65.43 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 112.034 -171.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.77 -42.13 77.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.849 0.093 . . . . 0.0 110.958 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.28 81.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.866 -0.521 . . . . 0.0 110.423 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.83 -47.67 71.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.19 -37.15 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.723 -0.655 . . . . 0.0 109.54 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.11 -46.63 86.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.675 0.67 . . . . 0.0 110.93 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -56.02 -41.64 75.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.439 0.696 . . . . 0.0 111.093 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -83.15 -42.0 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.506 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 10.5 t30 -56.4 -35.53 67.88 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.523 1.129 . . . . 0.0 111.801 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -69.18 -7.67 38.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.36 -25.7 4.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.472 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 16.1 tp . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.606 1.962 . . . . 0.0 109.275 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.14 27.49 4.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.842 1.257 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -157.39 129.73 7.31 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.479 ' H ' ' HA ' ' B' ' 32' ' ' TRP . 95.4 mttt -118.87 114.3 22.39 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 129.333 3.053 . . . . 0.0 103.677 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -90.12 141.16 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.22 141.49 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -131.53 138.86 49.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -115.76 152.66 32.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.75 0.705 . . . . 0.0 109.305 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 mt -132.11 118.35 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.6 p -150.22 157.49 43.14 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.804 1.242 . . . . 0.0 109.402 169.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 31.3 m -53.6 123.97 13.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.313 1.045 . . . . 0.0 110.361 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.95 18.49 11.79 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.657 0.646 . . . . 0.0 113.312 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t30 43.05 47.68 5.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.189 1.796 . . . . 0.0 112.691 -169.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -74.77 -157.35 0.06 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.82 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . -33.92 -63.3 0.27 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.55 2.74 . . . . 0.0 116.82 -168.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -57.99 -47.23 83.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 0.896 . . . . 0.0 111.611 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -60.51 -49.4 77.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.718 0.69 . . . . 0.0 111.681 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -57.14 -48.8 77.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.317 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.4 ttm -66.81 -42.93 85.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.551 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.93 84.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.923 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.16 -28.93 57.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.615 1.098 . . . . 0.0 111.179 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 -43.86 48.44 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -56.1 -41.72 75.65 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.18 0.99 . . . . 0.0 111.117 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.45 -50.58 70.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -63.39 -21.76 66.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 118.079 -0.962 . . . . 0.0 113.277 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.37 -16.45 63.93 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.612 1.096 . . . . 0.0 113.824 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.6 -39.79 0.57 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.896 1.226 . . . . 0.0 113.107 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.427 ' HG ' ' CG ' ' B' ' 32' ' ' TRP . 4.3 tp -77.45 75.6 4.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.534 2.734 . . . . 0.0 105.081 169.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.64 -166.9 1.86 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.85 2.167 . . . . 0.0 114.767 -169.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -56.93 -20.61 24.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.23 1.412 . . . . 0.0 112.968 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -55.65 -20.54 14.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 112.482 169.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' TRP . . . . . 0.479 ' HA ' ' H ' ' B' ' 4' ' ' LYS . 63.9 m95 -118.22 174.17 6.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.383 1.873 . . . . 0.0 109.789 -176.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 114.61 5.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.78 149.2 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -150.8 167.36 27.7 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 168.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -152.17 147.54 26.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 110.391 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.06 178.16 9.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.855 1.262 . . . . 0.0 111.216 -169.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.14 -175.63 42.75 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -47.75 -58.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.492 . . . . 0.0 114.541 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.07 31.56 4.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.573 1.549 . . . . 0.0 108.425 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.45 151.32 47.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.68 1.992 . . . . 0.0 115.17 -169.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 p80 162.8 47.2 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 130.906 3.683 . . . . 0.0 107.567 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.8 177.28 27.86 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.894 0.759 . . . . 0.0 112.017 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 36.3 tp -161.28 83.67 0.64 Allowed 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.44 126.47 90.66 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.476 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.41 -24.98 75.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.214 1.943 . . . . 0.0 112.722 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.3 -51.17 70.9 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -59.22 -35.76 74.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.849 1.204 . . . . 0.0 111.214 -175.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.04 -53.76 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.58 -48.09 80.33 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 110.567 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.984 1.714 . . . . 0.0 111.855 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.72 -43.49 14.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.861 0.864 . . . . 0.0 110.051 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.24 -30.71 69.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.623 0.647 . . . . 0.0 110.832 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -27.59 62.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.874 1.27 . . . . 0.0 112.292 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.37 15.48 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.147 1.379 . . . . 0.0 111.158 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.66 72.66 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.179 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 63.0 mt -110.19 149.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -117.93 135.45 54.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.589 0.756 . . . . 0.0 108.993 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 pt -136.56 17.4 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.4 1.08 . . . . 0.0 111.048 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -67.23 13.46 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -169.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -137.75 -4.56 1.78 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.235 2.614 . . . . 0.0 111.539 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -57.92 147.73 27.94 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.532 1.06 . . . . 0.0 111.324 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -126.89 168.95 13.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.61 1.964 . . . . 0.0 109.184 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 7.0 p -155.03 -174.45 4.99 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.172 0.989 . . . . 0.0 108.442 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -159.23 168.51 26.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.559 1.543 . . . . 0.0 107.933 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.7 pt -60.26 164.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.464 0.705 . . . . 0.0 111.304 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -48.22 127.04 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -135.83 99.17 4.1 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.67 1.224 . . . . 0.0 109.194 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -42.68 -31.68 0.49 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.731 2.413 . . . . 0.0 114.559 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.07 -17.67 63.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.243 0.928 . . . . 0.0 112.212 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.33 -38.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.345 1.058 . . . . 0.0 109.04 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.433 HD23 ' C ' ' B' ' 72' ' ' LEU . 7.9 tt -61.77 -56.56 18.22 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.02 1.282 . . . . 0.0 109.332 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.0 66.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.566 0.621 . . . . 0.0 111.279 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.41 -24.76 36.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.025 1.73 . . . . 0.0 112.525 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.55 172.03 2.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.481 1.513 . . . . 0.0 112.149 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.92 -36.93 13.85 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.67 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' B' ' 97' ' ' LYS . 14.4 tp -143.64 133.26 23.64 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 109.634 -171.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.38 115.15 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.16 107.82 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.1 m -75.53 88.06 2.67 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 167.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 48.01 1.16 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.949 1.7 . . . . 0.0 107.114 -169.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.443 -0.785 0 C-N-CA 124.725 1.21 . . . . 0.0 109.937 -169.732 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.64 50.15 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.327 1.451 . . . . 0.0 113.527 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 52.78 -147.53 0.47 Allowed 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.999 -1.063 . . . . 0.0 108.627 -169.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.48 55.53 1.98 Allowed Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 126.683 1.993 . . . . 0.0 106.1 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.7 135.03 50.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.181 1.254 . . . . 0.0 112.003 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.432 ' HG3' ' H ' ' B' ' 91' ' ' MET 0.255 0.0 OUTLIER -83.69 4.93 26.51 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.742 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p 39.91 84.88 0.17 Allowed Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 125.245 1.418 . . . . 0.0 113.063 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -53.57 138.97 67.03 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.201 2.601 . . . . 0.0 110.614 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.95 8.6 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 125.669 4.246 . . . . 0.0 117.225 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.04 -5.13 20.0 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.218 -0.926 . . . . 0.0 111.608 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.9 149.88 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.655 1.182 . . . . 0.0 110.473 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.616 ' HD2' HD13 ' B' ' 77' ' ' LEU . 0.4 OUTLIER -75.85 155.75 35.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.124 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -142.2 146.99 35.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 120.713 -1.242 . . . . 0.0 108.507 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -139.4 151.46 46.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -133.9 115.93 15.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -152.64 1.73 0.31 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.17 -53.33 45.6 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.756 1.162 . . . . 0.0 111.123 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.8 t80 58.18 -12.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.405 2.682 . . . . 0.0 117.03 169.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -152.28 82.0 1.25 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.252 1.421 . . . . 0.0 108.497 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.05 129.6 77.94 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.646 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.08 -26.64 9.06 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.661 2.907 . . . . 0.0 112.909 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.73 11.85 0.45 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.601 1.092 . . . . 0.0 112.035 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -123.61 16.18 9.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.234 2.214 . . . . 0.0 111.14 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.06 153.12 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -67.63 140.81 56.87 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.51 58.28 4.99 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.268 -168.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -127.17 149.87 49.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.19 -40.32 46.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.698 1.599 . . . . 0.0 111.507 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.83 -41.06 60.6 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.916 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.15 -31.49 49.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.948 0.795 . . . . 0.0 109.8 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -57.64 -59.85 4.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -62.75 -39.83 95.36 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.665 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.6 84.2 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.684 0.794 . . . . 0.0 112.313 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -63.95 -47.74 79.29 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.46 -40.51 96.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.387 0.54 . . . . 0.0 110.399 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -64.34 -51.69 62.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.691 1.196 . . . . 0.0 109.627 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.2 ttp-105 -59.1 -46.12 89.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.75 -43.86 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.377 -1.297 . . . . 0.0 111.19 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.69 81.99 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.554 1.979 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.42 -45.7 89.75 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.58 -53.79 46.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.665 0.786 . . . . 0.0 110.354 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.69 -47.38 85.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.938 0.895 . . . . 0.0 109.765 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.96 -44.11 98.56 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -62.05 -43.66 98.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.049 0.925 . . . . 0.0 111.801 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -65.3 -45.93 82.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.421 0.555 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.67 -31.87 70.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.057 0.844 . . . . 0.0 111.198 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.87 -39.84 91.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.103 171.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -59.7 -38.37 81.39 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.075 -1.44 . . . . 0.0 111.155 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -60.26 -37.23 79.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.69 2.041 . . . . 0.0 109.928 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.36 79.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.374 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -81.75 -47.92 12.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.411 1.085 . . . . 0.0 111.672 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.1 p -82.0 -24.19 35.56 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.835 2.054 . . . . 0.0 112.526 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.94 24.17 62.4 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 C-N-CA 128.381 2.672 . . . . 0.0 112.226 -169.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.54 169.74 23.96 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.556 1.542 . . . . 0.0 107.581 171.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.76 96.53 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.36 166.27 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.148 1.379 . . . . 0.0 108.065 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -126.03 116.14 20.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.151 1.38 . . . . 0.0 108.088 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.14 173.95 10.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.861 1.264 . . . . 0.0 111.157 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -155.36 179.07 9.52 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.986 2.514 . . . . 0.0 105.544 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -48.33 -29.88 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.543 1.937 . . . . 0.0 115.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.79 -27.29 3.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.85 0.86 . . . . 0.0 112.394 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.3 m -59.86 -40.35 88.28 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.83 122.28 18.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 167.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m 118.9 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.693 1 C-N-CA 132.034 4.133 . . . . 0.0 106.126 -169.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.32 93.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 110.361 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -80.03 -13.15 59.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.42 1.488 . . . . 0.0 112.225 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.0 p -120.24 -9.96 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -168.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -80.81 0.28 35.56 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.165 0.893 . . . . 0.0 113.299 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.1 150.87 47.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.997 0.817 . . . . 0.0 110.159 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.83 -152.55 51.74 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.22 131.66 69.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.73 114.37 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -169.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.48 97.36 7.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 107.474 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.43 26.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -138.84 147.54 42.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.439 1.496 . . . . 0.0 109.299 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -128.49 110.96 12.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -171.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.534 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.0 p-90 -123.35 150.01 44.19 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -173.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.3 154.94 22.69 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.351 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.67 -20.76 22.65 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.981 2.454 . . . . 0.0 115.426 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -49.65 -28.81 6.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.761 2.024 . . . . 0.0 115.755 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -156.55 169.66 24.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.72 1.6 . . . . 0.0 113.463 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.6 -45.3 96.6 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.364 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -52.21 -29.63 38.45 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.533 2.666 . . . . 0.0 114.96 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -58.82 -20.99 55.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 120.32 1.418 . . . . 0.0 113.783 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -109.5 11.61 24.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.389 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -121.6 -43.85 2.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.385 1.074 . . . . 0.0 109.426 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.61 -35.62 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.003 0.921 . . . . 0.0 109.577 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.23 14.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.827 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.01 -38.59 77.15 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.018 1.812 . . . . 0.0 111.784 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.04 -41.57 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.169 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mp -66.37 -41.08 89.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.226 0.921 . . . . 0.0 110.987 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.98 -35.51 80.77 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.085 0.857 . . . . 0.0 110.063 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -71.2 -24.12 62.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.802 1.241 . . . . 0.0 112.152 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 3.4 tm? -81.55 -44.97 16.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.132 1.373 . . . . 0.0 108.735 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' HD13 ' A' ' 52' ' ' ILE . 25.6 t70 -66.11 -38.47 88.3 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.922 -0.486 . . . . 0.0 111.058 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.95 -5.02 31.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.479 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -105.31 -49.14 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.517 1.127 . . . . 0.0 111.038 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.4 ptm -130.38 15.12 5.55 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.235 0.614 . . . . 0.0 112.152 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -5.85 23.39 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 121.223 -0.923 . . . . 0.0 113.453 170.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.51 -25.23 67.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.009 1.324 . . . . 0.0 110.668 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -25.36 6.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.284 1.034 . . . . 0.0 112.126 -175.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.1 tp -118.84 153.35 34.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.678 1.191 . . . . 0.0 112.428 -167.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -116.1 147.92 40.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' A' ' 43' ' ' ASP . 4.4 mp -123.95 144.8 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.63 143.12 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 22.4 mtpt -117.3 152.26 35.24 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.831 0.741 . . . . 0.0 110.417 175.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mm -115.5 115.17 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -80.0 76.93 6.72 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 108.508 169.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 61' ' ' GLN . 32.7 t -31.83 -59.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 129.081 2.952 . . . . 0.0 114.264 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.71 -23.42 64.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 121.528 1.967 . . . . 0.0 112.788 -170.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.93 -32.12 10.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.412 1.485 . . . . 0.0 112.066 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -136.51 25.15 3.17 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.433 ' HB3' HG13 ' A' ' 57' ' ' VAL . 8.1 pt20 -70.08 -0.08 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.584 1.154 . . . . 0.0 112.851 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -50.61 -46.51 58.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.549 1.14 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -56.57 -43.71 80.26 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.676 0.79 . . . . 0.0 111.634 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.93 2.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.728 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.57 -43.57 28.53 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.911 1.243 . . . . 0.0 113.423 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -64.08 -41.59 97.27 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.442 1.121 . . . . 0.0 111.216 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -70.34 -35.92 73.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.61 0.641 . . . . 0.0 110.101 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.35 69.06 1.0 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.428 -2.269 . . . . 0.0 107.428 -169.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.87 -60.76 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.421 ' HG3' HD12 ' B' ' 67' ' ' ILE . 9.3 ptm 50.64 7.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.166 2.987 . . . . 0.0 115.158 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 p -142.97 165.22 27.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.667 1.587 . . . . 0.0 112.146 -171.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.0 mm -142.76 145.54 34.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.209 1.403 . . . . 0.0 107.336 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.16 133.98 26.92 Favored 'Cis proline' 0 N--CA 1.452 -0.914 0 N-CA-C 106.603 -2.114 . . . . 0.0 106.603 -11.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.2 m -114.19 142.28 46.45 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.79 137.48 53.36 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -124.37 105.37 9.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 169.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.82 112.85 24.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.78 151.87 21.17 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.719 0.808 . . . . 0.0 109.116 174.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -149.39 126.5 11.32 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 44.7 22.36 0.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.176 2.59 . . . . 0.0 115.097 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.32 -22.57 3.21 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.229 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.13 159.33 42.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.921 1.36 . . . . 0.0 112.679 -168.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.69 134.04 30.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.27 -18.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.092 1.357 . . . . 0.0 110.917 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -144.7 154.8 43.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.41 133.69 15.3 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 p -150.55 158.36 44.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.474 0.579 . . . . 0.0 109.926 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.22 71.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 122.387 1.089 . . . . 0.0 108.708 -169.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 157.22 12.15 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 121.287 -0.883 . . . . 0.0 111.422 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.85 148.78 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.995 0.518 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -142.56 131.03 11.63 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.36 167.94 17.4 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.809 1.673 . . . . 0.0 109.723 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -46.24 -46.07 17.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.717 1.607 . . . . 0.0 112.468 -176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.86 -42.98 69.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.229 0.468 . . . . 0.0 111.461 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.93 79.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.722 -0.612 . . . . 0.0 110.631 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -54.5 42.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.56 0.744 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.34 -38.75 92.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.626 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.49 -47.62 84.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.993 0.815 . . . . 0.0 110.884 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.61 -43.86 80.57 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.766 0.827 . . . . 0.0 110.693 -174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.72 -33.03 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.747 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 7.5 t30 -61.89 -26.92 68.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.653 1.115 . . . . 0.0 111.552 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -22.91 35.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.13 0.972 . . . . 0.0 112.629 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -129.74 -22.02 3.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.736 0.814 . . . . 0.0 112.393 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 1.7 tm? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.99 2.116 . . . . 0.0 108.543 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.76 136.69 45.53 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.251 6.5 m120 67.35 120.78 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 128.542 2.737 . . . . 0.0 111.417 -170.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -148.89 137.38 21.12 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 129.178 2.991 . . . . 0.0 104.145 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.67 139.93 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 109.159 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tt -137.61 143.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.429 ' CD1' HD23 ' B' ' 72' ' ' LEU . 24.1 t80 -138.08 142.95 40.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -169.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -115.8 144.36 44.11 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 mt -133.19 122.28 23.77 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.4 p -165.82 156.89 13.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.349 1.06 . . . . 0.0 109.673 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 56.0 m -52.24 118.61 3.64 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.33 1.052 . . . . 0.0 112.129 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.58 3.26 2.1 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 124.892 1.37 . . . . 0.0 113.979 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 39.51 24.18 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.438 2.695 . . . . 0.0 114.54 -169.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 -40.08 77.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.36 -73.28 0.51 Allowed 'General case' 0 C--O 1.227 -0.08 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -168.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -32.83 68.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.641 -0.662 . . . . 0.0 112.377 -169.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -43.77 76.75 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.366 1.066 . . . . 0.0 110.379 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -55.75 -45.26 78.06 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 110.388 174.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 16.3 ttm -67.99 -46.42 71.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.829 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.23 87.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.31 0.644 . . . . 0.0 111.218 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.96 -28.65 57.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.268 0.94 . . . . 0.0 110.644 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.93 -44.53 46.18 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.434 ' HE1' ' HB2' ' B' ' 124' ' ' ARG . 23.1 m95 -54.49 -41.97 70.18 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.158 0.979 . . . . 0.0 110.887 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' B' ' 28' ' ' LEU . . . -61.33 -50.68 71.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -66.45 -21.5 66.2 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.387 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -66.31 -16.67 64.23 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.467 1.03 . . . . 0.0 113.025 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.67 -4.49 4.14 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.587 1.155 . . . . 0.0 113.007 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.468 HD12 ' HB1' ' B' ' 24' ' ' ALA . 22.9 mt -121.01 89.75 3.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.51 -171.6 1.38 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.815 0.722 . . . . 0.0 111.962 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.46 -18.15 16.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.436 1.094 . . . . 0.0 112.893 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -54.07 -18.86 4.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.518 1.927 . . . . 0.0 112.655 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.26 158.22 44.72 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.817 1.247 . . . . 0.0 109.62 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -130.35 133.36 46.36 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.014 0.926 . . . . 0.0 108.572 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.72 142.96 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.669 1.587 . . . . 0.0 107.367 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.97 159.47 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 m -139.82 142.37 36.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.07 178.22 10.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.104 0.962 . . . . 0.0 109.839 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.11 -177.71 47.67 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -44.21 -57.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.676 1.99 . . . . 0.0 114.154 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.98 29.59 4.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.335 1.454 . . . . 0.0 108.446 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.3 42.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.46 1.904 . . . . 0.0 113.964 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 75.7 t60 141.17 104.43 0.0 OUTLIER 'General case' 0 C--O 1.235 0.34 0 C-N-CA 130.656 3.582 . . . . 0.0 104.361 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.94 48.19 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -171.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -163.19 94.68 0.83 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.29 1.836 . . . . 0.0 106.67 169.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -68.99 126.55 92.88 Favored Pre-proline 0 C--O 1.239 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.64 -20.87 60.11 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.99 1.794 . . . . 0.0 112.846 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.405 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -62.37 -37.23 84.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.508 1.049 . . . . 0.0 111.199 171.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.98 -34.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.33 -52.18 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -56.21 -46.58 79.4 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.88 0.764 . . . . 0.0 110.553 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.37 -32.46 64.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.007 0.923 . . . . 0.0 111.842 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.7 -38.56 25.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.695 0.798 . . . . 0.0 110.76 177.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -27.21 69.15 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.983 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.423 ' CD ' ' HE ' ' B' ' 124' ' ' ARG . 35.3 mt-10 -55.05 -32.67 62.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.478 1.035 . . . . 0.0 111.817 172.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.12 14.56 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.042 1.337 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.77 35.42 91.99 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.38 -1.233 . . . . 0.0 113.152 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.2 mt -104.95 145.16 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 170.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.66 136.0 53.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 29.0 pt -138.15 17.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 110.655 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -60.39 -13.91 15.9 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -91.72 -14.28 30.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.751 1.62 . . . . 0.0 113.237 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.21 151.31 23.28 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.539 1.161 . . . . 0.0 112.417 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.5 t -152.87 171.79 17.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.588 1.955 . . . . 0.0 107.105 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.0 m -153.69 -167.8 2.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.845 0.858 . . . . 0.0 111.028 -169.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -159.53 168.54 25.92 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.809 1.644 . . . . 0.0 109.562 -171.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.52 172.5 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.111 1.364 . . . . 0.0 112.134 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.421 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.7 OUTLIER -48.31 132.86 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.567 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -143.98 100.17 3.52 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.309 1.052 . . . . 0.0 109.457 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.0 m -44.77 -32.32 1.5 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.108 2.163 . . . . 0.0 113.974 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.8 -17.3 64.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.128 0.876 . . . . 0.0 112.351 -174.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.16 -35.62 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.111 0.965 . . . . 0.0 108.842 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.429 HD23 ' CD1' ' B' ' 7' ' ' TYR . 2.2 tm? -63.01 -57.3 11.17 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.584 1.084 . . . . 0.0 109.98 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -22.36 66.93 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.44 0.564 . . . . 0.0 110.05 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.84 -24.38 44.44 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.064 2.146 . . . . 0.0 112.696 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.2 167.71 2.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.854 1.262 . . . . 0.0 111.347 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.9 -30.77 14.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.33 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.48 HD23 ' HE2' ' B' ' 97' ' ' LYS . 1.7 tm? -149.19 135.5 19.24 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 110.505 -172.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.425 ' N ' HD22 ' B' ' 77' ' ' LEU . 10.7 t -107.02 108.02 24.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 127.494 2.318 . . . . 0.0 107.983 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.09 106.32 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -72.97 122.3 21.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 167.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.2 132.92 42.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 127.415 2.286 . . . . 0.0 113.293 176.26 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.67 42.67 0.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.421 1.489 . . . . 0.0 112.075 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm 61.27 -149.79 0.4 Allowed 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.306 -1.496 . . . . 0.0 107.064 -168.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -139.74 71.21 36.85 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.83 129.27 29.89 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.93 1.754 . . . . 0.0 109.019 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.24 5.83 45.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p 39.08 88.65 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 127.942 2.497 . . . . 0.0 113.03 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -58.47 139.0 88.91 Favored 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 122.382 2.055 . . . . 0.0 108.663 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.65 -0.24 1.85 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.957 3.771 . . . . 0.0 115.455 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -61.75 -12.64 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.451 1.101 . . . . 0.0 111.26 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.42 149.03 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.487 1.515 . . . . 0.0 109.237 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HE2' HD23 ' B' ' 77' ' ' LEU . 5.1 tmmm? -82.97 155.56 23.93 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 ttm-85 -139.7 144.67 37.66 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.126 -0.984 . . . . 0.0 108.479 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -150.85 147.7 27.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.6 130.9 35.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -116.75 18.42 14.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.48 162.35 35.33 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -137.53 18.93 2.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.517 1.127 . . . . 0.0 110.15 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.12 158.38 44.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.178 1.791 . . . . 0.0 107.535 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -134.14 119.64 14.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.873 1.269 . . . . 0.0 107.663 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 -27.2 40.76 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.343 2.695 . . . . 0.0 112.56 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.1 -5.22 6.07 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.633 1.106 . . . . 0.0 112.709 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -100.99 8.25 43.12 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.61 1.164 . . . . 0.0 111.356 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.63 144.05 2.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.17 -45.78 75.75 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 123.845 0.716 . . . . 0.0 109.98 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.74 -16.04 4.04 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.8 p -68.76 162.23 26.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.67 -38.78 92.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 110.776 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.69 -42.57 77.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 117.109 -1.424 . . . . 0.0 109.206 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.58 -31.56 62.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 120.925 1.693 . . . . 0.0 109.555 -175.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -56.64 -63.58 1.15 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -58.24 -39.63 79.63 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.04 94.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.812 0.845 . . . . 0.0 112.231 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.71 -45.61 85.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.825 0.739 . . . . 0.0 109.564 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.9 m-30 -64.84 -43.36 93.29 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -175.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -67.35 -41.99 84.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.611 0.764 . . . . 0.0 111.097 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -59.43 -52.23 66.51 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.32 -42.04 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.396 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.434 ' HB2' ' HE1' ' B' ' 23' ' ' TRP . 41.1 ptt85 -62.24 -37.4 85.25 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.094 1.316 . . . . 0.0 111.471 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.84 -44.01 94.45 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.228 0.33 . . . . 0.0 110.299 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.08 -57.69 9.77 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.738 0.415 . . . . 0.0 110.22 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 12.4 mt -57.53 -47.9 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.345 1.058 . . . . 0.0 109.727 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.35 97.74 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.984 -0.898 . . . . 0.0 111.31 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -44.6 88.25 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.651 1.225 . . . . 0.0 110.762 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.58 92.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.1 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.24 -38.45 78.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.691 1.132 . . . . 0.0 111.328 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.89 -41.18 99.32 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -60.84 -39.95 91.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 116.988 -1.482 . . . . 0.0 110.993 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -58.9 -37.54 76.85 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.856 2.116 . . . . 0.0 111.26 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -31.28 71.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.132 0.573 . . . . 0.0 112.496 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.66 -43.54 10.67 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.537 . . . . 0.0 111.17 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.5 p -89.78 -24.29 21.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.21 1.804 . . . . 0.0 110.729 -169.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 55.29 31.62 56.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 111.608 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt . . . . . 0 C--O 1.245 0.826 0 C-N-CA 123.97 0.908 . . . . 0.0 111.477 -172.438 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.72 165.32 36.35 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.765 1.226 . . . . 0.0 108.176 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.08 101.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 t -80.48 169.47 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.882 1.673 . . . . 0.0 107.54 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.89 53.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.709 0.804 . . . . 0.0 109.188 169.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.463 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -97.23 171.51 8.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.998 1.719 . . . . 0.0 109.713 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -134.94 -170.25 2.53 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.472 1.509 . . . . 0.0 108.821 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -45.09 -29.27 0.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.374 2.27 . . . . 0.0 113.488 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -135.88 -31.18 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.976 1.311 . . . . 0.0 112.097 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -63.53 -21.36 66.29 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.69 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -52.18 -58.04 7.8 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.185 0.902 . . . . 0.0 109.417 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -60.71 -43.85 97.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.956 0.344 . . . . 0.0 110.185 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.15 77.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.367 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -84.23 -15.81 45.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.393 1.077 . . . . 0.0 113.109 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.2 p -114.95 -7.15 12.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.755 1.161 . . . . 0.0 113.805 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -74.7 -5.62 44.21 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.1 153.49 45.45 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.558 1.143 . . . . 0.0 109.053 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.98 -161.02 49.99 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.058 0.837 . . . . 0.0 111.148 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.56 129.53 70.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.15 119.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.157 -168.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.7 98.45 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.84 150.89 27.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -140.46 150.73 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.573 1.549 . . . . 0.0 109.319 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -132.66 115.74 15.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.587 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -136.62 152.9 50.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.919 1.688 . . . . 0.0 107.988 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.9 163.27 6.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.036 0.835 . . . . 0.0 110.41 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.63 -11.98 3.9 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.364 3.376 . . . . 0.0 116.719 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -59.98 -17.44 38.32 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.865 1.211 . . . . 0.0 113.811 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.95 155.68 41.83 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.945 1.248 . . . . 0.0 114.07 -170.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.88 -46.68 80.68 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.725 -1.597 . . . . 0.0 112.81 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -49.0 -31.05 19.43 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.4 2.734 . . . . 0.0 114.785 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -60.52 -15.18 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 120.06 1.3 . . . . 0.0 114.028 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 9.45 13.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.286 1.435 . . . . 0.0 111.339 176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.6 mtm -120.1 -44.61 2.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.311 1.044 . . . . 0.0 109.486 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.97 -36.42 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.16 18.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.768 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.11 -39.86 55.9 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.879 1.719 . . . . 0.0 111.728 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.664 HG12 HD22 ' A' ' 96' ' ' LEU . 2.6 t -57.16 -33.73 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.328 1.051 . . . . 0.0 111.468 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.81 -41.63 59.6 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.888 0.767 . . . . 0.0 110.687 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.74 -33.09 75.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.203 0.911 . . . . 0.0 109.709 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.04 -25.76 63.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.018 1.327 . . . . 0.0 111.672 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.405 HD11 ' SD ' ' A' ' 46' ' ' MET . 58.2 tp -77.1 -44.72 29.5 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 119.063 0.847 . . . . 0.0 109.96 173.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.49 -34.79 70.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.671 -0.643 . . . . 0.0 111.112 -172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.67 -10.69 59.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.511 -0.743 . . . . 0.0 112.251 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -99.79 -42.77 6.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.279 1.432 . . . . 0.0 110.931 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 42' ' ' LEU . 20.1 ptm -143.08 18.38 1.94 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.37 0.668 . . . . 0.0 112.399 -172.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.43 -4.6 13.33 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 121.243 -0.911 . . . . 0.0 114.299 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.69 -23.63 66.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.026 0.93 . . . . 0.0 110.919 169.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.24 -11.76 8.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.527 1.131 . . . . 0.0 112.48 -174.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -128.29 148.62 50.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.982 1.313 . . . . 0.0 111.454 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -114.42 147.56 39.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mt -125.22 141.07 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 6' ' ' ALA . 12.4 t -138.95 113.02 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.8 mtpt -86.54 155.08 20.63 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.243 -0.91 . . . . 0.0 110.337 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.75 122.52 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.58 108.74 12.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.306 33.6 m -79.2 47.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -153.01 -41.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.791 1.237 . . . . 0.0 108.984 167.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -83.64 -34.6 25.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.065 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -134.62 27.78 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.958 1.303 . . . . 0.0 110.807 -170.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -71.55 -7.54 48.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.021 0.928 . . . . 0.0 112.851 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -49.05 -51.96 28.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.768 2.027 . . . . 0.0 110.322 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.2 m -61.34 -32.6 72.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.636 0.775 . . . . 0.0 111.829 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.74 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.77 -46.58 7.51 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.676 0.655 . . . . 0.0 113.325 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -60.35 -40.68 91.59 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.097 0.959 . . . . 0.0 111.631 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -89.98 -0.0 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.811 0.845 . . . . 0.0 112.497 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.05 68.81 1.44 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t -146.45 129.99 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 100.951 -3.722 . . . . 0.0 100.951 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -144.44 16.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.306 0.242 . . . . 0.0 110.847 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -130.77 170.11 14.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.121 2.568 . . . . 0.0 112.64 -168.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.88 143.52 46.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.695 0.798 . . . . 0.0 108.902 172.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.26 154.26 65.73 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 -11.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -127.48 147.45 50.31 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -124.3 137.69 54.47 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 106.655 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.7 mt -124.27 107.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -82.41 110.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.3 mp -106.61 148.71 27.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -147.68 125.44 11.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 41.17 30.44 0.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.27 2.628 . . . . 0.0 114.413 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.66 -23.38 4.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.827 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.27 156.88 46.3 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.244 1.522 . . . . 0.0 113.263 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.07 135.76 27.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.14 -22.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.182 1.393 . . . . 0.0 110.554 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -147.4 163.83 35.23 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.287 1.035 . . . . 0.0 110.418 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.34 149.19 30.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -153.46 142.44 21.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.6 72.71 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.35 156.73 8.43 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.441 1.496 . . . . 0.0 110.05 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.3 148.39 51.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.371 0.668 . . . . 0.0 110.456 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.7 141.79 26.2 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.2 167.61 25.69 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.463 2.109 . . . . 0.0 110.834 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.32 -47.72 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 112.799 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.07 -42.51 76.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 110.799 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -32.44 73.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.111 -0.368 . . . . 0.0 110.436 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.664 HD22 HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -57.95 -54.56 45.51 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.563 1.145 . . . . 0.0 109.681 172.567 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.87 -39.24 90.51 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.6 -46.29 90.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.314 0.506 . . . . 0.0 111.325 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.86 -41.0 81.5 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.198 0.999 . . . . 0.0 111.105 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.9 -37.32 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.252 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -57.79 -25.88 61.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.632 1.105 . . . . 0.0 112.553 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -53.08 -26.75 17.23 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.005 0.922 . . . . 0.0 112.645 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -128.88 -23.96 3.01 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 112.674 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 170.224 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.96 35.0 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.032 -1.043 . . . . 0.0 110.696 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -152.39 131.69 12.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -137.94 118.62 14.03 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 129.315 3.046 . . . . 0.0 106.431 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mm -90.56 131.78 36.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tt -133.62 135.0 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -169.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -117.15 144.14 45.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -131.75 128.37 38.72 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.232 1.013 . . . . 0.0 108.622 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 66.7 m -148.38 144.27 27.38 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 124.577 1.151 . . . . 0.0 109.096 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 26.2 m -53.69 121.21 7.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.915 0.886 . . . . 0.0 110.185 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.537 ' H ' ' CG2' ' B' ' 39' ' ' ILE . . . 50.01 35.01 24.72 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.948 1.261 . . . . 0.0 111.792 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -31.58 101.85 0.02 OUTLIER 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -135.8 -0.98 2.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.997 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.81 -79.33 0.37 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.194 1.361 . . . . 0.0 113.264 -169.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -46.12 75.67 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.714 0.806 . . . . 0.0 113.074 -169.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.8 m -69.47 -28.56 66.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.111 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -68.26 -47.04 68.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.689 1.131 . . . . 0.0 110.073 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.14 -42.27 76.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.258 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.35 96.85 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.584 -0.697 . . . . 0.0 111.367 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.17 -30.96 65.5 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.1 0.863 . . . . 0.0 110.898 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.58 -50.31 62.87 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -57.22 -33.36 67.45 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.347 1.059 . . . . 0.0 112.225 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.01 -53.41 7.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.571 0.748 . . . . 0.0 111.234 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -68.46 -17.98 64.31 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -168.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.1 -17.75 54.27 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.415 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 33.1 m-85 -126.46 -37.6 2.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.373 0.988 . . . . 0.0 111.996 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.24 71.79 4.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.757 1.623 . . . . 0.0 106.62 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.05 -147.14 0.09 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.562 2.03 . . . . 0.0 114.671 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.19 -23.82 62.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.461 1.104 . . . . 0.0 113.021 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -65.37 -13.27 58.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.247 1.019 . . . . 0.0 113.244 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -123.53 151.93 42.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.431 1.014 . . . . 0.0 111.712 -169.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -132.12 82.74 2.04 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.633 1.973 . . . . 0.0 105.854 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.71 139.68 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.31 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -144.8 166.87 24.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 p -143.28 145.91 33.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.771 -0.581 . . . . 0.0 111.615 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.75 177.79 10.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.296 0.638 . . . . 0.0 112.38 -173.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.35 -178.75 48.53 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.643 0.64 . . . . 0.0 112.289 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.537 ' CG2' ' H ' ' B' ' 12' ' ' GLY . 2.9 tt -46.64 -56.35 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 127.632 2.373 . . . . 0.0 113.272 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -133.87 30.49 3.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.569 1.548 . . . . 0.0 108.779 -172.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 154.79 40.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.843 2.057 . . . . 0.0 112.075 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 137.45 82.88 0.0 OUTLIER 'General case' 0 C--O 1.236 0.37 0 C-N-CA 130.891 3.676 . . . . 0.0 105.274 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.21 175.3 46.64 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -172.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.3 88.92 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -60.48 124.4 78.32 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 125.544 1.538 . . . . 0.0 108.056 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.76 -18.41 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.799 1.666 . . . . 0.0 112.401 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -59.12 -56.81 17.43 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.86 1.209 . . . . 0.0 108.429 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.37 76.05 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.894 1.225 . . . . 0.0 109.719 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.86 -55.81 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.44 -45.51 80.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.917 0.887 . . . . 0.0 110.486 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.89 56.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.378 1.871 . . . . 0.0 111.17 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 73.9 mmm -92.68 -32.16 14.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.632 0.773 . . . . 0.0 111.765 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.06 -26.67 67.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.846 171.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -58.54 -28.73 65.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.412 1.006 . . . . 0.0 112.019 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.46 16.34 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.873 1.269 . . . . 0.0 110.578 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.09 95.21 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.643 -1.087 . . . . 0.0 112.608 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.5 mt -114.32 109.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.51 132.66 43.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 13.8 pt -134.9 18.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.566 1.146 . . . . 0.0 111.019 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.4 m -65.31 14.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -169.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -140.8 -2.7 1.32 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.95 2.5 . . . . 0.0 112.173 -176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -47.34 -59.52 3.14 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p 53.06 -171.72 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.74 1.616 . . . . 0.0 112.293 -171.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -163.08 -169.53 2.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.459 1.104 . . . . 0.0 109.029 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.2 168.76 23.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.193 2.597 . . . . 0.0 106.555 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.85 175.4 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 120.212 1.369 . . . . 0.0 112.295 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -54.42 36.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 C-N-CA 129.195 2.998 . . . . 0.0 118.11 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -52.32 106.4 0.15 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.93 2.092 . . . . 0.0 113.532 -173.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.1 m -51.51 -26.35 8.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.113 1.765 . . . . 0.0 114.378 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.69 -23.94 66.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.57 1.077 . . . . 0.0 111.845 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.31 -40.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -58.8 -51.61 69.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.355 0.525 . . . . 0.0 110.779 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -26.01 64.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.488 0.586 . . . . 0.0 110.941 -177.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -79.53 -19.14 50.28 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.435 1.094 . . . . 0.0 112.229 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.08 159.19 7.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 111.222 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.3 -22.77 35.51 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.867 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.424 HD23 ' H ' ' B' ' 78' ' ' VAL . 0.5 OUTLIER -152.81 153.22 32.69 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.106 0.962 . . . . 0.0 111.132 -177.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.424 ' H ' HD23 ' B' ' 77' ' ' LEU . 61.1 t -122.52 99.32 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 127.22 2.208 . . . . 0.0 105.657 169.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.39 100.46 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.7 m -70.57 125.98 28.32 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.28 136.08 33.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 CA--C 1.538 0.517 0 C-N-CA 128.488 2.715 . . . . 0.0 113.509 175.131 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -72.01 35.45 0.06 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.97 1.308 . . . . 0.0 113.751 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 64.46 35.23 9.64 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.113 1.765 . . . . 0.0 112.853 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.8 p 33.07 50.54 0.68 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.552 1.941 . . . . 0.0 113.151 174.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.28 133.99 61.45 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.452 2.101 . . . . 0.0 114.0 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.456 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -76.69 -23.77 53.18 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.313 175.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p 51.86 117.83 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.712 2.405 . . . . 0.0 113.367 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.38 150.26 64.16 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.931 1.754 . . . . 0.0 109.285 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.86 -5.45 10.63 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.634 2.89 . . . . 0.0 114.125 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -62.11 -17.31 57.31 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.197 0.999 . . . . 0.0 112.086 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.95 149.99 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.217 0.917 . . . . 0.0 111.031 -173.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -75.66 151.91 37.66 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.482 1.113 . . . . 0.0 108.954 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 ttp-105 -139.07 137.95 36.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -147.69 149.43 32.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -91.78 133.8 35.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' TRP . . . . . 0.411 ' CZ2' ' HE3' ' B' ' 139' ' ' LYS . 88.6 m95 -125.51 9.36 7.78 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.0 159.93 27.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.5 9.19 4.67 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.705 0.802 . . . . 0.0 111.289 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -150.19 163.72 37.51 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.097 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.34 121.47 15.39 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 125.097 1.359 . . . . 0.0 108.608 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.544 ' HD3' HG11 ' B' ' 123' ' ' VAL . 58.2 Cg_endo -69.97 -29.63 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.859 2.373 . . . . 0.0 112.166 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.26 -7.62 6.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.256 0.934 . . . . 0.0 112.994 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt-85 -83.74 -1.65 54.61 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.085 -0.959 . . . . 0.0 112.095 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' B' ' 116' ' ' LYS . . . -34.64 127.4 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.73 1.612 . . . . 0.0 112.507 -175.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -69.3 136.76 52.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.98 29.88 2.39 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -167.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 26.3 p -89.57 159.32 17.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.565 1.683 . . . . 0.0 107.262 169.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.95 -37.2 83.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.31 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -77.31 -43.09 34.32 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 117.489 -1.244 . . . . 0.0 109.409 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.1 -27.33 54.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 120.563 1.529 . . . . 0.0 110.269 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' LYS . . . . . 0.576 ' HA ' ' HB1' ' B' ' 109' ' ' ALA . 7.8 mtpt -59.83 -57.42 12.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -60.2 -40.91 91.74 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.08 91.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.069 0.948 . . . . 0.0 111.932 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.73 -45.46 92.61 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.617 0.644 . . . . 0.0 109.786 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.66 -49.89 74.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -62.2 -47.0 86.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.778 1.231 . . . . 0.0 110.11 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -56.87 -55.39 35.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.544 HG11 ' HD3' ' B' ' 106' ' ' PRO . 49.8 t -75.13 -39.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.119 -171.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -64.05 -39.48 94.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.751 1.614 . . . . 0.0 111.281 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.95 -41.89 95.1 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.216 0.462 . . . . 0.0 111.105 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -67.36 -46.92 71.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.819 0.448 . . . . 0.0 110.07 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.0 mt -53.09 -49.39 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.042 1.337 . . . . 0.0 108.607 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.99 -50.19 70.5 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 118.387 0.539 . . . . 0.0 112.538 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -64.03 -41.67 97.35 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.632 0.216 . . . . 0.0 110.724 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -66.62 -43.54 84.47 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.615 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.5 mm? -65.05 -34.32 78.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.759 1.163 . . . . 0.0 111.376 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.415 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 39.3 ttmt -60.94 -32.07 71.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.194 0.906 . . . . 0.0 111.16 174.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.05 -30.19 71.4 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-O 116.902 -1.523 . . . . 0.0 112.06 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -63.1 -37.37 86.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 122.454 2.388 . . . . 0.0 109.785 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.89 73.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.611 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -81.92 -43.3 18.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.366 1.066 . . . . 0.0 112.049 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 82.1 p -88.34 -18.38 28.58 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.65 1.98 . . . . 0.0 111.074 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.51 15.16 75.17 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.158 0.885 . . . . 0.0 112.107 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.411 ' HE3' ' CZ2' ' B' ' 101' ' ' TRP . 5.0 ttpm? . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.116 1.367 . . . . 0.0 109.434 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.76 155.64 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.786 2.434 . . . . 0.0 111.839 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.5 107.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.2 t -79.48 167.14 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.904 1.682 . . . . 0.0 107.988 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -122.99 119.25 29.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.123 1.369 . . . . 0.0 107.924 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.67 168.92 19.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.914 0.886 . . . . 0.0 108.783 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 p -135.26 -167.23 1.97 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.781 1.232 . . . . 0.0 109.354 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -51.88 -20.33 2.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.143 1.777 . . . . 0.0 113.751 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -140.78 -31.72 0.6 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.667 1.187 . . . . 0.0 112.811 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.4 m -63.26 -19.57 64.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.165 0.893 . . . . 0.0 112.202 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -50.6 -55.18 17.44 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 109.76 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -62.29 -44.23 96.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.104 -0.372 . . . . 0.0 110.036 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.06 83.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.946 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -79.87 -19.6 47.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.991 0.917 . . . . 0.0 113.047 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 p -108.96 -7.51 15.39 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.661 1.119 . . . . 0.0 112.943 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -72.22 -7.2 47.96 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -141.8 154.11 44.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 109.615 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.82 -157.15 51.13 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 124.951 1.262 . . . . 0.0 111.996 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 t -113.43 131.41 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 t -140.13 116.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 122.257 1.027 . . . . 0.0 108.493 -169.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.69 121.59 25.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.3 36.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -141.57 149.86 41.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 109.538 -170.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 31.4 m-85 -132.2 113.25 13.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.652 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.1 p-90 -132.76 149.3 52.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.845 1.658 . . . . 0.0 107.876 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.88 165.12 6.07 Favored Pre-proline 0 C--O 1.235 0.331 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.34 -17.44 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.882 3.055 . . . . 0.0 116.02 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -52.48 -26.8 13.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.854 1.662 . . . . 0.0 114.318 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.55 150.92 48.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.721 1.146 . . . . 0.0 111.509 -172.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.25 -50.9 57.16 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.496 -1.169 . . . . 0.0 111.459 172.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -46.54 -26.15 4.03 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.423 3.415 . . . . 0.0 117.076 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -56.51 -35.46 68.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 121.538 1.972 . . . . 0.0 111.726 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -90.18 7.92 35.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.963 0.905 . . . . 0.0 111.883 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -118.56 -42.82 2.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.023 0.929 . . . . 0.0 109.606 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.63 -33.99 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.793 0.837 . . . . 0.0 109.269 169.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.8 -60.95 7.87 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.08 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.14 -40.19 72.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.07 1.847 . . . . 0.0 111.614 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.18 -40.02 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.473 0.579 . . . . 0.0 110.525 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.72 -39.32 64.38 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.767 0.712 . . . . 0.0 111.574 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.37 -34.92 79.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.43 1.014 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.54 -17.85 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.198 1.399 . . . . 0.0 112.643 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.0 tp -86.94 -43.63 12.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.235 1.014 . . . . 0.0 108.794 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB2' HD12 ' A' ' 52' ' ' ILE . 22.7 t70 -71.78 -37.46 70.46 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.146 -0.346 . . . . 0.0 110.945 -175.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.8 -11.86 59.38 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.561 . . . . 0.0 111.942 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -100.02 -47.85 4.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -135.81 15.01 3.36 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.504 0.722 . . . . 0.0 112.392 -170.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.83 -2.09 21.43 Favored Glycine 0 CA--C 1.52 0.383 0 O-C-N 121.093 -1.004 . . . . 0.0 113.951 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.21 -25.27 65.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.696 0.798 . . . . 0.0 110.624 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 -26.84 9.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 -177.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.0 tp -119.76 146.53 45.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.036 1.335 . . . . 0.0 111.886 -168.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -103.31 143.54 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 168.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 43' ' ' ASP . 15.1 mt -124.74 136.48 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.39 124.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.652 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpp -99.85 156.28 17.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.036 0.834 . . . . 0.0 109.716 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mm -116.61 127.95 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.01 104.99 10.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 169.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.01 41.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.437 1.113 . . . . 0.0 111.844 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.1 -44.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.594 1.158 . . . . 0.0 110.479 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 110.262 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.75 30.22 3.76 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.59 1.156 . . . . 0.0 110.74 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -3.56 32.56 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.434 1.094 . . . . 0.0 112.586 -169.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -52.14 -45.16 64.9 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.584 1.554 . . . . 0.0 111.233 -169.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -65.71 -26.27 67.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' B' ' 91' ' ' MET . . . -68.48 -64.33 0.89 Allowed 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.072 -1.018 . . . . 0.0 108.801 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.22 -38.48 19.03 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.937 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -60.82 -48.58 81.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.37 1.585 . . . . 0.0 110.117 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.54 -13.2 60.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.569 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.95 55.93 14.69 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.67 -43.82 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.507 ' HG3' HD12 ' B' ' 67' ' ' ILE . 9.6 ptm 45.29 19.77 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 129.415 3.086 . . . . 0.0 113.567 174.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -133.72 155.66 49.35 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.039 1.736 . . . . 0.0 109.516 -174.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.9 mt -142.45 143.64 27.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 119.034 0.834 . . . . 0.0 109.091 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -67.52 144.83 72.62 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.303 0.787 . . . . 0.0 110.317 -10.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 53.5 m -114.4 142.03 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.89 136.08 54.12 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.8 mt -125.93 109.15 12.14 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 103.784 -2.673 . . . . 0.0 103.784 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.8 t -83.53 118.51 31.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.11 151.58 36.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.19 0.996 . . . . 0.0 108.498 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -147.87 144.04 27.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 43.69 28.4 0.22 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.952 2.101 . . . . 0.0 113.67 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.16 8.09 55.53 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.928 1.251 . . . . 0.0 116.164 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -134.99 147.87 49.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.926 1.363 . . . . 0.0 111.886 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.0 140.7 17.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.98 0.912 . . . . 0.0 109.186 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.42 -20.79 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.982 1.313 . . . . 0.0 111.122 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.74 161.67 40.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.173 0.989 . . . . 0.0 109.713 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 m -154.19 148.74 26.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.1 m -151.58 150.2 30.04 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.383 1.073 . . . . 0.0 108.531 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -133.18 63.0 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.591 1.556 . . . . 0.0 107.135 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.53 168.13 37.36 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.647 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.06 152.21 45.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.183 0.993 . . . . 0.0 111.034 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 141.2 17.51 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 169.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.81 168.38 23.09 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.447 2.098 . . . . 0.0 110.388 173.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -44.69 65.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 112.524 -170.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.83 -43.84 74.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 117.472 0.124 . . . . 0.0 110.867 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.25 75.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.973 -0.454 . . . . 0.0 110.346 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -53.74 53.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.805 . . . . 0.0 109.844 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.61 -38.25 90.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -61.78 -48.25 81.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.508 0.595 . . . . 0.0 110.75 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -55.86 -44.27 77.9 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 124.457 1.103 . . . . 0.0 110.898 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.03 -37.04 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.508 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 8.0 t30 -58.94 -26.36 64.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.172 0.989 . . . . 0.0 112.208 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -22.67 39.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.644 0.778 . . . . 0.0 112.459 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -131.12 -19.67 2.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.133 0.973 . . . . 0.0 112.969 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 1.7 tm? . . . . . 0 C--O 1.248 1.017 0 C-N-CA 127.521 2.329 . . . . 0.0 107.87 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.84 128.62 36.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.22 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.325 2.65 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -137.83 128.74 27.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -92.88 144.65 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.623 0.577 . . . . 0.0 110.377 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.7 147.98 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.642 1.577 . . . . 0.0 106.746 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.45 142.64 37.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -169.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -97.84 143.27 28.62 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -145.27 131.42 19.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -169.79 172.01 6.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.32 1.848 . . . . 0.0 108.96 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -48.61 125.01 9.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.495 1.518 . . . . 0.0 109.832 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.49 4.9 0.27 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.209 1.861 . . . . 0.0 117.699 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ASN . . . . . 0.406 ' HB2' ' HB1' ' B' ' 41' ' ' ALA . 5.0 t30 47.4 18.32 0.1 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.63 1.715 . . . . 0.0 113.315 -169.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 9.9 p -84.43 57.42 4.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.341 2.257 . . . . 0.0 114.787 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 136.94 -58.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.446 3.098 . . . . 0.0 113.433 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -53.95 -53.97 45.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.807 0.843 . . . . 0.0 110.948 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.39 -33.16 72.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.88 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -58.7 -48.33 81.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.681 0.673 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 8.1 ptp -69.83 -41.51 74.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.09 99.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.507 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.08 -31.11 68.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.755 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.57 60.88 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.502 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 25.5 m95 -56.56 -36.47 69.35 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.619 1.168 . . . . 0.0 111.688 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.41 -55.12 8.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 122.577 0.351 . . . . 0.0 110.477 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.35 -24.44 67.25 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.88 -16.17 63.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.29 0.95 . . . . 0.0 113.364 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.462 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 7.5 m-85 -124.7 -12.46 7.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 112.858 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -114.69 83.45 1.9 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.126 -2.175 . . . . 0.0 105.126 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.49 -168.73 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.421 1.01 . . . . 0.0 112.075 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.51 -5.03 4.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.177 0.991 . . . . 0.0 113.07 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.35 -24.81 67.55 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.623 -1.298 . . . . 0.0 109.564 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -123.11 179.31 4.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.474 1.91 . . . . 0.0 108.93 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -155.48 127.6 7.64 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.3 p -123.32 143.42 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.909 0.484 . . . . 0.0 110.094 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.49 171.23 14.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.151 1.78 . . . . 0.0 108.76 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -147.07 145.35 29.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.289 1.035 . . . . 0.0 109.126 -172.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.94 170.58 21.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.166 0.987 . . . . 0.0 111.775 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.76 178.61 46.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.202 1.382 . . . . 0.0 110.554 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 tt -48.67 -54.54 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.541 1.936 . . . . 0.0 113.775 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -135.1 31.42 3.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.097 1.759 . . . . 0.0 108.035 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' B' ' 13' ' ' ASN . . . -66.12 128.15 34.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.599 1.959 . . . . 0.0 115.957 -168.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -166.41 1.38 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.641 2.376 . . . . 0.0 110.62 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.9 109.49 3.44 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 120.725 -1.234 . . . . 0.0 114.864 -168.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.6 tp -82.52 83.13 7.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -62.12 123.68 79.04 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.633 -0.698 . . . . 0.0 109.782 -176.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.73 -23.42 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.224 1.95 . . . . 0.0 113.201 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -33.73 76.16 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.762 1.165 . . . . 0.0 110.856 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -34.46 50.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.187 0.449 . . . . 0.0 109.947 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.67 -51.38 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -56.49 -46.12 80.65 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.287 0.635 . . . . 0.0 110.709 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.49 -32.56 58.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.26 1.024 . . . . 0.0 112.323 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mmm -90.54 -30.06 17.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.241 -0.912 . . . . 0.0 111.323 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.87 -24.73 67.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.437 169.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.436 ' CD ' HH21 ' B' ' 124' ' ' ARG . 42.8 mt-10 -55.52 -36.37 66.65 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.829 1.195 . . . . 0.0 111.201 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.28 15.92 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.19 1.396 . . . . 0.0 111.296 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.56 41.58 99.12 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.036 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 39.1 mt -114.64 116.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 171.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.79 132.12 43.17 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -131.78 13.08 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.28 169.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 75.3 p -59.76 -17.59 36.46 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.667 1.121 . . . . 0.0 111.495 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -80.37 -12.5 59.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.503 2.321 . . . . 0.0 114.282 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -69.96 157.0 38.29 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.374 1.443 . . . . 0.0 112.335 -171.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -129.65 168.81 15.9 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.542 2.337 . . . . 0.0 108.809 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.3 m -156.21 168.62 26.71 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.948 -1.095 . . . . 0.0 110.714 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -162.79 162.67 26.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.68 1.992 . . . . 0.0 108.763 -169.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.24 172.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 0.0 112.424 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.507 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.3 OUTLIER -50.39 133.31 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -145.5 99.96 3.37 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.167 0.984 . . . . 0.0 108.8 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -49.55 -28.0 5.09 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.673 1.989 . . . . 0.0 113.699 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.65 -18.37 63.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.247 0.93 . . . . 0.0 112.387 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.68 -34.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.089 0.956 . . . . 0.0 108.745 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.03 -54.9 14.97 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.594 1.088 . . . . 0.0 110.173 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -26.31 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.906 0.776 . . . . 0.0 110.159 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -72.83 -24.04 60.85 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 112.357 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.35 164.74 4.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.851 1.261 . . . . 0.0 112.194 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.15 -31.0 15.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.134 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -145.16 135.93 24.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.283 1.033 . . . . 0.0 110.661 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 t -113.56 115.02 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.28 108.81 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.7 m -73.92 145.61 44.62 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.36 31.29 4.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.929 0.892 . . . . 0.0 111.635 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.258 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 111.19 0.07 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.88 -8.79 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.36 2.264 . . . . 0.0 115.776 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm 92.51 15.89 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 128.492 2.717 . . . . 0.0 111.366 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 6.9 m 37.66 49.11 1.5 Allowed Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.673 1.589 . . . . 0.0 111.716 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.72 131.43 46.01 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.574 -1.356 . . . . 0.0 108.574 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.505 ' HE2' ' HB1' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -89.58 8.14 32.78 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -168.253 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 14.3 p 40.95 81.57 0.24 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.953 1.701 . . . . 0.0 112.705 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' B' ' 94' ' ' PRO . 60.6 Cg_endo -57.38 141.73 94.89 Favored 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 122.649 2.233 . . . . 0.0 111.304 -169.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 93' ' ' PRO . 85.9 Cg_exo -49.95 -12.53 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 127.014 5.143 . . . . 0.0 118.672 -170.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -60.27 -16.35 33.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.328 0.967 . . . . 0.0 111.785 171.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.2 137.7 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 109.124 -172.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -75.82 156.4 34.48 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -142.42 147.95 37.01 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.217 -0.927 . . . . 0.0 110.538 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -150.0 161.28 42.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.623 1.569 . . . . 0.0 107.5 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -99.22 123.63 43.66 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 168.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -109.6 2.98 20.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.409 0.684 . . . . 0.0 110.108 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.6 149.23 21.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 105.779 -2.928 . . . . 0.0 105.779 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -146.82 10.0 1.03 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.974 1.71 . . . . 0.0 110.633 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -153.28 168.59 25.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.742 2.417 . . . . 0.0 105.984 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -133.33 115.82 13.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.63 0.772 . . . . 0.0 109.412 -171.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.17 -25.24 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.004 2.469 . . . . 0.0 113.584 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -8.38 21.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.179 0.9 . . . . 0.0 111.819 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -93.88 10.99 30.98 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 111.835 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.47 148.49 0.67 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.832 1.253 . . . . 0.0 112.767 -173.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -55.45 -47.4 76.09 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.119 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.93 -17.38 4.14 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 115.552 0.981 . . . . 0.0 115.552 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.43 158.88 34.29 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.54 -37.77 79.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.354 0.597 . . . . 0.0 111.157 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -73.36 -43.75 60.04 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.119 -1.42 . . . . 0.0 109.814 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.3 -28.24 59.63 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 121.208 1.822 . . . . 0.0 110.259 -172.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -60.41 -59.14 5.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 118.73 0.695 . . . . 0.0 109.765 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -60.64 -39.62 88.99 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.553 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.4 95.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.276 0.631 . . . . 0.0 112.24 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.21 -47.3 83.11 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -61.09 -51.42 69.2 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -62.47 -43.72 98.14 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.03 0.932 . . . . 0.0 111.518 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -60.94 -52.75 63.72 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 35.5 t -69.81 -36.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.502 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.3 tmm_? -60.23 -43.34 96.14 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.572 1.078 . . . . 0.0 111.774 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.85 -44.78 96.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.31 0.505 . . . . 0.0 110.822 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -63.13 -51.7 65.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.43 0.692 . . . . 0.0 110.117 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -54.19 -49.59 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.624 1.57 . . . . 0.0 109.054 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.23 -43.1 81.37 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 118.936 -0.925 . . . . 0.0 112.316 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -44.38 94.98 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.806 1.303 . . . . 0.0 110.428 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -34.72 78.6 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.577 178.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.73 1.15 . . . . 0.0 111.492 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.462 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -62.75 -41.24 99.11 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -62.4 -40.54 96.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 117.395 -1.288 . . . . 0.0 111.301 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -60.56 -36.24 78.0 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 121.665 2.029 . . . . 0.0 111.295 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.61 -28.58 69.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.029 0.531 . . . . 0.0 112.431 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.69 -46.6 7.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.609 1.564 . . . . 0.0 111.141 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 62.9 p -89.14 -27.21 20.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.278 1.831 . . . . 0.0 110.784 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.13 25.94 54.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.9 -169.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.748 1.619 . . . . 0.0 111.82 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.32 172.3 18.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.839 1.656 . . . . 0.0 107.493 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.74 97.09 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 168.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.02 167.98 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.509 1.523 . . . . 0.0 108.009 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -128.07 112.76 14.95 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.799 0.84 . . . . 0.0 108.983 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.04 10.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.579 1.552 . . . . 0.0 110.095 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -159.71 -173.39 4.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.966 2.107 . . . . 0.0 105.617 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.62 -36.62 0.42 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.37 2.668 . . . . 0.0 115.934 -169.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -130.57 -29.96 1.92 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.586 1.154 . . . . 0.0 111.543 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -23.06 65.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.149 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -51.55 -56.48 13.2 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.356 0.98 . . . . 0.0 109.244 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -62.36 -44.25 96.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -36.65 81.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -174.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -80.15 -16.95 53.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.072 0.949 . . . . 0.0 113.056 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.8 p -114.06 -7.18 13.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.651 1.114 . . . . 0.0 113.113 -169.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -77.48 -3.95 43.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.41 148.38 37.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.226 1.011 . . . . 0.0 109.092 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.08 -170.84 40.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.19 0.9 . . . . 0.0 111.62 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.43 125.81 54.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 t -140.03 117.96 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.6 135.89 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.7 46.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.41 151.25 49.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.279 1.432 . . . . 0.0 108.626 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.7 111.34 13.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.557 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.3 p-90 -131.68 155.11 48.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.716 1.606 . . . . 0.0 107.789 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.11 162.67 9.13 Favored Pre-proline 0 C--O 1.233 0.188 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.8 -19.0 10.03 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.613 2.875 . . . . 0.0 116.167 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -57.69 -26.4 61.65 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.6 161.66 34.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.457 1.026 . . . . 0.0 112.997 -169.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.72 -48.76 53.93 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.168 -1.351 . . . . 0.0 112.658 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -51.38 -27.07 22.83 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.099 2.532 . . . . 0.0 115.11 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -60.51 -13.89 16.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 119.624 1.102 . . . . 0.0 113.798 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -118.1 12.28 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.664 1.186 . . . . 0.0 111.449 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.0 mtm -123.67 -45.69 2.04 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.358 1.063 . . . . 0.0 109.642 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.78 -34.72 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -58.26 17.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.14 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.05 -39.16 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.762 1.641 . . . . 0.0 111.639 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.73 HG12 HD22 ' A' ' 96' ' ' LEU . 2.6 t -57.89 -34.56 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.957 0.903 . . . . 0.0 111.3 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 HD21 ' A' ' 96' ' ' LEU . 21.1 mt -71.37 -44.13 65.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.993 0.815 . . . . 0.0 110.534 175.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.92 -36.55 83.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.65 0.659 . . . . 0.0 109.469 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.35 -18.68 62.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 112.314 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.3 tp -79.55 -45.76 18.63 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.617 1.099 . . . . 0.0 108.879 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.06 -35.58 76.72 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.881 -0.512 . . . . 0.0 111.496 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -64.95 -19.65 66.07 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.502 -0.749 . . . . 0.0 112.21 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -95.84 -42.91 8.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.679 1.192 . . . . 0.0 111.225 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ptm -144.27 17.95 1.72 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.343 0.657 . . . . 0.0 112.283 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -5.76 14.12 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.35 -0.844 . . . . 0.0 114.312 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.72 -23.41 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.671 0.788 . . . . 0.0 111.033 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -15.51 8.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.446 -175.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.0 149.84 50.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.608 1.163 . . . . 0.0 112.267 -168.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -112.95 144.55 42.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.28 146.4 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.69 146.85 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.1 mtpt -121.82 147.57 45.79 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 121.83 -0.544 . . . . 0.0 110.377 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.82 128.74 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.94 103.5 14.72 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 170.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.305 32.6 m -77.6 50.51 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 122.616 1.198 . . . . 0.0 114.179 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.29 -44.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.594 1.557 . . . . 0.0 108.519 168.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -75.24 -50.58 15.7 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.019 1.327 . . . . 0.0 110.065 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -132.11 37.74 3.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.908 1.283 . . . . 0.0 110.873 -170.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -67.04 -4.2 9.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.601 1.161 . . . . 0.0 112.872 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -53.26 -47.88 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.114 1.766 . . . . 0.0 110.851 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.0 m -55.29 -41.51 72.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.848 0.749 . . . . 0.0 111.154 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 -65.43 0.72 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -170.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.86 -42.88 15.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.128 0.87 . . . . 0.0 113.361 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -63.45 -44.55 94.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.428 1.114 . . . . 0.0 111.377 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -68.04 -34.8 77.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.603 0.638 . . . . 0.0 109.796 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.07 66.24 0.71 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 -169.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.35 132.7 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.43 ' CE ' HD13 ' B' ' 72' ' ' LEU . 24.2 mtm -149.02 18.99 0.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.29 160.37 38.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -167.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.21 134.39 26.09 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.214 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.67 132.7 15.98 Favored 'Cis proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.443 -1.791 . . . . 0.0 107.443 -11.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.5 m -98.77 150.35 21.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 169.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.81 117.47 8.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.75 111.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -93.49 134.7 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.17 158.06 39.11 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.643 1.177 . . . . 0.0 110.286 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -147.95 137.42 22.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.99 29.01 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.042 2.537 . . . . 0.0 114.902 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.43 -28.3 2.79 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 116.595 1.398 . . . . 0.0 116.595 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.68 158.72 43.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.418 1.609 . . . . 0.0 114.839 -167.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.39 136.54 26.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.288 1.035 . . . . 0.0 108.28 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.01 -21.07 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.784 1.633 . . . . 0.0 111.428 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -144.72 157.87 44.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.961 0.8 . . . . 0.0 108.922 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.1 148.42 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -169.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.9 m -153.62 148.59 26.66 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.777 1.231 . . . . 0.0 108.011 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.26 66.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.65 156.94 8.98 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -73.46 156.71 37.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.676 0.39 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -153.37 150.63 24.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.203 1.001 . . . . 0.0 108.652 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.84 172.81 12.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.847 2.365 . . . . 0.0 111.536 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -45.9 71.14 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.237 1.015 . . . . 0.0 111.966 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.26 -39.95 93.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.863 0.301 . . . . 0.0 110.429 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.893 0.477 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.73 HD22 HG12 ' A' ' 38' ' ' VAL . 1.8 tp -61.97 -54.82 36.35 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.322 1.049 . . . . 0.0 109.645 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.81 -36.6 84.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.34 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.41 -47.09 87.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.887 0.767 . . . . 0.0 110.933 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -55.67 -42.14 74.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.213 0.605 . . . . 0.0 110.545 -174.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.1 -40.49 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 123.667 0.604 . . . . 0.0 111.245 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 11.4 t30 -57.46 -25.65 60.01 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.906 -1.121 . . . . 0.0 112.417 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -50.49 -31.17 14.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.691 1.196 . . . . 0.0 112.4 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -137.87 -7.14 1.64 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.786 2.034 . . . . 0.0 105.985 169.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.79 145.36 42.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 65.12 122.65 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 128.112 2.565 . . . . 0.0 111.298 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -147.69 145.21 28.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 129.122 2.969 . . . . 0.0 104.224 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 6.4 mt -123.45 145.95 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 119.59 1.087 . . . . 0.0 108.584 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.0 148.3 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.904 1.282 . . . . 0.0 107.836 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.66 149.34 52.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 109.988 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.06 145.74 41.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.45 127.49 44.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 8.5 m -151.26 170.31 19.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.508 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -67.16 89.51 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.393 1.077 . . . . 0.0 110.924 172.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.31 20.53 58.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 117.073 -1.96 . . . . 0.0 114.835 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 26.01 84.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 124.769 2.224 . . . . 0.0 112.932 -177.034 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -152.41 167.71 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.529 3.132 . . . . 0.0 104.94 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.658 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 42.03 -103.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.227 1.811 . . . . 0.0 112.956 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -40.73 27.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.037 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -53.35 33.5 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.146 1.339 . . . . 0.0 109.769 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -49.91 -48.31 51.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.353 2.261 . . . . 0.0 109.64 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.3 ttm -67.79 -45.16 75.62 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.903 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.31 83.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.562 1.145 . . . . 0.0 110.728 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.61 -32.06 63.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 111.853 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.98 -49.65 57.18 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -58.77 -37.94 77.37 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.258 1.023 . . . . 0.0 111.769 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.47 -49.38 77.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -65.0 -22.65 67.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.31 -20.14 66.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.156 0.889 . . . . 0.0 112.951 175.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.499 ' CD1' ' HE2' ' B' ' 132' ' ' LYS . 0.1 OUTLIER -132.35 -0.54 3.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.379 0.991 . . . . 0.0 113.428 -175.473 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mt -126.42 85.83 2.44 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.4 -165.95 1.05 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.562 2.029 . . . . 0.0 114.204 -169.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.13 -20.05 23.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.673 1.189 . . . . 0.0 112.894 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.87 -23.99 34.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.156 1.782 . . . . 0.0 112.225 169.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -123.88 155.6 37.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.732 1.613 . . . . 0.0 110.6 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -131.22 144.91 51.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.132 1.773 . . . . 0.0 106.674 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.71 148.27 31.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 108.511 -171.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -147.88 162.42 39.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 52.4 m -134.12 140.42 46.57 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.036 1.335 . . . . 0.0 108.263 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.97 174.37 13.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 111.295 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.5 -174.93 44.31 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -51.23 -55.65 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.332 1.853 . . . . 0.0 114.157 -173.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -138.18 29.57 2.49 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.957 1.703 . . . . 0.0 108.655 -171.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.6 157.39 37.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.69 1.996 . . . . 0.0 114.193 -169.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 146.98 104.97 0.0 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 131.072 3.749 . . . . 0.0 104.414 172.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.6 174.38 46.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 14.5 tp -154.84 65.36 0.66 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.518 1.127 . . . . 0.0 108.064 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -49.87 121.73 13.04 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.315 1.446 . . . . 0.0 110.494 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -64.8 -24.44 61.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.202 1.935 . . . . 0.0 113.399 -175.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -18.37 64.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.703 1.592 . . . . 0.0 112.15 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -85.84 -40.58 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -60.2 -50.74 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.74 -42.68 84.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.95 0.9 . . . . 0.0 110.687 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.45 -30.55 60.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.565 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mmm -84.49 -40.64 17.42 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.519 1.054 . . . . 0.0 110.907 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.91 -29.15 68.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.541 0.61 . . . . 0.0 110.824 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.79 -28.28 67.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.498 0.719 . . . . 0.0 112.088 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.67 16.0 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.954 1.302 . . . . 0.0 110.765 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.08 38.87 92.74 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.497 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.76 150.46 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -124.3 139.63 53.73 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.998 0.919 . . . . 0.0 109.104 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.49 ' HB ' HE21 ' B' ' 62' ' ' GLN . 30.7 pt -140.67 17.56 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.102 1.361 . . . . 0.0 110.745 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -67.48 15.82 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -143.26 -5.11 0.87 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.161 2.585 . . . . 0.0 112.019 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.49 HE21 ' HB ' ' B' ' 59' ' ' ILE . 2.8 pt20 -56.67 144.71 31.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.684 1.129 . . . . 0.0 112.1 -169.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -69.04 155.77 39.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.981 1.312 . . . . 0.0 110.38 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 9.0 m -167.29 145.99 4.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 107.306 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -171.18 167.7 6.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.844 1.258 . . . . 0.0 109.837 -170.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.83 168.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.045 0.839 . . . . 0.0 111.41 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -48.99 135.55 6.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -144.32 103.84 4.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.307 1.051 . . . . 0.0 109.143 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.9 m -49.15 -27.27 3.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.626 1.57 . . . . 0.0 113.864 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.08 -22.76 64.92 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.725 1.148 . . . . 0.0 111.652 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.0 -42.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 117.75 -1.119 . . . . 0.0 108.622 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.43 HD13 ' CE ' ' A' ' 70' ' ' MET . 6.9 tt -61.06 -51.35 69.54 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.91 1.232 . . . . 0.0 109.451 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -25.17 68.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.218 0.917 . . . . 0.0 111.412 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.96 -18.65 33.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.597 1.159 . . . . 0.0 112.894 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.89 163.46 4.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.216 1.007 . . . . 0.0 111.29 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.55 -32.71 15.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.839 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 tp -143.91 144.43 31.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.027 1.331 . . . . 0.0 109.725 -172.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.6 108.67 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 169.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 74.8 t -82.34 105.99 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -65.5 129.27 39.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 168.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 tp -139.94 66.39 1.4 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.715 0.406 . . . . 0.0 111.699 -168.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.332 -0.171 0 O-C-N 122.03 -0.419 . . . . 0.0 110.312 169.628 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.86 -6.68 2.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm 96.58 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.317 3.047 . . . . 0.0 110.979 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.8 m 38.37 45.77 0.82 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.044 2.137 . . . . 0.0 113.179 -169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.09 132.78 39.52 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.395 2.063 . . . . 0.0 112.031 -169.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.59 1.75 36.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 116.74 -1.6 . . . . 0.0 114.594 -175.243 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.8 p 45.08 89.76 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.538 1.535 . . . . 0.0 113.294 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -54.95 138.11 77.33 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.775 2.317 . . . . 0.0 109.485 -169.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.76 3.07 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.666 1 C-N-CA 125.318 4.012 . . . . 0.0 117.124 -168.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -67.55 -5.81 17.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.158 0.983 . . . . 0.0 112.332 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 148.33 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 110.147 -169.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -78.63 158.92 28.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.963 0.905 . . . . 0.0 108.839 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -151.73 145.37 24.97 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.757 -1.214 . . . . 0.0 109.488 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -155.73 148.43 24.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.82 137.79 32.08 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -139.57 -21.59 0.91 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.16 149.61 19.47 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 119.583 1.083 . . . . 0.0 110.648 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -160.75 169.3 23.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.38 1.872 . . . . 0.0 107.387 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.91 46.75 26.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.243 1.417 . . . . 0.0 112.399 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -43.61 116.62 2.3 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.766 2.026 . . . . 0.0 113.592 -171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.23 -16.62 28.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.97 3.113 . . . . 0.0 113.318 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.87 -2.52 1.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.314 1.416 . . . . 0.0 111.824 169.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -125.88 13.01 7.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.154 1.782 . . . . 0.0 110.934 -171.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.29 154.21 0.42 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.729 0.811 . . . . 0.0 109.884 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -53.3 -44.08 68.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.867 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.4 2.74 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 115.001 0.76 . . . . 0.0 115.001 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.4 p -68.94 166.02 18.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.0 -42.18 98.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.401 0.62 . . . . 0.0 110.311 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -69.23 -42.19 75.99 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.918 -1.515 . . . . 0.0 109.403 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.78 -35.66 60.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.149 1.795 . . . . 0.0 109.713 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -56.38 -52.53 64.27 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 121.719 -0.613 . . . . 0.0 110.728 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -63.95 -44.72 91.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.773 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.84 86.92 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.441 1.096 . . . . 0.0 111.667 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.89 -49.67 69.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.44 69.01 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.951 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -65.27 -50.51 65.47 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.39 1.076 . . . . 0.0 109.457 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -59.85 -48.34 82.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.87 -37.92 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 117.535 -1.221 . . . . 0.0 110.862 -176.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.29 -38.92 92.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.453 1.933 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.86 -44.89 93.89 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.483 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.05 -56.49 14.64 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.308 0.643 . . . . 0.0 110.148 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.8 mt -56.91 -47.7 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.837 1.255 . . . . 0.0 110.255 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.17 96.62 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.93 -42.89 99.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.79 0.795 . . . . 0.0 111.891 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.6 -0.688 . . . . 0.0 111.908 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.2 mm? -71.5 -33.6 69.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.572 1.078 . . . . 0.0 110.709 175.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' B' ' 27' ' ' TYR . 22.6 ttmt -61.03 -43.97 98.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.888 170.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.46 -41.04 96.61 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.36 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.94 -40.74 85.58 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.77 2.077 . . . . 0.0 110.496 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.62 74.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.32 -39.82 17.24 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.267 1.427 . . . . 0.0 111.623 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.7 p -97.38 -16.0 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.005 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 65.44 25.34 71.32 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.887 1.232 . . . . 0.0 112.332 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.749 1.219 . . . . 0.0 108.466 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.64 165.07 37.66 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.157 1.383 . . . . 0.0 107.529 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.66 101.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 168.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.13 166.83 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -121.92 107.33 12.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.85 175.46 4.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.422 1.089 . . . . 0.0 109.679 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -159.41 -172.71 3.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.92 1.688 . . . . 0.0 107.054 169.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -38.18 -41.8 0.63 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.092 2.957 . . . . 0.0 115.941 -169.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -128.41 -27.86 2.61 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.224 1.41 . . . . 0.0 111.064 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -61.74 -23.55 66.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.753 -1.118 . . . . 0.0 111.87 172.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 15' ' ' THR . 40.3 t80 -54.69 -54.45 41.63 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.617 1.553 . . . . 0.0 107.952 169.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -57.96 -47.84 81.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.367 0.531 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.12 96.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.556 0.217 . . . . 0.0 111.305 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -80.07 -15.71 56.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.772 1.229 . . . . 0.0 112.169 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.492 HG22 HG11 ' A' ' 20' ' ' VAL . 67.1 p -107.11 -9.28 16.21 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.122 0.969 . . . . 0.0 112.613 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.435 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 67.2 m -71.3 -3.13 18.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.83 0.741 . . . . 0.0 112.991 -175.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -144.12 155.97 44.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.314 1.446 . . . . 0.0 108.119 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -167.4 54.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 123.878 0.751 . . . . 0.0 112.407 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.481 HG22 ' HG2' ' A' ' 79' ' ' LYS . 38.7 t -119.97 121.27 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 172.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 53' ' ' VAL . 7.7 p -131.83 124.49 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 122.739 1.257 . . . . 0.0 108.207 -170.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.9 tp -83.43 100.23 10.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.53 141.16 36.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.22 145.25 45.47 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.392 1.077 . . . . 0.0 109.328 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.79 109.13 10.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -170.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.549 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.6 p-90 -121.79 160.03 25.46 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -163.71 159.29 17.33 Favored Pre-proline 0 C--O 1.233 0.2 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.23 -27.16 46.08 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.234 1.956 . . . . 0.0 113.062 168.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -58.61 -24.65 61.45 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 151.58 50.96 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.928 1.24 . . . . 0.0 111.875 -169.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.34 -48.73 71.15 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.201 -1.333 . . . . 0.0 112.512 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.79 -27.35 20.01 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.435 2.757 . . . . 0.0 115.464 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -58.59 -18.56 31.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 120.172 1.351 . . . . 0.0 113.644 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.95 12.11 20.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.315 1.046 . . . . 0.0 111.522 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.9 mtm -122.88 -43.93 2.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.6 1.16 . . . . 0.0 109.546 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.53 -35.88 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.405 0.682 . . . . 0.0 109.337 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.54 23.53 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.243 -0.884 . . . . 0.0 112.01 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.17 -40.51 59.43 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.664 1.576 . . . . 0.0 111.493 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.652 HG12 HD22 ' A' ' 96' ' ' LEU . 2.3 t -56.65 -38.27 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.892 0.769 . . . . 0.0 111.197 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 96' ' ' LEU . 20.4 mt -66.59 -48.69 68.78 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-N 118.568 0.622 . . . . 0.0 110.095 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.62 -36.43 82.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.776 0.322 . . . . 0.0 110.42 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.31 -24.53 66.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.259 1.424 . . . . 0.0 111.723 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.427 HD11 ' SD ' ' A' ' 46' ' ' MET . 34.8 tp -84.55 -40.02 18.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.69 0.677 . . . . 0.0 110.976 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.18 -33.14 72.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.982 -0.449 . . . . 0.0 110.473 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -70.53 -3.81 19.88 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -113.64 -42.43 3.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.624 1.569 . . . . 0.0 111.609 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.427 ' SD ' HD11 ' A' ' 42' ' ' LEU . 20.6 ptm -136.04 16.79 3.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.825 0.85 . . . . 0.0 112.336 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.84 -5.42 18.72 Favored Glycine 0 C--O 1.227 -0.286 0 O-C-N 120.771 -1.205 . . . . 0.0 114.23 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.94 -23.8 67.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.425 0.612 . . . . 0.0 111.342 169.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -32.87 4.87 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 110.983 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 151.6 19.82 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.978 1.311 . . . . 0.0 111.816 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -128.23 154.18 46.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.4 143.53 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 20' ' ' VAL . 1.7 m -131.84 109.61 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.549 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 47.5 mtpt -82.91 157.09 23.19 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 120.56 -1.338 . . . . 0.0 109.75 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mm -130.08 124.02 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -85.75 109.8 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 26' ' ' ALA . 13.0 m -73.15 9.96 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -171.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.85 -34.58 4.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.315 0.962 . . . . 0.0 110.644 169.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.69 -43.13 12.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.869 0.759 . . . . 0.0 111.447 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -141.79 42.94 1.71 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.643 1.211 . . . . 0.0 110.819 -170.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -4.25 45.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.717 1.207 . . . . 0.0 113.833 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -52.4 -43.87 65.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.257 1.023 . . . . 0.0 110.342 -169.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.8 m -58.08 -38.84 77.14 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.38 1.072 . . . . 0.0 112.379 174.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.42 -64.29 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.323 1.049 . . . . 0.0 109.115 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.41 -41.43 17.12 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.645 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -62.2 -43.12 99.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.296 1.548 . . . . 0.0 111.131 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -76.58 -9.32 58.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.193 0.597 . . . . 0.0 112.422 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.79 60.26 6.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 -173.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.17 -64.07 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 -173.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 mtm 58.0 5.13 0.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.23 2.612 . . . . 0.0 114.719 172.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -141.02 157.38 45.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.346 0.975 . . . . 0.0 111.638 -169.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.2 mm -138.96 139.51 23.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.37 138.77 49.14 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 -10.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.5 m -112.97 143.56 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.8 mt -120.84 127.54 52.0 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.95 1.7 . . . . 0.0 107.465 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -116.25 114.39 24.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.47 122.13 46.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.92 153.08 38.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 110.167 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG2' HG22 ' A' ' 19' ' ' VAL . 44.8 mtpt -137.12 130.79 31.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.001 174.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.7 t70 42.15 35.23 0.56 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.791 2.036 . . . . 0.0 114.21 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 113.9 -8.51 23.5 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 116.628 1.411 . . . . 0.0 116.628 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.73 152.39 47.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.444 1.622 . . . . 0.0 112.942 -169.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.86 141.93 16.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.78 1.232 . . . . 0.0 108.663 175.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.74 -22.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 124.166 0.986 . . . . 0.0 109.537 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -153.76 166.44 32.85 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 122.587 1.184 . . . . 0.0 107.805 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -158.13 132.5 8.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.939 1.696 . . . . 0.0 106.703 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m -147.62 148.63 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.064 0.945 . . . . 0.0 109.053 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.21 124.22 41.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.18 156.17 9.28 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 124.618 1.104 . . . . 0.0 110.675 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.2 148.99 46.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.314 0.557 . . . . 0.0 111.211 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.03 148.04 18.93 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.5 177.68 6.49 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.33 2.687 . . . . 0.0 112.443 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -33.25 69.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.345 1.458 . . . . 0.0 112.334 -169.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -81.85 -40.72 22.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.081 0.552 . . . . 0.0 110.199 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.21 92.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.051 0.54 . . . . 0.0 110.65 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.652 HD22 HG12 ' A' ' 38' ' ' VAL . 2.1 tp -57.84 -52.58 64.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.823 0.849 . . . . 0.0 109.72 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.1 -36.39 77.51 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.478 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.06 -46.64 88.86 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.551 1.068 . . . . 0.0 110.599 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.5 tp -58.23 -40.28 81.29 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 124.809 1.244 . . . . 0.0 111.673 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -87.97 -40.57 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.164 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -57.77 -34.29 69.41 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.977 1.311 . . . . 0.0 112.131 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -65.61 -8.73 21.71 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -123.77 -33.54 3.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.501 1.12 . . . . 0.0 112.197 174.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.247 0.925 0 C-N-CA 126.752 2.021 . . . . 0.0 109.717 178.688 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -79.16 80.2 5.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.987 0.915 . . . . 0.0 108.756 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m120 78.98 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.654 2.781 . . . . 0.0 111.753 175.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.458 ' H ' ' HA ' ' B' ' 32' ' ' TRP . 54.9 mtmt -125.34 123.76 40.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 129.598 3.159 . . . . 0.0 103.725 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -92.78 141.46 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.76 -168.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.3 tt -133.65 140.44 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -131.24 136.16 47.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -110.44 141.86 42.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.85 123.03 36.36 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 78.7 p -156.1 147.67 22.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -46.47 111.74 0.41 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.425 1.49 . . . . 0.0 111.848 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.22 11.01 50.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.711 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 38.18 35.51 0.09 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.916 2.486 . . . . 0.0 113.793 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -69.64 -46.74 65.47 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.65 -65.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -168.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -33.89 68.45 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.833 0.742 . . . . 0.0 111.736 -174.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.3 p -56.24 -55.65 30.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.31 1.444 . . . . 0.0 111.398 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -52.1 -49.76 62.95 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.346 1.858 . . . . 0.0 109.657 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 9.2 ttm -67.83 -46.02 73.0 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.599 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.819 0.848 . . . . 0.0 110.77 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.0 -27.72 61.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.111 0.869 . . . . 0.0 110.149 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.05 -45.94 24.21 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -55.27 -33.67 63.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.414 1.086 . . . . 0.0 111.34 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.64 11.87 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.888 0.875 . . . . 0.0 110.604 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -64.96 -22.84 67.07 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.403 1.002 . . . . 0.0 113.665 -168.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.14 -16.35 52.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 170.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 11.9 m-85 -130.01 -40.85 1.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.395 1.078 . . . . 0.0 112.789 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.22 75.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.624 1.97 . . . . 0.0 106.234 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -164.04 1.2 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.977 1.751 . . . . 0.0 112.255 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.49 -7.9 8.03 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.543 -0.974 . . . . 0.0 113.137 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.16 -19.29 62.92 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.909 -1.119 . . . . 0.0 109.573 168.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' TRP . . . . . 0.458 ' HA ' ' H ' ' B' ' 4' ' ' LYS . 56.5 m95 -130.87 175.7 8.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 127.776 2.431 . . . . 0.0 110.121 -174.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -153.04 129.9 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.35 144.31 14.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.871 0.868 . . . . 0.0 109.273 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.46 156.8 46.72 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 107.308 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.2 m -145.5 137.69 25.61 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.52 173.39 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.617 0.767 . . . . 0.0 111.339 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.08 40.64 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 122.247 -0.283 . . . . 0.0 112.978 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.403 HG13 ' HE3' ' B' ' 88' ' ' LYS . 1.7 tt -53.19 -57.19 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 113.679 -170.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -132.11 30.7 4.22 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.079 1.752 . . . . 0.0 108.039 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.8 149.93 49.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.563 1.945 . . . . 0.0 112.82 -169.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 146.45 100.4 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 130.995 3.718 . . . . 0.0 104.071 177.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.23 -179.29 48.7 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -171.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 23.0 tp -161.45 100.86 1.19 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -60.88 122.62 70.28 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.352 -0.832 . . . . 0.0 108.782 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.62 -26.56 80.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 121.734 1.622 . . . . 0.0 112.097 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.573 ' ND2' ' CE1' ' B' ' 120' ' ' PHE . 1.2 t30 -68.25 -27.92 66.76 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.979 -1.076 . . . . 0.0 112.086 171.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.127 1.785 . . . . 0.0 109.746 171.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.87 -51.66 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -52.57 -47.97 66.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.852 0.751 . . . . 0.0 109.977 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.89 57.24 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.655 1.182 . . . . 0.0 111.508 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.86 -38.79 20.71 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -61.75 -28.74 69.65 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.553 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.44 -27.95 64.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.931 0.787 . . . . 0.0 111.908 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.09 14.15 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 110.97 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.7 36.38 82.59 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.466 -1.186 . . . . 0.0 113.222 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.97 149.07 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -116.8 137.1 52.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.793 0.837 . . . . 0.0 108.92 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.2 pt -139.31 16.95 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 124.861 1.264 . . . . 0.0 110.836 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -58.91 -15.21 11.68 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -91.44 -15.8 28.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.308 1.443 . . . . 0.0 113.498 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -56.65 151.45 13.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.6 p -133.47 174.14 10.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.663 2.385 . . . . 0.0 109.359 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 15.7 m -153.01 -173.77 4.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.143 0.977 . . . . 0.0 109.517 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -161.66 167.93 24.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.274 1.829 . . . . 0.0 108.044 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.0 pt -63.37 169.1 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -48.62 135.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -142.0 98.84 3.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.544 1.164 . . . . 0.0 108.211 -171.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -51.38 -28.07 11.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.48 1.912 . . . . 0.0 113.989 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.81 -23.34 61.54 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 119.608 1.094 . . . . 0.0 110.494 -172.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -33.64 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 118.285 -0.865 . . . . 0.0 109.788 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.61 -52.93 61.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.639 1.109 . . . . 0.0 109.522 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -29.07 66.36 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.24 0.473 . . . . 0.0 110.964 -176.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -87.12 -12.45 47.06 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.673 1.589 . . . . 0.0 112.663 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.96 162.35 22.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.967 0.889 . . . . 0.0 110.434 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.89 -34.15 15.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.052 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.43 142.97 33.66 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.744 1.217 . . . . 0.0 110.202 -172.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -114.56 103.76 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 169.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.8 98.12 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -66.77 122.88 18.64 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 tp -124.66 52.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 110.083 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 124.18 0.992 . . . . 0.0 108.761 171.468 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -71.24 28.08 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -169.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' LYS . . . . . 0.403 ' HE3' HG13 ' B' ' 39' ' ' ILE . 26.1 ttmt 80.84 17.45 0.55 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.709 2.004 . . . . 0.0 112.432 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 m 34.63 52.09 1.26 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.353 1.861 . . . . 0.0 112.732 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.5 131.03 40.27 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.812 1.675 . . . . 0.0 110.785 -169.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -1.24 57.49 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 116.785 -1.579 . . . . 0.0 113.706 -175.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.9 p 48.0 95.47 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 126.12 1.768 . . . . 0.0 114.177 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.49 132.79 52.72 Favored 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 122.17 1.913 . . . . 0.0 109.51 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.4 -5.28 11.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.819 3.679 . . . . 0.0 117.817 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -74.4 15.35 0.35 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.093 1.315 . . . . 0.0 112.237 170.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 t -135.29 142.92 38.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.364 1.866 . . . . 0.0 106.736 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -69.99 153.69 42.9 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -141.39 141.12 33.79 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -145.97 157.97 43.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.56 137.06 47.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -142.02 -2.12 1.18 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.615 0.766 . . . . 0.0 112.668 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.68 -54.06 4.39 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 59.11 -2.68 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.534 2.334 . . . . 0.0 115.076 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -160.92 170.13 21.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.331 2.653 . . . . 0.0 105.771 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -137.97 106.62 8.12 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 118.877 0.762 . . . . 0.0 109.36 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.446 ' C ' ' CE1' ' B' ' 120' ' ' PHE . 95.4 Cg_endo -66.82 -36.0 25.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 124.033 3.155 . . . . 0.0 112.175 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.88 -13.63 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 129.598 3.159 . . . . 0.0 113.918 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -103.45 -54.42 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.394 1.478 . . . . 0.0 107.488 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . 39.25 -164.11 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.468 1.907 . . . . 0.0 113.34 -170.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -70.11 -48.03 59.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.37 -22.12 2.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 62.6 p -71.02 168.54 16.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.3 -41.96 98.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.379 0.609 . . . . 0.0 110.516 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.55 -41.13 69.49 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 117.395 -1.288 . . . . 0.0 109.066 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -76.59 -33.44 58.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.544 1.52 . . . . 0.0 110.036 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -56.07 -56.51 19.94 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.009 0.822 . . . . 0.0 109.154 169.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -59.38 -41.87 90.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.45 93.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.59 1.156 . . . . 0.0 112.006 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -64.53 -46.98 80.55 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.573 ' CE1' ' ND2' ' B' ' 47' ' ' ASN . 14.5 m-85 -64.82 -36.07 83.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.425 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -61.27 -49.23 77.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.132 0.878 . . . . 0.0 110.046 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.9 ttp-105 -62.84 -52.53 62.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.27 -35.71 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.26 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 30.7 ptt85 -61.68 -41.05 97.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.212 1.824 . . . . 0.0 111.132 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.97 -43.7 94.91 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.459 0.475 . . . . 0.0 110.377 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -68.63 -50.56 50.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 0.0 110.887 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 mt -56.05 -48.67 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.405 1.082 . . . . 0.0 109.114 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.32 -46.96 92.26 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.45 -47.07 85.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.801 0.8 . . . . 0.0 111.737 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -62.95 -47.54 82.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.068 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.81 -37.04 86.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.374 0.534 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 41.3 ttmt -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.97 0.805 . . . . 0.0 109.739 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.2 -37.34 79.95 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-O 116.74 -1.6 . . . . 0.0 111.16 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -59.38 -40.09 85.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 122.008 2.185 . . . . 0.0 110.039 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.05 75.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.202 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.45 -47.68 11.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.393 1.077 . . . . 0.0 111.796 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.2 p -82.7 -22.73 34.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.969 2.108 . . . . 0.0 112.103 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.7 11.24 62.35 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -168.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.5 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.685 2.394 . . . . 0.0 113.772 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.32 167.36 28.91 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.318 1.447 . . . . 0.0 107.84 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.1 98.51 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 169.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.14 168.6 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.714 1.606 . . . . 0.0 108.307 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -125.11 122.1 36.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.811 1.245 . . . . 0.0 109.09 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.33 171.7 13.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.858 1.663 . . . . 0.0 109.859 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -136.09 -167.83 2.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.082 1.753 . . . . 0.0 108.614 169.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -47.12 -27.78 1.53 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.387 2.275 . . . . 0.0 113.627 170.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.49 -30.8 0.82 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.662 1.185 . . . . 0.0 112.06 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m -62.57 -20.02 64.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.895 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -48.32 -55.7 9.98 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.608 1.094 . . . . 0.0 110.427 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -64.18 -44.55 91.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.949 0.34 . . . . 0.0 110.168 -176.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.23 81.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.924 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -82.2 -13.3 57.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.401 1.081 . . . . 0.0 112.541 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 66.6 p -115.89 -5.82 12.04 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 0.0 112.914 -170.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -74.75 -6.05 46.74 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.86 147.13 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.245 1.018 . . . . 0.0 109.346 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.13 -175.8 34.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.309 0.957 . . . . 0.0 111.689 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.59 125.75 48.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -136.03 117.95 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.111 0.964 . . . . 0.0 108.727 -169.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -89.66 116.06 27.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.87 135.81 39.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.883 0.765 . . . . 0.0 109.027 173.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.91 138.7 53.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.068 1.347 . . . . 0.0 108.984 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -119.88 105.07 10.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.425 ' CD1' ' CE ' ' A' ' 54' ' ' LYS . 4.8 p-90 -123.77 147.78 47.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.896 1.278 . . . . 0.0 108.202 -173.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -166.36 160.62 12.29 Favored Pre-proline 0 CA--C 1.534 0.344 0 O-C-N 121.545 -0.722 . . . . 0.0 111.56 171.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.73 -7.58 2.36 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.453 3.435 . . . . 0.0 116.504 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -54.73 -29.28 53.07 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.718 1.207 . . . . 0.0 113.104 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -163.58 162.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.13 -47.55 10.25 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.46 2.457 . . . . 0.0 115.596 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.57 -30.78 56.36 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.582 2.691 . . . . 0.0 114.041 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 m -62.48 -18.11 61.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.658 1.572 . . . . 0.0 113.909 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.79 22.03 13.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 0.0 111.211 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.2 mtm -131.24 -38.79 1.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.704 1.202 . . . . 0.0 110.27 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.82 -37.02 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.196 -0.94 . . . . 0.0 108.607 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.23 -54.31 57.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.874 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -58.96 -39.71 78.29 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.285 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.17 -38.96 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.055 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 2.3 mm? -68.01 -44.51 76.4 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.69 1.132 . . . . 0.0 110.589 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.53 -34.45 77.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.856 0.753 . . . . 0.0 109.813 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -71.2 -19.8 62.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.749 1.62 . . . . 0.0 112.54 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -84.24 -44.63 13.7 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 108.596 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.89 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.385 -0.197 . . . . 0.0 111.127 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.71 -10.09 56.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.236 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.46 -47.08 4.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.24 1.016 . . . . 0.0 111.064 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.7 ptm -135.46 15.96 3.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.528 0.731 . . . . 0.0 112.215 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.6 -3.47 20.68 Favored Glycine 0 CA--C 1.519 0.343 0 O-C-N 121.102 -0.999 . . . . 0.0 114.192 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.67 -24.43 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.83 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 -25.49 8.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.509 1.124 . . . . 0.0 111.83 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.1 tp -118.46 146.56 44.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 111.483 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.79 147.78 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.82 145.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.67 148.33 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' CE ' ' CD1' ' A' ' 25' ' ' TRP . 15.0 mtpt -122.09 146.56 47.08 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 118.862 0.755 . . . . 0.0 111.187 175.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.471 HG22 HG22 ' A' ' 57' ' ' VAL . 6.5 mm -107.78 132.97 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.29 88.98 6.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 55' ' ' ILE . 1.4 t -70.41 50.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 127.416 2.286 . . . . 0.0 114.761 -168.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -159.48 -33.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.067 2.147 . . . . 0.0 109.234 169.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -89.53 -42.34 11.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.688 0.795 . . . . 0.0 109.522 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -133.19 33.85 3.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.329 1.052 . . . . 0.0 111.648 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.58 -7.07 9.01 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.907 1.283 . . . . 0.0 113.375 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -47.39 -50.06 23.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 110.552 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.0 m -59.66 -36.11 75.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.234 0.614 . . . . 0.0 111.938 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.77 -57.31 6.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.45 -43.16 51.98 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.985 0.802 . . . . 0.0 113.434 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.94 -38.29 90.43 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.604 1.162 . . . . 0.0 110.97 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -76.89 -32.12 57.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.584 0.629 . . . . 0.0 110.077 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 77.59 1.38 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -170.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.86 -64.81 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.413 3.1 ppp? 45.47 24.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.428 2.691 . . . . 0.0 114.96 172.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.1 p -149.32 163.97 36.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.187 2.195 . . . . 0.0 110.96 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.3 mm -140.54 146.48 45.12 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -175.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.78 143.52 67.67 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 -10.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.4 m -119.37 150.16 40.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.267 0.556 . . . . 0.0 110.517 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.28 124.6 32.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -116.27 113.87 23.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.5 127.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.17 157.25 35.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.533 1.133 . . . . 0.0 110.169 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.82 130.86 20.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.43 32.29 0.5 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.447 2.299 . . . . 0.0 114.572 170.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.31 -19.2 6.03 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 116.489 1.356 . . . . 0.0 116.489 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -135.29 151.82 50.92 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 119.425 1.612 . . . . 0.0 112.878 -168.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -69.05 137.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.74 -25.21 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.997 1.719 . . . . 0.0 109.553 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -143.89 152.76 41.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.06 137.07 27.34 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.5 t -151.27 146.28 25.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.7 t -140.6 76.57 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.97 163.64 18.6 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.409 1.004 . . . . 0.0 110.878 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.37 147.38 51.13 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.807 0.803 . . . . 0.0 110.644 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 91' ' ' LYS . 2.8 mppt? -139.32 144.44 40.22 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.633 1.173 . . . . 0.0 108.482 170.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.55 170.94 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.521 2.147 . . . . 0.0 110.052 169.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -45.31 69.98 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.998 0.919 . . . . 0.0 112.359 -173.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.7 -43.12 76.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.541 0.155 . . . . 0.0 110.782 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.1 84.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.0 -0.438 . . . . 0.0 110.61 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 tp -67.68 -47.64 68.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.427 0.103 . . . . 0.0 110.979 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.94 -37.85 88.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.15 -46.21 88.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.819 0.447 . . . . 0.0 110.8 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.2 tp -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 110.825 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.47 -41.16 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.588 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -55.33 -29.06 57.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 112.412 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -49.11 -33.87 12.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.219 1.408 . . . . 0.0 112.306 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -135.72 -6.56 2.18 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.659 1.984 . . . . 0.0 108.576 170.166 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.02 125.39 26.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.253 31.5 m120 61.53 119.94 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 C-N-CA 129.317 3.047 . . . . 0.0 113.939 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -148.46 141.12 24.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.562 3.145 . . . . 0.0 103.731 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mt -117.95 144.5 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.845 1.202 . . . . 0.0 107.777 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.76 146.57 19.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -130.33 128.32 41.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.6 133.95 49.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -132.99 117.43 17.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -168.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 58.0 m -139.9 163.99 31.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 124.118 0.886 . . . . 0.0 111.875 -168.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.6 m -68.54 114.06 6.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.451 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 49.73 41.39 35.02 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.338 1.447 . . . . 0.0 112.801 173.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -36.53 104.31 0.03 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 18.0 m -135.21 0.97 2.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.77 169.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.11 -55.11 0.09 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.142 0.977 . . . . 0.0 112.902 -169.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -57.84 -54.67 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.176 0.444 . . . . 0.0 110.599 -171.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.7 m -76.73 -26.74 54.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.702 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -54.85 -51.1 66.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.822 1.192 . . . . 0.0 110.488 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 13.9 ttm -67.73 -44.19 78.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.529 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.75 99.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.368 0.667 . . . . 0.0 111.568 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.83 -31.76 61.76 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.418 1.008 . . . . 0.0 110.683 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -42.62 74.46 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -56.73 -40.0 74.94 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 117.931 0.865 . . . . 0.0 111.21 170.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.24 -54.23 43.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -69.84 -17.83 63.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.836 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.03 -14.93 63.36 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.874 1.216 . . . . 0.0 112.579 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.491 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 2.5 m-85 -126.32 -20.86 4.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.265 1.026 . . . . 0.0 113.732 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.26 -107.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 -172.28 40.78 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 119.126 0.875 . . . . 0.0 111.426 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.68 -20.22 65.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.35 1.46 . . . . 0.0 111.962 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.45 -40.18 74.41 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.97 0.908 . . . . 0.0 111.471 174.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.54 153.09 18.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.864 0.84 . . . . 0.0 112.587 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -124.61 107.33 10.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.48 103.28 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -92.51 160.98 14.8 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.806 0.842 . . . . 0.0 108.781 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -151.01 134.9 16.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.498 0.719 . . . . 0.0 109.576 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.67 176.92 11.98 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.343 0.592 . . . . 0.0 112.353 -174.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.22 -177.84 47.22 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.924 1.249 . . . . 0.0 111.141 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.451 HG22 ' H ' ' B' ' 12' ' ' GLY . 3.5 tt -52.55 -53.33 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.116 1.366 . . . . 0.0 113.255 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -133.31 29.05 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.147 1.779 . . . . 0.0 108.611 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.86 146.8 54.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.168 2.187 . . . . 0.0 111.766 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 144.91 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 129.987 3.315 . . . . 0.0 105.287 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.89 162.67 33.45 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 62.3 tp -140.61 76.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.36 128.85 90.37 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.25 -20.05 45.35 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.936 1.757 . . . . 0.0 112.63 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -38.64 90.34 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 120.077 1.308 . . . . 0.0 111.777 171.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.31 60.26 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.824 0.738 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -60.41 -52.76 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 171.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -58.44 -44.27 89.11 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.695 0.798 . . . . 0.0 110.824 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.12 68.02 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.914 0.885 . . . . 0.0 111.791 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -39.58 53.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -63.03 -26.29 68.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.49 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.03 -29.52 60.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.035 1.288 . . . . 0.0 111.643 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 m -116.85 16.86 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.244 1.418 . . . . 0.0 111.242 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.73 33.97 88.67 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.444 -1.198 . . . . 0.0 113.423 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.71 150.89 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 169.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -118.34 137.84 52.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.806 0.843 . . . . 0.0 108.97 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 21.5 pt -137.81 18.14 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 124.571 1.149 . . . . 0.0 110.988 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -67.03 15.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -137.26 -6.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.24 2.616 . . . . 0.0 111.822 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.9 157.06 22.53 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.128 -0.983 . . . . 0.0 110.942 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.9 p -123.44 176.62 6.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.39 1.876 . . . . 0.0 109.707 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -157.99 170.26 22.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -165.43 163.28 19.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.527 1.931 . . . . 0.0 108.15 -176.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.4 pt -64.97 167.37 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.787 0.835 . . . . 0.0 111.801 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -49.43 138.72 4.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.489 0.715 . . . . 0.0 109.58 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.45 103.79 3.85 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.469 1.128 . . . . 0.0 108.954 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -48.84 -32.53 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.944 1.698 . . . . 0.0 113.924 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.0 -22.91 63.08 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.419 0.554 . . . . 0.0 111.194 -169.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.87 -39.42 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.147 -0.93 . . . . 0.0 109.344 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.05 -49.43 77.67 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.573 1.079 . . . . 0.0 110.449 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -25.21 67.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.918 0.781 . . . . 0.0 111.416 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -87.62 -11.41 48.59 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.996 1.318 . . . . 0.0 113.018 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.64 169.74 5.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.025 0.916 . . . . 0.0 111.281 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -85.29 -34.98 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 169.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.51 HD13 ' CE ' ' B' ' 97' ' ' LYS . 20.1 tp -151.41 144.13 24.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.974 1.309 . . . . 0.0 109.933 -173.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.82 101.91 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 126.269 1.827 . . . . 0.0 107.074 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 88.6 t -80.49 100.82 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 82.9 m -78.85 131.39 36.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -150.66 64.78 0.93 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.915 0.864 . . . . 0.0 111.65 -174.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 124.438 1.095 . . . . 0.0 109.736 169.975 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.44 14.74 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.611 1.965 . . . . 0.0 113.978 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm 77.3 31.02 0.5 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.114 2.566 . . . . 0.0 111.799 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 p 29.78 56.45 0.73 Allowed Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.596 1.958 . . . . 0.0 112.694 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.77 131.98 46.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.191 2.594 . . . . 0.0 110.162 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.99 0.4 55.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.979 -173.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.6 p 46.28 90.39 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.986 2.114 . . . . 0.0 113.147 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -64.54 147.21 90.24 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.026 2.484 . . . . 0.0 108.842 -169.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.21 -0.06 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.112 3.208 . . . . 0.0 115.359 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -64.08 -16.95 62.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.752 0.821 . . . . 0.0 111.754 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 152.39 37.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.416 1.007 . . . . 0.0 112.796 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.51 ' CE ' HD13 ' B' ' 77' ' ' LEU . 5.1 tmmm? -80.08 154.72 27.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 168.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -139.79 146.22 39.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -144.81 149.31 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 133.48 50.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.291 1.036 . . . . 0.0 108.423 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -131.39 -5.7 3.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.386 1.074 . . . . 0.0 111.626 -171.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.62 147.18 16.26 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -144.09 24.41 1.63 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.699 1.599 . . . . 0.0 110.884 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -152.45 163.41 39.59 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.085 2.154 . . . . 0.0 106.499 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -147.31 121.9 5.13 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.288 1.404 . . . . 0.0 108.349 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.03 -21.59 15.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.548 2.165 . . . . 0.0 112.876 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.25 -6.14 12.81 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.551 1.069 . . . . 0.0 112.16 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -103.54 12.13 35.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.822 1.249 . . . . 0.0 111.544 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.68 148.9 0.66 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.001 1.321 . . . . 0.0 112.55 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -38.56 85.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.942 -171.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.47 -20.49 4.93 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 169.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.6 p -69.93 163.59 25.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.66 -39.57 84.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.265 0.555 . . . . 0.0 110.919 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.89 -44.64 61.05 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.349 -1.31 . . . . 0.0 109.87 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -73.82 -29.12 61.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 120.922 1.692 . . . . 0.0 110.5 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -58.17 -62.34 1.9 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.526 0.603 . . . . 0.0 109.516 170.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -60.44 -40.14 90.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.13 99.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.057 -177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.89 -46.0 83.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.798 0.726 . . . . 0.0 109.648 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -63.34 -44.15 95.71 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.956 0.902 . . . . 0.0 111.41 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 -59.13 -49.47 77.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.02 -38.79 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.587 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -55.65 -46.3 77.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.948 1.703 . . . . 0.0 111.495 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.09 -44.62 95.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.204 0.315 . . . . 0.0 110.762 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -61.44 2.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 110.133 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -39.96 60.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.614 1.565 . . . . 0.0 110.956 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.96 76.65 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 118.531 -1.15 . . . . 0.0 110.861 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -58.93 -46.66 87.42 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.373 1.587 . . . . 0.0 111.209 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.05 -50.33 73.08 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -37.27 75.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.485 0.584 . . . . 0.0 112.319 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.491 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -60.69 -42.34 96.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.97 -41.3 95.56 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.864 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.8 -37.64 74.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.802 2.547 . . . . 0.0 111.372 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.49 -29.94 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.5 -46.89 8.36 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.163 1.785 . . . . 0.0 110.983 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.6 p -79.17 -28.48 42.71 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.661 1.984 . . . . 0.0 109.087 -172.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 47.44 44.11 21.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm . . . . . 0 C--O 1.247 0.957 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.232 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 tpp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 118.906 -0.568 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.53 169.22 24.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.175 1.39 . . . . 0.0 108.268 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.54 100.48 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.25 167.3 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.858 1.663 . . . . 0.0 108.72 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -121.14 112.4 18.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.628 1.571 . . . . 0.0 108.017 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.05 172.49 13.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.325 1.05 . . . . 0.0 110.156 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -156.69 -177.77 6.86 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.633 1.973 . . . . 0.0 106.447 169.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -38.45 -38.83 0.4 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.673 2.789 . . . . 0.0 116.005 -169.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.18 -31.3 2.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.125 0.97 . . . . 0.0 111.154 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -61.68 -21.76 64.73 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 117.816 -1.088 . . . . 0.0 112.293 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -48.66 -51.32 28.97 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.323 1.42 . . . . 0.0 110.166 169.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -64.85 -45.29 86.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.03 87.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.532 0.206 . . . . 0.0 110.87 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -74.34 -16.1 60.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.546 1.138 . . . . 0.0 112.434 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.9 p -115.64 -2.83 12.39 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 112.122 -171.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.8 m -72.61 -10.83 60.26 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.73 144.47 34.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.135 0.879 . . . . 0.0 110.111 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.62 -174.92 31.09 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.59 1.091 . . . . 0.0 111.808 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 104' ' ' LEU . 31.0 t -89.99 129.84 40.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.2 116.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -169.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.6 tp -79.23 138.25 37.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.12 115.08 15.93 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.367 0.985 . . . . 0.0 109.24 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -111.97 147.67 35.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.01 1.324 . . . . 0.0 110.203 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -128.52 109.05 11.03 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.6 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -129.7 153.14 48.45 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.066 1.746 . . . . 0.0 107.711 -170.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -171.24 162.24 5.24 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 119.426 1.012 . . . . 0.0 109.836 169.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.63 -19.79 14.96 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.917 3.078 . . . . 0.0 116.626 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.404 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 15.0 m95 -53.72 -30.46 44.01 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.999 1.32 . . . . 0.0 114.293 -176.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 161.27 34.27 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.31 0.959 . . . . 0.0 113.214 -169.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.79 -48.92 52.59 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.08 -1.4 . . . . 0.0 112.669 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.4 -28.0 19.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.363 2.709 . . . . 0.0 115.075 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.85 -20.31 49.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 119.742 1.156 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.63 13.8 21.23 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.126 0.97 . . . . 0.0 111.442 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.1 mtm -123.73 -46.05 2.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.249 1.02 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.0 -34.75 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.15 10.94 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.691 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -59.66 -39.84 70.38 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.02 1.813 . . . . 0.0 111.634 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.35 -39.07 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 118.65 0.659 . . . . 0.0 110.451 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 mp -72.53 -39.76 67.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.991 0.814 . . . . 0.0 111.466 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.42 -33.48 75.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.723 1.147 . . . . 0.0 110.049 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.06 -21.56 59.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.0 1.32 . . . . 0.0 111.597 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.9 -44.71 16.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 108.932 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.407 ' HB2' HD12 ' A' ' 52' ' ' ILE . 17.9 t70 -70.46 -32.42 69.96 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.436 -1.415 . . . . 0.0 111.211 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -67.14 -6.88 19.54 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.537 -0.727 . . . . 0.0 112.755 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.8 -46.61 3.33 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.733 2.013 . . . . 0.0 109.615 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . 0.289 59.7 mmm -104.08 -12.42 16.77 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 125.486 1.515 . . . . 0.0 113.121 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.99 -7.8 9.33 Favored Glycine 0 C--N 1.318 -0.457 0 N-CA-C 113.962 0.345 . . . . 0.0 113.962 -171.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.03 -25.54 65.43 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.16 2.184 . . . . 0.0 112.489 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.7 -20.37 3.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.169 1.388 . . . . 0.0 112.074 -171.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.43 HD22 ' H ' ' A' ' 51' ' ' LYS . 1.6 tm? -129.43 156.41 44.14 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.21 1.404 . . . . 0.0 112.32 -166.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' H ' HD22 ' A' ' 50' ' ' LEU . 87.7 tttt -122.61 148.06 45.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.589 1.556 . . . . 0.0 108.28 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.407 HD12 ' HB2' ' A' ' 43' ' ' ASP . 13.7 mt -128.15 144.13 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.23 146.49 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 24.7 mtpt -121.32 153.02 38.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.181 0.446 . . . . 0.0 110.883 173.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -121.29 127.33 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.29 106.74 15.31 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.299 33.4 m -79.76 49.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -177.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -154.52 -42.18 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.538 1.135 . . . . 0.0 109.453 168.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -84.36 -40.97 17.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.053 1.341 . . . . 0.0 109.831 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -127.73 28.78 5.57 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.283 1.833 . . . . 0.0 111.3 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.98 -3.44 26.04 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.477 0.711 . . . . 0.0 112.696 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.75 -46.76 74.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.815 1.646 . . . . 0.0 111.127 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.15 -46.12 75.69 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.34 -63.93 0.97 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.723 0.809 . . . . 0.0 108.989 -169.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.21 -46.3 15.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.051 0.834 . . . . 0.0 113.096 174.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.02 -42.95 99.91 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.238 1.019 . . . . 0.0 111.724 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -69.17 -18.93 63.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.549 . . . . 0.0 110.712 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.22 66.48 1.52 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.12 129.9 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.46 ' HE3' HD13 ' B' ' 72' ' ' LEU . 27.6 mtm -147.64 20.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -134.32 160.69 37.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.608 1.163 . . . . 0.0 113.98 -167.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 136.45 29.14 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.042 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.43 128.48 11.64 Favored 'Cis proline' 0 N--CA 1.453 -0.869 0 N-CA-C 106.367 -2.205 . . . . 0.0 106.367 -11.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.6 m -92.91 140.49 29.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -136.45 92.79 2.81 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -80.5 132.36 35.68 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.67 120.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -127.96 157.95 39.2 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.057 0.943 . . . . 0.0 109.502 -170.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.06 144.08 25.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 169.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.8 30.29 0.83 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.178 1.791 . . . . 0.0 113.538 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.0 11.99 58.19 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.828 1.204 . . . . 0.0 115.939 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.31 149.26 50.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.647 1.224 . . . . 0.0 111.297 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.38 141.83 15.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 m -128.8 -20.62 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.504 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 153.0 40.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.241 1.016 . . . . 0.0 109.123 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.56 116.61 7.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -177.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -135.67 147.27 48.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.58 95.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -174.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.46 155.9 7.62 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -64.78 143.0 58.24 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.673 0.737 . . . . 0.0 110.526 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 139.75 32.05 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 169.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.24 167.24 22.62 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.463 2.109 . . . . 0.0 110.333 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -46.92 -46.71 21.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.702 1.601 . . . . 0.0 112.386 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.2 -44.34 72.3 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.562 0.619 . . . . 0.0 111.118 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.32 83.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.122 -0.361 . . . . 0.0 110.415 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -52.08 63.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.131 0.572 . . . . 0.0 109.998 176.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -64.24 -36.26 83.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.983 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.96 -49.37 77.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.167 0.439 . . . . 0.0 110.981 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.49 -40.03 85.71 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 123.683 0.793 . . . . 0.0 111.557 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.04 -40.73 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.228 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -55.0 -30.65 59.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.365 1.066 . . . . 0.0 112.276 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -59.62 -18.12 38.92 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.146 0.978 . . . . 0.0 113.298 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -131.88 -22.81 2.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.337 0.971 . . . . 0.0 112.774 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.487 ' HA ' HG21 ' A' ' 19' ' ' VAL . 20.2 tp . . . . . 0 C--O 1.248 0.984 0 C-N-CA 126.484 1.913 . . . . 0.0 107.528 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.67 24.22 2.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.839 0.855 . . . . 0.0 112.605 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.98 133.85 11.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 169.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -142.65 118.29 10.42 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 129.302 3.041 . . . . 0.0 104.23 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.72 130.66 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -134.34 139.67 47.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -127.13 142.27 51.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.201 1.0 . . . . 0.0 108.511 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' B' ' 131' ' ' LEU . 63.3 m-85 -126.41 107.38 10.23 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.146 0.978 . . . . 0.0 108.558 -172.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.97 127.31 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 91.9 p -152.17 162.51 41.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.077 0.399 . . . . 0.0 111.407 169.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 76.5 m -50.05 115.54 1.46 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.623 1.169 . . . . 0.0 110.145 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.46 19.46 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.685 2.088 . . . . 0.0 115.541 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 42.08 31.9 0.27 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.195 1.398 . . . . 0.0 111.493 -168.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -85.95 17.8 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.364 -1.46 . . . . 0.0 113.166 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.67 -67.66 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.662 1.185 . . . . 0.0 111.887 169.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.54 -56.62 15.48 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -168.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m -70.51 -32.99 70.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.891 -169.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.66 -50.15 55.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.305 1.05 . . . . 0.0 111.394 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 31.4 ttm -67.76 -47.12 70.1 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.76 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.99 97.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.001 0.92 . . . . 0.0 111.114 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.57 -31.18 69.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.569 1.077 . . . . 0.0 111.069 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.75 -49.7 53.32 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -56.34 -39.79 73.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.81 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.7 -51.52 64.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -63.37 -22.55 66.95 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -69.87 -11.19 60.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.478 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 14.4 m-85 -130.17 -44.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.735 1.214 . . . . 0.0 111.657 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' B' ' 135' ' ' ALA . 10.7 mp -81.44 75.37 8.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.329 2.252 . . . . 0.0 105.521 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.52 -159.07 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.821 2.153 . . . . 0.0 113.306 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.19 -21.21 21.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.439 1.096 . . . . 0.0 113.245 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.13 -19.85 15.09 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.35 1.86 . . . . 0.0 113.071 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -128.66 161.22 30.16 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.818 1.247 . . . . 0.0 111.005 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.5 136.95 49.48 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.66 136.1 60.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -140.36 157.15 45.98 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.178 0.991 . . . . 0.0 109.217 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -138.43 140.66 39.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.734 1.213 . . . . 0.0 108.56 -172.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.36 173.84 16.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.913 0.485 . . . . 0.0 110.953 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.87 -171.4 42.05 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.304 0.954 . . . . 0.0 111.193 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.73 -56.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.008 1.723 . . . . 0.0 113.999 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.38 31.0 2.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.711 2.004 . . . . 0.0 107.581 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.02 131.09 47.46 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.519 1.928 . . . . 0.0 113.821 -169.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -171.21 8.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.175 1.79 . . . . 0.0 111.31 169.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.73 107.56 3.13 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 119.175 0.898 . . . . 0.0 111.696 -169.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -78.39 86.7 4.44 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -62.04 125.43 85.23 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.534 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.3 -20.08 53.73 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.243 1.962 . . . . 0.0 113.013 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.424 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -60.52 -39.63 88.52 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.696 1.135 . . . . 0.0 111.027 171.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.25 59.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.76 -50.81 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -56.93 -47.01 81.61 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 123.375 0.67 . . . . 0.0 110.28 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.55 -33.26 59.81 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.208 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 82.6 mmm -91.67 -30.64 16.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.997 0.817 . . . . 0.0 111.219 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.47 -24.39 67.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.845 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.67 -31.39 68.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.929 1.24 . . . . 0.0 111.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 m -113.73 15.36 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.085 1.354 . . . . 0.0 110.808 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.67 39.97 98.59 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.634 -1.092 . . . . 0.0 112.824 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.56 107.88 24.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.33 132.7 48.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 pt -127.99 11.42 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.881 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -19.81 46.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.06 0.845 . . . . 0.0 111.163 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -76.97 -13.83 59.92 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.493 2.317 . . . . 0.0 114.073 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -62.9 161.62 12.53 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.217 1.371 . . . . 0.0 113.586 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 63.8 p -126.44 171.23 11.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.883 2.473 . . . . 0.0 108.528 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -157.89 163.62 37.74 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.819 -1.176 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -167.78 164.94 14.28 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 -175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.5 pt -69.29 175.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 111.274 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.53 133.62 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -143.17 104.8 4.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.869 0.842 . . . . 0.0 108.988 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -46.92 -28.63 1.67 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.766 2.026 . . . . 0.0 114.022 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.85 -15.77 62.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.125 0.875 . . . . 0.0 112.049 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.48 -38.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.38 1.072 . . . . 0.0 109.259 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.46 HD13 ' HE3' ' A' ' 70' ' ' MET . 6.9 tt -65.31 -58.54 5.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 120.206 1.366 . . . . 0.0 109.399 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -24.08 66.57 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.362 0.528 . . . . 0.0 110.757 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -78.63 -26.13 45.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 113.092 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 169.33 2.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.467 1.507 . . . . 0.0 111.959 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -91.31 -30.34 16.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.07 138.63 22.97 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.189 0.996 . . . . 0.0 110.556 -170.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 t -113.57 106.14 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.64 114.35 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 30.4 m -77.21 129.23 35.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 168.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.6 tp -131.43 56.12 1.82 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.998 0.919 . . . . 0.0 111.304 -168.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 CA--C 1.534 0.334 0 O-C-N 120.883 -1.135 . . . . 0.0 109.339 170.571 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.5 -0.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.116 2.166 . . . . 0.0 116.685 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 85.89 7.39 0.36 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.472 2.309 . . . . 0.0 111.528 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.6 m 32.79 49.63 0.55 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 127.821 2.448 . . . . 0.0 113.5 -170.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.48 134.15 38.69 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.731 2.287 . . . . 0.0 111.685 -169.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.462 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.3 0.23 49.87 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 116.987 -1.482 . . . . 0.0 114.882 -172.624 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p 48.31 88.45 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.202 1.401 . . . . 0.0 112.879 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.6 146.61 74.98 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 122.802 2.335 . . . . 0.0 110.112 -169.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.76 2.96 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 125.551 4.167 . . . . 0.0 116.617 -168.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -68.39 -6.16 23.03 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.951 0.796 . . . . 0.0 111.945 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.95 147.31 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.533 1.133 . . . . 0.0 110.26 -169.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -72.73 156.53 38.84 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -151.43 139.11 19.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.627 -1.296 . . . . 0.0 108.472 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -149.11 144.86 26.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.31 136.73 34.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -133.76 -10.64 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.958 0.903 . . . . 0.0 111.655 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.44 168.08 49.6 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.11 -7.28 0.18 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.432 0.693 . . . . 0.0 112.836 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -161.98 179.41 8.03 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.262 1.425 . . . . 0.0 107.928 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -135.76 114.91 11.21 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.26 1.424 . . . . 0.0 108.389 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.05 -18.58 21.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.474 2.783 . . . . 0.0 112.855 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.88 -7.19 7.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.786 1.176 . . . . 0.0 112.461 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -101.66 11.3 39.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.359 1.464 . . . . 0.0 111.347 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.64 147.05 0.65 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.481 1.112 . . . . 0.0 111.595 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -53.37 -45.99 69.43 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 124.078 0.861 . . . . 0.0 109.889 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.98 -20.48 2.86 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 53.2 p -68.7 165.38 19.59 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.37 -41.72 97.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.48 0.657 . . . . 0.0 110.308 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.98 -43.73 67.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 117.007 -1.473 . . . . 0.0 109.718 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.36 -32.43 62.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.18 1.809 . . . . 0.0 109.582 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -56.2 -62.28 1.82 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.153 0.581 . . . . 0.0 109.658 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.89 -39.78 86.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.989 0.916 . . . . 0.0 112.25 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -64.33 -44.92 90.02 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.9 m-30 -60.88 -51.53 68.9 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -64.08 -46.8 82.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 111.299 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -65.51 -48.61 71.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.084 0.402 . . . . 0.0 110.016 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.07 -40.23 88.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.151 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -58.17 -46.73 85.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.543 1.065 . . . . 0.0 111.84 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.23 -44.09 83.47 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.183 0.447 . . . . 0.0 110.524 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -74.37 -39.52 62.7 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.66 -49.17 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 108.913 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.55 -41.44 96.17 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.409 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -56.78 -51.34 69.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 118.13 0.965 . . . . 0.0 111.228 174.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -63.7 -42.31 98.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.638 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.441 HD11 ' CZ ' ' B' ' 8' ' ' PHE . 3.2 mm? -64.5 -40.88 96.49 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.152 0.887 . . . . 0.0 112.202 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.478 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 41.5 ttmt -60.13 -38.0 81.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.461 0.573 . . . . 0.0 110.416 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.64 77.9 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 116.672 -1.633 . . . . 0.0 112.611 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -59.16 -34.46 72.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 122.539 2.427 . . . . 0.0 110.957 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.491 ' HB2' HD12 ' B' ' 28' ' ' LEU . . . -62.69 -32.53 73.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.086 0.554 . . . . 0.0 111.036 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -88.63 -44.57 10.52 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.293 1.437 . . . . 0.0 111.239 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 68.0 p -87.04 -17.44 32.94 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.899 2.08 . . . . 0.0 111.017 -170.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.32 39.57 92.83 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.225 0.917 . . . . 0.0 110.932 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.743 0.817 . . . . 0.0 112.293 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.67 157.86 0.08 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.916 2.486 . . . . 0.0 113.074 -171.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.83 100.92 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 t -74.87 165.98 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.243 1.417 . . . . 0.0 108.057 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -125.79 117.46 23.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.319 1.048 . . . . 0.0 108.625 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -76.79 171.82 14.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.667 1.587 . . . . 0.0 110.12 176.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -156.02 -176.07 5.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.642 1.577 . . . . 0.0 107.053 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -36.67 -36.97 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 130.202 3.401 . . . . 0.0 116.743 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.97 -30.24 1.23 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.999 1.32 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -60.84 -22.18 63.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.335 -0.84 . . . . 0.0 112.319 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -50.79 -52.44 40.96 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.613 1.097 . . . . 0.0 109.292 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.45 -44.57 96.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.02 80.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.444 -0.16 . . . . 0.0 111.13 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.38 -11.95 59.98 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.855 1.262 . . . . 0.0 112.843 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -123.29 -3.09 8.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.942 1.246 . . . . 0.0 113.27 -169.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -71.33 -10.74 60.25 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.65 156.87 45.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.11 0.964 . . . . 0.0 109.574 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.98 -150.92 48.34 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.359 0.98 . . . . 0.0 110.988 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.42 132.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.0 t -143.13 116.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.94 123.33 27.16 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.47 140.15 46.31 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -134.09 151.32 51.33 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.876 1.671 . . . . 0.0 108.786 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.403 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 25.2 m-85 -131.66 117.35 18.54 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.572 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.9 p-90 -139.58 153.89 47.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.344 1.458 . . . . 0.0 108.849 -169.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.48 158.33 9.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.262 1.025 . . . . 0.0 108.489 168.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.37 -15.18 5.4 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.764 2.976 . . . . 0.0 116.846 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -59.86 -24.75 64.48 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.12 160.26 36.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.456 1.026 . . . . 0.0 112.588 -169.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.24 -49.62 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.253 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.1 -28.09 24.03 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.225 2.617 . . . . 0.0 115.093 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 m -59.38 -16.42 22.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.585 1.084 . . . . 0.0 113.692 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -116.92 14.98 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.788 1.235 . . . . 0.0 111.681 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.0 mtm -123.47 -45.2 2.08 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.182 0.993 . . . . 0.0 109.416 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tp -62.77 -34.9 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.798 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.84 24.02 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.985 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.04 -40.1 73.96 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.955 1.77 . . . . 0.0 111.476 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.44 -37.93 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.467 0.576 . . . . 0.0 110.701 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mp -71.58 -41.22 69.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.952 0.796 . . . . 0.0 111.363 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.06 -35.13 80.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.673 1.124 . . . . 0.0 109.727 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.3 -16.41 61.9 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.619 1.567 . . . . 0.0 112.608 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -86.98 -43.45 12.35 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 124.657 1.183 . . . . 0.0 108.382 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.2 -36.59 69.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.79 -0.569 . . . . 0.0 111.118 -174.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.78 -12.55 61.61 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.614 -0.679 . . . . 0.0 112.193 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -99.92 -42.57 6.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.366 1.467 . . . . 0.0 110.797 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -145.03 17.89 1.59 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.665 0.786 . . . . 0.0 112.284 -172.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.91 -1.99 21.36 Favored Glycine 0 CA--C 1.523 0.574 0 O-C-N 121.343 -0.848 . . . . 0.0 113.984 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.37 -24.88 63.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.599 1.16 . . . . 0.0 110.97 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.12 -18.3 11.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.911 0.884 . . . . 0.0 112.576 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -130.63 147.32 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 111.101 -168.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -107.11 146.01 31.77 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 168.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.71 137.44 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 7.4 t -136.58 141.56 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -175.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.572 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 26.3 mtpt -116.41 152.79 33.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -117.72 120.75 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -79.03 109.37 13.27 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.48 33.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -141.8 -42.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.057 -1.027 . . . . 0.0 109.819 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -79.82 -36.12 37.37 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.94 0.896 . . . . 0.0 110.67 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -134.2 32.37 3.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.439 1.495 . . . . 0.0 109.94 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -15.26 62.9 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.21 -169.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -50.54 -44.57 56.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.971 1.309 . . . . 0.0 111.783 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -60.38 -38.61 84.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.895 0.77 . . . . 0.0 111.872 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -66.91 0.5 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.83 1.252 . . . . 0.0 108.883 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.23 -44.84 5.04 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.641 1.115 . . . . 0.0 113.609 170.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -64.44 -45.2 88.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.574 1.187 . . . . 0.0 111.535 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -70.02 -31.57 69.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.49 0.586 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 68.05 0.74 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.8 t -142.39 132.49 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 100.744 -3.799 . . . . 0.0 100.744 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.633 ' HG3' HD12 ' B' ' 67' ' ' ILE . 10.3 ptm -150.59 17.66 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.767 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -138.3 163.56 31.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.222 2.209 . . . . 0.0 111.155 -169.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 143.89 49.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.944 0.898 . . . . 0.0 108.781 176.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.91 149.6 38.77 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 N-CA-C 107.345 -1.829 . . . . 0.0 107.345 -11.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 96.7 m -118.45 147.52 43.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 172.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.6 mt -125.71 141.71 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -129.0 106.86 9.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.04 118.63 31.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -110.31 149.05 30.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.518 0.727 . . . . 0.0 109.405 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -148.75 132.95 17.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.6 t70 43.23 30.84 0.32 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.678 1.991 . . . . 0.0 113.499 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.64 9.99 57.09 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.43 152.59 51.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.693 1.197 . . . . 0.0 110.757 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.07 133.06 32.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -120.24 -22.45 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.223 1.409 . . . . 0.0 110.704 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.36 163.73 34.64 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.215 1.006 . . . . 0.0 110.063 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.74 150.39 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -169.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -154.79 151.25 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.52 67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.76 154.92 8.94 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -170.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -71.86 158.88 35.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.946 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.59 143.63 20.46 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.18 168.15 22.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.352 2.035 . . . . 0.0 110.425 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -44.99 70.94 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.085 0.954 . . . . 0.0 112.071 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.86 -43.17 84.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.563 0.165 . . . . 0.0 110.891 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.0 78.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.04 -0.412 . . . . 0.0 110.666 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -53.21 59.65 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 109.477 175.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -64.44 -37.81 88.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.72 -46.61 88.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.425 0.557 . . . . 0.0 111.264 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -58.08 -40.12 80.29 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 123.868 0.867 . . . . 0.0 111.151 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.95 -39.87 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.267 -0.397 . . . . 0.0 110.687 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -56.36 -28.24 58.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.583 1.153 . . . . 0.0 112.414 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -56.35 -22.39 30.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.149 0.98 . . . . 0.0 112.959 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -127.97 -26.17 2.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.052 0.941 . . . . 0.0 112.338 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.704 1.602 . . . . 0.0 108.033 171.211 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.69 142.5 40.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.289 0.636 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m120 70.63 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 128.608 2.763 . . . . 0.0 110.566 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 127.23 27.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.57 136.16 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -137.91 140.46 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.38 139.89 49.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.898 0.479 . . . . 0.0 110.775 -169.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -100.94 141.18 34.19 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.62 120.07 10.99 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -172.23 155.92 3.75 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -39.53 102.19 0.02 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.18 1.792 . . . . 0.0 112.707 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.27 22.35 50.16 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.652 -1.638 . . . . 0.0 113.784 171.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ASN . . . . . 0.511 HD22 ' HB3' ' B' ' 36' ' ' SER . 0.2 OUTLIER 33.5 2.67 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 1 C-N-CA 132.715 4.406 . . . . 0.0 121.046 173.791 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -70.84 -5.95 34.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.914 -1.741 . . . . 0.0 115.312 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.31 -95.65 0.48 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 120.496 1.498 . . . . 0.0 111.102 -177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -37.5 62.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.611 0.765 . . . . 0.0 112.536 -171.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -44.42 97.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.62 0.646 . . . . 0.0 110.089 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -56.7 -48.62 77.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.051 0.94 . . . . 0.0 110.188 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -43.3 91.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 124.068 0.855 . . . . 0.0 108.906 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.75 71.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.942 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -48.29 80.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.903 1.229 . . . . 0.0 109.883 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 -47.17 92.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -58.36 -42.34 86.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 112.055 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.27 -54.25 36.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.46 -23.66 65.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.703 -1.142 . . . . 0.0 112.025 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -68.22 -21.19 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.883 1.219 . . . . 0.0 113.558 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' B' ' 132' ' ' LYS . 2.3 m-85 -115.69 -16.31 11.27 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.971 0.908 . . . . 0.0 112.715 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.53 -128.23 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.13 -174.4 40.23 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 127.3 2.381 . . . . 0.0 107.361 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.61 -14.24 40.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.376 1.088 . . . . 0.0 112.026 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -52.79 -28.0 20.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.309 1.444 . . . . 0.0 110.429 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -122.46 168.65 11.86 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.24 2.216 . . . . 0.0 107.228 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -139.04 106.21 5.48 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 120.974 -1.079 . . . . 0.0 108.982 -173.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 82.3 t -99.31 132.22 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.67 166.73 23.82 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.517 1.527 . . . . 0.0 108.775 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.511 ' HB3' HD22 ' B' ' 13' ' ' ASN . 37.3 m -147.15 150.55 35.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.484 1.114 . . . . 0.0 109.213 176.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.56 177.35 11.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.975 0.91 . . . . 0.0 110.03 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.24 -175.78 47.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.401 1.477 . . . . 0.0 110.035 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -53.07 -55.45 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.346 1.458 . . . . 0.0 113.114 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.12 29.82 5.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.343 1.457 . . . . 0.0 108.297 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 121.47 14.77 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.092 2.157 . . . . 0.0 111.72 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -174.85 -19.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.46 1.504 . . . . 0.0 111.194 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.76 179.31 53.6 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 124.333 0.968 . . . . 0.0 113.981 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -147.26 92.31 2.09 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.416 1.486 . . . . 0.0 107.041 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.57 129.06 94.07 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.622 1.169 . . . . 0.0 108.16 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -59.53 -19.66 53.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.875 1.717 . . . . 0.0 112.809 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.425 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.2 OUTLIER -61.67 -38.72 88.8 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.104 1.32 . . . . 0.0 111.239 171.602 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.72 65.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.91 -52.7 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.675 0.79 . . . . 0.0 110.264 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -36.94 58.45 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.996 0.918 . . . . 0.0 111.206 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.7 mmm -82.3 -30.54 30.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.141 0.882 . . . . 0.0 111.568 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -61.62 -25.47 67.38 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.47 1.032 . . . . 0.0 110.992 171.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.15 -22.46 66.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.768 1.167 . . . . 0.0 112.246 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 p -116.67 9.7 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.978 1.711 . . . . 0.0 109.526 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.0 38.79 96.54 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 120.964 -1.085 . . . . 0.0 111.928 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.9 mt -114.48 140.35 35.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.25 136.8 44.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 pt -135.78 15.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.437 1.095 . . . . 0.0 110.855 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 17.1 p -59.48 -13.12 7.65 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.657 1.117 . . . . 0.0 113.63 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -91.29 -14.81 30.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.862 1.665 . . . . 0.0 113.492 176.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.69 142.0 53.95 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.746 1.157 . . . . 0.0 112.611 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -129.36 173.6 10.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.893 2.477 . . . . 0.0 108.486 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.3 m -155.36 -175.38 5.41 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.966 -1.083 . . . . 0.0 110.924 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -155.93 158.87 38.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.94 1.696 . . . . 0.0 109.031 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.5 pt -71.61 170.31 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.583 1.153 . . . . 0.0 112.215 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.633 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.2 OUTLIER -49.7 127.45 5.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -146.01 97.18 2.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.351 1.072 . . . . 0.0 108.75 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -46.42 -27.37 1.06 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.348 1.859 . . . . 0.0 114.429 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.78 -17.9 61.84 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.94 1.245 . . . . 0.0 112.604 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.19 -34.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.917 0.887 . . . . 0.0 108.933 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.66 -54.77 19.67 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.365 0.984 . . . . 0.0 110.209 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -22.41 67.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.561 0.619 . . . . 0.0 110.48 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.1 -20.79 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.809 1.644 . . . . 0.0 112.418 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.56 167.34 2.68 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.759 1.224 . . . . 0.0 111.947 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.29 -28.58 16.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.74 169.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.53 132.45 19.13 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 110.73 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.19 99.98 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -81.09 102.69 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 57.5 m -67.04 136.09 54.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 tp -125.13 43.54 3.02 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 CA--C 1.54 0.59 0 C-N-CA 124.64 1.176 . . . . 0.0 112.724 174.763 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 17.73 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 130.96 3.704 . . . . 0.0 110.643 -168.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -157.12 32.89 0.29 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 128.996 2.918 . . . . 0.0 107.663 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 m 32.38 52.8 0.84 Allowed Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.421 1.888 . . . . 0.0 112.478 -168.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -45.43 131.76 12.22 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.486 2.79 . . . . 0.0 114.8 -169.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.427 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -85.42 -1.3 56.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.2 p 44.36 93.05 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.888 2.075 . . . . 0.0 113.831 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -55.89 134.97 67.27 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.776 2.317 . . . . 0.0 109.089 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.16 8.47 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.765 3.643 . . . . 0.0 116.095 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -67.8 -6.08 19.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.087 0.955 . . . . 0.0 111.904 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.37 146.79 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 109.391 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -69.67 156.14 39.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -144.36 142.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.404 0 O-C-N 121.029 -1.044 . . . . 0.0 108.208 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.85 154.07 32.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 169.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -95.95 127.31 41.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -110.02 -3.62 16.37 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.706 0.802 . . . . 0.0 110.499 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 162.38 13.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -145.82 -9.39 0.54 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.398 1.079 . . . . 0.0 111.738 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -156.87 168.58 27.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.353 2.261 . . . . 0.0 106.02 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -125.33 112.15 26.04 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.035 0.934 . . . . 0.0 108.636 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.0 -22.91 34.86 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.404 3.403 . . . . 0.0 113.189 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.87 -10.69 9.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.976 0.807 . . . . 0.0 112.637 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -97.82 7.95 45.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 111.858 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.61 143.29 2.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.027 0.931 . . . . 0.0 112.362 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -57.04 -47.7 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.968 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.15 -17.25 4.1 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 44.0 p -70.16 159.87 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.61 -38.81 82.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.352 0.596 . . . . 0.0 111.068 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.3 pt-20 -72.71 -43.43 63.02 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.764 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.49 -30.82 59.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.103 1.774 . . . . 0.0 110.077 -172.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -59.89 -57.11 14.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.76 -0.638 . . . . 0.0 109.837 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -61.5 -41.68 97.66 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.146 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.32 87.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.144 0.884 . . . . 0.0 112.372 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -62.92 -47.63 82.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.3 m-30 -64.13 -43.38 95.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -59.43 -53.84 53.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.018 1.727 . . . . 0.0 109.693 -173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.08 -49.36 70.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.1 -41.19 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.216 -0.897 . . . . 0.0 109.736 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp-105 -58.39 -47.17 84.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.974 1.261 . . . . 0.0 111.21 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.31 -43.49 88.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.242 0.474 . . . . 0.0 110.92 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -64.72 -48.87 73.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.05 0.54 . . . . 0.0 110.06 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.88 -50.66 59.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 125.206 1.402 . . . . 0.0 110.042 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.21 -40.84 95.0 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -61.58 -42.99 99.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.17 0.985 . . . . 0.0 111.689 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -69.74 -34.16 73.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.956 0.798 . . . . 0.0 111.345 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 131' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' B' ' 131' ' ' LEU . 3.4 mm? -73.19 -37.8 66.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.698 1.135 . . . . 0.0 111.756 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.403 ' HE3' ' CE2' ' B' ' 27' ' ' TYR . 7.9 ptmt -67.75 -37.34 82.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.945 0.793 . . . . 0.0 109.836 175.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -59.24 -40.75 86.92 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.218 -1.372 . . . . 0.0 109.904 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -60.4 -38.15 83.06 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 122.163 2.256 . . . . 0.0 111.181 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.99 70.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.037 0.535 . . . . 0.0 112.221 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.22 -47.57 8.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.474 1.51 . . . . 0.0 111.499 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.1 p -84.19 -23.28 30.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 110.78 -169.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 50.58 41.28 41.73 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.273 1.429 . . . . 0.0 113.613 -169.049 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.51 170.04 21.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.27 1.428 . . . . 0.0 107.882 169.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 96.81 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 169.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.06 167.63 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.594 1.557 . . . . 0.0 108.132 178.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -123.6 120.28 32.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.257 1.423 . . . . 0.0 107.771 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.52 169.25 15.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.314 1.046 . . . . 0.0 109.214 176.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -133.59 -167.25 1.9 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.557 1.543 . . . . 0.0 108.245 169.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.26 -27.09 2.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.955 2.102 . . . . 0.0 113.409 169.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -136.53 -31.25 0.88 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 111.947 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.0 m -63.81 -20.51 65.84 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.807 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -52.24 -58.38 6.81 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.247 0.931 . . . . 0.0 109.272 169.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -62.58 -43.18 99.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.908 -0.495 . . . . 0.0 110.316 -176.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.79 83.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.193 -174.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -81.34 -16.13 53.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.207 1.003 . . . . 0.0 112.927 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -114.2 -4.19 13.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.446 1.021 . . . . 0.0 113.578 -169.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 m -73.4 -4.57 34.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.66 156.98 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.806 1.242 . . . . 0.0 109.554 -177.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.09 -163.36 45.24 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 124.754 1.169 . . . . 0.0 112.058 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.46 134.97 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.82 149.13 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 113.679 -1.6 . . . . 0.0 108.674 -168.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.4 tp -119.0 100.89 7.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.982 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.84 144.77 25.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -139.49 148.85 43.25 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.417 1.487 . . . . 0.0 108.724 -173.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.34 105.5 7.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -169.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.571 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.1 p-90 -123.7 151.58 42.99 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.237 1.815 . . . . 0.0 107.62 -169.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -166.75 163.09 11.08 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.689 0.677 . . . . 0.0 111.316 173.037 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.32 -10.42 8.51 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.179 3.253 . . . . 0.0 116.534 -177.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.426 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 84.0 m95 -50.12 -49.33 52.21 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.472 -1.251 . . . . 0.0 112.482 -177.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -152.67 168.57 25.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -173.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.24 -54.07 3.91 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 127.865 2.65 . . . . 0.0 115.821 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -53.33 -29.73 49.09 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.597 2.699 . . . . 0.0 114.816 -173.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -61.02 -14.89 26.33 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.779 1.172 . . . . 0.0 114.047 174.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 8.78 19.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.6 1.56 . . . . 0.0 111.167 177.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.8 mtp -125.16 -44.91 1.87 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.477 1.111 . . . . 0.0 108.441 -175.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.91 -35.95 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 -59.28 10.49 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.275 1.03 . . . . 0.0 112.356 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.71 -40.75 61.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.188 1.925 . . . . 0.0 111.607 174.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -40.15 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.238 0.615 . . . . 0.0 110.865 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.82 -43.72 74.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.935 0.789 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.49 -35.16 80.07 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.99 0.814 . . . . 0.0 109.93 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.53 -17.55 62.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.507 1.523 . . . . 0.0 112.536 174.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -87.63 -44.42 11.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.48 1.112 . . . . 0.0 108.674 176.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 52' ' ' ILE . 18.7 t70 -70.23 -36.41 74.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.137 -0.352 . . . . 0.0 110.934 -175.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -69.1 -8.52 46.09 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.919 -0.563 . . . . 0.0 112.32 175.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.91 -46.49 4.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.496 1.118 . . . . 0.0 111.23 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.6 ptm -135.63 15.98 3.37 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.063 0.945 . . . . 0.0 112.304 -171.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.89 -4.82 11.79 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 120.978 -1.077 . . . . 0.0 114.228 170.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.06 -23.33 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.752 0.821 . . . . 0.0 111.054 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -14.38 8.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.259 1.024 . . . . 0.0 112.262 -174.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -129.06 142.01 51.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.515 1.126 . . . . 0.0 111.854 -168.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.52 146.86 27.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 168.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 43' ' ' ASP . 58.6 mt -123.49 144.59 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.119 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.03 143.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 29.2 mtpt -118.56 150.48 39.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.65 0.659 . . . . 0.0 110.197 174.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -118.91 127.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 169.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.49 105.12 12.4 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.297 34.6 m -79.64 46.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -152.2 -38.77 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.549 1.14 . . . . 0.0 109.435 168.367 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -78.79 -52.34 8.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.948 1.299 . . . . 0.0 110.101 177.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.04 46.0 2.47 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.884 1.274 . . . . 0.0 110.052 -172.102 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.62 2.83 5.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.75 1.62 . . . . 0.0 113.032 -176.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.7 -45.46 89.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.104 1.361 . . . . 0.0 111.102 -169.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -59.64 -36.16 75.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.386 0.994 . . . . 0.0 111.469 173.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB1' ' HE2' ' B' ' 91' ' ' MET . . . -69.58 -58.41 3.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.67 -39.2 45.8 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.075 0.845 . . . . 0.0 113.807 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.11 -43.45 98.41 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.008 1.404 . . . . 0.0 110.821 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -74.92 -11.46 60.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.356 0.662 . . . . 0.0 111.745 173.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.85 55.56 13.73 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.065 1.317 . . . . 0.0 109.85 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.64 -46.89 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 117.911 0.855 . . . . 0.0 109.495 -169.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mtm 53.87 14.6 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 127.936 2.494 . . . . 0.0 113.583 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.408 ' O ' HD13 ' A' ' 72' ' ' ILE . 16.6 m -135.59 163.6 29.75 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.835 1.198 . . . . 0.0 112.993 -168.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.691 HD11 ' HB3' ' B' ' 91' ' ' MET . 2.8 mm -135.09 137.61 27.34 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.975 0.91 . . . . 0.0 110.176 -177.051 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.74 125.85 10.38 Favored 'Cis proline' 0 N--CA 1.454 -0.846 0 N-CA-C 105.496 -2.54 . . . . 0.0 105.496 -11.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.8 m -85.4 146.36 27.02 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tp -137.21 125.49 23.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.05 108.3 13.21 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 177.167 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.8 129.79 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.4 156.31 42.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -142.2 138.7 31.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 44.17 28.45 0.27 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.867 2.067 . . . . 0.0 114.258 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.06 41.62 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 124.725 1.155 . . . . 0.0 115.748 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -130.95 143.62 50.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.735 1.268 . . . . 0.0 110.414 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 134.03 30.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -125.73 -22.74 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.356 1.063 . . . . 0.0 109.925 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.81 161.98 40.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.601 1.161 . . . . 0.0 109.534 169.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 148.64 29.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.006 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -154.16 155.89 36.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.56 72.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.29 154.83 9.05 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.954 -171.545 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -65.25 149.21 50.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.212 0.605 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.59 140.29 20.08 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.72 169.19 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 175.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -45.91 67.22 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.038 0.935 . . . . 0.0 112.078 -171.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.12 -43.82 77.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.45 0.114 . . . . 0.0 110.864 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.44 83.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.12 -0.362 . . . . 0.0 110.171 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 tp -68.17 -46.59 70.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.515 0.326 . . . . 0.0 110.781 178.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -62.65 -38.74 91.48 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.71 -45.64 91.82 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.579 0.627 . . . . 0.0 110.906 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.8 tp -58.65 -36.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.988 1.315 . . . . 0.0 111.644 -175.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.08 -40.78 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.469 174.397 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -56.99 -34.32 67.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.989 0.916 . . . . 0.0 111.555 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.52 -6.82 33.2 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.09 -22.9 4.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.904 1.282 . . . . 0.0 112.736 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.254 2.222 . . . . 0.0 109.063 170.378 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mpp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.91 139.29 58.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.524 0.73 . . . . 0.0 110.177 -178.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' B' ' 33' ' ' LYS 0.453 53.8 p30 31.15 103.21 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.441 3.096 . . . . 0.0 119.129 -179.067 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.84 120.36 23.35 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.35 140.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -169.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.16 145.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.425 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -131.41 150.51 52.12 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.704 0.802 . . . . 0.0 110.548 -168.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -113.61 143.37 44.69 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.911 1.284 . . . . 0.0 107.582 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.8 tp -145.52 109.21 4.73 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -169.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -166.81 153.66 8.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.173 0.989 . . . . 0.0 109.974 -178.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 94.8 m -38.43 116.52 0.55 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.22 2.208 . . . . 0.0 113.607 -169.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.31 8.45 31.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.01 0.814 . . . . 0.0 113.763 172.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 13' ' ' ASN . . . . . 0.465 ' HB2' ' HB1' ' B' ' 41' ' ' ALA . 7.4 t30 52.53 20.63 1.53 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.919 1.288 . . . . 0.0 112.384 -169.073 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 10.5 m -67.27 133.8 50.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.427 -0.795 . . . . 0.0 109.933 -174.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 56.53 -85.65 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 169.471 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.438 ' HG3' ' HD2' ' B' ' 106' ' ' PRO . 0.0 OUTLIER -54.12 -40.74 67.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.998 0.817 . . . . 0.0 111.829 -169.839 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -33.76 76.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.03 0.932 . . . . 0.0 111.403 -177.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -68.95 -52.28 30.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.63 1.572 . . . . 0.0 108.949 175.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 11.3 ptp -65.83 -37.55 86.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.712 -174.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.41 80.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.979 -0.534 . . . . 0.0 110.495 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.73 -28.29 66.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.976 176.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.02 -46.37 10.52 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 119.217 0.917 . . . . 0.0 111.215 173.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -53.59 -44.06 69.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 124.712 1.205 . . . . 0.0 111.223 173.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -49.73 72.21 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.97 -28.47 70.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.665 -171.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.69 -15.81 62.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 1.1 m-85 -127.29 -17.37 4.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.4 -124.53 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.24 -168.6 38.03 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.55 -18.68 31.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.262 1.425 . . . . 0.0 112.361 172.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -55.83 -20.57 15.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.468 1.507 . . . . 0.0 111.192 169.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -134.16 168.2 19.27 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.334 1.453 . . . . 0.0 111.516 -177.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' B' ' 3' ' ' ASN . 1.6 tmtp? -137.42 126.13 23.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 169.334 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.23 124.37 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -169.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -135.13 169.49 17.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.034 0.934 . . . . 0.0 109.068 177.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -146.92 140.35 25.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.96 177.36 9.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.888 . . . . 0.0 112.227 -177.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 -175.2 44.8 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.453 1.025 . . . . 0.0 112.349 176.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.421 HG13 ' HE3' ' B' ' 88' ' ' LYS . 2.4 tt -41.06 -64.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.062 . . . . 0.0 114.607 -170.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.15 31.93 4.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.394 2.278 . . . . 0.0 107.014 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 41' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' B' ' 13' ' ' ASN . . . -54.55 138.58 40.45 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -168.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -177.86 21.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 129.054 2.942 . . . . 0.0 108.414 169.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.42 58.09 4.42 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 117.111 1.605 . . . . 0.0 117.111 -168.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.7 tp -67.85 115.22 7.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.174 1.987 . . . . 0.0 106.897 168.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -110.13 130.27 23.03 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -174.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -21.18 51.75 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.274 1.982 . . . . 0.0 112.887 177.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.4 OUTLIER -62.56 -35.55 79.83 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.764 1.166 . . . . 0.0 111.654 172.164 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -77.64 -33.19 53.61 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.871 0.76 . . . . 0.0 109.621 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.09 -49.9 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -59.39 -45.77 90.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.377 -0.827 . . . . 0.0 110.807 176.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.63 69.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.353 1.061 . . . . 0.0 111.526 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -77.11 -40.86 44.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.818 0.847 . . . . 0.0 110.001 176.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.26 -27.67 69.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.502 178.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.8 -30.27 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.84 1.2 . . . . 0.0 111.85 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.08 16.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.221 1.408 . . . . 0.0 110.81 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.07 28.44 72.92 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.162 -1.354 . . . . 0.0 113.491 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.41 152.05 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 169.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -124.18 140.17 53.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.3 pt -135.94 17.77 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.979 1.312 . . . . 0.0 110.868 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -59.44 -17.07 27.91 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.421 -0.799 . . . . 0.0 111.978 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -77.9 -18.03 56.61 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.282 1.833 . . . . 0.0 113.907 174.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -65.59 167.14 9.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.697 1.237 . . . . 0.0 112.761 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -153.21 174.98 13.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.653 1.981 . . . . 0.0 106.681 170.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -149.89 174.46 12.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.623 0.769 . . . . 0.0 110.318 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -161.55 164.35 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.876 1.67 . . . . 0.0 109.217 -169.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 pt -63.02 165.57 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.702 1.201 . . . . 0.0 112.716 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.58 128.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -134.75 100.14 4.53 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.698 1.237 . . . . 0.0 108.34 -176.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.3 m -46.28 -29.82 1.79 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.132 2.173 . . . . 0.0 113.674 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.87 -25.22 68.18 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.392 0.996 . . . . 0.0 111.446 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.92 -42.14 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.35 -49.44 76.96 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.608 1.094 . . . . 0.0 110.199 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -27.76 69.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 110.95 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -84.9 -20.18 31.14 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.817 1.247 . . . . 0.0 112.413 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.19 157.16 10.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.295 1.045 . . . . 0.0 110.649 175.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.7 -33.29 20.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.776 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -146.28 135.0 22.29 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.954 -169.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.485 HG23 HG11 ' B' ' 96' ' ' VAL . 69.0 t -111.29 116.08 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 126.222 1.809 . . . . 0.0 107.559 172.601 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 46.3 t -88.81 105.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -70.99 134.51 47.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 167.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.4 tp -132.54 38.89 3.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 C--N 1.329 -0.294 0 O-C-N 121.299 -0.875 . . . . 0.0 109.35 169.861 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -73.74 3.13 6.89 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -169.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 88' ' ' LYS . . . . . 0.421 ' HE3' HG13 ' B' ' 39' ' ' ILE . 61.4 mttt 88.15 5.0 0.25 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.441 2.696 . . . . 0.0 110.018 -169.083 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 21.0 m 33.57 54.68 1.38 Allowed Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 127.052 2.141 . . . . 0.0 111.063 -169.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.51 140.89 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.917 3.078 . . . . 0.0 114.255 -168.361 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 91' ' ' MET . . . . . 0.691 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -91.21 4.43 52.28 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -172.405 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.1 p 44.24 86.22 0.14 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.453 1.501 . . . . 0.0 113.259 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -55.09 143.1 75.56 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 122.505 2.137 . . . . 0.0 109.534 -172.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.44 4.47 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.605 1 C-N-CA 126.041 4.494 . . . . 0.0 117.572 -168.371 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.04 -5.42 21.8 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.452 -0.78 . . . . 0.0 111.995 169.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.485 HG11 HG23 ' B' ' 78' ' ' VAL . 2.4 t -134.6 148.56 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.678 1.191 . . . . 0.0 110.492 -168.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -84.63 157.23 21.23 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -144.09 148.53 35.25 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.561 -1.337 . . . . 0.0 109.701 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -152.32 151.52 30.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.99 126.34 42.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -118.44 -3.09 10.96 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.506 1.122 . . . . 0.0 111.329 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.65 142.07 13.44 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 175.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.84 12.32 1.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.006 2.123 . . . . 0.0 109.922 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -154.32 164.01 39.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.069 2.547 . . . . 0.0 105.973 -173.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -147.41 109.79 3.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 118.9 0.773 . . . . 0.0 110.072 -171.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' B' ' 16' ' ' ARG . 72.9 Cg_endo -72.35 -21.61 22.81 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.237 3.291 . . . . 0.0 112.678 -172.708 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.35 2.72 0.55 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.681 1.193 . . . . 0.0 112.518 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -123.71 13.85 9.34 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.438 1.495 . . . . 0.0 111.309 -177.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.79 148.08 1.13 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.225 1.01 . . . . 0.0 111.38 177.053 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -56.2 -46.94 79.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.091 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.05 -16.31 4.71 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 169.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.25 158.47 34.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -37.53 78.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.422 0.629 . . . . 0.0 111.262 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.58 -43.26 60.2 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.926 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.97 -28.82 60.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 121.126 1.785 . . . . 0.0 110.078 -172.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -60.43 -59.39 5.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.739 0.7 . . . . 0.0 109.722 171.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.84 -39.66 89.9 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.17 97.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.572 -0.705 . . . . 0.0 112.133 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.54 -46.44 85.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.245 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.1 m-30 -62.8 -46.16 89.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -64.18 -46.38 84.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.358 1.063 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 41.1 ttp-105 -58.69 -49.67 76.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.66 -42.65 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.234 -175.221 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -65.75 -37.06 85.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.611 1.55 . . . . 0.0 111.993 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.89 -46.36 90.95 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.293 0.37 . . . . 0.0 110.495 175.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.91 -50.9 62.8 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.152 0.581 . . . . 0.0 110.687 -179.076 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.69 -49.84 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.242 1.017 . . . . 0.0 109.483 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.26 96.15 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 119.017 -0.88 . . . . 0.0 111.828 -174.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -61.04 -45.89 92.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.704 1.252 . . . . 0.0 110.642 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.42 -39.85 92.64 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.696 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.37 -33.69 71.73 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 119.137 0.88 . . . . 0.0 111.715 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 39.8 ttmt -65.73 -42.78 90.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.22 174.137 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.8 -38.72 86.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.144 -1.407 . . . . 0.0 111.106 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.77 -38.26 78.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 121.691 2.041 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.2 -34.53 72.25 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.67 -46.79 11.13 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.297 1.039 . . . . 0.0 111.591 -177.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 61.1 p -84.05 -27.64 28.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.238 1.815 . . . . 0.0 111.396 -169.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.72 25.65 51.97 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -168.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.103 0 C-N-CA 126.745 2.018 . . . . 0.0 112.467 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 tpp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.25 171.33 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.31 1.444 . . . . 0.0 107.401 167.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.04 96.7 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.94 165.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -126.21 144.03 50.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.51 175.1 6.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.731 1.212 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -158.52 -169.09 2.62 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.696 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -43.81 -36.1 2.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.739 2.816 . . . . 0.0 115.533 -163.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.25 -25.01 2.51 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.551 1.141 . . . . 0.0 111.5 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 m -64.95 -17.57 64.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.528 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -49.46 -58.02 5.94 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.1 0.864 . . . . 0.0 109.27 166.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -43.21 99.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.782 0.833 . . . . 0.0 110.621 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -23.04 62.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -99.44 -17.01 18.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.228 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -110.29 -12.43 14.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.182 1.355 . . . . 0.0 113.621 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m -63.9 -11.17 25.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -139.91 156.59 46.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.063 1.301 . . . . 0.0 109.055 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.57 53.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.37 133.2 68.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.1 t -143.93 135.31 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -161.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.6 tp -111.31 99.5 8.29 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.37 138.07 33.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.58 153.56 50.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 109.218 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -133.89 120.08 19.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -170.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.548 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -143.16 154.31 43.76 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.231 1.412 . . . . 0.0 108.501 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.8 165.16 8.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.799 0.84 . . . . 0.0 109.025 170.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.37 -19.09 6.21 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.72 2.947 . . . . 0.0 116.483 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -55.09 -25.73 33.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.194 1.398 . . . . 0.0 114.493 -173.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -138.63 159.37 42.27 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.481 1.037 . . . . 0.0 111.441 -166.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.82 -48.87 31.88 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.554 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -47.92 -29.33 11.57 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.005 3.136 . . . . 0.0 115.352 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 m -53.41 -26.93 21.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.58 1.082 . . . . 0.0 113.26 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -108.46 10.89 27.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.827 1.251 . . . . 0.0 111.322 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -118.73 -42.55 2.73 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.481 1.113 . . . . 0.0 109.438 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.82 -34.73 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.854 -0.529 . . . . 0.0 109.584 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.42 -57.98 22.93 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.617 -1.182 . . . . 0.0 112.68 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.55 -33.97 54.33 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.604 1.609 . . . . 0.0 111.5 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.04 -40.03 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.525 1.057 . . . . 0.0 110.965 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 mt -70.82 -37.59 73.23 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.254 0.934 . . . . 0.0 110.725 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.16 -36.36 81.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.117 0.871 . . . . 0.0 110.475 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.62 -25.28 64.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.454 1.102 . . . . 0.0 111.059 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.31 -46.42 23.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.136 0.975 . . . . 0.0 109.862 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.61 -43.19 99.31 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 122.796 0.438 . . . . 0.0 111.444 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.13 -9.32 58.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -97.33 -48.81 5.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.274 0.943 . . . . 0.0 110.875 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.6 ptm -137.7 13.89 2.94 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -15.04 33.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.019 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.03 -25.45 58.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.758 1.279 . . . . 0.0 112.508 168.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 -10.47 10.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.653 0.781 . . . . 0.0 112.432 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -132.19 135.66 46.5 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.223 0.92 . . . . 0.0 109.612 -162.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -95.68 144.54 26.01 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 164.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.95 142.49 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.58 147.36 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.548 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 40.5 mtpt -127.18 148.24 50.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.514 0.597 . . . . 0.0 110.742 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 121.2 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 167.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.56 110.94 9.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 164.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.283 27.6 m -87.34 48.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 122.263 1.03 . . . . 0.0 112.357 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -141.06 -40.67 0.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.454 1.102 . . . . 0.0 109.228 154.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -76.06 -40.61 52.84 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.913 0.885 . . . . 0.0 111.461 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.94 24.59 4.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.807 1.243 . . . . 0.0 110.621 -167.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.4 -5.15 6.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.45 -44.33 84.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.262 0.937 . . . . 0.0 110.796 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -60.61 -41.04 94.01 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.698 0.681 . . . . 0.0 110.488 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -53.66 42.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.181 0.592 . . . . 0.0 109.493 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.69 95.33 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.19 -47.97 83.34 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.155 0.982 . . . . 0.0 110.893 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.93 -22.48 60.72 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.192 0.451 . . . . 0.0 111.424 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.4 19.09 31.1 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.221 0.915 . . . . 0.0 112.025 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -76.02 142.14 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 163.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.422 ' CE ' HD13 ' B' ' 72' ' ' LEU . 1.9 ptm -151.47 22.17 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.886 0.474 . . . . 0.0 111.914 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.69 156.18 40.8 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.445 -0.784 . . . . 0.0 110.893 -153.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.1 mm -130.41 138.74 33.72 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.377 -168.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.8 162.58 83.93 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 N-CA-C 108.299 -1.462 . . . . 0.0 108.299 -22.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.6 m -132.94 150.12 52.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 169.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.2 mt -143.16 127.75 18.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -170.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -124.1 115.29 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.62 126.2 45.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -123.81 155.11 38.58 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.595 0.758 . . . . 0.0 109.553 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -144.29 144.49 31.51 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 161.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.5 t70 43.81 35.9 1.19 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.833 1.653 . . . . 0.0 113.687 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.56 15.61 59.8 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.938 -1.479 . . . . 0.0 115.776 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.68 149.77 45.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.49 2.145 . . . . 0.0 110.784 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.81 143.25 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 m -132.31 -18.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.485 1.114 . . . . 0.0 112.162 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.02 156.79 43.31 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.78 32.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -173.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.3 m -150.31 139.84 21.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.408 HG12 ' HD3' ' B' ' 88' ' ' LYS . 62.1 t -136.71 45.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -171.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.68 156.04 23.23 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.665 1.126 . . . . 0.0 110.374 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.09 147.79 46.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.303 1.441 . . . . 0.0 111.378 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.3 141.88 33.23 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.612 1.565 . . . . 0.0 107.683 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.21 167.06 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.501 2.134 . . . . 0.0 110.63 167.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -50.34 -51.33 46.54 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.915 1.286 . . . . 0.0 112.726 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.12 -39.83 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 110.368 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.91 -38.29 76.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.789 -0.569 . . . . 0.0 110.856 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.78 -39.8 80.01 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.462 0.574 . . . . 0.0 110.77 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.15 -39.86 94.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.44 0.563 . . . . 0.0 109.686 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.72 -44.62 96.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.972 0.509 . . . . 0.0 110.626 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.24 -43.47 70.9 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.217 1.007 . . . . 0.0 111.383 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.4 p -84.04 -35.24 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.975 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -58.11 -27.58 63.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.416 1.007 . . . . 0.0 112.632 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -54.72 -27.54 41.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.166 0.986 . . . . 0.0 113.568 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -128.79 -21.28 3.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.341 0.973 . . . . 0.0 112.581 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.424 1.49 . . . . 0.0 109.771 167.426 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -73.42 92.56 1.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 m120 113.14 127.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 130.916 3.686 . . . . 0.0 107.575 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -143.47 111.84 6.32 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.97 133.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 146.97 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.863 1.665 . . . . 0.0 107.287 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.42 ' CD2' HD12 ' B' ' 72' ' ' LEU . 0.8 OUTLIER -127.54 143.53 51.17 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.905 0.882 . . . . 0.0 110.137 -165.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -106.33 140.89 38.54 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.2 114.38 15.0 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.37 140.23 15.1 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.475 0.484 . . . . 0.0 111.389 -166.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -50.6 121.97 6.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.997 1.319 . . . . 0.0 110.628 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.13 -14.94 1.47 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.598 1.571 . . . . 0.0 114.601 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 45.18 24.31 0.13 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.505 1.922 . . . . 0.0 113.117 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -73.98 -34.74 64.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.413 -0.805 . . . . 0.0 110.877 -166.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.53 -69.71 0.47 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -161.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' B' ' 105' ' ' ASP . 11.6 mtm105 -58.67 -44.97 90.36 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.683 -171.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.32 -37.91 84.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.064 0.847 . . . . 0.0 110.516 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -61.41 -43.37 98.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.135 0.574 . . . . 0.0 109.812 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.16 -48.16 79.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.957 1.303 . . . . 0.0 109.732 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.54 77.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.389 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.2 -28.29 64.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.806 1.184 . . . . 0.0 110.911 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.39 -50.04 57.79 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.416 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 42.1 m95 -59.77 -43.45 94.33 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.373 0.587 . . . . 0.0 111.649 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.6 -55.65 29.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 109.419 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -69.62 -10.97 60.36 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -80.1 -9.26 59.69 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.575 1.534 . . . . 0.0 112.897 171.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -129.97 -24.62 2.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.531 1.132 . . . . 0.0 112.794 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.3 mt -105.81 94.27 5.09 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.64 -165.04 5.59 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.814 0.721 . . . . 0.0 112.425 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.84 -17.36 15.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.306 1.442 . . . . 0.0 113.37 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.489 1.515 . . . . 0.0 112.363 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -127.28 161.25 29.04 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.086 1.754 . . . . 0.0 109.617 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -134.08 133.63 41.35 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.0 t -129.86 126.57 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -164.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.84 162.51 33.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.815 1.246 . . . . 0.0 109.065 -173.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 7.1 m -150.91 135.83 17.42 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.76 177.65 10.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.94 0.791 . . . . 0.0 112.134 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.26 176.51 46.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.892 1.234 . . . . 0.0 111.216 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 tt -36.77 -55.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.896 2.078 . . . . 0.0 114.876 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -134.29 31.38 3.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.153 1.381 . . . . 0.0 108.671 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.52 145.35 44.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.999 1.32 . . . . 0.0 112.604 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t60 148.33 84.66 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 130.534 3.533 . . . . 0.0 105.544 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.85 157.61 16.73 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.403 1.001 . . . . 0.0 111.197 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -139.65 93.7 2.69 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -66.31 127.58 93.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.55 -20.88 59.48 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.363 2.042 . . . . 0.0 113.015 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.71 80.32 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.455 1.025 . . . . 0.0 111.689 174.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.68 66.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.58 0.627 . . . . 0.0 109.875 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.2 -51.99 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.11 -45.6 79.43 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.809 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.32 75.76 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.696 0.68 . . . . 0.0 111.513 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.2 mmm -76.42 -32.64 58.6 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.4 -0.812 . . . . 0.0 111.709 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -62.92 -28.22 69.91 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.084 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.19 -25.07 58.4 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.77 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.4 m -121.83 16.32 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.846 1.259 . . . . 0.0 111.186 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.23 34.9 81.73 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.312 -0.716 . . . . 0.0 113.147 171.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -117.1 135.97 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -98.69 135.13 40.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 pt -134.44 10.56 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.581 0.752 . . . . 0.0 111.77 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.7 m -60.01 -23.7 63.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.306 1.042 . . . . 0.0 112.695 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -77.36 -18.01 57.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.013 1.325 . . . . 0.0 113.339 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.54 166.72 14.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.198 0.999 . . . . 0.0 112.8 -167.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.6 p -139.43 -177.68 5.04 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.003 2.121 . . . . 0.0 108.22 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.6 p -159.42 171.06 20.44 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -149.77 164.82 34.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 pt -61.95 164.04 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.189 0.518 . . . . 0.0 110.4 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.415 HG23 ' H ' ' B' ' 67' ' ' ILE . 4.9 pt -48.63 128.96 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 109.306 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -137.71 98.55 3.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.798 1.285 . . . . 0.0 109.98 -172.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.71 -28.8 36.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.216 2.606 . . . . 0.0 112.638 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.58 -24.26 67.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.948 0.795 . . . . 0.0 111.628 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.62 -40.85 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.962 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.422 HD13 ' CE ' ' A' ' 70' ' ' MET . 9.8 tt -62.45 -48.46 79.54 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.266 1.394 . . . . 0.0 110.536 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -18.65 65.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.467 1.03 . . . . 0.0 111.874 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.62 -13.29 52.05 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.211 1.004 . . . . 0.0 112.032 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 166.08 15.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.034 0.833 . . . . 0.0 110.773 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.72 -27.62 16.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 111.155 168.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.59 128.13 15.07 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.826 1.25 . . . . 0.0 107.776 -161.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.03 118.26 56.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -83.86 110.71 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 165.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -67.94 123.98 22.11 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 156.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.1 tp -118.57 31.43 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.521 0.728 . . . . 0.0 109.974 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -140.78 166.81 23.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.072 1.349 . . . . 0.0 108.162 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.27 53.1 0.67 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 162.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -144.56 159.26 43.07 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.998 1.719 . . . . 0.0 109.39 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.34 -4.58 10.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.809 1.243 . . . . 0.0 113.132 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.06 -10.06 57.44 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.589 1.086 . . . . 0.0 111.536 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.48 19.58 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.679 1.592 . . . . 0.0 114.833 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LYS . . . . . 0.408 ' HD3' HG12 ' A' ' 88' ' ' VAL . 13.9 ttmm 67.83 25.42 7.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.198 1.399 . . . . 0.0 112.459 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 30.4 m 36.85 53.59 2.65 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 0.0 114.497 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.71 150.27 54.32 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.439 2.093 . . . . 0.0 112.123 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.63 3.09 15.5 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -170.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p 40.81 89.55 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.435 2.294 . . . . 0.0 114.123 166.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.69 151.98 59.52 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.62 1.01 4.72 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.064 3.176 . . . . 0.0 114.242 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 42.8 m170 -61.69 -16.25 47.31 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.6 143.64 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.179 0.992 . . . . 0.0 109.362 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -79.25 151.99 30.84 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -136.32 147.23 47.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -152.07 158.9 43.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 161.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -97.5 131.17 44.37 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -123.1 -29.36 3.9 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.553 1.141 . . . . 0.0 110.175 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -79.57 161.45 46.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 168.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.54 -4.47 0.33 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.709 0.803 . . . . 0.0 112.305 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -158.1 170.89 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.698 1.999 . . . . 0.0 107.259 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' B' ' 16' ' ' ARG . 56.4 t0 -136.17 113.64 10.54 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 123.833 0.853 . . . . 0.0 110.992 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.47 -19.85 54.69 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.166 2.577 . . . . 0.0 112.893 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.95 -7.92 32.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.157 0.89 . . . . 0.0 112.092 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -115.51 19.33 15.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.202 1.401 . . . . 0.0 110.604 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.76 155.24 2.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.858 0.863 . . . . 0.0 111.043 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -57.66 -29.37 64.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.116 0.966 . . . . 0.0 112.42 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.46 -8.66 30.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.661 -1.077 . . . . 0.0 113.89 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 76.6 p -67.43 156.64 36.08 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.169 1.484 . . . . 0.0 107.825 166.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.64 -39.38 84.17 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.705 -0.622 . . . . 0.0 110.145 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.2 -44.56 68.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.326 0.65 . . . . 0.0 111.203 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -70.56 -35.7 73.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.383 0.992 . . . . 0.0 110.043 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -56.86 -58.34 8.54 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.137 0.881 . . . . 0.0 109.641 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -60.27 -42.02 94.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.992 0.814 . . . . 0.0 110.342 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.44 92.15 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.495 1.043 . . . . 0.0 111.885 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -62.97 -46.96 85.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.117 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -58.08 -50.75 72.37 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -64.48 -43.27 94.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.821 1.248 . . . . 0.0 111.312 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -63.91 -47.95 78.53 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.595 0.634 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.65 -35.97 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.416 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.9 tmm_? -62.21 -45.44 93.37 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.665 1.186 . . . . 0.0 110.45 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.1 -42.43 96.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.046 0.384 . . . . 0.0 110.683 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.58 -54.35 37.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.063 0.545 . . . . 0.0 110.304 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.56 -43.55 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.401 1.081 . . . . 0.0 109.322 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.38 75.51 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 118.652 0.66 . . . . 0.0 111.794 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -59.77 -44.03 94.07 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.098 0.449 . . . . 0.0 110.906 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -63.26 -45.69 90.34 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.769 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.9 mm? -67.32 -36.41 81.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.504 1.047 . . . . 0.0 110.461 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -61.33 -45.76 93.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.316 0.507 . . . . 0.0 110.028 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.08 -44.21 94.93 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.535 0.607 . . . . 0.0 110.586 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.22 -38.51 80.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.882 0.765 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.16 72.22 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.734 0.697 . . . . 0.0 112.163 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.49 -41.92 23.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.31 0.644 . . . . 0.0 110.529 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 76.6 p -85.19 -34.53 22.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.478 0.581 . . . . 0.0 111.578 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.7 64.15 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 118.365 -1.241 . . . . 0.0 112.701 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.172 2.189 . . . . 0.0 111.591 -163.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.03 157.03 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.78 2.432 . . . . 0.0 112.756 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.61 112.94 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.82 168.66 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.86 1.664 . . . . 0.0 108.274 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -124.31 117.67 25.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.665 1.586 . . . . 0.0 108.477 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -84.9 171.41 12.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.6 1.16 . . . . 0.0 110.595 174.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -155.85 -178.19 7.11 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.085 1.754 . . . . 0.0 107.313 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -37.0 -33.94 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 130.932 3.693 . . . . 0.0 117.004 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.06 -31.76 0.9 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.822 1.249 . . . . 0.0 110.926 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -60.76 -19.23 58.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.692 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -47.19 -50.02 21.61 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 120.028 1.286 . . . . 0.0 109.874 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -66.09 -43.83 86.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.078 0.399 . . . . 0.0 110.211 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.96 85.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.545 0.212 . . . . 0.0 110.56 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -74.12 -13.76 60.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.745 1.218 . . . . 0.0 112.593 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -121.76 0.58 9.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.785 1.175 . . . . 0.0 113.134 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.9 m -74.87 -2.85 28.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.541 0.737 . . . . 0.0 112.949 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.66 156.47 45.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.128 0.971 . . . . 0.0 110.485 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.19 -161.56 37.5 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.377 1.465 . . . . 0.0 112.063 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.23 129.62 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.66 155.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.629 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 tp -128.83 91.5 3.23 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.767 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.5 148.58 33.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -141.65 148.43 39.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.819 1.248 . . . . 0.0 109.238 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -130.15 109.62 10.96 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.693 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.7 p-90 -130.93 149.88 52.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.834 1.653 . . . . 0.0 108.155 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -172.98 164.05 3.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 109.42 169.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.53 -16.02 9.93 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.82 3.014 . . . . 0.0 116.691 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.457 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 24.6 m95 -50.46 -28.78 8.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.735 1.614 . . . . 0.0 113.74 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.88 146.36 51.6 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 119.14 0.882 . . . . 0.0 111.811 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.14 -50.26 61.42 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.596 -1.113 . . . . 0.0 110.706 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -46.58 -26.65 4.49 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.222 3.281 . . . . 0.0 116.867 170.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 m -57.77 -29.58 64.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 121.4 1.909 . . . . 0.0 112.286 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -97.65 9.35 42.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.283 1.033 . . . . 0.0 111.813 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -119.61 -43.1 2.6 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.062 0.945 . . . . 0.0 109.602 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.15 -34.76 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.607 0.763 . . . . 0.0 109.066 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.18 -61.25 6.26 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.9 -41.19 64.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.958 1.772 . . . . 0.0 111.659 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.24 -40.57 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.06 0.544 . . . . 0.0 110.819 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 mt -73.08 -38.49 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.4 0.546 . . . . 0.0 110.292 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.92 -34.14 77.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.284 0.947 . . . . 0.0 109.833 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.91 -27.47 64.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.96 1.304 . . . . 0.0 111.603 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.81 -43.59 45.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.48 1.112 . . . . 0.0 110.195 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.61 -35.98 62.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.22 -13.21 62.07 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.378 -0.826 . . . . 0.0 112.019 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -49.7 5.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.743 1.617 . . . . 0.0 110.504 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.5 16.68 2.74 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.805 0.842 . . . . 0.0 111.741 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.06 -3.22 22.19 Favored Glycine 0 CA--C 1.521 0.446 0 O-C-N 121.23 -0.919 . . . . 0.0 113.974 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.34 -24.15 65.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.333 1.053 . . . . 0.0 111.104 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.44 -20.95 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.523 1.129 . . . . 0.0 112.226 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.64 149.66 46.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 110.874 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.36 150.48 40.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.529 1.532 . . . . 0.0 108.335 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mt -130.39 140.89 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 6' ' ' ALA . 12.6 t -136.78 108.92 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.693 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 21.6 mtpp -84.68 151.14 24.65 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.367 -0.833 . . . . 0.0 109.757 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -113.59 128.03 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.26 103.78 11.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.88 48.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.075 1.35 . . . . 0.0 112.092 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -156.11 -43.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.833 1.253 . . . . 0.0 109.578 168.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.27 -36.5 29.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 109.868 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -133.24 27.11 4.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 111.925 -168.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -69.76 -5.31 24.43 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -50.0 -49.69 49.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.582 1.953 . . . . 0.0 110.647 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.6 m -58.26 -35.95 72.53 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 123.122 0.569 . . . . 0.0 111.466 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.54 0.84 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.15 -45.31 15.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.204 0.907 . . . . 0.0 113.625 170.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.097 0.948 . . . . 0.0 111.033 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.99 -30.48 67.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.177 0.444 . . . . 0.0 110.36 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.27 67.65 0.81 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.6 t -139.17 127.67 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.422 ' SD ' HD12 ' B' ' 67' ' ' ILE 0.315 0.1 OUTLIER -137.3 17.11 2.96 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.883 0.311 . . . . 0.0 111.22 174.61 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 p -137.48 159.89 40.67 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.884 2.474 . . . . 0.0 110.722 -170.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.14 149.02 56.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.03 148.09 87.43 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 109.701 -0.923 . . . . 0.0 109.701 -10.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -122.76 145.16 48.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.21 136.55 54.78 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.976 1.71 . . . . 0.0 106.518 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.4 mt -121.44 102.7 8.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.69 122.53 38.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.88 153.19 44.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.521 1.128 . . . . 0.0 108.12 -171.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -140.23 138.65 35.23 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.88 27.29 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.541 1.937 . . . . 0.0 114.412 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 15.97 43.1 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.083 1.325 . . . . 0.0 115.945 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -130.85 142.8 50.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.038 1.419 . . . . 0.0 110.524 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.28 140.71 19.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.35 -21.59 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.185 0.994 . . . . 0.0 109.985 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.64 161.6 41.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.174 1.389 . . . . 0.0 109.087 169.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.23 148.3 31.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -149.99 145.99 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.721 HG12 ' HD3' ' B' ' 88' ' ' LYS . 11.1 t -137.82 67.74 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.41 157.86 10.18 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.16 1.838 . . . . 0.0 109.02 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -74.33 157.8 35.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.933 0.493 . . . . 0.0 111.107 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.43 145.33 25.83 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.64 165.88 30.54 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.528 2.152 . . . . 0.0 110.704 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -45.95 -47.88 16.45 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.373 1.869 . . . . 0.0 112.416 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.17 -43.34 74.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.477 0.581 . . . . 0.0 111.23 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.3 -32.79 74.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.745 -0.597 . . . . 0.0 110.72 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -52.18 64.35 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.937 0.895 . . . . 0.0 109.903 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.96 -38.84 92.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.1 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.69 -46.29 90.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.704 0.684 . . . . 0.0 111.437 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.52 -40.78 79.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.755 1.222 . . . . 0.0 111.198 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -88.05 -39.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.885 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 12.3 t30 -56.37 -34.88 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.517 1.053 . . . . 0.0 111.801 -176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.08 -6.96 25.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.56 -27.11 3.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.668 1.187 . . . . 0.0 112.666 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 19.5 tp . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.988 2.115 . . . . 0.0 109.388 171.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.78 143.38 44.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.1 m120 63.77 119.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.184 0 C-N-CA 128.71 2.804 . . . . 0.0 110.639 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -164.26 134.3 4.05 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mt -106.65 143.25 17.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.41 143.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.45 144.39 51.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.489 0.715 . . . . 0.0 111.553 -168.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -103.58 144.04 31.96 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.8 tp -128.97 114.47 16.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 75.4 m -142.77 135.41 27.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.871 0.868 . . . . 0.0 111.139 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -48.75 113.7 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.737 1.215 . . . . 0.0 110.976 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.53 8.41 51.52 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.941 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 7.02 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 130.738 3.615 . . . . 0.0 115.536 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -142.28 5.96 1.69 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.01 -70.24 0.26 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.794 1.179 . . . . 0.0 112.385 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -47.2 -52.98 14.31 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.09 0.859 . . . . 0.0 110.495 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -55.63 -52.44 63.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.067 1.747 . . . . 0.0 111.801 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -53.85 -50.07 67.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.094 0.958 . . . . 0.0 110.606 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.0 ttm -62.59 -42.24 99.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.269 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.86 82.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.619 -1.181 . . . . 0.0 112.019 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.59 -45.65 89.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.732 1.605 . . . . 0.0 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.89 -43.63 57.85 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -58.07 -39.45 78.52 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.993 0.896 . . . . 0.0 111.495 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.23 62.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -65.26 -24.22 67.26 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.779 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.19 -14.98 63.28 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -126.46 -12.01 6.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.934 1.293 . . . . 0.0 113.131 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.11 85.6 2.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.89 -165.92 0.89 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.073 1.321 . . . . 0.0 113.173 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.79 -17.82 18.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.653 1.181 . . . . 0.0 113.214 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.57 -21.31 25.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.884 1.673 . . . . 0.0 112.411 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -127.83 161.62 28.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.391 1.476 . . . . 0.0 109.158 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -132.79 135.53 45.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -125.34 132.17 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -169.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -143.08 171.23 14.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.773 1.629 . . . . 0.0 108.035 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 81.7 p -158.92 154.07 25.34 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.519 -0.738 . . . . 0.0 110.788 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.06 169.97 23.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.904 0.881 . . . . 0.0 111.807 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.43 -176.22 39.18 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.592 0.615 . . . . 0.0 112.578 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 tt -50.73 -57.44 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.007 1.723 . . . . 0.0 114.043 -172.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -133.1 29.68 4.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.75 1.62 . . . . 0.0 108.816 -169.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 159.19 34.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.956 2.102 . . . . 0.0 113.06 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 136.24 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 130.723 3.609 . . . . 0.0 104.782 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.93 29.55 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -172.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.56 82.62 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -62.76 128.88 92.49 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -58.6 -23.34 64.77 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.093 1.862 . . . . 0.0 112.953 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.444 HD21 ' HG2' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -62.8 -36.06 81.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.821 1.191 . . . . 0.0 111.305 172.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.43 64.9 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.749 0.704 . . . . 0.0 110.073 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.56 -51.26 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -59.56 -43.95 93.42 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 123.2 0.6 . . . . 0.0 110.593 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.28 -31.38 63.57 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 112.523 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -37.05 24.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.254 -0.904 . . . . 0.0 110.493 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.44 -24.67 67.93 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.288 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.79 -32.84 60.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.948 1.249 . . . . 0.0 111.633 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 m -114.56 15.89 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.285 1.434 . . . . 0.0 110.997 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.17 34.98 91.37 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.283 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -106.01 132.65 52.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.64 135.89 33.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.5 ' C ' ' H ' ' B' ' 61' ' ' ASN . 13.6 pt -132.31 20.9 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.482 0.713 . . . . 0.0 110.829 169.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -70.96 24.42 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.793 0.837 . . . . 0.0 112.067 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.5 ' H ' ' C ' ' B' ' 59' ' ' ILE . 12.1 p30 -143.86 -4.47 0.84 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.841 3.657 . . . . 0.0 110.755 -169.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.33 153.55 20.36 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.307 0.958 . . . . 0.0 110.341 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 55.1 p -134.28 -175.71 3.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.549 1.94 . . . . 0.0 108.863 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 23.5 p -155.87 -177.18 6.38 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -163.56 165.22 23.78 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.232 1.813 . . . . 0.0 107.79 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.84 167.18 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.551 0.741 . . . . 0.0 111.728 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.422 HD12 ' SD ' ' A' ' 70' ' ' MET . 0.2 OUTLIER -48.33 131.08 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.225 1.01 . . . . 0.0 108.671 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -146.01 97.12 2.91 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.279 1.037 . . . . 0.0 109.409 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 17.5 m -47.87 -26.62 1.75 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.02 1.728 . . . . 0.0 114.603 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.27 -18.04 60.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.153 1.342 . . . . 0.0 112.647 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.24 -33.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 109.184 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -61.63 -60.14 4.13 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.036 0.834 . . . . 0.0 109.17 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -24.42 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.748 0.704 . . . . 0.0 110.836 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -75.59 -23.37 56.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.777 . . . . 0.0 112.588 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 173.29 1.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.687 1.195 . . . . 0.0 112.155 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.15 -33.91 12.46 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.869 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -139.41 139.35 37.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.331 1.452 . . . . 0.0 109.395 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.8 t -117.01 96.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -80.16 115.11 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 47.9 m -71.75 131.43 43.09 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 tp -135.08 6.09 3.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -167.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m -157.34 -22.57 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.219 1.372 . . . . 0.0 114.271 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 160.1 178.35 34.02 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -145.42 -48.67 0.23 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.64 0.72 . . . . 0.0 111.086 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.55 -56.36 20.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.446 0.566 . . . . 0.0 110.974 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.42 67.79 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 119.372 -0.347 . . . . 0.0 111.347 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.51 11.99 2.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.56 0.744 . . . . 0.0 112.726 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LYS . . . . . 0.721 ' HD3' HG12 ' A' ' 88' ' ' VAL . 14.2 ttmm 90.17 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.306 2.642 . . . . 0.0 111.127 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m 31.38 54.85 0.85 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 126.987 2.115 . . . . 0.0 113.151 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.46 135.31 47.24 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 CA-C-N 120.602 1.251 . . . . 0.0 112.173 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.59 6.05 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -171.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p 38.36 93.9 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 127.838 2.455 . . . . 0.0 114.379 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -56.15 141.39 87.69 Favored 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 122.485 2.123 . . . . 0.0 108.26 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -61.78 -1.3 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.323 3.349 . . . . 0.0 116.95 -168.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -69.15 -9.38 52.52 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.164 0.893 . . . . 0.0 112.829 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 144.93 36.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.906 1.282 . . . . 0.0 111.192 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -73.84 153.18 40.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -146.83 143.78 28.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.779 0.718 . . . . 0.0 109.498 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -150.15 144.21 25.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.52 127.7 33.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -111.85 -12.31 13.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.185 0.994 . . . . 0.0 110.591 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.58 161.42 31.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -158.24 26.81 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.788 1.235 . . . . 0.0 110.541 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -149.47 161.54 41.91 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.871 2.469 . . . . 0.0 106.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -147.54 139.55 14.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.228 0.922 . . . . 0.0 109.291 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.444 ' HG2' HD21 ' B' ' 47' ' ' ASN . 91.3 Cg_endo -78.0 -19.16 12.51 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.437 2.092 . . . . 0.0 113.336 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.82 -4.06 11.44 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.837 1.199 . . . . 0.0 111.03 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -98.41 6.22 47.44 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.427 1.091 . . . . 0.0 111.05 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.02 153.38 1.38 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.114 0.566 . . . . 0.0 110.065 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -54.42 -43.81 71.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.8 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.34 -19.59 2.64 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.6 p -69.53 165.92 20.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.38 -42.16 99.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.527 0.68 . . . . 0.0 110.289 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.61 -42.82 77.57 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 116.929 -1.51 . . . . 0.0 109.326 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.28 -35.26 61.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 121.184 1.811 . . . . 0.0 109.693 -173.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -55.3 -56.6 18.13 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 118.501 0.591 . . . . 0.0 110.693 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -64.35 -40.45 95.89 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.886 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.77 91.62 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.804 0.842 . . . . 0.0 111.765 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.55 -49.88 69.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.284 2.6 p90 -71.1 -27.06 63.32 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.793 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -64.53 -51.35 63.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.558 1.072 . . . . 0.0 109.668 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -59.83 -51.33 70.19 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.38 -43.76 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.575 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.53 -46.51 80.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.876 1.216 . . . . 0.0 111.533 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.01 -44.47 96.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 123.217 0.323 . . . . 0.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -51.66 59.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.369 0.668 . . . . 0.0 110.467 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.77 -45.49 91.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.536 1.134 . . . . 0.0 110.176 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.38 -44.01 91.41 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -60.26 -49.08 79.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.458 1.129 . . . . 0.0 111.306 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -59.01 -44.03 91.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.837 0.455 . . . . 0.0 110.803 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.72 -36.41 67.78 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.757 0.708 . . . . 0.0 111.696 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -66.95 -49.74 64.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.845 -0.534 . . . . 0.0 110.426 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -61.5 -38.26 86.7 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.742 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -56.15 -38.81 71.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.95 1.25 . . . . 0.0 111.077 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.37 -31.53 71.43 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -87.88 -47.85 8.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.839 1.656 . . . . 0.0 111.629 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.0 p -83.63 -28.18 28.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.672 2.389 . . . . 0.0 110.983 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.25 17.18 55.61 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.613 -1.104 . . . . 0.0 111.473 -168.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.249 1.06 0 C-N-CA 127.93 2.492 . . . . 0.0 112.003 -169.941 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.59 172.55 18.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.03 1.732 . . . . 0.0 107.067 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.88 96.2 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 102.845 -3.021 . . . . 0.0 102.845 168.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.28 168.69 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.831 1.652 . . . . 0.0 108.115 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.25 111.77 16.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.14 1.376 . . . . 0.0 108.358 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -80.9 172.8 13.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.574 1.15 . . . . 0.0 110.527 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -155.34 -174.87 5.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.933 2.093 . . . . 0.0 105.898 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -41.19 -36.81 0.8 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.019 2.527 . . . . 0.0 115.572 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -129.85 -30.19 2.05 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.559 1.144 . . . . 0.0 111.522 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 m -61.57 -22.74 65.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.059 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.65 -55.62 18.31 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.384 0.993 . . . . 0.0 108.773 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -62.11 -43.79 98.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.139 -0.35 . . . . 0.0 110.183 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.78 82.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.386 0.136 . . . . 0.0 111.295 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -79.84 -13.79 59.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.412 1.085 . . . . 0.0 113.143 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.5 p -118.33 -3.94 10.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.604 1.093 . . . . 0.0 113.535 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -73.75 -5.02 38.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.24 155.7 45.98 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.461 1.104 . . . . 0.0 109.825 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.64 -163.04 44.12 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.843 1.211 . . . . 0.0 112.163 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.43 132.14 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.37 149.82 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 113.45 -1.705 . . . . 0.0 107.797 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tt -124.98 100.83 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.931 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.17 148.72 26.61 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -142.41 149.7 39.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -130.06 115.54 17.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -169.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.62 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.5 p-90 -137.58 154.35 49.8 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.901 1.68 . . . . 0.0 108.007 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -174.48 162.15 2.69 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.068 0.947 . . . . 0.0 108.95 169.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.97 -19.04 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.635 2.89 . . . . 0.0 116.895 -174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.44 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 10.3 m95 -52.62 -33.88 48.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.837 1.198 . . . . 0.0 114.078 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.15 163.23 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.972 0.805 . . . . 0.0 112.76 -169.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.12 -48.78 57.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.923 -1.487 . . . . 0.0 113.197 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.78 -27.59 20.63 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.571 2.847 . . . . 0.0 115.397 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 m -57.17 -23.77 49.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.695 1.134 . . . . 0.0 113.25 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -108.87 12.71 25.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.111 0.964 . . . . 0.0 111.575 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -122.71 -44.11 2.23 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.292 1.037 . . . . 0.0 109.67 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -64.38 -34.22 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 121.685 -0.634 . . . . 0.0 109.451 169.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.47 11.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.911 -1.042 . . . . 0.0 112.39 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -59.05 -41.03 65.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.967 1.778 . . . . 0.0 111.631 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.46 -40.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.115 0.566 . . . . 0.0 110.877 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.8 mt -73.59 -40.92 63.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.691 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.87 -34.51 78.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.013 0.824 . . . . 0.0 109.737 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -70.35 -21.39 62.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.077 1.351 . . . . 0.0 112.184 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.89 -42.09 18.14 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 119.161 0.892 . . . . 0.0 110.125 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.39 -37.61 85.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.944 -0.472 . . . . 0.0 110.831 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -72.21 -4.86 31.87 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -107.71 -43.17 4.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.674 1.589 . . . . 0.0 111.032 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.63 15.57 2.34 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.363 0.665 . . . . 0.0 112.535 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.79 -2.18 11.24 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.392 -0.817 . . . . 0.0 113.867 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.86 -24.0 65.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.328 1.051 . . . . 0.0 111.147 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -11.7 8.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.74 0.816 . . . . 0.0 112.682 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -139.4 149.54 44.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.32 1.048 . . . . 0.0 111.622 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.99 147.67 38.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.068 1.747 . . . . 0.0 108.327 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mt -119.41 143.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 6' ' ' ALA . 5.0 t -137.44 109.32 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.6 mtpp -84.03 151.78 24.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.341 -0.85 . . . . 0.0 109.3 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mm -118.99 120.86 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 170.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.59 105.94 7.95 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 33.9 m -78.43 49.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -156.01 -41.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.801 1.241 . . . . 0.0 108.977 167.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.73 -33.98 21.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.063 0.945 . . . . 0.0 111.079 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -134.05 27.99 3.84 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.518 1.527 . . . . 0.0 110.796 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -72.09 -5.74 37.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.825 0.85 . . . . 0.0 112.898 -170.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -53.27 -48.17 68.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.3 1.84 . . . . 0.0 110.769 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 m -56.29 -41.57 76.1 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.091 0.556 . . . . 0.0 110.837 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.96 -64.57 0.83 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.67 -43.82 11.74 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.985 0.802 . . . . 0.0 113.454 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.02 -44.63 95.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.24 1.02 . . . . 0.0 111.663 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -73.64 -21.35 60.32 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.477 0.58 . . . . 0.0 111.731 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.03 64.72 0.99 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.05 129.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.5 ptm -150.64 23.11 0.79 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.74 161.44 35.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.101 1.76 . . . . 0.0 112.027 -168.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.1 136.98 29.67 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.53 146.51 47.78 Favored 'Cis proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.067 -1.551 . . . . 0.0 108.067 -10.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -116.58 151.72 35.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 169.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tt -148.82 123.7 9.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -170.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.5 mt -122.24 106.09 10.81 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.54 131.96 33.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.88 158.33 39.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.815 0.846 . . . . 0.0 109.382 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -144.27 139.64 28.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 44.95 28.35 0.36 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.605 1.962 . . . . 0.0 113.761 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.56 10.32 47.67 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 116.103 1.201 . . . . 0.0 116.103 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -133.72 145.17 49.62 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.909 1.354 . . . . 0.0 111.528 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.25 137.37 24.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.96 -19.41 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.51 1.124 . . . . 0.0 111.635 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.8 159.18 43.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.001 0.819 . . . . 0.0 110.185 169.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.62 147.94 28.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -171.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.2 m -152.58 147.55 26.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.8 t -133.63 64.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.56 159.57 10.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.236 1.874 . . . . 0.0 109.535 -169.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.53 167.86 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.578 0.751 . . . . 0.0 112.032 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -150.31 141.58 14.91 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.422 1.489 . . . . 0.0 107.459 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.88 165.95 29.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.118 . . . . 0.0 110.388 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.98 -48.71 21.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.74 1.616 . . . . 0.0 112.39 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.1 -42.79 79.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.161 0.437 . . . . 0.0 110.897 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.39 -29.95 68.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.035 -0.416 . . . . 0.0 111.011 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -52.3 61.09 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.934 0.894 . . . . 0.0 109.207 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -63.6 -36.28 83.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.799 -0.62 . . . . 0.0 109.654 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.15 -46.46 88.87 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.678 0.672 . . . . 0.0 111.224 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.9 tp -54.64 -40.39 68.93 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.073 0.949 . . . . 0.0 110.96 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.27 -41.14 13.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 118.819 -0.61 . . . . 0.0 112.071 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -56.7 -33.55 66.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.581 1.082 . . . . 0.0 111.45 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -70.07 -6.47 34.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -127.66 -21.98 3.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.168 1.387 . . . . 0.0 112.659 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--O 1.249 1.072 0 C-N-CA 127.286 2.234 . . . . 0.0 109.05 171.319 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -139.36 41.45 2.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.314 1.045 . . . . 0.0 109.36 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m120 130.58 132.77 0.0 OUTLIER 'General case' 0 C--N 1.341 0.198 1 C-N-CA 132.385 4.274 . . . . 0.0 107.513 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.402 ' HE3' ' CE3' ' B' ' 32' ' ' TRP . 53.1 pttt -157.08 145.85 19.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 130.175 3.39 . . . . 0.0 102.499 168.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.49 139.44 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 118.755 0.707 . . . . 0.0 109.431 -168.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.68 140.0 46.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -132.04 149.01 52.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.4 155.48 31.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.392 0.542 . . . . 0.0 110.11 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -133.2 132.4 41.49 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.028 1.331 . . . . 0.0 107.925 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -162.26 157.24 22.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.3 m -47.8 107.88 0.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.996 1.318 . . . . 0.0 111.435 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.75 59.4 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.685 -1.064 . . . . 0.0 113.443 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.324 0.3 OUTLIER 39.01 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.537 2.735 . . . . 0.0 116.044 -173.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -64.85 169.05 5.51 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.284 1.04 . . . . 0.0 108.543 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 46.37 -94.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.425 2.29 . . . . 0.0 113.717 169.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.67 -50.06 64.0 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.774 1.63 . . . . 0.0 111.219 -169.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.2 m -66.97 -41.7 86.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.237 0.926 . . . . 0.0 112.17 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -59.41 -49.3 78.32 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.402 1.096 . . . . 0.0 109.823 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 18.9 ttm -65.31 -40.57 93.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.429 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.69 -36.86 73.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.068 0.947 . . . . 0.0 110.297 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.94 60.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 109.911 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.7 -46.23 62.26 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -55.37 -44.19 75.82 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.611 0.764 . . . . 0.0 111.483 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.77 61.91 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.121 0.568 . . . . 0.0 110.108 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.458 ' HE3' ' HB ' ' B' ' 34' ' ' VAL . 65.2 mttt -65.64 -20.57 66.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.509 -168.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.87 -14.74 62.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.384 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -40.21 2.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.791 1.178 . . . . 0.0 112.382 174.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' B' ' 135' ' ' ALA . 10.0 mp -79.76 75.68 6.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.41 -163.6 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.575 2.036 . . . . 0.0 112.564 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.49 -13.86 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.752 1.221 . . . . 0.0 113.21 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -57.69 -23.79 53.45 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.928 168.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' TRP . . . . . 0.402 ' CE3' ' HE3' ' B' ' 4' ' ' LYS . 41.7 m95 -127.63 171.36 11.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.391 2.276 . . . . 0.0 110.424 -177.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -139.74 129.32 24.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 168.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.458 ' HB ' ' HE3' ' B' ' 25' ' ' LYS . 13.9 t -123.18 129.02 75.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -171.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -143.09 169.33 17.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.396 1.478 . . . . 0.0 108.536 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 74.6 p -154.97 162.83 40.97 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.415 -0.803 . . . . 0.0 110.867 172.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 178.77 9.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.344 1.458 . . . . 0.0 108.859 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.27 -176.62 44.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 tt -48.8 -52.96 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.089 1.756 . . . . 0.0 113.991 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -130.36 26.27 5.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.909 2.084 . . . . 0.0 107.992 -169.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.9 46.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.705 1.602 . . . . 0.0 112.965 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 78.4 t60 133.85 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 131.244 3.817 . . . . 0.0 104.458 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.13 175.5 46.58 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -153.21 102.78 2.65 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 171.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -73.56 126.09 90.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.44 -22.18 70.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.861 1.707 . . . . 0.0 112.514 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.406 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -59.54 -37.5 78.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.252 0.933 . . . . 0.0 110.796 170.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -73.32 -38.58 65.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.32 -55.88 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.6 -45.9 77.37 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.274 0.63 . . . . 0.0 111.06 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.12 -33.51 65.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.448 1.099 . . . . 0.0 112.512 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 1.1 mmt -82.54 -38.87 23.13 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.934 0.893 . . . . 0.0 110.453 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -60.83 -29.7 69.65 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.896 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.98 -31.46 60.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.471 1.032 . . . . 0.0 111.814 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.95 15.1 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.146 1.379 . . . . 0.0 110.821 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.78 34.03 81.82 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.163 -1.354 . . . . 0.0 113.034 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -107.43 149.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.07 135.12 54.8 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.84 22.68 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.94 1.296 . . . . 0.0 110.448 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -67.59 14.73 0.05 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.4 13.69 2.17 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.047 2.139 . . . . 0.0 111.641 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -53.3 162.38 0.75 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.309 -1.494 . . . . 0.0 113.559 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -149.63 161.16 42.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.22 2.208 . . . . 0.0 105.619 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 67.1 m -157.89 -172.87 4.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.89 1.276 . . . . 0.0 109.021 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.55 163.67 24.51 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.149 1.379 . . . . 0.0 109.389 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.0 165.75 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.227 1.011 . . . . 0.0 111.411 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 pt -50.29 128.59 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.199 0.6 . . . . 0.0 110.452 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -143.14 104.5 4.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.261 1.029 . . . . 0.0 109.575 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -53.55 -25.65 17.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.682 1.593 . . . . 0.0 113.282 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -17.64 62.91 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.591 1.087 . . . . 0.0 112.498 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -129.78 -37.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.146 0.978 . . . . 0.0 108.903 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.29 -50.19 28.95 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.1 0.863 . . . . 0.0 110.254 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -24.41 67.54 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.928 0.786 . . . . 0.0 110.7 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -73.75 -23.05 59.69 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.119 1.368 . . . . 0.0 112.337 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.0 166.56 3.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.939 1.295 . . . . 0.0 112.268 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.75 -34.15 17.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.709 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.639 HD13 ' HD2' ' B' ' 97' ' ' LYS . 18.6 tp -146.93 139.87 25.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 0.0 110.594 -170.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.81 110.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 125.976 1.711 . . . . 0.0 107.786 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.78 102.3 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 75.4 m -71.37 128.75 36.9 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 68.5 mt -136.14 64.19 1.57 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.298 1.039 . . . . 0.0 109.178 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -153.96 -178.65 7.22 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.554 -0.716 . . . . 0.0 110.457 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -134.88 35.94 2.13 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 127.285 2.374 . . . . 0.0 108.297 171.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -145.07 156.55 43.98 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.66 2.384 . . . . 0.0 107.16 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -127.44 11.33 6.84 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.064 0.946 . . . . 0.0 113.106 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.84 -8.83 47.33 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.487 1.04 . . . . 0.0 112.243 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -66.47 20.04 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -170.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm 71.67 21.03 4.48 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.071 -1.643 . . . . 0.0 111.948 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.0 m 29.24 56.97 0.68 Allowed Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 128.369 2.668 . . . . 0.0 113.162 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.55 132.29 48.13 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.609 2.206 . . . . 0.0 112.856 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.453 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.55 4.06 33.78 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -175.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.5 p 41.64 94.1 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.222 2.209 . . . . 0.0 113.494 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -60.0 143.87 99.53 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.203 1.935 . . . . 0.0 110.488 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.21 -2.83 5.27 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.509 3.473 . . . . 0.0 115.028 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -63.92 -11.62 29.79 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.829 0.852 . . . . 0.0 111.678 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.41 143.94 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 109.605 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.639 ' HD2' HD13 ' B' ' 77' ' ' LEU . 3.3 tmmm? -73.18 159.02 34.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -145.6 146.95 31.56 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.49 -1.381 . . . . 0.0 109.35 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -146.86 156.51 43.16 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -114.98 133.29 56.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.337 1.455 . . . . 0.0 108.1 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.11 1.29 1.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.04 -62.27 2.5 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 39.9 p90 47.49 14.72 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.23 2.612 . . . . 0.0 115.328 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -161.24 161.9 30.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.174 2.19 . . . . 0.0 106.473 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -141.94 105.91 5.76 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.175 0.99 . . . . 0.0 110.427 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.76 -10.92 18.45 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.636 3.558 . . . . 0.0 112.981 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.58 0.28 5.62 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.737 1.153 . . . . 0.0 111.517 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -121.22 -60.77 1.61 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . 43.39 -170.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 113.59 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -90.81 138.72 31.37 Favored 'General case' 0 C--O 1.236 0.388 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -83.0 56.82 5.08 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.641 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 p -121.65 164.16 17.79 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 169.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.18 -39.05 89.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.479 0.657 . . . . 0.0 110.61 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.04 -42.89 59.6 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.768 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -76.2 -29.93 57.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.941 1.246 . . . . 0.0 109.891 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.8 -59.6 4.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.792 0.724 . . . . 0.0 109.436 169.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -57.84 -41.97 83.45 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.97 90.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.869 0.868 . . . . 0.0 112.006 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -65.81 -43.85 87.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.158 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.3 m-30 -58.7 -47.57 84.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.219 0.918 . . . . 0.0 108.958 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -65.53 -43.71 89.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 111.111 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -60.67 -53.67 54.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.34 -41.4 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.414 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -36.87 85.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 120.299 1.409 . . . . 0.0 112.011 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.04 -41.49 90.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.996 0.362 . . . . 0.0 111.043 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.21 -49.09 68.47 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.996 0.519 . . . . 0.0 110.192 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -56.57 -47.66 81.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 124.216 1.006 . . . . 0.0 109.234 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.63 95.93 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 119.677 1.126 . . . . 0.0 111.737 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -65.12 -43.3 92.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.322 0.561 . . . . 0.0 111.584 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -48.13 81.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.012 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.7 mm? -65.26 -32.68 74.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.556 1.071 . . . . 0.0 111.208 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.06 -38.17 82.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.446 0.566 . . . . 0.0 110.677 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -62.13 -34.72 76.91 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.779 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' PHE . . . . . 0.43 ' CE2' ' HE3' ' B' ' 139' ' ' LYS . 20.9 m-85 -63.6 -35.79 81.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 122.325 2.329 . . . . 0.0 109.458 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' B' ' 28' ' ' LEU . . . -62.82 -36.54 83.53 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.138 0.575 . . . . 0.0 110.837 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -84.22 -43.76 14.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.194 1.398 . . . . 0.0 112.0 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -93.04 -21.41 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.442 1.897 . . . . 0.0 111.544 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.17 20.12 60.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.708 0.671 . . . . 0.0 111.463 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.43 ' HE3' ' CE2' ' B' ' 134' ' ' PHE . 10.3 tppt? . . . . . 0 C--O 1.251 1.178 0 C-N-CA 128.698 2.799 . . . . 0.0 112.692 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.84 171.25 20.75 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.871 1.668 . . . . 0.0 106.915 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.47 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -79.88 170.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.829 1.651 . . . . 0.0 107.42 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -124.75 129.81 51.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.906 1.282 . . . . 0.0 108.287 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.455 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -95.23 177.1 5.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.042 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 t -159.62 -173.56 4.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.399 1.88 . . . . 0.0 106.247 168.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -36.89 -36.58 0.12 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 129.599 3.159 . . . . 0.0 116.447 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -133.41 -29.87 1.35 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 111.438 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 m -60.46 -22.26 63.28 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.353 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -51.26 -54.02 29.95 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.18 0.9 . . . . 0.0 109.407 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -61.45 -44.08 97.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.045 -0.409 . . . . 0.0 110.033 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -36.46 81.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.999 -0.091 . . . . 0.0 111.204 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -80.13 -14.31 58.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.335 1.054 . . . . 0.0 113.252 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.2 p -117.79 -4.0 11.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.651 1.114 . . . . 0.0 112.907 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -72.85 -8.84 57.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.07 153.99 44.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.338 1.055 . . . . 0.0 109.246 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.67 -160.55 49.7 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.404 1.002 . . . . 0.0 111.532 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 t -113.96 129.15 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.19 122.2 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.151 -168.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -92.39 100.84 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 108.185 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.33 149.73 25.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.09 150.8 44.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.411 1.485 . . . . 0.0 109.284 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -132.84 113.04 12.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.4 p-90 -132.79 153.28 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.126 1.771 . . . . 0.0 107.416 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.81 165.04 7.27 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 119.146 0.885 . . . . 0.0 111.122 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.66 -18.08 8.09 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.147 3.231 . . . . 0.0 116.285 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -58.22 -19.65 35.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.798 1.181 . . . . 0.0 114.088 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.0 161.57 39.07 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.76 1.163 . . . . 0.0 113.814 -169.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.06 21.91 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.794 -1.559 . . . . 0.0 112.777 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.56 -27.33 18.89 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.326 2.684 . . . . 0.0 114.94 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -58.51 -18.36 28.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 113.839 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -113.48 11.57 18.44 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.524 1.13 . . . . 0.0 111.697 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mtm -121.35 -43.67 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.099 0.96 . . . . 0.0 109.467 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.1 -36.03 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.445 0.698 . . . . 0.0 109.272 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.37 -57.91 21.74 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.979 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -60.27 -39.56 66.78 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.962 1.775 . . . . 0.0 111.676 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG12 HD22 ' A' ' 96' ' ' LEU . 2.2 t -56.45 -36.78 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.27 1.028 . . . . 0.0 111.178 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.1 mt -72.36 -41.58 66.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.699 0.681 . . . . 0.0 110.687 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.84 -35.01 79.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.999 0.818 . . . . 0.0 109.848 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.16 -28.7 68.34 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.773 1.229 . . . . 0.0 112.06 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD11 ' SD ' ' A' ' 46' ' ' MET . 47.9 tp -76.41 -46.27 27.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.193 0.597 . . . . 0.0 110.282 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.38 -36.25 71.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.123 0.419 . . . . 0.0 110.759 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -68.42 -9.2 46.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.133 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.08 -51.96 3.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.168 0.987 . . . . 0.0 110.742 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.407 ' SD ' HD11 ' A' ' 42' ' ' LEU . 19.7 ptm -127.56 14.7 7.07 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.835 0.854 . . . . 0.0 112.238 -170.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.87 -6.44 12.22 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.082 -1.011 . . . . 0.0 114.209 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.37 -23.22 67.22 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.829 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.06 -15.08 8.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.688 1.195 . . . . 0.0 112.515 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 tp -127.95 149.8 50.17 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.749 1.22 . . . . 0.0 112.139 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -114.34 147.53 38.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.85 141.82 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 10.0 t -139.21 113.1 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpt -87.48 155.0 20.2 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.284 -0.885 . . . . 0.0 110.184 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -124.52 127.27 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 171.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -83.05 104.99 13.67 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.334 27.5 m -77.98 48.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -153.54 -42.71 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.481 1.513 . . . . 0.0 108.677 167.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.78 -42.62 19.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.688 0.676 . . . . 0.0 110.767 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -134.59 38.08 3.08 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.42 1.088 . . . . 0.0 111.053 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -69.25 -4.93 19.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.887 1.275 . . . . 0.0 113.147 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.74 -47.16 70.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.982 1.713 . . . . 0.0 111.049 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.3 m -58.81 -40.97 85.71 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.618 0.645 . . . . 0.0 111.061 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.87 -55.28 13.49 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.7 -45.26 39.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.934 0.778 . . . . 0.0 113.213 169.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.73 -41.39 95.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.226 1.013 . . . . 0.0 111.036 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -80.62 -5.45 56.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.151 0.981 . . . . 0.0 112.707 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.34 60.38 5.55 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.44 -64.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.46 ' CE ' HD13 ' B' ' 72' ' ' LEU . 10.5 mtm 58.89 5.14 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.389 2.676 . . . . 0.0 115.242 173.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.4 p -143.38 159.55 42.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.811 1.187 . . . . 0.0 112.921 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 141.54 41.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.79 151.33 71.78 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 N-CA-C 106.942 -1.984 . . . . 0.0 106.942 -11.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.7 m -123.99 147.01 48.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -122.99 138.17 54.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.188 1.795 . . . . 0.0 106.64 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.34 107.81 12.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.61 128.46 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.58 151.24 43.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.58 0.752 . . . . 0.0 109.496 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -137.73 135.92 36.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.0 t70 43.8 29.98 0.34 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.705 2.002 . . . . 0.0 114.432 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.59 15.74 42.24 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.548 1.071 . . . . 0.0 115.758 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -130.45 144.67 51.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.521 1.16 . . . . 0.0 110.115 172.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.11 134.45 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.94 -22.99 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.699 1.199 . . . . 0.0 110.091 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.17 165.69 28.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.967 0.907 . . . . 0.0 110.329 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 149.33 29.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.8 m -153.51 139.39 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 169.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.04 67.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -171.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.37 156.56 9.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.873 1.702 . . . . 0.0 109.596 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.9 148.22 51.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.157 0.583 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.66 142.11 27.47 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -70.07 166.34 28.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.355 2.036 . . . . 0.0 110.703 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -46.58 -47.05 19.88 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.494 1.918 . . . . 0.0 112.495 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.5 -43.29 77.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.931 0.787 . . . . 0.0 111.055 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.89 76.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.779 -0.575 . . . . 0.0 110.4 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.614 HD22 HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -58.04 -53.32 59.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.264 1.026 . . . . 0.0 109.707 173.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.05 -38.18 85.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.572 -174.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.03 -46.66 88.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.981 0.81 . . . . 0.0 111.146 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -58.09 -38.68 76.87 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.887 1.275 . . . . 0.0 111.682 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 p -88.74 -40.54 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.509 -0.281 . . . . 0.0 111.079 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -57.72 -32.83 67.8 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.406 1.082 . . . . 0.0 111.854 -176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -69.46 -5.96 27.28 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -126.63 -27.39 3.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.015 1.326 . . . . 0.0 112.581 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.247 0.952 0 C-N-CA 126.155 1.782 . . . . 0.0 107.539 169.92 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.63 19.43 2.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.162 0.985 . . . . 0.0 112.575 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -157.46 129.68 7.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -153.48 148.86 27.11 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 129.041 2.936 . . . . 0.0 104.649 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.35 146.38 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.28 144.29 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.59 141.38 49.66 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -116.47 145.46 43.28 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 mt -121.05 114.29 21.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 m -136.87 136.37 38.65 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.6 m -52.36 119.48 4.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.711 0.804 . . . . 0.0 109.344 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.25 0.29 5.67 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.724 1.631 . . . . 0.0 115.091 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.2 t30 44.1 26.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.919 2.088 . . . . 0.0 113.328 -169.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.8 m -68.43 -42.93 78.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.67 -61.85 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -54.97 -46.35 75.05 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 120.718 1.599 . . . . 0.0 111.48 -174.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.4 p -51.58 -49.55 61.88 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.9 1.68 . . . . 0.0 112.115 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.28 -46.78 85.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.099 0.96 . . . . 0.0 110.532 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 30.5 ttm -63.02 -45.22 93.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.41 90.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.085 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -27.52 58.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.424 1.465 . . . . 0.0 110.441 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.98 -50.99 42.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.01 -39.63 72.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.638 0.775 . . . . 0.0 111.41 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.37 -52.98 62.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -64.77 -23.19 67.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.8 -14.18 61.46 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -126.7 -16.67 5.19 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.609 1.163 . . . . 0.0 113.31 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -121.84 77.68 1.39 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.34 -161.3 1.01 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.685 1.612 . . . . 0.0 113.09 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.81 -20.83 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.438 -1.036 . . . . 0.0 113.18 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -58.73 -16.3 15.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.506 1.922 . . . . 0.0 112.889 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -128.29 156.95 42.21 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.406 1.882 . . . . 0.0 109.045 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -125.54 143.09 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.34 137.19 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.61 158.12 44.23 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.132 1.373 . . . . 0.0 108.222 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 77.3 p -147.18 150.2 34.45 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.75 172.84 17.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.067 0.947 . . . . 0.0 111.768 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.79 -172.27 35.43 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.266 0.936 . . . . 0.0 111.818 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 tt -53.88 -57.6 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 113.62 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.02 28.41 4.16 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.205 1.802 . . . . 0.0 108.002 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.83 148.18 40.22 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.896 2.078 . . . . 0.0 112.066 -170.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 145.16 66.22 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 131.568 3.947 . . . . 0.0 104.371 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.12 152.09 23.26 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -139.81 100.7 4.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -71.52 128.44 89.91 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -59.73 -21.86 65.11 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.028 1.819 . . . . 0.0 112.813 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -36.01 80.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.701 1.137 . . . . 0.0 111.293 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.56 -38.55 67.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.83 -51.62 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -59.05 -42.65 90.79 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.353 0.661 . . . . 0.0 110.727 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.51 -32.06 57.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.127 0.971 . . . . 0.0 112.18 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 65.2 mmm -84.77 -34.67 22.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.176 0.898 . . . . 0.0 111.276 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -62.53 -24.05 67.3 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.163 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.0 -31.67 63.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.858 1.208 . . . . 0.0 111.673 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.66 15.11 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.196 1.398 . . . . 0.0 111.2 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.74 41.42 98.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.598 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.09 146.4 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -119.26 135.13 54.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.089 0.556 . . . . 0.0 109.967 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.62 25.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 126.969 2.108 . . . . 0.0 109.713 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.8 m -68.09 14.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.518 -1.364 . . . . 0.0 113.403 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.2 23.96 0.93 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.321 1.848 . . . . 0.0 112.251 -169.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -47.46 150.17 0.99 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.82 1.645 . . . . 0.0 114.013 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -128.32 41.17 3.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.851 2.06 . . . . 0.0 110.437 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 12.7 m -59.83 172.33 0.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.04 1.336 . . . . 0.0 113.375 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -166.22 168.2 15.45 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.392 1.477 . . . . 0.0 109.78 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.2 pt -65.37 170.69 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.032 1.333 . . . . 0.0 112.348 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -48.95 132.21 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.329 0.652 . . . . 0.0 109.241 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -138.26 95.96 3.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.915 1.34 . . . . 0.0 108.263 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -44.69 -31.18 1.09 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.741 2.017 . . . . 0.0 114.673 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.64 -22.77 62.47 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-N 119.298 0.954 . . . . 0.0 110.636 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -39.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.457 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.46 HD13 ' CE ' ' A' ' 70' ' ' MET . 7.5 tt -60.89 -50.92 71.48 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.616 1.098 . . . . 0.0 110.145 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -29.17 69.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.546 0.612 . . . . 0.0 111.353 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -85.31 -11.35 54.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.192 1.397 . . . . 0.0 112.743 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 171.12 5.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.742 0.782 . . . . 0.0 110.683 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -105.28 -12.62 15.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.171 0.989 . . . . 0.0 111.58 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.17 145.59 24.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.398 1.079 . . . . 0.0 109.252 173.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.64 99.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.4 102.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -65.39 119.56 11.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tp -135.31 53.29 1.98 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.627 0.771 . . . . 0.0 111.592 -167.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 92.0 p -166.25 175.74 8.08 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.18 7.93 2.38 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.505 174.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.61 -19.85 63.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.93 1.365 . . . . 0.0 110.663 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . 53.92 43.64 30.57 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.746 2.018 . . . . 0.0 112.825 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -116.96 11.08 14.23 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.725 0.81 . . . . 0.0 110.43 170.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.43 20.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.328 2.651 . . . . 0.0 116.117 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 68.64 27.85 5.88 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.3 1.84 . . . . 0.0 112.859 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 33.96 48.32 0.56 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.085 2.154 . . . . 0.0 112.789 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.87 136.05 70.54 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.872 2.381 . . . . 0.0 112.451 -168.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.439 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.62 -1.37 50.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 116.71 -1.614 . . . . 0.0 114.852 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p 46.07 86.63 0.13 Allowed Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.374 1.47 . . . . 0.0 112.879 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -58.36 143.94 96.89 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.461 2.107 . . . . 0.0 110.112 -169.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.9 5.53 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 125.072 3.848 . . . . 0.0 116.212 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -63.95 -12.18 35.14 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 112.29 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.63 154.25 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 0.988 . . . . 0.0 111.375 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -74.33 156.25 37.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.488 1.915 . . . . 0.0 109.834 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.74 144.56 30.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.719 -1.238 . . . . 0.0 108.09 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.44 147.3 27.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -87.26 133.68 33.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.576 1.15 . . . . 0.0 109.658 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -140.32 25.01 2.27 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.704 1.601 . . . . 0.0 110.327 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.68 155.62 26.48 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -157.36 19.91 0.29 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.532 1.933 . . . . 0.0 109.05 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -170.24 175.55 4.87 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 129.257 3.023 . . . . 0.0 105.719 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -161.32 138.39 6.54 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 168.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.44 -17.43 21.09 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.743 . . . . 0.0 112.306 -170.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.93 6.62 1.15 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.681 1.128 . . . . 0.0 110.769 168.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -122.0 12.73 10.46 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 110.501 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.44 158.18 0.44 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -34.65 72.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.828 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.07 -15.1 6.53 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 115.759 1.064 . . . . 0.0 115.759 168.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.5 p -70.33 162.7 28.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.51 -40.11 95.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.515 0.674 . . . . 0.0 110.558 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.84 -42.79 85.18 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.09 -1.433 . . . . 0.0 109.087 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -73.99 -33.16 63.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.928 1.694 . . . . 0.0 109.73 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -56.54 -56.77 17.08 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 119.119 0.872 . . . . 0.0 110.721 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -64.27 -39.78 94.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.758 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.59 98.07 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.29 -0.881 . . . . 0.0 111.996 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.84 -51.54 61.52 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.285 1.3 p90 -70.12 -30.91 68.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 117.546 -1.216 . . . . 0.0 112.542 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -72.58 -41.65 65.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 120.268 1.395 . . . . 0.0 111.004 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -59.52 -54.1 50.48 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.108 0.963 . . . . 0.0 109.302 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.33 -39.42 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.449 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.413 ' HA ' ' SD ' ' B' ' 19' ' ' MET . 5.4 tmm_? -56.92 -45.36 82.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.339 1.427 . . . . 0.0 112.08 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.09 -45.48 94.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.076 0.398 . . . . 0.0 110.65 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.2 -41.58 73.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.713 0.233 . . . . 0.0 111.281 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -60.22 -47.84 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.337 -0.852 . . . . 0.0 109.275 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.76 97.04 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.934 0.788 . . . . 0.0 111.239 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -59.52 -50.83 72.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.379 1.089 . . . . 0.0 111.98 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -69.76 -33.14 72.01 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.506 -0.746 . . . . 0.0 111.448 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.1 mm? -69.1 -36.48 77.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.249 0.931 . . . . 0.0 111.023 175.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -57.05 -41.15 78.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.168 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.46 -36.41 75.91 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 116.487 -1.72 . . . . 0.0 112.375 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -64.97 -37.32 87.26 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 122.437 2.381 . . . . 0.0 111.111 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.74 70.8 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -91.85 -38.86 12.07 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 112.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 63.5 p -101.62 -19.27 15.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.335 1.854 . . . . 0.0 110.979 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.42 32.44 64.3 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.835 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 124.083 0.953 . . . . 0.0 111.499 -174.377 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.42 152.9 4.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.637 1.175 . . . . 0.0 109.924 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.23 95.46 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 168.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.06 167.16 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.338 1.455 . . . . 0.0 107.336 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -126.96 117.84 23.32 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -79.02 176.76 9.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.112 1.365 . . . . 0.0 110.264 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -154.77 -173.2 4.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.884 2.074 . . . . 0.0 106.048 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -39.55 -33.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.872 3.269 . . . . 0.0 116.511 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -133.52 -21.88 1.97 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.951 1.3 . . . . 0.0 112.234 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -38.39 75.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.136 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -71.03 123.88 23.09 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.7 m 116.83 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 1 C-N-CA 131.772 4.029 . . . . 0.0 105.471 -169.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.07 99.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.0 110.578 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -79.65 -8.77 59.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.473 1.509 . . . . 0.0 112.163 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 p -124.25 -2.09 8.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.44 1.018 . . . . 0.0 113.429 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.6 m -72.19 -10.61 60.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.81 155.75 45.57 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.792 0.724 . . . . 0.0 110.432 -172.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.86 -158.2 51.77 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 124.223 0.916 . . . . 0.0 110.999 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.66 124.22 71.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.05 115.7 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.156 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.7 tp -87.69 92.89 9.27 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 148.04 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -142.75 149.99 39.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -132.29 110.83 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.582 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.0 p-90 -131.08 152.73 50.07 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.806 1.643 . . . . 0.0 107.477 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.69 162.4 8.32 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 118.882 0.765 . . . . 0.0 110.297 169.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.88 -14.88 6.27 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.916 3.078 . . . . 0.0 115.993 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -61.49 -27.48 68.62 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.83 1.195 . . . . 0.0 113.663 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.66 154.95 47.64 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.448 1.022 . . . . 0.0 112.162 -169.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.93 -49.07 79.25 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 117.955 -1.469 . . . . 0.0 113.729 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.99 -24.71 25.65 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.035 2.49 . . . . 0.0 115.323 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 m -59.15 -21.25 59.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 120.249 1.386 . . . . 0.0 113.502 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.07 7.96 34.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.952 0.901 . . . . 0.0 111.89 174.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.1 mtm -118.59 -44.9 2.63 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.273 0.942 . . . . 0.0 109.562 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.11 -34.59 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.587 0.755 . . . . 0.0 109.301 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.4 ' HB3' ' CD ' ' A' ' 37' ' ' PRO . . . -54.84 -61.54 5.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.15 0.98 . . . . 0.0 112.243 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 36' ' ' ALA . 6.8 Cg_endo -60.06 -39.91 65.81 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.077 1.852 . . . . 0.0 111.84 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.26 -44.81 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.677 0.791 . . . . 0.0 110.429 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.39 -44.75 90.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.207 0.458 . . . . 0.0 110.094 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.17 -36.56 82.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.066 0.394 . . . . 0.0 110.441 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.19 -32.68 73.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.643 1.177 . . . . 0.0 111.908 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -72.78 -45.71 57.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.218 1.407 . . . . 0.0 109.889 175.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.82 -36.33 72.88 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.389 -0.82 . . . . 0.0 111.312 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.99 -6.65 29.09 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.129 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -104.86 -47.09 4.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.974 1.31 . . . . 0.0 111.585 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.4 ptm -134.58 18.19 3.6 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.402 0.681 . . . . 0.0 112.09 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 -6.77 24.02 Favored Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.871 -1.143 . . . . 0.0 113.82 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.74 -23.88 67.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.44 0.62 . . . . 0.0 110.807 169.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 -24.61 7.88 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.937 1.295 . . . . 0.0 111.59 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 tp -110.28 152.14 26.52 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 111.838 -169.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.73 148.48 49.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.94 144.05 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 11.0 t -138.25 111.19 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.582 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 33.1 mtpt -84.53 159.39 20.71 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.543 -0.723 . . . . 0.0 109.239 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.22 122.69 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 170.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.89 107.35 10.36 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 32.7 m -79.14 48.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.88 -45.52 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.461 1.505 . . . . 0.0 108.456 167.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.27 -36.39 34.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.984 0.914 . . . . 0.0 110.934 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -133.19 29.24 4.04 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 0.0 110.604 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -72.43 -5.99 40.48 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -54.15 -47.62 71.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.638 1.575 . . . . 0.0 110.902 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.2 m -56.11 -40.89 74.41 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.598 0.759 . . . . 0.0 111.367 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.76 -57.23 4.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.22 -42.46 41.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.836 0.732 . . . . 0.0 113.561 169.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -62.81 -43.39 98.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.364 1.082 . . . . 0.0 110.834 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -71.46 -31.61 67.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.077 0.399 . . . . 0.0 110.325 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.12 68.7 1.18 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 -170.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.68 -66.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.423 ' CE ' HD13 ' B' ' 72' ' ' LEU . 7.8 mtm 58.45 7.16 0.66 Allowed 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 127.472 2.309 . . . . 0.0 114.801 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -143.99 160.98 39.9 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.273 1.397 . . . . 0.0 112.991 -169.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 138.56 32.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 109.649 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.17 138.44 33.68 Favored 'Cis proline' 0 N--CA 1.449 -1.104 0 N-CA-C 105.866 -2.398 . . . . 0.0 105.866 -11.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -107.81 150.44 27.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 tp -141.36 123.23 15.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -170.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.0 mt -121.21 105.35 10.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.31 108.59 15.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.33 149.52 23.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -146.57 130.43 17.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.98 30.76 0.44 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.489 1.916 . . . . 0.0 113.329 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.06 8.66 55.13 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 171.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -133.31 151.61 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.765 1.226 . . . . 0.0 110.521 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -70.97 132.72 32.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.44 -23.01 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.981 1.313 . . . . 0.0 110.729 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -146.58 160.57 41.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.523 1.129 . . . . 0.0 109.769 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 148.53 30.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -152.08 149.52 28.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.36 -0.837 . . . . 0.0 108.905 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.75 62.76 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.03 154.12 9.43 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.973 1.273 . . . . 0.0 110.714 -170.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.31 162.9 9.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.426 1.491 . . . . 0.0 112.087 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.33 139.26 10.75 Favored Pre-proline 0 N--CA 1.469 0.486 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -69.43 171.35 14.26 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 111.012 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -38.69 -55.69 1.43 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.469 2.307 . . . . 0.0 111.924 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.88 -42.41 63.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.496 -173.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.68 78.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.849 -0.532 . . . . 0.0 110.992 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.86 -47.51 58.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.507 0.323 . . . . 0.0 110.283 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB2' HD13 ' A' ' 42' ' ' LEU . 7.9 pt20 -63.26 -35.72 81.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.38 -47.53 78.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.173 0.442 . . . . 0.0 110.713 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.72 -38.17 71.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.573 0.749 . . . . 0.0 111.587 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.33 -38.66 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.404 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.22 -25.75 64.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.363 0.983 . . . . 0.0 112.56 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -55.09 -26.08 35.65 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.675 0.79 . . . . 0.0 112.614 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.25 -28.42 3.69 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.438 1.095 . . . . 0.0 111.973 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.328 1.851 . . . . 0.0 108.19 174.453 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.43 22.12 1.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.899 0.88 . . . . 0.0 112.399 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.2 127.74 6.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -146.42 142.28 28.0 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 129.523 3.129 . . . . 0.0 105.273 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -125.4 142.6 41.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 109.0 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.1 151.05 31.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.836 1.254 . . . . 0.0 107.682 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -132.87 151.65 51.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.979 1.311 . . . . 0.0 108.26 -169.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -126.84 147.44 50.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.926 0.89 . . . . 0.0 109.212 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.57 130.41 38.37 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.774 0.83 . . . . 0.0 109.428 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -145.44 149.69 35.16 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.434 1.494 . . . . 0.0 110.351 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -59.63 130.17 45.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.79 37.18 8.96 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.025 1.774 . . . . 0.0 112.85 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -39.87 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.235 1.814 . . . . 0.0 114.961 -168.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.1 m -139.24 4.19 2.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.403 1.081 . . . . 0.0 111.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.88 -49.18 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -59.26 -57.22 13.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.831 1.651 . . . . 0.0 112.047 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -75.42 -26.15 58.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.287 0.949 . . . . 0.0 110.965 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -51.29 -49.66 60.82 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.805 1.642 . . . . 0.0 109.676 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.2 ttm -69.12 -45.2 70.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.659 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.38 90.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.879 0.871 . . . . 0.0 111.946 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -73.94 -33.27 63.86 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.175 0.898 . . . . 0.0 110.798 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.31 70.75 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -59.38 -40.89 87.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.715 0.806 . . . . 0.0 111.601 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.88 71.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -64.26 -24.81 67.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.07 -13.08 62.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -126.82 -8.47 6.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.82 1.248 . . . . 0.0 112.906 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -133.33 81.84 1.95 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -171.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 -161.88 2.14 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.442 1.496 . . . . 0.0 113.07 -171.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.23 -21.14 31.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.729 1.211 . . . . 0.0 113.373 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.14 -14.2 6.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.604 1.962 . . . . 0.0 113.008 169.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -136.48 158.17 45.06 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.094 1.758 . . . . 0.0 109.081 -174.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -132.68 151.38 51.98 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.5 t -135.41 142.9 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -145.32 161.6 39.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.332 0.653 . . . . 0.0 109.911 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.3 m -137.63 145.47 42.76 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.342 1.457 . . . . 0.0 109.165 -169.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.85 164.32 38.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.684 0.754 . . . . 0.0 112.179 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.43 -177.23 46.14 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.333 1.921 . . . . 0.0 108.875 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -57.19 -56.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.577 1.151 . . . . 0.0 112.813 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -132.17 23.76 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.76 2.024 . . . . 0.0 108.005 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.82 118.61 6.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.229 2.212 . . . . 0.0 111.01 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -161.7 -0.17 0.05 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.04 0.536 . . . . 0.0 111.626 169.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.86 168.63 51.25 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -144.71 77.12 1.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.51 131.5 90.67 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -172.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.63 -21.68 48.23 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.968 1.779 . . . . 0.0 112.755 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -37.38 83.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.863 1.211 . . . . 0.0 111.817 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.63 -38.09 65.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 119.099 0.863 . . . . 0.0 109.927 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.56 -51.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.12 -42.55 90.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.989 0.916 . . . . 0.0 110.679 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.78 -30.71 61.74 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.754 0.822 . . . . 0.0 112.304 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.1 mmm -86.41 -33.74 20.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.003 0.819 . . . . 0.0 111.134 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -62.19 -25.59 67.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.187 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -56.51 -30.16 62.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.918 1.236 . . . . 0.0 111.516 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 m -117.27 15.11 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.242 1.417 . . . . 0.0 111.195 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.6 39.95 97.18 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.946 -0.919 . . . . 0.0 112.879 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -115.38 126.99 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -87.15 134.56 33.51 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.917 -0.489 . . . . 0.0 109.752 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -131.51 14.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.288 0.635 . . . . 0.0 111.246 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -59.45 -20.14 52.93 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.171 0.896 . . . . 0.0 110.949 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -76.27 -11.28 59.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.4 2.28 . . . . 0.0 114.116 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -63.83 165.07 9.1 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.368 1.44 . . . . 0.0 113.164 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.2 p -128.44 -37.15 1.83 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.765 1.626 . . . . 0.0 112.08 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.2 m 64.51 162.03 0.12 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.759 2.023 . . . . 0.0 112.803 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -165.52 160.5 17.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.611 1.164 . . . . 0.0 110.212 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -78.14 178.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.731 2.012 . . . . 0.0 111.27 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.12 134.88 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -145.23 103.39 3.84 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.778 1.231 . . . . 0.0 108.283 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -48.26 -30.33 4.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.341 1.856 . . . . 0.0 113.748 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.61 -21.78 66.54 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.068 0.849 . . . . 0.0 111.716 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -118.7 -36.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 117.792 -1.099 . . . . 0.0 108.931 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.423 HD13 ' CE ' ' A' ' 70' ' ' MET . 6.3 tt -60.01 -51.38 69.89 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.876 1.217 . . . . 0.0 109.059 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.63 -27.59 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.07 0.85 . . . . 0.0 111.622 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -85.72 -18.48 32.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.519 1.128 . . . . 0.0 112.444 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.12 160.22 6.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.233 1.016 . . . . 0.0 111.235 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.9 -33.49 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.638 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.595 HD13 ' HD2' ' B' ' 97' ' ' LYS . 13.4 tp -146.69 139.3 25.1 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.225 1.41 . . . . 0.0 109.399 -171.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.77 107.58 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.875 1.67 . . . . 0.0 106.734 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.69 100.78 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -75.6 102.41 5.29 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 101.209 -3.626 . . . . 0.0 101.209 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -116.64 11.19 14.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -166.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m -136.41 -75.38 0.43 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.355 0.979 . . . . 0.0 112.217 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 173.78 164.6 29.18 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -119.4 23.51 11.2 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.815 1.646 . . . . 0.0 111.278 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.26 68.68 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.152 0.981 . . . . 0.0 112.6 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.55 4.09 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 176.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.62 9.72 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -172.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.3 0.3 OUTLIER 50.78 31.0 5.49 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.85 2.06 . . . . 0.0 114.641 -169.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.5 m 38.69 52.8 3.77 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 128.057 2.543 . . . . 0.0 113.926 170.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.21 131.11 41.52 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.029 2.486 . . . . 0.0 111.576 -169.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.411 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.5 2.12 34.42 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -174.444 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p 45.72 88.3 0.1 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.622 1.569 . . . . 0.0 113.244 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -56.02 141.18 86.94 Favored 'Trans proline' 0 CA--C 1.55 1.323 0 C-N-CA 122.549 2.166 . . . . 0.0 110.263 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.23 -2.51 3.17 Favored 'Trans proline' 0 C--N 1.351 0.663 1 C-N-CA 125.38 4.053 . . . . 0.0 116.961 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -65.7 -9.81 31.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.175 0.898 . . . . 0.0 111.506 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.81 144.39 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.828 1.251 . . . . 0.0 109.844 -169.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.595 ' HD2' HD13 ' B' ' 77' ' ' LEU . 0.7 OUTLIER -76.6 156.61 32.6 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.742 0.817 . . . . 0.0 108.94 171.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -145.08 143.62 30.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -137.21 139.83 41.31 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -89.93 135.13 33.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.673 1.189 . . . . 0.0 108.787 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -140.08 14.47 2.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.95 1.7 . . . . 0.0 110.323 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.34 167.1 54.43 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 123.941 0.781 . . . . 0.0 113.328 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -164.04 -43.11 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.137 1.775 . . . . 0.0 109.469 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -165.21 175.31 9.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.688 1.995 . . . . 0.0 109.798 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -139.26 137.87 19.83 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.26 -18.02 16.43 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.266 1.977 . . . . 0.0 113.078 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.96 6.98 1.78 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.002 1.273 . . . . 0.0 110.226 168.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -118.7 10.68 12.52 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.339 1.455 . . . . 0.0 110.901 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.84 156.76 0.91 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.314 0.646 . . . . 0.0 110.119 171.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -35.8 73.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.512 -172.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.1 -21.32 3.92 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -69.76 166.75 18.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.13 -42.47 99.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.441 0.639 . . . . 0.0 110.292 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.7 pt-20 -68.83 -43.03 76.38 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 117.072 -1.442 . . . . 0.0 109.32 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.2 -34.91 61.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 121.034 1.743 . . . . 0.0 109.827 -173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -55.84 -56.62 18.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.631 0.651 . . . . 0.0 110.763 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -64.56 -39.78 94.38 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.853 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.95 92.46 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.896 0.878 . . . . 0.0 111.665 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -63.31 -51.74 64.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.288 2.2 p90 -70.77 -25.81 63.06 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.0 -172.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -65.61 -51.53 58.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.706 1.139 . . . . 0.0 109.746 172.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -57.27 -51.34 69.76 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.32 -49.02 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 118.333 -0.842 . . . . 0.0 109.485 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -56.52 -48.29 77.53 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 111.85 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.78 -43.44 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.326 0.391 . . . . 0.0 110.965 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -66.41 -49.96 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -48.5 79.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.806 1.243 . . . . 0.0 109.991 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.72 -42.45 95.27 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -61.37 -44.51 97.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.799 0.8 . . . . 0.0 112.025 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -69.97 -36.85 75.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.084 0.856 . . . . 0.0 111.759 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.1 mm? -74.56 -33.54 62.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.553 1.07 . . . . 0.0 111.38 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.28 -43.96 96.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.784 0.72 . . . . 0.0 109.201 170.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.33 -39.05 81.92 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.595 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.66 -42.61 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 122.476 2.398 . . . . 0.0 110.222 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.38 72.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.07 -37.83 18.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.825 1.25 . . . . 0.0 112.959 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.2 p -101.14 -20.09 15.47 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.801 1.64 . . . . 0.0 111.613 -169.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.37 50.01 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.75 0.691 . . . . 0.0 111.51 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 C-N-CA 128.229 2.612 . . . . 0.0 112.681 -169.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.25 160.93 0.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.645 2.378 . . . . 0.0 112.882 -169.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.52 102.84 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -73.09 166.73 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.772 1.629 . . . . 0.0 108.258 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.81 133.9 46.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.23 176.04 5.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.859 1.264 . . . . 0.0 110.189 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.0 p -137.98 -170.73 2.85 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.101 1.761 . . . . 0.0 109.232 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -44.46 -30.37 0.85 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.88 2.472 . . . . 0.0 113.9 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -138.45 -22.82 1.0 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.481 1.112 . . . . 0.0 112.959 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 m -59.03 -36.06 74.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -71.75 122.72 21.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m 117.71 -60.93 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.707 1 C-N-CA 131.977 4.111 . . . . 0.0 106.065 -169.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.2 95.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.424 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -81.68 -9.24 59.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.612 1.565 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.1 p -122.77 -6.59 8.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -168.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -79.98 -1.48 39.8 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -140.39 147.61 40.01 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.238 0.926 . . . . 0.0 109.787 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.56 -174.63 31.37 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.332 0.968 . . . . 0.0 111.659 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.31 129.97 45.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.06 119.51 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.123 0.969 . . . . 0.0 109.009 -168.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.8 107.53 18.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.73 27.82 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.477 1.035 . . . . 0.0 108.282 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -135.7 152.45 51.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.866 1.667 . . . . 0.0 108.84 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -132.22 114.2 14.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.597 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.3 p-90 -135.58 153.07 51.8 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.034 1.733 . . . . 0.0 108.191 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.51 163.33 7.06 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 119.262 0.937 . . . . 0.0 109.183 169.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.86 -16.86 9.41 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.486 2.791 . . . . 0.0 116.384 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -57.67 -27.43 62.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.79 159.49 41.7 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.633 1.106 . . . . 0.0 112.494 -169.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.73 -48.65 75.1 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.039 -1.423 . . . . 0.0 112.677 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.68 -30.69 17.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.657 2.904 . . . . 0.0 115.461 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.71 -25.47 62.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 120.247 1.385 . . . . 0.0 112.924 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -103.89 10.06 36.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.27 1.028 . . . . 0.0 111.708 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.4 mtm -120.78 -44.36 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.192 0.997 . . . . 0.0 109.481 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.44 -34.94 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 0.0 109.254 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.16 6.98 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.183 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.82 -40.16 74.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.009 1.806 . . . . 0.0 111.671 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.97 -42.01 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.007 0.523 . . . . 0.0 110.548 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.26 -40.12 71.17 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.499 0.59 . . . . 0.0 110.812 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.32 -35.32 80.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.275 0.943 . . . . 0.0 109.723 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.8 -25.32 63.72 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.405 1.482 . . . . 0.0 112.363 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.427 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 48.3 tp -79.42 -44.48 21.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 109.637 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.5 -37.48 74.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.723 0.297 . . . . 0.0 110.793 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -68.64 -10.04 53.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.275 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -101.89 -48.18 4.35 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.148 0.979 . . . . 0.0 111.149 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -134.14 15.41 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.419 0.688 . . . . 0.0 112.331 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.95 -2.88 26.3 Favored Glycine 0 CA--C 1.52 0.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.912 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.5 -24.8 64.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.202 1.001 . . . . 0.0 110.808 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -23.01 9.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.164 0.986 . . . . 0.0 112.061 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.57 147.54 46.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.593 1.157 . . . . 0.0 111.57 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -107.42 143.88 35.12 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.7 mt -128.14 139.23 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.84 141.86 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 125.722 1.609 . . . . 0.0 106.672 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.597 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.2 mtpp -113.41 159.52 19.37 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.262 0.625 . . . . 0.0 109.576 173.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.56 121.16 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 170.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.2 106.2 6.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 33.0 m -78.66 50.19 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -155.7 -45.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.491 1.516 . . . . 0.0 108.291 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.04 -36.71 35.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 110.869 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -134.08 28.67 3.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 111.019 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -71.77 -6.27 40.18 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.653 0.781 . . . . 0.0 112.735 -171.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -53.74 -49.3 68.46 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.009 1.724 . . . . 0.0 110.708 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -60.04 -34.67 73.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.387 0.675 . . . . 0.0 111.677 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.06 -64.01 0.94 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.82 -45.84 7.45 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.802 0.715 . . . . 0.0 113.298 169.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.29 -43.15 96.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.124 0.962 . . . . 0.0 111.506 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -84.56 -4.98 59.26 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.639 0.776 . . . . 0.0 112.659 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.45 66.32 1.61 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.1 t -144.1 131.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.814 ' HG3' HD12 ' B' ' 67' ' ' ILE . 25.6 ptm -149.97 24.71 0.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -140.48 161.31 38.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.622 1.569 . . . . 0.0 112.727 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 136.17 28.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.572 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.11 145.42 41.32 Favored 'Cis proline' 0 N--CA 1.45 -1.052 0 N-CA-C 107.43 -1.796 . . . . 0.0 107.43 -11.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.2 m -113.81 145.23 41.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.1 133.06 54.77 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.2 mt -122.11 110.1 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -101.82 122.23 53.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.34 1.456 . . . . 0.0 108.547 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.51 130.31 20.38 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 43.13 31.1 0.33 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.609 2.364 . . . . 0.0 114.804 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.16 -19.15 5.77 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.988 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -136.43 149.49 48.28 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.24 1.52 . . . . 0.0 113.24 -168.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.58 138.83 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.81 -26.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.855 1.662 . . . . 0.0 109.418 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -144.07 157.51 44.28 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -154.6 133.45 12.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.98 -2.229 . . . . 0.0 104.98 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.3 t -155.17 148.79 25.3 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.5 t -138.75 82.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.24 160.01 10.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.435 1.017 . . . . 0.0 110.883 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -66.67 145.58 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.118 0.959 . . . . 0.0 111.118 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -135.91 138.92 29.01 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 124.724 1.21 . . . . 0.0 108.167 170.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.25 169.74 17.57 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.195 1.93 . . . . 0.0 109.946 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 18.1 tptm -46.03 -48.58 16.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.072 1.749 . . . . 0.0 112.41 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.68 -42.37 74.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 118.005 0.366 . . . . 0.0 111.132 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.67 85.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.134 0.425 . . . . 0.0 110.662 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.45 45.8 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.509 0.724 . . . . 0.0 109.305 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -65.32 -37.47 87.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.56 -47.27 86.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.63 0.65 . . . . 0.0 110.957 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.48 -40.07 77.77 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.417 0.687 . . . . 0.0 111.292 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -85.72 -41.61 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 123.064 0.228 . . . . 0.0 110.627 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -56.69 -27.35 58.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.751 1.221 . . . . 0.0 112.302 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -50.08 -32.68 16.28 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.974 1.31 . . . . 0.0 112.294 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -135.81 -8.48 2.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.249 1.041 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.164 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 52.3 48.31 22.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.894 1.677 . . . . 0.0 113.113 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 135.73 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.171 3.788 . . . . 0.0 109.151 169.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -150.66 158.48 44.2 Favored 'General case' 0 C--N 1.325 -0.491 1 C-N-CA 133.896 4.878 . . . . 0.0 103.905 169.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mt -122.61 142.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.657 1.117 . . . . 0.0 109.215 -169.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -143.44 146.94 20.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.33 1.452 . . . . 0.0 107.125 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.59 134.55 37.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.049 0.539 . . . . 0.0 109.835 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.58 143.09 26.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -132.51 111.11 10.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -140.05 143.18 36.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.174 0.99 . . . . 0.0 108.665 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -42.81 96.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.806 2.442 . . . . 0.0 112.681 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.39 36.64 89.91 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.637 -1.091 . . . . 0.0 111.185 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -2.34 103.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 129.764 3.226 . . . . 0.0 113.696 -169.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -122.51 -145.58 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.067 -2.333 . . . . 0.0 104.787 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . -38.4 -50.7 1.53 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -168.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.489 ' HE ' ' HG ' ' B' ' 81' ' ' LEU . 27.5 mtp85 -53.68 -51.15 64.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.784 1.175 . . . . 0.0 111.003 -172.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -43.31 73.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.144 -171.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -54.92 -49.66 70.74 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.098 0.959 . . . . 0.0 110.241 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 26.2 ttm -63.01 -44.26 96.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.484 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 117.765 -1.112 . . . . 0.0 112.491 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -64.92 -47.3 78.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.649 1.568 . . . . 0.0 109.636 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.75 -47.75 89.66 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.527 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -61.92 -42.62 99.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 117.375 0.587 . . . . 0.0 112.283 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.1 83.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -65.64 -26.96 68.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.206 -170.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -18.22 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.313 0.961 . . . . 0.0 113.285 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.443 ' CZ ' ' HE3' ' B' ' 132' ' ' LYS . 1.9 m-85 -119.05 -11.5 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 113.078 -175.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 39.0 mt -103.05 -125.46 0.2 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.78 -168.71 40.84 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.64 -16.1 60.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.556 1.143 . . . . 0.0 111.805 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -53.84 -25.55 20.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 111.268 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -130.3 158.65 39.2 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.713 1.205 . . . . 0.0 110.825 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -128.14 125.71 39.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 67.0 t -115.36 134.42 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 -169.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.1 168.94 18.64 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.463 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -146.6 150.73 36.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.943 0.897 . . . . 0.0 110.353 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 67' ' ' ILE . . . -151.39 166.4 31.15 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.126 1.37 . . . . 0.0 110.375 -177.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.29 -178.44 47.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.175 1.369 . . . . 0.0 110.333 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -52.76 -54.03 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.619 1.168 . . . . 0.0 113.739 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.01 27.88 4.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.581 1.953 . . . . 0.0 108.269 -169.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.74 140.65 49.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.195 1.798 . . . . 0.0 111.942 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 p80 158.43 56.99 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.334 3.054 . . . . 0.0 107.719 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.9 93.97 0.15 Allowed Glycine 0 C--N 1.336 0.574 0 O-C-N 121.219 -0.926 . . . . 0.0 111.404 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.0 tp -72.65 91.02 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -66.21 126.59 92.26 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.896 0.878 . . . . 0.0 109.774 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.75 -26.58 68.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.186 1.924 . . . . 0.0 113.266 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -20.04 65.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.151 1.341 . . . . 0.0 112.204 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -82.39 -38.2 24.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 110.147 174.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.51 -51.22 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.33 -38.49 83.93 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.808 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.67 65.19 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.722 0.692 . . . . 0.0 111.842 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 52.8 mmm -76.66 -35.38 58.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.22 0.918 . . . . 0.0 111.163 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -62.33 -24.53 67.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.389 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.47 -26.93 65.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.76 1.164 . . . . 0.0 111.721 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.5 m -120.28 15.01 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.196 1.398 . . . . 0.0 111.151 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.1 42.41 99.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.94 0.781 . . . . 0.0 112.598 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -115.11 155.67 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 172.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -124.14 140.93 52.49 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.789 0.836 . . . . 0.0 109.473 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 37.5 pt -138.23 22.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.671 1.588 . . . . 0.0 109.794 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -60.71 -15.53 30.04 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 120.641 -1.287 . . . . 0.0 111.881 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -63.15 -31.45 72.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.687 2.395 . . . . 0.0 114.172 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -62.45 158.14 18.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.587 1.155 . . . . 0.0 111.16 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.6 t -149.89 -30.65 0.22 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.628 0.771 . . . . 0.0 112.426 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p 56.52 173.74 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.847 2.059 . . . . 0.0 115.272 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -166.47 166.01 16.63 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.281 2.232 . . . . 0.0 107.997 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 31.2 pt -68.55 174.73 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.332 1.053 . . . . 0.0 111.366 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.814 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.2 OUTLIER -48.64 131.95 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -147.3 97.51 2.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.192 0.996 . . . . 0.0 108.886 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 9.7 m -50.73 -25.41 4.31 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.926 1.291 . . . . 0.0 114.021 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.71 -21.26 65.64 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.647 1.567 . . . . 0.0 112.098 -175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.55 -37.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tt -68.12 -41.84 81.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.821 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.37 66.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.678 1.126 . . . . 0.0 111.379 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -82.77 -13.52 56.12 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.145 0.978 . . . . 0.0 112.383 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.8 162.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.44 1.018 . . . . 0.0 111.449 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.68 -34.57 16.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.627 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' B' ' 97' ' ' LYS . 23.2 tp -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.091 1.356 . . . . 0.0 109.221 -171.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.49 104.1 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.19 99.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -65.43 121.55 15.13 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 169.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.489 ' HG ' ' HE ' ' B' ' 16' ' ' ARG . 4.4 tp -135.58 54.26 1.93 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.832 0.853 . . . . 0.0 111.14 -167.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -165.85 -168.64 1.33 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.846 2.059 . . . . 0.0 105.827 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.5 40.1 0.54 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 123.883 0.754 . . . . 0.0 111.379 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -133.7 127.97 34.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.915 0.857 . . . . 0.0 108.888 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.86 -5.42 25.68 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -169.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.15 -12.3 18.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.433 1.47 . . . . 0.0 112.731 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.21 16.07 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm 74.89 22.3 1.9 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.238 1.815 . . . . 0.0 112.194 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 29.03 57.17 0.66 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 128.149 2.58 . . . . 0.0 112.859 -173.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.04 133.4 51.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.617 2.211 . . . . 0.0 111.914 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.435 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.06 -4.65 57.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -174.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p 44.28 103.13 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 127.89 2.476 . . . . 0.0 113.858 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -63.56 145.02 91.43 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.461 1.441 . . . . 0.0 109.645 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.59 -4.54 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.119 3.213 . . . . 0.0 114.513 -170.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -61.3 -12.71 14.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.44 147.33 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.218 1.007 . . . . 0.0 110.524 -170.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.4 tmmm? -77.25 157.96 30.52 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 169.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -145.03 145.91 31.68 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.751 -1.218 . . . . 0.0 109.104 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.55 151.32 34.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -108.56 140.48 41.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.895 1.278 . . . . 0.0 110.64 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -144.24 22.61 1.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.724 1.21 . . . . 0.0 111.034 -170.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.94 25.45 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.161 0.886 . . . . 0.0 110.949 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -154.57 -30.4 0.11 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.95 1.7 . . . . 0.0 110.564 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.13 165.0 37.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.92 2.488 . . . . 0.0 107.364 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.12 139.29 20.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.301 1.441 . . . . 0.0 108.328 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.66 -17.86 9.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.355 2.036 . . . . 0.0 113.769 -169.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.01 -0.25 5.43 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.39 0.996 . . . . 0.0 110.666 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 11.17 15.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.894 1.277 . . . . 0.0 110.989 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.52 159.84 0.31 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.059 0.944 . . . . 0.0 110.729 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.51 -36.09 68.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.654 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.96 5.32 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 115.73 1.052 . . . . 0.0 115.73 168.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 65.6 p -69.98 165.08 22.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.8 -42.73 99.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.44 0.638 . . . . 0.0 110.208 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.1 -43.29 82.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.857 -1.545 . . . . 0.0 109.395 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.95 -35.73 62.12 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 121.232 1.833 . . . . 0.0 109.428 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -57.08 -53.94 52.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.679 0.672 . . . . 0.0 110.656 171.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' TRP . . . . . 0.434 ' HA ' ' CD2' ' B' ' 120' ' ' PHE . 7.6 t90 -62.93 -45.19 93.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.694 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.97 99.51 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.943 0.897 . . . . 0.0 111.857 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.12 -48.78 72.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.434 ' CD2' ' HA ' ' B' ' 117' ' ' TRP 0.253 0.3 OUTLIER -65.92 -38.91 89.91 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.366 -174.685 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.02 -48.5 80.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.374 0.988 . . . . 0.0 110.672 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -63.13 -52.15 63.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.91 -35.45 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.222 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.527 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.1 tmm_? -61.84 -43.99 97.74 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.781 1.173 . . . . 0.0 112.373 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.46 -46.19 80.48 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.17 0.441 . . . . 0.0 110.725 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.66 -41.35 68.86 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 122.32 -0.238 . . . . 0.0 111.57 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.3 -46.25 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.105 0.962 . . . . 0.0 109.642 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.19 98.39 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.07 -44.54 94.68 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.262 1.031 . . . . 0.0 112.325 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -72.42 -34.93 68.19 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.044 -1.035 . . . . 0.0 111.489 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -36.08 68.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.682 1.128 . . . . 0.0 111.415 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.443 ' HE3' ' CZ ' ' B' ' 27' ' ' TYR . 9.4 ptmt -67.18 -37.39 83.62 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.165 0.893 . . . . 0.0 109.576 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.76 -43.19 98.33 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 117.302 -1.332 . . . . 0.0 110.855 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -57.44 -41.25 80.09 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 121.579 1.99 . . . . 0.0 110.552 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.09 73.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.824 0.85 . . . . 0.0 112.617 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.33 -41.73 14.29 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.459 1.503 . . . . 0.0 111.158 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.6 p -90.06 -23.62 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.129 1.372 . . . . 0.0 110.452 -169.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 51.3 54.33 24.14 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.602 1.561 . . . . 0.0 114.533 -169.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.9 168.06 23.61 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.431 2.292 . . . . 0.0 106.293 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.05 99.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 169.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.41 165.33 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.943 1.297 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 118.25 28.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 107.909 172.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.15 172.86 12.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.982 0.913 . . . . 0.0 108.616 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t -155.34 -177.7 6.73 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 169.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -36.92 -36.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 129.529 3.132 . . . . 0.0 116.275 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.7 -30.95 1.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.518 1.127 . . . . 0.0 111.421 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 m -61.74 -19.39 62.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.732 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -50.61 -50.52 53.94 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.346 0.975 . . . . 0.0 109.535 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -62.62 -44.77 95.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.087 -0.383 . . . . 0.0 110.064 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.15 92.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.417 -0.177 . . . . 0.0 111.017 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -72.09 -21.0 61.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.061 0.944 . . . . 0.0 112.81 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.5 p -110.41 -4.03 15.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.174 0.99 . . . . 0.0 112.117 -169.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -70.78 -11.77 61.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.112 0.965 . . . . 0.0 113.304 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.24 146.53 35.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.867 0.758 . . . . 0.0 109.918 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.8 -171.43 26.46 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.761 1.172 . . . . 0.0 111.949 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.85 133.45 34.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -142.01 116.05 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -81.73 134.2 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.27 139.69 53.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 169.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -132.24 148.65 52.46 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.734 1.614 . . . . 0.0 108.757 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.49 110.83 12.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -169.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.573 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.9 p-90 -129.28 152.55 48.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.562 1.945 . . . . 0.0 107.634 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -171.83 164.05 4.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.783 1.174 . . . . 0.0 111.761 170.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -56.99 -9.38 4.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.461 3.441 . . . . 0.0 117.476 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.525 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 71.3 m95 -48.47 -46.91 38.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.256 1.389 . . . . 0.0 111.889 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.7 m -152.61 165.42 35.28 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.19 -46.3 27.53 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.161 2.315 . . . . 0.0 115.861 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -51.6 -32.37 44.08 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.818 2.809 . . . . 0.0 114.611 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -58.58 -30.18 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 120.266 1.393 . . . . 0.0 112.743 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.91 7.92 45.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.594 1.157 . . . . 0.0 111.838 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.1 mtm -117.67 -44.02 2.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.034 0.934 . . . . 0.0 109.339 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.14 -33.25 55.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.344 1.058 . . . . 0.0 109.4 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.53 -60.46 10.26 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.294 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.25 -39.86 81.0 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.03 1.82 . . . . 0.0 111.47 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.67 -41.42 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.029 0.531 . . . . 0.0 110.586 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 mp -71.15 -38.45 72.23 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 118.907 0.776 . . . . 0.0 110.897 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.28 -34.95 79.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.033 . . . . 0.0 109.9 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -69.86 -30.56 68.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.564 1.146 . . . . 0.0 111.288 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.84 -43.77 64.99 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.582 1.153 . . . . 0.0 110.112 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.59 -37.3 65.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.523 -0.735 . . . . 0.0 110.962 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.86 -14.31 62.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.844 -0.535 . . . . 0.0 111.735 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.12 -49.25 6.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.943 1.297 . . . . 0.0 110.554 -176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.29 16.34 2.78 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.802 0.841 . . . . 0.0 112.115 -169.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.63 2.87 10.07 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.408 -0.808 . . . . 0.0 113.769 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.39 -24.62 61.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.785 1.234 . . . . 0.0 110.593 169.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -19.1 11.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.004 0.921 . . . . 0.0 112.57 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.28 144.91 51.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.687 1.195 . . . . 0.0 110.733 -168.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.45 144.34 30.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -127.19 135.91 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.15 143.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 22.7 mtpp -117.77 156.35 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.441 0.564 . . . . 0.0 110.49 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -126.26 125.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.26 107.7 12.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 169.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.289 33.7 m -82.85 50.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.42 -35.13 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.446 -0.783 . . . . 0.0 111.329 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -103.95 -27.26 12.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.583 1.153 . . . . 0.0 109.777 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.12 25.1 5.24 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.602 1.161 . . . . 0.0 111.634 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.8 -1.79 23.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.687 1.195 . . . . 0.0 112.982 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.55 -46.44 83.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.014 1.326 . . . . 0.0 110.84 -173.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.32 -39.91 70.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.099 0.863 . . . . 0.0 111.422 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.34 -64.29 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -171.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.61 -41.33 9.42 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.166 0.889 . . . . 0.0 114.103 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -62.85 -46.92 85.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.892 1.346 . . . . 0.0 110.534 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -69.79 -33.78 72.84 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.231 0.469 . . . . 0.0 110.457 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.55 68.02 0.81 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -137.28 132.69 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 100.488 -3.893 . . . . 0.0 100.488 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.408 ' HB2' HD12 ' B' ' 67' ' ' ILE . 28.7 mtm -147.83 17.04 1.12 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.079 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.8 p -133.92 162.04 33.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 112.339 -168.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.66 139.33 35.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.253 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.91 135.57 16.88 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 N-CA-C 106.26 -2.246 . . . . 0.0 106.26 -11.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.6 m -103.77 140.41 37.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -117.15 135.48 53.73 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 107.659 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.5 mt -121.15 113.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 169.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.09 124.67 43.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -122.69 155.04 37.23 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.909 0.884 . . . . 0.0 109.546 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.36 141.69 24.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 45.47 30.76 0.78 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.353 1.861 . . . . 0.0 113.56 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.72 9.8 51.65 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 116.428 1.331 . . . . 0.0 116.428 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.79 149.56 47.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.718 1.259 . . . . 0.0 111.502 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.71 138.28 21.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.75 -20.75 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.599 1.16 . . . . 0.0 110.966 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -144.51 153.86 42.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.134 0.879 . . . . 0.0 108.914 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -139.83 137.29 34.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.3 t -151.16 148.84 28.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.0 t -138.82 112.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.32 155.84 6.62 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.93 142.68 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.635 0.718 . . . . 0.0 110.537 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -136.01 140.81 34.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -68.64 167.91 21.46 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.343 2.029 . . . . 0.0 110.357 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -44.24 -49.58 9.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.616 1.966 . . . . 0.0 112.281 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -43.6 70.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.28 0.491 . . . . 0.0 111.445 -174.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.59 87.92 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.958 -0.464 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -54.4 45.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.5 0.72 . . . . 0.0 109.612 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.07 -38.87 92.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.546 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' A' ' 102' ' ' LYS . 35.8 tt0 -61.99 -44.04 97.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.759 0.424 . . . . 0.0 111.506 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.09 -44.3 91.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.147 0.979 . . . . 0.0 110.703 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.71 -36.71 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.1 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.24 -30.72 62.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 112.131 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.411 ' HE2' ' HG2' ' A' ' 98' ' ' GLU . 41.4 mttm -56.56 -26.58 55.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 112.954 175.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -125.82 -16.75 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.122 0.969 . . . . 0.0 112.265 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 126.619 1.968 . . . . 0.0 108.701 169.827 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -58.83 131.59 51.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.776 1.231 . . . . 0.0 111.074 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 m120 71.01 124.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.191 2.996 . . . . 0.0 112.378 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -146.73 143.71 28.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 130.809 3.644 . . . . 0.0 103.604 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mt -123.12 142.38 39.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 120.571 1.532 . . . . 0.0 108.344 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.22 142.27 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -128.88 138.3 51.95 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -110.83 148.59 32.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -142.08 112.17 6.93 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 42.4 p -158.51 149.26 20.34 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.741 0.416 . . . . 0.0 111.187 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -47.8 120.59 3.49 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.347 1.459 . . . . 0.0 111.866 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.425 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 65.19 13.69 58.21 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.477 174.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -7.02 85.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 129.486 3.114 . . . . 0.0 114.926 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -152.53 6.77 0.42 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.368 0.667 . . . . 0.0 111.951 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.44 -93.03 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.869 1.213 . . . . 0.0 111.47 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -24.97 67.61 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.425 -0.797 . . . . 0.0 112.221 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.8 p -61.05 -47.7 85.17 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.519 2.328 . . . . 0.0 112.464 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -64.12 -44.98 90.57 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.796 1.284 . . . . 0.0 108.525 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ttm -59.74 -50.83 72.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.84 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.14 79.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.46 -0.775 . . . . 0.0 111.907 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.64 -26.68 45.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.818 1.19 . . . . 0.0 110.547 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.56 -47.35 69.77 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.494 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 19.4 m95 -54.73 -42.6 71.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 111.319 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.74 72.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -173.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -65.42 -22.26 66.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -69.02 -15.27 63.43 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.312 0.96 . . . . 0.0 113.472 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -130.95 -44.01 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.529 1.059 . . . . 0.0 112.44 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -79.47 73.2 6.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.091 1.756 . . . . 0.0 106.351 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.11 -151.17 0.18 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 127.277 2.37 . . . . 0.0 113.748 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.15 -19.53 63.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.824 1.25 . . . . 0.0 113.399 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.92 -19.49 64.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.2 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -122.39 160.23 25.88 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.378 0.99 . . . . 0.0 111.558 -169.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -133.64 142.18 47.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.852 2.061 . . . . 0.0 105.925 170.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.05 135.01 59.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -142.11 164.51 29.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -146.01 136.37 23.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -169.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 166.75 29.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.481 0.713 . . . . 0.0 111.103 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.06 -172.54 38.73 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 118.018 0.372 . . . . 0.0 113.453 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.425 HG22 ' H ' ' B' ' 12' ' ' GLY . 2.4 tt -49.04 -57.58 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.634 1.974 . . . . 0.0 113.417 -172.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -135.31 28.89 3.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.147 1.779 . . . . 0.0 108.746 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.01 151.76 47.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 79.6 t60 143.34 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 130.444 3.498 . . . . 0.0 105.049 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.19 177.54 48.43 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.823 -0.548 . . . . 0.0 111.779 -172.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -153.05 92.64 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -65.3 127.36 92.83 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.87 -21.55 71.01 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -36.49 81.14 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 120.171 1.35 . . . . 0.0 110.71 172.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.1 -39.17 63.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -57.8 -53.59 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -60.56 -40.96 93.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.899 0.88 . . . . 0.0 110.883 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.19 -37.0 61.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.55 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 68.5 mmm -82.15 -34.38 29.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.225 0.92 . . . . 0.0 111.496 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.96 -23.41 67.4 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.016 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.87 -31.65 66.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.047 1.294 . . . . 0.0 111.624 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.36 14.34 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.045 1.338 . . . . 0.0 111.268 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.23 41.96 98.09 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.938 -0.923 . . . . 0.0 112.556 175.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.81 147.4 20.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -118.6 135.45 54.43 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 pt -137.02 16.3 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.619 1.568 . . . . 0.0 110.611 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -60.47 -10.04 4.45 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -99.0 -14.15 19.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.048 1.739 . . . . 0.0 113.387 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -58.69 161.3 4.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 t -161.77 -175.78 4.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.802 2.041 . . . . 0.0 107.393 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.6 m -145.47 -162.27 1.47 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.599 1.56 . . . . 0.0 109.803 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -160.35 167.72 26.81 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.74 2.416 . . . . 0.0 106.918 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.6 pt -64.95 168.14 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.47 0.708 . . . . 0.0 111.623 173.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 70' ' ' MET . 1.4 pt -47.06 129.2 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 108.816 176.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -137.55 98.55 3.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.897 1.332 . . . . 0.0 109.388 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.0 m -43.87 -32.37 1.07 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.364 2.266 . . . . 0.0 114.045 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.92 -16.57 59.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.164 0.893 . . . . 0.0 112.252 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.04 -37.65 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 117.846 -1.073 . . . . 0.0 109.339 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.09 -55.41 29.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.616 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -23.21 66.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.835 0.289 . . . . 0.0 110.929 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.49 -22.89 28.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.9 2.08 . . . . 0.0 112.814 -175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.05 173.51 1.39 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.985 1.314 . . . . 0.0 111.8 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.17 -24.81 15.55 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.958 0.903 . . . . 0.0 111.614 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' B' ' 97' ' ' LYS . 18.5 tp -151.25 143.03 23.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.977 1.311 . . . . 0.0 109.548 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.59 106.37 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 127.165 2.186 . . . . 0.0 106.66 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.22 99.79 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -66.88 128.83 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 tp -125.51 48.85 1.99 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.916 0.887 . . . . 0.0 111.498 -167.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 47.5 m -162.05 176.79 10.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 107.877 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.16 46.9 1.07 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -147.82 161.7 40.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.574 1.95 . . . . 0.0 108.042 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -131.81 1.71 4.0 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.261 1.424 . . . . 0.0 112.576 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.03 -19.03 4.16 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.31 0.959 . . . . 0.0 112.827 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -64.83 18.91 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.699 2.4 . . . . 0.0 116.62 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LYS . . . . . 0.415 ' HE3' HG13 ' B' ' 39' ' ' ILE . 60.7 mttt 83.15 18.86 0.24 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 128.744 2.818 . . . . 0.0 112.216 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.2 m 32.9 52.82 0.93 Allowed Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 126.502 1.921 . . . . 0.0 111.67 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.87 132.59 22.05 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.056 2.504 . . . . 0.0 114.409 -168.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.418 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.85 -1.16 56.13 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 116.774 -1.584 . . . . 0.0 114.459 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p 43.49 89.54 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.476 1.51 . . . . 0.0 113.62 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -57.27 137.57 82.26 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.03 2.487 . . . . 0.0 109.714 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.18 10.97 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.892 3.728 . . . . 0.0 116.015 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -67.65 -9.48 43.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.299 1.04 . . . . 0.0 111.844 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.55 153.14 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.71 1.204 . . . . 0.0 110.115 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.482 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.5 tmmm? -72.82 153.7 40.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.35 1.06 . . . . 0.0 109.254 174.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -143.06 144.75 32.39 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.9 150.67 27.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -92.75 137.38 32.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -139.61 39.47 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.389 1.476 . . . . 0.0 108.525 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.29 167.79 29.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -157.77 -15.93 0.08 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.728 1.211 . . . . 0.0 111.575 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.54 168.22 25.61 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.232 2.213 . . . . 0.0 106.448 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -142.72 117.38 6.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.139 0.976 . . . . 0.0 109.075 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.71 -17.91 25.62 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.682 2.921 . . . . 0.0 112.752 -175.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.5 -0.56 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.516 1.053 . . . . 0.0 112.067 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 -123.43 11.23 9.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.59 1.556 . . . . 0.0 111.379 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.95 152.91 0.71 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.133 0.973 . . . . 0.0 111.563 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -35.39 73.77 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.837 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.36 9.13 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -72.92 149.81 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -47.82 -41.6 24.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.583 1.553 . . . . 0.0 111.507 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.61 -40.45 69.79 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.425 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -78.0 -31.55 50.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.907 1.23 . . . . 0.0 109.651 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -63.15 -48.48 78.29 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 119.147 0.885 . . . . 0.0 110.029 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' TRP . . . . . 0.407 ' CD1' ' CZ ' ' B' ' 120' ' ' PHE . 6.1 t90 -64.92 -46.63 80.85 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.751 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.63 95.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.544 0.738 . . . . 0.0 112.125 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.86 -50.22 71.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' B' ' 117' ' ' TRP 0.251 0.5 OUTLIER -66.51 -40.27 89.1 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.482 -174.66 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -62.2 -49.04 77.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.375 0.989 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -64.96 -48.87 72.49 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.9 -35.12 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.547 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.494 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 6.8 tmm_? -60.11 -44.73 94.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.102 1.319 . . . . 0.0 111.732 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.58 -45.81 84.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.678 0.391 . . . . 0.0 110.923 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.82 -47.58 74.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.776 0.262 . . . . 0.0 110.908 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.8 mt -54.25 -49.89 59.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.415 1.486 . . . . 0.0 109.579 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.21 -42.82 97.76 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.203 -0.776 . . . . 0.0 111.249 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -61.28 -46.19 91.39 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.229 1.015 . . . . 0.0 111.61 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.7 -37.67 85.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.88 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.798 0.726 . . . . 0.0 110.86 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.89 -37.12 83.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.851 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.34 -36.85 78.95 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.581 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -62.11 -41.34 98.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 122.863 2.574 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.27 67.63 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 124.169 0.918 . . . . 0.0 112.356 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.01 -43.92 11.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 111.839 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.8 p -88.49 -17.78 29.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.868 2.067 . . . . 0.0 110.994 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.32 49.82 73.5 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.537 -174.685 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 mtt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.2 149.84 7.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.046 1.338 . . . . 0.0 109.434 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.66 98.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 102.558 -3.127 . . . . 0.0 102.558 168.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.54 165.38 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.924 1.289 . . . . 0.0 107.787 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 122.17 41.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -84.56 172.47 11.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -161.17 -176.32 5.37 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -36.94 -42.01 0.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.875 2.47 . . . . 0.0 115.487 -169.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.33 -29.83 3.21 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.29 1.036 . . . . 0.0 111.533 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m -62.24 -23.28 66.58 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.336 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.15 -54.26 38.36 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.51 1.05 . . . . 0.0 109.051 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -61.46 -45.09 95.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.078 -0.389 . . . . 0.0 109.988 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.73 89.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.309 0.1 . . . . 0.0 111.214 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -74.75 -22.95 58.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.146 0.978 . . . . 0.0 112.557 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 p -106.79 -6.57 17.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.305 0.957 . . . . 0.0 112.691 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -71.65 -10.26 59.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.12 147.36 34.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.087 0.955 . . . . 0.0 109.434 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.81 -175.13 27.6 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.631 1.11 . . . . 0.0 111.959 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 104' ' ' LEU . 22.1 t -93.22 132.79 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 169.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.5 t -141.22 116.71 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -169.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -82.23 127.33 33.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.4 138.73 51.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.963 0.801 . . . . 0.0 108.988 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.26 146.89 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.09 1.356 . . . . 0.0 108.902 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.23 114.29 16.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -169.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.538 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.7 p-90 -132.96 156.14 47.83 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.762 1.625 . . . . 0.0 107.153 -170.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -176.37 167.28 1.51 Allowed Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.471 1.108 . . . . 0.0 110.749 169.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.51 -13.59 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.348 3.366 . . . . 0.0 116.601 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -60.13 -20.57 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.292 1.405 . . . . 0.0 113.648 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.13 152.14 38.8 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.86 1.209 . . . . 0.0 113.235 -171.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.41 -49.24 71.69 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.131 -1.371 . . . . 0.0 112.304 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -50.64 -27.27 19.1 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 115.815 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -58.71 -20.85 52.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 120.48 1.491 . . . . 0.0 113.209 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.62 12.15 27.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.906 1.282 . . . . 0.0 111.42 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -122.15 -43.61 2.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.33 1.052 . . . . 0.0 109.427 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.81 -33.59 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.846 0.858 . . . . 0.0 109.242 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.64 25.14 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 117.942 -1.027 . . . . 0.0 112.471 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.53 -39.41 75.58 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.159 1.906 . . . . 0.0 111.576 174.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 93' ' ' LYS . 3.0 t -55.45 -41.2 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.18 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.7 -43.53 84.09 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.106 0.866 . . . . 0.0 111.151 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.96 -35.41 79.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.795 0.725 . . . . 0.0 109.97 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -68.5 -40.12 81.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.58 1.152 . . . . 0.0 110.692 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.6 -46.05 84.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.734 1.213 . . . . 0.0 110.014 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.0 -40.85 71.61 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.184 -0.323 . . . . 0.0 110.822 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -70.37 -6.9 38.71 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.957 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -102.08 -47.31 4.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.627 1.171 . . . . 0.0 111.092 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.2 ptm -134.76 13.6 3.68 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 112.414 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.67 10.97 4.7 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.204 -0.935 . . . . 0.0 113.638 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.85 -26.17 37.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.497 1.519 . . . . 0.0 109.485 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.67 -24.42 11.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.107 0.963 . . . . 0.0 112.124 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 tp -125.3 148.57 48.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.676 1.59 . . . . 0.0 110.728 -168.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -104.55 144.4 31.74 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mt -127.2 137.68 57.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 4.9 t -139.01 145.11 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -173.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 23.6 mtpt -122.12 157.15 32.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.324 0.511 . . . . 0.0 110.767 175.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mm -125.37 127.35 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -87.97 107.46 18.73 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.835 HG21 HD11 ' A' ' 72' ' ' ILE . 33.2 m -76.29 39.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -146.19 -38.34 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.468 1.107 . . . . 0.0 109.168 168.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.88 -42.19 19.91 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.5 0.72 . . . . 0.0 111.179 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -138.96 36.61 2.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.238 1.018 . . . . 0.0 111.792 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -70.2 -6.49 34.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 113.429 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -50.81 -45.01 59.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.281 1.832 . . . . 0.0 110.796 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.6 m -54.5 -44.74 72.97 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.828 0.851 . . . . 0.0 111.199 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.21 -57.13 4.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.329 1.052 . . . . 0.0 108.996 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.61 -45.86 47.14 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.058 0.837 . . . . 0.0 113.557 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.0 -43.24 99.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.02 0.91 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.72 -33.35 73.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.293 0.497 . . . . 0.0 109.883 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.48 64.99 0.97 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.24 -61.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.252 7.0 ptm 49.44 7.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.815 3.246 . . . . 0.0 115.406 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.4 p -140.68 163.96 31.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 111.987 -172.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.835 HD11 HG21 ' A' ' 57' ' ' VAL . 26.0 mm -142.66 149.64 51.09 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.096 0.959 . . . . 0.0 108.925 -174.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.42 134.47 31.84 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 106.962 -1.976 . . . . 0.0 106.962 -11.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.7 m -112.27 146.74 37.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -131.79 121.47 24.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.4 mt -115.02 112.17 22.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.19 127.21 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -126.33 156.73 39.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.941 0.896 . . . . 0.0 109.587 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -146.66 140.08 25.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.8 t70 44.86 30.41 0.55 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.265 1.826 . . . . 0.0 114.125 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.64 14.69 49.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.835 1.207 . . . . 0.0 115.899 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.51 148.31 52.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.745 1.218 . . . . 0.0 110.803 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.81 134.87 29.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -122.79 -22.41 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.796 1.238 . . . . 0.0 109.799 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -146.68 156.15 42.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.548 1.139 . . . . 0.0 109.477 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 133.59 16.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.2 p -154.12 163.28 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.471 0.653 . . . . 0.0 110.246 172.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.9 113.74 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.54 153.95 6.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.22 142.18 58.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.914 0.486 . . . . 0.0 110.612 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -134.32 140.69 36.63 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -66.84 169.51 14.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.201 1.934 . . . . 0.0 110.109 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HA ' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -48.33 -50.03 31.9 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.595 1.158 . . . . 0.0 111.082 -175.283 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.81 -43.22 72.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.924 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.19 87.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.061 0.392 . . . . 0.0 110.33 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.8 tp -68.46 -46.99 68.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.928 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.63 -36.24 83.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.69 -47.03 82.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.306 0.503 . . . . 0.0 110.713 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.2 -39.13 78.16 Favored 'General case' 0 N--CA 1.459 -0.015 0 C-N-CA 123.659 0.783 . . . . 0.0 111.512 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -81.61 -41.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.795 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -54.39 -31.87 55.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.594 1.158 . . . . 0.0 112.177 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -56.23 -24.73 44.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.478 1.111 . . . . 0.0 113.218 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -128.83 -16.55 4.15 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.078 0.951 . . . . 0.0 112.518 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HA ' HG21 ' A' ' 19' ' ' VAL . 16.7 tp . . . . . 0 C--O 1.248 1.025 0 C-N-CA 127.176 2.19 . . . . 0.0 108.812 169.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.6 86.92 2.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 m120 74.72 130.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.016 2.926 . . . . 0.0 112.103 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.454 ' HE3' ' CZ3' ' B' ' 32' ' ' TRP . 37.2 mtmt -127.69 122.98 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 128.846 2.858 . . . . 0.0 103.363 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mt -90.54 142.97 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 110.353 -167.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.43 150.23 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.703 1.601 . . . . 0.0 107.225 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.56 157.37 45.92 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.16 0.584 . . . . 0.0 111.831 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -116.63 142.79 46.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.946 1.299 . . . . 0.0 107.593 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 23.7 mt -126.21 125.7 42.85 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 71.8 m -155.17 135.05 12.84 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.321 1.848 . . . . 0.0 109.133 -169.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.2 m -51.33 118.58 3.37 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.802 1.241 . . . . 0.0 110.927 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.97 4.68 11.78 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.701 -1.055 . . . . 0.0 113.737 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 3.1 t30 33.26 40.05 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.246 2.619 . . . . 0.0 113.74 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -81.75 -40.63 22.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.711 0.804 . . . . 0.0 111.126 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.38 -55.69 0.9 Allowed 'General case' 0 CA--C 1.526 0.058 0 C-N-CA 123.471 0.709 . . . . 0.0 112.707 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -49.89 -60.47 2.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.306 1.042 . . . . 0.0 110.184 -169.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -73.18 -28.43 62.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.602 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -54.86 -46.97 74.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -43.93 67.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.103 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.92 89.12 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 118.82 0.737 . . . . 0.0 112.374 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.65 -32.03 69.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.896 0.771 . . . . 0.0 110.582 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.67 -51.2 53.94 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -56.72 -32.91 65.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.88 1.272 . . . . 0.0 112.278 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.2 -53.82 7.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 111.079 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.54 -26.73 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -62.62 -17.57 60.55 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 173.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.4 -10.15 5.17 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.78 1.232 . . . . 0.0 113.011 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -124.69 81.54 1.96 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -163.23 3.01 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.063 1.792 . . . . 0.0 112.585 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.99 -9.91 18.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.915 1.286 . . . . 0.0 113.641 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -61.17 -22.53 64.82 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.903 -1.123 . . . . 0.0 109.745 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' TRP . . . . . 0.454 ' CZ3' ' HE3' ' B' ' 4' ' ' LYS . 30.9 m95 -126.7 177.37 6.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.363 2.265 . . . . 0.0 108.46 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -157.26 130.55 7.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.73 142.42 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.58 169.76 16.99 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.048 1.739 . . . . 0.0 108.21 -174.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 98.5 p -150.13 149.79 30.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.74 174.09 15.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.459 0.704 . . . . 0.0 111.313 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.98 -177.66 41.01 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.535 -0.302 . . . . 0.0 113.119 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.445 HG13 ' HE3' ' B' ' 88' ' ' LYS . 3.0 tt -43.97 -58.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.315 2.246 . . . . 0.0 114.228 -173.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -134.37 30.09 3.57 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.308 1.843 . . . . 0.0 108.191 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.37 137.01 55.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.355 1.862 . . . . 0.0 114.571 -169.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 172.14 114.4 0.01 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 130.377 3.471 . . . . 0.0 102.412 169.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.18 -179.72 43.61 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 118.875 0.761 . . . . 0.0 112.214 -174.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.5 tp -164.07 93.07 0.69 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 169.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -64.61 125.9 89.66 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.08 -21.14 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.036 1.824 . . . . 0.0 112.715 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.41 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -61.51 -37.41 83.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.273 0.942 . . . . 0.0 111.143 171.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.16 61.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t -57.22 -50.93 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.55 -44.77 85.45 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.561 0.619 . . . . 0.0 110.496 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.36 -22.81 45.07 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.96 0.904 . . . . 0.0 112.694 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 77.8 mmm -102.65 -34.13 9.18 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.365 0.984 . . . . 0.0 112.301 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -60.22 -27.9 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.172 0.896 . . . . 0.0 110.092 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.73 -33.04 32.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.755 1.622 . . . . 0.0 112.383 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.89 17.39 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.299 1.44 . . . . 0.0 110.796 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.27 37.95 93.33 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.935 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 47.4 mt -115.94 107.32 22.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 172.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -73.22 132.65 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 30.8 pt -135.81 19.05 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.991 1.316 . . . . 0.0 110.823 173.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -59.76 -15.64 21.74 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.837 0.744 . . . . 0.0 111.963 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -83.97 -15.29 48.35 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.7 2.4 . . . . 0.0 114.345 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -69.9 159.55 33.47 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.742 1.156 . . . . 0.0 112.762 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 66.8 p -139.64 -169.78 2.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.125 2.57 . . . . 0.0 108.806 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 p -157.86 -173.43 4.36 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.101 0.961 . . . . 0.0 108.708 169.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -166.44 159.25 14.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 127.491 2.316 . . . . 0.0 108.017 -170.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.64 166.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.05 0.94 . . . . 0.0 111.888 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -50.07 133.28 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -142.85 98.79 3.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.237 1.017 . . . . 0.0 109.161 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.6 m -44.49 -32.43 1.4 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.827 2.051 . . . . 0.0 113.773 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.92 -17.65 63.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.383 0.992 . . . . 0.0 112.648 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -126.93 -34.01 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.811 0.844 . . . . 0.0 108.852 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.25 -54.18 23.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.603 1.092 . . . . 0.0 110.172 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -23.93 67.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.986 0.812 . . . . 0.0 110.416 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.91 -23.02 55.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.806 1.642 . . . . 0.0 112.138 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.94 165.69 3.11 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.763 1.225 . . . . 0.0 111.8 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.15 -29.32 15.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.036 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -145.26 133.91 22.16 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.156 0.982 . . . . 0.0 110.996 -173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.438 HG23 HG11 ' B' ' 96' ' ' VAL . 20.6 t -107.55 116.33 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.074 1.75 . . . . 0.0 108.227 170.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.38 109.33 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -76.17 123.32 25.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 167.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 tp -116.32 39.09 3.2 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.732 -0.605 . . . . 0.0 109.489 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 5.4 m -153.93 165.18 36.91 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.369 0.668 . . . . 0.0 111.644 -168.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.91 48.1 0.97 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 105.858 -2.897 . . . . 0.0 105.858 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -149.64 159.77 44.06 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.148 2.179 . . . . 0.0 107.58 -169.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -132.64 2.67 3.78 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.704 1.602 . . . . 0.0 112.192 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.26 -17.58 20.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.938 0.895 . . . . 0.0 112.601 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.15 38.17 0.05 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.67 1.988 . . . . 0.0 115.055 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LYS . . . . . 0.445 ' HE3' HG13 ' B' ' 39' ' ' ILE . 14.1 mttt 64.37 21.94 12.62 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.642 -1.911 . . . . 0.0 111.742 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p 30.41 62.38 0.96 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 127.504 2.322 . . . . 0.0 112.049 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.36 132.18 49.29 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.791 2.327 . . . . 0.0 111.066 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.6 3.18 55.64 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p 43.2 92.22 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.009 2.524 . . . . 0.0 113.698 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -61.71 147.51 95.16 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.013 1.809 . . . . 0.0 109.942 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.4 -2.52 6.16 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.915 3.743 . . . . 0.0 115.348 -169.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -62.58 -10.03 10.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.6 1.16 . . . . 0.0 112.154 170.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.438 HG11 HG23 ' B' ' 78' ' ' VAL . 2.1 t -137.52 143.95 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.842 1.257 . . . . 0.0 109.525 -169.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -76.04 155.46 34.86 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -139.98 142.61 36.31 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.833 -1.167 . . . . 0.0 108.993 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -145.45 159.28 43.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 169.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -106.74 128.72 54.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -119.16 8.73 11.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.583 1.153 . . . . 0.0 110.501 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.58 162.38 24.62 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -157.81 24.63 0.27 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.776 1.23 . . . . 0.0 109.422 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.35 172.62 18.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.407 1.883 . . . . 0.0 106.642 -171.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -148.25 116.14 4.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.57 1.148 . . . . 0.0 108.737 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.24 -28.51 22.86 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.13 2.553 . . . . 0.0 111.917 -171.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.79 -3.28 3.16 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.448 1.099 . . . . 0.0 112.755 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -97.05 5.74 49.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.249 1.02 . . . . 0.0 111.673 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.75 142.9 3.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.778 0.831 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -55.24 -45.95 76.04 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.474 0.71 . . . . 0.0 109.914 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.32 -15.11 4.22 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.8 p -69.22 162.37 27.27 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.74 -39.08 90.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.473 0.654 . . . . 0.0 110.534 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.04 -41.43 82.1 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 116.983 -1.484 . . . . 0.0 109.05 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.85 -31.46 59.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 120.851 1.66 . . . . 0.0 109.607 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -57.12 -62.91 1.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -59.44 -39.99 85.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.03 95.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.608 0.763 . . . . 0.0 112.305 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -63.17 -48.27 79.1 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 118.583 0.628 . . . . 0.0 109.474 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.5 m-30 -65.89 -40.46 91.59 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -65.85 -46.69 77.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.265 1.026 . . . . 0.0 110.297 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -60.23 -49.52 77.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.21 -46.76 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.018 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -62.59 -39.62 94.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.154 1.343 . . . . 0.0 111.347 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.26 -43.87 96.74 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.212 0.32 . . . . 0.0 110.615 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.66 -55.36 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.128 0.571 . . . . 0.0 109.641 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.1 mt -54.86 -52.45 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.309 1.044 . . . . 0.0 109.416 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.98 97.84 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.817 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -61.38 -47.15 87.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.42 1.11 . . . . 0.0 111.409 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -65.81 -41.11 92.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.466 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.46 -37.86 83.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.771 0.714 . . . . 0.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -62.92 -47.13 84.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.588 0.631 . . . . 0.0 109.731 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.05 -36.11 82.49 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.253 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.62 -40.94 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 121.543 1.974 . . . . 0.0 110.735 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.64 71.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.27 0.628 . . . . 0.0 112.629 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.99 -37.05 13.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 111.636 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 51.4 p -100.3 -14.13 18.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.72 1.608 . . . . 0.0 111.546 -169.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.98 48.37 86.62 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.108 0.563 . . . . 0.0 111.876 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.08 169.66 21.99 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.334 1.453 . . . . 0.0 107.778 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.29 93.65 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 169.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.01 170.71 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.473 1.909 . . . . 0.0 107.804 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -129.24 130.84 46.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.846 0.858 . . . . 0.0 108.757 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.55 176.94 6.37 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.411 1.884 . . . . 0.0 110.375 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -152.03 -176.73 5.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.043 1.737 . . . . 0.0 106.692 169.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -38.67 -37.6 0.34 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.774 2.83 . . . . 0.0 116.067 -169.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -128.81 -30.6 2.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.301 1.04 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.8 m -61.49 -20.89 63.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.422 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -49.47 -53.33 23.69 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -64.2 -45.04 90.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.09 77.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.397 -0.189 . . . . 0.0 111.369 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.37 -14.03 59.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.723 1.209 . . . . 0.0 112.494 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 p -120.79 -6.38 9.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.66 1.118 . . . . 0.0 113.474 -169.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.1 m -78.11 -0.77 29.43 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.382 -0.824 . . . . 0.0 113.11 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.86 145.51 36.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.16 0.984 . . . . 0.0 108.935 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.99 -170.86 54.68 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.893 0.759 . . . . 0.0 111.752 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.99 116.47 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.1 t -133.18 118.98 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.09 137.61 32.2 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.9 144.8 47.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -139.3 144.48 38.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 108.275 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.48 111.52 15.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.441 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.3 p-90 -131.52 154.16 49.06 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.926 1.69 . . . . 0.0 108.153 -169.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.89 163.14 7.88 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.896 0.771 . . . . 0.0 110.07 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -54.02 -14.02 5.45 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.981 3.121 . . . . 0.0 116.272 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -60.8 -24.32 65.74 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.836 1.198 . . . . 0.0 113.84 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.22 155.8 47.53 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.523 1.056 . . . . 0.0 112.335 -169.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.65 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.166 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.26 -27.41 23.05 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.347 2.698 . . . . 0.0 115.139 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m -57.83 -20.47 36.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 120.108 1.322 . . . . 0.0 113.324 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 11.33 22.71 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.404 1.082 . . . . 0.0 111.352 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.9 mtm -122.34 -43.65 2.29 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.09 -37.92 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.11 -58.55 14.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.203 -0.904 . . . . 0.0 112.332 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.75 -39.22 75.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.111 1.874 . . . . 0.0 111.919 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' A' ' 93' ' ' LYS . 2.2 t -57.01 -39.98 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.781 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.97 -42.82 80.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.989 0.813 . . . . 0.0 110.491 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.9 -36.88 85.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.558 0.617 . . . . 0.0 110.009 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.66 -36.91 81.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.301 -0.874 . . . . 0.0 110.642 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.93 -44.61 92.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.426 1.09 . . . . 0.0 110.231 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.66 -34.74 72.35 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.565 -0.71 . . . . 0.0 111.425 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.14 -27.02 68.64 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.451 -0.78 . . . . 0.0 111.657 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -90.29 -42.99 10.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.641 1.176 . . . . 0.0 111.291 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.1 ptm -144.2 18.98 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.704 0.802 . . . . 0.0 112.126 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.15 -7.0 15.27 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.311 -0.868 . . . . 0.0 114.309 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.35 -22.78 67.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.711 0.804 . . . . 0.0 111.054 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 -10.66 7.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.852 1.261 . . . . 0.0 112.779 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.9 tp -127.48 150.53 49.62 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.497 1.119 . . . . 0.0 112.092 -168.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -124.27 150.03 45.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.38 143.0 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.1 121.43 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.79 0.723 . . . . 0.0 109.215 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.9 mmmm -85.91 155.54 20.88 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mm -128.22 116.13 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 101.759 -3.422 . . . . 0.0 101.759 168.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.29 107.7 9.88 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.315 33.2 m -79.6 48.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -154.87 -45.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.34 1.456 . . . . 0.0 108.527 167.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.3 -35.84 30.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.175 0.99 . . . . 0.0 110.91 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -133.89 30.27 3.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.625 1.57 . . . . 0.0 110.514 -169.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -73.73 -5.84 43.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -56.05 -45.78 79.14 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.3 1.44 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.9 m -54.85 -42.62 72.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.335 0.654 . . . . 0.0 110.755 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.21 0.73 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.13 -44.2 14.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.103 0.858 . . . . 0.0 113.411 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.93 -44.99 87.67 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.265 1.033 . . . . 0.0 111.442 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -69.53 -26.71 64.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.743 0.701 . . . . 0.0 110.369 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.81 65.98 0.83 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.86 130.59 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 101.189 -3.634 . . . . 0.0 101.189 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.475 ' CE ' HD13 ' B' ' 72' ' ' LEU . 29.8 mtm -148.78 21.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -138.96 163.08 33.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.814 1.245 . . . . 0.0 113.603 -167.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.17 135.57 27.4 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.266 -0.874 . . . . 0.0 109.497 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -85.98 125.05 8.53 Favored 'Cis proline' 0 N--CA 1.45 -1.042 0 N-CA-C 106.001 -2.346 . . . . 0.0 106.001 -11.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.0 m -88.9 148.14 23.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.26 119.69 10.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.9 mt -118.2 109.63 16.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.86 138.42 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.24 157.09 41.84 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.419 1.088 . . . . 0.0 111.251 -172.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -138.11 127.75 25.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.71 1.204 . . . . 0.0 107.79 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 36.48 37.99 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.252 2.621 . . . . 0.0 115.507 168.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.94 -30.67 2.35 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.44 158.9 44.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -165.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.43 134.88 28.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.393 1.077 . . . . 0.0 108.721 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -122.42 -24.88 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.837 1.655 . . . . 0.0 111.321 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -144.78 153.35 41.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.95 146.96 33.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.6 m -155.1 153.82 31.45 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.519 1.128 . . . . 0.0 108.631 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.68 69.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.01 159.46 15.93 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 121.717 -0.614 . . . . 0.0 111.779 -173.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.48 145.5 56.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.275 0.63 . . . . 0.0 110.906 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.51 141.31 35.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.031 1.332 . . . . 0.0 107.744 170.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.31 169.46 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.589 2.193 . . . . 0.0 110.558 169.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HA ' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -53.7 -45.01 70.27 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.416 1.086 . . . . 0.0 111.971 -173.384 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.27 -41.97 84.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.201 0.201 . . . . 0.0 110.693 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.73 76.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.093 -0.38 . . . . 0.0 110.843 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -52.89 57.47 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.454 0.645 . . . . 0.0 109.895 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -62.83 -36.99 85.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.82 -46.7 88.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.729 0.695 . . . . 0.0 111.428 173.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.85 -28.82 62.21 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.829 1.252 . . . . 0.0 111.912 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.2 -42.13 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -57.34 -27.96 62.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.047 -1.033 . . . . 0.0 112.103 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -59.57 -22.54 61.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.57 -16.37 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 169.212 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.98 21.34 0.43 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -169.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.15 128.78 8.54 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 103.857 -2.645 . . . . 0.0 103.857 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -148.39 144.43 27.48 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 130.254 3.421 . . . . 0.0 104.605 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 mt -122.27 142.02 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -141.19 140.95 31.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -121.93 139.91 53.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -169.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -121.96 132.9 54.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -138.9 116.84 11.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.661 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.32 150.26 43.77 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.106 0.963 . . . . 0.0 111.005 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 83.9 m -45.05 106.28 0.07 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.843 1.657 . . . . 0.0 111.352 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.442 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 53.33 39.33 58.87 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.106 1.336 . . . . 0.0 111.188 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -39.09 125.41 1.56 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 38.9 p -141.64 -3.53 1.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.175 168.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.01 -80.42 0.38 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.29 1.036 . . . . 0.0 113.06 -169.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -52.43 -42.74 64.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.565 1.53 . . . . 0.0 113.062 -169.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -76.05 -25.14 55.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.665 1.121 . . . . 0.0 111.948 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.423 HE22 ' C ' ' B' ' 63' ' ' THR . 52.5 mm-40 -62.0 -47.66 83.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.708 1.14 . . . . 0.0 109.588 169.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.1 mtp -66.91 -43.99 81.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.97 93.71 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.705 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.0 -33.68 75.08 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.756 1.162 . . . . 0.0 110.96 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.61 -49.08 58.24 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.44 -41.04 75.77 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.182 0.993 . . . . 0.0 111.233 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.94 87.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -66.19 -19.85 65.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.461 -169.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -78.09 -16.26 58.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.608 1.094 . . . . 0.0 113.505 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.23 -16.42 3.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.86 -116.52 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.73 -167.93 38.07 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 119.161 0.892 . . . . 0.0 110.928 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.54 -20.71 63.55 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.219 1.008 . . . . 0.0 111.348 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -54.28 -24.3 18.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.133 2.173 . . . . 0.0 112.546 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -123.72 156.85 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.355 1.062 . . . . 0.0 110.708 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -125.84 139.56 53.39 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.98 140.25 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.58 157.53 46.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.531 0.732 . . . . 0.0 109.901 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 10.0 p -135.24 131.78 37.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.185 1.394 . . . . 0.0 109.194 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.31 173.75 14.12 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.43 -175.85 46.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.006 1.765 . . . . 0.0 110.405 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.442 HG22 ' H ' ' B' ' 12' ' ' GLY . 3.0 tt -52.43 -53.64 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.83 25.9 4.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.564 1.546 . . . . 0.0 109.078 -174.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.63 147.37 49.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.396 1.879 . . . . 0.0 112.245 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 29.7 p80 174.02 -17.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.579 2.352 . . . . 0.0 110.885 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.26 53.65 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-O 121.871 0.706 . . . . 0.0 113.018 -169.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.78 86.64 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 170.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -59.21 132.97 87.77 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.22 -22.52 57.43 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.757 1.638 . . . . 0.0 112.428 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -56.07 -56.08 25.2 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.4 75.06 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.288 0.949 . . . . 0.0 110.423 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.89 -55.56 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -56.64 -45.93 81.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 110.852 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.85 66.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.97 2.108 . . . . 0.0 111.331 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.3 mmm -89.03 -31.95 17.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.284 0.634 . . . . 0.0 110.27 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -61.63 -25.86 67.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.926 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.68 -27.99 66.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.171 1.351 . . . . 0.0 111.409 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.66 15.61 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.014 1.326 . . . . 0.0 110.971 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.39 93.38 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.693 -1.059 . . . . 0.0 112.964 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 82.1 mt -113.9 109.18 27.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.99 138.44 52.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 pt -134.82 16.07 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.856 0.862 . . . . 0.0 111.309 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 m -60.91 -13.79 18.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.246 0.93 . . . . 0.0 113.187 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -94.08 -13.98 26.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.9 1.68 . . . . 0.0 113.097 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.09 166.49 11.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.549 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.423 ' C ' HE22 ' B' ' 18' ' ' GLN . 13.9 t -156.25 -179.17 7.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.5 1.92 . . . . 0.0 107.458 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 64.0 m -143.41 -174.41 4.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.74 1.616 . . . . 0.0 107.675 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -150.98 171.47 17.23 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.022 1.329 . . . . 0.0 107.596 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.9 pt -62.66 170.71 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.071 0.851 . . . . 0.0 110.821 170.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.81 132.16 6.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -141.95 98.01 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.241 1.019 . . . . 0.0 108.419 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.8 m -47.15 -28.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.544 1.938 . . . . 0.0 114.451 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.08 -22.02 61.42 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 119.496 1.044 . . . . 0.0 110.515 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -40.57 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.693 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.475 HD13 ' CE ' ' A' ' 70' ' ' MET . 7.1 tt -61.57 -54.48 42.45 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.741 1.155 . . . . 0.0 109.47 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -22.89 67.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.025 0.829 . . . . 0.0 111.69 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.4 -12.58 54.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.738 1.215 . . . . 0.0 113.132 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.85 167.01 12.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.278 0.945 . . . . 0.0 110.544 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.38 -35.35 16.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.733 169.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.538 HD13 ' HD2' ' B' ' 97' ' ' LYS . 23.5 tp -146.38 136.05 23.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.113 1.365 . . . . 0.0 109.814 -172.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.454 HG21 HD21 ' B' ' 72' ' ' LEU . 16.0 t -105.06 105.22 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.5 109.4 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -68.49 132.12 46.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 39.1 mt -118.94 151.03 38.9 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m 78.34 -33.11 0.16 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 128.837 2.855 . . . . 0.0 111.623 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.83 145.86 18.67 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 105.198 -3.161 . . . . 0.0 105.198 -169.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -67.4 126.29 28.82 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -128.24 -29.14 2.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.259 1.024 . . . . 0.0 110.565 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.61 21.88 0.28 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.916 1.286 . . . . 0.0 110.031 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -85.13 18.72 2.45 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.872 -1.143 . . . . 0.0 113.795 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.305 0.2 OUTLIER 53.32 35.21 19.65 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.102 1.761 . . . . 0.0 113.49 -169.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 37.36 52.6 2.66 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.642 2.377 . . . . 0.0 114.212 172.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.49 130.69 37.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.211 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.41 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.87 0.48 50.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 116.636 -1.649 . . . . 0.0 115.14 -175.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.9 p 46.43 89.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.948 1.299 . . . . 0.0 113.436 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.98 143.48 92.33 Favored 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 123.132 2.554 . . . . 0.0 110.424 -169.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.19 4.23 0.79 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.092 3.861 . . . . 0.0 116.21 -169.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -67.8 -7.41 27.49 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.397 -0.814 . . . . 0.0 111.941 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -135.84 150.12 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.085 0.954 . . . . 0.0 111.055 -168.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.538 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.0 tmmm? -75.58 158.07 32.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -143.63 147.06 33.78 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.74 -1.225 . . . . 0.0 109.17 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.39 151.4 30.77 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -100.45 131.86 46.14 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.207 1.003 . . . . 0.0 109.627 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -115.88 10.75 15.34 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.04 0.936 . . . . 0.0 111.372 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.57 162.42 35.93 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 121.299 -0.876 . . . . 0.0 111.784 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -144.45 34.76 1.18 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.51 2.324 . . . . 0.0 107.985 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.15 139.27 20.14 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.035 2.134 . . . . 0.0 105.76 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -136.68 125.3 15.15 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 120.072 1.305 . . . . 0.0 111.216 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -82.9 -22.63 4.18 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.566 2.844 . . . . 0.0 113.684 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.77 63.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 118.44 0.564 . . . . 0.0 109.826 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -92.62 -64.61 1.08 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' B' ' 119' ' ' PHE . . . 46.6 -176.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.147 1.779 . . . . 0.0 114.451 -170.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -40.04 77.08 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.09 -20.41 5.05 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.2 p -70.65 166.7 20.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.632 0.716 . . . . 0.0 109.396 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -41.63 90.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.266 0.555 . . . . 0.0 110.937 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.12 -41.18 62.01 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.668 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.27 -31.85 58.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.569 1.531 . . . . 0.0 109.895 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -58.08 -58.4 8.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -58.98 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.276 0.489 . . . . 0.0 110.605 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.19 97.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.237 -0.914 . . . . 0.0 111.632 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 6.9 m-85 -66.57 -41.0 89.24 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.446 -0.787 . . . . 0.0 109.905 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -54.99 -52.91 61.65 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.289 0.95 . . . . 0.0 109.138 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -67.32 -45.82 75.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.74 0.816 . . . . 0.0 111.004 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttp-105 -62.07 -45.64 92.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.64 -43.19 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.741 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -64.45 -35.43 80.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.32 1.418 . . . . 0.0 111.009 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.46 -45.04 92.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.963 0.347 . . . . 0.0 111.424 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.45 -50.7 72.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.643 0.777 . . . . 0.0 110.195 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.7 -52.66 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.782 1.233 . . . . 0.0 109.342 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.05 -41.84 98.38 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 118.971 -0.905 . . . . 0.0 111.721 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -59.3 -46.53 88.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.297 1.049 . . . . 0.0 110.865 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -66.48 -37.87 86.06 Favored 'General case' 0 C--N 1.335 -0.049 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.499 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' B' ' 131' ' ' LEU . 2.4 mm? -64.67 -42.44 95.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.892 1.224 . . . . 0.0 110.912 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.53 -43.78 88.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.335 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.27 -40.06 89.04 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 117.361 -1.304 . . . . 0.0 110.654 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.35 -39.43 87.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 121.893 2.133 . . . . 0.0 111.29 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.73 70.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.153 0.581 . . . . 0.0 112.248 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.03 -44.73 9.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.581 1.552 . . . . 0.0 111.319 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.3 p -88.39 -24.39 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.291 1.836 . . . . 0.0 110.632 -169.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 49.11 51.14 26.27 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -169.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 125.246 1.418 . . . . 0.0 112.379 -172.65 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.37 161.14 0.08 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.496 2.318 . . . . 0.0 112.842 -170.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.5 109.6 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.4 t -80.86 167.15 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.827 1.651 . . . . 0.0 107.71 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -125.7 118.18 25.07 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.143 0.977 . . . . 0.0 108.411 170.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.461 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -75.98 174.0 10.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.299 1.439 . . . . 0.0 110.015 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -156.3 -175.87 5.66 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.306 1.442 . . . . 0.0 107.51 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -31.45 -40.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 130.794 3.638 . . . . 0.0 117.101 -169.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.23 -29.58 2.02 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.841 1.256 . . . . 0.0 111.033 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -59.23 -22.56 61.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.731 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -48.58 -51.77 26.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.164 1.347 . . . . 0.0 110.521 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 m -64.89 -45.01 87.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.23 0.468 . . . . 0.0 109.83 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.44 -36.73 83.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.34 -0.225 . . . . 0.0 110.884 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -76.77 -13.83 59.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.722 1.209 . . . . 0.0 112.471 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.5 p -119.8 -2.81 10.31 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.66 1.118 . . . . 0.0 112.504 -170.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.3 m -71.73 -10.89 60.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.18 147.66 38.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.562 0.745 . . . . 0.0 109.809 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.93 -167.56 45.59 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.49 1.043 . . . . 0.0 111.611 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 104' ' ' LEU . 28.5 t -102.58 122.25 54.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.03 115.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -81.07 140.5 35.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.0 44.18 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -141.6 148.2 38.86 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 109.001 -171.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -130.64 115.23 16.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.55 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.5 p-90 -133.7 156.15 48.46 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.603 1.561 . . . . 0.0 107.455 -171.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -176.2 167.88 1.5 Allowed Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.118 0.967 . . . . 0.0 110.905 169.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.05 -18.0 2.82 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.205 3.27 . . . . 0.0 116.407 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -57.77 -21.89 44.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.333 1.424 . . . . 0.0 114.174 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.73 158.08 44.25 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.672 1.124 . . . . 0.0 112.602 -171.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.6 -49.78 28.79 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.212 -1.327 . . . . 0.0 111.896 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -49.2 -27.29 12.47 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.819 3.013 . . . . 0.0 115.762 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.55 -23.23 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.45 1.477 . . . . 0.0 113.409 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -105.71 9.88 32.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.097 0.959 . . . . 0.0 112.035 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.6 mtm -120.46 -42.35 2.55 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.09 0.956 . . . . 0.0 109.586 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.98 -38.01 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.75 -58.65 13.37 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.187 -0.911 . . . . 0.0 112.259 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.01 -39.72 68.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 111.856 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.32 -41.9 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.231 0.469 . . . . 0.0 110.578 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.09 -42.52 80.24 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.554 0.615 . . . . 0.0 110.573 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.95 -39.81 94.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.733 0.697 . . . . 0.0 109.669 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -68.52 -24.21 64.63 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.102 -0.999 . . . . 0.0 112.11 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.444 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 42.0 tp -77.79 -45.61 23.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.648 1.179 . . . . 0.0 109.837 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HB2' HD12 ' A' ' 52' ' ' ILE . 25.3 t70 -69.77 -34.83 74.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.293 0.497 . . . . 0.0 110.964 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -59.36 -26.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 172.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -96.61 -46.33 6.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.173 0.589 . . . . 0.0 111.433 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.6 ptm -134.49 15.44 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 112.228 -169.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.04 16.9 Favored Glycine 0 CA--C 1.52 0.382 0 O-C-N 121.19 -0.944 . . . . 0.0 114.212 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.83 -24.08 64.33 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.836 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -25.92 7.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.59 1.156 . . . . 0.0 111.494 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.0 tp -112.62 151.67 29.83 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.324 1.45 . . . . 0.0 110.584 -169.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.77 148.53 46.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 43' ' ' ASP . 75.1 mt -131.66 137.09 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 14.3 t -137.17 113.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.4 mtpt -88.36 162.43 16.56 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.126 -0.984 . . . . 0.0 110.182 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -131.12 124.5 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -84.32 109.43 17.81 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.848 HG21 HD11 ' A' ' 72' ' ' ILE . 32.5 m -79.7 39.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -145.46 -37.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 168.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -74.89 -52.02 12.37 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.919 1.288 . . . . 0.0 109.842 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.14 46.68 1.93 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.364 1.066 . . . . 0.0 111.235 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.4 ' CD ' ' HD3' ' B' ' 94' ' ' PRO . 10.7 pt20 -72.12 -3.05 20.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.899 1.28 . . . . 0.0 113.138 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -56.38 -42.76 78.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.026 1.33 . . . . 0.0 110.894 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -54.53 -43.22 71.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.021 0.828 . . . . 0.0 111.371 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.96 -57.77 4.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.92 -43.0 39.4 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.908 0.766 . . . . 0.0 113.593 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -64.56 -42.11 95.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.506 1.153 . . . . 0.0 111.115 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -70.17 -30.69 67.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.371 0.532 . . . . 0.0 110.146 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.34 67.5 1.2 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -171.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.28 -62.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.496 ' HG3' HD12 ' B' ' 67' ' ' ILE 0.265 6.7 ptm 49.28 10.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.135 2.974 . . . . 0.0 115.183 178.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.8 p -140.89 162.98 34.17 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.565 1.546 . . . . 0.0 112.598 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.848 HD11 HG21 ' A' ' 57' ' ' VAL . 28.6 mm -142.7 148.3 45.8 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.162 0.985 . . . . 0.0 108.682 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -78.17 137.91 48.6 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 N-CA-C 106.477 -2.163 . . . . 0.0 106.477 -11.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -115.16 147.17 40.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -130.38 124.21 31.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.7 mt -121.56 112.48 18.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.2 t -104.75 128.49 58.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.31 156.9 41.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.239 1.016 . . . . 0.0 110.367 -169.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -146.02 139.25 25.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.73 29.57 0.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.318 1.847 . . . . 0.0 113.509 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.84 54.84 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.665 1.233 . . . . 0.0 111.21 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.76 138.14 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.95 -18.54 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.304 1.441 . . . . 0.0 111.241 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -141.05 157.36 45.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.227 0.922 . . . . 0.0 110.25 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.37 142.22 22.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 m -155.09 151.69 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.95 88.37 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 169.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.48 158.79 11.43 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -67.5 149.88 49.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.99 0.516 . . . . 0.0 110.501 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.88 135.8 14.76 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.69 169.19 16.51 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.315 2.01 . . . . 0.0 110.412 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -45.72 -48.22 15.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.894 1.678 . . . . 0.0 112.348 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.93 -43.66 71.21 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.259 0.481 . . . . 0.0 111.275 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.54 97.15 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.124 -0.36 . . . . 0.0 110.332 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -52.15 66.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.258 0.623 . . . . 0.0 109.711 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.53 -39.83 94.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.631 -0.699 . . . . 0.0 109.413 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.65 -45.77 92.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.807 0.73 . . . . 0.0 110.964 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.8 -37.55 76.6 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 125.277 1.431 . . . . 0.0 111.233 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.34 -37.09 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.824 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -57.98 -33.73 69.22 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.641 1.11 . . . . 0.0 111.374 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.41 -7.44 37.66 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -125.62 -23.55 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.867 1.267 . . . . 0.0 112.481 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.435 ' HA ' HG21 ' A' ' 19' ' ' VAL . 18.5 tp . . . . . 0 C--O 1.248 1.014 0 C-N-CA 127.168 2.187 . . . . 0.0 108.847 170.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -141.43 161.07 38.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.874 0.87 . . . . 0.0 109.658 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.27 28.5 m120 65.32 117.73 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 129.906 3.283 . . . . 0.0 113.567 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -153.94 137.22 15.72 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.99 3.316 . . . . 0.0 103.402 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -114.19 141.48 30.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -169.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.49 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.9 152.8 49.83 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.881 0.872 . . . . 0.0 110.429 -169.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -119.75 135.17 54.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.7 tp -128.99 119.01 23.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -144.35 163.26 34.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 0.0 111.186 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.7 m -61.33 134.3 56.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.469 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 53.93 5.19 0.37 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.357 2.408 . . . . 0.0 118.587 169.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASN . . . . . 0.47 ' ND2' ' H ' ' B' ' 65' ' ' ASP 0.319 1.8 t30 12.98 71.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.424 2.69 . . . . 0.0 112.57 -169.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.5 p -135.33 -27.07 1.23 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.094 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.37 -68.0 0.78 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.332 0.969 . . . . 0.0 112.225 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.47 HH21 ' HB3' ' B' ' 107' ' ' ALA . 0.0 OUTLIER -46.34 -55.86 6.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.478 0.581 . . . . 0.0 112.176 -169.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -37.42 81.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.891 -171.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -53.88 -43.88 69.97 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.075 1.35 . . . . 0.0 109.837 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 10.5 mtp -70.04 -49.21 53.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 -40.51 96.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.888 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.87 -33.94 72.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.529 1.059 . . . . 0.0 110.775 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.01 71.5 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -55.85 -39.7 71.82 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.046 0.938 . . . . 0.0 111.394 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.62 75.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -174.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -23.99 67.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.402 -169.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.52 -18.16 60.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.02 -23.12 4.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.884 0.766 . . . . 0.0 112.697 -174.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.6 mt -83.19 -113.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.69 -170.33 36.59 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.93 -17.69 57.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.837 0.855 . . . . 0.0 111.615 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -56.17 -23.55 35.73 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.42 1.888 . . . . 0.0 111.843 169.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -120.92 161.75 21.04 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.283 1.433 . . . . 0.0 109.674 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -124.21 135.74 53.67 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 t -127.81 134.16 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -139.71 166.19 25.27 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.691 1.196 . . . . 0.0 108.786 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 68.6 m -143.35 150.73 39.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.588 0.755 . . . . 0.0 110.261 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' B' ' 67' ' ' ILE . . . -148.99 158.86 44.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.784 1.234 . . . . 0.0 110.366 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 -176.39 38.53 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.116 0.865 . . . . 0.0 110.941 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.469 HG22 ' H ' ' B' ' 12' ' ' GLY . 1.3 tt -53.69 -63.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 113.482 -169.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -141.28 33.49 1.7 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.766 2.426 . . . . 0.0 105.76 -172.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.13 146.73 52.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.636 2.774 . . . . 0.0 114.26 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -177.24 17.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.899 1.68 . . . . 0.0 111.967 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.86 172.41 40.39 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 120.892 -1.13 . . . . 0.0 112.04 -169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.8 tp -148.68 75.5 1.31 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.89 131.29 79.26 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 125.023 1.329 . . . . 0.0 108.945 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.0 -22.28 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.966 1.777 . . . . 0.0 112.62 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.23 -54.67 44.17 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 119.616 1.098 . . . . 0.0 108.118 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.84 77.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.689 1.131 . . . . 0.0 110.538 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.77 -54.65 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -56.31 -46.08 79.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.006 0.922 . . . . 0.0 110.899 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -34.08 63.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.734 2.014 . . . . 0.0 111.673 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.0 mmm -92.11 -31.21 15.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.114 0.566 . . . . 0.0 110.481 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -61.65 -26.14 67.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.795 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.67 -31.57 64.56 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.961 1.255 . . . . 0.0 111.248 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.47 15.92 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.185 1.394 . . . . 0.0 110.852 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.51 37.55 93.83 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.908 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 81.8 mt -114.13 107.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.9 138.51 54.71 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 pt -133.42 13.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.624 0.77 . . . . 0.0 111.558 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -60.88 -14.34 21.49 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.925 0.784 . . . . 0.0 112.375 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -85.85 -16.05 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.809 1.644 . . . . 0.0 113.659 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.35 153.4 3.97 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.6 p -116.16 159.86 21.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.921 2.088 . . . . 0.0 108.953 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -148.34 153.71 38.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.803 1.241 . . . . 0.0 108.184 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.47 ' H ' ' ND2' ' B' ' 13' ' ' ASN . 39.2 t0 -164.52 161.83 21.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.963 0.801 . . . . 0.0 111.462 -169.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.4 pt -70.43 174.83 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.655 1.182 . . . . 0.0 111.466 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.575 ' HA ' ' HB1' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -52.07 134.0 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.632 0.773 . . . . 0.0 108.918 169.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.93 95.37 2.76 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.477 1.132 . . . . 0.0 109.237 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.44 -34.29 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.878 2.071 . . . . 0.0 113.744 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.81 -20.82 66.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.072 0.851 . . . . 0.0 112.185 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -122.57 -35.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.7 tt -66.21 -46.69 76.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.654 0.661 . . . . 0.0 110.633 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -30.42 71.58 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.847 0.749 . . . . 0.0 110.42 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -78.42 -18.24 55.24 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.662 1.185 . . . . 0.0 112.88 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 167.34 1.75 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.171 0.986 . . . . 0.0 111.961 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -90.19 -25.32 20.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.565 1.146 . . . . 0.0 111.286 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.34 128.68 11.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.994 0.918 . . . . 0.0 109.467 -173.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.09 100.6 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.872 1.669 . . . . 0.0 107.391 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.67 109.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -75.49 101.48 4.87 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.456 HD11 HG12 ' B' ' 127' ' ' ILE . 15.6 tp -80.98 -43.63 19.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.762 -0.586 . . . . 0.0 111.703 -168.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 16.5 m -73.36 174.11 8.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.269 0.627 . . . . 0.0 110.463 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.45 -82.04 1.21 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 106.996 -2.442 . . . . 0.0 106.996 169.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -164.86 132.63 3.19 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.496 1.518 . . . . 0.0 107.177 170.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.31 -51.58 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.99 0.916 . . . . 0.0 109.681 170.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.22 63.29 0.45 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -101.05 -1.23 34.73 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LYS . . . . . 0.419 ' HE3' HG13 ' B' ' 39' ' ' ILE . 3.4 tttt 73.09 19.04 3.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.852 2.061 . . . . 0.0 113.335 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 30.63 55.68 0.79 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.304 2.242 . . . . 0.0 112.521 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.31 139.69 91.09 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.169 1.913 . . . . 0.0 109.795 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.62 4.1 52.14 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.1 p 40.1 98.54 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 128.919 2.888 . . . . 0.0 114.947 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -61.48 138.42 75.92 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.077 1.851 . . . . 0.0 108.856 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.4 ' HD3' ' CD ' ' A' ' 61' ' ' GLN . 57.6 Cg_endo -66.81 3.18 1.62 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.788 3.659 . . . . 0.0 116.398 -168.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -63.33 -13.9 44.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.041 0.837 . . . . 0.0 112.017 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.47 151.32 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.201 0.91 . . . . 0.0 111.483 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 154.73 40.53 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.04 1.736 . . . . 0.0 108.865 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -139.93 145.5 38.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -151.47 141.85 22.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.5 139.72 33.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.75 0.704 . . . . 0.0 111.088 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -123.57 -63.95 1.19 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.009 0.524 . . . . 0.0 112.126 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.83 -44.01 39.81 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 55.86 27.55 11.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.27 1.828 . . . . 0.0 112.997 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -156.18 172.28 18.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.881 1.272 . . . . 0.0 109.032 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -135.12 113.34 11.41 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.166 1.387 . . . . 0.0 108.417 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.92 -21.01 21.55 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.866 3.044 . . . . 0.0 112.513 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.47 ' HB3' HH21 ' B' ' 16' ' ' ARG . . . -70.15 8.36 0.78 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.243 1.017 . . . . 0.0 112.385 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -117.79 13.93 14.22 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.254 1.421 . . . . 0.0 111.288 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.0 151.73 0.6 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.1 0.96 . . . . 0.0 110.984 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.24 -46.16 76.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 -172.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.86 -17.13 3.93 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.2 p -69.63 162.88 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.44 -41.06 88.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.397 0.617 . . . . 0.0 110.791 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -72.16 -43.9 63.91 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 117.079 -1.438 . . . . 0.0 109.851 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.19 -31.05 60.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 121.19 1.813 . . . . 0.0 110.024 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -59.37 -60.4 3.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.54 -39.13 86.77 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.04 97.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.36 -0.838 . . . . 0.0 112.317 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.64 -46.12 83.89 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -58.09 -50.15 74.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.19 -49.01 68.81 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.006 0.922 . . . . 0.0 110.69 -174.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -64.43 -44.09 92.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.894 0.77 . . . . 0.0 110.284 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.82 -42.09 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.985 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -34.82 78.91 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.435 1.47 . . . . 0.0 110.868 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.32 -44.57 83.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.87 0.468 . . . . 0.0 111.484 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.28 -48.31 78.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.456 HG12 HD11 ' B' ' 81' ' ' LEU . 17.1 mt -51.44 -53.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.944 1.297 . . . . 0.0 109.066 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.84 -41.71 99.66 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.252 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -63.4 -41.13 98.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.386 1.093 . . . . 0.0 111.765 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -71.72 -31.83 67.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.07 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' B' ' 131' ' ' LEU . 1.7 mm? -63.21 -48.08 79.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.354 0.979 . . . . 0.0 111.021 171.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -68.94 -37.64 78.98 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.989 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.62 -45.77 88.49 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.788 169.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -59.61 -38.41 81.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.423 1.919 . . . . 0.0 111.128 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.59 76.66 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.17 -44.75 12.66 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.594 1.557 . . . . 0.0 112.162 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.3 p -91.94 -23.0 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.687 1.995 . . . . 0.0 111.198 -169.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.03 54.15 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.306 0.955 . . . . 0.0 112.241 -169.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 127.761 2.425 . . . . 0.0 112.794 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.23 165.41 0.09 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.061 2.145 . . . . 0.0 113.32 -171.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.19 105.34 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.88 169.68 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.54 1.936 . . . . 0.0 108.614 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -123.14 114.81 20.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.073 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -80.95 170.94 15.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.996 0.918 . . . . 0.0 109.861 174.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -156.41 174.5 15.32 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.37 1.868 . . . . 0.0 106.148 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -32.71 -40.65 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 129.277 3.031 . . . . 0.0 116.425 -169.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.06 -31.08 3.14 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.26 1.024 . . . . 0.0 111.651 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -62.42 -21.45 65.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.558 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -50.85 -51.4 51.64 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.796 1.18 . . . . 0.0 109.178 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -62.64 -44.58 95.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.068 -0.395 . . . . 0.0 110.012 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.74 87.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.429 -0.169 . . . . 0.0 110.906 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.75 -12.85 60.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.723 1.209 . . . . 0.0 112.89 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.8 p -118.46 -5.87 10.76 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.626 1.103 . . . . 0.0 112.591 -170.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.3 m -75.81 -7.38 54.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.972 . . . . 0.0 113.454 -175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.05 155.35 45.39 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.366 1.066 . . . . 0.0 109.057 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.15 -155.6 48.86 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.27 0.938 . . . . 0.0 111.052 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.05 131.4 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 t -138.89 122.02 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.15 -168.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -94.35 94.74 8.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 107.891 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.41 148.61 28.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -141.37 146.68 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.665 1.586 . . . . 0.0 109.15 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -129.44 114.25 15.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.433 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.1 p-90 -124.63 161.75 25.59 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.148 1.379 . . . . 0.0 107.358 -174.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.34 159.34 23.82 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.5 -26.37 44.83 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.421 2.08 . . . . 0.0 114.281 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -51.29 -33.43 28.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -171.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -154.85 166.96 31.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.425 1.466 . . . . 0.0 114.075 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.61 -45.63 95.32 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.385 -1.786 . . . . 0.0 114.431 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.78 -29.65 43.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.383 2.592 . . . . 0.0 114.472 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -59.29 -18.74 40.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.139 1.336 . . . . 0.0 114.089 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -114.23 12.32 17.68 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.644 1.177 . . . . 0.0 111.162 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.1 mtm -121.52 -43.79 2.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.589 1.156 . . . . 0.0 109.238 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.68 -37.99 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.964 0.906 . . . . 0.0 109.226 169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.13 -57.88 19.78 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.045 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.7 -39.74 60.92 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.125 1.883 . . . . 0.0 112.064 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.17 -40.49 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.138 0.975 . . . . 0.0 110.85 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.47 -44.37 74.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.947 0.794 . . . . 0.0 110.524 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.8 -37.82 88.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.489 0.586 . . . . 0.0 109.909 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -72.34 -19.97 61.56 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.148 -0.97 . . . . 0.0 111.831 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 tp -80.89 -44.67 17.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.64 1.176 . . . . 0.0 108.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.7 -34.12 73.47 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.764 -0.585 . . . . 0.0 111.063 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.79 -24.81 66.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.779 -0.576 . . . . 0.0 112.176 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -97.13 -44.3 7.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.796 0.838 . . . . 0.0 111.302 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.3 ptm -139.49 14.33 2.56 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.857 0.863 . . . . 0.0 112.108 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.7 -5.11 22.49 Favored Glycine 0 C--O 1.227 -0.341 0 O-C-N 121.088 -1.007 . . . . 0.0 114.07 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.65 -24.25 66.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 110.788 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 -27.07 8.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.391 1.076 . . . . 0.0 111.875 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -116.01 151.01 36.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.466 1.506 . . . . 0.0 112.059 -168.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -116.97 148.56 41.32 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.81 143.55 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 5.6 t -140.54 120.18 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.6 mmmm -87.31 154.13 20.93 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.651 0.66 . . . . 0.0 110.963 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -127.98 115.18 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 102.933 -2.988 . . . . 0.0 102.933 168.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -88.26 87.87 7.45 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 m -42.61 -44.48 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.871 1.669 . . . . 0.0 113.669 -172.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.7 -23.9 65.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.489 1.495 . . . . 0.0 112.443 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -108.53 -30.24 8.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.588 1.555 . . . . 0.0 111.873 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -135.59 25.06 3.43 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -168.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.68 -5.79 13.13 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.585 -0.697 . . . . 0.0 112.645 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.84 -28.35 49.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 111.162 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -74.83 -46.92 33.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 0.0 109.847 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.45 -71.07 0.2 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.357 1.463 . . . . 0.0 111.989 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.37 -41.08 11.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.622 1.105 . . . . 0.0 113.292 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.8 -44.58 89.47 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 118.457 -0.783 . . . . 0.0 111.571 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -65.08 -40.73 95.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.21 67.98 0.41 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.93 127.47 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.838 ' HG3' HD12 ' B' ' 67' ' ' ILE . 15.3 ptm -147.19 19.38 1.23 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.118 -0.468 . . . . 0.0 109.991 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' B' ' 90' ' ' PRO . 3.3 m -141.86 169.86 16.8 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.587 1.155 . . . . 0.0 110.573 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.6 mm -137.92 145.16 46.99 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 107.563 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.15 134.59 30.76 Favored 'Cis proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 -10.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.0 m -102.16 146.68 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.98 137.47 54.6 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.964 1.706 . . . . 0.0 106.639 170.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -124.95 112.45 16.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.68 119.61 49.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.49 152.07 37.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.061 0.944 . . . . 0.0 109.421 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.7 136.13 38.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.2 t70 43.14 28.09 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.886 2.074 . . . . 0.0 114.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.68 48.34 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.579 1.085 . . . . 0.0 115.317 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -129.98 143.96 51.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.891 1.276 . . . . 0.0 110.058 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.0 139.4 19.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.95 -22.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.961 1.304 . . . . 0.0 111.187 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.64 161.01 39.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.723 0.773 . . . . 0.0 109.877 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -155.76 147.08 22.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.8 m -153.4 149.93 28.31 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.089 -1.007 . . . . 0.0 108.432 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.86 68.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.99 156.18 10.83 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.028 1.775 . . . . 0.0 109.521 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -73.22 163.99 27.32 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.886 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.519 ' HE3' HD22 ' A' ' 99' ' ' LEU . 5.8 mtmm -149.89 135.95 10.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.638 1.575 . . . . 0.0 107.26 174.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -68.58 167.74 21.84 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.0 109.903 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -169.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.96 -43.94 70.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.271 0.487 . . . . 0.0 110.853 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.46 78.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.326 0.512 . . . . 0.0 110.403 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 96' ' ' LEU . 17.9 tp -70.7 -48.48 54.42 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.439 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -61.13 -37.68 83.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.2 -48.43 81.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.766 1.166 . . . . 0.0 110.827 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.519 HD22 ' HE3' ' A' ' 91' ' ' LYS . 11.6 tp -54.46 -42.22 70.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.715 1.206 . . . . 0.0 111.291 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -90.52 -37.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.195 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -61.01 -21.94 64.06 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.345 1.429 . . . . 0.0 112.594 -176.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -78.98 -5.92 55.04 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.128 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -126.4 -30.21 2.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.85 1.26 . . . . 0.0 111.993 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 2.4 tm? . . . . . 0 C--O 1.249 1.065 0 C-N-CA 125.978 1.711 . . . . 0.0 108.408 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.08 136.4 53.71 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 109.448 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m120 69.85 127.36 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.967 2.507 . . . . 0.0 110.712 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -137.76 119.06 14.63 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 128.822 2.849 . . . . 0.0 103.98 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.61 139.6 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -169.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.08 149.28 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.906 1.282 . . . . 0.0 107.567 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.514 ' CD1' HD12 ' B' ' 72' ' ' LEU . 2.6 t80 -133.72 146.6 50.93 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.439 -168.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.2 140.53 48.48 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 31.8 tp -136.71 110.97 8.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.5 p -146.22 156.21 43.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -57.78 129.82 43.63 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.863 1.665 . . . . 0.0 111.477 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.422 ' H ' ' CG2' ' B' ' 39' ' ' ILE . . . 46.9 39.25 11.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.335 23.1 t-20 -37.07 99.85 0.02 OUTLIER 'General case' 0 C--N 1.345 0.39 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -166.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -144.47 -2.18 0.88 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.834 1.253 . . . . 0.0 111.626 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.93 -60.71 0.73 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -171.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -51.9 60.83 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.781 -1.2 . . . . 0.0 111.862 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 14.9 m -64.34 -34.27 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.142 0.177 . . . . 0.0 110.811 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -60.57 -50.73 72.37 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.141 1.776 . . . . 0.0 109.636 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 6.0 ptp -67.56 -40.09 84.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.72 94.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.838 0.855 . . . . 0.0 111.683 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.07 -30.27 64.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.332 0.969 . . . . 0.0 111.251 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.37 -50.59 54.99 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.443 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -55.93 -37.26 68.71 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.117 0.967 . . . . 0.0 111.585 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.67 56.02 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 122.599 0.36 . . . . 0.0 110.414 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -65.16 -24.36 67.37 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.85 -12.52 61.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.417 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 10.9 m-85 -130.39 -14.33 3.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.433 1.093 . . . . 0.0 113.876 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 25.4 mt -120.19 88.49 2.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.22 -166.86 0.57 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.78 1.657 . . . . 0.0 113.586 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.71 -17.0 12.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.623 1.169 . . . . 0.0 112.718 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.29 -24.38 7.34 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.702 1.601 . . . . 0.0 110.946 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -127.46 153.4 46.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.048 1.739 . . . . 0.0 110.061 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 135.21 47.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.04 152.98 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -169.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -145.99 164.06 33.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.438 1.095 . . . . 0.0 109.236 177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.5 m -142.22 126.08 17.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 108.958 -169.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.16 -177.85 6.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.499 0.591 . . . . 0.0 111.266 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.69 -167.75 40.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.422 ' CG2' ' H ' ' B' ' 12' ' ' GLY . 16.0 tt -70.11 154.65 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 31.8 58.13 0.33 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 130.016 3.326 . . . . 0.0 110.041 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.29 137.53 53.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.459 1.103 . . . . 0.0 111.896 -168.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 28.0 p80 174.99 -2.36 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.84 2.056 . . . . 0.0 111.568 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.09 174.97 54.3 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.923 0.783 . . . . 0.0 111.828 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 tp -139.33 83.83 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -55.39 128.93 68.44 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.58 1.152 . . . . 0.0 108.03 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.73 -21.67 57.42 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.735 1.623 . . . . 0.0 112.326 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -57.44 -54.21 49.37 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 168.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.93 80.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.089 1.313 . . . . 0.0 110.893 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.22 -54.11 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.35 -43.42 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.393 0.677 . . . . 0.0 110.757 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -35.54 62.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.712 2.005 . . . . 0.0 110.339 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 75.1 mmm -93.75 -33.0 13.78 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.988 0.915 . . . . 0.0 111.831 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -59.84 -29.41 68.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.034 0.834 . . . . 0.0 110.901 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -60.32 -33.03 71.81 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.388 0.994 . . . . 0.0 111.63 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.87 13.95 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.609 1.164 . . . . 0.0 111.363 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.2 38.62 92.09 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.648 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.75 107.54 22.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.54 137.82 52.75 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.62 13.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 123.751 0.821 . . . . 0.0 111.773 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -60.4 -15.83 29.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.125 0.875 . . . . 0.0 112.543 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -81.6 -17.07 49.55 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.557 1.543 . . . . 0.0 113.556 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -54.52 154.04 5.14 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -125.51 158.42 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.184 2.194 . . . . 0.0 108.86 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 6.4 m -150.12 157.3 42.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.784 1.234 . . . . 0.0 108.354 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -162.39 168.84 21.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.581 1.152 . . . . 0.0 109.621 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 10.7 pt -69.21 172.23 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.296 1.038 . . . . 0.0 112.124 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.838 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.6 OUTLIER -44.24 131.31 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 125.517 1.527 . . . . 0.0 108.413 175.401 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -142.69 94.25 2.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.863 0.84 . . . . 0.0 108.926 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -50.63 -24.01 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.259 1.423 . . . . 0.0 114.791 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 -29.43 66.35 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 120.661 1.573 . . . . 0.0 109.917 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.37 -42.08 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.172 171.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.521 HD13 ' CE ' ' A' ' 70' ' ' MET . 4.5 tt -63.12 -49.59 73.82 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.652 1.114 . . . . 0.0 110.578 -174.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -29.49 70.74 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.884 1.22 . . . . 0.0 110.138 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -77.12 -14.67 59.76 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.553 1.141 . . . . 0.0 112.867 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.17 163.64 19.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.176 0.988 . . . . 0.0 110.167 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.81 -36.94 16.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.828 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.425 HD23 ' CE ' ' B' ' 97' ' ' LYS . 2.8 tm? -145.33 139.89 27.35 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.415 0.686 . . . . 0.0 111.357 -168.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.4 t -118.54 109.64 27.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 126.252 1.821 . . . . 0.0 107.538 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.7 97.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -66.2 125.86 26.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 167.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -129.96 61.67 1.57 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.958 0.903 . . . . 0.0 111.437 -167.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 51.4 m -155.42 -172.68 4.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.796 1.239 . . . . 0.0 108.299 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -147.66 42.09 0.9 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -141.31 153.43 45.16 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.842 1.257 . . . . 0.0 109.374 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.48 -11.34 54.48 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.58 -18.68 64.38 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.464 1.029 . . . . 0.0 112.986 -173.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -73.55 43.53 0.14 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.65 1.58 . . . . 0.0 113.882 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 52.54 -155.71 0.18 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.808 1.643 . . . . 0.0 110.706 -169.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.68 63.54 59.53 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.57 2.348 . . . . 0.0 105.421 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 37.4 Cg_exo -57.14 128.3 29.18 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.932 1.755 . . . . 0.0 110.572 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 3.11 48.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.149 -0.929 . . . . 0.0 113.036 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p 37.05 91.93 0.06 OUTLIER Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 128.283 2.633 . . . . 0.0 113.695 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -55.2 130.09 38.8 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.399 2.733 . . . . 0.0 107.939 -174.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.83 2.66 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 126.129 4.553 . . . . 0.0 118.351 -168.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.9 -24.82 68.02 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 119.446 1.021 . . . . 0.0 109.87 169.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.03 153.53 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.39 1.076 . . . . 0.0 112.393 175.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.425 ' CE ' HD23 ' B' ' 77' ' ' LEU . 4.6 tmmm? -93.38 154.72 17.8 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 167.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -152.94 146.08 24.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.532 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -156.11 154.78 31.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 168.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -104.77 140.22 38.41 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.885 1.274 . . . . 0.0 109.284 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -142.81 -1.17 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.12 -58.65 3.34 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.387 0.994 . . . . 0.0 110.939 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 55.78 14.83 1.42 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.264 1.825 . . . . 0.0 113.656 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -163.2 171.06 16.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 0.0 107.822 -169.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -150.51 104.92 3.09 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.311 1.045 . . . . 0.0 108.984 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.45 -29.6 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.931 2.42 . . . . 0.0 114.301 -169.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.28 64.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.526 0.731 . . . . 0.0 111.026 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -83.67 -56.7 3.57 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ALA . . . . . 0.437 ' HB3' ' HE3' ' B' ' 116' ' ' LYS . . . 44.29 -176.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.097 2.159 . . . . 0.0 115.233 -169.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.54 -40.46 73.4 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.1 -20.9 4.69 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 49.1 p -70.93 166.4 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.689 0.745 . . . . 0.0 109.385 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.95 -39.66 86.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.119 0.485 . . . . 0.0 111.042 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.4 pt-20 -75.65 -42.69 50.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 117.504 -1.236 . . . . 0.0 109.593 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.39 -30.14 60.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.513 1.506 . . . . 0.0 110.231 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' B' ' 109' ' ' ALA . 2.9 mmpt? -57.21 -59.25 5.39 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 169.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -61.47 -38.8 88.57 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.794 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.56 94.05 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.216 -0.928 . . . . 0.0 111.865 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 4.0 m-85 -64.63 -46.49 82.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.216 -0.421 . . . . 0.0 109.965 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -56.3 -49.62 73.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -62.54 -48.54 79.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.853 1.661 . . . . 0.0 110.128 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -60.22 -51.9 67.59 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.86 -41.67 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.61 -0.709 . . . . 0.0 109.427 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.443 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 3.7 tmm_? -59.62 -43.01 93.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.511 1.051 . . . . 0.0 111.777 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.8 -46.23 88.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.263 0.483 . . . . 0.0 110.928 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.73 -38.89 73.59 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.23 -0.294 . . . . 0.0 110.99 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.25 -45.74 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.36 1.064 . . . . 0.0 108.875 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.81 -42.7 86.03 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-O 119.165 -0.797 . . . . 0.0 111.682 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -56.97 -45.66 82.73 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.346 1.073 . . . . 0.0 110.988 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -61.34 -39.64 91.33 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.612 0.765 . . . . 0.0 110.44 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.4 mm? -77.01 -34.15 57.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 119.094 0.861 . . . . 0.0 112.589 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.9 ttmt -66.83 -39.17 87.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.751 0.705 . . . . 0.0 109.413 172.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -61.31 -35.22 76.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 117.296 -1.335 . . . . 0.0 110.077 169.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.4 -41.07 88.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 120.881 1.673 . . . . 0.0 109.814 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.64 70.47 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.81 0.844 . . . . 0.0 112.591 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -92.27 -36.55 13.16 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.378 1.471 . . . . 0.0 112.721 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 70.6 p -109.1 -11.81 14.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.962 1.705 . . . . 0.0 111.905 -169.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.75 23.63 67.41 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.034 1.302 . . . . 0.0 113.515 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.034 1.734 . . . . 0.0 106.848 -169.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 tpp . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.31 171.15 19.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.639 1.576 . . . . 0.0 107.571 170.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.2 93.82 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.73 171.29 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.148 1.779 . . . . 0.0 107.842 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.82 144.92 49.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.279 1.032 . . . . 0.0 109.174 172.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.439 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -116.25 169.94 8.91 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.257 1.823 . . . . 0.0 108.594 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -156.54 -173.79 4.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -38.67 -39.48 0.5 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.932 2.493 . . . . 0.0 115.811 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -129.01 -30.2 2.24 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.337 1.055 . . . . 0.0 111.505 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -60.77 -25.25 66.38 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.657 -0.687 . . . . 0.0 111.815 172.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -52.15 -56.55 13.8 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.064 0.847 . . . . 0.0 109.226 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -61.02 -44.16 97.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.89 -34.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.352 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.41 -12.91 57.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.573 1.149 . . . . 0.0 113.333 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.4 p -120.83 -7.92 9.48 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.096 1.316 . . . . 0.0 114.398 -168.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -78.71 -2.32 38.74 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -140.43 153.0 46.14 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.28 1.032 . . . . 0.0 109.237 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.14 -157.23 49.38 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.71 128.92 72.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.36 115.16 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.9 tt -78.93 139.06 38.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.62 141.56 51.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.54 142.09 48.03 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.372 1.469 . . . . 0.0 108.563 -173.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.5 116.42 21.07 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -135.02 154.23 51.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.95 1.3 . . . . 0.0 108.711 -170.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.1 161.49 18.46 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.51 0.724 . . . . 0.0 109.651 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.87 -14.83 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.498 2.799 . . . . 0.0 116.514 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -55.15 -24.21 25.34 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.4 p -155.94 169.6 24.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.771 1.168 . . . . 0.0 113.481 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.57 89.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.39 -1.783 . . . . 0.0 114.28 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.31 -28.46 43.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.381 2.591 . . . . 0.0 114.311 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -59.2 -16.83 22.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.898 1.226 . . . . 0.0 113.828 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -116.59 13.0 15.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.737 1.215 . . . . 0.0 111.525 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.0 mtm -122.91 -43.62 2.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.301 1.04 . . . . 0.0 109.415 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.09 -38.06 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -56.49 32.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.716 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.57 -38.68 80.88 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.87 1.713 . . . . 0.0 111.54 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.49 -38.11 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.9 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.52 -48.03 79.22 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 119.559 1.072 . . . . 0.0 109.979 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -66.57 -35.7 80.84 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.905 -0.497 . . . . 0.0 109.848 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.62 -15.33 61.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.74 1.616 . . . . 0.0 112.833 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.25 -44.6 10.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 108.56 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.7 -37.98 76.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.298 -0.251 . . . . 0.0 111.082 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -68.4 -9.85 51.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.948 -0.548 . . . . 0.0 112.15 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.0 -48.32 3.77 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.112 0.965 . . . . 0.0 110.967 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -132.35 16.11 4.52 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.822 0.849 . . . . 0.0 112.45 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.54 19.23 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 121.175 -0.953 . . . . 0.0 114.134 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.28 -23.83 65.71 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 169.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.3 -18.81 9.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.191 0.996 . . . . 0.0 112.439 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.9 tp -128.47 148.08 50.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.364 1.066 . . . . 0.0 111.413 -168.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -110.54 146.98 35.09 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.92 142.23 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 3.5 t -136.43 140.27 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -106.77 145.34 32.2 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 123.868 0.867 . . . . 0.0 110.281 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.02 122.78 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -85.47 111.21 19.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.261 33.8 m -82.48 41.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -148.49 -38.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.932 0.893 . . . . 0.0 109.415 168.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.86 -51.4 12.6 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.88 1.272 . . . . 0.0 109.862 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.47 47.77 2.17 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.68 1.192 . . . . 0.0 110.088 -172.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -73.55 -1.75 19.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.861 1.265 . . . . 0.0 112.758 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -55.28 -44.47 75.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.243 1.417 . . . . 0.0 110.86 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -57.92 -41.72 83.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.685 0.675 . . . . 0.0 111.152 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB1' ' CE ' ' B' ' 91' ' ' MET . . . -69.24 -61.81 1.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.455 1.102 . . . . 0.0 108.719 -171.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.86 -41.74 28.53 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.753 -1.026 . . . . 0.0 113.851 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -62.75 -44.35 96.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.432 1.616 . . . . 0.0 110.961 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -71.78 -11.78 60.98 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.196 0.453 . . . . 0.0 111.276 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.66 56.13 6.9 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 m -103.71 -46.41 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.976 0.888 . . . . 0.0 108.942 -169.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.3 mtm 52.73 15.23 0.5 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 127.574 2.35 . . . . 0.0 113.397 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 m -138.08 159.77 41.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.589 1.155 . . . . 0.0 110.945 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.46 143.77 42.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.07 129.91 20.09 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 N-CA-C 107.71 -1.689 . . . . 0.0 107.71 -10.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -98.04 145.36 26.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tp -137.01 126.57 25.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -124.82 110.45 14.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.99 120.22 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 171.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp -112.47 150.79 30.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.697 1.199 . . . . 0.0 109.298 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -150.77 124.75 9.26 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.09 27.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.5 2.72 . . . . 0.0 114.93 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.32 -24.01 3.26 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.606 -1.108 . . . . 0.0 115.378 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.48 159.04 43.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.032 1.416 . . . . 0.0 113.156 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.15 133.62 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.59 -20.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.888 1.275 . . . . 0.0 111.04 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.76 157.7 44.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.235 1.014 . . . . 0.0 109.524 169.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.94 148.28 29.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -171.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -152.71 149.54 28.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.06 57.68 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.09 20.4 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.921 1.724 . . . . 0.0 110.622 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -66.63 157.2 33.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.995 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -148.13 135.33 10.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -68.43 169.66 16.6 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.484 2.123 . . . . 0.0 110.412 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -46.8 65.43 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 112.034 -171.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.77 -42.13 77.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.849 0.093 . . . . 0.0 110.958 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.28 81.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.866 -0.521 . . . . 0.0 110.423 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.83 -47.67 71.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.19 -37.15 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.723 -0.655 . . . . 0.0 109.54 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.11 -46.63 86.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.675 0.67 . . . . 0.0 110.93 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -56.02 -41.64 75.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.439 0.696 . . . . 0.0 111.093 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -83.15 -42.0 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.506 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 10.5 t30 -56.4 -35.53 67.88 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.523 1.129 . . . . 0.0 111.801 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -69.18 -7.67 38.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.36 -25.7 4.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.472 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 16.1 tp . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.606 1.962 . . . . 0.0 109.275 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.14 27.49 4.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.842 1.257 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -157.39 129.73 7.31 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.479 ' H ' ' HA ' ' B' ' 32' ' ' TRP . 95.4 mttt -118.87 114.3 22.39 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 129.333 3.053 . . . . 0.0 103.677 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -90.12 141.16 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.22 141.49 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -131.53 138.86 49.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -115.76 152.66 32.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.75 0.705 . . . . 0.0 109.305 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 mt -132.11 118.35 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.6 p -150.22 157.49 43.14 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.804 1.242 . . . . 0.0 109.402 169.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 31.3 m -53.6 123.97 13.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.313 1.045 . . . . 0.0 110.361 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.95 18.49 11.79 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.657 0.646 . . . . 0.0 113.312 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t30 43.05 47.68 5.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.189 1.796 . . . . 0.0 112.691 -169.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -74.77 -157.35 0.06 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.82 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . -33.92 -63.3 0.27 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.55 2.74 . . . . 0.0 116.82 -168.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -57.99 -47.23 83.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 0.896 . . . . 0.0 111.611 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -60.51 -49.4 77.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.718 0.69 . . . . 0.0 111.681 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -57.14 -48.8 77.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.317 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.4 ttm -66.81 -42.93 85.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.551 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.93 84.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.923 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.16 -28.93 57.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.615 1.098 . . . . 0.0 111.179 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 -43.86 48.44 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -56.1 -41.72 75.65 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.18 0.99 . . . . 0.0 111.117 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.45 -50.58 70.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -63.39 -21.76 66.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 118.079 -0.962 . . . . 0.0 113.277 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.37 -16.45 63.93 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.612 1.096 . . . . 0.0 113.824 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.6 -39.79 0.57 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.896 1.226 . . . . 0.0 113.107 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.427 ' HG ' ' CG ' ' B' ' 32' ' ' TRP . 4.3 tp -77.45 75.6 4.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.534 2.734 . . . . 0.0 105.081 169.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.64 -166.9 1.86 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.85 2.167 . . . . 0.0 114.767 -169.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -56.93 -20.61 24.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.23 1.412 . . . . 0.0 112.968 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -55.65 -20.54 14.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 112.482 169.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' TRP . . . . . 0.479 ' HA ' ' H ' ' B' ' 4' ' ' LYS . 63.9 m95 -118.22 174.17 6.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.383 1.873 . . . . 0.0 109.789 -176.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 114.61 5.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.78 149.2 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -150.8 167.36 27.7 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 168.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -152.17 147.54 26.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 110.391 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.06 178.16 9.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.855 1.262 . . . . 0.0 111.216 -169.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.14 -175.63 42.75 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -47.75 -58.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.492 . . . . 0.0 114.541 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.07 31.56 4.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.573 1.549 . . . . 0.0 108.425 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.45 151.32 47.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.68 1.992 . . . . 0.0 115.17 -169.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 p80 162.8 47.2 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 130.906 3.683 . . . . 0.0 107.567 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.8 177.28 27.86 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.894 0.759 . . . . 0.0 112.017 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 36.3 tp -161.28 83.67 0.64 Allowed 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.44 126.47 90.66 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.476 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.41 -24.98 75.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.214 1.943 . . . . 0.0 112.722 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.3 -51.17 70.9 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -59.22 -35.76 74.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.849 1.204 . . . . 0.0 111.214 -175.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.04 -53.76 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.58 -48.09 80.33 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 110.567 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.984 1.714 . . . . 0.0 111.855 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.72 -43.49 14.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.861 0.864 . . . . 0.0 110.051 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.24 -30.71 69.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.623 0.647 . . . . 0.0 110.832 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -27.59 62.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.874 1.27 . . . . 0.0 112.292 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.37 15.48 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.147 1.379 . . . . 0.0 111.158 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.66 72.66 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.179 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 63.0 mt -110.19 149.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -117.93 135.45 54.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.589 0.756 . . . . 0.0 108.993 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 pt -136.56 17.4 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.4 1.08 . . . . 0.0 111.048 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -67.23 13.46 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -169.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -137.75 -4.56 1.78 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.235 2.614 . . . . 0.0 111.539 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -57.92 147.73 27.94 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.532 1.06 . . . . 0.0 111.324 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -126.89 168.95 13.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.61 1.964 . . . . 0.0 109.184 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 7.0 p -155.03 -174.45 4.99 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.172 0.989 . . . . 0.0 108.442 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -159.23 168.51 26.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.559 1.543 . . . . 0.0 107.933 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.7 pt -60.26 164.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.464 0.705 . . . . 0.0 111.304 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -48.22 127.04 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -135.83 99.17 4.1 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.67 1.224 . . . . 0.0 109.194 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -42.68 -31.68 0.49 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.731 2.413 . . . . 0.0 114.559 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.07 -17.67 63.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.243 0.928 . . . . 0.0 112.212 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.33 -38.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.345 1.058 . . . . 0.0 109.04 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.433 HD23 ' C ' ' B' ' 72' ' ' LEU . 7.9 tt -61.77 -56.56 18.22 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.02 1.282 . . . . 0.0 109.332 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.0 66.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.566 0.621 . . . . 0.0 111.279 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.41 -24.76 36.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.025 1.73 . . . . 0.0 112.525 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.55 172.03 2.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.481 1.513 . . . . 0.0 112.149 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.92 -36.93 13.85 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.67 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' B' ' 97' ' ' LYS . 14.4 tp -143.64 133.26 23.64 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 109.634 -171.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.38 115.15 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.16 107.82 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.1 m -75.53 88.06 2.67 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 167.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 48.01 1.16 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.949 1.7 . . . . 0.0 107.114 -169.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 2.8 p -148.1 170.13 18.46 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.725 1.21 . . . . 0.0 109.937 -169.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.78 43.81 0.74 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -145.92 118.31 8.46 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.68 -7.36 50.05 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -169.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.59 -13.44 61.01 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.64 50.15 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.327 1.451 . . . . 0.0 113.527 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 52.78 -147.53 0.47 Allowed 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.999 -1.063 . . . . 0.0 108.627 -169.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.48 55.53 1.98 Allowed Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 126.683 1.993 . . . . 0.0 106.1 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.7 135.03 50.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.181 1.254 . . . . 0.0 112.003 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.432 ' HG3' ' H ' ' B' ' 91' ' ' MET 0.255 0.0 OUTLIER -83.69 4.93 26.51 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.742 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p 39.91 84.88 0.17 Allowed Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 125.245 1.418 . . . . 0.0 113.063 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -53.57 138.97 67.03 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.201 2.601 . . . . 0.0 110.614 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.95 8.6 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 125.669 4.246 . . . . 0.0 117.225 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.04 -5.13 20.0 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.218 -0.926 . . . . 0.0 111.608 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.9 149.88 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.655 1.182 . . . . 0.0 110.473 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.616 ' HD2' HD13 ' B' ' 77' ' ' LEU . 0.4 OUTLIER -75.85 155.75 35.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.124 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -142.2 146.99 35.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 120.713 -1.242 . . . . 0.0 108.507 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -139.4 151.46 46.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -133.9 115.93 15.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -152.64 1.73 0.31 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.17 -53.33 45.6 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.756 1.162 . . . . 0.0 111.123 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.8 t80 58.18 -12.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.405 2.682 . . . . 0.0 117.03 169.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -152.28 82.0 1.25 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.252 1.421 . . . . 0.0 108.497 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.05 129.6 77.94 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.646 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.08 -26.64 9.06 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.661 2.907 . . . . 0.0 112.909 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.73 11.85 0.45 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.601 1.092 . . . . 0.0 112.035 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -123.61 16.18 9.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.234 2.214 . . . . 0.0 111.14 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.06 153.12 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -67.63 140.81 56.87 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.51 58.28 4.99 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.268 -168.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -127.17 149.87 49.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.19 -40.32 46.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.698 1.599 . . . . 0.0 111.507 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.83 -41.06 60.6 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.916 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.15 -31.49 49.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.948 0.795 . . . . 0.0 109.8 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -57.64 -59.85 4.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -62.75 -39.83 95.36 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.665 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.6 84.2 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.684 0.794 . . . . 0.0 112.313 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -63.95 -47.74 79.29 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.46 -40.51 96.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.387 0.54 . . . . 0.0 110.399 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -64.34 -51.69 62.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.691 1.196 . . . . 0.0 109.627 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.2 ttp-105 -59.1 -46.12 89.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.75 -43.86 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.377 -1.297 . . . . 0.0 111.19 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.69 81.99 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.554 1.979 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.42 -45.7 89.75 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.58 -53.79 46.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.665 0.786 . . . . 0.0 110.354 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.69 -47.38 85.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.938 0.895 . . . . 0.0 109.765 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.96 -44.11 98.56 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -62.05 -43.66 98.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.049 0.925 . . . . 0.0 111.801 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -65.3 -45.93 82.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.421 0.555 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.67 -31.87 70.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.057 0.844 . . . . 0.0 111.198 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.87 -39.84 91.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.103 171.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -59.7 -38.37 81.39 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.075 -1.44 . . . . 0.0 111.155 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -60.26 -37.23 79.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.69 2.041 . . . . 0.0 109.928 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.36 79.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.374 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -81.75 -47.92 12.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.411 1.085 . . . . 0.0 111.672 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.1 p -82.0 -24.19 35.56 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.835 2.054 . . . . 0.0 112.526 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.94 24.17 62.4 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 C-N-CA 128.381 2.672 . . . . 0.0 112.226 -169.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.54 169.74 23.96 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.556 1.542 . . . . 0.0 107.581 171.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.76 96.53 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.36 166.27 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.148 1.379 . . . . 0.0 108.065 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -126.03 116.14 20.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.151 1.38 . . . . 0.0 108.088 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.14 173.95 10.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.861 1.264 . . . . 0.0 111.157 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -155.36 179.07 9.52 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.986 2.514 . . . . 0.0 105.544 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -48.33 -29.88 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.543 1.937 . . . . 0.0 115.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.79 -27.29 3.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.85 0.86 . . . . 0.0 112.394 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.3 m -59.86 -40.35 88.28 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.83 122.28 18.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 167.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m 118.9 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.693 1 C-N-CA 132.034 4.133 . . . . 0.0 106.126 -169.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.32 93.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 110.361 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -80.03 -13.15 59.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.42 1.488 . . . . 0.0 112.225 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.0 p -120.24 -9.96 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -168.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -80.81 0.28 35.56 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.165 0.893 . . . . 0.0 113.299 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.1 150.87 47.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.997 0.817 . . . . 0.0 110.159 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.83 -152.55 51.74 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.22 131.66 69.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.73 114.37 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -169.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.48 97.36 7.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 107.474 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.43 26.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -138.84 147.54 42.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.439 1.496 . . . . 0.0 109.299 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -128.49 110.96 12.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -171.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.534 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.0 p-90 -123.35 150.01 44.19 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -173.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.3 154.94 22.69 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.351 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.67 -20.76 22.65 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.981 2.454 . . . . 0.0 115.426 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -49.65 -28.81 6.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.761 2.024 . . . . 0.0 115.755 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -156.55 169.66 24.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.72 1.6 . . . . 0.0 113.463 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.6 -45.3 96.6 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.364 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -52.21 -29.63 38.45 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.533 2.666 . . . . 0.0 114.96 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -58.82 -20.99 55.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 120.32 1.418 . . . . 0.0 113.783 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -109.5 11.61 24.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.389 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -121.6 -43.85 2.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.385 1.074 . . . . 0.0 109.426 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.61 -35.62 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.003 0.921 . . . . 0.0 109.577 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.23 14.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.827 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.01 -38.59 77.15 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.018 1.812 . . . . 0.0 111.784 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.04 -41.57 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.169 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mp -66.37 -41.08 89.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.226 0.921 . . . . 0.0 110.987 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.98 -35.51 80.77 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.085 0.857 . . . . 0.0 110.063 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -71.2 -24.12 62.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.802 1.241 . . . . 0.0 112.152 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 3.4 tm? -81.55 -44.97 16.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.132 1.373 . . . . 0.0 108.735 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' HD13 ' A' ' 52' ' ' ILE . 25.6 t70 -66.11 -38.47 88.3 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.922 -0.486 . . . . 0.0 111.058 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.95 -5.02 31.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.479 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -105.31 -49.14 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.517 1.127 . . . . 0.0 111.038 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.4 ptm -130.38 15.12 5.55 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.235 0.614 . . . . 0.0 112.152 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -5.85 23.39 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 121.223 -0.923 . . . . 0.0 113.453 170.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.51 -25.23 67.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.009 1.324 . . . . 0.0 110.668 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -25.36 6.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.284 1.034 . . . . 0.0 112.126 -175.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.1 tp -118.84 153.35 34.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.678 1.191 . . . . 0.0 112.428 -167.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -116.1 147.92 40.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' A' ' 43' ' ' ASP . 4.4 mp -123.95 144.8 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.63 143.12 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 22.4 mtpt -117.3 152.26 35.24 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.831 0.741 . . . . 0.0 110.417 175.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mm -115.5 115.17 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -80.0 76.93 6.72 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 108.508 169.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 61' ' ' GLN . 32.7 t -31.83 -59.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 129.081 2.952 . . . . 0.0 114.264 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.71 -23.42 64.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 121.528 1.967 . . . . 0.0 112.788 -170.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.93 -32.12 10.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.412 1.485 . . . . 0.0 112.066 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -136.51 25.15 3.17 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.433 ' HB3' HG13 ' A' ' 57' ' ' VAL . 8.1 pt20 -70.08 -0.08 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.584 1.154 . . . . 0.0 112.851 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -50.61 -46.51 58.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.549 1.14 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -56.57 -43.71 80.26 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.676 0.79 . . . . 0.0 111.634 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.93 2.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.728 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.57 -43.57 28.53 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.911 1.243 . . . . 0.0 113.423 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -64.08 -41.59 97.27 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.442 1.121 . . . . 0.0 111.216 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -70.34 -35.92 73.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.61 0.641 . . . . 0.0 110.101 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.35 69.06 1.0 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.428 -2.269 . . . . 0.0 107.428 -169.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.87 -60.76 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.421 ' HG3' HD12 ' B' ' 67' ' ' ILE . 9.3 ptm 50.64 7.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.166 2.987 . . . . 0.0 115.158 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 p -142.97 165.22 27.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.667 1.587 . . . . 0.0 112.146 -171.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.0 mm -142.76 145.54 34.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.209 1.403 . . . . 0.0 107.336 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.16 133.98 26.92 Favored 'Cis proline' 0 N--CA 1.452 -0.914 0 N-CA-C 106.603 -2.114 . . . . 0.0 106.603 -11.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.2 m -114.19 142.28 46.45 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.79 137.48 53.36 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -124.37 105.37 9.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 169.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.82 112.85 24.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.78 151.87 21.17 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.719 0.808 . . . . 0.0 109.116 174.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -149.39 126.5 11.32 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 44.7 22.36 0.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.176 2.59 . . . . 0.0 115.097 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.32 -22.57 3.21 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.229 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.13 159.33 42.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.921 1.36 . . . . 0.0 112.679 -168.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.69 134.04 30.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.27 -18.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.092 1.357 . . . . 0.0 110.917 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -144.7 154.8 43.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.41 133.69 15.3 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 p -150.55 158.36 44.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.474 0.579 . . . . 0.0 109.926 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.22 71.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 122.387 1.089 . . . . 0.0 108.708 -169.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 157.22 12.15 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 121.287 -0.883 . . . . 0.0 111.422 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.85 148.78 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.995 0.518 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -142.56 131.03 11.63 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.36 167.94 17.4 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.809 1.673 . . . . 0.0 109.723 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -46.24 -46.07 17.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.717 1.607 . . . . 0.0 112.468 -176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.86 -42.98 69.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.229 0.468 . . . . 0.0 111.461 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.93 79.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.722 -0.612 . . . . 0.0 110.631 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -54.5 42.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.56 0.744 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.34 -38.75 92.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.626 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.49 -47.62 84.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.993 0.815 . . . . 0.0 110.884 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.61 -43.86 80.57 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.766 0.827 . . . . 0.0 110.693 -174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.72 -33.03 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.747 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 7.5 t30 -61.89 -26.92 68.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.653 1.115 . . . . 0.0 111.552 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -22.91 35.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.13 0.972 . . . . 0.0 112.629 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -129.74 -22.02 3.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.736 0.814 . . . . 0.0 112.393 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 1.7 tm? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.99 2.116 . . . . 0.0 108.543 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.76 136.69 45.53 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.251 6.5 m120 67.35 120.78 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 128.542 2.737 . . . . 0.0 111.417 -170.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -148.89 137.38 21.12 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 129.178 2.991 . . . . 0.0 104.145 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.67 139.93 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 109.159 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tt -137.61 143.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.429 ' CD1' HD23 ' B' ' 72' ' ' LEU . 24.1 t80 -138.08 142.95 40.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -169.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -115.8 144.36 44.11 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 mt -133.19 122.28 23.77 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.4 p -165.82 156.89 13.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.349 1.06 . . . . 0.0 109.673 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 56.0 m -52.24 118.61 3.64 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.33 1.052 . . . . 0.0 112.129 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.58 3.26 2.1 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 124.892 1.37 . . . . 0.0 113.979 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 39.51 24.18 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.438 2.695 . . . . 0.0 114.54 -169.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 -40.08 77.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.36 -73.28 0.51 Allowed 'General case' 0 C--O 1.227 -0.08 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -168.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -32.83 68.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.641 -0.662 . . . . 0.0 112.377 -169.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -43.77 76.75 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.366 1.066 . . . . 0.0 110.379 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -55.75 -45.26 78.06 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 110.388 174.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 16.3 ttm -67.99 -46.42 71.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.829 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.23 87.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.31 0.644 . . . . 0.0 111.218 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.96 -28.65 57.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.268 0.94 . . . . 0.0 110.644 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.93 -44.53 46.18 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.434 ' HE1' ' HB2' ' B' ' 124' ' ' ARG . 23.1 m95 -54.49 -41.97 70.18 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.158 0.979 . . . . 0.0 110.887 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' B' ' 28' ' ' LEU . . . -61.33 -50.68 71.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -66.45 -21.5 66.2 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.387 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -66.31 -16.67 64.23 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.467 1.03 . . . . 0.0 113.025 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.67 -4.49 4.14 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.587 1.155 . . . . 0.0 113.007 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.468 HD12 ' HB1' ' B' ' 24' ' ' ALA . 22.9 mt -121.01 89.75 3.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.51 -171.6 1.38 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.815 0.722 . . . . 0.0 111.962 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.46 -18.15 16.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.436 1.094 . . . . 0.0 112.893 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -54.07 -18.86 4.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.518 1.927 . . . . 0.0 112.655 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.26 158.22 44.72 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.817 1.247 . . . . 0.0 109.62 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -130.35 133.36 46.36 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.014 0.926 . . . . 0.0 108.572 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.72 142.96 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.669 1.587 . . . . 0.0 107.367 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.97 159.47 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 m -139.82 142.37 36.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.07 178.22 10.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.104 0.962 . . . . 0.0 109.839 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.11 -177.71 47.67 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -44.21 -57.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.676 1.99 . . . . 0.0 114.154 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.98 29.59 4.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.335 1.454 . . . . 0.0 108.446 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.3 42.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.46 1.904 . . . . 0.0 113.964 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 75.7 t60 141.17 104.43 0.0 OUTLIER 'General case' 0 C--O 1.235 0.34 0 C-N-CA 130.656 3.582 . . . . 0.0 104.361 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.94 48.19 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -171.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -163.19 94.68 0.83 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.29 1.836 . . . . 0.0 106.67 169.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -68.99 126.55 92.88 Favored Pre-proline 0 C--O 1.239 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.64 -20.87 60.11 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.99 1.794 . . . . 0.0 112.846 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.405 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -62.37 -37.23 84.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.508 1.049 . . . . 0.0 111.199 171.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.98 -34.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.33 -52.18 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -56.21 -46.58 79.4 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.88 0.764 . . . . 0.0 110.553 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.37 -32.46 64.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.007 0.923 . . . . 0.0 111.842 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.7 -38.56 25.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.695 0.798 . . . . 0.0 110.76 177.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -27.21 69.15 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.983 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.423 ' CD ' ' HE ' ' B' ' 124' ' ' ARG . 35.3 mt-10 -55.05 -32.67 62.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.478 1.035 . . . . 0.0 111.817 172.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.12 14.56 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.042 1.337 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.77 35.42 91.99 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.38 -1.233 . . . . 0.0 113.152 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.2 mt -104.95 145.16 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 170.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.66 136.0 53.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 29.0 pt -138.15 17.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 110.655 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -60.39 -13.91 15.9 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -91.72 -14.28 30.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.751 1.62 . . . . 0.0 113.237 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.21 151.31 23.28 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.539 1.161 . . . . 0.0 112.417 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.5 t -152.87 171.79 17.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.588 1.955 . . . . 0.0 107.105 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.0 m -153.69 -167.8 2.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.845 0.858 . . . . 0.0 111.028 -169.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -159.53 168.54 25.92 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.809 1.644 . . . . 0.0 109.562 -171.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.52 172.5 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.111 1.364 . . . . 0.0 112.134 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.421 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.7 OUTLIER -48.31 132.86 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.567 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -143.98 100.17 3.52 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.309 1.052 . . . . 0.0 109.457 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.0 m -44.77 -32.32 1.5 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.108 2.163 . . . . 0.0 113.974 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.8 -17.3 64.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.128 0.876 . . . . 0.0 112.351 -174.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.16 -35.62 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.111 0.965 . . . . 0.0 108.842 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.429 HD23 ' CD1' ' B' ' 7' ' ' TYR . 2.2 tm? -63.01 -57.3 11.17 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.584 1.084 . . . . 0.0 109.98 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -22.36 66.93 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.44 0.564 . . . . 0.0 110.05 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.84 -24.38 44.44 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.064 2.146 . . . . 0.0 112.696 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.2 167.71 2.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.854 1.262 . . . . 0.0 111.347 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.9 -30.77 14.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.33 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.48 HD23 ' HE2' ' B' ' 97' ' ' LYS . 1.7 tm? -149.19 135.5 19.24 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 110.505 -172.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.425 ' N ' HD22 ' B' ' 77' ' ' LEU . 10.7 t -107.02 108.02 24.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 127.494 2.318 . . . . 0.0 107.983 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.09 106.32 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -72.97 122.3 21.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 167.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.2 132.92 42.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 13.4 m 72.59 -15.72 0.48 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.415 2.286 . . . . 0.0 113.293 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.61 34.95 91.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 107.834 -2.106 . . . . 0.0 107.834 -169.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.2 118.07 8.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.551 0.74 . . . . 0.0 111.645 -168.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.42 -20.48 63.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.383 0.673 . . . . 0.0 112.81 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.03 -8.53 59.11 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.821 0.737 . . . . 0.0 112.346 -175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.67 42.67 0.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.421 1.489 . . . . 0.0 112.075 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm 61.27 -149.79 0.4 Allowed 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.306 -1.496 . . . . 0.0 107.064 -168.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -139.74 71.21 36.85 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.83 129.27 29.89 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.93 1.754 . . . . 0.0 109.019 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.24 5.83 45.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p 39.08 88.65 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 127.942 2.497 . . . . 0.0 113.03 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -58.47 139.0 88.91 Favored 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 122.382 2.055 . . . . 0.0 108.663 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.65 -0.24 1.85 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.957 3.771 . . . . 0.0 115.455 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -61.75 -12.64 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.451 1.101 . . . . 0.0 111.26 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.42 149.03 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.487 1.515 . . . . 0.0 109.237 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HE2' HD23 ' B' ' 77' ' ' LEU . 5.1 tmmm? -82.97 155.56 23.93 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 ttm-85 -139.7 144.67 37.66 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.126 -0.984 . . . . 0.0 108.479 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -150.85 147.7 27.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.6 130.9 35.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -116.75 18.42 14.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.48 162.35 35.33 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -137.53 18.93 2.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.517 1.127 . . . . 0.0 110.15 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.12 158.38 44.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.178 1.791 . . . . 0.0 107.535 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -134.14 119.64 14.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.873 1.269 . . . . 0.0 107.663 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 -27.2 40.76 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.343 2.695 . . . . 0.0 112.56 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.1 -5.22 6.07 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.633 1.106 . . . . 0.0 112.709 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -100.99 8.25 43.12 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.61 1.164 . . . . 0.0 111.356 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.63 144.05 2.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.17 -45.78 75.75 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 123.845 0.716 . . . . 0.0 109.98 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.74 -16.04 4.04 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.8 p -68.76 162.23 26.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.67 -38.78 92.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 110.776 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.69 -42.57 77.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 117.109 -1.424 . . . . 0.0 109.206 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.58 -31.56 62.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 120.925 1.693 . . . . 0.0 109.555 -175.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -56.64 -63.58 1.15 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -58.24 -39.63 79.63 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.04 94.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.812 0.845 . . . . 0.0 112.231 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.71 -45.61 85.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.825 0.739 . . . . 0.0 109.564 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.9 m-30 -64.84 -43.36 93.29 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -175.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -67.35 -41.99 84.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.611 0.764 . . . . 0.0 111.097 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -59.43 -52.23 66.51 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.32 -42.04 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.396 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.434 ' HB2' ' HE1' ' B' ' 23' ' ' TRP . 41.1 ptt85 -62.24 -37.4 85.25 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.094 1.316 . . . . 0.0 111.471 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.84 -44.01 94.45 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.228 0.33 . . . . 0.0 110.299 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.08 -57.69 9.77 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.738 0.415 . . . . 0.0 110.22 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 12.4 mt -57.53 -47.9 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.345 1.058 . . . . 0.0 109.727 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.35 97.74 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.984 -0.898 . . . . 0.0 111.31 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -44.6 88.25 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.651 1.225 . . . . 0.0 110.762 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.58 92.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.1 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.24 -38.45 78.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.691 1.132 . . . . 0.0 111.328 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.89 -41.18 99.32 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -60.84 -39.95 91.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 116.988 -1.482 . . . . 0.0 110.993 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -58.9 -37.54 76.85 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.856 2.116 . . . . 0.0 111.26 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -31.28 71.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.132 0.573 . . . . 0.0 112.496 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.66 -43.54 10.67 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.537 . . . . 0.0 111.17 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.5 p -89.78 -24.29 21.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.21 1.804 . . . . 0.0 110.729 -169.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 55.29 31.62 56.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 111.608 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt . . . . . 0 C--O 1.245 0.826 0 C-N-CA 123.97 0.908 . . . . 0.0 111.477 -172.438 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.72 165.32 36.35 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.765 1.226 . . . . 0.0 108.176 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.08 101.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 t -80.48 169.47 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.882 1.673 . . . . 0.0 107.54 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.89 53.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.709 0.804 . . . . 0.0 109.188 169.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.463 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -97.23 171.51 8.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.998 1.719 . . . . 0.0 109.713 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -134.94 -170.25 2.53 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.472 1.509 . . . . 0.0 108.821 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -45.09 -29.27 0.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.374 2.27 . . . . 0.0 113.488 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -135.88 -31.18 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.976 1.311 . . . . 0.0 112.097 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -63.53 -21.36 66.29 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.69 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -52.18 -58.04 7.8 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.185 0.902 . . . . 0.0 109.417 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -60.71 -43.85 97.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.956 0.344 . . . . 0.0 110.185 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.15 77.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.367 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -84.23 -15.81 45.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.393 1.077 . . . . 0.0 113.109 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.2 p -114.95 -7.15 12.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.755 1.161 . . . . 0.0 113.805 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -74.7 -5.62 44.21 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.1 153.49 45.45 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.558 1.143 . . . . 0.0 109.053 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.98 -161.02 49.99 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.058 0.837 . . . . 0.0 111.148 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.56 129.53 70.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.15 119.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.157 -168.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.7 98.45 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.84 150.89 27.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -140.46 150.73 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.573 1.549 . . . . 0.0 109.319 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -132.66 115.74 15.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.587 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -136.62 152.9 50.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.919 1.688 . . . . 0.0 107.988 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.9 163.27 6.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.036 0.835 . . . . 0.0 110.41 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.63 -11.98 3.9 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.364 3.376 . . . . 0.0 116.719 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -59.98 -17.44 38.32 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.865 1.211 . . . . 0.0 113.811 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.95 155.68 41.83 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.945 1.248 . . . . 0.0 114.07 -170.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.88 -46.68 80.68 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.725 -1.597 . . . . 0.0 112.81 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -49.0 -31.05 19.43 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.4 2.734 . . . . 0.0 114.785 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -60.52 -15.18 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 120.06 1.3 . . . . 0.0 114.028 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 9.45 13.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.286 1.435 . . . . 0.0 111.339 176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.6 mtm -120.1 -44.61 2.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.311 1.044 . . . . 0.0 109.486 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.97 -36.42 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.16 18.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.768 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.11 -39.86 55.9 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.879 1.719 . . . . 0.0 111.728 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.664 HG12 HD22 ' A' ' 96' ' ' LEU . 2.6 t -57.16 -33.73 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.328 1.051 . . . . 0.0 111.468 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.81 -41.63 59.6 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.888 0.767 . . . . 0.0 110.687 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.74 -33.09 75.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.203 0.911 . . . . 0.0 109.709 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.04 -25.76 63.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.018 1.327 . . . . 0.0 111.672 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.405 HD11 ' SD ' ' A' ' 46' ' ' MET . 58.2 tp -77.1 -44.72 29.5 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 119.063 0.847 . . . . 0.0 109.96 173.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.49 -34.79 70.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.671 -0.643 . . . . 0.0 111.112 -172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.67 -10.69 59.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.511 -0.743 . . . . 0.0 112.251 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -99.79 -42.77 6.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.279 1.432 . . . . 0.0 110.931 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 42' ' ' LEU . 20.1 ptm -143.08 18.38 1.94 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.37 0.668 . . . . 0.0 112.399 -172.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.43 -4.6 13.33 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 121.243 -0.911 . . . . 0.0 114.299 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.69 -23.63 66.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.026 0.93 . . . . 0.0 110.919 169.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.24 -11.76 8.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.527 1.131 . . . . 0.0 112.48 -174.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -128.29 148.62 50.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.982 1.313 . . . . 0.0 111.454 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -114.42 147.56 39.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mt -125.22 141.07 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 6' ' ' ALA . 12.4 t -138.95 113.02 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.8 mtpt -86.54 155.08 20.63 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.243 -0.91 . . . . 0.0 110.337 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.75 122.52 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.58 108.74 12.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.306 33.6 m -79.2 47.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -153.01 -41.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.791 1.237 . . . . 0.0 108.984 167.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -83.64 -34.6 25.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.065 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -134.62 27.78 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.958 1.303 . . . . 0.0 110.807 -170.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -71.55 -7.54 48.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.021 0.928 . . . . 0.0 112.851 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -49.05 -51.96 28.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.768 2.027 . . . . 0.0 110.322 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.2 m -61.34 -32.6 72.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.636 0.775 . . . . 0.0 111.829 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.74 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.77 -46.58 7.51 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.676 0.655 . . . . 0.0 113.325 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -60.35 -40.68 91.59 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.097 0.959 . . . . 0.0 111.631 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -89.98 -0.0 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.811 0.845 . . . . 0.0 112.497 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.05 68.81 1.44 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t -146.45 129.99 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 100.951 -3.722 . . . . 0.0 100.951 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -144.44 16.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.306 0.242 . . . . 0.0 110.847 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -130.77 170.11 14.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.121 2.568 . . . . 0.0 112.64 -168.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.88 143.52 46.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.695 0.798 . . . . 0.0 108.902 172.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.26 154.26 65.73 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 -11.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -127.48 147.45 50.31 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -124.3 137.69 54.47 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 106.655 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.7 mt -124.27 107.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -82.41 110.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.3 mp -106.61 148.71 27.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -147.68 125.44 11.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 41.17 30.44 0.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.27 2.628 . . . . 0.0 114.413 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.66 -23.38 4.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.827 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.27 156.88 46.3 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.244 1.522 . . . . 0.0 113.263 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.07 135.76 27.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.14 -22.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.182 1.393 . . . . 0.0 110.554 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -147.4 163.83 35.23 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.287 1.035 . . . . 0.0 110.418 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.34 149.19 30.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -153.46 142.44 21.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.6 72.71 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.35 156.73 8.43 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.441 1.496 . . . . 0.0 110.05 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.3 148.39 51.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.371 0.668 . . . . 0.0 110.456 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.7 141.79 26.2 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.2 167.61 25.69 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.463 2.109 . . . . 0.0 110.834 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.32 -47.72 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 112.799 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.07 -42.51 76.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 110.799 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -32.44 73.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.111 -0.368 . . . . 0.0 110.436 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.664 HD22 HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -57.95 -54.56 45.51 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.563 1.145 . . . . 0.0 109.681 172.567 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.87 -39.24 90.51 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.6 -46.29 90.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.314 0.506 . . . . 0.0 111.325 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.86 -41.0 81.5 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.198 0.999 . . . . 0.0 111.105 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.9 -37.32 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.252 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -57.79 -25.88 61.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.632 1.105 . . . . 0.0 112.553 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -53.08 -26.75 17.23 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.005 0.922 . . . . 0.0 112.645 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -128.88 -23.96 3.01 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 112.674 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 170.224 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.96 35.0 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.032 -1.043 . . . . 0.0 110.696 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -152.39 131.69 12.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -137.94 118.62 14.03 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 129.315 3.046 . . . . 0.0 106.431 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mm -90.56 131.78 36.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tt -133.62 135.0 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -169.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -117.15 144.14 45.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -131.75 128.37 38.72 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.232 1.013 . . . . 0.0 108.622 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 66.7 m -148.38 144.27 27.38 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 124.577 1.151 . . . . 0.0 109.096 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 26.2 m -53.69 121.21 7.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.915 0.886 . . . . 0.0 110.185 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.537 ' H ' ' CG2' ' B' ' 39' ' ' ILE . . . 50.01 35.01 24.72 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.948 1.261 . . . . 0.0 111.792 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -31.58 101.85 0.02 OUTLIER 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -135.8 -0.98 2.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.997 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.81 -79.33 0.37 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.194 1.361 . . . . 0.0 113.264 -169.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -46.12 75.67 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.714 0.806 . . . . 0.0 113.074 -169.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.8 m -69.47 -28.56 66.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.111 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -68.26 -47.04 68.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.689 1.131 . . . . 0.0 110.073 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.14 -42.27 76.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.258 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.35 96.85 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.584 -0.697 . . . . 0.0 111.367 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.17 -30.96 65.5 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.1 0.863 . . . . 0.0 110.898 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.58 -50.31 62.87 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -57.22 -33.36 67.45 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.347 1.059 . . . . 0.0 112.225 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.01 -53.41 7.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.571 0.748 . . . . 0.0 111.234 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -68.46 -17.98 64.31 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -168.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.1 -17.75 54.27 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.415 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 33.1 m-85 -126.46 -37.6 2.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.373 0.988 . . . . 0.0 111.996 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.24 71.79 4.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.757 1.623 . . . . 0.0 106.62 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.05 -147.14 0.09 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.562 2.03 . . . . 0.0 114.671 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.19 -23.82 62.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.461 1.104 . . . . 0.0 113.021 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -65.37 -13.27 58.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.247 1.019 . . . . 0.0 113.244 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -123.53 151.93 42.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.431 1.014 . . . . 0.0 111.712 -169.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -132.12 82.74 2.04 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.633 1.973 . . . . 0.0 105.854 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.71 139.68 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.31 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -144.8 166.87 24.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 p -143.28 145.91 33.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.771 -0.581 . . . . 0.0 111.615 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.75 177.79 10.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.296 0.638 . . . . 0.0 112.38 -173.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.35 -178.75 48.53 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.643 0.64 . . . . 0.0 112.289 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.537 ' CG2' ' H ' ' B' ' 12' ' ' GLY . 2.9 tt -46.64 -56.35 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 127.632 2.373 . . . . 0.0 113.272 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -133.87 30.49 3.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.569 1.548 . . . . 0.0 108.779 -172.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 154.79 40.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.843 2.057 . . . . 0.0 112.075 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 137.45 82.88 0.0 OUTLIER 'General case' 0 C--O 1.236 0.37 0 C-N-CA 130.891 3.676 . . . . 0.0 105.274 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.21 175.3 46.64 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -172.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.3 88.92 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -60.48 124.4 78.32 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 125.544 1.538 . . . . 0.0 108.056 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.76 -18.41 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.799 1.666 . . . . 0.0 112.401 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -59.12 -56.81 17.43 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.86 1.209 . . . . 0.0 108.429 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.37 76.05 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.894 1.225 . . . . 0.0 109.719 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.86 -55.81 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.44 -45.51 80.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.917 0.887 . . . . 0.0 110.486 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.89 56.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.378 1.871 . . . . 0.0 111.17 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 73.9 mmm -92.68 -32.16 14.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.632 0.773 . . . . 0.0 111.765 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.06 -26.67 67.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.846 171.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -58.54 -28.73 65.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.412 1.006 . . . . 0.0 112.019 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.46 16.34 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.873 1.269 . . . . 0.0 110.578 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.09 95.21 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.643 -1.087 . . . . 0.0 112.608 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.5 mt -114.32 109.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.51 132.66 43.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 13.8 pt -134.9 18.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.566 1.146 . . . . 0.0 111.019 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.4 m -65.31 14.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -169.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -140.8 -2.7 1.32 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.95 2.5 . . . . 0.0 112.173 -176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -47.34 -59.52 3.14 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p 53.06 -171.72 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.74 1.616 . . . . 0.0 112.293 -171.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -163.08 -169.53 2.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.459 1.104 . . . . 0.0 109.029 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.2 168.76 23.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.193 2.597 . . . . 0.0 106.555 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.85 175.4 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 120.212 1.369 . . . . 0.0 112.295 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -54.42 36.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 C-N-CA 129.195 2.998 . . . . 0.0 118.11 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -52.32 106.4 0.15 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.93 2.092 . . . . 0.0 113.532 -173.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.1 m -51.51 -26.35 8.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.113 1.765 . . . . 0.0 114.378 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.69 -23.94 66.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.57 1.077 . . . . 0.0 111.845 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.31 -40.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -58.8 -51.61 69.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.355 0.525 . . . . 0.0 110.779 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -26.01 64.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.488 0.586 . . . . 0.0 110.941 -177.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -79.53 -19.14 50.28 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.435 1.094 . . . . 0.0 112.229 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.08 159.19 7.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 111.222 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.3 -22.77 35.51 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.867 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.424 HD23 ' H ' ' B' ' 78' ' ' VAL . 0.5 OUTLIER -152.81 153.22 32.69 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.106 0.962 . . . . 0.0 111.132 -177.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.424 ' H ' HD23 ' B' ' 77' ' ' LEU . 61.1 t -122.52 99.32 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 127.22 2.208 . . . . 0.0 105.657 169.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.39 100.46 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.7 m -70.57 125.98 28.32 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.28 136.08 33.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.4 m 76.42 -26.49 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.488 2.715 . . . . 0.0 113.509 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.22 32.94 65.07 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -90.32 115.02 27.2 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.652 0.781 . . . . 0.0 110.88 -169.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.82 -20.76 65.37 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.1 -19.27 30.93 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.548 0.739 . . . . 0.0 112.488 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -72.01 35.45 0.06 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.97 1.308 . . . . 0.0 113.751 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 64.46 35.23 9.64 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.113 1.765 . . . . 0.0 112.853 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.8 p 33.07 50.54 0.68 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.552 1.941 . . . . 0.0 113.151 174.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.28 133.99 61.45 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.452 2.101 . . . . 0.0 114.0 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.456 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -76.69 -23.77 53.18 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.313 175.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p 51.86 117.83 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.712 2.405 . . . . 0.0 113.367 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.38 150.26 64.16 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.931 1.754 . . . . 0.0 109.285 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.86 -5.45 10.63 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.634 2.89 . . . . 0.0 114.125 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -62.11 -17.31 57.31 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.197 0.999 . . . . 0.0 112.086 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.95 149.99 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.217 0.917 . . . . 0.0 111.031 -173.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -75.66 151.91 37.66 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.482 1.113 . . . . 0.0 108.954 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 ttp-105 -139.07 137.95 36.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -147.69 149.43 32.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -91.78 133.8 35.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' TRP . . . . . 0.411 ' CZ2' ' HE3' ' B' ' 139' ' ' LYS . 88.6 m95 -125.51 9.36 7.78 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.0 159.93 27.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.5 9.19 4.67 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.705 0.802 . . . . 0.0 111.289 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -150.19 163.72 37.51 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.097 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.34 121.47 15.39 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 125.097 1.359 . . . . 0.0 108.608 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.544 ' HD3' HG11 ' B' ' 123' ' ' VAL . 58.2 Cg_endo -69.97 -29.63 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.859 2.373 . . . . 0.0 112.166 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.26 -7.62 6.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.256 0.934 . . . . 0.0 112.994 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt-85 -83.74 -1.65 54.61 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.085 -0.959 . . . . 0.0 112.095 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' B' ' 116' ' ' LYS . . . -34.64 127.4 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.73 1.612 . . . . 0.0 112.507 -175.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -69.3 136.76 52.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.98 29.88 2.39 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -167.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 26.3 p -89.57 159.32 17.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.565 1.683 . . . . 0.0 107.262 169.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.95 -37.2 83.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.31 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -77.31 -43.09 34.32 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 117.489 -1.244 . . . . 0.0 109.409 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.1 -27.33 54.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 120.563 1.529 . . . . 0.0 110.269 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' LYS . . . . . 0.576 ' HA ' ' HB1' ' B' ' 109' ' ' ALA . 7.8 mtpt -59.83 -57.42 12.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -60.2 -40.91 91.74 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.08 91.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.069 0.948 . . . . 0.0 111.932 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.73 -45.46 92.61 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.617 0.644 . . . . 0.0 109.786 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.66 -49.89 74.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -62.2 -47.0 86.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.778 1.231 . . . . 0.0 110.11 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -56.87 -55.39 35.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.544 HG11 ' HD3' ' B' ' 106' ' ' PRO . 49.8 t -75.13 -39.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.119 -171.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -64.05 -39.48 94.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.751 1.614 . . . . 0.0 111.281 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.95 -41.89 95.1 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.216 0.462 . . . . 0.0 111.105 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -67.36 -46.92 71.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.819 0.448 . . . . 0.0 110.07 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.0 mt -53.09 -49.39 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.042 1.337 . . . . 0.0 108.607 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.99 -50.19 70.5 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 118.387 0.539 . . . . 0.0 112.538 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -64.03 -41.67 97.35 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.632 0.216 . . . . 0.0 110.724 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -66.62 -43.54 84.47 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.615 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.5 mm? -65.05 -34.32 78.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.759 1.163 . . . . 0.0 111.376 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.415 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 39.3 ttmt -60.94 -32.07 71.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.194 0.906 . . . . 0.0 111.16 174.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.05 -30.19 71.4 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-O 116.902 -1.523 . . . . 0.0 112.06 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -63.1 -37.37 86.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 122.454 2.388 . . . . 0.0 109.785 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.89 73.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.611 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -81.92 -43.3 18.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.366 1.066 . . . . 0.0 112.049 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 82.1 p -88.34 -18.38 28.58 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.65 1.98 . . . . 0.0 111.074 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.51 15.16 75.17 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.158 0.885 . . . . 0.0 112.107 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.411 ' HE3' ' CZ2' ' B' ' 101' ' ' TRP . 5.0 ttpm? . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.116 1.367 . . . . 0.0 109.434 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.76 155.64 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.786 2.434 . . . . 0.0 111.839 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.5 107.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.2 t -79.48 167.14 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.904 1.682 . . . . 0.0 107.988 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -122.99 119.25 29.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.123 1.369 . . . . 0.0 107.924 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.67 168.92 19.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.914 0.886 . . . . 0.0 108.783 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 p -135.26 -167.23 1.97 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.781 1.232 . . . . 0.0 109.354 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -51.88 -20.33 2.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.143 1.777 . . . . 0.0 113.751 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -140.78 -31.72 0.6 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.667 1.187 . . . . 0.0 112.811 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.4 m -63.26 -19.57 64.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.165 0.893 . . . . 0.0 112.202 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -50.6 -55.18 17.44 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 109.76 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -62.29 -44.23 96.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.104 -0.372 . . . . 0.0 110.036 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.06 83.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.946 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -79.87 -19.6 47.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.991 0.917 . . . . 0.0 113.047 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 p -108.96 -7.51 15.39 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.661 1.119 . . . . 0.0 112.943 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -72.22 -7.2 47.96 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -141.8 154.11 44.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 109.615 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.82 -157.15 51.13 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 124.951 1.262 . . . . 0.0 111.996 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 t -113.43 131.41 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 t -140.13 116.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 122.257 1.027 . . . . 0.0 108.493 -169.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.69 121.59 25.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.3 36.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -141.57 149.86 41.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 109.538 -170.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 31.4 m-85 -132.2 113.25 13.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.652 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.1 p-90 -132.76 149.3 52.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.845 1.658 . . . . 0.0 107.876 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.88 165.12 6.07 Favored Pre-proline 0 C--O 1.235 0.331 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.34 -17.44 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.882 3.055 . . . . 0.0 116.02 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -52.48 -26.8 13.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.854 1.662 . . . . 0.0 114.318 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.55 150.92 48.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.721 1.146 . . . . 0.0 111.509 -172.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.25 -50.9 57.16 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.496 -1.169 . . . . 0.0 111.459 172.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -46.54 -26.15 4.03 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.423 3.415 . . . . 0.0 117.076 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -56.51 -35.46 68.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 121.538 1.972 . . . . 0.0 111.726 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -90.18 7.92 35.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.963 0.905 . . . . 0.0 111.883 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -118.56 -42.82 2.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.023 0.929 . . . . 0.0 109.606 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.63 -33.99 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.793 0.837 . . . . 0.0 109.269 169.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.8 -60.95 7.87 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.08 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.14 -40.19 72.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.07 1.847 . . . . 0.0 111.614 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.18 -40.02 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.473 0.579 . . . . 0.0 110.525 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.72 -39.32 64.38 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.767 0.712 . . . . 0.0 111.574 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.37 -34.92 79.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.43 1.014 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.54 -17.85 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.198 1.399 . . . . 0.0 112.643 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.0 tp -86.94 -43.63 12.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.235 1.014 . . . . 0.0 108.794 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB2' HD12 ' A' ' 52' ' ' ILE . 22.7 t70 -71.78 -37.46 70.46 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.146 -0.346 . . . . 0.0 110.945 -175.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.8 -11.86 59.38 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.561 . . . . 0.0 111.942 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -100.02 -47.85 4.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -135.81 15.01 3.36 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.504 0.722 . . . . 0.0 112.392 -170.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.83 -2.09 21.43 Favored Glycine 0 CA--C 1.52 0.383 0 O-C-N 121.093 -1.004 . . . . 0.0 113.951 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.21 -25.27 65.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.696 0.798 . . . . 0.0 110.624 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 -26.84 9.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 -177.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.0 tp -119.76 146.53 45.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.036 1.335 . . . . 0.0 111.886 -168.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -103.31 143.54 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 168.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 43' ' ' ASP . 15.1 mt -124.74 136.48 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.39 124.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.652 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpp -99.85 156.28 17.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.036 0.834 . . . . 0.0 109.716 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mm -116.61 127.95 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.01 104.99 10.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 169.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.01 41.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.437 1.113 . . . . 0.0 111.844 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.1 -44.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.594 1.158 . . . . 0.0 110.479 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 110.262 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.75 30.22 3.76 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.59 1.156 . . . . 0.0 110.74 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -3.56 32.56 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.434 1.094 . . . . 0.0 112.586 -169.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -52.14 -45.16 64.9 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.584 1.554 . . . . 0.0 111.233 -169.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -65.71 -26.27 67.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' B' ' 91' ' ' MET . . . -68.48 -64.33 0.89 Allowed 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.072 -1.018 . . . . 0.0 108.801 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.22 -38.48 19.03 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.937 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -60.82 -48.58 81.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.37 1.585 . . . . 0.0 110.117 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.54 -13.2 60.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.569 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.95 55.93 14.69 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.67 -43.82 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.507 ' HG3' HD12 ' B' ' 67' ' ' ILE . 9.6 ptm 45.29 19.77 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 129.415 3.086 . . . . 0.0 113.567 174.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -133.72 155.66 49.35 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.039 1.736 . . . . 0.0 109.516 -174.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.9 mt -142.45 143.64 27.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 119.034 0.834 . . . . 0.0 109.091 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -67.52 144.83 72.62 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.303 0.787 . . . . 0.0 110.317 -10.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 53.5 m -114.4 142.03 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.89 136.08 54.12 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.8 mt -125.93 109.15 12.14 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 103.784 -2.673 . . . . 0.0 103.784 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.8 t -83.53 118.51 31.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.11 151.58 36.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.19 0.996 . . . . 0.0 108.498 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -147.87 144.04 27.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 43.69 28.4 0.22 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.952 2.101 . . . . 0.0 113.67 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.16 8.09 55.53 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.928 1.251 . . . . 0.0 116.164 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -134.99 147.87 49.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.926 1.363 . . . . 0.0 111.886 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.0 140.7 17.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.98 0.912 . . . . 0.0 109.186 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.42 -20.79 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.982 1.313 . . . . 0.0 111.122 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.74 161.67 40.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.173 0.989 . . . . 0.0 109.713 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 m -154.19 148.74 26.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.1 m -151.58 150.2 30.04 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.383 1.073 . . . . 0.0 108.531 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -133.18 63.0 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.591 1.556 . . . . 0.0 107.135 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.53 168.13 37.36 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.647 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.06 152.21 45.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.183 0.993 . . . . 0.0 111.034 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 141.2 17.51 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 169.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.81 168.38 23.09 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.447 2.098 . . . . 0.0 110.388 173.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -44.69 65.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 112.524 -170.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.83 -43.84 74.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 117.472 0.124 . . . . 0.0 110.867 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.25 75.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.973 -0.454 . . . . 0.0 110.346 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -53.74 53.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.805 . . . . 0.0 109.844 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.61 -38.25 90.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -61.78 -48.25 81.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.508 0.595 . . . . 0.0 110.75 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -55.86 -44.27 77.9 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 124.457 1.103 . . . . 0.0 110.898 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.03 -37.04 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.508 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 8.0 t30 -58.94 -26.36 64.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.172 0.989 . . . . 0.0 112.208 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -22.67 39.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.644 0.778 . . . . 0.0 112.459 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -131.12 -19.67 2.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.133 0.973 . . . . 0.0 112.969 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 1.7 tm? . . . . . 0 C--O 1.248 1.017 0 C-N-CA 127.521 2.329 . . . . 0.0 107.87 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.84 128.62 36.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.22 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.325 2.65 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -137.83 128.74 27.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -92.88 144.65 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.623 0.577 . . . . 0.0 110.377 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.7 147.98 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.642 1.577 . . . . 0.0 106.746 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.45 142.64 37.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -169.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -97.84 143.27 28.62 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -145.27 131.42 19.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -169.79 172.01 6.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.32 1.848 . . . . 0.0 108.96 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -48.61 125.01 9.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.495 1.518 . . . . 0.0 109.832 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.49 4.9 0.27 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.209 1.861 . . . . 0.0 117.699 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ASN . . . . . 0.406 ' HB2' ' HB1' ' B' ' 41' ' ' ALA . 5.0 t30 47.4 18.32 0.1 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.63 1.715 . . . . 0.0 113.315 -169.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 9.9 p -84.43 57.42 4.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.341 2.257 . . . . 0.0 114.787 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 136.94 -58.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.446 3.098 . . . . 0.0 113.433 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -53.95 -53.97 45.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.807 0.843 . . . . 0.0 110.948 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.39 -33.16 72.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.88 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -58.7 -48.33 81.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.681 0.673 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 8.1 ptp -69.83 -41.51 74.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.09 99.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.507 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.08 -31.11 68.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.755 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.57 60.88 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.502 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 25.5 m95 -56.56 -36.47 69.35 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.619 1.168 . . . . 0.0 111.688 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.41 -55.12 8.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 122.577 0.351 . . . . 0.0 110.477 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.35 -24.44 67.25 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.88 -16.17 63.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.29 0.95 . . . . 0.0 113.364 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.462 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 7.5 m-85 -124.7 -12.46 7.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 112.858 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -114.69 83.45 1.9 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.126 -2.175 . . . . 0.0 105.126 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.49 -168.73 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.421 1.01 . . . . 0.0 112.075 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.51 -5.03 4.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.177 0.991 . . . . 0.0 113.07 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.35 -24.81 67.55 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.623 -1.298 . . . . 0.0 109.564 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -123.11 179.31 4.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.474 1.91 . . . . 0.0 108.93 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -155.48 127.6 7.64 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.3 p -123.32 143.42 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.909 0.484 . . . . 0.0 110.094 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.49 171.23 14.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.151 1.78 . . . . 0.0 108.76 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -147.07 145.35 29.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.289 1.035 . . . . 0.0 109.126 -172.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.94 170.58 21.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.166 0.987 . . . . 0.0 111.775 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.76 178.61 46.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.202 1.382 . . . . 0.0 110.554 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 tt -48.67 -54.54 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.541 1.936 . . . . 0.0 113.775 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -135.1 31.42 3.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.097 1.759 . . . . 0.0 108.035 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' B' ' 13' ' ' ASN . . . -66.12 128.15 34.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.599 1.959 . . . . 0.0 115.957 -168.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -166.41 1.38 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.641 2.376 . . . . 0.0 110.62 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.9 109.49 3.44 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 120.725 -1.234 . . . . 0.0 114.864 -168.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.6 tp -82.52 83.13 7.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -62.12 123.68 79.04 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.633 -0.698 . . . . 0.0 109.782 -176.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.73 -23.42 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.224 1.95 . . . . 0.0 113.201 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -33.73 76.16 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.762 1.165 . . . . 0.0 110.856 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -34.46 50.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.187 0.449 . . . . 0.0 109.947 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.67 -51.38 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -56.49 -46.12 80.65 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.287 0.635 . . . . 0.0 110.709 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.49 -32.56 58.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.26 1.024 . . . . 0.0 112.323 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mmm -90.54 -30.06 17.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.241 -0.912 . . . . 0.0 111.323 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.87 -24.73 67.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.437 169.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.436 ' CD ' HH21 ' B' ' 124' ' ' ARG . 42.8 mt-10 -55.52 -36.37 66.65 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.829 1.195 . . . . 0.0 111.201 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.28 15.92 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.19 1.396 . . . . 0.0 111.296 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.56 41.58 99.12 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.036 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 39.1 mt -114.64 116.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 171.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.79 132.12 43.17 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -131.78 13.08 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.28 169.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 75.3 p -59.76 -17.59 36.46 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.667 1.121 . . . . 0.0 111.495 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -80.37 -12.5 59.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.503 2.321 . . . . 0.0 114.282 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -69.96 157.0 38.29 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.374 1.443 . . . . 0.0 112.335 -171.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -129.65 168.81 15.9 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.542 2.337 . . . . 0.0 108.809 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.3 m -156.21 168.62 26.71 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.948 -1.095 . . . . 0.0 110.714 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -162.79 162.67 26.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.68 1.992 . . . . 0.0 108.763 -169.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.24 172.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 0.0 112.424 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.507 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.3 OUTLIER -50.39 133.31 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -145.5 99.96 3.37 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.167 0.984 . . . . 0.0 108.8 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -49.55 -28.0 5.09 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.673 1.989 . . . . 0.0 113.699 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.65 -18.37 63.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.247 0.93 . . . . 0.0 112.387 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.68 -34.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.089 0.956 . . . . 0.0 108.745 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.03 -54.9 14.97 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.594 1.088 . . . . 0.0 110.173 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -26.31 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.906 0.776 . . . . 0.0 110.159 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -72.83 -24.04 60.85 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 112.357 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.35 164.74 4.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.851 1.261 . . . . 0.0 112.194 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.15 -31.0 15.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.134 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -145.16 135.93 24.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.283 1.033 . . . . 0.0 110.661 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 t -113.56 115.02 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.28 108.81 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.7 m -73.92 145.61 44.62 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.36 31.29 4.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.929 0.892 . . . . 0.0 111.635 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -157.49 174.59 15.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.62 57.88 0.71 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -137.67 179.56 6.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.262 1.425 . . . . 0.0 109.737 -169.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -132.31 -8.15 3.35 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.377 1.871 . . . . 0.0 112.118 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.75 -22.21 57.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.55 0.74 . . . . 0.0 111.19 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.88 -8.79 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.36 2.264 . . . . 0.0 115.776 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm 92.51 15.89 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 128.492 2.717 . . . . 0.0 111.366 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 6.9 m 37.66 49.11 1.5 Allowed Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.673 1.589 . . . . 0.0 111.716 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.72 131.43 46.01 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.574 -1.356 . . . . 0.0 108.574 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.505 ' HE2' ' HB1' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -89.58 8.14 32.78 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -168.253 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 14.3 p 40.95 81.57 0.24 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.953 1.701 . . . . 0.0 112.705 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' B' ' 94' ' ' PRO . 60.6 Cg_endo -57.38 141.73 94.89 Favored 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 122.649 2.233 . . . . 0.0 111.304 -169.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 93' ' ' PRO . 85.9 Cg_exo -49.95 -12.53 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 127.014 5.143 . . . . 0.0 118.672 -170.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -60.27 -16.35 33.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.328 0.967 . . . . 0.0 111.785 171.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.2 137.7 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 109.124 -172.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -75.82 156.4 34.48 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -142.42 147.95 37.01 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.217 -0.927 . . . . 0.0 110.538 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -150.0 161.28 42.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.623 1.569 . . . . 0.0 107.5 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -99.22 123.63 43.66 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 168.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -109.6 2.98 20.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.409 0.684 . . . . 0.0 110.108 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.6 149.23 21.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 105.779 -2.928 . . . . 0.0 105.779 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -146.82 10.0 1.03 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.974 1.71 . . . . 0.0 110.633 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -153.28 168.59 25.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.742 2.417 . . . . 0.0 105.984 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -133.33 115.82 13.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.63 0.772 . . . . 0.0 109.412 -171.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.17 -25.24 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.004 2.469 . . . . 0.0 113.584 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -8.38 21.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.179 0.9 . . . . 0.0 111.819 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -93.88 10.99 30.98 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 111.835 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.47 148.49 0.67 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.832 1.253 . . . . 0.0 112.767 -173.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -55.45 -47.4 76.09 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.119 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.93 -17.38 4.14 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 115.552 0.981 . . . . 0.0 115.552 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.43 158.88 34.29 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.54 -37.77 79.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.354 0.597 . . . . 0.0 111.157 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -73.36 -43.75 60.04 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.119 -1.42 . . . . 0.0 109.814 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.3 -28.24 59.63 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 121.208 1.822 . . . . 0.0 110.259 -172.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -60.41 -59.14 5.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 118.73 0.695 . . . . 0.0 109.765 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -60.64 -39.62 88.99 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.553 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.4 95.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.276 0.631 . . . . 0.0 112.24 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.21 -47.3 83.11 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -61.09 -51.42 69.2 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -62.47 -43.72 98.14 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.03 0.932 . . . . 0.0 111.518 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -60.94 -52.75 63.72 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 35.5 t -69.81 -36.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.502 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.3 tmm_? -60.23 -43.34 96.14 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.572 1.078 . . . . 0.0 111.774 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.85 -44.78 96.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.31 0.505 . . . . 0.0 110.822 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -63.13 -51.7 65.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.43 0.692 . . . . 0.0 110.117 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -54.19 -49.59 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.624 1.57 . . . . 0.0 109.054 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.23 -43.1 81.37 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 118.936 -0.925 . . . . 0.0 112.316 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -44.38 94.98 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.806 1.303 . . . . 0.0 110.428 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -34.72 78.6 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.577 178.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.73 1.15 . . . . 0.0 111.492 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.462 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -62.75 -41.24 99.11 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -62.4 -40.54 96.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 117.395 -1.288 . . . . 0.0 111.301 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -60.56 -36.24 78.0 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 121.665 2.029 . . . . 0.0 111.295 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.61 -28.58 69.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.029 0.531 . . . . 0.0 112.431 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.69 -46.6 7.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.609 1.564 . . . . 0.0 111.141 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 62.9 p -89.14 -27.21 20.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.278 1.831 . . . . 0.0 110.784 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.13 25.94 54.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.9 -169.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.748 1.619 . . . . 0.0 111.82 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.32 172.3 18.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.839 1.656 . . . . 0.0 107.493 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.74 97.09 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 168.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.02 167.98 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.509 1.523 . . . . 0.0 108.009 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -128.07 112.76 14.95 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.799 0.84 . . . . 0.0 108.983 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.04 10.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.579 1.552 . . . . 0.0 110.095 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -159.71 -173.39 4.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.966 2.107 . . . . 0.0 105.617 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.62 -36.62 0.42 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.37 2.668 . . . . 0.0 115.934 -169.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -130.57 -29.96 1.92 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.586 1.154 . . . . 0.0 111.543 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -23.06 65.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.149 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -51.55 -56.48 13.2 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.356 0.98 . . . . 0.0 109.244 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -62.36 -44.25 96.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -36.65 81.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -174.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -80.15 -16.95 53.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.072 0.949 . . . . 0.0 113.056 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.8 p -114.06 -7.18 13.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.651 1.114 . . . . 0.0 113.113 -169.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -77.48 -3.95 43.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.41 148.38 37.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.226 1.011 . . . . 0.0 109.092 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.08 -170.84 40.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.19 0.9 . . . . 0.0 111.62 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.43 125.81 54.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 t -140.03 117.96 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.6 135.89 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.7 46.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.41 151.25 49.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.279 1.432 . . . . 0.0 108.626 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.7 111.34 13.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.557 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.3 p-90 -131.68 155.11 48.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.716 1.606 . . . . 0.0 107.789 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.11 162.67 9.13 Favored Pre-proline 0 C--O 1.233 0.188 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.8 -19.0 10.03 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.613 2.875 . . . . 0.0 116.167 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -57.69 -26.4 61.65 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.6 161.66 34.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.457 1.026 . . . . 0.0 112.997 -169.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.72 -48.76 53.93 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.168 -1.351 . . . . 0.0 112.658 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -51.38 -27.07 22.83 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.099 2.532 . . . . 0.0 115.11 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -60.51 -13.89 16.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 119.624 1.102 . . . . 0.0 113.798 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -118.1 12.28 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.664 1.186 . . . . 0.0 111.449 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.0 mtm -123.67 -45.69 2.04 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.358 1.063 . . . . 0.0 109.642 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.78 -34.72 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -58.26 17.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.14 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.05 -39.16 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.762 1.641 . . . . 0.0 111.639 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.73 HG12 HD22 ' A' ' 96' ' ' LEU . 2.6 t -57.89 -34.56 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.957 0.903 . . . . 0.0 111.3 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 HD21 ' A' ' 96' ' ' LEU . 21.1 mt -71.37 -44.13 65.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.993 0.815 . . . . 0.0 110.534 175.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.92 -36.55 83.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.65 0.659 . . . . 0.0 109.469 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.35 -18.68 62.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 112.314 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.3 tp -79.55 -45.76 18.63 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.617 1.099 . . . . 0.0 108.879 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.06 -35.58 76.72 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.881 -0.512 . . . . 0.0 111.496 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -64.95 -19.65 66.07 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.502 -0.749 . . . . 0.0 112.21 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -95.84 -42.91 8.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.679 1.192 . . . . 0.0 111.225 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ptm -144.27 17.95 1.72 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.343 0.657 . . . . 0.0 112.283 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -5.76 14.12 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.35 -0.844 . . . . 0.0 114.312 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.72 -23.41 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.671 0.788 . . . . 0.0 111.033 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -15.51 8.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.446 -175.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.0 149.84 50.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.608 1.163 . . . . 0.0 112.267 -168.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -112.95 144.55 42.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.28 146.4 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.69 146.85 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.1 mtpt -121.82 147.57 45.79 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 121.83 -0.544 . . . . 0.0 110.377 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.82 128.74 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.94 103.5 14.72 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 170.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.305 32.6 m -77.6 50.51 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 122.616 1.198 . . . . 0.0 114.179 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.29 -44.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.594 1.557 . . . . 0.0 108.519 168.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -75.24 -50.58 15.7 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.019 1.327 . . . . 0.0 110.065 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -132.11 37.74 3.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.908 1.283 . . . . 0.0 110.873 -170.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -67.04 -4.2 9.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.601 1.161 . . . . 0.0 112.872 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -53.26 -47.88 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.114 1.766 . . . . 0.0 110.851 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.0 m -55.29 -41.51 72.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.848 0.749 . . . . 0.0 111.154 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 -65.43 0.72 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -170.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.86 -42.88 15.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.128 0.87 . . . . 0.0 113.361 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -63.45 -44.55 94.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.428 1.114 . . . . 0.0 111.377 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -68.04 -34.8 77.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.603 0.638 . . . . 0.0 109.796 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.07 66.24 0.71 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 -169.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.35 132.7 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.43 ' CE ' HD13 ' B' ' 72' ' ' LEU . 24.2 mtm -149.02 18.99 0.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.29 160.37 38.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -167.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.21 134.39 26.09 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.214 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.67 132.7 15.98 Favored 'Cis proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.443 -1.791 . . . . 0.0 107.443 -11.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.5 m -98.77 150.35 21.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 169.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.81 117.47 8.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.75 111.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -93.49 134.7 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.17 158.06 39.11 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.643 1.177 . . . . 0.0 110.286 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -147.95 137.42 22.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.99 29.01 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.042 2.537 . . . . 0.0 114.902 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.43 -28.3 2.79 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 116.595 1.398 . . . . 0.0 116.595 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.68 158.72 43.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.418 1.609 . . . . 0.0 114.839 -167.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.39 136.54 26.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.288 1.035 . . . . 0.0 108.28 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.01 -21.07 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.784 1.633 . . . . 0.0 111.428 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -144.72 157.87 44.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.961 0.8 . . . . 0.0 108.922 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.1 148.42 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -169.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.9 m -153.62 148.59 26.66 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.777 1.231 . . . . 0.0 108.011 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.26 66.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.65 156.94 8.98 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -73.46 156.71 37.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.676 0.39 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -153.37 150.63 24.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.203 1.001 . . . . 0.0 108.652 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.84 172.81 12.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.847 2.365 . . . . 0.0 111.536 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -45.9 71.14 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.237 1.015 . . . . 0.0 111.966 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.26 -39.95 93.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.863 0.301 . . . . 0.0 110.429 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.893 0.477 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.73 HD22 HG12 ' A' ' 38' ' ' VAL . 1.8 tp -61.97 -54.82 36.35 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.322 1.049 . . . . 0.0 109.645 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.81 -36.6 84.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.34 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.41 -47.09 87.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.887 0.767 . . . . 0.0 110.933 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -55.67 -42.14 74.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.213 0.605 . . . . 0.0 110.545 -174.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.1 -40.49 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 123.667 0.604 . . . . 0.0 111.245 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 11.4 t30 -57.46 -25.65 60.01 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.906 -1.121 . . . . 0.0 112.417 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -50.49 -31.17 14.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.691 1.196 . . . . 0.0 112.4 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -137.87 -7.14 1.64 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.786 2.034 . . . . 0.0 105.985 169.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.79 145.36 42.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 65.12 122.65 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 128.112 2.565 . . . . 0.0 111.298 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -147.69 145.21 28.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 129.122 2.969 . . . . 0.0 104.224 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 6.4 mt -123.45 145.95 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 119.59 1.087 . . . . 0.0 108.584 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.0 148.3 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.904 1.282 . . . . 0.0 107.836 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.66 149.34 52.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 109.988 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.06 145.74 41.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.45 127.49 44.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 8.5 m -151.26 170.31 19.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.508 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -67.16 89.51 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.393 1.077 . . . . 0.0 110.924 172.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.31 20.53 58.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 117.073 -1.96 . . . . 0.0 114.835 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 26.01 84.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 124.769 2.224 . . . . 0.0 112.932 -177.034 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -152.41 167.71 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.529 3.132 . . . . 0.0 104.94 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.658 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 42.03 -103.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.227 1.811 . . . . 0.0 112.956 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -40.73 27.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.037 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -53.35 33.5 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.146 1.339 . . . . 0.0 109.769 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -49.91 -48.31 51.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.353 2.261 . . . . 0.0 109.64 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.3 ttm -67.79 -45.16 75.62 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.903 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.31 83.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.562 1.145 . . . . 0.0 110.728 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.61 -32.06 63.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 111.853 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.98 -49.65 57.18 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -58.77 -37.94 77.37 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.258 1.023 . . . . 0.0 111.769 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.47 -49.38 77.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -65.0 -22.65 67.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.31 -20.14 66.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.156 0.889 . . . . 0.0 112.951 175.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.499 ' CD1' ' HE2' ' B' ' 132' ' ' LYS . 0.1 OUTLIER -132.35 -0.54 3.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.379 0.991 . . . . 0.0 113.428 -175.473 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mt -126.42 85.83 2.44 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.4 -165.95 1.05 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.562 2.029 . . . . 0.0 114.204 -169.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.13 -20.05 23.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.673 1.189 . . . . 0.0 112.894 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.87 -23.99 34.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.156 1.782 . . . . 0.0 112.225 169.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -123.88 155.6 37.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.732 1.613 . . . . 0.0 110.6 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -131.22 144.91 51.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.132 1.773 . . . . 0.0 106.674 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.71 148.27 31.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 108.511 -171.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -147.88 162.42 39.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 52.4 m -134.12 140.42 46.57 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.036 1.335 . . . . 0.0 108.263 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.97 174.37 13.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 111.295 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.5 -174.93 44.31 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -51.23 -55.65 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.332 1.853 . . . . 0.0 114.157 -173.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -138.18 29.57 2.49 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.957 1.703 . . . . 0.0 108.655 -171.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.6 157.39 37.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.69 1.996 . . . . 0.0 114.193 -169.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 146.98 104.97 0.0 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 131.072 3.749 . . . . 0.0 104.414 172.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.6 174.38 46.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 14.5 tp -154.84 65.36 0.66 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.518 1.127 . . . . 0.0 108.064 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -49.87 121.73 13.04 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.315 1.446 . . . . 0.0 110.494 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -64.8 -24.44 61.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.202 1.935 . . . . 0.0 113.399 -175.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -18.37 64.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.703 1.592 . . . . 0.0 112.15 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -85.84 -40.58 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -60.2 -50.74 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.74 -42.68 84.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.95 0.9 . . . . 0.0 110.687 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.45 -30.55 60.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.565 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mmm -84.49 -40.64 17.42 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.519 1.054 . . . . 0.0 110.907 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.91 -29.15 68.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.541 0.61 . . . . 0.0 110.824 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.79 -28.28 67.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.498 0.719 . . . . 0.0 112.088 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.67 16.0 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.954 1.302 . . . . 0.0 110.765 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.08 38.87 92.74 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.497 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.76 150.46 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -124.3 139.63 53.73 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.998 0.919 . . . . 0.0 109.104 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.49 ' HB ' HE21 ' B' ' 62' ' ' GLN . 30.7 pt -140.67 17.56 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.102 1.361 . . . . 0.0 110.745 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -67.48 15.82 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -143.26 -5.11 0.87 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.161 2.585 . . . . 0.0 112.019 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.49 HE21 ' HB ' ' B' ' 59' ' ' ILE . 2.8 pt20 -56.67 144.71 31.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.684 1.129 . . . . 0.0 112.1 -169.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -69.04 155.77 39.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.981 1.312 . . . . 0.0 110.38 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 9.0 m -167.29 145.99 4.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 107.306 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -171.18 167.7 6.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.844 1.258 . . . . 0.0 109.837 -170.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.83 168.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.045 0.839 . . . . 0.0 111.41 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -48.99 135.55 6.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -144.32 103.84 4.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.307 1.051 . . . . 0.0 109.143 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.9 m -49.15 -27.27 3.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.626 1.57 . . . . 0.0 113.864 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.08 -22.76 64.92 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.725 1.148 . . . . 0.0 111.652 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.0 -42.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 117.75 -1.119 . . . . 0.0 108.622 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.43 HD13 ' CE ' ' A' ' 70' ' ' MET . 6.9 tt -61.06 -51.35 69.54 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.91 1.232 . . . . 0.0 109.451 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -25.17 68.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.218 0.917 . . . . 0.0 111.412 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.96 -18.65 33.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.597 1.159 . . . . 0.0 112.894 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.89 163.46 4.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.216 1.007 . . . . 0.0 111.29 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.55 -32.71 15.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.839 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 tp -143.91 144.43 31.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.027 1.331 . . . . 0.0 109.725 -172.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.6 108.67 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 169.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 74.8 t -82.34 105.99 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -65.5 129.27 39.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 168.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 tp -139.94 66.39 1.4 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.715 0.406 . . . . 0.0 111.699 -168.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 54.4 p -164.29 -45.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 O-C-N 122.03 -0.419 . . . . 0.0 110.312 169.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.81 28.2 43.3 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -141.29 120.89 13.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.584 0.754 . . . . 0.0 111.197 -169.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.34 -17.6 59.27 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.715 1.606 . . . . 0.0 113.865 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.91 -13.49 16.15 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.197 0.908 . . . . 0.0 111.743 174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.86 -6.68 2.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm 96.58 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.317 3.047 . . . . 0.0 110.979 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.8 m 38.37 45.77 0.82 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.044 2.137 . . . . 0.0 113.179 -169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.09 132.78 39.52 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.395 2.063 . . . . 0.0 112.031 -169.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.59 1.75 36.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 116.74 -1.6 . . . . 0.0 114.594 -175.243 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.8 p 45.08 89.76 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.538 1.535 . . . . 0.0 113.294 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -54.95 138.11 77.33 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.775 2.317 . . . . 0.0 109.485 -169.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.76 3.07 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.666 1 C-N-CA 125.318 4.012 . . . . 0.0 117.124 -168.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -67.55 -5.81 17.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.158 0.983 . . . . 0.0 112.332 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 148.33 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 110.147 -169.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -78.63 158.92 28.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.963 0.905 . . . . 0.0 108.839 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -151.73 145.37 24.97 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.757 -1.214 . . . . 0.0 109.488 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -155.73 148.43 24.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.82 137.79 32.08 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -139.57 -21.59 0.91 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.16 149.61 19.47 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 119.583 1.083 . . . . 0.0 110.648 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -160.75 169.3 23.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.38 1.872 . . . . 0.0 107.387 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.91 46.75 26.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.243 1.417 . . . . 0.0 112.399 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -43.61 116.62 2.3 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.766 2.026 . . . . 0.0 113.592 -171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.23 -16.62 28.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.97 3.113 . . . . 0.0 113.318 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.87 -2.52 1.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.314 1.416 . . . . 0.0 111.824 169.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -125.88 13.01 7.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.154 1.782 . . . . 0.0 110.934 -171.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.29 154.21 0.42 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.729 0.811 . . . . 0.0 109.884 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -53.3 -44.08 68.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.867 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.4 2.74 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 115.001 0.76 . . . . 0.0 115.001 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.4 p -68.94 166.02 18.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.0 -42.18 98.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.401 0.62 . . . . 0.0 110.311 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -69.23 -42.19 75.99 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.918 -1.515 . . . . 0.0 109.403 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.78 -35.66 60.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.149 1.795 . . . . 0.0 109.713 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -56.38 -52.53 64.27 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 121.719 -0.613 . . . . 0.0 110.728 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -63.95 -44.72 91.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.773 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.84 86.92 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.441 1.096 . . . . 0.0 111.667 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.89 -49.67 69.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.44 69.01 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.951 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -65.27 -50.51 65.47 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.39 1.076 . . . . 0.0 109.457 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -59.85 -48.34 82.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.87 -37.92 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 117.535 -1.221 . . . . 0.0 110.862 -176.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.29 -38.92 92.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.453 1.933 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.86 -44.89 93.89 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.483 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.05 -56.49 14.64 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.308 0.643 . . . . 0.0 110.148 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.8 mt -56.91 -47.7 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.837 1.255 . . . . 0.0 110.255 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.17 96.62 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.93 -42.89 99.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.79 0.795 . . . . 0.0 111.891 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.6 -0.688 . . . . 0.0 111.908 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.2 mm? -71.5 -33.6 69.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.572 1.078 . . . . 0.0 110.709 175.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' B' ' 27' ' ' TYR . 22.6 ttmt -61.03 -43.97 98.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.888 170.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.46 -41.04 96.61 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.36 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.94 -40.74 85.58 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.77 2.077 . . . . 0.0 110.496 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.62 74.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.32 -39.82 17.24 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.267 1.427 . . . . 0.0 111.623 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.7 p -97.38 -16.0 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.005 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 65.44 25.34 71.32 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.887 1.232 . . . . 0.0 112.332 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.749 1.219 . . . . 0.0 108.466 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.64 165.07 37.66 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.157 1.383 . . . . 0.0 107.529 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.66 101.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 168.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.13 166.83 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -121.92 107.33 12.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.85 175.46 4.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.422 1.089 . . . . 0.0 109.679 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -159.41 -172.71 3.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.92 1.688 . . . . 0.0 107.054 169.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -38.18 -41.8 0.63 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.092 2.957 . . . . 0.0 115.941 -169.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -128.41 -27.86 2.61 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.224 1.41 . . . . 0.0 111.064 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -61.74 -23.55 66.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.753 -1.118 . . . . 0.0 111.87 172.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 15' ' ' THR . 40.3 t80 -54.69 -54.45 41.63 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.617 1.553 . . . . 0.0 107.952 169.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -57.96 -47.84 81.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.367 0.531 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.12 96.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.556 0.217 . . . . 0.0 111.305 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -80.07 -15.71 56.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.772 1.229 . . . . 0.0 112.169 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.492 HG22 HG11 ' A' ' 20' ' ' VAL . 67.1 p -107.11 -9.28 16.21 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.122 0.969 . . . . 0.0 112.613 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.435 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 67.2 m -71.3 -3.13 18.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.83 0.741 . . . . 0.0 112.991 -175.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -144.12 155.97 44.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.314 1.446 . . . . 0.0 108.119 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -167.4 54.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 123.878 0.751 . . . . 0.0 112.407 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.481 HG22 ' HG2' ' A' ' 79' ' ' LYS . 38.7 t -119.97 121.27 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 172.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 53' ' ' VAL . 7.7 p -131.83 124.49 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 122.739 1.257 . . . . 0.0 108.207 -170.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.9 tp -83.43 100.23 10.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.53 141.16 36.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.22 145.25 45.47 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.392 1.077 . . . . 0.0 109.328 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.79 109.13 10.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -170.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.549 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.6 p-90 -121.79 160.03 25.46 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -163.71 159.29 17.33 Favored Pre-proline 0 C--O 1.233 0.2 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.23 -27.16 46.08 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.234 1.956 . . . . 0.0 113.062 168.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -58.61 -24.65 61.45 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 151.58 50.96 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.928 1.24 . . . . 0.0 111.875 -169.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.34 -48.73 71.15 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.201 -1.333 . . . . 0.0 112.512 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.79 -27.35 20.01 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.435 2.757 . . . . 0.0 115.464 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -58.59 -18.56 31.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 120.172 1.351 . . . . 0.0 113.644 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.95 12.11 20.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.315 1.046 . . . . 0.0 111.522 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.9 mtm -122.88 -43.93 2.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.6 1.16 . . . . 0.0 109.546 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.53 -35.88 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.405 0.682 . . . . 0.0 109.337 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.54 23.53 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.243 -0.884 . . . . 0.0 112.01 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.17 -40.51 59.43 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.664 1.576 . . . . 0.0 111.493 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.652 HG12 HD22 ' A' ' 96' ' ' LEU . 2.3 t -56.65 -38.27 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.892 0.769 . . . . 0.0 111.197 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 96' ' ' LEU . 20.4 mt -66.59 -48.69 68.78 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-N 118.568 0.622 . . . . 0.0 110.095 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.62 -36.43 82.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.776 0.322 . . . . 0.0 110.42 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.31 -24.53 66.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.259 1.424 . . . . 0.0 111.723 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.427 HD11 ' SD ' ' A' ' 46' ' ' MET . 34.8 tp -84.55 -40.02 18.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.69 0.677 . . . . 0.0 110.976 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.18 -33.14 72.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.982 -0.449 . . . . 0.0 110.473 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -70.53 -3.81 19.88 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -113.64 -42.43 3.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.624 1.569 . . . . 0.0 111.609 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.427 ' SD ' HD11 ' A' ' 42' ' ' LEU . 20.6 ptm -136.04 16.79 3.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.825 0.85 . . . . 0.0 112.336 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.84 -5.42 18.72 Favored Glycine 0 C--O 1.227 -0.286 0 O-C-N 120.771 -1.205 . . . . 0.0 114.23 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.94 -23.8 67.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.425 0.612 . . . . 0.0 111.342 169.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -32.87 4.87 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 110.983 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 151.6 19.82 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.978 1.311 . . . . 0.0 111.816 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -128.23 154.18 46.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.4 143.53 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 20' ' ' VAL . 1.7 m -131.84 109.61 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.549 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 47.5 mtpt -82.91 157.09 23.19 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 120.56 -1.338 . . . . 0.0 109.75 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mm -130.08 124.02 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -85.75 109.8 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 26' ' ' ALA . 13.0 m -73.15 9.96 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -171.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.85 -34.58 4.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.315 0.962 . . . . 0.0 110.644 169.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.69 -43.13 12.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.869 0.759 . . . . 0.0 111.447 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -141.79 42.94 1.71 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.643 1.211 . . . . 0.0 110.819 -170.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -4.25 45.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.717 1.207 . . . . 0.0 113.833 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -52.4 -43.87 65.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.257 1.023 . . . . 0.0 110.342 -169.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.8 m -58.08 -38.84 77.14 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.38 1.072 . . . . 0.0 112.379 174.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.42 -64.29 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.323 1.049 . . . . 0.0 109.115 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.41 -41.43 17.12 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.645 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -62.2 -43.12 99.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.296 1.548 . . . . 0.0 111.131 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -76.58 -9.32 58.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.193 0.597 . . . . 0.0 112.422 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.79 60.26 6.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 -173.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.17 -64.07 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 -173.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 mtm 58.0 5.13 0.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.23 2.612 . . . . 0.0 114.719 172.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -141.02 157.38 45.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.346 0.975 . . . . 0.0 111.638 -169.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.2 mm -138.96 139.51 23.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.37 138.77 49.14 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 -10.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.5 m -112.97 143.56 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.8 mt -120.84 127.54 52.0 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.95 1.7 . . . . 0.0 107.465 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -116.25 114.39 24.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.47 122.13 46.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.92 153.08 38.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 110.167 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG2' HG22 ' A' ' 19' ' ' VAL . 44.8 mtpt -137.12 130.79 31.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.001 174.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.7 t70 42.15 35.23 0.56 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.791 2.036 . . . . 0.0 114.21 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 113.9 -8.51 23.5 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 116.628 1.411 . . . . 0.0 116.628 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.73 152.39 47.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.444 1.622 . . . . 0.0 112.942 -169.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.86 141.93 16.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.78 1.232 . . . . 0.0 108.663 175.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.74 -22.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 124.166 0.986 . . . . 0.0 109.537 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -153.76 166.44 32.85 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 122.587 1.184 . . . . 0.0 107.805 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -158.13 132.5 8.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.939 1.696 . . . . 0.0 106.703 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m -147.62 148.63 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.064 0.945 . . . . 0.0 109.053 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.21 124.22 41.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.18 156.17 9.28 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 124.618 1.104 . . . . 0.0 110.675 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.2 148.99 46.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.314 0.557 . . . . 0.0 111.211 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.03 148.04 18.93 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.5 177.68 6.49 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.33 2.687 . . . . 0.0 112.443 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -33.25 69.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.345 1.458 . . . . 0.0 112.334 -169.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -81.85 -40.72 22.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.081 0.552 . . . . 0.0 110.199 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.21 92.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.051 0.54 . . . . 0.0 110.65 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.652 HD22 HG12 ' A' ' 38' ' ' VAL . 2.1 tp -57.84 -52.58 64.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.823 0.849 . . . . 0.0 109.72 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.1 -36.39 77.51 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.478 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.06 -46.64 88.86 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.551 1.068 . . . . 0.0 110.599 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.5 tp -58.23 -40.28 81.29 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 124.809 1.244 . . . . 0.0 111.673 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -87.97 -40.57 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.164 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -57.77 -34.29 69.41 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.977 1.311 . . . . 0.0 112.131 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -65.61 -8.73 21.71 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -123.77 -33.54 3.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.501 1.12 . . . . 0.0 112.197 174.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.247 0.925 0 C-N-CA 126.752 2.021 . . . . 0.0 109.717 178.688 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -79.16 80.2 5.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.987 0.915 . . . . 0.0 108.756 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m120 78.98 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.654 2.781 . . . . 0.0 111.753 175.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.458 ' H ' ' HA ' ' B' ' 32' ' ' TRP . 54.9 mtmt -125.34 123.76 40.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 129.598 3.159 . . . . 0.0 103.725 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -92.78 141.46 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.76 -168.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.3 tt -133.65 140.44 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -131.24 136.16 47.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -110.44 141.86 42.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.85 123.03 36.36 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 78.7 p -156.1 147.67 22.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -46.47 111.74 0.41 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.425 1.49 . . . . 0.0 111.848 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.22 11.01 50.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.711 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 38.18 35.51 0.09 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.916 2.486 . . . . 0.0 113.793 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -69.64 -46.74 65.47 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.65 -65.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -168.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -33.89 68.45 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.833 0.742 . . . . 0.0 111.736 -174.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.3 p -56.24 -55.65 30.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.31 1.444 . . . . 0.0 111.398 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -52.1 -49.76 62.95 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.346 1.858 . . . . 0.0 109.657 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 9.2 ttm -67.83 -46.02 73.0 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.599 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.819 0.848 . . . . 0.0 110.77 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.0 -27.72 61.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.111 0.869 . . . . 0.0 110.149 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.05 -45.94 24.21 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -55.27 -33.67 63.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.414 1.086 . . . . 0.0 111.34 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.64 11.87 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.888 0.875 . . . . 0.0 110.604 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -64.96 -22.84 67.07 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.403 1.002 . . . . 0.0 113.665 -168.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.14 -16.35 52.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 170.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 11.9 m-85 -130.01 -40.85 1.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.395 1.078 . . . . 0.0 112.789 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.22 75.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.624 1.97 . . . . 0.0 106.234 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -164.04 1.2 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.977 1.751 . . . . 0.0 112.255 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.49 -7.9 8.03 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.543 -0.974 . . . . 0.0 113.137 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.16 -19.29 62.92 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.909 -1.119 . . . . 0.0 109.573 168.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' TRP . . . . . 0.458 ' HA ' ' H ' ' B' ' 4' ' ' LYS . 56.5 m95 -130.87 175.7 8.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 127.776 2.431 . . . . 0.0 110.121 -174.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -153.04 129.9 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.35 144.31 14.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.871 0.868 . . . . 0.0 109.273 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.46 156.8 46.72 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 107.308 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.2 m -145.5 137.69 25.61 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.52 173.39 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.617 0.767 . . . . 0.0 111.339 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.08 40.64 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 122.247 -0.283 . . . . 0.0 112.978 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.403 HG13 ' HE3' ' B' ' 88' ' ' LYS . 1.7 tt -53.19 -57.19 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 113.679 -170.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -132.11 30.7 4.22 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.079 1.752 . . . . 0.0 108.039 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.8 149.93 49.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.563 1.945 . . . . 0.0 112.82 -169.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 146.45 100.4 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 130.995 3.718 . . . . 0.0 104.071 177.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.23 -179.29 48.7 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -171.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 23.0 tp -161.45 100.86 1.19 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -60.88 122.62 70.28 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.352 -0.832 . . . . 0.0 108.782 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.62 -26.56 80.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 121.734 1.622 . . . . 0.0 112.097 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.573 ' ND2' ' CE1' ' B' ' 120' ' ' PHE . 1.2 t30 -68.25 -27.92 66.76 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.979 -1.076 . . . . 0.0 112.086 171.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.127 1.785 . . . . 0.0 109.746 171.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.87 -51.66 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -52.57 -47.97 66.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.852 0.751 . . . . 0.0 109.977 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.89 57.24 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.655 1.182 . . . . 0.0 111.508 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.86 -38.79 20.71 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -61.75 -28.74 69.65 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.553 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.44 -27.95 64.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.931 0.787 . . . . 0.0 111.908 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.09 14.15 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 110.97 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.7 36.38 82.59 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.466 -1.186 . . . . 0.0 113.222 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.97 149.07 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -116.8 137.1 52.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.793 0.837 . . . . 0.0 108.92 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.2 pt -139.31 16.95 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 124.861 1.264 . . . . 0.0 110.836 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -58.91 -15.21 11.68 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -91.44 -15.8 28.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.308 1.443 . . . . 0.0 113.498 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -56.65 151.45 13.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.6 p -133.47 174.14 10.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.663 2.385 . . . . 0.0 109.359 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 15.7 m -153.01 -173.77 4.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.143 0.977 . . . . 0.0 109.517 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -161.66 167.93 24.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.274 1.829 . . . . 0.0 108.044 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.0 pt -63.37 169.1 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -48.62 135.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -142.0 98.84 3.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.544 1.164 . . . . 0.0 108.211 -171.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -51.38 -28.07 11.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.48 1.912 . . . . 0.0 113.989 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.81 -23.34 61.54 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 119.608 1.094 . . . . 0.0 110.494 -172.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -33.64 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 118.285 -0.865 . . . . 0.0 109.788 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.61 -52.93 61.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.639 1.109 . . . . 0.0 109.522 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -29.07 66.36 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.24 0.473 . . . . 0.0 110.964 -176.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -87.12 -12.45 47.06 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.673 1.589 . . . . 0.0 112.663 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.96 162.35 22.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.967 0.889 . . . . 0.0 110.434 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.89 -34.15 15.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.052 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.43 142.97 33.66 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.744 1.217 . . . . 0.0 110.202 -172.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -114.56 103.76 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 169.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.8 98.12 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -66.77 122.88 18.64 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 tp -124.66 52.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 110.083 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -153.02 -174.82 5.07 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.18 0.992 . . . . 0.0 108.761 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.1 44.56 1.2 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 106.789 -2.525 . . . . 0.0 106.789 169.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -150.97 164.59 36.02 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.215 2.206 . . . . 0.0 108.244 -169.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -131.38 7.45 4.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.229 1.412 . . . . 0.0 112.701 -172.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.21 -15.9 49.71 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.889 0.768 . . . . 0.0 112.709 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -71.24 28.08 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -169.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' LYS . . . . . 0.403 ' HE3' HG13 ' B' ' 39' ' ' ILE . 26.1 ttmt 80.84 17.45 0.55 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.709 2.004 . . . . 0.0 112.432 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 m 34.63 52.09 1.26 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.353 1.861 . . . . 0.0 112.732 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.5 131.03 40.27 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.812 1.675 . . . . 0.0 110.785 -169.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -1.24 57.49 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 116.785 -1.579 . . . . 0.0 113.706 -175.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.9 p 48.0 95.47 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 126.12 1.768 . . . . 0.0 114.177 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.49 132.79 52.72 Favored 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 122.17 1.913 . . . . 0.0 109.51 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.4 -5.28 11.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.819 3.679 . . . . 0.0 117.817 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -74.4 15.35 0.35 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.093 1.315 . . . . 0.0 112.237 170.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 t -135.29 142.92 38.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.364 1.866 . . . . 0.0 106.736 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -69.99 153.69 42.9 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -141.39 141.12 33.79 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -145.97 157.97 43.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.56 137.06 47.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -142.02 -2.12 1.18 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.615 0.766 . . . . 0.0 112.668 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.68 -54.06 4.39 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 59.11 -2.68 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.534 2.334 . . . . 0.0 115.076 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -160.92 170.13 21.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.331 2.653 . . . . 0.0 105.771 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -137.97 106.62 8.12 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 118.877 0.762 . . . . 0.0 109.36 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.446 ' C ' ' CE1' ' B' ' 120' ' ' PHE . 95.4 Cg_endo -66.82 -36.0 25.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 124.033 3.155 . . . . 0.0 112.175 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.88 -13.63 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 129.598 3.159 . . . . 0.0 113.918 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -103.45 -54.42 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.394 1.478 . . . . 0.0 107.488 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . 39.25 -164.11 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.468 1.907 . . . . 0.0 113.34 -170.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -70.11 -48.03 59.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.37 -22.12 2.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 62.6 p -71.02 168.54 16.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.3 -41.96 98.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.379 0.609 . . . . 0.0 110.516 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.55 -41.13 69.49 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 117.395 -1.288 . . . . 0.0 109.066 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -76.59 -33.44 58.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.544 1.52 . . . . 0.0 110.036 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -56.07 -56.51 19.94 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.009 0.822 . . . . 0.0 109.154 169.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -59.38 -41.87 90.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.45 93.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.59 1.156 . . . . 0.0 112.006 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -64.53 -46.98 80.55 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.573 ' CE1' ' ND2' ' B' ' 47' ' ' ASN . 14.5 m-85 -64.82 -36.07 83.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.425 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -61.27 -49.23 77.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.132 0.878 . . . . 0.0 110.046 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.9 ttp-105 -62.84 -52.53 62.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.27 -35.71 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.26 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 30.7 ptt85 -61.68 -41.05 97.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.212 1.824 . . . . 0.0 111.132 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.97 -43.7 94.91 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.459 0.475 . . . . 0.0 110.377 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -68.63 -50.56 50.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 0.0 110.887 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 mt -56.05 -48.67 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.405 1.082 . . . . 0.0 109.114 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.32 -46.96 92.26 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.45 -47.07 85.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.801 0.8 . . . . 0.0 111.737 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -62.95 -47.54 82.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.068 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.81 -37.04 86.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.374 0.534 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 41.3 ttmt -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.97 0.805 . . . . 0.0 109.739 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.2 -37.34 79.95 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-O 116.74 -1.6 . . . . 0.0 111.16 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -59.38 -40.09 85.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 122.008 2.185 . . . . 0.0 110.039 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.05 75.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.202 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.45 -47.68 11.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.393 1.077 . . . . 0.0 111.796 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.2 p -82.7 -22.73 34.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.969 2.108 . . . . 0.0 112.103 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.7 11.24 62.35 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -168.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.5 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.685 2.394 . . . . 0.0 113.772 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.32 167.36 28.91 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.318 1.447 . . . . 0.0 107.84 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.1 98.51 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 169.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.14 168.6 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.714 1.606 . . . . 0.0 108.307 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -125.11 122.1 36.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.811 1.245 . . . . 0.0 109.09 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.33 171.7 13.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.858 1.663 . . . . 0.0 109.859 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -136.09 -167.83 2.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.082 1.753 . . . . 0.0 108.614 169.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -47.12 -27.78 1.53 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.387 2.275 . . . . 0.0 113.627 170.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.49 -30.8 0.82 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.662 1.185 . . . . 0.0 112.06 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m -62.57 -20.02 64.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.895 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -48.32 -55.7 9.98 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.608 1.094 . . . . 0.0 110.427 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -64.18 -44.55 91.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.949 0.34 . . . . 0.0 110.168 -176.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.23 81.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.924 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -82.2 -13.3 57.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.401 1.081 . . . . 0.0 112.541 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 66.6 p -115.89 -5.82 12.04 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 0.0 112.914 -170.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -74.75 -6.05 46.74 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.86 147.13 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.245 1.018 . . . . 0.0 109.346 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.13 -175.8 34.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.309 0.957 . . . . 0.0 111.689 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.59 125.75 48.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -136.03 117.95 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.111 0.964 . . . . 0.0 108.727 -169.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -89.66 116.06 27.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.87 135.81 39.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.883 0.765 . . . . 0.0 109.027 173.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.91 138.7 53.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.068 1.347 . . . . 0.0 108.984 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -119.88 105.07 10.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.425 ' CD1' ' CE ' ' A' ' 54' ' ' LYS . 4.8 p-90 -123.77 147.78 47.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.896 1.278 . . . . 0.0 108.202 -173.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -166.36 160.62 12.29 Favored Pre-proline 0 CA--C 1.534 0.344 0 O-C-N 121.545 -0.722 . . . . 0.0 111.56 171.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.73 -7.58 2.36 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.453 3.435 . . . . 0.0 116.504 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -54.73 -29.28 53.07 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.718 1.207 . . . . 0.0 113.104 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -163.58 162.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.13 -47.55 10.25 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.46 2.457 . . . . 0.0 115.596 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.57 -30.78 56.36 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.582 2.691 . . . . 0.0 114.041 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 m -62.48 -18.11 61.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.658 1.572 . . . . 0.0 113.909 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.79 22.03 13.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 0.0 111.211 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.2 mtm -131.24 -38.79 1.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.704 1.202 . . . . 0.0 110.27 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.82 -37.02 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.196 -0.94 . . . . 0.0 108.607 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.23 -54.31 57.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.874 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -58.96 -39.71 78.29 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.285 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.17 -38.96 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.055 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 2.3 mm? -68.01 -44.51 76.4 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.69 1.132 . . . . 0.0 110.589 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.53 -34.45 77.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.856 0.753 . . . . 0.0 109.813 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -71.2 -19.8 62.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.749 1.62 . . . . 0.0 112.54 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -84.24 -44.63 13.7 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 108.596 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.89 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.385 -0.197 . . . . 0.0 111.127 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.71 -10.09 56.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.236 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.46 -47.08 4.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.24 1.016 . . . . 0.0 111.064 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.7 ptm -135.46 15.96 3.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.528 0.731 . . . . 0.0 112.215 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.6 -3.47 20.68 Favored Glycine 0 CA--C 1.519 0.343 0 O-C-N 121.102 -0.999 . . . . 0.0 114.192 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.67 -24.43 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.83 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 -25.49 8.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.509 1.124 . . . . 0.0 111.83 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.1 tp -118.46 146.56 44.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 111.483 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.79 147.78 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.82 145.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.67 148.33 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' CE ' ' CD1' ' A' ' 25' ' ' TRP . 15.0 mtpt -122.09 146.56 47.08 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 118.862 0.755 . . . . 0.0 111.187 175.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.471 HG22 HG22 ' A' ' 57' ' ' VAL . 6.5 mm -107.78 132.97 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.29 88.98 6.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 55' ' ' ILE . 1.4 t -70.41 50.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 127.416 2.286 . . . . 0.0 114.761 -168.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -159.48 -33.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.067 2.147 . . . . 0.0 109.234 169.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -89.53 -42.34 11.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.688 0.795 . . . . 0.0 109.522 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -133.19 33.85 3.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.329 1.052 . . . . 0.0 111.648 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.58 -7.07 9.01 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.907 1.283 . . . . 0.0 113.375 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -47.39 -50.06 23.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 110.552 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.0 m -59.66 -36.11 75.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.234 0.614 . . . . 0.0 111.938 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.77 -57.31 6.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.45 -43.16 51.98 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.985 0.802 . . . . 0.0 113.434 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.94 -38.29 90.43 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.604 1.162 . . . . 0.0 110.97 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -76.89 -32.12 57.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.584 0.629 . . . . 0.0 110.077 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 77.59 1.38 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -170.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.86 -64.81 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.413 3.1 ppp? 45.47 24.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.428 2.691 . . . . 0.0 114.96 172.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.1 p -149.32 163.97 36.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.187 2.195 . . . . 0.0 110.96 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.3 mm -140.54 146.48 45.12 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -175.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.78 143.52 67.67 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 -10.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.4 m -119.37 150.16 40.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.267 0.556 . . . . 0.0 110.517 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.28 124.6 32.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -116.27 113.87 23.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.5 127.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.17 157.25 35.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.533 1.133 . . . . 0.0 110.169 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.82 130.86 20.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.43 32.29 0.5 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.447 2.299 . . . . 0.0 114.572 170.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.31 -19.2 6.03 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 116.489 1.356 . . . . 0.0 116.489 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -135.29 151.82 50.92 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 119.425 1.612 . . . . 0.0 112.878 -168.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -69.05 137.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.74 -25.21 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.997 1.719 . . . . 0.0 109.553 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -143.89 152.76 41.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.06 137.07 27.34 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.5 t -151.27 146.28 25.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.7 t -140.6 76.57 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.97 163.64 18.6 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.409 1.004 . . . . 0.0 110.878 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.37 147.38 51.13 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.807 0.803 . . . . 0.0 110.644 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 91' ' ' LYS . 2.8 mppt? -139.32 144.44 40.22 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.633 1.173 . . . . 0.0 108.482 170.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.55 170.94 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.521 2.147 . . . . 0.0 110.052 169.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -45.31 69.98 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.998 0.919 . . . . 0.0 112.359 -173.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.7 -43.12 76.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.541 0.155 . . . . 0.0 110.782 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.1 84.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.0 -0.438 . . . . 0.0 110.61 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 tp -67.68 -47.64 68.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.427 0.103 . . . . 0.0 110.979 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.94 -37.85 88.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.15 -46.21 88.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.819 0.447 . . . . 0.0 110.8 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.2 tp -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 110.825 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.47 -41.16 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.588 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -55.33 -29.06 57.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 112.412 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -49.11 -33.87 12.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.219 1.408 . . . . 0.0 112.306 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -135.72 -6.56 2.18 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.659 1.984 . . . . 0.0 108.576 170.166 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.02 125.39 26.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.253 31.5 m120 61.53 119.94 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 C-N-CA 129.317 3.047 . . . . 0.0 113.939 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -148.46 141.12 24.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.562 3.145 . . . . 0.0 103.731 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mt -117.95 144.5 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.845 1.202 . . . . 0.0 107.777 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.76 146.57 19.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -130.33 128.32 41.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.6 133.95 49.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -132.99 117.43 17.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -168.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 58.0 m -139.9 163.99 31.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 124.118 0.886 . . . . 0.0 111.875 -168.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.6 m -68.54 114.06 6.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.451 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 49.73 41.39 35.02 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.338 1.447 . . . . 0.0 112.801 173.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -36.53 104.31 0.03 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 18.0 m -135.21 0.97 2.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.77 169.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.11 -55.11 0.09 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.142 0.977 . . . . 0.0 112.902 -169.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -57.84 -54.67 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.176 0.444 . . . . 0.0 110.599 -171.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.7 m -76.73 -26.74 54.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.702 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -54.85 -51.1 66.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.822 1.192 . . . . 0.0 110.488 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 13.9 ttm -67.73 -44.19 78.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.529 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.75 99.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.368 0.667 . . . . 0.0 111.568 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.83 -31.76 61.76 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.418 1.008 . . . . 0.0 110.683 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -42.62 74.46 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -56.73 -40.0 74.94 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 117.931 0.865 . . . . 0.0 111.21 170.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.24 -54.23 43.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -69.84 -17.83 63.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.836 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.03 -14.93 63.36 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.874 1.216 . . . . 0.0 112.579 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.491 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 2.5 m-85 -126.32 -20.86 4.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.265 1.026 . . . . 0.0 113.732 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.26 -107.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 -172.28 40.78 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 119.126 0.875 . . . . 0.0 111.426 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.68 -20.22 65.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.35 1.46 . . . . 0.0 111.962 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.45 -40.18 74.41 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.97 0.908 . . . . 0.0 111.471 174.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.54 153.09 18.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.864 0.84 . . . . 0.0 112.587 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -124.61 107.33 10.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.48 103.28 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -92.51 160.98 14.8 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.806 0.842 . . . . 0.0 108.781 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -151.01 134.9 16.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.498 0.719 . . . . 0.0 109.576 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.67 176.92 11.98 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.343 0.592 . . . . 0.0 112.353 -174.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.22 -177.84 47.22 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.924 1.249 . . . . 0.0 111.141 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.451 HG22 ' H ' ' B' ' 12' ' ' GLY . 3.5 tt -52.55 -53.33 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.116 1.366 . . . . 0.0 113.255 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -133.31 29.05 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.147 1.779 . . . . 0.0 108.611 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.86 146.8 54.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.168 2.187 . . . . 0.0 111.766 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 144.91 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 129.987 3.315 . . . . 0.0 105.287 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.89 162.67 33.45 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 62.3 tp -140.61 76.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.36 128.85 90.37 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.25 -20.05 45.35 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.936 1.757 . . . . 0.0 112.63 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -38.64 90.34 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 120.077 1.308 . . . . 0.0 111.777 171.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.31 60.26 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.824 0.738 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -60.41 -52.76 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 171.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -58.44 -44.27 89.11 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.695 0.798 . . . . 0.0 110.824 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.12 68.02 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.914 0.885 . . . . 0.0 111.791 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -39.58 53.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -63.03 -26.29 68.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.49 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.03 -29.52 60.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.035 1.288 . . . . 0.0 111.643 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 m -116.85 16.86 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.244 1.418 . . . . 0.0 111.242 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.73 33.97 88.67 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.444 -1.198 . . . . 0.0 113.423 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.71 150.89 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 169.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -118.34 137.84 52.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.806 0.843 . . . . 0.0 108.97 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 21.5 pt -137.81 18.14 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 124.571 1.149 . . . . 0.0 110.988 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -67.03 15.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -137.26 -6.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.24 2.616 . . . . 0.0 111.822 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.9 157.06 22.53 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.128 -0.983 . . . . 0.0 110.942 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.9 p -123.44 176.62 6.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.39 1.876 . . . . 0.0 109.707 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -157.99 170.26 22.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -165.43 163.28 19.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.527 1.931 . . . . 0.0 108.15 -176.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.4 pt -64.97 167.37 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.787 0.835 . . . . 0.0 111.801 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -49.43 138.72 4.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.489 0.715 . . . . 0.0 109.58 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.45 103.79 3.85 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.469 1.128 . . . . 0.0 108.954 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -48.84 -32.53 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.944 1.698 . . . . 0.0 113.924 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.0 -22.91 63.08 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.419 0.554 . . . . 0.0 111.194 -169.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.87 -39.42 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.147 -0.93 . . . . 0.0 109.344 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.05 -49.43 77.67 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.573 1.079 . . . . 0.0 110.449 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -25.21 67.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.918 0.781 . . . . 0.0 111.416 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -87.62 -11.41 48.59 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.996 1.318 . . . . 0.0 113.018 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.64 169.74 5.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.025 0.916 . . . . 0.0 111.281 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -85.29 -34.98 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 169.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.51 HD13 ' CE ' ' B' ' 97' ' ' LYS . 20.1 tp -151.41 144.13 24.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.974 1.309 . . . . 0.0 109.933 -173.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.82 101.91 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 126.269 1.827 . . . . 0.0 107.074 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 88.6 t -80.49 100.82 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 82.9 m -78.85 131.39 36.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -150.66 64.78 0.93 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.915 0.864 . . . . 0.0 111.65 -174.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 58.7 m -166.87 -38.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.438 1.095 . . . . 0.0 109.736 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 156.48 -171.84 34.17 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.518 2.485 . . . . 0.0 106.914 -169.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -143.3 64.19 1.35 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.191 0.995 . . . . 0.0 108.408 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -157.63 -77.79 0.08 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.162 1.385 . . . . 0.0 109.313 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.7 -28.1 69.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.92 0.488 . . . . 0.0 111.55 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.44 14.74 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.611 1.965 . . . . 0.0 113.978 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm 77.3 31.02 0.5 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.114 2.566 . . . . 0.0 111.799 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 p 29.78 56.45 0.73 Allowed Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.596 1.958 . . . . 0.0 112.694 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.77 131.98 46.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.191 2.594 . . . . 0.0 110.162 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.99 0.4 55.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.979 -173.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.6 p 46.28 90.39 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.986 2.114 . . . . 0.0 113.147 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -64.54 147.21 90.24 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.026 2.484 . . . . 0.0 108.842 -169.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.21 -0.06 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.112 3.208 . . . . 0.0 115.359 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -64.08 -16.95 62.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.752 0.821 . . . . 0.0 111.754 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 152.39 37.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.416 1.007 . . . . 0.0 112.796 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.51 ' CE ' HD13 ' B' ' 77' ' ' LEU . 5.1 tmmm? -80.08 154.72 27.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 168.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -139.79 146.22 39.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -144.81 149.31 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 133.48 50.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.291 1.036 . . . . 0.0 108.423 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -131.39 -5.7 3.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.386 1.074 . . . . 0.0 111.626 -171.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.62 147.18 16.26 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -144.09 24.41 1.63 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.699 1.599 . . . . 0.0 110.884 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -152.45 163.41 39.59 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.085 2.154 . . . . 0.0 106.499 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -147.31 121.9 5.13 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.288 1.404 . . . . 0.0 108.349 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.03 -21.59 15.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.548 2.165 . . . . 0.0 112.876 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.25 -6.14 12.81 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.551 1.069 . . . . 0.0 112.16 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -103.54 12.13 35.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.822 1.249 . . . . 0.0 111.544 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.68 148.9 0.66 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.001 1.321 . . . . 0.0 112.55 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -38.56 85.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.942 -171.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.47 -20.49 4.93 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 169.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.6 p -69.93 163.59 25.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.66 -39.57 84.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.265 0.555 . . . . 0.0 110.919 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.89 -44.64 61.05 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.349 -1.31 . . . . 0.0 109.87 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -73.82 -29.12 61.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 120.922 1.692 . . . . 0.0 110.5 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -58.17 -62.34 1.9 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.526 0.603 . . . . 0.0 109.516 170.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -60.44 -40.14 90.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.13 99.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.057 -177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.89 -46.0 83.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.798 0.726 . . . . 0.0 109.648 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -63.34 -44.15 95.71 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.956 0.902 . . . . 0.0 111.41 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 -59.13 -49.47 77.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.02 -38.79 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.587 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -55.65 -46.3 77.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.948 1.703 . . . . 0.0 111.495 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.09 -44.62 95.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.204 0.315 . . . . 0.0 110.762 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -61.44 2.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 110.133 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -39.96 60.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.614 1.565 . . . . 0.0 110.956 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.96 76.65 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 118.531 -1.15 . . . . 0.0 110.861 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -58.93 -46.66 87.42 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.373 1.587 . . . . 0.0 111.209 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.05 -50.33 73.08 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -37.27 75.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.485 0.584 . . . . 0.0 112.319 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.491 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -60.69 -42.34 96.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.97 -41.3 95.56 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.864 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.8 -37.64 74.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.802 2.547 . . . . 0.0 111.372 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.49 -29.94 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.5 -46.89 8.36 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.163 1.785 . . . . 0.0 110.983 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.6 p -79.17 -28.48 42.71 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.661 1.984 . . . . 0.0 109.087 -172.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 47.44 44.11 21.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm . . . . . 0 C--O 1.247 0.957 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.232 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 tpp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 118.906 -0.568 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.53 169.22 24.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.175 1.39 . . . . 0.0 108.268 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.54 100.48 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.25 167.3 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.858 1.663 . . . . 0.0 108.72 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -121.14 112.4 18.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.628 1.571 . . . . 0.0 108.017 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.05 172.49 13.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.325 1.05 . . . . 0.0 110.156 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -156.69 -177.77 6.86 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.633 1.973 . . . . 0.0 106.447 169.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -38.45 -38.83 0.4 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.673 2.789 . . . . 0.0 116.005 -169.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.18 -31.3 2.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.125 0.97 . . . . 0.0 111.154 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -61.68 -21.76 64.73 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 117.816 -1.088 . . . . 0.0 112.293 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -48.66 -51.32 28.97 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.323 1.42 . . . . 0.0 110.166 169.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -64.85 -45.29 86.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.03 87.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.532 0.206 . . . . 0.0 110.87 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -74.34 -16.1 60.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.546 1.138 . . . . 0.0 112.434 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.9 p -115.64 -2.83 12.39 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 112.122 -171.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.8 m -72.61 -10.83 60.26 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.73 144.47 34.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.135 0.879 . . . . 0.0 110.111 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.62 -174.92 31.09 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.59 1.091 . . . . 0.0 111.808 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 104' ' ' LEU . 31.0 t -89.99 129.84 40.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.2 116.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -169.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.6 tp -79.23 138.25 37.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.12 115.08 15.93 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.367 0.985 . . . . 0.0 109.24 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -111.97 147.67 35.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.01 1.324 . . . . 0.0 110.203 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -128.52 109.05 11.03 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.6 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -129.7 153.14 48.45 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.066 1.746 . . . . 0.0 107.711 -170.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -171.24 162.24 5.24 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 119.426 1.012 . . . . 0.0 109.836 169.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.63 -19.79 14.96 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.917 3.078 . . . . 0.0 116.626 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.404 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 15.0 m95 -53.72 -30.46 44.01 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.999 1.32 . . . . 0.0 114.293 -176.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 161.27 34.27 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.31 0.959 . . . . 0.0 113.214 -169.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.79 -48.92 52.59 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.08 -1.4 . . . . 0.0 112.669 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.4 -28.0 19.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.363 2.709 . . . . 0.0 115.075 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.85 -20.31 49.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 119.742 1.156 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.63 13.8 21.23 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.126 0.97 . . . . 0.0 111.442 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.1 mtm -123.73 -46.05 2.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.249 1.02 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.0 -34.75 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.15 10.94 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.691 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -59.66 -39.84 70.38 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.02 1.813 . . . . 0.0 111.634 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.35 -39.07 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 118.65 0.659 . . . . 0.0 110.451 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 mp -72.53 -39.76 67.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.991 0.814 . . . . 0.0 111.466 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.42 -33.48 75.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.723 1.147 . . . . 0.0 110.049 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.06 -21.56 59.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.0 1.32 . . . . 0.0 111.597 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.9 -44.71 16.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 108.932 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.407 ' HB2' HD12 ' A' ' 52' ' ' ILE . 17.9 t70 -70.46 -32.42 69.96 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.436 -1.415 . . . . 0.0 111.211 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -67.14 -6.88 19.54 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.537 -0.727 . . . . 0.0 112.755 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.8 -46.61 3.33 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.733 2.013 . . . . 0.0 109.615 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . 0.289 59.7 mmm -104.08 -12.42 16.77 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 125.486 1.515 . . . . 0.0 113.121 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.99 -7.8 9.33 Favored Glycine 0 C--N 1.318 -0.457 0 N-CA-C 113.962 0.345 . . . . 0.0 113.962 -171.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.03 -25.54 65.43 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.16 2.184 . . . . 0.0 112.489 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.7 -20.37 3.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.169 1.388 . . . . 0.0 112.074 -171.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.43 HD22 ' H ' ' A' ' 51' ' ' LYS . 1.6 tm? -129.43 156.41 44.14 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.21 1.404 . . . . 0.0 112.32 -166.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' H ' HD22 ' A' ' 50' ' ' LEU . 87.7 tttt -122.61 148.06 45.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.589 1.556 . . . . 0.0 108.28 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.407 HD12 ' HB2' ' A' ' 43' ' ' ASP . 13.7 mt -128.15 144.13 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.23 146.49 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 24.7 mtpt -121.32 153.02 38.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.181 0.446 . . . . 0.0 110.883 173.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -121.29 127.33 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.29 106.74 15.31 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.299 33.4 m -79.76 49.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -177.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -154.52 -42.18 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.538 1.135 . . . . 0.0 109.453 168.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -84.36 -40.97 17.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.053 1.341 . . . . 0.0 109.831 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -127.73 28.78 5.57 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.283 1.833 . . . . 0.0 111.3 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.98 -3.44 26.04 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.477 0.711 . . . . 0.0 112.696 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.75 -46.76 74.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.815 1.646 . . . . 0.0 111.127 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.15 -46.12 75.69 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.34 -63.93 0.97 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.723 0.809 . . . . 0.0 108.989 -169.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.21 -46.3 15.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.051 0.834 . . . . 0.0 113.096 174.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.02 -42.95 99.91 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.238 1.019 . . . . 0.0 111.724 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -69.17 -18.93 63.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.549 . . . . 0.0 110.712 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.22 66.48 1.52 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.12 129.9 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.46 ' HE3' HD13 ' B' ' 72' ' ' LEU . 27.6 mtm -147.64 20.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -134.32 160.69 37.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.608 1.163 . . . . 0.0 113.98 -167.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 136.45 29.14 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.042 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.43 128.48 11.64 Favored 'Cis proline' 0 N--CA 1.453 -0.869 0 N-CA-C 106.367 -2.205 . . . . 0.0 106.367 -11.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.6 m -92.91 140.49 29.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -136.45 92.79 2.81 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -80.5 132.36 35.68 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.67 120.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -127.96 157.95 39.2 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.057 0.943 . . . . 0.0 109.502 -170.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.06 144.08 25.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 169.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.8 30.29 0.83 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.178 1.791 . . . . 0.0 113.538 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.0 11.99 58.19 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.828 1.204 . . . . 0.0 115.939 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.31 149.26 50.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.647 1.224 . . . . 0.0 111.297 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.38 141.83 15.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 m -128.8 -20.62 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.504 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 153.0 40.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.241 1.016 . . . . 0.0 109.123 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.56 116.61 7.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -177.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -135.67 147.27 48.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.58 95.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -174.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.46 155.9 7.62 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -64.78 143.0 58.24 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.673 0.737 . . . . 0.0 110.526 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 139.75 32.05 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 169.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.24 167.24 22.62 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.463 2.109 . . . . 0.0 110.333 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -46.92 -46.71 21.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.702 1.601 . . . . 0.0 112.386 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.2 -44.34 72.3 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.562 0.619 . . . . 0.0 111.118 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.32 83.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.122 -0.361 . . . . 0.0 110.415 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -52.08 63.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.131 0.572 . . . . 0.0 109.998 176.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -64.24 -36.26 83.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.983 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.96 -49.37 77.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.167 0.439 . . . . 0.0 110.981 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.49 -40.03 85.71 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 123.683 0.793 . . . . 0.0 111.557 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.04 -40.73 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.228 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -55.0 -30.65 59.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.365 1.066 . . . . 0.0 112.276 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -59.62 -18.12 38.92 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.146 0.978 . . . . 0.0 113.298 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -131.88 -22.81 2.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.337 0.971 . . . . 0.0 112.774 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.487 ' HA ' HG21 ' A' ' 19' ' ' VAL . 20.2 tp . . . . . 0 C--O 1.248 0.984 0 C-N-CA 126.484 1.913 . . . . 0.0 107.528 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.67 24.22 2.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.839 0.855 . . . . 0.0 112.605 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.98 133.85 11.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 169.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -142.65 118.29 10.42 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 129.302 3.041 . . . . 0.0 104.23 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.72 130.66 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -134.34 139.67 47.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -127.13 142.27 51.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.201 1.0 . . . . 0.0 108.511 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' B' ' 131' ' ' LEU . 63.3 m-85 -126.41 107.38 10.23 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.146 0.978 . . . . 0.0 108.558 -172.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.97 127.31 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 91.9 p -152.17 162.51 41.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.077 0.399 . . . . 0.0 111.407 169.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 76.5 m -50.05 115.54 1.46 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.623 1.169 . . . . 0.0 110.145 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.46 19.46 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.685 2.088 . . . . 0.0 115.541 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 42.08 31.9 0.27 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.195 1.398 . . . . 0.0 111.493 -168.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -85.95 17.8 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.364 -1.46 . . . . 0.0 113.166 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.67 -67.66 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.662 1.185 . . . . 0.0 111.887 169.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.54 -56.62 15.48 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -168.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m -70.51 -32.99 70.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.891 -169.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.66 -50.15 55.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.305 1.05 . . . . 0.0 111.394 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 31.4 ttm -67.76 -47.12 70.1 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.76 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.99 97.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.001 0.92 . . . . 0.0 111.114 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.57 -31.18 69.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.569 1.077 . . . . 0.0 111.069 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.75 -49.7 53.32 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -56.34 -39.79 73.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.81 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.7 -51.52 64.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -63.37 -22.55 66.95 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -69.87 -11.19 60.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.478 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 14.4 m-85 -130.17 -44.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.735 1.214 . . . . 0.0 111.657 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' B' ' 135' ' ' ALA . 10.7 mp -81.44 75.37 8.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.329 2.252 . . . . 0.0 105.521 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.52 -159.07 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.821 2.153 . . . . 0.0 113.306 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.19 -21.21 21.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.439 1.096 . . . . 0.0 113.245 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.13 -19.85 15.09 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.35 1.86 . . . . 0.0 113.071 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -128.66 161.22 30.16 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.818 1.247 . . . . 0.0 111.005 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.5 136.95 49.48 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.66 136.1 60.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -140.36 157.15 45.98 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.178 0.991 . . . . 0.0 109.217 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -138.43 140.66 39.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.734 1.213 . . . . 0.0 108.56 -172.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.36 173.84 16.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.913 0.485 . . . . 0.0 110.953 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.87 -171.4 42.05 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.304 0.954 . . . . 0.0 111.193 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.73 -56.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.008 1.723 . . . . 0.0 113.999 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.38 31.0 2.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.711 2.004 . . . . 0.0 107.581 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.02 131.09 47.46 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.519 1.928 . . . . 0.0 113.821 -169.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -171.21 8.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.175 1.79 . . . . 0.0 111.31 169.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.73 107.56 3.13 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 119.175 0.898 . . . . 0.0 111.696 -169.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -78.39 86.7 4.44 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -62.04 125.43 85.23 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.534 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.3 -20.08 53.73 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.243 1.962 . . . . 0.0 113.013 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.424 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -60.52 -39.63 88.52 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.696 1.135 . . . . 0.0 111.027 171.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.25 59.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.76 -50.81 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -56.93 -47.01 81.61 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 123.375 0.67 . . . . 0.0 110.28 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.55 -33.26 59.81 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.208 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 82.6 mmm -91.67 -30.64 16.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.997 0.817 . . . . 0.0 111.219 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.47 -24.39 67.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.845 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.67 -31.39 68.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.929 1.24 . . . . 0.0 111.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 m -113.73 15.36 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.085 1.354 . . . . 0.0 110.808 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.67 39.97 98.59 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.634 -1.092 . . . . 0.0 112.824 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.56 107.88 24.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.33 132.7 48.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 pt -127.99 11.42 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.881 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -19.81 46.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.06 0.845 . . . . 0.0 111.163 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -76.97 -13.83 59.92 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.493 2.317 . . . . 0.0 114.073 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -62.9 161.62 12.53 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.217 1.371 . . . . 0.0 113.586 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 63.8 p -126.44 171.23 11.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.883 2.473 . . . . 0.0 108.528 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -157.89 163.62 37.74 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.819 -1.176 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -167.78 164.94 14.28 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 -175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.5 pt -69.29 175.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 111.274 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.53 133.62 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -143.17 104.8 4.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.869 0.842 . . . . 0.0 108.988 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -46.92 -28.63 1.67 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.766 2.026 . . . . 0.0 114.022 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.85 -15.77 62.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.125 0.875 . . . . 0.0 112.049 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.48 -38.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.38 1.072 . . . . 0.0 109.259 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.46 HD13 ' HE3' ' A' ' 70' ' ' MET . 6.9 tt -65.31 -58.54 5.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 120.206 1.366 . . . . 0.0 109.399 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -24.08 66.57 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.362 0.528 . . . . 0.0 110.757 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -78.63 -26.13 45.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 113.092 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 169.33 2.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.467 1.507 . . . . 0.0 111.959 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -91.31 -30.34 16.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.07 138.63 22.97 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.189 0.996 . . . . 0.0 110.556 -170.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 t -113.57 106.14 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.64 114.35 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 30.4 m -77.21 129.23 35.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 168.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.6 tp -131.43 56.12 1.82 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.998 0.919 . . . . 0.0 111.304 -168.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 69.7 m -153.86 172.72 16.93 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.883 -1.135 . . . . 0.0 109.339 170.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -127.24 45.42 1.15 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -152.84 162.32 41.44 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.471 2.308 . . . . 0.0 107.829 -169.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -125.58 2.71 7.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.391 1.077 . . . . 0.0 112.774 -170.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.01 -16.15 63.65 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.62 -0.675 . . . . 0.0 111.714 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.5 -0.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.116 2.166 . . . . 0.0 116.685 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 85.89 7.39 0.36 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.472 2.309 . . . . 0.0 111.528 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.6 m 32.79 49.63 0.55 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 127.821 2.448 . . . . 0.0 113.5 -170.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.48 134.15 38.69 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.731 2.287 . . . . 0.0 111.685 -169.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.462 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.3 0.23 49.87 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 116.987 -1.482 . . . . 0.0 114.882 -172.624 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p 48.31 88.45 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.202 1.401 . . . . 0.0 112.879 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.6 146.61 74.98 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 122.802 2.335 . . . . 0.0 110.112 -169.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.76 2.96 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 125.551 4.167 . . . . 0.0 116.617 -168.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -68.39 -6.16 23.03 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.951 0.796 . . . . 0.0 111.945 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.95 147.31 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.533 1.133 . . . . 0.0 110.26 -169.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -72.73 156.53 38.84 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -151.43 139.11 19.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.627 -1.296 . . . . 0.0 108.472 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -149.11 144.86 26.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.31 136.73 34.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -133.76 -10.64 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.958 0.903 . . . . 0.0 111.655 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.44 168.08 49.6 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.11 -7.28 0.18 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.432 0.693 . . . . 0.0 112.836 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -161.98 179.41 8.03 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.262 1.425 . . . . 0.0 107.928 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -135.76 114.91 11.21 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.26 1.424 . . . . 0.0 108.389 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.05 -18.58 21.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.474 2.783 . . . . 0.0 112.855 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.88 -7.19 7.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.786 1.176 . . . . 0.0 112.461 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -101.66 11.3 39.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.359 1.464 . . . . 0.0 111.347 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.64 147.05 0.65 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.481 1.112 . . . . 0.0 111.595 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -53.37 -45.99 69.43 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 124.078 0.861 . . . . 0.0 109.889 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.98 -20.48 2.86 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 53.2 p -68.7 165.38 19.59 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.37 -41.72 97.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.48 0.657 . . . . 0.0 110.308 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.98 -43.73 67.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 117.007 -1.473 . . . . 0.0 109.718 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.36 -32.43 62.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.18 1.809 . . . . 0.0 109.582 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -56.2 -62.28 1.82 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.153 0.581 . . . . 0.0 109.658 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.89 -39.78 86.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.989 0.916 . . . . 0.0 112.25 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -64.33 -44.92 90.02 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.9 m-30 -60.88 -51.53 68.9 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -64.08 -46.8 82.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 111.299 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -65.51 -48.61 71.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.084 0.402 . . . . 0.0 110.016 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.07 -40.23 88.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.151 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -58.17 -46.73 85.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.543 1.065 . . . . 0.0 111.84 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.23 -44.09 83.47 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.183 0.447 . . . . 0.0 110.524 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -74.37 -39.52 62.7 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.66 -49.17 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 108.913 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.55 -41.44 96.17 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.409 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -56.78 -51.34 69.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 118.13 0.965 . . . . 0.0 111.228 174.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -63.7 -42.31 98.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.638 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.441 HD11 ' CZ ' ' B' ' 8' ' ' PHE . 3.2 mm? -64.5 -40.88 96.49 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.152 0.887 . . . . 0.0 112.202 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.478 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 41.5 ttmt -60.13 -38.0 81.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.461 0.573 . . . . 0.0 110.416 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.64 77.9 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 116.672 -1.633 . . . . 0.0 112.611 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -59.16 -34.46 72.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 122.539 2.427 . . . . 0.0 110.957 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.491 ' HB2' HD12 ' B' ' 28' ' ' LEU . . . -62.69 -32.53 73.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.086 0.554 . . . . 0.0 111.036 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -88.63 -44.57 10.52 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.293 1.437 . . . . 0.0 111.239 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 68.0 p -87.04 -17.44 32.94 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.899 2.08 . . . . 0.0 111.017 -170.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.32 39.57 92.83 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.225 0.917 . . . . 0.0 110.932 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.743 0.817 . . . . 0.0 112.293 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.67 157.86 0.08 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.916 2.486 . . . . 0.0 113.074 -171.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.83 100.92 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 t -74.87 165.98 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.243 1.417 . . . . 0.0 108.057 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -125.79 117.46 23.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.319 1.048 . . . . 0.0 108.625 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -76.79 171.82 14.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.667 1.587 . . . . 0.0 110.12 176.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -156.02 -176.07 5.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.642 1.577 . . . . 0.0 107.053 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -36.67 -36.97 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 130.202 3.401 . . . . 0.0 116.743 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.97 -30.24 1.23 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.999 1.32 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -60.84 -22.18 63.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.335 -0.84 . . . . 0.0 112.319 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -50.79 -52.44 40.96 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.613 1.097 . . . . 0.0 109.292 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.45 -44.57 96.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.02 80.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.444 -0.16 . . . . 0.0 111.13 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.38 -11.95 59.98 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.855 1.262 . . . . 0.0 112.843 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -123.29 -3.09 8.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.942 1.246 . . . . 0.0 113.27 -169.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -71.33 -10.74 60.25 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.65 156.87 45.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.11 0.964 . . . . 0.0 109.574 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.98 -150.92 48.34 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.359 0.98 . . . . 0.0 110.988 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.42 132.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.0 t -143.13 116.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.94 123.33 27.16 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.47 140.15 46.31 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -134.09 151.32 51.33 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.876 1.671 . . . . 0.0 108.786 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.403 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 25.2 m-85 -131.66 117.35 18.54 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.572 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.9 p-90 -139.58 153.89 47.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.344 1.458 . . . . 0.0 108.849 -169.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.48 158.33 9.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.262 1.025 . . . . 0.0 108.489 168.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.37 -15.18 5.4 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.764 2.976 . . . . 0.0 116.846 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -59.86 -24.75 64.48 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.12 160.26 36.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.456 1.026 . . . . 0.0 112.588 -169.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.24 -49.62 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.253 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.1 -28.09 24.03 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.225 2.617 . . . . 0.0 115.093 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 m -59.38 -16.42 22.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.585 1.084 . . . . 0.0 113.692 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -116.92 14.98 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.788 1.235 . . . . 0.0 111.681 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.0 mtm -123.47 -45.2 2.08 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.182 0.993 . . . . 0.0 109.416 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tp -62.77 -34.9 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.798 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.84 24.02 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.985 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.04 -40.1 73.96 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.955 1.77 . . . . 0.0 111.476 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.44 -37.93 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.467 0.576 . . . . 0.0 110.701 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mp -71.58 -41.22 69.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.952 0.796 . . . . 0.0 111.363 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.06 -35.13 80.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.673 1.124 . . . . 0.0 109.727 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.3 -16.41 61.9 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.619 1.567 . . . . 0.0 112.608 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -86.98 -43.45 12.35 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 124.657 1.183 . . . . 0.0 108.382 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.2 -36.59 69.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.79 -0.569 . . . . 0.0 111.118 -174.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.78 -12.55 61.61 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.614 -0.679 . . . . 0.0 112.193 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -99.92 -42.57 6.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.366 1.467 . . . . 0.0 110.797 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -145.03 17.89 1.59 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.665 0.786 . . . . 0.0 112.284 -172.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.91 -1.99 21.36 Favored Glycine 0 CA--C 1.523 0.574 0 O-C-N 121.343 -0.848 . . . . 0.0 113.984 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.37 -24.88 63.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.599 1.16 . . . . 0.0 110.97 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.12 -18.3 11.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.911 0.884 . . . . 0.0 112.576 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -130.63 147.32 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 111.101 -168.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -107.11 146.01 31.77 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 168.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.71 137.44 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 7.4 t -136.58 141.56 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -175.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.572 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 26.3 mtpt -116.41 152.79 33.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -117.72 120.75 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -79.03 109.37 13.27 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.48 33.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -141.8 -42.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.057 -1.027 . . . . 0.0 109.819 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -79.82 -36.12 37.37 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.94 0.896 . . . . 0.0 110.67 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -134.2 32.37 3.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.439 1.495 . . . . 0.0 109.94 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -15.26 62.9 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.21 -169.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -50.54 -44.57 56.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.971 1.309 . . . . 0.0 111.783 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -60.38 -38.61 84.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.895 0.77 . . . . 0.0 111.872 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -66.91 0.5 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.83 1.252 . . . . 0.0 108.883 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.23 -44.84 5.04 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.641 1.115 . . . . 0.0 113.609 170.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -64.44 -45.2 88.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.574 1.187 . . . . 0.0 111.535 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -70.02 -31.57 69.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.49 0.586 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 68.05 0.74 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.8 t -142.39 132.49 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 100.744 -3.799 . . . . 0.0 100.744 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.633 ' HG3' HD12 ' B' ' 67' ' ' ILE . 10.3 ptm -150.59 17.66 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.767 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -138.3 163.56 31.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.222 2.209 . . . . 0.0 111.155 -169.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 143.89 49.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.944 0.898 . . . . 0.0 108.781 176.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.91 149.6 38.77 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 N-CA-C 107.345 -1.829 . . . . 0.0 107.345 -11.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 96.7 m -118.45 147.52 43.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 172.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.6 mt -125.71 141.71 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -129.0 106.86 9.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.04 118.63 31.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -110.31 149.05 30.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.518 0.727 . . . . 0.0 109.405 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -148.75 132.95 17.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.6 t70 43.23 30.84 0.32 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.678 1.991 . . . . 0.0 113.499 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.64 9.99 57.09 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.43 152.59 51.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.693 1.197 . . . . 0.0 110.757 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.07 133.06 32.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -120.24 -22.45 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.223 1.409 . . . . 0.0 110.704 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.36 163.73 34.64 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.215 1.006 . . . . 0.0 110.063 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.74 150.39 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -169.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -154.79 151.25 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.52 67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.76 154.92 8.94 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -170.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -71.86 158.88 35.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.946 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.59 143.63 20.46 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.18 168.15 22.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.352 2.035 . . . . 0.0 110.425 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -44.99 70.94 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.085 0.954 . . . . 0.0 112.071 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.86 -43.17 84.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.563 0.165 . . . . 0.0 110.891 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.0 78.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.04 -0.412 . . . . 0.0 110.666 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -53.21 59.65 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 109.477 175.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -64.44 -37.81 88.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.72 -46.61 88.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.425 0.557 . . . . 0.0 111.264 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -58.08 -40.12 80.29 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 123.868 0.867 . . . . 0.0 111.151 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.95 -39.87 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.267 -0.397 . . . . 0.0 110.687 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -56.36 -28.24 58.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.583 1.153 . . . . 0.0 112.414 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -56.35 -22.39 30.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.149 0.98 . . . . 0.0 112.959 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -127.97 -26.17 2.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.052 0.941 . . . . 0.0 112.338 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.704 1.602 . . . . 0.0 108.033 171.211 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.69 142.5 40.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.289 0.636 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m120 70.63 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 128.608 2.763 . . . . 0.0 110.566 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 127.23 27.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.57 136.16 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -137.91 140.46 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.38 139.89 49.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.898 0.479 . . . . 0.0 110.775 -169.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -100.94 141.18 34.19 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.62 120.07 10.99 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -172.23 155.92 3.75 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -39.53 102.19 0.02 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.18 1.792 . . . . 0.0 112.707 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.27 22.35 50.16 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.652 -1.638 . . . . 0.0 113.784 171.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ASN . . . . . 0.511 HD22 ' HB3' ' B' ' 36' ' ' SER . 0.2 OUTLIER 33.5 2.67 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 1 C-N-CA 132.715 4.406 . . . . 0.0 121.046 173.791 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -70.84 -5.95 34.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.914 -1.741 . . . . 0.0 115.312 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.31 -95.65 0.48 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 120.496 1.498 . . . . 0.0 111.102 -177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -37.5 62.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.611 0.765 . . . . 0.0 112.536 -171.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -44.42 97.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.62 0.646 . . . . 0.0 110.089 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -56.7 -48.62 77.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.051 0.94 . . . . 0.0 110.188 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -43.3 91.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 124.068 0.855 . . . . 0.0 108.906 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.75 71.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.942 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -48.29 80.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.903 1.229 . . . . 0.0 109.883 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 -47.17 92.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -58.36 -42.34 86.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 112.055 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.27 -54.25 36.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.46 -23.66 65.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.703 -1.142 . . . . 0.0 112.025 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -68.22 -21.19 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.883 1.219 . . . . 0.0 113.558 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' B' ' 132' ' ' LYS . 2.3 m-85 -115.69 -16.31 11.27 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.971 0.908 . . . . 0.0 112.715 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.53 -128.23 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.13 -174.4 40.23 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 127.3 2.381 . . . . 0.0 107.361 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.61 -14.24 40.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.376 1.088 . . . . 0.0 112.026 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -52.79 -28.0 20.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.309 1.444 . . . . 0.0 110.429 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -122.46 168.65 11.86 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.24 2.216 . . . . 0.0 107.228 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -139.04 106.21 5.48 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 120.974 -1.079 . . . . 0.0 108.982 -173.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 82.3 t -99.31 132.22 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.67 166.73 23.82 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.517 1.527 . . . . 0.0 108.775 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.511 ' HB3' HD22 ' B' ' 13' ' ' ASN . 37.3 m -147.15 150.55 35.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.484 1.114 . . . . 0.0 109.213 176.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.56 177.35 11.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.975 0.91 . . . . 0.0 110.03 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.24 -175.78 47.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.401 1.477 . . . . 0.0 110.035 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -53.07 -55.45 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.346 1.458 . . . . 0.0 113.114 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.12 29.82 5.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.343 1.457 . . . . 0.0 108.297 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 121.47 14.77 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.092 2.157 . . . . 0.0 111.72 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -174.85 -19.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.46 1.504 . . . . 0.0 111.194 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.76 179.31 53.6 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 124.333 0.968 . . . . 0.0 113.981 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -147.26 92.31 2.09 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.416 1.486 . . . . 0.0 107.041 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.57 129.06 94.07 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.622 1.169 . . . . 0.0 108.16 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -59.53 -19.66 53.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.875 1.717 . . . . 0.0 112.809 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.425 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.2 OUTLIER -61.67 -38.72 88.8 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.104 1.32 . . . . 0.0 111.239 171.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.72 65.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.91 -52.7 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.675 0.79 . . . . 0.0 110.264 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -36.94 58.45 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.996 0.918 . . . . 0.0 111.206 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.7 mmm -82.3 -30.54 30.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.141 0.882 . . . . 0.0 111.568 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -61.62 -25.47 67.38 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.47 1.032 . . . . 0.0 110.992 171.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.15 -22.46 66.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.768 1.167 . . . . 0.0 112.246 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 p -116.67 9.7 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.978 1.711 . . . . 0.0 109.526 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.0 38.79 96.54 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 120.964 -1.085 . . . . 0.0 111.928 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.9 mt -114.48 140.35 35.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.25 136.8 44.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 pt -135.78 15.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.437 1.095 . . . . 0.0 110.855 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 17.1 p -59.48 -13.12 7.65 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.657 1.117 . . . . 0.0 113.63 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -91.29 -14.81 30.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.862 1.665 . . . . 0.0 113.492 176.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.69 142.0 53.95 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.746 1.157 . . . . 0.0 112.611 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -129.36 173.6 10.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.893 2.477 . . . . 0.0 108.486 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.3 m -155.36 -175.38 5.41 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.966 -1.083 . . . . 0.0 110.924 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -155.93 158.87 38.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.94 1.696 . . . . 0.0 109.031 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.5 pt -71.61 170.31 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.583 1.153 . . . . 0.0 112.215 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.633 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.2 OUTLIER -49.7 127.45 5.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -146.01 97.18 2.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.351 1.072 . . . . 0.0 108.75 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -46.42 -27.37 1.06 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.348 1.859 . . . . 0.0 114.429 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.78 -17.9 61.84 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.94 1.245 . . . . 0.0 112.604 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.19 -34.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.917 0.887 . . . . 0.0 108.933 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.66 -54.77 19.67 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.365 0.984 . . . . 0.0 110.209 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -22.41 67.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.561 0.619 . . . . 0.0 110.48 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.1 -20.79 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.809 1.644 . . . . 0.0 112.418 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.56 167.34 2.68 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.759 1.224 . . . . 0.0 111.947 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.29 -28.58 16.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.74 169.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.53 132.45 19.13 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 110.73 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.19 99.98 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -81.09 102.69 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 57.5 m -67.04 136.09 54.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 tp -125.13 43.54 3.02 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 66.2 m -158.34 -16.83 0.07 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.64 1.176 . . . . 0.0 112.724 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.5 -42.7 2.9 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -148.27 144.74 27.84 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.119 2.168 . . . . 0.0 105.617 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.42 149.46 31.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.793 0.837 . . . . 0.0 109.505 -171.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.74 -54.85 18.59 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 17.73 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 130.96 3.704 . . . . 0.0 110.643 -168.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -157.12 32.89 0.29 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 128.996 2.918 . . . . 0.0 107.663 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 m 32.38 52.8 0.84 Allowed Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.421 1.888 . . . . 0.0 112.478 -168.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -45.43 131.76 12.22 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.486 2.79 . . . . 0.0 114.8 -169.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.427 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -85.42 -1.3 56.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.2 p 44.36 93.05 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.888 2.075 . . . . 0.0 113.831 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -55.89 134.97 67.27 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.776 2.317 . . . . 0.0 109.089 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.16 8.47 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.765 3.643 . . . . 0.0 116.095 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -67.8 -6.08 19.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.087 0.955 . . . . 0.0 111.904 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.37 146.79 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 109.391 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -69.67 156.14 39.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -144.36 142.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.404 0 O-C-N 121.029 -1.044 . . . . 0.0 108.208 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.85 154.07 32.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 169.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -95.95 127.31 41.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -110.02 -3.62 16.37 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.706 0.802 . . . . 0.0 110.499 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 162.38 13.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -145.82 -9.39 0.54 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.398 1.079 . . . . 0.0 111.738 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -156.87 168.58 27.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.353 2.261 . . . . 0.0 106.02 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -125.33 112.15 26.04 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.035 0.934 . . . . 0.0 108.636 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.0 -22.91 34.86 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.404 3.403 . . . . 0.0 113.189 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.87 -10.69 9.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.976 0.807 . . . . 0.0 112.637 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -97.82 7.95 45.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 111.858 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.61 143.29 2.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.027 0.931 . . . . 0.0 112.362 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -57.04 -47.7 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.968 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.15 -17.25 4.1 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 44.0 p -70.16 159.87 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.61 -38.81 82.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.352 0.596 . . . . 0.0 111.068 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.3 pt-20 -72.71 -43.43 63.02 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.764 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.49 -30.82 59.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.103 1.774 . . . . 0.0 110.077 -172.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -59.89 -57.11 14.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.76 -0.638 . . . . 0.0 109.837 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -61.5 -41.68 97.66 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.146 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.32 87.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.144 0.884 . . . . 0.0 112.372 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -62.92 -47.63 82.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.3 m-30 -64.13 -43.38 95.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -59.43 -53.84 53.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.018 1.727 . . . . 0.0 109.693 -173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.08 -49.36 70.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.1 -41.19 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.216 -0.897 . . . . 0.0 109.736 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp-105 -58.39 -47.17 84.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.974 1.261 . . . . 0.0 111.21 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.31 -43.49 88.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.242 0.474 . . . . 0.0 110.92 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -64.72 -48.87 73.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.05 0.54 . . . . 0.0 110.06 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.88 -50.66 59.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 125.206 1.402 . . . . 0.0 110.042 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.21 -40.84 95.0 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -61.58 -42.99 99.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.17 0.985 . . . . 0.0 111.689 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -69.74 -34.16 73.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.956 0.798 . . . . 0.0 111.345 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' B' ' 131' ' ' LEU . 3.4 mm? -73.19 -37.8 66.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.698 1.135 . . . . 0.0 111.756 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.403 ' HE3' ' CE2' ' B' ' 27' ' ' TYR . 7.9 ptmt -67.75 -37.34 82.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.945 0.793 . . . . 0.0 109.836 175.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -59.24 -40.75 86.92 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.218 -1.372 . . . . 0.0 109.904 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -60.4 -38.15 83.06 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 122.163 2.256 . . . . 0.0 111.181 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.99 70.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.037 0.535 . . . . 0.0 112.221 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.22 -47.57 8.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.474 1.51 . . . . 0.0 111.499 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.1 p -84.19 -23.28 30.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 110.78 -169.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 50.58 41.28 41.73 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.273 1.429 . . . . 0.0 113.613 -169.049 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.51 170.04 21.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.27 1.428 . . . . 0.0 107.882 169.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 96.81 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 169.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.06 167.63 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.594 1.557 . . . . 0.0 108.132 178.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -123.6 120.28 32.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.257 1.423 . . . . 0.0 107.771 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.52 169.25 15.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.314 1.046 . . . . 0.0 109.214 176.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -133.59 -167.25 1.9 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.557 1.543 . . . . 0.0 108.245 169.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.26 -27.09 2.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.955 2.102 . . . . 0.0 113.409 169.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -136.53 -31.25 0.88 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 111.947 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.0 m -63.81 -20.51 65.84 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.807 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -52.24 -58.38 6.81 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.247 0.931 . . . . 0.0 109.272 169.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -62.58 -43.18 99.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.908 -0.495 . . . . 0.0 110.316 -176.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.79 83.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.193 -174.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -81.34 -16.13 53.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.207 1.003 . . . . 0.0 112.927 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -114.2 -4.19 13.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.446 1.021 . . . . 0.0 113.578 -169.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 m -73.4 -4.57 34.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.66 156.98 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.806 1.242 . . . . 0.0 109.554 -177.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.09 -163.36 45.24 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 124.754 1.169 . . . . 0.0 112.058 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.46 134.97 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.82 149.13 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 113.679 -1.6 . . . . 0.0 108.674 -168.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.4 tp -119.0 100.89 7.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.982 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.84 144.77 25.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -139.49 148.85 43.25 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.417 1.487 . . . . 0.0 108.724 -173.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.34 105.5 7.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -169.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.571 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.1 p-90 -123.7 151.58 42.99 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.237 1.815 . . . . 0.0 107.62 -169.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -166.75 163.09 11.08 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.689 0.677 . . . . 0.0 111.316 173.037 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.32 -10.42 8.51 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.179 3.253 . . . . 0.0 116.534 -177.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.426 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 84.0 m95 -50.12 -49.33 52.21 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.472 -1.251 . . . . 0.0 112.482 -177.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -152.67 168.57 25.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -173.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.24 -54.07 3.91 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 127.865 2.65 . . . . 0.0 115.821 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -53.33 -29.73 49.09 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.597 2.699 . . . . 0.0 114.816 -173.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -61.02 -14.89 26.33 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.779 1.172 . . . . 0.0 114.047 174.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 8.78 19.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.6 1.56 . . . . 0.0 111.167 177.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.8 mtp -125.16 -44.91 1.87 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.477 1.111 . . . . 0.0 108.441 -175.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.91 -35.95 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 -59.28 10.49 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.275 1.03 . . . . 0.0 112.356 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.71 -40.75 61.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.188 1.925 . . . . 0.0 111.607 174.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -40.15 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.238 0.615 . . . . 0.0 110.865 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.82 -43.72 74.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.935 0.789 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.49 -35.16 80.07 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.99 0.814 . . . . 0.0 109.93 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.53 -17.55 62.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.507 1.523 . . . . 0.0 112.536 174.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -87.63 -44.42 11.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.48 1.112 . . . . 0.0 108.674 176.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 52' ' ' ILE . 18.7 t70 -70.23 -36.41 74.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.137 -0.352 . . . . 0.0 110.934 -175.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -69.1 -8.52 46.09 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.919 -0.563 . . . . 0.0 112.32 175.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.91 -46.49 4.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.496 1.118 . . . . 0.0 111.23 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.6 ptm -135.63 15.98 3.37 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.063 0.945 . . . . 0.0 112.304 -171.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.89 -4.82 11.79 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 120.978 -1.077 . . . . 0.0 114.228 170.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.06 -23.33 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.752 0.821 . . . . 0.0 111.054 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -14.38 8.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.259 1.024 . . . . 0.0 112.262 -174.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -129.06 142.01 51.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.515 1.126 . . . . 0.0 111.854 -168.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.52 146.86 27.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 168.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 43' ' ' ASP . 58.6 mt -123.49 144.59 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.119 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.03 143.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 29.2 mtpt -118.56 150.48 39.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.65 0.659 . . . . 0.0 110.197 174.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -118.91 127.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 169.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.49 105.12 12.4 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.297 34.6 m -79.64 46.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -152.2 -38.77 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.549 1.14 . . . . 0.0 109.435 168.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -78.79 -52.34 8.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.948 1.299 . . . . 0.0 110.101 177.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.04 46.0 2.47 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.884 1.274 . . . . 0.0 110.052 -172.102 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.62 2.83 5.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.75 1.62 . . . . 0.0 113.032 -176.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.7 -45.46 89.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.104 1.361 . . . . 0.0 111.102 -169.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -59.64 -36.16 75.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.386 0.994 . . . . 0.0 111.469 173.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB1' ' HE2' ' B' ' 91' ' ' MET . . . -69.58 -58.41 3.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.67 -39.2 45.8 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.075 0.845 . . . . 0.0 113.807 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.11 -43.45 98.41 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.008 1.404 . . . . 0.0 110.821 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -74.92 -11.46 60.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.356 0.662 . . . . 0.0 111.745 173.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.85 55.56 13.73 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.065 1.317 . . . . 0.0 109.85 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.64 -46.89 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 117.911 0.855 . . . . 0.0 109.495 -169.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mtm 53.87 14.6 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 127.936 2.494 . . . . 0.0 113.583 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.408 ' O ' HD13 ' A' ' 72' ' ' ILE . 16.6 m -135.59 163.6 29.75 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.835 1.198 . . . . 0.0 112.993 -168.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.691 HD11 ' HB3' ' B' ' 91' ' ' MET . 2.8 mm -135.09 137.61 27.34 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.975 0.91 . . . . 0.0 110.176 -177.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.74 125.85 10.38 Favored 'Cis proline' 0 N--CA 1.454 -0.846 0 N-CA-C 105.496 -2.54 . . . . 0.0 105.496 -11.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.8 m -85.4 146.36 27.02 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tp -137.21 125.49 23.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.05 108.3 13.21 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 177.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.8 129.79 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.4 156.31 42.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -142.2 138.7 31.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 44.17 28.45 0.27 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.867 2.067 . . . . 0.0 114.258 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.06 41.62 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 124.725 1.155 . . . . 0.0 115.748 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -130.95 143.62 50.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.735 1.268 . . . . 0.0 110.414 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 134.03 30.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -125.73 -22.74 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.356 1.063 . . . . 0.0 109.925 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.81 161.98 40.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.601 1.161 . . . . 0.0 109.534 169.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 148.64 29.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.006 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -154.16 155.89 36.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.56 72.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.29 154.83 9.05 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.954 -171.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -65.25 149.21 50.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.212 0.605 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.59 140.29 20.08 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.72 169.19 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 175.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -45.91 67.22 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.038 0.935 . . . . 0.0 112.078 -171.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.12 -43.82 77.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.45 0.114 . . . . 0.0 110.864 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.44 83.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.12 -0.362 . . . . 0.0 110.171 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 tp -68.17 -46.59 70.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.515 0.326 . . . . 0.0 110.781 178.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -62.65 -38.74 91.48 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.71 -45.64 91.82 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.579 0.627 . . . . 0.0 110.906 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.8 tp -58.65 -36.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.988 1.315 . . . . 0.0 111.644 -175.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.08 -40.78 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.469 174.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -56.99 -34.32 67.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.989 0.916 . . . . 0.0 111.555 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.52 -6.82 33.2 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.09 -22.9 4.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.904 1.282 . . . . 0.0 112.736 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.254 2.222 . . . . 0.0 109.063 170.378 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mpp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.91 139.29 58.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.524 0.73 . . . . 0.0 110.177 -178.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' B' ' 33' ' ' LYS 0.453 53.8 p30 31.15 103.21 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.441 3.096 . . . . 0.0 119.129 -179.067 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.84 120.36 23.35 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.35 140.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -169.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.16 145.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.425 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -131.41 150.51 52.12 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.704 0.802 . . . . 0.0 110.548 -168.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -113.61 143.37 44.69 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.911 1.284 . . . . 0.0 107.582 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.8 tp -145.52 109.21 4.73 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -169.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -166.81 153.66 8.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.173 0.989 . . . . 0.0 109.974 -178.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 94.8 m -38.43 116.52 0.55 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.22 2.208 . . . . 0.0 113.607 -169.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.31 8.45 31.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.01 0.814 . . . . 0.0 113.763 172.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 13' ' ' ASN . . . . . 0.465 ' HB2' ' HB1' ' B' ' 41' ' ' ALA . 7.4 t30 52.53 20.63 1.53 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.919 1.288 . . . . 0.0 112.384 -169.073 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 10.5 m -67.27 133.8 50.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.427 -0.795 . . . . 0.0 109.933 -174.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 56.53 -85.65 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 169.471 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.438 ' HG3' ' HD2' ' B' ' 106' ' ' PRO . 0.0 OUTLIER -54.12 -40.74 67.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.998 0.817 . . . . 0.0 111.829 -169.839 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -33.76 76.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.03 0.932 . . . . 0.0 111.403 -177.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -68.95 -52.28 30.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.63 1.572 . . . . 0.0 108.949 175.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 11.3 ptp -65.83 -37.55 86.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.712 -174.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.41 80.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.979 -0.534 . . . . 0.0 110.495 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.73 -28.29 66.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.976 176.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.02 -46.37 10.52 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 119.217 0.917 . . . . 0.0 111.215 173.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -53.59 -44.06 69.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 124.712 1.205 . . . . 0.0 111.223 173.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -49.73 72.21 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.97 -28.47 70.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.665 -171.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.69 -15.81 62.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 1.1 m-85 -127.29 -17.37 4.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.4 -124.53 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.24 -168.6 38.03 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.55 -18.68 31.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.262 1.425 . . . . 0.0 112.361 172.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -55.83 -20.57 15.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.468 1.507 . . . . 0.0 111.192 169.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -134.16 168.2 19.27 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.334 1.453 . . . . 0.0 111.516 -177.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' B' ' 3' ' ' ASN . 1.6 tmtp? -137.42 126.13 23.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 169.334 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.23 124.37 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -169.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -135.13 169.49 17.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.034 0.934 . . . . 0.0 109.068 177.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -146.92 140.35 25.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.96 177.36 9.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.888 . . . . 0.0 112.227 -177.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 -175.2 44.8 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.453 1.025 . . . . 0.0 112.349 176.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.421 HG13 ' HE3' ' B' ' 88' ' ' LYS . 2.4 tt -41.06 -64.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.062 . . . . 0.0 114.607 -170.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.15 31.93 4.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.394 2.278 . . . . 0.0 107.014 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' B' ' 13' ' ' ASN . . . -54.55 138.58 40.45 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -168.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -177.86 21.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 129.054 2.942 . . . . 0.0 108.414 169.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.42 58.09 4.42 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 117.111 1.605 . . . . 0.0 117.111 -168.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.7 tp -67.85 115.22 7.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.174 1.987 . . . . 0.0 106.897 168.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -110.13 130.27 23.03 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -174.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -21.18 51.75 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.274 1.982 . . . . 0.0 112.887 177.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.4 OUTLIER -62.56 -35.55 79.83 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.764 1.166 . . . . 0.0 111.654 172.164 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -77.64 -33.19 53.61 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.871 0.76 . . . . 0.0 109.621 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.09 -49.9 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -59.39 -45.77 90.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.377 -0.827 . . . . 0.0 110.807 176.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.63 69.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.353 1.061 . . . . 0.0 111.526 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -77.11 -40.86 44.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.818 0.847 . . . . 0.0 110.001 176.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.26 -27.67 69.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.502 178.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.8 -30.27 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.84 1.2 . . . . 0.0 111.85 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.08 16.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.221 1.408 . . . . 0.0 110.81 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.07 28.44 72.92 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.162 -1.354 . . . . 0.0 113.491 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.41 152.05 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 169.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -124.18 140.17 53.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.3 pt -135.94 17.77 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.979 1.312 . . . . 0.0 110.868 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -59.44 -17.07 27.91 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.421 -0.799 . . . . 0.0 111.978 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -77.9 -18.03 56.61 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.282 1.833 . . . . 0.0 113.907 174.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -65.59 167.14 9.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.697 1.237 . . . . 0.0 112.761 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -153.21 174.98 13.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.653 1.981 . . . . 0.0 106.681 170.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -149.89 174.46 12.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.623 0.769 . . . . 0.0 110.318 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -161.55 164.35 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.876 1.67 . . . . 0.0 109.217 -169.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 pt -63.02 165.57 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.702 1.201 . . . . 0.0 112.716 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.58 128.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -134.75 100.14 4.53 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.698 1.237 . . . . 0.0 108.34 -176.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.3 m -46.28 -29.82 1.79 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.132 2.173 . . . . 0.0 113.674 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.87 -25.22 68.18 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.392 0.996 . . . . 0.0 111.446 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.92 -42.14 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.35 -49.44 76.96 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.608 1.094 . . . . 0.0 110.199 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -27.76 69.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 110.95 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -84.9 -20.18 31.14 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.817 1.247 . . . . 0.0 112.413 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.19 157.16 10.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.295 1.045 . . . . 0.0 110.649 175.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.7 -33.29 20.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.776 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -146.28 135.0 22.29 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.954 -169.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.485 HG23 HG11 ' B' ' 96' ' ' VAL . 69.0 t -111.29 116.08 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 126.222 1.809 . . . . 0.0 107.559 172.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 46.3 t -88.81 105.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -70.99 134.51 47.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 167.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.4 tp -132.54 38.89 3.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 62.3 p -169.04 -40.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.299 -0.875 . . . . 0.0 109.35 169.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.28 10.46 84.67 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -172.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.81 137.33 39.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.798 0.799 . . . . 0.0 110.634 -169.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.74 -17.03 61.16 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -170.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.39 -12.3 60.03 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.589 1.086 . . . . 0.0 112.453 -173.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -73.74 3.13 6.89 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -169.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 88' ' ' LYS . . . . . 0.421 ' HE3' HG13 ' B' ' 39' ' ' ILE . 61.4 mttt 88.15 5.0 0.25 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.441 2.696 . . . . 0.0 110.018 -169.083 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 21.0 m 33.57 54.68 1.38 Allowed Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 127.052 2.141 . . . . 0.0 111.063 -169.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.51 140.89 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.917 3.078 . . . . 0.0 114.255 -168.361 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 91' ' ' MET . . . . . 0.691 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -91.21 4.43 52.28 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -172.405 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.1 p 44.24 86.22 0.14 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.453 1.501 . . . . 0.0 113.259 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -55.09 143.1 75.56 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 122.505 2.137 . . . . 0.0 109.534 -172.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.44 4.47 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.605 1 C-N-CA 126.041 4.494 . . . . 0.0 117.572 -168.371 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.04 -5.42 21.8 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.452 -0.78 . . . . 0.0 111.995 169.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.485 HG11 HG23 ' B' ' 78' ' ' VAL . 2.4 t -134.6 148.56 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.678 1.191 . . . . 0.0 110.492 -168.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -84.63 157.23 21.23 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -144.09 148.53 35.25 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.561 -1.337 . . . . 0.0 109.701 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -152.32 151.52 30.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.99 126.34 42.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -118.44 -3.09 10.96 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.506 1.122 . . . . 0.0 111.329 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.65 142.07 13.44 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 175.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.84 12.32 1.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.006 2.123 . . . . 0.0 109.922 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -154.32 164.01 39.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.069 2.547 . . . . 0.0 105.973 -173.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -147.41 109.79 3.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 118.9 0.773 . . . . 0.0 110.072 -171.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' B' ' 16' ' ' ARG . 72.9 Cg_endo -72.35 -21.61 22.81 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.237 3.291 . . . . 0.0 112.678 -172.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.35 2.72 0.55 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.681 1.193 . . . . 0.0 112.518 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -123.71 13.85 9.34 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.438 1.495 . . . . 0.0 111.309 -177.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.79 148.08 1.13 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.225 1.01 . . . . 0.0 111.38 177.053 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -56.2 -46.94 79.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.091 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.05 -16.31 4.71 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 169.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.25 158.47 34.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -37.53 78.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.422 0.629 . . . . 0.0 111.262 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.58 -43.26 60.2 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.926 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.97 -28.82 60.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 121.126 1.785 . . . . 0.0 110.078 -172.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -60.43 -59.39 5.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.739 0.7 . . . . 0.0 109.722 171.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.84 -39.66 89.9 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.17 97.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.572 -0.705 . . . . 0.0 112.133 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.54 -46.44 85.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.245 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.1 m-30 -62.8 -46.16 89.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -64.18 -46.38 84.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.358 1.063 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 41.1 ttp-105 -58.69 -49.67 76.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.66 -42.65 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.234 -175.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -65.75 -37.06 85.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.611 1.55 . . . . 0.0 111.993 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.89 -46.36 90.95 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.293 0.37 . . . . 0.0 110.495 175.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.91 -50.9 62.8 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.152 0.581 . . . . 0.0 110.687 -179.076 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.69 -49.84 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.242 1.017 . . . . 0.0 109.483 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.26 96.15 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 119.017 -0.88 . . . . 0.0 111.828 -174.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -61.04 -45.89 92.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.704 1.252 . . . . 0.0 110.642 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.42 -39.85 92.64 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.696 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.37 -33.69 71.73 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 119.137 0.88 . . . . 0.0 111.715 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 39.8 ttmt -65.73 -42.78 90.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.22 174.137 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.8 -38.72 86.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.144 -1.407 . . . . 0.0 111.106 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.77 -38.26 78.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 121.691 2.041 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.2 -34.53 72.25 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.67 -46.79 11.13 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.297 1.039 . . . . 0.0 111.591 -177.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 61.1 p -84.05 -27.64 28.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.238 1.815 . . . . 0.0 111.396 -169.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.72 25.65 51.97 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -168.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.103 0 C-N-CA 126.745 2.018 . . . . 0.0 112.467 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 tpp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.25 171.33 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.31 1.444 . . . . 0.0 107.401 167.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.04 96.7 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.94 165.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -126.21 144.03 50.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.51 175.1 6.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.731 1.212 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -158.52 -169.09 2.62 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.696 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -43.81 -36.1 2.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.739 2.816 . . . . 0.0 115.533 -163.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.25 -25.01 2.51 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.551 1.141 . . . . 0.0 111.5 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 m -64.95 -17.57 64.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.528 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -49.46 -58.02 5.94 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.1 0.864 . . . . 0.0 109.27 166.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -43.21 99.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.782 0.833 . . . . 0.0 110.621 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -23.04 62.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -99.44 -17.01 18.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.228 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -110.29 -12.43 14.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.182 1.355 . . . . 0.0 113.621 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m -63.9 -11.17 25.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -139.91 156.59 46.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.063 1.301 . . . . 0.0 109.055 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.57 53.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.37 133.2 68.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.1 t -143.93 135.31 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -161.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.6 tp -111.31 99.5 8.29 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.37 138.07 33.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.58 153.56 50.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 109.218 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -133.89 120.08 19.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -170.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.548 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -143.16 154.31 43.76 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.231 1.412 . . . . 0.0 108.501 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.8 165.16 8.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.799 0.84 . . . . 0.0 109.025 170.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.37 -19.09 6.21 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.72 2.947 . . . . 0.0 116.483 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -55.09 -25.73 33.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.194 1.398 . . . . 0.0 114.493 -173.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -138.63 159.37 42.27 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.481 1.037 . . . . 0.0 111.441 -166.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.82 -48.87 31.88 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.554 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -47.92 -29.33 11.57 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.005 3.136 . . . . 0.0 115.352 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 m -53.41 -26.93 21.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.58 1.082 . . . . 0.0 113.26 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -108.46 10.89 27.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.827 1.251 . . . . 0.0 111.322 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -118.73 -42.55 2.73 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.481 1.113 . . . . 0.0 109.438 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.82 -34.73 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.854 -0.529 . . . . 0.0 109.584 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.42 -57.98 22.93 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.617 -1.182 . . . . 0.0 112.68 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.55 -33.97 54.33 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.604 1.609 . . . . 0.0 111.5 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.04 -40.03 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.525 1.057 . . . . 0.0 110.965 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 mt -70.82 -37.59 73.23 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.254 0.934 . . . . 0.0 110.725 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.16 -36.36 81.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.117 0.871 . . . . 0.0 110.475 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.62 -25.28 64.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.454 1.102 . . . . 0.0 111.059 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.31 -46.42 23.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.136 0.975 . . . . 0.0 109.862 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.61 -43.19 99.31 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 122.796 0.438 . . . . 0.0 111.444 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.13 -9.32 58.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -97.33 -48.81 5.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.274 0.943 . . . . 0.0 110.875 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.6 ptm -137.7 13.89 2.94 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -15.04 33.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.019 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.03 -25.45 58.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.758 1.279 . . . . 0.0 112.508 168.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 -10.47 10.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.653 0.781 . . . . 0.0 112.432 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -132.19 135.66 46.5 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.223 0.92 . . . . 0.0 109.612 -162.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -95.68 144.54 26.01 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 164.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.95 142.49 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.58 147.36 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.548 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 40.5 mtpt -127.18 148.24 50.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.514 0.597 . . . . 0.0 110.742 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 121.2 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 167.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.56 110.94 9.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 164.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.283 27.6 m -87.34 48.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 122.263 1.03 . . . . 0.0 112.357 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -141.06 -40.67 0.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.454 1.102 . . . . 0.0 109.228 154.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -76.06 -40.61 52.84 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.913 0.885 . . . . 0.0 111.461 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.94 24.59 4.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.807 1.243 . . . . 0.0 110.621 -167.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.4 -5.15 6.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.45 -44.33 84.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.262 0.937 . . . . 0.0 110.796 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -60.61 -41.04 94.01 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.698 0.681 . . . . 0.0 110.488 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -53.66 42.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.181 0.592 . . . . 0.0 109.493 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.69 95.33 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.19 -47.97 83.34 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.155 0.982 . . . . 0.0 110.893 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.93 -22.48 60.72 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.192 0.451 . . . . 0.0 111.424 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.4 19.09 31.1 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.221 0.915 . . . . 0.0 112.025 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -76.02 142.14 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 163.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.422 ' CE ' HD13 ' B' ' 72' ' ' LEU . 1.9 ptm -151.47 22.17 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.886 0.474 . . . . 0.0 111.914 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.69 156.18 40.8 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.445 -0.784 . . . . 0.0 110.893 -153.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.1 mm -130.41 138.74 33.72 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.377 -168.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.8 162.58 83.93 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 N-CA-C 108.299 -1.462 . . . . 0.0 108.299 -22.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.6 m -132.94 150.12 52.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 169.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.2 mt -143.16 127.75 18.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -170.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -124.1 115.29 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.62 126.2 45.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -123.81 155.11 38.58 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.595 0.758 . . . . 0.0 109.553 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -144.29 144.49 31.51 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 161.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.5 t70 43.81 35.9 1.19 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.833 1.653 . . . . 0.0 113.687 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.56 15.61 59.8 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.938 -1.479 . . . . 0.0 115.776 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.68 149.77 45.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.49 2.145 . . . . 0.0 110.784 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.81 143.25 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 m -132.31 -18.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.485 1.114 . . . . 0.0 112.162 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.02 156.79 43.31 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.78 32.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -173.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.3 m -150.31 139.84 21.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.408 HG12 ' HD3' ' B' ' 88' ' ' LYS . 62.1 t -136.71 45.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -171.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.68 156.04 23.23 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.665 1.126 . . . . 0.0 110.374 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.09 147.79 46.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.303 1.441 . . . . 0.0 111.378 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.3 141.88 33.23 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.612 1.565 . . . . 0.0 107.683 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.21 167.06 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.501 2.134 . . . . 0.0 110.63 167.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -50.34 -51.33 46.54 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.915 1.286 . . . . 0.0 112.726 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.12 -39.83 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 110.368 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.91 -38.29 76.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.789 -0.569 . . . . 0.0 110.856 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.78 -39.8 80.01 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.462 0.574 . . . . 0.0 110.77 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.15 -39.86 94.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.44 0.563 . . . . 0.0 109.686 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.72 -44.62 96.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.972 0.509 . . . . 0.0 110.626 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.24 -43.47 70.9 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.217 1.007 . . . . 0.0 111.383 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.4 p -84.04 -35.24 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.975 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -58.11 -27.58 63.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.416 1.007 . . . . 0.0 112.632 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -54.72 -27.54 41.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.166 0.986 . . . . 0.0 113.568 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -128.79 -21.28 3.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.341 0.973 . . . . 0.0 112.581 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.424 1.49 . . . . 0.0 109.771 167.426 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -73.42 92.56 1.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 m120 113.14 127.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 130.916 3.686 . . . . 0.0 107.575 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -143.47 111.84 6.32 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.97 133.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 146.97 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.863 1.665 . . . . 0.0 107.287 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.42 ' CD2' HD12 ' B' ' 72' ' ' LEU . 0.8 OUTLIER -127.54 143.53 51.17 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.905 0.882 . . . . 0.0 110.137 -165.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -106.33 140.89 38.54 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.2 114.38 15.0 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.37 140.23 15.1 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.475 0.484 . . . . 0.0 111.389 -166.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -50.6 121.97 6.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.997 1.319 . . . . 0.0 110.628 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.13 -14.94 1.47 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.598 1.571 . . . . 0.0 114.601 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 45.18 24.31 0.13 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.505 1.922 . . . . 0.0 113.117 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -73.98 -34.74 64.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.413 -0.805 . . . . 0.0 110.877 -166.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.53 -69.71 0.47 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -161.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' B' ' 105' ' ' ASP . 11.6 mtm105 -58.67 -44.97 90.36 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.683 -171.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.32 -37.91 84.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.064 0.847 . . . . 0.0 110.516 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -61.41 -43.37 98.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.135 0.574 . . . . 0.0 109.812 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.16 -48.16 79.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.957 1.303 . . . . 0.0 109.732 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.54 77.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.389 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.2 -28.29 64.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.806 1.184 . . . . 0.0 110.911 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.39 -50.04 57.79 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.416 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 42.1 m95 -59.77 -43.45 94.33 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.373 0.587 . . . . 0.0 111.649 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.6 -55.65 29.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 109.419 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -69.62 -10.97 60.36 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -80.1 -9.26 59.69 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.575 1.534 . . . . 0.0 112.897 171.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -129.97 -24.62 2.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.531 1.132 . . . . 0.0 112.794 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.3 mt -105.81 94.27 5.09 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.64 -165.04 5.59 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.814 0.721 . . . . 0.0 112.425 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.84 -17.36 15.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.306 1.442 . . . . 0.0 113.37 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.489 1.515 . . . . 0.0 112.363 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -127.28 161.25 29.04 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.086 1.754 . . . . 0.0 109.617 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -134.08 133.63 41.35 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.0 t -129.86 126.57 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -164.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.84 162.51 33.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.815 1.246 . . . . 0.0 109.065 -173.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 7.1 m -150.91 135.83 17.42 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.76 177.65 10.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.94 0.791 . . . . 0.0 112.134 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.26 176.51 46.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.892 1.234 . . . . 0.0 111.216 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 tt -36.77 -55.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.896 2.078 . . . . 0.0 114.876 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -134.29 31.38 3.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.153 1.381 . . . . 0.0 108.671 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.52 145.35 44.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.999 1.32 . . . . 0.0 112.604 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t60 148.33 84.66 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 130.534 3.533 . . . . 0.0 105.544 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.85 157.61 16.73 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.403 1.001 . . . . 0.0 111.197 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -139.65 93.7 2.69 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -66.31 127.58 93.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.55 -20.88 59.48 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.363 2.042 . . . . 0.0 113.015 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.71 80.32 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.455 1.025 . . . . 0.0 111.689 174.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.68 66.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.58 0.627 . . . . 0.0 109.875 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.2 -51.99 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.11 -45.6 79.43 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.809 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.32 75.76 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.696 0.68 . . . . 0.0 111.513 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.2 mmm -76.42 -32.64 58.6 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.4 -0.812 . . . . 0.0 111.709 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -62.92 -28.22 69.91 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.084 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.19 -25.07 58.4 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.77 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.4 m -121.83 16.32 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.846 1.259 . . . . 0.0 111.186 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.23 34.9 81.73 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.312 -0.716 . . . . 0.0 113.147 171.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -117.1 135.97 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -98.69 135.13 40.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 pt -134.44 10.56 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.581 0.752 . . . . 0.0 111.77 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.7 m -60.01 -23.7 63.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.306 1.042 . . . . 0.0 112.695 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -77.36 -18.01 57.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.013 1.325 . . . . 0.0 113.339 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.54 166.72 14.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.198 0.999 . . . . 0.0 112.8 -167.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.6 p -139.43 -177.68 5.04 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.003 2.121 . . . . 0.0 108.22 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.6 p -159.42 171.06 20.44 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -149.77 164.82 34.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 pt -61.95 164.04 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.189 0.518 . . . . 0.0 110.4 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.415 HG23 ' H ' ' B' ' 67' ' ' ILE . 4.9 pt -48.63 128.96 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 109.306 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -137.71 98.55 3.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.798 1.285 . . . . 0.0 109.98 -172.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.71 -28.8 36.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.216 2.606 . . . . 0.0 112.638 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.58 -24.26 67.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.948 0.795 . . . . 0.0 111.628 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.62 -40.85 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.962 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.422 HD13 ' CE ' ' A' ' 70' ' ' MET . 9.8 tt -62.45 -48.46 79.54 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.266 1.394 . . . . 0.0 110.536 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -18.65 65.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.467 1.03 . . . . 0.0 111.874 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.62 -13.29 52.05 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.211 1.004 . . . . 0.0 112.032 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 166.08 15.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.034 0.833 . . . . 0.0 110.773 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.72 -27.62 16.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 111.155 168.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.59 128.13 15.07 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.826 1.25 . . . . 0.0 107.776 -161.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.03 118.26 56.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -83.86 110.71 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 165.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -67.94 123.98 22.11 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 156.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.1 tp -118.57 31.43 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.521 0.728 . . . . 0.0 109.974 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.534 0.329 0 C-N-CA 125.072 1.349 . . . . 0.0 108.162 172.749 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 119.465 -0.303 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.48 19.58 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.679 1.592 . . . . 0.0 114.833 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . 0.408 ' HD3' HG12 ' A' ' 88' ' ' VAL . 13.9 ttmm 67.83 25.42 7.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.198 1.399 . . . . 0.0 112.459 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 30.4 m 36.85 53.59 2.65 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 0.0 114.497 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.71 150.27 54.32 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.439 2.093 . . . . 0.0 112.123 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.63 3.09 15.5 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -170.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p 40.81 89.55 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.435 2.294 . . . . 0.0 114.123 166.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.69 151.98 59.52 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.62 1.01 4.72 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.064 3.176 . . . . 0.0 114.242 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 42.8 m170 -61.69 -16.25 47.31 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.6 143.64 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.179 0.992 . . . . 0.0 109.362 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -79.25 151.99 30.84 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -136.32 147.23 47.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -152.07 158.9 43.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 161.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -97.5 131.17 44.37 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -123.1 -29.36 3.9 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.553 1.141 . . . . 0.0 110.175 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -79.57 161.45 46.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 168.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.54 -4.47 0.33 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.709 0.803 . . . . 0.0 112.305 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -158.1 170.89 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.698 1.999 . . . . 0.0 107.259 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' B' ' 16' ' ' ARG . 56.4 t0 -136.17 113.64 10.54 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 123.833 0.853 . . . . 0.0 110.992 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.47 -19.85 54.69 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.166 2.577 . . . . 0.0 112.893 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.95 -7.92 32.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.157 0.89 . . . . 0.0 112.092 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -115.51 19.33 15.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.202 1.401 . . . . 0.0 110.604 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.76 155.24 2.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.858 0.863 . . . . 0.0 111.043 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -57.66 -29.37 64.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.116 0.966 . . . . 0.0 112.42 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.46 -8.66 30.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.661 -1.077 . . . . 0.0 113.89 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 76.6 p -67.43 156.64 36.08 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.169 1.484 . . . . 0.0 107.825 166.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.64 -39.38 84.17 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.705 -0.622 . . . . 0.0 110.145 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.2 -44.56 68.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.326 0.65 . . . . 0.0 111.203 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -70.56 -35.7 73.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.383 0.992 . . . . 0.0 110.043 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -56.86 -58.34 8.54 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.137 0.881 . . . . 0.0 109.641 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -60.27 -42.02 94.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.992 0.814 . . . . 0.0 110.342 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.44 92.15 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.495 1.043 . . . . 0.0 111.885 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -62.97 -46.96 85.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.117 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -58.08 -50.75 72.37 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -64.48 -43.27 94.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.821 1.248 . . . . 0.0 111.312 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -63.91 -47.95 78.53 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.595 0.634 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.65 -35.97 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.416 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.9 tmm_? -62.21 -45.44 93.37 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.665 1.186 . . . . 0.0 110.45 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.1 -42.43 96.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.046 0.384 . . . . 0.0 110.683 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.58 -54.35 37.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.063 0.545 . . . . 0.0 110.304 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.56 -43.55 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.401 1.081 . . . . 0.0 109.322 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.38 75.51 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 118.652 0.66 . . . . 0.0 111.794 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -59.77 -44.03 94.07 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.098 0.449 . . . . 0.0 110.906 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -63.26 -45.69 90.34 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.769 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.9 mm? -67.32 -36.41 81.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.504 1.047 . . . . 0.0 110.461 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -61.33 -45.76 93.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.316 0.507 . . . . 0.0 110.028 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.08 -44.21 94.93 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.535 0.607 . . . . 0.0 110.586 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.22 -38.51 80.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.882 0.765 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.16 72.22 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.734 0.697 . . . . 0.0 112.163 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.49 -41.92 23.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.31 0.644 . . . . 0.0 110.529 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 76.6 p -85.19 -34.53 22.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.478 0.581 . . . . 0.0 111.578 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.7 64.15 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 118.365 -1.241 . . . . 0.0 112.701 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.172 2.189 . . . . 0.0 111.591 -163.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.03 157.03 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.78 2.432 . . . . 0.0 112.756 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.61 112.94 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.82 168.66 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.86 1.664 . . . . 0.0 108.274 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -124.31 117.67 25.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.665 1.586 . . . . 0.0 108.477 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -84.9 171.41 12.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.6 1.16 . . . . 0.0 110.595 174.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -155.85 -178.19 7.11 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.085 1.754 . . . . 0.0 107.313 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -37.0 -33.94 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 130.932 3.693 . . . . 0.0 117.004 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.06 -31.76 0.9 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.822 1.249 . . . . 0.0 110.926 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -60.76 -19.23 58.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.692 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -47.19 -50.02 21.61 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 120.028 1.286 . . . . 0.0 109.874 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -66.09 -43.83 86.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.078 0.399 . . . . 0.0 110.211 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.96 85.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.545 0.212 . . . . 0.0 110.56 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -74.12 -13.76 60.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.745 1.218 . . . . 0.0 112.593 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -121.76 0.58 9.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.785 1.175 . . . . 0.0 113.134 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.9 m -74.87 -2.85 28.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.541 0.737 . . . . 0.0 112.949 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.66 156.47 45.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.128 0.971 . . . . 0.0 110.485 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.19 -161.56 37.5 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.377 1.465 . . . . 0.0 112.063 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.23 129.62 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.66 155.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.629 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 tp -128.83 91.5 3.23 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.767 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.5 148.58 33.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -141.65 148.43 39.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.819 1.248 . . . . 0.0 109.238 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -130.15 109.62 10.96 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.693 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.7 p-90 -130.93 149.88 52.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.834 1.653 . . . . 0.0 108.155 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -172.98 164.05 3.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 109.42 169.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.53 -16.02 9.93 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.82 3.014 . . . . 0.0 116.691 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.457 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 24.6 m95 -50.46 -28.78 8.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.735 1.614 . . . . 0.0 113.74 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.88 146.36 51.6 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 119.14 0.882 . . . . 0.0 111.811 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.14 -50.26 61.42 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.596 -1.113 . . . . 0.0 110.706 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -46.58 -26.65 4.49 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.222 3.281 . . . . 0.0 116.867 170.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 m -57.77 -29.58 64.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 121.4 1.909 . . . . 0.0 112.286 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -97.65 9.35 42.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.283 1.033 . . . . 0.0 111.813 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -119.61 -43.1 2.6 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.062 0.945 . . . . 0.0 109.602 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.15 -34.76 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.607 0.763 . . . . 0.0 109.066 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.18 -61.25 6.26 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.9 -41.19 64.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.958 1.772 . . . . 0.0 111.659 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.24 -40.57 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.06 0.544 . . . . 0.0 110.819 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 mt -73.08 -38.49 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.4 0.546 . . . . 0.0 110.292 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.92 -34.14 77.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.284 0.947 . . . . 0.0 109.833 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.91 -27.47 64.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.96 1.304 . . . . 0.0 111.603 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.81 -43.59 45.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.48 1.112 . . . . 0.0 110.195 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.61 -35.98 62.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.22 -13.21 62.07 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.378 -0.826 . . . . 0.0 112.019 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -49.7 5.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.743 1.617 . . . . 0.0 110.504 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.5 16.68 2.74 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.805 0.842 . . . . 0.0 111.741 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.06 -3.22 22.19 Favored Glycine 0 CA--C 1.521 0.446 0 O-C-N 121.23 -0.919 . . . . 0.0 113.974 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.34 -24.15 65.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.333 1.053 . . . . 0.0 111.104 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.44 -20.95 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.523 1.129 . . . . 0.0 112.226 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.64 149.66 46.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 110.874 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.36 150.48 40.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.529 1.532 . . . . 0.0 108.335 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mt -130.39 140.89 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 6' ' ' ALA . 12.6 t -136.78 108.92 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.693 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 21.6 mtpp -84.68 151.14 24.65 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.367 -0.833 . . . . 0.0 109.757 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -113.59 128.03 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.26 103.78 11.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.88 48.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.075 1.35 . . . . 0.0 112.092 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -156.11 -43.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.833 1.253 . . . . 0.0 109.578 168.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.27 -36.5 29.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 109.868 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -133.24 27.11 4.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 111.925 -168.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -69.76 -5.31 24.43 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -50.0 -49.69 49.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.582 1.953 . . . . 0.0 110.647 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.6 m -58.26 -35.95 72.53 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 123.122 0.569 . . . . 0.0 111.466 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.54 0.84 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.15 -45.31 15.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.204 0.907 . . . . 0.0 113.625 170.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.097 0.948 . . . . 0.0 111.033 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.99 -30.48 67.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.177 0.444 . . . . 0.0 110.36 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.27 67.65 0.81 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.6 t -139.17 127.67 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.422 ' SD ' HD12 ' B' ' 67' ' ' ILE 0.315 0.1 OUTLIER -137.3 17.11 2.96 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.883 0.311 . . . . 0.0 111.22 174.61 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 p -137.48 159.89 40.67 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.884 2.474 . . . . 0.0 110.722 -170.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.14 149.02 56.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.03 148.09 87.43 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 109.701 -0.923 . . . . 0.0 109.701 -10.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -122.76 145.16 48.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.21 136.55 54.78 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.976 1.71 . . . . 0.0 106.518 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.4 mt -121.44 102.7 8.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.69 122.53 38.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.88 153.19 44.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.521 1.128 . . . . 0.0 108.12 -171.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -140.23 138.65 35.23 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.88 27.29 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.541 1.937 . . . . 0.0 114.412 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 15.97 43.1 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.083 1.325 . . . . 0.0 115.945 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -130.85 142.8 50.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.038 1.419 . . . . 0.0 110.524 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.28 140.71 19.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.35 -21.59 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.185 0.994 . . . . 0.0 109.985 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.64 161.6 41.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.174 1.389 . . . . 0.0 109.087 169.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.23 148.3 31.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -149.99 145.99 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.721 HG12 ' HD3' ' B' ' 88' ' ' LYS . 11.1 t -137.82 67.74 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.41 157.86 10.18 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.16 1.838 . . . . 0.0 109.02 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -74.33 157.8 35.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.933 0.493 . . . . 0.0 111.107 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.43 145.33 25.83 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.64 165.88 30.54 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.528 2.152 . . . . 0.0 110.704 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -45.95 -47.88 16.45 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.373 1.869 . . . . 0.0 112.416 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.17 -43.34 74.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.477 0.581 . . . . 0.0 111.23 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.3 -32.79 74.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.745 -0.597 . . . . 0.0 110.72 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -52.18 64.35 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.937 0.895 . . . . 0.0 109.903 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.96 -38.84 92.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.1 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.69 -46.29 90.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.704 0.684 . . . . 0.0 111.437 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.52 -40.78 79.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.755 1.222 . . . . 0.0 111.198 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -88.05 -39.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.885 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 12.3 t30 -56.37 -34.88 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.517 1.053 . . . . 0.0 111.801 -176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.08 -6.96 25.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.56 -27.11 3.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.668 1.187 . . . . 0.0 112.666 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 19.5 tp . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.988 2.115 . . . . 0.0 109.388 171.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.78 143.38 44.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.1 m120 63.77 119.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.184 0 C-N-CA 128.71 2.804 . . . . 0.0 110.639 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -164.26 134.3 4.05 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mt -106.65 143.25 17.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.41 143.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.45 144.39 51.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.489 0.715 . . . . 0.0 111.553 -168.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -103.58 144.04 31.96 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.8 tp -128.97 114.47 16.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 75.4 m -142.77 135.41 27.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.871 0.868 . . . . 0.0 111.139 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -48.75 113.7 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.737 1.215 . . . . 0.0 110.976 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.53 8.41 51.52 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.941 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 7.02 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 130.738 3.615 . . . . 0.0 115.536 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -142.28 5.96 1.69 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.01 -70.24 0.26 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.794 1.179 . . . . 0.0 112.385 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -47.2 -52.98 14.31 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.09 0.859 . . . . 0.0 110.495 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -55.63 -52.44 63.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.067 1.747 . . . . 0.0 111.801 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -53.85 -50.07 67.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.094 0.958 . . . . 0.0 110.606 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.0 ttm -62.59 -42.24 99.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.269 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.86 82.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.619 -1.181 . . . . 0.0 112.019 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.59 -45.65 89.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.732 1.605 . . . . 0.0 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.89 -43.63 57.85 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -58.07 -39.45 78.52 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.993 0.896 . . . . 0.0 111.495 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.23 62.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -65.26 -24.22 67.26 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.779 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.19 -14.98 63.28 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -126.46 -12.01 6.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.934 1.293 . . . . 0.0 113.131 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.11 85.6 2.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.89 -165.92 0.89 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.073 1.321 . . . . 0.0 113.173 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.79 -17.82 18.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.653 1.181 . . . . 0.0 113.214 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.57 -21.31 25.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.884 1.673 . . . . 0.0 112.411 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -127.83 161.62 28.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.391 1.476 . . . . 0.0 109.158 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -132.79 135.53 45.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -125.34 132.17 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -169.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -143.08 171.23 14.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.773 1.629 . . . . 0.0 108.035 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 81.7 p -158.92 154.07 25.34 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.519 -0.738 . . . . 0.0 110.788 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.06 169.97 23.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.904 0.881 . . . . 0.0 111.807 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.43 -176.22 39.18 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.592 0.615 . . . . 0.0 112.578 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 tt -50.73 -57.44 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.007 1.723 . . . . 0.0 114.043 -172.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -133.1 29.68 4.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.75 1.62 . . . . 0.0 108.816 -169.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 159.19 34.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.956 2.102 . . . . 0.0 113.06 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 136.24 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 130.723 3.609 . . . . 0.0 104.782 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.93 29.55 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -172.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.56 82.62 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -62.76 128.88 92.49 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -58.6 -23.34 64.77 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.093 1.862 . . . . 0.0 112.953 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.444 HD21 ' HG2' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -62.8 -36.06 81.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.821 1.191 . . . . 0.0 111.305 172.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.43 64.9 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.749 0.704 . . . . 0.0 110.073 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.56 -51.26 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -59.56 -43.95 93.42 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 123.2 0.6 . . . . 0.0 110.593 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.28 -31.38 63.57 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 112.523 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -37.05 24.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.254 -0.904 . . . . 0.0 110.493 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.44 -24.67 67.93 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.288 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.79 -32.84 60.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.948 1.249 . . . . 0.0 111.633 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 m -114.56 15.89 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.285 1.434 . . . . 0.0 110.997 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.17 34.98 91.37 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.283 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -106.01 132.65 52.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.64 135.89 33.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.5 ' C ' ' H ' ' B' ' 61' ' ' ASN . 13.6 pt -132.31 20.9 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.482 0.713 . . . . 0.0 110.829 169.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -70.96 24.42 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.793 0.837 . . . . 0.0 112.067 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.5 ' H ' ' C ' ' B' ' 59' ' ' ILE . 12.1 p30 -143.86 -4.47 0.84 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.841 3.657 . . . . 0.0 110.755 -169.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.33 153.55 20.36 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.307 0.958 . . . . 0.0 110.341 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 55.1 p -134.28 -175.71 3.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.549 1.94 . . . . 0.0 108.863 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 23.5 p -155.87 -177.18 6.38 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -163.56 165.22 23.78 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.232 1.813 . . . . 0.0 107.79 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.84 167.18 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.551 0.741 . . . . 0.0 111.728 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.422 HD12 ' SD ' ' A' ' 70' ' ' MET . 0.2 OUTLIER -48.33 131.08 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.225 1.01 . . . . 0.0 108.671 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -146.01 97.12 2.91 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.279 1.037 . . . . 0.0 109.409 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 17.5 m -47.87 -26.62 1.75 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.02 1.728 . . . . 0.0 114.603 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.27 -18.04 60.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.153 1.342 . . . . 0.0 112.647 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.24 -33.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 109.184 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -61.63 -60.14 4.13 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.036 0.834 . . . . 0.0 109.17 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -24.42 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.748 0.704 . . . . 0.0 110.836 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -75.59 -23.37 56.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.777 . . . . 0.0 112.588 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 173.29 1.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.687 1.195 . . . . 0.0 112.155 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.15 -33.91 12.46 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.869 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -139.41 139.35 37.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.331 1.452 . . . . 0.0 109.395 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.8 t -117.01 96.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -80.16 115.11 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 47.9 m -71.75 131.43 43.09 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 tp -135.08 6.09 3.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -167.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-N 120.219 1.372 . . . . 0.0 114.271 -169.324 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.239 0 CA-C-O 119.372 -0.347 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.51 11.99 2.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.56 0.744 . . . . 0.0 112.726 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . 0.721 ' HD3' HG12 ' A' ' 88' ' ' VAL . 14.2 ttmm 90.17 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.306 2.642 . . . . 0.0 111.127 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m 31.38 54.85 0.85 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 126.987 2.115 . . . . 0.0 113.151 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.46 135.31 47.24 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 CA-C-N 120.602 1.251 . . . . 0.0 112.173 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.59 6.05 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -171.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p 38.36 93.9 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 127.838 2.455 . . . . 0.0 114.379 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -56.15 141.39 87.69 Favored 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 122.485 2.123 . . . . 0.0 108.26 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -61.78 -1.3 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.323 3.349 . . . . 0.0 116.95 -168.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -69.15 -9.38 52.52 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.164 0.893 . . . . 0.0 112.829 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 144.93 36.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.906 1.282 . . . . 0.0 111.192 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -73.84 153.18 40.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -146.83 143.78 28.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.779 0.718 . . . . 0.0 109.498 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -150.15 144.21 25.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.52 127.7 33.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -111.85 -12.31 13.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.185 0.994 . . . . 0.0 110.591 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.58 161.42 31.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -158.24 26.81 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.788 1.235 . . . . 0.0 110.541 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -149.47 161.54 41.91 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.871 2.469 . . . . 0.0 106.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -147.54 139.55 14.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.228 0.922 . . . . 0.0 109.291 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.444 ' HG2' HD21 ' B' ' 47' ' ' ASN . 91.3 Cg_endo -78.0 -19.16 12.51 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.437 2.092 . . . . 0.0 113.336 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.82 -4.06 11.44 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.837 1.199 . . . . 0.0 111.03 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -98.41 6.22 47.44 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.427 1.091 . . . . 0.0 111.05 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.02 153.38 1.38 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.114 0.566 . . . . 0.0 110.065 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -54.42 -43.81 71.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.8 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.34 -19.59 2.64 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.6 p -69.53 165.92 20.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.38 -42.16 99.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.527 0.68 . . . . 0.0 110.289 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.61 -42.82 77.57 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 116.929 -1.51 . . . . 0.0 109.326 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.28 -35.26 61.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 121.184 1.811 . . . . 0.0 109.693 -173.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -55.3 -56.6 18.13 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 118.501 0.591 . . . . 0.0 110.693 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -64.35 -40.45 95.89 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.886 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.77 91.62 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.804 0.842 . . . . 0.0 111.765 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.55 -49.88 69.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.284 2.6 p90 -71.1 -27.06 63.32 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.793 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -64.53 -51.35 63.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.558 1.072 . . . . 0.0 109.668 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -59.83 -51.33 70.19 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.38 -43.76 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.575 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.53 -46.51 80.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.876 1.216 . . . . 0.0 111.533 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.01 -44.47 96.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 123.217 0.323 . . . . 0.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -51.66 59.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.369 0.668 . . . . 0.0 110.467 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.77 -45.49 91.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.536 1.134 . . . . 0.0 110.176 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.38 -44.01 91.41 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -60.26 -49.08 79.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.458 1.129 . . . . 0.0 111.306 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -59.01 -44.03 91.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.837 0.455 . . . . 0.0 110.803 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.72 -36.41 67.78 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.757 0.708 . . . . 0.0 111.696 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -66.95 -49.74 64.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.845 -0.534 . . . . 0.0 110.426 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -61.5 -38.26 86.7 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.742 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -56.15 -38.81 71.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.95 1.25 . . . . 0.0 111.077 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.37 -31.53 71.43 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -87.88 -47.85 8.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.839 1.656 . . . . 0.0 111.629 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.0 p -83.63 -28.18 28.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.672 2.389 . . . . 0.0 110.983 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.25 17.18 55.61 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.613 -1.104 . . . . 0.0 111.473 -168.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.249 1.06 0 C-N-CA 127.93 2.492 . . . . 0.0 112.003 -169.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.59 172.55 18.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.03 1.732 . . . . 0.0 107.067 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.88 96.2 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 102.845 -3.021 . . . . 0.0 102.845 168.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.28 168.69 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.831 1.652 . . . . 0.0 108.115 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.25 111.77 16.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.14 1.376 . . . . 0.0 108.358 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -80.9 172.8 13.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.574 1.15 . . . . 0.0 110.527 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -155.34 -174.87 5.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.933 2.093 . . . . 0.0 105.898 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -41.19 -36.81 0.8 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.019 2.527 . . . . 0.0 115.572 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -129.85 -30.19 2.05 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.559 1.144 . . . . 0.0 111.522 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 m -61.57 -22.74 65.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.059 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.65 -55.62 18.31 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.384 0.993 . . . . 0.0 108.773 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -62.11 -43.79 98.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.139 -0.35 . . . . 0.0 110.183 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.78 82.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.386 0.136 . . . . 0.0 111.295 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -79.84 -13.79 59.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.412 1.085 . . . . 0.0 113.143 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.5 p -118.33 -3.94 10.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.604 1.093 . . . . 0.0 113.535 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -73.75 -5.02 38.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.24 155.7 45.98 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.461 1.104 . . . . 0.0 109.825 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.64 -163.04 44.12 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.843 1.211 . . . . 0.0 112.163 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.43 132.14 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.37 149.82 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 113.45 -1.705 . . . . 0.0 107.797 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tt -124.98 100.83 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.931 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.17 148.72 26.61 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -142.41 149.7 39.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -130.06 115.54 17.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -169.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.62 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.5 p-90 -137.58 154.35 49.8 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.901 1.68 . . . . 0.0 108.007 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -174.48 162.15 2.69 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.068 0.947 . . . . 0.0 108.95 169.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.97 -19.04 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.635 2.89 . . . . 0.0 116.895 -174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.44 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 10.3 m95 -52.62 -33.88 48.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.837 1.198 . . . . 0.0 114.078 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.15 163.23 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.972 0.805 . . . . 0.0 112.76 -169.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.12 -48.78 57.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.923 -1.487 . . . . 0.0 113.197 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.78 -27.59 20.63 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.571 2.847 . . . . 0.0 115.397 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 m -57.17 -23.77 49.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.695 1.134 . . . . 0.0 113.25 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -108.87 12.71 25.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.111 0.964 . . . . 0.0 111.575 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -122.71 -44.11 2.23 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.292 1.037 . . . . 0.0 109.67 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -64.38 -34.22 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 121.685 -0.634 . . . . 0.0 109.451 169.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.47 11.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.911 -1.042 . . . . 0.0 112.39 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -59.05 -41.03 65.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.967 1.778 . . . . 0.0 111.631 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.46 -40.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.115 0.566 . . . . 0.0 110.877 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.8 mt -73.59 -40.92 63.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.691 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.87 -34.51 78.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.013 0.824 . . . . 0.0 109.737 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -70.35 -21.39 62.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.077 1.351 . . . . 0.0 112.184 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.89 -42.09 18.14 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 119.161 0.892 . . . . 0.0 110.125 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.39 -37.61 85.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.944 -0.472 . . . . 0.0 110.831 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -72.21 -4.86 31.87 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -107.71 -43.17 4.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.674 1.589 . . . . 0.0 111.032 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.63 15.57 2.34 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.363 0.665 . . . . 0.0 112.535 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.79 -2.18 11.24 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.392 -0.817 . . . . 0.0 113.867 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.86 -24.0 65.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.328 1.051 . . . . 0.0 111.147 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -11.7 8.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.74 0.816 . . . . 0.0 112.682 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -139.4 149.54 44.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.32 1.048 . . . . 0.0 111.622 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.99 147.67 38.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.068 1.747 . . . . 0.0 108.327 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mt -119.41 143.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 6' ' ' ALA . 5.0 t -137.44 109.32 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.6 mtpp -84.03 151.78 24.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.341 -0.85 . . . . 0.0 109.3 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mm -118.99 120.86 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 170.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.59 105.94 7.95 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 33.9 m -78.43 49.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -156.01 -41.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.801 1.241 . . . . 0.0 108.977 167.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.73 -33.98 21.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.063 0.945 . . . . 0.0 111.079 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -134.05 27.99 3.84 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.518 1.527 . . . . 0.0 110.796 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -72.09 -5.74 37.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.825 0.85 . . . . 0.0 112.898 -170.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -53.27 -48.17 68.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.3 1.84 . . . . 0.0 110.769 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 m -56.29 -41.57 76.1 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.091 0.556 . . . . 0.0 110.837 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.96 -64.57 0.83 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.67 -43.82 11.74 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.985 0.802 . . . . 0.0 113.454 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.02 -44.63 95.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.24 1.02 . . . . 0.0 111.663 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -73.64 -21.35 60.32 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.477 0.58 . . . . 0.0 111.731 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.03 64.72 0.99 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.05 129.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.5 ptm -150.64 23.11 0.79 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.74 161.44 35.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.101 1.76 . . . . 0.0 112.027 -168.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.1 136.98 29.67 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.53 146.51 47.78 Favored 'Cis proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.067 -1.551 . . . . 0.0 108.067 -10.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -116.58 151.72 35.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 169.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tt -148.82 123.7 9.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -170.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.5 mt -122.24 106.09 10.81 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.54 131.96 33.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.88 158.33 39.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.815 0.846 . . . . 0.0 109.382 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -144.27 139.64 28.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 44.95 28.35 0.36 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.605 1.962 . . . . 0.0 113.761 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.56 10.32 47.67 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 116.103 1.201 . . . . 0.0 116.103 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -133.72 145.17 49.62 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.909 1.354 . . . . 0.0 111.528 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.25 137.37 24.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.96 -19.41 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.51 1.124 . . . . 0.0 111.635 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.8 159.18 43.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.001 0.819 . . . . 0.0 110.185 169.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.62 147.94 28.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -171.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.2 m -152.58 147.55 26.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.8 t -133.63 64.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.56 159.57 10.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.236 1.874 . . . . 0.0 109.535 -169.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.53 167.86 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.578 0.751 . . . . 0.0 112.032 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -150.31 141.58 14.91 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.422 1.489 . . . . 0.0 107.459 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.88 165.95 29.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.118 . . . . 0.0 110.388 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.98 -48.71 21.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.74 1.616 . . . . 0.0 112.39 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.1 -42.79 79.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.161 0.437 . . . . 0.0 110.897 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.39 -29.95 68.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.035 -0.416 . . . . 0.0 111.011 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -52.3 61.09 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.934 0.894 . . . . 0.0 109.207 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -63.6 -36.28 83.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.799 -0.62 . . . . 0.0 109.654 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.15 -46.46 88.87 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.678 0.672 . . . . 0.0 111.224 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.9 tp -54.64 -40.39 68.93 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.073 0.949 . . . . 0.0 110.96 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.27 -41.14 13.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 118.819 -0.61 . . . . 0.0 112.071 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -56.7 -33.55 66.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.581 1.082 . . . . 0.0 111.45 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -70.07 -6.47 34.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -127.66 -21.98 3.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.168 1.387 . . . . 0.0 112.659 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--O 1.249 1.072 0 C-N-CA 127.286 2.234 . . . . 0.0 109.05 171.319 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -139.36 41.45 2.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.314 1.045 . . . . 0.0 109.36 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m120 130.58 132.77 0.0 OUTLIER 'General case' 0 C--N 1.341 0.198 1 C-N-CA 132.385 4.274 . . . . 0.0 107.513 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.402 ' HE3' ' CE3' ' B' ' 32' ' ' TRP . 53.1 pttt -157.08 145.85 19.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 130.175 3.39 . . . . 0.0 102.499 168.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.49 139.44 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 118.755 0.707 . . . . 0.0 109.431 -168.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.68 140.0 46.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -132.04 149.01 52.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.4 155.48 31.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.392 0.542 . . . . 0.0 110.11 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -133.2 132.4 41.49 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.028 1.331 . . . . 0.0 107.925 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -162.26 157.24 22.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.3 m -47.8 107.88 0.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.996 1.318 . . . . 0.0 111.435 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.75 59.4 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.685 -1.064 . . . . 0.0 113.443 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.324 0.3 OUTLIER 39.01 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.537 2.735 . . . . 0.0 116.044 -173.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -64.85 169.05 5.51 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.284 1.04 . . . . 0.0 108.543 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 46.37 -94.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.425 2.29 . . . . 0.0 113.717 169.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.67 -50.06 64.0 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.774 1.63 . . . . 0.0 111.219 -169.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.2 m -66.97 -41.7 86.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.237 0.926 . . . . 0.0 112.17 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -59.41 -49.3 78.32 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.402 1.096 . . . . 0.0 109.823 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 18.9 ttm -65.31 -40.57 93.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.429 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.69 -36.86 73.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.068 0.947 . . . . 0.0 110.297 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.94 60.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 109.911 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.7 -46.23 62.26 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -55.37 -44.19 75.82 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.611 0.764 . . . . 0.0 111.483 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.77 61.91 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.121 0.568 . . . . 0.0 110.108 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.458 ' HE3' ' HB ' ' B' ' 34' ' ' VAL . 65.2 mttt -65.64 -20.57 66.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.509 -168.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.87 -14.74 62.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.384 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -40.21 2.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.791 1.178 . . . . 0.0 112.382 174.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' B' ' 135' ' ' ALA . 10.0 mp -79.76 75.68 6.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.41 -163.6 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.575 2.036 . . . . 0.0 112.564 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.49 -13.86 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.752 1.221 . . . . 0.0 113.21 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -57.69 -23.79 53.45 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.928 168.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . 0.402 ' CE3' ' HE3' ' B' ' 4' ' ' LYS . 41.7 m95 -127.63 171.36 11.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.391 2.276 . . . . 0.0 110.424 -177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -139.74 129.32 24.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 168.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.458 ' HB ' ' HE3' ' B' ' 25' ' ' LYS . 13.9 t -123.18 129.02 75.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -171.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -143.09 169.33 17.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.396 1.478 . . . . 0.0 108.536 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 74.6 p -154.97 162.83 40.97 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.415 -0.803 . . . . 0.0 110.867 172.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 178.77 9.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.344 1.458 . . . . 0.0 108.859 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.27 -176.62 44.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 tt -48.8 -52.96 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.089 1.756 . . . . 0.0 113.991 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -130.36 26.27 5.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.909 2.084 . . . . 0.0 107.992 -169.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.9 46.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.705 1.602 . . . . 0.0 112.965 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 78.4 t60 133.85 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 131.244 3.817 . . . . 0.0 104.458 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.13 175.5 46.58 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -153.21 102.78 2.65 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 171.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -73.56 126.09 90.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.44 -22.18 70.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.861 1.707 . . . . 0.0 112.514 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.406 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -59.54 -37.5 78.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.252 0.933 . . . . 0.0 110.796 170.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -73.32 -38.58 65.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.32 -55.88 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.6 -45.9 77.37 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.274 0.63 . . . . 0.0 111.06 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.12 -33.51 65.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.448 1.099 . . . . 0.0 112.512 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 1.1 mmt -82.54 -38.87 23.13 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.934 0.893 . . . . 0.0 110.453 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -60.83 -29.7 69.65 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.896 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.98 -31.46 60.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.471 1.032 . . . . 0.0 111.814 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.95 15.1 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.146 1.379 . . . . 0.0 110.821 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.78 34.03 81.82 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.163 -1.354 . . . . 0.0 113.034 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -107.43 149.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.07 135.12 54.8 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.84 22.68 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.94 1.296 . . . . 0.0 110.448 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -67.59 14.73 0.05 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.4 13.69 2.17 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.047 2.139 . . . . 0.0 111.641 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -53.3 162.38 0.75 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.309 -1.494 . . . . 0.0 113.559 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -149.63 161.16 42.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.22 2.208 . . . . 0.0 105.619 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 67.1 m -157.89 -172.87 4.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.89 1.276 . . . . 0.0 109.021 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.55 163.67 24.51 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.149 1.379 . . . . 0.0 109.389 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.0 165.75 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.227 1.011 . . . . 0.0 111.411 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 pt -50.29 128.59 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.199 0.6 . . . . 0.0 110.452 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -143.14 104.5 4.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.261 1.029 . . . . 0.0 109.575 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -53.55 -25.65 17.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.682 1.593 . . . . 0.0 113.282 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -17.64 62.91 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.591 1.087 . . . . 0.0 112.498 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -129.78 -37.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.146 0.978 . . . . 0.0 108.903 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.29 -50.19 28.95 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.1 0.863 . . . . 0.0 110.254 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -24.41 67.54 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.928 0.786 . . . . 0.0 110.7 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -73.75 -23.05 59.69 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.119 1.368 . . . . 0.0 112.337 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.0 166.56 3.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.939 1.295 . . . . 0.0 112.268 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.75 -34.15 17.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.709 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.639 HD13 ' HD2' ' B' ' 97' ' ' LYS . 18.6 tp -146.93 139.87 25.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 0.0 110.594 -170.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.81 110.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 125.976 1.711 . . . . 0.0 107.786 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.78 102.3 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 75.4 m -71.37 128.75 36.9 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 68.5 mt -136.14 64.19 1.57 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.298 1.039 . . . . 0.0 109.178 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.234 0.261 0 O-C-N 121.554 -0.716 . . . . 0.0 110.457 171.07 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -66.47 20.04 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -170.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm 71.67 21.03 4.48 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.071 -1.643 . . . . 0.0 111.948 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.0 m 29.24 56.97 0.68 Allowed Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 128.369 2.668 . . . . 0.0 113.162 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.55 132.29 48.13 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.609 2.206 . . . . 0.0 112.856 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.453 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.55 4.06 33.78 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -175.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.5 p 41.64 94.1 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.222 2.209 . . . . 0.0 113.494 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -60.0 143.87 99.53 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.203 1.935 . . . . 0.0 110.488 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.21 -2.83 5.27 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.509 3.473 . . . . 0.0 115.028 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -63.92 -11.62 29.79 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.829 0.852 . . . . 0.0 111.678 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.41 143.94 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 109.605 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.639 ' HD2' HD13 ' B' ' 77' ' ' LEU . 3.3 tmmm? -73.18 159.02 34.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -145.6 146.95 31.56 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.49 -1.381 . . . . 0.0 109.35 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -146.86 156.51 43.16 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -114.98 133.29 56.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.337 1.455 . . . . 0.0 108.1 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.11 1.29 1.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.04 -62.27 2.5 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 39.9 p90 47.49 14.72 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.23 2.612 . . . . 0.0 115.328 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -161.24 161.9 30.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.174 2.19 . . . . 0.0 106.473 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -141.94 105.91 5.76 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.175 0.99 . . . . 0.0 110.427 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.76 -10.92 18.45 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.636 3.558 . . . . 0.0 112.981 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.58 0.28 5.62 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.737 1.153 . . . . 0.0 111.517 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -121.22 -60.77 1.61 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . 43.39 -170.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 113.59 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -90.81 138.72 31.37 Favored 'General case' 0 C--O 1.236 0.388 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -83.0 56.82 5.08 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.641 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 p -121.65 164.16 17.79 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 169.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.18 -39.05 89.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.479 0.657 . . . . 0.0 110.61 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.04 -42.89 59.6 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.768 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -76.2 -29.93 57.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.941 1.246 . . . . 0.0 109.891 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.8 -59.6 4.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.792 0.724 . . . . 0.0 109.436 169.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -57.84 -41.97 83.45 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.97 90.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.869 0.868 . . . . 0.0 112.006 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -65.81 -43.85 87.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.158 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.3 m-30 -58.7 -47.57 84.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.219 0.918 . . . . 0.0 108.958 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -65.53 -43.71 89.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 111.111 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -60.67 -53.67 54.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.34 -41.4 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.414 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -36.87 85.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 120.299 1.409 . . . . 0.0 112.011 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.04 -41.49 90.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.996 0.362 . . . . 0.0 111.043 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.21 -49.09 68.47 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.996 0.519 . . . . 0.0 110.192 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -56.57 -47.66 81.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 124.216 1.006 . . . . 0.0 109.234 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.63 95.93 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 119.677 1.126 . . . . 0.0 111.737 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -65.12 -43.3 92.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.322 0.561 . . . . 0.0 111.584 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -48.13 81.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.012 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.7 mm? -65.26 -32.68 74.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.556 1.071 . . . . 0.0 111.208 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.06 -38.17 82.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.446 0.566 . . . . 0.0 110.677 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -62.13 -34.72 76.91 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.779 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . 0.43 ' CE2' ' HE3' ' B' ' 139' ' ' LYS . 20.9 m-85 -63.6 -35.79 81.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 122.325 2.329 . . . . 0.0 109.458 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' B' ' 28' ' ' LEU . . . -62.82 -36.54 83.53 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.138 0.575 . . . . 0.0 110.837 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -84.22 -43.76 14.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.194 1.398 . . . . 0.0 112.0 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -93.04 -21.41 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.442 1.897 . . . . 0.0 111.544 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.17 20.12 60.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.708 0.671 . . . . 0.0 111.463 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.43 ' HE3' ' CE2' ' B' ' 134' ' ' PHE . 10.3 tppt? . . . . . 0 C--O 1.251 1.178 0 C-N-CA 128.698 2.799 . . . . 0.0 112.692 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.84 171.25 20.75 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.871 1.668 . . . . 0.0 106.915 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.47 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -79.88 170.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.829 1.651 . . . . 0.0 107.42 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -124.75 129.81 51.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.906 1.282 . . . . 0.0 108.287 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.455 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -95.23 177.1 5.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.042 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 t -159.62 -173.56 4.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.399 1.88 . . . . 0.0 106.247 168.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -36.89 -36.58 0.12 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 129.599 3.159 . . . . 0.0 116.447 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -133.41 -29.87 1.35 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 111.438 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 m -60.46 -22.26 63.28 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.353 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -51.26 -54.02 29.95 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.18 0.9 . . . . 0.0 109.407 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -61.45 -44.08 97.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.045 -0.409 . . . . 0.0 110.033 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -36.46 81.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.999 -0.091 . . . . 0.0 111.204 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -80.13 -14.31 58.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.335 1.054 . . . . 0.0 113.252 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.2 p -117.79 -4.0 11.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.651 1.114 . . . . 0.0 112.907 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -72.85 -8.84 57.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.07 153.99 44.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.338 1.055 . . . . 0.0 109.246 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.67 -160.55 49.7 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.404 1.002 . . . . 0.0 111.532 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 t -113.96 129.15 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.19 122.2 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.151 -168.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -92.39 100.84 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 108.185 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.33 149.73 25.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.09 150.8 44.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.411 1.485 . . . . 0.0 109.284 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -132.84 113.04 12.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.4 p-90 -132.79 153.28 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.126 1.771 . . . . 0.0 107.416 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.81 165.04 7.27 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 119.146 0.885 . . . . 0.0 111.122 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.66 -18.08 8.09 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.147 3.231 . . . . 0.0 116.285 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -58.22 -19.65 35.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.798 1.181 . . . . 0.0 114.088 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.0 161.57 39.07 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.76 1.163 . . . . 0.0 113.814 -169.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.06 21.91 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.794 -1.559 . . . . 0.0 112.777 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.56 -27.33 18.89 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.326 2.684 . . . . 0.0 114.94 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -58.51 -18.36 28.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 113.839 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -113.48 11.57 18.44 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.524 1.13 . . . . 0.0 111.697 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mtm -121.35 -43.67 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.099 0.96 . . . . 0.0 109.467 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.1 -36.03 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.445 0.698 . . . . 0.0 109.272 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.37 -57.91 21.74 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.979 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -60.27 -39.56 66.78 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.962 1.775 . . . . 0.0 111.676 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG12 HD22 ' A' ' 96' ' ' LEU . 2.2 t -56.45 -36.78 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.27 1.028 . . . . 0.0 111.178 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.1 mt -72.36 -41.58 66.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.699 0.681 . . . . 0.0 110.687 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.84 -35.01 79.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.999 0.818 . . . . 0.0 109.848 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.16 -28.7 68.34 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.773 1.229 . . . . 0.0 112.06 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD11 ' SD ' ' A' ' 46' ' ' MET . 47.9 tp -76.41 -46.27 27.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.193 0.597 . . . . 0.0 110.282 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.38 -36.25 71.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.123 0.419 . . . . 0.0 110.759 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -68.42 -9.2 46.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.133 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.08 -51.96 3.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.168 0.987 . . . . 0.0 110.742 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.407 ' SD ' HD11 ' A' ' 42' ' ' LEU . 19.7 ptm -127.56 14.7 7.07 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.835 0.854 . . . . 0.0 112.238 -170.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.87 -6.44 12.22 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.082 -1.011 . . . . 0.0 114.209 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.37 -23.22 67.22 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.829 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.06 -15.08 8.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.688 1.195 . . . . 0.0 112.515 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 tp -127.95 149.8 50.17 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.749 1.22 . . . . 0.0 112.139 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -114.34 147.53 38.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.85 141.82 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 10.0 t -139.21 113.1 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpt -87.48 155.0 20.2 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.284 -0.885 . . . . 0.0 110.184 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -124.52 127.27 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 171.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -83.05 104.99 13.67 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.334 27.5 m -77.98 48.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -153.54 -42.71 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.481 1.513 . . . . 0.0 108.677 167.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.78 -42.62 19.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.688 0.676 . . . . 0.0 110.767 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -134.59 38.08 3.08 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.42 1.088 . . . . 0.0 111.053 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -69.25 -4.93 19.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.887 1.275 . . . . 0.0 113.147 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.74 -47.16 70.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.982 1.713 . . . . 0.0 111.049 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.3 m -58.81 -40.97 85.71 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.618 0.645 . . . . 0.0 111.061 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.87 -55.28 13.49 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.7 -45.26 39.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.934 0.778 . . . . 0.0 113.213 169.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.73 -41.39 95.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.226 1.013 . . . . 0.0 111.036 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -80.62 -5.45 56.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.151 0.981 . . . . 0.0 112.707 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.34 60.38 5.55 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.44 -64.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.46 ' CE ' HD13 ' B' ' 72' ' ' LEU . 10.5 mtm 58.89 5.14 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.389 2.676 . . . . 0.0 115.242 173.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.4 p -143.38 159.55 42.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.811 1.187 . . . . 0.0 112.921 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 141.54 41.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.79 151.33 71.78 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 N-CA-C 106.942 -1.984 . . . . 0.0 106.942 -11.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.7 m -123.99 147.01 48.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -122.99 138.17 54.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.188 1.795 . . . . 0.0 106.64 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.34 107.81 12.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.61 128.46 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.58 151.24 43.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.58 0.752 . . . . 0.0 109.496 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -137.73 135.92 36.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.0 t70 43.8 29.98 0.34 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.705 2.002 . . . . 0.0 114.432 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.59 15.74 42.24 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.548 1.071 . . . . 0.0 115.758 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -130.45 144.67 51.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.521 1.16 . . . . 0.0 110.115 172.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.11 134.45 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.94 -22.99 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.699 1.199 . . . . 0.0 110.091 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.17 165.69 28.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.967 0.907 . . . . 0.0 110.329 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 149.33 29.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.8 m -153.51 139.39 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 169.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.04 67.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -171.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.37 156.56 9.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.873 1.702 . . . . 0.0 109.596 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.9 148.22 51.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.157 0.583 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.66 142.11 27.47 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -70.07 166.34 28.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.355 2.036 . . . . 0.0 110.703 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -46.58 -47.05 19.88 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.494 1.918 . . . . 0.0 112.495 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.5 -43.29 77.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.931 0.787 . . . . 0.0 111.055 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.89 76.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.779 -0.575 . . . . 0.0 110.4 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.614 HD22 HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -58.04 -53.32 59.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.264 1.026 . . . . 0.0 109.707 173.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.05 -38.18 85.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.572 -174.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.03 -46.66 88.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.981 0.81 . . . . 0.0 111.146 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -58.09 -38.68 76.87 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.887 1.275 . . . . 0.0 111.682 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 p -88.74 -40.54 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.509 -0.281 . . . . 0.0 111.079 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -57.72 -32.83 67.8 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.406 1.082 . . . . 0.0 111.854 -176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -69.46 -5.96 27.28 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -126.63 -27.39 3.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.015 1.326 . . . . 0.0 112.581 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.247 0.952 0 C-N-CA 126.155 1.782 . . . . 0.0 107.539 169.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.63 19.43 2.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.162 0.985 . . . . 0.0 112.575 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -157.46 129.68 7.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -153.48 148.86 27.11 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 129.041 2.936 . . . . 0.0 104.649 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.35 146.38 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.28 144.29 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.59 141.38 49.66 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -116.47 145.46 43.28 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 mt -121.05 114.29 21.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 m -136.87 136.37 38.65 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.6 m -52.36 119.48 4.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.711 0.804 . . . . 0.0 109.344 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.25 0.29 5.67 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.724 1.631 . . . . 0.0 115.091 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.2 t30 44.1 26.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.919 2.088 . . . . 0.0 113.328 -169.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.8 m -68.43 -42.93 78.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.67 -61.85 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -54.97 -46.35 75.05 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 120.718 1.599 . . . . 0.0 111.48 -174.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.4 p -51.58 -49.55 61.88 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.9 1.68 . . . . 0.0 112.115 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.28 -46.78 85.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.099 0.96 . . . . 0.0 110.532 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 30.5 ttm -63.02 -45.22 93.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.41 90.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.085 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -27.52 58.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.424 1.465 . . . . 0.0 110.441 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.98 -50.99 42.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.01 -39.63 72.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.638 0.775 . . . . 0.0 111.41 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.37 -52.98 62.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -64.77 -23.19 67.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.8 -14.18 61.46 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -126.7 -16.67 5.19 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.609 1.163 . . . . 0.0 113.31 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -121.84 77.68 1.39 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.34 -161.3 1.01 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.685 1.612 . . . . 0.0 113.09 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.81 -20.83 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.438 -1.036 . . . . 0.0 113.18 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -58.73 -16.3 15.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.506 1.922 . . . . 0.0 112.889 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -128.29 156.95 42.21 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.406 1.882 . . . . 0.0 109.045 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -125.54 143.09 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.34 137.19 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.61 158.12 44.23 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.132 1.373 . . . . 0.0 108.222 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 77.3 p -147.18 150.2 34.45 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.75 172.84 17.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.067 0.947 . . . . 0.0 111.768 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.79 -172.27 35.43 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.266 0.936 . . . . 0.0 111.818 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 tt -53.88 -57.6 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 113.62 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.02 28.41 4.16 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.205 1.802 . . . . 0.0 108.002 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.83 148.18 40.22 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.896 2.078 . . . . 0.0 112.066 -170.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 145.16 66.22 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 131.568 3.947 . . . . 0.0 104.371 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.12 152.09 23.26 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -139.81 100.7 4.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -71.52 128.44 89.91 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -59.73 -21.86 65.11 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.028 1.819 . . . . 0.0 112.813 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -36.01 80.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.701 1.137 . . . . 0.0 111.293 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.56 -38.55 67.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.83 -51.62 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -59.05 -42.65 90.79 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.353 0.661 . . . . 0.0 110.727 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.51 -32.06 57.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.127 0.971 . . . . 0.0 112.18 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 65.2 mmm -84.77 -34.67 22.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.176 0.898 . . . . 0.0 111.276 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -62.53 -24.05 67.3 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.163 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.0 -31.67 63.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.858 1.208 . . . . 0.0 111.673 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.66 15.11 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.196 1.398 . . . . 0.0 111.2 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.74 41.42 98.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.598 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.09 146.4 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -119.26 135.13 54.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.089 0.556 . . . . 0.0 109.967 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.62 25.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 126.969 2.108 . . . . 0.0 109.713 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.8 m -68.09 14.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.518 -1.364 . . . . 0.0 113.403 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.2 23.96 0.93 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.321 1.848 . . . . 0.0 112.251 -169.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -47.46 150.17 0.99 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.82 1.645 . . . . 0.0 114.013 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -128.32 41.17 3.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.851 2.06 . . . . 0.0 110.437 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 12.7 m -59.83 172.33 0.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.04 1.336 . . . . 0.0 113.375 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -166.22 168.2 15.45 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.392 1.477 . . . . 0.0 109.78 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.2 pt -65.37 170.69 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.032 1.333 . . . . 0.0 112.348 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -48.95 132.21 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.329 0.652 . . . . 0.0 109.241 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -138.26 95.96 3.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.915 1.34 . . . . 0.0 108.263 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -44.69 -31.18 1.09 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.741 2.017 . . . . 0.0 114.673 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.64 -22.77 62.47 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-N 119.298 0.954 . . . . 0.0 110.636 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -39.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.457 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.46 HD13 ' CE ' ' A' ' 70' ' ' MET . 7.5 tt -60.89 -50.92 71.48 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.616 1.098 . . . . 0.0 110.145 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -29.17 69.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.546 0.612 . . . . 0.0 111.353 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -85.31 -11.35 54.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.192 1.397 . . . . 0.0 112.743 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 171.12 5.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.742 0.782 . . . . 0.0 110.683 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -105.28 -12.62 15.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.171 0.989 . . . . 0.0 111.58 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.17 145.59 24.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.398 1.079 . . . . 0.0 109.252 173.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.64 99.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.4 102.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -65.39 119.56 11.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tp -135.31 53.29 1.98 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.627 0.771 . . . . 0.0 111.592 -167.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.631 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.43 20.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.328 2.651 . . . . 0.0 116.117 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 68.64 27.85 5.88 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.3 1.84 . . . . 0.0 112.859 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 33.96 48.32 0.56 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.085 2.154 . . . . 0.0 112.789 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.87 136.05 70.54 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.872 2.381 . . . . 0.0 112.451 -168.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.439 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.62 -1.37 50.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 116.71 -1.614 . . . . 0.0 114.852 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p 46.07 86.63 0.13 Allowed Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.374 1.47 . . . . 0.0 112.879 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -58.36 143.94 96.89 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.461 2.107 . . . . 0.0 110.112 -169.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.9 5.53 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 125.072 3.848 . . . . 0.0 116.212 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -63.95 -12.18 35.14 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 112.29 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.63 154.25 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 0.988 . . . . 0.0 111.375 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -74.33 156.25 37.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.488 1.915 . . . . 0.0 109.834 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.74 144.56 30.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.719 -1.238 . . . . 0.0 108.09 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.44 147.3 27.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -87.26 133.68 33.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.576 1.15 . . . . 0.0 109.658 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -140.32 25.01 2.27 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.704 1.601 . . . . 0.0 110.327 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.68 155.62 26.48 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -157.36 19.91 0.29 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.532 1.933 . . . . 0.0 109.05 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -170.24 175.55 4.87 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 129.257 3.023 . . . . 0.0 105.719 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -161.32 138.39 6.54 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 168.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.44 -17.43 21.09 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.743 . . . . 0.0 112.306 -170.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.93 6.62 1.15 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.681 1.128 . . . . 0.0 110.769 168.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -122.0 12.73 10.46 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 110.501 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.44 158.18 0.44 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -34.65 72.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.828 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.07 -15.1 6.53 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 115.759 1.064 . . . . 0.0 115.759 168.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.5 p -70.33 162.7 28.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.51 -40.11 95.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.515 0.674 . . . . 0.0 110.558 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.84 -42.79 85.18 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.09 -1.433 . . . . 0.0 109.087 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -73.99 -33.16 63.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.928 1.694 . . . . 0.0 109.73 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -56.54 -56.77 17.08 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 119.119 0.872 . . . . 0.0 110.721 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -64.27 -39.78 94.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.758 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.59 98.07 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.29 -0.881 . . . . 0.0 111.996 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.84 -51.54 61.52 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.285 1.3 p90 -70.12 -30.91 68.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 117.546 -1.216 . . . . 0.0 112.542 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -72.58 -41.65 65.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 120.268 1.395 . . . . 0.0 111.004 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -59.52 -54.1 50.48 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.108 0.963 . . . . 0.0 109.302 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.33 -39.42 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.449 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.413 ' HA ' ' SD ' ' B' ' 19' ' ' MET . 5.4 tmm_? -56.92 -45.36 82.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.339 1.427 . . . . 0.0 112.08 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.09 -45.48 94.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.076 0.398 . . . . 0.0 110.65 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.2 -41.58 73.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.713 0.233 . . . . 0.0 111.281 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -60.22 -47.84 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.337 -0.852 . . . . 0.0 109.275 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.76 97.04 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.934 0.788 . . . . 0.0 111.239 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -59.52 -50.83 72.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.379 1.089 . . . . 0.0 111.98 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -69.76 -33.14 72.01 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.506 -0.746 . . . . 0.0 111.448 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.1 mm? -69.1 -36.48 77.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.249 0.931 . . . . 0.0 111.023 175.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -57.05 -41.15 78.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.168 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.46 -36.41 75.91 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 116.487 -1.72 . . . . 0.0 112.375 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -64.97 -37.32 87.26 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 122.437 2.381 . . . . 0.0 111.111 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.74 70.8 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -91.85 -38.86 12.07 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 112.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 63.5 p -101.62 -19.27 15.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.335 1.854 . . . . 0.0 110.979 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.42 32.44 64.3 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.835 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 124.083 0.953 . . . . 0.0 111.499 -174.377 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.42 152.9 4.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.637 1.175 . . . . 0.0 109.924 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.23 95.46 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 168.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.06 167.16 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.338 1.455 . . . . 0.0 107.336 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -126.96 117.84 23.32 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -79.02 176.76 9.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.112 1.365 . . . . 0.0 110.264 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -154.77 -173.2 4.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.884 2.074 . . . . 0.0 106.048 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -39.55 -33.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.872 3.269 . . . . 0.0 116.511 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -133.52 -21.88 1.97 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.951 1.3 . . . . 0.0 112.234 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -38.39 75.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.136 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -71.03 123.88 23.09 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.7 m 116.83 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 1 C-N-CA 131.772 4.029 . . . . 0.0 105.471 -169.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.07 99.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.0 110.578 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -79.65 -8.77 59.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.473 1.509 . . . . 0.0 112.163 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 p -124.25 -2.09 8.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.44 1.018 . . . . 0.0 113.429 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.6 m -72.19 -10.61 60.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.81 155.75 45.57 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.792 0.724 . . . . 0.0 110.432 -172.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.86 -158.2 51.77 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 124.223 0.916 . . . . 0.0 110.999 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.66 124.22 71.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.05 115.7 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.156 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.7 tp -87.69 92.89 9.27 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 148.04 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -142.75 149.99 39.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -132.29 110.83 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.582 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.0 p-90 -131.08 152.73 50.07 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.806 1.643 . . . . 0.0 107.477 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.69 162.4 8.32 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 118.882 0.765 . . . . 0.0 110.297 169.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.88 -14.88 6.27 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.916 3.078 . . . . 0.0 115.993 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -61.49 -27.48 68.62 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.83 1.195 . . . . 0.0 113.663 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.66 154.95 47.64 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.448 1.022 . . . . 0.0 112.162 -169.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.93 -49.07 79.25 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 117.955 -1.469 . . . . 0.0 113.729 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.99 -24.71 25.65 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.035 2.49 . . . . 0.0 115.323 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 m -59.15 -21.25 59.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 120.249 1.386 . . . . 0.0 113.502 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.07 7.96 34.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.952 0.901 . . . . 0.0 111.89 174.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.1 mtm -118.59 -44.9 2.63 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.273 0.942 . . . . 0.0 109.562 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.11 -34.59 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.587 0.755 . . . . 0.0 109.301 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.4 ' HB3' ' CD ' ' A' ' 37' ' ' PRO . . . -54.84 -61.54 5.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.15 0.98 . . . . 0.0 112.243 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 36' ' ' ALA . 6.8 Cg_endo -60.06 -39.91 65.81 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.077 1.852 . . . . 0.0 111.84 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.26 -44.81 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.677 0.791 . . . . 0.0 110.429 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.39 -44.75 90.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.207 0.458 . . . . 0.0 110.094 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.17 -36.56 82.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.066 0.394 . . . . 0.0 110.441 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.19 -32.68 73.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.643 1.177 . . . . 0.0 111.908 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -72.78 -45.71 57.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.218 1.407 . . . . 0.0 109.889 175.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.82 -36.33 72.88 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.389 -0.82 . . . . 0.0 111.312 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.99 -6.65 29.09 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.129 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -104.86 -47.09 4.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.974 1.31 . . . . 0.0 111.585 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.4 ptm -134.58 18.19 3.6 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.402 0.681 . . . . 0.0 112.09 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 -6.77 24.02 Favored Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.871 -1.143 . . . . 0.0 113.82 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.74 -23.88 67.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.44 0.62 . . . . 0.0 110.807 169.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 -24.61 7.88 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.937 1.295 . . . . 0.0 111.59 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 tp -110.28 152.14 26.52 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 111.838 -169.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.73 148.48 49.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.94 144.05 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 11.0 t -138.25 111.19 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.582 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 33.1 mtpt -84.53 159.39 20.71 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.543 -0.723 . . . . 0.0 109.239 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.22 122.69 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 170.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.89 107.35 10.36 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 32.7 m -79.14 48.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.88 -45.52 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.461 1.505 . . . . 0.0 108.456 167.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.27 -36.39 34.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.984 0.914 . . . . 0.0 110.934 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -133.19 29.24 4.04 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 0.0 110.604 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -72.43 -5.99 40.48 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -54.15 -47.62 71.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.638 1.575 . . . . 0.0 110.902 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.2 m -56.11 -40.89 74.41 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.598 0.759 . . . . 0.0 111.367 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.76 -57.23 4.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.22 -42.46 41.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.836 0.732 . . . . 0.0 113.561 169.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -62.81 -43.39 98.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.364 1.082 . . . . 0.0 110.834 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -71.46 -31.61 67.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.077 0.399 . . . . 0.0 110.325 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.12 68.7 1.18 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 -170.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.68 -66.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.423 ' CE ' HD13 ' B' ' 72' ' ' LEU . 7.8 mtm 58.45 7.16 0.66 Allowed 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 127.472 2.309 . . . . 0.0 114.801 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -143.99 160.98 39.9 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.273 1.397 . . . . 0.0 112.991 -169.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 138.56 32.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 109.649 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.17 138.44 33.68 Favored 'Cis proline' 0 N--CA 1.449 -1.104 0 N-CA-C 105.866 -2.398 . . . . 0.0 105.866 -11.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -107.81 150.44 27.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 tp -141.36 123.23 15.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -170.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.0 mt -121.21 105.35 10.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.31 108.59 15.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.33 149.52 23.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -146.57 130.43 17.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.98 30.76 0.44 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.489 1.916 . . . . 0.0 113.329 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.06 8.66 55.13 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 171.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -133.31 151.61 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.765 1.226 . . . . 0.0 110.521 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -70.97 132.72 32.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.44 -23.01 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.981 1.313 . . . . 0.0 110.729 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -146.58 160.57 41.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.523 1.129 . . . . 0.0 109.769 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 148.53 30.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -152.08 149.52 28.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.36 -0.837 . . . . 0.0 108.905 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.75 62.76 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.03 154.12 9.43 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.973 1.273 . . . . 0.0 110.714 -170.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.31 162.9 9.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.426 1.491 . . . . 0.0 112.087 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.33 139.26 10.75 Favored Pre-proline 0 N--CA 1.469 0.486 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -69.43 171.35 14.26 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 111.012 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -38.69 -55.69 1.43 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.469 2.307 . . . . 0.0 111.924 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.88 -42.41 63.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.496 -173.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.68 78.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.849 -0.532 . . . . 0.0 110.992 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.86 -47.51 58.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.507 0.323 . . . . 0.0 110.283 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB2' HD13 ' A' ' 42' ' ' LEU . 7.9 pt20 -63.26 -35.72 81.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.38 -47.53 78.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.173 0.442 . . . . 0.0 110.713 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.72 -38.17 71.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.573 0.749 . . . . 0.0 111.587 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.33 -38.66 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.404 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.22 -25.75 64.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.363 0.983 . . . . 0.0 112.56 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -55.09 -26.08 35.65 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.675 0.79 . . . . 0.0 112.614 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.25 -28.42 3.69 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.438 1.095 . . . . 0.0 111.973 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.328 1.851 . . . . 0.0 108.19 174.453 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.43 22.12 1.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.899 0.88 . . . . 0.0 112.399 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.2 127.74 6.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -146.42 142.28 28.0 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 129.523 3.129 . . . . 0.0 105.273 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -125.4 142.6 41.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 109.0 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.1 151.05 31.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.836 1.254 . . . . 0.0 107.682 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -132.87 151.65 51.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.979 1.311 . . . . 0.0 108.26 -169.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -126.84 147.44 50.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.926 0.89 . . . . 0.0 109.212 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.57 130.41 38.37 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.774 0.83 . . . . 0.0 109.428 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -145.44 149.69 35.16 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.434 1.494 . . . . 0.0 110.351 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -59.63 130.17 45.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.79 37.18 8.96 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.025 1.774 . . . . 0.0 112.85 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -39.87 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.235 1.814 . . . . 0.0 114.961 -168.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.1 m -139.24 4.19 2.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.403 1.081 . . . . 0.0 111.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.88 -49.18 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -59.26 -57.22 13.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.831 1.651 . . . . 0.0 112.047 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -75.42 -26.15 58.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.287 0.949 . . . . 0.0 110.965 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -51.29 -49.66 60.82 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.805 1.642 . . . . 0.0 109.676 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.2 ttm -69.12 -45.2 70.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.659 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.38 90.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.879 0.871 . . . . 0.0 111.946 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -73.94 -33.27 63.86 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.175 0.898 . . . . 0.0 110.798 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.31 70.75 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -59.38 -40.89 87.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.715 0.806 . . . . 0.0 111.601 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.88 71.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -64.26 -24.81 67.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.07 -13.08 62.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -126.82 -8.47 6.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.82 1.248 . . . . 0.0 112.906 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -133.33 81.84 1.95 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -171.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 -161.88 2.14 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.442 1.496 . . . . 0.0 113.07 -171.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.23 -21.14 31.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.729 1.211 . . . . 0.0 113.373 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.14 -14.2 6.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.604 1.962 . . . . 0.0 113.008 169.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -136.48 158.17 45.06 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.094 1.758 . . . . 0.0 109.081 -174.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -132.68 151.38 51.98 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.5 t -135.41 142.9 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -145.32 161.6 39.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.332 0.653 . . . . 0.0 109.911 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.3 m -137.63 145.47 42.76 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.342 1.457 . . . . 0.0 109.165 -169.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.85 164.32 38.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.684 0.754 . . . . 0.0 112.179 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.43 -177.23 46.14 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.333 1.921 . . . . 0.0 108.875 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -57.19 -56.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.577 1.151 . . . . 0.0 112.813 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -132.17 23.76 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.76 2.024 . . . . 0.0 108.005 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.82 118.61 6.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.229 2.212 . . . . 0.0 111.01 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -161.7 -0.17 0.05 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.04 0.536 . . . . 0.0 111.626 169.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.86 168.63 51.25 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -144.71 77.12 1.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.51 131.5 90.67 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -172.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.63 -21.68 48.23 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.968 1.779 . . . . 0.0 112.755 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -37.38 83.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.863 1.211 . . . . 0.0 111.817 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.63 -38.09 65.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 119.099 0.863 . . . . 0.0 109.927 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.56 -51.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.12 -42.55 90.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.989 0.916 . . . . 0.0 110.679 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.78 -30.71 61.74 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.754 0.822 . . . . 0.0 112.304 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.1 mmm -86.41 -33.74 20.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.003 0.819 . . . . 0.0 111.134 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -62.19 -25.59 67.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.187 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -56.51 -30.16 62.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.918 1.236 . . . . 0.0 111.516 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 m -117.27 15.11 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.242 1.417 . . . . 0.0 111.195 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.6 39.95 97.18 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.946 -0.919 . . . . 0.0 112.879 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -115.38 126.99 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -87.15 134.56 33.51 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.917 -0.489 . . . . 0.0 109.752 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -131.51 14.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.288 0.635 . . . . 0.0 111.246 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -59.45 -20.14 52.93 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.171 0.896 . . . . 0.0 110.949 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -76.27 -11.28 59.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.4 2.28 . . . . 0.0 114.116 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -63.83 165.07 9.1 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.368 1.44 . . . . 0.0 113.164 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.2 p -128.44 -37.15 1.83 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.765 1.626 . . . . 0.0 112.08 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.2 m 64.51 162.03 0.12 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.759 2.023 . . . . 0.0 112.803 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -165.52 160.5 17.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.611 1.164 . . . . 0.0 110.212 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -78.14 178.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.731 2.012 . . . . 0.0 111.27 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.12 134.88 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -145.23 103.39 3.84 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.778 1.231 . . . . 0.0 108.283 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -48.26 -30.33 4.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.341 1.856 . . . . 0.0 113.748 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.61 -21.78 66.54 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.068 0.849 . . . . 0.0 111.716 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -118.7 -36.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 117.792 -1.099 . . . . 0.0 108.931 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.423 HD13 ' CE ' ' A' ' 70' ' ' MET . 6.3 tt -60.01 -51.38 69.89 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.876 1.217 . . . . 0.0 109.059 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.63 -27.59 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.07 0.85 . . . . 0.0 111.622 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -85.72 -18.48 32.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.519 1.128 . . . . 0.0 112.444 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.12 160.22 6.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.233 1.016 . . . . 0.0 111.235 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.9 -33.49 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.638 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.595 HD13 ' HD2' ' B' ' 97' ' ' LYS . 13.4 tp -146.69 139.3 25.1 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.225 1.41 . . . . 0.0 109.399 -171.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.77 107.58 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.875 1.67 . . . . 0.0 106.734 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.69 100.78 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -75.6 102.41 5.29 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 101.209 -3.626 . . . . 0.0 101.209 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -116.64 11.19 14.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -166.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.52 -0.196 0 CA-C-N 119.355 0.979 . . . . 0.0 112.217 -169.574 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.62 9.72 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -172.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.3 0.3 OUTLIER 50.78 31.0 5.49 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.85 2.06 . . . . 0.0 114.641 -169.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.5 m 38.69 52.8 3.77 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 128.057 2.543 . . . . 0.0 113.926 170.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.21 131.11 41.52 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.029 2.486 . . . . 0.0 111.576 -169.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.411 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.5 2.12 34.42 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -174.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p 45.72 88.3 0.1 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.622 1.569 . . . . 0.0 113.244 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -56.02 141.18 86.94 Favored 'Trans proline' 0 CA--C 1.55 1.323 0 C-N-CA 122.549 2.166 . . . . 0.0 110.263 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.23 -2.51 3.17 Favored 'Trans proline' 0 C--N 1.351 0.663 1 C-N-CA 125.38 4.053 . . . . 0.0 116.961 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -65.7 -9.81 31.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.175 0.898 . . . . 0.0 111.506 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.81 144.39 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.828 1.251 . . . . 0.0 109.844 -169.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.595 ' HD2' HD13 ' B' ' 77' ' ' LEU . 0.7 OUTLIER -76.6 156.61 32.6 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.742 0.817 . . . . 0.0 108.94 171.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -145.08 143.62 30.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -137.21 139.83 41.31 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -89.93 135.13 33.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.673 1.189 . . . . 0.0 108.787 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -140.08 14.47 2.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.95 1.7 . . . . 0.0 110.323 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.34 167.1 54.43 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 123.941 0.781 . . . . 0.0 113.328 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -164.04 -43.11 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.137 1.775 . . . . 0.0 109.469 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -165.21 175.31 9.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.688 1.995 . . . . 0.0 109.798 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -139.26 137.87 19.83 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.26 -18.02 16.43 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.266 1.977 . . . . 0.0 113.078 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.96 6.98 1.78 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.002 1.273 . . . . 0.0 110.226 168.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -118.7 10.68 12.52 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.339 1.455 . . . . 0.0 110.901 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.84 156.76 0.91 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.314 0.646 . . . . 0.0 110.119 171.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -35.8 73.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.512 -172.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.1 -21.32 3.92 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -69.76 166.75 18.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.13 -42.47 99.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.441 0.639 . . . . 0.0 110.292 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.7 pt-20 -68.83 -43.03 76.38 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 117.072 -1.442 . . . . 0.0 109.32 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.2 -34.91 61.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 121.034 1.743 . . . . 0.0 109.827 -173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -55.84 -56.62 18.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.631 0.651 . . . . 0.0 110.763 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -64.56 -39.78 94.38 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.853 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.95 92.46 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.896 0.878 . . . . 0.0 111.665 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -63.31 -51.74 64.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.288 2.2 p90 -70.77 -25.81 63.06 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.0 -172.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -65.61 -51.53 58.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.706 1.139 . . . . 0.0 109.746 172.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -57.27 -51.34 69.76 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.32 -49.02 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 118.333 -0.842 . . . . 0.0 109.485 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -56.52 -48.29 77.53 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 111.85 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.78 -43.44 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.326 0.391 . . . . 0.0 110.965 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -66.41 -49.96 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -48.5 79.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.806 1.243 . . . . 0.0 109.991 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.72 -42.45 95.27 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -61.37 -44.51 97.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.799 0.8 . . . . 0.0 112.025 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -69.97 -36.85 75.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.084 0.856 . . . . 0.0 111.759 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.1 mm? -74.56 -33.54 62.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.553 1.07 . . . . 0.0 111.38 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.28 -43.96 96.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.784 0.72 . . . . 0.0 109.201 170.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.33 -39.05 81.92 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.595 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.66 -42.61 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 122.476 2.398 . . . . 0.0 110.222 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.38 72.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.07 -37.83 18.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.825 1.25 . . . . 0.0 112.959 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.2 p -101.14 -20.09 15.47 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.801 1.64 . . . . 0.0 111.613 -169.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.37 50.01 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.75 0.691 . . . . 0.0 111.51 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 C-N-CA 128.229 2.612 . . . . 0.0 112.681 -169.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.25 160.93 0.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.645 2.378 . . . . 0.0 112.882 -169.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.52 102.84 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -73.09 166.73 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.772 1.629 . . . . 0.0 108.258 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.81 133.9 46.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.23 176.04 5.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.859 1.264 . . . . 0.0 110.189 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.0 p -137.98 -170.73 2.85 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.101 1.761 . . . . 0.0 109.232 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -44.46 -30.37 0.85 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.88 2.472 . . . . 0.0 113.9 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -138.45 -22.82 1.0 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.481 1.112 . . . . 0.0 112.959 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 m -59.03 -36.06 74.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -71.75 122.72 21.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m 117.71 -60.93 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.707 1 C-N-CA 131.977 4.111 . . . . 0.0 106.065 -169.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.2 95.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.424 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -81.68 -9.24 59.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.612 1.565 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.1 p -122.77 -6.59 8.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -168.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -79.98 -1.48 39.8 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -140.39 147.61 40.01 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.238 0.926 . . . . 0.0 109.787 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.56 -174.63 31.37 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.332 0.968 . . . . 0.0 111.659 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.31 129.97 45.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.06 119.51 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.123 0.969 . . . . 0.0 109.009 -168.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.8 107.53 18.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.73 27.82 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.477 1.035 . . . . 0.0 108.282 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -135.7 152.45 51.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.866 1.667 . . . . 0.0 108.84 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -132.22 114.2 14.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.597 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.3 p-90 -135.58 153.07 51.8 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.034 1.733 . . . . 0.0 108.191 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.51 163.33 7.06 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 119.262 0.937 . . . . 0.0 109.183 169.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.86 -16.86 9.41 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.486 2.791 . . . . 0.0 116.384 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -57.67 -27.43 62.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.79 159.49 41.7 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.633 1.106 . . . . 0.0 112.494 -169.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.73 -48.65 75.1 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.039 -1.423 . . . . 0.0 112.677 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.68 -30.69 17.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.657 2.904 . . . . 0.0 115.461 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.71 -25.47 62.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 120.247 1.385 . . . . 0.0 112.924 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -103.89 10.06 36.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.27 1.028 . . . . 0.0 111.708 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.4 mtm -120.78 -44.36 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.192 0.997 . . . . 0.0 109.481 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.44 -34.94 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 0.0 109.254 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.16 6.98 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.183 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.82 -40.16 74.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.009 1.806 . . . . 0.0 111.671 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.97 -42.01 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.007 0.523 . . . . 0.0 110.548 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.26 -40.12 71.17 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.499 0.59 . . . . 0.0 110.812 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.32 -35.32 80.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.275 0.943 . . . . 0.0 109.723 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.8 -25.32 63.72 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.405 1.482 . . . . 0.0 112.363 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.427 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 48.3 tp -79.42 -44.48 21.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 109.637 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.5 -37.48 74.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.723 0.297 . . . . 0.0 110.793 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -68.64 -10.04 53.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.275 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -101.89 -48.18 4.35 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.148 0.979 . . . . 0.0 111.149 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -134.14 15.41 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.419 0.688 . . . . 0.0 112.331 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.95 -2.88 26.3 Favored Glycine 0 CA--C 1.52 0.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.912 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.5 -24.8 64.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.202 1.001 . . . . 0.0 110.808 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -23.01 9.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.164 0.986 . . . . 0.0 112.061 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.57 147.54 46.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.593 1.157 . . . . 0.0 111.57 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -107.42 143.88 35.12 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.7 mt -128.14 139.23 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.84 141.86 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 125.722 1.609 . . . . 0.0 106.672 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.597 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.2 mtpp -113.41 159.52 19.37 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.262 0.625 . . . . 0.0 109.576 173.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.56 121.16 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 170.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.2 106.2 6.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 33.0 m -78.66 50.19 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -155.7 -45.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.491 1.516 . . . . 0.0 108.291 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.04 -36.71 35.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 110.869 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -134.08 28.67 3.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 111.019 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -71.77 -6.27 40.18 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.653 0.781 . . . . 0.0 112.735 -171.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -53.74 -49.3 68.46 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.009 1.724 . . . . 0.0 110.708 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -60.04 -34.67 73.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.387 0.675 . . . . 0.0 111.677 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.06 -64.01 0.94 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.82 -45.84 7.45 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.802 0.715 . . . . 0.0 113.298 169.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.29 -43.15 96.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.124 0.962 . . . . 0.0 111.506 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -84.56 -4.98 59.26 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.639 0.776 . . . . 0.0 112.659 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.45 66.32 1.61 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.1 t -144.1 131.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.814 ' HG3' HD12 ' B' ' 67' ' ' ILE . 25.6 ptm -149.97 24.71 0.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -140.48 161.31 38.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.622 1.569 . . . . 0.0 112.727 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 136.17 28.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.572 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.11 145.42 41.32 Favored 'Cis proline' 0 N--CA 1.45 -1.052 0 N-CA-C 107.43 -1.796 . . . . 0.0 107.43 -11.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.2 m -113.81 145.23 41.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.1 133.06 54.77 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.2 mt -122.11 110.1 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -101.82 122.23 53.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.34 1.456 . . . . 0.0 108.547 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.51 130.31 20.38 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 43.13 31.1 0.33 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.609 2.364 . . . . 0.0 114.804 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.16 -19.15 5.77 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.988 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -136.43 149.49 48.28 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.24 1.52 . . . . 0.0 113.24 -168.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.58 138.83 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.81 -26.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.855 1.662 . . . . 0.0 109.418 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -144.07 157.51 44.28 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -154.6 133.45 12.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.98 -2.229 . . . . 0.0 104.98 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.3 t -155.17 148.79 25.3 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.5 t -138.75 82.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.24 160.01 10.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.435 1.017 . . . . 0.0 110.883 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -66.67 145.58 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.118 0.959 . . . . 0.0 111.118 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -135.91 138.92 29.01 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 124.724 1.21 . . . . 0.0 108.167 170.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.25 169.74 17.57 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.195 1.93 . . . . 0.0 109.946 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 18.1 tptm -46.03 -48.58 16.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.072 1.749 . . . . 0.0 112.41 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.68 -42.37 74.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 118.005 0.366 . . . . 0.0 111.132 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.67 85.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.134 0.425 . . . . 0.0 110.662 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.45 45.8 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.509 0.724 . . . . 0.0 109.305 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -65.32 -37.47 87.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.56 -47.27 86.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.63 0.65 . . . . 0.0 110.957 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.48 -40.07 77.77 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.417 0.687 . . . . 0.0 111.292 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -85.72 -41.61 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 123.064 0.228 . . . . 0.0 110.627 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -56.69 -27.35 58.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.751 1.221 . . . . 0.0 112.302 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -50.08 -32.68 16.28 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.974 1.31 . . . . 0.0 112.294 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -135.81 -8.48 2.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.249 1.041 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.164 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 52.3 48.31 22.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.894 1.677 . . . . 0.0 113.113 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 135.73 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.171 3.788 . . . . 0.0 109.151 169.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -150.66 158.48 44.2 Favored 'General case' 0 C--N 1.325 -0.491 1 C-N-CA 133.896 4.878 . . . . 0.0 103.905 169.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mt -122.61 142.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.657 1.117 . . . . 0.0 109.215 -169.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -143.44 146.94 20.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.33 1.452 . . . . 0.0 107.125 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.59 134.55 37.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.049 0.539 . . . . 0.0 109.835 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.58 143.09 26.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -132.51 111.11 10.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -140.05 143.18 36.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.174 0.99 . . . . 0.0 108.665 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -42.81 96.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.806 2.442 . . . . 0.0 112.681 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.39 36.64 89.91 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.637 -1.091 . . . . 0.0 111.185 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -2.34 103.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 129.764 3.226 . . . . 0.0 113.696 -169.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -122.51 -145.58 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.067 -2.333 . . . . 0.0 104.787 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . -38.4 -50.7 1.53 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -168.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.489 ' HE ' ' HG ' ' B' ' 81' ' ' LEU . 27.5 mtp85 -53.68 -51.15 64.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.784 1.175 . . . . 0.0 111.003 -172.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -43.31 73.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.144 -171.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -54.92 -49.66 70.74 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.098 0.959 . . . . 0.0 110.241 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 26.2 ttm -63.01 -44.26 96.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.484 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 117.765 -1.112 . . . . 0.0 112.491 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -64.92 -47.3 78.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.649 1.568 . . . . 0.0 109.636 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.75 -47.75 89.66 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.527 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -61.92 -42.62 99.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 117.375 0.587 . . . . 0.0 112.283 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.1 83.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -65.64 -26.96 68.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.206 -170.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -18.22 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.313 0.961 . . . . 0.0 113.285 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.443 ' CZ ' ' HE3' ' B' ' 132' ' ' LYS . 1.9 m-85 -119.05 -11.5 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 113.078 -175.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 39.0 mt -103.05 -125.46 0.2 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.78 -168.71 40.84 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.64 -16.1 60.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.556 1.143 . . . . 0.0 111.805 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -53.84 -25.55 20.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 111.268 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -130.3 158.65 39.2 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.713 1.205 . . . . 0.0 110.825 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -128.14 125.71 39.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 67.0 t -115.36 134.42 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 -169.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.1 168.94 18.64 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.463 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -146.6 150.73 36.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.943 0.897 . . . . 0.0 110.353 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 67' ' ' ILE . . . -151.39 166.4 31.15 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.126 1.37 . . . . 0.0 110.375 -177.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.29 -178.44 47.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.175 1.369 . . . . 0.0 110.333 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -52.76 -54.03 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.619 1.168 . . . . 0.0 113.739 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.01 27.88 4.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.581 1.953 . . . . 0.0 108.269 -169.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.74 140.65 49.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.195 1.798 . . . . 0.0 111.942 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 p80 158.43 56.99 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.334 3.054 . . . . 0.0 107.719 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.9 93.97 0.15 Allowed Glycine 0 C--N 1.336 0.574 0 O-C-N 121.219 -0.926 . . . . 0.0 111.404 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.0 tp -72.65 91.02 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -66.21 126.59 92.26 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.896 0.878 . . . . 0.0 109.774 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.75 -26.58 68.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.186 1.924 . . . . 0.0 113.266 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -20.04 65.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.151 1.341 . . . . 0.0 112.204 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -82.39 -38.2 24.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 110.147 174.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.51 -51.22 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.33 -38.49 83.93 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.808 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.67 65.19 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.722 0.692 . . . . 0.0 111.842 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 52.8 mmm -76.66 -35.38 58.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.22 0.918 . . . . 0.0 111.163 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -62.33 -24.53 67.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.389 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.47 -26.93 65.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.76 1.164 . . . . 0.0 111.721 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.5 m -120.28 15.01 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.196 1.398 . . . . 0.0 111.151 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.1 42.41 99.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.94 0.781 . . . . 0.0 112.598 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -115.11 155.67 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 172.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -124.14 140.93 52.49 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.789 0.836 . . . . 0.0 109.473 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 37.5 pt -138.23 22.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.671 1.588 . . . . 0.0 109.794 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -60.71 -15.53 30.04 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 120.641 -1.287 . . . . 0.0 111.881 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -63.15 -31.45 72.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.687 2.395 . . . . 0.0 114.172 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -62.45 158.14 18.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.587 1.155 . . . . 0.0 111.16 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.6 t -149.89 -30.65 0.22 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.628 0.771 . . . . 0.0 112.426 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p 56.52 173.74 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.847 2.059 . . . . 0.0 115.272 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -166.47 166.01 16.63 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.281 2.232 . . . . 0.0 107.997 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 31.2 pt -68.55 174.73 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.332 1.053 . . . . 0.0 111.366 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.814 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.2 OUTLIER -48.64 131.95 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -147.3 97.51 2.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.192 0.996 . . . . 0.0 108.886 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 9.7 m -50.73 -25.41 4.31 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.926 1.291 . . . . 0.0 114.021 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.71 -21.26 65.64 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.647 1.567 . . . . 0.0 112.098 -175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.55 -37.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tt -68.12 -41.84 81.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.821 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.37 66.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.678 1.126 . . . . 0.0 111.379 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -82.77 -13.52 56.12 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.145 0.978 . . . . 0.0 112.383 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.8 162.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.44 1.018 . . . . 0.0 111.449 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.68 -34.57 16.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.627 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' B' ' 97' ' ' LYS . 23.2 tp -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.091 1.356 . . . . 0.0 109.221 -171.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.49 104.1 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.19 99.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -65.43 121.55 15.13 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 169.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.489 ' HG ' ' HE ' ' B' ' 16' ' ' ARG . 4.4 tp -135.58 54.26 1.93 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.832 0.853 . . . . 0.0 111.14 -167.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 126.846 2.059 . . . . 0.0 105.827 171.856 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.21 16.07 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm 74.89 22.3 1.9 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.238 1.815 . . . . 0.0 112.194 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 29.03 57.17 0.66 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 128.149 2.58 . . . . 0.0 112.859 -173.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.04 133.4 51.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.617 2.211 . . . . 0.0 111.914 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.435 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.06 -4.65 57.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -174.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p 44.28 103.13 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 127.89 2.476 . . . . 0.0 113.858 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -63.56 145.02 91.43 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.461 1.441 . . . . 0.0 109.645 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.59 -4.54 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.119 3.213 . . . . 0.0 114.513 -170.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -61.3 -12.71 14.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.44 147.33 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.218 1.007 . . . . 0.0 110.524 -170.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.4 tmmm? -77.25 157.96 30.52 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 169.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -145.03 145.91 31.68 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.751 -1.218 . . . . 0.0 109.104 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.55 151.32 34.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -108.56 140.48 41.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.895 1.278 . . . . 0.0 110.64 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -144.24 22.61 1.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.724 1.21 . . . . 0.0 111.034 -170.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.94 25.45 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.161 0.886 . . . . 0.0 110.949 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -154.57 -30.4 0.11 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.95 1.7 . . . . 0.0 110.564 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.13 165.0 37.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.92 2.488 . . . . 0.0 107.364 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.12 139.29 20.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.301 1.441 . . . . 0.0 108.328 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.66 -17.86 9.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.355 2.036 . . . . 0.0 113.769 -169.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.01 -0.25 5.43 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.39 0.996 . . . . 0.0 110.666 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 11.17 15.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.894 1.277 . . . . 0.0 110.989 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.52 159.84 0.31 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.059 0.944 . . . . 0.0 110.729 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.51 -36.09 68.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.654 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.96 5.32 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 115.73 1.052 . . . . 0.0 115.73 168.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 65.6 p -69.98 165.08 22.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.8 -42.73 99.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.44 0.638 . . . . 0.0 110.208 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.1 -43.29 82.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.857 -1.545 . . . . 0.0 109.395 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.95 -35.73 62.12 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 121.232 1.833 . . . . 0.0 109.428 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -57.08 -53.94 52.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.679 0.672 . . . . 0.0 110.656 171.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . 0.434 ' HA ' ' CD2' ' B' ' 120' ' ' PHE . 7.6 t90 -62.93 -45.19 93.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.694 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.97 99.51 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.943 0.897 . . . . 0.0 111.857 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.12 -48.78 72.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.434 ' CD2' ' HA ' ' B' ' 117' ' ' TRP 0.253 0.3 OUTLIER -65.92 -38.91 89.91 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.366 -174.685 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.02 -48.5 80.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.374 0.988 . . . . 0.0 110.672 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -63.13 -52.15 63.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.91 -35.45 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.222 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.527 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.1 tmm_? -61.84 -43.99 97.74 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.781 1.173 . . . . 0.0 112.373 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.46 -46.19 80.48 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.17 0.441 . . . . 0.0 110.725 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.66 -41.35 68.86 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 122.32 -0.238 . . . . 0.0 111.57 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.3 -46.25 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.105 0.962 . . . . 0.0 109.642 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.19 98.39 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.07 -44.54 94.68 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.262 1.031 . . . . 0.0 112.325 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -72.42 -34.93 68.19 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.044 -1.035 . . . . 0.0 111.489 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -36.08 68.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.682 1.128 . . . . 0.0 111.415 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.443 ' HE3' ' CZ ' ' B' ' 27' ' ' TYR . 9.4 ptmt -67.18 -37.39 83.62 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.165 0.893 . . . . 0.0 109.576 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.76 -43.19 98.33 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 117.302 -1.332 . . . . 0.0 110.855 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -57.44 -41.25 80.09 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 121.579 1.99 . . . . 0.0 110.552 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.09 73.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.824 0.85 . . . . 0.0 112.617 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.33 -41.73 14.29 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.459 1.503 . . . . 0.0 111.158 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.6 p -90.06 -23.62 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.129 1.372 . . . . 0.0 110.452 -169.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 51.3 54.33 24.14 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.602 1.561 . . . . 0.0 114.533 -169.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.9 168.06 23.61 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.431 2.292 . . . . 0.0 106.293 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.05 99.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 169.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.41 165.33 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.943 1.297 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 118.25 28.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 107.909 172.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.15 172.86 12.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.982 0.913 . . . . 0.0 108.616 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t -155.34 -177.7 6.73 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 169.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -36.92 -36.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 129.529 3.132 . . . . 0.0 116.275 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.7 -30.95 1.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.518 1.127 . . . . 0.0 111.421 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 m -61.74 -19.39 62.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.732 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -50.61 -50.52 53.94 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.346 0.975 . . . . 0.0 109.535 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -62.62 -44.77 95.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.087 -0.383 . . . . 0.0 110.064 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.15 92.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.417 -0.177 . . . . 0.0 111.017 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -72.09 -21.0 61.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.061 0.944 . . . . 0.0 112.81 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.5 p -110.41 -4.03 15.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.174 0.99 . . . . 0.0 112.117 -169.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -70.78 -11.77 61.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.112 0.965 . . . . 0.0 113.304 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.24 146.53 35.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.867 0.758 . . . . 0.0 109.918 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.8 -171.43 26.46 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.761 1.172 . . . . 0.0 111.949 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.85 133.45 34.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -142.01 116.05 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -81.73 134.2 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.27 139.69 53.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 169.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -132.24 148.65 52.46 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.734 1.614 . . . . 0.0 108.757 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.49 110.83 12.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -169.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.573 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.9 p-90 -129.28 152.55 48.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.562 1.945 . . . . 0.0 107.634 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -171.83 164.05 4.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.783 1.174 . . . . 0.0 111.761 170.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -56.99 -9.38 4.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.461 3.441 . . . . 0.0 117.476 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.525 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 71.3 m95 -48.47 -46.91 38.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.256 1.389 . . . . 0.0 111.889 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.7 m -152.61 165.42 35.28 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.19 -46.3 27.53 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.161 2.315 . . . . 0.0 115.861 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -51.6 -32.37 44.08 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.818 2.809 . . . . 0.0 114.611 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -58.58 -30.18 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 120.266 1.393 . . . . 0.0 112.743 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.91 7.92 45.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.594 1.157 . . . . 0.0 111.838 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.1 mtm -117.67 -44.02 2.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.034 0.934 . . . . 0.0 109.339 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.14 -33.25 55.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.344 1.058 . . . . 0.0 109.4 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.53 -60.46 10.26 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.294 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.25 -39.86 81.0 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.03 1.82 . . . . 0.0 111.47 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.67 -41.42 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.029 0.531 . . . . 0.0 110.586 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 mp -71.15 -38.45 72.23 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 118.907 0.776 . . . . 0.0 110.897 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.28 -34.95 79.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.033 . . . . 0.0 109.9 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -69.86 -30.56 68.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.564 1.146 . . . . 0.0 111.288 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.84 -43.77 64.99 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.582 1.153 . . . . 0.0 110.112 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.59 -37.3 65.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.523 -0.735 . . . . 0.0 110.962 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.86 -14.31 62.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.844 -0.535 . . . . 0.0 111.735 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.12 -49.25 6.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.943 1.297 . . . . 0.0 110.554 -176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.29 16.34 2.78 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.802 0.841 . . . . 0.0 112.115 -169.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.63 2.87 10.07 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.408 -0.808 . . . . 0.0 113.769 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.39 -24.62 61.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.785 1.234 . . . . 0.0 110.593 169.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -19.1 11.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.004 0.921 . . . . 0.0 112.57 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.28 144.91 51.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.687 1.195 . . . . 0.0 110.733 -168.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.45 144.34 30.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -127.19 135.91 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.15 143.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 22.7 mtpp -117.77 156.35 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.441 0.564 . . . . 0.0 110.49 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -126.26 125.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.26 107.7 12.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 169.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.289 33.7 m -82.85 50.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.42 -35.13 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.446 -0.783 . . . . 0.0 111.329 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -103.95 -27.26 12.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.583 1.153 . . . . 0.0 109.777 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.12 25.1 5.24 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.602 1.161 . . . . 0.0 111.634 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.8 -1.79 23.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.687 1.195 . . . . 0.0 112.982 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.55 -46.44 83.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.014 1.326 . . . . 0.0 110.84 -173.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.32 -39.91 70.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.099 0.863 . . . . 0.0 111.422 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.34 -64.29 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -171.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.61 -41.33 9.42 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.166 0.889 . . . . 0.0 114.103 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -62.85 -46.92 85.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.892 1.346 . . . . 0.0 110.534 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -69.79 -33.78 72.84 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.231 0.469 . . . . 0.0 110.457 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.55 68.02 0.81 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -137.28 132.69 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 100.488 -3.893 . . . . 0.0 100.488 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.408 ' HB2' HD12 ' B' ' 67' ' ' ILE . 28.7 mtm -147.83 17.04 1.12 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.079 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.8 p -133.92 162.04 33.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 112.339 -168.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.66 139.33 35.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.253 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.91 135.57 16.88 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 N-CA-C 106.26 -2.246 . . . . 0.0 106.26 -11.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.6 m -103.77 140.41 37.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -117.15 135.48 53.73 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 107.659 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.5 mt -121.15 113.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 169.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.09 124.67 43.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -122.69 155.04 37.23 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.909 0.884 . . . . 0.0 109.546 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.36 141.69 24.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 45.47 30.76 0.78 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.353 1.861 . . . . 0.0 113.56 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.72 9.8 51.65 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 116.428 1.331 . . . . 0.0 116.428 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.79 149.56 47.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.718 1.259 . . . . 0.0 111.502 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.71 138.28 21.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.75 -20.75 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.599 1.16 . . . . 0.0 110.966 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -144.51 153.86 42.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.134 0.879 . . . . 0.0 108.914 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -139.83 137.29 34.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.3 t -151.16 148.84 28.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.0 t -138.82 112.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.32 155.84 6.62 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.93 142.68 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.635 0.718 . . . . 0.0 110.537 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -136.01 140.81 34.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -68.64 167.91 21.46 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.343 2.029 . . . . 0.0 110.357 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -44.24 -49.58 9.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.616 1.966 . . . . 0.0 112.281 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -43.6 70.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.28 0.491 . . . . 0.0 111.445 -174.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.59 87.92 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.958 -0.464 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -54.4 45.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.5 0.72 . . . . 0.0 109.612 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.07 -38.87 92.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.546 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' A' ' 102' ' ' LYS . 35.8 tt0 -61.99 -44.04 97.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.759 0.424 . . . . 0.0 111.506 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.09 -44.3 91.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.147 0.979 . . . . 0.0 110.703 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.71 -36.71 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.1 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.24 -30.72 62.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 112.131 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.411 ' HE2' ' HG2' ' A' ' 98' ' ' GLU . 41.4 mttm -56.56 -26.58 55.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 112.954 175.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -125.82 -16.75 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.122 0.969 . . . . 0.0 112.265 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 126.619 1.968 . . . . 0.0 108.701 169.827 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -58.83 131.59 51.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.776 1.231 . . . . 0.0 111.074 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 m120 71.01 124.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.191 2.996 . . . . 0.0 112.378 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -146.73 143.71 28.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 130.809 3.644 . . . . 0.0 103.604 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mt -123.12 142.38 39.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 120.571 1.532 . . . . 0.0 108.344 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.22 142.27 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -128.88 138.3 51.95 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -110.83 148.59 32.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -142.08 112.17 6.93 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 42.4 p -158.51 149.26 20.34 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.741 0.416 . . . . 0.0 111.187 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -47.8 120.59 3.49 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.347 1.459 . . . . 0.0 111.866 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.425 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 65.19 13.69 58.21 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.477 174.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -7.02 85.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 129.486 3.114 . . . . 0.0 114.926 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -152.53 6.77 0.42 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.368 0.667 . . . . 0.0 111.951 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.44 -93.03 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.869 1.213 . . . . 0.0 111.47 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -24.97 67.61 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.425 -0.797 . . . . 0.0 112.221 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.8 p -61.05 -47.7 85.17 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.519 2.328 . . . . 0.0 112.464 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -64.12 -44.98 90.57 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.796 1.284 . . . . 0.0 108.525 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ttm -59.74 -50.83 72.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.84 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.14 79.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.46 -0.775 . . . . 0.0 111.907 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.64 -26.68 45.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.818 1.19 . . . . 0.0 110.547 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.56 -47.35 69.77 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.494 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 19.4 m95 -54.73 -42.6 71.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 111.319 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.74 72.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -173.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -65.42 -22.26 66.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -69.02 -15.27 63.43 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.312 0.96 . . . . 0.0 113.472 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -130.95 -44.01 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.529 1.059 . . . . 0.0 112.44 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -79.47 73.2 6.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.091 1.756 . . . . 0.0 106.351 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.11 -151.17 0.18 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 127.277 2.37 . . . . 0.0 113.748 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.15 -19.53 63.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.824 1.25 . . . . 0.0 113.399 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.92 -19.49 64.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.2 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -122.39 160.23 25.88 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.378 0.99 . . . . 0.0 111.558 -169.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -133.64 142.18 47.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.852 2.061 . . . . 0.0 105.925 170.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.05 135.01 59.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -142.11 164.51 29.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -146.01 136.37 23.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -169.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 166.75 29.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.481 0.713 . . . . 0.0 111.103 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.06 -172.54 38.73 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 118.018 0.372 . . . . 0.0 113.453 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.425 HG22 ' H ' ' B' ' 12' ' ' GLY . 2.4 tt -49.04 -57.58 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.634 1.974 . . . . 0.0 113.417 -172.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -135.31 28.89 3.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.147 1.779 . . . . 0.0 108.746 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.01 151.76 47.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 79.6 t60 143.34 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 130.444 3.498 . . . . 0.0 105.049 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.19 177.54 48.43 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.823 -0.548 . . . . 0.0 111.779 -172.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -153.05 92.64 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -65.3 127.36 92.83 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.87 -21.55 71.01 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -36.49 81.14 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 120.171 1.35 . . . . 0.0 110.71 172.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.1 -39.17 63.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -57.8 -53.59 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -60.56 -40.96 93.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.899 0.88 . . . . 0.0 110.883 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.19 -37.0 61.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.55 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 68.5 mmm -82.15 -34.38 29.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.225 0.92 . . . . 0.0 111.496 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.96 -23.41 67.4 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.016 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.87 -31.65 66.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.047 1.294 . . . . 0.0 111.624 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.36 14.34 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.045 1.338 . . . . 0.0 111.268 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.23 41.96 98.09 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.938 -0.923 . . . . 0.0 112.556 175.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.81 147.4 20.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -118.6 135.45 54.43 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 pt -137.02 16.3 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.619 1.568 . . . . 0.0 110.611 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -60.47 -10.04 4.45 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -99.0 -14.15 19.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.048 1.739 . . . . 0.0 113.387 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -58.69 161.3 4.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 t -161.77 -175.78 4.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.802 2.041 . . . . 0.0 107.393 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.6 m -145.47 -162.27 1.47 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.599 1.56 . . . . 0.0 109.803 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -160.35 167.72 26.81 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.74 2.416 . . . . 0.0 106.918 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.6 pt -64.95 168.14 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.47 0.708 . . . . 0.0 111.623 173.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 70' ' ' MET . 1.4 pt -47.06 129.2 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 108.816 176.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -137.55 98.55 3.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.897 1.332 . . . . 0.0 109.388 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.0 m -43.87 -32.37 1.07 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.364 2.266 . . . . 0.0 114.045 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.92 -16.57 59.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.164 0.893 . . . . 0.0 112.252 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.04 -37.65 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 117.846 -1.073 . . . . 0.0 109.339 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.09 -55.41 29.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.616 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -23.21 66.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.835 0.289 . . . . 0.0 110.929 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.49 -22.89 28.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.9 2.08 . . . . 0.0 112.814 -175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.05 173.51 1.39 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.985 1.314 . . . . 0.0 111.8 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.17 -24.81 15.55 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.958 0.903 . . . . 0.0 111.614 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' B' ' 97' ' ' LYS . 18.5 tp -151.25 143.03 23.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.977 1.311 . . . . 0.0 109.548 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.59 106.37 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 127.165 2.186 . . . . 0.0 106.66 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.22 99.79 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -66.88 128.83 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 tp -125.51 48.85 1.99 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.916 0.887 . . . . 0.0 111.498 -167.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 107.877 175.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -64.83 18.91 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.699 2.4 . . . . 0.0 116.62 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . 0.415 ' HE3' HG13 ' B' ' 39' ' ' ILE . 60.7 mttt 83.15 18.86 0.24 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 128.744 2.818 . . . . 0.0 112.216 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.2 m 32.9 52.82 0.93 Allowed Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 126.502 1.921 . . . . 0.0 111.67 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.87 132.59 22.05 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.056 2.504 . . . . 0.0 114.409 -168.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.418 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.85 -1.16 56.13 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 116.774 -1.584 . . . . 0.0 114.459 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p 43.49 89.54 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.476 1.51 . . . . 0.0 113.62 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -57.27 137.57 82.26 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.03 2.487 . . . . 0.0 109.714 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.18 10.97 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.892 3.728 . . . . 0.0 116.015 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -67.65 -9.48 43.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.299 1.04 . . . . 0.0 111.844 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.55 153.14 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.71 1.204 . . . . 0.0 110.115 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.482 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.5 tmmm? -72.82 153.7 40.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.35 1.06 . . . . 0.0 109.254 174.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -143.06 144.75 32.39 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.9 150.67 27.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -92.75 137.38 32.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -139.61 39.47 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.389 1.476 . . . . 0.0 108.525 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.29 167.79 29.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -157.77 -15.93 0.08 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.728 1.211 . . . . 0.0 111.575 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.54 168.22 25.61 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.232 2.213 . . . . 0.0 106.448 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -142.72 117.38 6.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.139 0.976 . . . . 0.0 109.075 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.71 -17.91 25.62 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.682 2.921 . . . . 0.0 112.752 -175.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.5 -0.56 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.516 1.053 . . . . 0.0 112.067 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 -123.43 11.23 9.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.59 1.556 . . . . 0.0 111.379 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.95 152.91 0.71 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.133 0.973 . . . . 0.0 111.563 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -35.39 73.77 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.837 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.36 9.13 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -72.92 149.81 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -47.82 -41.6 24.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.583 1.553 . . . . 0.0 111.507 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.61 -40.45 69.79 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.425 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -78.0 -31.55 50.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.907 1.23 . . . . 0.0 109.651 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -63.15 -48.48 78.29 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 119.147 0.885 . . . . 0.0 110.029 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . 0.407 ' CD1' ' CZ ' ' B' ' 120' ' ' PHE . 6.1 t90 -64.92 -46.63 80.85 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.751 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.63 95.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.544 0.738 . . . . 0.0 112.125 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.86 -50.22 71.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' B' ' 117' ' ' TRP 0.251 0.5 OUTLIER -66.51 -40.27 89.1 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.482 -174.66 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -62.2 -49.04 77.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.375 0.989 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -64.96 -48.87 72.49 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.9 -35.12 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.547 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.494 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 6.8 tmm_? -60.11 -44.73 94.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.102 1.319 . . . . 0.0 111.732 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.58 -45.81 84.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.678 0.391 . . . . 0.0 110.923 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.82 -47.58 74.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.776 0.262 . . . . 0.0 110.908 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.8 mt -54.25 -49.89 59.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.415 1.486 . . . . 0.0 109.579 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.21 -42.82 97.76 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.203 -0.776 . . . . 0.0 111.249 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -61.28 -46.19 91.39 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.229 1.015 . . . . 0.0 111.61 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.7 -37.67 85.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.88 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.798 0.726 . . . . 0.0 110.86 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.89 -37.12 83.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.851 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.34 -36.85 78.95 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.581 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -62.11 -41.34 98.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 122.863 2.574 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.27 67.63 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 124.169 0.918 . . . . 0.0 112.356 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.01 -43.92 11.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 111.839 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.8 p -88.49 -17.78 29.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.868 2.067 . . . . 0.0 110.994 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.32 49.82 73.5 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.537 -174.685 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 mtt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.2 149.84 7.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.046 1.338 . . . . 0.0 109.434 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.66 98.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 102.558 -3.127 . . . . 0.0 102.558 168.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.54 165.38 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.924 1.289 . . . . 0.0 107.787 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 122.17 41.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -84.56 172.47 11.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -161.17 -176.32 5.37 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -36.94 -42.01 0.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.875 2.47 . . . . 0.0 115.487 -169.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.33 -29.83 3.21 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.29 1.036 . . . . 0.0 111.533 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m -62.24 -23.28 66.58 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.336 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.15 -54.26 38.36 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.51 1.05 . . . . 0.0 109.051 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -61.46 -45.09 95.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.078 -0.389 . . . . 0.0 109.988 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.73 89.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.309 0.1 . . . . 0.0 111.214 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -74.75 -22.95 58.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.146 0.978 . . . . 0.0 112.557 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 p -106.79 -6.57 17.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.305 0.957 . . . . 0.0 112.691 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -71.65 -10.26 59.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.12 147.36 34.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.087 0.955 . . . . 0.0 109.434 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.81 -175.13 27.6 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.631 1.11 . . . . 0.0 111.959 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 104' ' ' LEU . 22.1 t -93.22 132.79 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 169.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.5 t -141.22 116.71 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -169.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -82.23 127.33 33.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.4 138.73 51.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.963 0.801 . . . . 0.0 108.988 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.26 146.89 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.09 1.356 . . . . 0.0 108.902 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.23 114.29 16.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -169.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.538 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.7 p-90 -132.96 156.14 47.83 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.762 1.625 . . . . 0.0 107.153 -170.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -176.37 167.28 1.51 Allowed Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.471 1.108 . . . . 0.0 110.749 169.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.51 -13.59 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.348 3.366 . . . . 0.0 116.601 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -60.13 -20.57 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.292 1.405 . . . . 0.0 113.648 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.13 152.14 38.8 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.86 1.209 . . . . 0.0 113.235 -171.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.41 -49.24 71.69 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.131 -1.371 . . . . 0.0 112.304 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -50.64 -27.27 19.1 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 115.815 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -58.71 -20.85 52.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 120.48 1.491 . . . . 0.0 113.209 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.62 12.15 27.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.906 1.282 . . . . 0.0 111.42 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -122.15 -43.61 2.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.33 1.052 . . . . 0.0 109.427 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.81 -33.59 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.846 0.858 . . . . 0.0 109.242 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.64 25.14 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 117.942 -1.027 . . . . 0.0 112.471 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.53 -39.41 75.58 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.159 1.906 . . . . 0.0 111.576 174.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 93' ' ' LYS . 3.0 t -55.45 -41.2 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.18 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.7 -43.53 84.09 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.106 0.866 . . . . 0.0 111.151 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.96 -35.41 79.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.795 0.725 . . . . 0.0 109.97 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -68.5 -40.12 81.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.58 1.152 . . . . 0.0 110.692 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.6 -46.05 84.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.734 1.213 . . . . 0.0 110.014 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.0 -40.85 71.61 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.184 -0.323 . . . . 0.0 110.822 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -70.37 -6.9 38.71 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.957 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -102.08 -47.31 4.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.627 1.171 . . . . 0.0 111.092 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.2 ptm -134.76 13.6 3.68 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 112.414 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.67 10.97 4.7 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.204 -0.935 . . . . 0.0 113.638 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.85 -26.17 37.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.497 1.519 . . . . 0.0 109.485 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.67 -24.42 11.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.107 0.963 . . . . 0.0 112.124 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 tp -125.3 148.57 48.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.676 1.59 . . . . 0.0 110.728 -168.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -104.55 144.4 31.74 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mt -127.2 137.68 57.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 4.9 t -139.01 145.11 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -173.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 23.6 mtpt -122.12 157.15 32.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.324 0.511 . . . . 0.0 110.767 175.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mm -125.37 127.35 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -87.97 107.46 18.73 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.835 HG21 HD11 ' A' ' 72' ' ' ILE . 33.2 m -76.29 39.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -146.19 -38.34 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.468 1.107 . . . . 0.0 109.168 168.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.88 -42.19 19.91 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.5 0.72 . . . . 0.0 111.179 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -138.96 36.61 2.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.238 1.018 . . . . 0.0 111.792 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -70.2 -6.49 34.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 113.429 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -50.81 -45.01 59.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.281 1.832 . . . . 0.0 110.796 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.6 m -54.5 -44.74 72.97 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.828 0.851 . . . . 0.0 111.199 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.21 -57.13 4.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.329 1.052 . . . . 0.0 108.996 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.61 -45.86 47.14 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.058 0.837 . . . . 0.0 113.557 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.0 -43.24 99.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.02 0.91 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.72 -33.35 73.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.293 0.497 . . . . 0.0 109.883 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.48 64.99 0.97 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.24 -61.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.252 7.0 ptm 49.44 7.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.815 3.246 . . . . 0.0 115.406 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.4 p -140.68 163.96 31.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 111.987 -172.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.835 HD11 HG21 ' A' ' 57' ' ' VAL . 26.0 mm -142.66 149.64 51.09 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.096 0.959 . . . . 0.0 108.925 -174.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.42 134.47 31.84 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 106.962 -1.976 . . . . 0.0 106.962 -11.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.7 m -112.27 146.74 37.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -131.79 121.47 24.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.4 mt -115.02 112.17 22.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.19 127.21 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -126.33 156.73 39.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.941 0.896 . . . . 0.0 109.587 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -146.66 140.08 25.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.8 t70 44.86 30.41 0.55 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.265 1.826 . . . . 0.0 114.125 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.64 14.69 49.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.835 1.207 . . . . 0.0 115.899 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.51 148.31 52.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.745 1.218 . . . . 0.0 110.803 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.81 134.87 29.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -122.79 -22.41 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.796 1.238 . . . . 0.0 109.799 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -146.68 156.15 42.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.548 1.139 . . . . 0.0 109.477 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 133.59 16.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.2 p -154.12 163.28 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.471 0.653 . . . . 0.0 110.246 172.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.9 113.74 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.54 153.95 6.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.22 142.18 58.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.914 0.486 . . . . 0.0 110.612 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -134.32 140.69 36.63 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -66.84 169.51 14.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.201 1.934 . . . . 0.0 110.109 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HA ' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -48.33 -50.03 31.9 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.595 1.158 . . . . 0.0 111.082 -175.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.81 -43.22 72.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.924 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.19 87.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.061 0.392 . . . . 0.0 110.33 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.8 tp -68.46 -46.99 68.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.928 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.63 -36.24 83.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.69 -47.03 82.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.306 0.503 . . . . 0.0 110.713 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.2 -39.13 78.16 Favored 'General case' 0 N--CA 1.459 -0.015 0 C-N-CA 123.659 0.783 . . . . 0.0 111.512 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -81.61 -41.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.795 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -54.39 -31.87 55.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.594 1.158 . . . . 0.0 112.177 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -56.23 -24.73 44.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.478 1.111 . . . . 0.0 113.218 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -128.83 -16.55 4.15 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.078 0.951 . . . . 0.0 112.518 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HA ' HG21 ' A' ' 19' ' ' VAL . 16.7 tp . . . . . 0 C--O 1.248 1.025 0 C-N-CA 127.176 2.19 . . . . 0.0 108.812 169.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.6 86.92 2.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 m120 74.72 130.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.016 2.926 . . . . 0.0 112.103 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.454 ' HE3' ' CZ3' ' B' ' 32' ' ' TRP . 37.2 mtmt -127.69 122.98 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 128.846 2.858 . . . . 0.0 103.363 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mt -90.54 142.97 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 110.353 -167.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.43 150.23 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.703 1.601 . . . . 0.0 107.225 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.56 157.37 45.92 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.16 0.584 . . . . 0.0 111.831 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -116.63 142.79 46.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.946 1.299 . . . . 0.0 107.593 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 23.7 mt -126.21 125.7 42.85 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 71.8 m -155.17 135.05 12.84 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.321 1.848 . . . . 0.0 109.133 -169.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.2 m -51.33 118.58 3.37 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.802 1.241 . . . . 0.0 110.927 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.97 4.68 11.78 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.701 -1.055 . . . . 0.0 113.737 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 3.1 t30 33.26 40.05 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.246 2.619 . . . . 0.0 113.74 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -81.75 -40.63 22.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.711 0.804 . . . . 0.0 111.126 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.38 -55.69 0.9 Allowed 'General case' 0 CA--C 1.526 0.058 0 C-N-CA 123.471 0.709 . . . . 0.0 112.707 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -49.89 -60.47 2.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.306 1.042 . . . . 0.0 110.184 -169.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -73.18 -28.43 62.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.602 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -54.86 -46.97 74.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -43.93 67.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.103 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.92 89.12 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 118.82 0.737 . . . . 0.0 112.374 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.65 -32.03 69.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.896 0.771 . . . . 0.0 110.582 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.67 -51.2 53.94 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -56.72 -32.91 65.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.88 1.272 . . . . 0.0 112.278 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.2 -53.82 7.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 111.079 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.54 -26.73 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -62.62 -17.57 60.55 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 173.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.4 -10.15 5.17 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.78 1.232 . . . . 0.0 113.011 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -124.69 81.54 1.96 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -163.23 3.01 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.063 1.792 . . . . 0.0 112.585 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.99 -9.91 18.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.915 1.286 . . . . 0.0 113.641 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -61.17 -22.53 64.82 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.903 -1.123 . . . . 0.0 109.745 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . 0.454 ' CZ3' ' HE3' ' B' ' 4' ' ' LYS . 30.9 m95 -126.7 177.37 6.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.363 2.265 . . . . 0.0 108.46 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -157.26 130.55 7.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.73 142.42 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.58 169.76 16.99 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.048 1.739 . . . . 0.0 108.21 -174.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 98.5 p -150.13 149.79 30.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.74 174.09 15.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.459 0.704 . . . . 0.0 111.313 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.98 -177.66 41.01 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.535 -0.302 . . . . 0.0 113.119 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.445 HG13 ' HE3' ' B' ' 88' ' ' LYS . 3.0 tt -43.97 -58.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.315 2.246 . . . . 0.0 114.228 -173.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -134.37 30.09 3.57 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.308 1.843 . . . . 0.0 108.191 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.37 137.01 55.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.355 1.862 . . . . 0.0 114.571 -169.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 172.14 114.4 0.01 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 130.377 3.471 . . . . 0.0 102.412 169.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.18 -179.72 43.61 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 118.875 0.761 . . . . 0.0 112.214 -174.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.5 tp -164.07 93.07 0.69 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 169.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -64.61 125.9 89.66 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.08 -21.14 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.036 1.824 . . . . 0.0 112.715 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.41 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -61.51 -37.41 83.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.273 0.942 . . . . 0.0 111.143 171.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.16 61.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t -57.22 -50.93 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.55 -44.77 85.45 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.561 0.619 . . . . 0.0 110.496 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.36 -22.81 45.07 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.96 0.904 . . . . 0.0 112.694 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 77.8 mmm -102.65 -34.13 9.18 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.365 0.984 . . . . 0.0 112.301 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -60.22 -27.9 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.172 0.896 . . . . 0.0 110.092 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.73 -33.04 32.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.755 1.622 . . . . 0.0 112.383 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.89 17.39 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.299 1.44 . . . . 0.0 110.796 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.27 37.95 93.33 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.935 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 47.4 mt -115.94 107.32 22.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 172.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -73.22 132.65 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 30.8 pt -135.81 19.05 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.991 1.316 . . . . 0.0 110.823 173.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -59.76 -15.64 21.74 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.837 0.744 . . . . 0.0 111.963 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -83.97 -15.29 48.35 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.7 2.4 . . . . 0.0 114.345 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -69.9 159.55 33.47 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.742 1.156 . . . . 0.0 112.762 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 66.8 p -139.64 -169.78 2.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.125 2.57 . . . . 0.0 108.806 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 p -157.86 -173.43 4.36 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.101 0.961 . . . . 0.0 108.708 169.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -166.44 159.25 14.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 127.491 2.316 . . . . 0.0 108.017 -170.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.64 166.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.05 0.94 . . . . 0.0 111.888 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -50.07 133.28 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -142.85 98.79 3.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.237 1.017 . . . . 0.0 109.161 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.6 m -44.49 -32.43 1.4 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.827 2.051 . . . . 0.0 113.773 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.92 -17.65 63.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.383 0.992 . . . . 0.0 112.648 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -126.93 -34.01 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.811 0.844 . . . . 0.0 108.852 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.25 -54.18 23.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.603 1.092 . . . . 0.0 110.172 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -23.93 67.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.986 0.812 . . . . 0.0 110.416 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.91 -23.02 55.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.806 1.642 . . . . 0.0 112.138 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.94 165.69 3.11 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.763 1.225 . . . . 0.0 111.8 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.15 -29.32 15.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.036 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -145.26 133.91 22.16 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.156 0.982 . . . . 0.0 110.996 -173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.438 HG23 HG11 ' B' ' 96' ' ' VAL . 20.6 t -107.55 116.33 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.074 1.75 . . . . 0.0 108.227 170.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.38 109.33 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -76.17 123.32 25.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 167.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 tp -116.32 39.09 3.2 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.732 -0.605 . . . . 0.0 109.489 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.448 -0.574 0 C-N-CA 123.369 0.668 . . . . 0.0 111.644 -168.797 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.15 38.17 0.05 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.67 1.988 . . . . 0.0 115.055 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . 0.445 ' HE3' HG13 ' B' ' 39' ' ' ILE . 14.1 mttt 64.37 21.94 12.62 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.642 -1.911 . . . . 0.0 111.742 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p 30.41 62.38 0.96 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 127.504 2.322 . . . . 0.0 112.049 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.36 132.18 49.29 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.791 2.327 . . . . 0.0 111.066 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.6 3.18 55.64 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p 43.2 92.22 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.009 2.524 . . . . 0.0 113.698 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -61.71 147.51 95.16 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.013 1.809 . . . . 0.0 109.942 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.4 -2.52 6.16 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.915 3.743 . . . . 0.0 115.348 -169.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -62.58 -10.03 10.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.6 1.16 . . . . 0.0 112.154 170.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.438 HG11 HG23 ' B' ' 78' ' ' VAL . 2.1 t -137.52 143.95 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.842 1.257 . . . . 0.0 109.525 -169.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -76.04 155.46 34.86 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -139.98 142.61 36.31 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.833 -1.167 . . . . 0.0 108.993 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -145.45 159.28 43.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 169.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -106.74 128.72 54.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -119.16 8.73 11.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.583 1.153 . . . . 0.0 110.501 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.58 162.38 24.62 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -157.81 24.63 0.27 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.776 1.23 . . . . 0.0 109.422 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.35 172.62 18.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.407 1.883 . . . . 0.0 106.642 -171.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -148.25 116.14 4.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.57 1.148 . . . . 0.0 108.737 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.24 -28.51 22.86 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.13 2.553 . . . . 0.0 111.917 -171.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.79 -3.28 3.16 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.448 1.099 . . . . 0.0 112.755 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -97.05 5.74 49.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.249 1.02 . . . . 0.0 111.673 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.75 142.9 3.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.778 0.831 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -55.24 -45.95 76.04 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.474 0.71 . . . . 0.0 109.914 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.32 -15.11 4.22 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.8 p -69.22 162.37 27.27 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.74 -39.08 90.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.473 0.654 . . . . 0.0 110.534 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.04 -41.43 82.1 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 116.983 -1.484 . . . . 0.0 109.05 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.85 -31.46 59.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 120.851 1.66 . . . . 0.0 109.607 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -57.12 -62.91 1.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -59.44 -39.99 85.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.03 95.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.608 0.763 . . . . 0.0 112.305 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -63.17 -48.27 79.1 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 118.583 0.628 . . . . 0.0 109.474 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.5 m-30 -65.89 -40.46 91.59 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -65.85 -46.69 77.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.265 1.026 . . . . 0.0 110.297 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -60.23 -49.52 77.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.21 -46.76 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.018 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -62.59 -39.62 94.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.154 1.343 . . . . 0.0 111.347 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.26 -43.87 96.74 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.212 0.32 . . . . 0.0 110.615 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.66 -55.36 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.128 0.571 . . . . 0.0 109.641 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.1 mt -54.86 -52.45 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.309 1.044 . . . . 0.0 109.416 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.98 97.84 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.817 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -61.38 -47.15 87.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.42 1.11 . . . . 0.0 111.409 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -65.81 -41.11 92.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.466 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.46 -37.86 83.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.771 0.714 . . . . 0.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -62.92 -47.13 84.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.588 0.631 . . . . 0.0 109.731 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.05 -36.11 82.49 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.253 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.62 -40.94 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 121.543 1.974 . . . . 0.0 110.735 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.64 71.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.27 0.628 . . . . 0.0 112.629 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.99 -37.05 13.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 111.636 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 51.4 p -100.3 -14.13 18.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.72 1.608 . . . . 0.0 111.546 -169.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.98 48.37 86.62 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.108 0.563 . . . . 0.0 111.876 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.08 169.66 21.99 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.334 1.453 . . . . 0.0 107.778 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.29 93.65 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 169.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.01 170.71 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.473 1.909 . . . . 0.0 107.804 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -129.24 130.84 46.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.846 0.858 . . . . 0.0 108.757 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.55 176.94 6.37 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.411 1.884 . . . . 0.0 110.375 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -152.03 -176.73 5.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.043 1.737 . . . . 0.0 106.692 169.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -38.67 -37.6 0.34 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.774 2.83 . . . . 0.0 116.067 -169.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -128.81 -30.6 2.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.301 1.04 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.8 m -61.49 -20.89 63.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.422 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -49.47 -53.33 23.69 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -64.2 -45.04 90.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.09 77.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.397 -0.189 . . . . 0.0 111.369 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.37 -14.03 59.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.723 1.209 . . . . 0.0 112.494 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 p -120.79 -6.38 9.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.66 1.118 . . . . 0.0 113.474 -169.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.1 m -78.11 -0.77 29.43 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.382 -0.824 . . . . 0.0 113.11 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.86 145.51 36.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.16 0.984 . . . . 0.0 108.935 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.99 -170.86 54.68 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.893 0.759 . . . . 0.0 111.752 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.99 116.47 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.1 t -133.18 118.98 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.09 137.61 32.2 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.9 144.8 47.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -139.3 144.48 38.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 108.275 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.48 111.52 15.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.441 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.3 p-90 -131.52 154.16 49.06 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.926 1.69 . . . . 0.0 108.153 -169.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.89 163.14 7.88 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.896 0.771 . . . . 0.0 110.07 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -54.02 -14.02 5.45 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.981 3.121 . . . . 0.0 116.272 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -60.8 -24.32 65.74 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.836 1.198 . . . . 0.0 113.84 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.22 155.8 47.53 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.523 1.056 . . . . 0.0 112.335 -169.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.65 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.166 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.26 -27.41 23.05 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.347 2.698 . . . . 0.0 115.139 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m -57.83 -20.47 36.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 120.108 1.322 . . . . 0.0 113.324 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 11.33 22.71 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.404 1.082 . . . . 0.0 111.352 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.9 mtm -122.34 -43.65 2.29 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.09 -37.92 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.11 -58.55 14.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.203 -0.904 . . . . 0.0 112.332 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.75 -39.22 75.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.111 1.874 . . . . 0.0 111.919 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' A' ' 93' ' ' LYS . 2.2 t -57.01 -39.98 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.781 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.97 -42.82 80.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.989 0.813 . . . . 0.0 110.491 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.9 -36.88 85.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.558 0.617 . . . . 0.0 110.009 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.66 -36.91 81.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.301 -0.874 . . . . 0.0 110.642 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.93 -44.61 92.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.426 1.09 . . . . 0.0 110.231 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.66 -34.74 72.35 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.565 -0.71 . . . . 0.0 111.425 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.14 -27.02 68.64 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.451 -0.78 . . . . 0.0 111.657 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -90.29 -42.99 10.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.641 1.176 . . . . 0.0 111.291 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.1 ptm -144.2 18.98 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.704 0.802 . . . . 0.0 112.126 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.15 -7.0 15.27 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.311 -0.868 . . . . 0.0 114.309 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.35 -22.78 67.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.711 0.804 . . . . 0.0 111.054 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 -10.66 7.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.852 1.261 . . . . 0.0 112.779 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.9 tp -127.48 150.53 49.62 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.497 1.119 . . . . 0.0 112.092 -168.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -124.27 150.03 45.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.38 143.0 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.1 121.43 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.79 0.723 . . . . 0.0 109.215 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.9 mmmm -85.91 155.54 20.88 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mm -128.22 116.13 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 101.759 -3.422 . . . . 0.0 101.759 168.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.29 107.7 9.88 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.315 33.2 m -79.6 48.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -154.87 -45.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.34 1.456 . . . . 0.0 108.527 167.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.3 -35.84 30.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.175 0.99 . . . . 0.0 110.91 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -133.89 30.27 3.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.625 1.57 . . . . 0.0 110.514 -169.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -73.73 -5.84 43.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -56.05 -45.78 79.14 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.3 1.44 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.9 m -54.85 -42.62 72.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.335 0.654 . . . . 0.0 110.755 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.21 0.73 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.13 -44.2 14.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.103 0.858 . . . . 0.0 113.411 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.93 -44.99 87.67 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.265 1.033 . . . . 0.0 111.442 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -69.53 -26.71 64.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.743 0.701 . . . . 0.0 110.369 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.81 65.98 0.83 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.86 130.59 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 101.189 -3.634 . . . . 0.0 101.189 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.475 ' CE ' HD13 ' B' ' 72' ' ' LEU . 29.8 mtm -148.78 21.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -138.96 163.08 33.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.814 1.245 . . . . 0.0 113.603 -167.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.17 135.57 27.4 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.266 -0.874 . . . . 0.0 109.497 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -85.98 125.05 8.53 Favored 'Cis proline' 0 N--CA 1.45 -1.042 0 N-CA-C 106.001 -2.346 . . . . 0.0 106.001 -11.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.0 m -88.9 148.14 23.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.26 119.69 10.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.9 mt -118.2 109.63 16.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.86 138.42 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.24 157.09 41.84 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.419 1.088 . . . . 0.0 111.251 -172.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -138.11 127.75 25.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.71 1.204 . . . . 0.0 107.79 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 36.48 37.99 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.252 2.621 . . . . 0.0 115.507 168.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.94 -30.67 2.35 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.44 158.9 44.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -165.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.43 134.88 28.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.393 1.077 . . . . 0.0 108.721 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -122.42 -24.88 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.837 1.655 . . . . 0.0 111.321 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -144.78 153.35 41.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.95 146.96 33.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.6 m -155.1 153.82 31.45 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.519 1.128 . . . . 0.0 108.631 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.68 69.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.01 159.46 15.93 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 121.717 -0.614 . . . . 0.0 111.779 -173.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.48 145.5 56.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.275 0.63 . . . . 0.0 110.906 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.51 141.31 35.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.031 1.332 . . . . 0.0 107.744 170.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.31 169.46 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.589 2.193 . . . . 0.0 110.558 169.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HA ' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -53.7 -45.01 70.27 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.416 1.086 . . . . 0.0 111.971 -173.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.27 -41.97 84.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.201 0.201 . . . . 0.0 110.693 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.73 76.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.093 -0.38 . . . . 0.0 110.843 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -52.89 57.47 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.454 0.645 . . . . 0.0 109.895 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -62.83 -36.99 85.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.82 -46.7 88.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.729 0.695 . . . . 0.0 111.428 173.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.85 -28.82 62.21 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.829 1.252 . . . . 0.0 111.912 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.2 -42.13 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -57.34 -27.96 62.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.047 -1.033 . . . . 0.0 112.103 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -59.57 -22.54 61.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.57 -16.37 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 169.212 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.98 21.34 0.43 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -169.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.15 128.78 8.54 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 103.857 -2.645 . . . . 0.0 103.857 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -148.39 144.43 27.48 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 130.254 3.421 . . . . 0.0 104.605 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 mt -122.27 142.02 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -141.19 140.95 31.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -121.93 139.91 53.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -169.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -121.96 132.9 54.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -138.9 116.84 11.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.661 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.32 150.26 43.77 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.106 0.963 . . . . 0.0 111.005 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 83.9 m -45.05 106.28 0.07 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.843 1.657 . . . . 0.0 111.352 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.442 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 53.33 39.33 58.87 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.106 1.336 . . . . 0.0 111.188 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -39.09 125.41 1.56 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 38.9 p -141.64 -3.53 1.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.175 168.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.01 -80.42 0.38 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.29 1.036 . . . . 0.0 113.06 -169.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -52.43 -42.74 64.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.565 1.53 . . . . 0.0 113.062 -169.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -76.05 -25.14 55.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.665 1.121 . . . . 0.0 111.948 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.423 HE22 ' C ' ' B' ' 63' ' ' THR . 52.5 mm-40 -62.0 -47.66 83.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.708 1.14 . . . . 0.0 109.588 169.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.1 mtp -66.91 -43.99 81.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.97 93.71 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.705 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.0 -33.68 75.08 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.756 1.162 . . . . 0.0 110.96 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.61 -49.08 58.24 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.44 -41.04 75.77 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.182 0.993 . . . . 0.0 111.233 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.94 87.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -66.19 -19.85 65.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.461 -169.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -78.09 -16.26 58.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.608 1.094 . . . . 0.0 113.505 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.23 -16.42 3.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.86 -116.52 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.73 -167.93 38.07 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 119.161 0.892 . . . . 0.0 110.928 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.54 -20.71 63.55 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.219 1.008 . . . . 0.0 111.348 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -54.28 -24.3 18.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.133 2.173 . . . . 0.0 112.546 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -123.72 156.85 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.355 1.062 . . . . 0.0 110.708 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -125.84 139.56 53.39 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.98 140.25 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.58 157.53 46.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.531 0.732 . . . . 0.0 109.901 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 10.0 p -135.24 131.78 37.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.185 1.394 . . . . 0.0 109.194 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.31 173.75 14.12 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.43 -175.85 46.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.006 1.765 . . . . 0.0 110.405 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.442 HG22 ' H ' ' B' ' 12' ' ' GLY . 3.0 tt -52.43 -53.64 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.83 25.9 4.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.564 1.546 . . . . 0.0 109.078 -174.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.63 147.37 49.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.396 1.879 . . . . 0.0 112.245 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 29.7 p80 174.02 -17.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.579 2.352 . . . . 0.0 110.885 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.26 53.65 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-O 121.871 0.706 . . . . 0.0 113.018 -169.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.78 86.64 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 170.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -59.21 132.97 87.77 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.22 -22.52 57.43 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.757 1.638 . . . . 0.0 112.428 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -56.07 -56.08 25.2 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.4 75.06 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.288 0.949 . . . . 0.0 110.423 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.89 -55.56 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -56.64 -45.93 81.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 110.852 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.85 66.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.97 2.108 . . . . 0.0 111.331 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.3 mmm -89.03 -31.95 17.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.284 0.634 . . . . 0.0 110.27 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -61.63 -25.86 67.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.926 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.68 -27.99 66.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.171 1.351 . . . . 0.0 111.409 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.66 15.61 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.014 1.326 . . . . 0.0 110.971 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.39 93.38 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.693 -1.059 . . . . 0.0 112.964 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 82.1 mt -113.9 109.18 27.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.99 138.44 52.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 pt -134.82 16.07 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.856 0.862 . . . . 0.0 111.309 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 m -60.91 -13.79 18.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.246 0.93 . . . . 0.0 113.187 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -94.08 -13.98 26.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.9 1.68 . . . . 0.0 113.097 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.09 166.49 11.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.549 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.423 ' C ' HE22 ' B' ' 18' ' ' GLN . 13.9 t -156.25 -179.17 7.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.5 1.92 . . . . 0.0 107.458 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 64.0 m -143.41 -174.41 4.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.74 1.616 . . . . 0.0 107.675 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -150.98 171.47 17.23 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.022 1.329 . . . . 0.0 107.596 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.9 pt -62.66 170.71 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.071 0.851 . . . . 0.0 110.821 170.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.81 132.16 6.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -141.95 98.01 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.241 1.019 . . . . 0.0 108.419 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.8 m -47.15 -28.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.544 1.938 . . . . 0.0 114.451 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.08 -22.02 61.42 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 119.496 1.044 . . . . 0.0 110.515 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -40.57 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.693 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.475 HD13 ' CE ' ' A' ' 70' ' ' MET . 7.1 tt -61.57 -54.48 42.45 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.741 1.155 . . . . 0.0 109.47 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -22.89 67.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.025 0.829 . . . . 0.0 111.69 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.4 -12.58 54.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.738 1.215 . . . . 0.0 113.132 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.85 167.01 12.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.278 0.945 . . . . 0.0 110.544 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.38 -35.35 16.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.733 169.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.538 HD13 ' HD2' ' B' ' 97' ' ' LYS . 23.5 tp -146.38 136.05 23.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.113 1.365 . . . . 0.0 109.814 -172.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.454 HG21 HD21 ' B' ' 72' ' ' LEU . 16.0 t -105.06 105.22 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.5 109.4 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -68.49 132.12 46.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 39.1 mt -118.94 151.03 38.9 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.319 -0.723 0 C-N-CA 128.837 2.855 . . . . 0.0 111.623 174.466 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -85.13 18.72 2.45 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.872 -1.143 . . . . 0.0 113.795 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.305 0.2 OUTLIER 53.32 35.21 19.65 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.102 1.761 . . . . 0.0 113.49 -169.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 37.36 52.6 2.66 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.642 2.377 . . . . 0.0 114.212 172.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.49 130.69 37.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.211 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.41 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.87 0.48 50.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 116.636 -1.649 . . . . 0.0 115.14 -175.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.9 p 46.43 89.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.948 1.299 . . . . 0.0 113.436 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.98 143.48 92.33 Favored 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 123.132 2.554 . . . . 0.0 110.424 -169.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.19 4.23 0.79 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.092 3.861 . . . . 0.0 116.21 -169.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -67.8 -7.41 27.49 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.397 -0.814 . . . . 0.0 111.941 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -135.84 150.12 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.085 0.954 . . . . 0.0 111.055 -168.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.538 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.0 tmmm? -75.58 158.07 32.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -143.63 147.06 33.78 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.74 -1.225 . . . . 0.0 109.17 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.39 151.4 30.77 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -100.45 131.86 46.14 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.207 1.003 . . . . 0.0 109.627 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -115.88 10.75 15.34 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.04 0.936 . . . . 0.0 111.372 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.57 162.42 35.93 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 121.299 -0.876 . . . . 0.0 111.784 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -144.45 34.76 1.18 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.51 2.324 . . . . 0.0 107.985 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.15 139.27 20.14 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.035 2.134 . . . . 0.0 105.76 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -136.68 125.3 15.15 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 120.072 1.305 . . . . 0.0 111.216 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -82.9 -22.63 4.18 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.566 2.844 . . . . 0.0 113.684 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.77 63.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 118.44 0.564 . . . . 0.0 109.826 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -92.62 -64.61 1.08 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' B' ' 119' ' ' PHE . . . 46.6 -176.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.147 1.779 . . . . 0.0 114.451 -170.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -40.04 77.08 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.09 -20.41 5.05 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.2 p -70.65 166.7 20.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.632 0.716 . . . . 0.0 109.396 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -41.63 90.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.266 0.555 . . . . 0.0 110.937 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.12 -41.18 62.01 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.668 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.27 -31.85 58.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.569 1.531 . . . . 0.0 109.895 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -58.08 -58.4 8.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -58.98 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.276 0.489 . . . . 0.0 110.605 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.19 97.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.237 -0.914 . . . . 0.0 111.632 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 6.9 m-85 -66.57 -41.0 89.24 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.446 -0.787 . . . . 0.0 109.905 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -54.99 -52.91 61.65 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.289 0.95 . . . . 0.0 109.138 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -67.32 -45.82 75.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.74 0.816 . . . . 0.0 111.004 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttp-105 -62.07 -45.64 92.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.64 -43.19 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.741 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -64.45 -35.43 80.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.32 1.418 . . . . 0.0 111.009 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.46 -45.04 92.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.963 0.347 . . . . 0.0 111.424 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.45 -50.7 72.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.643 0.777 . . . . 0.0 110.195 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.7 -52.66 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.782 1.233 . . . . 0.0 109.342 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.05 -41.84 98.38 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 118.971 -0.905 . . . . 0.0 111.721 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -59.3 -46.53 88.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.297 1.049 . . . . 0.0 110.865 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -66.48 -37.87 86.06 Favored 'General case' 0 C--N 1.335 -0.049 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.499 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' B' ' 131' ' ' LEU . 2.4 mm? -64.67 -42.44 95.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.892 1.224 . . . . 0.0 110.912 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.53 -43.78 88.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.335 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.27 -40.06 89.04 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 117.361 -1.304 . . . . 0.0 110.654 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.35 -39.43 87.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 121.893 2.133 . . . . 0.0 111.29 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.73 70.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.153 0.581 . . . . 0.0 112.248 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.03 -44.73 9.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.581 1.552 . . . . 0.0 111.319 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.3 p -88.39 -24.39 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.291 1.836 . . . . 0.0 110.632 -169.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 49.11 51.14 26.27 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -169.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 125.246 1.418 . . . . 0.0 112.379 -172.65 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.37 161.14 0.08 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.496 2.318 . . . . 0.0 112.842 -170.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.5 109.6 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.4 t -80.86 167.15 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.827 1.651 . . . . 0.0 107.71 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -125.7 118.18 25.07 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.143 0.977 . . . . 0.0 108.411 170.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.461 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -75.98 174.0 10.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.299 1.439 . . . . 0.0 110.015 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -156.3 -175.87 5.66 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.306 1.442 . . . . 0.0 107.51 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -31.45 -40.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 130.794 3.638 . . . . 0.0 117.101 -169.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.23 -29.58 2.02 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.841 1.256 . . . . 0.0 111.033 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -59.23 -22.56 61.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.731 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -48.58 -51.77 26.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.164 1.347 . . . . 0.0 110.521 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 m -64.89 -45.01 87.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.23 0.468 . . . . 0.0 109.83 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.44 -36.73 83.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.34 -0.225 . . . . 0.0 110.884 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -76.77 -13.83 59.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.722 1.209 . . . . 0.0 112.471 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.5 p -119.8 -2.81 10.31 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.66 1.118 . . . . 0.0 112.504 -170.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.3 m -71.73 -10.89 60.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.18 147.66 38.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.562 0.745 . . . . 0.0 109.809 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.93 -167.56 45.59 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.49 1.043 . . . . 0.0 111.611 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 104' ' ' LEU . 28.5 t -102.58 122.25 54.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.03 115.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -81.07 140.5 35.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.0 44.18 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -141.6 148.2 38.86 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 109.001 -171.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -130.64 115.23 16.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.55 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.5 p-90 -133.7 156.15 48.46 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.603 1.561 . . . . 0.0 107.455 -171.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -176.2 167.88 1.5 Allowed Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.118 0.967 . . . . 0.0 110.905 169.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.05 -18.0 2.82 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.205 3.27 . . . . 0.0 116.407 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -57.77 -21.89 44.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.333 1.424 . . . . 0.0 114.174 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.73 158.08 44.25 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.672 1.124 . . . . 0.0 112.602 -171.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.6 -49.78 28.79 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.212 -1.327 . . . . 0.0 111.896 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -49.2 -27.29 12.47 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.819 3.013 . . . . 0.0 115.762 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.55 -23.23 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.45 1.477 . . . . 0.0 113.409 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -105.71 9.88 32.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.097 0.959 . . . . 0.0 112.035 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.6 mtm -120.46 -42.35 2.55 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.09 0.956 . . . . 0.0 109.586 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.98 -38.01 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.75 -58.65 13.37 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.187 -0.911 . . . . 0.0 112.259 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.01 -39.72 68.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 111.856 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.32 -41.9 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.231 0.469 . . . . 0.0 110.578 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.09 -42.52 80.24 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.554 0.615 . . . . 0.0 110.573 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.95 -39.81 94.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.733 0.697 . . . . 0.0 109.669 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -68.52 -24.21 64.63 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.102 -0.999 . . . . 0.0 112.11 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.444 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 42.0 tp -77.79 -45.61 23.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.648 1.179 . . . . 0.0 109.837 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HB2' HD12 ' A' ' 52' ' ' ILE . 25.3 t70 -69.77 -34.83 74.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.293 0.497 . . . . 0.0 110.964 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -59.36 -26.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 172.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -96.61 -46.33 6.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.173 0.589 . . . . 0.0 111.433 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.6 ptm -134.49 15.44 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 112.228 -169.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.04 16.9 Favored Glycine 0 CA--C 1.52 0.382 0 O-C-N 121.19 -0.944 . . . . 0.0 114.212 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.83 -24.08 64.33 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.836 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -25.92 7.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.59 1.156 . . . . 0.0 111.494 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.0 tp -112.62 151.67 29.83 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.324 1.45 . . . . 0.0 110.584 -169.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.77 148.53 46.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 43' ' ' ASP . 75.1 mt -131.66 137.09 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 14.3 t -137.17 113.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.4 mtpt -88.36 162.43 16.56 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.126 -0.984 . . . . 0.0 110.182 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -131.12 124.5 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -84.32 109.43 17.81 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.848 HG21 HD11 ' A' ' 72' ' ' ILE . 32.5 m -79.7 39.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -145.46 -37.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 168.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -74.89 -52.02 12.37 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.919 1.288 . . . . 0.0 109.842 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.14 46.68 1.93 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.364 1.066 . . . . 0.0 111.235 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.4 ' CD ' ' HD3' ' B' ' 94' ' ' PRO . 10.7 pt20 -72.12 -3.05 20.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.899 1.28 . . . . 0.0 113.138 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -56.38 -42.76 78.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.026 1.33 . . . . 0.0 110.894 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -54.53 -43.22 71.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.021 0.828 . . . . 0.0 111.371 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.96 -57.77 4.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.92 -43.0 39.4 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.908 0.766 . . . . 0.0 113.593 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -64.56 -42.11 95.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.506 1.153 . . . . 0.0 111.115 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -70.17 -30.69 67.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.371 0.532 . . . . 0.0 110.146 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.34 67.5 1.2 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -171.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.28 -62.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.496 ' HG3' HD12 ' B' ' 67' ' ' ILE 0.265 6.7 ptm 49.28 10.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.135 2.974 . . . . 0.0 115.183 178.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.8 p -140.89 162.98 34.17 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.565 1.546 . . . . 0.0 112.598 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.848 HD11 HG21 ' A' ' 57' ' ' VAL . 28.6 mm -142.7 148.3 45.8 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.162 0.985 . . . . 0.0 108.682 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -78.17 137.91 48.6 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 N-CA-C 106.477 -2.163 . . . . 0.0 106.477 -11.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -115.16 147.17 40.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -130.38 124.21 31.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.7 mt -121.56 112.48 18.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.2 t -104.75 128.49 58.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.31 156.9 41.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.239 1.016 . . . . 0.0 110.367 -169.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -146.02 139.25 25.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.73 29.57 0.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.318 1.847 . . . . 0.0 113.509 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.84 54.84 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.665 1.233 . . . . 0.0 111.21 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.76 138.14 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.95 -18.54 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.304 1.441 . . . . 0.0 111.241 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -141.05 157.36 45.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.227 0.922 . . . . 0.0 110.25 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.37 142.22 22.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 m -155.09 151.69 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.95 88.37 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 169.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.48 158.79 11.43 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -67.5 149.88 49.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.99 0.516 . . . . 0.0 110.501 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.88 135.8 14.76 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.69 169.19 16.51 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.315 2.01 . . . . 0.0 110.412 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -45.72 -48.22 15.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.894 1.678 . . . . 0.0 112.348 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.93 -43.66 71.21 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.259 0.481 . . . . 0.0 111.275 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.54 97.15 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.124 -0.36 . . . . 0.0 110.332 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -52.15 66.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.258 0.623 . . . . 0.0 109.711 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.53 -39.83 94.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.631 -0.699 . . . . 0.0 109.413 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.65 -45.77 92.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.807 0.73 . . . . 0.0 110.964 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.8 -37.55 76.6 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 125.277 1.431 . . . . 0.0 111.233 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.34 -37.09 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.824 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -57.98 -33.73 69.22 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.641 1.11 . . . . 0.0 111.374 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.41 -7.44 37.66 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -125.62 -23.55 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.867 1.267 . . . . 0.0 112.481 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.435 ' HA ' HG21 ' A' ' 19' ' ' VAL . 18.5 tp . . . . . 0 C--O 1.248 1.014 0 C-N-CA 127.168 2.187 . . . . 0.0 108.847 170.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -141.43 161.07 38.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.874 0.87 . . . . 0.0 109.658 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.27 28.5 m120 65.32 117.73 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 129.906 3.283 . . . . 0.0 113.567 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -153.94 137.22 15.72 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.99 3.316 . . . . 0.0 103.402 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -114.19 141.48 30.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -169.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.49 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.9 152.8 49.83 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.881 0.872 . . . . 0.0 110.429 -169.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -119.75 135.17 54.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.7 tp -128.99 119.01 23.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -144.35 163.26 34.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 0.0 111.186 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.456 ' HG1' ' N ' ' B' ' 86' ' ' ALA . 14.7 m -61.33 134.3 56.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.469 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 53.93 5.19 0.37 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.357 2.408 . . . . 0.0 118.587 169.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.319 1.9 t-20 12.98 71.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.424 2.69 . . . . 0.0 112.57 -169.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.5 p -135.33 -27.07 1.23 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.094 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.37 -68.0 0.78 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.332 0.969 . . . . 0.0 112.225 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.47 HH21 ' HB3' ' B' ' 107' ' ' ALA . 0.0 OUTLIER -46.34 -55.86 6.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.478 0.581 . . . . 0.0 112.176 -169.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -37.42 81.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.891 -171.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -53.88 -43.88 69.97 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.075 1.35 . . . . 0.0 109.837 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 10.5 mtp -70.04 -49.21 53.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 -40.51 96.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.888 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.87 -33.94 72.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.529 1.059 . . . . 0.0 110.775 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.01 71.5 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -55.85 -39.7 71.82 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.046 0.938 . . . . 0.0 111.394 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.62 75.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -174.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -23.99 67.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.402 -169.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.52 -18.16 60.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.02 -23.12 4.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.884 0.766 . . . . 0.0 112.697 -174.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.6 mt -83.19 -113.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.69 -170.33 36.59 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.93 -17.69 57.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.837 0.855 . . . . 0.0 111.615 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -56.17 -23.55 35.73 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.42 1.888 . . . . 0.0 111.843 169.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -120.92 161.75 21.04 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.283 1.433 . . . . 0.0 109.674 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -124.21 135.74 53.67 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 t -127.81 134.16 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -139.71 166.19 25.27 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.691 1.196 . . . . 0.0 108.786 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 68.6 m -143.35 150.73 39.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.588 0.755 . . . . 0.0 110.261 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' B' ' 67' ' ' ILE . . . -148.99 158.86 44.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.784 1.234 . . . . 0.0 110.366 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 -176.39 38.53 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.116 0.865 . . . . 0.0 110.941 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.469 HG22 ' H ' ' B' ' 12' ' ' GLY . 1.3 tt -53.69 -63.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 113.482 -169.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -141.28 33.49 1.7 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.766 2.426 . . . . 0.0 105.76 -172.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.13 146.73 52.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.636 2.774 . . . . 0.0 114.26 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -177.24 17.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.899 1.68 . . . . 0.0 111.967 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.86 172.41 40.39 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 120.892 -1.13 . . . . 0.0 112.04 -169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.8 tp -148.68 75.5 1.31 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.89 131.29 79.26 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 125.023 1.329 . . . . 0.0 108.945 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.0 -22.28 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.966 1.777 . . . . 0.0 112.62 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.23 -54.67 44.17 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 119.616 1.098 . . . . 0.0 108.118 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.84 77.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.689 1.131 . . . . 0.0 110.538 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.77 -54.65 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -56.31 -46.08 79.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.006 0.922 . . . . 0.0 110.899 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -34.08 63.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.734 2.014 . . . . 0.0 111.673 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.0 mmm -92.11 -31.21 15.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.114 0.566 . . . . 0.0 110.481 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -61.65 -26.14 67.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.795 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.67 -31.57 64.56 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.961 1.255 . . . . 0.0 111.248 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.47 15.92 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.185 1.394 . . . . 0.0 110.852 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.51 37.55 93.83 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.908 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 81.8 mt -114.13 107.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.9 138.51 54.71 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 pt -133.42 13.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.624 0.77 . . . . 0.0 111.558 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -60.88 -14.34 21.49 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.925 0.784 . . . . 0.0 112.375 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -85.85 -16.05 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.809 1.644 . . . . 0.0 113.659 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.35 153.4 3.97 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.6 p -116.16 159.86 21.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.921 2.088 . . . . 0.0 108.953 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -148.34 153.71 38.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.803 1.241 . . . . 0.0 108.184 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -164.52 161.83 21.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.963 0.801 . . . . 0.0 111.462 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.4 pt -70.43 174.83 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.655 1.182 . . . . 0.0 111.466 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.575 ' HA ' ' HB1' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -52.07 134.0 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.632 0.773 . . . . 0.0 108.918 169.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.93 95.37 2.76 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.477 1.132 . . . . 0.0 109.237 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.44 -34.29 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.878 2.071 . . . . 0.0 113.744 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.81 -20.82 66.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.072 0.851 . . . . 0.0 112.185 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -122.57 -35.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.7 tt -66.21 -46.69 76.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.654 0.661 . . . . 0.0 110.633 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -30.42 71.58 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.847 0.749 . . . . 0.0 110.42 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -78.42 -18.24 55.24 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.662 1.185 . . . . 0.0 112.88 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 167.34 1.75 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.171 0.986 . . . . 0.0 111.961 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -90.19 -25.32 20.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.565 1.146 . . . . 0.0 111.286 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.34 128.68 11.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.994 0.918 . . . . 0.0 109.467 -173.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.09 100.6 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.872 1.669 . . . . 0.0 107.391 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.67 109.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -75.49 101.48 4.87 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.456 HD11 HG12 ' B' ' 127' ' ' ILE . 15.6 tp -80.98 -43.63 19.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.762 -0.586 . . . . 0.0 111.703 -168.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 123.269 0.627 . . . . 0.0 110.463 175.152 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.456 ' N ' ' HG1' ' B' ' 11' ' ' THR . . . . . . . . 0 C--O 1.225 -0.209 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -101.05 -1.23 34.73 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . 0.419 ' HE3' HG13 ' B' ' 39' ' ' ILE . 3.4 tttt 73.09 19.04 3.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.852 2.061 . . . . 0.0 113.335 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 30.63 55.68 0.79 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.304 2.242 . . . . 0.0 112.521 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.31 139.69 91.09 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.169 1.913 . . . . 0.0 109.795 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.62 4.1 52.14 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.1 p 40.1 98.54 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 128.919 2.888 . . . . 0.0 114.947 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -61.48 138.42 75.92 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.077 1.851 . . . . 0.0 108.856 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.4 ' HD3' ' CD ' ' A' ' 61' ' ' GLN . 57.6 Cg_endo -66.81 3.18 1.62 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.788 3.659 . . . . 0.0 116.398 -168.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -63.33 -13.9 44.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.041 0.837 . . . . 0.0 112.017 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.47 151.32 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.201 0.91 . . . . 0.0 111.483 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 154.73 40.53 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.04 1.736 . . . . 0.0 108.865 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -139.93 145.5 38.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -151.47 141.85 22.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.5 139.72 33.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.75 0.704 . . . . 0.0 111.088 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -123.57 -63.95 1.19 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.009 0.524 . . . . 0.0 112.126 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.83 -44.01 39.81 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 55.86 27.55 11.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.27 1.828 . . . . 0.0 112.997 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -156.18 172.28 18.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.881 1.272 . . . . 0.0 109.032 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -135.12 113.34 11.41 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.166 1.387 . . . . 0.0 108.417 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.92 -21.01 21.55 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.866 3.044 . . . . 0.0 112.513 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.47 ' HB3' HH21 ' B' ' 16' ' ' ARG . . . -70.15 8.36 0.78 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.243 1.017 . . . . 0.0 112.385 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -117.79 13.93 14.22 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.254 1.421 . . . . 0.0 111.288 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.0 151.73 0.6 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.1 0.96 . . . . 0.0 110.984 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.24 -46.16 76.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 -172.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.86 -17.13 3.93 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.2 p -69.63 162.88 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.44 -41.06 88.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.397 0.617 . . . . 0.0 110.791 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -72.16 -43.9 63.91 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 117.079 -1.438 . . . . 0.0 109.851 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.19 -31.05 60.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 121.19 1.813 . . . . 0.0 110.024 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -59.37 -60.4 3.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.54 -39.13 86.77 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.04 97.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.36 -0.838 . . . . 0.0 112.317 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.64 -46.12 83.89 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -58.09 -50.15 74.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.19 -49.01 68.81 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.006 0.922 . . . . 0.0 110.69 -174.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -64.43 -44.09 92.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.894 0.77 . . . . 0.0 110.284 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.82 -42.09 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.985 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -34.82 78.91 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.435 1.47 . . . . 0.0 110.868 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.32 -44.57 83.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.87 0.468 . . . . 0.0 111.484 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.28 -48.31 78.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.456 HG12 HD11 ' B' ' 81' ' ' LEU . 17.1 mt -51.44 -53.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.944 1.297 . . . . 0.0 109.066 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.84 -41.71 99.66 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.252 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -63.4 -41.13 98.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.386 1.093 . . . . 0.0 111.765 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -71.72 -31.83 67.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.07 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' B' ' 131' ' ' LEU . 1.7 mm? -63.21 -48.08 79.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.354 0.979 . . . . 0.0 111.021 171.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -68.94 -37.64 78.98 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.989 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.62 -45.77 88.49 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.788 169.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -59.61 -38.41 81.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.423 1.919 . . . . 0.0 111.128 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.59 76.66 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.17 -44.75 12.66 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.594 1.557 . . . . 0.0 112.162 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.3 p -91.94 -23.0 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.687 1.995 . . . . 0.0 111.198 -169.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.03 54.15 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.306 0.955 . . . . 0.0 112.241 -169.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 127.761 2.425 . . . . 0.0 112.794 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.23 165.41 0.09 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.061 2.145 . . . . 0.0 113.32 -171.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.19 105.34 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.88 169.68 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.54 1.936 . . . . 0.0 108.614 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -123.14 114.81 20.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.073 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -80.95 170.94 15.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.996 0.918 . . . . 0.0 109.861 174.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -156.41 174.5 15.32 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.37 1.868 . . . . 0.0 106.148 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -32.71 -40.65 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 129.277 3.031 . . . . 0.0 116.425 -169.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.06 -31.08 3.14 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.26 1.024 . . . . 0.0 111.651 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -62.42 -21.45 65.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.558 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -50.85 -51.4 51.64 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.796 1.18 . . . . 0.0 109.178 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -62.64 -44.58 95.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.068 -0.395 . . . . 0.0 110.012 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.74 87.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.429 -0.169 . . . . 0.0 110.906 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.75 -12.85 60.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.723 1.209 . . . . 0.0 112.89 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.8 p -118.46 -5.87 10.76 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.626 1.103 . . . . 0.0 112.591 -170.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.3 m -75.81 -7.38 54.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.972 . . . . 0.0 113.454 -175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.05 155.35 45.39 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.366 1.066 . . . . 0.0 109.057 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.15 -155.6 48.86 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.27 0.938 . . . . 0.0 111.052 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.05 131.4 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 t -138.89 122.02 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.15 -168.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -94.35 94.74 8.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 107.891 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.41 148.61 28.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -141.37 146.68 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.665 1.586 . . . . 0.0 109.15 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -129.44 114.25 15.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.433 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.1 p-90 -124.63 161.75 25.59 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.148 1.379 . . . . 0.0 107.358 -174.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.34 159.34 23.82 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.5 -26.37 44.83 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.421 2.08 . . . . 0.0 114.281 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -51.29 -33.43 28.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -171.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -154.85 166.96 31.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.425 1.466 . . . . 0.0 114.075 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.61 -45.63 95.32 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.385 -1.786 . . . . 0.0 114.431 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.78 -29.65 43.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.383 2.592 . . . . 0.0 114.472 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -59.29 -18.74 40.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.139 1.336 . . . . 0.0 114.089 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -114.23 12.32 17.68 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.644 1.177 . . . . 0.0 111.162 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.1 mtm -121.52 -43.79 2.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.589 1.156 . . . . 0.0 109.238 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.68 -37.99 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.964 0.906 . . . . 0.0 109.226 169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.13 -57.88 19.78 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.045 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.7 -39.74 60.92 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.125 1.883 . . . . 0.0 112.064 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.17 -40.49 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.138 0.975 . . . . 0.0 110.85 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.47 -44.37 74.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.947 0.794 . . . . 0.0 110.524 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.8 -37.82 88.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.489 0.586 . . . . 0.0 109.909 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -72.34 -19.97 61.56 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.148 -0.97 . . . . 0.0 111.831 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 tp -80.89 -44.67 17.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.64 1.176 . . . . 0.0 108.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.7 -34.12 73.47 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.764 -0.585 . . . . 0.0 111.063 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.79 -24.81 66.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.779 -0.576 . . . . 0.0 112.176 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -97.13 -44.3 7.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.796 0.838 . . . . 0.0 111.302 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.3 ptm -139.49 14.33 2.56 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.857 0.863 . . . . 0.0 112.108 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.7 -5.11 22.49 Favored Glycine 0 C--O 1.227 -0.341 0 O-C-N 121.088 -1.007 . . . . 0.0 114.07 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.65 -24.25 66.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 110.788 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 -27.07 8.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.391 1.076 . . . . 0.0 111.875 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -116.01 151.01 36.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.466 1.506 . . . . 0.0 112.059 -168.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -116.97 148.56 41.32 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.81 143.55 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 5.6 t -140.54 120.18 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.6 mmmm -87.31 154.13 20.93 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.651 0.66 . . . . 0.0 110.963 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -127.98 115.18 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 102.933 -2.988 . . . . 0.0 102.933 168.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -88.26 87.87 7.45 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 m -42.61 -44.48 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.871 1.669 . . . . 0.0 113.669 -172.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.7 -23.9 65.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.489 1.495 . . . . 0.0 112.443 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -108.53 -30.24 8.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.588 1.555 . . . . 0.0 111.873 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -135.59 25.06 3.43 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -168.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.68 -5.79 13.13 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.585 -0.697 . . . . 0.0 112.645 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.84 -28.35 49.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 111.162 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -74.83 -46.92 33.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 0.0 109.847 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.45 -71.07 0.2 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.357 1.463 . . . . 0.0 111.989 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.37 -41.08 11.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.622 1.105 . . . . 0.0 113.292 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.8 -44.58 89.47 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 118.457 -0.783 . . . . 0.0 111.571 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -65.08 -40.73 95.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.21 67.98 0.41 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.93 127.47 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.838 ' HG3' HD12 ' B' ' 67' ' ' ILE . 15.3 ptm -147.19 19.38 1.23 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.118 -0.468 . . . . 0.0 109.991 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' B' ' 90' ' ' PRO . 3.3 m -141.86 169.86 16.8 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.587 1.155 . . . . 0.0 110.573 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.6 mm -137.92 145.16 46.99 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 107.563 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.15 134.59 30.76 Favored 'Cis proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 -10.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.0 m -102.16 146.68 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.98 137.47 54.6 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.964 1.706 . . . . 0.0 106.639 170.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -124.95 112.45 16.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.68 119.61 49.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.49 152.07 37.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.061 0.944 . . . . 0.0 109.421 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.7 136.13 38.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.2 t70 43.14 28.09 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.886 2.074 . . . . 0.0 114.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.68 48.34 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.579 1.085 . . . . 0.0 115.317 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -129.98 143.96 51.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.891 1.276 . . . . 0.0 110.058 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.0 139.4 19.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.95 -22.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.961 1.304 . . . . 0.0 111.187 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.64 161.01 39.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.723 0.773 . . . . 0.0 109.877 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -155.76 147.08 22.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.8 m -153.4 149.93 28.31 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.089 -1.007 . . . . 0.0 108.432 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.86 68.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.99 156.18 10.83 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.028 1.775 . . . . 0.0 109.521 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -73.22 163.99 27.32 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.886 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.519 ' HE3' HD22 ' A' ' 99' ' ' LEU . 5.8 mtmm -149.89 135.95 10.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.638 1.575 . . . . 0.0 107.26 174.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -68.58 167.74 21.84 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.0 109.903 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -169.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.96 -43.94 70.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.271 0.487 . . . . 0.0 110.853 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.46 78.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.326 0.512 . . . . 0.0 110.403 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 96' ' ' LEU . 17.9 tp -70.7 -48.48 54.42 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.439 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -61.13 -37.68 83.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.2 -48.43 81.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.766 1.166 . . . . 0.0 110.827 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.519 HD22 ' HE3' ' A' ' 91' ' ' LYS . 11.6 tp -54.46 -42.22 70.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.715 1.206 . . . . 0.0 111.291 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -90.52 -37.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.195 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -61.01 -21.94 64.06 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.345 1.429 . . . . 0.0 112.594 -176.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -78.98 -5.92 55.04 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.128 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -126.4 -30.21 2.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.85 1.26 . . . . 0.0 111.993 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 2.4 tm? . . . . . 0 C--O 1.249 1.065 0 C-N-CA 125.978 1.711 . . . . 0.0 108.408 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.08 136.4 53.71 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 109.448 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m120 69.85 127.36 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.967 2.507 . . . . 0.0 110.712 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -137.76 119.06 14.63 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 128.822 2.849 . . . . 0.0 103.98 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.61 139.6 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -169.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.08 149.28 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.906 1.282 . . . . 0.0 107.567 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.514 ' CD1' HD12 ' B' ' 72' ' ' LEU . 2.6 t80 -133.72 146.6 50.93 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.439 -168.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.2 140.53 48.48 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 31.8 tp -136.71 110.97 8.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.5 p -146.22 156.21 43.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -57.78 129.82 43.63 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.863 1.665 . . . . 0.0 111.477 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.422 ' H ' ' CG2' ' B' ' 39' ' ' ILE . . . 46.9 39.25 11.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.335 23.1 t-20 -37.07 99.85 0.02 OUTLIER 'General case' 0 C--N 1.345 0.39 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -166.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -144.47 -2.18 0.88 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.834 1.253 . . . . 0.0 111.626 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.93 -60.71 0.73 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -171.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -51.9 60.83 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.781 -1.2 . . . . 0.0 111.862 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 14.9 m -64.34 -34.27 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.142 0.177 . . . . 0.0 110.811 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -60.57 -50.73 72.37 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.141 1.776 . . . . 0.0 109.636 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 6.0 ptp -67.56 -40.09 84.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.72 94.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.838 0.855 . . . . 0.0 111.683 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.07 -30.27 64.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.332 0.969 . . . . 0.0 111.251 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.37 -50.59 54.99 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.443 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -55.93 -37.26 68.71 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.117 0.967 . . . . 0.0 111.585 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.67 56.02 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 122.599 0.36 . . . . 0.0 110.414 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -65.16 -24.36 67.37 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.85 -12.52 61.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.417 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 10.9 m-85 -130.39 -14.33 3.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.433 1.093 . . . . 0.0 113.876 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 25.4 mt -120.19 88.49 2.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.22 -166.86 0.57 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.78 1.657 . . . . 0.0 113.586 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.71 -17.0 12.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.623 1.169 . . . . 0.0 112.718 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.29 -24.38 7.34 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.702 1.601 . . . . 0.0 110.946 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -127.46 153.4 46.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.048 1.739 . . . . 0.0 110.061 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 135.21 47.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.04 152.98 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -169.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -145.99 164.06 33.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.438 1.095 . . . . 0.0 109.236 177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.5 m -142.22 126.08 17.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 108.958 -169.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.16 -177.85 6.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.499 0.591 . . . . 0.0 111.266 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.69 -167.75 40.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.422 ' CG2' ' H ' ' B' ' 12' ' ' GLY . 16.0 tt -70.11 154.65 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 31.8 58.13 0.33 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 130.016 3.326 . . . . 0.0 110.041 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.29 137.53 53.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.459 1.103 . . . . 0.0 111.896 -168.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 28.0 p80 174.99 -2.36 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.84 2.056 . . . . 0.0 111.568 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.09 174.97 54.3 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.923 0.783 . . . . 0.0 111.828 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 tp -139.33 83.83 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -55.39 128.93 68.44 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.58 1.152 . . . . 0.0 108.03 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.73 -21.67 57.42 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.735 1.623 . . . . 0.0 112.326 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -57.44 -54.21 49.37 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 168.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.93 80.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.089 1.313 . . . . 0.0 110.893 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.22 -54.11 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.35 -43.42 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.393 0.677 . . . . 0.0 110.757 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -35.54 62.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.712 2.005 . . . . 0.0 110.339 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 75.1 mmm -93.75 -33.0 13.78 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.988 0.915 . . . . 0.0 111.831 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -59.84 -29.41 68.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.034 0.834 . . . . 0.0 110.901 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -60.32 -33.03 71.81 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.388 0.994 . . . . 0.0 111.63 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.87 13.95 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.609 1.164 . . . . 0.0 111.363 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.2 38.62 92.09 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.648 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.75 107.54 22.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.54 137.82 52.75 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.62 13.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 123.751 0.821 . . . . 0.0 111.773 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -60.4 -15.83 29.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.125 0.875 . . . . 0.0 112.543 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -81.6 -17.07 49.55 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.557 1.543 . . . . 0.0 113.556 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -54.52 154.04 5.14 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -125.51 158.42 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.184 2.194 . . . . 0.0 108.86 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 6.4 m -150.12 157.3 42.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.784 1.234 . . . . 0.0 108.354 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -162.39 168.84 21.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.581 1.152 . . . . 0.0 109.621 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 10.7 pt -69.21 172.23 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.296 1.038 . . . . 0.0 112.124 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.838 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.6 OUTLIER -44.24 131.31 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 125.517 1.527 . . . . 0.0 108.413 175.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -142.69 94.25 2.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.863 0.84 . . . . 0.0 108.926 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -50.63 -24.01 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.259 1.423 . . . . 0.0 114.791 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 -29.43 66.35 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 120.661 1.573 . . . . 0.0 109.917 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.37 -42.08 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.172 171.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.521 HD13 ' CE ' ' A' ' 70' ' ' MET . 4.5 tt -63.12 -49.59 73.82 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.652 1.114 . . . . 0.0 110.578 -174.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -29.49 70.74 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.884 1.22 . . . . 0.0 110.138 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -77.12 -14.67 59.76 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.553 1.141 . . . . 0.0 112.867 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.17 163.64 19.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.176 0.988 . . . . 0.0 110.167 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.81 -36.94 16.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.828 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.425 HD23 ' CE ' ' B' ' 97' ' ' LYS . 2.8 tm? -145.33 139.89 27.35 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.415 0.686 . . . . 0.0 111.357 -168.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.4 t -118.54 109.64 27.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 126.252 1.821 . . . . 0.0 107.538 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.7 97.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -66.2 125.86 26.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 167.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -129.96 61.67 1.57 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.958 0.903 . . . . 0.0 111.437 -167.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 51.4 m . . . . . 0 CA--C 1.536 0.409 0 C-N-CA 124.796 1.239 . . . . 0.0 108.299 169.736 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -73.55 43.53 0.14 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.65 1.58 . . . . 0.0 113.882 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 52.54 -155.71 0.18 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.808 1.643 . . . . 0.0 110.706 -169.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.68 63.54 59.53 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.57 2.348 . . . . 0.0 105.421 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 37.4 Cg_exo -57.14 128.3 29.18 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.932 1.755 . . . . 0.0 110.572 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 3.11 48.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.149 -0.929 . . . . 0.0 113.036 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p 37.05 91.93 0.06 OUTLIER Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 128.283 2.633 . . . . 0.0 113.695 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -55.2 130.09 38.8 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.399 2.733 . . . . 0.0 107.939 -174.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.83 2.66 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 126.129 4.553 . . . . 0.0 118.351 -168.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.9 -24.82 68.02 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 119.446 1.021 . . . . 0.0 109.87 169.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.03 153.53 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.39 1.076 . . . . 0.0 112.393 175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.425 ' CE ' HD23 ' B' ' 77' ' ' LEU . 4.6 tmmm? -93.38 154.72 17.8 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 167.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -152.94 146.08 24.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.532 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -156.11 154.78 31.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 168.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -104.77 140.22 38.41 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.885 1.274 . . . . 0.0 109.284 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -142.81 -1.17 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.12 -58.65 3.34 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.387 0.994 . . . . 0.0 110.939 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 55.78 14.83 1.42 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.264 1.825 . . . . 0.0 113.656 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -163.2 171.06 16.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 0.0 107.822 -169.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -150.51 104.92 3.09 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.311 1.045 . . . . 0.0 108.984 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.45 -29.6 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.931 2.42 . . . . 0.0 114.301 -169.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.28 64.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.526 0.731 . . . . 0.0 111.026 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -83.67 -56.7 3.57 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . 0.437 ' HB3' ' HE3' ' B' ' 116' ' ' LYS . . . 44.29 -176.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.097 2.159 . . . . 0.0 115.233 -169.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.54 -40.46 73.4 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.1 -20.9 4.69 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 49.1 p -70.93 166.4 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.689 0.745 . . . . 0.0 109.385 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.95 -39.66 86.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.119 0.485 . . . . 0.0 111.042 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.4 pt-20 -75.65 -42.69 50.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 117.504 -1.236 . . . . 0.0 109.593 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.39 -30.14 60.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.513 1.506 . . . . 0.0 110.231 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' B' ' 109' ' ' ALA . 2.9 mmpt? -57.21 -59.25 5.39 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 169.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -61.47 -38.8 88.57 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.794 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.56 94.05 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.216 -0.928 . . . . 0.0 111.865 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 4.0 m-85 -64.63 -46.49 82.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.216 -0.421 . . . . 0.0 109.965 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -56.3 -49.62 73.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -62.54 -48.54 79.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.853 1.661 . . . . 0.0 110.128 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -60.22 -51.9 67.59 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.86 -41.67 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.61 -0.709 . . . . 0.0 109.427 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.443 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 3.7 tmm_? -59.62 -43.01 93.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.511 1.051 . . . . 0.0 111.777 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.8 -46.23 88.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.263 0.483 . . . . 0.0 110.928 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.73 -38.89 73.59 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.23 -0.294 . . . . 0.0 110.99 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.25 -45.74 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.36 1.064 . . . . 0.0 108.875 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.81 -42.7 86.03 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-O 119.165 -0.797 . . . . 0.0 111.682 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -56.97 -45.66 82.73 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.346 1.073 . . . . 0.0 110.988 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -61.34 -39.64 91.33 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.612 0.765 . . . . 0.0 110.44 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.4 mm? -77.01 -34.15 57.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 119.094 0.861 . . . . 0.0 112.589 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.9 ttmt -66.83 -39.17 87.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.751 0.705 . . . . 0.0 109.413 172.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -61.31 -35.22 76.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 117.296 -1.335 . . . . 0.0 110.077 169.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.4 -41.07 88.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 120.881 1.673 . . . . 0.0 109.814 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.64 70.47 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.81 0.844 . . . . 0.0 112.591 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -92.27 -36.55 13.16 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.378 1.471 . . . . 0.0 112.721 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 70.6 p -109.1 -11.81 14.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.962 1.705 . . . . 0.0 111.905 -169.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.75 23.63 67.41 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.034 1.302 . . . . 0.0 113.515 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.034 1.734 . . . . 0.0 106.848 -169.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 tpp . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.31 171.15 19.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.639 1.576 . . . . 0.0 107.571 170.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.2 93.82 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.73 171.29 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.148 1.779 . . . . 0.0 107.842 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.82 144.92 49.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.279 1.032 . . . . 0.0 109.174 172.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.439 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -116.25 169.94 8.91 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.257 1.823 . . . . 0.0 108.594 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -156.54 -173.79 4.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -38.67 -39.48 0.5 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.932 2.493 . . . . 0.0 115.811 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -129.01 -30.2 2.24 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.337 1.055 . . . . 0.0 111.505 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -60.77 -25.25 66.38 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.657 -0.687 . . . . 0.0 111.815 172.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -52.15 -56.55 13.8 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.064 0.847 . . . . 0.0 109.226 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -61.02 -44.16 97.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.89 -34.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.352 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.41 -12.91 57.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.573 1.149 . . . . 0.0 113.333 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.4 p -120.83 -7.92 9.48 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.096 1.316 . . . . 0.0 114.398 -168.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -78.71 -2.32 38.74 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -140.43 153.0 46.14 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.28 1.032 . . . . 0.0 109.237 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.14 -157.23 49.38 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.71 128.92 72.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.36 115.16 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.9 tt -78.93 139.06 38.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.62 141.56 51.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.54 142.09 48.03 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.372 1.469 . . . . 0.0 108.563 -173.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.5 116.42 21.07 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -135.02 154.23 51.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.95 1.3 . . . . 0.0 108.711 -170.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.1 161.49 18.46 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.51 0.724 . . . . 0.0 109.651 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.87 -14.83 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.498 2.799 . . . . 0.0 116.514 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -55.15 -24.21 25.34 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.4 p -155.94 169.6 24.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.771 1.168 . . . . 0.0 113.481 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.57 89.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.39 -1.783 . . . . 0.0 114.28 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.31 -28.46 43.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.381 2.591 . . . . 0.0 114.311 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -59.2 -16.83 22.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.898 1.226 . . . . 0.0 113.828 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -116.59 13.0 15.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.737 1.215 . . . . 0.0 111.525 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.0 mtm -122.91 -43.62 2.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.301 1.04 . . . . 0.0 109.415 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.09 -38.06 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -56.49 32.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.716 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.57 -38.68 80.88 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.87 1.713 . . . . 0.0 111.54 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.49 -38.11 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.9 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.52 -48.03 79.22 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 119.559 1.072 . . . . 0.0 109.979 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -66.57 -35.7 80.84 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.905 -0.497 . . . . 0.0 109.848 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.62 -15.33 61.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.74 1.616 . . . . 0.0 112.833 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.25 -44.6 10.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 108.56 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.7 -37.98 76.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.298 -0.251 . . . . 0.0 111.082 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -68.4 -9.85 51.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.948 -0.548 . . . . 0.0 112.15 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.0 -48.32 3.77 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.112 0.965 . . . . 0.0 110.967 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -132.35 16.11 4.52 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.822 0.849 . . . . 0.0 112.45 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.54 19.23 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 121.175 -0.953 . . . . 0.0 114.134 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.28 -23.83 65.71 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 169.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.3 -18.81 9.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.191 0.996 . . . . 0.0 112.439 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.9 tp -128.47 148.08 50.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.364 1.066 . . . . 0.0 111.413 -168.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -110.54 146.98 35.09 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.92 142.23 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 3.5 t -136.43 140.27 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -106.77 145.34 32.2 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 123.868 0.867 . . . . 0.0 110.281 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.02 122.78 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -85.47 111.21 19.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.261 33.8 m -82.48 41.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -148.49 -38.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.932 0.893 . . . . 0.0 109.415 168.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.86 -51.4 12.6 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.88 1.272 . . . . 0.0 109.862 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.47 47.77 2.17 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.68 1.192 . . . . 0.0 110.088 -172.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -73.55 -1.75 19.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.861 1.265 . . . . 0.0 112.758 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -55.28 -44.47 75.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.243 1.417 . . . . 0.0 110.86 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -57.92 -41.72 83.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.685 0.675 . . . . 0.0 111.152 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB1' ' CE ' ' B' ' 91' ' ' MET . . . -69.24 -61.81 1.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.455 1.102 . . . . 0.0 108.719 -171.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.86 -41.74 28.53 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.753 -1.026 . . . . 0.0 113.851 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -62.75 -44.35 96.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.432 1.616 . . . . 0.0 110.961 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -71.78 -11.78 60.98 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.196 0.453 . . . . 0.0 111.276 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.66 56.13 6.9 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 m -103.71 -46.41 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.976 0.888 . . . . 0.0 108.942 -169.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.3 mtm 52.73 15.23 0.5 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 127.574 2.35 . . . . 0.0 113.397 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 m -138.08 159.77 41.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.589 1.155 . . . . 0.0 110.945 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.46 143.77 42.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.07 129.91 20.09 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 N-CA-C 107.71 -1.689 . . . . 0.0 107.71 -10.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -98.04 145.36 26.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tp -137.01 126.57 25.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -124.82 110.45 14.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.99 120.22 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 171.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp -112.47 150.79 30.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.697 1.199 . . . . 0.0 109.298 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -150.77 124.75 9.26 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.09 27.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.5 2.72 . . . . 0.0 114.93 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.32 -24.01 3.26 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.606 -1.108 . . . . 0.0 115.378 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.48 159.04 43.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.032 1.416 . . . . 0.0 113.156 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.15 133.62 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.59 -20.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.888 1.275 . . . . 0.0 111.04 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.76 157.7 44.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.235 1.014 . . . . 0.0 109.524 169.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.94 148.28 29.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -171.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -152.71 149.54 28.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.06 57.68 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.09 20.4 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.921 1.724 . . . . 0.0 110.622 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -66.63 157.2 33.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.995 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -148.13 135.33 10.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -68.43 169.66 16.6 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.484 2.123 . . . . 0.0 110.412 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -46.8 65.43 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 112.034 -171.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.77 -42.13 77.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.849 0.093 . . . . 0.0 110.958 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.28 81.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.866 -0.521 . . . . 0.0 110.423 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.83 -47.67 71.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.19 -37.15 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.723 -0.655 . . . . 0.0 109.54 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.11 -46.63 86.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.675 0.67 . . . . 0.0 110.93 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -56.02 -41.64 75.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.439 0.696 . . . . 0.0 111.093 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -83.15 -42.0 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.506 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 10.5 t30 -56.4 -35.53 67.88 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.523 1.129 . . . . 0.0 111.801 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -69.18 -7.67 38.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.36 -25.7 4.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.472 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 16.1 tp . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.606 1.962 . . . . 0.0 109.275 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.14 27.49 4.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.842 1.257 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -157.39 129.73 7.31 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.479 ' H ' ' HA ' ' B' ' 32' ' ' TRP . 95.4 mttt -118.87 114.3 22.39 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 129.333 3.053 . . . . 0.0 103.677 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -90.12 141.16 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.22 141.49 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -131.53 138.86 49.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -115.76 152.66 32.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.75 0.705 . . . . 0.0 109.305 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 mt -132.11 118.35 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.6 p -150.22 157.49 43.14 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.804 1.242 . . . . 0.0 109.402 169.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 31.3 m -53.6 123.97 13.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.313 1.045 . . . . 0.0 110.361 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.95 18.49 11.79 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.657 0.646 . . . . 0.0 113.312 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t30 43.05 47.68 5.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.189 1.796 . . . . 0.0 112.691 -169.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -74.77 -157.35 0.06 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.82 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . -33.92 -63.3 0.27 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.55 2.74 . . . . 0.0 116.82 -168.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -57.99 -47.23 83.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 0.896 . . . . 0.0 111.611 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -60.51 -49.4 77.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.718 0.69 . . . . 0.0 111.681 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -57.14 -48.8 77.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.317 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.4 ttm -66.81 -42.93 85.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.551 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.93 84.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.923 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.16 -28.93 57.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.615 1.098 . . . . 0.0 111.179 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 -43.86 48.44 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -56.1 -41.72 75.65 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.18 0.99 . . . . 0.0 111.117 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.45 -50.58 70.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -63.39 -21.76 66.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 118.079 -0.962 . . . . 0.0 113.277 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.37 -16.45 63.93 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.612 1.096 . . . . 0.0 113.824 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.6 -39.79 0.57 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.896 1.226 . . . . 0.0 113.107 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.427 ' HG ' ' CG ' ' B' ' 32' ' ' TRP . 4.3 tp -77.45 75.6 4.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.534 2.734 . . . . 0.0 105.081 169.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.64 -166.9 1.86 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.85 2.167 . . . . 0.0 114.767 -169.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -56.93 -20.61 24.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.23 1.412 . . . . 0.0 112.968 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -55.65 -20.54 14.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 112.482 169.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . 0.479 ' HA ' ' H ' ' B' ' 4' ' ' LYS . 63.9 m95 -118.22 174.17 6.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.383 1.873 . . . . 0.0 109.789 -176.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 114.61 5.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.78 149.2 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -150.8 167.36 27.7 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 168.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -152.17 147.54 26.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 110.391 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.06 178.16 9.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.855 1.262 . . . . 0.0 111.216 -169.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.14 -175.63 42.75 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -47.75 -58.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.492 . . . . 0.0 114.541 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.07 31.56 4.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.573 1.549 . . . . 0.0 108.425 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.45 151.32 47.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.68 1.992 . . . . 0.0 115.17 -169.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 p80 162.8 47.2 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 130.906 3.683 . . . . 0.0 107.567 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.8 177.28 27.86 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.894 0.759 . . . . 0.0 112.017 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 36.3 tp -161.28 83.67 0.64 Allowed 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.44 126.47 90.66 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.476 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.41 -24.98 75.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.214 1.943 . . . . 0.0 112.722 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.3 -51.17 70.9 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -59.22 -35.76 74.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.849 1.204 . . . . 0.0 111.214 -175.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.04 -53.76 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.58 -48.09 80.33 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 110.567 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.984 1.714 . . . . 0.0 111.855 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.72 -43.49 14.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.861 0.864 . . . . 0.0 110.051 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.24 -30.71 69.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.623 0.647 . . . . 0.0 110.832 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -27.59 62.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.874 1.27 . . . . 0.0 112.292 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.37 15.48 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.147 1.379 . . . . 0.0 111.158 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.66 72.66 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.179 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 63.0 mt -110.19 149.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -117.93 135.45 54.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.589 0.756 . . . . 0.0 108.993 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 pt -136.56 17.4 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.4 1.08 . . . . 0.0 111.048 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -67.23 13.46 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -169.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -137.75 -4.56 1.78 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.235 2.614 . . . . 0.0 111.539 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -57.92 147.73 27.94 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.532 1.06 . . . . 0.0 111.324 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -126.89 168.95 13.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.61 1.964 . . . . 0.0 109.184 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 7.0 p -155.03 -174.45 4.99 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.172 0.989 . . . . 0.0 108.442 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -159.23 168.51 26.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.559 1.543 . . . . 0.0 107.933 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.7 pt -60.26 164.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.464 0.705 . . . . 0.0 111.304 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -48.22 127.04 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -135.83 99.17 4.1 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.67 1.224 . . . . 0.0 109.194 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -42.68 -31.68 0.49 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.731 2.413 . . . . 0.0 114.559 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.07 -17.67 63.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.243 0.928 . . . . 0.0 112.212 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.33 -38.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.345 1.058 . . . . 0.0 109.04 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.433 HD23 ' C ' ' B' ' 72' ' ' LEU . 7.9 tt -61.77 -56.56 18.22 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.02 1.282 . . . . 0.0 109.332 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.0 66.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.566 0.621 . . . . 0.0 111.279 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.41 -24.76 36.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.025 1.73 . . . . 0.0 112.525 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.55 172.03 2.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.481 1.513 . . . . 0.0 112.149 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.92 -36.93 13.85 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.67 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' B' ' 97' ' ' LYS . 14.4 tp -143.64 133.26 23.64 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 109.634 -171.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.38 115.15 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.16 107.82 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.1 m -75.53 88.06 2.67 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 167.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 48.01 1.16 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.949 1.7 . . . . 0.0 107.114 -169.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.443 -0.785 0 C-N-CA 124.725 1.21 . . . . 0.0 109.937 -169.732 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.64 50.15 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.327 1.451 . . . . 0.0 113.527 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 52.78 -147.53 0.47 Allowed 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.999 -1.063 . . . . 0.0 108.627 -169.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.48 55.53 1.98 Allowed Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 126.683 1.993 . . . . 0.0 106.1 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.7 135.03 50.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.181 1.254 . . . . 0.0 112.003 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.432 ' HG3' ' H ' ' B' ' 91' ' ' MET 0.255 0.0 OUTLIER -83.69 4.93 26.51 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.742 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p 39.91 84.88 0.17 Allowed Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 125.245 1.418 . . . . 0.0 113.063 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -53.57 138.97 67.03 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.201 2.601 . . . . 0.0 110.614 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.95 8.6 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 125.669 4.246 . . . . 0.0 117.225 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.04 -5.13 20.0 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.218 -0.926 . . . . 0.0 111.608 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.9 149.88 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.655 1.182 . . . . 0.0 110.473 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.616 ' HD2' HD13 ' B' ' 77' ' ' LEU . 0.4 OUTLIER -75.85 155.75 35.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -142.2 146.99 35.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 120.713 -1.242 . . . . 0.0 108.507 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -139.4 151.46 46.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -133.9 115.93 15.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -152.64 1.73 0.31 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.17 -53.33 45.6 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.756 1.162 . . . . 0.0 111.123 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.8 t80 58.18 -12.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.405 2.682 . . . . 0.0 117.03 169.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -152.28 82.0 1.25 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.252 1.421 . . . . 0.0 108.497 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.05 129.6 77.94 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.646 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.08 -26.64 9.06 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.661 2.907 . . . . 0.0 112.909 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.73 11.85 0.45 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.601 1.092 . . . . 0.0 112.035 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -123.61 16.18 9.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.234 2.214 . . . . 0.0 111.14 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.06 153.12 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -67.63 140.81 56.87 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.51 58.28 4.99 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.268 -168.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -127.17 149.87 49.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.19 -40.32 46.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.698 1.599 . . . . 0.0 111.507 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.83 -41.06 60.6 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.916 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.15 -31.49 49.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.948 0.795 . . . . 0.0 109.8 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -57.64 -59.85 4.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -62.75 -39.83 95.36 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.665 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.6 84.2 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.684 0.794 . . . . 0.0 112.313 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -63.95 -47.74 79.29 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.46 -40.51 96.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.387 0.54 . . . . 0.0 110.399 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -64.34 -51.69 62.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.691 1.196 . . . . 0.0 109.627 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.2 ttp-105 -59.1 -46.12 89.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.75 -43.86 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.377 -1.297 . . . . 0.0 111.19 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.69 81.99 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.554 1.979 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.42 -45.7 89.75 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.58 -53.79 46.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.665 0.786 . . . . 0.0 110.354 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.69 -47.38 85.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.938 0.895 . . . . 0.0 109.765 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.96 -44.11 98.56 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -62.05 -43.66 98.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.049 0.925 . . . . 0.0 111.801 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -65.3 -45.93 82.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.421 0.555 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.67 -31.87 70.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.057 0.844 . . . . 0.0 111.198 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.87 -39.84 91.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.103 171.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -59.7 -38.37 81.39 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.075 -1.44 . . . . 0.0 111.155 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -60.26 -37.23 79.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.69 2.041 . . . . 0.0 109.928 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.36 79.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.374 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -81.75 -47.92 12.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.411 1.085 . . . . 0.0 111.672 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.1 p -82.0 -24.19 35.56 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.835 2.054 . . . . 0.0 112.526 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.94 24.17 62.4 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 C-N-CA 128.381 2.672 . . . . 0.0 112.226 -169.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.54 169.74 23.96 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.556 1.542 . . . . 0.0 107.581 171.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.76 96.53 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.36 166.27 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.148 1.379 . . . . 0.0 108.065 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -126.03 116.14 20.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.151 1.38 . . . . 0.0 108.088 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.14 173.95 10.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.861 1.264 . . . . 0.0 111.157 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -155.36 179.07 9.52 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.986 2.514 . . . . 0.0 105.544 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -48.33 -29.88 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.543 1.937 . . . . 0.0 115.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.79 -27.29 3.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.85 0.86 . . . . 0.0 112.394 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.3 m -59.86 -40.35 88.28 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.83 122.28 18.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 167.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m 118.9 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.693 1 C-N-CA 132.034 4.133 . . . . 0.0 106.126 -169.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.32 93.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 110.361 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -80.03 -13.15 59.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.42 1.488 . . . . 0.0 112.225 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.0 p -120.24 -9.96 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -168.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -80.81 0.28 35.56 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.165 0.893 . . . . 0.0 113.299 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.1 150.87 47.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.997 0.817 . . . . 0.0 110.159 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.83 -152.55 51.74 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.22 131.66 69.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.73 114.37 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -169.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.48 97.36 7.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 107.474 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.43 26.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -138.84 147.54 42.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.439 1.496 . . . . 0.0 109.299 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -128.49 110.96 12.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -171.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.534 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.0 p-90 -123.35 150.01 44.19 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -173.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.3 154.94 22.69 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.351 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.67 -20.76 22.65 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.981 2.454 . . . . 0.0 115.426 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -49.65 -28.81 6.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.761 2.024 . . . . 0.0 115.755 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -156.55 169.66 24.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.72 1.6 . . . . 0.0 113.463 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.6 -45.3 96.6 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.364 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -52.21 -29.63 38.45 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.533 2.666 . . . . 0.0 114.96 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -58.82 -20.99 55.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 120.32 1.418 . . . . 0.0 113.783 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -109.5 11.61 24.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.389 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -121.6 -43.85 2.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.385 1.074 . . . . 0.0 109.426 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.61 -35.62 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.003 0.921 . . . . 0.0 109.577 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.23 14.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.827 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.01 -38.59 77.15 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.018 1.812 . . . . 0.0 111.784 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.04 -41.57 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.169 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mp -66.37 -41.08 89.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.226 0.921 . . . . 0.0 110.987 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.98 -35.51 80.77 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.085 0.857 . . . . 0.0 110.063 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -71.2 -24.12 62.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.802 1.241 . . . . 0.0 112.152 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 3.4 tm? -81.55 -44.97 16.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.132 1.373 . . . . 0.0 108.735 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' HD13 ' A' ' 52' ' ' ILE . 25.6 t70 -66.11 -38.47 88.3 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.922 -0.486 . . . . 0.0 111.058 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.95 -5.02 31.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.479 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -105.31 -49.14 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.517 1.127 . . . . 0.0 111.038 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.4 ptm -130.38 15.12 5.55 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.235 0.614 . . . . 0.0 112.152 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -5.85 23.39 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 121.223 -0.923 . . . . 0.0 113.453 170.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.51 -25.23 67.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.009 1.324 . . . . 0.0 110.668 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -25.36 6.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.284 1.034 . . . . 0.0 112.126 -175.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.1 tp -118.84 153.35 34.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.678 1.191 . . . . 0.0 112.428 -167.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -116.1 147.92 40.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' A' ' 43' ' ' ASP . 4.4 mp -123.95 144.8 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.63 143.12 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 22.4 mtpt -117.3 152.26 35.24 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.831 0.741 . . . . 0.0 110.417 175.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mm -115.5 115.17 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -80.0 76.93 6.72 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 108.508 169.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 61' ' ' GLN . 32.7 t -31.83 -59.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 129.081 2.952 . . . . 0.0 114.264 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.71 -23.42 64.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 121.528 1.967 . . . . 0.0 112.788 -170.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.93 -32.12 10.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.412 1.485 . . . . 0.0 112.066 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -136.51 25.15 3.17 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.433 ' HB3' HG13 ' A' ' 57' ' ' VAL . 8.1 pt20 -70.08 -0.08 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.584 1.154 . . . . 0.0 112.851 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -50.61 -46.51 58.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.549 1.14 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -56.57 -43.71 80.26 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.676 0.79 . . . . 0.0 111.634 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.93 2.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.728 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.57 -43.57 28.53 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.911 1.243 . . . . 0.0 113.423 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -64.08 -41.59 97.27 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.442 1.121 . . . . 0.0 111.216 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -70.34 -35.92 73.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.61 0.641 . . . . 0.0 110.101 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.35 69.06 1.0 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.428 -2.269 . . . . 0.0 107.428 -169.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.87 -60.76 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.421 ' HG3' HD12 ' B' ' 67' ' ' ILE . 9.3 ptm 50.64 7.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.166 2.987 . . . . 0.0 115.158 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 p -142.97 165.22 27.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.667 1.587 . . . . 0.0 112.146 -171.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.0 mm -142.76 145.54 34.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.209 1.403 . . . . 0.0 107.336 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.16 133.98 26.92 Favored 'Cis proline' 0 N--CA 1.452 -0.914 0 N-CA-C 106.603 -2.114 . . . . 0.0 106.603 -11.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.2 m -114.19 142.28 46.45 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.79 137.48 53.36 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -124.37 105.37 9.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 169.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.82 112.85 24.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.78 151.87 21.17 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.719 0.808 . . . . 0.0 109.116 174.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -149.39 126.5 11.32 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 44.7 22.36 0.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.176 2.59 . . . . 0.0 115.097 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.32 -22.57 3.21 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.229 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.13 159.33 42.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.921 1.36 . . . . 0.0 112.679 -168.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.69 134.04 30.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.27 -18.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.092 1.357 . . . . 0.0 110.917 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -144.7 154.8 43.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.41 133.69 15.3 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 p -150.55 158.36 44.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.474 0.579 . . . . 0.0 109.926 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.22 71.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 122.387 1.089 . . . . 0.0 108.708 -169.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 157.22 12.15 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 121.287 -0.883 . . . . 0.0 111.422 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.85 148.78 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.995 0.518 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -142.56 131.03 11.63 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.36 167.94 17.4 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.809 1.673 . . . . 0.0 109.723 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -46.24 -46.07 17.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.717 1.607 . . . . 0.0 112.468 -176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.86 -42.98 69.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.229 0.468 . . . . 0.0 111.461 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.93 79.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.722 -0.612 . . . . 0.0 110.631 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -54.5 42.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.56 0.744 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.34 -38.75 92.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.626 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.49 -47.62 84.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.993 0.815 . . . . 0.0 110.884 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.61 -43.86 80.57 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.766 0.827 . . . . 0.0 110.693 -174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.72 -33.03 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.747 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 7.5 t30 -61.89 -26.92 68.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.653 1.115 . . . . 0.0 111.552 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -22.91 35.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.13 0.972 . . . . 0.0 112.629 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -129.74 -22.02 3.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.736 0.814 . . . . 0.0 112.393 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 1.7 tm? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.99 2.116 . . . . 0.0 108.543 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.76 136.69 45.53 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.251 6.5 m120 67.35 120.78 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 128.542 2.737 . . . . 0.0 111.417 -170.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -148.89 137.38 21.12 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 129.178 2.991 . . . . 0.0 104.145 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.67 139.93 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 109.159 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tt -137.61 143.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.429 ' CD1' HD23 ' B' ' 72' ' ' LEU . 24.1 t80 -138.08 142.95 40.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -169.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -115.8 144.36 44.11 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 mt -133.19 122.28 23.77 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.4 p -165.82 156.89 13.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.349 1.06 . . . . 0.0 109.673 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 56.0 m -52.24 118.61 3.64 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.33 1.052 . . . . 0.0 112.129 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.58 3.26 2.1 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 124.892 1.37 . . . . 0.0 113.979 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 39.51 24.18 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.438 2.695 . . . . 0.0 114.54 -169.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 -40.08 77.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.36 -73.28 0.51 Allowed 'General case' 0 C--O 1.227 -0.08 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -168.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -32.83 68.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.641 -0.662 . . . . 0.0 112.377 -169.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -43.77 76.75 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.366 1.066 . . . . 0.0 110.379 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -55.75 -45.26 78.06 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 110.388 174.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 16.3 ttm -67.99 -46.42 71.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.829 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.23 87.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.31 0.644 . . . . 0.0 111.218 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.96 -28.65 57.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.268 0.94 . . . . 0.0 110.644 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.93 -44.53 46.18 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.434 ' HE1' ' HB2' ' B' ' 124' ' ' ARG . 23.1 m95 -54.49 -41.97 70.18 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.158 0.979 . . . . 0.0 110.887 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' B' ' 28' ' ' LEU . . . -61.33 -50.68 71.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -66.45 -21.5 66.2 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.387 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -66.31 -16.67 64.23 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.467 1.03 . . . . 0.0 113.025 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.67 -4.49 4.14 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.587 1.155 . . . . 0.0 113.007 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.468 HD12 ' HB1' ' B' ' 24' ' ' ALA . 22.9 mt -121.01 89.75 3.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.51 -171.6 1.38 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.815 0.722 . . . . 0.0 111.962 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.46 -18.15 16.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.436 1.094 . . . . 0.0 112.893 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -54.07 -18.86 4.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.518 1.927 . . . . 0.0 112.655 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.26 158.22 44.72 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.817 1.247 . . . . 0.0 109.62 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -130.35 133.36 46.36 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.014 0.926 . . . . 0.0 108.572 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.72 142.96 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.669 1.587 . . . . 0.0 107.367 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.97 159.47 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 m -139.82 142.37 36.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.07 178.22 10.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.104 0.962 . . . . 0.0 109.839 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.11 -177.71 47.67 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -44.21 -57.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.676 1.99 . . . . 0.0 114.154 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.98 29.59 4.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.335 1.454 . . . . 0.0 108.446 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.3 42.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.46 1.904 . . . . 0.0 113.964 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 75.7 t60 141.17 104.43 0.0 OUTLIER 'General case' 0 C--O 1.235 0.34 0 C-N-CA 130.656 3.582 . . . . 0.0 104.361 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.94 48.19 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -171.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -163.19 94.68 0.83 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.29 1.836 . . . . 0.0 106.67 169.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -68.99 126.55 92.88 Favored Pre-proline 0 C--O 1.239 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.64 -20.87 60.11 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.99 1.794 . . . . 0.0 112.846 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.405 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -62.37 -37.23 84.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.508 1.049 . . . . 0.0 111.199 171.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.98 -34.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.33 -52.18 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -56.21 -46.58 79.4 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.88 0.764 . . . . 0.0 110.553 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.37 -32.46 64.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.007 0.923 . . . . 0.0 111.842 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.7 -38.56 25.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.695 0.798 . . . . 0.0 110.76 177.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -27.21 69.15 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.983 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.423 ' CD ' ' HE ' ' B' ' 124' ' ' ARG . 35.3 mt-10 -55.05 -32.67 62.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.478 1.035 . . . . 0.0 111.817 172.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.12 14.56 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.042 1.337 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.77 35.42 91.99 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.38 -1.233 . . . . 0.0 113.152 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.2 mt -104.95 145.16 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 170.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.66 136.0 53.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 29.0 pt -138.15 17.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 110.655 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -60.39 -13.91 15.9 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -91.72 -14.28 30.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.751 1.62 . . . . 0.0 113.237 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.21 151.31 23.28 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.539 1.161 . . . . 0.0 112.417 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.5 t -152.87 171.79 17.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.588 1.955 . . . . 0.0 107.105 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.0 m -153.69 -167.8 2.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.845 0.858 . . . . 0.0 111.028 -169.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -159.53 168.54 25.92 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.809 1.644 . . . . 0.0 109.562 -171.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.52 172.5 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.111 1.364 . . . . 0.0 112.134 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.421 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.7 OUTLIER -48.31 132.86 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -143.98 100.17 3.52 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.309 1.052 . . . . 0.0 109.457 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.0 m -44.77 -32.32 1.5 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.108 2.163 . . . . 0.0 113.974 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.8 -17.3 64.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.128 0.876 . . . . 0.0 112.351 -174.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.16 -35.62 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.111 0.965 . . . . 0.0 108.842 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.429 HD23 ' CD1' ' B' ' 7' ' ' TYR . 2.2 tm? -63.01 -57.3 11.17 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.584 1.084 . . . . 0.0 109.98 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -22.36 66.93 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.44 0.564 . . . . 0.0 110.05 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.84 -24.38 44.44 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.064 2.146 . . . . 0.0 112.696 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.2 167.71 2.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.854 1.262 . . . . 0.0 111.347 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.9 -30.77 14.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.33 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.48 HD23 ' HE2' ' B' ' 97' ' ' LYS . 1.7 tm? -149.19 135.5 19.24 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 110.505 -172.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.425 ' N ' HD22 ' B' ' 77' ' ' LEU . 10.7 t -107.02 108.02 24.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 127.494 2.318 . . . . 0.0 107.983 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.09 106.32 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -72.97 122.3 21.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 167.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.2 132.92 42.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 127.415 2.286 . . . . 0.0 113.293 176.26 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.67 42.67 0.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.421 1.489 . . . . 0.0 112.075 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm 61.27 -149.79 0.4 Allowed 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.306 -1.496 . . . . 0.0 107.064 -168.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -139.74 71.21 36.85 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.83 129.27 29.89 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.93 1.754 . . . . 0.0 109.019 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.24 5.83 45.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p 39.08 88.65 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 127.942 2.497 . . . . 0.0 113.03 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -58.47 139.0 88.91 Favored 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 122.382 2.055 . . . . 0.0 108.663 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.65 -0.24 1.85 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.957 3.771 . . . . 0.0 115.455 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -61.75 -12.64 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.451 1.101 . . . . 0.0 111.26 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.42 149.03 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.487 1.515 . . . . 0.0 109.237 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HE2' HD23 ' B' ' 77' ' ' LEU . 5.1 tmmm? -82.97 155.56 23.93 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 ttm-85 -139.7 144.67 37.66 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.126 -0.984 . . . . 0.0 108.479 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -150.85 147.7 27.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.6 130.9 35.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -116.75 18.42 14.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.48 162.35 35.33 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -137.53 18.93 2.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.517 1.127 . . . . 0.0 110.15 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.12 158.38 44.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.178 1.791 . . . . 0.0 107.535 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -134.14 119.64 14.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.873 1.269 . . . . 0.0 107.663 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 -27.2 40.76 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.343 2.695 . . . . 0.0 112.56 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.1 -5.22 6.07 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.633 1.106 . . . . 0.0 112.709 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -100.99 8.25 43.12 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.61 1.164 . . . . 0.0 111.356 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.63 144.05 2.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.17 -45.78 75.75 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 123.845 0.716 . . . . 0.0 109.98 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.74 -16.04 4.04 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.8 p -68.76 162.23 26.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.67 -38.78 92.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 110.776 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.69 -42.57 77.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 117.109 -1.424 . . . . 0.0 109.206 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.58 -31.56 62.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 120.925 1.693 . . . . 0.0 109.555 -175.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -56.64 -63.58 1.15 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -58.24 -39.63 79.63 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.04 94.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.812 0.845 . . . . 0.0 112.231 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.71 -45.61 85.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.825 0.739 . . . . 0.0 109.564 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.9 m-30 -64.84 -43.36 93.29 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -175.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -67.35 -41.99 84.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.611 0.764 . . . . 0.0 111.097 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -59.43 -52.23 66.51 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.32 -42.04 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.396 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.434 ' HB2' ' HE1' ' B' ' 23' ' ' TRP . 41.1 ptt85 -62.24 -37.4 85.25 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.094 1.316 . . . . 0.0 111.471 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.84 -44.01 94.45 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.228 0.33 . . . . 0.0 110.299 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.08 -57.69 9.77 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.738 0.415 . . . . 0.0 110.22 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 12.4 mt -57.53 -47.9 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.345 1.058 . . . . 0.0 109.727 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.35 97.74 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.984 -0.898 . . . . 0.0 111.31 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -44.6 88.25 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.651 1.225 . . . . 0.0 110.762 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.58 92.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.1 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.24 -38.45 78.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.691 1.132 . . . . 0.0 111.328 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.89 -41.18 99.32 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -60.84 -39.95 91.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 116.988 -1.482 . . . . 0.0 110.993 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -58.9 -37.54 76.85 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.856 2.116 . . . . 0.0 111.26 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -31.28 71.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.132 0.573 . . . . 0.0 112.496 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.66 -43.54 10.67 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.537 . . . . 0.0 111.17 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.5 p -89.78 -24.29 21.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.21 1.804 . . . . 0.0 110.729 -169.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 55.29 31.62 56.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 111.608 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt . . . . . 0 C--O 1.245 0.826 0 C-N-CA 123.97 0.908 . . . . 0.0 111.477 -172.438 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.72 165.32 36.35 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.765 1.226 . . . . 0.0 108.176 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.08 101.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 t -80.48 169.47 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.882 1.673 . . . . 0.0 107.54 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.89 53.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.709 0.804 . . . . 0.0 109.188 169.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.463 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -97.23 171.51 8.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.998 1.719 . . . . 0.0 109.713 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -134.94 -170.25 2.53 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.472 1.509 . . . . 0.0 108.821 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -45.09 -29.27 0.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.374 2.27 . . . . 0.0 113.488 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -135.88 -31.18 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.976 1.311 . . . . 0.0 112.097 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -63.53 -21.36 66.29 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.69 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -52.18 -58.04 7.8 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.185 0.902 . . . . 0.0 109.417 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -60.71 -43.85 97.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.956 0.344 . . . . 0.0 110.185 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.15 77.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.367 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -84.23 -15.81 45.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.393 1.077 . . . . 0.0 113.109 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.2 p -114.95 -7.15 12.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.755 1.161 . . . . 0.0 113.805 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -74.7 -5.62 44.21 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.1 153.49 45.45 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.558 1.143 . . . . 0.0 109.053 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.98 -161.02 49.99 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.058 0.837 . . . . 0.0 111.148 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.56 129.53 70.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.15 119.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.157 -168.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.7 98.45 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.84 150.89 27.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -140.46 150.73 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.573 1.549 . . . . 0.0 109.319 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -132.66 115.74 15.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.587 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -136.62 152.9 50.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.919 1.688 . . . . 0.0 107.988 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.9 163.27 6.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.036 0.835 . . . . 0.0 110.41 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.63 -11.98 3.9 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.364 3.376 . . . . 0.0 116.719 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -59.98 -17.44 38.32 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.865 1.211 . . . . 0.0 113.811 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.95 155.68 41.83 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.945 1.248 . . . . 0.0 114.07 -170.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.88 -46.68 80.68 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.725 -1.597 . . . . 0.0 112.81 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -49.0 -31.05 19.43 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.4 2.734 . . . . 0.0 114.785 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -60.52 -15.18 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 120.06 1.3 . . . . 0.0 114.028 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 9.45 13.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.286 1.435 . . . . 0.0 111.339 176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.6 mtm -120.1 -44.61 2.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.311 1.044 . . . . 0.0 109.486 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.97 -36.42 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.16 18.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.768 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.11 -39.86 55.9 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.879 1.719 . . . . 0.0 111.728 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.664 HG12 HD22 ' A' ' 96' ' ' LEU . 2.6 t -57.16 -33.73 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.328 1.051 . . . . 0.0 111.468 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.81 -41.63 59.6 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.888 0.767 . . . . 0.0 110.687 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.74 -33.09 75.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.203 0.911 . . . . 0.0 109.709 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.04 -25.76 63.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.018 1.327 . . . . 0.0 111.672 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.405 HD11 ' SD ' ' A' ' 46' ' ' MET . 58.2 tp -77.1 -44.72 29.5 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 119.063 0.847 . . . . 0.0 109.96 173.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.49 -34.79 70.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.671 -0.643 . . . . 0.0 111.112 -172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.67 -10.69 59.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.511 -0.743 . . . . 0.0 112.251 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -99.79 -42.77 6.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.279 1.432 . . . . 0.0 110.931 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 42' ' ' LEU . 20.1 ptm -143.08 18.38 1.94 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.37 0.668 . . . . 0.0 112.399 -172.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.43 -4.6 13.33 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 121.243 -0.911 . . . . 0.0 114.299 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.69 -23.63 66.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.026 0.93 . . . . 0.0 110.919 169.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.24 -11.76 8.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.527 1.131 . . . . 0.0 112.48 -174.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -128.29 148.62 50.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.982 1.313 . . . . 0.0 111.454 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -114.42 147.56 39.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mt -125.22 141.07 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 6' ' ' ALA . 12.4 t -138.95 113.02 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.8 mtpt -86.54 155.08 20.63 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.243 -0.91 . . . . 0.0 110.337 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.75 122.52 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.58 108.74 12.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.306 33.6 m -79.2 47.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -153.01 -41.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.791 1.237 . . . . 0.0 108.984 167.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -83.64 -34.6 25.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.065 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -134.62 27.78 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.958 1.303 . . . . 0.0 110.807 -170.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -71.55 -7.54 48.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.021 0.928 . . . . 0.0 112.851 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -49.05 -51.96 28.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.768 2.027 . . . . 0.0 110.322 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.2 m -61.34 -32.6 72.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.636 0.775 . . . . 0.0 111.829 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.74 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.77 -46.58 7.51 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.676 0.655 . . . . 0.0 113.325 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -60.35 -40.68 91.59 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.097 0.959 . . . . 0.0 111.631 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -89.98 -0.0 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.811 0.845 . . . . 0.0 112.497 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.05 68.81 1.44 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t -146.45 129.99 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 100.951 -3.722 . . . . 0.0 100.951 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -144.44 16.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.306 0.242 . . . . 0.0 110.847 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -130.77 170.11 14.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.121 2.568 . . . . 0.0 112.64 -168.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.88 143.52 46.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.695 0.798 . . . . 0.0 108.902 172.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.26 154.26 65.73 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 -11.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -127.48 147.45 50.31 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -124.3 137.69 54.47 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 106.655 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.7 mt -124.27 107.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -82.41 110.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.3 mp -106.61 148.71 27.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -147.68 125.44 11.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 41.17 30.44 0.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.27 2.628 . . . . 0.0 114.413 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.66 -23.38 4.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.827 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.27 156.88 46.3 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.244 1.522 . . . . 0.0 113.263 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.07 135.76 27.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.14 -22.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.182 1.393 . . . . 0.0 110.554 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -147.4 163.83 35.23 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.287 1.035 . . . . 0.0 110.418 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.34 149.19 30.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -153.46 142.44 21.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.6 72.71 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.35 156.73 8.43 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.441 1.496 . . . . 0.0 110.05 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.3 148.39 51.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.371 0.668 . . . . 0.0 110.456 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.7 141.79 26.2 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.2 167.61 25.69 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.463 2.109 . . . . 0.0 110.834 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.32 -47.72 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 112.799 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.07 -42.51 76.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 110.799 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -32.44 73.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.111 -0.368 . . . . 0.0 110.436 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.664 HD22 HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -57.95 -54.56 45.51 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.563 1.145 . . . . 0.0 109.681 172.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.87 -39.24 90.51 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.6 -46.29 90.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.314 0.506 . . . . 0.0 111.325 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.86 -41.0 81.5 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.198 0.999 . . . . 0.0 111.105 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.9 -37.32 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.252 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -57.79 -25.88 61.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.632 1.105 . . . . 0.0 112.553 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -53.08 -26.75 17.23 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.005 0.922 . . . . 0.0 112.645 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -128.88 -23.96 3.01 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 112.674 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 170.224 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.96 35.0 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.032 -1.043 . . . . 0.0 110.696 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -152.39 131.69 12.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -137.94 118.62 14.03 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 129.315 3.046 . . . . 0.0 106.431 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mm -90.56 131.78 36.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tt -133.62 135.0 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -169.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -117.15 144.14 45.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -131.75 128.37 38.72 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.232 1.013 . . . . 0.0 108.622 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 66.7 m -148.38 144.27 27.38 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 124.577 1.151 . . . . 0.0 109.096 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 26.2 m -53.69 121.21 7.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.915 0.886 . . . . 0.0 110.185 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.537 ' H ' ' CG2' ' B' ' 39' ' ' ILE . . . 50.01 35.01 24.72 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.948 1.261 . . . . 0.0 111.792 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -31.58 101.85 0.02 OUTLIER 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -135.8 -0.98 2.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.997 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.81 -79.33 0.37 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.194 1.361 . . . . 0.0 113.264 -169.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -46.12 75.67 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.714 0.806 . . . . 0.0 113.074 -169.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.8 m -69.47 -28.56 66.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.111 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -68.26 -47.04 68.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.689 1.131 . . . . 0.0 110.073 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.14 -42.27 76.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.258 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.35 96.85 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.584 -0.697 . . . . 0.0 111.367 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.17 -30.96 65.5 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.1 0.863 . . . . 0.0 110.898 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.58 -50.31 62.87 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -57.22 -33.36 67.45 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.347 1.059 . . . . 0.0 112.225 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.01 -53.41 7.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.571 0.748 . . . . 0.0 111.234 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -68.46 -17.98 64.31 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -168.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.1 -17.75 54.27 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.415 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 33.1 m-85 -126.46 -37.6 2.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.373 0.988 . . . . 0.0 111.996 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.24 71.79 4.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.757 1.623 . . . . 0.0 106.62 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.05 -147.14 0.09 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.562 2.03 . . . . 0.0 114.671 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.19 -23.82 62.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.461 1.104 . . . . 0.0 113.021 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -65.37 -13.27 58.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.247 1.019 . . . . 0.0 113.244 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -123.53 151.93 42.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.431 1.014 . . . . 0.0 111.712 -169.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -132.12 82.74 2.04 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.633 1.973 . . . . 0.0 105.854 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.71 139.68 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.31 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -144.8 166.87 24.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 p -143.28 145.91 33.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.771 -0.581 . . . . 0.0 111.615 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.75 177.79 10.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.296 0.638 . . . . 0.0 112.38 -173.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.35 -178.75 48.53 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.643 0.64 . . . . 0.0 112.289 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.537 ' CG2' ' H ' ' B' ' 12' ' ' GLY . 2.9 tt -46.64 -56.35 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 127.632 2.373 . . . . 0.0 113.272 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -133.87 30.49 3.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.569 1.548 . . . . 0.0 108.779 -172.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 154.79 40.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.843 2.057 . . . . 0.0 112.075 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 137.45 82.88 0.0 OUTLIER 'General case' 0 C--O 1.236 0.37 0 C-N-CA 130.891 3.676 . . . . 0.0 105.274 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.21 175.3 46.64 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -172.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.3 88.92 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -60.48 124.4 78.32 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 125.544 1.538 . . . . 0.0 108.056 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.76 -18.41 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.799 1.666 . . . . 0.0 112.401 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -59.12 -56.81 17.43 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.86 1.209 . . . . 0.0 108.429 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.37 76.05 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.894 1.225 . . . . 0.0 109.719 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.86 -55.81 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.44 -45.51 80.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.917 0.887 . . . . 0.0 110.486 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.89 56.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.378 1.871 . . . . 0.0 111.17 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 73.9 mmm -92.68 -32.16 14.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.632 0.773 . . . . 0.0 111.765 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.06 -26.67 67.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.846 171.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -58.54 -28.73 65.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.412 1.006 . . . . 0.0 112.019 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.46 16.34 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.873 1.269 . . . . 0.0 110.578 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.09 95.21 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.643 -1.087 . . . . 0.0 112.608 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.5 mt -114.32 109.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.51 132.66 43.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 13.8 pt -134.9 18.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.566 1.146 . . . . 0.0 111.019 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.4 m -65.31 14.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -169.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -140.8 -2.7 1.32 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.95 2.5 . . . . 0.0 112.173 -176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -47.34 -59.52 3.14 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p 53.06 -171.72 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.74 1.616 . . . . 0.0 112.293 -171.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -163.08 -169.53 2.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.459 1.104 . . . . 0.0 109.029 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.2 168.76 23.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.193 2.597 . . . . 0.0 106.555 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.85 175.4 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 120.212 1.369 . . . . 0.0 112.295 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -54.42 36.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 C-N-CA 129.195 2.998 . . . . 0.0 118.11 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -52.32 106.4 0.15 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.93 2.092 . . . . 0.0 113.532 -173.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.1 m -51.51 -26.35 8.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.113 1.765 . . . . 0.0 114.378 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.69 -23.94 66.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.57 1.077 . . . . 0.0 111.845 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.31 -40.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -58.8 -51.61 69.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.355 0.525 . . . . 0.0 110.779 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -26.01 64.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.488 0.586 . . . . 0.0 110.941 -177.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -79.53 -19.14 50.28 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.435 1.094 . . . . 0.0 112.229 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.08 159.19 7.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 111.222 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.3 -22.77 35.51 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.867 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.424 HD23 ' H ' ' B' ' 78' ' ' VAL . 0.5 OUTLIER -152.81 153.22 32.69 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.106 0.962 . . . . 0.0 111.132 -177.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.424 ' H ' HD23 ' B' ' 77' ' ' LEU . 61.1 t -122.52 99.32 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 127.22 2.208 . . . . 0.0 105.657 169.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.39 100.46 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.7 m -70.57 125.98 28.32 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.28 136.08 33.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 CA--C 1.538 0.517 0 C-N-CA 128.488 2.715 . . . . 0.0 113.509 175.131 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -72.01 35.45 0.06 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.97 1.308 . . . . 0.0 113.751 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 64.46 35.23 9.64 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.113 1.765 . . . . 0.0 112.853 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.8 p 33.07 50.54 0.68 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.552 1.941 . . . . 0.0 113.151 174.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.28 133.99 61.45 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.452 2.101 . . . . 0.0 114.0 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.456 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -76.69 -23.77 53.18 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.313 175.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p 51.86 117.83 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.712 2.405 . . . . 0.0 113.367 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.38 150.26 64.16 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.931 1.754 . . . . 0.0 109.285 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.86 -5.45 10.63 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.634 2.89 . . . . 0.0 114.125 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -62.11 -17.31 57.31 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.197 0.999 . . . . 0.0 112.086 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.95 149.99 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.217 0.917 . . . . 0.0 111.031 -173.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -75.66 151.91 37.66 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.482 1.113 . . . . 0.0 108.954 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 ttp-105 -139.07 137.95 36.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -147.69 149.43 32.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -91.78 133.8 35.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . 0.411 ' CZ2' ' HE3' ' B' ' 139' ' ' LYS . 88.6 m95 -125.51 9.36 7.78 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.0 159.93 27.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.5 9.19 4.67 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.705 0.802 . . . . 0.0 111.289 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -150.19 163.72 37.51 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.097 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.34 121.47 15.39 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 125.097 1.359 . . . . 0.0 108.608 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.544 ' HD3' HG11 ' B' ' 123' ' ' VAL . 58.2 Cg_endo -69.97 -29.63 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.859 2.373 . . . . 0.0 112.166 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.26 -7.62 6.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.256 0.934 . . . . 0.0 112.994 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt-85 -83.74 -1.65 54.61 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.085 -0.959 . . . . 0.0 112.095 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' B' ' 116' ' ' LYS . . . -34.64 127.4 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.73 1.612 . . . . 0.0 112.507 -175.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -69.3 136.76 52.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.98 29.88 2.39 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -167.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 26.3 p -89.57 159.32 17.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.565 1.683 . . . . 0.0 107.262 169.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.95 -37.2 83.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.31 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -77.31 -43.09 34.32 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 117.489 -1.244 . . . . 0.0 109.409 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.1 -27.33 54.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 120.563 1.529 . . . . 0.0 110.269 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . 0.576 ' HA ' ' HB1' ' B' ' 109' ' ' ALA . 7.8 mtpt -59.83 -57.42 12.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -60.2 -40.91 91.74 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.08 91.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.069 0.948 . . . . 0.0 111.932 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.73 -45.46 92.61 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.617 0.644 . . . . 0.0 109.786 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.66 -49.89 74.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -62.2 -47.0 86.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.778 1.231 . . . . 0.0 110.11 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -56.87 -55.39 35.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.544 HG11 ' HD3' ' B' ' 106' ' ' PRO . 49.8 t -75.13 -39.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.119 -171.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -64.05 -39.48 94.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.751 1.614 . . . . 0.0 111.281 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.95 -41.89 95.1 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.216 0.462 . . . . 0.0 111.105 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -67.36 -46.92 71.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.819 0.448 . . . . 0.0 110.07 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.0 mt -53.09 -49.39 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.042 1.337 . . . . 0.0 108.607 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.99 -50.19 70.5 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 118.387 0.539 . . . . 0.0 112.538 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -64.03 -41.67 97.35 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.632 0.216 . . . . 0.0 110.724 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -66.62 -43.54 84.47 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.615 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.5 mm? -65.05 -34.32 78.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.759 1.163 . . . . 0.0 111.376 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.415 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 39.3 ttmt -60.94 -32.07 71.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.194 0.906 . . . . 0.0 111.16 174.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.05 -30.19 71.4 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-O 116.902 -1.523 . . . . 0.0 112.06 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -63.1 -37.37 86.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 122.454 2.388 . . . . 0.0 109.785 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.89 73.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.611 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -81.92 -43.3 18.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.366 1.066 . . . . 0.0 112.049 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 82.1 p -88.34 -18.38 28.58 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.65 1.98 . . . . 0.0 111.074 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.51 15.16 75.17 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.158 0.885 . . . . 0.0 112.107 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.411 ' HE3' ' CZ2' ' B' ' 101' ' ' TRP . 5.0 ttpm? . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.116 1.367 . . . . 0.0 109.434 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.76 155.64 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.786 2.434 . . . . 0.0 111.839 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.5 107.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.2 t -79.48 167.14 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.904 1.682 . . . . 0.0 107.988 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -122.99 119.25 29.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.123 1.369 . . . . 0.0 107.924 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.67 168.92 19.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.914 0.886 . . . . 0.0 108.783 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 p -135.26 -167.23 1.97 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.781 1.232 . . . . 0.0 109.354 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -51.88 -20.33 2.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.143 1.777 . . . . 0.0 113.751 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -140.78 -31.72 0.6 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.667 1.187 . . . . 0.0 112.811 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.4 m -63.26 -19.57 64.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.165 0.893 . . . . 0.0 112.202 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -50.6 -55.18 17.44 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 109.76 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -62.29 -44.23 96.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.104 -0.372 . . . . 0.0 110.036 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.06 83.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.946 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -79.87 -19.6 47.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.991 0.917 . . . . 0.0 113.047 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 p -108.96 -7.51 15.39 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.661 1.119 . . . . 0.0 112.943 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -72.22 -7.2 47.96 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -141.8 154.11 44.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 109.615 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.82 -157.15 51.13 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 124.951 1.262 . . . . 0.0 111.996 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 t -113.43 131.41 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 t -140.13 116.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 122.257 1.027 . . . . 0.0 108.493 -169.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.69 121.59 25.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.3 36.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -141.57 149.86 41.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 109.538 -170.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 31.4 m-85 -132.2 113.25 13.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.652 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.1 p-90 -132.76 149.3 52.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.845 1.658 . . . . 0.0 107.876 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.88 165.12 6.07 Favored Pre-proline 0 C--O 1.235 0.331 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.34 -17.44 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.882 3.055 . . . . 0.0 116.02 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -52.48 -26.8 13.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.854 1.662 . . . . 0.0 114.318 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.55 150.92 48.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.721 1.146 . . . . 0.0 111.509 -172.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.25 -50.9 57.16 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.496 -1.169 . . . . 0.0 111.459 172.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -46.54 -26.15 4.03 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.423 3.415 . . . . 0.0 117.076 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -56.51 -35.46 68.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 121.538 1.972 . . . . 0.0 111.726 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -90.18 7.92 35.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.963 0.905 . . . . 0.0 111.883 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -118.56 -42.82 2.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.023 0.929 . . . . 0.0 109.606 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.63 -33.99 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.793 0.837 . . . . 0.0 109.269 169.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.8 -60.95 7.87 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.08 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.14 -40.19 72.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.07 1.847 . . . . 0.0 111.614 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.18 -40.02 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.473 0.579 . . . . 0.0 110.525 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.72 -39.32 64.38 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.767 0.712 . . . . 0.0 111.574 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.37 -34.92 79.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.43 1.014 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.54 -17.85 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.198 1.399 . . . . 0.0 112.643 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.0 tp -86.94 -43.63 12.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.235 1.014 . . . . 0.0 108.794 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB2' HD12 ' A' ' 52' ' ' ILE . 22.7 t70 -71.78 -37.46 70.46 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.146 -0.346 . . . . 0.0 110.945 -175.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.8 -11.86 59.38 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.561 . . . . 0.0 111.942 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -100.02 -47.85 4.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -135.81 15.01 3.36 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.504 0.722 . . . . 0.0 112.392 -170.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.83 -2.09 21.43 Favored Glycine 0 CA--C 1.52 0.383 0 O-C-N 121.093 -1.004 . . . . 0.0 113.951 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.21 -25.27 65.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.696 0.798 . . . . 0.0 110.624 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 -26.84 9.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 -177.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.0 tp -119.76 146.53 45.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.036 1.335 . . . . 0.0 111.886 -168.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -103.31 143.54 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 168.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 43' ' ' ASP . 15.1 mt -124.74 136.48 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.39 124.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.652 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpp -99.85 156.28 17.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.036 0.834 . . . . 0.0 109.716 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mm -116.61 127.95 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.01 104.99 10.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 169.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.01 41.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.437 1.113 . . . . 0.0 111.844 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.1 -44.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.594 1.158 . . . . 0.0 110.479 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 110.262 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.75 30.22 3.76 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.59 1.156 . . . . 0.0 110.74 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -3.56 32.56 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.434 1.094 . . . . 0.0 112.586 -169.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -52.14 -45.16 64.9 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.584 1.554 . . . . 0.0 111.233 -169.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -65.71 -26.27 67.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' B' ' 91' ' ' MET . . . -68.48 -64.33 0.89 Allowed 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.072 -1.018 . . . . 0.0 108.801 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.22 -38.48 19.03 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.937 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -60.82 -48.58 81.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.37 1.585 . . . . 0.0 110.117 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.54 -13.2 60.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.569 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.95 55.93 14.69 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.67 -43.82 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.507 ' HG3' HD12 ' B' ' 67' ' ' ILE . 9.6 ptm 45.29 19.77 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 129.415 3.086 . . . . 0.0 113.567 174.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -133.72 155.66 49.35 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.039 1.736 . . . . 0.0 109.516 -174.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.9 mt -142.45 143.64 27.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 119.034 0.834 . . . . 0.0 109.091 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -67.52 144.83 72.62 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.303 0.787 . . . . 0.0 110.317 -10.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 53.5 m -114.4 142.03 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.89 136.08 54.12 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.8 mt -125.93 109.15 12.14 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 103.784 -2.673 . . . . 0.0 103.784 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.8 t -83.53 118.51 31.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.11 151.58 36.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.19 0.996 . . . . 0.0 108.498 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -147.87 144.04 27.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 43.69 28.4 0.22 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.952 2.101 . . . . 0.0 113.67 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.16 8.09 55.53 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.928 1.251 . . . . 0.0 116.164 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -134.99 147.87 49.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.926 1.363 . . . . 0.0 111.886 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.0 140.7 17.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.98 0.912 . . . . 0.0 109.186 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.42 -20.79 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.982 1.313 . . . . 0.0 111.122 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.74 161.67 40.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.173 0.989 . . . . 0.0 109.713 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 m -154.19 148.74 26.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.1 m -151.58 150.2 30.04 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.383 1.073 . . . . 0.0 108.531 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -133.18 63.0 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.591 1.556 . . . . 0.0 107.135 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.53 168.13 37.36 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.647 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.06 152.21 45.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.183 0.993 . . . . 0.0 111.034 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 141.2 17.51 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 169.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.81 168.38 23.09 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.447 2.098 . . . . 0.0 110.388 173.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -44.69 65.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 112.524 -170.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.83 -43.84 74.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 117.472 0.124 . . . . 0.0 110.867 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.25 75.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.973 -0.454 . . . . 0.0 110.346 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -53.74 53.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.805 . . . . 0.0 109.844 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.61 -38.25 90.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -61.78 -48.25 81.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.508 0.595 . . . . 0.0 110.75 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -55.86 -44.27 77.9 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 124.457 1.103 . . . . 0.0 110.898 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.03 -37.04 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.508 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 8.0 t30 -58.94 -26.36 64.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.172 0.989 . . . . 0.0 112.208 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -22.67 39.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.644 0.778 . . . . 0.0 112.459 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -131.12 -19.67 2.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.133 0.973 . . . . 0.0 112.969 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 1.7 tm? . . . . . 0 C--O 1.248 1.017 0 C-N-CA 127.521 2.329 . . . . 0.0 107.87 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.84 128.62 36.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.22 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.325 2.65 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -137.83 128.74 27.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -92.88 144.65 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.623 0.577 . . . . 0.0 110.377 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.7 147.98 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.642 1.577 . . . . 0.0 106.746 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.45 142.64 37.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -169.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -97.84 143.27 28.62 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -145.27 131.42 19.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -169.79 172.01 6.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.32 1.848 . . . . 0.0 108.96 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -48.61 125.01 9.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.495 1.518 . . . . 0.0 109.832 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.49 4.9 0.27 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.209 1.861 . . . . 0.0 117.699 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . 0.406 ' HB2' ' HB1' ' B' ' 41' ' ' ALA . 5.0 t30 47.4 18.32 0.1 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.63 1.715 . . . . 0.0 113.315 -169.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 9.9 p -84.43 57.42 4.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.341 2.257 . . . . 0.0 114.787 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 136.94 -58.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.446 3.098 . . . . 0.0 113.433 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -53.95 -53.97 45.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.807 0.843 . . . . 0.0 110.948 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.39 -33.16 72.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.88 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -58.7 -48.33 81.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.681 0.673 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 8.1 ptp -69.83 -41.51 74.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.09 99.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.507 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.08 -31.11 68.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.755 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.57 60.88 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.502 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 25.5 m95 -56.56 -36.47 69.35 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.619 1.168 . . . . 0.0 111.688 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.41 -55.12 8.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 122.577 0.351 . . . . 0.0 110.477 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.35 -24.44 67.25 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.88 -16.17 63.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.29 0.95 . . . . 0.0 113.364 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.462 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 7.5 m-85 -124.7 -12.46 7.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 112.858 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -114.69 83.45 1.9 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.126 -2.175 . . . . 0.0 105.126 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.49 -168.73 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.421 1.01 . . . . 0.0 112.075 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.51 -5.03 4.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.177 0.991 . . . . 0.0 113.07 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.35 -24.81 67.55 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.623 -1.298 . . . . 0.0 109.564 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -123.11 179.31 4.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.474 1.91 . . . . 0.0 108.93 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -155.48 127.6 7.64 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.3 p -123.32 143.42 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.909 0.484 . . . . 0.0 110.094 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.49 171.23 14.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.151 1.78 . . . . 0.0 108.76 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -147.07 145.35 29.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.289 1.035 . . . . 0.0 109.126 -172.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.94 170.58 21.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.166 0.987 . . . . 0.0 111.775 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.76 178.61 46.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.202 1.382 . . . . 0.0 110.554 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 tt -48.67 -54.54 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.541 1.936 . . . . 0.0 113.775 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -135.1 31.42 3.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.097 1.759 . . . . 0.0 108.035 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' B' ' 13' ' ' ASN . . . -66.12 128.15 34.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.599 1.959 . . . . 0.0 115.957 -168.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -166.41 1.38 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.641 2.376 . . . . 0.0 110.62 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.9 109.49 3.44 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 120.725 -1.234 . . . . 0.0 114.864 -168.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.6 tp -82.52 83.13 7.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -62.12 123.68 79.04 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.633 -0.698 . . . . 0.0 109.782 -176.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.73 -23.42 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.224 1.95 . . . . 0.0 113.201 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -33.73 76.16 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.762 1.165 . . . . 0.0 110.856 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -34.46 50.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.187 0.449 . . . . 0.0 109.947 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.67 -51.38 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -56.49 -46.12 80.65 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.287 0.635 . . . . 0.0 110.709 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.49 -32.56 58.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.26 1.024 . . . . 0.0 112.323 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mmm -90.54 -30.06 17.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.241 -0.912 . . . . 0.0 111.323 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.87 -24.73 67.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.437 169.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.436 ' CD ' HH21 ' B' ' 124' ' ' ARG . 42.8 mt-10 -55.52 -36.37 66.65 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.829 1.195 . . . . 0.0 111.201 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.28 15.92 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.19 1.396 . . . . 0.0 111.296 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.56 41.58 99.12 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.036 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 39.1 mt -114.64 116.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 171.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.79 132.12 43.17 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -131.78 13.08 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.28 169.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 75.3 p -59.76 -17.59 36.46 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.667 1.121 . . . . 0.0 111.495 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -80.37 -12.5 59.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.503 2.321 . . . . 0.0 114.282 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -69.96 157.0 38.29 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.374 1.443 . . . . 0.0 112.335 -171.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -129.65 168.81 15.9 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.542 2.337 . . . . 0.0 108.809 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.3 m -156.21 168.62 26.71 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.948 -1.095 . . . . 0.0 110.714 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -162.79 162.67 26.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.68 1.992 . . . . 0.0 108.763 -169.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.24 172.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 0.0 112.424 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.507 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.3 OUTLIER -50.39 133.31 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -145.5 99.96 3.37 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.167 0.984 . . . . 0.0 108.8 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -49.55 -28.0 5.09 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.673 1.989 . . . . 0.0 113.699 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.65 -18.37 63.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.247 0.93 . . . . 0.0 112.387 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.68 -34.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.089 0.956 . . . . 0.0 108.745 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.03 -54.9 14.97 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.594 1.088 . . . . 0.0 110.173 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -26.31 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.906 0.776 . . . . 0.0 110.159 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -72.83 -24.04 60.85 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 112.357 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.35 164.74 4.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.851 1.261 . . . . 0.0 112.194 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.15 -31.0 15.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.134 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -145.16 135.93 24.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.283 1.033 . . . . 0.0 110.661 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 t -113.56 115.02 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.28 108.81 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.7 m -73.92 145.61 44.62 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.36 31.29 4.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.929 0.892 . . . . 0.0 111.635 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.258 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 111.19 0.07 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.88 -8.79 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.36 2.264 . . . . 0.0 115.776 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm 92.51 15.89 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 128.492 2.717 . . . . 0.0 111.366 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 6.9 m 37.66 49.11 1.5 Allowed Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.673 1.589 . . . . 0.0 111.716 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.72 131.43 46.01 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.574 -1.356 . . . . 0.0 108.574 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.505 ' HE2' ' HB1' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -89.58 8.14 32.78 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -168.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 14.3 p 40.95 81.57 0.24 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.953 1.701 . . . . 0.0 112.705 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' B' ' 94' ' ' PRO . 60.6 Cg_endo -57.38 141.73 94.89 Favored 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 122.649 2.233 . . . . 0.0 111.304 -169.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 93' ' ' PRO . 85.9 Cg_exo -49.95 -12.53 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 127.014 5.143 . . . . 0.0 118.672 -170.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -60.27 -16.35 33.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.328 0.967 . . . . 0.0 111.785 171.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.2 137.7 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 109.124 -172.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -75.82 156.4 34.48 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -142.42 147.95 37.01 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.217 -0.927 . . . . 0.0 110.538 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -150.0 161.28 42.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.623 1.569 . . . . 0.0 107.5 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -99.22 123.63 43.66 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 168.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -109.6 2.98 20.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.409 0.684 . . . . 0.0 110.108 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.6 149.23 21.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 105.779 -2.928 . . . . 0.0 105.779 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -146.82 10.0 1.03 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.974 1.71 . . . . 0.0 110.633 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -153.28 168.59 25.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.742 2.417 . . . . 0.0 105.984 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -133.33 115.82 13.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.63 0.772 . . . . 0.0 109.412 -171.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.17 -25.24 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.004 2.469 . . . . 0.0 113.584 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -8.38 21.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.179 0.9 . . . . 0.0 111.819 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -93.88 10.99 30.98 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 111.835 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.47 148.49 0.67 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.832 1.253 . . . . 0.0 112.767 -173.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -55.45 -47.4 76.09 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.119 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.93 -17.38 4.14 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 115.552 0.981 . . . . 0.0 115.552 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.43 158.88 34.29 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.54 -37.77 79.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.354 0.597 . . . . 0.0 111.157 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -73.36 -43.75 60.04 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.119 -1.42 . . . . 0.0 109.814 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.3 -28.24 59.63 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 121.208 1.822 . . . . 0.0 110.259 -172.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -60.41 -59.14 5.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 118.73 0.695 . . . . 0.0 109.765 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -60.64 -39.62 88.99 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.553 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.4 95.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.276 0.631 . . . . 0.0 112.24 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.21 -47.3 83.11 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -61.09 -51.42 69.2 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -62.47 -43.72 98.14 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.03 0.932 . . . . 0.0 111.518 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -60.94 -52.75 63.72 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 35.5 t -69.81 -36.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.502 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.3 tmm_? -60.23 -43.34 96.14 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.572 1.078 . . . . 0.0 111.774 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.85 -44.78 96.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.31 0.505 . . . . 0.0 110.822 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -63.13 -51.7 65.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.43 0.692 . . . . 0.0 110.117 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -54.19 -49.59 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.624 1.57 . . . . 0.0 109.054 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.23 -43.1 81.37 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 118.936 -0.925 . . . . 0.0 112.316 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -44.38 94.98 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.806 1.303 . . . . 0.0 110.428 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -34.72 78.6 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.577 178.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.73 1.15 . . . . 0.0 111.492 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.462 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -62.75 -41.24 99.11 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -62.4 -40.54 96.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 117.395 -1.288 . . . . 0.0 111.301 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -60.56 -36.24 78.0 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 121.665 2.029 . . . . 0.0 111.295 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.61 -28.58 69.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.029 0.531 . . . . 0.0 112.431 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.69 -46.6 7.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.609 1.564 . . . . 0.0 111.141 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 62.9 p -89.14 -27.21 20.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.278 1.831 . . . . 0.0 110.784 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.13 25.94 54.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.9 -169.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.748 1.619 . . . . 0.0 111.82 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.32 172.3 18.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.839 1.656 . . . . 0.0 107.493 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.74 97.09 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 168.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.02 167.98 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.509 1.523 . . . . 0.0 108.009 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -128.07 112.76 14.95 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.799 0.84 . . . . 0.0 108.983 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.04 10.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.579 1.552 . . . . 0.0 110.095 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -159.71 -173.39 4.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.966 2.107 . . . . 0.0 105.617 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.62 -36.62 0.42 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.37 2.668 . . . . 0.0 115.934 -169.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -130.57 -29.96 1.92 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.586 1.154 . . . . 0.0 111.543 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -23.06 65.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.149 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -51.55 -56.48 13.2 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.356 0.98 . . . . 0.0 109.244 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -62.36 -44.25 96.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -36.65 81.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -174.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -80.15 -16.95 53.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.072 0.949 . . . . 0.0 113.056 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.8 p -114.06 -7.18 13.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.651 1.114 . . . . 0.0 113.113 -169.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -77.48 -3.95 43.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.41 148.38 37.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.226 1.011 . . . . 0.0 109.092 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.08 -170.84 40.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.19 0.9 . . . . 0.0 111.62 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.43 125.81 54.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 t -140.03 117.96 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.6 135.89 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.7 46.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.41 151.25 49.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.279 1.432 . . . . 0.0 108.626 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.7 111.34 13.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.557 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.3 p-90 -131.68 155.11 48.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.716 1.606 . . . . 0.0 107.789 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.11 162.67 9.13 Favored Pre-proline 0 C--O 1.233 0.188 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.8 -19.0 10.03 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.613 2.875 . . . . 0.0 116.167 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -57.69 -26.4 61.65 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.6 161.66 34.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.457 1.026 . . . . 0.0 112.997 -169.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.72 -48.76 53.93 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.168 -1.351 . . . . 0.0 112.658 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -51.38 -27.07 22.83 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.099 2.532 . . . . 0.0 115.11 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -60.51 -13.89 16.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 119.624 1.102 . . . . 0.0 113.798 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -118.1 12.28 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.664 1.186 . . . . 0.0 111.449 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.0 mtm -123.67 -45.69 2.04 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.358 1.063 . . . . 0.0 109.642 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.78 -34.72 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -58.26 17.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.14 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.05 -39.16 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.762 1.641 . . . . 0.0 111.639 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.73 HG12 HD22 ' A' ' 96' ' ' LEU . 2.6 t -57.89 -34.56 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.957 0.903 . . . . 0.0 111.3 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 HD21 ' A' ' 96' ' ' LEU . 21.1 mt -71.37 -44.13 65.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.993 0.815 . . . . 0.0 110.534 175.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.92 -36.55 83.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.65 0.659 . . . . 0.0 109.469 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.35 -18.68 62.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 112.314 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.3 tp -79.55 -45.76 18.63 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.617 1.099 . . . . 0.0 108.879 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.06 -35.58 76.72 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.881 -0.512 . . . . 0.0 111.496 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -64.95 -19.65 66.07 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.502 -0.749 . . . . 0.0 112.21 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -95.84 -42.91 8.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.679 1.192 . . . . 0.0 111.225 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ptm -144.27 17.95 1.72 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.343 0.657 . . . . 0.0 112.283 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -5.76 14.12 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.35 -0.844 . . . . 0.0 114.312 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.72 -23.41 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.671 0.788 . . . . 0.0 111.033 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -15.51 8.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.446 -175.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.0 149.84 50.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.608 1.163 . . . . 0.0 112.267 -168.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -112.95 144.55 42.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.28 146.4 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.69 146.85 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.1 mtpt -121.82 147.57 45.79 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 121.83 -0.544 . . . . 0.0 110.377 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.82 128.74 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.94 103.5 14.72 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 170.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.305 32.6 m -77.6 50.51 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 122.616 1.198 . . . . 0.0 114.179 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.29 -44.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.594 1.557 . . . . 0.0 108.519 168.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -75.24 -50.58 15.7 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.019 1.327 . . . . 0.0 110.065 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -132.11 37.74 3.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.908 1.283 . . . . 0.0 110.873 -170.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -67.04 -4.2 9.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.601 1.161 . . . . 0.0 112.872 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -53.26 -47.88 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.114 1.766 . . . . 0.0 110.851 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.0 m -55.29 -41.51 72.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.848 0.749 . . . . 0.0 111.154 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 -65.43 0.72 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -170.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.86 -42.88 15.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.128 0.87 . . . . 0.0 113.361 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -63.45 -44.55 94.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.428 1.114 . . . . 0.0 111.377 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -68.04 -34.8 77.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.603 0.638 . . . . 0.0 109.796 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.07 66.24 0.71 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 -169.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.35 132.7 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.43 ' CE ' HD13 ' B' ' 72' ' ' LEU . 24.2 mtm -149.02 18.99 0.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.29 160.37 38.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -167.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.21 134.39 26.09 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.214 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.67 132.7 15.98 Favored 'Cis proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.443 -1.791 . . . . 0.0 107.443 -11.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.5 m -98.77 150.35 21.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 169.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.81 117.47 8.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.75 111.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -93.49 134.7 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.17 158.06 39.11 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.643 1.177 . . . . 0.0 110.286 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -147.95 137.42 22.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.99 29.01 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.042 2.537 . . . . 0.0 114.902 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.43 -28.3 2.79 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 116.595 1.398 . . . . 0.0 116.595 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.68 158.72 43.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.418 1.609 . . . . 0.0 114.839 -167.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.39 136.54 26.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.288 1.035 . . . . 0.0 108.28 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.01 -21.07 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.784 1.633 . . . . 0.0 111.428 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -144.72 157.87 44.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.961 0.8 . . . . 0.0 108.922 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.1 148.42 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -169.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.9 m -153.62 148.59 26.66 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.777 1.231 . . . . 0.0 108.011 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.26 66.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.65 156.94 8.98 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -73.46 156.71 37.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.676 0.39 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -153.37 150.63 24.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.203 1.001 . . . . 0.0 108.652 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.84 172.81 12.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.847 2.365 . . . . 0.0 111.536 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -45.9 71.14 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.237 1.015 . . . . 0.0 111.966 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.26 -39.95 93.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.863 0.301 . . . . 0.0 110.429 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.893 0.477 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.73 HD22 HG12 ' A' ' 38' ' ' VAL . 1.8 tp -61.97 -54.82 36.35 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.322 1.049 . . . . 0.0 109.645 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.81 -36.6 84.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.34 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.41 -47.09 87.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.887 0.767 . . . . 0.0 110.933 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -55.67 -42.14 74.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.213 0.605 . . . . 0.0 110.545 -174.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.1 -40.49 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 123.667 0.604 . . . . 0.0 111.245 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 11.4 t30 -57.46 -25.65 60.01 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.906 -1.121 . . . . 0.0 112.417 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -50.49 -31.17 14.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.691 1.196 . . . . 0.0 112.4 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -137.87 -7.14 1.64 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.786 2.034 . . . . 0.0 105.985 169.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.79 145.36 42.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 65.12 122.65 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 128.112 2.565 . . . . 0.0 111.298 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -147.69 145.21 28.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 129.122 2.969 . . . . 0.0 104.224 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 6.4 mt -123.45 145.95 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 119.59 1.087 . . . . 0.0 108.584 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.0 148.3 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.904 1.282 . . . . 0.0 107.836 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.66 149.34 52.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 109.988 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.06 145.74 41.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.45 127.49 44.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 8.5 m -151.26 170.31 19.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.508 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -67.16 89.51 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.393 1.077 . . . . 0.0 110.924 172.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.31 20.53 58.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 117.073 -1.96 . . . . 0.0 114.835 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 26.01 84.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 124.769 2.224 . . . . 0.0 112.932 -177.034 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -152.41 167.71 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.529 3.132 . . . . 0.0 104.94 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.658 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 42.03 -103.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.227 1.811 . . . . 0.0 112.956 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -40.73 27.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.037 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -53.35 33.5 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.146 1.339 . . . . 0.0 109.769 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -49.91 -48.31 51.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.353 2.261 . . . . 0.0 109.64 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.3 ttm -67.79 -45.16 75.62 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.903 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.31 83.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.562 1.145 . . . . 0.0 110.728 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.61 -32.06 63.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 111.853 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.98 -49.65 57.18 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -58.77 -37.94 77.37 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.258 1.023 . . . . 0.0 111.769 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.47 -49.38 77.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -65.0 -22.65 67.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.31 -20.14 66.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.156 0.889 . . . . 0.0 112.951 175.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.499 ' CD1' ' HE2' ' B' ' 132' ' ' LYS . 0.1 OUTLIER -132.35 -0.54 3.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.379 0.991 . . . . 0.0 113.428 -175.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mt -126.42 85.83 2.44 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.4 -165.95 1.05 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.562 2.029 . . . . 0.0 114.204 -169.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.13 -20.05 23.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.673 1.189 . . . . 0.0 112.894 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.87 -23.99 34.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.156 1.782 . . . . 0.0 112.225 169.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -123.88 155.6 37.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.732 1.613 . . . . 0.0 110.6 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -131.22 144.91 51.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.132 1.773 . . . . 0.0 106.674 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.71 148.27 31.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 108.511 -171.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -147.88 162.42 39.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 52.4 m -134.12 140.42 46.57 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.036 1.335 . . . . 0.0 108.263 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.97 174.37 13.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 111.295 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.5 -174.93 44.31 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -51.23 -55.65 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.332 1.853 . . . . 0.0 114.157 -173.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -138.18 29.57 2.49 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.957 1.703 . . . . 0.0 108.655 -171.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.6 157.39 37.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.69 1.996 . . . . 0.0 114.193 -169.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 146.98 104.97 0.0 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 131.072 3.749 . . . . 0.0 104.414 172.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.6 174.38 46.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 14.5 tp -154.84 65.36 0.66 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.518 1.127 . . . . 0.0 108.064 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -49.87 121.73 13.04 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.315 1.446 . . . . 0.0 110.494 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -64.8 -24.44 61.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.202 1.935 . . . . 0.0 113.399 -175.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -18.37 64.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.703 1.592 . . . . 0.0 112.15 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -85.84 -40.58 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -60.2 -50.74 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.74 -42.68 84.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.95 0.9 . . . . 0.0 110.687 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.45 -30.55 60.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.565 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mmm -84.49 -40.64 17.42 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.519 1.054 . . . . 0.0 110.907 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.91 -29.15 68.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.541 0.61 . . . . 0.0 110.824 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.79 -28.28 67.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.498 0.719 . . . . 0.0 112.088 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.67 16.0 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.954 1.302 . . . . 0.0 110.765 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.08 38.87 92.74 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.497 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.76 150.46 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -124.3 139.63 53.73 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.998 0.919 . . . . 0.0 109.104 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.49 ' HB ' HE21 ' B' ' 62' ' ' GLN . 30.7 pt -140.67 17.56 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.102 1.361 . . . . 0.0 110.745 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -67.48 15.82 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -143.26 -5.11 0.87 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.161 2.585 . . . . 0.0 112.019 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.49 HE21 ' HB ' ' B' ' 59' ' ' ILE . 2.8 pt20 -56.67 144.71 31.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.684 1.129 . . . . 0.0 112.1 -169.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -69.04 155.77 39.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.981 1.312 . . . . 0.0 110.38 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 9.0 m -167.29 145.99 4.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 107.306 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -171.18 167.7 6.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.844 1.258 . . . . 0.0 109.837 -170.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.83 168.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.045 0.839 . . . . 0.0 111.41 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -48.99 135.55 6.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -144.32 103.84 4.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.307 1.051 . . . . 0.0 109.143 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.9 m -49.15 -27.27 3.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.626 1.57 . . . . 0.0 113.864 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.08 -22.76 64.92 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.725 1.148 . . . . 0.0 111.652 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.0 -42.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 117.75 -1.119 . . . . 0.0 108.622 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.43 HD13 ' CE ' ' A' ' 70' ' ' MET . 6.9 tt -61.06 -51.35 69.54 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.91 1.232 . . . . 0.0 109.451 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -25.17 68.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.218 0.917 . . . . 0.0 111.412 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.96 -18.65 33.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.597 1.159 . . . . 0.0 112.894 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.89 163.46 4.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.216 1.007 . . . . 0.0 111.29 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.55 -32.71 15.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.839 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 tp -143.91 144.43 31.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.027 1.331 . . . . 0.0 109.725 -172.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.6 108.67 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 169.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 74.8 t -82.34 105.99 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -65.5 129.27 39.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 168.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 tp -139.94 66.39 1.4 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.715 0.406 . . . . 0.0 111.699 -168.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.332 -0.171 0 O-C-N 122.03 -0.419 . . . . 0.0 110.312 169.628 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.86 -6.68 2.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm 96.58 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.317 3.047 . . . . 0.0 110.979 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.8 m 38.37 45.77 0.82 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.044 2.137 . . . . 0.0 113.179 -169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.09 132.78 39.52 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.395 2.063 . . . . 0.0 112.031 -169.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.59 1.75 36.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 116.74 -1.6 . . . . 0.0 114.594 -175.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.8 p 45.08 89.76 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.538 1.535 . . . . 0.0 113.294 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -54.95 138.11 77.33 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.775 2.317 . . . . 0.0 109.485 -169.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.76 3.07 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.666 1 C-N-CA 125.318 4.012 . . . . 0.0 117.124 -168.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -67.55 -5.81 17.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.158 0.983 . . . . 0.0 112.332 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 148.33 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 110.147 -169.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -78.63 158.92 28.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.963 0.905 . . . . 0.0 108.839 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -151.73 145.37 24.97 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.757 -1.214 . . . . 0.0 109.488 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -155.73 148.43 24.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.82 137.79 32.08 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -139.57 -21.59 0.91 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.16 149.61 19.47 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 119.583 1.083 . . . . 0.0 110.648 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -160.75 169.3 23.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.38 1.872 . . . . 0.0 107.387 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.91 46.75 26.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.243 1.417 . . . . 0.0 112.399 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -43.61 116.62 2.3 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.766 2.026 . . . . 0.0 113.592 -171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.23 -16.62 28.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.97 3.113 . . . . 0.0 113.318 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.87 -2.52 1.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.314 1.416 . . . . 0.0 111.824 169.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -125.88 13.01 7.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.154 1.782 . . . . 0.0 110.934 -171.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.29 154.21 0.42 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.729 0.811 . . . . 0.0 109.884 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -53.3 -44.08 68.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.867 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.4 2.74 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 115.001 0.76 . . . . 0.0 115.001 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.4 p -68.94 166.02 18.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.0 -42.18 98.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.401 0.62 . . . . 0.0 110.311 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -69.23 -42.19 75.99 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.918 -1.515 . . . . 0.0 109.403 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.78 -35.66 60.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.149 1.795 . . . . 0.0 109.713 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -56.38 -52.53 64.27 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 121.719 -0.613 . . . . 0.0 110.728 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -63.95 -44.72 91.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.773 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.84 86.92 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.441 1.096 . . . . 0.0 111.667 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.89 -49.67 69.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.44 69.01 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.951 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -65.27 -50.51 65.47 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.39 1.076 . . . . 0.0 109.457 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -59.85 -48.34 82.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.87 -37.92 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 117.535 -1.221 . . . . 0.0 110.862 -176.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.29 -38.92 92.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.453 1.933 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.86 -44.89 93.89 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.483 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.05 -56.49 14.64 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.308 0.643 . . . . 0.0 110.148 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.8 mt -56.91 -47.7 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.837 1.255 . . . . 0.0 110.255 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.17 96.62 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.93 -42.89 99.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.79 0.795 . . . . 0.0 111.891 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.6 -0.688 . . . . 0.0 111.908 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.2 mm? -71.5 -33.6 69.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.572 1.078 . . . . 0.0 110.709 175.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' B' ' 27' ' ' TYR . 22.6 ttmt -61.03 -43.97 98.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.888 170.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.46 -41.04 96.61 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.36 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.94 -40.74 85.58 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.77 2.077 . . . . 0.0 110.496 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.62 74.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.32 -39.82 17.24 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.267 1.427 . . . . 0.0 111.623 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.7 p -97.38 -16.0 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.005 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 65.44 25.34 71.32 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.887 1.232 . . . . 0.0 112.332 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.749 1.219 . . . . 0.0 108.466 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.64 165.07 37.66 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.157 1.383 . . . . 0.0 107.529 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.66 101.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 168.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.13 166.83 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -121.92 107.33 12.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.85 175.46 4.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.422 1.089 . . . . 0.0 109.679 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -159.41 -172.71 3.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.92 1.688 . . . . 0.0 107.054 169.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -38.18 -41.8 0.63 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.092 2.957 . . . . 0.0 115.941 -169.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -128.41 -27.86 2.61 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.224 1.41 . . . . 0.0 111.064 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -61.74 -23.55 66.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.753 -1.118 . . . . 0.0 111.87 172.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 15' ' ' THR . 40.3 t80 -54.69 -54.45 41.63 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.617 1.553 . . . . 0.0 107.952 169.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -57.96 -47.84 81.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.367 0.531 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.12 96.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.556 0.217 . . . . 0.0 111.305 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -80.07 -15.71 56.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.772 1.229 . . . . 0.0 112.169 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.492 HG22 HG11 ' A' ' 20' ' ' VAL . 67.1 p -107.11 -9.28 16.21 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.122 0.969 . . . . 0.0 112.613 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.435 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 67.2 m -71.3 -3.13 18.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.83 0.741 . . . . 0.0 112.991 -175.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -144.12 155.97 44.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.314 1.446 . . . . 0.0 108.119 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -167.4 54.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 123.878 0.751 . . . . 0.0 112.407 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.481 HG22 ' HG2' ' A' ' 79' ' ' LYS . 38.7 t -119.97 121.27 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 172.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 53' ' ' VAL . 7.7 p -131.83 124.49 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 122.739 1.257 . . . . 0.0 108.207 -170.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.9 tp -83.43 100.23 10.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.53 141.16 36.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.22 145.25 45.47 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.392 1.077 . . . . 0.0 109.328 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.79 109.13 10.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -170.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.549 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.6 p-90 -121.79 160.03 25.46 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -163.71 159.29 17.33 Favored Pre-proline 0 C--O 1.233 0.2 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.23 -27.16 46.08 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.234 1.956 . . . . 0.0 113.062 168.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -58.61 -24.65 61.45 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 151.58 50.96 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.928 1.24 . . . . 0.0 111.875 -169.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.34 -48.73 71.15 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.201 -1.333 . . . . 0.0 112.512 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.79 -27.35 20.01 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.435 2.757 . . . . 0.0 115.464 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -58.59 -18.56 31.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 120.172 1.351 . . . . 0.0 113.644 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.95 12.11 20.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.315 1.046 . . . . 0.0 111.522 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.9 mtm -122.88 -43.93 2.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.6 1.16 . . . . 0.0 109.546 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.53 -35.88 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.405 0.682 . . . . 0.0 109.337 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.54 23.53 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.243 -0.884 . . . . 0.0 112.01 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.17 -40.51 59.43 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.664 1.576 . . . . 0.0 111.493 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.652 HG12 HD22 ' A' ' 96' ' ' LEU . 2.3 t -56.65 -38.27 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.892 0.769 . . . . 0.0 111.197 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 96' ' ' LEU . 20.4 mt -66.59 -48.69 68.78 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-N 118.568 0.622 . . . . 0.0 110.095 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.62 -36.43 82.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.776 0.322 . . . . 0.0 110.42 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.31 -24.53 66.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.259 1.424 . . . . 0.0 111.723 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.427 HD11 ' SD ' ' A' ' 46' ' ' MET . 34.8 tp -84.55 -40.02 18.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.69 0.677 . . . . 0.0 110.976 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.18 -33.14 72.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.982 -0.449 . . . . 0.0 110.473 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -70.53 -3.81 19.88 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -113.64 -42.43 3.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.624 1.569 . . . . 0.0 111.609 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.427 ' SD ' HD11 ' A' ' 42' ' ' LEU . 20.6 ptm -136.04 16.79 3.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.825 0.85 . . . . 0.0 112.336 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.84 -5.42 18.72 Favored Glycine 0 C--O 1.227 -0.286 0 O-C-N 120.771 -1.205 . . . . 0.0 114.23 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.94 -23.8 67.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.425 0.612 . . . . 0.0 111.342 169.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -32.87 4.87 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 110.983 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 151.6 19.82 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.978 1.311 . . . . 0.0 111.816 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -128.23 154.18 46.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.4 143.53 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 20' ' ' VAL . 1.7 m -131.84 109.61 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.549 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 47.5 mtpt -82.91 157.09 23.19 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 120.56 -1.338 . . . . 0.0 109.75 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mm -130.08 124.02 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -85.75 109.8 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 26' ' ' ALA . 13.0 m -73.15 9.96 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -171.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.85 -34.58 4.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.315 0.962 . . . . 0.0 110.644 169.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.69 -43.13 12.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.869 0.759 . . . . 0.0 111.447 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -141.79 42.94 1.71 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.643 1.211 . . . . 0.0 110.819 -170.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -4.25 45.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.717 1.207 . . . . 0.0 113.833 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -52.4 -43.87 65.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.257 1.023 . . . . 0.0 110.342 -169.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.8 m -58.08 -38.84 77.14 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.38 1.072 . . . . 0.0 112.379 174.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.42 -64.29 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.323 1.049 . . . . 0.0 109.115 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.41 -41.43 17.12 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.645 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -62.2 -43.12 99.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.296 1.548 . . . . 0.0 111.131 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -76.58 -9.32 58.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.193 0.597 . . . . 0.0 112.422 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.79 60.26 6.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 -173.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.17 -64.07 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 -173.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 mtm 58.0 5.13 0.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.23 2.612 . . . . 0.0 114.719 172.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -141.02 157.38 45.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.346 0.975 . . . . 0.0 111.638 -169.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.2 mm -138.96 139.51 23.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.37 138.77 49.14 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 -10.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.5 m -112.97 143.56 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.8 mt -120.84 127.54 52.0 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.95 1.7 . . . . 0.0 107.465 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -116.25 114.39 24.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.47 122.13 46.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.92 153.08 38.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 110.167 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG2' HG22 ' A' ' 19' ' ' VAL . 44.8 mtpt -137.12 130.79 31.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.001 174.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.7 t70 42.15 35.23 0.56 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.791 2.036 . . . . 0.0 114.21 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 113.9 -8.51 23.5 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 116.628 1.411 . . . . 0.0 116.628 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.73 152.39 47.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.444 1.622 . . . . 0.0 112.942 -169.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.86 141.93 16.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.78 1.232 . . . . 0.0 108.663 175.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.74 -22.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 124.166 0.986 . . . . 0.0 109.537 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -153.76 166.44 32.85 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 122.587 1.184 . . . . 0.0 107.805 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -158.13 132.5 8.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.939 1.696 . . . . 0.0 106.703 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m -147.62 148.63 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.064 0.945 . . . . 0.0 109.053 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.21 124.22 41.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.18 156.17 9.28 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 124.618 1.104 . . . . 0.0 110.675 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.2 148.99 46.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.314 0.557 . . . . 0.0 111.211 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.03 148.04 18.93 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.5 177.68 6.49 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.33 2.687 . . . . 0.0 112.443 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -33.25 69.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.345 1.458 . . . . 0.0 112.334 -169.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -81.85 -40.72 22.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.081 0.552 . . . . 0.0 110.199 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.21 92.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.051 0.54 . . . . 0.0 110.65 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.652 HD22 HG12 ' A' ' 38' ' ' VAL . 2.1 tp -57.84 -52.58 64.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.823 0.849 . . . . 0.0 109.72 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.1 -36.39 77.51 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.478 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.06 -46.64 88.86 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.551 1.068 . . . . 0.0 110.599 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.5 tp -58.23 -40.28 81.29 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 124.809 1.244 . . . . 0.0 111.673 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -87.97 -40.57 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.164 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -57.77 -34.29 69.41 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.977 1.311 . . . . 0.0 112.131 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -65.61 -8.73 21.71 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -123.77 -33.54 3.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.501 1.12 . . . . 0.0 112.197 174.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.247 0.925 0 C-N-CA 126.752 2.021 . . . . 0.0 109.717 178.688 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -79.16 80.2 5.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.987 0.915 . . . . 0.0 108.756 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m120 78.98 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.654 2.781 . . . . 0.0 111.753 175.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.458 ' H ' ' HA ' ' B' ' 32' ' ' TRP . 54.9 mtmt -125.34 123.76 40.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 129.598 3.159 . . . . 0.0 103.725 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -92.78 141.46 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.76 -168.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.3 tt -133.65 140.44 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -131.24 136.16 47.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -110.44 141.86 42.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.85 123.03 36.36 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 78.7 p -156.1 147.67 22.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -46.47 111.74 0.41 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.425 1.49 . . . . 0.0 111.848 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.22 11.01 50.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.711 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 38.18 35.51 0.09 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.916 2.486 . . . . 0.0 113.793 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -69.64 -46.74 65.47 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.65 -65.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -168.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -33.89 68.45 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.833 0.742 . . . . 0.0 111.736 -174.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.3 p -56.24 -55.65 30.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.31 1.444 . . . . 0.0 111.398 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -52.1 -49.76 62.95 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.346 1.858 . . . . 0.0 109.657 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 9.2 ttm -67.83 -46.02 73.0 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.599 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.819 0.848 . . . . 0.0 110.77 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.0 -27.72 61.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.111 0.869 . . . . 0.0 110.149 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.05 -45.94 24.21 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -55.27 -33.67 63.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.414 1.086 . . . . 0.0 111.34 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.64 11.87 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.888 0.875 . . . . 0.0 110.604 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -64.96 -22.84 67.07 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.403 1.002 . . . . 0.0 113.665 -168.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.14 -16.35 52.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 170.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 11.9 m-85 -130.01 -40.85 1.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.395 1.078 . . . . 0.0 112.789 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.22 75.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.624 1.97 . . . . 0.0 106.234 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -164.04 1.2 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.977 1.751 . . . . 0.0 112.255 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.49 -7.9 8.03 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.543 -0.974 . . . . 0.0 113.137 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.16 -19.29 62.92 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.909 -1.119 . . . . 0.0 109.573 168.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . 0.458 ' HA ' ' H ' ' B' ' 4' ' ' LYS . 56.5 m95 -130.87 175.7 8.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 127.776 2.431 . . . . 0.0 110.121 -174.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -153.04 129.9 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.35 144.31 14.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.871 0.868 . . . . 0.0 109.273 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.46 156.8 46.72 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 107.308 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.2 m -145.5 137.69 25.61 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.52 173.39 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.617 0.767 . . . . 0.0 111.339 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.08 40.64 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 122.247 -0.283 . . . . 0.0 112.978 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.403 HG13 ' HE3' ' B' ' 88' ' ' LYS . 1.7 tt -53.19 -57.19 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 113.679 -170.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -132.11 30.7 4.22 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.079 1.752 . . . . 0.0 108.039 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.8 149.93 49.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.563 1.945 . . . . 0.0 112.82 -169.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 146.45 100.4 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 130.995 3.718 . . . . 0.0 104.071 177.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.23 -179.29 48.7 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -171.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 23.0 tp -161.45 100.86 1.19 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -60.88 122.62 70.28 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.352 -0.832 . . . . 0.0 108.782 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.62 -26.56 80.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 121.734 1.622 . . . . 0.0 112.097 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.573 ' ND2' ' CE1' ' B' ' 120' ' ' PHE . 1.2 t30 -68.25 -27.92 66.76 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.979 -1.076 . . . . 0.0 112.086 171.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.127 1.785 . . . . 0.0 109.746 171.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.87 -51.66 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -52.57 -47.97 66.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.852 0.751 . . . . 0.0 109.977 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.89 57.24 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.655 1.182 . . . . 0.0 111.508 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.86 -38.79 20.71 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -61.75 -28.74 69.65 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.553 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.44 -27.95 64.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.931 0.787 . . . . 0.0 111.908 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.09 14.15 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 110.97 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.7 36.38 82.59 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.466 -1.186 . . . . 0.0 113.222 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.97 149.07 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -116.8 137.1 52.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.793 0.837 . . . . 0.0 108.92 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.2 pt -139.31 16.95 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 124.861 1.264 . . . . 0.0 110.836 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -58.91 -15.21 11.68 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -91.44 -15.8 28.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.308 1.443 . . . . 0.0 113.498 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -56.65 151.45 13.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.6 p -133.47 174.14 10.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.663 2.385 . . . . 0.0 109.359 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 15.7 m -153.01 -173.77 4.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.143 0.977 . . . . 0.0 109.517 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -161.66 167.93 24.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.274 1.829 . . . . 0.0 108.044 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.0 pt -63.37 169.1 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -48.62 135.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -142.0 98.84 3.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.544 1.164 . . . . 0.0 108.211 -171.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -51.38 -28.07 11.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.48 1.912 . . . . 0.0 113.989 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.81 -23.34 61.54 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 119.608 1.094 . . . . 0.0 110.494 -172.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -33.64 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 118.285 -0.865 . . . . 0.0 109.788 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.61 -52.93 61.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.639 1.109 . . . . 0.0 109.522 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -29.07 66.36 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.24 0.473 . . . . 0.0 110.964 -176.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -87.12 -12.45 47.06 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.673 1.589 . . . . 0.0 112.663 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.96 162.35 22.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.967 0.889 . . . . 0.0 110.434 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.89 -34.15 15.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.052 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.43 142.97 33.66 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.744 1.217 . . . . 0.0 110.202 -172.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -114.56 103.76 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 169.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.8 98.12 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -66.77 122.88 18.64 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 tp -124.66 52.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 110.083 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 124.18 0.992 . . . . 0.0 108.761 171.468 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -71.24 28.08 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -169.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . 0.403 ' HE3' HG13 ' B' ' 39' ' ' ILE . 26.1 ttmt 80.84 17.45 0.55 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.709 2.004 . . . . 0.0 112.432 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 m 34.63 52.09 1.26 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.353 1.861 . . . . 0.0 112.732 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.5 131.03 40.27 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.812 1.675 . . . . 0.0 110.785 -169.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -1.24 57.49 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 116.785 -1.579 . . . . 0.0 113.706 -175.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.9 p 48.0 95.47 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 126.12 1.768 . . . . 0.0 114.177 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.49 132.79 52.72 Favored 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 122.17 1.913 . . . . 0.0 109.51 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.4 -5.28 11.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.819 3.679 . . . . 0.0 117.817 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -74.4 15.35 0.35 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.093 1.315 . . . . 0.0 112.237 170.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 t -135.29 142.92 38.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.364 1.866 . . . . 0.0 106.736 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -69.99 153.69 42.9 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -141.39 141.12 33.79 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -145.97 157.97 43.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.56 137.06 47.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -142.02 -2.12 1.18 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.615 0.766 . . . . 0.0 112.668 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.68 -54.06 4.39 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 59.11 -2.68 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.534 2.334 . . . . 0.0 115.076 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -160.92 170.13 21.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.331 2.653 . . . . 0.0 105.771 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -137.97 106.62 8.12 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 118.877 0.762 . . . . 0.0 109.36 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.446 ' C ' ' CE1' ' B' ' 120' ' ' PHE . 95.4 Cg_endo -66.82 -36.0 25.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 124.033 3.155 . . . . 0.0 112.175 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.88 -13.63 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 129.598 3.159 . . . . 0.0 113.918 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -103.45 -54.42 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.394 1.478 . . . . 0.0 107.488 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . 39.25 -164.11 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.468 1.907 . . . . 0.0 113.34 -170.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -70.11 -48.03 59.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.37 -22.12 2.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 62.6 p -71.02 168.54 16.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.3 -41.96 98.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.379 0.609 . . . . 0.0 110.516 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.55 -41.13 69.49 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 117.395 -1.288 . . . . 0.0 109.066 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -76.59 -33.44 58.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.544 1.52 . . . . 0.0 110.036 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -56.07 -56.51 19.94 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.009 0.822 . . . . 0.0 109.154 169.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -59.38 -41.87 90.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.45 93.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.59 1.156 . . . . 0.0 112.006 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -64.53 -46.98 80.55 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.573 ' CE1' ' ND2' ' B' ' 47' ' ' ASN . 14.5 m-85 -64.82 -36.07 83.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.425 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -61.27 -49.23 77.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.132 0.878 . . . . 0.0 110.046 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.9 ttp-105 -62.84 -52.53 62.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.27 -35.71 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.26 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 30.7 ptt85 -61.68 -41.05 97.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.212 1.824 . . . . 0.0 111.132 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.97 -43.7 94.91 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.459 0.475 . . . . 0.0 110.377 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -68.63 -50.56 50.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 0.0 110.887 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 mt -56.05 -48.67 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.405 1.082 . . . . 0.0 109.114 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.32 -46.96 92.26 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.45 -47.07 85.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.801 0.8 . . . . 0.0 111.737 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -62.95 -47.54 82.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.068 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.81 -37.04 86.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.374 0.534 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 41.3 ttmt -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.97 0.805 . . . . 0.0 109.739 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.2 -37.34 79.95 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-O 116.74 -1.6 . . . . 0.0 111.16 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -59.38 -40.09 85.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 122.008 2.185 . . . . 0.0 110.039 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.05 75.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.202 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.45 -47.68 11.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.393 1.077 . . . . 0.0 111.796 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.2 p -82.7 -22.73 34.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.969 2.108 . . . . 0.0 112.103 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.7 11.24 62.35 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -168.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.5 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.685 2.394 . . . . 0.0 113.772 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.32 167.36 28.91 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.318 1.447 . . . . 0.0 107.84 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.1 98.51 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 169.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.14 168.6 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.714 1.606 . . . . 0.0 108.307 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -125.11 122.1 36.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.811 1.245 . . . . 0.0 109.09 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.33 171.7 13.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.858 1.663 . . . . 0.0 109.859 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -136.09 -167.83 2.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.082 1.753 . . . . 0.0 108.614 169.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -47.12 -27.78 1.53 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.387 2.275 . . . . 0.0 113.627 170.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.49 -30.8 0.82 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.662 1.185 . . . . 0.0 112.06 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m -62.57 -20.02 64.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.895 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -48.32 -55.7 9.98 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.608 1.094 . . . . 0.0 110.427 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -64.18 -44.55 91.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.949 0.34 . . . . 0.0 110.168 -176.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.23 81.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.924 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -82.2 -13.3 57.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.401 1.081 . . . . 0.0 112.541 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 66.6 p -115.89 -5.82 12.04 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 0.0 112.914 -170.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -74.75 -6.05 46.74 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.86 147.13 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.245 1.018 . . . . 0.0 109.346 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.13 -175.8 34.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.309 0.957 . . . . 0.0 111.689 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.59 125.75 48.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -136.03 117.95 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.111 0.964 . . . . 0.0 108.727 -169.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -89.66 116.06 27.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.87 135.81 39.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.883 0.765 . . . . 0.0 109.027 173.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.91 138.7 53.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.068 1.347 . . . . 0.0 108.984 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -119.88 105.07 10.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.425 ' CD1' ' CE ' ' A' ' 54' ' ' LYS . 4.8 p-90 -123.77 147.78 47.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.896 1.278 . . . . 0.0 108.202 -173.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -166.36 160.62 12.29 Favored Pre-proline 0 CA--C 1.534 0.344 0 O-C-N 121.545 -0.722 . . . . 0.0 111.56 171.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.73 -7.58 2.36 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.453 3.435 . . . . 0.0 116.504 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -54.73 -29.28 53.07 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.718 1.207 . . . . 0.0 113.104 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -163.58 162.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.13 -47.55 10.25 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.46 2.457 . . . . 0.0 115.596 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.57 -30.78 56.36 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.582 2.691 . . . . 0.0 114.041 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 m -62.48 -18.11 61.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.658 1.572 . . . . 0.0 113.909 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.79 22.03 13.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 0.0 111.211 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.2 mtm -131.24 -38.79 1.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.704 1.202 . . . . 0.0 110.27 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.82 -37.02 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.196 -0.94 . . . . 0.0 108.607 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.23 -54.31 57.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.874 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -58.96 -39.71 78.29 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.285 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.17 -38.96 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.055 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 2.3 mm? -68.01 -44.51 76.4 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.69 1.132 . . . . 0.0 110.589 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.53 -34.45 77.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.856 0.753 . . . . 0.0 109.813 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -71.2 -19.8 62.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.749 1.62 . . . . 0.0 112.54 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -84.24 -44.63 13.7 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 108.596 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.89 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.385 -0.197 . . . . 0.0 111.127 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.71 -10.09 56.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.236 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.46 -47.08 4.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.24 1.016 . . . . 0.0 111.064 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.7 ptm -135.46 15.96 3.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.528 0.731 . . . . 0.0 112.215 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.6 -3.47 20.68 Favored Glycine 0 CA--C 1.519 0.343 0 O-C-N 121.102 -0.999 . . . . 0.0 114.192 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.67 -24.43 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.83 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 -25.49 8.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.509 1.124 . . . . 0.0 111.83 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.1 tp -118.46 146.56 44.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 111.483 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.79 147.78 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.82 145.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.67 148.33 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' CE ' ' CD1' ' A' ' 25' ' ' TRP . 15.0 mtpt -122.09 146.56 47.08 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 118.862 0.755 . . . . 0.0 111.187 175.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.471 HG22 HG22 ' A' ' 57' ' ' VAL . 6.5 mm -107.78 132.97 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.29 88.98 6.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 55' ' ' ILE . 1.4 t -70.41 50.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 127.416 2.286 . . . . 0.0 114.761 -168.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -159.48 -33.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.067 2.147 . . . . 0.0 109.234 169.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -89.53 -42.34 11.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.688 0.795 . . . . 0.0 109.522 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -133.19 33.85 3.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.329 1.052 . . . . 0.0 111.648 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.58 -7.07 9.01 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.907 1.283 . . . . 0.0 113.375 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -47.39 -50.06 23.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 110.552 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.0 m -59.66 -36.11 75.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.234 0.614 . . . . 0.0 111.938 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.77 -57.31 6.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.45 -43.16 51.98 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.985 0.802 . . . . 0.0 113.434 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.94 -38.29 90.43 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.604 1.162 . . . . 0.0 110.97 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -76.89 -32.12 57.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.584 0.629 . . . . 0.0 110.077 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 77.59 1.38 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -170.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.86 -64.81 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.413 3.1 ppp? 45.47 24.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.428 2.691 . . . . 0.0 114.96 172.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.1 p -149.32 163.97 36.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.187 2.195 . . . . 0.0 110.96 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.3 mm -140.54 146.48 45.12 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -175.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.78 143.52 67.67 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 -10.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.4 m -119.37 150.16 40.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.267 0.556 . . . . 0.0 110.517 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.28 124.6 32.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -116.27 113.87 23.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.5 127.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.17 157.25 35.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.533 1.133 . . . . 0.0 110.169 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.82 130.86 20.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.43 32.29 0.5 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.447 2.299 . . . . 0.0 114.572 170.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.31 -19.2 6.03 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 116.489 1.356 . . . . 0.0 116.489 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -135.29 151.82 50.92 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 119.425 1.612 . . . . 0.0 112.878 -168.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -69.05 137.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.74 -25.21 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.997 1.719 . . . . 0.0 109.553 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -143.89 152.76 41.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.06 137.07 27.34 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.5 t -151.27 146.28 25.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.7 t -140.6 76.57 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.97 163.64 18.6 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.409 1.004 . . . . 0.0 110.878 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.37 147.38 51.13 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.807 0.803 . . . . 0.0 110.644 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 91' ' ' LYS . 2.8 mppt? -139.32 144.44 40.22 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.633 1.173 . . . . 0.0 108.482 170.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.55 170.94 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.521 2.147 . . . . 0.0 110.052 169.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -45.31 69.98 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.998 0.919 . . . . 0.0 112.359 -173.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.7 -43.12 76.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.541 0.155 . . . . 0.0 110.782 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.1 84.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.0 -0.438 . . . . 0.0 110.61 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 tp -67.68 -47.64 68.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.427 0.103 . . . . 0.0 110.979 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.94 -37.85 88.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.15 -46.21 88.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.819 0.447 . . . . 0.0 110.8 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.2 tp -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 110.825 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.47 -41.16 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.588 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -55.33 -29.06 57.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 112.412 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -49.11 -33.87 12.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.219 1.408 . . . . 0.0 112.306 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -135.72 -6.56 2.18 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.659 1.984 . . . . 0.0 108.576 170.166 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.02 125.39 26.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.253 31.5 m120 61.53 119.94 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 C-N-CA 129.317 3.047 . . . . 0.0 113.939 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -148.46 141.12 24.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.562 3.145 . . . . 0.0 103.731 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mt -117.95 144.5 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.845 1.202 . . . . 0.0 107.777 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.76 146.57 19.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -130.33 128.32 41.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.6 133.95 49.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -132.99 117.43 17.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -168.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 58.0 m -139.9 163.99 31.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 124.118 0.886 . . . . 0.0 111.875 -168.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.6 m -68.54 114.06 6.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.451 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 49.73 41.39 35.02 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.338 1.447 . . . . 0.0 112.801 173.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -36.53 104.31 0.03 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 18.0 m -135.21 0.97 2.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.77 169.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.11 -55.11 0.09 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.142 0.977 . . . . 0.0 112.902 -169.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -57.84 -54.67 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.176 0.444 . . . . 0.0 110.599 -171.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.7 m -76.73 -26.74 54.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.702 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -54.85 -51.1 66.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.822 1.192 . . . . 0.0 110.488 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 13.9 ttm -67.73 -44.19 78.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.529 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.75 99.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.368 0.667 . . . . 0.0 111.568 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.83 -31.76 61.76 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.418 1.008 . . . . 0.0 110.683 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -42.62 74.46 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -56.73 -40.0 74.94 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 117.931 0.865 . . . . 0.0 111.21 170.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.24 -54.23 43.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -69.84 -17.83 63.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.836 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.03 -14.93 63.36 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.874 1.216 . . . . 0.0 112.579 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.491 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 2.5 m-85 -126.32 -20.86 4.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.265 1.026 . . . . 0.0 113.732 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.26 -107.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 -172.28 40.78 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 119.126 0.875 . . . . 0.0 111.426 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.68 -20.22 65.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.35 1.46 . . . . 0.0 111.962 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.45 -40.18 74.41 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.97 0.908 . . . . 0.0 111.471 174.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.54 153.09 18.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.864 0.84 . . . . 0.0 112.587 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -124.61 107.33 10.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.48 103.28 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -92.51 160.98 14.8 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.806 0.842 . . . . 0.0 108.781 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -151.01 134.9 16.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.498 0.719 . . . . 0.0 109.576 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.67 176.92 11.98 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.343 0.592 . . . . 0.0 112.353 -174.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.22 -177.84 47.22 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.924 1.249 . . . . 0.0 111.141 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.451 HG22 ' H ' ' B' ' 12' ' ' GLY . 3.5 tt -52.55 -53.33 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.116 1.366 . . . . 0.0 113.255 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -133.31 29.05 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.147 1.779 . . . . 0.0 108.611 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.86 146.8 54.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.168 2.187 . . . . 0.0 111.766 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 144.91 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 129.987 3.315 . . . . 0.0 105.287 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.89 162.67 33.45 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 62.3 tp -140.61 76.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.36 128.85 90.37 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.25 -20.05 45.35 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.936 1.757 . . . . 0.0 112.63 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -38.64 90.34 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 120.077 1.308 . . . . 0.0 111.777 171.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.31 60.26 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.824 0.738 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -60.41 -52.76 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 171.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -58.44 -44.27 89.11 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.695 0.798 . . . . 0.0 110.824 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.12 68.02 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.914 0.885 . . . . 0.0 111.791 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -39.58 53.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -63.03 -26.29 68.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.49 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.03 -29.52 60.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.035 1.288 . . . . 0.0 111.643 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 m -116.85 16.86 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.244 1.418 . . . . 0.0 111.242 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.73 33.97 88.67 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.444 -1.198 . . . . 0.0 113.423 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.71 150.89 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 169.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -118.34 137.84 52.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.806 0.843 . . . . 0.0 108.97 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 21.5 pt -137.81 18.14 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 124.571 1.149 . . . . 0.0 110.988 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -67.03 15.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -137.26 -6.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.24 2.616 . . . . 0.0 111.822 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.9 157.06 22.53 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.128 -0.983 . . . . 0.0 110.942 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.9 p -123.44 176.62 6.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.39 1.876 . . . . 0.0 109.707 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -157.99 170.26 22.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -165.43 163.28 19.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.527 1.931 . . . . 0.0 108.15 -176.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.4 pt -64.97 167.37 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.787 0.835 . . . . 0.0 111.801 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -49.43 138.72 4.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.489 0.715 . . . . 0.0 109.58 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.45 103.79 3.85 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.469 1.128 . . . . 0.0 108.954 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -48.84 -32.53 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.944 1.698 . . . . 0.0 113.924 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.0 -22.91 63.08 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.419 0.554 . . . . 0.0 111.194 -169.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.87 -39.42 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.147 -0.93 . . . . 0.0 109.344 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.05 -49.43 77.67 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.573 1.079 . . . . 0.0 110.449 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -25.21 67.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.918 0.781 . . . . 0.0 111.416 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -87.62 -11.41 48.59 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.996 1.318 . . . . 0.0 113.018 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.64 169.74 5.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.025 0.916 . . . . 0.0 111.281 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -85.29 -34.98 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 169.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.51 HD13 ' CE ' ' B' ' 97' ' ' LYS . 20.1 tp -151.41 144.13 24.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.974 1.309 . . . . 0.0 109.933 -173.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.82 101.91 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 126.269 1.827 . . . . 0.0 107.074 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 88.6 t -80.49 100.82 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 82.9 m -78.85 131.39 36.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -150.66 64.78 0.93 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.915 0.864 . . . . 0.0 111.65 -174.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 124.438 1.095 . . . . 0.0 109.736 169.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.44 14.74 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.611 1.965 . . . . 0.0 113.978 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm 77.3 31.02 0.5 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.114 2.566 . . . . 0.0 111.799 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 p 29.78 56.45 0.73 Allowed Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.596 1.958 . . . . 0.0 112.694 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.77 131.98 46.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.191 2.594 . . . . 0.0 110.162 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.99 0.4 55.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.979 -173.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.6 p 46.28 90.39 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.986 2.114 . . . . 0.0 113.147 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -64.54 147.21 90.24 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.026 2.484 . . . . 0.0 108.842 -169.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.21 -0.06 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.112 3.208 . . . . 0.0 115.359 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -64.08 -16.95 62.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.752 0.821 . . . . 0.0 111.754 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 152.39 37.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.416 1.007 . . . . 0.0 112.796 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.51 ' CE ' HD13 ' B' ' 77' ' ' LEU . 5.1 tmmm? -80.08 154.72 27.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 168.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -139.79 146.22 39.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -144.81 149.31 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 133.48 50.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.291 1.036 . . . . 0.0 108.423 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -131.39 -5.7 3.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.386 1.074 . . . . 0.0 111.626 -171.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.62 147.18 16.26 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -144.09 24.41 1.63 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.699 1.599 . . . . 0.0 110.884 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -152.45 163.41 39.59 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.085 2.154 . . . . 0.0 106.499 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -147.31 121.9 5.13 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.288 1.404 . . . . 0.0 108.349 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.03 -21.59 15.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.548 2.165 . . . . 0.0 112.876 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.25 -6.14 12.81 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.551 1.069 . . . . 0.0 112.16 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -103.54 12.13 35.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.822 1.249 . . . . 0.0 111.544 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.68 148.9 0.66 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.001 1.321 . . . . 0.0 112.55 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -38.56 85.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.942 -171.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.47 -20.49 4.93 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 169.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.6 p -69.93 163.59 25.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.66 -39.57 84.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.265 0.555 . . . . 0.0 110.919 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.89 -44.64 61.05 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.349 -1.31 . . . . 0.0 109.87 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -73.82 -29.12 61.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 120.922 1.692 . . . . 0.0 110.5 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -58.17 -62.34 1.9 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.526 0.603 . . . . 0.0 109.516 170.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -60.44 -40.14 90.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.13 99.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.057 -177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.89 -46.0 83.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.798 0.726 . . . . 0.0 109.648 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -63.34 -44.15 95.71 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.956 0.902 . . . . 0.0 111.41 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 -59.13 -49.47 77.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.02 -38.79 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.587 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -55.65 -46.3 77.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.948 1.703 . . . . 0.0 111.495 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.09 -44.62 95.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.204 0.315 . . . . 0.0 110.762 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -61.44 2.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 110.133 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -39.96 60.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.614 1.565 . . . . 0.0 110.956 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.96 76.65 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 118.531 -1.15 . . . . 0.0 110.861 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -58.93 -46.66 87.42 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.373 1.587 . . . . 0.0 111.209 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.05 -50.33 73.08 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -37.27 75.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.485 0.584 . . . . 0.0 112.319 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.491 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -60.69 -42.34 96.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.97 -41.3 95.56 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.864 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.8 -37.64 74.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.802 2.547 . . . . 0.0 111.372 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.49 -29.94 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.5 -46.89 8.36 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.163 1.785 . . . . 0.0 110.983 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.6 p -79.17 -28.48 42.71 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.661 1.984 . . . . 0.0 109.087 -172.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 47.44 44.11 21.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm . . . . . 0 C--O 1.247 0.957 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.232 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 tpp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 118.906 -0.568 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.53 169.22 24.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.175 1.39 . . . . 0.0 108.268 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.54 100.48 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.25 167.3 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.858 1.663 . . . . 0.0 108.72 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -121.14 112.4 18.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.628 1.571 . . . . 0.0 108.017 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.05 172.49 13.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.325 1.05 . . . . 0.0 110.156 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -156.69 -177.77 6.86 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.633 1.973 . . . . 0.0 106.447 169.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -38.45 -38.83 0.4 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.673 2.789 . . . . 0.0 116.005 -169.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.18 -31.3 2.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.125 0.97 . . . . 0.0 111.154 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -61.68 -21.76 64.73 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 117.816 -1.088 . . . . 0.0 112.293 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -48.66 -51.32 28.97 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.323 1.42 . . . . 0.0 110.166 169.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -64.85 -45.29 86.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.03 87.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.532 0.206 . . . . 0.0 110.87 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -74.34 -16.1 60.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.546 1.138 . . . . 0.0 112.434 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.9 p -115.64 -2.83 12.39 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 112.122 -171.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.8 m -72.61 -10.83 60.26 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.73 144.47 34.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.135 0.879 . . . . 0.0 110.111 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.62 -174.92 31.09 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.59 1.091 . . . . 0.0 111.808 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 104' ' ' LEU . 31.0 t -89.99 129.84 40.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.2 116.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -169.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.6 tp -79.23 138.25 37.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.12 115.08 15.93 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.367 0.985 . . . . 0.0 109.24 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -111.97 147.67 35.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.01 1.324 . . . . 0.0 110.203 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -128.52 109.05 11.03 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.6 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -129.7 153.14 48.45 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.066 1.746 . . . . 0.0 107.711 -170.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -171.24 162.24 5.24 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 119.426 1.012 . . . . 0.0 109.836 169.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.63 -19.79 14.96 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.917 3.078 . . . . 0.0 116.626 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.404 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 15.0 m95 -53.72 -30.46 44.01 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.999 1.32 . . . . 0.0 114.293 -176.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 161.27 34.27 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.31 0.959 . . . . 0.0 113.214 -169.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.79 -48.92 52.59 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.08 -1.4 . . . . 0.0 112.669 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.4 -28.0 19.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.363 2.709 . . . . 0.0 115.075 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.85 -20.31 49.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 119.742 1.156 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.63 13.8 21.23 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.126 0.97 . . . . 0.0 111.442 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.1 mtm -123.73 -46.05 2.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.249 1.02 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.0 -34.75 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.15 10.94 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.691 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -59.66 -39.84 70.38 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.02 1.813 . . . . 0.0 111.634 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.35 -39.07 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 118.65 0.659 . . . . 0.0 110.451 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 mp -72.53 -39.76 67.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.991 0.814 . . . . 0.0 111.466 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.42 -33.48 75.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.723 1.147 . . . . 0.0 110.049 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.06 -21.56 59.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.0 1.32 . . . . 0.0 111.597 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.9 -44.71 16.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 108.932 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.407 ' HB2' HD12 ' A' ' 52' ' ' ILE . 17.9 t70 -70.46 -32.42 69.96 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.436 -1.415 . . . . 0.0 111.211 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -67.14 -6.88 19.54 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.537 -0.727 . . . . 0.0 112.755 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.8 -46.61 3.33 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.733 2.013 . . . . 0.0 109.615 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . 0.289 59.7 mmm -104.08 -12.42 16.77 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 125.486 1.515 . . . . 0.0 113.121 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.99 -7.8 9.33 Favored Glycine 0 C--N 1.318 -0.457 0 N-CA-C 113.962 0.345 . . . . 0.0 113.962 -171.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.03 -25.54 65.43 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.16 2.184 . . . . 0.0 112.489 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.7 -20.37 3.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.169 1.388 . . . . 0.0 112.074 -171.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.43 HD22 ' H ' ' A' ' 51' ' ' LYS . 1.6 tm? -129.43 156.41 44.14 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.21 1.404 . . . . 0.0 112.32 -166.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' H ' HD22 ' A' ' 50' ' ' LEU . 87.7 tttt -122.61 148.06 45.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.589 1.556 . . . . 0.0 108.28 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.407 HD12 ' HB2' ' A' ' 43' ' ' ASP . 13.7 mt -128.15 144.13 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.23 146.49 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 24.7 mtpt -121.32 153.02 38.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.181 0.446 . . . . 0.0 110.883 173.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -121.29 127.33 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.29 106.74 15.31 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.299 33.4 m -79.76 49.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -177.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -154.52 -42.18 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.538 1.135 . . . . 0.0 109.453 168.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -84.36 -40.97 17.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.053 1.341 . . . . 0.0 109.831 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -127.73 28.78 5.57 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.283 1.833 . . . . 0.0 111.3 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.98 -3.44 26.04 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.477 0.711 . . . . 0.0 112.696 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.75 -46.76 74.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.815 1.646 . . . . 0.0 111.127 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.15 -46.12 75.69 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.34 -63.93 0.97 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.723 0.809 . . . . 0.0 108.989 -169.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.21 -46.3 15.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.051 0.834 . . . . 0.0 113.096 174.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.02 -42.95 99.91 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.238 1.019 . . . . 0.0 111.724 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -69.17 -18.93 63.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.549 . . . . 0.0 110.712 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.22 66.48 1.52 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.12 129.9 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.46 ' HE3' HD13 ' B' ' 72' ' ' LEU . 27.6 mtm -147.64 20.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -134.32 160.69 37.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.608 1.163 . . . . 0.0 113.98 -167.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 136.45 29.14 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.042 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.43 128.48 11.64 Favored 'Cis proline' 0 N--CA 1.453 -0.869 0 N-CA-C 106.367 -2.205 . . . . 0.0 106.367 -11.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.6 m -92.91 140.49 29.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -136.45 92.79 2.81 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -80.5 132.36 35.68 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.67 120.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -127.96 157.95 39.2 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.057 0.943 . . . . 0.0 109.502 -170.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.06 144.08 25.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 169.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.8 30.29 0.83 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.178 1.791 . . . . 0.0 113.538 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.0 11.99 58.19 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.828 1.204 . . . . 0.0 115.939 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.31 149.26 50.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.647 1.224 . . . . 0.0 111.297 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.38 141.83 15.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 m -128.8 -20.62 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.504 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 153.0 40.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.241 1.016 . . . . 0.0 109.123 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.56 116.61 7.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -177.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -135.67 147.27 48.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.58 95.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -174.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.46 155.9 7.62 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -64.78 143.0 58.24 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.673 0.737 . . . . 0.0 110.526 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 139.75 32.05 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 169.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.24 167.24 22.62 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.463 2.109 . . . . 0.0 110.333 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -46.92 -46.71 21.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.702 1.601 . . . . 0.0 112.386 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.2 -44.34 72.3 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.562 0.619 . . . . 0.0 111.118 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.32 83.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.122 -0.361 . . . . 0.0 110.415 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -52.08 63.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.131 0.572 . . . . 0.0 109.998 176.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -64.24 -36.26 83.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.983 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.96 -49.37 77.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.167 0.439 . . . . 0.0 110.981 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.49 -40.03 85.71 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 123.683 0.793 . . . . 0.0 111.557 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.04 -40.73 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.228 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -55.0 -30.65 59.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.365 1.066 . . . . 0.0 112.276 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -59.62 -18.12 38.92 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.146 0.978 . . . . 0.0 113.298 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -131.88 -22.81 2.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.337 0.971 . . . . 0.0 112.774 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.487 ' HA ' HG21 ' A' ' 19' ' ' VAL . 20.2 tp . . . . . 0 C--O 1.248 0.984 0 C-N-CA 126.484 1.913 . . . . 0.0 107.528 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.67 24.22 2.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.839 0.855 . . . . 0.0 112.605 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.98 133.85 11.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 169.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -142.65 118.29 10.42 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 129.302 3.041 . . . . 0.0 104.23 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.72 130.66 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -134.34 139.67 47.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -127.13 142.27 51.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.201 1.0 . . . . 0.0 108.511 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' B' ' 131' ' ' LEU . 63.3 m-85 -126.41 107.38 10.23 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.146 0.978 . . . . 0.0 108.558 -172.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.97 127.31 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 91.9 p -152.17 162.51 41.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.077 0.399 . . . . 0.0 111.407 169.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 76.5 m -50.05 115.54 1.46 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.623 1.169 . . . . 0.0 110.145 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.46 19.46 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.685 2.088 . . . . 0.0 115.541 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 42.08 31.9 0.27 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.195 1.398 . . . . 0.0 111.493 -168.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -85.95 17.8 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.364 -1.46 . . . . 0.0 113.166 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.67 -67.66 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.662 1.185 . . . . 0.0 111.887 169.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.54 -56.62 15.48 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -168.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m -70.51 -32.99 70.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.891 -169.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.66 -50.15 55.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.305 1.05 . . . . 0.0 111.394 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 31.4 ttm -67.76 -47.12 70.1 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.76 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.99 97.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.001 0.92 . . . . 0.0 111.114 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.57 -31.18 69.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.569 1.077 . . . . 0.0 111.069 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.75 -49.7 53.32 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -56.34 -39.79 73.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.81 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.7 -51.52 64.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -63.37 -22.55 66.95 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -69.87 -11.19 60.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.478 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 14.4 m-85 -130.17 -44.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.735 1.214 . . . . 0.0 111.657 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' B' ' 135' ' ' ALA . 10.7 mp -81.44 75.37 8.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.329 2.252 . . . . 0.0 105.521 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.52 -159.07 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.821 2.153 . . . . 0.0 113.306 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.19 -21.21 21.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.439 1.096 . . . . 0.0 113.245 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.13 -19.85 15.09 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.35 1.86 . . . . 0.0 113.071 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -128.66 161.22 30.16 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.818 1.247 . . . . 0.0 111.005 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.5 136.95 49.48 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.66 136.1 60.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -140.36 157.15 45.98 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.178 0.991 . . . . 0.0 109.217 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -138.43 140.66 39.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.734 1.213 . . . . 0.0 108.56 -172.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.36 173.84 16.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.913 0.485 . . . . 0.0 110.953 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.87 -171.4 42.05 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.304 0.954 . . . . 0.0 111.193 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.73 -56.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.008 1.723 . . . . 0.0 113.999 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.38 31.0 2.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.711 2.004 . . . . 0.0 107.581 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.02 131.09 47.46 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.519 1.928 . . . . 0.0 113.821 -169.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -171.21 8.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.175 1.79 . . . . 0.0 111.31 169.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.73 107.56 3.13 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 119.175 0.898 . . . . 0.0 111.696 -169.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -78.39 86.7 4.44 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -62.04 125.43 85.23 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.534 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.3 -20.08 53.73 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.243 1.962 . . . . 0.0 113.013 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.424 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -60.52 -39.63 88.52 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.696 1.135 . . . . 0.0 111.027 171.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.25 59.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.76 -50.81 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -56.93 -47.01 81.61 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 123.375 0.67 . . . . 0.0 110.28 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.55 -33.26 59.81 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.208 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 82.6 mmm -91.67 -30.64 16.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.997 0.817 . . . . 0.0 111.219 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.47 -24.39 67.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.845 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.67 -31.39 68.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.929 1.24 . . . . 0.0 111.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 m -113.73 15.36 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.085 1.354 . . . . 0.0 110.808 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.67 39.97 98.59 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.634 -1.092 . . . . 0.0 112.824 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.56 107.88 24.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.33 132.7 48.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 pt -127.99 11.42 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.881 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -19.81 46.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.06 0.845 . . . . 0.0 111.163 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -76.97 -13.83 59.92 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.493 2.317 . . . . 0.0 114.073 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -62.9 161.62 12.53 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.217 1.371 . . . . 0.0 113.586 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 63.8 p -126.44 171.23 11.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.883 2.473 . . . . 0.0 108.528 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -157.89 163.62 37.74 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.819 -1.176 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -167.78 164.94 14.28 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 -175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.5 pt -69.29 175.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 111.274 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.53 133.62 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -143.17 104.8 4.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.869 0.842 . . . . 0.0 108.988 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -46.92 -28.63 1.67 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.766 2.026 . . . . 0.0 114.022 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.85 -15.77 62.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.125 0.875 . . . . 0.0 112.049 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.48 -38.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.38 1.072 . . . . 0.0 109.259 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.46 HD13 ' HE3' ' A' ' 70' ' ' MET . 6.9 tt -65.31 -58.54 5.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 120.206 1.366 . . . . 0.0 109.399 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -24.08 66.57 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.362 0.528 . . . . 0.0 110.757 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -78.63 -26.13 45.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 113.092 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 169.33 2.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.467 1.507 . . . . 0.0 111.959 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -91.31 -30.34 16.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.07 138.63 22.97 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.189 0.996 . . . . 0.0 110.556 -170.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 t -113.57 106.14 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.64 114.35 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 30.4 m -77.21 129.23 35.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 168.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.6 tp -131.43 56.12 1.82 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.998 0.919 . . . . 0.0 111.304 -168.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 CA--C 1.534 0.334 0 O-C-N 120.883 -1.135 . . . . 0.0 109.339 170.571 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.5 -0.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.116 2.166 . . . . 0.0 116.685 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 85.89 7.39 0.36 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.472 2.309 . . . . 0.0 111.528 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.6 m 32.79 49.63 0.55 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 127.821 2.448 . . . . 0.0 113.5 -170.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.48 134.15 38.69 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.731 2.287 . . . . 0.0 111.685 -169.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.462 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.3 0.23 49.87 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 116.987 -1.482 . . . . 0.0 114.882 -172.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p 48.31 88.45 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.202 1.401 . . . . 0.0 112.879 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.6 146.61 74.98 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 122.802 2.335 . . . . 0.0 110.112 -169.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.76 2.96 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 125.551 4.167 . . . . 0.0 116.617 -168.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -68.39 -6.16 23.03 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.951 0.796 . . . . 0.0 111.945 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.95 147.31 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.533 1.133 . . . . 0.0 110.26 -169.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -72.73 156.53 38.84 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -151.43 139.11 19.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.627 -1.296 . . . . 0.0 108.472 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -149.11 144.86 26.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.31 136.73 34.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -133.76 -10.64 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.958 0.903 . . . . 0.0 111.655 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.44 168.08 49.6 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.11 -7.28 0.18 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.432 0.693 . . . . 0.0 112.836 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -161.98 179.41 8.03 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.262 1.425 . . . . 0.0 107.928 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -135.76 114.91 11.21 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.26 1.424 . . . . 0.0 108.389 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.05 -18.58 21.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.474 2.783 . . . . 0.0 112.855 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.88 -7.19 7.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.786 1.176 . . . . 0.0 112.461 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -101.66 11.3 39.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.359 1.464 . . . . 0.0 111.347 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.64 147.05 0.65 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.481 1.112 . . . . 0.0 111.595 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -53.37 -45.99 69.43 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 124.078 0.861 . . . . 0.0 109.889 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.98 -20.48 2.86 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 53.2 p -68.7 165.38 19.59 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.37 -41.72 97.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.48 0.657 . . . . 0.0 110.308 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.98 -43.73 67.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 117.007 -1.473 . . . . 0.0 109.718 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.36 -32.43 62.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.18 1.809 . . . . 0.0 109.582 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -56.2 -62.28 1.82 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.153 0.581 . . . . 0.0 109.658 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.89 -39.78 86.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.989 0.916 . . . . 0.0 112.25 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -64.33 -44.92 90.02 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.9 m-30 -60.88 -51.53 68.9 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -64.08 -46.8 82.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 111.299 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -65.51 -48.61 71.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.084 0.402 . . . . 0.0 110.016 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.07 -40.23 88.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.151 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -58.17 -46.73 85.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.543 1.065 . . . . 0.0 111.84 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.23 -44.09 83.47 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.183 0.447 . . . . 0.0 110.524 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -74.37 -39.52 62.7 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.66 -49.17 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 108.913 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.55 -41.44 96.17 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.409 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -56.78 -51.34 69.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 118.13 0.965 . . . . 0.0 111.228 174.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -63.7 -42.31 98.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.638 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.441 HD11 ' CZ ' ' B' ' 8' ' ' PHE . 3.2 mm? -64.5 -40.88 96.49 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.152 0.887 . . . . 0.0 112.202 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.478 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 41.5 ttmt -60.13 -38.0 81.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.461 0.573 . . . . 0.0 110.416 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.64 77.9 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 116.672 -1.633 . . . . 0.0 112.611 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -59.16 -34.46 72.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 122.539 2.427 . . . . 0.0 110.957 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.491 ' HB2' HD12 ' B' ' 28' ' ' LEU . . . -62.69 -32.53 73.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.086 0.554 . . . . 0.0 111.036 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -88.63 -44.57 10.52 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.293 1.437 . . . . 0.0 111.239 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 68.0 p -87.04 -17.44 32.94 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.899 2.08 . . . . 0.0 111.017 -170.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.32 39.57 92.83 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.225 0.917 . . . . 0.0 110.932 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.743 0.817 . . . . 0.0 112.293 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.67 157.86 0.08 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.916 2.486 . . . . 0.0 113.074 -171.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.83 100.92 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 t -74.87 165.98 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.243 1.417 . . . . 0.0 108.057 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -125.79 117.46 23.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.319 1.048 . . . . 0.0 108.625 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -76.79 171.82 14.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.667 1.587 . . . . 0.0 110.12 176.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -156.02 -176.07 5.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.642 1.577 . . . . 0.0 107.053 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -36.67 -36.97 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 130.202 3.401 . . . . 0.0 116.743 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.97 -30.24 1.23 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.999 1.32 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -60.84 -22.18 63.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.335 -0.84 . . . . 0.0 112.319 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -50.79 -52.44 40.96 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.613 1.097 . . . . 0.0 109.292 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.45 -44.57 96.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.02 80.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.444 -0.16 . . . . 0.0 111.13 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.38 -11.95 59.98 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.855 1.262 . . . . 0.0 112.843 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -123.29 -3.09 8.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.942 1.246 . . . . 0.0 113.27 -169.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -71.33 -10.74 60.25 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.65 156.87 45.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.11 0.964 . . . . 0.0 109.574 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.98 -150.92 48.34 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.359 0.98 . . . . 0.0 110.988 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.42 132.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.0 t -143.13 116.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.94 123.33 27.16 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.47 140.15 46.31 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -134.09 151.32 51.33 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.876 1.671 . . . . 0.0 108.786 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.403 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 25.2 m-85 -131.66 117.35 18.54 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.572 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.9 p-90 -139.58 153.89 47.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.344 1.458 . . . . 0.0 108.849 -169.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.48 158.33 9.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.262 1.025 . . . . 0.0 108.489 168.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.37 -15.18 5.4 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.764 2.976 . . . . 0.0 116.846 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -59.86 -24.75 64.48 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.12 160.26 36.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.456 1.026 . . . . 0.0 112.588 -169.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.24 -49.62 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.253 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.1 -28.09 24.03 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.225 2.617 . . . . 0.0 115.093 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 m -59.38 -16.42 22.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.585 1.084 . . . . 0.0 113.692 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -116.92 14.98 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.788 1.235 . . . . 0.0 111.681 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.0 mtm -123.47 -45.2 2.08 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.182 0.993 . . . . 0.0 109.416 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tp -62.77 -34.9 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.798 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.84 24.02 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.985 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.04 -40.1 73.96 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.955 1.77 . . . . 0.0 111.476 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.44 -37.93 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.467 0.576 . . . . 0.0 110.701 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mp -71.58 -41.22 69.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.952 0.796 . . . . 0.0 111.363 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.06 -35.13 80.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.673 1.124 . . . . 0.0 109.727 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.3 -16.41 61.9 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.619 1.567 . . . . 0.0 112.608 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -86.98 -43.45 12.35 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 124.657 1.183 . . . . 0.0 108.382 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.2 -36.59 69.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.79 -0.569 . . . . 0.0 111.118 -174.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.78 -12.55 61.61 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.614 -0.679 . . . . 0.0 112.193 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -99.92 -42.57 6.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.366 1.467 . . . . 0.0 110.797 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -145.03 17.89 1.59 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.665 0.786 . . . . 0.0 112.284 -172.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.91 -1.99 21.36 Favored Glycine 0 CA--C 1.523 0.574 0 O-C-N 121.343 -0.848 . . . . 0.0 113.984 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.37 -24.88 63.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.599 1.16 . . . . 0.0 110.97 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.12 -18.3 11.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.911 0.884 . . . . 0.0 112.576 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -130.63 147.32 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 111.101 -168.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -107.11 146.01 31.77 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 168.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.71 137.44 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 7.4 t -136.58 141.56 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -175.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.572 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 26.3 mtpt -116.41 152.79 33.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -117.72 120.75 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -79.03 109.37 13.27 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.48 33.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -141.8 -42.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.057 -1.027 . . . . 0.0 109.819 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -79.82 -36.12 37.37 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.94 0.896 . . . . 0.0 110.67 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -134.2 32.37 3.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.439 1.495 . . . . 0.0 109.94 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -15.26 62.9 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.21 -169.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -50.54 -44.57 56.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.971 1.309 . . . . 0.0 111.783 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -60.38 -38.61 84.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.895 0.77 . . . . 0.0 111.872 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -66.91 0.5 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.83 1.252 . . . . 0.0 108.883 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.23 -44.84 5.04 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.641 1.115 . . . . 0.0 113.609 170.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -64.44 -45.2 88.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.574 1.187 . . . . 0.0 111.535 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -70.02 -31.57 69.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.49 0.586 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 68.05 0.74 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.8 t -142.39 132.49 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 100.744 -3.799 . . . . 0.0 100.744 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.633 ' HG3' HD12 ' B' ' 67' ' ' ILE . 10.3 ptm -150.59 17.66 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.767 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -138.3 163.56 31.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.222 2.209 . . . . 0.0 111.155 -169.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 143.89 49.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.944 0.898 . . . . 0.0 108.781 176.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.91 149.6 38.77 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 N-CA-C 107.345 -1.829 . . . . 0.0 107.345 -11.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 96.7 m -118.45 147.52 43.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 172.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.6 mt -125.71 141.71 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -129.0 106.86 9.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.04 118.63 31.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -110.31 149.05 30.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.518 0.727 . . . . 0.0 109.405 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -148.75 132.95 17.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.6 t70 43.23 30.84 0.32 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.678 1.991 . . . . 0.0 113.499 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.64 9.99 57.09 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.43 152.59 51.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.693 1.197 . . . . 0.0 110.757 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.07 133.06 32.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -120.24 -22.45 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.223 1.409 . . . . 0.0 110.704 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.36 163.73 34.64 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.215 1.006 . . . . 0.0 110.063 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.74 150.39 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -169.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -154.79 151.25 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.52 67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.76 154.92 8.94 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -170.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -71.86 158.88 35.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.946 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.59 143.63 20.46 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.18 168.15 22.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.352 2.035 . . . . 0.0 110.425 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -44.99 70.94 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.085 0.954 . . . . 0.0 112.071 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.86 -43.17 84.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.563 0.165 . . . . 0.0 110.891 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.0 78.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.04 -0.412 . . . . 0.0 110.666 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -53.21 59.65 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 109.477 175.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -64.44 -37.81 88.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.72 -46.61 88.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.425 0.557 . . . . 0.0 111.264 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -58.08 -40.12 80.29 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 123.868 0.867 . . . . 0.0 111.151 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.95 -39.87 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.267 -0.397 . . . . 0.0 110.687 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -56.36 -28.24 58.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.583 1.153 . . . . 0.0 112.414 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -56.35 -22.39 30.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.149 0.98 . . . . 0.0 112.959 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -127.97 -26.17 2.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.052 0.941 . . . . 0.0 112.338 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.704 1.602 . . . . 0.0 108.033 171.211 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.69 142.5 40.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.289 0.636 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m120 70.63 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 128.608 2.763 . . . . 0.0 110.566 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 127.23 27.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.57 136.16 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -137.91 140.46 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.38 139.89 49.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.898 0.479 . . . . 0.0 110.775 -169.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -100.94 141.18 34.19 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.62 120.07 10.99 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -172.23 155.92 3.75 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -39.53 102.19 0.02 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.18 1.792 . . . . 0.0 112.707 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.27 22.35 50.16 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.652 -1.638 . . . . 0.0 113.784 171.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . 0.511 HD22 ' HB3' ' B' ' 36' ' ' SER . 0.2 OUTLIER 33.5 2.67 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 1 C-N-CA 132.715 4.406 . . . . 0.0 121.046 173.791 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -70.84 -5.95 34.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.914 -1.741 . . . . 0.0 115.312 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.31 -95.65 0.48 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 120.496 1.498 . . . . 0.0 111.102 -177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -37.5 62.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.611 0.765 . . . . 0.0 112.536 -171.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -44.42 97.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.62 0.646 . . . . 0.0 110.089 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -56.7 -48.62 77.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.051 0.94 . . . . 0.0 110.188 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -43.3 91.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 124.068 0.855 . . . . 0.0 108.906 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.75 71.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.942 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -48.29 80.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.903 1.229 . . . . 0.0 109.883 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 -47.17 92.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -58.36 -42.34 86.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 112.055 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.27 -54.25 36.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.46 -23.66 65.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.703 -1.142 . . . . 0.0 112.025 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -68.22 -21.19 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.883 1.219 . . . . 0.0 113.558 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' B' ' 132' ' ' LYS . 2.3 m-85 -115.69 -16.31 11.27 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.971 0.908 . . . . 0.0 112.715 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.53 -128.23 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.13 -174.4 40.23 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 127.3 2.381 . . . . 0.0 107.361 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.61 -14.24 40.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.376 1.088 . . . . 0.0 112.026 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -52.79 -28.0 20.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.309 1.444 . . . . 0.0 110.429 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -122.46 168.65 11.86 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.24 2.216 . . . . 0.0 107.228 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -139.04 106.21 5.48 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 120.974 -1.079 . . . . 0.0 108.982 -173.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 82.3 t -99.31 132.22 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.67 166.73 23.82 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.517 1.527 . . . . 0.0 108.775 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.511 ' HB3' HD22 ' B' ' 13' ' ' ASN . 37.3 m -147.15 150.55 35.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.484 1.114 . . . . 0.0 109.213 176.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.56 177.35 11.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.975 0.91 . . . . 0.0 110.03 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.24 -175.78 47.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.401 1.477 . . . . 0.0 110.035 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -53.07 -55.45 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.346 1.458 . . . . 0.0 113.114 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.12 29.82 5.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.343 1.457 . . . . 0.0 108.297 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 121.47 14.77 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.092 2.157 . . . . 0.0 111.72 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -174.85 -19.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.46 1.504 . . . . 0.0 111.194 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.76 179.31 53.6 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 124.333 0.968 . . . . 0.0 113.981 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -147.26 92.31 2.09 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.416 1.486 . . . . 0.0 107.041 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.57 129.06 94.07 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.622 1.169 . . . . 0.0 108.16 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -59.53 -19.66 53.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.875 1.717 . . . . 0.0 112.809 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.425 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.2 OUTLIER -61.67 -38.72 88.8 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.104 1.32 . . . . 0.0 111.239 171.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.72 65.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.91 -52.7 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.675 0.79 . . . . 0.0 110.264 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -36.94 58.45 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.996 0.918 . . . . 0.0 111.206 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.7 mmm -82.3 -30.54 30.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.141 0.882 . . . . 0.0 111.568 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -61.62 -25.47 67.38 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.47 1.032 . . . . 0.0 110.992 171.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.15 -22.46 66.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.768 1.167 . . . . 0.0 112.246 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 p -116.67 9.7 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.978 1.711 . . . . 0.0 109.526 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.0 38.79 96.54 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 120.964 -1.085 . . . . 0.0 111.928 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.9 mt -114.48 140.35 35.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.25 136.8 44.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 pt -135.78 15.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.437 1.095 . . . . 0.0 110.855 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 17.1 p -59.48 -13.12 7.65 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.657 1.117 . . . . 0.0 113.63 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -91.29 -14.81 30.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.862 1.665 . . . . 0.0 113.492 176.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.69 142.0 53.95 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.746 1.157 . . . . 0.0 112.611 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -129.36 173.6 10.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.893 2.477 . . . . 0.0 108.486 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.3 m -155.36 -175.38 5.41 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.966 -1.083 . . . . 0.0 110.924 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -155.93 158.87 38.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.94 1.696 . . . . 0.0 109.031 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.5 pt -71.61 170.31 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.583 1.153 . . . . 0.0 112.215 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.633 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.2 OUTLIER -49.7 127.45 5.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -146.01 97.18 2.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.351 1.072 . . . . 0.0 108.75 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -46.42 -27.37 1.06 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.348 1.859 . . . . 0.0 114.429 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.78 -17.9 61.84 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.94 1.245 . . . . 0.0 112.604 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.19 -34.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.917 0.887 . . . . 0.0 108.933 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.66 -54.77 19.67 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.365 0.984 . . . . 0.0 110.209 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -22.41 67.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.561 0.619 . . . . 0.0 110.48 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.1 -20.79 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.809 1.644 . . . . 0.0 112.418 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.56 167.34 2.68 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.759 1.224 . . . . 0.0 111.947 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.29 -28.58 16.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.74 169.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.53 132.45 19.13 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 110.73 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.19 99.98 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -81.09 102.69 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 57.5 m -67.04 136.09 54.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 tp -125.13 43.54 3.02 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 CA--C 1.54 0.59 0 C-N-CA 124.64 1.176 . . . . 0.0 112.724 174.763 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 17.73 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 130.96 3.704 . . . . 0.0 110.643 -168.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -157.12 32.89 0.29 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 128.996 2.918 . . . . 0.0 107.663 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 m 32.38 52.8 0.84 Allowed Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.421 1.888 . . . . 0.0 112.478 -168.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -45.43 131.76 12.22 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.486 2.79 . . . . 0.0 114.8 -169.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.427 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -85.42 -1.3 56.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.2 p 44.36 93.05 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.888 2.075 . . . . 0.0 113.831 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -55.89 134.97 67.27 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.776 2.317 . . . . 0.0 109.089 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.16 8.47 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.765 3.643 . . . . 0.0 116.095 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -67.8 -6.08 19.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.087 0.955 . . . . 0.0 111.904 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.37 146.79 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 109.391 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -69.67 156.14 39.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -144.36 142.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.404 0 O-C-N 121.029 -1.044 . . . . 0.0 108.208 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.85 154.07 32.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 169.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -95.95 127.31 41.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -110.02 -3.62 16.37 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.706 0.802 . . . . 0.0 110.499 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 162.38 13.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -145.82 -9.39 0.54 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.398 1.079 . . . . 0.0 111.738 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -156.87 168.58 27.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.353 2.261 . . . . 0.0 106.02 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -125.33 112.15 26.04 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.035 0.934 . . . . 0.0 108.636 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.0 -22.91 34.86 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.404 3.403 . . . . 0.0 113.189 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.87 -10.69 9.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.976 0.807 . . . . 0.0 112.637 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -97.82 7.95 45.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 111.858 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.61 143.29 2.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.027 0.931 . . . . 0.0 112.362 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -57.04 -47.7 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.968 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.15 -17.25 4.1 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 44.0 p -70.16 159.87 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.61 -38.81 82.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.352 0.596 . . . . 0.0 111.068 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.3 pt-20 -72.71 -43.43 63.02 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.764 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.49 -30.82 59.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.103 1.774 . . . . 0.0 110.077 -172.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -59.89 -57.11 14.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.76 -0.638 . . . . 0.0 109.837 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -61.5 -41.68 97.66 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.146 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.32 87.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.144 0.884 . . . . 0.0 112.372 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -62.92 -47.63 82.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.3 m-30 -64.13 -43.38 95.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -59.43 -53.84 53.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.018 1.727 . . . . 0.0 109.693 -173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.08 -49.36 70.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.1 -41.19 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.216 -0.897 . . . . 0.0 109.736 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp-105 -58.39 -47.17 84.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.974 1.261 . . . . 0.0 111.21 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.31 -43.49 88.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.242 0.474 . . . . 0.0 110.92 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -64.72 -48.87 73.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.05 0.54 . . . . 0.0 110.06 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.88 -50.66 59.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 125.206 1.402 . . . . 0.0 110.042 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.21 -40.84 95.0 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -61.58 -42.99 99.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.17 0.985 . . . . 0.0 111.689 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -69.74 -34.16 73.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.956 0.798 . . . . 0.0 111.345 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' B' ' 131' ' ' LEU . 3.4 mm? -73.19 -37.8 66.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.698 1.135 . . . . 0.0 111.756 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.403 ' HE3' ' CE2' ' B' ' 27' ' ' TYR . 7.9 ptmt -67.75 -37.34 82.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.945 0.793 . . . . 0.0 109.836 175.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -59.24 -40.75 86.92 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.218 -1.372 . . . . 0.0 109.904 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -60.4 -38.15 83.06 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 122.163 2.256 . . . . 0.0 111.181 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.99 70.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.037 0.535 . . . . 0.0 112.221 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.22 -47.57 8.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.474 1.51 . . . . 0.0 111.499 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.1 p -84.19 -23.28 30.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 110.78 -169.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 50.58 41.28 41.73 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.273 1.429 . . . . 0.0 113.613 -169.049 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.51 170.04 21.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.27 1.428 . . . . 0.0 107.882 169.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 96.81 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 169.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.06 167.63 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.594 1.557 . . . . 0.0 108.132 178.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -123.6 120.28 32.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.257 1.423 . . . . 0.0 107.771 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.52 169.25 15.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.314 1.046 . . . . 0.0 109.214 176.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -133.59 -167.25 1.9 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.557 1.543 . . . . 0.0 108.245 169.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.26 -27.09 2.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.955 2.102 . . . . 0.0 113.409 169.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -136.53 -31.25 0.88 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 111.947 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.0 m -63.81 -20.51 65.84 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.807 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -52.24 -58.38 6.81 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.247 0.931 . . . . 0.0 109.272 169.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -62.58 -43.18 99.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.908 -0.495 . . . . 0.0 110.316 -176.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.79 83.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.193 -174.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -81.34 -16.13 53.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.207 1.003 . . . . 0.0 112.927 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -114.2 -4.19 13.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.446 1.021 . . . . 0.0 113.578 -169.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 m -73.4 -4.57 34.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.66 156.98 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.806 1.242 . . . . 0.0 109.554 -177.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.09 -163.36 45.24 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 124.754 1.169 . . . . 0.0 112.058 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.46 134.97 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.82 149.13 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 113.679 -1.6 . . . . 0.0 108.674 -168.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.4 tp -119.0 100.89 7.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.982 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.84 144.77 25.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -139.49 148.85 43.25 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.417 1.487 . . . . 0.0 108.724 -173.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.34 105.5 7.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -169.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.571 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.1 p-90 -123.7 151.58 42.99 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.237 1.815 . . . . 0.0 107.62 -169.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -166.75 163.09 11.08 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.689 0.677 . . . . 0.0 111.316 173.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.32 -10.42 8.51 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.179 3.253 . . . . 0.0 116.534 -177.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.426 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 84.0 m95 -50.12 -49.33 52.21 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.472 -1.251 . . . . 0.0 112.482 -177.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -152.67 168.57 25.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -173.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.24 -54.07 3.91 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 127.865 2.65 . . . . 0.0 115.821 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -53.33 -29.73 49.09 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.597 2.699 . . . . 0.0 114.816 -173.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -61.02 -14.89 26.33 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.779 1.172 . . . . 0.0 114.047 174.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 8.78 19.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.6 1.56 . . . . 0.0 111.167 177.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.8 mtp -125.16 -44.91 1.87 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.477 1.111 . . . . 0.0 108.441 -175.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.91 -35.95 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 -59.28 10.49 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.275 1.03 . . . . 0.0 112.356 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.71 -40.75 61.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.188 1.925 . . . . 0.0 111.607 174.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -40.15 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.238 0.615 . . . . 0.0 110.865 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.82 -43.72 74.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.935 0.789 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.49 -35.16 80.07 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.99 0.814 . . . . 0.0 109.93 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.53 -17.55 62.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.507 1.523 . . . . 0.0 112.536 174.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -87.63 -44.42 11.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.48 1.112 . . . . 0.0 108.674 176.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 52' ' ' ILE . 18.7 t70 -70.23 -36.41 74.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.137 -0.352 . . . . 0.0 110.934 -175.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -69.1 -8.52 46.09 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.919 -0.563 . . . . 0.0 112.32 175.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.91 -46.49 4.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.496 1.118 . . . . 0.0 111.23 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.6 ptm -135.63 15.98 3.37 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.063 0.945 . . . . 0.0 112.304 -171.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.89 -4.82 11.79 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 120.978 -1.077 . . . . 0.0 114.228 170.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.06 -23.33 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.752 0.821 . . . . 0.0 111.054 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -14.38 8.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.259 1.024 . . . . 0.0 112.262 -174.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -129.06 142.01 51.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.515 1.126 . . . . 0.0 111.854 -168.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.52 146.86 27.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 168.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 43' ' ' ASP . 58.6 mt -123.49 144.59 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.03 143.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 29.2 mtpt -118.56 150.48 39.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.65 0.659 . . . . 0.0 110.197 174.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -118.91 127.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 169.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.49 105.12 12.4 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.297 34.6 m -79.64 46.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -152.2 -38.77 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.549 1.14 . . . . 0.0 109.435 168.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -78.79 -52.34 8.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.948 1.299 . . . . 0.0 110.101 177.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.04 46.0 2.47 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.884 1.274 . . . . 0.0 110.052 -172.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.62 2.83 5.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.75 1.62 . . . . 0.0 113.032 -176.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.7 -45.46 89.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.104 1.361 . . . . 0.0 111.102 -169.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -59.64 -36.16 75.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.386 0.994 . . . . 0.0 111.469 173.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB1' ' HE2' ' B' ' 91' ' ' MET . . . -69.58 -58.41 3.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.67 -39.2 45.8 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.075 0.845 . . . . 0.0 113.807 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.11 -43.45 98.41 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.008 1.404 . . . . 0.0 110.821 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -74.92 -11.46 60.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.356 0.662 . . . . 0.0 111.745 173.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.85 55.56 13.73 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.065 1.317 . . . . 0.0 109.85 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.64 -46.89 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 117.911 0.855 . . . . 0.0 109.495 -169.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mtm 53.87 14.6 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 127.936 2.494 . . . . 0.0 113.583 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.408 ' O ' HD13 ' A' ' 72' ' ' ILE . 16.6 m -135.59 163.6 29.75 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.835 1.198 . . . . 0.0 112.993 -168.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.691 HD11 ' HB3' ' B' ' 91' ' ' MET . 2.8 mm -135.09 137.61 27.34 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.975 0.91 . . . . 0.0 110.176 -177.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.74 125.85 10.38 Favored 'Cis proline' 0 N--CA 1.454 -0.846 0 N-CA-C 105.496 -2.54 . . . . 0.0 105.496 -11.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.8 m -85.4 146.36 27.02 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tp -137.21 125.49 23.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.05 108.3 13.21 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 177.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.8 129.79 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.4 156.31 42.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -142.2 138.7 31.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 44.17 28.45 0.27 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.867 2.067 . . . . 0.0 114.258 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.06 41.62 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 124.725 1.155 . . . . 0.0 115.748 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -130.95 143.62 50.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.735 1.268 . . . . 0.0 110.414 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 134.03 30.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -125.73 -22.74 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.356 1.063 . . . . 0.0 109.925 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.81 161.98 40.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.601 1.161 . . . . 0.0 109.534 169.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 148.64 29.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -154.16 155.89 36.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.56 72.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.29 154.83 9.05 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.954 -171.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -65.25 149.21 50.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.212 0.605 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.59 140.29 20.08 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.72 169.19 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 175.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -45.91 67.22 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.038 0.935 . . . . 0.0 112.078 -171.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.12 -43.82 77.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.45 0.114 . . . . 0.0 110.864 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.44 83.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.12 -0.362 . . . . 0.0 110.171 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 tp -68.17 -46.59 70.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.515 0.326 . . . . 0.0 110.781 178.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -62.65 -38.74 91.48 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.71 -45.64 91.82 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.579 0.627 . . . . 0.0 110.906 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.8 tp -58.65 -36.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.988 1.315 . . . . 0.0 111.644 -175.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.08 -40.78 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.469 174.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -56.99 -34.32 67.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.989 0.916 . . . . 0.0 111.555 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.52 -6.82 33.2 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.09 -22.9 4.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.904 1.282 . . . . 0.0 112.736 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.254 2.222 . . . . 0.0 109.063 170.378 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mpp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.91 139.29 58.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.524 0.73 . . . . 0.0 110.177 -178.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' B' ' 33' ' ' LYS 0.453 0.1 OUTLIER 31.15 103.21 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.441 3.096 . . . . 0.0 119.129 -179.067 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.84 120.36 23.35 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.35 140.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -169.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.16 145.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -131.41 150.51 52.12 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.704 0.802 . . . . 0.0 110.548 -168.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -113.61 143.37 44.69 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.911 1.284 . . . . 0.0 107.582 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.8 tp -145.52 109.21 4.73 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -169.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -166.81 153.66 8.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.173 0.989 . . . . 0.0 109.974 -178.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 94.8 m -38.43 116.52 0.55 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.22 2.208 . . . . 0.0 113.607 -169.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.31 8.45 31.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.01 0.814 . . . . 0.0 113.763 172.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . 0.5 HD22 ' NE2' ' B' ' 18' ' ' GLN . 7.4 t30 52.53 20.63 1.53 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.919 1.288 . . . . 0.0 112.384 -169.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 10.5 m -67.27 133.8 50.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.427 -0.795 . . . . 0.0 109.933 -174.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 56.53 -85.65 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 169.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.438 ' HG3' ' HD2' ' B' ' 106' ' ' PRO . 0.0 OUTLIER -54.12 -40.74 67.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.998 0.817 . . . . 0.0 111.829 -169.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -33.76 76.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.03 0.932 . . . . 0.0 111.403 -177.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.5 ' NE2' HD22 ' B' ' 13' ' ' ASN . 41.2 mm-40 -68.95 -52.28 30.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.63 1.572 . . . . 0.0 108.949 175.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 11.3 ptp -65.83 -37.55 86.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.712 -174.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.41 80.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.979 -0.534 . . . . 0.0 110.495 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.73 -28.29 66.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.976 176.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.02 -46.37 10.52 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 119.217 0.917 . . . . 0.0 111.215 173.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -53.59 -44.06 69.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 124.712 1.205 . . . . 0.0 111.223 173.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -49.73 72.21 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.97 -28.47 70.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.665 -171.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.69 -15.81 62.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 1.1 m-85 -127.29 -17.37 4.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.4 -124.53 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.24 -168.6 38.03 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.55 -18.68 31.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.262 1.425 . . . . 0.0 112.361 172.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -55.83 -20.57 15.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.468 1.507 . . . . 0.0 111.192 169.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -134.16 168.2 19.27 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.334 1.453 . . . . 0.0 111.516 -177.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' B' ' 3' ' ' ASN . 1.6 tmtp? -137.42 126.13 23.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 169.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.23 124.37 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -169.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -135.13 169.49 17.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.034 0.934 . . . . 0.0 109.068 177.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -146.92 140.35 25.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.96 177.36 9.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.888 . . . . 0.0 112.227 -177.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 -175.2 44.8 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.453 1.025 . . . . 0.0 112.349 176.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.421 HG13 ' HE3' ' B' ' 88' ' ' LYS . 2.4 tt -41.06 -64.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.062 . . . . 0.0 114.607 -170.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.15 31.93 4.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.394 2.278 . . . . 0.0 107.014 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 41' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' B' ' 13' ' ' ASN . . . -54.55 138.58 40.45 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -168.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -177.86 21.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 129.054 2.942 . . . . 0.0 108.414 169.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.42 58.09 4.42 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 117.111 1.605 . . . . 0.0 117.111 -168.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.7 tp -67.85 115.22 7.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.174 1.987 . . . . 0.0 106.897 168.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -110.13 130.27 23.03 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -174.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -21.18 51.75 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.274 1.982 . . . . 0.0 112.887 177.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.4 OUTLIER -62.56 -35.55 79.83 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.764 1.166 . . . . 0.0 111.654 172.164 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -77.64 -33.19 53.61 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.871 0.76 . . . . 0.0 109.621 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.09 -49.9 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -59.39 -45.77 90.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.377 -0.827 . . . . 0.0 110.807 176.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.63 69.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.353 1.061 . . . . 0.0 111.526 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -77.11 -40.86 44.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.818 0.847 . . . . 0.0 110.001 176.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.26 -27.67 69.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.502 178.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.8 -30.27 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.84 1.2 . . . . 0.0 111.85 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.08 16.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.221 1.408 . . . . 0.0 110.81 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.07 28.44 72.92 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.162 -1.354 . . . . 0.0 113.491 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.41 152.05 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 169.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -124.18 140.17 53.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.3 pt -135.94 17.77 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.979 1.312 . . . . 0.0 110.868 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -59.44 -17.07 27.91 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.421 -0.799 . . . . 0.0 111.978 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -77.9 -18.03 56.61 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.282 1.833 . . . . 0.0 113.907 174.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -65.59 167.14 9.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.697 1.237 . . . . 0.0 112.761 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -153.21 174.98 13.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.653 1.981 . . . . 0.0 106.681 170.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -149.89 174.46 12.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.623 0.769 . . . . 0.0 110.318 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -161.55 164.35 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.876 1.67 . . . . 0.0 109.217 -169.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 pt -63.02 165.57 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.702 1.201 . . . . 0.0 112.716 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.58 128.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -134.75 100.14 4.53 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.698 1.237 . . . . 0.0 108.34 -176.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.3 m -46.28 -29.82 1.79 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.132 2.173 . . . . 0.0 113.674 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.87 -25.22 68.18 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.392 0.996 . . . . 0.0 111.446 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.92 -42.14 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.35 -49.44 76.96 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.608 1.094 . . . . 0.0 110.199 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -27.76 69.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 110.95 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -84.9 -20.18 31.14 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.817 1.247 . . . . 0.0 112.413 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.19 157.16 10.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.295 1.045 . . . . 0.0 110.649 175.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.7 -33.29 20.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.776 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -146.28 135.0 22.29 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.954 -169.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.485 HG23 HG11 ' B' ' 96' ' ' VAL . 69.0 t -111.29 116.08 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 126.222 1.809 . . . . 0.0 107.559 172.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 46.3 t -88.81 105.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -70.99 134.51 47.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 167.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.4 tp -132.54 38.89 3.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 C--N 1.329 -0.294 0 O-C-N 121.299 -0.875 . . . . 0.0 109.35 169.861 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -73.74 3.13 6.89 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -169.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 88' ' ' LYS . . . . . 0.421 ' HE3' HG13 ' B' ' 39' ' ' ILE . 61.4 mttt 88.15 5.0 0.25 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.441 2.696 . . . . 0.0 110.018 -169.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 21.0 m 33.57 54.68 1.38 Allowed Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 127.052 2.141 . . . . 0.0 111.063 -169.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.51 140.89 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.917 3.078 . . . . 0.0 114.255 -168.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 91' ' ' MET . . . . . 0.691 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -91.21 4.43 52.28 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -172.405 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.1 p 44.24 86.22 0.14 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.453 1.501 . . . . 0.0 113.259 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -55.09 143.1 75.56 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 122.505 2.137 . . . . 0.0 109.534 -172.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.44 4.47 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.605 1 C-N-CA 126.041 4.494 . . . . 0.0 117.572 -168.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.04 -5.42 21.8 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.452 -0.78 . . . . 0.0 111.995 169.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.485 HG11 HG23 ' B' ' 78' ' ' VAL . 2.4 t -134.6 148.56 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.678 1.191 . . . . 0.0 110.492 -168.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -84.63 157.23 21.23 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -144.09 148.53 35.25 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.561 -1.337 . . . . 0.0 109.701 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -152.32 151.52 30.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.99 126.34 42.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -118.44 -3.09 10.96 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.506 1.122 . . . . 0.0 111.329 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.65 142.07 13.44 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 175.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.84 12.32 1.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.006 2.123 . . . . 0.0 109.922 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -154.32 164.01 39.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.069 2.547 . . . . 0.0 105.973 -173.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -147.41 109.79 3.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 118.9 0.773 . . . . 0.0 110.072 -171.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' B' ' 16' ' ' ARG . 72.9 Cg_endo -72.35 -21.61 22.81 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.237 3.291 . . . . 0.0 112.678 -172.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.35 2.72 0.55 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.681 1.193 . . . . 0.0 112.518 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -123.71 13.85 9.34 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.438 1.495 . . . . 0.0 111.309 -177.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.79 148.08 1.13 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.225 1.01 . . . . 0.0 111.38 177.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -56.2 -46.94 79.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.091 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.05 -16.31 4.71 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 169.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.25 158.47 34.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -37.53 78.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.422 0.629 . . . . 0.0 111.262 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.58 -43.26 60.2 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.926 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.97 -28.82 60.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 121.126 1.785 . . . . 0.0 110.078 -172.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -60.43 -59.39 5.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.739 0.7 . . . . 0.0 109.722 171.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.84 -39.66 89.9 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.17 97.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.572 -0.705 . . . . 0.0 112.133 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.54 -46.44 85.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.1 m-30 -62.8 -46.16 89.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -64.18 -46.38 84.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.358 1.063 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 41.1 ttp-105 -58.69 -49.67 76.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.66 -42.65 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.234 -175.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -65.75 -37.06 85.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.611 1.55 . . . . 0.0 111.993 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.89 -46.36 90.95 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.293 0.37 . . . . 0.0 110.495 175.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.91 -50.9 62.8 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.152 0.581 . . . . 0.0 110.687 -179.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.69 -49.84 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.242 1.017 . . . . 0.0 109.483 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.26 96.15 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 119.017 -0.88 . . . . 0.0 111.828 -174.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -61.04 -45.89 92.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.704 1.252 . . . . 0.0 110.642 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.42 -39.85 92.64 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.696 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.37 -33.69 71.73 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 119.137 0.88 . . . . 0.0 111.715 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 39.8 ttmt -65.73 -42.78 90.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.22 174.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.8 -38.72 86.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.144 -1.407 . . . . 0.0 111.106 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.77 -38.26 78.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 121.691 2.041 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.2 -34.53 72.25 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.67 -46.79 11.13 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.297 1.039 . . . . 0.0 111.591 -177.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 61.1 p -84.05 -27.64 28.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.238 1.815 . . . . 0.0 111.396 -169.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.72 25.65 51.97 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -168.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.103 0 C-N-CA 126.745 2.018 . . . . 0.0 112.467 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 tpp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.25 171.33 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.31 1.444 . . . . 0.0 107.401 167.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.04 96.7 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 163.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.94 165.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -126.21 144.03 50.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.51 175.1 6.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.731 1.212 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -158.52 -169.09 2.62 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.696 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -43.81 -36.1 2.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.739 2.816 . . . . 0.0 115.533 -163.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.25 -25.01 2.51 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.551 1.141 . . . . 0.0 111.5 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 m -64.95 -17.57 64.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.528 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -49.46 -58.02 5.94 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 119.1 0.864 . . . . 0.0 109.27 166.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.97 -43.21 99.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.782 0.833 . . . . 0.0 110.621 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -23.04 62.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -99.44 -17.01 18.16 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 117.958 -1.02 . . . . 0.0 112.228 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -110.29 -12.43 14.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.182 1.355 . . . . 0.0 113.621 -172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m -63.9 -11.17 25.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -139.91 156.59 46.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.063 1.301 . . . . 0.0 109.055 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.57 53.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.37 133.2 68.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.1 t -143.93 135.31 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -161.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.6 tp -111.31 99.5 8.29 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.37 138.07 33.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.58 153.56 50.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 109.218 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -133.89 120.08 19.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -170.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.548 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -143.16 154.31 43.76 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.231 1.412 . . . . 0.0 108.501 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.8 165.16 8.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.799 0.84 . . . . 0.0 109.025 170.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.37 -19.09 6.21 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.72 2.947 . . . . 0.0 116.483 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -55.09 -25.73 33.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.194 1.398 . . . . 0.0 114.493 -173.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -138.63 159.37 42.27 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.481 1.037 . . . . 0.0 111.441 -166.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.82 -48.87 31.88 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.554 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -47.92 -29.33 11.57 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.005 3.136 . . . . 0.0 115.352 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 m -53.41 -26.93 21.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.58 1.082 . . . . 0.0 113.26 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -108.46 10.89 27.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.827 1.251 . . . . 0.0 111.322 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -118.73 -42.55 2.73 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.481 1.113 . . . . 0.0 109.438 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 tp -62.82 -34.73 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.854 -0.529 . . . . 0.0 109.584 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.42 -57.98 22.93 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.617 -1.182 . . . . 0.0 112.68 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.55 -33.97 54.33 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.604 1.609 . . . . 0.0 111.5 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -58.04 -40.03 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.525 1.057 . . . . 0.0 110.965 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 mt -70.82 -37.59 73.23 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.254 0.934 . . . . 0.0 110.725 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.16 -36.36 81.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.117 0.871 . . . . 0.0 110.475 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.62 -25.28 64.77 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.454 1.102 . . . . 0.0 111.059 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.31 -46.42 23.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.136 0.975 . . . . 0.0 109.862 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.61 -43.19 99.31 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 122.796 0.438 . . . . 0.0 111.444 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.13 -9.32 58.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -97.33 -48.81 5.18 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.274 0.943 . . . . 0.0 110.875 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.6 ptm -137.7 13.89 2.94 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.84 -15.04 33.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.019 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -57.03 -25.45 58.61 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.758 1.279 . . . . 0.0 112.508 168.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 -10.47 10.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.653 0.781 . . . . 0.0 112.432 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -132.19 135.66 46.5 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.223 0.92 . . . . 0.0 109.612 -162.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -95.68 144.54 26.01 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 164.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.95 142.49 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.58 147.36 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.548 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 40.5 mtpt -127.18 148.24 50.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.514 0.597 . . . . 0.0 110.742 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 mm -115.91 121.2 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 167.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.56 110.94 9.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 164.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.283 27.6 m -87.34 48.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 122.263 1.03 . . . . 0.0 112.357 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -141.06 -40.67 0.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.454 1.102 . . . . 0.0 109.228 154.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -76.06 -40.61 52.84 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.913 0.885 . . . . 0.0 111.461 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -130.94 24.59 4.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.807 1.243 . . . . 0.0 110.621 -167.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.4 -5.15 6.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.45 -44.33 84.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.262 0.937 . . . . 0.0 110.796 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.2 m -60.61 -41.04 94.01 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.698 0.681 . . . . 0.0 110.488 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -53.66 42.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.181 0.592 . . . . 0.0 109.493 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.69 95.33 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -59.19 -47.97 83.34 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.155 0.982 . . . . 0.0 110.893 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.93 -22.48 60.72 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.192 0.451 . . . . 0.0 111.424 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.4 19.09 31.1 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.221 0.915 . . . . 0.0 112.025 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -76.02 142.14 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 163.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.422 ' CE ' HD13 ' B' ' 72' ' ' LEU . 1.9 ptm -151.47 22.17 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.886 0.474 . . . . 0.0 111.914 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.69 156.18 40.8 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.445 -0.784 . . . . 0.0 110.893 -153.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.1 mm -130.41 138.74 33.72 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.377 -168.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.8 162.58 83.93 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 N-CA-C 108.299 -1.462 . . . . 0.0 108.299 -22.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.6 m -132.94 150.12 52.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 169.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.2 mt -143.16 127.75 18.02 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -170.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -124.1 115.29 20.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.62 126.2 45.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -123.81 155.11 38.58 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.595 0.758 . . . . 0.0 109.553 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -144.29 144.49 31.51 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 161.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.5 t70 43.81 35.9 1.19 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.833 1.653 . . . . 0.0 113.687 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.56 15.61 59.8 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.938 -1.479 . . . . 0.0 115.776 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.68 149.77 45.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.49 2.145 . . . . 0.0 110.784 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.81 143.25 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 m -132.31 -18.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.485 1.114 . . . . 0.0 112.162 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -147.02 156.79 43.31 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.78 32.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -173.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.3 m -150.31 139.84 21.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.408 HG12 ' HD3' ' B' ' 88' ' ' LYS . 62.1 t -136.71 45.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -171.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.68 156.04 23.23 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.665 1.126 . . . . 0.0 110.374 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.09 147.79 46.31 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.303 1.441 . . . . 0.0 111.378 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.3 141.88 33.23 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.612 1.565 . . . . 0.0 107.683 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.21 167.06 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.501 2.134 . . . . 0.0 110.63 167.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -50.34 -51.33 46.54 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.915 1.286 . . . . 0.0 112.726 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.12 -39.83 93.63 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 110.368 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.91 -38.29 76.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.789 -0.569 . . . . 0.0 110.856 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.78 -39.8 80.01 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.462 0.574 . . . . 0.0 110.77 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.15 -39.86 94.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.44 0.563 . . . . 0.0 109.686 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.72 -44.62 96.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.972 0.509 . . . . 0.0 110.626 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.24 -43.47 70.9 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.217 1.007 . . . . 0.0 111.383 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.4 p -84.04 -35.24 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.975 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -58.11 -27.58 63.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.416 1.007 . . . . 0.0 112.632 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -54.72 -27.54 41.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.166 0.986 . . . . 0.0 113.568 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -128.79 -21.28 3.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.341 0.973 . . . . 0.0 112.581 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.424 1.49 . . . . 0.0 109.771 167.426 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -73.42 92.56 1.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 m120 113.14 127.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 130.916 3.686 . . . . 0.0 107.575 170.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -143.47 111.84 6.32 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.97 133.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 146.97 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.863 1.665 . . . . 0.0 107.287 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.42 ' CD2' HD12 ' B' ' 72' ' ' LEU . 0.8 OUTLIER -127.54 143.53 51.17 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.905 0.882 . . . . 0.0 110.137 -165.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -106.33 140.89 38.54 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.2 114.38 15.0 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.37 140.23 15.1 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.475 0.484 . . . . 0.0 111.389 -166.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -50.6 121.97 6.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.997 1.319 . . . . 0.0 110.628 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.13 -14.94 1.47 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.598 1.571 . . . . 0.0 114.601 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 45.18 24.31 0.13 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.505 1.922 . . . . 0.0 113.117 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -73.98 -34.74 64.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.413 -0.805 . . . . 0.0 110.877 -166.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.53 -69.71 0.47 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -161.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' B' ' 105' ' ' ASP . 11.6 mtm105 -58.67 -44.97 90.36 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.683 -171.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.32 -37.91 84.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.064 0.847 . . . . 0.0 110.516 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -61.41 -43.37 98.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.135 0.574 . . . . 0.0 109.812 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 32.9 ttm -63.16 -48.16 79.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.957 1.303 . . . . 0.0 109.732 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.54 77.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.389 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.2 -28.29 64.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.806 1.184 . . . . 0.0 110.911 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.39 -50.04 57.79 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.416 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 42.1 m95 -59.77 -43.45 94.33 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.373 0.587 . . . . 0.0 111.649 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.6 -55.65 29.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 109.419 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -69.62 -10.97 60.36 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -80.1 -9.26 59.69 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.575 1.534 . . . . 0.0 112.897 171.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -129.97 -24.62 2.63 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.531 1.132 . . . . 0.0 112.794 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.3 mt -105.81 94.27 5.09 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.64 -165.04 5.59 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.814 0.721 . . . . 0.0 112.425 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -57.84 -17.36 15.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.306 1.442 . . . . 0.0 113.37 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.489 1.515 . . . . 0.0 112.363 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -127.28 161.25 29.04 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.086 1.754 . . . . 0.0 109.617 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -134.08 133.63 41.35 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.0 t -129.86 126.57 62.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 -164.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.84 162.51 33.05 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.815 1.246 . . . . 0.0 109.065 -173.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 7.1 m -150.91 135.83 17.42 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.76 177.65 10.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.94 0.791 . . . . 0.0 112.134 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.26 176.51 46.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.892 1.234 . . . . 0.0 111.216 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 tt -36.77 -55.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.896 2.078 . . . . 0.0 114.876 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -134.29 31.38 3.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.153 1.381 . . . . 0.0 108.671 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.52 145.35 44.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.999 1.32 . . . . 0.0 112.604 -172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t60 148.33 84.66 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 130.534 3.533 . . . . 0.0 105.544 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.85 157.61 16.73 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.403 1.001 . . . . 0.0 111.197 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -139.65 93.7 2.69 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -66.31 127.58 93.36 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.55 -20.88 59.48 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.363 2.042 . . . . 0.0 113.015 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.71 80.32 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.455 1.025 . . . . 0.0 111.689 174.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.68 66.42 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.58 0.627 . . . . 0.0 109.875 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.2 -51.99 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.11 -45.6 79.43 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.809 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.32 75.76 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.696 0.68 . . . . 0.0 111.513 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.2 mmm -76.42 -32.64 58.6 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 121.4 -0.812 . . . . 0.0 111.709 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -62.92 -28.22 69.91 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.084 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.19 -25.07 58.4 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.095 1.316 . . . . 0.0 111.77 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.4 m -121.83 16.32 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.846 1.259 . . . . 0.0 111.186 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.23 34.9 81.73 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.312 -0.716 . . . . 0.0 113.147 171.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -117.1 135.97 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -98.69 135.13 40.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 pt -134.44 10.56 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.581 0.752 . . . . 0.0 111.77 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.7 m -60.01 -23.7 63.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.306 1.042 . . . . 0.0 112.695 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -77.36 -18.01 57.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.013 1.325 . . . . 0.0 113.339 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.54 166.72 14.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.198 0.999 . . . . 0.0 112.8 -167.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.6 p -139.43 -177.68 5.04 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.003 2.121 . . . . 0.0 108.22 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.6 p -159.42 171.06 20.44 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -149.77 164.82 34.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 pt -61.95 164.04 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.189 0.518 . . . . 0.0 110.4 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.415 HG23 ' H ' ' B' ' 67' ' ' ILE . 4.9 pt -48.63 128.96 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 109.306 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -137.71 98.55 3.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 122.798 1.285 . . . . 0.0 109.98 -172.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.71 -28.8 36.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.216 2.606 . . . . 0.0 112.638 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.58 -24.26 67.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.948 0.795 . . . . 0.0 111.628 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.62 -40.85 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.962 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.422 HD13 ' CE ' ' A' ' 70' ' ' MET . 9.8 tt -62.45 -48.46 79.54 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 120.266 1.394 . . . . 0.0 110.536 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -18.65 65.48 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.467 1.03 . . . . 0.0 111.874 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.62 -13.29 52.05 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.211 1.004 . . . . 0.0 112.032 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 166.08 15.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.034 0.833 . . . . 0.0 110.773 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.72 -27.62 16.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 111.155 168.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.59 128.13 15.07 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.826 1.25 . . . . 0.0 107.776 -161.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.03 118.26 56.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 167.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -83.86 110.71 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 165.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -67.94 123.98 22.11 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 156.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.1 tp -118.57 31.43 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.521 0.728 . . . . 0.0 109.974 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -140.78 166.81 23.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.072 1.349 . . . . 0.0 108.162 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.27 53.1 0.67 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 162.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -144.56 159.26 43.07 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.998 1.719 . . . . 0.0 109.39 -166.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.34 -4.58 10.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.809 1.243 . . . . 0.0 113.132 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.06 -10.06 57.44 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.589 1.086 . . . . 0.0 111.536 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.48 19.58 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.679 1.592 . . . . 0.0 114.833 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . 0.408 ' HD3' HG12 ' A' ' 88' ' ' VAL . 13.9 ttmm 67.83 25.42 7.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.198 1.399 . . . . 0.0 112.459 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 30.4 m 36.85 53.59 2.65 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 0.0 114.497 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.71 150.27 54.32 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.439 2.093 . . . . 0.0 112.123 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.63 3.09 15.5 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -170.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p 40.81 89.55 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.435 2.294 . . . . 0.0 114.123 166.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -58.69 151.98 59.52 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.62 1.01 4.72 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.064 3.176 . . . . 0.0 114.242 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 42.8 m170 -61.69 -16.25 47.31 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -133.6 143.64 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.179 0.992 . . . . 0.0 109.362 -166.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -79.25 151.99 30.84 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -136.32 147.23 47.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -152.07 158.9 43.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 161.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -97.5 131.17 44.37 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -123.1 -29.36 3.9 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.553 1.141 . . . . 0.0 110.175 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -79.57 161.45 46.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 168.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.54 -4.47 0.33 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.709 0.803 . . . . 0.0 112.305 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -158.1 170.89 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.698 1.999 . . . . 0.0 107.259 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' B' ' 16' ' ' ARG . 56.4 t0 -136.17 113.64 10.54 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 123.833 0.853 . . . . 0.0 110.992 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.47 -19.85 54.69 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.166 2.577 . . . . 0.0 112.893 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.95 -7.92 32.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.157 0.89 . . . . 0.0 112.092 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -115.51 19.33 15.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.202 1.401 . . . . 0.0 110.604 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.76 155.24 2.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.858 0.863 . . . . 0.0 111.043 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -57.66 -29.37 64.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.116 0.966 . . . . 0.0 112.42 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.46 -8.66 30.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.661 -1.077 . . . . 0.0 113.89 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 76.6 p -67.43 156.64 36.08 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.169 1.484 . . . . 0.0 107.825 166.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.64 -39.38 84.17 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.705 -0.622 . . . . 0.0 110.145 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.2 -44.56 68.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.326 0.65 . . . . 0.0 111.203 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -70.56 -35.7 73.22 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.383 0.992 . . . . 0.0 110.043 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -56.86 -58.34 8.54 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.137 0.881 . . . . 0.0 109.641 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -60.27 -42.02 94.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.992 0.814 . . . . 0.0 110.342 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.44 92.15 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.495 1.043 . . . . 0.0 111.885 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -62.97 -46.96 85.24 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.117 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -58.08 -50.75 72.37 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -64.48 -43.27 94.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.821 1.248 . . . . 0.0 111.312 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 ttp-105 -63.91 -47.95 78.53 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.595 0.634 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.65 -35.97 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.416 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.9 tmm_? -62.21 -45.44 93.37 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.665 1.186 . . . . 0.0 110.45 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.1 -42.43 96.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.046 0.384 . . . . 0.0 110.683 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -63.58 -54.35 37.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.063 0.545 . . . . 0.0 110.304 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.56 -43.55 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.401 1.081 . . . . 0.0 109.322 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.13 -49.38 75.51 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 118.652 0.66 . . . . 0.0 111.794 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -59.77 -44.03 94.07 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.098 0.449 . . . . 0.0 110.906 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -63.26 -45.69 90.34 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.769 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.9 mm? -67.32 -36.41 81.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.504 1.047 . . . . 0.0 110.461 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -61.33 -45.76 93.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.316 0.507 . . . . 0.0 110.028 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.08 -44.21 94.93 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.535 0.607 . . . . 0.0 110.586 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -59.22 -38.51 80.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.882 0.765 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.16 72.22 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.734 0.697 . . . . 0.0 112.163 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.49 -41.92 23.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.31 0.644 . . . . 0.0 110.529 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 76.6 p -85.19 -34.53 22.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.478 0.581 . . . . 0.0 111.578 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.7 64.15 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 118.365 -1.241 . . . . 0.0 112.701 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.172 2.189 . . . . 0.0 111.591 -163.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.03 157.03 0.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.78 2.432 . . . . 0.0 112.756 -169.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.61 112.94 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.82 168.66 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.86 1.664 . . . . 0.0 108.274 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -124.31 117.67 25.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.665 1.586 . . . . 0.0 108.477 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -84.9 171.41 12.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.6 1.16 . . . . 0.0 110.595 174.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -155.85 -178.19 7.11 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.085 1.754 . . . . 0.0 107.313 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -37.0 -33.94 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 130.932 3.693 . . . . 0.0 117.004 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -136.06 -31.76 0.9 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.822 1.249 . . . . 0.0 110.926 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -60.76 -19.23 58.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.744 -1.122 . . . . 0.0 112.692 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -47.19 -50.02 21.61 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 120.028 1.286 . . . . 0.0 109.874 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 m -66.09 -43.83 86.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.078 0.399 . . . . 0.0 110.211 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.15 -36.96 85.35 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.545 0.212 . . . . 0.0 110.56 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -74.12 -13.76 60.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.745 1.218 . . . . 0.0 112.593 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -121.76 0.58 9.84 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.785 1.175 . . . . 0.0 113.134 -170.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.9 m -74.87 -2.85 28.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.541 0.737 . . . . 0.0 112.949 -175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.66 156.47 45.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.128 0.971 . . . . 0.0 110.485 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.19 -161.56 37.5 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 125.377 1.465 . . . . 0.0 112.063 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.23 129.62 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.66 155.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.629 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.2 tp -128.83 91.5 3.23 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.767 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.5 148.58 33.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -141.65 148.43 39.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.819 1.248 . . . . 0.0 109.238 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -130.15 109.62 10.96 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.693 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.7 p-90 -130.93 149.88 52.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.834 1.653 . . . . 0.0 108.155 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -172.98 164.05 3.49 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.882 0.873 . . . . 0.0 109.42 169.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -54.53 -16.02 9.93 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.82 3.014 . . . . 0.0 116.691 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.457 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 24.6 m95 -50.46 -28.78 8.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.735 1.614 . . . . 0.0 113.74 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.88 146.36 51.6 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 119.14 0.882 . . . . 0.0 111.811 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.14 -50.26 61.42 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.596 -1.113 . . . . 0.0 110.706 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -46.58 -26.65 4.49 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.222 3.281 . . . . 0.0 116.867 170.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.5 m -57.77 -29.58 64.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 121.4 1.909 . . . . 0.0 112.286 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -97.65 9.35 42.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.283 1.033 . . . . 0.0 111.813 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.7 mtm -119.61 -43.1 2.6 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.062 0.945 . . . . 0.0 109.602 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -62.15 -34.76 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.607 0.763 . . . . 0.0 109.066 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.18 -61.25 6.26 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.9 -41.19 64.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.958 1.772 . . . . 0.0 111.659 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.24 -40.57 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.06 0.544 . . . . 0.0 110.819 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 mt -73.08 -38.49 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.4 0.546 . . . . 0.0 110.292 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.92 -34.14 77.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.284 0.947 . . . . 0.0 109.833 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.91 -27.47 64.81 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.96 1.304 . . . . 0.0 111.603 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.1 tp -75.81 -43.59 45.39 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.48 1.112 . . . . 0.0 110.195 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.61 -35.98 62.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.22 -13.21 62.07 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.378 -0.826 . . . . 0.0 112.019 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -49.7 5.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.743 1.617 . . . . 0.0 110.504 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.5 16.68 2.74 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.805 0.842 . . . . 0.0 111.741 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.06 -3.22 22.19 Favored Glycine 0 CA--C 1.521 0.446 0 O-C-N 121.23 -0.919 . . . . 0.0 113.974 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.34 -24.15 65.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.333 1.053 . . . . 0.0 111.104 169.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.44 -20.95 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.523 1.129 . . . . 0.0 112.226 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.64 149.66 46.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.493 1.517 . . . . 0.0 110.874 -167.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.36 150.48 40.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.529 1.532 . . . . 0.0 108.335 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mt -130.39 140.89 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 6' ' ' ALA . 12.6 t -136.78 108.92 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.693 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 21.6 mtpp -84.68 151.14 24.65 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.367 -0.833 . . . . 0.0 109.757 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mm -113.59 128.03 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.26 103.78 11.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.88 48.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.075 1.35 . . . . 0.0 112.092 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -156.11 -43.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.833 1.253 . . . . 0.0 109.578 168.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.27 -36.5 29.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 109.868 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -133.24 27.11 4.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 126.359 1.864 . . . . 0.0 111.925 -168.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -69.76 -5.31 24.43 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -50.0 -49.69 49.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.582 1.953 . . . . 0.0 110.647 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.6 m -58.26 -35.95 72.53 Favored 'General case' 0 C--O 1.228 -0.073 0 C-N-CA 123.122 0.569 . . . . 0.0 111.466 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.54 0.84 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.15 -45.31 15.22 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.204 0.907 . . . . 0.0 113.625 170.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.097 0.948 . . . . 0.0 111.033 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.99 -30.48 67.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.177 0.444 . . . . 0.0 110.36 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.27 67.65 0.81 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.6 t -139.17 127.67 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.422 ' SD ' HD12 ' B' ' 67' ' ' ILE 0.315 0.1 OUTLIER -137.3 17.11 2.96 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 117.883 0.311 . . . . 0.0 111.22 174.61 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 p -137.48 159.89 40.67 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.884 2.474 . . . . 0.0 110.722 -170.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.14 149.02 56.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.03 148.09 87.43 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 109.701 -0.923 . . . . 0.0 109.701 -10.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -122.76 145.16 48.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.21 136.55 54.78 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.976 1.71 . . . . 0.0 106.518 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.4 mt -121.44 102.7 8.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.69 122.53 38.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.88 153.19 44.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.521 1.128 . . . . 0.0 108.12 -171.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -140.23 138.65 35.23 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.88 27.29 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.541 1.937 . . . . 0.0 114.412 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.01 15.97 43.1 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.083 1.325 . . . . 0.0 115.945 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -130.85 142.8 50.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.038 1.419 . . . . 0.0 110.524 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.28 140.71 19.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.35 -21.59 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.185 0.994 . . . . 0.0 109.985 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.64 161.6 41.4 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.174 1.389 . . . . 0.0 109.087 169.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.23 148.3 31.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -149.99 145.99 26.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.721 HG12 ' HD3' ' B' ' 88' ' ' LYS . 11.1 t -137.82 67.74 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.41 157.86 10.18 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.16 1.838 . . . . 0.0 109.02 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -74.33 157.8 35.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.933 0.493 . . . . 0.0 111.107 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.43 145.33 25.83 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.64 165.88 30.54 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.528 2.152 . . . . 0.0 110.704 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -45.95 -47.88 16.45 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.373 1.869 . . . . 0.0 112.416 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.17 -43.34 74.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.477 0.581 . . . . 0.0 111.23 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.3 -32.79 74.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.745 -0.597 . . . . 0.0 110.72 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -52.18 64.35 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.937 0.895 . . . . 0.0 109.903 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -64.96 -38.84 92.29 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.1 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.69 -46.29 90.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.704 0.684 . . . . 0.0 111.437 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.52 -40.78 79.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.755 1.222 . . . . 0.0 111.198 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -88.05 -39.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.885 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 12.3 t30 -56.37 -34.88 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.517 1.053 . . . . 0.0 111.801 -176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -68.08 -6.96 25.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.56 -27.11 3.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.668 1.187 . . . . 0.0 112.666 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 19.5 tp . . . . . 0 C--O 1.249 1.037 0 C-N-CA 126.988 2.115 . . . . 0.0 109.388 171.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.78 143.38 44.05 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.1 m120 63.77 119.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.184 0 C-N-CA 128.71 2.804 . . . . 0.0 110.639 -169.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -164.26 134.3 4.05 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mt -106.65 143.25 17.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.41 143.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.45 144.39 51.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.489 0.715 . . . . 0.0 111.553 -168.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -103.58 144.04 31.96 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.8 tp -128.97 114.47 16.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 75.4 m -142.77 135.41 27.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.871 0.868 . . . . 0.0 111.139 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -48.75 113.7 0.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.737 1.215 . . . . 0.0 110.976 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.53 8.41 51.52 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.941 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 7.02 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 130.738 3.615 . . . . 0.0 115.536 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -142.28 5.96 1.69 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.01 -70.24 0.26 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.794 1.179 . . . . 0.0 112.385 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -47.2 -52.98 14.31 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.09 0.859 . . . . 0.0 110.495 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -55.63 -52.44 63.78 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.067 1.747 . . . . 0.0 111.801 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -53.85 -50.07 67.05 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.094 0.958 . . . . 0.0 110.606 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.0 ttm -62.59 -42.24 99.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.269 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.86 82.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.619 -1.181 . . . . 0.0 112.019 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.59 -45.65 89.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.732 1.605 . . . . 0.0 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.89 -43.63 57.85 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -58.07 -39.45 78.52 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.993 0.896 . . . . 0.0 111.495 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -52.23 62.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -65.26 -24.22 67.26 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.779 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.19 -14.98 63.28 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -126.46 -12.01 6.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.934 1.293 . . . . 0.0 113.131 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.11 85.6 2.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.89 -165.92 0.89 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.073 1.321 . . . . 0.0 113.173 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.79 -17.82 18.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.653 1.181 . . . . 0.0 113.214 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.57 -21.31 25.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.884 1.673 . . . . 0.0 112.411 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -127.83 161.62 28.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.391 1.476 . . . . 0.0 109.158 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -132.79 135.53 45.74 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -125.34 132.17 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -169.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -143.08 171.23 14.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.773 1.629 . . . . 0.0 108.035 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 81.7 p -158.92 154.07 25.34 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.519 -0.738 . . . . 0.0 110.788 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.06 169.97 23.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.904 0.881 . . . . 0.0 111.807 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.43 -176.22 39.18 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.592 0.615 . . . . 0.0 112.578 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 tt -50.73 -57.44 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.007 1.723 . . . . 0.0 114.043 -172.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -133.1 29.68 4.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.75 1.62 . . . . 0.0 108.816 -169.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 159.19 34.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.956 2.102 . . . . 0.0 113.06 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 136.24 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 130.723 3.609 . . . . 0.0 104.782 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.93 29.55 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -172.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.56 82.62 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -62.76 128.88 92.49 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -58.6 -23.34 64.77 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.093 1.862 . . . . 0.0 112.953 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.444 HD21 ' HG2' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -62.8 -36.06 81.9 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.821 1.191 . . . . 0.0 111.305 172.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.8 -35.43 64.9 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 118.749 0.704 . . . . 0.0 110.073 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.56 -51.26 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -59.56 -43.95 93.42 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 123.2 0.6 . . . . 0.0 110.593 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.28 -31.38 63.57 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.305 1.042 . . . . 0.0 112.523 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -37.05 24.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.254 -0.904 . . . . 0.0 110.493 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.44 -24.67 67.93 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.288 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.79 -32.84 60.71 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.948 1.249 . . . . 0.0 111.633 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 m -114.56 15.89 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.285 1.434 . . . . 0.0 110.997 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.17 34.98 91.37 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.283 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -106.01 132.65 52.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.64 135.89 33.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.5 ' C ' ' H ' ' B' ' 61' ' ' ASN . 13.6 pt -132.31 20.9 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.482 0.713 . . . . 0.0 110.829 169.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -70.96 24.42 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.793 0.837 . . . . 0.0 112.067 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.5 ' H ' ' C ' ' B' ' 59' ' ' ILE . 12.1 p30 -143.86 -4.47 0.84 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.841 3.657 . . . . 0.0 110.755 -169.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.33 153.55 20.36 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.307 0.958 . . . . 0.0 110.341 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 55.1 p -134.28 -175.71 3.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.549 1.94 . . . . 0.0 108.863 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 23.5 p -155.87 -177.18 6.38 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -163.56 165.22 23.78 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.232 1.813 . . . . 0.0 107.79 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.84 167.18 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.551 0.741 . . . . 0.0 111.728 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.422 HD12 ' SD ' ' A' ' 70' ' ' MET . 0.2 OUTLIER -48.33 131.08 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.225 1.01 . . . . 0.0 108.671 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -146.01 97.12 2.91 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 122.279 1.037 . . . . 0.0 109.409 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 17.5 m -47.87 -26.62 1.75 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.02 1.728 . . . . 0.0 114.603 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.27 -18.04 60.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.153 1.342 . . . . 0.0 112.647 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.24 -33.8 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.753 0.821 . . . . 0.0 109.184 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -61.63 -60.14 4.13 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.036 0.834 . . . . 0.0 109.17 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -24.42 67.31 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.748 0.704 . . . . 0.0 110.836 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -75.59 -23.37 56.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.777 . . . . 0.0 112.588 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.85 173.29 1.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.687 1.195 . . . . 0.0 112.155 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.15 -33.91 12.46 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.869 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -139.41 139.35 37.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.331 1.452 . . . . 0.0 109.395 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.8 t -117.01 96.73 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -80.16 115.11 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 169.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 47.9 m -71.75 131.43 43.09 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 tp -135.08 6.09 3.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -167.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m -157.34 -22.57 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.219 1.372 . . . . 0.0 114.271 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 160.1 178.35 34.02 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -145.42 -48.67 0.23 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.64 0.72 . . . . 0.0 111.086 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.55 -56.36 20.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.446 0.566 . . . . 0.0 110.974 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.42 67.79 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 119.372 -0.347 . . . . 0.0 111.347 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -78.51 11.99 2.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.56 0.744 . . . . 0.0 112.726 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . 0.721 ' HD3' HG12 ' A' ' 88' ' ' VAL . 14.2 ttmm 90.17 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.306 2.642 . . . . 0.0 111.127 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m 31.38 54.85 0.85 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 126.987 2.115 . . . . 0.0 113.151 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.46 135.31 47.24 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 CA-C-N 120.602 1.251 . . . . 0.0 112.173 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.59 6.05 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -171.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p 38.36 93.9 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 127.838 2.455 . . . . 0.0 114.379 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -56.15 141.39 87.69 Favored 'Trans proline' 0 CA--C 1.548 1.185 0 C-N-CA 122.485 2.123 . . . . 0.0 108.26 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -61.78 -1.3 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.323 3.349 . . . . 0.0 116.95 -168.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -69.15 -9.38 52.52 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.164 0.893 . . . . 0.0 112.829 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.02 144.93 36.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.906 1.282 . . . . 0.0 111.192 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -73.84 153.18 40.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -146.83 143.78 28.84 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.779 0.718 . . . . 0.0 109.498 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -150.15 144.21 25.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 168.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.52 127.7 33.93 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -111.85 -12.31 13.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.185 0.994 . . . . 0.0 110.591 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.58 161.42 31.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -158.24 26.81 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.788 1.235 . . . . 0.0 110.541 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -149.47 161.54 41.91 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 127.871 2.469 . . . . 0.0 106.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -147.54 139.55 14.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.228 0.922 . . . . 0.0 109.291 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.444 ' HG2' HD21 ' B' ' 47' ' ' ASN . 91.3 Cg_endo -78.0 -19.16 12.51 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.437 2.092 . . . . 0.0 113.336 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.82 -4.06 11.44 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.837 1.199 . . . . 0.0 111.03 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -98.41 6.22 47.44 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.427 1.091 . . . . 0.0 111.05 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.02 153.38 1.38 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.114 0.566 . . . . 0.0 110.065 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -54.42 -43.81 71.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.8 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.34 -19.59 2.64 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.6 p -69.53 165.92 20.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.38 -42.16 99.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.527 0.68 . . . . 0.0 110.289 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -68.61 -42.82 77.57 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 116.929 -1.51 . . . . 0.0 109.326 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.28 -35.26 61.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 121.184 1.811 . . . . 0.0 109.693 -173.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -55.3 -56.6 18.13 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 118.501 0.591 . . . . 0.0 110.693 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -64.35 -40.45 95.89 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.886 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.98 -44.77 91.62 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.804 0.842 . . . . 0.0 111.765 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.55 -49.88 69.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.284 2.6 p90 -71.1 -27.06 63.32 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.108 -0.948 . . . . 0.0 112.793 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -64.53 -51.35 63.33 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.558 1.072 . . . . 0.0 109.668 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -59.83 -51.33 70.19 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.38 -43.76 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.575 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -56.53 -46.51 80.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.876 1.216 . . . . 0.0 111.533 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.01 -44.47 96.64 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 123.217 0.323 . . . . 0.0 110.808 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -51.66 59.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.369 0.668 . . . . 0.0 110.467 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.77 -45.49 91.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.536 1.134 . . . . 0.0 110.176 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.38 -44.01 91.41 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -60.26 -49.08 79.03 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.458 1.129 . . . . 0.0 111.306 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -59.01 -44.03 91.62 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.837 0.455 . . . . 0.0 110.803 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.72 -36.41 67.78 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.757 0.708 . . . . 0.0 111.696 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -66.95 -49.74 64.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.845 -0.534 . . . . 0.0 110.426 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -61.5 -38.26 86.7 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.742 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -56.15 -38.81 71.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 119.95 1.25 . . . . 0.0 111.077 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.37 -31.53 71.43 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -87.88 -47.85 8.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.839 1.656 . . . . 0.0 111.629 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.0 p -83.63 -28.18 28.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.672 2.389 . . . . 0.0 110.983 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.25 17.18 55.61 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.613 -1.104 . . . . 0.0 111.473 -168.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.249 1.06 0 C-N-CA 127.93 2.492 . . . . 0.0 112.003 -169.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.59 172.55 18.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.03 1.732 . . . . 0.0 107.067 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.88 96.2 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 102.845 -3.021 . . . . 0.0 102.845 168.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.28 168.69 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.831 1.652 . . . . 0.0 108.115 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.25 111.77 16.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.14 1.376 . . . . 0.0 108.358 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -80.9 172.8 13.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.574 1.15 . . . . 0.0 110.527 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -155.34 -174.87 5.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.933 2.093 . . . . 0.0 105.898 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -41.19 -36.81 0.8 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.019 2.527 . . . . 0.0 115.572 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -129.85 -30.19 2.05 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.559 1.144 . . . . 0.0 111.522 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 m -61.57 -22.74 65.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.059 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.65 -55.62 18.31 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.384 0.993 . . . . 0.0 108.773 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -62.11 -43.79 98.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.139 -0.35 . . . . 0.0 110.183 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.78 82.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.386 0.136 . . . . 0.0 111.295 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -79.84 -13.79 59.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.412 1.085 . . . . 0.0 113.143 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.5 p -118.33 -3.94 10.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.604 1.093 . . . . 0.0 113.535 -169.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -73.75 -5.02 38.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.24 155.7 45.98 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.461 1.104 . . . . 0.0 109.825 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.64 -163.04 44.12 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 124.843 1.211 . . . . 0.0 112.163 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.43 132.14 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 169.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.37 149.82 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 113.45 -1.705 . . . . 0.0 107.797 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tt -124.98 100.83 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.931 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.17 148.72 26.61 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -142.41 149.7 39.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -130.06 115.54 17.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -169.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.62 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.5 p-90 -137.58 154.35 49.8 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.901 1.68 . . . . 0.0 108.007 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -174.48 162.15 2.69 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.068 0.947 . . . . 0.0 108.95 169.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.97 -19.04 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.635 2.89 . . . . 0.0 116.895 -174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.44 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 10.3 m95 -52.62 -33.88 48.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.837 1.198 . . . . 0.0 114.078 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.15 163.23 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.972 0.805 . . . . 0.0 112.76 -169.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.12 -48.78 57.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 117.923 -1.487 . . . . 0.0 113.197 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.78 -27.59 20.63 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.571 2.847 . . . . 0.0 115.397 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 m -57.17 -23.77 49.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.695 1.134 . . . . 0.0 113.25 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -108.87 12.71 25.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.111 0.964 . . . . 0.0 111.575 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -122.71 -44.11 2.23 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.292 1.037 . . . . 0.0 109.67 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -64.38 -34.22 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 121.685 -0.634 . . . . 0.0 109.451 169.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.47 11.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.911 -1.042 . . . . 0.0 112.39 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -59.05 -41.03 65.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.967 1.778 . . . . 0.0 111.631 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.46 -40.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.115 0.566 . . . . 0.0 110.877 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.8 mt -73.59 -40.92 63.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.691 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.87 -34.51 78.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.013 0.824 . . . . 0.0 109.737 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -70.35 -21.39 62.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.077 1.351 . . . . 0.0 112.184 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.89 -42.09 18.14 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 119.161 0.892 . . . . 0.0 110.125 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.39 -37.61 85.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.944 -0.472 . . . . 0.0 110.831 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -72.21 -4.86 31.87 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -107.71 -43.17 4.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.674 1.589 . . . . 0.0 111.032 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.63 15.57 2.34 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.363 0.665 . . . . 0.0 112.535 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.79 -2.18 11.24 Favored Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.392 -0.817 . . . . 0.0 113.867 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.86 -24.0 65.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.328 1.051 . . . . 0.0 111.147 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -11.7 8.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.74 0.816 . . . . 0.0 112.682 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -139.4 149.54 44.22 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.32 1.048 . . . . 0.0 111.622 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.99 147.67 38.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.068 1.747 . . . . 0.0 108.327 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mt -119.41 143.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 6' ' ' ALA . 5.0 t -137.44 109.32 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.6 mtpp -84.03 151.78 24.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.341 -0.85 . . . . 0.0 109.3 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mm -118.99 120.86 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 170.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -76.59 105.94 7.95 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 33.9 m -78.43 49.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -156.01 -41.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.801 1.241 . . . . 0.0 108.977 167.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.73 -33.98 21.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.063 0.945 . . . . 0.0 111.079 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -134.05 27.99 3.84 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.518 1.527 . . . . 0.0 110.796 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -72.09 -5.74 37.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.825 0.85 . . . . 0.0 112.898 -170.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -53.27 -48.17 68.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.3 1.84 . . . . 0.0 110.769 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 m -56.29 -41.57 76.1 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.091 0.556 . . . . 0.0 110.837 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.96 -64.57 0.83 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.67 -43.82 11.74 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.985 0.802 . . . . 0.0 113.454 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.02 -44.63 95.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.24 1.02 . . . . 0.0 111.663 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -73.64 -21.35 60.32 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.477 0.58 . . . . 0.0 111.731 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.03 64.72 0.99 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.05 129.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.5 ptm -150.64 23.11 0.79 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.74 161.44 35.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.101 1.76 . . . . 0.0 112.027 -168.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.1 136.98 29.67 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.53 146.51 47.78 Favored 'Cis proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.067 -1.551 . . . . 0.0 108.067 -10.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -116.58 151.72 35.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 169.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tt -148.82 123.7 9.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -170.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.5 mt -122.24 106.09 10.81 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.54 131.96 33.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.88 158.33 39.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.815 0.846 . . . . 0.0 109.382 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -144.27 139.64 28.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 44.95 28.35 0.36 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.605 1.962 . . . . 0.0 113.761 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.56 10.32 47.67 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 116.103 1.201 . . . . 0.0 116.103 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -133.72 145.17 49.62 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.909 1.354 . . . . 0.0 111.528 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.25 137.37 24.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.96 -19.41 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.51 1.124 . . . . 0.0 111.635 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.8 159.18 43.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.001 0.819 . . . . 0.0 110.185 169.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.62 147.94 28.02 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -171.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.2 m -152.58 147.55 26.31 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.8 t -133.63 64.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.56 159.57 10.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.236 1.874 . . . . 0.0 109.535 -169.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.53 167.86 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.578 0.751 . . . . 0.0 112.032 -174.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -150.31 141.58 14.91 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.422 1.489 . . . . 0.0 107.459 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.88 165.95 29.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.478 2.118 . . . . 0.0 110.388 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.98 -48.71 21.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.74 1.616 . . . . 0.0 112.39 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.1 -42.79 79.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.161 0.437 . . . . 0.0 110.897 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.39 -29.95 68.76 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 122.035 -0.416 . . . . 0.0 111.011 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -52.3 61.09 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.934 0.894 . . . . 0.0 109.207 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -63.6 -36.28 83.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.799 -0.62 . . . . 0.0 109.654 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.15 -46.46 88.87 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.678 0.672 . . . . 0.0 111.224 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.9 tp -54.64 -40.39 68.93 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.073 0.949 . . . . 0.0 110.96 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.27 -41.14 13.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 118.819 -0.61 . . . . 0.0 112.071 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -56.7 -33.55 66.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.581 1.082 . . . . 0.0 111.45 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -70.07 -6.47 34.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -127.66 -21.98 3.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.168 1.387 . . . . 0.0 112.659 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--O 1.249 1.072 0 C-N-CA 127.286 2.234 . . . . 0.0 109.05 171.319 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -139.36 41.45 2.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.314 1.045 . . . . 0.0 109.36 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m120 130.58 132.77 0.0 OUTLIER 'General case' 0 C--N 1.341 0.198 1 C-N-CA 132.385 4.274 . . . . 0.0 107.513 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.402 ' HE3' ' CE3' ' B' ' 32' ' ' TRP . 53.1 pttt -157.08 145.85 19.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 130.175 3.39 . . . . 0.0 102.499 168.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.49 139.44 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 118.755 0.707 . . . . 0.0 109.431 -168.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.68 140.0 46.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -132.04 149.01 52.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -169.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.4 155.48 31.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.392 0.542 . . . . 0.0 110.11 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -133.2 132.4 41.49 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.028 1.331 . . . . 0.0 107.925 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -162.26 157.24 22.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.3 m -47.8 107.88 0.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.996 1.318 . . . . 0.0 111.435 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.75 59.4 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.685 -1.064 . . . . 0.0 113.443 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.324 0.3 OUTLIER 39.01 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.537 2.735 . . . . 0.0 116.044 -173.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.2 p -64.85 169.05 5.51 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.284 1.04 . . . . 0.0 108.543 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 46.37 -94.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.425 2.29 . . . . 0.0 113.717 169.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.67 -50.06 64.0 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.774 1.63 . . . . 0.0 111.219 -169.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.2 m -66.97 -41.7 86.41 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.237 0.926 . . . . 0.0 112.17 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -59.41 -49.3 78.32 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.402 1.096 . . . . 0.0 109.823 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 18.9 ttm -65.31 -40.57 93.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.429 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.69 -36.86 73.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.068 0.947 . . . . 0.0 110.297 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -30.94 60.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 109.911 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.7 -46.23 62.26 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -55.37 -44.19 75.82 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.611 0.764 . . . . 0.0 111.483 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.62 -50.77 61.91 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.121 0.568 . . . . 0.0 110.108 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.458 ' HE3' ' HB ' ' B' ' 34' ' ' VAL . 65.2 mttt -65.64 -20.57 66.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.509 -168.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.87 -14.74 62.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.384 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.09 -40.21 2.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.791 1.178 . . . . 0.0 112.382 174.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' B' ' 135' ' ' ALA . 10.0 mp -79.76 75.68 6.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.41 -163.6 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.575 2.036 . . . . 0.0 112.564 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.49 -13.86 10.49 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.752 1.221 . . . . 0.0 113.21 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -57.69 -23.79 53.45 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.928 168.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . 0.402 ' CE3' ' HE3' ' B' ' 4' ' ' LYS . 41.7 m95 -127.63 171.36 11.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.391 2.276 . . . . 0.0 110.424 -177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -139.74 129.32 24.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 168.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.458 ' HB ' ' HE3' ' B' ' 25' ' ' LYS . 13.9 t -123.18 129.02 75.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -171.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -143.09 169.33 17.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.396 1.478 . . . . 0.0 108.536 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 74.6 p -154.97 162.83 40.97 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.415 -0.803 . . . . 0.0 110.867 172.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 178.77 9.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.344 1.458 . . . . 0.0 108.859 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.27 -176.62 44.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 tt -48.8 -52.96 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.089 1.756 . . . . 0.0 113.991 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -130.36 26.27 5.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.909 2.084 . . . . 0.0 107.992 -169.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.9 46.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.705 1.602 . . . . 0.0 112.965 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 78.4 t60 133.85 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 131.244 3.817 . . . . 0.0 104.458 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.13 175.5 46.58 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -153.21 102.78 2.65 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 171.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -73.56 126.09 90.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.44 -22.18 70.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.861 1.707 . . . . 0.0 112.514 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.406 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -59.54 -37.5 78.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.252 0.933 . . . . 0.0 110.796 170.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -73.32 -38.58 65.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -57.32 -55.88 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -55.6 -45.9 77.37 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.274 0.63 . . . . 0.0 111.06 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.12 -33.51 65.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.448 1.099 . . . . 0.0 112.512 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 1.1 mmt -82.54 -38.87 23.13 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.934 0.893 . . . . 0.0 110.453 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -60.83 -29.7 69.65 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.896 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.98 -31.46 60.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.471 1.032 . . . . 0.0 111.814 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.95 15.1 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.146 1.379 . . . . 0.0 110.821 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.78 34.03 81.82 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.163 -1.354 . . . . 0.0 113.034 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -107.43 149.13 11.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.07 135.12 54.8 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.84 22.68 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.94 1.296 . . . . 0.0 110.448 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.0 m -67.59 14.73 0.05 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.4 13.69 2.17 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.047 2.139 . . . . 0.0 111.641 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -53.3 162.38 0.75 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.309 -1.494 . . . . 0.0 113.559 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -149.63 161.16 42.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.22 2.208 . . . . 0.0 105.619 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 67.1 m -157.89 -172.87 4.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.89 1.276 . . . . 0.0 109.021 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.55 163.67 24.51 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.149 1.379 . . . . 0.0 109.389 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.0 165.75 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.227 1.011 . . . . 0.0 111.411 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 pt -50.29 128.59 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.199 0.6 . . . . 0.0 110.452 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -143.14 104.5 4.29 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.261 1.029 . . . . 0.0 109.575 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -53.55 -25.65 17.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.682 1.593 . . . . 0.0 113.282 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -17.64 62.91 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.591 1.087 . . . . 0.0 112.498 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -129.78 -37.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.146 0.978 . . . . 0.0 108.903 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 7.1 tt -72.29 -50.19 28.95 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.1 0.863 . . . . 0.0 110.254 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -24.41 67.54 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.928 0.786 . . . . 0.0 110.7 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -73.75 -23.05 59.69 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.119 1.368 . . . . 0.0 112.337 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.0 166.56 3.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.939 1.295 . . . . 0.0 112.268 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.75 -34.15 17.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.709 169.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.639 HD13 ' HD2' ' B' ' 97' ' ' LYS . 18.6 tp -146.93 139.87 25.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 0.0 110.594 -170.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.81 110.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 C-N-CA 125.976 1.711 . . . . 0.0 107.786 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.78 102.3 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 75.4 m -71.37 128.75 36.9 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 68.5 mt -136.14 64.19 1.57 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.298 1.039 . . . . 0.0 109.178 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -153.96 -178.65 7.22 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.554 -0.716 . . . . 0.0 110.457 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -134.88 35.94 2.13 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 127.285 2.374 . . . . 0.0 108.297 171.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -145.07 156.55 43.98 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.66 2.384 . . . . 0.0 107.16 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -127.44 11.33 6.84 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.064 0.946 . . . . 0.0 113.106 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.84 -8.83 47.33 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.487 1.04 . . . . 0.0 112.243 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -66.47 20.04 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -170.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm 71.67 21.03 4.48 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.071 -1.643 . . . . 0.0 111.948 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.0 m 29.24 56.97 0.68 Allowed Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 128.369 2.668 . . . . 0.0 113.162 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.55 132.29 48.13 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.609 2.206 . . . . 0.0 112.856 -168.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.453 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.55 4.06 33.78 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -175.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.5 p 41.64 94.1 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.222 2.209 . . . . 0.0 113.494 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -60.0 143.87 99.53 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.203 1.935 . . . . 0.0 110.488 -169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.21 -2.83 5.27 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.509 3.473 . . . . 0.0 115.028 -169.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -63.92 -11.62 29.79 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.829 0.852 . . . . 0.0 111.678 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.41 143.94 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.636 1.174 . . . . 0.0 109.605 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.639 ' HD2' HD13 ' B' ' 77' ' ' LEU . 3.3 tmmm? -73.18 159.02 34.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 169.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -145.6 146.95 31.56 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.49 -1.381 . . . . 0.0 109.35 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -146.86 156.51 43.16 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -114.98 133.29 56.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.337 1.455 . . . . 0.0 108.1 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.11 1.29 1.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.04 -62.27 2.5 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 39.9 p90 47.49 14.72 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.23 2.612 . . . . 0.0 115.328 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -161.24 161.9 30.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.174 2.19 . . . . 0.0 106.473 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -141.94 105.91 5.76 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.175 0.99 . . . . 0.0 110.427 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.76 -10.92 18.45 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.636 3.558 . . . . 0.0 112.981 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.58 0.28 5.62 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.737 1.153 . . . . 0.0 111.517 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -121.22 -60.77 1.61 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . 43.39 -170.65 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 113.59 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -90.81 138.72 31.37 Favored 'General case' 0 C--O 1.236 0.388 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -83.0 56.82 5.08 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.641 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 p -121.65 164.16 17.79 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 169.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.18 -39.05 89.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.479 0.657 . . . . 0.0 110.61 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.04 -42.89 59.6 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.768 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -76.2 -29.93 57.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.941 1.246 . . . . 0.0 109.891 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -55.8 -59.6 4.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.792 0.724 . . . . 0.0 109.436 169.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -57.84 -41.97 83.45 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.97 90.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.869 0.868 . . . . 0.0 112.006 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -65.81 -43.85 87.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.158 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.3 m-30 -58.7 -47.57 84.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.219 0.918 . . . . 0.0 108.958 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -65.53 -43.71 89.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 111.111 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -60.67 -53.67 54.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.34 -41.4 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.414 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -36.87 85.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 120.299 1.409 . . . . 0.0 112.011 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.04 -41.49 90.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.996 0.362 . . . . 0.0 111.043 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.21 -49.09 68.47 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.996 0.519 . . . . 0.0 110.192 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -56.57 -47.66 81.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 124.216 1.006 . . . . 0.0 109.234 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.63 95.93 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 119.677 1.126 . . . . 0.0 111.737 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -65.12 -43.3 92.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.322 0.561 . . . . 0.0 111.584 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -48.13 81.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.012 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.7 mm? -65.26 -32.68 74.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.556 1.071 . . . . 0.0 111.208 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.06 -38.17 82.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.446 0.566 . . . . 0.0 110.677 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -62.13 -34.72 76.91 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.779 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . 0.43 ' CE2' ' HE3' ' B' ' 139' ' ' LYS . 20.9 m-85 -63.6 -35.79 81.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 122.325 2.329 . . . . 0.0 109.458 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' B' ' 28' ' ' LEU . . . -62.82 -36.54 83.53 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.138 0.575 . . . . 0.0 110.837 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -84.22 -43.76 14.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.194 1.398 . . . . 0.0 112.0 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -93.04 -21.41 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.442 1.897 . . . . 0.0 111.544 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.17 20.12 60.2 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.708 0.671 . . . . 0.0 111.463 -168.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.43 ' HE3' ' CE2' ' B' ' 134' ' ' PHE . 10.3 tppt? . . . . . 0 C--O 1.251 1.178 0 C-N-CA 128.698 2.799 . . . . 0.0 112.692 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 ttp . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.84 171.25 20.75 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.871 1.668 . . . . 0.0 106.915 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.47 98.59 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.5 t -79.88 170.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.829 1.651 . . . . 0.0 107.42 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -124.75 129.81 51.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.906 1.282 . . . . 0.0 108.287 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.455 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -95.23 177.1 5.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.288 1.435 . . . . 0.0 109.042 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 t -159.62 -173.56 4.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.399 1.88 . . . . 0.0 106.247 168.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -36.89 -36.58 0.12 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 129.599 3.159 . . . . 0.0 116.447 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -133.41 -29.87 1.35 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 111.438 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.3 m -60.46 -22.26 63.28 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.353 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -51.26 -54.02 29.95 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.18 0.9 . . . . 0.0 109.407 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -61.45 -44.08 97.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.045 -0.409 . . . . 0.0 110.033 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -36.46 81.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.999 -0.091 . . . . 0.0 111.204 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -80.13 -14.31 58.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.335 1.054 . . . . 0.0 113.252 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.2 p -117.79 -4.0 11.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.651 1.114 . . . . 0.0 112.907 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -72.85 -8.84 57.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.07 153.99 44.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.338 1.055 . . . . 0.0 109.246 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.67 -160.55 49.7 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.404 1.002 . . . . 0.0 111.532 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 t -113.96 129.15 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.19 122.2 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.151 -168.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 tp -92.39 100.84 13.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 108.185 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.33 149.73 25.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.09 150.8 44.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.411 1.485 . . . . 0.0 109.284 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -132.84 113.04 12.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.4 p-90 -132.79 153.28 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.126 1.771 . . . . 0.0 107.416 -172.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.81 165.04 7.27 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 119.146 0.885 . . . . 0.0 111.122 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.66 -18.08 8.09 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.147 3.231 . . . . 0.0 116.285 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -58.22 -19.65 35.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.798 1.181 . . . . 0.0 114.088 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.0 161.57 39.07 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.76 1.163 . . . . 0.0 113.814 -169.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -74.35 -46.06 21.91 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.794 -1.559 . . . . 0.0 112.777 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.56 -27.33 18.89 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.326 2.684 . . . . 0.0 114.94 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -58.51 -18.36 28.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.701 1.137 . . . . 0.0 113.839 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -113.48 11.57 18.44 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.524 1.13 . . . . 0.0 111.697 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mtm -121.35 -43.67 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.099 0.96 . . . . 0.0 109.467 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.1 -36.03 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.445 0.698 . . . . 0.0 109.272 169.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.37 -57.91 21.74 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.979 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -60.27 -39.56 66.78 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.962 1.775 . . . . 0.0 111.676 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG12 HD22 ' A' ' 96' ' ' LEU . 2.2 t -56.45 -36.78 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.27 1.028 . . . . 0.0 111.178 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.1 mt -72.36 -41.58 66.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.699 0.681 . . . . 0.0 110.687 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.84 -35.01 79.72 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.999 0.818 . . . . 0.0 109.848 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.16 -28.7 68.34 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.773 1.229 . . . . 0.0 112.06 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD11 ' SD ' ' A' ' 46' ' ' MET . 47.9 tp -76.41 -46.27 27.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.193 0.597 . . . . 0.0 110.282 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.38 -36.25 71.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.123 0.419 . . . . 0.0 110.759 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -68.42 -9.2 46.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.133 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.08 -51.96 3.04 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.168 0.987 . . . . 0.0 110.742 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.407 ' SD ' HD11 ' A' ' 42' ' ' LEU . 19.7 ptm -127.56 14.7 7.07 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.835 0.854 . . . . 0.0 112.238 -170.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.87 -6.44 12.22 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.082 -1.011 . . . . 0.0 114.209 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.37 -23.22 67.22 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.829 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.06 -15.08 8.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.688 1.195 . . . . 0.0 112.515 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 tp -127.95 149.8 50.17 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.749 1.22 . . . . 0.0 112.139 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -114.34 147.53 38.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.85 141.82 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 10.0 t -139.21 113.1 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpt -87.48 155.0 20.2 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.284 -0.885 . . . . 0.0 110.184 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -124.52 127.27 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 171.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -83.05 104.99 13.67 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.334 27.5 m -77.98 48.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -153.54 -42.71 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.481 1.513 . . . . 0.0 108.677 167.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.78 -42.62 19.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.688 0.676 . . . . 0.0 110.767 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -134.59 38.08 3.08 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.42 1.088 . . . . 0.0 111.053 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -69.25 -4.93 19.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.887 1.275 . . . . 0.0 113.147 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.74 -47.16 70.9 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.982 1.713 . . . . 0.0 111.049 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.3 m -58.81 -40.97 85.71 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.618 0.645 . . . . 0.0 111.061 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.87 -55.28 13.49 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.7 -45.26 39.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.934 0.778 . . . . 0.0 113.213 169.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.73 -41.39 95.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.226 1.013 . . . . 0.0 111.036 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -80.62 -5.45 56.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.151 0.981 . . . . 0.0 112.707 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.34 60.38 5.55 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.44 -64.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.46 ' CE ' HD13 ' B' ' 72' ' ' LEU . 10.5 mtm 58.89 5.14 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.389 2.676 . . . . 0.0 115.242 173.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.4 p -143.38 159.55 42.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.811 1.187 . . . . 0.0 112.921 -169.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 141.54 41.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.79 151.33 71.78 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 N-CA-C 106.942 -1.984 . . . . 0.0 106.942 -11.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.7 m -123.99 147.01 48.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -122.99 138.17 54.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.188 1.795 . . . . 0.0 106.64 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.34 107.81 12.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.61 128.46 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.58 151.24 43.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.58 0.752 . . . . 0.0 109.496 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -137.73 135.92 36.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.0 t70 43.8 29.98 0.34 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.705 2.002 . . . . 0.0 114.432 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.59 15.74 42.24 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.548 1.071 . . . . 0.0 115.758 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -130.45 144.67 51.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.521 1.16 . . . . 0.0 110.115 172.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.11 134.45 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.94 -22.99 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.699 1.199 . . . . 0.0 110.091 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.17 165.69 28.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.967 0.907 . . . . 0.0 110.329 171.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 149.33 29.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.8 m -153.51 139.39 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 169.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.04 67.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -171.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.37 156.56 9.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.873 1.702 . . . . 0.0 109.596 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.9 148.22 51.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.157 0.583 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.66 142.11 27.47 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -70.07 166.34 28.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.355 2.036 . . . . 0.0 110.703 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -46.58 -47.05 19.88 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.494 1.918 . . . . 0.0 112.495 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.5 -43.29 77.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.931 0.787 . . . . 0.0 111.055 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.89 76.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.779 -0.575 . . . . 0.0 110.4 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.614 HD22 HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -58.04 -53.32 59.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.264 1.026 . . . . 0.0 109.707 173.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.05 -38.18 85.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.572 -174.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.03 -46.66 88.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.981 0.81 . . . . 0.0 111.146 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -58.09 -38.68 76.87 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.887 1.275 . . . . 0.0 111.682 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 p -88.74 -40.54 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 119.509 -0.281 . . . . 0.0 111.079 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -57.72 -32.83 67.8 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.406 1.082 . . . . 0.0 111.854 -176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -69.46 -5.96 27.28 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -126.63 -27.39 3.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.015 1.326 . . . . 0.0 112.581 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--O 1.247 0.952 0 C-N-CA 126.155 1.782 . . . . 0.0 107.539 169.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.63 19.43 2.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.162 0.985 . . . . 0.0 112.575 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -157.46 129.68 7.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -153.48 148.86 27.11 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 129.041 2.936 . . . . 0.0 104.649 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.35 146.38 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.28 144.29 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.59 141.38 49.66 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -171.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -116.47 145.46 43.28 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 mt -121.05 114.29 21.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 60.1 m -136.87 136.37 38.65 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.6 m -52.36 119.48 4.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.711 0.804 . . . . 0.0 109.344 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.25 0.29 5.67 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.724 1.631 . . . . 0.0 115.091 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.2 t30 44.1 26.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.919 2.088 . . . . 0.0 113.328 -169.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.8 m -68.43 -42.93 78.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.67 -61.85 0.49 Allowed 'General case' 0 C--O 1.233 0.219 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -54.97 -46.35 75.05 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 120.718 1.599 . . . . 0.0 111.48 -174.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.4 p -51.58 -49.55 61.88 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.9 1.68 . . . . 0.0 112.115 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.28 -46.78 85.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 124.099 0.96 . . . . 0.0 110.532 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 30.5 ttm -63.02 -45.22 93.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.23 -40.41 90.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 117.809 -1.091 . . . . 0.0 111.085 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -27.52 58.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.424 1.465 . . . . 0.0 110.441 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.98 -50.99 42.65 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.01 -39.63 72.19 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.638 0.775 . . . . 0.0 111.41 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.37 -52.98 62.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -64.77 -23.19 67.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -169.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.8 -14.18 61.46 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -126.7 -16.67 5.19 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.609 1.163 . . . . 0.0 113.31 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -121.84 77.68 1.39 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.34 -161.3 1.01 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.685 1.612 . . . . 0.0 113.09 -170.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.81 -20.83 38.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.438 -1.036 . . . . 0.0 113.18 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -58.73 -16.3 15.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.506 1.922 . . . . 0.0 112.889 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -128.29 156.95 42.21 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.406 1.882 . . . . 0.0 109.045 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -125.54 143.09 51.16 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.34 137.19 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -141.61 158.12 44.23 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.132 1.373 . . . . 0.0 108.222 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 77.3 p -147.18 150.2 34.45 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.75 172.84 17.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.067 0.947 . . . . 0.0 111.768 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.79 -172.27 35.43 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.266 0.936 . . . . 0.0 111.818 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 tt -53.88 -57.6 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.335 1.854 . . . . 0.0 113.62 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.02 28.41 4.16 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.205 1.802 . . . . 0.0 108.002 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.83 148.18 40.22 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.896 2.078 . . . . 0.0 112.066 -170.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 145.16 66.22 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 131.568 3.947 . . . . 0.0 104.371 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.12 152.09 23.26 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 29.4 tp -139.81 100.7 4.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -71.52 128.44 89.91 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -59.73 -21.86 65.11 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.028 1.819 . . . . 0.0 112.813 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -36.01 80.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.701 1.137 . . . . 0.0 111.293 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.56 -38.55 67.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 45.5 t -57.83 -51.62 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -59.05 -42.65 90.79 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.353 0.661 . . . . 0.0 110.727 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.51 -32.06 57.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.127 0.971 . . . . 0.0 112.18 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 65.2 mmm -84.77 -34.67 22.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.176 0.898 . . . . 0.0 111.276 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -62.53 -24.05 67.3 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.163 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.0 -31.67 63.27 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.858 1.208 . . . . 0.0 111.673 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.66 15.11 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.196 1.398 . . . . 0.0 111.2 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.74 41.42 98.95 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.598 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.09 146.4 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -119.26 135.13 54.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.089 0.556 . . . . 0.0 109.967 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.62 25.96 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 126.969 2.108 . . . . 0.0 109.713 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.8 m -68.09 14.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.518 -1.364 . . . . 0.0 113.403 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.2 23.96 0.93 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.321 1.848 . . . . 0.0 112.251 -169.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -47.46 150.17 0.99 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.82 1.645 . . . . 0.0 114.013 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -128.32 41.17 3.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.851 2.06 . . . . 0.0 110.437 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 12.7 m -59.83 172.33 0.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.04 1.336 . . . . 0.0 113.375 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -166.22 168.2 15.45 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.392 1.477 . . . . 0.0 109.78 -169.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 28.2 pt -65.37 170.69 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.032 1.333 . . . . 0.0 112.348 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -48.95 132.21 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.329 0.652 . . . . 0.0 109.241 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -138.26 95.96 3.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.915 1.34 . . . . 0.0 108.263 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -44.69 -31.18 1.09 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.741 2.017 . . . . 0.0 114.673 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.64 -22.77 62.47 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-N 119.298 0.954 . . . . 0.0 110.636 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -39.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.314 -0.85 . . . . 0.0 109.457 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.46 HD13 ' CE ' ' A' ' 70' ' ' MET . 7.5 tt -60.89 -50.92 71.48 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.616 1.098 . . . . 0.0 110.145 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -29.17 69.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.546 0.612 . . . . 0.0 111.353 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -85.31 -11.35 54.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.192 1.397 . . . . 0.0 112.743 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.3 171.12 5.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.742 0.782 . . . . 0.0 110.683 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -105.28 -12.62 15.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.171 0.989 . . . . 0.0 111.58 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.17 145.59 24.82 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.398 1.079 . . . . 0.0 109.252 173.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.64 99.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 168.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.4 102.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -65.39 119.56 11.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tp -135.31 53.29 1.98 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.627 0.771 . . . . 0.0 111.592 -167.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 92.0 p -166.25 175.74 8.08 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.18 7.93 2.38 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.505 174.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.61 -19.85 63.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.93 1.365 . . . . 0.0 110.663 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . 53.92 43.64 30.57 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.746 2.018 . . . . 0.0 112.825 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -116.96 11.08 14.23 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.725 0.81 . . . . 0.0 110.43 170.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.43 20.21 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.328 2.651 . . . . 0.0 116.117 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 68.64 27.85 5.88 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.3 1.84 . . . . 0.0 112.859 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 33.96 48.32 0.56 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.085 2.154 . . . . 0.0 112.789 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.87 136.05 70.54 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.872 2.381 . . . . 0.0 112.451 -168.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.439 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.62 -1.37 50.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 116.71 -1.614 . . . . 0.0 114.852 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p 46.07 86.63 0.13 Allowed Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.374 1.47 . . . . 0.0 112.879 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -58.36 143.94 96.89 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.461 2.107 . . . . 0.0 110.112 -169.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.9 5.53 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 125.072 3.848 . . . . 0.0 116.212 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -63.95 -12.18 35.14 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 112.29 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.63 154.25 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 119.373 0.988 . . . . 0.0 111.375 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -74.33 156.25 37.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.488 1.915 . . . . 0.0 109.834 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.74 144.56 30.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.719 -1.238 . . . . 0.0 108.09 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.44 147.3 27.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 168.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -87.26 133.68 33.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.576 1.15 . . . . 0.0 109.658 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -140.32 25.01 2.27 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.704 1.601 . . . . 0.0 110.327 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.68 155.62 26.48 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -157.36 19.91 0.29 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.532 1.933 . . . . 0.0 109.05 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -170.24 175.55 4.87 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 129.257 3.023 . . . . 0.0 105.719 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -161.32 138.39 6.54 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 168.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.44 -17.43 21.09 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.743 . . . . 0.0 112.306 -170.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.93 6.62 1.15 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.681 1.128 . . . . 0.0 110.769 168.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -122.0 12.73 10.46 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 110.501 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.44 158.18 0.44 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 170.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -34.65 72.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.828 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.07 -15.1 6.53 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 115.759 1.064 . . . . 0.0 115.759 168.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.5 p -70.33 162.7 28.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.51 -40.11 95.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.515 0.674 . . . . 0.0 110.558 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.84 -42.79 85.18 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.09 -1.433 . . . . 0.0 109.087 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -73.99 -33.16 63.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 120.928 1.694 . . . . 0.0 109.73 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -56.54 -56.77 17.08 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 119.119 0.872 . . . . 0.0 110.721 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -64.27 -39.78 94.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.758 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.59 98.07 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.29 -0.881 . . . . 0.0 111.996 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.84 -51.54 61.52 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.285 1.3 p90 -70.12 -30.91 68.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 117.546 -1.216 . . . . 0.0 112.542 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -72.58 -41.65 65.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 120.268 1.395 . . . . 0.0 111.004 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -59.52 -54.1 50.48 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.108 0.963 . . . . 0.0 109.302 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.33 -39.42 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.449 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.413 ' HA ' ' SD ' ' B' ' 19' ' ' MET . 5.4 tmm_? -56.92 -45.36 82.74 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.339 1.427 . . . . 0.0 112.08 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.09 -45.48 94.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.076 0.398 . . . . 0.0 110.65 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.2 -41.58 73.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.713 0.233 . . . . 0.0 111.281 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -60.22 -47.84 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 O-C-N 121.337 -0.852 . . . . 0.0 109.275 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.76 97.04 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.934 0.788 . . . . 0.0 111.239 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -59.52 -50.83 72.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.379 1.089 . . . . 0.0 111.98 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -69.76 -33.14 72.01 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.506 -0.746 . . . . 0.0 111.448 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.1 mm? -69.1 -36.48 77.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.249 0.931 . . . . 0.0 111.023 175.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -57.05 -41.15 78.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.168 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.46 -36.41 75.91 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 116.487 -1.72 . . . . 0.0 112.375 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -64.97 -37.32 87.26 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 122.437 2.381 . . . . 0.0 111.111 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.74 70.8 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -91.85 -38.86 12.07 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.731 1.212 . . . . 0.0 112.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 63.5 p -101.62 -19.27 15.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.335 1.854 . . . . 0.0 110.979 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.42 32.44 64.3 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.835 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 124.083 0.953 . . . . 0.0 111.499 -174.377 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.42 152.9 4.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.637 1.175 . . . . 0.0 109.924 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.23 95.46 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 168.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.06 167.16 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.338 1.455 . . . . 0.0 107.336 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -126.96 117.84 23.32 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -79.02 176.76 9.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.112 1.365 . . . . 0.0 110.264 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -154.77 -173.2 4.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.884 2.074 . . . . 0.0 106.048 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -39.55 -33.89 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.872 3.269 . . . . 0.0 116.511 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -133.52 -21.88 1.97 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.951 1.3 . . . . 0.0 112.234 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -38.39 75.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.136 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -71.03 123.88 23.09 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 167.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.7 m 116.83 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.696 1 C-N-CA 131.772 4.029 . . . . 0.0 105.471 -169.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.07 99.17 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.0 110.578 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -79.65 -8.77 59.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.473 1.509 . . . . 0.0 112.163 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 p -124.25 -2.09 8.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.44 1.018 . . . . 0.0 113.429 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.6 m -72.19 -10.61 60.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.81 155.75 45.57 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.792 0.724 . . . . 0.0 110.432 -172.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.86 -158.2 51.77 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 124.223 0.916 . . . . 0.0 110.999 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.66 124.22 71.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.05 115.7 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.156 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.7 tp -87.69 92.89 9.27 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 148.04 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -142.75 149.99 39.46 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -132.29 110.83 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.582 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.0 p-90 -131.08 152.73 50.07 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.806 1.643 . . . . 0.0 107.477 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.69 162.4 8.32 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 118.882 0.765 . . . . 0.0 110.297 169.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -53.88 -14.88 6.27 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.916 3.078 . . . . 0.0 115.993 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -61.49 -27.48 68.62 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.83 1.195 . . . . 0.0 113.663 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.66 154.95 47.64 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.448 1.022 . . . . 0.0 112.162 -169.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.93 -49.07 79.25 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 117.955 -1.469 . . . . 0.0 113.729 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.99 -24.71 25.65 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.035 2.49 . . . . 0.0 115.323 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 m -59.15 -21.25 59.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 120.249 1.386 . . . . 0.0 113.502 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.07 7.96 34.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.952 0.901 . . . . 0.0 111.89 174.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.1 mtm -118.59 -44.9 2.63 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.273 0.942 . . . . 0.0 109.562 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.11 -34.59 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.587 0.755 . . . . 0.0 109.301 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.4 ' HB3' ' CD ' ' A' ' 37' ' ' PRO . . . -54.84 -61.54 5.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.15 0.98 . . . . 0.0 112.243 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 36' ' ' ALA . 6.8 Cg_endo -60.06 -39.91 65.81 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.077 1.852 . . . . 0.0 111.84 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.26 -44.81 76.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.677 0.791 . . . . 0.0 110.429 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.39 -44.75 90.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.207 0.458 . . . . 0.0 110.094 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.17 -36.56 82.04 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.066 0.394 . . . . 0.0 110.441 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.19 -32.68 73.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.643 1.177 . . . . 0.0 111.908 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -72.78 -45.71 57.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.218 1.407 . . . . 0.0 109.889 175.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.82 -36.33 72.88 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.389 -0.82 . . . . 0.0 111.312 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -68.99 -6.65 29.09 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.129 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -104.86 -47.09 4.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.974 1.31 . . . . 0.0 111.585 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.4 ptm -134.58 18.19 3.6 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.402 0.681 . . . . 0.0 112.09 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 -6.77 24.02 Favored Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.871 -1.143 . . . . 0.0 113.82 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.74 -23.88 67.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.44 0.62 . . . . 0.0 110.807 169.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 -24.61 7.88 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.937 1.295 . . . . 0.0 111.59 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 tp -110.28 152.14 26.52 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 111.838 -169.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.73 148.48 49.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.94 144.05 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 11.0 t -138.25 111.19 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.582 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 33.1 mtpt -84.53 159.39 20.71 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.543 -0.723 . . . . 0.0 109.239 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.22 122.69 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 170.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.89 107.35 10.36 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 32.7 m -79.14 48.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.88 -45.52 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.461 1.505 . . . . 0.0 108.456 167.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.27 -36.39 34.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.984 0.914 . . . . 0.0 110.934 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -133.19 29.24 4.04 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 0.0 110.604 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -72.43 -5.99 40.48 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -54.15 -47.62 71.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.638 1.575 . . . . 0.0 110.902 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.2 m -56.11 -40.89 74.41 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.598 0.759 . . . . 0.0 111.367 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.76 -57.23 4.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.22 -42.46 41.07 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.836 0.732 . . . . 0.0 113.561 169.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -62.81 -43.39 98.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.364 1.082 . . . . 0.0 110.834 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -71.46 -31.61 67.37 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.077 0.399 . . . . 0.0 110.325 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.12 68.7 1.18 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 -170.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.68 -66.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.423 ' CE ' HD13 ' B' ' 72' ' ' LEU . 7.8 mtm 58.45 7.16 0.66 Allowed 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 127.472 2.309 . . . . 0.0 114.801 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 p -143.99 160.98 39.9 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.273 1.397 . . . . 0.0 112.991 -169.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 138.56 32.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 109.649 -169.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -83.17 138.44 33.68 Favored 'Cis proline' 0 N--CA 1.449 -1.104 0 N-CA-C 105.866 -2.398 . . . . 0.0 105.866 -11.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -107.81 150.44 27.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 tp -141.36 123.23 15.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -170.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.0 mt -121.21 105.35 10.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.31 108.59 15.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.33 149.52 23.53 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -146.57 130.43 17.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 43.98 30.76 0.44 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.489 1.916 . . . . 0.0 113.329 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.06 8.66 55.13 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 171.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -133.31 151.61 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.765 1.226 . . . . 0.0 110.521 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -70.97 132.72 32.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.44 -23.01 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.981 1.313 . . . . 0.0 110.729 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -146.58 160.57 41.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.523 1.129 . . . . 0.0 109.769 169.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 148.53 30.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.6 m -152.08 149.52 28.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.36 -0.837 . . . . 0.0 108.905 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.75 62.76 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.03 154.12 9.43 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.973 1.273 . . . . 0.0 110.714 -170.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -62.31 162.9 9.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.426 1.491 . . . . 0.0 112.087 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.33 139.26 10.75 Favored Pre-proline 0 N--CA 1.469 0.486 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -69.43 171.35 14.26 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 111.012 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -38.69 -55.69 1.43 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.469 2.307 . . . . 0.0 111.924 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.88 -42.41 63.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.496 -173.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.68 78.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.849 -0.532 . . . . 0.0 110.992 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.86 -47.51 58.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.507 0.323 . . . . 0.0 110.283 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB2' HD13 ' A' ' 42' ' ' LEU . 7.9 pt20 -63.26 -35.72 81.27 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.38 -47.53 78.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.173 0.442 . . . . 0.0 110.713 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.72 -38.17 71.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.573 0.749 . . . . 0.0 111.587 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.33 -38.66 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.404 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.22 -25.75 64.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.363 0.983 . . . . 0.0 112.56 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -55.09 -26.08 35.65 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.675 0.79 . . . . 0.0 112.614 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.25 -28.42 3.69 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.438 1.095 . . . . 0.0 111.973 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.328 1.851 . . . . 0.0 108.19 174.453 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.43 22.12 1.08 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.899 0.88 . . . . 0.0 112.399 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.2 127.74 6.52 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -146.42 142.28 28.0 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 129.523 3.129 . . . . 0.0 105.273 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -125.4 142.6 41.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 109.0 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.1 151.05 31.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.836 1.254 . . . . 0.0 107.682 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -132.87 151.65 51.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.979 1.311 . . . . 0.0 108.26 -169.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -126.84 147.44 50.04 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.926 0.89 . . . . 0.0 109.212 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.57 130.41 38.37 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.774 0.83 . . . . 0.0 109.428 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -145.44 149.69 35.16 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.434 1.494 . . . . 0.0 110.351 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -59.63 130.17 45.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.79 37.18 8.96 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.025 1.774 . . . . 0.0 112.85 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -39.87 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.235 1.814 . . . . 0.0 114.961 -168.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.1 m -139.24 4.19 2.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.403 1.081 . . . . 0.0 111.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.88 -49.18 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -59.26 -57.22 13.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.831 1.651 . . . . 0.0 112.047 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 m -75.42 -26.15 58.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.287 0.949 . . . . 0.0 110.965 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -51.29 -49.66 60.82 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.805 1.642 . . . . 0.0 109.676 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.2 ttm -69.12 -45.2 70.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.659 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.38 90.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.879 0.871 . . . . 0.0 111.946 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -73.94 -33.27 63.86 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.175 0.898 . . . . 0.0 110.798 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.31 70.75 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -59.38 -40.89 87.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.715 0.806 . . . . 0.0 111.601 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.32 -50.88 71.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -64.26 -24.81 67.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.07 -13.08 62.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -126.82 -8.47 6.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.82 1.248 . . . . 0.0 112.906 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -133.33 81.84 1.95 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -171.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 -161.88 2.14 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.442 1.496 . . . . 0.0 113.07 -171.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -57.23 -21.14 31.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.729 1.211 . . . . 0.0 113.373 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.14 -14.2 6.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.604 1.962 . . . . 0.0 113.008 169.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -136.48 158.17 45.06 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.094 1.758 . . . . 0.0 109.081 -174.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -132.68 151.38 51.98 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 24.5 t -135.41 142.9 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -145.32 161.6 39.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.332 0.653 . . . . 0.0 109.911 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.3 m -137.63 145.47 42.76 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.342 1.457 . . . . 0.0 109.165 -169.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.85 164.32 38.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.684 0.754 . . . . 0.0 112.179 -174.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.43 -177.23 46.14 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.333 1.921 . . . . 0.0 108.875 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tt -57.19 -56.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.577 1.151 . . . . 0.0 112.813 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -132.17 23.76 4.51 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.76 2.024 . . . . 0.0 108.005 -171.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.82 118.61 6.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.229 2.212 . . . . 0.0 111.01 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -161.7 -0.17 0.05 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.04 0.536 . . . . 0.0 111.626 169.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.86 168.63 51.25 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -144.71 77.12 1.52 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -60.51 131.5 90.67 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -172.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.63 -21.68 48.23 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.968 1.779 . . . . 0.0 112.755 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -37.38 83.63 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.863 1.211 . . . . 0.0 111.817 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.63 -38.09 65.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 119.099 0.863 . . . . 0.0 109.927 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.56 -51.77 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.12 -42.55 90.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.989 0.916 . . . . 0.0 110.679 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.78 -30.71 61.74 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.754 0.822 . . . . 0.0 112.304 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.1 mmm -86.41 -33.74 20.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.003 0.819 . . . . 0.0 111.134 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -62.19 -25.59 67.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.187 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -56.51 -30.16 62.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.918 1.236 . . . . 0.0 111.516 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 26.0 m -117.27 15.11 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.242 1.417 . . . . 0.0 111.195 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.6 39.95 97.18 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.946 -0.919 . . . . 0.0 112.879 174.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -115.38 126.99 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -87.15 134.56 33.51 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.917 -0.489 . . . . 0.0 109.752 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -131.51 14.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.288 0.635 . . . . 0.0 111.246 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -59.45 -20.14 52.93 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.171 0.896 . . . . 0.0 110.949 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -76.27 -11.28 59.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.4 2.28 . . . . 0.0 114.116 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -63.83 165.07 9.1 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.368 1.44 . . . . 0.0 113.164 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.2 p -128.44 -37.15 1.83 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.765 1.626 . . . . 0.0 112.08 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.2 m 64.51 162.03 0.12 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.759 2.023 . . . . 0.0 112.803 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -165.52 160.5 17.81 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.611 1.164 . . . . 0.0 110.212 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 pt -78.14 178.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.731 2.012 . . . . 0.0 111.27 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.12 134.88 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -145.23 103.39 3.84 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.778 1.231 . . . . 0.0 108.283 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -48.26 -30.33 4.67 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.341 1.856 . . . . 0.0 113.748 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.61 -21.78 66.54 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.068 0.849 . . . . 0.0 111.716 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -118.7 -36.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 117.792 -1.099 . . . . 0.0 108.931 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.423 HD13 ' CE ' ' A' ' 70' ' ' MET . 6.3 tt -60.01 -51.38 69.89 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.876 1.217 . . . . 0.0 109.059 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.63 -27.59 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.07 0.85 . . . . 0.0 111.622 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -85.72 -18.48 32.95 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.519 1.128 . . . . 0.0 112.444 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.12 160.22 6.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.233 1.016 . . . . 0.0 111.235 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.9 -33.49 16.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.638 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.595 HD13 ' HD2' ' B' ' 97' ' ' LYS . 13.4 tp -146.69 139.3 25.1 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.225 1.41 . . . . 0.0 109.399 -171.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.77 107.58 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.875 1.67 . . . . 0.0 106.734 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.69 100.78 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 93.6 m -75.6 102.41 5.29 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 101.209 -3.626 . . . . 0.0 101.209 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -116.64 11.19 14.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -166.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m -136.41 -75.38 0.43 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.355 0.979 . . . . 0.0 112.217 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 173.78 164.6 29.18 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -119.4 23.51 11.2 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.815 1.646 . . . . 0.0 111.278 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.26 68.68 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.152 0.981 . . . . 0.0 112.6 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.55 4.09 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 176.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.62 9.72 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -172.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.3 0.3 OUTLIER 50.78 31.0 5.49 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.85 2.06 . . . . 0.0 114.641 -169.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.5 m 38.69 52.8 3.77 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 128.057 2.543 . . . . 0.0 113.926 170.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.21 131.11 41.52 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.029 2.486 . . . . 0.0 111.576 -169.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.411 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.5 2.12 34.42 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -174.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p 45.72 88.3 0.1 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.622 1.569 . . . . 0.0 113.244 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -56.02 141.18 86.94 Favored 'Trans proline' 0 CA--C 1.55 1.323 0 C-N-CA 122.549 2.166 . . . . 0.0 110.263 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.23 -2.51 3.17 Favored 'Trans proline' 0 C--N 1.351 0.663 1 C-N-CA 125.38 4.053 . . . . 0.0 116.961 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -65.7 -9.81 31.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.175 0.898 . . . . 0.0 111.506 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.81 144.39 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.828 1.251 . . . . 0.0 109.844 -169.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.595 ' HD2' HD13 ' B' ' 77' ' ' LEU . 0.7 OUTLIER -76.6 156.61 32.6 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.742 0.817 . . . . 0.0 108.94 171.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -145.08 143.62 30.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -137.21 139.83 41.31 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -89.93 135.13 33.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.673 1.189 . . . . 0.0 108.787 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -140.08 14.47 2.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.95 1.7 . . . . 0.0 110.323 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.34 167.1 54.43 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 123.941 0.781 . . . . 0.0 113.328 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -164.04 -43.11 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.137 1.775 . . . . 0.0 109.469 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -165.21 175.31 9.38 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.688 1.995 . . . . 0.0 109.798 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -139.26 137.87 19.83 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.26 -18.02 16.43 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.266 1.977 . . . . 0.0 113.078 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.96 6.98 1.78 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.002 1.273 . . . . 0.0 110.226 168.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -118.7 10.68 12.52 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.339 1.455 . . . . 0.0 110.901 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.84 156.76 0.91 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.314 0.646 . . . . 0.0 110.119 171.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -35.8 73.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.512 -172.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.1 -21.32 3.92 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 169.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 61.8 p -69.76 166.75 18.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.13 -42.47 99.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.441 0.639 . . . . 0.0 110.292 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.7 pt-20 -68.83 -43.03 76.38 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 117.072 -1.442 . . . . 0.0 109.32 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.2 -34.91 61.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 121.034 1.743 . . . . 0.0 109.827 -173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -55.84 -56.62 18.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.631 0.651 . . . . 0.0 110.763 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -64.56 -39.78 94.38 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.853 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.95 92.46 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.896 0.878 . . . . 0.0 111.665 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -63.31 -51.74 64.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . 0.288 2.2 p90 -70.77 -25.81 63.06 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.0 -172.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -65.61 -51.53 58.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.706 1.139 . . . . 0.0 109.746 172.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -57.27 -51.34 69.76 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.32 -49.02 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 118.333 -0.842 . . . . 0.0 109.485 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -56.52 -48.29 77.53 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 111.85 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.78 -43.44 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.326 0.391 . . . . 0.0 110.965 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -66.41 -49.96 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -48.5 79.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.806 1.243 . . . . 0.0 109.991 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.72 -42.45 95.27 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -61.37 -44.51 97.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.799 0.8 . . . . 0.0 112.025 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -69.97 -36.85 75.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.084 0.856 . . . . 0.0 111.759 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.1 mm? -74.56 -33.54 62.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.553 1.07 . . . . 0.0 111.38 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.28 -43.96 96.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.784 0.72 . . . . 0.0 109.201 170.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -59.33 -39.05 81.92 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.595 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.66 -42.61 97.37 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 122.476 2.398 . . . . 0.0 110.222 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.38 72.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.07 -37.83 18.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.825 1.25 . . . . 0.0 112.959 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.2 p -101.14 -20.09 15.47 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.801 1.64 . . . . 0.0 111.613 -169.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.37 50.01 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.75 0.691 . . . . 0.0 111.51 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 C-N-CA 128.229 2.612 . . . . 0.0 112.681 -169.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.25 160.93 0.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.645 2.378 . . . . 0.0 112.882 -169.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.52 102.84 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -73.09 166.73 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.772 1.629 . . . . 0.0 108.258 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -130.81 133.9 46.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.23 176.04 5.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.859 1.264 . . . . 0.0 110.189 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.0 p -137.98 -170.73 2.85 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.101 1.761 . . . . 0.0 109.232 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -44.46 -30.37 0.85 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.88 2.472 . . . . 0.0 113.9 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -138.45 -22.82 1.0 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.481 1.112 . . . . 0.0 112.959 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 m -59.03 -36.06 74.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -71.75 122.72 21.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m 117.71 -60.93 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.707 1 C-N-CA 131.977 4.111 . . . . 0.0 106.065 -169.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.2 95.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.424 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -81.68 -9.24 59.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.612 1.565 . . . . 0.0 112.163 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.1 p -122.77 -6.59 8.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -168.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -79.98 -1.48 39.8 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -140.39 147.61 40.01 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.238 0.926 . . . . 0.0 109.787 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.56 -174.63 31.37 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.332 0.968 . . . . 0.0 111.659 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.31 129.97 45.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.06 119.51 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.123 0.969 . . . . 0.0 109.009 -168.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.8 107.53 18.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.73 27.82 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.477 1.035 . . . . 0.0 108.282 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -135.7 152.45 51.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.866 1.667 . . . . 0.0 108.84 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -132.22 114.2 14.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -169.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.597 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 2.3 p-90 -135.58 153.07 51.8 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.034 1.733 . . . . 0.0 108.191 -169.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.51 163.33 7.06 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 119.262 0.937 . . . . 0.0 109.183 169.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.86 -16.86 9.41 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.486 2.791 . . . . 0.0 116.384 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -57.67 -27.43 62.86 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.79 159.49 41.7 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.633 1.106 . . . . 0.0 112.494 -169.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.73 -48.65 75.1 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.039 -1.423 . . . . 0.0 112.677 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.68 -30.69 17.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.657 2.904 . . . . 0.0 115.461 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.71 -25.47 62.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 120.247 1.385 . . . . 0.0 112.924 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -103.89 10.06 36.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.27 1.028 . . . . 0.0 111.708 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.4 mtm -120.78 -44.36 2.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.192 0.997 . . . . 0.0 109.481 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.44 -34.94 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 0.0 109.254 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.16 6.98 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.183 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.82 -40.16 74.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.009 1.806 . . . . 0.0 111.671 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.97 -42.01 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 123.007 0.523 . . . . 0.0 110.548 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.26 -40.12 71.17 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.499 0.59 . . . . 0.0 110.812 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.32 -35.32 80.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.275 0.943 . . . . 0.0 109.723 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.8 -25.32 63.72 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.405 1.482 . . . . 0.0 112.363 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.427 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 48.3 tp -79.42 -44.48 21.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.504 1.122 . . . . 0.0 109.637 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.5 -37.48 74.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.723 0.297 . . . . 0.0 110.793 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -68.64 -10.04 53.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.275 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -101.89 -48.18 4.35 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.148 0.979 . . . . 0.0 111.149 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -134.14 15.41 3.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.419 0.688 . . . . 0.0 112.331 -169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.95 -2.88 26.3 Favored Glycine 0 CA--C 1.52 0.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.912 174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.5 -24.8 64.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.202 1.001 . . . . 0.0 110.808 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -23.01 9.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.164 0.986 . . . . 0.0 112.061 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -122.57 147.54 46.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.593 1.157 . . . . 0.0 111.57 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -107.42 143.88 35.12 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.7 mt -128.14 139.23 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.84 141.86 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 125.722 1.609 . . . . 0.0 106.672 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.597 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 24.2 mtpp -113.41 159.52 19.37 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.262 0.625 . . . . 0.0 109.576 173.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.56 121.16 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.796 -3.039 . . . . 0.0 102.796 170.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.2 106.2 6.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 170.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.318 33.0 m -78.66 50.19 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -155.7 -45.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.491 1.516 . . . . 0.0 108.291 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -80.04 -36.71 35.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 110.869 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -134.08 28.67 3.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 111.019 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -71.77 -6.27 40.18 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.653 0.781 . . . . 0.0 112.735 -171.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -53.74 -49.3 68.46 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.009 1.724 . . . . 0.0 110.708 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -60.04 -34.67 73.7 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.387 0.675 . . . . 0.0 111.677 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.06 -64.01 0.94 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.82 -45.84 7.45 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.802 0.715 . . . . 0.0 113.298 169.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.29 -43.15 96.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.124 0.962 . . . . 0.0 111.506 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -84.56 -4.98 59.26 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.639 0.776 . . . . 0.0 112.659 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.45 66.32 1.61 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.1 t -144.1 131.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 101.058 -3.682 . . . . 0.0 101.058 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.814 ' HG3' HD12 ' B' ' 67' ' ' ILE . 25.6 ptm -149.97 24.71 0.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -140.48 161.31 38.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.622 1.569 . . . . 0.0 112.727 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 136.17 28.75 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.572 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.11 145.42 41.32 Favored 'Cis proline' 0 N--CA 1.45 -1.052 0 N-CA-C 107.43 -1.796 . . . . 0.0 107.43 -11.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.2 m -113.81 145.23 41.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.1 133.06 54.77 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.2 mt -122.11 110.1 15.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -101.82 122.23 53.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.34 1.456 . . . . 0.0 108.547 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.51 130.31 20.38 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t70 43.13 31.1 0.33 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.609 2.364 . . . . 0.0 114.804 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.16 -19.15 5.77 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.988 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -136.43 149.49 48.28 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.24 1.52 . . . . 0.0 113.24 -168.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.58 138.83 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 169.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.81 -26.55 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.855 1.662 . . . . 0.0 109.418 -172.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -144.07 157.51 44.28 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -154.6 133.45 12.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.98 -2.229 . . . . 0.0 104.98 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.3 t -155.17 148.79 25.3 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.5 t -138.75 82.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.24 160.01 10.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.435 1.017 . . . . 0.0 110.883 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -66.67 145.58 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.118 0.959 . . . . 0.0 111.118 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -135.91 138.92 29.01 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 124.724 1.21 . . . . 0.0 108.167 170.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.25 169.74 17.57 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.195 1.93 . . . . 0.0 109.946 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 18.1 tptm -46.03 -48.58 16.75 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.072 1.749 . . . . 0.0 112.41 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.68 -42.37 74.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 118.005 0.366 . . . . 0.0 111.132 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.67 85.04 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.134 0.425 . . . . 0.0 110.662 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -54.45 45.8 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.509 0.724 . . . . 0.0 109.305 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -65.32 -37.47 87.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.754 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.56 -47.27 86.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.63 0.65 . . . . 0.0 110.957 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.48 -40.07 77.77 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.417 0.687 . . . . 0.0 111.292 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.2 p -85.72 -41.61 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 123.064 0.228 . . . . 0.0 110.627 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -56.69 -27.35 58.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.751 1.221 . . . . 0.0 112.302 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -50.08 -32.68 16.28 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.974 1.31 . . . . 0.0 112.294 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -135.81 -8.48 2.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.249 1.041 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.164 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 52.3 48.31 22.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.894 1.677 . . . . 0.0 113.113 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 135.73 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.171 3.788 . . . . 0.0 109.151 169.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -150.66 158.48 44.2 Favored 'General case' 0 C--N 1.325 -0.491 1 C-N-CA 133.896 4.878 . . . . 0.0 103.905 169.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mt -122.61 142.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.657 1.117 . . . . 0.0 109.215 -169.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.0 tt -143.44 146.94 20.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.33 1.452 . . . . 0.0 107.125 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.59 134.55 37.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.049 0.539 . . . . 0.0 109.835 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -92.58 143.09 26.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -132.51 111.11 10.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -140.05 143.18 36.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.174 0.99 . . . . 0.0 108.665 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -42.81 96.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.806 2.442 . . . . 0.0 112.681 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.39 36.64 89.91 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 118.637 -1.091 . . . . 0.0 111.185 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -2.34 103.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 129.764 3.226 . . . . 0.0 113.696 -169.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -122.51 -145.58 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 112.067 -2.333 . . . . 0.0 104.787 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . -38.4 -50.7 1.53 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -168.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.489 ' HE ' ' HG ' ' B' ' 81' ' ' LEU . 27.5 mtp85 -53.68 -51.15 64.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.784 1.175 . . . . 0.0 111.003 -172.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -43.31 73.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.144 -171.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -54.92 -49.66 70.74 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.098 0.959 . . . . 0.0 110.241 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' B' ' 124' ' ' ARG . 26.2 ttm -63.01 -44.26 96.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.484 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 117.765 -1.112 . . . . 0.0 112.491 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -64.92 -47.3 78.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 120.649 1.568 . . . . 0.0 109.636 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.75 -47.75 89.66 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.527 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -61.92 -42.62 99.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 117.375 0.587 . . . . 0.0 112.283 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.1 83.19 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -65.64 -26.96 68.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.206 -170.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -18.22 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.313 0.961 . . . . 0.0 113.285 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.443 ' CZ ' ' HE3' ' B' ' 132' ' ' LYS . 1.9 m-85 -119.05 -11.5 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 113.078 -175.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 39.0 mt -103.05 -125.46 0.2 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.78 -168.71 40.84 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.64 -16.1 60.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.556 1.143 . . . . 0.0 111.805 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -53.84 -25.55 20.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 111.268 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -130.3 158.65 39.2 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.713 1.205 . . . . 0.0 110.825 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -128.14 125.71 39.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 67.0 t -115.36 134.42 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 -169.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.1 168.94 18.64 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.463 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -146.6 150.73 36.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.943 0.897 . . . . 0.0 110.353 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 67' ' ' ILE . . . -151.39 166.4 31.15 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.126 1.37 . . . . 0.0 110.375 -177.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.29 -178.44 47.72 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.175 1.369 . . . . 0.0 110.333 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -52.76 -54.03 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.619 1.168 . . . . 0.0 113.739 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.01 27.88 4.51 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.581 1.953 . . . . 0.0 108.269 -169.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.74 140.65 49.62 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.195 1.798 . . . . 0.0 111.942 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 p80 158.43 56.99 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.334 3.054 . . . . 0.0 107.719 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.9 93.97 0.15 Allowed Glycine 0 C--N 1.336 0.574 0 O-C-N 121.219 -0.926 . . . . 0.0 111.404 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.0 tp -72.65 91.02 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -66.21 126.59 92.26 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.896 0.878 . . . . 0.0 109.774 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.75 -26.58 68.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.186 1.924 . . . . 0.0 113.266 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -20.04 65.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.151 1.341 . . . . 0.0 112.204 173.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -82.39 -38.2 24.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 110.147 174.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.51 -51.22 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.33 -38.49 83.93 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.808 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.35 -37.67 65.19 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.722 0.692 . . . . 0.0 111.842 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 52.8 mmm -76.66 -35.38 58.0 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.22 0.918 . . . . 0.0 111.163 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -62.33 -24.53 67.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.085 -0.959 . . . . 0.0 111.389 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.47 -26.93 65.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.76 1.164 . . . . 0.0 111.721 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.5 m -120.28 15.01 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.196 1.398 . . . . 0.0 111.151 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.1 42.41 99.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 123.94 0.781 . . . . 0.0 112.598 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -115.11 155.67 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 172.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -124.14 140.93 52.49 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.789 0.836 . . . . 0.0 109.473 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 37.5 pt -138.23 22.13 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.671 1.588 . . . . 0.0 109.794 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -60.71 -15.53 30.04 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 120.641 -1.287 . . . . 0.0 111.881 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -63.15 -31.45 72.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.687 2.395 . . . . 0.0 114.172 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -62.45 158.14 18.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.587 1.155 . . . . 0.0 111.16 -169.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.6 t -149.89 -30.65 0.22 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.628 0.771 . . . . 0.0 112.426 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p 56.52 173.74 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.847 2.059 . . . . 0.0 115.272 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -166.47 166.01 16.63 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.281 2.232 . . . . 0.0 107.997 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 31.2 pt -68.55 174.73 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.332 1.053 . . . . 0.0 111.366 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.814 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.2 OUTLIER -48.64 131.95 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -147.3 97.51 2.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.192 0.996 . . . . 0.0 108.886 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 9.7 m -50.73 -25.41 4.31 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.926 1.291 . . . . 0.0 114.021 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.71 -21.26 65.64 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.647 1.567 . . . . 0.0 112.098 -175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.55 -37.74 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tt -68.12 -41.84 81.12 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.821 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.37 66.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.678 1.126 . . . . 0.0 111.379 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -82.77 -13.52 56.12 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.145 0.978 . . . . 0.0 112.383 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.8 162.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.44 1.018 . . . . 0.0 111.449 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.68 -34.57 16.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.627 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' B' ' 97' ' ' LYS . 23.2 tp -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.091 1.356 . . . . 0.0 109.221 -171.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -100.49 104.1 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.19 99.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -65.43 121.55 15.13 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 169.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.489 ' HG ' ' HE ' ' B' ' 16' ' ' ARG . 4.4 tp -135.58 54.26 1.93 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.832 0.853 . . . . 0.0 111.14 -167.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -165.85 -168.64 1.33 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.846 2.059 . . . . 0.0 105.827 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.5 40.1 0.54 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 123.883 0.754 . . . . 0.0 111.379 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -133.7 127.97 34.0 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.915 0.857 . . . . 0.0 108.888 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.86 -5.42 25.68 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -169.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.15 -12.3 18.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.433 1.47 . . . . 0.0 112.731 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.21 16.07 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm 74.89 22.3 1.9 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.238 1.815 . . . . 0.0 112.194 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 29.03 57.17 0.66 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 128.149 2.58 . . . . 0.0 112.859 -173.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.04 133.4 51.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.617 2.211 . . . . 0.0 111.914 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.435 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.06 -4.65 57.29 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -174.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p 44.28 103.13 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 127.89 2.476 . . . . 0.0 113.858 -175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -63.56 145.02 91.43 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.461 1.441 . . . . 0.0 109.645 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.59 -4.54 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.119 3.213 . . . . 0.0 114.513 -170.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -61.3 -12.71 14.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.44 147.33 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.218 1.007 . . . . 0.0 110.524 -170.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.4 tmmm? -77.25 157.96 30.52 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 169.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -145.03 145.91 31.68 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.751 -1.218 . . . . 0.0 109.104 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.55 151.32 34.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 168.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -108.56 140.48 41.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.895 1.278 . . . . 0.0 110.64 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -144.24 22.61 1.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.724 1.21 . . . . 0.0 111.034 -170.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.94 25.45 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.161 0.886 . . . . 0.0 110.949 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -154.57 -30.4 0.11 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.95 1.7 . . . . 0.0 110.564 -171.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -153.13 165.0 37.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.92 2.488 . . . . 0.0 107.364 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.12 139.29 20.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.301 1.441 . . . . 0.0 108.328 -171.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.66 -17.86 9.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.355 2.036 . . . . 0.0 113.769 -169.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.01 -0.25 5.43 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.39 0.996 . . . . 0.0 110.666 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 11.17 15.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.894 1.277 . . . . 0.0 110.989 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.52 159.84 0.31 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.059 0.944 . . . . 0.0 110.729 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.51 -36.09 68.78 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.654 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.01 -15.96 5.32 Favored Glycine 0 C--N 1.336 0.554 0 N-CA-C 115.73 1.052 . . . . 0.0 115.73 168.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 65.6 p -69.98 165.08 22.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.8 -42.73 99.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.44 0.638 . . . . 0.0 110.208 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -67.1 -43.29 82.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 116.857 -1.545 . . . . 0.0 109.395 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.95 -35.73 62.12 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 121.232 1.833 . . . . 0.0 109.428 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -57.08 -53.94 52.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 118.679 0.672 . . . . 0.0 110.656 171.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . 0.434 ' HA ' ' CD2' ' B' ' 120' ' ' PHE . 7.6 t90 -62.93 -45.19 93.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.694 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.97 99.51 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.943 0.897 . . . . 0.0 111.857 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.12 -48.78 72.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.434 ' CD2' ' HA ' ' B' ' 117' ' ' TRP 0.253 0.3 OUTLIER -65.92 -38.91 89.91 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.366 -174.685 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.02 -48.5 80.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 119.374 0.988 . . . . 0.0 110.672 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 23.5 ttt-85 -63.13 -52.15 63.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.91 -35.45 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.222 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.527 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.1 tmm_? -61.84 -43.99 97.74 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.781 1.173 . . . . 0.0 112.373 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.46 -46.19 80.48 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.17 0.441 . . . . 0.0 110.725 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.66 -41.35 68.86 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 122.32 -0.238 . . . . 0.0 111.57 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.3 -46.25 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.105 0.962 . . . . 0.0 109.642 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.19 98.39 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.07 -44.54 94.68 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.262 1.031 . . . . 0.0 112.325 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -72.42 -34.93 68.19 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.044 -1.035 . . . . 0.0 111.489 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -36.08 68.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.682 1.128 . . . . 0.0 111.415 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.443 ' HE3' ' CZ ' ' B' ' 27' ' ' TYR . 9.4 ptmt -67.18 -37.39 83.62 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.165 0.893 . . . . 0.0 109.576 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.76 -43.19 98.33 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 117.302 -1.332 . . . . 0.0 110.855 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -57.44 -41.25 80.09 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 121.579 1.99 . . . . 0.0 110.552 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.09 73.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.824 0.85 . . . . 0.0 112.617 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.33 -41.73 14.29 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.459 1.503 . . . . 0.0 111.158 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 58.6 p -90.06 -23.62 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.129 1.372 . . . . 0.0 110.452 -169.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 51.3 54.33 24.14 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.602 1.561 . . . . 0.0 114.533 -169.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.9 168.06 23.61 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.431 2.292 . . . . 0.0 106.293 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.05 99.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 169.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.41 165.33 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.943 1.297 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 118.25 28.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 107.909 172.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.15 172.86 12.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.982 0.913 . . . . 0.0 108.616 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t -155.34 -177.7 6.73 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 169.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -36.92 -36.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 129.529 3.132 . . . . 0.0 116.275 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -132.7 -30.95 1.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.518 1.127 . . . . 0.0 111.421 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 m -61.74 -19.39 62.38 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.732 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -50.61 -50.52 53.94 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.346 0.975 . . . . 0.0 109.535 169.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -62.62 -44.77 95.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 122.087 -0.383 . . . . 0.0 110.064 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.15 92.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 122.417 -0.177 . . . . 0.0 111.017 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -72.09 -21.0 61.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.061 0.944 . . . . 0.0 112.81 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.5 p -110.41 -4.03 15.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.174 0.99 . . . . 0.0 112.117 -169.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.2 m -70.78 -11.77 61.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.112 0.965 . . . . 0.0 113.304 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.24 146.53 35.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.867 0.758 . . . . 0.0 109.918 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.8 -171.43 26.46 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.761 1.172 . . . . 0.0 111.949 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.85 133.45 34.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.0 t -142.01 116.05 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -81.73 134.2 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.27 139.69 53.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 169.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -132.24 148.65 52.46 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.734 1.614 . . . . 0.0 108.757 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -129.49 110.83 12.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -169.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.573 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.9 p-90 -129.28 152.55 48.72 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.562 1.945 . . . . 0.0 107.634 -169.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -171.83 164.05 4.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.783 1.174 . . . . 0.0 111.761 170.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -56.99 -9.38 4.24 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.461 3.441 . . . . 0.0 117.476 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.525 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 71.3 m95 -48.47 -46.91 38.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.256 1.389 . . . . 0.0 111.889 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.7 m -152.61 165.42 35.28 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -174.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.19 -46.3 27.53 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.161 2.315 . . . . 0.0 115.861 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -51.6 -32.37 44.08 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.818 2.809 . . . . 0.0 114.611 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -58.58 -30.18 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 120.266 1.393 . . . . 0.0 112.743 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.91 7.92 45.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.594 1.157 . . . . 0.0 111.838 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.1 mtm -117.67 -44.02 2.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.034 0.934 . . . . 0.0 109.339 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.14 -33.25 55.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.344 1.058 . . . . 0.0 109.4 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.53 -60.46 10.26 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.294 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.25 -39.86 81.0 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.03 1.82 . . . . 0.0 111.47 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.67 -41.42 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 123.029 0.531 . . . . 0.0 110.586 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 mp -71.15 -38.45 72.23 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 118.907 0.776 . . . . 0.0 110.897 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.28 -34.95 79.16 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.033 . . . . 0.0 109.9 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -69.86 -30.56 68.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.564 1.146 . . . . 0.0 111.288 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.84 -43.77 64.99 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.582 1.153 . . . . 0.0 110.112 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.59 -37.3 65.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.523 -0.735 . . . . 0.0 110.962 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -69.86 -14.31 62.68 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.844 -0.535 . . . . 0.0 111.735 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.12 -49.25 6.09 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.943 1.297 . . . . 0.0 110.554 -176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.7 ptm -138.29 16.34 2.78 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.802 0.841 . . . . 0.0 112.115 -169.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.63 2.87 10.07 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.408 -0.808 . . . . 0.0 113.769 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.39 -24.62 61.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.785 1.234 . . . . 0.0 110.593 169.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.91 -19.1 11.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.004 0.921 . . . . 0.0 112.57 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 tp -131.28 144.91 51.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.687 1.195 . . . . 0.0 110.733 -168.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -101.45 144.34 30.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.3 mt -127.19 135.91 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.15 143.37 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -173.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 22.7 mtpp -117.77 156.35 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.441 0.564 . . . . 0.0 110.49 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -126.26 125.27 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.26 107.7 12.22 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 169.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.289 33.7 m -82.85 50.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -152.42 -35.13 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.446 -0.783 . . . . 0.0 111.329 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -103.95 -27.26 12.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.583 1.153 . . . . 0.0 109.777 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.12 25.1 5.24 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.602 1.161 . . . . 0.0 111.634 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.8 -1.79 23.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.687 1.195 . . . . 0.0 112.982 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.55 -46.44 83.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.014 1.326 . . . . 0.0 110.84 -173.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.32 -39.91 70.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.099 0.863 . . . . 0.0 111.422 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.34 -64.29 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -171.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.61 -41.33 9.42 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.166 0.889 . . . . 0.0 114.103 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -62.85 -46.92 85.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.892 1.346 . . . . 0.0 110.534 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -69.79 -33.78 72.84 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.231 0.469 . . . . 0.0 110.457 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.55 68.02 0.81 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -137.28 132.69 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 100.488 -3.893 . . . . 0.0 100.488 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.408 ' HB2' HD12 ' B' ' 67' ' ' ILE . 28.7 mtm -147.83 17.04 1.12 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.079 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.8 p -133.92 162.04 33.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 112.339 -168.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.66 139.33 35.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.253 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.91 135.57 16.88 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 N-CA-C 106.26 -2.246 . . . . 0.0 106.26 -11.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.6 m -103.77 140.41 37.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -117.15 135.48 53.73 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 107.659 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.5 mt -121.15 113.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 169.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.09 124.67 43.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -122.69 155.04 37.23 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.909 0.884 . . . . 0.0 109.546 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.36 141.69 24.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 45.47 30.76 0.78 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.353 1.861 . . . . 0.0 113.56 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.72 9.8 51.65 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 116.428 1.331 . . . . 0.0 116.428 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.79 149.56 47.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.718 1.259 . . . . 0.0 111.502 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.3 t -71.71 138.28 21.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.75 -20.75 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.599 1.16 . . . . 0.0 110.966 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -144.51 153.86 42.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.134 0.879 . . . . 0.0 108.914 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -139.83 137.29 34.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.3 t -151.16 148.84 28.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.0 t -138.82 112.15 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.32 155.84 6.62 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.93 142.68 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.635 0.718 . . . . 0.0 110.537 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -136.01 140.81 34.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -68.64 167.91 21.46 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.343 2.029 . . . . 0.0 110.357 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -44.24 -49.58 9.2 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.616 1.966 . . . . 0.0 112.281 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -43.6 70.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.28 0.491 . . . . 0.0 111.445 -174.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.59 87.92 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.958 -0.464 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -54.4 45.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.5 0.72 . . . . 0.0 109.612 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -64.07 -38.87 92.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.546 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' A' ' 102' ' ' LYS . 35.8 tt0 -61.99 -44.04 97.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.759 0.424 . . . . 0.0 111.506 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.09 -44.3 91.9 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.147 0.979 . . . . 0.0 110.703 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.71 -36.71 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.1 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.24 -30.72 62.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 112.131 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.411 ' HE2' ' HG2' ' A' ' 98' ' ' GLU . 41.4 mttm -56.56 -26.58 55.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.068 0.947 . . . . 0.0 112.954 175.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -125.82 -16.75 5.59 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.122 0.969 . . . . 0.0 112.265 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.249 1.052 0 C-N-CA 126.619 1.968 . . . . 0.0 108.701 169.827 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -58.83 131.59 51.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.776 1.231 . . . . 0.0 111.074 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 m120 71.01 124.91 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.191 2.996 . . . . 0.0 112.378 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -146.73 143.71 28.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 130.809 3.644 . . . . 0.0 103.604 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mt -123.12 142.38 39.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 120.571 1.532 . . . . 0.0 108.344 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.22 142.27 29.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -128.88 138.3 51.95 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -110.83 148.59 32.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.0 tp -142.08 112.17 6.93 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -169.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 42.4 p -158.51 149.26 20.34 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.741 0.416 . . . . 0.0 111.187 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 88.2 m -47.8 120.59 3.49 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.347 1.459 . . . . 0.0 111.866 -173.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.425 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 65.19 13.69 58.21 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.477 174.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -7.02 85.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 129.486 3.114 . . . . 0.0 114.926 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -152.53 6.77 0.42 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.368 0.667 . . . . 0.0 111.951 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.44 -93.03 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.869 1.213 . . . . 0.0 111.47 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -24.97 67.61 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 121.425 -0.797 . . . . 0.0 112.221 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.8 p -61.05 -47.7 85.17 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.519 2.328 . . . . 0.0 112.464 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -64.12 -44.98 90.57 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.796 1.284 . . . . 0.0 108.525 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ttm -59.74 -50.83 72.29 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.84 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.14 79.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.46 -0.775 . . . . 0.0 111.907 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.64 -26.68 45.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.818 1.19 . . . . 0.0 110.547 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.56 -47.35 69.77 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.494 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 19.4 m95 -54.73 -42.6 71.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.822 0.849 . . . . 0.0 111.319 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.74 72.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -173.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -65.42 -22.26 66.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -69.02 -15.27 63.43 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.312 0.96 . . . . 0.0 113.472 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -130.95 -44.01 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.529 1.059 . . . . 0.0 112.44 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 71.0 mt -79.47 73.2 6.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.091 1.756 . . . . 0.0 106.351 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.11 -151.17 0.18 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 127.277 2.37 . . . . 0.0 113.748 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.15 -19.53 63.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.824 1.25 . . . . 0.0 113.399 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.92 -19.49 64.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.2 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -122.39 160.23 25.88 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.378 0.99 . . . . 0.0 111.558 -169.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -133.64 142.18 47.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.852 2.061 . . . . 0.0 105.925 170.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.05 135.01 59.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -170.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -142.11 164.51 29.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -146.01 136.37 23.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -169.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.63 166.75 29.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.481 0.713 . . . . 0.0 111.103 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.06 -172.54 38.73 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 118.018 0.372 . . . . 0.0 113.453 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.425 HG22 ' H ' ' B' ' 12' ' ' GLY . 2.4 tt -49.04 -57.58 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.634 1.974 . . . . 0.0 113.417 -172.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -135.31 28.89 3.36 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.147 1.779 . . . . 0.0 108.746 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.01 151.76 47.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.082 2.153 . . . . 0.0 112.865 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 79.6 t60 143.34 94.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 130.444 3.498 . . . . 0.0 105.049 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.19 177.54 48.43 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.823 -0.548 . . . . 0.0 111.779 -172.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -153.05 92.64 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -65.3 127.36 92.83 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -60.87 -21.55 71.01 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -36.49 81.14 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 120.171 1.35 . . . . 0.0 110.71 172.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.1 -39.17 63.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -57.8 -53.59 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -60.56 -40.96 93.53 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.899 0.88 . . . . 0.0 110.883 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.19 -37.0 61.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.55 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 68.5 mmm -82.15 -34.38 29.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.225 0.92 . . . . 0.0 111.496 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -62.96 -23.41 67.4 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.894 -1.051 . . . . 0.0 111.016 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.87 -31.65 66.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.047 1.294 . . . . 0.0 111.624 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.9 m -116.36 14.34 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.045 1.338 . . . . 0.0 111.268 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.23 41.96 98.09 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.938 -0.923 . . . . 0.0 112.556 175.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.81 147.4 20.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -118.6 135.45 54.43 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 pt -137.02 16.3 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.619 1.568 . . . . 0.0 110.611 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -60.47 -10.04 4.45 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -99.0 -14.15 19.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.048 1.739 . . . . 0.0 113.387 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -58.69 161.3 4.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 t -161.77 -175.78 4.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.802 2.041 . . . . 0.0 107.393 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 50.6 m -145.47 -162.27 1.47 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.599 1.56 . . . . 0.0 109.803 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -160.35 167.72 26.81 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.74 2.416 . . . . 0.0 106.918 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.6 pt -64.95 168.14 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.47 0.708 . . . . 0.0 111.623 173.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 70' ' ' MET . 1.4 pt -47.06 129.2 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 108.816 176.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -137.55 98.55 3.72 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.897 1.332 . . . . 0.0 109.388 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.0 m -43.87 -32.37 1.07 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.364 2.266 . . . . 0.0 114.045 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.92 -16.57 59.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.164 0.893 . . . . 0.0 112.252 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.04 -37.65 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 117.846 -1.073 . . . . 0.0 109.339 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.09 -55.41 29.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.616 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -23.21 66.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.835 0.289 . . . . 0.0 110.929 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.49 -22.89 28.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.9 2.08 . . . . 0.0 112.814 -175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.05 173.51 1.39 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.985 1.314 . . . . 0.0 111.8 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.17 -24.81 15.55 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.958 0.903 . . . . 0.0 111.614 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' B' ' 97' ' ' LYS . 18.5 tp -151.25 143.03 23.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.977 1.311 . . . . 0.0 109.548 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.59 106.37 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 127.165 2.186 . . . . 0.0 106.66 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.22 99.79 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.3 m -66.88 128.83 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 tp -125.51 48.85 1.99 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.916 0.887 . . . . 0.0 111.498 -167.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 47.5 m -162.05 176.79 10.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 107.877 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.16 46.9 1.07 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -147.82 161.7 40.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.574 1.95 . . . . 0.0 108.042 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -131.81 1.71 4.0 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.261 1.424 . . . . 0.0 112.576 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.03 -19.03 4.16 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.31 0.959 . . . . 0.0 112.827 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -64.83 18.91 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.699 2.4 . . . . 0.0 116.62 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . 0.415 ' HE3' HG13 ' B' ' 39' ' ' ILE . 60.7 mttt 83.15 18.86 0.24 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 128.744 2.818 . . . . 0.0 112.216 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.2 m 32.9 52.82 0.93 Allowed Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 126.502 1.921 . . . . 0.0 111.67 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.87 132.59 22.05 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.056 2.504 . . . . 0.0 114.409 -168.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.418 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.85 -1.16 56.13 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 116.774 -1.584 . . . . 0.0 114.459 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.3 p 43.49 89.54 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.476 1.51 . . . . 0.0 113.62 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -57.27 137.57 82.26 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.03 2.487 . . . . 0.0 109.714 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.18 10.97 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.892 3.728 . . . . 0.0 116.015 -169.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -67.65 -9.48 43.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.299 1.04 . . . . 0.0 111.844 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.55 153.14 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.71 1.204 . . . . 0.0 110.115 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.482 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.5 tmmm? -72.82 153.7 40.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.35 1.06 . . . . 0.0 109.254 174.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -143.06 144.75 32.39 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.9 150.67 27.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -92.75 137.38 32.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -139.61 39.47 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.389 1.476 . . . . 0.0 108.525 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.29 167.79 29.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -157.77 -15.93 0.08 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.728 1.211 . . . . 0.0 111.575 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.54 168.22 25.61 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.232 2.213 . . . . 0.0 106.448 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -142.72 117.38 6.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.139 0.976 . . . . 0.0 109.075 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.71 -17.91 25.62 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.682 2.921 . . . . 0.0 112.752 -175.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.5 -0.56 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.516 1.053 . . . . 0.0 112.067 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 -123.43 11.23 9.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.59 1.556 . . . . 0.0 111.379 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.95 152.91 0.71 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.133 0.973 . . . . 0.0 111.563 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -35.39 73.77 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.837 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.36 9.13 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -72.92 149.81 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -47.82 -41.6 24.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.583 1.553 . . . . 0.0 111.507 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.61 -40.45 69.79 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.425 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -78.0 -31.55 50.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.907 1.23 . . . . 0.0 109.651 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -63.15 -48.48 78.29 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 119.147 0.885 . . . . 0.0 110.029 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . 0.407 ' CD1' ' CZ ' ' B' ' 120' ' ' PHE . 6.1 t90 -64.92 -46.63 80.85 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.751 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.63 95.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.544 0.738 . . . . 0.0 112.125 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.86 -50.22 71.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' B' ' 117' ' ' TRP 0.251 0.5 OUTLIER -66.51 -40.27 89.1 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.482 -174.66 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -62.2 -49.04 77.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.375 0.989 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -64.96 -48.87 72.49 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.9 -35.12 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.547 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.494 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 6.8 tmm_? -60.11 -44.73 94.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.102 1.319 . . . . 0.0 111.732 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.58 -45.81 84.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.678 0.391 . . . . 0.0 110.923 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.82 -47.58 74.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.776 0.262 . . . . 0.0 110.908 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.8 mt -54.25 -49.89 59.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.415 1.486 . . . . 0.0 109.579 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.21 -42.82 97.76 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.203 -0.776 . . . . 0.0 111.249 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -61.28 -46.19 91.39 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.229 1.015 . . . . 0.0 111.61 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.7 -37.67 85.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.88 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.798 0.726 . . . . 0.0 110.86 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.89 -37.12 83.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.851 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.34 -36.85 78.95 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.581 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -62.11 -41.34 98.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 122.863 2.574 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.93 -32.27 67.63 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 124.169 0.918 . . . . 0.0 112.356 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.01 -43.92 11.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.007 1.323 . . . . 0.0 111.839 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.8 p -88.49 -17.78 29.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.868 2.067 . . . . 0.0 110.994 -169.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.32 49.82 73.5 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.537 -174.685 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.1 mtt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.2 149.84 7.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.046 1.338 . . . . 0.0 109.434 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.66 98.26 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 102.558 -3.127 . . . . 0.0 102.558 168.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.54 165.38 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.924 1.289 . . . . 0.0 107.787 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 122.17 41.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -84.56 172.47 11.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 171.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -161.17 -176.32 5.37 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -36.94 -42.01 0.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.875 2.47 . . . . 0.0 115.487 -169.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.33 -29.83 3.21 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.29 1.036 . . . . 0.0 111.533 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.5 m -62.24 -23.28 66.58 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.336 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -53.15 -54.26 38.36 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.51 1.05 . . . . 0.0 109.051 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 m -61.46 -45.09 95.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.078 -0.389 . . . . 0.0 109.988 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.73 89.81 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.309 0.1 . . . . 0.0 111.214 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -74.75 -22.95 58.51 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.146 0.978 . . . . 0.0 112.557 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 p -106.79 -6.57 17.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.305 0.957 . . . . 0.0 112.691 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -71.65 -10.26 59.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.12 147.36 34.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.087 0.955 . . . . 0.0 109.434 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.81 -175.13 27.6 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 124.631 1.11 . . . . 0.0 111.959 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 104' ' ' LEU . 22.1 t -93.22 132.79 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 169.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.5 t -141.22 116.71 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -169.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -82.23 127.33 33.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.4 138.73 51.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.963 0.801 . . . . 0.0 108.988 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.26 146.89 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.09 1.356 . . . . 0.0 108.902 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -128.23 114.29 16.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -169.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.538 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.7 p-90 -132.96 156.14 47.83 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.762 1.625 . . . . 0.0 107.153 -170.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -176.37 167.28 1.51 Allowed Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.471 1.108 . . . . 0.0 110.749 169.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.51 -13.59 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.348 3.366 . . . . 0.0 116.601 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -60.13 -20.57 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.292 1.405 . . . . 0.0 113.648 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.13 152.14 38.8 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.86 1.209 . . . . 0.0 113.235 -171.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.41 -49.24 71.69 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.131 -1.371 . . . . 0.0 112.304 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -50.64 -27.27 19.1 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 115.815 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -58.71 -20.85 52.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 120.48 1.491 . . . . 0.0 113.209 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.62 12.15 27.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.906 1.282 . . . . 0.0 111.42 177.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -122.15 -43.61 2.32 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.33 1.052 . . . . 0.0 109.427 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -61.81 -33.59 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.846 0.858 . . . . 0.0 109.242 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.64 25.14 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 117.942 -1.027 . . . . 0.0 112.471 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.53 -39.41 75.58 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.159 1.906 . . . . 0.0 111.576 174.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 93' ' ' LYS . 3.0 t -55.45 -41.2 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.18 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.7 -43.53 84.09 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.106 0.866 . . . . 0.0 111.151 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.96 -35.41 79.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.795 0.725 . . . . 0.0 109.97 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -68.5 -40.12 81.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.58 1.152 . . . . 0.0 110.692 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.6 -46.05 84.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.734 1.213 . . . . 0.0 110.014 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.0 -40.85 71.61 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.184 -0.323 . . . . 0.0 110.822 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -70.37 -6.9 38.71 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.957 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -102.08 -47.31 4.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.627 1.171 . . . . 0.0 111.092 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.2 ptm -134.76 13.6 3.68 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 112.414 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.67 10.97 4.7 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.204 -0.935 . . . . 0.0 113.638 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.85 -26.17 37.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.497 1.519 . . . . 0.0 109.485 168.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.67 -24.42 11.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.107 0.963 . . . . 0.0 112.124 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 tp -125.3 148.57 48.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.676 1.59 . . . . 0.0 110.728 -168.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -104.55 144.4 31.74 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mt -127.2 137.68 57.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 4.9 t -139.01 145.11 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -173.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 23.6 mtpt -122.12 157.15 32.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.324 0.511 . . . . 0.0 110.767 175.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mm -125.37 127.35 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 172.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -87.97 107.46 18.73 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.835 HG21 HD11 ' A' ' 72' ' ' ILE . 33.2 m -76.29 39.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -146.19 -38.34 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.468 1.107 . . . . 0.0 109.168 168.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.88 -42.19 19.91 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.5 0.72 . . . . 0.0 111.179 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -138.96 36.61 2.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.238 1.018 . . . . 0.0 111.792 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -70.2 -6.49 34.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 113.429 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -50.81 -45.01 59.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.281 1.832 . . . . 0.0 110.796 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.6 m -54.5 -44.74 72.97 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.828 0.851 . . . . 0.0 111.199 174.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.21 -57.13 4.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.329 1.052 . . . . 0.0 108.996 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.61 -45.86 47.14 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.058 0.837 . . . . 0.0 113.557 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.0 -43.24 99.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.02 0.91 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.72 -33.35 73.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.293 0.497 . . . . 0.0 109.883 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.48 64.99 0.97 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.24 -61.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.55 -2.018 . . . . 0.0 105.55 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.252 7.0 ptm 49.44 7.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.815 3.246 . . . . 0.0 115.406 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.4 p -140.68 163.96 31.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.773 1.629 . . . . 0.0 111.987 -172.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.835 HD11 HG21 ' A' ' 57' ' ' VAL . 26.0 mm -142.66 149.64 51.09 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.096 0.959 . . . . 0.0 108.925 -174.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.42 134.47 31.84 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 N-CA-C 106.962 -1.976 . . . . 0.0 106.962 -11.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 99.7 m -112.27 146.74 37.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -131.79 121.47 24.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.4 mt -115.02 112.17 22.24 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.19 127.21 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -126.33 156.73 39.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.941 0.896 . . . . 0.0 109.587 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -146.66 140.08 25.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.8 t70 44.86 30.41 0.55 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.265 1.826 . . . . 0.0 114.125 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.64 14.69 49.25 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.835 1.207 . . . . 0.0 115.899 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.51 148.31 52.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.745 1.218 . . . . 0.0 110.803 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.81 134.87 29.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -122.79 -22.41 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.796 1.238 . . . . 0.0 109.799 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -146.68 156.15 42.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.548 1.139 . . . . 0.0 109.477 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 133.59 16.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.2 p -154.12 163.28 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.471 0.653 . . . . 0.0 110.246 172.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.9 113.74 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.54 153.95 6.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.22 142.18 58.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.914 0.486 . . . . 0.0 110.612 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -134.32 140.69 36.63 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -66.84 169.51 14.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.201 1.934 . . . . 0.0 110.109 171.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HA ' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -48.33 -50.03 31.9 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.595 1.158 . . . . 0.0 111.082 -175.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.81 -43.22 72.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.924 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.19 87.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.061 0.392 . . . . 0.0 110.33 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.8 tp -68.46 -46.99 68.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.928 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.63 -36.24 83.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.69 -47.03 82.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.306 0.503 . . . . 0.0 110.713 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.2 -39.13 78.16 Favored 'General case' 0 N--CA 1.459 -0.015 0 C-N-CA 123.659 0.783 . . . . 0.0 111.512 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -81.61 -41.32 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.795 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -54.39 -31.87 55.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.594 1.158 . . . . 0.0 112.177 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -56.23 -24.73 44.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.478 1.111 . . . . 0.0 113.218 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -128.83 -16.55 4.15 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.078 0.951 . . . . 0.0 112.518 -173.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HA ' HG21 ' A' ' 19' ' ' VAL . 16.7 tp . . . . . 0 C--O 1.248 1.025 0 C-N-CA 127.176 2.19 . . . . 0.0 108.812 169.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.6 86.92 2.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 m120 74.72 130.29 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.016 2.926 . . . . 0.0 112.103 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.454 ' HE3' ' CZ3' ' B' ' 32' ' ' TRP . 37.2 mtmt -127.69 122.98 34.35 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 128.846 2.858 . . . . 0.0 103.363 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mt -90.54 142.97 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 110.353 -167.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.43 150.23 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.703 1.601 . . . . 0.0 107.225 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.56 157.37 45.92 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.16 0.584 . . . . 0.0 111.831 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -116.63 142.79 46.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.946 1.299 . . . . 0.0 107.593 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 23.7 mt -126.21 125.7 42.85 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 71.8 m -155.17 135.05 12.84 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.321 1.848 . . . . 0.0 109.133 -169.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 17.2 m -51.33 118.58 3.37 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.802 1.241 . . . . 0.0 110.927 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.97 4.68 11.78 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.701 -1.055 . . . . 0.0 113.737 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 3.1 t30 33.26 40.05 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.246 2.619 . . . . 0.0 113.74 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -81.75 -40.63 22.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.711 0.804 . . . . 0.0 111.126 -169.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.38 -55.69 0.9 Allowed 'General case' 0 CA--C 1.526 0.058 0 C-N-CA 123.471 0.709 . . . . 0.0 112.707 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -49.89 -60.47 2.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.306 1.042 . . . . 0.0 110.184 -169.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -73.18 -28.43 62.2 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.602 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -54.86 -46.97 74.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -43.93 67.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.103 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.92 89.12 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 118.82 0.737 . . . . 0.0 112.374 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.65 -32.03 69.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.896 0.771 . . . . 0.0 110.582 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.67 -51.2 53.94 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -56.72 -32.91 65.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.88 1.272 . . . . 0.0 112.278 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.2 -53.82 7.7 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 111.079 -175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.54 -26.73 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -62.62 -17.57 60.55 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 173.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.4 -10.15 5.17 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.78 1.232 . . . . 0.0 113.011 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -124.69 81.54 1.96 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -163.23 3.01 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.063 1.792 . . . . 0.0 112.585 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -63.99 -9.91 18.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.915 1.286 . . . . 0.0 113.641 -174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -61.17 -22.53 64.82 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.903 -1.123 . . . . 0.0 109.745 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . 0.454 ' CZ3' ' HE3' ' B' ' 4' ' ' LYS . 30.9 m95 -126.7 177.37 6.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.363 2.265 . . . . 0.0 108.46 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -157.26 130.55 7.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.73 142.42 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.58 169.76 16.99 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.048 1.739 . . . . 0.0 108.21 -174.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 98.5 p -150.13 149.79 30.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.74 174.09 15.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.459 0.704 . . . . 0.0 111.313 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.98 -177.66 41.01 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.535 -0.302 . . . . 0.0 113.119 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.445 HG13 ' HE3' ' B' ' 88' ' ' LYS . 3.0 tt -43.97 -58.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.315 2.246 . . . . 0.0 114.228 -173.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -134.37 30.09 3.57 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.308 1.843 . . . . 0.0 108.191 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.37 137.01 55.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.355 1.862 . . . . 0.0 114.571 -169.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 172.14 114.4 0.01 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 130.377 3.471 . . . . 0.0 102.412 169.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.18 -179.72 43.61 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 118.875 0.761 . . . . 0.0 112.214 -174.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.5 tp -164.07 93.07 0.69 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 169.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -64.61 125.9 89.66 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.08 -21.14 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.036 1.824 . . . . 0.0 112.715 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.41 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -61.51 -37.41 83.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.273 0.942 . . . . 0.0 111.143 171.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.36 -36.16 61.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t -57.22 -50.93 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -57.55 -44.77 85.45 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.561 0.619 . . . . 0.0 110.496 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.36 -22.81 45.07 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.96 0.904 . . . . 0.0 112.694 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 77.8 mmm -102.65 -34.13 9.18 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.365 0.984 . . . . 0.0 112.301 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -60.22 -27.9 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.172 0.896 . . . . 0.0 110.092 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.73 -33.04 32.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.755 1.622 . . . . 0.0 112.383 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.89 17.39 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.299 1.44 . . . . 0.0 110.796 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.27 37.95 93.33 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.935 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 47.4 mt -115.94 107.32 22.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 172.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -73.22 132.65 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 30.8 pt -135.81 19.05 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.991 1.316 . . . . 0.0 110.823 173.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -59.76 -15.64 21.74 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.837 0.744 . . . . 0.0 111.963 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -83.97 -15.29 48.35 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.7 2.4 . . . . 0.0 114.345 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -69.9 159.55 33.47 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.742 1.156 . . . . 0.0 112.762 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 66.8 p -139.64 -169.78 2.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.125 2.57 . . . . 0.0 108.806 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 p -157.86 -173.43 4.36 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.101 0.961 . . . . 0.0 108.708 169.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -166.44 159.25 14.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 127.491 2.316 . . . . 0.0 108.017 -170.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.64 166.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.05 0.94 . . . . 0.0 111.888 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -50.07 133.28 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -142.85 98.79 3.35 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.237 1.017 . . . . 0.0 109.161 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.6 m -44.49 -32.43 1.4 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.827 2.051 . . . . 0.0 113.773 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.92 -17.65 63.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.383 0.992 . . . . 0.0 112.648 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -126.93 -34.01 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.811 0.844 . . . . 0.0 108.852 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.25 -54.18 23.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.603 1.092 . . . . 0.0 110.172 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -23.93 67.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.986 0.812 . . . . 0.0 110.416 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.91 -23.02 55.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.806 1.642 . . . . 0.0 112.138 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.94 165.69 3.11 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.763 1.225 . . . . 0.0 111.8 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.15 -29.32 15.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.036 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -145.26 133.91 22.16 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.156 0.982 . . . . 0.0 110.996 -173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.438 HG23 HG11 ' B' ' 96' ' ' VAL . 20.6 t -107.55 116.33 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.074 1.75 . . . . 0.0 108.227 170.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.38 109.33 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -76.17 123.32 25.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 167.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 tp -116.32 39.09 3.2 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.732 -0.605 . . . . 0.0 109.489 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 5.4 m -153.93 165.18 36.91 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.369 0.668 . . . . 0.0 111.644 -168.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.91 48.1 0.97 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 105.858 -2.897 . . . . 0.0 105.858 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -149.64 159.77 44.06 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.148 2.179 . . . . 0.0 107.58 -169.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -132.64 2.67 3.78 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.704 1.602 . . . . 0.0 112.192 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.26 -17.58 20.38 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.938 0.895 . . . . 0.0 112.601 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.15 38.17 0.05 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.67 1.988 . . . . 0.0 115.055 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . 0.445 ' HE3' HG13 ' B' ' 39' ' ' ILE . 14.1 mttt 64.37 21.94 12.62 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.642 -1.911 . . . . 0.0 111.742 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p 30.41 62.38 0.96 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 127.504 2.322 . . . . 0.0 112.049 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.36 132.18 49.29 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.791 2.327 . . . . 0.0 111.066 -169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.6 3.18 55.64 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.4 p 43.2 92.22 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.009 2.524 . . . . 0.0 113.698 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -61.71 147.51 95.16 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.013 1.809 . . . . 0.0 109.942 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.4 -2.52 6.16 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.915 3.743 . . . . 0.0 115.348 -169.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -62.58 -10.03 10.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.6 1.16 . . . . 0.0 112.154 170.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.438 HG11 HG23 ' B' ' 78' ' ' VAL . 2.1 t -137.52 143.95 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.842 1.257 . . . . 0.0 109.525 -169.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -76.04 155.46 34.86 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -139.98 142.61 36.31 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.833 -1.167 . . . . 0.0 108.993 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -145.45 159.28 43.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 169.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -106.74 128.72 54.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -119.16 8.73 11.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.583 1.153 . . . . 0.0 110.501 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.58 162.38 24.62 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 169.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -157.81 24.63 0.27 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.776 1.23 . . . . 0.0 109.422 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.35 172.62 18.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.407 1.883 . . . . 0.0 106.642 -171.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -148.25 116.14 4.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.57 1.148 . . . . 0.0 108.737 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.24 -28.51 22.86 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.13 2.553 . . . . 0.0 111.917 -171.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.79 -3.28 3.16 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.448 1.099 . . . . 0.0 112.755 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -97.05 5.74 49.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.249 1.02 . . . . 0.0 111.673 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.75 142.9 3.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.778 0.831 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -55.24 -45.95 76.04 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.474 0.71 . . . . 0.0 109.914 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.32 -15.11 4.22 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.8 p -69.22 162.37 27.27 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 172.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.74 -39.08 90.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.473 0.654 . . . . 0.0 110.534 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.04 -41.43 82.1 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 116.983 -1.484 . . . . 0.0 109.05 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.85 -31.46 59.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 120.851 1.66 . . . . 0.0 109.607 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -57.12 -62.91 1.43 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -59.44 -39.99 85.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.03 95.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.608 0.763 . . . . 0.0 112.305 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -63.17 -48.27 79.1 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 118.583 0.628 . . . . 0.0 109.474 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.5 m-30 -65.89 -40.46 91.59 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -65.85 -46.69 77.56 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.265 1.026 . . . . 0.0 110.297 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -60.23 -49.52 77.3 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.21 -46.76 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.018 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -62.59 -39.62 94.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.154 1.343 . . . . 0.0 111.347 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.26 -43.87 96.74 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.212 0.32 . . . . 0.0 110.615 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.66 -55.36 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.128 0.571 . . . . 0.0 109.641 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.1 mt -54.86 -52.45 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.309 1.044 . . . . 0.0 109.416 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.98 97.84 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.817 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -61.38 -47.15 87.13 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.42 1.11 . . . . 0.0 111.409 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -65.81 -41.11 92.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.466 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.46 -37.86 83.57 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.771 0.714 . . . . 0.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -62.92 -47.13 84.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.588 0.631 . . . . 0.0 109.731 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.05 -36.11 82.49 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.253 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.62 -40.94 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 121.543 1.974 . . . . 0.0 110.735 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.64 71.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.27 0.628 . . . . 0.0 112.629 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.99 -37.05 13.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 111.636 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 51.4 p -100.3 -14.13 18.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.72 1.608 . . . . 0.0 111.546 -169.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.98 48.37 86.62 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.108 0.563 . . . . 0.0 111.876 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.08 169.66 21.99 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.334 1.453 . . . . 0.0 107.778 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.29 93.65 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 169.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.01 170.71 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.473 1.909 . . . . 0.0 107.804 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -129.24 130.84 46.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.846 0.858 . . . . 0.0 108.757 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.55 176.94 6.37 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.411 1.884 . . . . 0.0 110.375 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -152.03 -176.73 5.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.043 1.737 . . . . 0.0 106.692 169.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -38.67 -37.6 0.34 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.774 2.83 . . . . 0.0 116.067 -169.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -128.81 -30.6 2.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.301 1.04 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.8 m -61.49 -20.89 63.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.422 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -49.47 -53.33 23.69 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 120.188 1.358 . . . . 0.0 109.813 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -64.2 -45.04 90.07 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.09 77.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.397 -0.189 . . . . 0.0 111.369 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.37 -14.03 59.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.723 1.209 . . . . 0.0 112.494 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.3 p -120.79 -6.38 9.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.66 1.118 . . . . 0.0 113.474 -169.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.1 m -78.11 -0.77 29.43 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.382 -0.824 . . . . 0.0 113.11 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.86 145.51 36.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.16 0.984 . . . . 0.0 108.935 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.99 -170.86 54.68 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.893 0.759 . . . . 0.0 111.752 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.99 116.47 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.1 t -133.18 118.98 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.09 137.61 32.2 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.9 144.8 47.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -139.3 144.48 38.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.66 1.184 . . . . 0.0 108.275 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.48 111.52 15.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.441 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.3 p-90 -131.52 154.16 49.06 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.926 1.69 . . . . 0.0 108.153 -169.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.89 163.14 7.88 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.896 0.771 . . . . 0.0 110.07 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -54.02 -14.02 5.45 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.981 3.121 . . . . 0.0 116.272 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -60.8 -24.32 65.74 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.836 1.198 . . . . 0.0 113.84 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.22 155.8 47.53 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.523 1.056 . . . . 0.0 112.335 -169.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.19 72.65 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.105 -1.386 . . . . 0.0 113.166 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.26 -27.41 23.05 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.347 2.698 . . . . 0.0 115.139 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m -57.83 -20.47 36.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 120.108 1.322 . . . . 0.0 113.324 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 11.33 22.71 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.404 1.082 . . . . 0.0 111.352 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.9 mtm -122.34 -43.65 2.29 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.09 -37.92 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.11 -58.55 14.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 118.203 -0.904 . . . . 0.0 112.332 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.75 -39.22 75.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.111 1.874 . . . . 0.0 111.919 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' A' ' 93' ' ' LYS . 2.2 t -57.01 -39.98 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.781 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.97 -42.82 80.28 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.989 0.813 . . . . 0.0 110.491 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.9 -36.88 85.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.558 0.617 . . . . 0.0 110.009 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -67.66 -36.91 81.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.301 -0.874 . . . . 0.0 110.642 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.93 -44.61 92.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.426 1.09 . . . . 0.0 110.231 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.66 -34.74 72.35 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.565 -0.71 . . . . 0.0 111.425 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -62.14 -27.02 68.64 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.451 -0.78 . . . . 0.0 111.657 171.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -90.29 -42.99 10.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.641 1.176 . . . . 0.0 111.291 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.1 ptm -144.2 18.98 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.704 0.802 . . . . 0.0 112.126 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.15 -7.0 15.27 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 121.311 -0.868 . . . . 0.0 114.309 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.35 -22.78 67.07 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.711 0.804 . . . . 0.0 111.054 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 -10.66 7.29 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.852 1.261 . . . . 0.0 112.779 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.9 tp -127.48 150.53 49.62 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.497 1.119 . . . . 0.0 112.092 -168.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -124.27 150.03 45.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.38 143.0 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.1 121.43 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 118.79 0.723 . . . . 0.0 109.215 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.9 mmmm -85.91 155.54 20.88 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mm -128.22 116.13 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 101.759 -3.422 . . . . 0.0 101.759 168.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.29 107.7 9.88 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.315 33.2 m -79.6 48.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -154.87 -45.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.34 1.456 . . . . 0.0 108.527 167.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.3 -35.84 30.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.175 0.99 . . . . 0.0 110.91 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -133.89 30.27 3.71 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.625 1.57 . . . . 0.0 110.514 -169.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -73.73 -5.84 43.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -56.05 -45.78 79.14 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.3 1.44 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.9 m -54.85 -42.62 72.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.335 0.654 . . . . 0.0 110.755 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.21 0.73 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -170.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.13 -44.2 14.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.103 0.858 . . . . 0.0 113.411 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.93 -44.99 87.67 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.265 1.033 . . . . 0.0 111.442 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -69.53 -26.71 64.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.743 0.701 . . . . 0.0 110.369 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.81 65.98 0.83 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 107.259 -2.336 . . . . 0.0 107.259 -173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.86 130.59 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 101.189 -3.634 . . . . 0.0 101.189 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.475 ' CE ' HD13 ' B' ' 72' ' ' LEU . 29.8 mtm -148.78 21.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -138.96 163.08 33.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.814 1.245 . . . . 0.0 113.603 -167.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.17 135.57 27.4 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.266 -0.874 . . . . 0.0 109.497 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -85.98 125.05 8.53 Favored 'Cis proline' 0 N--CA 1.45 -1.042 0 N-CA-C 106.001 -2.346 . . . . 0.0 106.001 -11.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.0 m -88.9 148.14 23.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.26 119.69 10.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.9 mt -118.2 109.63 16.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.86 138.42 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.24 157.09 41.84 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.419 1.088 . . . . 0.0 111.251 -172.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -138.11 127.75 25.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.71 1.204 . . . . 0.0 107.79 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 36.48 37.99 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.252 2.621 . . . . 0.0 115.507 168.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.94 -30.67 2.35 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.44 158.9 44.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -165.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.43 134.88 28.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.393 1.077 . . . . 0.0 108.721 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -122.42 -24.88 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.837 1.655 . . . . 0.0 111.321 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -144.78 153.35 41.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.95 146.96 33.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -173.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.6 m -155.1 153.82 31.45 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.519 1.128 . . . . 0.0 108.631 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.68 69.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.01 159.46 15.93 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 121.717 -0.614 . . . . 0.0 111.779 -173.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.48 145.5 56.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.275 0.63 . . . . 0.0 110.906 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.51 141.31 35.13 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.031 1.332 . . . . 0.0 107.744 170.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.31 169.46 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.589 2.193 . . . . 0.0 110.558 169.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HA ' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -53.7 -45.01 70.27 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.416 1.086 . . . . 0.0 111.971 -173.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.27 -41.97 84.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.201 0.201 . . . . 0.0 110.693 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.73 76.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.093 -0.38 . . . . 0.0 110.843 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -52.89 57.47 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.454 0.645 . . . . 0.0 109.895 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -62.83 -36.99 85.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.82 -46.7 88.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.729 0.695 . . . . 0.0 111.428 173.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.85 -28.82 62.21 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.829 1.252 . . . . 0.0 111.912 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.2 -42.13 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -57.34 -27.96 62.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.047 -1.033 . . . . 0.0 112.103 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -59.57 -22.54 61.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -131.57 -16.37 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 169.212 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.98 21.34 0.43 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -169.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.15 128.78 8.54 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 103.857 -2.645 . . . . 0.0 103.857 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -148.39 144.43 27.48 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 130.254 3.421 . . . . 0.0 104.605 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 mt -122.27 142.02 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 tt -141.19 140.95 31.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -121.93 139.91 53.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -169.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -121.96 132.9 54.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -138.9 116.84 11.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.661 -168.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.32 150.26 43.77 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.106 0.963 . . . . 0.0 111.005 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 83.9 m -45.05 106.28 0.07 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.843 1.657 . . . . 0.0 111.352 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.442 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 53.33 39.33 58.87 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.106 1.336 . . . . 0.0 111.188 175.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -39.09 125.41 1.56 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 38.9 p -141.64 -3.53 1.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.175 168.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.01 -80.42 0.38 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.29 1.036 . . . . 0.0 113.06 -169.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -52.43 -42.74 64.37 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.565 1.53 . . . . 0.0 113.062 -169.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -76.05 -25.14 55.33 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.665 1.121 . . . . 0.0 111.948 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.423 HE22 ' C ' ' B' ' 63' ' ' THR . 52.5 mm-40 -62.0 -47.66 83.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.708 1.14 . . . . 0.0 109.588 169.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 14.1 mtp -66.91 -43.99 81.91 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.97 93.71 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.705 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.0 -33.68 75.08 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.756 1.162 . . . . 0.0 110.96 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.61 -49.08 58.24 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -56.44 -41.04 75.77 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.182 0.993 . . . . 0.0 111.233 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.94 87.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -66.19 -19.85 65.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.461 -169.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -78.09 -16.26 58.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.608 1.094 . . . . 0.0 113.505 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.23 -16.42 3.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.86 -116.52 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.73 -167.93 38.07 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 119.161 0.892 . . . . 0.0 110.928 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.54 -20.71 63.55 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.219 1.008 . . . . 0.0 111.348 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -54.28 -24.3 18.39 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.133 2.173 . . . . 0.0 112.546 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -123.72 156.85 35.22 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.355 1.062 . . . . 0.0 110.708 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -125.84 139.56 53.39 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -131.98 140.25 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.58 157.53 46.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.531 0.732 . . . . 0.0 109.901 -175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 10.0 p -135.24 131.78 37.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.185 1.394 . . . . 0.0 109.194 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.31 173.75 14.12 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.43 -175.85 46.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.006 1.765 . . . . 0.0 110.405 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.442 HG22 ' H ' ' B' ' 12' ' ' GLY . 3.0 tt -52.43 -53.64 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 113.562 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.83 25.9 4.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.564 1.546 . . . . 0.0 109.078 -174.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.63 147.37 49.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.396 1.879 . . . . 0.0 112.245 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 29.7 p80 174.02 -17.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.579 2.352 . . . . 0.0 110.885 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.26 53.65 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-O 121.871 0.706 . . . . 0.0 113.018 -169.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.78 86.64 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 170.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -59.21 132.97 87.77 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.22 -22.52 57.43 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.757 1.638 . . . . 0.0 112.428 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -56.07 -56.08 25.2 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.4 75.06 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.288 0.949 . . . . 0.0 110.423 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.89 -55.56 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -56.64 -45.93 81.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.604 0.762 . . . . 0.0 110.852 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.85 66.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.97 2.108 . . . . 0.0 111.331 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.3 mmm -89.03 -31.95 17.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.284 0.634 . . . . 0.0 110.27 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -61.63 -25.86 67.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.926 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.68 -27.99 66.9 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.171 1.351 . . . . 0.0 111.409 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.66 15.61 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.014 1.326 . . . . 0.0 110.971 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.39 93.38 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.693 -1.059 . . . . 0.0 112.964 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 82.1 mt -113.9 109.18 27.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.99 138.44 52.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 pt -134.82 16.07 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.856 0.862 . . . . 0.0 111.309 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 m -60.91 -13.79 18.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.246 0.93 . . . . 0.0 113.187 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -94.08 -13.98 26.26 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.9 1.68 . . . . 0.0 113.097 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.09 166.49 11.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.549 -175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.423 ' C ' HE22 ' B' ' 18' ' ' GLN . 13.9 t -156.25 -179.17 7.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.5 1.92 . . . . 0.0 107.458 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 64.0 m -143.41 -174.41 4.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.74 1.616 . . . . 0.0 107.675 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -150.98 171.47 17.23 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.022 1.329 . . . . 0.0 107.596 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.9 pt -62.66 170.71 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 119.071 0.851 . . . . 0.0 110.821 170.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.81 132.16 6.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -141.95 98.01 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.241 1.019 . . . . 0.0 108.419 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.8 m -47.15 -28.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.544 1.938 . . . . 0.0 114.451 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.08 -22.02 61.42 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 119.496 1.044 . . . . 0.0 110.515 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.79 -40.57 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.693 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.475 HD13 ' CE ' ' A' ' 70' ' ' MET . 7.1 tt -61.57 -54.48 42.45 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.741 1.155 . . . . 0.0 109.47 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -22.89 67.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.025 0.829 . . . . 0.0 111.69 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.4 -12.58 54.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.738 1.215 . . . . 0.0 113.132 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.85 167.01 12.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.278 0.945 . . . . 0.0 110.544 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.38 -35.35 16.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.733 169.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.538 HD13 ' HD2' ' B' ' 97' ' ' LYS . 23.5 tp -146.38 136.05 23.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.113 1.365 . . . . 0.0 109.814 -172.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.454 HG21 HD21 ' B' ' 72' ' ' LEU . 16.0 t -105.06 105.22 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 169.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.5 109.4 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 2.6 m -68.49 132.12 46.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 39.1 mt -118.94 151.03 38.9 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.7 m 78.34 -33.11 0.16 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 128.837 2.855 . . . . 0.0 111.623 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.83 145.86 18.67 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 105.198 -3.161 . . . . 0.0 105.198 -169.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -67.4 126.29 28.82 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -128.24 -29.14 2.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.259 1.024 . . . . 0.0 110.565 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.61 21.88 0.28 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.916 1.286 . . . . 0.0 110.031 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -85.13 18.72 2.45 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.872 -1.143 . . . . 0.0 113.795 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . 0.305 0.2 OUTLIER 53.32 35.21 19.65 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.102 1.761 . . . . 0.0 113.49 -169.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.9 m 37.36 52.6 2.66 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.642 2.377 . . . . 0.0 114.212 172.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.49 130.69 37.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.211 -169.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.41 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.87 0.48 50.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 116.636 -1.649 . . . . 0.0 115.14 -175.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.9 p 46.43 89.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.948 1.299 . . . . 0.0 113.436 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -56.98 143.48 92.33 Favored 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 123.132 2.554 . . . . 0.0 110.424 -169.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.19 4.23 0.79 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.092 3.861 . . . . 0.0 116.21 -169.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -67.8 -7.41 27.49 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.397 -0.814 . . . . 0.0 111.941 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -135.84 150.12 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.085 0.954 . . . . 0.0 111.055 -168.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.538 ' HD2' HD13 ' B' ' 77' ' ' LEU . 4.0 tmmm? -75.58 158.07 32.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -143.63 147.06 33.78 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.74 -1.225 . . . . 0.0 109.17 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.39 151.4 30.77 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -100.45 131.86 46.14 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.207 1.003 . . . . 0.0 109.627 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -115.88 10.75 15.34 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.04 0.936 . . . . 0.0 111.372 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -169.57 162.42 35.93 Favored Glycine 0 C--N 1.34 0.784 0 O-C-N 121.299 -0.876 . . . . 0.0 111.784 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -144.45 34.76 1.18 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.51 2.324 . . . . 0.0 107.985 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -151.15 139.27 20.14 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.035 2.134 . . . . 0.0 105.76 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -136.68 125.3 15.15 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 120.072 1.305 . . . . 0.0 111.216 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -82.9 -22.63 4.18 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.566 2.844 . . . . 0.0 113.684 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.93 -16.77 63.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 118.44 0.564 . . . . 0.0 109.826 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -92.62 -64.61 1.08 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' B' ' 119' ' ' PHE . . . 46.6 -176.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.147 1.779 . . . . 0.0 114.451 -170.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -40.04 77.08 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.09 -20.41 5.05 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 116.045 1.178 . . . . 0.0 116.045 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.2 p -70.65 166.7 20.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.632 0.716 . . . . 0.0 109.396 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -41.63 90.49 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.266 0.555 . . . . 0.0 110.937 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.12 -41.18 62.01 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.668 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.27 -31.85 58.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.569 1.531 . . . . 0.0 109.895 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -58.08 -58.4 8.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -58.98 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.276 0.489 . . . . 0.0 110.605 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.19 97.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.237 -0.914 . . . . 0.0 111.632 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 6.9 m-85 -66.57 -41.0 89.24 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.446 -0.787 . . . . 0.0 109.905 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -54.99 -52.91 61.65 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.289 0.95 . . . . 0.0 109.138 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -67.32 -45.82 75.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.74 0.816 . . . . 0.0 111.004 -173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 43.0 ttp-105 -62.07 -45.64 92.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.64 -43.19 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.741 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -64.45 -35.43 80.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.32 1.418 . . . . 0.0 111.009 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.46 -45.04 92.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.963 0.347 . . . . 0.0 111.424 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -59.45 -50.7 72.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.643 0.777 . . . . 0.0 110.195 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.7 -52.66 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.782 1.233 . . . . 0.0 109.342 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.05 -41.84 98.38 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 118.971 -0.905 . . . . 0.0 111.721 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -59.3 -46.53 88.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.297 1.049 . . . . 0.0 110.865 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -66.48 -37.87 86.06 Favored 'General case' 0 C--N 1.335 -0.049 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.499 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' B' ' 131' ' ' LEU . 2.4 mm? -64.67 -42.44 95.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.892 1.224 . . . . 0.0 110.912 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.53 -43.78 88.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.335 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.27 -40.06 89.04 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 117.361 -1.304 . . . . 0.0 110.654 171.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.35 -39.43 87.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 121.893 2.133 . . . . 0.0 111.29 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.73 70.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.153 0.581 . . . . 0.0 112.248 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.03 -44.73 9.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.581 1.552 . . . . 0.0 111.319 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.3 p -88.39 -24.39 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.291 1.836 . . . . 0.0 110.632 -169.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 49.11 51.14 26.27 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -169.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 125.246 1.418 . . . . 0.0 112.379 -172.65 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.37 161.14 0.08 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.496 2.318 . . . . 0.0 112.842 -170.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.5 109.6 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.4 t -80.86 167.15 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.827 1.651 . . . . 0.0 107.71 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -125.7 118.18 25.07 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.143 0.977 . . . . 0.0 108.411 170.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.461 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -75.98 174.0 10.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.299 1.439 . . . . 0.0 110.015 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -156.3 -175.87 5.66 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.306 1.442 . . . . 0.0 107.51 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -31.45 -40.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 130.794 3.638 . . . . 0.0 117.101 -169.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.23 -29.58 2.02 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.841 1.256 . . . . 0.0 111.033 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 m -59.23 -22.56 61.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.731 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -48.58 -51.77 26.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.164 1.347 . . . . 0.0 110.521 170.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 m -64.89 -45.01 87.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.23 0.468 . . . . 0.0 109.83 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.44 -36.73 83.35 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 122.34 -0.225 . . . . 0.0 110.884 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -76.77 -13.83 59.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.722 1.209 . . . . 0.0 112.471 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.5 p -119.8 -2.81 10.31 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.66 1.118 . . . . 0.0 112.504 -170.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.3 m -71.73 -10.89 60.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.18 147.66 38.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.562 0.745 . . . . 0.0 109.809 -175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.93 -167.56 45.59 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.49 1.043 . . . . 0.0 111.611 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 104' ' ' LEU . 28.5 t -102.58 122.25 54.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 172.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.03 115.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -81.07 140.5 35.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.0 44.18 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -141.6 148.2 38.86 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.923 1.289 . . . . 0.0 109.001 -171.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -130.64 115.23 16.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.55 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.5 p-90 -133.7 156.15 48.46 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.603 1.561 . . . . 0.0 107.455 -171.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -176.2 167.88 1.5 Allowed Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.118 0.967 . . . . 0.0 110.905 169.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.05 -18.0 2.82 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.205 3.27 . . . . 0.0 116.407 172.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -57.77 -21.89 44.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.333 1.424 . . . . 0.0 114.174 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.73 158.08 44.25 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.672 1.124 . . . . 0.0 112.602 -171.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.6 -49.78 28.79 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.212 -1.327 . . . . 0.0 111.896 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -49.2 -27.29 12.47 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.819 3.013 . . . . 0.0 115.762 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -57.55 -23.23 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.45 1.477 . . . . 0.0 113.409 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -105.71 9.88 32.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.097 0.959 . . . . 0.0 112.035 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.6 mtm -120.46 -42.35 2.55 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.09 0.956 . . . . 0.0 109.586 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.98 -38.01 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.75 -58.65 13.37 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.187 -0.911 . . . . 0.0 112.259 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.01 -39.72 68.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.093 1.862 . . . . 0.0 111.856 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.32 -41.9 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 118.231 0.469 . . . . 0.0 110.578 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.09 -42.52 80.24 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.554 0.615 . . . . 0.0 110.573 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.95 -39.81 94.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.733 0.697 . . . . 0.0 109.669 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -68.52 -24.21 64.63 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.102 -0.999 . . . . 0.0 112.11 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.444 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 42.0 tp -77.79 -45.61 23.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.648 1.179 . . . . 0.0 109.837 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HB2' HD12 ' A' ' 52' ' ' ILE . 25.3 t70 -69.77 -34.83 74.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.293 0.497 . . . . 0.0 110.964 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -59.36 -26.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 172.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -96.61 -46.33 6.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.173 0.589 . . . . 0.0 111.433 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.6 ptm -134.49 15.44 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 112.228 -169.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.04 16.9 Favored Glycine 0 CA--C 1.52 0.382 0 O-C-N 121.19 -0.944 . . . . 0.0 114.212 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.83 -24.08 64.33 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.836 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -25.92 7.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.59 1.156 . . . . 0.0 111.494 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.0 tp -112.62 151.67 29.83 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.324 1.45 . . . . 0.0 110.584 -169.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.77 148.53 46.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 43' ' ' ASP . 75.1 mt -131.66 137.09 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 14.3 t -137.17 113.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.4 mtpt -88.36 162.43 16.56 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.126 -0.984 . . . . 0.0 110.182 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mm -131.12 124.5 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -84.32 109.43 17.81 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.848 HG21 HD11 ' A' ' 72' ' ' ILE . 32.5 m -79.7 39.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -145.46 -37.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.939 -1.101 . . . . 0.0 109.424 168.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -74.89 -52.02 12.37 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.919 1.288 . . . . 0.0 109.842 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.14 46.68 1.93 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.364 1.066 . . . . 0.0 111.235 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.4 ' CD ' ' HD3' ' B' ' 94' ' ' PRO . 10.7 pt20 -72.12 -3.05 20.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.899 1.28 . . . . 0.0 113.138 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -56.38 -42.76 78.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.026 1.33 . . . . 0.0 110.894 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -54.53 -43.22 71.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.021 0.828 . . . . 0.0 111.371 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.96 -57.77 4.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.096 0.958 . . . . 0.0 108.757 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.92 -43.0 39.4 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.908 0.766 . . . . 0.0 113.593 170.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -64.56 -42.11 95.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.506 1.153 . . . . 0.0 111.115 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -70.17 -30.69 67.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.371 0.532 . . . . 0.0 110.146 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.34 67.5 1.2 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -171.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.28 -62.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.496 ' HG3' HD12 ' B' ' 67' ' ' ILE 0.265 6.7 ptm 49.28 10.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.135 2.974 . . . . 0.0 115.183 178.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.8 p -140.89 162.98 34.17 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.565 1.546 . . . . 0.0 112.598 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.848 HD11 HG21 ' A' ' 57' ' ' VAL . 28.6 mm -142.7 148.3 45.8 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.162 0.985 . . . . 0.0 108.682 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -78.17 137.91 48.6 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 N-CA-C 106.477 -2.163 . . . . 0.0 106.477 -11.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -115.16 147.17 40.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -130.38 124.21 31.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.7 mt -121.56 112.48 18.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.2 t -104.75 128.49 58.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.31 156.9 41.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.239 1.016 . . . . 0.0 110.367 -169.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -146.02 139.25 25.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.73 29.57 0.7 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.318 1.847 . . . . 0.0 113.509 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.84 54.84 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -132.6 147.83 52.35 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.665 1.233 . . . . 0.0 111.21 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.76 138.14 22.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.95 -18.54 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.304 1.441 . . . . 0.0 111.241 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -141.05 157.36 45.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.227 0.922 . . . . 0.0 110.25 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.37 142.22 22.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 m -155.09 151.69 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.95 88.37 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 169.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.48 158.79 11.43 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -67.5 149.88 49.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.99 0.516 . . . . 0.0 110.501 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.88 135.8 14.76 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 169.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.69 169.19 16.51 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.315 2.01 . . . . 0.0 110.412 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -45.72 -48.22 15.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.894 1.678 . . . . 0.0 112.348 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.93 -43.66 71.21 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.259 0.481 . . . . 0.0 111.275 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.54 97.15 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.124 -0.36 . . . . 0.0 110.332 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -52.15 66.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.258 0.623 . . . . 0.0 109.711 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.53 -39.83 94.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.631 -0.699 . . . . 0.0 109.413 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.65 -45.77 92.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.807 0.73 . . . . 0.0 110.964 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.8 -37.55 76.6 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 125.277 1.431 . . . . 0.0 111.233 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.34 -37.09 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.824 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -57.98 -33.73 69.22 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.641 1.11 . . . . 0.0 111.374 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.41 -7.44 37.66 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -125.62 -23.55 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.867 1.267 . . . . 0.0 112.481 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.435 ' HA ' HG21 ' A' ' 19' ' ' VAL . 18.5 tp . . . . . 0 C--O 1.248 1.014 0 C-N-CA 127.168 2.187 . . . . 0.0 108.847 170.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -141.43 161.07 38.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.874 0.87 . . . . 0.0 109.658 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.27 28.5 m120 65.32 117.73 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 129.906 3.283 . . . . 0.0 113.567 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -153.94 137.22 15.72 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.99 3.316 . . . . 0.0 103.402 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -114.19 141.48 30.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -169.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.49 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.9 152.8 49.83 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.881 0.872 . . . . 0.0 110.429 -169.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -119.75 135.17 54.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.7 tp -128.99 119.01 23.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -144.35 163.26 34.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.051 0.453 . . . . 0.0 111.186 -168.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 14.7 m -61.33 134.3 56.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.469 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 53.93 5.19 0.37 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 127.357 2.408 . . . . 0.0 118.587 169.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.319 1.9 t-20 12.98 71.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.424 2.69 . . . . 0.0 112.57 -169.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.5 p -135.33 -27.07 1.23 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.094 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.37 -68.0 0.78 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.332 0.969 . . . . 0.0 112.225 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.47 HH21 ' HB3' ' B' ' 107' ' ' ALA . 0.0 OUTLIER -46.34 -55.86 6.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.478 0.581 . . . . 0.0 112.176 -169.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -37.42 81.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.891 -171.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -53.88 -43.88 69.97 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.075 1.35 . . . . 0.0 109.837 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 10.5 mtp -70.04 -49.21 53.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 -40.51 96.99 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.888 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.87 -33.94 72.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.529 1.059 . . . . 0.0 110.775 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.01 71.5 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -55.85 -39.7 71.82 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.046 0.938 . . . . 0.0 111.394 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.62 75.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -174.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -23.99 67.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.402 -169.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.52 -18.16 60.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.02 -23.12 4.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.884 0.766 . . . . 0.0 112.697 -174.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.6 mt -83.19 -113.23 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.69 -170.33 36.59 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.93 -17.69 57.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.837 0.855 . . . . 0.0 111.615 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -56.17 -23.55 35.73 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.42 1.888 . . . . 0.0 111.843 169.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -120.92 161.75 21.04 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.283 1.433 . . . . 0.0 109.674 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -124.21 135.74 53.67 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 t -127.81 134.16 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -139.71 166.19 25.27 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.691 1.196 . . . . 0.0 108.786 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 68.6 m -143.35 150.73 39.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.588 0.755 . . . . 0.0 110.261 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' B' ' 67' ' ' ILE . . . -148.99 158.86 44.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.784 1.234 . . . . 0.0 110.366 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.07 -176.39 38.53 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.116 0.865 . . . . 0.0 110.941 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.469 HG22 ' H ' ' B' ' 12' ' ' GLY . 1.3 tt -53.69 -63.46 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 113.482 -169.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -141.28 33.49 1.7 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.766 2.426 . . . . 0.0 105.76 -172.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.13 146.73 52.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.636 2.774 . . . . 0.0 114.26 -169.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -177.24 17.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.899 1.68 . . . . 0.0 111.967 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.86 172.41 40.39 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 120.892 -1.13 . . . . 0.0 112.04 -169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.8 tp -148.68 75.5 1.31 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -56.89 131.29 79.26 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 125.023 1.329 . . . . 0.0 108.945 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.0 -22.28 62.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.966 1.777 . . . . 0.0 112.62 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -57.23 -54.67 44.17 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 119.616 1.098 . . . . 0.0 108.118 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.84 77.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.689 1.131 . . . . 0.0 110.538 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -57.77 -54.65 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -56.31 -46.08 79.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.006 0.922 . . . . 0.0 110.899 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -34.08 63.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.734 2.014 . . . . 0.0 111.673 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 76.0 mmm -92.11 -31.21 15.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.114 0.566 . . . . 0.0 110.481 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -61.65 -26.14 67.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.795 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -56.67 -31.57 64.56 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.961 1.255 . . . . 0.0 111.248 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.47 15.92 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.185 1.394 . . . . 0.0 110.852 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.51 37.55 93.83 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.908 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 81.8 mt -114.13 107.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.9 138.51 54.71 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 pt -133.42 13.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.624 0.77 . . . . 0.0 111.558 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -60.88 -14.34 21.49 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.925 0.784 . . . . 0.0 112.375 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -85.85 -16.05 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.809 1.644 . . . . 0.0 113.659 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.35 153.4 3.97 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.6 p -116.16 159.86 21.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.921 2.088 . . . . 0.0 108.953 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -148.34 153.71 38.98 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.803 1.241 . . . . 0.0 108.184 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -164.52 161.83 21.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.963 0.801 . . . . 0.0 111.462 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.4 pt -70.43 174.83 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.655 1.182 . . . . 0.0 111.466 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.575 ' HA ' ' HB1' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -52.07 134.0 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.632 0.773 . . . . 0.0 108.918 169.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.93 95.37 2.76 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.477 1.132 . . . . 0.0 109.237 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.44 -34.29 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.878 2.071 . . . . 0.0 113.744 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.81 -20.82 66.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.072 0.851 . . . . 0.0 112.185 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -122.57 -35.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.7 tt -66.21 -46.69 76.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.654 0.661 . . . . 0.0 110.633 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -30.42 71.58 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.847 0.749 . . . . 0.0 110.42 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -78.42 -18.24 55.24 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.662 1.185 . . . . 0.0 112.88 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 167.34 1.75 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.171 0.986 . . . . 0.0 111.961 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -90.19 -25.32 20.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.565 1.146 . . . . 0.0 111.286 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.34 128.68 11.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.994 0.918 . . . . 0.0 109.467 -173.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.09 100.6 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 125.872 1.669 . . . . 0.0 107.391 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.67 109.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -75.49 101.48 4.87 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.456 HD11 HG12 ' B' ' 127' ' ' ILE . 15.6 tp -80.98 -43.63 19.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.762 -0.586 . . . . 0.0 111.703 -168.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 16.5 m -73.36 174.11 8.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.269 0.627 . . . . 0.0 110.463 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.45 -82.04 1.21 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 106.996 -2.442 . . . . 0.0 106.996 169.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -164.86 132.63 3.19 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.496 1.518 . . . . 0.0 107.177 170.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.31 -51.58 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.99 0.916 . . . . 0.0 109.681 170.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.22 63.29 0.45 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -101.05 -1.23 34.73 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . 0.419 ' HE3' HG13 ' B' ' 39' ' ' ILE . 3.4 tttt 73.09 19.04 3.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.852 2.061 . . . . 0.0 113.335 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 p 30.63 55.68 0.79 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.304 2.242 . . . . 0.0 112.521 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.31 139.69 91.09 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.169 1.913 . . . . 0.0 109.795 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.62 4.1 52.14 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.1 p 40.1 98.54 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 128.919 2.888 . . . . 0.0 114.947 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -61.48 138.42 75.92 Favored 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 122.077 1.851 . . . . 0.0 108.856 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.4 ' HD3' ' CD ' ' A' ' 61' ' ' GLN . 57.6 Cg_endo -66.81 3.18 1.62 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.788 3.659 . . . . 0.0 116.398 -168.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -63.33 -13.9 44.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.041 0.837 . . . . 0.0 112.017 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.47 151.32 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.201 0.91 . . . . 0.0 111.483 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 154.73 40.53 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.04 1.736 . . . . 0.0 108.865 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -139.93 145.5 38.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -151.47 141.85 22.46 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.5 139.72 33.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.75 0.704 . . . . 0.0 111.088 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -123.57 -63.95 1.19 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.009 0.524 . . . . 0.0 112.126 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.83 -44.01 39.81 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 5.7 t80 55.86 27.55 11.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.27 1.828 . . . . 0.0 112.997 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -156.18 172.28 18.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.881 1.272 . . . . 0.0 109.032 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -135.12 113.34 11.41 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.166 1.387 . . . . 0.0 108.417 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.92 -21.01 21.55 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.866 3.044 . . . . 0.0 112.513 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.47 ' HB3' HH21 ' B' ' 16' ' ' ARG . . . -70.15 8.36 0.78 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.243 1.017 . . . . 0.0 112.385 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -117.79 13.93 14.22 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.254 1.421 . . . . 0.0 111.288 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.0 151.73 0.6 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.1 0.96 . . . . 0.0 110.984 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.24 -46.16 76.02 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 -172.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.86 -17.13 3.93 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.2 p -69.63 162.88 26.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.44 -41.06 88.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.397 0.617 . . . . 0.0 110.791 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -72.16 -43.9 63.91 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 117.079 -1.438 . . . . 0.0 109.851 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.19 -31.05 60.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 121.19 1.813 . . . . 0.0 110.024 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -59.37 -60.4 3.92 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.54 -39.13 86.77 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.04 97.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.36 -0.838 . . . . 0.0 112.317 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.64 -46.12 83.89 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -58.09 -50.15 74.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.19 -49.01 68.81 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.006 0.922 . . . . 0.0 110.69 -174.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -64.43 -44.09 92.29 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.894 0.77 . . . . 0.0 110.284 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.82 -42.09 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.176 -0.916 . . . . 0.0 109.985 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -34.82 78.91 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.435 1.47 . . . . 0.0 110.868 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.32 -44.57 83.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.87 0.468 . . . . 0.0 111.484 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.28 -48.31 78.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.456 HG12 HD11 ' B' ' 81' ' ' LEU . 17.1 mt -51.44 -53.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.944 1.297 . . . . 0.0 109.066 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.84 -41.71 99.66 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.252 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -63.4 -41.13 98.74 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.386 1.093 . . . . 0.0 111.765 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -71.72 -31.83 67.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.07 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' B' ' 131' ' ' LEU . 1.7 mm? -63.21 -48.08 79.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.354 0.979 . . . . 0.0 111.021 171.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -68.94 -37.64 78.98 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.989 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.62 -45.77 88.49 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.788 169.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -59.61 -38.41 81.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.423 1.919 . . . . 0.0 111.128 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.59 76.66 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.17 -44.75 12.66 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.594 1.557 . . . . 0.0 112.162 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.3 p -91.94 -23.0 19.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.687 1.995 . . . . 0.0 111.198 -169.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.03 54.15 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.306 0.955 . . . . 0.0 112.241 -169.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 127.761 2.425 . . . . 0.0 112.794 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.23 165.41 0.09 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.061 2.145 . . . . 0.0 113.32 -171.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.19 105.34 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.88 169.68 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 126.54 1.936 . . . . 0.0 108.614 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -123.14 114.81 20.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.721 1.608 . . . . 0.0 108.073 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -80.95 170.94 15.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.996 0.918 . . . . 0.0 109.861 174.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -156.41 174.5 15.32 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.37 1.868 . . . . 0.0 106.148 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -32.71 -40.65 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 129.277 3.031 . . . . 0.0 116.425 -169.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -125.06 -31.08 3.14 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.26 1.024 . . . . 0.0 111.651 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -62.42 -21.45 65.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.558 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -50.85 -51.4 51.64 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.796 1.18 . . . . 0.0 109.178 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -62.64 -44.58 95.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.068 -0.395 . . . . 0.0 110.012 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.74 87.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.429 -0.169 . . . . 0.0 110.906 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.75 -12.85 60.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.723 1.209 . . . . 0.0 112.89 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.8 p -118.46 -5.87 10.76 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.626 1.103 . . . . 0.0 112.591 -170.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.3 m -75.81 -7.38 54.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.131 0.972 . . . . 0.0 113.454 -175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.05 155.35 45.39 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.366 1.066 . . . . 0.0 109.057 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.15 -155.6 48.86 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.27 0.938 . . . . 0.0 111.052 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.05 131.4 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.8 t -138.89 122.02 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.15 -168.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.4 tp -94.35 94.74 8.46 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 107.891 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.41 148.61 28.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -141.37 146.68 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.665 1.586 . . . . 0.0 109.15 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -129.44 114.25 15.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.433 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.1 p-90 -124.63 161.75 25.59 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.148 1.379 . . . . 0.0 107.358 -174.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.34 159.34 23.82 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.5 -26.37 44.83 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.421 2.08 . . . . 0.0 114.281 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -51.29 -33.43 28.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -171.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -154.85 166.96 31.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.425 1.466 . . . . 0.0 114.075 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.61 -45.63 95.32 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.385 -1.786 . . . . 0.0 114.431 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.78 -29.65 43.45 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.383 2.592 . . . . 0.0 114.472 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 m -59.29 -18.74 40.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.139 1.336 . . . . 0.0 114.089 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -114.23 12.32 17.68 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.644 1.177 . . . . 0.0 111.162 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.1 mtm -121.52 -43.79 2.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.589 1.156 . . . . 0.0 109.238 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.68 -37.99 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.964 0.906 . . . . 0.0 109.226 169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.13 -57.88 19.78 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.045 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.7 -39.74 60.92 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.125 1.883 . . . . 0.0 112.064 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.17 -40.49 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.138 0.975 . . . . 0.0 110.85 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.5 mt -68.47 -44.37 74.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.947 0.794 . . . . 0.0 110.524 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.8 -37.82 88.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.489 0.586 . . . . 0.0 109.909 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -72.34 -19.97 61.56 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.148 -0.97 . . . . 0.0 111.831 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 tp -80.89 -44.67 17.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.64 1.176 . . . . 0.0 108.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.7 -34.12 73.47 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.764 -0.585 . . . . 0.0 111.063 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.79 -24.81 66.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.779 -0.576 . . . . 0.0 112.176 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -97.13 -44.3 7.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.796 0.838 . . . . 0.0 111.302 -173.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.3 ptm -139.49 14.33 2.56 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.857 0.863 . . . . 0.0 112.108 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.7 -5.11 22.49 Favored Glycine 0 C--O 1.227 -0.341 0 O-C-N 121.088 -1.007 . . . . 0.0 114.07 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.65 -24.25 66.98 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.442 0.697 . . . . 0.0 110.788 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 -27.07 8.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.391 1.076 . . . . 0.0 111.875 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -116.01 151.01 36.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.466 1.506 . . . . 0.0 112.059 -168.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -116.97 148.56 41.32 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.81 143.55 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 5.6 t -140.54 120.18 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 13.6 mmmm -87.31 154.13 20.93 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.651 0.66 . . . . 0.0 110.963 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.2 mm -127.98 115.18 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 102.933 -2.988 . . . . 0.0 102.933 168.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -88.26 87.87 7.45 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 m -42.61 -44.48 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.871 1.669 . . . . 0.0 113.669 -172.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.7 -23.9 65.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.489 1.495 . . . . 0.0 112.443 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -108.53 -30.24 8.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.588 1.555 . . . . 0.0 111.873 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -135.59 25.06 3.43 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -168.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.68 -5.79 13.13 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.585 -0.697 . . . . 0.0 112.645 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -54.84 -28.35 49.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.506 1.122 . . . . 0.0 111.162 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -74.83 -46.92 33.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 0.0 109.847 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.45 -71.07 0.2 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.357 1.463 . . . . 0.0 111.989 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.37 -41.08 11.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.622 1.105 . . . . 0.0 113.292 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.8 -44.58 89.47 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 118.457 -0.783 . . . . 0.0 111.571 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -65.08 -40.73 95.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.21 67.98 0.41 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.1 t -140.93 127.47 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.838 ' HG3' HD12 ' B' ' 67' ' ' ILE . 15.3 ptm -147.19 19.38 1.23 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.118 -0.468 . . . . 0.0 109.991 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' B' ' 90' ' ' PRO . 3.3 m -141.86 169.86 16.8 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.587 1.155 . . . . 0.0 110.573 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.6 mm -137.92 145.16 46.99 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.131 1.372 . . . . 0.0 107.563 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.15 134.59 30.76 Favored 'Cis proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 -10.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.0 m -102.16 146.68 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.98 137.47 54.6 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 125.964 1.706 . . . . 0.0 106.639 170.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -124.95 112.45 16.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.68 119.61 49.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.49 152.07 37.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.061 0.944 . . . . 0.0 109.421 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.7 136.13 38.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.2 t70 43.14 28.09 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.886 2.074 . . . . 0.0 114.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.52 17.68 48.34 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.579 1.085 . . . . 0.0 115.317 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -129.98 143.96 51.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.891 1.276 . . . . 0.0 110.058 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.0 139.4 19.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.95 -22.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 124.961 1.304 . . . . 0.0 111.187 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.64 161.01 39.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.723 0.773 . . . . 0.0 109.877 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -155.76 147.08 22.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.8 m -153.4 149.93 28.31 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.089 -1.007 . . . . 0.0 108.432 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.86 68.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.99 156.18 10.83 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.028 1.775 . . . . 0.0 109.521 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -73.22 163.99 27.32 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.489 0.715 . . . . 0.0 111.886 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.519 ' HE3' HD22 ' A' ' 99' ' ' LEU . 5.8 mtmm -149.89 135.95 10.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.638 1.575 . . . . 0.0 107.26 174.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -68.58 167.74 21.84 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.0 109.903 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -169.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.96 -43.94 70.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.271 0.487 . . . . 0.0 110.853 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.46 78.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.326 0.512 . . . . 0.0 110.403 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 96' ' ' LEU . 17.9 tp -70.7 -48.48 54.42 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.439 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -61.13 -37.68 83.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.2 -48.43 81.55 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.766 1.166 . . . . 0.0 110.827 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.519 HD22 ' HE3' ' A' ' 91' ' ' LYS . 11.6 tp -54.46 -42.22 70.4 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.715 1.206 . . . . 0.0 111.291 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.5 p -90.52 -37.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.195 -174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -61.01 -21.94 64.06 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.345 1.429 . . . . 0.0 112.594 -176.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -78.98 -5.92 55.04 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.128 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -126.4 -30.21 2.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.85 1.26 . . . . 0.0 111.993 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 2.4 tm? . . . . . 0 C--O 1.249 1.065 0 C-N-CA 125.978 1.711 . . . . 0.0 108.408 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.08 136.4 53.71 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.442 0.697 . . . . 0.0 109.448 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m120 69.85 127.36 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.967 2.507 . . . . 0.0 110.712 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -137.76 119.06 14.63 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 128.822 2.849 . . . . 0.0 103.98 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.61 139.6 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -169.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.08 149.28 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.906 1.282 . . . . 0.0 107.567 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.514 ' CD1' HD12 ' B' ' 72' ' ' LEU . 2.6 t80 -133.72 146.6 50.93 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.439 -168.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -114.2 140.53 48.48 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 31.8 tp -136.71 110.97 8.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.5 p -146.22 156.21 43.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -57.78 129.82 43.63 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.863 1.665 . . . . 0.0 111.477 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.422 ' H ' ' CG2' ' B' ' 39' ' ' ILE . . . 46.9 39.25 11.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.335 23.1 t-20 -37.07 99.85 0.02 OUTLIER 'General case' 0 C--N 1.345 0.39 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -166.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -144.47 -2.18 0.88 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.834 1.253 . . . . 0.0 111.626 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.93 -60.71 0.73 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -171.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -51.9 60.83 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.781 -1.2 . . . . 0.0 111.862 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 14.9 m -64.34 -34.27 77.75 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.142 0.177 . . . . 0.0 110.811 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -60.57 -50.73 72.37 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.141 1.776 . . . . 0.0 109.636 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 6.0 ptp -67.56 -40.09 84.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.72 94.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.838 0.855 . . . . 0.0 111.683 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -72.07 -30.27 64.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.332 0.969 . . . . 0.0 111.251 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.37 -50.59 54.99 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.443 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 26.6 m95 -55.93 -37.26 68.71 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.117 0.967 . . . . 0.0 111.585 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.67 56.02 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 122.599 0.36 . . . . 0.0 110.414 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -65.16 -24.36 67.37 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.85 -12.52 61.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.417 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 10.9 m-85 -130.39 -14.33 3.77 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.433 1.093 . . . . 0.0 113.876 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 25.4 mt -120.19 88.49 2.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.22 -166.86 0.57 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.78 1.657 . . . . 0.0 113.586 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -57.71 -17.0 12.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.623 1.169 . . . . 0.0 112.718 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.29 -24.38 7.34 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.702 1.601 . . . . 0.0 110.946 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -127.46 153.4 46.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.048 1.739 . . . . 0.0 110.061 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 135.21 47.16 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.04 152.98 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -169.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -145.99 164.06 33.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.438 1.095 . . . . 0.0 109.236 177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 67.5 m -142.22 126.08 17.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 108.958 -169.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.16 -177.85 6.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.499 0.591 . . . . 0.0 111.266 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 168.69 -167.75 40.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.422 ' CG2' ' H ' ' B' ' 12' ' ' GLY . 16.0 tt -70.11 154.65 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 31.8 58.13 0.33 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 130.016 3.326 . . . . 0.0 110.041 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.29 137.53 53.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.459 1.103 . . . . 0.0 111.896 -168.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 28.0 p80 174.99 -2.36 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.84 2.056 . . . . 0.0 111.568 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.09 174.97 54.3 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.923 0.783 . . . . 0.0 111.828 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 tp -139.33 83.83 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -55.39 128.93 68.44 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.58 1.152 . . . . 0.0 108.03 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.73 -21.67 57.42 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.735 1.623 . . . . 0.0 112.326 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -57.44 -54.21 49.37 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 168.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.93 80.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.089 1.313 . . . . 0.0 110.893 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.22 -54.11 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.35 -43.42 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.393 0.677 . . . . 0.0 110.757 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.09 -35.54 62.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.712 2.005 . . . . 0.0 110.339 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 75.1 mmm -93.75 -33.0 13.78 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.988 0.915 . . . . 0.0 111.831 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -59.84 -29.41 68.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.034 0.834 . . . . 0.0 110.901 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -60.32 -33.03 71.81 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.388 0.994 . . . . 0.0 111.63 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.87 13.95 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.609 1.164 . . . . 0.0 111.363 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.2 38.62 92.09 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.648 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.75 107.54 22.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.54 137.82 52.75 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.62 13.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 123.751 0.821 . . . . 0.0 111.773 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.6 m -60.4 -15.83 29.94 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.125 0.875 . . . . 0.0 112.543 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -81.6 -17.07 49.55 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.557 1.543 . . . . 0.0 113.556 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -54.52 154.04 5.14 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -125.51 158.42 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.184 2.194 . . . . 0.0 108.86 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 6.4 m -150.12 157.3 42.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.784 1.234 . . . . 0.0 108.354 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -162.39 168.84 21.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.581 1.152 . . . . 0.0 109.621 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 10.7 pt -69.21 172.23 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.296 1.038 . . . . 0.0 112.124 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.838 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.6 OUTLIER -44.24 131.31 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.448 0 C-N-CA 125.517 1.527 . . . . 0.0 108.413 175.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -142.69 94.25 2.62 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.863 0.84 . . . . 0.0 108.926 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -50.63 -24.01 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.259 1.423 . . . . 0.0 114.791 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 -29.43 66.35 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 120.661 1.573 . . . . 0.0 109.917 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.37 -42.08 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.172 171.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.521 HD13 ' CE ' ' A' ' 70' ' ' MET . 4.5 tt -63.12 -49.59 73.82 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.652 1.114 . . . . 0.0 110.578 -174.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -29.49 70.74 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.884 1.22 . . . . 0.0 110.138 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -77.12 -14.67 59.76 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.553 1.141 . . . . 0.0 112.867 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.17 163.64 19.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.176 0.988 . . . . 0.0 110.167 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.81 -36.94 16.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.828 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.425 HD23 ' CE ' ' B' ' 97' ' ' LYS . 2.8 tm? -145.33 139.89 27.35 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.415 0.686 . . . . 0.0 111.357 -168.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.4 t -118.54 109.64 27.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 126.252 1.821 . . . . 0.0 107.538 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.7 97.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 171.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -66.2 125.86 26.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 167.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -129.96 61.67 1.57 Allowed 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.958 0.903 . . . . 0.0 111.437 -167.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 51.4 m -155.42 -172.68 4.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.796 1.239 . . . . 0.0 108.299 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -147.66 42.09 0.9 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -141.31 153.43 45.16 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.842 1.257 . . . . 0.0 109.374 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.48 -11.34 54.48 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.58 -18.68 64.38 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.464 1.029 . . . . 0.0 112.986 -173.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -73.55 43.53 0.14 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.65 1.58 . . . . 0.0 113.882 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 52.54 -155.71 0.18 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.808 1.643 . . . . 0.0 110.706 -169.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.68 63.54 59.53 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.57 2.348 . . . . 0.0 105.421 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 37.4 Cg_exo -57.14 128.3 29.18 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.932 1.755 . . . . 0.0 110.572 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.49 3.11 48.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.149 -0.929 . . . . 0.0 113.036 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p 37.05 91.93 0.06 OUTLIER Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 128.283 2.633 . . . . 0.0 113.695 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -55.2 130.09 38.8 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 123.399 2.733 . . . . 0.0 107.939 -174.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.83 2.66 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.707 1 C-N-CA 126.129 4.553 . . . . 0.0 118.351 -168.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.9 -24.82 68.02 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 119.446 1.021 . . . . 0.0 109.87 169.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.03 153.53 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.39 1.076 . . . . 0.0 112.393 175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.425 ' CE ' HD23 ' B' ' 77' ' ' LEU . 4.6 tmmm? -93.38 154.72 17.8 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 167.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -152.94 146.08 24.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.532 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -156.11 154.78 31.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 168.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -104.77 140.22 38.41 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.885 1.274 . . . . 0.0 109.284 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -142.81 -1.17 1.13 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -169.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.12 -58.65 3.34 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.387 0.994 . . . . 0.0 110.939 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 55.78 14.83 1.42 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.264 1.825 . . . . 0.0 113.656 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -163.2 171.06 16.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.375 1.47 . . . . 0.0 107.822 -169.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -150.51 104.92 3.09 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.311 1.045 . . . . 0.0 108.984 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.45 -29.6 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.931 2.42 . . . . 0.0 114.301 -169.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.28 64.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.526 0.731 . . . . 0.0 111.026 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -83.67 -56.7 3.57 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . 0.437 ' HB3' ' HE3' ' B' ' 116' ' ' LYS . . . 44.29 -176.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.097 2.159 . . . . 0.0 115.233 -169.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.54 -40.46 73.4 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 169.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.1 -20.9 4.69 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 49.1 p -70.93 166.4 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.689 0.745 . . . . 0.0 109.385 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.95 -39.66 86.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.119 0.485 . . . . 0.0 111.042 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.4 pt-20 -75.65 -42.69 50.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 117.504 -1.236 . . . . 0.0 109.593 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.39 -30.14 60.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.513 1.506 . . . . 0.0 110.231 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' B' ' 109' ' ' ALA . 2.9 mmpt? -57.21 -59.25 5.39 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 169.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -61.47 -38.8 88.57 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.794 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.56 94.05 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.216 -0.928 . . . . 0.0 111.865 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' B' ' 109' ' ' ALA . 4.0 m-85 -64.63 -46.49 82.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.216 -0.421 . . . . 0.0 109.965 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -56.3 -49.62 73.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -62.54 -48.54 79.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.853 1.661 . . . . 0.0 110.128 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -60.22 -51.9 67.59 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.86 -41.67 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.61 -0.709 . . . . 0.0 109.427 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.443 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 3.7 tmm_? -59.62 -43.01 93.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.511 1.051 . . . . 0.0 111.777 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.8 -46.23 88.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.263 0.483 . . . . 0.0 110.928 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -70.73 -38.89 73.59 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.23 -0.294 . . . . 0.0 110.99 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.25 -45.74 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.36 1.064 . . . . 0.0 108.875 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.81 -42.7 86.03 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-O 119.165 -0.797 . . . . 0.0 111.682 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -56.97 -45.66 82.73 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.346 1.073 . . . . 0.0 110.988 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -61.34 -39.64 91.33 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.612 0.765 . . . . 0.0 110.44 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.4 mm? -77.01 -34.15 57.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 119.094 0.861 . . . . 0.0 112.589 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.9 ttmt -66.83 -39.17 87.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.751 0.705 . . . . 0.0 109.413 172.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -61.31 -35.22 76.77 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 117.296 -1.335 . . . . 0.0 110.077 169.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.4 -41.07 88.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 120.881 1.673 . . . . 0.0 109.814 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.64 70.47 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.81 0.844 . . . . 0.0 112.591 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -92.27 -36.55 13.16 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.378 1.471 . . . . 0.0 112.721 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 70.6 p -109.1 -11.81 14.89 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.962 1.705 . . . . 0.0 111.905 -169.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 63.75 23.63 67.41 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.034 1.302 . . . . 0.0 113.515 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.034 1.734 . . . . 0.0 106.848 -169.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 tpp . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.31 171.15 19.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.639 1.576 . . . . 0.0 107.571 170.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.2 93.82 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.73 171.29 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.148 1.779 . . . . 0.0 107.842 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.82 144.92 49.43 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.279 1.032 . . . . 0.0 109.174 172.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.439 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -116.25 169.94 8.91 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.257 1.823 . . . . 0.0 108.594 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -156.54 -173.79 4.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -38.67 -39.48 0.5 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.932 2.493 . . . . 0.0 115.811 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -129.01 -30.2 2.24 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.337 1.055 . . . . 0.0 111.505 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -60.77 -25.25 66.38 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.657 -0.687 . . . . 0.0 111.815 172.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -52.15 -56.55 13.8 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.064 0.847 . . . . 0.0 109.226 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -61.02 -44.16 97.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.89 -34.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.352 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -82.41 -12.91 57.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.573 1.149 . . . . 0.0 113.333 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.4 p -120.83 -7.92 9.48 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.096 1.316 . . . . 0.0 114.398 -168.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -78.71 -2.32 38.74 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -140.43 153.0 46.14 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.28 1.032 . . . . 0.0 109.237 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.14 -157.23 49.38 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.71 128.92 72.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.36 115.16 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.9 tt -78.93 139.06 38.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.62 141.56 51.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.54 142.09 48.03 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.372 1.469 . . . . 0.0 108.563 -173.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.5 116.42 21.07 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -135.02 154.23 51.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.95 1.3 . . . . 0.0 108.711 -170.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.1 161.49 18.46 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.51 0.724 . . . . 0.0 109.651 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.87 -14.83 8.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.498 2.799 . . . . 0.0 116.514 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -55.15 -24.21 25.34 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.4 p -155.94 169.6 24.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.771 1.168 . . . . 0.0 113.481 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.57 89.97 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.39 -1.783 . . . . 0.0 114.28 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -53.31 -28.46 43.18 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.381 2.591 . . . . 0.0 114.311 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -59.2 -16.83 22.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 119.898 1.226 . . . . 0.0 113.828 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -116.59 13.0 15.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.737 1.215 . . . . 0.0 111.525 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.0 mtm -122.91 -43.62 2.23 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.301 1.04 . . . . 0.0 109.415 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.09 -38.06 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -56.49 32.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.716 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.57 -38.68 80.88 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.87 1.713 . . . . 0.0 111.54 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.49 -38.11 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.9 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.52 -48.03 79.22 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 119.559 1.072 . . . . 0.0 109.979 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -66.57 -35.7 80.84 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.905 -0.497 . . . . 0.0 109.848 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -72.62 -15.33 61.73 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.74 1.616 . . . . 0.0 112.833 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.25 -44.6 10.14 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.477 1.111 . . . . 0.0 108.56 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.7 -37.98 76.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.298 -0.251 . . . . 0.0 111.082 -175.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -68.4 -9.85 51.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.948 -0.548 . . . . 0.0 112.15 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.0 -48.32 3.77 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.112 0.965 . . . . 0.0 110.967 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -132.35 16.11 4.52 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.822 0.849 . . . . 0.0 112.45 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.31 -3.54 19.23 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 121.175 -0.953 . . . . 0.0 114.134 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.28 -23.83 65.71 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 169.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.3 -18.81 9.81 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.191 0.996 . . . . 0.0 112.439 -175.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.9 tp -128.47 148.08 50.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.364 1.066 . . . . 0.0 111.413 -168.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -110.54 146.98 35.09 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.92 142.23 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 3.5 t -136.43 140.27 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -106.77 145.34 32.2 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 123.868 0.867 . . . . 0.0 110.281 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.02 122.78 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -85.47 111.21 19.77 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.261 33.8 m -82.48 41.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -148.49 -38.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.932 0.893 . . . . 0.0 109.415 168.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.86 -51.4 12.6 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.88 1.272 . . . . 0.0 109.862 176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.47 47.77 2.17 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.68 1.192 . . . . 0.0 110.088 -172.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -73.55 -1.75 19.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.861 1.265 . . . . 0.0 112.758 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -55.28 -44.47 75.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.243 1.417 . . . . 0.0 110.86 -170.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -57.92 -41.72 83.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.685 0.675 . . . . 0.0 111.152 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB1' ' CE ' ' B' ' 91' ' ' MET . . . -69.24 -61.81 1.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.455 1.102 . . . . 0.0 108.719 -171.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.86 -41.74 28.53 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.753 -1.026 . . . . 0.0 113.851 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -62.75 -44.35 96.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.432 1.616 . . . . 0.0 110.961 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -71.78 -11.78 60.98 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.196 0.453 . . . . 0.0 111.276 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.66 56.13 6.9 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 m -103.71 -46.41 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 117.976 0.888 . . . . 0.0 108.942 -169.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.3 mtm 52.73 15.23 0.5 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 127.574 2.35 . . . . 0.0 113.397 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 m -138.08 159.77 41.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.589 1.155 . . . . 0.0 110.945 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.46 143.77 42.46 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.07 129.91 20.09 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 N-CA-C 107.71 -1.689 . . . . 0.0 107.71 -10.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -98.04 145.36 26.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tp -137.01 126.57 25.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -124.82 110.45 14.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.99 120.22 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 171.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp -112.47 150.79 30.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.697 1.199 . . . . 0.0 109.298 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -150.77 124.75 9.26 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.09 27.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.5 2.72 . . . . 0.0 114.93 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.32 -24.01 3.26 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.606 -1.108 . . . . 0.0 115.378 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.48 159.04 43.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.032 1.416 . . . . 0.0 113.156 -168.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.15 133.62 30.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.59 -20.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.888 1.275 . . . . 0.0 111.04 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.76 157.7 44.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.235 1.014 . . . . 0.0 109.524 169.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.94 148.28 29.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -171.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -152.71 149.54 28.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 169.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.06 57.68 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.09 20.4 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.921 1.724 . . . . 0.0 110.622 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -66.63 157.2 33.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.995 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 mtmm -148.13 135.33 10.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -68.43 169.66 16.6 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.484 2.123 . . . . 0.0 110.412 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 -46.8 65.43 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.646 0.778 . . . . 0.0 112.034 -171.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.77 -42.13 77.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.849 0.093 . . . . 0.0 110.958 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.28 81.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.866 -0.521 . . . . 0.0 110.423 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.83 -47.67 71.28 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.19 -37.15 86.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.723 -0.655 . . . . 0.0 109.54 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.11 -46.63 86.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.675 0.67 . . . . 0.0 110.93 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 tp -56.02 -41.64 75.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.439 0.696 . . . . 0.0 111.093 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -83.15 -42.0 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.506 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 10.5 t30 -56.4 -35.53 67.88 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.523 1.129 . . . . 0.0 111.801 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -69.18 -7.67 38.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.36 -25.7 4.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.472 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 16.1 tp . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.606 1.962 . . . . 0.0 109.275 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.14 27.49 4.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.842 1.257 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -157.39 129.73 7.31 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.479 ' H ' ' HA ' ' B' ' 32' ' ' TRP . 95.4 mttt -118.87 114.3 22.39 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 129.333 3.053 . . . . 0.0 103.677 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -90.12 141.16 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.22 141.49 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -131.53 138.86 49.1 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -115.76 152.66 32.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.75 0.705 . . . . 0.0 109.305 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 mt -132.11 118.35 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.6 p -150.22 157.49 43.14 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.804 1.242 . . . . 0.0 109.402 169.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 31.3 m -53.6 123.97 13.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.313 1.045 . . . . 0.0 110.361 -174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.95 18.49 11.79 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.657 0.646 . . . . 0.0 113.312 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t30 43.05 47.68 5.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.189 1.796 . . . . 0.0 112.691 -169.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -74.77 -157.35 0.06 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.82 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . -33.92 -63.3 0.27 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.55 2.74 . . . . 0.0 116.82 -168.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -57.99 -47.23 83.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 0.896 . . . . 0.0 111.611 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m -60.51 -49.4 77.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.718 0.69 . . . . 0.0 111.681 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -57.14 -48.8 77.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.317 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.4 ttm -66.81 -42.93 85.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.551 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.93 84.21 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.923 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.16 -28.93 57.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.615 1.098 . . . . 0.0 111.179 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 -43.86 48.44 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -56.1 -41.72 75.65 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.18 0.99 . . . . 0.0 111.117 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.45 -50.58 70.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -63.39 -21.76 66.48 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 118.079 -0.962 . . . . 0.0 113.277 -169.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.37 -16.45 63.93 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.612 1.096 . . . . 0.0 113.824 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.6 -39.79 0.57 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.896 1.226 . . . . 0.0 113.107 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.427 ' HG ' ' CG ' ' B' ' 32' ' ' TRP . 4.3 tp -77.45 75.6 4.0 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.534 2.734 . . . . 0.0 105.081 169.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.64 -166.9 1.86 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.85 2.167 . . . . 0.0 114.767 -169.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -56.93 -20.61 24.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.23 1.412 . . . . 0.0 112.968 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -55.65 -20.54 14.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 112.482 169.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . 0.479 ' HA ' ' H ' ' B' ' 4' ' ' LYS . 63.9 m95 -118.22 174.17 6.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.383 1.873 . . . . 0.0 109.789 -176.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 114.61 5.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.78 149.2 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -150.8 167.36 27.7 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 168.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -152.17 147.54 26.54 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 110.391 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.06 178.16 9.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.855 1.262 . . . . 0.0 111.216 -169.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.14 -175.63 42.75 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -47.75 -58.06 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.431 1.492 . . . . 0.0 114.541 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.07 31.56 4.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.573 1.549 . . . . 0.0 108.425 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.45 151.32 47.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.68 1.992 . . . . 0.0 115.17 -169.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 p80 162.8 47.2 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 130.906 3.683 . . . . 0.0 107.567 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.8 177.28 27.86 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 123.894 0.759 . . . . 0.0 112.017 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 36.3 tp -161.28 83.67 0.64 Allowed 'General case' 0 C--O 1.232 0.156 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -64.44 126.47 90.66 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.476 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.41 -24.98 75.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.214 1.943 . . . . 0.0 112.722 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.3 -51.17 70.9 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -59.22 -35.76 74.21 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.849 1.204 . . . . 0.0 111.214 -175.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.04 -53.76 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.58 -48.09 80.33 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 110.567 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.3 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.984 1.714 . . . . 0.0 111.855 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.72 -43.49 14.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.861 0.864 . . . . 0.0 110.051 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.24 -30.71 69.59 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.623 0.647 . . . . 0.0 110.832 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -27.59 62.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.874 1.27 . . . . 0.0 112.292 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.37 15.48 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.147 1.379 . . . . 0.0 111.158 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.66 72.66 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.179 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 63.0 mt -110.19 149.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -117.93 135.45 54.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.589 0.756 . . . . 0.0 108.993 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 pt -136.56 17.4 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.4 1.08 . . . . 0.0 111.048 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 7.3 m -67.23 13.46 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -169.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -137.75 -4.56 1.78 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.235 2.614 . . . . 0.0 111.539 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -57.92 147.73 27.94 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.532 1.06 . . . . 0.0 111.324 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -126.89 168.95 13.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.61 1.964 . . . . 0.0 109.184 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 7.0 p -155.03 -174.45 4.99 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.172 0.989 . . . . 0.0 108.442 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -159.23 168.51 26.3 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.559 1.543 . . . . 0.0 107.933 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 32.7 pt -60.26 164.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.464 0.705 . . . . 0.0 111.304 173.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -48.22 127.04 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -135.83 99.17 4.1 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.67 1.224 . . . . 0.0 109.194 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -42.68 -31.68 0.49 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.731 2.413 . . . . 0.0 114.559 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.07 -17.67 63.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.243 0.928 . . . . 0.0 112.212 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.33 -38.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.345 1.058 . . . . 0.0 109.04 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.433 HD23 ' C ' ' B' ' 72' ' ' LEU . 7.9 tt -61.77 -56.56 18.22 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.02 1.282 . . . . 0.0 109.332 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -23.0 66.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.566 0.621 . . . . 0.0 111.279 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.41 -24.76 36.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.025 1.73 . . . . 0.0 112.525 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.55 172.03 2.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.481 1.513 . . . . 0.0 112.149 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.92 -36.93 13.85 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.67 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' B' ' 97' ' ' LYS . 14.4 tp -143.64 133.26 23.64 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 109.634 -171.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.38 115.15 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.16 107.82 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.1 m -75.53 88.06 2.67 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 167.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 48.01 1.16 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.949 1.7 . . . . 0.0 107.114 -169.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 2.8 p -148.1 170.13 18.46 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.725 1.21 . . . . 0.0 109.937 -169.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.78 43.81 0.74 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -145.92 118.31 8.46 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.68 -7.36 50.05 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -169.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.59 -13.44 61.01 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.64 50.15 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.327 1.451 . . . . 0.0 113.527 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 52.78 -147.53 0.47 Allowed 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.999 -1.063 . . . . 0.0 108.627 -169.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.48 55.53 1.98 Allowed Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 126.683 1.993 . . . . 0.0 106.1 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.7 135.03 50.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.181 1.254 . . . . 0.0 112.003 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.432 ' HG3' ' H ' ' B' ' 91' ' ' MET 0.255 0.0 OUTLIER -83.69 4.93 26.51 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.742 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p 39.91 84.88 0.17 Allowed Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 125.245 1.418 . . . . 0.0 113.063 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -53.57 138.97 67.03 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.201 2.601 . . . . 0.0 110.614 -169.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.95 8.6 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.716 1 C-N-CA 125.669 4.246 . . . . 0.0 117.225 -168.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.04 -5.13 20.0 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.218 -0.926 . . . . 0.0 111.608 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.9 149.88 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.655 1.182 . . . . 0.0 110.473 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.616 ' HD2' HD13 ' B' ' 77' ' ' LEU . 0.4 OUTLIER -75.85 155.75 35.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -142.2 146.99 35.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 120.713 -1.242 . . . . 0.0 108.507 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -139.4 151.46 46.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -133.9 115.93 15.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -152.64 1.73 0.31 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -171.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.17 -53.33 45.6 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.756 1.162 . . . . 0.0 111.123 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.8 t80 58.18 -12.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.405 2.682 . . . . 0.0 117.03 169.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -152.28 82.0 1.25 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.252 1.421 . . . . 0.0 108.497 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -77.05 129.6 77.94 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.646 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.08 -26.64 9.06 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.661 2.907 . . . . 0.0 112.909 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.73 11.85 0.45 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.601 1.092 . . . . 0.0 112.035 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -123.61 16.18 9.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.234 2.214 . . . . 0.0 111.14 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.06 153.12 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -67.63 140.81 56.87 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.51 58.28 4.99 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.268 -168.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -127.17 149.87 49.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.19 -40.32 46.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.698 1.599 . . . . 0.0 111.507 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.83 -41.06 60.6 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.916 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.15 -31.49 49.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.948 0.795 . . . . 0.0 109.8 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -57.64 -59.85 4.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 170.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -62.75 -39.83 95.36 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.665 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.6 84.2 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.684 0.794 . . . . 0.0 112.313 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -63.95 -47.74 79.29 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.46 -40.51 96.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.387 0.54 . . . . 0.0 110.399 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -64.34 -51.69 62.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.691 1.196 . . . . 0.0 109.627 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 42.2 ttp-105 -59.1 -46.12 89.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 68.1 t -68.75 -43.86 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 117.377 -1.297 . . . . 0.0 111.19 -175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.69 81.99 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.554 1.979 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.42 -45.7 89.75 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.58 -53.79 46.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.665 0.786 . . . . 0.0 110.354 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.69 -47.38 85.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.938 0.895 . . . . 0.0 109.765 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.96 -44.11 98.56 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -62.05 -43.66 98.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.049 0.925 . . . . 0.0 111.801 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -65.3 -45.93 82.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.421 0.555 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.67 -31.87 70.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.057 0.844 . . . . 0.0 111.198 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -65.87 -39.84 91.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.103 171.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -59.7 -38.37 81.39 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 117.075 -1.44 . . . . 0.0 111.155 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -60.26 -37.23 79.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.69 2.041 . . . . 0.0 109.928 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.36 79.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.374 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -81.75 -47.92 12.3 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.411 1.085 . . . . 0.0 111.672 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.1 p -82.0 -24.19 35.56 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.835 2.054 . . . . 0.0 112.526 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.94 24.17 62.4 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 C-N-CA 128.381 2.672 . . . . 0.0 112.226 -169.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.54 169.74 23.96 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.556 1.542 . . . . 0.0 107.581 171.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.76 96.53 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.36 166.27 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.148 1.379 . . . . 0.0 108.065 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -126.03 116.14 20.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.151 1.38 . . . . 0.0 108.088 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.14 173.95 10.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.861 1.264 . . . . 0.0 111.157 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -155.36 179.07 9.52 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.986 2.514 . . . . 0.0 105.544 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -48.33 -29.88 4.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.543 1.937 . . . . 0.0 115.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.79 -27.29 3.98 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.85 0.86 . . . . 0.0 112.394 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.3 m -59.86 -40.35 88.28 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.83 122.28 18.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 167.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m 118.9 -61.4 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.693 1 C-N-CA 132.034 4.133 . . . . 0.0 106.126 -169.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.32 93.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 110.361 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -80.03 -13.15 59.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.42 1.488 . . . . 0.0 112.225 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.0 p -120.24 -9.96 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -168.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -80.81 0.28 35.56 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.165 0.893 . . . . 0.0 113.299 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.1 150.87 47.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.997 0.817 . . . . 0.0 110.159 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.83 -152.55 51.74 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.22 131.66 69.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.73 114.37 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -169.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.4 tp -81.48 97.36 7.75 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 107.474 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.43 26.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -138.84 147.54 42.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.439 1.496 . . . . 0.0 109.299 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -128.49 110.96 12.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -171.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.534 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.0 p-90 -123.35 150.01 44.19 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -173.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.3 154.94 22.69 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.351 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.67 -20.76 22.65 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.981 2.454 . . . . 0.0 115.426 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -49.65 -28.81 6.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.761 2.024 . . . . 0.0 115.755 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -156.55 169.66 24.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.72 1.6 . . . . 0.0 113.463 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.6 -45.3 96.6 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.364 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -52.21 -29.63 38.45 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.533 2.666 . . . . 0.0 114.96 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.9 m -58.82 -20.99 55.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 120.32 1.418 . . . . 0.0 113.783 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -109.5 11.61 24.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.389 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.5 mtm -121.6 -43.85 2.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.385 1.074 . . . . 0.0 109.426 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -60.61 -35.62 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.003 0.921 . . . . 0.0 109.577 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.23 14.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.827 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.01 -38.59 77.15 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.018 1.812 . . . . 0.0 111.784 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.04 -41.57 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.169 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mp -66.37 -41.08 89.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.226 0.921 . . . . 0.0 110.987 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.98 -35.51 80.77 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.085 0.857 . . . . 0.0 110.063 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -71.2 -24.12 62.16 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.802 1.241 . . . . 0.0 112.152 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 3.4 tm? -81.55 -44.97 16.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.132 1.373 . . . . 0.0 108.735 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' HD13 ' A' ' 52' ' ' ILE . 25.6 t70 -66.11 -38.47 88.3 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.922 -0.486 . . . . 0.0 111.058 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.95 -5.02 31.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.479 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -105.31 -49.14 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.517 1.127 . . . . 0.0 111.038 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.4 ptm -130.38 15.12 5.55 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.235 0.614 . . . . 0.0 112.152 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -5.85 23.39 Favored Glycine 0 CA--C 1.521 0.455 0 O-C-N 121.223 -0.923 . . . . 0.0 113.453 170.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.51 -25.23 67.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.009 1.324 . . . . 0.0 110.668 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -25.36 6.23 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.284 1.034 . . . . 0.0 112.126 -175.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.1 tp -118.84 153.35 34.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.678 1.191 . . . . 0.0 112.428 -167.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -116.1 147.92 40.82 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.428 HD13 ' HB2' ' A' ' 43' ' ' ASP . 4.4 mp -123.95 144.8 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.63 143.12 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 22.4 mtpt -117.3 152.26 35.24 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.831 0.741 . . . . 0.0 110.417 175.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mm -115.5 115.17 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -80.0 76.93 6.72 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.904 1.282 . . . . 0.0 108.508 169.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 61' ' ' GLN . 32.7 t -31.83 -59.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 129.081 2.952 . . . . 0.0 114.264 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.71 -23.42 64.87 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 121.528 1.967 . . . . 0.0 112.788 -170.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.93 -32.12 10.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.412 1.485 . . . . 0.0 112.066 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -136.51 25.15 3.17 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.433 ' HB3' HG13 ' A' ' 57' ' ' VAL . 8.1 pt20 -70.08 -0.08 7.03 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.584 1.154 . . . . 0.0 112.851 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -50.61 -46.51 58.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.549 1.14 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -56.57 -43.71 80.26 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.676 0.79 . . . . 0.0 111.634 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.93 2.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.728 -169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.57 -43.57 28.53 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.911 1.243 . . . . 0.0 113.423 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -64.08 -41.59 97.27 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.442 1.121 . . . . 0.0 111.216 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -70.34 -35.92 73.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.61 0.641 . . . . 0.0 110.101 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.35 69.06 1.0 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.428 -2.269 . . . . 0.0 107.428 -169.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.87 -60.76 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.421 ' HG3' HD12 ' B' ' 67' ' ' ILE . 9.3 ptm 50.64 7.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.166 2.987 . . . . 0.0 115.158 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 p -142.97 165.22 27.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.667 1.587 . . . . 0.0 112.146 -171.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.0 mm -142.76 145.54 34.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.209 1.403 . . . . 0.0 107.336 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.16 133.98 26.92 Favored 'Cis proline' 0 N--CA 1.452 -0.914 0 N-CA-C 106.603 -2.114 . . . . 0.0 106.603 -11.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.2 m -114.19 142.28 46.45 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.79 137.48 53.36 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -124.37 105.37 9.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 169.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.5 t -88.82 112.85 24.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.78 151.87 21.17 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.719 0.808 . . . . 0.0 109.116 174.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -149.39 126.5 11.32 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 44.7 22.36 0.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.176 2.59 . . . . 0.0 115.097 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.32 -22.57 3.21 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.229 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.13 159.33 42.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.921 1.36 . . . . 0.0 112.679 -168.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.69 134.04 30.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.27 -18.34 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.092 1.357 . . . . 0.0 110.917 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -144.7 154.8 43.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.41 133.69 15.3 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 p -150.55 158.36 44.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.474 0.579 . . . . 0.0 109.926 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.22 71.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 122.387 1.089 . . . . 0.0 108.708 -169.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.34 157.22 12.15 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 121.287 -0.883 . . . . 0.0 111.422 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.85 148.78 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.995 0.518 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -142.56 131.03 11.63 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.36 167.94 17.4 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.809 1.673 . . . . 0.0 109.723 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 42' ' ' LEU . 17.9 tptm -46.24 -46.07 17.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.717 1.607 . . . . 0.0 112.468 -176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.86 -42.98 69.39 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.229 0.468 . . . . 0.0 111.461 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.36 -34.93 79.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.722 -0.612 . . . . 0.0 110.631 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -54.5 42.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.56 0.744 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.34 -38.75 92.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.626 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.49 -47.62 84.82 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.993 0.815 . . . . 0.0 110.884 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.61 -43.86 80.57 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.766 0.827 . . . . 0.0 110.693 -174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.72 -33.03 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.747 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 7.5 t30 -61.89 -26.92 68.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.653 1.115 . . . . 0.0 111.552 -175.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -22.91 35.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.13 0.972 . . . . 0.0 112.629 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -129.74 -22.02 3.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.736 0.814 . . . . 0.0 112.393 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 1.7 tm? . . . . . 0 C--O 1.248 1.012 0 C-N-CA 126.99 2.116 . . . . 0.0 108.543 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.76 136.69 45.53 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.251 6.5 m120 67.35 120.78 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 128.542 2.737 . . . . 0.0 111.417 -170.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -148.89 137.38 21.12 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 129.178 2.991 . . . . 0.0 104.145 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.67 139.93 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 109.159 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tt -137.61 143.29 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.429 ' CD1' HD23 ' B' ' 72' ' ' LEU . 24.1 t80 -138.08 142.95 40.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -169.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -115.8 144.36 44.11 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 mt -133.19 122.28 23.77 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 7.4 p -165.82 156.89 13.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.349 1.06 . . . . 0.0 109.673 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 56.0 m -52.24 118.61 3.64 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.33 1.052 . . . . 0.0 112.129 -169.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.58 3.26 2.1 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 124.892 1.37 . . . . 0.0 113.979 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 39.51 24.18 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.438 2.695 . . . . 0.0 114.54 -169.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 -40.08 77.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -132.36 -73.28 0.51 Allowed 'General case' 0 C--O 1.227 -0.08 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -168.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -32.83 68.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.641 -0.662 . . . . 0.0 112.377 -169.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -43.77 76.75 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.366 1.066 . . . . 0.0 110.379 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -55.75 -45.26 78.06 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 110.388 174.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 16.3 ttm -67.99 -46.42 71.36 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.829 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.23 87.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.31 0.644 . . . . 0.0 111.218 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.96 -28.65 57.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.268 0.94 . . . . 0.0 110.644 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.93 -44.53 46.18 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.434 ' HE1' ' HB2' ' B' ' 124' ' ' ARG . 23.1 m95 -54.49 -41.97 70.18 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.158 0.979 . . . . 0.0 110.887 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' B' ' 28' ' ' LEU . . . -61.33 -50.68 71.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -66.45 -21.5 66.2 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.387 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -66.31 -16.67 64.23 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.467 1.03 . . . . 0.0 113.025 173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.67 -4.49 4.14 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.587 1.155 . . . . 0.0 113.007 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.468 HD12 ' HB1' ' B' ' 24' ' ' ALA . 22.9 mt -121.01 89.75 3.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.51 -171.6 1.38 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.815 0.722 . . . . 0.0 111.962 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.46 -18.15 16.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.436 1.094 . . . . 0.0 112.893 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -54.07 -18.86 4.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.518 1.927 . . . . 0.0 112.655 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.26 158.22 44.72 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.817 1.247 . . . . 0.0 109.62 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -130.35 133.36 46.36 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.014 0.926 . . . . 0.0 108.572 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.72 142.96 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.669 1.587 . . . . 0.0 107.367 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.97 159.47 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 m -139.82 142.37 36.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.07 178.22 10.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.104 0.962 . . . . 0.0 109.839 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.11 -177.71 47.67 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 tt -44.21 -57.64 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.676 1.99 . . . . 0.0 114.154 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -130.98 29.59 4.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.335 1.454 . . . . 0.0 108.446 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.3 42.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.46 1.904 . . . . 0.0 113.964 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 75.7 t60 141.17 104.43 0.0 OUTLIER 'General case' 0 C--O 1.235 0.34 0 C-N-CA 130.656 3.582 . . . . 0.0 104.361 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.94 48.19 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -171.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -163.19 94.68 0.83 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.29 1.836 . . . . 0.0 106.67 169.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -68.99 126.55 92.88 Favored Pre-proline 0 C--O 1.239 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.64 -20.87 60.11 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.99 1.794 . . . . 0.0 112.846 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.405 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -62.37 -37.23 84.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.508 1.049 . . . . 0.0 111.199 171.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.98 -34.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.33 -52.18 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -56.21 -46.58 79.4 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.88 0.764 . . . . 0.0 110.553 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.37 -32.46 64.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.007 0.923 . . . . 0.0 111.842 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.7 -38.56 25.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.695 0.798 . . . . 0.0 110.76 177.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -27.21 69.15 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.983 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.423 ' CD ' ' HE ' ' B' ' 124' ' ' ARG . 35.3 mt-10 -55.05 -32.67 62.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.478 1.035 . . . . 0.0 111.817 172.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.12 14.56 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.042 1.337 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.77 35.42 91.99 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.38 -1.233 . . . . 0.0 113.152 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.2 mt -104.95 145.16 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 170.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.66 136.0 53.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 29.0 pt -138.15 17.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 110.655 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -60.39 -13.91 15.9 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -91.72 -14.28 30.25 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.751 1.62 . . . . 0.0 113.237 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.21 151.31 23.28 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.539 1.161 . . . . 0.0 112.417 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.5 t -152.87 171.79 17.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.588 1.955 . . . . 0.0 107.105 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 13.0 m -153.69 -167.8 2.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.845 0.858 . . . . 0.0 111.028 -169.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -159.53 168.54 25.92 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.809 1.644 . . . . 0.0 109.562 -171.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.2 pt -66.52 172.5 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.111 1.364 . . . . 0.0 112.134 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.421 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.7 OUTLIER -48.31 132.86 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -143.98 100.17 3.52 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.309 1.052 . . . . 0.0 109.457 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.0 m -44.77 -32.32 1.5 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.108 2.163 . . . . 0.0 113.974 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.8 -17.3 64.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.128 0.876 . . . . 0.0 112.351 -174.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.16 -35.62 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.111 0.965 . . . . 0.0 108.842 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.429 HD23 ' CD1' ' B' ' 7' ' ' TYR . 2.2 tm? -63.01 -57.3 11.17 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.584 1.084 . . . . 0.0 109.98 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -22.36 66.93 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.44 0.564 . . . . 0.0 110.05 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.84 -24.38 44.44 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.064 2.146 . . . . 0.0 112.696 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.2 167.71 2.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.854 1.262 . . . . 0.0 111.347 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.9 -30.77 14.61 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.33 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.48 HD23 ' HE2' ' B' ' 97' ' ' LYS . 1.7 tm? -149.19 135.5 19.24 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.016 0.926 . . . . 0.0 110.505 -172.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.425 ' N ' HD22 ' B' ' 77' ' ' LEU . 10.7 t -107.02 108.02 24.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 127.494 2.318 . . . . 0.0 107.983 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.09 106.32 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 36.7 m -72.97 122.3 21.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 167.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 62.8 mt -97.2 132.92 42.49 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 13.4 m 72.59 -15.72 0.48 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.415 2.286 . . . . 0.0 113.293 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.61 34.95 91.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 107.834 -2.106 . . . . 0.0 107.834 -169.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.2 118.07 8.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.551 0.74 . . . . 0.0 111.645 -168.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.42 -20.48 63.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.383 0.673 . . . . 0.0 112.81 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.03 -8.53 59.11 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.821 0.737 . . . . 0.0 112.346 -175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.67 42.67 0.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.421 1.489 . . . . 0.0 112.075 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm 61.27 -149.79 0.4 Allowed 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.306 -1.496 . . . . 0.0 107.064 -168.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -139.74 71.21 36.85 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.83 129.27 29.89 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.93 1.754 . . . . 0.0 109.019 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.24 5.83 45.42 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p 39.08 88.65 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 127.942 2.497 . . . . 0.0 113.03 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -58.47 139.0 88.91 Favored 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 122.382 2.055 . . . . 0.0 108.663 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.65 -0.24 1.85 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.957 3.771 . . . . 0.0 115.455 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -61.75 -12.64 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.451 1.101 . . . . 0.0 111.26 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.42 149.03 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.487 1.515 . . . . 0.0 109.237 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HE2' HD23 ' B' ' 77' ' ' LEU . 5.1 tmmm? -82.97 155.56 23.93 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.5 ttm-85 -139.7 144.67 37.66 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.126 -0.984 . . . . 0.0 108.479 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -150.85 147.7 27.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 169.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.6 130.9 35.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -116.75 18.42 14.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -164.48 162.35 35.33 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -137.53 18.93 2.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.517 1.127 . . . . 0.0 110.15 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -149.12 158.38 44.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.178 1.791 . . . . 0.0 107.535 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -134.14 119.64 14.62 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.873 1.269 . . . . 0.0 107.663 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 -27.2 40.76 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.343 2.695 . . . . 0.0 112.56 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.1 -5.22 6.07 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.633 1.106 . . . . 0.0 112.709 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -100.99 8.25 43.12 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.61 1.164 . . . . 0.0 111.356 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.63 144.05 2.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -55.17 -45.78 75.75 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 123.845 0.716 . . . . 0.0 109.98 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.74 -16.04 4.04 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 45.8 p -68.76 162.23 26.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.67 -38.78 92.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.379 0.609 . . . . 0.0 110.776 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.69 -42.57 77.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 117.109 -1.424 . . . . 0.0 109.206 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.58 -31.56 62.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 120.925 1.693 . . . . 0.0 109.555 -175.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -56.64 -63.58 1.15 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -58.24 -39.63 79.63 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.04 94.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.812 0.845 . . . . 0.0 112.231 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.71 -45.61 85.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.825 0.739 . . . . 0.0 109.564 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.9 m-30 -64.84 -43.36 93.29 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -175.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -67.35 -41.99 84.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.611 0.764 . . . . 0.0 111.097 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -59.43 -52.23 66.51 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.32 -42.04 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.396 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.434 ' HB2' ' HE1' ' B' ' 23' ' ' TRP . 41.1 ptt85 -62.24 -37.4 85.25 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.094 1.316 . . . . 0.0 111.471 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.84 -44.01 94.45 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.228 0.33 . . . . 0.0 110.299 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.08 -57.69 9.77 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.738 0.415 . . . . 0.0 110.22 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 12.4 mt -57.53 -47.9 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 124.345 1.058 . . . . 0.0 109.727 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.46 -44.35 97.74 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 118.984 -0.898 . . . . 0.0 111.31 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -44.6 88.25 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.651 1.225 . . . . 0.0 110.762 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.58 92.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.1 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.24 -38.45 78.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.691 1.132 . . . . 0.0 111.328 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.89 -41.18 99.32 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -60.84 -39.95 91.0 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 116.988 -1.482 . . . . 0.0 110.993 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -58.9 -37.54 76.85 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.856 2.116 . . . . 0.0 111.26 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.11 -31.28 71.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.132 0.573 . . . . 0.0 112.496 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.66 -43.54 10.67 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.537 . . . . 0.0 111.17 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 80.5 p -89.78 -24.29 21.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.21 1.804 . . . . 0.0 110.729 -169.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 55.29 31.62 56.79 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 111.608 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt . . . . . 0 C--O 1.245 0.826 0 C-N-CA 123.97 0.908 . . . . 0.0 111.477 -172.438 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.72 165.32 36.35 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.765 1.226 . . . . 0.0 108.176 170.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.08 101.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 t -80.48 169.47 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.882 1.673 . . . . 0.0 107.54 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.89 53.98 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.709 0.804 . . . . 0.0 109.188 169.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.463 ' HB2' HG12 ' A' ' 53' ' ' VAL . . . -97.23 171.51 8.39 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.998 1.719 . . . . 0.0 109.713 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -134.94 -170.25 2.53 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.472 1.509 . . . . 0.0 108.821 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -45.09 -29.27 0.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.374 2.27 . . . . 0.0 113.488 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -135.88 -31.18 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.976 1.311 . . . . 0.0 112.097 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -63.53 -21.36 66.29 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.69 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -52.18 -58.04 7.8 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.185 0.902 . . . . 0.0 109.417 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -60.71 -43.85 97.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.956 0.344 . . . . 0.0 110.185 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.15 77.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.367 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -84.23 -15.81 45.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.393 1.077 . . . . 0.0 113.109 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.2 p -114.95 -7.15 12.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.755 1.161 . . . . 0.0 113.805 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -74.7 -5.62 44.21 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.1 153.49 45.45 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.558 1.143 . . . . 0.0 109.053 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.98 -161.02 49.99 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.058 0.837 . . . . 0.0 111.148 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.56 129.53 70.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.15 119.26 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.157 -168.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.7 98.45 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.84 150.89 27.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -140.46 150.73 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.573 1.549 . . . . 0.0 109.319 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -132.66 115.74 15.77 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.587 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -136.62 152.9 50.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.919 1.688 . . . . 0.0 107.988 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.9 163.27 6.63 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.036 0.835 . . . . 0.0 110.41 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.63 -11.98 3.9 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.364 3.376 . . . . 0.0 116.719 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -59.98 -17.44 38.32 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.865 1.211 . . . . 0.0 113.811 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.95 155.68 41.83 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.945 1.248 . . . . 0.0 114.07 -170.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.88 -46.68 80.68 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.725 -1.597 . . . . 0.0 112.81 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -49.0 -31.05 19.43 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.4 2.734 . . . . 0.0 114.785 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -60.52 -15.18 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 120.06 1.3 . . . . 0.0 114.028 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 9.45 13.74 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.286 1.435 . . . . 0.0 111.339 176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.6 mtm -120.1 -44.61 2.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.311 1.044 . . . . 0.0 109.486 176.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 tp -60.97 -36.42 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.16 18.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.768 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.11 -39.86 55.9 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.879 1.719 . . . . 0.0 111.728 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.664 HG12 HD22 ' A' ' 96' ' ' LEU . 2.6 t -57.16 -33.73 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.328 1.051 . . . . 0.0 111.468 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.81 -41.63 59.6 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.888 0.767 . . . . 0.0 110.687 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.74 -33.09 75.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.203 0.911 . . . . 0.0 109.709 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.04 -25.76 63.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.018 1.327 . . . . 0.0 111.672 173.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.405 HD11 ' SD ' ' A' ' 46' ' ' MET . 58.2 tp -77.1 -44.72 29.5 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 119.063 0.847 . . . . 0.0 109.96 173.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.49 -34.79 70.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.671 -0.643 . . . . 0.0 111.112 -172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.67 -10.69 59.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.511 -0.743 . . . . 0.0 112.251 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -99.79 -42.77 6.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.279 1.432 . . . . 0.0 110.931 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 42' ' ' LEU . 20.1 ptm -143.08 18.38 1.94 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.37 0.668 . . . . 0.0 112.399 -172.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.43 -4.6 13.33 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 121.243 -0.911 . . . . 0.0 114.299 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.69 -23.63 66.15 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.026 0.93 . . . . 0.0 110.919 169.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.24 -11.76 8.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.527 1.131 . . . . 0.0 112.48 -174.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -128.29 148.62 50.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.982 1.313 . . . . 0.0 111.454 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -114.42 147.56 39.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mt -125.22 141.07 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 6' ' ' ALA . 12.4 t -138.95 113.02 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 27.8 mtpt -86.54 155.08 20.63 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.243 -0.91 . . . . 0.0 110.337 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.75 122.52 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.58 108.74 12.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.306 33.6 m -79.2 47.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -153.01 -41.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.791 1.237 . . . . 0.0 108.984 167.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -83.64 -34.6 25.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.065 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -134.62 27.78 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.958 1.303 . . . . 0.0 110.807 -170.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -71.55 -7.54 48.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.021 0.928 . . . . 0.0 112.851 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -49.05 -51.96 28.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.768 2.027 . . . . 0.0 110.322 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.2 m -61.34 -32.6 72.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.636 0.775 . . . . 0.0 111.829 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.74 -64.76 0.79 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.77 -46.58 7.51 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.676 0.655 . . . . 0.0 113.325 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -60.35 -40.68 91.59 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.097 0.959 . . . . 0.0 111.631 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -89.98 -0.0 57.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.811 0.845 . . . . 0.0 112.497 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.05 68.81 1.44 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t -146.45 129.99 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 100.951 -3.722 . . . . 0.0 100.951 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -144.44 16.57 1.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.306 0.242 . . . . 0.0 110.847 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -130.77 170.11 14.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.121 2.568 . . . . 0.0 112.64 -168.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.88 143.52 46.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.695 0.798 . . . . 0.0 108.902 172.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.26 154.26 65.73 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 107.278 -1.855 . . . . 0.0 107.278 -11.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.9 m -127.48 147.45 50.31 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -124.3 137.69 54.47 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 106.655 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.7 mt -124.27 107.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -82.41 110.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.3 mp -106.61 148.71 27.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -147.68 125.44 11.88 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 41.17 30.44 0.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.27 2.628 . . . . 0.0 114.413 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.66 -23.38 4.49 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.827 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.27 156.88 46.3 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 119.244 1.522 . . . . 0.0 113.263 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.07 135.76 27.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.14 -22.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.182 1.393 . . . . 0.0 110.554 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -147.4 163.83 35.23 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.287 1.035 . . . . 0.0 110.418 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.34 149.19 30.49 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -153.46 142.44 21.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 169.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.6 72.71 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.35 156.73 8.43 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.441 1.496 . . . . 0.0 110.05 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -65.3 148.39 51.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.371 0.668 . . . . 0.0 110.456 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.7 141.79 26.2 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.2 167.61 25.69 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.463 2.109 . . . . 0.0 110.834 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -46.32 -47.72 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.462 1.905 . . . . 0.0 112.799 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.07 -42.51 76.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.619 0.645 . . . . 0.0 110.799 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -32.44 73.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.111 -0.368 . . . . 0.0 110.436 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.664 HD22 HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -57.95 -54.56 45.51 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.563 1.145 . . . . 0.0 109.681 172.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.87 -39.24 90.51 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.6 -46.29 90.82 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.314 0.506 . . . . 0.0 111.325 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.86 -41.0 81.5 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.198 0.999 . . . . 0.0 111.105 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.9 -37.32 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.252 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -57.79 -25.88 61.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.632 1.105 . . . . 0.0 112.553 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -53.08 -26.75 17.23 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.005 0.922 . . . . 0.0 112.645 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -128.88 -23.96 3.01 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 112.674 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 170.224 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.96 35.0 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.032 -1.043 . . . . 0.0 110.696 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -152.39 131.69 12.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -137.94 118.62 14.03 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 129.315 3.046 . . . . 0.0 106.431 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mm -90.56 131.78 36.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tt -133.62 135.0 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -169.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -117.15 144.14 45.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -131.75 128.37 38.72 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.232 1.013 . . . . 0.0 108.622 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 66.7 m -148.38 144.27 27.38 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 124.577 1.151 . . . . 0.0 109.096 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 26.2 m -53.69 121.21 7.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.915 0.886 . . . . 0.0 110.185 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.537 ' H ' ' CG2' ' B' ' 39' ' ' ILE . . . 50.01 35.01 24.72 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.948 1.261 . . . . 0.0 111.792 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -31.58 101.85 0.02 OUTLIER 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -135.8 -0.98 2.52 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.997 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.81 -79.33 0.37 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.194 1.361 . . . . 0.0 113.264 -169.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -46.12 75.67 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.714 0.806 . . . . 0.0 113.074 -169.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.8 m -69.47 -28.56 66.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.111 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -68.26 -47.04 68.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.689 1.131 . . . . 0.0 110.073 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 2.7 ptm -69.14 -42.27 76.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.258 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.35 96.85 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 121.584 -0.697 . . . . 0.0 111.367 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.17 -30.96 65.5 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.1 0.863 . . . . 0.0 110.898 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.58 -50.31 62.87 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 169.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -57.22 -33.36 67.45 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.347 1.059 . . . . 0.0 112.225 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.01 -53.41 7.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.571 0.748 . . . . 0.0 111.234 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -68.46 -17.98 64.31 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -168.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.1 -17.75 54.27 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.415 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 33.1 m-85 -126.46 -37.6 2.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.373 0.988 . . . . 0.0 111.996 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 23.9 mt -78.24 71.79 4.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.757 1.623 . . . . 0.0 106.62 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.05 -147.14 0.09 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.562 2.03 . . . . 0.0 114.671 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.19 -23.82 62.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.461 1.104 . . . . 0.0 113.021 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -65.37 -13.27 58.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.247 1.019 . . . . 0.0 113.244 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -123.53 151.93 42.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.431 1.014 . . . . 0.0 111.712 -169.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -132.12 82.74 2.04 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.633 1.973 . . . . 0.0 105.854 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.71 139.68 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.31 169.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -144.8 166.87 24.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 32.2 p -143.28 145.91 33.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.771 -0.581 . . . . 0.0 111.615 -169.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.75 177.79 10.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.296 0.638 . . . . 0.0 112.38 -173.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.35 -178.75 48.53 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.643 0.64 . . . . 0.0 112.289 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.537 ' CG2' ' H ' ' B' ' 12' ' ' GLY . 2.9 tt -46.64 -56.35 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 127.632 2.373 . . . . 0.0 113.272 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -133.87 30.49 3.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.569 1.548 . . . . 0.0 108.779 -172.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 154.79 40.91 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.843 2.057 . . . . 0.0 112.075 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 137.45 82.88 0.0 OUTLIER 'General case' 0 C--O 1.236 0.37 0 C-N-CA 130.891 3.676 . . . . 0.0 105.274 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.21 175.3 46.64 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -172.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.3 88.92 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -60.48 124.4 78.32 Favored Pre-proline 0 C--O 1.241 0.633 0 C-N-CA 125.544 1.538 . . . . 0.0 108.056 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.76 -18.41 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.799 1.666 . . . . 0.0 112.401 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -59.12 -56.81 17.43 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.86 1.209 . . . . 0.0 108.429 169.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.37 76.05 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.894 1.225 . . . . 0.0 109.719 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.86 -55.81 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.44 -45.51 80.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.917 0.887 . . . . 0.0 110.486 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.89 56.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.378 1.871 . . . . 0.0 111.17 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 73.9 mmm -92.68 -32.16 14.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.632 0.773 . . . . 0.0 111.765 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.06 -26.67 67.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.846 171.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -58.54 -28.73 65.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.412 1.006 . . . . 0.0 112.019 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.46 16.34 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.873 1.269 . . . . 0.0 110.578 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.09 95.21 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.643 -1.087 . . . . 0.0 112.608 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 48.5 mt -114.32 109.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.51 132.66 43.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 13.8 pt -134.9 18.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.566 1.146 . . . . 0.0 111.019 173.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.4 m -65.31 14.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -169.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -140.8 -2.7 1.32 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.95 2.5 . . . . 0.0 112.173 -176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -47.34 -59.52 3.14 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p 53.06 -171.72 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.74 1.616 . . . . 0.0 112.293 -171.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -163.08 -169.53 2.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.459 1.104 . . . . 0.0 109.029 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.2 168.76 23.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.193 2.597 . . . . 0.0 106.555 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.85 175.4 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 120.212 1.369 . . . . 0.0 112.295 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -54.42 36.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 C-N-CA 129.195 2.998 . . . . 0.0 118.11 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -52.32 106.4 0.15 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.93 2.092 . . . . 0.0 113.532 -173.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.1 m -51.51 -26.35 8.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.113 1.765 . . . . 0.0 114.378 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.69 -23.94 66.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.57 1.077 . . . . 0.0 111.845 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.31 -40.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -58.8 -51.61 69.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.355 0.525 . . . . 0.0 110.779 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -26.01 64.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.488 0.586 . . . . 0.0 110.941 -177.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -79.53 -19.14 50.28 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.435 1.094 . . . . 0.0 112.229 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.08 159.19 7.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 111.222 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.3 -22.77 35.51 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.867 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.424 HD23 ' H ' ' B' ' 78' ' ' VAL . 0.5 OUTLIER -152.81 153.22 32.69 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.106 0.962 . . . . 0.0 111.132 -177.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.424 ' H ' HD23 ' B' ' 77' ' ' LEU . 61.1 t -122.52 99.32 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 127.22 2.208 . . . . 0.0 105.657 169.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.39 100.46 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.7 m -70.57 125.98 28.32 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.28 136.08 33.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 14.4 m 76.42 -26.49 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.488 2.715 . . . . 0.0 113.509 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.22 32.94 65.07 Favored Glycine 0 C--N 1.34 0.756 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -90.32 115.02 27.2 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.652 0.781 . . . . 0.0 110.88 -169.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.82 -20.76 65.37 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.1 -19.27 30.93 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.548 0.739 . . . . 0.0 112.488 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -72.01 35.45 0.06 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.97 1.308 . . . . 0.0 113.751 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm 64.46 35.23 9.64 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.113 1.765 . . . . 0.0 112.853 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.8 p 33.07 50.54 0.68 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.552 1.941 . . . . 0.0 113.151 174.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.28 133.99 61.45 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.452 2.101 . . . . 0.0 114.0 -168.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.456 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -76.69 -23.77 53.18 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.313 175.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p 51.86 117.83 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.712 2.405 . . . . 0.0 113.367 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.38 150.26 64.16 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.931 1.754 . . . . 0.0 109.285 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.86 -5.45 10.63 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.634 2.89 . . . . 0.0 114.125 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -62.11 -17.31 57.31 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.197 0.999 . . . . 0.0 112.086 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.95 149.99 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.217 0.917 . . . . 0.0 111.031 -173.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -75.66 151.91 37.66 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.482 1.113 . . . . 0.0 108.954 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 ttp-105 -139.07 137.95 36.69 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -147.69 149.43 32.43 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -91.78 133.8 35.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . 0.411 ' CZ2' ' HE3' ' B' ' 139' ' ' LYS . 88.6 m95 -125.51 9.36 7.78 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.0 159.93 27.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.5 9.19 4.67 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.705 0.802 . . . . 0.0 111.289 -173.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -150.19 163.72 37.51 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.311 1.844 . . . . 0.0 107.097 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -134.34 121.47 15.39 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 125.097 1.359 . . . . 0.0 108.608 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.544 ' HD3' HG11 ' B' ' 123' ' ' VAL . 58.2 Cg_endo -69.97 -29.63 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.859 2.373 . . . . 0.0 112.166 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.26 -7.62 6.54 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.256 0.934 . . . . 0.0 112.994 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt-85 -83.74 -1.65 54.61 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.085 -0.959 . . . . 0.0 112.095 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' B' ' 116' ' ' LYS . . . -34.64 127.4 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.73 1.612 . . . . 0.0 112.507 -175.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -69.3 136.76 52.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 102.564 -3.125 . . . . 0.0 102.564 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.98 29.88 2.39 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -167.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 26.3 p -89.57 159.32 17.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.565 1.683 . . . . 0.0 107.262 169.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.95 -37.2 83.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.202 0.525 . . . . 0.0 111.31 -174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -77.31 -43.09 34.32 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 117.489 -1.244 . . . . 0.0 109.409 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -77.1 -27.33 54.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 120.563 1.529 . . . . 0.0 110.269 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . 0.576 ' HA ' ' HB1' ' B' ' 109' ' ' ALA . 7.8 mtpt -59.83 -57.42 12.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 169.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -60.2 -40.91 91.74 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.08 91.56 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.069 0.948 . . . . 0.0 111.932 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -62.73 -45.46 92.61 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.617 0.644 . . . . 0.0 109.786 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.66 -49.89 74.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -62.2 -47.0 86.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.778 1.231 . . . . 0.0 110.11 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -56.87 -55.39 35.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.544 HG11 ' HD3' ' B' ' 106' ' ' PRO . 49.8 t -75.13 -39.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.119 -171.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -64.05 -39.48 94.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.751 1.614 . . . . 0.0 111.281 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.95 -41.89 95.1 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.216 0.462 . . . . 0.0 111.105 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -67.36 -46.92 71.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.819 0.448 . . . . 0.0 110.07 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 11.0 mt -53.09 -49.39 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.042 1.337 . . . . 0.0 108.607 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.99 -50.19 70.5 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 118.387 0.539 . . . . 0.0 112.538 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -64.03 -41.67 97.35 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.632 0.216 . . . . 0.0 110.724 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -66.62 -43.54 84.47 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.615 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' B' ' 131' ' ' LEU . 3.5 mm? -65.05 -34.32 78.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 119.759 1.163 . . . . 0.0 111.376 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.415 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 39.3 ttmt -60.94 -32.07 71.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.194 0.906 . . . . 0.0 111.16 174.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.05 -30.19 71.4 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-O 116.902 -1.523 . . . . 0.0 112.06 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -63.1 -37.37 86.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 122.454 2.388 . . . . 0.0 109.785 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.89 73.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.611 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -81.92 -43.3 18.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.366 1.066 . . . . 0.0 112.049 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 82.1 p -88.34 -18.38 28.58 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.65 1.98 . . . . 0.0 111.074 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.51 15.16 75.17 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.158 0.885 . . . . 0.0 112.107 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.411 ' HE3' ' CZ2' ' B' ' 101' ' ' TRP . 5.0 ttpm? . . . . . 0 C--O 1.247 0.944 0 C-N-CA 125.116 1.367 . . . . 0.0 109.434 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.76 155.64 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.786 2.434 . . . . 0.0 111.839 -169.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.5 107.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.2 t -79.48 167.14 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.904 1.682 . . . . 0.0 107.988 176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -122.99 119.25 29.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.123 1.369 . . . . 0.0 107.924 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.67 168.92 19.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.914 0.886 . . . . 0.0 108.783 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 p -135.26 -167.23 1.97 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.781 1.232 . . . . 0.0 109.354 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -51.88 -20.33 2.22 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.143 1.777 . . . . 0.0 113.751 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -140.78 -31.72 0.6 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.667 1.187 . . . . 0.0 112.811 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.4 m -63.26 -19.57 64.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.165 0.893 . . . . 0.0 112.202 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -50.6 -55.18 17.44 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 109.76 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -62.29 -44.23 96.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.104 -0.372 . . . . 0.0 110.036 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.06 83.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.946 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -79.87 -19.6 47.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.991 0.917 . . . . 0.0 113.047 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 p -108.96 -7.51 15.39 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.661 1.119 . . . . 0.0 112.943 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.0 m -72.22 -7.2 47.96 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -141.8 154.11 44.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 109.615 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.82 -157.15 51.13 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 124.951 1.262 . . . . 0.0 111.996 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 t -113.43 131.41 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 t -140.13 116.26 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 122.257 1.027 . . . . 0.0 108.493 -169.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.69 121.59 25.51 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.3 36.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -141.57 149.86 41.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.954 1.302 . . . . 0.0 109.538 -170.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 31.4 m-85 -132.2 113.25 13.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -169.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.652 ' CD1' ' HE3' ' A' ' 54' ' ' LYS . 3.1 p-90 -132.76 149.3 52.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.845 1.658 . . . . 0.0 107.876 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.88 165.12 6.07 Favored Pre-proline 0 C--O 1.235 0.331 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.34 -17.44 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.882 3.055 . . . . 0.0 116.02 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -52.48 -26.8 13.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.854 1.662 . . . . 0.0 114.318 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.55 150.92 48.87 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.721 1.146 . . . . 0.0 111.509 -172.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.25 -50.9 57.16 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.496 -1.169 . . . . 0.0 111.459 172.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -46.54 -26.15 4.03 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.423 3.415 . . . . 0.0 117.076 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -56.51 -35.46 68.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 121.538 1.972 . . . . 0.0 111.726 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -90.18 7.92 35.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.963 0.905 . . . . 0.0 111.883 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 68.4 mtm -118.56 -42.82 2.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.023 0.929 . . . . 0.0 109.606 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.63 -33.99 59.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.793 0.837 . . . . 0.0 109.269 169.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.8 -60.95 7.87 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.08 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.14 -40.19 72.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.07 1.847 . . . . 0.0 111.614 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.18 -40.02 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.473 0.579 . . . . 0.0 110.525 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.72 -39.32 64.38 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 118.767 0.712 . . . . 0.0 111.574 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.37 -34.92 79.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.43 1.014 . . . . 0.0 109.735 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -71.54 -17.85 62.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.198 1.399 . . . . 0.0 112.643 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.0 tp -86.94 -43.63 12.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.235 1.014 . . . . 0.0 108.794 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB2' HD12 ' A' ' 52' ' ' ILE . 22.7 t70 -71.78 -37.46 70.46 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.146 -0.346 . . . . 0.0 110.945 -175.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.8 -11.86 59.38 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.561 . . . . 0.0 111.942 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -100.02 -47.85 4.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptm -135.81 15.01 3.36 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.504 0.722 . . . . 0.0 112.392 -170.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.83 -2.09 21.43 Favored Glycine 0 CA--C 1.52 0.383 0 O-C-N 121.093 -1.004 . . . . 0.0 113.951 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.21 -25.27 65.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.696 0.798 . . . . 0.0 110.624 169.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 -26.84 9.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 -177.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.0 tp -119.76 146.53 45.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.036 1.335 . . . . 0.0 111.886 -168.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -103.31 143.54 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 168.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 43' ' ' ASP . 15.1 mt -124.74 136.48 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.39 124.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.652 ' HE3' ' CD1' ' A' ' 25' ' ' TRP . 25.6 mtpp -99.85 156.28 17.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.036 0.834 . . . . 0.0 109.716 173.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mm -116.61 127.95 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.01 104.99 10.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 169.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.01 41.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.437 1.113 . . . . 0.0 111.844 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.1 -44.8 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.594 1.158 . . . . 0.0 110.479 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 110.262 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.75 30.22 3.76 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.59 1.156 . . . . 0.0 110.74 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -3.56 32.56 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.434 1.094 . . . . 0.0 112.586 -169.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -52.14 -45.16 64.9 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.584 1.554 . . . . 0.0 111.233 -169.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -65.71 -26.27 67.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' B' ' 91' ' ' MET . . . -68.48 -64.33 0.89 Allowed 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.072 -1.018 . . . . 0.0 108.801 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.22 -38.48 19.03 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.937 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -60.82 -48.58 81.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.37 1.585 . . . . 0.0 110.117 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.54 -13.2 60.99 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.569 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.95 55.93 14.69 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.67 -43.82 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.507 ' HG3' HD12 ' B' ' 67' ' ' ILE . 9.6 ptm 45.29 19.77 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 129.415 3.086 . . . . 0.0 113.567 174.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -133.72 155.66 49.35 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.039 1.736 . . . . 0.0 109.516 -174.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.9 mt -142.45 143.64 27.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 119.034 0.834 . . . . 0.0 109.091 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -67.52 144.83 72.62 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.303 0.787 . . . . 0.0 110.317 -10.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 53.5 m -114.4 142.03 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.89 136.08 54.12 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.8 mt -125.93 109.15 12.14 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 103.784 -2.673 . . . . 0.0 103.784 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.8 t -83.53 118.51 31.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.11 151.58 36.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.19 0.996 . . . . 0.0 108.498 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -147.87 144.04 27.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 43.69 28.4 0.22 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.952 2.101 . . . . 0.0 113.67 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.16 8.09 55.53 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.928 1.251 . . . . 0.0 116.164 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -134.99 147.87 49.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.926 1.363 . . . . 0.0 111.886 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.0 140.7 17.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.98 0.912 . . . . 0.0 109.186 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.42 -20.79 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.982 1.313 . . . . 0.0 111.122 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.74 161.67 40.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.173 0.989 . . . . 0.0 109.713 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 m -154.19 148.74 26.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.1 m -151.58 150.2 30.04 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.383 1.073 . . . . 0.0 108.531 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -133.18 63.0 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 125.591 1.556 . . . . 0.0 107.135 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.53 168.13 37.36 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.647 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.06 152.21 45.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.183 0.993 . . . . 0.0 111.034 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 141.2 17.51 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 169.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.81 168.38 23.09 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.447 2.098 . . . . 0.0 110.388 173.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -44.69 65.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 112.524 -170.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.83 -43.84 74.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 117.472 0.124 . . . . 0.0 110.867 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.25 75.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.973 -0.454 . . . . 0.0 110.346 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -53.74 53.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.711 0.805 . . . . 0.0 109.844 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -64.61 -38.25 90.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -61.78 -48.25 81.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.508 0.595 . . . . 0.0 110.75 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -55.86 -44.27 77.9 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 124.457 1.103 . . . . 0.0 110.898 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.03 -37.04 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.508 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 8.0 t30 -58.94 -26.36 64.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.172 0.989 . . . . 0.0 112.208 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -22.67 39.49 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.644 0.778 . . . . 0.0 112.459 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -131.12 -19.67 2.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.133 0.973 . . . . 0.0 112.969 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 1.7 tm? . . . . . 0 C--O 1.248 1.017 0 C-N-CA 127.521 2.329 . . . . 0.0 107.87 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -66.84 128.62 36.99 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.22 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.325 2.65 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -137.83 128.74 27.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 mt -92.88 144.65 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 123.623 0.577 . . . . 0.0 110.377 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.7 147.98 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.642 1.577 . . . . 0.0 106.746 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.45 142.64 37.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -169.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -97.84 143.27 28.62 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -145.27 131.42 19.42 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -169.79 172.01 6.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.32 1.848 . . . . 0.0 108.96 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -48.61 125.01 9.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.495 1.518 . . . . 0.0 109.832 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.49 4.9 0.27 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.209 1.861 . . . . 0.0 117.699 169.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . 0.406 ' HB2' ' HB1' ' B' ' 41' ' ' ALA . 5.0 t30 47.4 18.32 0.1 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.63 1.715 . . . . 0.0 113.315 -169.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 9.9 p -84.43 57.42 4.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.341 2.257 . . . . 0.0 114.787 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 136.94 -58.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.446 3.098 . . . . 0.0 113.433 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -53.95 -53.97 45.44 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.807 0.843 . . . . 0.0 110.948 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -69.39 -33.16 72.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.88 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -58.7 -48.33 81.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.681 0.673 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 8.1 ptp -69.83 -41.51 74.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.09 99.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.507 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.08 -31.11 68.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.186 0.903 . . . . 0.0 111.755 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.57 60.88 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.502 ' HE1' ' HG2' ' B' ' 124' ' ' ARG . 25.5 m95 -56.56 -36.47 69.35 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.619 1.168 . . . . 0.0 111.688 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.41 -55.12 8.58 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 122.577 0.351 . . . . 0.0 110.477 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.35 -24.44 67.25 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -168.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.88 -16.17 63.6 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.29 0.95 . . . . 0.0 113.364 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.462 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 7.5 m-85 -124.7 -12.46 7.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 112.858 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -114.69 83.45 1.9 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.126 -2.175 . . . . 0.0 105.126 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.49 -168.73 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.421 1.01 . . . . 0.0 112.075 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.51 -5.03 4.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.177 0.991 . . . . 0.0 113.07 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.35 -24.81 67.55 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.623 -1.298 . . . . 0.0 109.564 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -123.11 179.31 4.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.474 1.91 . . . . 0.0 108.93 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -155.48 127.6 7.64 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 13.3 p -123.32 143.42 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.909 0.484 . . . . 0.0 110.094 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.49 171.23 14.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.151 1.78 . . . . 0.0 108.76 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -147.07 145.35 29.61 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.289 1.035 . . . . 0.0 109.126 -172.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.94 170.58 21.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.166 0.987 . . . . 0.0 111.775 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.76 178.61 46.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.202 1.382 . . . . 0.0 110.554 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 tt -48.67 -54.54 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.541 1.936 . . . . 0.0 113.775 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -135.1 31.42 3.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.097 1.759 . . . . 0.0 108.035 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' B' ' 13' ' ' ASN . . . -66.12 128.15 34.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.599 1.959 . . . . 0.0 115.957 -168.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -166.41 1.38 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.641 2.376 . . . . 0.0 110.62 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.9 109.49 3.44 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 120.725 -1.234 . . . . 0.0 114.864 -168.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 56.6 tp -82.52 83.13 7.67 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -62.12 123.68 79.04 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.633 -0.698 . . . . 0.0 109.782 -176.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.73 -23.42 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.224 1.95 . . . . 0.0 113.201 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -33.73 76.16 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.762 1.165 . . . . 0.0 110.856 174.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -34.46 50.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.187 0.449 . . . . 0.0 109.947 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -56.67 -51.38 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -56.49 -46.12 80.65 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.287 0.635 . . . . 0.0 110.709 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.49 -32.56 58.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.26 1.024 . . . . 0.0 112.323 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mmm -90.54 -30.06 17.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.241 -0.912 . . . . 0.0 111.323 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.87 -24.73 67.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.437 169.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.436 ' CD ' HH21 ' B' ' 124' ' ' ARG . 42.8 mt-10 -55.52 -36.37 66.65 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.829 1.195 . . . . 0.0 111.201 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.3 m -112.28 15.92 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.19 1.396 . . . . 0.0 111.296 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.56 41.58 99.12 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.036 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 39.1 mt -114.64 116.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 171.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.79 132.12 43.17 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -131.78 13.08 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.28 169.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 75.3 p -59.76 -17.59 36.46 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.667 1.121 . . . . 0.0 111.495 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -80.37 -12.5 59.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.503 2.321 . . . . 0.0 114.282 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -69.96 157.0 38.29 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.374 1.443 . . . . 0.0 112.335 -171.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -129.65 168.81 15.9 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.542 2.337 . . . . 0.0 108.809 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.3 m -156.21 168.62 26.71 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.948 -1.095 . . . . 0.0 110.714 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -162.79 162.67 26.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.68 1.992 . . . . 0.0 108.763 -169.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 29.5 pt -70.24 172.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 0.0 112.424 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.507 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.3 OUTLIER -50.39 133.31 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -145.5 99.96 3.37 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.167 0.984 . . . . 0.0 108.8 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -49.55 -28.0 5.09 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.673 1.989 . . . . 0.0 113.699 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.65 -18.37 63.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.247 0.93 . . . . 0.0 112.387 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.68 -34.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.089 0.956 . . . . 0.0 108.745 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.03 -54.9 14.97 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.594 1.088 . . . . 0.0 110.173 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -26.31 68.35 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.906 0.776 . . . . 0.0 110.159 175.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -72.83 -24.04 60.85 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 112.357 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.35 164.74 4.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.851 1.261 . . . . 0.0 112.194 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.15 -31.0 15.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.134 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -145.16 135.93 24.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.283 1.033 . . . . 0.0 110.661 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 t -113.56 115.02 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.28 108.81 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.7 m -73.92 145.61 44.62 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.36 31.29 4.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.929 0.892 . . . . 0.0 111.635 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -157.49 174.59 15.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.62 57.88 0.71 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -137.67 179.56 6.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.262 1.425 . . . . 0.0 109.737 -169.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -132.31 -8.15 3.35 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.377 1.871 . . . . 0.0 112.118 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.75 -22.21 57.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.55 0.74 . . . . 0.0 111.19 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.88 -8.79 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.36 2.264 . . . . 0.0 115.776 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm 92.51 15.89 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 128.492 2.717 . . . . 0.0 111.366 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 6.9 m 37.66 49.11 1.5 Allowed Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.673 1.589 . . . . 0.0 111.716 -169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -55.72 131.43 46.01 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 108.574 -1.356 . . . . 0.0 108.574 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.505 ' HE2' ' HB1' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -89.58 8.14 32.78 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -168.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 14.3 p 40.95 81.57 0.24 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.953 1.701 . . . . 0.0 112.705 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' B' ' 94' ' ' PRO . 60.6 Cg_endo -57.38 141.73 94.89 Favored 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 122.649 2.233 . . . . 0.0 111.304 -169.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 93' ' ' PRO . 85.9 Cg_exo -49.95 -12.53 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 127.014 5.143 . . . . 0.0 118.672 -170.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -60.27 -16.35 33.22 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.328 0.967 . . . . 0.0 111.785 171.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.2 137.7 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 109.124 -172.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -75.82 156.4 34.48 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -142.42 147.95 37.01 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.217 -0.927 . . . . 0.0 110.538 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -150.0 161.28 42.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.623 1.569 . . . . 0.0 107.5 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -99.22 123.63 43.66 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 168.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -109.6 2.98 20.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.409 0.684 . . . . 0.0 110.108 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.6 149.23 21.09 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 105.779 -2.928 . . . . 0.0 105.779 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -146.82 10.0 1.03 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.974 1.71 . . . . 0.0 110.633 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -153.28 168.59 25.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.742 2.417 . . . . 0.0 105.984 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -133.33 115.82 13.96 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.63 0.772 . . . . 0.0 109.412 -171.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.17 -25.24 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.004 2.469 . . . . 0.0 113.584 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -8.38 21.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.179 0.9 . . . . 0.0 111.819 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -93.88 10.99 30.98 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.645 1.978 . . . . 0.0 111.835 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.47 148.49 0.67 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.832 1.253 . . . . 0.0 112.767 -173.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -55.45 -47.4 76.09 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.119 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.93 -17.38 4.14 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 115.552 0.981 . . . . 0.0 115.552 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.43 158.88 34.29 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.54 -37.77 79.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.354 0.597 . . . . 0.0 111.157 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -73.36 -43.75 60.04 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.119 -1.42 . . . . 0.0 109.814 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.3 -28.24 59.63 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 121.208 1.822 . . . . 0.0 110.259 -172.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -60.41 -59.14 5.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 118.73 0.695 . . . . 0.0 109.765 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -60.64 -39.62 88.99 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.553 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.4 95.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.276 0.631 . . . . 0.0 112.24 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.21 -47.3 83.11 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -61.09 -51.42 69.2 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -62.47 -43.72 98.14 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.03 0.932 . . . . 0.0 111.518 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -60.94 -52.75 63.72 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 35.5 t -69.81 -36.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.502 ' HG2' ' HE1' ' B' ' 23' ' ' TRP . 7.3 tmm_? -60.23 -43.34 96.14 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.572 1.078 . . . . 0.0 111.774 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.85 -44.78 96.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.31 0.505 . . . . 0.0 110.822 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -63.13 -51.7 65.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.43 0.692 . . . . 0.0 110.117 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -54.19 -49.59 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.624 1.57 . . . . 0.0 109.054 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.23 -43.1 81.37 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 118.936 -0.925 . . . . 0.0 112.316 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -44.38 94.98 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.806 1.303 . . . . 0.0 110.428 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -34.72 78.6 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.577 178.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.73 1.15 . . . . 0.0 111.492 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.462 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -62.75 -41.24 99.11 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -62.4 -40.54 96.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 117.395 -1.288 . . . . 0.0 111.301 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -60.56 -36.24 78.0 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 121.665 2.029 . . . . 0.0 111.295 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.61 -28.58 69.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.029 0.531 . . . . 0.0 112.431 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.69 -46.6 7.49 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.609 1.564 . . . . 0.0 111.141 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 62.9 p -89.14 -27.21 20.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.278 1.831 . . . . 0.0 110.784 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.13 25.94 54.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.9 -169.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.748 1.619 . . . . 0.0 111.82 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.32 172.3 18.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.839 1.656 . . . . 0.0 107.493 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.74 97.09 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 168.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -78.02 167.98 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.509 1.523 . . . . 0.0 108.009 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -128.07 112.76 14.95 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.799 0.84 . . . . 0.0 108.983 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.17 175.04 10.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.579 1.552 . . . . 0.0 110.095 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -159.71 -173.39 4.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.966 2.107 . . . . 0.0 105.617 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.62 -36.62 0.42 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.37 2.668 . . . . 0.0 115.934 -169.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -130.57 -29.96 1.92 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.586 1.154 . . . . 0.0 111.543 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -23.06 65.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.149 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -51.55 -56.48 13.2 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.356 0.98 . . . . 0.0 109.244 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -62.36 -44.25 96.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -36.65 81.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -174.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -80.15 -16.95 53.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.072 0.949 . . . . 0.0 113.056 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.8 p -114.06 -7.18 13.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.651 1.114 . . . . 0.0 113.113 -169.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -77.48 -3.95 43.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.41 148.38 37.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.226 1.011 . . . . 0.0 109.092 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.08 -170.84 40.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.19 0.9 . . . . 0.0 111.62 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -100.43 125.81 54.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 t -140.03 117.96 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.6 135.89 33.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.7 46.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.41 151.25 49.31 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.279 1.432 . . . . 0.0 108.626 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.7 111.34 13.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -169.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.557 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.3 p-90 -131.68 155.11 48.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.716 1.606 . . . . 0.0 107.789 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -168.11 162.67 9.13 Favored Pre-proline 0 C--O 1.233 0.188 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.8 -19.0 10.03 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.613 2.875 . . . . 0.0 116.167 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -57.69 -26.4 61.65 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.6 161.66 34.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.457 1.026 . . . . 0.0 112.997 -169.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.72 -48.76 53.93 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.168 -1.351 . . . . 0.0 112.658 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -51.38 -27.07 22.83 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.099 2.532 . . . . 0.0 115.11 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -60.51 -13.89 16.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 119.624 1.102 . . . . 0.0 113.798 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -118.1 12.28 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.664 1.186 . . . . 0.0 111.449 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.0 mtm -123.67 -45.69 2.04 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.358 1.063 . . . . 0.0 109.642 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.78 -34.72 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -58.26 17.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.14 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.05 -39.16 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.762 1.641 . . . . 0.0 111.639 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.73 HG12 HD22 ' A' ' 96' ' ' LEU . 2.6 t -57.89 -34.56 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.957 0.903 . . . . 0.0 111.3 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 HD21 ' A' ' 96' ' ' LEU . 21.1 mt -71.37 -44.13 65.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.993 0.815 . . . . 0.0 110.534 175.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.92 -36.55 83.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.65 0.659 . . . . 0.0 109.469 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.35 -18.68 62.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 112.314 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.3 tp -79.55 -45.76 18.63 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.617 1.099 . . . . 0.0 108.879 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.06 -35.58 76.72 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.881 -0.512 . . . . 0.0 111.496 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -64.95 -19.65 66.07 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.502 -0.749 . . . . 0.0 112.21 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -95.84 -42.91 8.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.679 1.192 . . . . 0.0 111.225 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ptm -144.27 17.95 1.72 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.343 0.657 . . . . 0.0 112.283 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -5.76 14.12 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.35 -0.844 . . . . 0.0 114.312 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.72 -23.41 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.671 0.788 . . . . 0.0 111.033 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -15.51 8.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.446 -175.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -128.0 149.84 50.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.608 1.163 . . . . 0.0 112.267 -168.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -112.95 144.55 42.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.28 146.4 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 t -134.69 146.85 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 25.1 mtpt -121.82 147.57 45.79 Favored 'General case' 0 N--CA 1.462 0.165 0 O-C-N 121.83 -0.544 . . . . 0.0 110.377 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.82 128.74 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -85.94 103.5 14.72 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 170.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.305 32.6 m -77.6 50.51 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 122.616 1.198 . . . . 0.0 114.179 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -155.29 -44.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.594 1.557 . . . . 0.0 108.519 168.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -75.24 -50.58 15.7 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.019 1.327 . . . . 0.0 110.065 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -132.11 37.74 3.55 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.908 1.283 . . . . 0.0 110.873 -170.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -67.04 -4.2 9.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.601 1.161 . . . . 0.0 112.872 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -53.26 -47.88 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.114 1.766 . . . . 0.0 110.851 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.0 m -55.29 -41.51 72.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.848 0.749 . . . . 0.0 111.154 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 -65.43 0.72 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -170.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.86 -42.88 15.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.128 0.87 . . . . 0.0 113.361 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -63.45 -44.55 94.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.428 1.114 . . . . 0.0 111.377 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -68.04 -34.8 77.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.603 0.638 . . . . 0.0 109.796 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.07 66.24 0.71 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 -169.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.35 132.7 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.43 ' CE ' HD13 ' B' ' 72' ' ' LEU . 24.2 mtm -149.02 18.99 0.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.29 160.37 38.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -167.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.21 134.39 26.09 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.214 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.67 132.7 15.98 Favored 'Cis proline' 0 N--CA 1.451 -0.989 0 N-CA-C 107.443 -1.791 . . . . 0.0 107.443 -11.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.5 m -98.77 150.35 21.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 169.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.81 117.47 8.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.75 111.52 19.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 t -93.49 134.7 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.17 158.06 39.11 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.643 1.177 . . . . 0.0 110.286 -173.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -147.95 137.42 22.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 42.99 29.01 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.042 2.537 . . . . 0.0 114.902 170.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.43 -28.3 2.79 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 116.595 1.398 . . . . 0.0 116.595 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.68 158.72 43.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.418 1.609 . . . . 0.0 114.839 -167.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.39 136.54 26.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.288 1.035 . . . . 0.0 108.28 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.01 -21.07 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.784 1.633 . . . . 0.0 111.428 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -144.72 157.87 44.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.961 0.8 . . . . 0.0 108.922 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.1 148.42 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -169.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.9 m -153.62 148.59 26.66 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.777 1.231 . . . . 0.0 108.011 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.26 66.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.65 156.94 8.98 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -73.46 156.71 37.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.676 0.39 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -153.37 150.63 24.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.203 1.001 . . . . 0.0 108.652 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.84 172.81 12.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.847 2.365 . . . . 0.0 111.536 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -45.9 71.14 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.237 1.015 . . . . 0.0 111.966 -173.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.26 -39.95 93.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.863 0.301 . . . . 0.0 110.429 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.77 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.893 0.477 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.73 HD22 HG12 ' A' ' 38' ' ' VAL . 1.8 tp -61.97 -54.82 36.35 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.322 1.049 . . . . 0.0 109.645 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.81 -36.6 84.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.34 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.41 -47.09 87.37 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.887 0.767 . . . . 0.0 110.933 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.0 tp -55.67 -42.14 74.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.213 0.605 . . . . 0.0 110.545 -174.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.8 p -86.1 -40.49 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 123.667 0.604 . . . . 0.0 111.245 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 104' ' ' LEU . 11.4 t30 -57.46 -25.65 60.01 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.906 -1.121 . . . . 0.0 112.417 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -50.49 -31.17 14.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.691 1.196 . . . . 0.0 112.4 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -137.87 -7.14 1.64 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.786 2.034 . . . . 0.0 105.985 169.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.79 145.36 42.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.9 m120 65.12 122.65 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 128.112 2.565 . . . . 0.0 111.298 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -147.69 145.21 28.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 129.122 2.969 . . . . 0.0 104.224 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 6.4 mt -123.45 145.95 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 119.59 1.087 . . . . 0.0 108.584 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.0 148.3 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.904 1.282 . . . . 0.0 107.836 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.66 149.34 52.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 109.988 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -114.06 145.74 41.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.45 127.49 44.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 8.5 m -151.26 170.31 19.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.508 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -67.16 89.51 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.393 1.077 . . . . 0.0 110.924 172.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.31 20.53 58.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 117.073 -1.96 . . . . 0.0 114.835 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 26.01 84.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 124.769 2.224 . . . . 0.0 112.932 -177.034 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -152.41 167.71 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.529 3.132 . . . . 0.0 104.94 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.658 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 42.03 -103.76 0.05 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.227 1.811 . . . . 0.0 112.956 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -40.73 27.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.037 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -53.35 33.5 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.146 1.339 . . . . 0.0 109.769 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -49.91 -48.31 51.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.353 2.261 . . . . 0.0 109.64 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 24.3 ttm -67.79 -45.16 75.62 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.903 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.27 -36.31 83.67 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.562 1.145 . . . . 0.0 110.728 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.61 -32.06 63.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 111.853 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.98 -49.65 57.18 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -58.77 -37.94 77.37 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.258 1.023 . . . . 0.0 111.769 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.47 -49.38 77.02 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -65.0 -22.65 67.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.31 -20.14 66.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.156 0.889 . . . . 0.0 112.951 175.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.499 ' CD1' ' HE2' ' B' ' 132' ' ' LYS . 0.1 OUTLIER -132.35 -0.54 3.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.379 0.991 . . . . 0.0 113.428 -175.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mt -126.42 85.83 2.44 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.4 -165.95 1.05 Allowed Glycine 0 CA--C 1.525 0.656 0 C-N-CA 126.562 2.029 . . . . 0.0 114.204 -169.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.13 -20.05 23.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.673 1.189 . . . . 0.0 112.894 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.87 -23.99 34.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.156 1.782 . . . . 0.0 112.225 169.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -123.88 155.6 37.77 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.732 1.613 . . . . 0.0 110.6 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -131.22 144.91 51.68 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 126.132 1.773 . . . . 0.0 106.674 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.71 148.27 31.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 124.032 0.933 . . . . 0.0 108.511 -171.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -147.88 162.42 39.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 52.4 m -134.12 140.42 46.57 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.036 1.335 . . . . 0.0 108.263 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.97 174.37 13.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 111.295 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.5 -174.93 44.31 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -51.23 -55.65 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 126.332 1.853 . . . . 0.0 114.157 -173.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -138.18 29.57 2.49 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.957 1.703 . . . . 0.0 108.655 -171.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.6 157.39 37.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.69 1.996 . . . . 0.0 114.193 -169.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 83.1 t60 146.98 104.97 0.0 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 131.072 3.749 . . . . 0.0 104.414 172.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.6 174.38 46.97 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 14.5 tp -154.84 65.36 0.66 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.518 1.127 . . . . 0.0 108.064 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -49.87 121.73 13.04 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.315 1.446 . . . . 0.0 110.494 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -64.8 -24.44 61.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.202 1.935 . . . . 0.0 113.399 -175.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -18.37 64.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.703 1.592 . . . . 0.0 112.15 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -85.84 -40.58 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -60.2 -50.74 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.74 -42.68 84.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.95 0.9 . . . . 0.0 110.687 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.45 -30.55 60.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.565 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mmm -84.49 -40.64 17.42 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.519 1.054 . . . . 0.0 110.907 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.91 -29.15 68.17 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.541 0.61 . . . . 0.0 110.824 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.79 -28.28 67.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.498 0.719 . . . . 0.0 112.088 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.67 16.0 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.954 1.302 . . . . 0.0 110.765 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.08 38.87 92.74 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.497 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.76 150.46 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -124.3 139.63 53.73 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.998 0.919 . . . . 0.0 109.104 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.49 ' HB ' HE21 ' B' ' 62' ' ' GLN . 30.7 pt -140.67 17.56 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.102 1.361 . . . . 0.0 110.745 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -67.48 15.82 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -169.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -143.26 -5.11 0.87 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.161 2.585 . . . . 0.0 112.019 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.49 HE21 ' HB ' ' B' ' 59' ' ' ILE . 2.8 pt20 -56.67 144.71 31.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.684 1.129 . . . . 0.0 112.1 -169.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -69.04 155.77 39.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.981 1.312 . . . . 0.0 110.38 169.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 9.0 m -167.29 145.99 4.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.47 1.908 . . . . 0.0 107.306 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -171.18 167.7 6.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.844 1.258 . . . . 0.0 109.837 -170.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.83 168.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.045 0.839 . . . . 0.0 111.41 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -48.99 135.55 6.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -144.32 103.84 4.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.307 1.051 . . . . 0.0 109.143 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 5.9 m -49.15 -27.27 3.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.626 1.57 . . . . 0.0 113.864 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.08 -22.76 64.92 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.725 1.148 . . . . 0.0 111.652 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.0 -42.22 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 117.75 -1.119 . . . . 0.0 108.622 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.43 HD13 ' CE ' ' A' ' 70' ' ' MET . 6.9 tt -61.06 -51.35 69.54 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.91 1.232 . . . . 0.0 109.451 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -25.17 68.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.218 0.917 . . . . 0.0 111.412 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -84.96 -18.65 33.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.597 1.159 . . . . 0.0 112.894 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.89 163.46 4.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.216 1.007 . . . . 0.0 111.29 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.55 -32.71 15.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.839 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 tp -143.91 144.43 31.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.027 1.331 . . . . 0.0 109.725 -172.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 t -117.6 108.67 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 169.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 74.8 t -82.34 105.99 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 5.8 m -65.5 129.27 39.14 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 168.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 tp -139.94 66.39 1.4 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 122.715 0.406 . . . . 0.0 111.699 -168.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 54.4 p -164.29 -45.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 O-C-N 122.03 -0.419 . . . . 0.0 110.312 169.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.81 28.2 43.3 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -141.29 120.89 13.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.584 0.754 . . . . 0.0 111.197 -169.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.34 -17.6 59.27 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.715 1.606 . . . . 0.0 113.865 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.91 -13.49 16.15 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.197 0.908 . . . . 0.0 111.743 174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.86 -6.68 2.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm 96.58 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.317 3.047 . . . . 0.0 110.979 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.8 m 38.37 45.77 0.82 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.044 2.137 . . . . 0.0 113.179 -169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.09 132.78 39.52 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.395 2.063 . . . . 0.0 112.031 -169.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' B' ' 91' ' ' MET . 0.0 OUTLIER -82.59 1.75 36.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 116.74 -1.6 . . . . 0.0 114.594 -175.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.8 p 45.08 89.76 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.538 1.535 . . . . 0.0 113.294 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -54.95 138.11 77.33 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.775 2.317 . . . . 0.0 109.485 -169.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.76 3.07 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.666 1 C-N-CA 125.318 4.012 . . . . 0.0 117.124 -168.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -67.55 -5.81 17.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.158 0.983 . . . . 0.0 112.332 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 148.33 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 110.147 -169.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -78.63 158.92 28.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.963 0.905 . . . . 0.0 108.839 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -151.73 145.37 24.97 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.757 -1.214 . . . . 0.0 109.488 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -155.73 148.43 24.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.82 137.79 32.08 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -139.57 -21.59 0.91 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.16 149.61 19.47 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 119.583 1.083 . . . . 0.0 110.648 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -160.75 169.3 23.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.38 1.872 . . . . 0.0 107.387 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.91 46.75 26.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.243 1.417 . . . . 0.0 112.399 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -43.61 116.62 2.3 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.766 2.026 . . . . 0.0 113.592 -171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.23 -16.62 28.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.97 3.113 . . . . 0.0 113.318 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.87 -2.52 1.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.314 1.416 . . . . 0.0 111.824 169.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -125.88 13.01 7.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.154 1.782 . . . . 0.0 110.934 -171.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.29 154.21 0.42 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.729 0.811 . . . . 0.0 109.884 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -53.3 -44.08 68.04 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.867 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.66 -20.4 2.74 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 115.001 0.76 . . . . 0.0 115.001 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.4 p -68.94 166.02 18.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.0 -42.18 98.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.401 0.62 . . . . 0.0 110.311 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -69.23 -42.19 75.99 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.918 -1.515 . . . . 0.0 109.403 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.78 -35.66 60.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.149 1.795 . . . . 0.0 109.713 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -56.38 -52.53 64.27 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 121.719 -0.613 . . . . 0.0 110.728 170.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -63.95 -44.72 91.96 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.773 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.84 86.92 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.441 1.096 . . . . 0.0 111.667 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.89 -49.67 69.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.44 69.01 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.951 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -65.27 -50.51 65.47 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.39 1.076 . . . . 0.0 109.457 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -59.85 -48.34 82.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.87 -37.92 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 117.535 -1.221 . . . . 0.0 110.862 -176.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.29 -38.92 92.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.453 1.933 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.86 -44.89 93.89 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.483 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.05 -56.49 14.64 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.308 0.643 . . . . 0.0 110.148 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.8 mt -56.91 -47.7 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.837 1.255 . . . . 0.0 110.255 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.31 -45.17 96.62 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.93 -42.89 99.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.79 0.795 . . . . 0.0 111.891 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.6 -0.688 . . . . 0.0 111.908 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' B' ' 131' ' ' LEU . 4.2 mm? -71.5 -33.6 69.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.572 1.078 . . . . 0.0 110.709 175.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' B' ' 27' ' ' TYR . 22.6 ttmt -61.03 -43.97 98.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.888 170.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.46 -41.04 96.61 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.36 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -58.94 -40.74 85.58 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 121.77 2.077 . . . . 0.0 110.496 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.62 74.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.32 -39.82 17.24 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.267 1.427 . . . . 0.0 111.623 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 59.7 p -97.38 -16.0 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.005 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 65.44 25.34 71.32 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.887 1.232 . . . . 0.0 112.332 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.749 1.219 . . . . 0.0 108.466 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.64 165.07 37.66 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.157 1.383 . . . . 0.0 107.529 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.66 101.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 168.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.13 166.83 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -121.92 107.33 12.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.85 175.46 4.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.422 1.089 . . . . 0.0 109.679 175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -159.41 -172.71 3.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.92 1.688 . . . . 0.0 107.054 169.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -38.18 -41.8 0.63 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.092 2.957 . . . . 0.0 115.941 -169.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -128.41 -27.86 2.61 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.224 1.41 . . . . 0.0 111.064 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -61.74 -23.55 66.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.753 -1.118 . . . . 0.0 111.87 172.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 15' ' ' THR . 40.3 t80 -54.69 -54.45 41.63 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.617 1.553 . . . . 0.0 107.952 169.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -57.96 -47.84 81.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.367 0.531 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.12 96.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.556 0.217 . . . . 0.0 111.305 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -80.07 -15.71 56.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.772 1.229 . . . . 0.0 112.169 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.492 HG22 HG11 ' A' ' 20' ' ' VAL . 67.1 p -107.11 -9.28 16.21 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.122 0.969 . . . . 0.0 112.613 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.435 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 67.2 m -71.3 -3.13 18.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.83 0.741 . . . . 0.0 112.991 -175.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -144.12 155.97 44.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.314 1.446 . . . . 0.0 108.119 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -167.4 54.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 123.878 0.751 . . . . 0.0 112.407 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.481 HG22 ' HG2' ' A' ' 79' ' ' LYS . 38.7 t -119.97 121.27 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 172.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 53' ' ' VAL . 7.7 p -131.83 124.49 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 122.739 1.257 . . . . 0.0 108.207 -170.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.9 tp -83.43 100.23 10.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.53 141.16 36.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.22 145.25 45.47 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.392 1.077 . . . . 0.0 109.328 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.79 109.13 10.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -170.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.549 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.6 p-90 -121.79 160.03 25.46 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -163.71 159.29 17.33 Favored Pre-proline 0 C--O 1.233 0.2 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.23 -27.16 46.08 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.234 1.956 . . . . 0.0 113.062 168.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -58.61 -24.65 61.45 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.99 151.58 50.96 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.928 1.24 . . . . 0.0 111.875 -169.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.34 -48.73 71.15 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.201 -1.333 . . . . 0.0 112.512 175.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.79 -27.35 20.01 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.435 2.757 . . . . 0.0 115.464 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 m -58.59 -18.56 31.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 120.172 1.351 . . . . 0.0 113.644 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.95 12.11 20.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.315 1.046 . . . . 0.0 111.522 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.9 mtm -122.88 -43.93 2.22 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.6 1.16 . . . . 0.0 109.546 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -62.53 -35.88 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 123.405 0.682 . . . . 0.0 109.337 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.54 23.53 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.243 -0.884 . . . . 0.0 112.01 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.17 -40.51 59.43 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.664 1.576 . . . . 0.0 111.493 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.652 HG12 HD22 ' A' ' 96' ' ' LEU . 2.3 t -56.65 -38.27 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.892 0.769 . . . . 0.0 111.197 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 96' ' ' LEU . 20.4 mt -66.59 -48.69 68.78 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-N 118.568 0.622 . . . . 0.0 110.095 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.62 -36.43 82.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.776 0.322 . . . . 0.0 110.42 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.31 -24.53 66.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.259 1.424 . . . . 0.0 111.723 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.427 HD11 ' SD ' ' A' ' 46' ' ' MET . 34.8 tp -84.55 -40.02 18.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.69 0.677 . . . . 0.0 110.976 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -69.18 -33.14 72.91 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.982 -0.449 . . . . 0.0 110.473 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -70.53 -3.81 19.88 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -113.64 -42.43 3.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.624 1.569 . . . . 0.0 111.609 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.427 ' SD ' HD11 ' A' ' 42' ' ' LEU . 20.6 ptm -136.04 16.79 3.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.825 0.85 . . . . 0.0 112.336 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.84 -5.42 18.72 Favored Glycine 0 C--O 1.227 -0.286 0 O-C-N 120.771 -1.205 . . . . 0.0 114.23 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.94 -23.8 67.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.425 0.612 . . . . 0.0 111.342 169.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -32.87 4.87 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.211 1.404 . . . . 0.0 110.983 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 151.6 19.82 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.978 1.311 . . . . 0.0 111.816 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -128.23 154.18 46.14 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.4 143.53 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 20' ' ' VAL . 1.7 m -131.84 109.61 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.549 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 47.5 mtpt -82.91 157.09 23.19 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 120.56 -1.338 . . . . 0.0 109.75 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mm -130.08 124.02 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -85.75 109.8 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 26' ' ' ALA . 13.0 m -73.15 9.96 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -171.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.85 -34.58 4.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.315 0.962 . . . . 0.0 110.644 169.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.69 -43.13 12.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.869 0.759 . . . . 0.0 111.447 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -141.79 42.94 1.71 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.643 1.211 . . . . 0.0 110.819 -170.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -4.25 45.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.717 1.207 . . . . 0.0 113.833 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -52.4 -43.87 65.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.257 1.023 . . . . 0.0 110.342 -169.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.8 m -58.08 -38.84 77.14 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.38 1.072 . . . . 0.0 112.379 174.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.42 -64.29 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.323 1.049 . . . . 0.0 109.115 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -47.41 -41.43 17.12 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.645 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -62.2 -43.12 99.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.296 1.548 . . . . 0.0 111.131 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -76.58 -9.32 58.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.193 0.597 . . . . 0.0 112.422 175.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.79 60.26 6.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 -173.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.17 -64.07 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 -173.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 mtm 58.0 5.13 0.34 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.23 2.612 . . . . 0.0 114.719 172.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -141.02 157.38 45.41 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.346 0.975 . . . . 0.0 111.638 -169.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.2 mm -138.96 139.51 23.83 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -169.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.37 138.77 49.14 Favored 'Cis proline' 0 N--CA 1.453 -0.867 0 N-CA-C 107.824 -1.645 . . . . 0.0 107.824 -10.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.5 m -112.97 143.56 44.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.8 mt -120.84 127.54 52.0 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.95 1.7 . . . . 0.0 107.465 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -116.25 114.39 24.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.47 122.13 46.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.92 153.08 38.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 110.167 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG2' HG22 ' A' ' 19' ' ' VAL . 44.8 mtpt -137.12 130.79 31.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.001 174.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.7 t70 42.15 35.23 0.56 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.791 2.036 . . . . 0.0 114.21 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 113.9 -8.51 23.5 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 116.628 1.411 . . . . 0.0 116.628 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.73 152.39 47.93 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.444 1.622 . . . . 0.0 112.942 -169.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.86 141.93 16.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.78 1.232 . . . . 0.0 108.663 175.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.74 -22.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 124.166 0.986 . . . . 0.0 109.537 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -153.76 166.44 32.85 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 122.587 1.184 . . . . 0.0 107.805 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -158.13 132.5 8.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.939 1.696 . . . . 0.0 106.703 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m -147.62 148.63 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.064 0.945 . . . . 0.0 109.053 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.21 124.22 41.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.18 156.17 9.28 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 124.618 1.104 . . . . 0.0 110.675 176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.2 148.99 46.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 117.314 0.557 . . . . 0.0 111.211 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.03 148.04 18.93 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 168.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.5 177.68 6.49 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.33 2.687 . . . . 0.0 112.443 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -33.25 69.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.345 1.458 . . . . 0.0 112.334 -169.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -81.85 -40.72 22.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.081 0.552 . . . . 0.0 110.199 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.21 92.68 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.051 0.54 . . . . 0.0 110.65 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.652 HD22 HG12 ' A' ' 38' ' ' VAL . 2.1 tp -57.84 -52.58 64.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.823 0.849 . . . . 0.0 109.72 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -69.1 -36.39 77.51 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 117.917 -1.039 . . . . 0.0 110.478 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.06 -46.64 88.86 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.551 1.068 . . . . 0.0 110.599 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.5 tp -58.23 -40.28 81.29 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 124.809 1.244 . . . . 0.0 111.673 -177.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 p -87.97 -40.57 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.164 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -57.77 -34.29 69.41 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.977 1.311 . . . . 0.0 112.131 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -65.61 -8.73 21.71 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -123.77 -33.54 3.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.501 1.12 . . . . 0.0 112.197 174.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.247 0.925 0 C-N-CA 126.752 2.021 . . . . 0.0 109.717 178.688 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -79.16 80.2 5.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.987 0.915 . . . . 0.0 108.756 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m120 78.98 129.1 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.654 2.781 . . . . 0.0 111.753 175.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.458 ' H ' ' HA ' ' B' ' 32' ' ' TRP . 54.9 mtmt -125.34 123.76 40.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 129.598 3.159 . . . . 0.0 103.725 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -92.78 141.46 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.76 -168.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 12.3 tt -133.65 140.44 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -131.24 136.16 47.98 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -110.44 141.86 42.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.85 123.03 36.36 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 78.7 p -156.1 147.67 22.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 98.9 m -46.47 111.74 0.41 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.425 1.49 . . . . 0.0 111.848 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.22 11.01 50.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.28 -0.733 . . . . 0.0 113.711 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 38.18 35.51 0.09 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.916 2.486 . . . . 0.0 113.793 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -69.64 -46.74 65.47 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.65 -65.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -168.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -33.89 68.45 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.833 0.742 . . . . 0.0 111.736 -174.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.3 p -56.24 -55.65 30.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.31 1.444 . . . . 0.0 111.398 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -52.1 -49.76 62.95 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.346 1.858 . . . . 0.0 109.657 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 9.2 ttm -67.83 -46.02 73.0 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.599 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.819 0.848 . . . . 0.0 110.77 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.0 -27.72 61.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.111 0.869 . . . . 0.0 110.149 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.05 -45.94 24.21 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -55.27 -33.67 63.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.414 1.086 . . . . 0.0 111.34 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.64 11.87 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 123.888 0.875 . . . . 0.0 110.604 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -64.96 -22.84 67.07 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.403 1.002 . . . . 0.0 113.665 -168.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.14 -16.35 52.02 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 170.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' B' ' 132' ' ' LYS . 11.9 m-85 -130.01 -40.85 1.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.395 1.078 . . . . 0.0 112.789 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.22 75.93 4.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.624 1.97 . . . . 0.0 106.234 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -164.04 1.2 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.977 1.751 . . . . 0.0 112.255 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.49 -7.9 8.03 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.543 -0.974 . . . . 0.0 113.137 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.16 -19.29 62.92 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.909 -1.119 . . . . 0.0 109.573 168.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . 0.458 ' HA ' ' H ' ' B' ' 4' ' ' LYS . 56.5 m95 -130.87 175.7 8.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 127.776 2.431 . . . . 0.0 110.121 -174.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -153.04 129.9 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.35 144.31 14.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.871 0.868 . . . . 0.0 109.273 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -139.46 156.8 46.72 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 107.308 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.2 m -145.5 137.69 25.61 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.52 173.39 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.617 0.767 . . . . 0.0 111.339 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.08 40.64 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 122.247 -0.283 . . . . 0.0 112.978 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.403 HG13 ' HE3' ' B' ' 88' ' ' LYS . 1.7 tt -53.19 -57.19 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 113.679 -170.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -132.11 30.7 4.22 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.079 1.752 . . . . 0.0 108.039 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.8 149.93 49.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.563 1.945 . . . . 0.0 112.82 -169.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 146.45 100.4 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 130.995 3.718 . . . . 0.0 104.071 177.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.23 -179.29 48.7 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -171.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 23.0 tp -161.45 100.86 1.19 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -60.88 122.62 70.28 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.352 -0.832 . . . . 0.0 108.782 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.62 -26.56 80.49 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 121.734 1.622 . . . . 0.0 112.097 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.573 ' ND2' ' CE1' ' B' ' 120' ' ' PHE . 1.2 t30 -68.25 -27.92 66.76 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.979 -1.076 . . . . 0.0 112.086 171.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.93 -36.04 79.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 121.127 1.785 . . . . 0.0 109.746 171.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.87 -51.66 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -52.57 -47.97 66.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.852 0.751 . . . . 0.0 109.977 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.89 57.24 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.655 1.182 . . . . 0.0 111.508 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.86 -38.79 20.71 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.012 0.925 . . . . 0.0 111.483 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -61.75 -28.74 69.65 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.553 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.44 -27.95 64.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.931 0.787 . . . . 0.0 111.908 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.09 14.15 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 110.97 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.7 36.38 82.59 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.466 -1.186 . . . . 0.0 113.222 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 59.7 mt -112.97 149.07 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -116.8 137.1 52.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.793 0.837 . . . . 0.0 108.92 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.2 pt -139.31 16.95 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 124.861 1.264 . . . . 0.0 110.836 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -58.91 -15.21 11.68 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -91.44 -15.8 28.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.308 1.443 . . . . 0.0 113.498 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -56.65 151.45 13.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.6 p -133.47 174.14 10.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.663 2.385 . . . . 0.0 109.359 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 15.7 m -153.01 -173.77 4.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.143 0.977 . . . . 0.0 109.517 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -161.66 167.93 24.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.274 1.829 . . . . 0.0 108.044 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.0 pt -63.37 169.1 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -48.62 135.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -142.0 98.84 3.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.544 1.164 . . . . 0.0 108.211 -171.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -51.38 -28.07 11.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.48 1.912 . . . . 0.0 113.989 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.81 -23.34 61.54 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 119.608 1.094 . . . . 0.0 110.494 -172.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -33.64 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 118.285 -0.865 . . . . 0.0 109.788 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.61 -52.93 61.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.639 1.109 . . . . 0.0 109.522 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -29.07 66.36 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.24 0.473 . . . . 0.0 110.964 -176.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -87.12 -12.45 47.06 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.673 1.589 . . . . 0.0 112.663 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.96 162.35 22.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.967 0.889 . . . . 0.0 110.434 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.89 -34.15 15.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.052 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.43 142.97 33.66 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.744 1.217 . . . . 0.0 110.202 -172.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -114.56 103.76 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 169.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.8 98.12 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -66.77 122.88 18.64 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 168.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 tp -124.66 52.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 110.083 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -153.02 -174.82 5.07 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.18 0.992 . . . . 0.0 108.761 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.1 44.56 1.2 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 106.789 -2.525 . . . . 0.0 106.789 169.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -150.97 164.59 36.02 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.215 2.206 . . . . 0.0 108.244 -169.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -131.38 7.45 4.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.229 1.412 . . . . 0.0 112.701 -172.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.21 -15.9 49.71 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.889 0.768 . . . . 0.0 112.709 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -71.24 28.08 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -169.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . 0.403 ' HE3' HG13 ' B' ' 39' ' ' ILE . 26.1 ttmt 80.84 17.45 0.55 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.709 2.004 . . . . 0.0 112.432 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 m 34.63 52.09 1.26 Allowed Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.353 1.861 . . . . 0.0 112.732 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.5 131.03 40.27 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.812 1.675 . . . . 0.0 110.785 -169.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -1.24 57.49 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 116.785 -1.579 . . . . 0.0 113.706 -175.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.9 p 48.0 95.47 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 126.12 1.768 . . . . 0.0 114.177 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.49 132.79 52.72 Favored 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 122.17 1.913 . . . . 0.0 109.51 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.4 -5.28 11.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.819 3.679 . . . . 0.0 117.817 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -74.4 15.35 0.35 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.093 1.315 . . . . 0.0 112.237 170.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 8.0 t -135.29 142.92 38.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.364 1.866 . . . . 0.0 106.736 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -69.99 153.69 42.9 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -141.39 141.12 33.79 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -145.97 157.97 43.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.56 137.06 47.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -142.02 -2.12 1.18 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.615 0.766 . . . . 0.0 112.668 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.68 -54.06 4.39 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 59.11 -2.68 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.534 2.334 . . . . 0.0 115.076 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -160.92 170.13 21.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.331 2.653 . . . . 0.0 105.771 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -137.97 106.62 8.12 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 118.877 0.762 . . . . 0.0 109.36 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.446 ' C ' ' CE1' ' B' ' 120' ' ' PHE . 95.4 Cg_endo -66.82 -36.0 25.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 124.033 3.155 . . . . 0.0 112.175 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.88 -13.63 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 129.598 3.159 . . . . 0.0 113.918 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -103.45 -54.42 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.394 1.478 . . . . 0.0 107.488 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . 39.25 -164.11 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.468 1.907 . . . . 0.0 113.34 -170.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -70.11 -48.03 59.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.37 -22.12 2.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 62.6 p -71.02 168.54 16.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.3 -41.96 98.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.379 0.609 . . . . 0.0 110.516 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.55 -41.13 69.49 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 117.395 -1.288 . . . . 0.0 109.066 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -76.59 -33.44 58.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.544 1.52 . . . . 0.0 110.036 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -56.07 -56.51 19.94 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 119.009 0.822 . . . . 0.0 109.154 169.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -59.38 -41.87 90.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.45 93.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.59 1.156 . . . . 0.0 112.006 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -64.53 -46.98 80.55 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.573 ' CE1' ' ND2' ' B' ' 47' ' ' ASN . 14.5 m-85 -64.82 -36.07 83.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.425 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -61.27 -49.23 77.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.132 0.878 . . . . 0.0 110.046 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 38.9 ttp-105 -62.84 -52.53 62.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.27 -35.71 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.26 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 30.7 ptt85 -61.68 -41.05 97.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.212 1.824 . . . . 0.0 111.132 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.97 -43.7 94.91 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.459 0.475 . . . . 0.0 110.377 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -68.63 -50.56 50.44 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.876 0.47 . . . . 0.0 110.887 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 mt -56.05 -48.67 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.405 1.082 . . . . 0.0 109.114 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -58.32 -46.96 92.26 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.45 -47.07 85.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.801 0.8 . . . . 0.0 111.737 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -62.95 -47.54 82.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.068 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.81 -37.04 86.29 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.374 0.534 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' B' ' 27' ' ' TYR . 41.3 ttmt -63.13 -43.75 97.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.97 0.805 . . . . 0.0 109.739 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.2 -37.34 79.95 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-O 116.74 -1.6 . . . . 0.0 111.16 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -59.38 -40.09 85.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 122.008 2.185 . . . . 0.0 110.039 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.05 75.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.202 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.45 -47.68 11.96 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.393 1.077 . . . . 0.0 111.796 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 65.2 p -82.7 -22.73 34.41 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.969 2.108 . . . . 0.0 112.103 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.7 11.24 62.35 Favored Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -168.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.5 ' HA ' ' HE2' ' B' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.685 2.394 . . . . 0.0 113.772 -173.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.32 167.36 28.91 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.318 1.447 . . . . 0.0 107.84 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.1 98.51 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 169.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.14 168.6 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.714 1.606 . . . . 0.0 108.307 177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -125.11 122.1 36.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.811 1.245 . . . . 0.0 109.09 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.33 171.7 13.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.858 1.663 . . . . 0.0 109.859 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -136.09 -167.83 2.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.082 1.753 . . . . 0.0 108.614 169.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -47.12 -27.78 1.53 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.387 2.275 . . . . 0.0 113.627 170.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.49 -30.8 0.82 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.662 1.185 . . . . 0.0 112.06 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.8 m -62.57 -20.02 64.28 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.895 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -48.32 -55.7 9.98 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.608 1.094 . . . . 0.0 110.427 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 m -64.18 -44.55 91.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.949 0.34 . . . . 0.0 110.168 -176.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.23 81.35 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.924 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -82.2 -13.3 57.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.401 1.081 . . . . 0.0 112.541 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 66.6 p -115.89 -5.82 12.04 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 0.0 112.914 -170.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -74.75 -6.05 46.74 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.86 147.13 36.66 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.245 1.018 . . . . 0.0 109.346 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.13 -175.8 34.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 124.309 0.957 . . . . 0.0 111.689 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.59 125.75 48.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -136.03 117.95 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.111 0.964 . . . . 0.0 108.727 -169.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt -89.66 116.06 27.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.87 135.81 39.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.883 0.765 . . . . 0.0 109.027 173.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.91 138.7 53.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.068 1.347 . . . . 0.0 108.984 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -119.88 105.07 10.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.425 ' CD1' ' CE ' ' A' ' 54' ' ' LYS . 4.8 p-90 -123.77 147.78 47.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.896 1.278 . . . . 0.0 108.202 -173.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -166.36 160.62 12.29 Favored Pre-proline 0 CA--C 1.534 0.344 0 O-C-N 121.545 -0.722 . . . . 0.0 111.56 171.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.73 -7.58 2.36 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.453 3.435 . . . . 0.0 116.504 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -54.73 -29.28 53.07 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.718 1.207 . . . . 0.0 113.104 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -163.58 162.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.13 -47.55 10.25 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.46 2.457 . . . . 0.0 115.596 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.57 -30.78 56.36 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.582 2.691 . . . . 0.0 114.041 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 m -62.48 -18.11 61.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.658 1.572 . . . . 0.0 113.909 175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.79 22.03 13.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 0.0 111.211 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 72.2 mtm -131.24 -38.79 1.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.704 1.202 . . . . 0.0 110.27 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tp -63.82 -37.02 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.196 -0.94 . . . . 0.0 108.607 169.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.23 -54.31 57.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.874 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -58.96 -39.71 78.29 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.285 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.17 -38.96 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.055 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 39' ' ' LEU . 2.3 mm? -68.01 -44.51 76.4 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.69 1.132 . . . . 0.0 110.589 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.53 -34.45 77.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.856 0.753 . . . . 0.0 109.813 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -71.2 -19.8 62.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.749 1.62 . . . . 0.0 112.54 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -84.24 -44.63 13.7 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 108.596 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.89 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.385 -0.197 . . . . 0.0 111.127 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.71 -10.09 56.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.236 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.46 -47.08 4.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.24 1.016 . . . . 0.0 111.064 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.7 ptm -135.46 15.96 3.42 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.528 0.731 . . . . 0.0 112.215 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.6 -3.47 20.68 Favored Glycine 0 CA--C 1.519 0.343 0 O-C-N 121.102 -0.999 . . . . 0.0 114.192 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.67 -24.43 65.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.83 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.16 -25.49 8.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.509 1.124 . . . . 0.0 111.83 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.1 tp -118.46 146.56 44.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 111.483 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.79 147.78 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.82 145.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.67 148.33 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' CE ' ' CD1' ' A' ' 25' ' ' TRP . 15.0 mtpt -122.09 146.56 47.08 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 118.862 0.755 . . . . 0.0 111.187 175.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.471 HG22 HG22 ' A' ' 57' ' ' VAL . 6.5 mm -107.78 132.97 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.075 -2.935 . . . . 0.0 103.075 169.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.29 88.98 6.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 55' ' ' ILE . 1.4 t -70.41 50.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 127.416 2.286 . . . . 0.0 114.761 -168.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -159.48 -33.83 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.067 2.147 . . . . 0.0 109.234 169.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -89.53 -42.34 11.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.688 0.795 . . . . 0.0 109.522 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -133.19 33.85 3.59 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.329 1.052 . . . . 0.0 111.648 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.58 -7.07 9.01 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.907 1.283 . . . . 0.0 113.375 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -47.39 -50.06 23.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 110.552 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.0 m -59.66 -36.11 75.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.234 0.614 . . . . 0.0 111.938 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.77 -57.31 6.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.45 -43.16 51.98 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.985 0.802 . . . . 0.0 113.434 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.94 -38.29 90.43 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.604 1.162 . . . . 0.0 110.97 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -76.89 -32.12 57.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.584 0.629 . . . . 0.0 110.077 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 77.59 1.38 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -170.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.86 -64.81 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . 0.413 3.1 ppp? 45.47 24.64 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.428 2.691 . . . . 0.0 114.96 172.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.1 p -149.32 163.97 36.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.187 2.195 . . . . 0.0 110.96 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.3 mm -140.54 146.48 45.12 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -175.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.78 143.52 67.67 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 -10.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.4 m -119.37 150.16 40.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.267 0.556 . . . . 0.0 110.517 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.28 124.6 32.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -116.27 113.87 23.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.5 127.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -124.17 157.25 35.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.533 1.133 . . . . 0.0 110.169 -169.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.82 130.86 20.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.43 32.29 0.5 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.447 2.299 . . . . 0.0 114.572 170.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.31 -19.2 6.03 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 116.489 1.356 . . . . 0.0 116.489 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -135.29 151.82 50.92 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 119.425 1.612 . . . . 0.0 112.878 -168.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.9 t -69.05 137.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.74 -25.21 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.997 1.719 . . . . 0.0 109.553 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -143.89 152.76 41.55 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.06 137.07 27.34 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.5 t -151.27 146.28 25.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.7 t -140.6 76.57 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.97 163.64 18.6 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.409 1.004 . . . . 0.0 110.878 -176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.37 147.38 51.13 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.807 0.803 . . . . 0.0 110.644 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 91' ' ' LYS . 2.8 mppt? -139.32 144.44 40.22 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.633 1.173 . . . . 0.0 108.482 170.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.55 170.94 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.521 2.147 . . . . 0.0 110.052 169.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -45.31 69.98 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.998 0.919 . . . . 0.0 112.359 -173.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.7 -43.12 76.72 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.541 0.155 . . . . 0.0 110.782 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.1 84.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.0 -0.438 . . . . 0.0 110.61 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 tp -67.68 -47.64 68.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.427 0.103 . . . . 0.0 110.979 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.94 -37.85 88.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.15 -46.21 88.28 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.819 0.447 . . . . 0.0 110.8 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.2 tp -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 110.825 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.47 -41.16 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.588 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -55.33 -29.06 57.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 112.412 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -49.11 -33.87 12.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.219 1.408 . . . . 0.0 112.306 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -135.72 -6.56 2.18 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.659 1.984 . . . . 0.0 108.576 170.166 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.02 125.39 26.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.253 31.5 m120 61.53 119.94 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 C-N-CA 129.317 3.047 . . . . 0.0 113.939 -175.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -148.46 141.12 24.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.562 3.145 . . . . 0.0 103.731 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mt -117.95 144.5 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 119.845 1.202 . . . . 0.0 107.777 -169.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.76 146.57 19.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -130.33 128.32 41.24 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.6 133.95 49.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -132.99 117.43 17.63 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -168.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 58.0 m -139.9 163.99 31.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 124.118 0.886 . . . . 0.0 111.875 -168.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 63.6 m -68.54 114.06 6.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.451 ' H ' HG22 ' B' ' 39' ' ' ILE . . . 49.73 41.39 35.02 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.338 1.447 . . . . 0.0 112.801 173.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -36.53 104.31 0.03 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 18.0 m -135.21 0.97 2.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.77 169.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.11 -55.11 0.09 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.142 0.977 . . . . 0.0 112.902 -169.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -57.84 -54.67 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.176 0.444 . . . . 0.0 110.599 -171.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.7 m -76.73 -26.74 54.97 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.702 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -54.85 -51.1 66.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.822 1.192 . . . . 0.0 110.488 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 13.9 ttm -67.73 -44.19 78.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.529 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.75 99.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.368 0.667 . . . . 0.0 111.568 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.83 -31.76 61.76 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.418 1.008 . . . . 0.0 110.683 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -42.62 74.46 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 171.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -56.73 -40.0 74.94 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 117.931 0.865 . . . . 0.0 111.21 170.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.24 -54.23 43.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -69.84 -17.83 63.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.836 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.03 -14.93 63.36 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.874 1.216 . . . . 0.0 112.579 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.491 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 2.5 m-85 -126.32 -20.86 4.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.265 1.026 . . . . 0.0 113.732 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.26 -107.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.21 -172.28 40.78 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 119.126 0.875 . . . . 0.0 111.426 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.68 -20.22 65.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.35 1.46 . . . . 0.0 111.962 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -56.45 -40.18 74.41 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.97 0.908 . . . . 0.0 111.471 174.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.54 153.09 18.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.864 0.84 . . . . 0.0 112.587 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -124.61 107.33 10.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.48 103.28 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -92.51 160.98 14.8 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.806 0.842 . . . . 0.0 108.781 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -151.01 134.9 16.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.498 0.719 . . . . 0.0 109.576 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.67 176.92 11.98 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.343 0.592 . . . . 0.0 112.353 -174.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.22 -177.84 47.22 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.924 1.249 . . . . 0.0 111.141 177.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.451 HG22 ' H ' ' B' ' 12' ' ' GLY . 3.5 tt -52.55 -53.33 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.116 1.366 . . . . 0.0 113.255 -175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -133.31 29.05 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.147 1.779 . . . . 0.0 108.611 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.86 146.8 54.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.168 2.187 . . . . 0.0 111.766 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 84.4 t60 144.91 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 129.987 3.315 . . . . 0.0 105.287 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.89 162.67 33.45 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 62.3 tp -140.61 76.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.36 128.85 90.37 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.25 -20.05 45.35 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.936 1.757 . . . . 0.0 112.63 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -38.64 90.34 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 120.077 1.308 . . . . 0.0 111.777 171.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.31 60.26 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.824 0.738 . . . . 0.0 109.997 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 22.5 t -60.41 -52.76 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 171.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -58.44 -44.27 89.11 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.695 0.798 . . . . 0.0 110.824 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.12 68.02 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.914 0.885 . . . . 0.0 111.791 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -76.31 -39.58 53.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -63.03 -26.29 68.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.49 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -56.03 -29.52 60.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.035 1.288 . . . . 0.0 111.643 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 m -116.85 16.86 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.244 1.418 . . . . 0.0 111.242 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.73 33.97 88.67 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.444 -1.198 . . . . 0.0 113.423 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.71 150.89 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 169.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -118.34 137.84 52.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.806 0.843 . . . . 0.0 108.97 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 21.5 pt -137.81 18.14 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 124.571 1.149 . . . . 0.0 110.988 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -67.03 15.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -137.26 -6.74 1.79 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.24 2.616 . . . . 0.0 111.822 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.9 157.06 22.53 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.128 -0.983 . . . . 0.0 110.942 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.9 p -123.44 176.62 6.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.39 1.876 . . . . 0.0 109.707 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -157.99 170.26 22.71 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -165.43 163.28 19.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.527 1.931 . . . . 0.0 108.15 -176.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 24.4 pt -64.97 167.37 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.787 0.835 . . . . 0.0 111.801 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -49.43 138.72 4.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.489 0.715 . . . . 0.0 109.58 175.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.45 103.79 3.85 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.469 1.128 . . . . 0.0 108.954 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -48.84 -32.53 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.944 1.698 . . . . 0.0 113.924 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.0 -22.91 63.08 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.419 0.554 . . . . 0.0 111.194 -169.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.87 -39.42 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 118.147 -0.93 . . . . 0.0 109.344 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.05 -49.43 77.67 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.573 1.079 . . . . 0.0 110.449 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -25.21 67.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.918 0.781 . . . . 0.0 111.416 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -87.62 -11.41 48.59 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.996 1.318 . . . . 0.0 113.018 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.64 169.74 5.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.025 0.916 . . . . 0.0 111.281 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -85.29 -34.98 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 169.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.51 HD13 ' CE ' ' B' ' 97' ' ' LYS . 20.1 tp -151.41 144.13 24.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.974 1.309 . . . . 0.0 109.933 -173.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.82 101.91 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 126.269 1.827 . . . . 0.0 107.074 171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 88.6 t -80.49 100.82 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 82.9 m -78.85 131.39 36.44 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -150.66 64.78 0.93 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.915 0.864 . . . . 0.0 111.65 -174.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 58.7 m -166.87 -38.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.438 1.095 . . . . 0.0 109.736 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 156.48 -171.84 34.17 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.518 2.485 . . . . 0.0 106.914 -169.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -143.3 64.19 1.35 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.191 0.995 . . . . 0.0 108.408 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -157.63 -77.79 0.08 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.162 1.385 . . . . 0.0 109.313 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.7 -28.1 69.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.92 0.488 . . . . 0.0 111.55 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.44 14.74 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.611 1.965 . . . . 0.0 113.978 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm 77.3 31.02 0.5 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.114 2.566 . . . . 0.0 111.799 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 1.3 p 29.78 56.45 0.73 Allowed Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.596 1.958 . . . . 0.0 112.694 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.77 131.98 46.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.191 2.594 . . . . 0.0 110.162 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.99 0.4 55.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.979 -173.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.6 p 46.28 90.39 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.986 2.114 . . . . 0.0 113.147 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -64.54 147.21 90.24 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 123.026 2.484 . . . . 0.0 108.842 -169.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.21 -0.06 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.112 3.208 . . . . 0.0 115.359 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -64.08 -16.95 62.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.752 0.821 . . . . 0.0 111.754 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 152.39 37.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.416 1.007 . . . . 0.0 112.796 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.51 ' CE ' HD13 ' B' ' 77' ' ' LEU . 5.1 tmmm? -80.08 154.72 27.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 168.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -139.79 146.22 39.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -144.81 149.31 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 133.48 50.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.291 1.036 . . . . 0.0 108.423 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -131.39 -5.7 3.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.386 1.074 . . . . 0.0 111.626 -171.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.62 147.18 16.26 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -144.09 24.41 1.63 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.699 1.599 . . . . 0.0 110.884 -169.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -152.45 163.41 39.59 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.085 2.154 . . . . 0.0 106.499 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -147.31 121.9 5.13 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.288 1.404 . . . . 0.0 108.349 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.03 -21.59 15.63 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.548 2.165 . . . . 0.0 112.876 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.25 -6.14 12.81 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.551 1.069 . . . . 0.0 112.16 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -103.54 12.13 35.43 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.822 1.249 . . . . 0.0 111.544 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.68 148.9 0.66 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.001 1.321 . . . . 0.0 112.55 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -38.56 85.79 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.942 -171.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 130.47 -20.49 4.93 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 169.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 47.6 p -69.93 163.59 25.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.66 -39.57 84.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.265 0.555 . . . . 0.0 110.919 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.89 -44.64 61.05 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.349 -1.31 . . . . 0.0 109.87 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -73.82 -29.12 61.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 120.922 1.692 . . . . 0.0 110.5 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -58.17 -62.34 1.9 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.526 0.603 . . . . 0.0 109.516 170.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -60.44 -40.14 90.05 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.13 99.41 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.057 -177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.89 -46.0 83.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.798 0.726 . . . . 0.0 109.648 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -63.34 -44.15 95.71 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.956 0.902 . . . . 0.0 111.41 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 -59.13 -49.47 77.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.02 -38.79 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 117.814 -1.089 . . . . 0.0 109.587 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -55.65 -46.3 77.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.948 1.703 . . . . 0.0 111.495 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -63.09 -44.62 95.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.204 0.315 . . . . 0.0 110.762 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -61.44 2.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 110.133 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -39.96 60.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.614 1.565 . . . . 0.0 110.956 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.96 76.65 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 118.531 -1.15 . . . . 0.0 110.861 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -58.93 -46.66 87.42 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.373 1.587 . . . . 0.0 111.209 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.05 -50.33 73.08 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -37.27 75.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.485 0.584 . . . . 0.0 112.319 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.491 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 40.7 ttmt -60.69 -42.34 96.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.97 -41.3 95.56 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.864 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.8 -37.64 74.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 122.802 2.547 . . . . 0.0 111.372 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.49 -29.94 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.5 -46.89 8.36 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.163 1.785 . . . . 0.0 110.983 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 69.6 p -79.17 -28.48 42.71 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.661 1.984 . . . . 0.0 109.087 -172.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 47.44 44.11 21.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm . . . . . 0 C--O 1.247 0.957 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -168.232 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 tpp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 118.906 -0.568 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.53 169.22 24.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.175 1.39 . . . . 0.0 108.268 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.54 100.48 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.25 167.3 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.858 1.663 . . . . 0.0 108.72 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -121.14 112.4 18.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.628 1.571 . . . . 0.0 108.017 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.05 172.49 13.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.325 1.05 . . . . 0.0 110.156 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -156.69 -177.77 6.86 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.633 1.973 . . . . 0.0 106.447 169.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -38.45 -38.83 0.4 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.673 2.789 . . . . 0.0 116.005 -169.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -128.18 -31.3 2.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.125 0.97 . . . . 0.0 111.154 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -61.68 -21.76 64.73 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 117.816 -1.088 . . . . 0.0 112.293 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -48.66 -51.32 28.97 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 120.323 1.42 . . . . 0.0 110.166 169.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -64.85 -45.29 86.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.03 87.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.532 0.206 . . . . 0.0 110.87 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -74.34 -16.1 60.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.546 1.138 . . . . 0.0 112.434 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.9 p -115.64 -2.83 12.39 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 112.122 -171.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.8 m -72.61 -10.83 60.26 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.73 144.47 34.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.135 0.879 . . . . 0.0 110.111 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.62 -174.92 31.09 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.59 1.091 . . . . 0.0 111.808 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 104' ' ' LEU . 31.0 t -89.99 129.84 40.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 t -140.2 116.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -169.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.6 tp -79.23 138.25 37.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.12 115.08 15.93 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.367 0.985 . . . . 0.0 109.24 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -111.97 147.67 35.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.01 1.324 . . . . 0.0 110.203 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -128.52 109.05 11.03 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.6 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.7 p-90 -129.7 153.14 48.45 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.066 1.746 . . . . 0.0 107.711 -170.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -171.24 162.24 5.24 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 119.426 1.012 . . . . 0.0 109.836 169.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.63 -19.79 14.96 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.917 3.078 . . . . 0.0 116.626 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.404 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 15.0 m95 -53.72 -30.46 44.01 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.999 1.32 . . . . 0.0 114.293 -176.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 161.27 34.27 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.31 0.959 . . . . 0.0 113.214 -169.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.79 -48.92 52.59 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.08 -1.4 . . . . 0.0 112.669 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.4 -28.0 19.93 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.363 2.709 . . . . 0.0 115.075 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -58.85 -20.31 49.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 119.742 1.156 . . . . 0.0 113.575 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -111.63 13.8 21.23 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.126 0.97 . . . . 0.0 111.442 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.1 mtm -123.73 -46.05 2.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.249 1.02 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.0 -34.75 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 121.537 -0.727 . . . . 0.0 109.605 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.15 10.94 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.691 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -59.66 -39.84 70.38 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.02 1.813 . . . . 0.0 111.634 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.35 -39.07 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 118.65 0.659 . . . . 0.0 110.451 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 mp -72.53 -39.76 67.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.991 0.814 . . . . 0.0 111.466 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.42 -33.48 75.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.723 1.147 . . . . 0.0 110.049 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.06 -21.56 59.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.0 1.32 . . . . 0.0 111.597 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.9 -44.71 16.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 108.932 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.407 ' HB2' HD12 ' A' ' 52' ' ' ILE . 17.9 t70 -70.46 -32.42 69.96 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.436 -1.415 . . . . 0.0 111.211 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -67.14 -6.88 19.54 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.537 -0.727 . . . . 0.0 112.755 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.8 -46.61 3.33 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.733 2.013 . . . . 0.0 109.615 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . 0.289 59.7 mmm -104.08 -12.42 16.77 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 125.486 1.515 . . . . 0.0 113.121 -171.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.99 -7.8 9.33 Favored Glycine 0 C--N 1.318 -0.457 0 N-CA-C 113.962 0.345 . . . . 0.0 113.962 -171.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.03 -25.54 65.43 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.16 2.184 . . . . 0.0 112.489 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.7 -20.37 3.22 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.169 1.388 . . . . 0.0 112.074 -171.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.43 HD22 ' H ' ' A' ' 51' ' ' LYS . 1.6 tm? -129.43 156.41 44.14 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.21 1.404 . . . . 0.0 112.32 -166.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' H ' HD22 ' A' ' 50' ' ' LEU . 87.7 tttt -122.61 148.06 45.69 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.589 1.556 . . . . 0.0 108.28 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.407 HD12 ' HB2' ' A' ' 43' ' ' ASP . 13.7 mt -128.15 144.13 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.23 146.49 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 24.7 mtpt -121.32 153.02 38.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.181 0.446 . . . . 0.0 110.883 173.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -121.29 127.33 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -83.29 106.74 15.31 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.299 33.4 m -79.76 49.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -177.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -154.52 -42.18 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.538 1.135 . . . . 0.0 109.453 168.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -84.36 -40.97 17.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.053 1.341 . . . . 0.0 109.831 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -127.73 28.78 5.57 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.283 1.833 . . . . 0.0 111.3 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.98 -3.44 26.04 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.477 0.711 . . . . 0.0 112.696 -172.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -54.75 -46.76 74.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.815 1.646 . . . . 0.0 111.127 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -55.15 -46.12 75.69 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.34 -63.93 0.97 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.723 0.809 . . . . 0.0 108.989 -169.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -46.21 -46.3 15.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.051 0.834 . . . . 0.0 113.096 174.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.02 -42.95 99.91 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.238 1.019 . . . . 0.0 111.724 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -69.17 -18.93 63.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.549 . . . . 0.0 110.712 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.22 66.48 1.52 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.12 129.9 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.46 ' HE3' HD13 ' B' ' 72' ' ' LEU . 27.6 mtm -147.64 20.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -174.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -134.32 160.69 37.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.608 1.163 . . . . 0.0 113.98 -167.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 136.45 29.14 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.042 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.43 128.48 11.64 Favored 'Cis proline' 0 N--CA 1.453 -0.869 0 N-CA-C 106.367 -2.205 . . . . 0.0 106.367 -11.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.6 m -92.91 140.49 29.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -136.45 92.79 2.81 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -80.5 132.36 35.68 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.67 120.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mp -127.96 157.95 39.2 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.057 0.943 . . . . 0.0 109.502 -170.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.06 144.08 25.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 169.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 45.8 30.29 0.83 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.178 1.791 . . . . 0.0 113.538 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.0 11.99 58.19 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.828 1.204 . . . . 0.0 115.939 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.31 149.26 50.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.647 1.224 . . . . 0.0 111.297 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.38 141.83 15.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 m -128.8 -20.62 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.504 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 153.0 40.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.241 1.016 . . . . 0.0 109.123 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.56 116.61 7.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -177.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -135.67 147.27 48.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.58 95.42 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -174.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.46 155.9 7.62 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -64.78 143.0 58.24 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.673 0.737 . . . . 0.0 110.526 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 139.75 32.05 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 169.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.24 167.24 22.62 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.463 2.109 . . . . 0.0 110.333 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -46.92 -46.71 21.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.702 1.601 . . . . 0.0 112.386 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.2 -44.34 72.3 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.562 0.619 . . . . 0.0 111.118 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.32 83.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.122 -0.361 . . . . 0.0 110.415 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -52.08 63.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.131 0.572 . . . . 0.0 109.998 176.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -64.24 -36.26 83.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.983 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.96 -49.37 77.72 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.167 0.439 . . . . 0.0 110.981 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.49 -40.03 85.71 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 123.683 0.793 . . . . 0.0 111.557 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.04 -40.73 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.228 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -55.0 -30.65 59.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.365 1.066 . . . . 0.0 112.276 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -59.62 -18.12 38.92 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.146 0.978 . . . . 0.0 113.298 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -131.88 -22.81 2.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.337 0.971 . . . . 0.0 112.774 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.487 ' HA ' HG21 ' A' ' 19' ' ' VAL . 20.2 tp . . . . . 0 C--O 1.248 0.984 0 C-N-CA 126.484 1.913 . . . . 0.0 107.528 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.67 24.22 2.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.839 0.855 . . . . 0.0 112.605 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -155.98 133.85 11.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 169.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -142.65 118.29 10.42 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 129.302 3.041 . . . . 0.0 104.23 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -98.72 130.66 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -134.34 139.67 47.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -127.13 142.27 51.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.201 1.0 . . . . 0.0 108.511 -169.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' B' ' 131' ' ' LEU . 63.3 m-85 -126.41 107.38 10.23 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.146 0.978 . . . . 0.0 108.558 -172.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.97 127.31 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 91.9 p -152.17 162.51 41.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.077 0.399 . . . . 0.0 111.407 169.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 76.5 m -50.05 115.54 1.46 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.623 1.169 . . . . 0.0 110.145 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.46 19.46 0.45 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.685 2.088 . . . . 0.0 115.541 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 42.08 31.9 0.27 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.195 1.398 . . . . 0.0 111.493 -168.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 17.7 p -85.95 17.8 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.364 -1.46 . . . . 0.0 113.166 -169.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.67 -67.66 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.662 1.185 . . . . 0.0 111.887 169.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.54 -56.62 15.48 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -168.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 16.9 m -70.51 -32.99 70.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 118.694 -1.202 . . . . 0.0 110.891 -169.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -50.66 -50.15 55.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.305 1.05 . . . . 0.0 111.394 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 31.4 ttm -67.76 -47.12 70.1 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.76 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.99 97.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.001 0.92 . . . . 0.0 111.114 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.57 -31.18 69.19 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.569 1.077 . . . . 0.0 111.069 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.75 -49.7 53.32 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -56.34 -39.79 73.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.668 0.787 . . . . 0.0 111.81 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.7 -51.52 64.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -63.37 -22.55 66.95 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -69.87 -11.19 60.68 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.478 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 14.4 m-85 -130.17 -44.39 1.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.735 1.214 . . . . 0.0 111.657 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' B' ' 135' ' ' ALA . 10.7 mp -81.44 75.37 8.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.329 2.252 . . . . 0.0 105.521 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.52 -159.07 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.821 2.153 . . . . 0.0 113.306 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -56.19 -21.21 21.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.439 1.096 . . . . 0.0 113.245 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.13 -19.85 15.09 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.35 1.86 . . . . 0.0 113.071 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -128.66 161.22 30.16 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.818 1.247 . . . . 0.0 111.005 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.5 136.95 49.48 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.66 136.1 60.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -140.36 157.15 45.98 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.178 0.991 . . . . 0.0 109.217 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -138.43 140.66 39.39 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.734 1.213 . . . . 0.0 108.56 -172.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.36 173.84 16.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.913 0.485 . . . . 0.0 110.953 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.87 -171.4 42.05 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.304 0.954 . . . . 0.0 111.193 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.73 -56.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.008 1.723 . . . . 0.0 113.999 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -136.38 31.0 2.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.711 2.004 . . . . 0.0 107.581 -176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.02 131.09 47.46 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.519 1.928 . . . . 0.0 113.821 -169.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -171.21 8.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.175 1.79 . . . . 0.0 111.31 169.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.73 107.56 3.13 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 119.175 0.898 . . . . 0.0 111.696 -169.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -78.39 86.7 4.44 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -62.04 125.43 85.23 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.534 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.3 -20.08 53.73 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.243 1.962 . . . . 0.0 113.013 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.424 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.1 OUTLIER -60.52 -39.63 88.52 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.696 1.135 . . . . 0.0 111.027 171.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.25 59.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.76 -50.81 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -56.93 -47.01 81.61 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 123.375 0.67 . . . . 0.0 110.28 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.55 -33.26 59.81 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.208 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 82.6 mmm -91.67 -30.64 16.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.997 0.817 . . . . 0.0 111.219 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -62.47 -24.39 67.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.845 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.67 -31.39 68.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.929 1.24 . . . . 0.0 111.288 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 m -113.73 15.36 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.085 1.354 . . . . 0.0 110.808 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.67 39.97 98.59 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.634 -1.092 . . . . 0.0 112.824 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.56 107.88 24.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.33 132.7 48.94 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 pt -127.99 11.42 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.881 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -19.81 46.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.06 0.845 . . . . 0.0 111.163 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -76.97 -13.83 59.92 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.493 2.317 . . . . 0.0 114.073 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -62.9 161.62 12.53 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.217 1.371 . . . . 0.0 113.586 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 63.8 p -126.44 171.23 11.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.883 2.473 . . . . 0.0 108.528 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -157.89 163.62 37.74 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.819 -1.176 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -167.78 164.94 14.28 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 -175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 23.5 pt -69.29 175.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 111.274 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.53 133.62 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -143.17 104.8 4.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.869 0.842 . . . . 0.0 108.988 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -46.92 -28.63 1.67 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.766 2.026 . . . . 0.0 114.022 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.85 -15.77 62.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.125 0.875 . . . . 0.0 112.049 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.48 -38.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.38 1.072 . . . . 0.0 109.259 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.46 HD13 ' HE3' ' A' ' 70' ' ' MET . 6.9 tt -65.31 -58.54 5.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 120.206 1.366 . . . . 0.0 109.399 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -24.08 66.57 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.362 0.528 . . . . 0.0 110.757 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -78.63 -26.13 45.18 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.847 1.659 . . . . 0.0 113.092 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 169.33 2.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.467 1.507 . . . . 0.0 111.959 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -91.31 -30.34 16.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.07 138.63 22.97 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.189 0.996 . . . . 0.0 110.556 -170.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 t -113.57 106.14 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.64 114.35 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 30.4 m -77.21 129.23 35.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 168.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.6 tp -131.43 56.12 1.82 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.998 0.919 . . . . 0.0 111.304 -168.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 69.7 m -153.86 172.72 16.93 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.883 -1.135 . . . . 0.0 109.339 170.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -127.24 45.42 1.15 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -152.84 162.32 41.44 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.471 2.308 . . . . 0.0 107.829 -169.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -125.58 2.71 7.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.391 1.077 . . . . 0.0 112.774 -170.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.01 -16.15 63.65 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.62 -0.675 . . . . 0.0 111.714 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.5 -0.58 0.62 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.116 2.166 . . . . 0.0 116.685 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt 85.89 7.39 0.36 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.472 2.309 . . . . 0.0 111.528 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 3.6 m 32.79 49.63 0.55 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 127.821 2.448 . . . . 0.0 113.5 -170.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.48 134.15 38.69 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.731 2.287 . . . . 0.0 111.685 -169.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.462 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -84.3 0.23 49.87 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 116.987 -1.482 . . . . 0.0 114.882 -172.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p 48.31 88.45 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.202 1.401 . . . . 0.0 112.879 170.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.6 146.61 74.98 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 122.802 2.335 . . . . 0.0 110.112 -169.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.76 2.96 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.658 1 C-N-CA 125.551 4.167 . . . . 0.0 116.617 -168.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -68.39 -6.16 23.03 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.951 0.796 . . . . 0.0 111.945 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.95 147.31 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.533 1.133 . . . . 0.0 110.26 -169.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -72.73 156.53 38.84 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -151.43 139.11 19.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.627 -1.296 . . . . 0.0 108.472 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -149.11 144.86 26.91 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.31 136.73 34.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -133.76 -10.64 2.72 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.958 0.903 . . . . 0.0 111.655 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.44 168.08 49.6 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 169.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.11 -7.28 0.18 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.432 0.693 . . . . 0.0 112.836 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -161.98 179.41 8.03 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.262 1.425 . . . . 0.0 107.928 -173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -135.76 114.91 11.21 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.26 1.424 . . . . 0.0 108.389 170.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.05 -18.58 21.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.474 2.783 . . . . 0.0 112.855 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.88 -7.19 7.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.786 1.176 . . . . 0.0 112.461 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -101.66 11.3 39.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.359 1.464 . . . . 0.0 111.347 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.64 147.05 0.65 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.481 1.112 . . . . 0.0 111.595 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -53.37 -45.99 69.43 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 124.078 0.861 . . . . 0.0 109.889 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.98 -20.48 2.86 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 115.329 0.891 . . . . 0.0 115.329 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 53.2 p -68.7 165.38 19.59 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.37 -41.72 97.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.48 0.657 . . . . 0.0 110.308 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.98 -43.73 67.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 117.007 -1.473 . . . . 0.0 109.718 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -74.36 -32.43 62.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 121.18 1.809 . . . . 0.0 109.582 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -56.2 -62.28 1.82 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.153 0.581 . . . . 0.0 109.658 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.89 -39.78 86.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.989 0.916 . . . . 0.0 112.25 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -64.33 -44.92 90.02 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.9 m-30 -60.88 -51.53 68.9 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -64.08 -46.8 82.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 111.299 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -65.51 -48.61 71.97 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.084 0.402 . . . . 0.0 110.016 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.07 -40.23 88.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.151 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -58.17 -46.73 85.22 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.543 1.065 . . . . 0.0 111.84 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.23 -44.09 83.47 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.183 0.447 . . . . 0.0 110.524 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -74.37 -39.52 62.7 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.66 -49.17 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 108.913 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.55 -41.44 96.17 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.409 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -56.78 -51.34 69.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 118.13 0.965 . . . . 0.0 111.228 174.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -63.7 -42.31 98.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 118.385 -0.817 . . . . 0.0 109.638 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.441 HD11 ' CZ ' ' B' ' 8' ' ' PHE . 3.2 mm? -64.5 -40.88 96.49 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.152 0.887 . . . . 0.0 112.202 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.478 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 41.5 ttmt -60.13 -38.0 81.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.461 0.573 . . . . 0.0 110.416 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -35.64 77.9 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 116.672 -1.633 . . . . 0.0 112.611 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -59.16 -34.46 72.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 122.539 2.427 . . . . 0.0 110.957 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.491 ' HB2' HD12 ' B' ' 28' ' ' LEU . . . -62.69 -32.53 73.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.086 0.554 . . . . 0.0 111.036 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -88.63 -44.57 10.52 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.293 1.437 . . . . 0.0 111.239 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 68.0 p -87.04 -17.44 32.94 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.899 2.08 . . . . 0.0 111.017 -170.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.32 39.57 92.83 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.225 0.917 . . . . 0.0 110.932 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.743 0.817 . . . . 0.0 112.293 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.67 157.86 0.08 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.916 2.486 . . . . 0.0 113.074 -171.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.83 100.92 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 t -74.87 165.98 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.243 1.417 . . . . 0.0 108.057 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -125.79 117.46 23.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.319 1.048 . . . . 0.0 108.625 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 53' ' ' VAL . . . -76.79 171.82 14.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.667 1.587 . . . . 0.0 110.12 176.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -156.02 -176.07 5.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.642 1.577 . . . . 0.0 107.053 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -36.67 -36.97 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 130.202 3.401 . . . . 0.0 116.743 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.97 -30.24 1.23 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.999 1.32 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -60.84 -22.18 63.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.335 -0.84 . . . . 0.0 112.319 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -50.79 -52.44 40.96 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.613 1.097 . . . . 0.0 109.292 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -62.45 -44.57 96.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.02 80.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.444 -0.16 . . . . 0.0 111.13 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.38 -11.95 59.98 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.855 1.262 . . . . 0.0 112.843 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -123.29 -3.09 8.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.942 1.246 . . . . 0.0 113.27 -169.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -71.33 -10.74 60.25 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.65 156.87 45.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.11 0.964 . . . . 0.0 109.574 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.98 -150.92 48.34 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.359 0.98 . . . . 0.0 110.988 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.42 132.7 69.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.0 t -143.13 116.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.94 123.33 27.16 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.47 140.15 46.31 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -134.09 151.32 51.33 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.876 1.671 . . . . 0.0 108.786 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.403 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 25.2 m-85 -131.66 117.35 18.54 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.572 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 4.9 p-90 -139.58 153.89 47.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.344 1.458 . . . . 0.0 108.849 -169.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.48 158.33 9.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 124.262 1.025 . . . . 0.0 108.489 168.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.37 -15.18 5.4 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.764 2.976 . . . . 0.0 116.846 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -59.86 -24.75 64.48 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.12 160.26 36.52 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.456 1.026 . . . . 0.0 112.588 -169.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.24 -49.62 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.253 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.1 -28.09 24.03 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.225 2.617 . . . . 0.0 115.093 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 m -59.38 -16.42 22.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.585 1.084 . . . . 0.0 113.692 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -116.92 14.98 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.788 1.235 . . . . 0.0 111.681 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.0 mtm -123.47 -45.2 2.08 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.182 0.993 . . . . 0.0 109.416 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tp -62.77 -34.9 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.405 0.682 . . . . 0.0 109.798 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.84 24.02 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.985 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.04 -40.1 73.96 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.955 1.77 . . . . 0.0 111.476 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.44 -37.93 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.467 0.576 . . . . 0.0 110.701 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mp -71.58 -41.22 69.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.952 0.796 . . . . 0.0 111.363 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.06 -35.13 80.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.673 1.124 . . . . 0.0 109.727 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.3 -16.41 61.9 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.619 1.567 . . . . 0.0 112.608 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -86.98 -43.45 12.35 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 124.657 1.183 . . . . 0.0 108.382 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.2 -36.59 69.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.79 -0.569 . . . . 0.0 111.118 -174.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -68.78 -12.55 61.61 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.614 -0.679 . . . . 0.0 112.193 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -99.92 -42.57 6.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.366 1.467 . . . . 0.0 110.797 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.9 ptm -145.03 17.89 1.59 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.665 0.786 . . . . 0.0 112.284 -172.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.91 -1.99 21.36 Favored Glycine 0 CA--C 1.523 0.574 0 O-C-N 121.343 -0.848 . . . . 0.0 113.984 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.37 -24.88 63.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.599 1.16 . . . . 0.0 110.97 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.12 -18.3 11.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.911 0.884 . . . . 0.0 112.576 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -130.63 147.32 52.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 111.101 -168.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -107.11 146.01 31.77 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 168.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.71 137.44 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 6' ' ' ALA . 7.4 t -136.58 141.56 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -175.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.572 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 26.3 mtpt -116.41 152.79 33.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 174.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.1 mm -117.72 120.75 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -79.03 109.37 13.27 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.48 33.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -141.8 -42.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.057 -1.027 . . . . 0.0 109.819 168.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -79.82 -36.12 37.37 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.94 0.896 . . . . 0.0 110.67 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -134.2 32.37 3.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.439 1.495 . . . . 0.0 109.94 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -15.26 62.9 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.21 -169.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -50.54 -44.57 56.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.971 1.309 . . . . 0.0 111.783 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -60.38 -38.61 84.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.895 0.77 . . . . 0.0 111.872 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -66.91 0.5 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.83 1.252 . . . . 0.0 108.883 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.23 -44.84 5.04 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.641 1.115 . . . . 0.0 113.609 170.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -64.44 -45.2 88.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.574 1.187 . . . . 0.0 111.535 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -70.02 -31.57 69.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.49 0.586 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.38 68.05 0.74 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.8 t -142.39 132.49 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 100.744 -3.799 . . . . 0.0 100.744 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.633 ' HG3' HD12 ' B' ' 67' ' ' ILE . 10.3 ptm -150.59 17.66 0.81 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.767 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -138.3 163.56 31.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.222 2.209 . . . . 0.0 111.155 -169.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 143.89 49.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.944 0.898 . . . . 0.0 108.781 176.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.91 149.6 38.77 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 N-CA-C 107.345 -1.829 . . . . 0.0 107.345 -11.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 96.7 m -118.45 147.52 43.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 172.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.6 mt -125.71 141.71 51.87 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -129.0 106.86 9.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.04 118.63 31.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -110.31 149.05 30.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.518 0.727 . . . . 0.0 109.405 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -148.75 132.95 17.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.6 t70 43.23 30.84 0.32 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.678 1.991 . . . . 0.0 113.499 -176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.64 9.99 57.09 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.43 152.59 51.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.693 1.197 . . . . 0.0 110.757 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.07 133.06 32.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -120.24 -22.45 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.223 1.409 . . . . 0.0 110.704 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -146.36 163.73 34.64 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.215 1.006 . . . . 0.0 110.063 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.74 150.39 30.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -169.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 m -154.79 151.25 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.52 67.73 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.76 154.92 8.94 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -170.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -71.86 158.88 35.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.874 0.47 . . . . 0.0 110.946 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.59 143.63 20.46 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.18 168.15 22.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.352 2.035 . . . . 0.0 110.425 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -44.99 70.94 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.085 0.954 . . . . 0.0 112.071 -171.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.86 -43.17 84.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.563 0.165 . . . . 0.0 110.891 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.0 78.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.04 -0.412 . . . . 0.0 110.666 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -53.21 59.65 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 109.477 175.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -64.44 -37.81 88.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.72 -46.61 88.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.425 0.557 . . . . 0.0 111.264 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -58.08 -40.12 80.29 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 123.868 0.867 . . . . 0.0 111.151 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.95 -39.87 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 119.267 -0.397 . . . . 0.0 110.687 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -56.36 -28.24 58.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.583 1.153 . . . . 0.0 112.414 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -56.35 -22.39 30.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.149 0.98 . . . . 0.0 112.959 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -127.97 -26.17 2.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.052 0.941 . . . . 0.0 112.338 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.704 1.602 . . . . 0.0 108.033 171.211 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.69 142.5 40.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.289 0.636 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m120 70.63 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 128.608 2.763 . . . . 0.0 110.566 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 127.23 27.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.57 136.16 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tt -137.91 140.46 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.38 139.89 49.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.898 0.479 . . . . 0.0 110.775 -169.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -100.94 141.18 34.19 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 29.5 tp -143.62 120.07 10.99 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 10.2 p -172.23 155.92 3.75 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -39.53 102.19 0.02 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.18 1.792 . . . . 0.0 112.707 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.27 22.35 50.16 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 117.652 -1.638 . . . . 0.0 113.784 171.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . 0.511 HD22 ' HB3' ' B' ' 36' ' ' SER . 0.2 OUTLIER 33.5 2.67 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.112 1 C-N-CA 132.715 4.406 . . . . 0.0 121.046 173.791 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -70.84 -5.95 34.26 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.914 -1.741 . . . . 0.0 115.312 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.31 -95.65 0.48 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 120.496 1.498 . . . . 0.0 111.102 -177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -37.5 62.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.611 0.765 . . . . 0.0 112.536 -171.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -44.42 97.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.62 0.646 . . . . 0.0 110.089 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -56.7 -48.62 77.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.051 0.94 . . . . 0.0 110.188 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -43.3 91.96 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 124.068 0.855 . . . . 0.0 108.906 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.75 71.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.185 -0.912 . . . . 0.0 111.942 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -48.29 80.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.903 1.229 . . . . 0.0 109.883 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 -47.17 92.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -58.36 -42.34 86.73 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 112.055 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.27 -54.25 36.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.46 -23.66 65.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.703 -1.142 . . . . 0.0 112.025 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -68.22 -21.19 64.86 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.883 1.219 . . . . 0.0 113.558 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' B' ' 132' ' ' LYS . 2.3 m-85 -115.69 -16.31 11.27 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.971 0.908 . . . . 0.0 112.715 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.53 -128.23 0.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.13 -174.4 40.23 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 127.3 2.381 . . . . 0.0 107.361 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.61 -14.24 40.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.376 1.088 . . . . 0.0 112.026 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -52.79 -28.0 20.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.309 1.444 . . . . 0.0 110.429 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -122.46 168.65 11.86 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.24 2.216 . . . . 0.0 107.228 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -139.04 106.21 5.48 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 120.974 -1.079 . . . . 0.0 108.982 -173.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 82.3 t -99.31 132.22 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.67 166.73 23.82 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.517 1.527 . . . . 0.0 108.775 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.511 ' HB3' HD22 ' B' ' 13' ' ' ASN . 37.3 m -147.15 150.55 35.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.484 1.114 . . . . 0.0 109.213 176.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.56 177.35 11.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.975 0.91 . . . . 0.0 110.03 171.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.24 -175.78 47.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.401 1.477 . . . . 0.0 110.035 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 tt -53.07 -55.45 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.346 1.458 . . . . 0.0 113.114 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.12 29.82 5.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.343 1.457 . . . . 0.0 108.297 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.0 121.47 14.77 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.092 2.157 . . . . 0.0 111.72 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -174.85 -19.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.46 1.504 . . . . 0.0 111.194 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.76 179.31 53.6 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 124.333 0.968 . . . . 0.0 113.981 -168.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -147.26 92.31 2.09 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.416 1.486 . . . . 0.0 107.041 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.57 129.06 94.07 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.622 1.169 . . . . 0.0 108.16 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -59.53 -19.66 53.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.875 1.717 . . . . 0.0 112.809 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.425 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.2 OUTLIER -61.67 -38.72 88.8 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.104 1.32 . . . . 0.0 111.239 171.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.67 -37.72 65.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.91 -52.7 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.6 -45.52 81.39 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.675 0.79 . . . . 0.0 110.264 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.73 -36.94 58.45 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.996 0.918 . . . . 0.0 111.206 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 67.7 mmm -82.3 -30.54 30.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.141 0.882 . . . . 0.0 111.568 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -61.62 -25.47 67.38 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.47 1.032 . . . . 0.0 110.992 171.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -63.15 -22.46 66.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.768 1.167 . . . . 0.0 112.246 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 p -116.67 9.7 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.978 1.711 . . . . 0.0 109.526 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.0 38.79 96.54 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 120.964 -1.085 . . . . 0.0 111.928 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 69.9 mt -114.48 140.35 35.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.25 136.8 44.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 pt -135.78 15.06 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.437 1.095 . . . . 0.0 110.855 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 17.1 p -59.48 -13.12 7.65 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.657 1.117 . . . . 0.0 113.63 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -91.29 -14.81 30.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.862 1.665 . . . . 0.0 113.492 176.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -59.69 142.0 53.95 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.746 1.157 . . . . 0.0 112.611 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 57.3 p -129.36 173.6 10.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.893 2.477 . . . . 0.0 108.486 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.3 m -155.36 -175.38 5.41 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.966 -1.083 . . . . 0.0 110.924 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -155.93 158.87 38.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.94 1.696 . . . . 0.0 109.031 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 37.5 pt -71.61 170.31 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.583 1.153 . . . . 0.0 112.215 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.633 HD12 ' HG3' ' A' ' 70' ' ' MET . 0.2 OUTLIER -49.7 127.45 5.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -146.01 97.18 2.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.351 1.072 . . . . 0.0 108.75 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 12.8 m -46.42 -27.37 1.06 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.348 1.859 . . . . 0.0 114.429 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.78 -17.9 61.84 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.94 1.245 . . . . 0.0 112.604 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.19 -34.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.917 0.887 . . . . 0.0 108.933 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.66 -54.77 19.67 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.365 0.984 . . . . 0.0 110.209 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -22.41 67.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.561 0.619 . . . . 0.0 110.48 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -77.1 -20.79 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.809 1.644 . . . . 0.0 112.418 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.56 167.34 2.68 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.759 1.224 . . . . 0.0 111.947 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.29 -28.58 16.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.74 169.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.53 132.45 19.13 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 110.73 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.19 99.98 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -81.09 102.69 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 57.5 m -67.04 136.09 54.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 tp -125.13 43.54 3.02 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 66.2 m -158.34 -16.83 0.07 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.64 1.176 . . . . 0.0 112.724 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.5 -42.7 2.9 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -148.27 144.74 27.84 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.119 2.168 . . . . 0.0 105.617 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.42 149.46 31.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.793 0.837 . . . . 0.0 109.505 -171.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.74 -54.85 18.59 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 17.73 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 130.96 3.704 . . . . 0.0 110.643 -168.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -157.12 32.89 0.29 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 128.996 2.918 . . . . 0.0 107.663 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 4.5 m 32.38 52.8 0.84 Allowed Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.421 1.888 . . . . 0.0 112.478 -168.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -45.43 131.76 12.22 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.486 2.79 . . . . 0.0 114.8 -169.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.427 ' H ' ' HG3' ' B' ' 91' ' ' MET . 0.0 OUTLIER -85.42 -1.3 56.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.2 p 44.36 93.05 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.888 2.075 . . . . 0.0 113.831 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -55.89 134.97 67.27 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.776 2.317 . . . . 0.0 109.089 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.16 8.47 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.765 3.643 . . . . 0.0 116.095 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -67.8 -6.08 19.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.087 0.955 . . . . 0.0 111.904 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.37 146.79 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 109.391 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -69.67 156.14 39.43 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -144.36 142.58 30.47 Favored 'General case' 0 CA--C 1.515 -0.404 0 O-C-N 121.029 -1.044 . . . . 0.0 108.208 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.85 154.07 32.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 169.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -95.95 127.31 41.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -110.02 -3.62 16.37 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.706 0.802 . . . . 0.0 110.499 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.19 162.38 13.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -145.82 -9.39 0.54 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.398 1.079 . . . . 0.0 111.738 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -156.87 168.58 27.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.353 2.261 . . . . 0.0 106.02 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -125.33 112.15 26.04 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.035 0.934 . . . . 0.0 108.636 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.0 -22.91 34.86 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.404 3.403 . . . . 0.0 113.189 -171.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.87 -10.69 9.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.976 0.807 . . . . 0.0 112.637 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -97.82 7.95 45.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 111.858 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.61 143.29 2.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.027 0.931 . . . . 0.0 112.362 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -57.04 -47.7 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.968 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.15 -17.25 4.1 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 171.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 44.0 p -70.16 159.87 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.61 -38.81 82.29 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.352 0.596 . . . . 0.0 111.068 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' B' ' 114' ' ' GLU . 5.3 pt-20 -72.71 -43.43 63.02 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.764 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.49 -30.82 59.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.103 1.774 . . . . 0.0 110.077 -172.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -59.89 -57.11 14.32 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.76 -0.638 . . . . 0.0 109.837 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -61.5 -41.68 97.66 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.146 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.32 87.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.144 0.884 . . . . 0.0 112.372 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -62.92 -47.63 82.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.3 m-30 -64.13 -43.38 95.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -59.43 -53.84 53.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.018 1.727 . . . . 0.0 109.693 -173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.08 -49.36 70.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.1 -41.19 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.216 -0.897 . . . . 0.0 109.736 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp-105 -58.39 -47.17 84.73 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.974 1.261 . . . . 0.0 111.21 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.31 -43.49 88.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.242 0.474 . . . . 0.0 110.92 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -64.72 -48.87 73.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.05 0.54 . . . . 0.0 110.06 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.88 -50.66 59.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 125.206 1.402 . . . . 0.0 110.042 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.21 -40.84 95.0 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -61.58 -42.99 99.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.17 0.985 . . . . 0.0 111.689 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -69.74 -34.16 73.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 118.956 0.798 . . . . 0.0 111.345 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' B' ' 131' ' ' LEU . 3.4 mm? -73.19 -37.8 66.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.698 1.135 . . . . 0.0 111.756 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.403 ' HE3' ' CE2' ' B' ' 27' ' ' TYR . 7.9 ptmt -67.75 -37.34 82.0 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.945 0.793 . . . . 0.0 109.836 175.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -59.24 -40.75 86.92 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.218 -1.372 . . . . 0.0 109.904 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -60.4 -38.15 83.06 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 122.163 2.256 . . . . 0.0 111.181 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.99 70.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.037 0.535 . . . . 0.0 112.221 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.22 -47.57 8.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.474 1.51 . . . . 0.0 111.499 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 72.1 p -84.19 -23.28 30.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 110.78 -169.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 50.58 41.28 41.73 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.273 1.429 . . . . 0.0 113.613 -169.049 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.51 170.04 21.73 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.27 1.428 . . . . 0.0 107.882 169.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 96.81 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 169.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 t -77.06 167.63 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.594 1.557 . . . . 0.0 108.132 178.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -123.6 120.28 32.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.257 1.423 . . . . 0.0 107.771 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.52 169.25 15.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.314 1.046 . . . . 0.0 109.214 176.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -133.59 -167.25 1.9 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.557 1.543 . . . . 0.0 108.245 169.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.26 -27.09 2.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.955 2.102 . . . . 0.0 113.409 169.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -136.53 -31.25 0.88 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 111.947 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.0 m -63.81 -20.51 65.84 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.807 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -52.24 -58.38 6.81 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.247 0.931 . . . . 0.0 109.272 169.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -62.58 -43.18 99.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.908 -0.495 . . . . 0.0 110.316 -176.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.79 83.16 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.193 -174.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -81.34 -16.13 53.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.207 1.003 . . . . 0.0 112.927 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -114.2 -4.19 13.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.446 1.021 . . . . 0.0 113.578 -169.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 m -73.4 -4.57 34.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.66 156.98 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.806 1.242 . . . . 0.0 109.554 -177.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.09 -163.36 45.24 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 124.754 1.169 . . . . 0.0 112.058 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.46 134.97 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.82 149.13 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 113.679 -1.6 . . . . 0.0 108.674 -168.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.4 tp -119.0 100.89 7.64 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 113.363 -1.744 . . . . 0.0 107.982 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.84 144.77 25.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -139.49 148.85 43.25 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.417 1.487 . . . . 0.0 108.724 -173.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -131.34 105.5 7.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -169.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.571 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 5.1 p-90 -123.7 151.58 42.99 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.237 1.815 . . . . 0.0 107.62 -169.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' HB3' ' HD1' ' A' ' 28' ' ' TRP . . . -166.75 163.09 11.08 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 118.689 0.677 . . . . 0.0 111.316 173.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.32 -10.42 8.51 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.179 3.253 . . . . 0.0 116.534 -177.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.426 ' HD1' ' HB3' ' A' ' 26' ' ' ALA . 84.0 m95 -50.12 -49.33 52.21 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.472 -1.251 . . . . 0.0 112.482 -177.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -152.67 168.57 25.22 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -173.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.24 -54.07 3.91 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 127.865 2.65 . . . . 0.0 115.821 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -53.33 -29.73 49.09 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.597 2.699 . . . . 0.0 114.816 -173.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -61.02 -14.89 26.33 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.779 1.172 . . . . 0.0 114.047 174.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 8.78 19.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.6 1.56 . . . . 0.0 111.167 177.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 67.8 mtp -125.16 -44.91 1.87 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.477 1.111 . . . . 0.0 108.441 -175.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tp -63.91 -35.95 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 169.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 -59.28 10.49 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.275 1.03 . . . . 0.0 112.356 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.71 -40.75 61.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.188 1.925 . . . . 0.0 111.607 174.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -55.46 -40.15 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.238 0.615 . . . . 0.0 110.865 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.5 mt -68.82 -43.72 74.98 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.935 0.789 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.49 -35.16 80.07 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.99 0.814 . . . . 0.0 109.93 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.53 -17.55 62.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.507 1.523 . . . . 0.0 112.536 174.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -87.63 -44.42 11.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.48 1.112 . . . . 0.0 108.674 176.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 52' ' ' ILE . 18.7 t70 -70.23 -36.41 74.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.137 -0.352 . . . . 0.0 110.934 -175.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -69.1 -8.52 46.09 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.919 -0.563 . . . . 0.0 112.32 175.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -105.91 -46.49 4.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.496 1.118 . . . . 0.0 111.23 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.6 ptm -135.63 15.98 3.37 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.063 0.945 . . . . 0.0 112.304 -171.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.89 -4.82 11.79 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 120.978 -1.077 . . . . 0.0 114.228 170.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.06 -23.33 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.752 0.821 . . . . 0.0 111.054 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -14.38 8.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.259 1.024 . . . . 0.0 112.262 -174.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.9 tp -129.06 142.01 51.04 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.515 1.126 . . . . 0.0 111.854 -168.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.52 146.86 27.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 168.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 43' ' ' ASP . 58.6 mt -123.49 144.59 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.03 143.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HE2' ' CD1' ' A' ' 25' ' ' TRP . 29.2 mtpt -118.56 150.48 39.58 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.65 0.659 . . . . 0.0 110.197 174.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -118.91 127.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 169.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.49 105.12 12.4 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.297 34.6 m -79.64 46.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -152.2 -38.77 0.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.549 1.14 . . . . 0.0 109.435 168.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -78.79 -52.34 8.49 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.948 1.299 . . . . 0.0 110.101 177.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.04 46.0 2.47 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.884 1.274 . . . . 0.0 110.052 -172.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.62 2.83 5.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.75 1.62 . . . . 0.0 113.032 -176.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.7 -45.46 89.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.104 1.361 . . . . 0.0 111.102 -169.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -59.64 -36.16 75.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.386 0.994 . . . . 0.0 111.469 173.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB1' ' HE2' ' B' ' 91' ' ' MET . . . -69.58 -58.41 3.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.67 -39.2 45.8 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.075 0.845 . . . . 0.0 113.807 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.11 -43.45 98.41 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.008 1.404 . . . . 0.0 110.821 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -74.92 -11.46 60.13 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.356 0.662 . . . . 0.0 111.745 173.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.85 55.56 13.73 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.065 1.317 . . . . 0.0 109.85 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.64 -46.89 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 117.911 0.855 . . . . 0.0 109.495 -169.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mtm 53.87 14.6 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 127.936 2.494 . . . . 0.0 113.583 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.408 ' O ' HD13 ' A' ' 72' ' ' ILE . 16.6 m -135.59 163.6 29.75 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.835 1.198 . . . . 0.0 112.993 -168.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.691 HD11 ' HB3' ' B' ' 91' ' ' MET . 2.8 mm -135.09 137.61 27.34 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.975 0.91 . . . . 0.0 110.176 -177.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.74 125.85 10.38 Favored 'Cis proline' 0 N--CA 1.454 -0.846 0 N-CA-C 105.496 -2.54 . . . . 0.0 105.496 -11.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.8 m -85.4 146.36 27.02 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tp -137.21 125.49 23.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.0 mt -122.05 108.3 13.21 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 177.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.8 129.79 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 169.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.4 156.31 42.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -142.2 138.7 31.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 44.17 28.45 0.27 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.867 2.067 . . . . 0.0 114.258 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.6 15.06 41.62 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 124.725 1.155 . . . . 0.0 115.748 174.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -130.95 143.62 50.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 118.735 1.268 . . . . 0.0 110.414 174.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 134.03 30.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 170.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -125.73 -22.74 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.356 1.063 . . . . 0.0 109.925 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.81 161.98 40.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.601 1.161 . . . . 0.0 109.534 169.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 148.64 29.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -154.16 155.89 36.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.56 72.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.29 154.83 9.05 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.954 -171.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -65.25 149.21 50.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.212 0.605 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.59 140.29 20.08 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.72 169.19 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.484 2.123 . . . . 0.0 110.563 175.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -45.91 67.22 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.038 0.935 . . . . 0.0 112.078 -171.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.12 -43.82 77.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.45 0.114 . . . . 0.0 110.864 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.44 83.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.12 -0.362 . . . . 0.0 110.171 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.1 tp -68.17 -46.59 70.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.515 0.326 . . . . 0.0 110.781 178.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -62.65 -38.74 91.48 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.71 -45.64 91.82 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.579 0.627 . . . . 0.0 110.906 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.8 tp -58.65 -36.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.988 1.315 . . . . 0.0 111.644 -175.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.08 -40.78 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.469 174.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -56.99 -34.32 67.99 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.989 0.916 . . . . 0.0 111.555 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.52 -6.82 33.2 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.09 -22.9 4.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.904 1.282 . . . . 0.0 112.736 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.254 2.222 . . . . 0.0 109.063 170.378 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mpp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.91 139.29 58.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.524 0.73 . . . . 0.0 110.177 -178.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' B' ' 33' ' ' LYS 0.453 0.1 OUTLIER 31.15 103.21 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.441 3.096 . . . . 0.0 119.129 -179.067 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.84 120.36 23.35 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.35 140.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -169.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.16 145.52 19.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -175.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -131.41 150.51 52.12 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.704 0.802 . . . . 0.0 110.548 -168.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -113.61 143.37 44.69 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.911 1.284 . . . . 0.0 107.582 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 15.8 tp -145.52 109.21 4.73 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -169.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -166.81 153.66 8.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.173 0.989 . . . . 0.0 109.974 -178.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 94.8 m -38.43 116.52 0.55 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.22 2.208 . . . . 0.0 113.607 -169.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.31 8.45 31.1 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.01 0.814 . . . . 0.0 113.763 172.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . 0.5 HD22 ' NE2' ' B' ' 18' ' ' GLN . 7.4 t30 52.53 20.63 1.53 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.919 1.288 . . . . 0.0 112.384 -169.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 10.5 m -67.27 133.8 50.38 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.427 -0.795 . . . . 0.0 109.933 -174.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' B' ' 48' ' ' ALA . . . 56.53 -85.65 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 169.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.438 ' HG3' ' HD2' ' B' ' 106' ' ' PRO . 0.0 OUTLIER -54.12 -40.74 67.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.998 0.817 . . . . 0.0 111.829 -169.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -33.76 76.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.03 0.932 . . . . 0.0 111.403 -177.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.5 ' NE2' HD22 ' B' ' 13' ' ' ASN . 41.2 mm-40 -68.95 -52.28 30.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.63 1.572 . . . . 0.0 108.949 175.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 19' ' ' MET . . . . . . . . . . . . . 11.3 ptp -65.83 -37.55 86.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.712 -174.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.41 80.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.979 -0.534 . . . . 0.0 110.495 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.73 -28.29 66.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.976 176.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.02 -46.37 10.52 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 119.217 0.917 . . . . 0.0 111.215 173.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -53.59 -44.06 69.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 124.712 1.205 . . . . 0.0 111.223 173.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -49.73 72.21 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -62.97 -28.47 70.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.665 -171.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.69 -15.81 62.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 176.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 132' ' ' LYS . 1.1 m-85 -127.29 -17.37 4.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.4 -124.53 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.24 -168.6 38.03 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.55 -18.68 31.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.262 1.425 . . . . 0.0 112.361 172.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -55.83 -20.57 15.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.468 1.507 . . . . 0.0 111.192 169.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 32' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -134.16 168.2 19.27 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.334 1.453 . . . . 0.0 111.516 -177.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' B' ' 3' ' ' ASN . 1.6 tmtp? -137.42 126.13 23.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 169.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.23 124.37 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -169.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -135.13 169.49 17.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.034 0.934 . . . . 0.0 109.068 177.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -146.92 140.35 25.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.96 177.36 9.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.888 . . . . 0.0 112.227 -177.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 -175.2 44.8 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.453 1.025 . . . . 0.0 112.349 176.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.421 HG13 ' HE3' ' B' ' 88' ' ' LYS . 2.4 tt -41.06 -64.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.062 . . . . 0.0 114.607 -170.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -131.15 31.93 4.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.394 2.278 . . . . 0.0 107.014 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' B' ' 13' ' ' ASN . . . -54.55 138.58 40.45 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -168.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -177.86 21.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 129.054 2.942 . . . . 0.0 108.414 169.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.42 58.09 4.42 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 117.111 1.605 . . . . 0.0 117.111 -168.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 41.7 tp -67.85 115.22 7.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.174 1.987 . . . . 0.0 106.897 168.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 45' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -110.13 130.27 23.03 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -174.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.35 -21.18 51.75 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.274 1.982 . . . . 0.0 112.887 177.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 120' ' ' PHE . 0.4 OUTLIER -62.56 -35.55 79.83 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.764 1.166 . . . . 0.0 111.654 172.164 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' B' ' 15' ' ' ALA . . . -77.64 -33.19 53.61 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.871 0.76 . . . . 0.0 109.621 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.09 -49.9 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -59.39 -45.77 90.55 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.377 -0.827 . . . . 0.0 110.807 176.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.96 -35.63 69.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.353 1.061 . . . . 0.0 111.526 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -77.11 -40.86 44.31 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.818 0.847 . . . . 0.0 110.001 176.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -62.26 -27.67 69.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.502 178.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.8 -30.27 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.84 1.2 . . . . 0.0 111.85 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.08 16.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.221 1.408 . . . . 0.0 110.81 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.07 28.44 72.92 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.162 -1.354 . . . . 0.0 113.491 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.41 152.05 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 169.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -124.18 140.17 53.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 27.3 pt -135.94 17.77 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.979 1.312 . . . . 0.0 110.868 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -59.44 -17.07 27.91 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.421 -0.799 . . . . 0.0 111.978 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -77.9 -18.03 56.61 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.282 1.833 . . . . 0.0 113.907 174.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -65.59 167.14 9.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.697 1.237 . . . . 0.0 112.761 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -153.21 174.98 13.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.653 1.981 . . . . 0.0 106.681 170.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 1.2 p -149.89 174.46 12.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.623 0.769 . . . . 0.0 110.318 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -161.55 164.35 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.876 1.67 . . . . 0.0 109.217 -169.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 36.0 pt -63.02 165.57 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.702 1.201 . . . . 0.0 112.716 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.58 128.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -134.75 100.14 4.53 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.698 1.237 . . . . 0.0 108.34 -176.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 2.3 m -46.28 -29.82 1.79 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.132 2.173 . . . . 0.0 113.674 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.87 -25.22 68.18 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.392 0.996 . . . . 0.0 111.446 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.92 -42.14 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.35 -49.44 76.96 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.608 1.094 . . . . 0.0 110.199 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -27.76 69.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 110.95 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -84.9 -20.18 31.14 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.817 1.247 . . . . 0.0 112.413 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.19 157.16 10.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.295 1.045 . . . . 0.0 110.649 175.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.7 -33.29 20.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.776 169.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -146.28 135.0 22.29 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.954 -169.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.485 HG23 HG11 ' B' ' 96' ' ' VAL . 69.0 t -111.29 116.08 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 126.222 1.809 . . . . 0.0 107.559 172.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 46.3 t -88.81 105.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -70.99 134.51 47.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 167.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 9.4 tp -132.54 38.89 3.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 62.3 p -169.04 -40.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.299 -0.875 . . . . 0.0 109.35 169.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.28 10.46 84.67 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -172.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.81 137.33 39.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.798 0.799 . . . . 0.0 110.634 -169.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.74 -17.03 61.16 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -170.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.39 -12.3 60.03 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.589 1.086 . . . . 0.0 112.453 -173.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -73.74 3.13 6.89 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -169.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 88' ' ' LYS . . . . . 0.421 ' HE3' HG13 ' B' ' 39' ' ' ILE . 61.4 mttt 88.15 5.0 0.25 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.441 2.696 . . . . 0.0 110.018 -169.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 89' ' ' CYS . . . . . . . . . . . . . 21.0 m 33.57 54.68 1.38 Allowed Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 127.052 2.141 . . . . 0.0 111.063 -169.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.51 140.89 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.917 3.078 . . . . 0.0 114.255 -168.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 91' ' ' MET . . . . . 0.691 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -91.21 4.43 52.28 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -172.405 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.1 p 44.24 86.22 0.14 Allowed Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.453 1.501 . . . . 0.0 113.259 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 93' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -55.09 143.1 75.56 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 C-N-CA 122.505 2.137 . . . . 0.0 109.534 -172.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -61.44 4.47 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.605 1 C-N-CA 126.041 4.494 . . . . 0.0 117.572 -168.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 95' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.04 -5.42 21.8 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.452 -0.78 . . . . 0.0 111.995 169.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.485 HG11 HG23 ' B' ' 78' ' ' VAL . 2.4 t -134.6 148.56 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.678 1.191 . . . . 0.0 110.492 -168.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -84.63 157.23 21.23 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -144.09 148.53 35.25 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.561 -1.337 . . . . 0.0 109.701 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -152.32 151.52 30.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 169.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.99 126.34 42.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 101' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -118.44 -3.09 10.96 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.506 1.122 . . . . 0.0 111.329 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.65 142.07 13.44 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 175.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.84 12.32 1.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.006 2.123 . . . . 0.0 109.922 -169.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 104' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -154.32 164.01 39.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 128.069 2.547 . . . . 0.0 105.973 -173.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -147.41 109.79 3.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 118.9 0.773 . . . . 0.0 110.072 -171.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' B' ' 16' ' ' ARG . 72.9 Cg_endo -72.35 -21.61 22.81 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.237 3.291 . . . . 0.0 112.678 -172.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.35 2.72 0.55 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.681 1.193 . . . . 0.0 112.518 169.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -123.71 13.85 9.34 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.438 1.495 . . . . 0.0 111.309 -177.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.79 148.08 1.13 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.225 1.01 . . . . 0.0 111.38 177.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -56.2 -46.94 79.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.091 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.05 -16.31 4.71 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 169.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -69.25 158.47 34.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.54 -37.53 78.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.422 0.629 . . . . 0.0 111.262 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -73.58 -43.26 60.2 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.926 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.97 -28.82 60.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 121.126 1.785 . . . . 0.0 110.078 -172.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -60.43 -59.39 5.47 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.739 0.7 . . . . 0.0 109.722 171.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 117' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -60.84 -39.66 89.9 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.29 -44.17 97.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.572 -0.705 . . . . 0.0 112.133 -178.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.54 -46.44 85.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' B' ' 47' ' ' ASN . 2.1 m-30 -62.8 -46.16 89.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 121' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -64.18 -46.38 84.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.358 1.063 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 122' ' ' ARG . . . . . . . . . . . . . 41.1 ttp-105 -58.69 -49.67 76.72 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.66 -42.65 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.234 -175.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -65.75 -37.06 85.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.611 1.55 . . . . 0.0 111.993 -179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.89 -46.36 90.95 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.293 0.37 . . . . 0.0 110.495 175.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.91 -50.9 62.8 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.152 0.581 . . . . 0.0 110.687 -179.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.69 -49.84 81.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.242 1.017 . . . . 0.0 109.483 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.26 96.15 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 119.017 -0.88 . . . . 0.0 111.828 -174.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -61.04 -45.89 92.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.704 1.252 . . . . 0.0 110.642 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.42 -39.85 92.64 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.696 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.37 -33.69 71.73 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 119.137 0.88 . . . . 0.0 111.715 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' B' ' 27' ' ' TYR . 39.8 ttmt -65.73 -42.78 90.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.22 174.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.8 -38.72 86.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 117.144 -1.407 . . . . 0.0 111.106 170.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 134' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.77 -38.26 78.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 121.691 2.041 . . . . 0.0 110.914 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.2 -34.53 72.25 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 173.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.67 -46.79 11.13 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.297 1.039 . . . . 0.0 111.591 -177.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 61.1 p -84.05 -27.64 28.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.238 1.815 . . . . 0.0 111.396 -169.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.72 25.65 51.97 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -168.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.103 0 C-N-CA 126.745 2.018 . . . . 0.0 112.467 -169.407 . . . . . . . . 1 1 . 1 stop_ save_